data_1mzk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mzk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.521 -0.141 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.7 m95 -150.52 134.22 16.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 197' ' ' ALA . 2.7 tp -119.99 139.96 51.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.49 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.608 ' O ' HD13 ' A' ' 184' ' ' LEU . 4.4 m-85 -138.94 137.94 36.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.441 0.639 . . . . 0.0 110.043 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.709 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 5.2 mp -132.7 151.45 51.97 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.019 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.433 ' C ' HG12 ' A' ' 289' ' ' VAL . 0.7 OUTLIER -144.11 122.37 12.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.473 HG23 ' CD1' ' A' ' 194' ' ' LEU . 42.1 t -64.6 118.75 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.436 ' CG2' ' HB3' ' A' ' 288' ' ' LYS . 3.7 tt -97.96 -23.94 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.75 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -161.85 92.41 0.85 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.541 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.541 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.58 -173.78 30.65 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.418 ' HG3' ' CA ' ' A' ' 222' ' ' ASP . 74.3 Cg_endo -79.88 30.58 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.179 1.919 . . . . 0.0 111.822 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.552 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -162.28 23.95 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.627 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.541 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.9 mt -39.63 113.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.072 0.463 . . . . 0.0 111.699 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.9 9.63 2.45 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.524 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.611 HD13 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -99.37 135.08 41.3 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.288 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.709 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 27.1 mt-30 -129.67 147.46 51.46 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.217 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.663 ' CG ' HG13 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -136.26 130.05 32.44 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.599 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 182' ' ' LEU . . . -144.63 166.02 26.37 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.942 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.759 HG23 ' HA ' ' A' ' 206' ' ' LEU . 3.2 p -175.21 157.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.098 0.475 . . . . 0.0 111.073 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 180' ' ' SER . 65.8 m-80 -90.92 149.13 22.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.872 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 54.8 p -66.82 -3.29 6.47 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.709 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.45 5.45 39.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.741 0.305 . . . . 0.0 111.444 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -87.35 127.34 35.2 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.04 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.5 t -90.56 -87.3 0.19 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.53 11.59 6.85 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.12 -11.0 9.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.917 0.389 . . . . 0.0 110.875 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.759 ' HA ' HG23 ' A' ' 198' ' ' VAL . 6.5 tt -70.11 -57.76 5.78 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -42.83 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.29 1.993 . . . . 0.0 112.745 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.663 HG13 ' CG ' ' A' ' 196' ' ' HIS . 99.2 t -69.59 164.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.183 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.62 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 3.8 mtmm -139.64 95.03 2.85 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 230' ' ' ALA . 1.3 mp -83.78 127.32 33.72 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.471 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -169.11 172.05 43.22 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.02 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.582 ' CG ' ' HA ' ' A' ' 221' ' ' LYS . 3.0 ttt85 -71.46 -76.16 0.11 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.408 ' O ' ' CG1' ' A' ' 213' ' ' VAL . 11.7 p -133.66 110.18 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.135 0.493 . . . . 0.0 110.991 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.459 ' HB2' ' HD2' ' A' ' 215' ' ' PRO . 0.0 OUTLIER 171.4 179.81 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.592 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 214' ' ' SER . 45.2 Cg_exo -56.65 -3.42 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 121.946 1.764 . . . . 0.0 112.478 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.498 ' HA ' ' HB3' ' A' ' 209' ' ' LYS . 0.4 OUTLIER -43.24 158.62 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.971 0.415 . . . . 0.0 111.535 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.471 ' HB3' HG11 ' A' ' 208' ' ' VAL . 21.5 t0 -83.68 -30.46 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.289 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.473 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 18.7 mt -113.88 127.99 56.22 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.611 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -88.62 84.78 6.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.487 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.7 mm? -100.94 66.74 1.17 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.582 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 0.4 OUTLIER -62.07 54.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.494 ' HB3' ' HG3' ' A' ' 224' ' ' GLU . 19.8 t0 -105.33 125.5 51.05 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.1 p -40.15 -31.83 0.15 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.494 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 0.0 OUTLIER -53.32 -40.36 64.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.795 0.331 . . . . 0.0 111.11 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.544 ' O ' ' HB2' ' A' ' 212' ' ' ARG . 2.5 p -99.89 96.33 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 83.1 p -41.63 -51.86 3.92 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.047 0.451 . . . . 0.0 111.145 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -142.72 -54.07 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.31 128.67 21.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 109.964 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.579 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.2 OUTLIER -94.62 -56.88 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.211 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.492 ' O ' HD13 ' A' ' 210' ' ' LEU . . . -150.45 177.24 10.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.37 0.605 . . . . 0.0 112.469 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.62 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.7 OUTLIER -157.93 178.67 9.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.152 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 4.8 mt -133.23 145.58 33.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.434 0.635 . . . . 0.0 111.734 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.94 131.37 5.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.914 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 16.3 p90 -125.3 167.02 15.48 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.99 133.43 56.04 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.233 -1.349 . . . . 0.0 112.503 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 48.0 t -91.52 0.44 57.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.11 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.2 m -79.01 -46.3 18.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.833 0.825 . . . . 0.0 109.457 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.413 ' C ' ' CG ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -111.77 9.53 20.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.936 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.413 ' CG ' ' C ' ' A' ' 238' ' ' LYS . 10.2 p90 43.75 65.9 0.92 Allowed 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.593 0.711 . . . . 0.0 109.924 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.914 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -135.61 145.82 47.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.269 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.725 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.9 OUTLIER -121.37 114.4 21.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.601 -1.182 . . . . 0.0 109.935 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.685 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 24.1 mt-10 -131.36 146.46 52.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.956 0.884 . . . . 0.0 113.156 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 1.6 pp -110.98 153.61 25.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.935 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.509 ' CG2' ' CD1' ' A' ' 269' ' ' TRP . 1.4 p -122.71 162.23 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.452 ' OD1' ' HB ' ' A' ' 252' ' ' THR . 5.2 m-20 -112.6 100.62 8.87 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.986 0.422 . . . . 0.0 111.988 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.673 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -78.15 106.11 9.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.678 178.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 49.19 65.0 2.96 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.252 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.411 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 0.0 OUTLIER -71.35 64.32 0.39 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.651 HD11 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -48.39 -62.32 1.55 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.023 0.439 . . . . 0.0 110.166 178.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.526 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . 0.4 OUTLIER -77.02 -31.71 56.56 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.854 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 248' ' ' SER . . . 99.19 149.09 24.06 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.172 -0.922 . . . . 0.0 114.006 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.485 HG22 HG23 ' A' ' 281' ' ' ILE . 2.9 m -115.95 107.63 15.22 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.722 0.409 . . . . 0.0 110.57 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.563 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -98.52 128.87 45.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.122 0.487 . . . . 0.0 111.554 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 259' ' ' ILE . 91.9 t -99.7 134.02 40.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.678 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.1 p30 47.93 38.01 8.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.279 0.561 . . . . 0.0 110.068 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.0 t 67.51 36.69 3.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.731 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.64 111.81 5.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.245 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 60.0 p -58.17 87.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.134 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.511 HD11 HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -88.97 -18.18 7.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.491 ' N ' HD11 ' A' ' 259' ' ' ILE . 9.7 t . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.008 0.432 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.673 ' CZ3' ' HB2' ' A' ' 246' ' ' MET . 38.4 t-105 -67.91 -23.32 65.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.276 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 73.38 167.76 13.51 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.748 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -102.68 143.77 27.28 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.5 Cg_exo -51.32 121.45 8.42 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.308 2.006 . . . . 0.0 113.12 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 70.2 t -96.42 132.15 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.606 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.3 125.65 29.67 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.408 -178.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -94.59 165.5 12.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.51 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.1 162.87 35.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.207 0.527 . . . . 0.0 112.418 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.56 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 13.4 p -60.61 128.55 37.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.428 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.8 m-20 86.05 7.84 0.33 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.279 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -75.89 -171.46 1.64 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.452 ' CG2' ' HD1' ' A' ' 290' ' ' TYR . 0.4 OUTLIER -160.73 133.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.102 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -111.63 149.85 14.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.987 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.563 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -139.33 112.4 8.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.622 ' N ' HD12 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -110.77 45.01 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.059 -177.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.33 -132.29 2.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 119.321 -1.419 . . . . 0.0 113.64 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 10.9 t -89.87 -43.68 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.654 0.264 . . . . 0.0 110.529 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.2 t -148.37 -0.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.75 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 25.8 m -69.04 102.57 1.65 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.257 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 2.5 ttmt -121.01 127.01 51.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.664 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -109.77 132.69 57.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.294 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.1 t80 -76.86 137.05 38.93 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.872 0.368 . . . . 0.0 110.194 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.563 ' HA ' ' CD1' ' A' ' 184' ' ' LEU . 1.3 t -106.04 115.75 48.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.262 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.79 142.6 50.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.912 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.444 HG12 HD11 ' A' ' 182' ' ' LEU . 6.4 mt -139.0 115.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.157 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.77 154.18 45.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 110.924 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 88.7 p -87.95 -173.2 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.726 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 2.7 m95 -141.07 132.29 26.49 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.649 HD23 ' CZ3' ' A' ' 234' ' ' TRP . 3.0 tp -121.94 133.56 54.84 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.116 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 2.4 m-85 -129.71 132.19 46.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.677 0.751 . . . . 0.0 110.246 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.733 ' HB3' ' CE1' ' A' ' 196' ' ' HIS . 4.5 mm? -117.97 140.68 49.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.832 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.529 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.7 OUTLIER -137.35 118.48 14.45 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.625 ' HA ' HG11 ' A' ' 289' ' ' VAL . 5.7 t -67.15 103.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.164 0.507 . . . . 0.0 109.657 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.448 HG21 ' HG2' ' A' ' 288' ' ' LYS . 7.0 tt -87.38 -20.84 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.839 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.54 97.02 0.4 Allowed 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.496 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.554 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.85 -169.57 25.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.55 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 87.1 Cg_endo -81.13 30.12 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.12 1.88 . . . . 0.0 111.313 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.559 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.48 24.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.372 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.554 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.8 mt -39.65 106.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.805 0.336 . . . . 0.0 111.851 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.62 2.42 2.55 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.469 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER -98.02 167.93 10.59 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.637 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.8 mt-30 -159.97 149.21 17.72 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.371 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.733 ' CE1' ' HB3' ' A' ' 184' ' ' LEU . 1.7 p-80 -135.42 128.66 31.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.341 0.591 . . . . 0.0 109.93 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 182' ' ' LEU . . . -143.24 163.03 34.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.475 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.665 HG21 ' HA ' ' A' ' 206' ' ' LEU . 6.1 p -173.2 157.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.041 0.448 . . . . 0.0 111.066 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.7 OUTLIER -90.41 153.47 20.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.988 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.524 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 12.4 t -69.49 -6.07 28.19 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.218 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.414 HG21 ' HB3' ' A' ' 199' ' ' ASN . 0.6 OUTLIER -99.35 7.6 45.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.862 -179.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.404 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 1.0 OUTLIER -86.41 138.56 31.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.797 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.0 m -90.22 -85.67 0.21 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.02 22.77 9.84 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.404 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 3.0 pttt -119.67 -11.85 9.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.868 0.365 . . . . 0.0 110.87 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.665 ' HA ' HG21 ' A' ' 198' ' ' VAL . 7.7 tt -71.22 -58.52 3.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -42.86 97.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.575 2.184 . . . . 0.0 113.127 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.585 HG11 ' CD2' ' A' ' 196' ' ' HIS . 60.9 t -69.07 164.78 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 17.5 mtpt -138.08 96.57 3.22 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.6 OUTLIER -84.3 125.37 32.2 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.88 166.97 38.38 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.418 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.777 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 9.9 ttt180 -69.33 -77.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.28 110.95 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.386 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.599 ' CB ' ' HD2' ' A' ' 215' ' ' PRO . 0.3 OUTLIER 171.98 -178.61 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.778 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 24.0 Cg_endo -61.68 12.64 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.002 1.801 . . . . 0.0 113.02 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.541 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -57.51 -173.61 0.01 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.91 0.386 . . . . 0.0 111.265 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -104.79 -30.04 10.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.09 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.701 HD12 ' CE1' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -110.95 133.66 53.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.072 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -98.45 82.23 2.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.162 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.777 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.8 mm? -103.73 83.5 2.14 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.55 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 24.6 pttt -58.94 65.04 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.766 0.317 . . . . 0.0 111.61 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 220' ' ' LEU . 6.7 m-20 -93.48 144.01 25.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.446 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.7 t -85.76 -4.14 59.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.519 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 12.7 pm0 -101.24 -16.29 17.02 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 61.9 t -97.93 77.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.893 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -34.03 -50.87 0.4 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.98 0.419 . . . . 0.0 111.535 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.4 -49.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.573 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.441 ' HG2' ' OG ' ' A' ' 216' ' ' SER . 1.6 mtmm -144.08 129.73 19.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.443 . . . . 0.0 110.915 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.539 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 3.1 t60 -96.32 -55.97 2.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.578 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.47 ' C ' HD13 ' A' ' 210' ' ' LEU . . . -148.57 177.49 9.44 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.647 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -156.58 173.17 17.32 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.932 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 35.6 mt -132.77 145.16 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.199 0.523 . . . . 0.0 112.225 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.476 ' N ' HG22 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -160.62 148.66 16.21 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.796 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 8.1 p90 -140.88 165.57 27.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.728 1.011 . . . . 0.0 113.728 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -117.35 133.95 55.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.726 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 10.2 t -90.58 2.02 56.21 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.333 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 4.5 m -76.28 -25.88 55.35 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.71 0.767 . . . . 0.0 110.238 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -145.87 23.47 1.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.123 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 238' ' ' LYS . 15.6 p90 36.97 62.16 0.82 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.51 0.671 . . . . 0.0 110.194 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.796 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -124.97 141.12 52.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.456 178.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.68 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -124.61 123.24 39.63 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.664 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.6 pt-20 -137.09 143.4 42.55 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.935 0.874 . . . . 0.0 112.826 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.647 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 1.4 pp -111.2 150.68 29.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.431 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.5 HG12 ' HG3' ' A' ' 231' ' ' GLN . 0.3 OUTLIER -117.78 162.79 15.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.5 ' CG ' ' HB2' ' A' ' 260' ' ' SER . 1.8 m-20 -112.03 105.79 14.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.547 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -73.32 99.18 2.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.463 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.63 64.49 4.17 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.504 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -68.5 64.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.629 HD11 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -55.42 -51.85 65.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.622 178.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.547 ' N ' HD23 ' A' ' 249' ' ' LEU . 0.3 OUTLIER -74.31 -31.71 62.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 110.914 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.458 ' O ' HD21 ' A' ' 253' ' ' LEU . . . 90.89 90.09 1.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.017 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 1.9 m -46.24 159.2 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.798 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -149.64 137.82 20.54 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.432 0.634 . . . . 0.0 111.85 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.423 ' N ' HD11 ' A' ' 259' ' ' ILE . 99.7 t -112.15 128.2 68.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.608 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.478 ' HA ' HD11 ' A' ' 280' ' ' ILE . 0.3 OUTLIER 56.18 44.61 24.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.129 0.49 . . . . 0.0 110.209 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 m 62.35 24.7 14.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.991 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -130.65 110.51 11.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.42 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 8.7 t -58.79 98.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.512 0.672 . . . . 0.0 111.747 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.602 ' CG1' HG22 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -77.52 -37.68 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.216 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.5 ' HB2' ' CG ' ' A' ' 245' ' ' ASP . 42.1 t . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.0 mttt . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.196 0.522 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.547 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 42.5 t-105 -65.92 -24.85 66.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.217 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.66 159.87 12.44 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.7 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -94.29 142.11 24.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.661 0.267 . . . . 0.0 110.543 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -48.44 113.73 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.502 2.134 . . . . 0.0 112.901 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.602 HG22 ' CG1' ' A' ' 259' ' ' ILE . 85.0 t -94.19 136.14 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -84.36 128.34 34.52 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.7 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.551 HD11 HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -94.0 165.8 12.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.198 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.0 156.59 46.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 60.1 p -60.86 130.38 46.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.987 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.0 OUTLIER 81.28 -2.95 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.406 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.622 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -77.91 138.98 39.19 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.126 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.478 HD11 ' HA ' ' A' ' 255' ' ' ASN . 0.9 OUTLIER -99.0 123.48 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.345 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.494 HG23 HD11 ' A' ' 281' ' ' ILE . 0.3 OUTLIER -103.4 158.79 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.189 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.798 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 47.5 m -151.06 130.3 12.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.539 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -123.74 42.3 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -177.17 -134.53 2.02 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.578 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.7 t -90.59 -47.87 7.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.702 0.287 . . . . 0.0 110.703 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.55 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -139.37 0.93 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 179.234 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.839 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.7 m -75.85 101.03 4.97 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.527 0.204 . . . . 0.0 111.182 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.529 ' HB3' ' OG1' ' A' ' 282' ' ' THR . 0.0 OUTLIER -120.38 129.56 53.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.231 0.539 . . . . 0.0 111.47 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.652 HG13 ' HE1' ' A' ' 196' ' ' HIS . 0.2 OUTLIER -109.84 132.53 57.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.649 -178.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 278' ' ' ASP . 1.4 t80 -77.46 133.35 38.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.981 0.42 . . . . 0.0 110.353 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.583 ' HA ' HD13 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -102.46 114.27 41.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.008 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.39 133.73 53.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.525 HD12 ' CE3' ' A' ' 241' ' ' TRP . 3.7 mt -132.72 134.66 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.377 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.51 165.67 30.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 111.129 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 13.7 m -97.74 177.79 5.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.781 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 179.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.143 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.9 m95 -143.59 132.35 22.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 1.2 tp -120.88 134.86 55.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.246 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 5.7 m-85 -133.42 138.77 46.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.706 0.765 . . . . 0.0 109.823 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.601 ' HB3' ' CE1' ' A' ' 196' ' ' HIS . 4.1 mm? -122.09 139.1 54.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.906 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.15 114.95 13.66 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 289' ' ' VAL . 11.2 t -64.33 102.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.074 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 188' ' ' ALA . 15.1 tt -83.59 -28.43 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.768 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -162.08 99.66 1.08 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.424 ' H ' ' CG1' ' A' ' 192' ' ' ILE . . . -162.18 -169.91 26.21 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.638 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 87.6 Cg_endo -83.67 30.85 0.52 Allowed 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.52 2.147 . . . . 0.0 111.748 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.451 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -162.83 24.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.303 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.424 ' CG1' ' H ' ' A' ' 189' ' ' GLY . 8.4 mt -39.32 108.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.471 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.98 3.4 2.56 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.48 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.542 ' CD1' HD12 ' A' ' 220' ' ' LEU . 0.0 OUTLIER -97.42 169.43 9.75 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 117.636 0.718 . . . . 0.0 109.14 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.1 mt-30 -160.06 147.63 16.54 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.563 -178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.802 ' CE1' HD12 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -135.87 129.04 31.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.88 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.52 170.04 16.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.003 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.647 HG11 ' HG ' ' A' ' 206' ' ' LEU . 8.5 p -177.4 153.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.2 0.524 . . . . 0.0 112.244 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 180' ' ' SER . 5.9 t-20 -88.48 150.54 23.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.969 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.49 ' HA ' ' CE2' ' A' ' 234' ' ' TRP . 5.9 t -68.69 -4.85 17.23 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.347 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.451 HG22 ' OD1' ' A' ' 199' ' ' ASN . 0.6 OUTLIER -101.04 20.34 15.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.808 0.337 . . . . 0.0 111.744 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.24 112.46 25.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.775 0.321 . . . . 0.0 110.363 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 16.5 m -72.72 -89.93 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 45.6 t -89.32 14.51 10.96 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 111.511 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 13.9 pttt -125.75 54.5 1.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.65 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 10.3 tt -143.58 -56.3 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.755 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 5.5 Cg_exo -41.36 100.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.995 1.796 . . . . 0.0 112.791 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.443 ' O ' ' CB ' ' A' ' 231' ' ' GLN . 87.8 t -67.96 163.9 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.996 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.641 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 31.5 mtmt -135.77 96.31 3.4 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.676 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.5 OUTLIER -83.28 128.34 34.41 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.091 178.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -173.59 174.85 46.27 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.745 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.5 OUTLIER -69.04 -72.32 0.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.996 0.427 . . . . 0.0 111.873 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.59 ' CG2' ' H ' ' A' ' 214' ' ' SER . 10.1 p -128.86 -142.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.728 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.59 ' H ' ' CG2' ' A' ' 213' ' ' VAL . 2.5 m 66.9 -179.42 0.04 OUTLIER Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 118.441 0.564 . . . . 0.0 110.228 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.535 ' CD ' ' HB3' ' A' ' 214' ' ' SER . 22.6 Cg_exo -65.31 7.75 0.28 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.656 2.238 . . . . 0.0 113.558 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.6 m -48.87 173.16 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.714 0.292 . . . . 0.0 110.909 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.06 -31.43 13.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.252 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.802 HD12 ' CE1' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -104.06 133.65 48.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.831 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -100.48 74.99 1.74 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 0.0 110.804 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.729 ' O ' ' N ' ' A' ' 222' ' ' ASP . 2.8 mm? -99.85 80.0 2.28 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.638 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -53.26 67.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 110.802 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.729 ' N ' ' O ' ' A' ' 220' ' ' LEU . 1.7 m-20 -99.65 128.67 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.402 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.7 p -73.46 -4.8 35.96 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.295 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -93.03 -25.0 18.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.698 0.285 . . . . 0.0 111.258 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 212' ' ' ARG . 3.4 p -105.49 85.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -32.39 -46.49 0.13 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.628 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.95 -52.37 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.616 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -141.79 128.78 20.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.139 0.495 . . . . 0.0 110.618 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.553 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 3.8 t60 -100.41 -56.26 2.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.281 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -139.38 172.88 12.16 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -162.53 174.49 12.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.276 179.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.755 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.0 mt -130.79 144.81 36.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.577 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.85 163.44 34.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.612 ' CE3' HD13 ' A' ' 206' ' ' LEU . 0.7 OUTLIER -96.86 150.63 20.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.337 -1.301 . . . . 0.0 114.255 -176.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 239' ' ' PHE . 0.8 OUTLIER -118.91 94.14 4.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.217 -1.356 . . . . 0.0 107.716 175.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 13.8 p -78.16 -25.44 47.25 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 32.3 m -74.24 -21.06 59.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.584 0.707 . . . . 0.0 109.713 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 33.0 tptt -123.01 6.23 9.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.344 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 235' ' ' ASN . 13.0 p90 36.98 43.55 0.31 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 120.713 0.292 . . . . 0.0 111.003 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.455 ' HG2' ' N ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -115.19 174.97 5.71 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.183 0.516 . . . . 0.0 109.697 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.541 ' CE3' ' CD1' ' A' ' 293' ' ' ILE . 0.0 OUTLIER -127.95 119.64 25.96 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.866 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 0.0 OUTLIER -143.13 152.34 41.71 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.946 0.879 . . . . 0.0 112.851 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 3.4 pp -116.79 154.04 31.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.765 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.532 ' CG2' ' CD1' ' A' ' 269' ' ' TRP . 3.3 p -121.3 163.7 18.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.669 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 269' ' ' TRP . 1.0 OUTLIER -106.09 101.4 10.89 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.151 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.546 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -70.6 97.46 1.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.728 177.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 52.33 64.65 3.85 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.213 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -76.32 66.89 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -178.036 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.718 HD21 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -54.77 -49.97 69.59 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.718 ' N ' HD21 ' A' ' 249' ' ' LEU . 2.6 t-20 -72.19 -30.19 64.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.971 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.425 ' O ' HD22 ' A' ' 253' ' ' LEU . . . 91.81 85.06 1.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.836 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.416 ' HB ' ' OD1' ' A' ' 245' ' ' ASP . 1.8 m -46.03 158.61 0.09 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.51 0.155 . . . . 0.0 111.077 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.57 HD21 ' O ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -149.83 137.26 19.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 111.808 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.424 ' HB ' HG23 ' A' ' 259' ' ' ILE . 75.2 t -111.28 132.2 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.014 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.517 ' HA ' HG13 ' A' ' 280' ' ' ILE . 0.5 OUTLIER 55.2 41.78 31.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 110.306 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 75.6 m 63.43 33.9 13.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.561 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.16 109.76 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 3.1 t -55.82 94.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 260' ' ' SER . 0.4 OUTLIER -79.85 -20.59 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.04 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.46 ' N ' ' CD1' ' A' ' 259' ' ' ILE . 6.3 t . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 10.3 mttt . . . . . 0 CA--C 1.516 -0.335 0 CA-C-O 121.061 0.458 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.546 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 36.0 t-105 -71.9 -26.52 62.35 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 75.3 164.28 13.39 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.743 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -98.5 146.14 31.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.723 0.297 . . . . 0.0 110.469 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 89.2 Cg_exo -48.83 142.55 18.97 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 122.725 2.283 . . . . 0.0 113.072 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 86.9 t -124.89 136.25 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 10.5 mt-10 -84.37 132.82 34.55 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.844 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.498 ' H ' ' CD1' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -97.05 165.98 11.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.396 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.64 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.13 158.34 44.05 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 93.2 p -60.61 129.25 40.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.063 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 277' ' ' SER . 38.5 m-20 82.47 -0.06 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.838 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.9 OUTLIER -68.29 -170.08 0.17 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.529 HG23 ' CD1' ' A' ' 290' ' ' TYR . 1.0 OUTLIER -161.02 124.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.076 177.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -105.55 155.39 6.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.122 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.57 ' O ' HD21 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -141.62 123.28 15.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.553 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -116.37 38.07 3.52 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.766 -178.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 178.68 -122.04 0.79 Allowed Glycine 0 N--CA 1.454 -0.141 0 C-N-CA 119.042 -1.551 . . . . 0.0 114.22 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.7 t -95.17 -51.72 4.5 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -141.54 2.17 1.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.72 -0.392 . . . . 0.0 112.007 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.768 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.9 m -72.57 104.77 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.806 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 0.4 OUTLIER -120.47 127.25 52.05 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.829 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.502 HG11 ' CE1' ' A' ' 196' ' ' HIS . 0.3 OUTLIER -110.03 130.07 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.796 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.529 ' CD1' HG23 ' A' ' 280' ' ' ILE . 1.6 t80 -77.42 133.57 38.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.306 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.51 ' HA ' HD12 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -101.12 116.25 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.488 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.34 135.81 48.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.77 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.541 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 13.6 mt -134.08 142.11 41.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.738 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.0 m -152.79 160.91 43.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 111.089 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.96 175.23 6.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.654 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.5 m95 -150.4 132.95 15.72 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.547 ' HG ' HD12 ' A' ' 184' ' ' LEU . 5.0 tp -116.25 130.22 56.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.807 176.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.654 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 4.6 m-85 -127.17 134.65 50.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.57 0.7 . . . . 0.0 110.564 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.634 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.1 mp -133.25 146.97 51.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.901 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 8.5 tt0 -142.21 124.76 15.77 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.476 ' HA ' HG13 ' A' ' 289' ' ' VAL . 11.8 t -62.09 119.8 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.459 HG21 ' O ' ' A' ' 288' ' ' LYS . 4.3 tt -101.05 -22.78 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.803 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.91 93.56 0.72 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.514 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.96 -170.35 26.58 Favored Glycine 0 CA--C 1.518 0.244 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.566 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 89.5 Cg_endo -81.32 30.3 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.032 1.822 . . . . 0.0 111.55 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.526 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -160.96 22.9 0.13 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.744 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.514 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.0 mt -39.77 109.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.916 0.389 . . . . 0.0 111.602 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.97 8.95 2.02 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.613 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.584 HD13 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -98.36 153.8 18.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.614 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.634 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 5.9 mt-30 -150.08 148.77 29.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.591 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.631 ' ND1' HG12 ' A' ' 208' ' ' VAL . 2.0 p80 -138.5 132.64 31.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.268 0.556 . . . . 0.0 110.47 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.73 169.93 18.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.746 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.513 HG11 ' CH2' ' A' ' 234' ' ' TRP . 2.7 p -177.64 157.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.197 0.522 . . . . 0.0 110.749 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 180' ' ' SER . 5.9 m120 -90.47 147.59 23.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.781 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.517 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 30.5 m -60.66 -6.17 1.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.92 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 9.1 t -102.34 32.19 3.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.154 0.502 . . . . 0.0 111.106 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.429 ' HB2' ' HG2' ' A' ' 205' ' ' LYS . 77.9 p -110.54 132.32 54.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.893 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.484 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 56.9 m -85.57 -84.31 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.8 21.72 14.08 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.484 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -115.88 -8.95 11.89 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.765 178.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 233' ' ' THR . 4.0 tt -69.8 -57.0 6.97 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.688 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.2 Cg_endo -43.32 86.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.797 2.331 . . . . 0.0 113.761 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.631 HG12 ' ND1' ' A' ' 196' ' ' HIS . 57.6 t -70.16 99.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.775 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 216' ' ' SER . 0.0 OUTLIER -69.48 87.26 0.46 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.664 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.0 OUTLIER -69.14 127.4 32.98 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.461 ' HA2' HG23 ' A' ' 225' ' ' VAL . . . -168.38 169.97 41.87 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.638 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.825 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -53.02 -95.84 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.788 -0.706 . . . . 0.0 112.606 -178.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.65 -7.69 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 O-C-N 122.187 -0.321 . . . . 0.0 111.812 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 216' ' ' SER . 0.3 OUTLIER -55.44 -177.22 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.493 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 53.1 Cg_exo -55.8 -1.21 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.397 2.065 . . . . 0.0 113.073 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -44.71 166.28 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.938 0.399 . . . . 0.0 111.432 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -83.93 -32.59 25.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.26 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.668 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 0.9 OUTLIER -105.46 131.88 52.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.584 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -97.48 82.76 3.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.768 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.668 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 2.9 mm? -104.47 64.53 0.75 Allowed 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.825 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -53.59 66.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.068 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.644 ' N ' ' O ' ' A' ' 220' ' ' LEU . 4.8 t0 -121.82 139.92 53.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.206 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.4 p -53.24 -31.33 42.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.624 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.557 ' CG ' ' HB3' ' A' ' 222' ' ' ASP . 2.9 pt-20 -49.6 -41.72 42.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.096 0.474 . . . . 0.0 110.147 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.563 ' O ' ' HB2' ' A' ' 212' ' ' ARG . 2.6 p -103.18 110.93 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.68 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.4 t -56.03 -56.07 25.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.233 0.539 . . . . 0.0 109.823 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -137.08 -51.91 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.539 ' CB ' ' HG2' ' A' ' 246' ' ' MET . 0.7 OUTLIER -141.35 125.65 17.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.167 0.508 . . . . 0.0 109.889 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.602 ' CE1' ' HB3' ' A' ' 250' ' ' ASN . 0.5 OUTLIER -92.45 -60.64 1.78 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.3 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -145.23 173.76 11.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 24.6 tt0 -153.28 161.78 42.0 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.688 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.6 mt -124.13 147.86 28.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.802 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.554 ' HA ' HD23 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.25 163.23 33.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.818 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 3.1 p90 -153.86 165.32 36.44 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.49 ' HB2' ' HD2' ' A' ' 240' ' ' LYS . 20.4 m-20 -117.44 133.47 55.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.311 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.49 3.04 55.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.091 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.2 m -76.99 -30.14 55.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.071 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 38.0 tptt -139.89 22.01 2.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.789 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 238' ' ' LYS . 15.5 p90 37.74 62.94 0.84 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.523 0.678 . . . . 0.0 110.16 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.818 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -125.47 142.32 51.57 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.7 178.251 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.722 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -129.15 123.23 31.59 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.957 -179.036 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 4.1 pt-20 -141.26 151.56 43.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.258 1.028 . . . . 0.0 113.323 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.554 ' CD2' HG13 ' A' ' 281' ' ' ILE . 2.2 pp -113.5 158.83 20.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.031 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.497 HG13 ' CZ2' ' A' ' 269' ' ' TRP . 4.1 p -136.82 162.35 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.844 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -81.89 123.61 28.99 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.539 ' HG2' ' CB ' ' A' ' 228' ' ' LYS . 10.4 tpt -76.77 32.42 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.47 50.31 32.67 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.707 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.401 ' HB2' ' HA ' ' A' ' 229' ' ' HIS . 5.5 t -99.05 179.1 4.72 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 110.912 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.699 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -105.89 -29.54 9.92 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.699 ' H ' HD13 ' A' ' 249' ' ' LEU . 1.3 t-20 -75.31 -35.9 61.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.311 0.577 . . . . 0.0 112.244 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.535 ' O ' ' NE2' ' A' ' 229' ' ' HIS . . . 93.29 166.72 38.21 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.017 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.439 ' C ' HD11 ' A' ' 259' ' ' ILE . 7.6 m -120.89 160.59 23.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.51 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.654 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -146.32 121.02 9.84 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.257 0.551 . . . . 0.0 111.117 179.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.49 129.01 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.046 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.425 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 2.5 m-20 53.85 42.62 31.68 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.191 0.52 . . . . 0.0 110.282 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 15.8 m 65.02 22.26 12.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.952 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.52 101.48 7.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.23 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 26.3 p -54.74 101.05 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.075 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.542 HG12 ' N ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -78.81 -52.41 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.751 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.542 ' N ' HG12 ' A' ' 259' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.525 ' HZ3' ' CE ' ' A' ' 246' ' ' MET . 7.0 t-105 -66.2 -26.09 67.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.043 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.432 ' O ' ' HD1' ' A' ' 269' ' ' TRP . . . 73.11 168.76 13.85 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.622 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.75 145.72 30.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.569 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 50.6 Cg_exo -53.24 110.55 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.483 2.122 . . . . 0.0 112.967 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 90.1 t -89.4 132.24 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 4.1 mt-10 -79.59 126.12 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.711 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.54 ' H ' HD12 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.9 166.19 12.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.98 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.4 158.69 43.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.233 0.54 . . . . 0.0 112.39 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.6 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 42.7 p -56.51 127.5 31.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.349 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 277' ' ' SER . 73.6 m-20 82.67 1.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.859 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 69.4 m-20 -78.87 133.84 36.95 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.507 ' HB ' ' HD3' ' A' ' 288' ' ' LYS . 0.8 OUTLIER -94.28 125.21 46.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.694 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.554 HG13 ' CD2' ' A' ' 243' ' ' LEU . 0.3 OUTLIER -105.14 155.8 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.137 178.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.654 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -148.73 132.52 16.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.54 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -128.34 53.1 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.432 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 169.1 -129.84 1.94 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 119.596 -1.287 . . . . 0.0 113.613 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.0 t -95.76 -47.85 6.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.335 0.112 . . . . 0.0 110.92 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.7 t -139.88 -6.25 1.29 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.335 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.803 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 29.3 m -69.11 101.25 1.4 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.781 0.325 . . . . 0.0 110.279 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.576 ' HG3' ' OG1' ' A' ' 282' ' ' THR . 20.4 ttmt -118.65 126.45 51.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.067 0.46 . . . . 0.0 111.576 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.476 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -110.79 131.91 60.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.424 -178.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.4 t80 -77.18 137.46 38.88 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.076 0.465 . . . . 0.0 109.942 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.19 112.27 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.022 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -126.55 139.42 53.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.069 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.534 HD11 ' CE3' ' A' ' 241' ' ' TRP . 3.4 mt -136.26 132.22 49.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.73 152.78 45.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.46 159.31 15.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.925 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.523 -0.075 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 9.8 m95 -147.89 133.34 18.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 3.6 tp -118.65 132.97 56.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.722 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 9.2 m-85 -128.32 126.0 39.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.669 0.747 . . . . 0.0 110.165 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.612 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 4.2 mm? -108.81 133.74 52.45 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.675 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.4 OUTLIER -129.9 108.02 9.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.455 ' CG1' HD11 ' A' ' 220' ' ' LEU . 40.8 t -60.97 104.98 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.443 HD13 HG23 ' A' ' 187' ' ' ILE . 12.4 tt -89.28 -24.85 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -175.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.704 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.8 96.66 0.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.538 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.627 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.11 -168.64 24.32 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.466 ' HB2' ' CG ' ' A' ' 221' ' ' LYS . 93.2 Cg_endo -82.91 30.53 0.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.243 1.962 . . . . 0.0 110.97 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.442 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.95 23.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.624 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.627 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.0 mt -39.34 109.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.89 6.33 2.89 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.717 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 219' ' ' ALA . 0.0 OUTLIER -100.14 139.66 35.48 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 117.841 0.821 . . . . 0.0 109.117 178.189 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 29.8 mt-30 -134.38 151.22 51.08 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.787 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.416 ' CD2' ' CG1' ' A' ' 208' ' ' VAL . 59.4 t60 -144.92 138.96 27.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.569 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -145.75 166.12 26.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.639 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 206' ' ' LEU . 7.9 p -169.22 152.66 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.731 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 180' ' ' SER . 2.8 m120 -88.93 144.57 26.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.972 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.518 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 97.8 p -60.32 -7.72 2.17 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.595 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 7.6 t -98.49 24.53 7.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.912 0.387 . . . . 0.0 110.685 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.416 ' HB3' ' HG2' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -106.04 119.02 38.11 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.362 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.1 t -71.68 -77.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.0 m -105.0 23.07 14.18 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.416 ' HG2' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -119.7 -10.38 9.58 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.578 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.782 HD22 ' CE3' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -82.11 -32.37 0.59 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.105 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.625 ' HD3' HD12 ' A' ' 206' ' ' LEU . 29.9 Cg_exo -59.23 100.46 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.14 1.227 . . . . 0.0 111.733 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 4.9 t -68.62 160.65 4.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.54 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.8 OUTLIER -137.4 86.48 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.4 OUTLIER -77.67 125.81 29.91 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.963 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.05 172.98 45.07 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.767 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 16.2 ttt-85 -71.62 -70.66 0.31 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.325 -0.438 . . . . 0.0 112.145 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.515 ' CG2' ' H ' ' A' ' 214' ' ' SER . 9.3 p -125.59 -149.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.952 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.515 ' H ' ' CG2' ' A' ' 213' ' ' VAL . 1.0 OUTLIER 66.94 -178.0 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 58.8 Cg_endo -73.85 45.73 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 121.807 1.671 . . . . 0.0 112.702 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.35 165.92 24.17 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.445 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.36 -38.46 13.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.161 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.725 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 3.1 mt -105.82 129.94 53.89 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.533 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -93.46 79.38 4.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.904 0.383 . . . . 0.0 111.173 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.725 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -101.55 83.95 2.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.466 ' CG ' ' HB2' ' A' ' 190' ' ' PRO . 3.5 pttp -60.2 59.72 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.981 0.42 . . . . 0.0 111.81 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 220' ' ' LEU . 0.3 OUTLIER -89.1 126.7 35.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 37.2 p -67.04 -7.53 23.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.218 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -87.31 -22.52 25.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.095 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 212' ' ' ARG . 2.6 p -106.54 83.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.3 p -35.0 -41.42 0.14 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.69 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.35 -57.6 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.608 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.3 OUTLIER -138.81 130.81 28.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.211 0.529 . . . . 0.0 110.316 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.597 ' O ' ' N ' ' A' ' 246' ' ' MET . 2.2 t60 -101.07 -56.45 2.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.888 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.446 ' C ' HD11 ' A' ' 210' ' ' LEU . . . -147.35 173.21 12.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.249 0.547 . . . . 0.0 112.273 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.691 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -156.3 179.85 8.84 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.824 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.44 ' CG2' HD12 ' A' ' 275' ' ' LEU . 19.8 mt -139.23 149.68 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.544 0.688 . . . . 0.0 112.436 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.89 160.67 31.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.782 ' CE3' HD22 ' A' ' 206' ' ' LEU . 5.3 p90 -149.58 165.51 32.02 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -116.49 132.98 56.53 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.138 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.07 0.27 57.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.867 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.16 -29.38 48.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.699 0.761 . . . . 0.0 109.963 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.418 ' HD3' ' HD3' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -138.44 23.12 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.129 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 238' ' ' LYS . 23.1 p90 37.0 59.09 1.11 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.355 0.597 . . . . 0.0 110.115 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.719 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 1.2 mptp? -122.72 141.37 51.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.105 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.687 ' CE3' ' CE3' ' A' ' 234' ' ' TRP . 2.1 m95 -124.46 121.61 35.33 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.912 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.8 pt-20 -138.57 144.86 40.05 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.8 pp -111.46 152.57 27.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.369 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.689 HG12 ' CZ3' ' A' ' 269' ' ' TRP . 6.1 p -123.41 165.1 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 122.859 0.464 . . . . 0.0 110.586 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.841 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 5.1 t0 -107.39 116.6 32.22 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.83 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -75.76 99.12 4.31 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 57.46 69.05 1.39 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.578 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 56.0 p -61.5 43.54 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.577 HD23 ' HB2' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.6 -54.19 49.68 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.622 0.646 . . . . 0.0 109.911 178.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.577 ' HB2' HD23 ' A' ' 249' ' ' LEU . 2.1 t-20 -77.87 -38.12 46.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.244 0.545 . . . . 0.0 110.672 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 93.79 96.87 1.54 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.13 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.87 165.17 0.97 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.645 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -150.97 140.02 21.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.285 0.564 . . . . 0.0 111.455 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 93.1 t -114.33 132.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.788 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.562 ' HA ' HG13 ' A' ' 280' ' ' ILE . 16.9 t-20 53.43 42.22 32.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.126 0.489 . . . . 0.0 110.28 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.2 p 63.52 32.35 14.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.835 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -138.88 110.32 7.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 52.4 p -60.12 88.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.431 0.634 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.492 HG12 HG11 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -90.75 -7.57 10.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.601 -178.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.841 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 38.9 m . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.83 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 0.0 OUTLIER -75.36 -25.38 57.65 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.646 -178.21 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.2 -174.55 7.47 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.581 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -111.94 157.71 38.84 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 117.482 0.641 . . . . 0.0 110.866 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 21.3 Cg_exo -66.91 138.23 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.86 2.374 . . . . 0.0 113.892 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.68 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 74.3 t -114.51 142.28 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.0 mm-40 -85.28 127.12 34.2 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 118.803 -1.159 . . . . 0.0 112.316 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.45 ' C ' ' CD2' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -95.05 164.85 12.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.018 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.1 160.0 41.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.57 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 80.1 p -59.77 132.24 53.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.509 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.5 OUTLIER 84.01 7.46 0.6 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.285 -179.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.656 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 3.0 m-20 -79.72 -167.31 1.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.562 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -160.34 134.92 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.301 177.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -107.09 157.21 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.985 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.645 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.7 OUTLIER -149.18 117.81 6.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.578 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -115.57 43.9 1.98 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.976 -178.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 172.28 -123.39 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 119.209 -1.472 . . . . 0.0 113.741 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.0 t -92.88 -51.16 5.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.586 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -143.6 -3.63 0.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 40.4 m -67.09 104.03 1.32 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 117.811 0.278 . . . . 0.0 110.807 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 3.6 mtpt -125.49 134.66 51.96 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.498 -0.481 . . . . 0.0 112.264 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 186' ' ' VAL . 9.6 p -112.98 136.92 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.289 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.436 ' HD1' HG22 ' A' ' 280' ' ' ILE . 2.0 t80 -77.66 137.06 38.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.249 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.98 110.48 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.625 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -129.99 134.57 47.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.586 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 4.6 mt -133.15 143.14 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.7 t -150.35 157.17 42.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.0 110.813 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 2.8 m -87.65 -176.94 5.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 16.0 m . . . . . 0 N--CA 1.457 -0.099 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.1 m95 -143.01 135.18 27.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 3.5 tp -118.29 123.5 45.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.502 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 3.3 m-85 -123.63 134.85 53.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.681 0.753 . . . . 0.0 110.679 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.74 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.0 OUTLIER -135.48 145.39 47.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.497 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.582 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 39.8 tt0 -140.11 127.39 21.2 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.624 HG11 HD13 ' A' ' 220' ' ' LEU . 16.9 t -64.97 107.72 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.512 HG21 ' HG2' ' A' ' 288' ' ' LYS . 6.5 tt -91.47 -21.51 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.822 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.55 94.56 0.7 Allowed 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.671 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.14 -177.99 35.65 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.511 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 88.2 Cg_endo -76.84 31.84 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 CA-C-N 119.591 1.696 . . . . 0.0 111.579 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.543 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.57 23.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.336 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.671 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.5 mt -39.81 111.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.85 6.89 2.45 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.011 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.605 HD11 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -98.72 154.59 17.86 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.74 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.3 mt-30 -151.66 148.67 28.22 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.213 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.621 ' CD2' ' HB2' ' A' ' 184' ' ' LEU . 1.1 p80 -136.31 130.74 33.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.308 0.575 . . . . 0.0 109.828 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.97 163.72 35.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.243 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.457 HG11 ' CD2' ' A' ' 206' ' ' LEU . 9.4 p -174.28 160.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.292 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 180' ' ' SER . 7.3 m120 -87.86 146.02 25.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.601 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 9.3 t -62.84 -5.26 2.67 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.854 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 2.7 t -91.82 34.79 0.98 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.039 0.447 . . . . 0.0 110.617 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.93 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 8.5 m -137.25 92.88 2.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.249 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 11.3 t -66.68 -73.3 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.392 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.0 t -89.93 -2.06 58.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.93 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.1 OUTLIER -115.63 47.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.132 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -152.28 -26.65 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.768 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 33.0 Cg_exo -55.05 102.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 CA-C-N 121.02 1.4 . . . . 0.0 111.739 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 217' ' ' ASP . 17.1 t -68.34 165.78 2.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.086 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 1.5 mtpt -134.99 88.38 2.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.151 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.582 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.8 OUTLIER -75.75 128.29 34.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.543 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -175.3 176.62 47.3 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.155 -1.021 . . . . 0.0 113.556 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.632 ' CG ' ' HA ' ' A' ' 221' ' ' LYS . 6.1 ttt180 -71.47 -72.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.876 0.47 . . . . 0.0 111.477 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 214' ' ' SER . 8.0 p -125.49 -139.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.648 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.643 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.3 OUTLIER 61.78 -179.92 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 118.894 0.77 . . . . 0.0 109.928 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 47.0 Cg_endo -70.46 31.24 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.836 1.691 . . . . 0.0 113.205 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.448 ' H ' ' C ' ' A' ' 214' ' ' SER . 3.9 m -65.03 157.71 27.63 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.796 0.331 . . . . 0.0 110.837 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.502 ' HB3' HG13 ' A' ' 208' ' ' VAL . 0.4 OUTLIER -85.4 -30.36 23.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.533 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.761 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.6 mt -110.01 133.51 53.11 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.605 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -94.95 77.32 3.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.522 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.761 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -100.44 66.88 1.29 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.632 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 0.3 OUTLIER -61.59 45.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -177.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.519 ' O ' HG12 ' A' ' 225' ' ' VAL . 10.3 t0 -94.1 124.05 37.87 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.4 t -39.55 -32.07 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.228 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.501 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -52.11 -37.42 54.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 110.366 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.543 HG21 ' HA2' ' A' ' 211' ' ' GLY . 4.3 p -103.51 102.14 13.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.496 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.41 ' O ' ' HD2' ' A' ' 212' ' ' ARG . 78.6 p -45.17 -62.2 1.35 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.08 0.466 . . . . 0.0 111.032 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -132.19 -50.58 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.643 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 0.1 OUTLIER -143.05 131.25 21.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.015 -0.592 . . . . 0.0 109.782 178.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.625 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.3 t60 -95.82 -55.58 2.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.327 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.425 ' C ' HD13 ' A' ' 210' ' ' LEU . . . -143.65 172.81 12.3 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -157.48 177.66 11.18 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.727 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.768 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.0 mt -135.78 150.17 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.885 0.374 . . . . 0.0 111.985 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.59 163.71 37.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.217 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.566 ' CZ3' HD22 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -91.92 149.46 21.54 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 240' ' ' LYS . 7.9 t-20 -119.78 80.83 1.64 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 5.9 p -68.61 -19.97 64.47 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 82.5 m -81.21 -32.16 33.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.425 0.631 . . . . 0.0 110.885 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.531 ' HD3' ' HD3' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -117.7 15.29 14.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.889 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.417 ' C ' ' O ' ' A' ' 238' ' ' LYS . 10.0 p90 38.9 71.98 0.15 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.531 ' HD3' ' HD3' ' A' ' 238' ' ' LYS . 6.0 mptt -137.84 148.21 45.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.445 -1.252 . . . . 0.0 112.375 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.672 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.5 OUTLIER -116.97 104.73 11.57 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.5 mt-10 -126.26 146.8 49.86 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 2.5 pp -116.12 149.76 38.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.767 -1.56 . . . . 0.0 110.984 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.655 HG23 ' CD1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -118.87 162.31 17.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.547 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 248' ' ' SER . 11.5 m-20 -115.6 99.26 7.21 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.172 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.798 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.36 108.81 9.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.207 0.527 . . . . 0.0 110.588 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 51.61 62.5 5.48 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.114 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 5.8 t -80.6 76.17 7.46 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.661 HD11 ' H ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -57.47 -48.83 78.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.527 ' N ' ' CD2' ' A' ' 249' ' ' LEU . 0.2 OUTLIER -74.68 -28.02 60.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.414 -179.188 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 87.3 99.05 0.86 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.858 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 282' ' ' THR . 4.9 m -60.31 159.22 10.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.359 0.123 . . . . 0.0 110.77 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.683 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -148.09 124.51 10.97 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.027 0.442 . . . . 0.0 111.374 179.064 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 90.9 t -101.26 132.02 47.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.819 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.425 ' HA ' HG13 ' A' ' 280' ' ' ILE . 32.0 t-20 51.27 39.58 24.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.069 0.461 . . . . 0.0 110.29 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 1.6 t 65.82 22.14 11.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.51 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -121.45 100.49 7.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.007 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 59.9 p -51.84 97.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.072 0.463 . . . . 0.0 112.19 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.542 HG12 ' N ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -78.14 -54.21 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.874 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.542 ' N ' HG12 ' A' ' 259' ' ' ILE . 2.0 t . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.932 0.396 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.798 ' CZ3' ' HB2' ' A' ' 246' ' ' MET . 36.8 t-105 -66.19 -26.58 67.46 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 76.92 160.88 11.58 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.911 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -94.56 146.47 31.52 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.88 147.87 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.166 1.911 . . . . 0.0 111.503 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 85.9 t -132.14 127.18 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.672 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.01 128.08 33.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.154 -178.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -93.11 164.38 13.28 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.957 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.707 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.02 159.23 42.64 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 57.2 p -62.48 132.1 51.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.245 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 81.8 -0.89 1.56 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.013 -179.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.707 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -71.97 -167.02 0.26 Allowed 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.425 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -162.7 133.37 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.444 177.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -109.9 156.18 10.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.483 178.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.683 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 5.8 m -147.42 112.82 5.59 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.642 HD11 ' N ' ' A' ' 283' ' ' LEU . 0.0 OUTLIER -112.1 46.43 1.16 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.614 -177.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -178.79 -129.74 1.34 Allowed Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 119.654 -1.26 . . . . 0.0 113.882 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' THR . . . . . 0.417 ' H ' ' HG3' ' A' ' 224' ' ' GLU . 5.4 t -97.59 -41.05 8.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.0 110.501 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.608 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -149.25 3.09 0.58 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.835 179.239 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.822 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 57.3 m -77.06 104.66 7.67 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.512 ' HG2' HG21 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -127.02 133.51 50.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.343 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -110.82 136.76 45.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.311 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 4.0 t80 -76.41 135.22 39.45 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' ' 275' ' ' LEU . 2.3 t -103.37 113.51 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.099 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.471 ' HD2' ' H ' ' A' ' 293' ' ' ILE . 6.7 tpt180 -126.43 145.5 50.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.471 ' H ' ' HD2' ' A' ' 292' ' ' ARG . 7.1 mt -143.32 116.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.908 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 6.1 t -125.48 155.76 40.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 0.0 110.725 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.02 162.25 24.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.204 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 296' ' ' GLN . 5.5 tp60 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.952 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.251 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.67 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.0 m95 -144.02 127.77 17.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.552 ' HB3' ' CZ3' ' A' ' 234' ' ' TRP . 1.2 tp -120.07 129.68 54.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.392 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.67 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 1.2 m-85 -130.25 135.8 48.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.786 0.803 . . . . 0.0 111.814 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -132.03 148.65 52.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.963 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.583 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 26.5 tt0 -140.64 124.96 17.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.593 ' HA ' HG12 ' A' ' 289' ' ' VAL . 17.4 t -60.8 108.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.925 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.2 tt -92.38 -18.38 7.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.777 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.53 93.6 0.34 Allowed 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.589 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.689 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.03 -172.06 27.84 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.605 ' O ' ' HG2' ' A' ' 221' ' ' LYS . 83.5 Cg_endo -80.41 29.06 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.232 1.954 . . . . 0.0 111.61 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.494 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.75 27.13 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.689 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.1 mt -41.76 111.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 112.136 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 8.16 2.26 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.11 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.637 HD11 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -101.18 136.28 41.29 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.697 0.761 . . . . 0.0 109.057 178.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.583 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 7.9 mt-30 -136.17 155.81 49.6 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.494 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.578 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -148.84 147.58 28.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.355 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.531 ' C ' ' HZ3' ' A' ' 181' ' ' TRP . . . -151.25 149.48 29.45 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.619 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' A' ' 206' ' ' LEU . 5.2 p -153.77 153.83 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.432 0.634 . . . . 0.0 111.542 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.62 ' HA ' ' O ' ' A' ' 180' ' ' SER . 6.3 m-80 -91.27 148.57 22.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.679 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.507 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 32.8 p -66.31 -0.63 2.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 2.1 t -103.17 26.78 7.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.432 0.634 . . . . 0.0 110.457 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 55.8 p -114.32 123.22 48.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.692 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.432 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 22.9 m -91.07 -80.88 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.3 t -82.34 6.46 16.93 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.432 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -117.26 -12.13 10.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.958 0.408 . . . . 0.0 110.939 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.763 HD11 ' CE2' ' A' ' 234' ' ' TRP . 6.8 tt -68.0 -60.97 4.58 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.295 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.608 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.6 Cg_endo -42.6 99.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.32 2.014 . . . . 0.0 112.571 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.872 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 2.3 t -67.38 160.44 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.438 ' N ' ' CG1' ' A' ' 208' ' ' VAL . 3.7 mtpt -133.83 93.11 3.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.0 OUTLIER -84.5 121.89 28.23 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.75 167.48 38.54 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.527 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.877 ' HB2' HG11 ' A' ' 225' ' ' VAL . 0.1 OUTLIER -57.42 -88.18 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.402 ' O ' HG21 ' A' ' 213' ' ' VAL . 13.1 p -126.89 -10.61 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 111.62 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.574 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.6 OUTLIER -52.34 179.78 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.461 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 36.1 Cg_exo -60.05 10.83 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.417 2.078 . . . . 0.0 113.202 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.531 ' H ' ' C ' ' A' ' 214' ' ' SER . 1.0 OUTLIER -52.39 -178.11 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.16 0.505 . . . . 0.0 111.461 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -99.24 -31.42 11.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.51 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.714 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.6 mt -104.33 127.61 52.01 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.637 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -94.27 82.24 4.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.91 0.386 . . . . 0.0 111.889 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.842 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.9 mm? -102.68 91.49 4.22 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 6.5 ptpt -61.53 60.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.147 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 220' ' ' LEU . 3.3 m-20 -93.15 146.59 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.702 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 54.2 p -86.77 -18.46 31.04 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.56 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.401 ' HB2' ' CG ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -79.48 -18.65 51.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.76 0.314 . . . . 0.0 111.466 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.877 HG11 ' HB2' ' A' ' 212' ' ' ARG . 3.0 p -109.37 81.45 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.023 0.44 . . . . 0.0 110.583 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.8 p -37.71 -39.45 0.34 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.514 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.37 -55.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.947 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.574 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 0.6 OUTLIER -140.75 130.82 24.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.115 0.483 . . . . 0.0 110.782 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.654 ' HD1' ' HB ' ' A' ' 225' ' ' VAL . 0.8 OUTLIER -96.57 -57.02 2.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.442 179.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.452 ' C ' HD11 ' A' ' 210' ' ' LEU . . . -151.57 175.81 11.96 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.555 0.693 . . . . 0.0 112.449 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.872 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -152.52 173.32 15.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.974 -179.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 9.0 mt -125.03 143.37 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.913 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.24 129.07 4.25 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.766 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 4.5 p90 -119.32 166.43 13.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.754 0.788 . . . . 0.0 112.624 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -113.66 133.25 55.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.201 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.44 -1.83 52.92 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.088 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.8 m -78.83 -23.86 44.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.518 0.675 . . . . 0.0 109.937 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.492 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 13.9 tptt -141.82 16.61 2.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.373 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 15.3 p90 42.83 60.44 2.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.537 0.684 . . . . 0.0 109.774 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.766 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 2.0 mptp? -124.08 141.25 52.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.91 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.631 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -124.68 127.02 46.65 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.316 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.805 ' HG2' ' HG3' ' A' ' 274' ' ' GLU . 24.5 mt-10 -134.87 139.85 45.35 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.487 ' CD2' HG12 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -92.37 143.1 26.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.738 -1.574 . . . . 0.0 107.45 177.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.593 HG22 ' CD1' ' A' ' 269' ' ' TRP . 1.3 p -140.16 161.64 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.272 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.711 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 10.5 t0 -84.93 135.03 34.23 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 120.881 0.372 . . . . 0.0 110.716 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.486 ' HG3' ' HG2' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -89.74 31.33 0.95 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.18 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.56 47.45 56.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.418 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.46 175.21 6.65 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.915 0.358 . . . . 0.0 111.077 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.716 HD11 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -101.67 -30.08 11.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.737 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.716 ' H ' HD11 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -75.82 -33.29 60.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.467 0.651 . . . . 0.0 111.579 -178.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.492 ' O ' ' NE2' ' A' ' 229' ' ' HIS . . . 93.27 160.47 35.38 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.769 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.417 HG23 ' CB ' ' A' ' 230' ' ' ALA . 7.6 m -117.98 157.37 26.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.049 -0.575 . . . . 0.0 110.763 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.625 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -144.87 141.82 29.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.041 0.448 . . . . 0.0 110.681 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.404 ' CG2' HG12 ' A' ' 259' ' ' ILE . 60.0 t -114.89 128.99 71.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.053 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.525 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 40.6 t30 55.93 48.68 17.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.099 0.476 . . . . 0.0 110.24 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 18.7 m 56.33 29.12 14.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.66 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . 0.4 ' O ' ' N ' ' A' ' 259' ' ' ILE . 1.7 t60 -133.3 103.4 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.816 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.574 ' HA ' ' HB3' ' A' ' 253' ' ' LEU . 64.8 p -55.03 89.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.286 0.565 . . . . 0.0 110.877 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.499 HD13 ' C ' ' A' ' 259' ' ' ILE . 2.6 pp -94.66 -8.19 9.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.229 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.711 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 3.3 m . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.425 ' NZ ' ' HA2' ' A' ' 270' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.196 0.522 . . . . 0.0 112.07 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.593 ' CD1' HG22 ' A' ' 244' ' ' VAL . 19.5 t-105 -78.29 -18.79 54.8 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.299 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.425 ' HA2' ' NZ ' ' A' ' 268' ' ' LYS . . . 71.78 173.29 18.31 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.33 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -105.0 138.31 19.47 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -50.28 111.43 0.53 Allowed 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.602 2.202 . . . . 0.0 113.316 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 39.6 t -97.97 139.53 19.97 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.805 ' HG3' ' HG2' ' A' ' 242' ' ' GLU . 1.7 mp0 -80.1 124.79 29.06 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.593 HD22 ' HB2' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -91.81 165.98 12.99 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.99 177.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.71 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.72 159.19 42.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 13.7 t -59.88 128.33 36.38 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.958 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 277' ' ' SER . 12.8 m-20 87.98 5.77 0.24 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.885 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.71 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -80.94 -163.29 0.57 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 255' ' ' ASN . 0.7 OUTLIER -161.52 131.02 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.365 177.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -104.46 156.3 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.117 0.484 . . . . 0.0 110.018 178.163 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.625 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 3.2 m -147.43 114.41 6.15 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.581 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -114.92 44.4 1.79 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.143 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.87 -131.54 1.79 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.585 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.6 t -92.36 -51.35 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.703 0.287 . . . . 0.0 110.522 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.584 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -138.58 -0.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.577 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.777 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 29.9 m -70.26 103.06 2.26 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.643 0.258 . . . . 0.0 110.953 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.731 ' O ' HG22 ' A' ' 187' ' ' ILE . 1.3 mtpp -126.01 137.78 53.68 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.349 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -115.54 134.81 57.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.457 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.572 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.1 t80 -76.5 141.23 41.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.26 109.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.422 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -124.29 141.28 52.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.606 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.505 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 9.3 mt -138.76 133.16 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.02 156.46 43.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.733 0.301 . . . . 0.0 111.001 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.32 -174.75 4.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.031 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.922 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.582 ' HB2' ' OG ' ' A' ' 200' ' ' SER . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.137 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.716 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 14.1 m95 -148.12 134.01 19.08 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.733 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 2.2 tp -112.98 119.78 39.11 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.458 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.716 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 5.6 m-85 -117.12 127.43 54.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.677 0.751 . . . . 0.0 110.66 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.614 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -118.28 134.62 54.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.676 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.553 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 2.3 tt0 -131.06 112.3 12.78 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.528 ' CG2' HD11 ' A' ' 220' ' ' LEU . 18.8 t -61.99 107.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 188' ' ' ALA . 11.0 tt -88.53 -26.01 5.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.729 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.31 98.35 0.71 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.418 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.564 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.1 -162.06 12.8 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.464 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 88.5 Cg_endo -86.59 27.93 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.677 2.251 . . . . 0.0 111.324 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.715 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -162.07 25.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.418 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.564 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.9 mt -39.63 107.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.52 5.47 2.28 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.203 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 191' ' ' ALA . 0.9 OUTLIER -102.81 133.7 47.44 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.544 0.687 . . . . 0.0 110.076 179.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.8 mt-30 -131.13 153.96 48.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.763 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.555 ' NE2' ' HB3' ' A' ' 217' ' ' ASP . 1.6 t-80 -144.28 138.66 28.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.134 0.492 . . . . 0.0 110.832 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.733 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.92 156.08 44.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.591 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.475 HG22 ' HA ' ' A' ' 206' ' ' LEU . 12.3 p -157.69 149.01 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.348 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.5 OUTLIER -91.65 140.56 29.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.317 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.582 ' OG ' ' HB2' ' A' ' 180' ' ' SER . 0.9 OUTLIER -62.23 -6.88 3.46 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 201' ' ' THR . 0.9 OUTLIER -93.76 28.55 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.323 0.582 . . . . 0.0 110.742 179.216 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.748 ' OG ' ' HB3' ' A' ' 206' ' ' LEU . 89.2 p -101.02 140.87 34.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.358 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -70.94 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 111.315 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.41 33.04 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.004 0.43 . . . . 0.0 110.752 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -117.15 4.13 12.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.862 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.748 ' HB3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -98.69 -19.19 0.21 Allowed Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.691 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 10.8 Cg_endo -58.14 97.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 CA-C-N 120.836 1.334 . . . . 0.0 111.058 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 58.5 t -67.64 164.07 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.276 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.3 OUTLIER -139.73 86.0 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.509 -178.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.481 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.0 OUTLIER -74.94 130.38 39.28 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.869 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -176.13 178.57 47.53 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.588 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 15.5 ttt180 -76.48 -67.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.53 ' CG2' ' H ' ' A' ' 214' ' ' SER . 9.8 p -125.99 -145.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.53 ' H ' ' CG2' ' A' ' 213' ' ' VAL . 1.1 p 64.78 179.9 0.04 OUTLIER Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 57.7 Cg_endo -73.15 39.37 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.913 1.742 . . . . 0.0 112.597 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 214' ' ' SER . 3.2 p -70.05 151.98 44.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.836 0.35 . . . . 0.0 110.553 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.555 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 2.8 m-20 -75.62 -38.15 59.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.086 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.645 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.6 mt -103.21 130.33 50.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.603 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -98.72 86.28 3.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.841 0.353 . . . . 0.0 111.078 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.677 ' O ' ' N ' ' A' ' 222' ' ' ASP . 2.3 mm? -108.03 69.66 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -47.75 72.82 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.919 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.677 ' N ' ' O ' ' A' ' 220' ' ' LEU . 41.8 t0 -101.58 137.45 39.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.468 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.0 p -76.89 -3.98 41.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.348 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -99.73 -22.39 15.4 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 90.4 t -96.73 76.37 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.419 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 225' ' ' VAL . 49.0 m -31.5 -48.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.999 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.6 -58.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.81 131.39 23.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.2 0.524 . . . . 0.0 110.336 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.605 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.6 t60 -99.5 -54.88 2.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.175 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.475 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -141.65 175.54 9.61 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.633 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -165.88 176.94 7.48 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.578 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.691 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.4 mt -135.27 148.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.682 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.17 164.11 38.01 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.46 ' CH2' ' CZ3' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -89.32 146.15 24.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -176.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.484 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 0.9 OUTLIER -119.33 81.28 1.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.515 175.023 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.7 p -64.77 -20.64 66.47 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.1 m -80.91 -30.87 35.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.33 0.586 . . . . 0.0 110.334 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.543 ' HD2' ' HE2' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -108.59 5.25 24.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.064 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 235' ' ' ASN . 2.8 p90 38.48 42.73 0.58 Allowed 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.245 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.543 ' HE2' ' HD2' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -118.64 173.95 6.55 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.279 0.562 . . . . 0.0 109.503 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.643 ' HZ3' ' HB2' ' A' ' 182' ' ' LEU . 2.0 m0 -121.88 113.41 19.6 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 13.7 pt-20 -133.26 149.13 51.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.8 pp -115.05 152.15 32.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.06 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.512 HG23 ' CD1' ' A' ' 269' ' ' TRP . 0.7 OUTLIER -118.98 163.12 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 248' ' ' SER . 0.4 OUTLIER -104.73 110.66 23.08 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.59 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.82 100.49 5.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.656 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.73 63.44 5.12 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.499 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 3.1 p -67.33 55.74 0.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.51 -46.52 80.51 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.685 ' N ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -78.91 -35.62 43.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.559 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 89.71 87.4 1.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.89 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.447 ' N ' ' HB3' ' A' ' 260' ' ' SER . 0.2 OUTLIER -45.24 164.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.47 0.176 . . . . 0.0 111.288 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.609 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -151.84 134.17 15.24 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.213 0.53 . . . . 0.0 111.686 178.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 96.6 t -110.65 137.61 42.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.225 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.415 ' HA ' HD11 ' A' ' 280' ' ' ILE . 3.1 p-10 49.45 35.41 8.09 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.207 0.527 . . . . 0.0 110.173 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 14.6 m 69.44 29.33 4.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.442 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -131.5 102.22 5.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.349 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 8.8 t -53.39 87.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.698 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.489 ' HB ' HG12 ' A' ' 273' ' ' VAL . 0.0 OUTLIER -90.18 6.86 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.932 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.447 ' HB3' ' N ' ' A' ' 252' ' ' THR . 2.4 t . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.59 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 3.4 t-105 -82.73 -29.14 29.99 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.72 -174.52 8.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.532 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -101.54 137.87 19.72 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.397 0.598 . . . . 0.0 110.497 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 75.6 Cg_exo -51.63 122.9 11.11 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.704 2.269 . . . . 0.0 113.621 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 98.7 t -94.12 141.11 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -82.93 130.13 35.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.033 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.702 HD11 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -96.46 163.25 13.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.895 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.31 160.33 41.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.296 0.569 . . . . 0.0 112.487 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 38.3 t -59.89 125.63 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.609 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 290' ' ' TYR . 14.8 m-20 85.97 0.77 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.736 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 2.3 m-20 -82.06 133.7 35.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.722 HG23 ' HD1' ' A' ' 290' ' ' TYR . 1.0 OUTLIER -101.91 130.36 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.992 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.56 ' O ' ' HG2' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -99.46 155.15 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.998 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.609 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -144.83 118.97 9.44 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.605 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -114.87 44.53 1.76 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.2 -122.93 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 119.277 -1.44 . . . . 0.0 113.843 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.2 t -93.44 -51.74 4.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.142 . . . . 0.0 111.188 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -142.65 -2.63 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.729 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 35.7 m -65.94 102.39 0.78 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 117.853 0.297 . . . . 0.0 110.614 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 281' ' ' ILE . 0.1 OUTLIER -117.63 123.73 46.87 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.752 -178.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.48 HG12 HG21 ' A' ' 281' ' ' ILE . 2.5 p -108.41 134.08 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.636 0.255 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.722 ' HD1' HG23 ' A' ' 280' ' ' ILE . 1.4 t80 -77.65 130.26 36.62 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 279' ' ' ASP . 2.2 t -104.01 115.91 46.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.894 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -129.3 146.64 51.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.576 -179.151 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.522 ' CG2' ' CZ3' ' A' ' 241' ' ' TRP . 9.1 mt -139.78 140.77 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.52 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.6 t -152.3 161.44 42.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.373 . . . . 0.0 111.29 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 54.5 p -102.97 141.52 35.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.533 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.772 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 73.1 m . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.752 0.311 . . . . 0.0 111.415 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 49.0 m95 -156.82 143.02 18.1 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.744 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.4 OUTLIER -118.79 106.16 12.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 14.2 m-85 -101.91 136.44 41.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.997 0.903 . . . . 0.0 112.179 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.529 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.4 OUTLIER -126.74 136.21 52.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.404 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.412 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 4.3 tm-20 -133.34 116.53 16.21 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.556 ' CG1' HD13 ' A' ' 220' ' ' LEU . 18.4 t -62.53 116.15 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 288' ' ' LYS . 9.2 tt -96.63 -23.21 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.722 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.39 91.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.54 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.632 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.86 -174.75 32.12 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.53 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 60.4 Cg_endo -75.34 27.56 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.371 2.047 . . . . 0.0 111.568 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.698 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -161.4 31.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.94 0.4 . . . . 0.0 110.0 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.632 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.1 mt -47.8 107.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.622 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.93 7.16 2.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.122 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.698 HD13 ' O ' ' A' ' 191' ' ' ALA . 0.6 OUTLIER -101.44 112.18 24.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.802 0.81 . . . . 0.0 109.906 179.151 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.0 mt-30 -111.03 152.62 26.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.554 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.435 ' CG ' HG11 ' A' ' 208' ' ' VAL . 1.1 t-80 -144.04 136.56 26.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.744 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -142.06 165.18 28.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.64 HG23 ' HA ' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -165.04 148.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.528 179.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 180' ' ' SER . 18.2 t-20 -88.57 137.18 32.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.474 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.57 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 32.4 t -49.32 -14.36 0.09 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.887 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 2.0 t -102.11 7.32 41.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -103.78 114.07 28.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.885 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 2.7 m -91.26 -67.39 0.86 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.69 -5.49 2.76 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.7 -1.81 11.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.126 -0.359 . . . . 0.0 111.313 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.64 ' HA ' HG23 ' A' ' 198' ' ' VAL . 1.3 tt -71.58 -61.66 2.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.4 Cg_endo -44.01 84.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.45 2.1 . . . . 0.0 113.276 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 206' ' ' LEU . 88.0 t -74.53 92.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.746 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.468 ' N ' ' HB2' ' A' ' 217' ' ' ASP . 0.7 OUTLIER -69.36 98.59 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.501 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.4 mp -82.65 128.79 34.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.778 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -179.11 179.37 48.91 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.899 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.835 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.0 OUTLIER -68.06 -76.39 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.548 ' CG2' ' H ' ' A' ' 214' ' ' SER . 8.0 p -126.57 -141.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.39 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.548 ' H ' ' CG2' ' A' ' 213' ' ' VAL . 0.1 OUTLIER 64.72 -175.88 0.03 OUTLIER Pre-proline 0 C--O 1.232 0.135 0 CA-C-N 118.314 0.506 . . . . 0.0 110.247 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 21.8 Cg_exo -65.66 10.03 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.745 2.297 . . . . 0.0 113.423 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 214' ' ' SER . 39.4 m -48.83 169.03 0.02 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.741 0.305 . . . . 0.0 111.092 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.468 ' HB2' ' N ' ' A' ' 209' ' ' LYS . 1.7 m-20 -95.48 -34.81 11.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.343 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.783 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 5.0 mt -105.81 127.31 53.02 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -92.57 80.02 4.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.724 0.297 . . . . 0.0 110.711 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.835 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.7 mm? -103.7 92.71 4.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -60.1 58.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.674 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 220' ' ' LEU . 5.5 t0 -92.72 124.88 37.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.349 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.7 p -69.05 -10.5 57.88 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.108 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.57 -24.76 33.81 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.783 0.325 . . . . 0.0 110.928 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 222' ' ' ASP . 3.0 p -108.41 79.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.1 m -35.17 -36.16 0.05 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.737 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.23 -58.01 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.976 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -143.19 132.48 23.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.135 0.493 . . . . 0.0 110.556 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.526 ' O ' ' N ' ' A' ' 246' ' ' MET . 0.6 OUTLIER -102.16 -57.0 2.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.376 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -141.83 171.21 14.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.192 0.52 . . . . 0.0 112.036 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 1.0 OUTLIER -152.54 159.36 43.29 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.486 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.565 HG12 ' HB3' ' A' ' 243' ' ' LEU . 19.4 mt -123.73 145.73 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.432 0.634 . . . . 0.0 111.87 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.418 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -161.41 150.51 16.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.8 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 3.2 p90 -138.76 165.64 26.46 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.12 132.43 56.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.792 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 73.4 m -88.99 2.09 54.5 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.872 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 21.4 m -78.63 -19.48 52.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.643 0.735 . . . . 0.0 110.276 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -150.73 23.63 0.78 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.496 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.2 p90 37.44 59.58 1.18 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.214 0.53 . . . . 0.0 110.446 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.8 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -128.63 143.12 50.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.673 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.665 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -123.42 122.5 38.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.774 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.671 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.8 pt-20 -134.18 142.35 47.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.698 0.761 . . . . 0.0 112.354 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.565 ' HB3' HG12 ' A' ' 232' ' ' ILE . 2.4 pp -107.82 152.76 23.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.784 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -115.75 162.24 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.663 0.268 . . . . 0.0 110.963 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.512 ' HB3' ' OG ' ' A' ' 260' ' ' SER . 1.2 m-20 -106.22 111.05 23.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.596 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.93 103.42 6.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.203 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.87 70.59 0.92 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.51 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.2 m -62.0 40.96 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.724 HD23 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.52 -52.54 64.37 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.793 -0.567 . . . . 0.0 109.881 178.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.724 ' N ' HD23 ' A' ' 249' ' ' LEU . 2.7 m120 -80.32 -39.36 28.83 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.145 0.498 . . . . 0.0 111.681 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 88.89 87.36 1.23 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.804 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.675 ' N ' ' HB3' ' A' ' 260' ' ' SER . 2.9 m -45.44 170.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.279 0.232 . . . . 0.0 110.553 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -149.11 133.66 17.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.205 0.526 . . . . 0.0 111.461 177.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 257' ' ' HIS . 86.0 t -109.83 133.11 56.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.083 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.467 ' HA ' HG13 ' A' ' 280' ' ' ILE . 3.3 m-20 51.11 44.41 28.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.174 0.512 . . . . 0.0 110.07 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 m 64.18 26.93 13.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.763 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . 0.497 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.1 OUTLIER -129.75 115.67 17.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.208 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 5.8 t -67.46 89.82 0.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.03 0.443 . . . . 0.0 111.548 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 257' ' ' HIS . 0.1 OUTLIER -89.36 0.33 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.431 -178.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.675 ' HB3' ' N ' ' A' ' 252' ' ' THR . 14.0 t . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.596 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 1.4 t-105 -77.68 -15.7 58.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.92 0.488 . . . . 0.0 112.232 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 59.94 -174.19 4.53 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.488 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -107.18 134.07 20.06 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.905 0.852 . . . . 0.0 110.494 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 96.4 Cg_exo -45.0 125.08 6.41 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.771 2.314 . . . . 0.0 113.521 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 74.9 t -98.77 129.3 49.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.665 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.13 128.65 34.79 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.46 -178.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.466 HD23 ' OD2' ' A' ' 279' ' ' ASP . 0.6 OUTLIER -87.27 163.5 16.82 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.031 -178.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -137.82 145.86 42.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.395 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 2.9 t -56.64 126.0 24.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.017 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.2 m-20 90.27 4.52 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.344 0.657 . . . . 0.0 111.949 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.472 ' OD2' ' HB ' ' A' ' 291' ' ' VAL . 0.6 OUTLIER -79.91 -164.51 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.522 HG21 ' HA ' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -162.3 136.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.406 178.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.46 ' O ' ' HG2' ' A' ' 288' ' ' LYS . 0.1 OUTLIER -108.46 156.64 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.607 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.665 ' OG1' ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -145.81 117.27 8.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.399 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.515 ' HB2' ' CB ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -113.07 44.61 1.49 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.79 -133.26 2.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.433 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.8 t -88.45 -49.44 6.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.643 0.259 . . . . 0.0 110.956 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.6 t -139.68 -7.3 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.722 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 49.0 m -63.97 101.31 0.38 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.665 ' HG3' ' OG1' ' A' ' 282' ' ' THR . 1.7 ttmt -118.8 129.51 55.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.637 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 289' ' ' VAL . 0.3 OUTLIER -106.98 128.49 61.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.542 0.21 . . . . 0.0 111.52 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.522 ' HA ' HG21 ' A' ' 280' ' ' ILE . 7.1 t80 -76.79 136.99 39.0 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.472 ' HB ' ' OD2' ' A' ' 279' ' ' ASP . 8.0 t -113.89 115.17 48.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.535 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.61 142.32 39.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.773 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.542 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 0.5 OUTLIER -129.89 147.24 33.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.501 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.67 129.54 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 0.0 111.482 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 8.7 p -81.42 159.37 24.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.58 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.687 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 295' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.458 -0.059 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.686 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.5 m95 -143.24 131.62 22.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.634 ' HB2' ' CZ3' ' A' ' 241' ' ' TRP . 3.4 tp -114.07 128.41 56.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.943 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.686 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 1.4 m-85 -130.27 129.94 43.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.747 0.784 . . . . 0.0 111.588 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.638 HD21 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -130.84 146.36 52.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.775 176.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.513 ' C ' HG12 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -140.19 127.21 20.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.456 -0.497 . . . . 0.0 112.308 -177.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.629 HG23 HD13 ' A' ' 220' ' ' LEU . 9.7 t -64.5 106.06 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.459 HG23 HD11 ' A' ' 187' ' ' ILE . 10.1 tt -90.6 -19.01 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.801 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.63 95.02 0.62 Allowed 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.268 -0.573 . . . . 0.0 112.466 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.659 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.2 -179.54 37.75 Favored Glycine 0 C--O 1.228 -0.26 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.56 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 58.9 Cg_endo -74.6 30.17 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 CA-C-N 119.433 1.617 . . . . 0.0 111.269 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.668 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -160.2 26.38 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.659 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.0 mt -42.11 108.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.07 7.57 1.75 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.099 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.668 HD13 ' O ' ' A' ' 191' ' ' ALA . 1.1 mp -100.86 119.72 39.08 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.139 0.971 . . . . 0.0 109.818 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.439 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 8.1 mt-30 -122.54 153.64 38.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.208 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.638 ' CD2' HD21 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -146.67 145.42 30.02 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.059 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -150.22 143.46 24.99 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.517 HG12 ' HG ' ' A' ' 206' ' ' LEU . 12.0 p -149.01 149.94 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.418 0.628 . . . . 0.0 111.309 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -87.72 148.14 24.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.356 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.541 ' CB ' ' HZ2' ' A' ' 234' ' ' TRP . 1.0 OUTLIER -65.55 -7.64 15.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.387 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.455 ' H ' HG22 ' A' ' 201' ' ' THR . 3.1 t -92.35 5.62 49.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.95 0.405 . . . . 0.0 111.209 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.613 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -94.93 113.68 25.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.57 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.8 m -60.1 -108.46 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.2 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.8 m -78.58 25.52 0.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.613 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.54 -10.55 10.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.93 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.529 ' HB3' ' HD3' ' A' ' 207' ' ' PRO . 9.0 tt -77.06 -49.22 2.45 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.557 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 206' ' ' LEU . 52.9 Cg_exo -46.48 100.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.467 1.445 . . . . 0.0 111.653 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.848 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 4.7 t -66.83 163.33 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 216' ' ' SER . 0.0 OUTLIER -138.38 92.55 2.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.851 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 230' ' ' ALA . 1.0 OUTLIER -83.91 127.32 33.76 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.402 ' HA2' HG22 ' A' ' 225' ' ' VAL . . . -173.31 178.11 45.41 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.136 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.98 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 8.5 ttt180 -63.38 -86.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.67 -4.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.624 ' HB2' ' CD ' ' A' ' 215' ' ' PRO . 67.5 p -53.76 -178.85 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.624 ' CD ' ' HB2' ' A' ' 214' ' ' SER . 32.6 Cg_exo -61.08 17.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.307 2.004 . . . . 0.0 112.709 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 214' ' ' SER . 6.4 m -58.39 -178.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.218 0.532 . . . . 0.0 111.619 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.1 -31.92 11.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.506 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.647 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.1 mt -103.46 124.89 49.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.62 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.623 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -94.67 86.42 4.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.795 0.331 . . . . 0.0 110.465 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.98 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.7 mm? -109.62 96.6 6.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -64.28 51.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.56 ' HA ' ' HG3' ' A' ' 190' ' ' PRO . 0.3 OUTLIER -84.9 138.14 32.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.2 p -78.95 -11.09 59.99 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.121 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -84.39 -20.34 32.06 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.769 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.694 HG23 ' N ' ' A' ' 229' ' ' HIS . 7.5 p -113.91 69.79 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-O 120.872 0.367 . . . . 0.0 110.069 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -35.2 -33.28 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.193 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 225' ' ' VAL . . . -144.1 -67.75 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.361 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.509 ' HD3' ' HG ' ' A' ' 216' ' ' SER . 6.8 mttp -140.38 128.48 22.23 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.32 0.581 . . . . 0.0 111.176 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.694 ' N ' HG23 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -95.8 -60.69 1.59 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.508 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 210' ' ' LEU . . . -150.35 163.02 39.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.904 -177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.848 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -138.76 -179.14 5.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.908 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 14.8 mt -131.1 141.55 45.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.012 0.435 . . . . 0.0 110.81 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.94 133.48 5.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.758 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.8 p90 -124.41 165.72 17.23 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.82 133.61 55.85 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.827 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 31.4 p -92.97 3.04 56.44 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.469 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 89.8 m -80.85 -27.99 36.25 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.42 0.629 . . . . 0.0 110.065 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 4.6 tptt -137.09 19.19 2.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.02 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.414 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 27.9 p90 40.43 60.03 1.94 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.5 0.667 . . . . 0.0 109.861 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.758 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -125.12 143.63 50.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.322 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.634 ' CZ3' ' HB2' ' A' ' 182' ' ' LEU . 11.6 m0 -123.79 125.16 44.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.497 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 1.1 pt-20 -129.06 134.87 48.28 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.635 HD11 ' N ' ' A' ' 244' ' ' VAL . 0.1 OUTLIER -107.0 124.74 50.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.048 177.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.635 ' N ' HD11 ' A' ' 243' ' ' LEU . 4.8 p -126.39 164.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 O-C-N 122.111 -0.368 . . . . 0.0 111.609 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 260' ' ' SER . 15.9 t0 -88.53 127.8 35.54 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.712 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -84.51 44.44 1.04 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.411 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.46 57.26 11.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.64 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.677 ' HB3' ' HA ' ' A' ' 229' ' ' HIS . 56.1 p -99.87 148.29 24.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.81 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.739 HD12 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -79.44 -37.67 36.47 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.961 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.739 ' H ' HD12 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -74.01 -31.25 62.86 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.844 0.354 . . . . 0.0 111.494 -179.066 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 95.3 163.96 34.68 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.946 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.413 HG22 ' N ' ' A' ' 253' ' ' LEU . 25.0 m -125.22 156.61 38.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.84 0.353 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 281' ' ' ILE . 0.1 OUTLIER -148.68 126.41 11.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.987 0.423 . . . . 0.0 111.41 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 36.0 t -102.25 127.64 55.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.735 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 53.14 41.22 32.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 110.34 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 16.6 m 62.99 20.22 12.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.404 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.06 90.97 3.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.92 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 96.1 p -45.79 97.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.596 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.562 HG12 ' N ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -78.63 -52.65 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.248 179.185 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.562 ' N ' HG12 ' A' ' 259' ' ' ILE . 19.7 p . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 2.5 mttt . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.38 0.61 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.712 ' CE3' ' HA ' ' A' ' 246' ' ' MET . 0.4 OUTLIER -72.86 -24.95 60.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.157 -0.928 . . . . 0.0 108.662 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.59 ' O ' ' HD1' ' A' ' 269' ' ' TRP . . . 79.52 166.17 31.93 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.747 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -89.74 138.64 27.93 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.397 0.598 . . . . 0.0 109.929 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.75 108.63 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.504 2.136 . . . . 0.0 112.753 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 40.0 t -102.0 147.24 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.674 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 20.9 mm-40 -85.53 130.21 34.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.51 0.671 . . . . 0.0 112.766 -177.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.421 ' C ' HD21 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -95.74 164.51 12.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.934 179.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.686 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.15 159.4 42.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 23.9 p -57.92 129.32 41.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.327 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.8 m-20 87.93 7.74 0.18 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.287 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.686 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.7 OUTLIER -80.72 -164.28 0.7 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.423 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.5 OUTLIER -162.27 135.17 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 177.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.582 HG21 ' HG ' ' A' ' 243' ' ' LEU . 0.1 OUTLIER -123.6 93.76 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 287' ' ' THR . 0.6 OUTLIER -79.0 121.96 25.59 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.553 ' HB3' ' CD2' ' A' ' 229' ' ' HIS . 0.3 OUTLIER -106.69 50.03 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.459 -0.497 . . . . 0.0 112.254 -178.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 162.54 -115.94 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 119.571 -1.299 . . . . 0.0 113.807 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 1.2 t -96.1 -57.62 2.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.594 0.235 . . . . 0.0 110.727 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -135.32 0.33 2.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.916 179.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.801 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 45.1 m -75.12 102.94 5.1 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 121.353 -0.139 . . . . 0.0 111.248 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 282' ' ' THR . 3.4 ptpt -129.08 135.46 48.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.222 0.534 . . . . 0.0 112.091 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -108.49 135.63 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.046 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.2 t80 -77.0 137.93 39.3 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.415 HG21 ' C ' ' A' ' 279' ' ' ASP . 0.1 OUTLIER -106.68 110.79 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.78 -178.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.39 140.6 50.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.775 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.483 ' CG2' ' CH2' ' A' ' 241' ' ' TRP . 32.3 mt -138.63 134.37 42.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.1 t -152.47 161.76 42.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 111.207 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.5 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 36.6 p -104.86 157.97 16.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.819 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.772 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.718 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 20.9 m . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.0 m95 -127.59 132.29 49.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 292' ' ' ARG . 2.2 tp -117.72 129.88 55.98 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.244 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 11.2 m-85 -125.95 133.15 51.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.681 0.753 . . . . 0.0 110.436 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.731 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 3.3 mt -123.84 141.37 52.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.889 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.476 ' C ' HG13 ' A' ' 289' ' ' VAL . 6.8 tt0 -134.8 111.3 9.8 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.622 ' CG1' HD12 ' A' ' 220' ' ' LEU . 8.8 t -58.64 117.98 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.49 HD13 HG23 ' A' ' 187' ' ' ILE . 5.6 tt -101.91 -24.41 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -175.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.76 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -155.86 91.2 1.27 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.994 0.815 . . . . 0.0 112.479 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -162.64 -165.89 20.48 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.41 ' HG3' ' CG ' ' A' ' 222' ' ' ASP . 58.6 Cg_endo -92.43 33.1 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.971 2.447 . . . . 0.0 111.509 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.672 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -162.34 29.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.459 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.584 HD11 ' N ' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -47.87 111.12 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.052 0.453 . . . . 0.0 111.322 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.12 4.52 2.58 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.666 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.672 HD11 ' O ' ' A' ' 191' ' ' ALA . 0.8 OUTLIER -102.33 118.9 37.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.599 0.714 . . . . 0.0 109.578 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.731 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.0 mt-30 -114.68 149.85 36.11 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.785 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.529 ' NE2' ' HB3' ' A' ' 217' ' ' ASP . 1.0 OUTLIER -138.48 133.26 32.47 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.102 178.436 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.59 156.62 43.36 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.399 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 206' ' ' LEU . 4.5 p -162.19 156.37 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.625 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.718 ' HA ' ' O ' ' A' ' 180' ' ' SER . 46.2 m-20 -94.78 145.73 24.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.619 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.473 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 28.3 p -58.34 -0.31 0.09 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.081 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.436 ' H ' ' C ' ' A' ' 199' ' ' ASN . 1.4 t -106.72 14.4 26.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.857 0.36 . . . . 0.0 111.301 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.428 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -106.33 124.53 49.73 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.179 179.362 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 m -87.48 -83.03 0.21 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 26.2 m -84.09 13.27 5.25 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.428 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.03 -14.31 9.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.015 0.436 . . . . 0.0 110.624 178.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.594 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.6 tt -65.69 -55.32 24.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.802 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.8 Cg_endo -42.84 92.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.653 2.235 . . . . 0.0 113.453 -178.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 231' ' ' GLN . 41.6 t -71.46 90.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.708 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.551 ' N ' ' HB2' ' A' ' 217' ' ' ASP . 0.7 OUTLIER -68.16 78.81 0.24 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.713 HD21 HD22 ' A' ' 218' ' ' LEU . 3.1 mp -65.35 129.55 40.13 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.975 -0.453 . . . . 0.0 110.043 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . -173.59 171.62 44.62 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.46 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.613 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -70.56 -74.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.893 0.477 . . . . 0.0 112.074 -179.155 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.654 HG22 ' H ' ' A' ' 214' ' ' SER . 9.9 p -124.28 -142.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.363 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.654 ' H ' HG22 ' A' ' 213' ' ' VAL . 1.9 m 60.5 173.25 0.06 OUTLIER Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 118.972 0.805 . . . . 0.0 109.616 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.596 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 37.5 Cg_endo -65.71 28.58 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.076 1.851 . . . . 0.0 113.064 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.531 ' H ' ' C ' ' A' ' 214' ' ' SER . 8.1 m -57.47 167.01 1.09 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.749 0.309 . . . . 0.0 110.756 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.551 ' HB2' ' N ' ' A' ' 209' ' ' LYS . 9.7 m-20 -89.0 -43.01 11.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.874 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.713 HD22 HD21 ' A' ' 210' ' ' LEU . 3.4 tp -99.07 131.63 44.97 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.559 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -95.68 75.75 3.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.954 0.407 . . . . 0.0 110.785 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.622 HD12 ' CG1' ' A' ' 186' ' ' VAL . 2.6 mm? -103.96 62.87 0.76 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.613 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 2.2 pttt -54.57 57.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 220' ' ' LEU . 10.0 t0 -88.75 153.81 20.78 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.2 p -73.18 -4.72 34.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.499 ' HG3' ' HA3' ' A' ' 284' ' ' GLY . 1.4 pt-20 -91.74 -21.79 20.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.977 0.418 . . . . 0.0 110.26 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -96.94 102.88 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.083 179.089 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 73.0 m -53.18 -49.26 67.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.468 0.651 . . . . 0.0 109.885 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 228' ' ' LYS . . . -148.34 -50.62 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.522 ' HD2' ' HD2' ' A' ' 209' ' ' LYS . 8.1 mttm -145.87 134.74 22.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.082 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.559 ' HD2' ' HB2' ' A' ' 283' ' ' LEU . 0.0 OUTLIER -101.18 -53.84 2.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.181 179.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.449 ' C ' ' HG3' ' A' ' 231' ' ' GLN . . . -148.97 170.32 18.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.774 ' O ' HD11 ' A' ' 243' ' ' LEU . 0.0 OUTLIER -152.68 170.24 20.75 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.764 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.802 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.7 mt -121.06 143.62 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.483 0.659 . . . . 0.0 111.814 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.478 ' HA ' HD23 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.14 126.3 4.2 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.775 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 10.5 p90 -120.32 166.85 12.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.528 HD22 ' HB2' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -115.58 133.58 55.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.02 -179.042 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.27 -0.88 52.49 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.71 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 18.6 m -78.97 -39.33 34.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.904 0.859 . . . . 0.0 109.382 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.585 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 10.0 tptm -117.8 10.08 13.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.21 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 10.6 p90 44.92 63.83 1.58 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.42 0.629 . . . . 0.0 109.772 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.775 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 2.1 mptp? -130.69 140.56 50.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.092 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.66 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 1.8 m95 -121.41 124.01 43.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.942 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 6.7 pt-20 -138.29 147.17 43.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.784 ' HG ' HG13 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -95.25 151.34 19.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 112.859 -1.973 . . . . 0.0 108.474 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.502 HG23 ' CD1' ' A' ' 269' ' ' TRP . 2.2 p -145.57 161.79 12.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.867 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 17.4 t0 -84.25 139.44 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.561 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.02 30.56 0.58 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.0 41.02 97.51 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.646 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.43 ' HB2' ' HA ' ' A' ' 229' ' ' HIS . 9.5 t -86.54 172.28 10.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 111.264 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.677 HD11 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -96.95 -30.95 12.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.809 179.283 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.677 ' H ' HD11 ' A' ' 249' ' ' LEU . 0.8 OUTLIER -75.53 -29.65 59.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.805 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 85.62 152.55 19.14 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.742 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 253' ' ' LEU . 87.6 m -108.94 154.73 21.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.463 -0.368 . . . . 0.0 110.772 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -138.06 136.43 36.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.159 178.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.463 ' HB ' HG12 ' A' ' 259' ' ' ILE . 89.6 t -107.6 127.45 63.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.971 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.582 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 27.2 t-20 56.56 50.54 12.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.376 0.608 . . . . 0.0 109.985 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.56 32.51 17.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.927 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . 0.415 ' O ' ' N ' ' A' ' 259' ' ' ILE . 0.1 OUTLIER -137.95 111.54 8.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.823 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.462 ' HA ' ' HB3' ' A' ' 253' ' ' LEU . 78.3 p -60.41 83.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.306 0.574 . . . . 0.0 110.34 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.463 HG12 ' HB ' ' A' ' 254' ' ' VAL . 2.6 pp -87.85 -9.49 10.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.815 -178.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.528 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp . . . . . 0 C--O 1.232 0.176 0 CA-C-O 121.263 0.554 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.521 ' CZ2' ' OE1' ' A' ' 231' ' ' GLN . 7.7 t-105 -81.02 -16.93 51.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.541 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 72.22 174.22 22.85 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.462 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -105.59 137.15 19.22 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.153 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.24 115.75 2.08 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.654 2.236 . . . . 0.0 113.789 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 80.9 t -103.96 135.18 42.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.586 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -75.56 127.8 33.88 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -176.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.626 HD11 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.29 164.65 13.45 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.517 178.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.82 159.3 42.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 28.3 t -61.38 129.28 40.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.367 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 277' ' ' SER . 0.4 OUTLIER 83.74 6.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.387 -178.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 16.0 t0 -81.1 -165.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 255' ' ' ASN . 0.8 OUTLIER -160.4 126.39 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.368 178.129 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.784 HG13 ' HG ' ' A' ' 243' ' ' LEU . 0.2 OUTLIER -100.58 148.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.663 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 13.9 m -140.53 136.81 33.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.612 0.72 . . . . 0.0 111.56 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.639 ' O ' ' HB ' ' A' ' 287' ' ' THR . 0.0 OUTLIER -136.95 134.78 37.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.359 178.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.499 ' HA3' ' HG3' ' A' ' 224' ' ' GLU . . . 95.64 -137.91 13.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.346 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 11.6 t -99.33 -30.16 12.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.898 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -156.53 5.14 0.16 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.76 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 7.4 m -73.47 107.14 5.58 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.881 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 282' ' ' THR . 11.6 ttmm -127.81 134.83 49.47 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.17 0.509 . . . . 0.0 111.807 -178.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.476 HG13 ' C ' ' A' ' 185' ' ' GLU . 16.7 t -115.44 135.38 55.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.809 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.541 ' CD1' HG23 ' A' ' 280' ' ' ILE . 2.5 t80 -76.9 137.98 39.45 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.122 0.487 . . . . 0.0 110.666 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.11 112.23 37.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.718 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.503 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -129.26 138.45 51.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.872 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 4.1 mt -138.78 122.36 19.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.23 162.34 32.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 110.835 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.6 -165.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.988 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.767 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.611 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.17 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.0 m95 -145.56 130.34 18.11 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.633 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 4.0 tp -119.82 136.56 54.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.059 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 3.5 m-85 -134.16 130.23 37.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.762 0.792 . . . . 0.0 109.809 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.622 HD13 ' HA ' ' A' ' 291' ' ' VAL . 3.7 mm? -116.98 139.43 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.276 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -135.49 111.96 9.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 194' ' ' LEU . 14.3 t -60.58 110.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.459 ' CG2' ' HG3' ' A' ' 288' ' ' LYS . 9.0 tt -92.64 -19.28 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.756 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.9 95.21 0.34 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.88 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.613 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.63 -173.25 30.06 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.504 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 94.6 Cg_endo -81.43 31.8 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 121.926 1.751 . . . . 0.0 110.91 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -160.83 24.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.077 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.613 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.3 mt -40.84 108.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.863 0.364 . . . . 0.0 111.979 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.62 6.03 2.13 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.375 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -95.94 143.86 26.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.605 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 16.6 mt-30 -139.88 147.12 40.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.421 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.58 ' CD2' HG13 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -136.82 131.05 32.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.392 0.615 . . . . 0.0 110.421 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.93 152.76 43.83 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.019 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.473 HG13 ' CH2' ' A' ' 234' ' ' TRP . 5.3 p -166.38 156.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.196 0.522 . . . . 0.0 110.937 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 180' ' ' SER . 1.2 m120 -93.38 147.31 23.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.405 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.527 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 1.4 t -64.58 -3.22 2.92 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.978 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 3.5 t -89.15 12.15 16.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.775 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -95.2 144.32 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.946 0.403 . . . . 0.0 111.238 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.53 -60.89 1.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.082 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.57 25.39 4.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.331 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.42 -1.05 12.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.764 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.634 ' N ' ' CD ' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -94.57 -22.96 0.24 Allowed Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 206' ' ' LEU . 22.2 Cg_exo -61.57 94.29 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.113 1.209 . . . . 0.0 111.384 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.58 HG13 ' CD2' ' A' ' 196' ' ' HIS . 45.5 t -80.61 102.06 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.34 0.591 . . . . 0.0 111.254 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 216' ' ' SER . 0.0 OUTLIER -69.46 97.22 0.97 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.624 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.5 mp -75.85 125.3 28.82 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -169.2 171.97 43.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.385 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.789 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 4.8 ttt180 -58.53 -90.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 10.6 p -127.5 -9.57 4.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.579 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.1 OUTLIER -53.82 -173.86 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.713 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 27.0 Cg_exo -62.42 3.89 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.438 2.092 . . . . 0.0 112.877 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.509 ' HA ' ' HB3' ' A' ' 209' ' ' LYS . 0.9 OUTLIER -49.76 165.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.895 0.378 . . . . 0.0 111.577 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.402 ' HB2' ' N ' ' A' ' 209' ' ' LYS . 3.4 m-20 -86.01 -31.36 22.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.679 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.746 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 2.9 mt -107.93 130.8 55.01 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.615 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -92.26 79.83 5.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.816 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.789 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.1 mm? -103.81 86.24 2.57 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.694 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 7.4 ptpt -59.51 20.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.608 ' H ' ' C ' ' A' ' 220' ' ' LEU . 6.3 t0 -48.99 125.73 11.03 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.2 t -63.41 -12.23 29.17 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.436 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 285' ' ' THR . 0.1 OUTLIER -82.49 -17.24 45.84 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.779 0.323 . . . . 0.0 110.544 179.159 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.701 ' O ' ' HB2' ' A' ' 212' ' ' ARG . 7.4 p -108.83 94.5 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.065 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.14 -45.22 16.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.036 0.446 . . . . 0.0 110.836 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.43 -50.38 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.476 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.579 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 7.0 mttt -139.41 126.55 21.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.111 0.482 . . . . 0.0 110.466 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.679 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.5 t60 -100.54 -58.07 1.98 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.752 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.445 ' C ' HD13 ' A' ' 210' ' ' LEU . . . -141.1 173.15 11.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.812 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.537 ' O ' HD12 ' A' ' 243' ' ' LEU . 61.2 tt0 -151.98 154.3 35.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.302 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.0 mt -111.96 140.6 30.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-O 121.197 0.522 . . . . 0.0 111.276 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.35 149.87 17.61 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.718 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 4.0 p90 -139.47 166.34 24.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -115.42 132.77 56.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.138 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.7 m -92.81 -1.07 57.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.949 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.3 m -77.58 -28.19 51.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.674 0.749 . . . . 0.0 109.876 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.32 19.18 2.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.804 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.7 p90 39.84 62.09 1.31 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.578 0.704 . . . . 0.0 109.56 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.718 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 1.4 mptm? -122.91 138.95 54.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.902 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.567 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -123.43 122.35 38.05 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.492 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 7.8 pt-20 -130.68 145.53 51.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 122.388 1.09 . . . . 0.0 113.872 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.649 ' HG ' HG13 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -102.24 138.44 39.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.988 178.103 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.472 HG22 ' CD1' ' A' ' 269' ' ' TRP . 3.7 p -133.47 162.42 39.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.78 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.474 ' HB2' ' CB ' ' A' ' 260' ' ' SER . 25.1 t0 -88.16 139.66 30.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.311 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.517 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -86.98 32.54 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.102 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.86 47.92 77.51 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.916 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.45 -178.55 5.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.72 HD12 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -106.0 -28.32 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.139 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.72 ' H ' HD12 ' A' ' 249' ' ' LEU . 8.1 t-20 -75.37 -36.07 61.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.127 0.489 . . . . 0.0 111.622 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.12 116.24 1.71 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.825 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.544 HG21 ' H ' ' A' ' 253' ' ' LEU . 16.7 m -70.98 165.29 23.75 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.655 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -149.28 128.85 13.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.314 0.578 . . . . 0.0 111.394 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.434 HG22 ' CG2' ' A' ' 259' ' ' ILE . 86.1 t -105.57 132.81 51.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.453 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 280' ' ' ILE . 12.2 p30 50.08 39.31 18.92 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.094 0.473 . . . . 0.0 110.084 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.95 27.68 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.534 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.74 103.18 6.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.243 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 7.6 t -51.46 95.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.61 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.501 ' HB ' ' CG2' ' A' ' 273' ' ' VAL . 0.2 OUTLIER -77.72 -23.01 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.416 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.474 ' CB ' ' HB2' ' A' ' 245' ' ' ASP . 24.7 p . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 19.0 mttt . . . . . 0 CA--C 1.521 -0.165 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.517 ' CE3' ' HA ' ' A' ' 246' ' ' MET . 13.0 t-105 -72.96 -18.92 61.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.98 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 75.9 168.91 26.54 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.403 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -99.66 134.64 20.94 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.116 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.17 108.76 0.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.608 2.206 . . . . 0.0 113.687 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.501 ' CG2' ' HB ' ' A' ' 259' ' ' ILE . 81.3 t -100.38 141.65 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 0.0 OUTLIER -83.03 129.3 35.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.07 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.457 ' C ' ' CD2' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.91 165.72 12.52 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.022 178.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.49 161.99 36.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.3 OUTLIER -60.24 130.33 46.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.126 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 277' ' ' SER . 18.0 m-20 82.86 3.08 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.952 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.606 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 2.6 t0 -75.1 -162.56 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.522 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.5 OUTLIER -161.73 127.96 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.994 178.371 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.649 HG13 ' HG ' ' A' ' 243' ' ' LEU . 0.2 OUTLIER -107.78 157.29 8.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.302 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.655 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 5.6 m -150.64 134.94 17.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.679 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -129.27 47.56 2.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.12 -125.69 1.04 Allowed Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 119.493 -1.337 . . . . 0.0 113.638 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' THR . . . . . 0.451 ' N ' ' HG3' ' A' ' 224' ' ' GLU . 3.8 t -99.98 -37.23 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 0.0 110.823 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -149.74 -10.12 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.756 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 87.2 m -66.34 106.06 1.61 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 117.77 0.259 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 0.1 OUTLIER -131.55 139.04 49.14 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.39 0.614 . . . . 0.0 111.619 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 186' ' ' VAL . 4.5 t -116.77 136.54 53.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.329 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.522 ' HD1' HG23 ' A' ' 280' ' ' ILE . 1.8 t80 -76.75 136.09 39.02 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 109.917 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.622 ' HA ' HD13 ' A' ' 184' ' ' LEU . 1.8 t -102.52 110.96 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.659 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.409 ' C ' HG13 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -123.35 137.93 54.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.538 HD11 ' CE3' ' A' ' 241' ' ' TRP . 2.5 mt -137.62 117.93 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.42 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.5 146.63 47.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.897 0.38 . . . . 0.0 111.226 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.75 167.7 14.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.873 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.957 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 25.1 m . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 121.235 0.54 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.714 ' HB3' ' CE1' ' A' ' 183' ' ' PHE . 3.7 m95 -142.77 133.48 25.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.448 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.5 OUTLIER -121.82 130.31 53.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.714 ' CE1' ' HB3' ' A' ' 181' ' ' TRP . 0.7 OUTLIER -132.28 143.14 49.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.712 0.768 . . . . 0.0 111.308 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.639 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -137.9 148.69 45.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.402 177.522 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.452 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 9.0 tt0 -137.77 125.11 21.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.968 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.575 HG13 HD13 ' A' ' 220' ' ' LEU . 18.9 t -64.69 119.6 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.509 ' CG2' ' HB3' ' A' ' 288' ' ' LYS . 3.8 tp -104.15 -23.41 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.809 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -159.2 91.8 1.04 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.47 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.579 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.71 -171.66 28.07 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.468 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 73.2 Cg_endo -81.43 31.26 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.878 1.719 . . . . 0.0 111.664 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.496 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -162.4 25.32 0.11 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.582 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.579 HG12 ' H ' ' A' ' 189' ' ' GLY . 7.5 mt -43.13 114.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.77 7.23 3.43 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.277 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -98.69 132.57 43.97 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.452 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 20.3 mt-30 -130.58 151.9 50.54 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.665 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.627 ' HB3' HD21 ' A' ' 184' ' ' LEU . 1.4 t60 -143.23 139.79 30.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.255 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -131.84 148.08 52.53 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.05 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.768 HG21 ' HA ' ' A' ' 206' ' ' LEU . 11.8 p -159.16 141.77 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.513 ' OD1' ' CH2' ' A' ' 181' ' ' TRP . 3.1 m120 -88.03 161.55 17.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.013 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.488 ' HB2' ' NE1' ' A' ' 234' ' ' TRP . 60.0 p -68.78 -48.64 63.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.342 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.23 1.84 0.29 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.579 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -83.04 129.7 35.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -89.72 -95.88 0.11 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.12 11.19 2.42 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.579 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -116.49 -17.79 10.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.684 0.278 . . . . 0.0 110.765 179.352 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.824 HD23 ' O ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -76.93 -42.93 2.81 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 6.2 Cg_endo -51.89 96.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.209 1.11 . . . . 0.0 112.118 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.653 ' O ' ' HG3' ' A' ' 231' ' ' GLN . 78.5 t -67.36 151.19 10.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -128.29 93.61 3.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.7 OUTLIER -84.76 127.88 34.33 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.306 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.437 ' HA2' HG23 ' A' ' 225' ' ' VAL . . . -173.39 174.21 45.97 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.02 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.581 ' CG ' ' HA ' ' A' ' 221' ' ' LYS . 2.0 ttm180 -69.98 -75.03 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.812 0.445 . . . . 0.0 111.834 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 214' ' ' SER . 9.2 p -121.82 -145.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.524 ' CB ' ' HD2' ' A' ' 215' ' ' PRO . 0.3 OUTLIER 65.91 179.03 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 118.731 0.696 . . . . 0.0 109.85 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 49.7 Cg_endo -69.58 28.7 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.089 1.859 . . . . 0.0 113.435 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 214' ' ' SER . 6.3 m -61.96 160.57 12.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.699 0.285 . . . . 0.0 110.679 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.77 -31.27 21.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.754 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 4.8 mt -111.49 133.13 53.99 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.606 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -92.52 76.46 5.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.415 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.754 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.1 mm? -97.99 62.52 1.58 Allowed 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.581 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 8.2 pttt -59.56 50.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.468 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 22.6 t0 -97.32 124.4 41.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 t -39.82 -27.88 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.614 ' HG2' ' HA2' ' A' ' 284' ' ' GLY . 0.4 OUTLIER -60.8 -39.9 90.62 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.097 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 212' ' ' ARG . 1.7 p -97.75 93.93 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.0 m -35.29 -62.05 0.41 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.105 0.479 . . . . 0.0 111.445 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 228' ' ' LYS . . . -133.33 -47.76 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 227' ' ' GLY . 3.6 mttt -144.19 127.3 16.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.493 -0.354 . . . . 0.0 110.172 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 246' ' ' MET . 4.4 t60 -96.09 -55.67 2.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.637 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -140.12 159.65 41.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.411 0.624 . . . . 0.0 112.614 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.653 ' HG3' ' O ' ' A' ' 208' ' ' VAL . 0.1 OUTLIER -145.72 161.96 38.7 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.704 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.769 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.6 mt -124.13 149.4 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.515 ' HA ' HD13 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -153.8 162.03 41.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.661 178.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.488 ' NE1' ' HB2' ' A' ' 200' ' ' SER . 0.6 OUTLIER -98.39 157.39 16.23 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -176.074 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 240' ' ' LYS . 2.0 t-20 -121.55 71.46 0.97 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.156 -1.384 . . . . 0.0 107.478 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 p -56.48 -19.44 15.38 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.9 m -75.54 -21.39 57.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.463 0.649 . . . . 0.0 110.567 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.517 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 0.3 OUTLIER -137.19 17.84 2.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.374 -179.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 239' ' ' PHE . 19.7 p90 42.67 68.0 0.54 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -130.19 144.48 51.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.295 -179.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -119.29 102.96 9.07 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.5 pt-20 -125.96 144.71 50.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.107 0.956 . . . . 0.0 113.002 -177.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 2.6 pp -115.94 149.96 37.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.681 -1.599 . . . . 0.0 111.208 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.525 ' CG2' ' CD1' ' A' ' 269' ' ' TRP . 2.0 p -113.99 163.06 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.657 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 260' ' ' SER . 6.1 m-20 -112.25 101.84 10.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.511 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -65.56 96.46 0.26 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.417 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.59 69.88 1.13 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.356 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.413 ' CB ' ' HB2' ' A' ' 260' ' ' SER . 0.4 OUTLIER -65.4 57.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.583 HD11 ' N ' ' A' ' 250' ' ' ASN . 0.8 OUTLIER -53.38 -57.72 9.62 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.31 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.583 ' N ' HD11 ' A' ' 249' ' ' LEU . 0.7 OUTLIER -78.77 -30.1 45.42 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.264 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.459 ' O ' HD23 ' A' ' 253' ' ' LEU . . . 92.07 125.82 3.67 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.513 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.442 ' O ' HG12 ' A' ' 259' ' ' ILE . 25.7 m -88.67 114.96 25.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.155 0.182 . . . . 0.0 110.601 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -103.98 130.51 51.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.278 0.561 . . . . 0.0 112.512 -178.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.434 HG23 ' CG1' ' A' ' 281' ' ' ILE . 33.1 t -108.55 131.95 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.63 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 280' ' ' ILE . 3.3 t-20 52.15 32.01 9.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.125 0.488 . . . . 0.0 109.877 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.8 m 68.82 21.04 7.84 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.686 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -120.49 93.35 4.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.802 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 21.7 p -43.79 97.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.356 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 260' ' ' SER . 14.4 pt -77.29 -53.88 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.508 ' N ' HG13 ' A' ' 259' ' ' ILE . 36.9 p . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt . . . . . 0 CA--C 1.518 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.525 ' CD1' ' CG2' ' A' ' 244' ' ' VAL . 28.2 t-105 -67.17 -24.87 65.92 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 79.97 157.81 14.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.099 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -96.6 140.94 22.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.39 119.0 2.8 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.575 2.184 . . . . 0.0 112.788 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 84.9 t -100.91 136.22 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -85.0 128.6 34.7 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.97 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.681 ' H ' HD12 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.48 165.58 12.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.08 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -137.43 155.61 49.13 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.564 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 89.0 p -63.78 133.21 53.06 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.258 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.564 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.0 OUTLIER 79.27 -4.99 2.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.254 -178.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 3.5 t70 -67.61 -167.24 0.06 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.538 ' HB ' ' HE3' ' A' ' 288' ' ' LYS . 0.7 OUTLIER -162.09 131.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.645 178.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -104.02 148.13 9.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.139 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.669 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 1.6 m -138.89 116.95 11.71 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.456 ' O ' ' HB ' ' A' ' 287' ' ' THR . 0.1 OUTLIER -113.44 136.54 52.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.444 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.614 ' HA2' ' HG2' ' A' ' 224' ' ' GLU . . . 82.91 -129.14 8.88 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.666 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 t -95.11 -31.65 13.46 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -159.67 8.15 0.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.577 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.809 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 14.9 m -69.51 99.26 1.23 Allowed 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.542 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 0.2 OUTLIER -111.86 115.26 28.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.456 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.434 ' O ' HG12 ' A' ' 289' ' ' VAL . 4.4 p -103.17 131.03 52.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 122.205 -0.31 . . . . 0.0 110.827 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.639 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.2 t80 -76.22 132.49 39.94 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.56 114.62 43.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.652 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.505 ' HD2' ' H ' ' A' ' 293' ' ' ILE . 5.6 tpt180 -132.0 143.85 50.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.235 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.515 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 8.8 mt -143.13 122.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.697 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.79 159.1 38.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.941 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 9.7 m -89.29 -179.12 5.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.484 -179.749 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.449 ' HB3' ' OG ' ' A' ' 200' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 10.9 m95 -147.09 142.06 26.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.849 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.507 ' HB2' ' CZ3' ' A' ' 241' ' ' TRP . 1.5 tp -125.96 122.72 36.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 1.4 m-85 -121.31 141.23 51.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.795 0.807 . . . . 0.0 111.313 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.64 ' CD2' ' N ' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -139.65 149.01 43.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.526 178.668 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.472 ' C ' HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -139.52 125.98 20.36 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.476 ' CG1' HD11 ' A' ' 220' ' ' LEU . 21.7 t -62.06 116.48 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.599 ' CG2' ' HG3' ' A' ' 288' ' ' LYS . 5.5 tt -100.03 -19.34 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.839 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.54 91.9 0.6 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.659 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -160.9 -171.12 26.43 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.654 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 64.0 Cg_endo -81.59 32.54 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.006 1.804 . . . . 0.0 111.311 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.49 22.12 0.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.574 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.659 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.4 mt -39.81 111.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.08 7.65 3.19 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.109 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 219' ' ' ALA . 0.2 OUTLIER -96.24 131.9 42.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.425 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 14.1 mt-30 -129.07 151.11 50.11 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.465 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.579 ' NE2' HD12 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -146.87 148.14 31.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.771 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.23 144.73 34.88 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.778 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.595 ' CG2' ' HA ' ' A' ' 206' ' ' LEU . 2.1 p -147.66 139.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.393 0.616 . . . . 0.0 111.437 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.564 HD21 HG23 ' A' ' 201' ' ' THR . 2.6 p-10 -92.65 148.36 22.13 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.768 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.553 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 61.5 m -66.19 -1.12 2.95 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.564 HG23 HD21 ' A' ' 199' ' ' ASN . 0.1 OUTLIER -111.38 11.66 21.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.054 0.454 . . . . 0.0 111.0 178.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.692 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -106.74 120.04 40.94 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.746 178.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -76.41 0.45 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.5 t -62.93 1.51 0.41 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.435 ' HG2' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -122.15 -10.19 8.58 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.083 -0.385 . . . . 0.0 110.814 178.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.693 ' CD2' ' HA ' ' A' ' 233' ' ' THR . 5.1 tt -62.09 -63.38 4.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.606 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.7 Cg_endo -43.03 88.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.412 2.075 . . . . 0.0 113.174 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.539 ' O ' ' CG1' ' A' ' 208' ' ' VAL . 1.7 t -69.51 85.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.461 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 216' ' ' SER . 1.3 mtpt -69.82 97.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.5 mp -82.93 127.94 33.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -167.35 167.61 40.0 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.571 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.876 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 4.7 ttt180 -56.54 -90.75 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.01 -9.89 6.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.69 0.281 . . . . 0.0 111.477 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.552 ' C ' ' H ' ' A' ' 216' ' ' SER . 0.6 OUTLIER -50.88 178.94 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.217 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 21.0 Cg_endo -63.51 13.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.661 1.574 . . . . 0.0 112.493 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 214' ' ' SER . 16.3 m -52.82 166.96 0.17 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 111.193 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -84.75 -26.09 27.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.761 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.715 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.2 mt -111.53 130.99 55.55 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.633 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -94.96 82.09 3.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.726 0.298 . . . . 0.0 111.355 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.715 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -102.14 63.85 0.92 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.876 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -51.9 72.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.445 -178.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.654 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 3.4 t0 -127.49 137.18 52.59 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-O 120.992 0.425 . . . . 0.0 110.774 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 43.9 t -51.31 -36.84 44.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.477 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.61 ' CD ' ' HA3' ' A' ' 284' ' ' GLY . 2.4 pt-20 -44.71 -45.71 9.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.015 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 212' ' ' ARG . 2.2 p -102.29 107.68 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.655 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.63 -51.7 20.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.224 0.535 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.94 -46.67 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.404 ' NZ ' ' HG2' ' A' ' 215' ' ' PRO . 0.1 OUTLIER -136.64 120.63 17.62 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.705 ' CD2' ' HB3' ' A' ' 283' ' ' LEU . 5.4 t60 -92.2 -61.1 1.68 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.702 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.593 ' CB ' HG23 ' A' ' 252' ' ' THR . . . -140.08 176.84 8.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.526 0.679 . . . . 0.0 112.315 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.594 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 10.6 tt0 -159.19 162.69 36.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.909 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 243' ' ' LEU . 54.4 mt -124.72 144.31 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.563 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.693 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.87 163.41 32.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.12 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.865 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 12.1 p90 -154.91 166.59 33.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -115.47 133.14 56.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.304 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.48 -2.87 57.94 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.295 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.5 m -76.43 -26.03 55.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.768 0.794 . . . . 0.0 110.231 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 239' ' ' PHE . 10.9 tptt -138.8 21.91 2.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.648 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.432 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 7.7 p90 35.48 60.09 0.76 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.638 0.732 . . . . 0.0 109.722 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.865 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.1 OUTLIER -125.09 141.0 52.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.126 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.756 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 1.3 m95 -122.25 126.51 48.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.395 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.4 pt-20 -143.2 144.52 32.21 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.808 0.813 . . . . 0.0 113.142 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.594 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 2.5 pp -111.09 152.08 27.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.776 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.509 HG21 ' CD1' ' A' ' 269' ' ' TRP . 2.8 p -121.32 163.18 19.48 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.617 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 248' ' ' SER . 2.6 m-20 -105.27 104.41 14.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.509 ' HG2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -71.4 97.26 1.59 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.428 177.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.09 65.67 3.23 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.312 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 0.2 OUTLIER -70.32 59.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.583 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -54.35 -52.69 60.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.338 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.583 ' H ' HD13 ' A' ' 249' ' ' LEU . 25.5 m-20 -74.37 -30.98 62.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.933 0.397 . . . . 0.0 111.304 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 95.55 99.56 1.79 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.19 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.593 HG23 ' CB ' ' A' ' 230' ' ' ALA . 1.6 m -64.97 114.85 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.021 -0.105 . . . . 0.0 110.993 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 258' ' ' SER . 2.4 mt -101.57 130.02 47.78 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.489 -0.484 . . . . 0.0 112.009 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.416 ' CG2' ' CD1' ' A' ' 259' ' ' ILE . 99.0 t -105.48 127.66 60.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.635 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 1.8 t30 55.14 40.75 31.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 110.215 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.12 32.1 21.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.83 107.93 6.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.795 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.422 ' HB3' HD22 ' A' ' 253' ' ' LEU . 25.0 p -55.15 91.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.541 0.686 . . . . 0.0 111.45 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 252' ' ' THR . 0.2 OUTLIER -78.56 -23.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.788 -178.413 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.451 ' HB2' ' CG ' ' A' ' 245' ' ' ASP . 13.9 t . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.436 0.636 . . . . 0.0 112.076 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.509 ' CD1' HG21 ' A' ' 244' ' ' VAL . 20.5 t-105 -72.82 -22.58 60.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.598 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 74.44 163.63 10.21 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.574 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -99.99 150.63 37.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.3 . . . . 0.0 110.397 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.61 145.4 17.2 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.411 2.074 . . . . 0.0 112.514 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 93.6 t -130.87 130.22 64.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.728 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 3.2 mp0 -80.83 129.02 34.31 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.877 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.425 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -94.02 166.7 12.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.935 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.614 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.62 159.62 41.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.151 0.5 . . . . 0.0 112.014 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 0.1 OUTLIER -62.0 129.4 40.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.143 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 277' ' ' SER . 0.3 OUTLIER 86.73 1.52 0.52 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.309 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -72.72 -170.98 0.76 Allowed 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.635 ' CD1' ' HA ' ' A' ' 255' ' ' ASN . 1.0 OUTLIER -163.22 122.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 176.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.574 HG13 HG13 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -97.12 156.12 3.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.156 177.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 288' ' ' LYS . 21.3 m -141.51 114.68 8.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.705 ' HB3' ' CD2' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -113.8 141.48 47.25 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.335 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.61 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 84.52 -133.32 11.73 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.126 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 286' ' ' THR . 9.9 t -97.93 -36.03 10.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.658 0.266 . . . . 0.0 111.516 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -152.37 7.49 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.839 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 25.8 m -76.78 101.16 5.73 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.838 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.599 ' HG3' ' CG2' ' A' ' 187' ' ' ILE . 0.0 OUTLIER -124.54 134.39 53.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.072 -179.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.574 HG13 HG13 ' A' ' 281' ' ' ILE . 9.1 p -113.53 139.61 38.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.876 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.625 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.8 t80 -76.55 132.17 39.36 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.765 0.317 . . . . 0.0 110.232 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 6.1 t -103.01 112.01 34.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.479 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.47 138.11 51.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 111.338 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 13.3 mt -132.89 139.79 48.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.431 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 40.7 m -155.49 164.21 38.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.913 0.387 . . . . 0.0 111.423 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.26 -173.22 2.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.683 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.727 -179.858 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 200' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.523 -0.075 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.633 ' O ' HG22 ' A' ' 293' ' ' ILE . 3.2 m95 -148.57 138.97 22.58 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.545 -0.462 . . . . 0.0 112.203 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.512 HD12 HG12 ' A' ' 293' ' ' ILE . 0.3 OUTLIER -123.77 140.71 52.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.96 178.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 6.2 m-85 -137.7 140.54 40.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.535 0.684 . . . . 0.0 110.442 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.794 ' HB3' ' CE1' ' A' ' 196' ' ' HIS . 4.0 mm? -123.96 140.95 52.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.889 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -135.35 116.7 14.61 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.614 HG13 HD12 ' A' ' 220' ' ' LEU . 6.0 t -66.98 98.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.476 HG21 ' HG3' ' A' ' 288' ' ' LYS . 9.0 tt -82.03 -24.5 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.812 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -166.24 98.9 0.62 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.593 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.49 -169.15 25.46 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.493 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 98.0 Cg_endo -80.13 29.67 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.358 2.038 . . . . 0.0 110.642 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.532 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.13 25.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.593 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.6 mt -40.82 106.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.969 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.43 2.65 2.88 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.898 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.604 ' CD1' HD13 ' A' ' 220' ' ' LEU . 0.0 OUTLIER -96.73 165.19 12.25 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 118.106 0.953 . . . . 0.0 108.692 177.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 5.0 mt-30 -156.72 146.18 20.6 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.063 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.794 ' CE1' ' HB3' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -136.12 128.43 30.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.183 0.516 . . . . 0.0 109.852 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 182' ' ' LEU . . . -130.8 165.1 23.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.899 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.678 HG13 ' HG ' ' A' ' 206' ' ' LEU . 11.9 p -175.25 143.86 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 121.327 0.584 . . . . 0.0 112.264 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -85.78 147.96 26.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.382 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.484 ' HB3' ' OG ' ' A' ' 180' ' ' SER . 15.3 t -62.65 -9.42 8.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 2.9 t -95.04 36.85 1.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.973 0.416 . . . . 0.0 111.882 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.484 ' OG ' HD11 ' A' ' 206' ' ' LEU . 4.7 p -128.59 108.74 10.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.403 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 3.4 m -70.71 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.228 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.7 m -86.99 8.37 23.58 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.401 ' CG ' ' HB2' ' A' ' 202' ' ' SER . 9.0 pttt -118.41 52.74 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.702 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 8.2 tt -143.77 -52.4 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.896 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 3.7 Cg_exo -40.57 93.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.41 2.074 . . . . 0.0 113.384 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 231' ' ' GLN . 59.8 t -73.25 107.91 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.923 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.573 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 19.5 mtmt -77.91 90.99 4.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.446 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.598 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.8 OUTLIER -78.51 136.75 37.65 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . 164.63 -161.22 34.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.964 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.707 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.0 OUTLIER -73.65 171.72 12.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.393 -0.404 . . . . 0.0 111.487 -179.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.87 110.95 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 122.2 1.0 . . . . 0.0 111.833 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 215' ' ' PRO . 12.4 p -171.11 -163.0 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 113.435 -1.711 . . . . 0.0 107.864 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 62.3 Cg_exo -51.8 -12.0 1.05 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.475 1.45 . . . . 0.0 112.665 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.405 ' OG ' ' HG2' ' A' ' 228' ' ' LYS . 0.1 OUTLIER -51.45 -178.36 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.962 0.411 . . . . 0.0 111.714 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.41 -37.72 8.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.697 HD12 ' CE1' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -100.47 140.53 34.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.641 179.087 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -103.06 78.18 1.62 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.892 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.9 mm? -102.49 91.72 4.36 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.493 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 1.5 ptpt -66.44 56.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.962 0.411 . . . . 0.0 110.653 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 220' ' ' LEU . 0.3 OUTLIER -88.96 123.35 33.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.518 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.0 p -66.25 -7.11 16.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.664 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.87 -24.47 23.66 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.759 0.314 . . . . 0.0 110.699 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 212' ' ' ARG . 7.2 p -100.66 93.4 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.02 0.438 . . . . 0.0 110.835 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.15 -38.71 18.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.053 0.454 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.13 -57.53 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.786 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.533 ' HA ' ' HA3' ' A' ' 211' ' ' GLY . 25.4 mtmm -143.7 129.02 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.421 0.629 . . . . 0.0 111.688 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.491 ' HE1' ' HB2' ' A' ' 250' ' ' ASN . 2.0 t60 -89.84 -61.82 1.6 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.154 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.561 ' C ' ' HE3' ' A' ' 246' ' ' MET . . . -140.72 171.17 14.47 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.8 OUTLIER -157.88 168.89 25.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.24 179.013 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.896 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 8.0 mt -125.39 138.16 55.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.604 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.48 163.64 32.4 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.471 ' CZ3' HD12 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -96.25 148.0 23.19 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.448 ' HB2' ' HD3' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -119.53 71.99 0.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.276 174.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.7 p -54.11 -21.13 7.86 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 46.3 m -73.72 -27.86 61.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.632 0.73 . . . . 0.0 109.33 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 20.0 tptt -116.31 6.29 13.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.465 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 235' ' ' ASN . 8.0 p90 37.05 49.56 0.83 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.885 0.374 . . . . 0.0 110.669 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.448 ' HD3' ' HB2' ' A' ' 235' ' ' ASN . 0.0 OUTLIER -119.8 176.21 5.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 0.0 109.78 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.58 ' HB2' HD21 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -124.61 110.0 13.88 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 0.7 OUTLIER -132.15 151.2 51.91 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.589 HD21 HD12 ' A' ' 281' ' ' ILE . 3.3 pp -119.16 152.65 36.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.579 -1.646 . . . . 0.0 111.456 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.541 HG21 ' CE3' ' A' ' 269' ' ' TRP . 4.7 p -119.33 162.6 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.139 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 13.6 m-20 -118.86 121.8 40.85 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.662 ' HB3' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -93.83 107.85 19.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.957 178.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 48.59 62.34 4.51 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.374 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.23 74.75 0.23 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -59.66 -48.77 80.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.859 178.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.624 ' N ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -78.7 -39.51 36.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.048 0.451 . . . . 0.0 110.851 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.515 ' O ' HD21 ' A' ' 253' ' ' LEU . . . 97.05 93.0 1.87 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.359 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.516 HG21 ' CD1' ' A' ' 281' ' ' ILE . 1.9 m -47.29 156.59 0.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.297 -0.261 . . . . 0.0 110.297 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.551 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -148.12 130.23 15.45 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.179 0.514 . . . . 0.0 111.521 179.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.422 ' CG2' HG23 ' A' ' 259' ' ' ILE . 55.5 t -104.14 130.04 55.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.829 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.472 ' HA ' HD11 ' A' ' 280' ' ' ILE . 6.1 t-20 55.09 42.33 30.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.048 0.451 . . . . 0.0 110.329 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.15 23.1 12.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.992 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.7 112.03 15.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.373 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 253' ' ' LEU . 85.9 p -63.12 99.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.431 0.634 . . . . 0.0 112.174 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.505 HG12 ' N ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -79.45 -47.68 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.774 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.505 ' N ' HG12 ' A' ' 259' ' ' ILE . 4.7 t . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.662 ' CH2' ' HB3' ' A' ' 246' ' ' MET . 2.8 m95 -63.77 -30.31 71.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.234 -0.893 . . . . 0.0 108.768 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 72.53 165.13 8.13 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.15 122.86 72.35 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.701 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 34.2 Cg_exo -31.05 111.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.21 2.607 . . . . 0.0 112.846 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.478 ' HB ' HD13 ' A' ' 243' ' ' LEU . 62.5 t -87.58 130.18 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.388 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 0.0 OUTLIER -78.3 131.71 37.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.977 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.666 ' H ' HD12 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -98.0 164.26 12.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.121 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.85 152.67 45.3 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.641 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.9 OUTLIER -54.62 130.89 41.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.362 179.031 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.641 ' HB2' ' O ' ' A' ' 277' ' ' SER . 9.0 m-20 82.17 -3.65 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.738 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.2 m-20 -77.24 141.15 40.15 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.744 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' A' ' 255' ' ' ASN . 0.9 OUTLIER -100.72 124.79 54.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 119.789 -0.765 . . . . 0.0 109.728 178.541 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.687 ' O ' ' CG2' ' A' ' 281' ' ' ILE . 0.3 OUTLIER -110.46 94.61 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -82.49 138.38 34.35 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.524 -0.735 . . . . 0.0 109.589 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.462 ' HB3' HG23 ' A' ' 252' ' ' THR . 0.0 OUTLIER -130.39 53.1 1.97 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.372 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 168.16 -122.5 1.03 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.494 -1.336 . . . . 0.0 113.43 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.5 t -98.0 -44.8 6.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.636 0.255 . . . . 0.0 110.675 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -147.64 1.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.812 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.1 m -79.32 104.75 10.15 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 282' ' ' THR . 9.0 ptpt -126.19 131.02 52.08 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.796 0.807 . . . . 0.0 111.931 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.428 HG12 ' CE1' ' A' ' 196' ' ' HIS . 14.9 t -106.2 132.1 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.758 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.538 ' CZ ' ' HA ' ' A' ' 278' ' ' ASP . 1.7 t80 -77.17 130.89 37.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.637 ' HA ' HD11 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -100.75 113.64 37.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.734 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -131.09 136.16 48.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.742 0.306 . . . . 0.0 110.82 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 181' ' ' TRP . 2.4 mt -135.46 139.65 46.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 3.2 m -142.81 156.09 44.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.776 0.322 . . . . 0.0 111.14 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.3 m -85.73 159.22 19.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.786 -179.991 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.111 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.643 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.6 m95 -145.29 131.77 19.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.594 HD12 ' O ' ' A' ' 292' ' ' ARG . 5.1 tp -118.12 128.2 54.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.214 177.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.643 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 1.1 m-85 -128.99 138.57 52.03 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.553 0.692 . . . . 0.0 110.799 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.774 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.5 mp -140.89 153.01 45.51 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.586 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.524 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 23.3 tt0 -144.61 124.85 13.73 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.511 HG11 HD12 ' A' ' 220' ' ' LEU . 22.0 t -59.49 113.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.7 tt -97.02 -20.76 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.722 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -157.76 91.27 1.12 Allowed 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.327 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.693 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.76 178.57 38.45 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.45 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 71.9 Cg_endo -75.4 32.13 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 121.79 1.66 . . . . 0.0 111.185 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 189' ' ' GLY . . . -163.94 28.92 0.08 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.966 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.693 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.7 mt -43.55 119.75 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.112 0.482 . . . . 0.0 112.239 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.24 -48.46 0.92 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.726 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 219' ' ' ALA . 0.7 OUTLIER -40.9 143.84 0.33 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.302 0.573 . . . . 0.0 110.752 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.774 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 20.8 mt-30 -141.64 152.03 43.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.776 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.598 ' CE1' HD13 ' A' ' 218' ' ' LEU . 3.9 p-80 -139.63 131.59 27.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.268 0.556 . . . . 0.0 109.635 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.86 153.6 40.34 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.38 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.94 HG23 ' HA ' ' A' ' 206' ' ' LEU . 7.2 p -160.92 161.24 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.349 0.595 . . . . 0.0 111.725 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.432 ' N ' ' CG2' ' A' ' 198' ' ' VAL . 1.4 t-20 -98.59 143.33 29.11 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.705 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.483 ' HA ' ' HE1' ' A' ' 234' ' ' TRP . 16.2 t -60.76 1.48 0.14 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 199' ' ' ASN . 1.3 t -107.09 -8.08 16.65 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.601 0.36 . . . . 0.0 111.562 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -69.05 118.13 11.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.027 0.441 . . . . 0.0 110.452 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 72.8 m -66.42 -101.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.1 m -91.41 20.1 5.55 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.24 -9.0 11.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.205 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.94 ' HA ' HG23 ' A' ' 198' ' ' VAL . 7.8 tt -67.74 -61.21 4.55 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.644 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -43.28 101.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.005 1.803 . . . . 0.0 112.395 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.917 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 98.7 t -67.26 165.52 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 217' ' ' ASP . 15.7 mtmt -136.9 90.12 2.51 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.5 OUTLIER -79.97 123.91 28.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.138 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . -165.98 167.69 39.35 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.391 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.682 ' HB2' ' CG1' ' A' ' 225' ' ' VAL . 4.7 ttt-85 -66.36 -73.01 0.14 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.701 HG13 ' HG2' ' A' ' 215' ' ' PRO . 15.0 p -79.39 159.42 4.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.447 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 1.0 OUTLIER -31.07 -52.78 0.42 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -178.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.701 ' HG2' HG13 ' A' ' 213' ' ' VAL . 2.9 Cg_endo -42.52 -24.76 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.205 1.936 . . . . 0.0 113.153 -177.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.431 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -83.93 156.51 22.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -69.96 -36.24 75.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.564 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.804 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 2.0 mt -103.68 134.35 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.593 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -90.31 73.32 7.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.562 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.804 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -97.15 68.39 2.25 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.557 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 2.2 pttt -60.71 39.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.546 ' O ' HG12 ' A' ' 225' ' ' VAL . 12.4 t0 -90.23 131.23 36.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.5 p -46.51 -33.57 4.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.207 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.528 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 1.1 pp20? -52.21 -32.03 34.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.341 . . . . 0.0 111.233 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.728 ' HB ' ' HD1' ' A' ' 229' ' ' HIS . 2.1 p -104.33 97.72 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.54 -46.99 14.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.203 0.525 . . . . 0.0 110.574 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.32 -50.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.431 ' HB3' ' HG3' ' A' ' 246' ' ' MET . 3.6 mptp? -140.85 127.01 19.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.237 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.728 ' HD1' ' HB ' ' A' ' 225' ' ' VAL . 0.2 OUTLIER -94.55 -55.22 3.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.631 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.569 ' HB1' HG22 ' A' ' 252' ' ' THR . . . -151.87 177.0 10.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.286 0.565 . . . . 0.0 111.996 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.917 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 3.9 mt-30 -156.84 -178.01 7.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.222 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.7 HD12 HD11 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -125.36 141.76 44.28 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.249 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.24 127.18 3.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.827 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.8 p90 -124.92 167.53 14.56 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -112.62 133.16 54.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.137 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.22 -1.96 50.58 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.515 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.7 m -80.55 -35.04 34.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.588 0.709 . . . . 0.0 109.593 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.519 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 33.8 tptt -121.91 10.4 10.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.596 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 24.4 p90 45.18 63.04 1.89 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.495 0.664 . . . . 0.0 109.694 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.827 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.2 OUTLIER -129.14 138.18 51.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.121 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.687 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -119.91 126.75 51.67 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.731 179.043 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 272' ' ' PRO . 27.1 mt-10 -142.58 146.35 34.5 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 232' ' ' ILE . 0.3 OUTLIER -97.92 150.94 20.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.767 -1.561 . . . . 0.0 109.486 178.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.495 HG11 ' CZ2' ' A' ' 269' ' ' TRP . 4.5 p -141.67 162.85 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.901 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.603 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 18.8 t70 -84.63 138.82 32.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.412 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.534 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -88.92 31.63 0.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.722 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.47 50.48 59.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.769 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.632 ' HB2' ' HA ' ' A' ' 229' ' ' HIS . 32.6 t -92.6 168.97 10.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.836 0.35 . . . . 0.0 111.146 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 250' ' ' ASN . 3.1 pp -93.01 -43.82 8.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.439 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.58 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.8 OUTLIER -68.32 -19.03 64.65 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.546 0.689 . . . . 0.0 109.921 -178.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 76.27 147.75 2.24 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.364 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.569 HG22 ' HB1' ' A' ' 230' ' ' ALA . 6.0 m -103.66 152.29 21.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.608 0.242 . . . . 0.0 110.99 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -140.13 138.88 35.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.053 177.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.422 ' CG2' ' CD1' ' A' ' 259' ' ' ILE . 95.5 t -110.03 133.62 54.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.956 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 280' ' ' ILE . 14.7 p30 52.98 38.32 26.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.332 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.47 36.87 2.11 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.436 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . 0.459 ' O ' HG21 ' A' ' 259' ' ' ILE . 20.0 t-80 -148.29 117.53 6.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 91.9 p -63.5 86.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.251 0.548 . . . . 0.0 110.275 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.573 ' CG1' HG23 ' A' ' 273' ' ' VAL . 0.1 OUTLIER -84.92 -13.08 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.229 -178.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 1.5 t . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.7 mttt . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.082 0.467 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.534 ' CE3' ' HA ' ' A' ' 246' ' ' MET . 14.7 t-105 -84.61 -19.59 32.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.705 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 64.25 -172.98 16.1 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.782 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.467 ' HB2' ' HD2' ' A' ' 272' ' ' PRO . 29.2 p30 -110.38 158.97 33.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 117.524 0.662 . . . . 0.0 110.304 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.584 ' HB2' ' HB2' ' A' ' 242' ' ' GLU . 58.7 Cg_endo -72.99 114.3 4.0 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.296 1.997 . . . . 0.0 113.628 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.573 HG23 ' CG1' ' A' ' 259' ' ' ILE . 66.9 t -97.38 138.53 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 2.3 pm0 -76.24 123.45 25.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.131 0.967 . . . . 0.0 113.572 -176.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.746 ' H ' HD12 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -90.87 163.96 14.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.525 -1.671 . . . . 0.0 109.167 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.628 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -146.87 162.75 38.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 26.3 t -60.34 127.77 33.41 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.849 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 86.09 7.85 0.32 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.273 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -83.61 -166.66 1.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -161.48 128.84 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.603 177.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.686 ' CG2' HG11 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -99.28 147.13 7.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.591 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.71 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 0.6 OUTLIER -134.17 125.57 28.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.627 0.727 . . . . 0.0 110.226 178.158 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.458 ' O ' ' HB ' ' A' ' 287' ' ' THR . 0.1 OUTLIER -125.72 131.61 52.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.897 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.407 ' HA3' ' CG ' ' A' ' 224' ' ' GLU . . . 86.26 -127.95 8.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.143 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 t -96.94 -30.67 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -160.46 5.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.722 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 7.2 m -64.69 99.67 0.34 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.898 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 0.0 OUTLIER -117.97 125.21 49.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -177.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.686 HG11 ' CG2' ' A' ' 281' ' ' ILE . 6.3 p -113.26 136.47 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.224 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.48 ' HD1' ' CG2' ' A' ' 280' ' ' ILE . 1.0 OUTLIER -78.19 140.54 38.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.884 0.373 . . . . 0.0 110.373 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 277' ' ' SER . 0.4 OUTLIER -108.82 114.13 45.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.046 -179.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.594 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.9 OUTLIER -130.05 140.99 50.77 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.812 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.548 HD12 ' CE3' ' A' ' 241' ' ' TRP . 11.6 mt -138.95 119.87 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.81 149.99 52.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 0.0 111.268 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.86 164.07 16.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.4 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.415 HE21 ' HA ' ' A' ' 296' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.981 0.42 . . . . 0.0 111.486 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.599 ' N ' ' HB3' ' A' ' 296' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 121.508 0.671 . . . . 0.0 112.167 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 1.2 m95 -137.22 135.71 37.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.188 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 1.1 tp -126.66 133.97 50.84 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.508 ' N ' HD11 ' A' ' 182' ' ' LEU . 2.0 m-85 -133.42 137.1 45.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.63 0.728 . . . . 0.0 110.447 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.533 ' HB3' ' CE1' ' A' ' 196' ' ' HIS . 4.3 mm? -119.62 139.72 51.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.414 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -134.49 112.25 10.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.479 ' HA ' HG21 ' A' ' 289' ' ' VAL . 40.6 t -60.1 98.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.132 0.492 . . . . 0.0 109.907 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.477 ' O ' HD13 ' A' ' 192' ' ' ILE . 11.5 tt -77.04 -23.2 14.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.929 -177.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.784 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -167.96 99.95 0.46 Allowed 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.9 -177.0 34.59 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.638 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 64.0 Cg_endo -79.82 34.5 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.96 1.773 . . . . 0.0 111.573 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.462 ' HB3' HD13 ' A' ' 220' ' ' LEU . . . -162.99 26.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 187' ' ' ILE . 0.7 OUTLIER -39.16 106.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.908 0.385 . . . . 0.0 110.592 -179.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.89 3.41 1.74 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.105 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.614 HD12 HD13 ' A' ' 220' ' ' LEU . 0.1 OUTLIER -99.31 141.74 31.7 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 117.724 0.762 . . . . 0.0 109.296 177.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 22.2 mt-30 -137.05 147.88 46.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.802 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.581 ' CE1' ' CD1' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -137.41 128.09 26.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.021 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -148.13 164.58 33.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 206' ' ' LEU . 3.5 p -171.19 158.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.336 0.589 . . . . 0.0 110.798 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.441 ' OD1' ' CZ2' ' A' ' 181' ' ' TRP . 8.0 m120 -88.14 146.77 25.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.268 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.839 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 2.6 t -66.65 -3.85 7.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.901 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 1.4 t -93.44 36.9 1.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.159 0.504 . . . . 0.0 110.44 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.502 ' O ' HD11 ' A' ' 206' ' ' LEU . 15.4 m -131.25 96.37 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.073 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.9 -76.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.799 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.91 12.33 34.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 111.465 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.418 ' CG ' ' HB3' ' A' ' 202' ' ' SER . 10.4 pttt -118.42 52.18 1.04 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.048 0.452 . . . . 0.0 110.539 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.996 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -147.76 -30.44 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.996 ' HD2' ' H ' ' A' ' 206' ' ' LEU . 3.1 Cg_endo -45.38 99.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 121.088 1.424 . . . . 0.0 112.078 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 231' ' ' GLN . 61.9 t -68.76 160.77 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.872 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.734 ' HB2' ' HB2' ' A' ' 217' ' ' ASP . 13.6 mtpp -136.8 127.74 27.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.805 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.553 HD11 ' N ' ' A' ' 210' ' ' LEU . 0.0 OUTLIER -126.61 148.32 49.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.127 0.489 . . . . 0.0 111.496 178.429 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . 153.45 -157.07 27.15 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.633 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -69.2 157.06 37.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.641 0.258 . . . . 0.0 111.355 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.419 ' O ' ' CB ' ' A' ' 214' ' ' SER . 7.2 p -77.42 123.43 34.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.777 0.799 . . . . 0.0 113.127 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.705 ' CB ' ' HD3' ' A' ' 215' ' ' PRO . 0.8 OUTLIER 160.27 -81.7 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 114.176 -1.374 . . . . 0.0 109.718 178.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.705 ' HD3' ' CB ' ' A' ' 214' ' ' SER . 16.6 Cg_endo -98.28 -14.4 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.255 1.97 . . . . 0.0 113.254 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.2 174.05 11.12 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.734 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.5 OUTLIER -88.49 -36.4 16.47 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.935 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.77 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 10.7 mt -94.04 132.69 38.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 191' ' ' ALA . . . -95.36 72.59 3.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.927 0.394 . . . . 0.0 110.0 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.77 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.1 mm? -96.23 88.05 4.68 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.638 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 8.0 ptpt -57.63 63.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 0.0 110.849 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 220' ' ' LEU . 2.0 m-20 -95.59 149.64 21.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.989 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.0 t -90.93 -5.8 54.97 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.11 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.448 ' HG3' ' CA ' ' A' ' 284' ' ' GLY . 4.5 pm0 -93.88 -21.13 19.43 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.564 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.671 ' O ' ' HB2' ' A' ' 212' ' ' ARG . 3.1 p -111.85 82.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.7 t -34.76 -44.35 0.21 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.835 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.11 -48.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.876 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -145.5 131.14 18.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.97 0.414 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.586 ' CD2' ' HB2' ' A' ' 283' ' ' LEU . 7.0 t60 -102.77 -49.81 3.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.447 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.523 ' CB ' HD23 ' A' ' 210' ' ' LEU . . . -147.65 179.08 7.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.204 0.526 . . . . 0.0 112.389 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -162.38 172.92 14.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.663 -179.349 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.707 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 10.9 mt -129.05 149.09 33.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.567 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.87 155.44 25.66 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.839 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 4.8 p90 -137.94 156.4 47.9 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.29 123.28 49.02 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.028 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 p -84.06 -4.32 58.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.515 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.0 m -77.8 -22.25 50.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.325 0.583 . . . . 0.0 110.392 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -144.47 20.71 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.855 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 17.6 p90 40.82 64.88 0.88 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.461 0.648 . . . . 0.0 109.811 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.614 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 10.5 mptt -128.31 141.4 51.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.058 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.707 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 4.8 m95 -120.69 117.25 27.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.211 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.3 mt-10 -133.93 141.78 47.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.779 0.8 . . . . 0.0 113.11 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 2.2 pp -108.13 154.0 22.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.658 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.451 HG22 ' CD1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -125.51 163.28 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.75 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 1.9 t0 -97.92 156.94 16.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.651 0.739 . . . . 0.0 112.502 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.562 ' N ' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -130.66 90.55 2.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.348 178.681 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 49.18 69.16 1.08 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.288 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.68 70.44 6.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.552 HD12 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.74 -51.44 67.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.944 178.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.552 ' H ' HD12 ' A' ' 249' ' ' LEU . 1.1 p-10 -72.74 -33.27 66.27 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.303 0.573 . . . . 0.0 110.977 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 100.95 101.19 2.46 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.922 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 258' ' ' SER . 11.3 m -64.9 160.12 21.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.532 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -156.55 153.86 29.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.301 0.572 . . . . 0.0 112.418 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.51 ' N ' HD12 ' A' ' 259' ' ' ILE . 78.0 t -129.99 130.47 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.268 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.586 ' HA ' HD11 ' A' ' 280' ' ' ILE . 54.1 t30 59.21 38.58 23.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.027 0.442 . . . . 0.0 110.319 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.1 36.58 5.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.041 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -148.61 118.92 7.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.998 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 25.1 p -62.67 94.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.383 0.611 . . . . 0.0 110.456 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 273' ' ' VAL . 0.1 OUTLIER -95.6 -17.98 6.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt . . . . . 0 CA--C 1.516 -0.361 0 CA-C-O 121.439 0.637 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.516 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 39.5 t-105 -71.46 -25.64 62.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.6 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.03 160.92 27.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.764 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -98.34 151.7 37.62 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.792 0.329 . . . . 0.0 111.142 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 32.5 Cg_exo -58.63 115.9 2.87 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.894 2.396 . . . . 0.0 113.479 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 78.4 t -99.76 138.16 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.2 pp20? -83.71 129.41 34.95 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.229 -0.988 . . . . 0.0 112.174 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.507 ' H ' ' CD1' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -94.32 164.32 13.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.755 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.528 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.06 160.01 41.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.282 0.563 . . . . 0.0 112.074 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.662 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 6.1 p -61.61 131.01 48.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.127 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.662 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.2 m-20 85.21 5.68 0.51 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.873 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.9 m-20 -79.11 -168.07 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.641 ' N ' ' CD1' ' A' ' 280' ' ' ILE . 0.1 OUTLIER -160.36 128.21 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.1 OUTLIER -103.25 154.49 5.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.162 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.532 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -142.17 116.93 9.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.586 ' HB2' ' CD2' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -114.72 40.62 2.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 -178.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.448 ' CA ' ' HG3' ' A' ' 224' ' ' GLU . . . 179.37 -130.99 1.6 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 119.57 -1.3 . . . . 0.0 113.555 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 5.0 t -92.09 -49.49 6.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.595 0.235 . . . . 0.0 111.21 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -139.75 0.67 1.83 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.784 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.5 m -72.58 103.66 3.62 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.248 -0.181 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.667 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 10.9 mtpt -121.45 129.55 53.04 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.667 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 186' ' ' VAL . 0.4 OUTLIER -107.83 129.71 61.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.539 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.477 ' CE2' ' HA ' ' A' ' 278' ' ' ASP . 4.4 t80 -77.52 137.2 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.491 ' HA ' HD11 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -104.69 114.01 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.626 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.11 129.73 42.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.664 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 16.8 mt -126.84 139.24 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.546 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.66 142.64 50.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.672 0.272 . . . . 0.0 110.388 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 41.1 p -79.7 150.52 30.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.07 0.462 . . . . 0.0 110.864 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . 0.599 ' HB3' ' N ' ' A' ' 180' ' ' SER . 2.8 tp-100 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.491 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.129 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.0 m95 -149.0 133.88 18.0 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.9 OUTLIER -119.23 133.13 55.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.045 177.014 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 6.2 m-85 -132.44 137.24 47.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.776 0.798 . . . . 0.0 110.975 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.753 ' HB3' ' CE1' ' A' ' 196' ' ' HIS . 4.5 mm? -120.97 140.52 51.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.494 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.467 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 3.6 tt0 -134.93 114.3 12.39 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -178.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.814 ' HA ' HG12 ' A' ' 289' ' ' VAL . 2.6 t -59.52 110.33 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.327 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 187' ' ' ILE . 10.2 tt -95.61 -23.77 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.735 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.84 95.09 0.7 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.441 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.527 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.4 -178.07 35.96 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.467 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 73.0 Cg_endo -78.52 32.36 0.45 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.153 1.902 . . . . 0.0 111.642 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.489 ' HB2' HD12 ' A' ' 220' ' ' LEU . . . -161.77 22.63 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.187 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.527 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -40.24 108.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.65 5.01 1.53 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.788 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.528 ' CD1' HD11 ' A' ' 220' ' ' LEU . 0.1 OUTLIER -100.41 170.04 8.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 22.1 mt-30 -159.92 148.74 17.46 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.928 0.394 . . . . 0.0 111.6 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.753 ' CE1' ' HB3' ' A' ' 184' ' ' LEU . 0.7 OUTLIER -134.27 124.76 26.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.469 0.652 . . . . 0.0 109.467 178.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 182' ' ' LEU . . . -145.22 168.66 19.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.357 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.749 HG21 ' HA ' ' A' ' 206' ' ' LEU . 2.3 p -178.03 160.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.424 0.631 . . . . 0.0 111.529 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.502 ' ND2' HG21 ' A' ' 201' ' ' THR . 0.7 OUTLIER -96.1 148.62 22.5 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.974 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.477 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 13.3 p -65.46 -1.18 2.33 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.502 HG21 ' ND2' ' A' ' 199' ' ' ASN . 0.6 OUTLIER -109.73 10.52 24.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.795 0.331 . . . . 0.0 111.44 179.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.407 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -87.9 137.83 31.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.057 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 61.1 m -90.14 -88.29 0.17 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 43.9 m -93.47 20.18 7.55 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.407 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.2 OUTLIER -118.05 -11.57 10.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.059 0.456 . . . . 0.0 110.742 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.749 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.8 tt -74.15 -60.59 1.43 Allowed Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.828 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.529 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 2.0 Cg_endo -42.99 99.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.338 2.025 . . . . 0.0 112.639 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.599 ' O ' ' CB ' ' A' ' 231' ' ' GLN . 99.1 t -69.26 158.39 6.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.971 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.678 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 16.4 mtpt -138.25 77.86 1.65 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.635 HD21 ' CD2' ' A' ' 218' ' ' LEU . 3.7 mp -65.5 122.39 17.08 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.116 -0.365 . . . . 0.0 110.655 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . -164.32 166.37 37.72 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.941 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.789 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.2 OUTLIER -67.12 -70.83 0.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -177.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.641 HG23 ' HD2' ' A' ' 215' ' ' PRO . 14.9 p -78.48 157.34 4.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.487 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -30.07 -54.89 0.34 Allowed Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.641 ' HD2' HG23 ' A' ' 213' ' ' VAL . 55.0 Cg_exo -36.83 -30.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.854 2.37 . . . . 0.0 113.133 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.441 ' CB ' ' HA3' ' A' ' 211' ' ' GLY . 0.9 OUTLIER -81.91 154.92 25.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.616 0.246 . . . . 0.0 110.512 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.556 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -69.24 -40.53 77.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.328 . . . . 0.0 110.194 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.659 HD23 ' CE1' ' A' ' 196' ' ' HIS . 2.6 tp -97.47 130.16 44.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.487 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -90.04 76.84 6.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.01 0.433 . . . . 0.0 110.963 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.789 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.5 mm? -106.69 90.64 3.39 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.44 ' CG ' ' HB2' ' A' ' 190' ' ' PRO . 4.6 pttt -64.0 36.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 220' ' ' LEU . 26.5 t0 -65.65 132.89 49.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.9 p -73.55 -4.53 34.55 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.255 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -18.73 24.24 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.717 0.294 . . . . 0.0 110.545 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.552 ' CG1' ' HB2' ' A' ' 212' ' ' ARG . 5.4 p -107.58 86.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.172 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.23 -42.95 0.49 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.346 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.39 -49.91 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 246' ' ' MET . 0.0 OUTLIER -143.5 135.32 26.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.461 . . . . 0.0 110.016 179.259 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.577 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.1 t60 -106.12 -52.95 2.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -148.34 176.04 10.59 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.678 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -159.17 178.51 9.93 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.881 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 243' ' ' LEU . 18.7 mt -137.22 147.63 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 121.471 0.653 . . . . 0.0 112.405 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.431 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -161.65 158.5 26.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.781 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 7.0 p90 -147.48 166.81 26.13 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -116.0 133.58 55.88 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.352 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 82.1 p -93.23 1.19 57.17 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.262 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.0 m -79.31 -37.92 36.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.888 0.851 . . . . 0.0 109.652 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.455 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 50.5 tptt -124.9 13.58 8.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.068 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.3 p90 42.47 61.27 2.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.528 0.68 . . . . 0.0 109.87 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.781 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.4 OUTLIER -125.32 137.57 54.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.146 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.688 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -118.95 120.33 36.97 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.062 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 6.9 mt-10 -138.32 144.04 40.22 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.836 0.827 . . . . 0.0 112.629 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 1.5 pp -105.01 152.02 23.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.474 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.48 HG13 ' HG3' ' A' ' 231' ' ' GLN . 4.3 p -122.37 163.36 20.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.462 ' OD1' ' HB ' ' A' ' 252' ' ' THR . 0.3 OUTLIER -105.96 156.43 18.39 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.659 ' HA ' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -80.97 149.17 29.46 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.18 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.481 ' HA2' ' C ' ' A' ' 268' ' ' LYS . . . -53.21 10.84 0.01 OUTLIER Glycine 0 C--N 1.317 -0.508 0 N-CA-C 115.569 0.988 . . . . 0.0 115.569 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 246' ' ' MET . 0.6 OUTLIER -89.4 130.48 35.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.025 1.412 . . . . 0.0 110.77 179.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.536 HD22 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -57.16 6.04 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.48 ' N ' HD12 ' A' ' 249' ' ' LEU . 4.9 m-20 -70.0 -40.25 75.4 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 119.666 1.121 . . . . 0.0 109.847 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 72.57 119.02 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.126 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 258' ' ' SER . 76.7 m -73.5 172.07 12.0 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.305 0.242 . . . . 0.0 110.457 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.616 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -144.4 121.23 11.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.174 0.512 . . . . 0.0 110.567 177.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.427 HG23 HG12 ' A' ' 259' ' ' ILE . 89.9 t -97.15 134.97 32.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.759 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 280' ' ' ILE . 11.9 p30 49.58 34.54 7.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.147 0.499 . . . . 0.0 110.104 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.55 36.64 1.24 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.831 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -144.61 112.49 6.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.646 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 77.7 p -61.03 85.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 110.811 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.511 ' HB ' HG22 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -84.98 -13.29 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.263 -179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.468 ' N ' HD11 ' A' ' 259' ' ' ILE . 17.0 p . . . . . 0 C--N 1.329 -0.315 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.481 ' C ' ' HA2' ' A' ' 247' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.659 ' CZ3' ' HA ' ' A' ' 246' ' ' MET . 11.6 t-105 -71.54 -16.38 62.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.06 -175.92 4.96 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -109.51 151.15 42.02 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 117.857 0.829 . . . . 0.0 110.95 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 34.6 Cg_exo -60.27 117.65 4.43 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.777 2.318 . . . . 0.0 113.463 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 97.6 t -95.49 137.06 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.5 OUTLIER -83.36 125.04 31.23 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.864 -179.013 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.441 ' C ' ' CD2' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -90.25 164.33 14.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.566 179.176 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.7 157.37 45.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.258 0.551 . . . . 0.0 112.043 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 68.3 p -58.21 127.81 33.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.483 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 84.24 8.84 0.5 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.418 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.6 t0 -83.18 -165.54 1.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.487 ' CG2' ' HD1' ' A' ' 290' ' ' TYR . 0.5 OUTLIER -162.36 134.45 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.592 177.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -108.57 156.6 9.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.67 178.471 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.616 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.3 m -146.52 113.8 6.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.577 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -114.64 47.8 1.21 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.589 -178.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 172.58 -125.14 1.13 Allowed Glycine 0 CA--C 1.517 0.205 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.453 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.5 t -96.9 -47.13 5.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.644 0.259 . . . . 0.0 111.244 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -144.83 -6.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.735 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 61.6 m -64.93 103.44 0.72 Allowed 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.432 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 2.8 mtpt -124.78 134.53 52.75 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.034 0.445 . . . . 0.0 111.259 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.814 HG12 ' HA ' ' A' ' 186' ' ' VAL . 0.1 OUTLIER -114.97 134.24 58.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.69 -178.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.487 ' HD1' ' CG2' ' A' ' 280' ' ' ILE . 2.3 t80 -76.98 139.49 40.12 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.971 0.415 . . . . 0.0 110.261 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.618 ' HA ' HD11 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -106.32 113.13 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.846 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.91 144.86 50.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.516 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.456 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 11.5 mt -144.15 116.81 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.443 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.1 m -123.74 147.52 47.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.951 0.405 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 70.4 m -80.8 -178.31 6.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.7 OUTLIER . . . . . 0 CA--C 1.521 -0.139 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 6.6 m95 -147.2 132.32 18.3 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.679 HD22 ' HZ3' ' A' ' 234' ' ' TRP . 6.1 tp -117.86 127.47 53.9 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.092 176.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 16.9 m-85 -125.74 136.5 53.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.676 0.751 . . . . 0.0 110.932 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.75 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.4 mp -138.13 149.84 46.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.917 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.513 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 12.9 tt0 -145.09 127.09 15.52 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.437 ' HA ' HG12 ' A' ' 289' ' ' VAL . 13.4 t -64.07 114.87 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.438 HG23 ' CB ' ' A' ' 288' ' ' LYS . 8.7 tt -99.01 -20.17 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.79 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.74 91.39 0.56 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.421 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.749 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.82 -172.68 29.53 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.663 ' HB2' ' HD2' ' A' ' 221' ' ' LYS . 70.7 Cg_endo -77.0 26.84 0.44 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.121 1.881 . . . . 0.0 111.931 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 189' ' ' GLY . . . -162.0 29.91 0.12 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.114 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.749 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.3 mt -42.84 116.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.46 -51.78 0.76 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.341 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -38.56 149.43 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.282 0.563 . . . . 0.0 111.215 -178.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.75 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.6 mt-30 -148.63 149.97 32.44 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.813 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.598 ' ND1' HD12 ' A' ' 184' ' ' LEU . 2.0 p80 -136.93 126.95 25.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.251 0.548 . . . . 0.0 109.847 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.6 161.26 38.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.476 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.46 HG11 ' CH2' ' A' ' 234' ' ' TRP . 4.0 p -172.61 160.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 111.812 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 180' ' ' SER . 29.9 m-80 -88.74 150.12 23.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.24 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.549 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 40.6 t -64.08 -9.01 13.78 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.623 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 1.8 t -101.18 34.47 2.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.209 0.528 . . . . 0.0 111.061 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.403 ' HB2' ' CG ' ' A' ' 205' ' ' LYS . 35.9 p -116.13 129.74 56.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.634 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.0 m -90.33 -86.93 0.19 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.0 m -86.8 14.24 7.5 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.403 ' CG ' ' HB2' ' A' ' 202' ' ' SER . 0.0 OUTLIER -115.83 -13.46 11.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.995 0.426 . . . . 0.0 110.412 178.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.602 ' HB3' ' CD ' ' A' ' 207' ' ' PRO . 6.4 tt -70.4 -60.29 3.4 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.314 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.602 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.0 OUTLIER -43.51 97.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.562 2.175 . . . . 0.0 113.47 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.71 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 98.9 t -68.32 163.16 3.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.535 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 3.6 mtpp -139.66 85.81 2.07 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.606 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.5 OUTLIER -73.67 126.43 30.29 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.163 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.449 ' HA3' ' OG ' ' A' ' 216' ' ' SER . . . -170.09 173.15 44.12 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.943 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.783 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.2 OUTLIER -70.58 -75.12 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.742 HG23 ' HD2' ' A' ' 215' ' ' PRO . 11.3 p -78.99 160.13 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -176.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.484 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 0.6 OUTLIER -27.68 -52.59 0.23 Allowed Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -178.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.742 ' HD2' HG23 ' A' ' 213' ' ' VAL . 5.0 Cg_exo -38.5 -29.77 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.634 2.223 . . . . 0.0 112.962 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.449 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 0.7 OUTLIER -82.98 151.24 25.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.648 179.011 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -31.03 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.108 0.48 . . . . 0.0 109.967 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.769 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 0.8 OUTLIER -105.74 131.24 53.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.234 178.591 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.611 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -91.23 77.75 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.84 0.353 . . . . 0.0 111.808 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.783 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.2 mm? -101.26 87.09 3.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.663 ' HD2' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -59.65 24.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.108 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.765 ' HB2' HG13 ' A' ' 225' ' ' VAL . 5.7 m-20 -54.48 115.04 1.9 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.805 0.336 . . . . 0.0 110.791 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 t -56.31 -16.21 5.17 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.45 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 1.9 pm0 -83.19 -23.51 32.82 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.765 HG13 ' HB2' ' A' ' 222' ' ' ASP . 2.4 p -97.18 92.26 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 0.0 110.084 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 36.1 m -37.89 -48.18 1.12 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.271 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.06 -50.1 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.698 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.401 ' HD3' ' CB ' ' A' ' 216' ' ' SER . 0.4 OUTLIER -141.26 125.87 17.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.424 0.63 . . . . 0.0 110.738 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.504 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.9 t60 -89.8 -62.17 1.53 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.6 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.488 ' C ' HD13 ' A' ' 210' ' ' LEU . . . -145.32 178.01 8.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.39 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.71 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -160.81 178.25 9.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.659 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.501 HG12 ' HB3' ' A' ' 243' ' ' LEU . 6.5 mt -138.85 149.92 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.149 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.421 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -161.24 143.49 12.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.091 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.783 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 5.2 p90 -131.89 165.25 24.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.65 133.78 55.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.645 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 95.5 p -91.75 0.71 57.47 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.264 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.8 m -77.72 -32.33 52.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.7 0.762 . . . . 0.0 109.825 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.518 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -134.78 16.22 3.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.308 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.416 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 17.8 p90 43.73 62.46 1.91 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.459 0.647 . . . . 0.0 109.609 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.783 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 5.1 mptt -125.86 140.58 52.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.207 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.667 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -125.21 118.0 25.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.37 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.7 pt-20 -133.97 148.09 51.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.994 0.902 . . . . 0.0 112.821 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.613 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 1.3 pp -112.19 149.71 31.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.925 -1.488 . . . . 0.0 110.843 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.476 ' CG2' ' HB3' ' A' ' 269' ' ' TRP . 0.8 OUTLIER -124.46 160.86 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 9.2 m-20 -110.7 108.66 18.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.536 ' CE ' ' HG2' ' A' ' 231' ' ' GLN . 1.8 ptp -86.38 106.85 17.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 50.25 62.73 4.84 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.173 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.8 p -79.14 71.35 5.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.706 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -55.08 -56.64 17.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.844 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.586 ' N ' HD23 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -73.35 -27.11 61.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 111.017 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 91.16 135.22 6.37 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.81 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 282' ' ' THR . 3.5 m -97.3 156.84 16.26 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.673 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -149.04 139.17 22.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.077 0.465 . . . . 0.0 111.297 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.83 133.02 56.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.266 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.686 ' HA ' HG13 ' A' ' 280' ' ' ILE . 11.4 p30 53.02 38.07 26.36 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.256 0.551 . . . . 0.0 110.689 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.2 m 70.68 36.75 1.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.876 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.01 113.18 6.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.947 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 69.0 p -63.82 82.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.471 0.653 . . . . 0.0 110.384 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.529 ' HB ' HG23 ' A' ' 273' ' ' VAL . 0.4 OUTLIER -81.31 -10.75 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.73 -178.141 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.436 ' N ' HD12 ' A' ' 259' ' ' ILE . 15.4 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.583 0.23 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.609 ' HA ' ' O ' ' A' ' 245' ' ' ASP . 0.5 OUTLIER -79.71 -6.17 56.67 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.709 179.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 74.85 -106.93 2.17 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 119.485 -1.34 . . . . 0.0 109.759 -177.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.589 ' O ' HG21 ' A' ' 273' ' ' VAL . 0.7 OUTLIER -152.14 125.1 4.1 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.67 174.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 84.9 Cg_exo -38.66 102.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.723 1.616 . . . . 0.0 110.04 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 271' ' ' ASN . 45.3 t -93.08 139.04 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.299 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.4 mm-40 -84.55 127.5 34.08 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.255 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.604 HD11 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.56 164.76 13.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.37 179.531 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.616 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.85 161.24 39.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 1.5 m -62.27 131.93 51.0 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.778 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.575 ' HB2' ' O ' ' A' ' 277' ' ' SER . 34.6 m-20 80.16 -0.2 2.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.414 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.616 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -71.73 -164.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.686 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.9 OUTLIER -157.13 123.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.161 177.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.579 HG21 ' CG2' ' A' ' 289' ' ' VAL . 0.3 OUTLIER -104.89 157.73 5.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.945 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.673 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 2.9 m -150.38 126.58 10.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.504 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -121.85 49.96 1.49 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 175.26 -134.26 2.67 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.496 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.5 t -89.44 -38.63 13.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.119 0.485 . . . . 0.0 109.805 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -151.65 -5.63 0.25 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.11 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.79 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 26.3 m -66.63 99.95 0.64 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.196 0.522 . . . . 0.0 111.353 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.442 ' C ' ' CG2' ' A' ' 289' ' ' VAL . 17.0 mttt -99.13 178.93 4.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.592 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.579 ' CG2' HG21 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -162.72 120.0 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.088 177.489 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.604 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.7 t80 -75.76 136.98 40.28 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.53 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -107.2 111.36 35.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.183 -178.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 9.0 tpt85 -128.24 144.14 51.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.458 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.456 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 20.9 mt -143.01 123.75 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.26 153.46 46.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.696 0.284 . . . . 0.0 110.533 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 73.1 m -80.63 174.95 11.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.821 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.93 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.308 0.099 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 17.8 m95 -151.09 148.8 28.75 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.632 HD22 ' HZ3' ' A' ' 234' ' ' TRP . 0.1 OUTLIER -128.36 127.57 42.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.021 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 2.3 m-85 -125.69 142.09 51.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.908 0.861 . . . . 0.0 112.531 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.634 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -137.66 147.44 44.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.022 176.421 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.477 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -139.56 129.45 24.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.505 HG13 HD12 ' A' ' 220' ' ' LEU . 26.9 t -66.41 116.18 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 288' ' ' LYS . 4.7 tt -99.01 -22.2 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.879 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -160.63 92.54 0.96 Allowed 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.665 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.4 -169.8 25.19 Favored Glycine 0 CA--C 1.516 0.116 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.61 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 96.3 Cg_endo -81.02 28.45 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.042 1.828 . . . . 0.0 111.631 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.51 24.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.912 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.665 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.5 mt -39.53 114.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.876 0.37 . . . . 0.0 111.954 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.24 7.74 4.34 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.924 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.723 HD11 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -97.12 128.25 43.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.477 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 10.8 mt-30 -127.71 150.84 49.6 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.022 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.628 ' HB3' HD23 ' A' ' 184' ' ' LEU . 1.0 OUTLIER -141.62 142.05 33.43 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.83 179.387 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -132.5 136.33 46.59 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.189 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.564 ' CG2' ' HG ' ' A' ' 206' ' ' LEU . 12.3 p -141.39 130.92 24.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.487 0.66 . . . . 0.0 111.863 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -85.88 145.56 27.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.949 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.425 ' HB2' ' CZ2' ' A' ' 234' ' ' TRP . 12.2 t -63.55 -3.55 2.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.69 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.52 6.46 32.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.464 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -85.69 130.59 34.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.0 110.289 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.9 t -90.65 -90.16 0.16 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 24.7 p -84.51 14.81 4.17 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -123.49 -14.39 7.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.036 0.446 . . . . 0.0 110.522 179.038 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.58 ' HB3' ' CD ' ' A' ' 207' ' ' PRO . 7.8 tt -65.61 -62.53 4.36 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.706 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -43.17 99.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.36 2.04 . . . . 0.0 112.584 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.585 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 87.3 t -68.36 164.71 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.902 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.619 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 25.5 mtmt -141.41 94.57 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.501 HD13 ' C ' ' A' ' 230' ' ' ALA . 0.6 OUTLIER -87.96 131.03 34.76 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.28 173.65 45.31 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.993 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.647 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 12.2 ttt180 -71.15 -74.96 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.808 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 10.2 p -140.54 110.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.462 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.57 ' C ' ' H ' ' A' ' 216' ' ' SER . 0.3 OUTLIER 178.61 179.89 0.23 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.962 -179.026 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 37.0 Cg_endo -66.1 25.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 121.907 1.738 . . . . 0.0 112.331 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.57 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -68.21 -172.93 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.966 0.412 . . . . 0.0 111.242 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.407 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 13.3 m-20 -104.7 -29.48 10.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.474 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.562 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 5.7 mt -112.64 131.68 55.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.723 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -98.25 87.72 3.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.567 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 222' ' ' ASP . 3.0 mm? -103.72 59.65 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.647 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -53.2 73.19 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.22 -178.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.61 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 7.0 t0 -116.58 143.11 46.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.003 0.43 . . . . 0.0 110.311 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.5 t -63.5 -5.3 3.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.541 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.592 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 0.1 OUTLIER -86.79 -30.73 21.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 109.869 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.594 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 0.1 OUTLIER -95.62 107.68 19.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.601 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -49.38 71.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.137 0.494 . . . . 0.0 110.297 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 228' ' ' LYS . . . -148.1 -51.06 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.468 ' HG2' ' HG ' ' A' ' 216' ' ' SER . 0.1 OUTLIER -145.81 125.11 13.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.013 0.435 . . . . 0.0 110.479 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.569 ' HB2' ' CG1' ' A' ' 225' ' ' VAL . 2.5 t60 -84.56 -58.95 2.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.196 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.501 ' C ' HD13 ' A' ' 210' ' ' LEU . . . -152.23 175.53 12.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.498 -177.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.619 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -155.55 179.96 8.68 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.817 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.706 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.5 mt -135.79 149.44 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.41 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.404 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -153.69 164.35 38.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.632 ' HZ3' HD22 ' A' ' 182' ' ' LEU . 0.6 OUTLIER -93.33 153.43 18.55 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.018 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 239' ' ' PHE . 2.3 m-20 -119.35 71.02 0.85 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.722 -1.581 . . . . 0.0 106.975 174.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.1 p -53.87 -23.24 11.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.9 m -74.38 -27.12 60.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.549 0.69 . . . . 0.0 109.235 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -117.25 8.66 13.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.334 178.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 235' ' ' ASN . 2.7 p90 38.38 39.47 0.29 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.622 0.248 . . . . 0.0 111.039 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.44 ' HD2' ' HB3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -112.27 179.96 3.85 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.423 0.63 . . . . 0.0 110.009 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.628 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -131.02 115.0 15.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.917 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 14.0 pt-20 -137.65 151.72 48.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.4 pp -116.34 153.85 31.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.053 -1.431 . . . . 0.0 111.802 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.534 HG13 ' HG3' ' A' ' 231' ' ' GLN . 2.1 p -121.7 162.69 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.672 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.758 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 8.3 t0 -102.49 116.88 33.52 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -77.53 98.0 5.21 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.488 ' O ' HD12 ' A' ' 249' ' ' LEU . . . 56.2 70.18 1.05 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.704 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.5 p -62.87 48.15 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.584 HD21 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.58 -49.81 73.76 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.231 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.584 ' N ' HD21 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.5 -39.02 28.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 93.52 93.39 1.54 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.614 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.558 HG23 ' CD1' ' A' ' 281' ' ' ILE . 20.0 m -50.2 164.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 258' ' ' SER . 0.2 OUTLIER -150.29 139.7 21.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.328 0.585 . . . . 0.0 111.303 179.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.512 HG21 HD13 ' A' ' 281' ' ' ILE . 70.3 t -114.37 137.13 48.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.748 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.666 ' HA ' HG13 ' A' ' 280' ' ' ILE . 23.4 p30 47.69 34.98 4.06 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.307 0.575 . . . . 0.0 110.421 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' SER . . . . . 0.47 ' N ' HD13 ' A' ' 280' ' ' ILE . 0.1 OUTLIER 72.87 35.35 1.02 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.481 -179.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . 0.432 ' O ' HG21 ' A' ' 259' ' ' ILE . 64.5 t-80 -137.56 111.42 8.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.714 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 5.4 t -63.05 84.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.454 0.645 . . . . 0.0 110.992 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.545 ' CG1' HG23 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -84.28 -8.49 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.724 -178.523 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.758 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 21.4 m . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.566 ' HE3' ' HB2' ' A' ' 269' ' ' TRP . 13.2 ttpt . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.595 ' HA ' ' O ' ' A' ' 245' ' ' ASP . 12.2 t-105 -83.66 -27.46 29.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.435 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.79 -178.29 5.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.203 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -105.09 146.89 33.57 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.106 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 71.8 Cg_exo -49.88 148.99 11.8 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.594 2.196 . . . . 0.0 112.857 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 69.2 t -129.86 136.31 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.4 mp0 -81.53 128.14 33.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 118.794 -1.162 . . . . 0.0 112.052 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.508 ' H ' HD12 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.0 165.93 12.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.027 178.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.666 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.28 161.73 37.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.673 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 3.7 p -62.64 130.04 43.24 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.281 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 277' ' ' SER . 30.9 m-20 81.87 -1.48 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.449 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.681 ' O ' HG21 ' A' ' 280' ' ' ILE . 0.2 OUTLIER -70.8 -162.83 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.681 HG21 ' O ' ' A' ' 279' ' ' ASP . 0.9 OUTLIER -159.97 129.09 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.226 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.718 ' O ' ' CG2' ' A' ' 281' ' ' ILE . 0.3 OUTLIER -117.3 93.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 288' ' ' LYS . 1.8 m -79.56 129.51 34.54 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.559 ' HB3' ' CD2' ' A' ' 229' ' ' HIS . 0.5 OUTLIER -118.92 50.53 1.2 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.424 -178.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.508 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 162.73 -119.01 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 119.198 -1.477 . . . . 0.0 113.673 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 1.7 t -95.51 -58.75 2.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.374 0.131 . . . . 0.0 111.159 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -134.08 -1.28 2.97 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.762 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.879 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 40.4 m -72.51 102.14 3.15 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 282' ' ' THR . 12.7 ttmt -119.4 123.36 43.92 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.104 0.478 . . . . 0.0 111.286 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 1.1 t -103.01 129.86 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.964 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.634 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 0.6 OUTLIER -77.36 133.85 38.62 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.659 -0.416 . . . . 0.0 109.912 -179.309 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.494 ' CG1' ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -103.44 112.81 38.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.633 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -130.59 141.14 50.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.949 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.525 HG12 HD11 ' A' ' 182' ' ' LEU . 2.1 mt -138.98 143.2 32.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.8 t -151.67 164.23 37.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.1 -169.87 2.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.428 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.77 0.319 . . . . 0.0 111.067 -179.81 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.664 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.9 m95 -147.65 130.58 16.21 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 184' ' ' LEU . 5.2 tp -113.27 124.37 52.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.058 177.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.664 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 6.5 m-85 -123.39 130.27 52.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.713 0.768 . . . . 0.0 110.791 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.748 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.2 mp -131.6 142.61 49.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.346 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.613 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 24.6 tt0 -140.2 124.8 18.08 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.272 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.743 HG21 HD12 ' A' ' 194' ' ' LEU . 11.1 t -61.33 113.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.013 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.6 tt -97.05 -20.46 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.69 95.01 0.71 Allowed 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.919 -179.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.7 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.32 -175.81 33.74 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 178.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.509 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 96.3 Cg_endo -79.23 30.95 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.782 1.655 . . . . 0.0 110.966 178.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.516 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -161.81 24.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.7 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.2 mt -39.55 113.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.75 11.26 2.98 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.3 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.743 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -100.67 155.89 17.63 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.823 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.748 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 27.2 mt-30 -150.61 151.3 32.35 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.801 -177.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.738 ' CE1' HD12 ' A' ' 218' ' ' LEU . 3.7 p-80 -138.56 128.62 25.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.08 164.43 30.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.407 -179.099 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.818 HG23 ' HA ' ' A' ' 206' ' ' LEU . 5.9 p -172.84 156.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.4 0.619 . . . . 0.0 111.726 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.519 ' N ' HG22 ' A' ' 198' ' ' VAL . 3.3 m120 -91.52 144.76 25.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.395 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.455 ' HB2' ' CZ2' ' A' ' 234' ' ' TRP . 3.2 t -61.37 -4.52 1.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.455 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.9 t -102.08 0.54 35.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.561 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -75.12 138.27 41.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.418 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.2 m -87.18 -89.08 0.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.2 18.8 17.8 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.777 0.323 . . . . 0.0 111.722 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -6.88 11.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.525 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.818 ' HA ' HG23 ' A' ' 198' ' ' VAL . 7.5 tt -75.6 -62.53 0.77 Allowed Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.782 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.8 Cg_endo -42.7 99.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.254 1.969 . . . . 0.0 112.765 -178.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.599 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 43.1 t -69.54 165.31 2.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.757 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.554 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 4.3 mtpp -135.18 90.19 2.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.8 OUTLIER -78.11 124.93 28.62 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.891 -179.945 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.711 ' HA2' HG23 ' A' ' 225' ' ' VAL . . . 177.01 -173.72 46.52 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.823 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.74 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.6 OUTLIER -60.32 155.92 16.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.583 0.23 . . . . 0.0 110.936 -179.755 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 219' ' ' ALA . 10.0 p -77.29 119.43 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.892 0.854 . . . . 0.0 113.204 -176.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.739 ' CB ' ' HD3' ' A' ' 215' ' ' PRO . 0.6 OUTLIER 160.88 -75.99 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.709 178.92 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.739 ' HD3' ' CB ' ' A' ' 214' ' ' SER . 42.9 Cg_endo -100.9 -14.82 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.653 2.235 . . . . 0.0 112.837 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.457 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 1.2 m -80.21 157.29 26.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.003 0.43 . . . . 0.0 111.758 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.7 OUTLIER -73.16 -37.23 66.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.805 178.898 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.789 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.7 mt -98.06 134.85 40.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.583 178.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.494 ' HB2' HG23 ' A' ' 213' ' ' VAL . . . -89.39 76.21 7.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.003 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.789 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 2.8 mm? -109.36 94.68 5.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.046 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.509 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -64.71 24.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.656 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.591 ' H ' ' C ' ' A' ' 220' ' ' LEU . 0.4 OUTLIER -55.75 116.05 2.71 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.222 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.4 t -58.73 -20.38 48.6 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.823 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.535 ' CG ' ' HB2' ' A' ' 250' ' ' ASN . 2.3 tp10 -75.11 -19.57 59.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 0.0 110.812 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.711 HG23 ' HA2' ' A' ' 211' ' ' GLY . 5.8 p -124.37 64.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.921 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 10.1 p -46.12 -31.93 2.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.834 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -125.69 -78.86 0.32 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.375 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -139.29 131.0 27.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.076 0.465 . . . . 0.0 110.74 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.677 ' N ' HG21 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -99.59 -55.94 2.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.637 178.908 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 245' ' ' ASP . . . -148.97 164.9 33.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.542 0.687 . . . . 0.0 112.563 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -149.97 -178.24 6.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.522 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.782 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.1 mt -135.9 151.86 29.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 121.071 0.463 . . . . 0.0 112.198 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.23 163.69 39.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.163 178.213 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.586 ' CE3' HD22 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -91.4 152.66 20.31 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -176.286 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 239' ' ' PHE . 26.8 t-20 -120.58 72.29 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.8 t -59.77 -15.83 23.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -175.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 90.7 m -84.33 -35.58 23.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.44 0.638 . . . . 0.0 110.625 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.464 ' HE3' ' CE1' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -112.6 11.83 19.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.355 179.881 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.464 ' CE1' ' HE3' ' A' ' 238' ' ' LYS . 12.5 p90 42.25 69.55 0.36 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 2.0 mptp? -136.96 147.29 46.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.296 -178.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.611 ' N ' ' CD1' ' A' ' 241' ' ' TRP . 0.5 OUTLIER -114.14 103.46 11.14 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 178.656 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 27.6 mt-10 -125.08 143.63 50.82 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.104 0.954 . . . . 0.0 113.286 -176.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 1.4 pp -109.0 151.59 26.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.296 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -125.06 154.09 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.182 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.565 ' C ' ' HB3' ' A' ' 269' ' ' TRP . 5.5 m-20 -117.04 100.49 7.78 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.596 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -64.17 106.64 1.11 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.012 178.332 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.72 68.32 1.75 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.577 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 52.2 p -76.87 61.04 1.86 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.624 HD11 ' N ' ' A' ' 250' ' ' ASN . 1.6 tm? -49.84 -60.01 3.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.149 0.5 . . . . 0.0 110.139 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.624 ' N ' HD11 ' A' ' 249' ' ' LEU . 4.1 t-20 -69.72 -22.34 63.4 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.832 -179.243 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.429 ' O ' HD22 ' A' ' 253' ' ' LEU . . . 81.67 84.57 0.76 Allowed Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.549 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.627 ' HB ' ' OG ' ' A' ' 260' ' ' SER . 55.7 m -46.46 164.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.555 0.178 . . . . 0.0 110.641 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 258' ' ' SER . 0.1 OUTLIER -148.38 126.69 12.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.26 0.552 . . . . 0.0 112.103 179.033 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.41 HG23 HG12 ' A' ' 259' ' ' ILE . 99.8 t -101.95 129.27 53.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.359 178.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.443 ' HA ' HD11 ' A' ' 280' ' ' ILE . 52.6 t-20 53.35 43.06 31.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.138 0.494 . . . . 0.0 110.195 -179.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.36 31.02 17.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.062 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . 0.406 ' O ' ' N ' ' A' ' 259' ' ' ILE . 0.1 OUTLIER -136.73 106.83 6.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.558 179.648 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 60.1 p -57.6 87.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.267 0.556 . . . . 0.0 110.76 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.505 HD13 ' C ' ' A' ' 259' ' ' ILE . 1.0 OUTLIER -88.34 -2.38 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.37 -178.961 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.627 ' OG ' ' HB ' ' A' ' 252' ' ' THR . 1.4 m . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.531 ' HD3' ' CD1' ' A' ' 269' ' ' TRP . 2.7 ptpt . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.596 ' CE3' ' HA ' ' A' ' 246' ' ' MET . 0.0 OUTLIER -95.0 -10.81 29.8 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 179.556 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.481 ' H ' ' HG3' ' A' ' 268' ' ' LYS . . . 58.06 -148.37 36.43 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 118.833 -1.651 . . . . 0.0 111.171 -178.048 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -96.36 126.51 43.58 Favored Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.507 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 4.0 Cg_exo -38.74 120.69 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.983 2.456 . . . . 0.0 111.887 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.47 ' CG2' ' HB ' ' A' ' 259' ' ' ILE . 48.5 t -94.36 135.3 29.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.921 -177.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -81.7 127.16 32.63 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.545 0.688 . . . . 0.0 110.984 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.596 ' HB2' HG13 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.49 162.63 14.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.96 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.11 156.76 45.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.047 0.451 . . . . 0.0 112.054 -179.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.649 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 29.7 p -59.05 128.76 38.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.649 ' HB2' ' O ' ' A' ' 277' ' ' SER . 30.7 m-20 87.13 2.45 0.44 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.143 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -75.78 -166.08 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.528 HG21 ' HD1' ' A' ' 290' ' ' TYR . 0.7 OUTLIER -161.51 130.82 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.085 178.208 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -112.22 156.97 13.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.052 0.453 . . . . 0.0 111.321 178.436 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.472 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.9 m -141.7 119.17 11.58 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.314 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.427 ' HB3' ' CD2' ' A' ' 229' ' ' HIS . 0.7 OUTLIER -111.84 47.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.898 -178.253 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 167.22 -128.14 1.69 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 119.621 -1.276 . . . . 0.0 113.796 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.8 t -89.9 -46.65 8.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.622 0.249 . . . . 0.0 111.137 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 188' ' ' ALA . 3.5 t -144.0 -7.36 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.728 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 47.6 m -64.15 103.21 0.59 Allowed 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 5.5 mtpt -124.72 133.05 53.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 111.318 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.635 HG11 ' HA ' ' A' ' 186' ' ' VAL . 0.1 OUTLIER -112.21 135.5 51.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.564 -179.311 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.4 t80 -77.05 139.29 39.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.596 HG13 ' HB2' ' A' ' 275' ' ' LEU . 0.7 OUTLIER -110.28 114.11 46.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.544 -178.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.521 ' HD2' ' H ' ' A' ' 293' ' ' ILE . 11.8 tpt180 -127.65 148.28 50.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.801 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.521 ' H ' ' HD2' ' A' ' 292' ' ' ARG . 14.3 mt -141.13 113.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.58 156.09 45.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.762 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 22.8 m -90.51 162.04 15.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.873 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.032 -179.869 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 1.4 t . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.703 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 9.9 m95 -149.53 137.79 20.64 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.29 -178.307 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 1.2 tp -119.85 131.05 55.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.703 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 1.7 m-85 -130.32 141.12 50.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.83 0.824 . . . . 0.0 111.595 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.62 ' CD2' ' N ' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -139.46 152.73 47.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.994 178.079 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.513 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 17.7 tt0 -143.56 126.25 16.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.551 ' HA ' HG13 ' A' ' 289' ' ' VAL . 10.9 t -62.01 115.52 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.464 ' CG2' ' HG3' ' A' ' 288' ' ' LYS . 6.2 tt -100.56 -22.11 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -176.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.805 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -161.58 91.03 0.81 Allowed 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.601 -178.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.562 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.89 -170.54 26.76 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 178.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.492 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 91.6 Cg_endo -81.81 29.34 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.253 1.969 . . . . 0.0 111.589 178.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 194' ' ' LEU . . . -162.05 27.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.562 HG12 ' H ' ' A' ' 189' ' ' GLY . 7.8 mt -45.38 112.11 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 111.506 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.47 6.05 2.17 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.223 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 219' ' ' ALA . 0.2 OUTLIER -98.47 138.94 34.95 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.703 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.513 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 17.1 mt-30 -137.92 153.08 49.53 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.515 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.608 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 0.1 OUTLIER -147.83 147.76 30.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.634 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -147.56 166.67 26.64 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.991 -179.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.582 ' CG2' ' HA ' ' A' ' 206' ' ' LEU . 5.7 p -171.82 147.92 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.535 0.683 . . . . 0.0 111.984 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.554 ' N ' HG21 ' A' ' 198' ' ' VAL . 0.8 OUTLIER -93.11 147.87 22.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.693 179.219 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.46 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 24.8 p -65.88 -2.23 3.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.255 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.77 -4.17 25.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.032 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.6 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -94.27 125.51 38.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.548 179.871 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 62.2 p -91.54 -81.28 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.12 3.21 0.63 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.458 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -120.87 -8.32 9.42 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.128 -0.358 . . . . 0.0 111.573 179.851 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' A' ' 202' ' ' SER . 6.6 tt -71.9 -61.25 2.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.562 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.7 Cg_endo -43.75 96.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.967 1.778 . . . . 0.0 112.764 -178.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.88 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 3.4 t -68.62 157.85 6.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.95 179.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 217' ' ' ASP . 4.5 mtmm -135.71 93.48 2.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.0 OUTLIER -86.86 123.19 31.71 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.735 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -168.14 169.72 41.6 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.504 -179.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.857 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 14.7 ttt180 -72.01 -74.4 0.16 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.014 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.6 p -138.94 115.08 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 216' ' ' SER . 0.3 OUTLIER 169.18 -176.29 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.1 -179.578 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 16.4 Cg_exo -67.96 23.26 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.47 2.113 . . . . 0.0 112.589 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.528 ' H ' ' C ' ' A' ' 214' ' ' SER . 3.5 m -64.23 -150.43 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.987 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.8 OUTLIER -132.16 -34.04 1.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.486 179.809 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.703 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.1 mt -105.47 126.08 51.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.516 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -92.09 83.1 5.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.887 0.375 . . . . 0.0 111.432 -179.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.857 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.3 mm? -104.69 89.44 3.19 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.069 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.427 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.1 OUTLIER -64.0 38.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.618 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 220' ' ' LEU . 12.6 t0 -64.18 123.32 18.79 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.18 179.191 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 60.1 p -67.45 -4.33 10.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.871 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -19.02 18.11 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.468 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 225' ' ' VAL . 79.0 t -93.81 81.98 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.49 178.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -38.68 -48.01 1.42 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.441 -179.038 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.58 -55.38 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.667 ' HB2' ' HG3' ' A' ' 246' ' ' MET . 0.2 OUTLIER -140.93 128.31 21.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.998 0.427 . . . . 0.0 110.772 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.59 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.7 OUTLIER -98.22 -59.71 1.7 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.46 179.088 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.465 ' C ' HD11 ' A' ' 210' ' ' LEU . . . -149.22 170.89 17.43 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.88 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 1.7 mt-30 -151.58 173.64 14.39 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.745 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.535 HD12 HG12 ' A' ' 208' ' ' VAL . 3.5 mt -127.03 143.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.519 0.676 . . . . 0.0 112.19 179.063 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.74 127.34 3.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.711 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 5.7 p90 -118.08 166.05 13.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.96 132.87 56.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.058 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.09 -0.26 57.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.453 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 19.8 m -79.02 -36.76 40.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.731 0.777 . . . . 0.0 109.521 178.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.38 17.4 7.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.476 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 12.8 p90 41.12 59.2 2.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.463 0.649 . . . . 0.0 110.014 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.711 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.97 138.4 54.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.624 179.872 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.603 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.71 120.02 32.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.89 179.571 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 21.8 mt-10 -132.97 144.03 49.85 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.679 ' HG ' HD11 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -89.03 146.8 24.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.959 -1.928 . . . . 0.0 108.4 178.064 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.514 HG12 ' CZ3' ' A' ' 269' ' ' TRP . 6.0 p -122.32 163.47 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 118.718 0.69 . . . . 0.0 109.316 178.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.526 ' CG ' ' HA ' ' A' ' 260' ' ' SER . 2.0 m-20 -118.84 110.14 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.725 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -79.82 105.15 10.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.466 178.148 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.29 69.38 1.28 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.205 -179.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.01 45.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.609 HD21 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -58.37 -54.03 51.61 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.781 -0.575 . . . . 0.0 109.846 178.38 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.609 ' N ' HD21 ' A' ' 249' ' ' LEU . 1.4 m-20 -79.12 -34.11 43.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.003 0.43 . . . . 0.0 110.627 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 260' ' ' SER . . . 87.46 98.42 0.88 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.774 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 282' ' ' THR . 3.1 m -61.07 170.56 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.479 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.699 HD21 ' O ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -153.25 127.0 8.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.433 178.54 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.484 ' CG2' HG12 ' A' ' 259' ' ' ILE . 86.1 t -103.44 130.58 53.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.522 178.347 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.506 ' HA ' HG13 ' A' ' 280' ' ' ILE . 23.8 t-20 54.03 48.8 20.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.096 0.474 . . . . 0.0 110.216 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.84 23.51 8.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -127.74 105.71 8.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.257 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 86.7 p -55.62 86.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.488 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.484 HG12 ' CG2' ' A' ' 254' ' ' VAL . 2.9 pp -86.15 20.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.332 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.526 ' HA ' ' CG ' ' A' ' 245' ' ' ASP . 78.5 p . . . . . 0 N--CA 1.451 -0.397 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.344 -178.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.725 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 0.0 OUTLIER -79.67 -14.58 58.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.149 -178.994 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 59.62 -172.34 5.09 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -178.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -113.68 131.94 22.81 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 118.242 1.021 . . . . 0.0 110.178 179.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 242' ' ' GLU . 80.0 Cg_exo -44.83 119.92 2.59 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.809 2.339 . . . . 0.0 114.055 -178.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.477 ' CG2' ' HB ' ' A' ' 259' ' ' ILE . 49.3 t -104.14 133.02 49.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -75.15 128.11 34.75 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -176.678 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.451 ' C ' ' CD2' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.44 165.09 13.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 113.86 -1.518 . . . . 0.0 108.864 178.088 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.52 158.43 44.01 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.57 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.69 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 5.5 p -58.25 130.09 45.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.652 178.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.69 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.1 m-20 85.55 7.15 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.831 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.8 m-20 -78.78 -169.52 1.79 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.631 HG21 ' O ' ' A' ' 279' ' ' ASP . 0.5 OUTLIER -160.78 129.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 177.488 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.679 HD11 ' HG ' ' A' ' 243' ' ' LEU . 1.0 OUTLIER -106.15 157.05 6.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.809 0.337 . . . . 0.0 111.394 179.762 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.699 ' O ' HD21 ' A' ' 253' ' ' LEU . 1.7 m -145.98 116.71 7.66 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.59 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -110.65 45.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.087 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 170.87 -128.81 1.68 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 119.317 -1.42 . . . . 0.0 114.201 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 t -86.49 -48.33 8.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.78 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.2 t -146.43 -4.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.805 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 17.0 m -66.92 104.29 1.33 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.25 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 1.3 ptmt -126.81 135.84 51.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 0.0 111.581 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.551 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.1 OUTLIER -111.92 135.18 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.093 -178.927 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 4.6 t80 -76.89 138.84 39.99 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.049 -179.438 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.91 112.09 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.753 -178.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -137.34 145.55 43.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.88 179.866 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 181' ' ' TRP . 1.3 mt -135.82 145.79 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.634 -179.388 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.01 139.68 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.988 0.423 . . . . 0.0 111.494 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.51 165.97 22.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.975 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.984 -179.572 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 3.1 m . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.716 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.1 m95 -140.06 130.41 25.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.3 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.5 OUTLIER -119.87 131.51 55.28 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.151 177.719 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.716 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 0.4 OUTLIER -135.92 145.68 46.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.891 0.853 . . . . 0.0 111.263 -179.858 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.632 HD21 ' HB3' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -144.14 149.8 37.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.837 178.588 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.427 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 1.3 tt0 -137.03 124.82 22.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.019 -177.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.548 ' CG2' HD11 ' A' ' 220' ' ' LEU . 40.1 t -64.21 116.3 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.49 HG23 ' HG2' ' A' ' 288' ' ' LYS . 8.7 tt -99.94 -23.3 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -175.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.865 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -155.42 91.21 1.3 Allowed 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.494 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.498 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.27 -177.11 35.94 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.524 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 74.0 Cg_endo -77.98 31.79 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.08 1.853 . . . . 0.0 111.788 178.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.623 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -161.64 21.52 0.12 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.794 178.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.498 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.7 mt -39.63 113.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 0.0 111.656 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.7 7.96 2.9 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.901 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.623 HD12 ' O ' ' A' ' 191' ' ' ALA . 0.6 OUTLIER -99.34 109.19 21.83 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.814 0.816 . . . . 0.0 109.749 178.771 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.427 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 16.4 mt-30 -111.39 153.79 25.55 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.727 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.632 ' HB3' HD21 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -146.43 146.41 30.58 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.88 179.921 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.31 153.4 40.5 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.769 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.496 HG13 ' HG ' ' A' ' 206' ' ' LEU . 14.8 p -155.35 146.48 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.349 0.595 . . . . 0.0 111.82 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.8 OUTLIER -85.06 145.81 27.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.546 178.128 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.452 ' HA ' ' CE2' ' A' ' 234' ' ' TRP . 5.7 t -63.15 -6.97 4.82 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.11 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 3.7 t -101.95 42.84 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.302 0.572 . . . . 0.0 111.323 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.431 ' HB2' ' CG ' ' A' ' 205' ' ' LYS . 6.3 p -135.0 106.27 6.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.523 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.7 m -76.02 -87.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.83 5.32 7.98 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.436 ' O ' ' CG ' ' A' ' 205' ' ' LYS . 2.4 pttt -122.48 56.27 1.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.68 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 7.9 tt -146.34 -53.84 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.925 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 3.4 Cg_exo -40.59 96.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.374 2.049 . . . . 0.0 113.076 -177.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 231' ' ' GLN . 61.7 t -74.96 97.83 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.337 0.062 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.167 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.674 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 6.0 mtmm -69.69 93.41 0.72 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.7 OUTLIER -78.53 129.55 34.97 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.611 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 179.55 -177.27 48.16 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.097 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.864 ' HB3' ' O ' ' A' ' 226' ' ' SER . 55.5 ttt180 -82.4 -68.66 0.68 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.094 0.558 . . . . 0.0 112.448 -178.518 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.545 ' CG2' ' H ' ' A' ' 214' ' ' SER . 9.6 p -116.9 -151.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.099 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.545 ' H ' ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER 66.37 173.31 0.08 OUTLIER Pre-proline 0 C--O 1.231 0.118 0 O-C-N 122.125 -0.36 . . . . 0.0 110.264 -179.806 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 72.0 Cg_endo -74.27 40.63 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.475 2.116 . . . . 0.0 113.336 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 209' ' ' LYS . 0.6 OUTLIER -71.56 168.01 18.53 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.616 0.246 . . . . 0.0 110.347 179.365 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.488 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 1.8 m-20 -85.02 -34.36 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.371 . . . . 0.0 110.605 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.67 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.8 mt -101.83 127.68 48.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.593 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -97.36 82.11 3.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.935 0.398 . . . . 0.0 110.992 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.705 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.5 mm? -105.97 73.36 0.99 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.184 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.28 60.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.609 ' N ' ' HG3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -107.26 127.79 53.85 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.961 0.41 . . . . 0.0 110.188 178.615 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.3 p -48.24 -24.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.454 0.645 . . . . 0.0 111.58 178.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 225' ' ' VAL . 0.2 OUTLIER -109.92 73.2 0.83 Allowed 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.215 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.719 HG11 ' O ' ' A' ' 225' ' ' VAL . 1.9 t 169.72 3.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 113.08 -1.873 . . . . 0.0 108.626 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.864 ' O ' ' HB3' ' A' ' 212' ' ' ARG . 0.3 OUTLIER -7.23 -116.47 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.628 1.571 . . . . 0.0 114.635 -179.297 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' A' ' 226' ' ' SER . . . -52.49 -89.54 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.029 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.644 ' O ' ' O ' ' A' ' 246' ' ' MET . 6.5 mttm -146.96 138.76 24.38 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.07 0.462 . . . . 0.0 109.95 179.591 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.576 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.1 OUTLIER -96.21 -59.94 1.73 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.58 -179.626 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.506 ' C ' HD11 ' A' ' 210' ' ' LEU . . . -149.19 177.66 9.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.621 0.724 . . . . 0.0 112.474 -178.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.674 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 3.8 pt20 -159.36 172.8 17.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.422 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.925 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 4.9 mt -126.77 143.82 38.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.308 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.49 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -145.5 162.53 37.17 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.721 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.472 ' CE3' ' CD1' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -92.33 152.84 19.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.471 -177.05 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -119.29 71.33 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 175.16 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 17.8 p -54.61 -23.97 19.29 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -176.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.8 m -74.77 -22.15 58.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.556 0.693 . . . . 0.0 109.343 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 22.5 tptt -122.98 8.95 9.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.4 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 235' ' ' ASN . 8.0 p90 39.92 42.93 1.15 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.332 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.515 ' HD2' ' HB3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -120.42 -179.02 3.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.489 0.662 . . . . 0.0 110.58 -179.643 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.988 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -131.86 119.82 21.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.783 -179.309 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 6.0 pt-20 -139.84 152.36 46.43 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.776 0.798 . . . . 0.0 113.099 -178.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.631 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 2.8 pp -111.16 153.29 25.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.775 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -123.14 162.34 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.55 -179.432 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.658 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 2.2 t0 -95.4 100.36 12.14 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 120.777 0.322 . . . . 0.0 111.508 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.644 ' O ' ' O ' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -87.09 90.57 8.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.041 178.964 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 48.01 70.67 0.69 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.933 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.414 ' OG ' ' CD2' ' A' ' 229' ' ' HIS . 3.2 t -95.6 78.23 3.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.473 HD11 ' C ' ' A' ' 249' ' ' LEU . 1.6 tm? -52.75 -58.85 5.53 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.142 0.496 . . . . 0.0 109.776 177.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.472 ' HB3' ' HE2' ' A' ' 229' ' ' HIS . 0.2 OUTLIER -68.33 -29.25 67.95 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.92 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.498 ' O ' ' CD2' ' A' ' 229' ' ' HIS . . . 101.32 156.43 26.89 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.726 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 46.7 m -124.86 155.18 39.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.819 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.587 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -150.06 145.6 26.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.036 0.446 . . . . 0.0 111.558 179.621 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.412 HG12 ' OD1' ' A' ' 279' ' ' ASP . 75.2 t -116.9 138.3 47.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.095 178.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.481 ' HA ' HG13 ' A' ' 280' ' ' ILE . 3.8 p-10 49.0 37.08 9.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.211 0.529 . . . . 0.0 110.471 -178.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.06 36.85 1.33 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.127 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.45 116.8 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.075 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 51.7 p -62.09 90.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.298 0.571 . . . . 0.0 110.746 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.413 ' HB ' HG23 ' A' ' 273' ' ' VAL . 0.1 OUTLIER -92.98 -11.79 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.352 -177.758 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.448 ' HB3' ' CG ' ' A' ' 245' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? . . . . . 0 CA--C 1.517 -0.327 0 CA-C-O 121.375 0.607 . . . . 0.0 112.392 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.658 ' HA ' ' O ' ' A' ' 245' ' ' ASP . 30.9 t-105 -77.34 -24.81 50.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.354 178.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 63.02 -179.01 5.66 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.322 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -107.82 134.15 20.18 Favored Pre-proline 0 C--N 1.332 -0.17 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.511 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 1.3 Cg_endo -44.93 136.64 9.84 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.166 2.577 . . . . 0.0 113.926 -178.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 62.2 t -109.21 129.43 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.0 pt-20 -74.31 132.24 41.89 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.417 -178.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.2 mt -89.1 163.22 15.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.973 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -135.81 144.33 45.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.729 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.599 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 6.4 m -55.92 131.9 48.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.189 178.042 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 84.58 1.76 0.82 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.133 -179.26 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 3.2 t70 -72.96 -166.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.481 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -160.4 133.49 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.896 178.542 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 289' ' ' VAL . 0.2 OUTLIER -110.94 156.57 12.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.061 0.458 . . . . 0.0 111.286 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.587 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 3.0 m -148.89 123.5 9.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.576 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -120.95 39.58 3.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.457 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -176.1 -136.42 2.35 Favored Glycine 0 C--N 1.328 0.095 0 C-N-CA 119.331 -1.414 . . . . 0.0 113.702 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 285' ' ' THR . . . . . 0.414 HG21 ' HG3' ' A' ' 224' ' ' GLU . 14.1 t -87.15 -48.85 7.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.588 0.232 . . . . 0.0 110.695 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.412 ' O ' ' HD2' ' A' ' 288' ' ' LYS . 1.3 t -140.25 2.32 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.319 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.865 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 31.7 m -74.93 102.09 4.66 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.69 0.281 . . . . 0.0 110.261 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.49 ' HG2' HG23 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -123.51 133.2 54.04 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.31 0.576 . . . . 0.0 110.918 -179.874 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 281' ' ' ILE . 1.2 t -107.9 130.61 60.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.372 -178.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.5 t80 -76.15 136.7 39.79 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 110.309 -178.189 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.446 HG21 ' HA ' ' A' ' 280' ' ' ILE . 3.5 t -102.25 107.81 22.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.196 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.32 122.4 37.62 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.988 HD12 ' CE3' ' A' ' 241' ' ' TRP . 1.2 mt -132.58 146.51 32.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.7 t -152.2 166.13 32.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 111.146 -179.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 7.0 m -94.57 159.77 14.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.631 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.926 179.776 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 121.068 0.461 . . . . 0.0 110.935 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.663 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.3 m95 -146.88 139.45 24.96 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.13 -178.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 8.8 tp -116.88 124.53 49.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.634 178.053 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 5.7 m-85 -123.87 131.54 53.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.775 0.798 . . . . 0.0 110.197 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.739 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.0 OUTLIER -131.45 142.69 50.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.331 -179.69 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.605 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 2.9 tt0 -139.39 124.68 19.06 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.705 ' HA ' HG12 ' A' ' 289' ' ' VAL . 10.5 t -62.95 104.84 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.102 0.477 . . . . 0.0 110.462 178.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 288' ' ' LYS . 10.6 tt -87.03 -24.26 6.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 -177.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.725 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -166.64 98.62 0.57 Allowed 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.874 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.656 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.9 -175.04 32.51 Favored Glycine 0 N--CA 1.452 -0.272 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 178.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.546 ' O ' ' HG2' ' A' ' 221' ' ' LYS . 89.1 Cg_endo -77.31 28.71 0.43 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.099 1.866 . . . . 0.0 111.533 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.562 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -162.15 27.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.656 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.4 mt -39.97 111.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.453 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.58 6.56 2.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.257 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER -99.51 162.2 13.16 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.883 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.739 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 12.7 mt-30 -156.59 149.67 24.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.076 -178.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.643 ' CE1' HD13 ' A' ' 218' ' ' LEU . 4.0 p-80 -136.98 129.06 29.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.67 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -139.12 164.62 29.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.075 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.79 HG12 ' HG ' ' A' ' 206' ' ' LEU . 10.1 p -175.32 155.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.56 0.695 . . . . 0.0 112.704 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 180' ' ' SER . 4.0 m-80 -90.39 147.8 23.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.832 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.589 ' HA ' ' CE2' ' A' ' 234' ' ' TRP . 65.2 m -56.03 -49.92 72.37 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.107 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.93 5.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.607 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.77 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.3 OUTLIER -87.19 105.14 17.0 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.294 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -107.48 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.2 m -70.48 6.23 1.48 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 8.9 pttt -120.32 55.98 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.212 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.79 ' HG ' HG12 ' A' ' 198' ' ' VAL . 8.0 tt -149.15 -59.87 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.761 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 4.5 Cg_exo -41.09 99.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.185 1.923 . . . . 0.0 112.189 -177.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 31.9 t -68.82 166.88 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.015 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.605 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -139.38 92.1 2.55 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.63 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.612 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.6 OUTLIER -76.79 125.24 28.95 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.324 178.895 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -166.22 168.59 39.97 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.64 -179.122 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 1.5 ttt85 -60.72 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.444 ' O ' HG22 ' A' ' 213' ' ' VAL . 12.4 p -133.42 -12.4 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 0.0 111.735 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.653 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 1.4 m -49.85 176.5 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.732 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 28.4 Cg_endo -62.03 18.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.134 1.89 . . . . 0.0 112.667 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.59 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.6 OUTLIER -58.59 -178.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 111.31 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -96.57 -31.55 12.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.138 179.238 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.696 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.4 mt -104.66 131.42 52.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.619 178.609 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.504 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -98.09 82.5 2.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.596 -179.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.824 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.3 mm? -102.2 86.37 2.83 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -60.07 67.83 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.856 179.865 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.629 ' N ' ' O ' ' A' ' 220' ' ' LEU . 5.3 t0 -97.77 151.17 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.232 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.5 p -90.38 -9.79 46.31 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.194 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.64 -20.64 24.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.427 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.494 ' CG1' ' HB2' ' A' ' 212' ' ' ARG . 3.6 p -107.26 86.76 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.4 m -37.62 -42.23 0.53 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.413 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.33 -55.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.9 OUTLIER -140.42 133.37 29.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.996 0.427 . . . . 0.0 109.93 179.122 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.576 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.9 t60 -98.27 -54.21 3.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.281 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.442 ' C ' HD13 ' A' ' 210' ' ' LEU . . . -146.56 177.24 9.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 112.212 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.616 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -163.72 175.8 10.19 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.475 -179.822 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.761 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.9 mt -132.8 148.96 31.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.757 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.427 ' O ' ' OE2' ' A' ' 242' ' ' GLU . 0.1 OUTLIER -149.8 164.65 34.75 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.56 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.74 ' HE3' HD23 ' A' ' 206' ' ' LEU . 0.4 OUTLIER -110.55 112.96 25.22 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.285 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.37 82.89 4.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.6 t -61.65 -9.2 5.63 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -176.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 55.2 m -74.7 -32.98 62.33 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.17 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.529 ' HG2' ' HG2' ' A' ' 240' ' ' LYS . 5.4 tptm -110.54 0.22 17.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.245 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 17.4 p90 41.32 47.86 3.1 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.087 0.47 . . . . 0.0 110.272 179.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.57 ' HE2' ' HG2' ' A' ' 242' ' ' GLU . 0.0 OUTLIER -119.88 170.34 9.33 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.574 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.603 ' CZ3' ' HB2' ' A' ' 182' ' ' LEU . 1.3 m0 -119.4 108.58 14.75 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.57 ' HG2' ' HE2' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -133.89 147.65 51.16 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.4 pp -111.92 152.16 28.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.357 -1.747 . . . . 0.0 110.59 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 269' ' ' TRP . 1.2 p -117.99 162.92 15.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.558 0.218 . . . . 0.0 110.527 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.615 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -103.18 111.25 23.53 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -177.983 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.594 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -79.36 95.72 5.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.692 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.73 64.0 4.7 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.023 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.48 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 21.8 p -64.59 50.34 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.321 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.621 HD13 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -55.56 -50.74 69.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.872 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.497 ' HB3' ' HE2' ' A' ' 229' ' ' HIS . 5.1 t30 -77.72 -37.15 50.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.469 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.1 85.91 1.35 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.218 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.538 ' N ' ' HB3' ' A' ' 260' ' ' SER . 0.5 OUTLIER -45.69 166.56 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 119.87 -0.11 . . . . 0.0 110.789 179.137 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.653 ' O ' ' HA ' ' A' ' 281' ' ' ILE . 0.2 OUTLIER -150.83 127.23 10.69 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.089 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.47 ' CG2' HG13 ' A' ' 281' ' ' ILE . 99.5 t -107.39 131.32 57.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.646 178.295 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.458 ' HA ' HD11 ' A' ' 280' ' ' ILE . 7.8 t-20 57.57 40.15 27.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.232 0.539 . . . . 0.0 109.852 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 7.9 p 61.53 24.78 14.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.445 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.42 97.64 4.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.604 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -46.4 93.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.6 -179.605 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.648 HD11 ' C ' ' A' ' 259' ' ' ILE . 0.0 OUTLIER -94.87 6.23 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.452 -178.855 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.568 ' N ' HD11 ' A' ' 259' ' ' ILE . 2.0 t . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.159 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.615 ' HA ' ' O ' ' A' ' 245' ' ' ASP . 1.8 t-105 -80.7 -30.89 36.31 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.17 -171.55 7.8 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.14 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -106.5 134.9 19.6 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 117.65 0.725 . . . . 0.0 111.158 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.567 ' HB3' ' OE1' ' A' ' 242' ' ' GLU . 84.2 Cg_exo -43.03 124.11 3.52 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.214 2.61 . . . . 0.0 113.74 -178.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 87.9 t -99.27 139.28 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.4 OUTLIER -86.45 131.05 34.29 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 119.099 -1.041 . . . . 0.0 111.979 -178.954 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.678 ' H ' HD12 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -96.59 163.91 12.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.496 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.5 158.48 43.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 8.5 t -61.55 131.44 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.803 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.609 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.7 m-20 85.4 -1.94 0.82 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.18 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -71.34 -166.78 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.44 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.717 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.8 OUTLIER -161.37 128.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.454 177.299 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.708 ' CG2' HG23 ' A' ' 289' ' ' VAL . 1.0 OUTLIER -108.74 155.13 9.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.706 179.23 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.607 ' OG1' ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -142.2 121.82 13.37 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.551 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.576 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -113.71 45.18 1.48 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.145 -178.008 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 170.26 -123.13 1.03 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 119.2 -1.476 . . . . 0.0 114.114 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.0 t -91.59 -54.8 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.186 . . . . 0.0 111.273 -179.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.573 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -139.94 -3.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.471 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.725 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 26.9 m -67.57 103.0 1.25 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.853 0.297 . . . . 0.0 110.58 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.657 ' O ' HG23 ' A' ' 187' ' ' ILE . 7.9 ttmt -118.39 130.98 56.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.708 HG23 ' CG2' ' A' ' 281' ' ' ILE . 0.0 OUTLIER -113.43 133.02 60.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.653 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.717 ' HD1' HG23 ' A' ' 280' ' ' ILE . 4.4 t80 -76.34 136.16 39.54 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.014 0.435 . . . . 0.0 110.031 -178.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 275' ' ' LEU . 1.0 OUTLIER -103.46 110.68 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.404 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.19 135.24 55.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.508 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.561 ' CG2' ' CZ3' ' A' ' 241' ' ' TRP . 16.0 mt -131.41 133.51 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.867 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.3 m -156.58 159.98 39.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 110.798 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 52.1 m -86.97 177.54 7.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.845 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 120.639 0.257 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 15.8 m95 -150.48 146.71 26.8 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.8 OUTLIER -122.26 134.54 54.68 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.922 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 13.3 m-85 -130.25 136.86 49.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.67 0.747 . . . . 0.0 110.466 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.592 HD13 ' HA ' ' A' ' 291' ' ' VAL . 2.4 mm? -123.4 138.91 54.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.049 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.55 117.15 15.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 194' ' ' LEU . 27.0 t -65.59 118.2 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.001 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.456 HG22 ' HB2' ' A' ' 288' ' ' LYS . 5.2 tt -98.04 -26.89 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -176.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.866 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -158.01 94.34 1.31 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.616 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.76 -174.58 31.81 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 178.255 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.441 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 85.2 Cg_endo -80.6 32.09 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.02 1.813 . . . . 0.0 110.785 178.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.583 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.26 21.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.749 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.616 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.1 mt -38.99 113.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 111.612 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.95 5.9 4.66 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.76 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 191' ' ' ALA . 0.2 OUTLIER -93.29 139.87 30.16 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.111 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 12.4 mt-30 -133.26 143.55 49.17 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.662 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.523 ' CD2' ' HB2' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -134.83 128.55 32.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.772 -179.537 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -140.82 162.81 34.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.773 -179.195 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.606 HG23 ' HA ' ' A' ' 206' ' ' LEU . 12.3 p -173.3 153.03 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.413 178.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.481 ' ND2' HG23 ' A' ' 201' ' ' THR . 0.3 OUTLIER -90.74 145.59 24.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.919 179.52 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.915 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 0.1 OUTLIER -62.59 -2.2 1.03 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.203 179.517 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.481 HG23 ' ND2' ' A' ' 199' ' ' ASN . 1.2 t -101.63 13.74 34.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.827 0.346 . . . . 0.0 110.8 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.486 ' CB ' ' HG2' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -103.96 117.34 34.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.166 179.761 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.4 m -76.92 -84.29 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.9 t -90.4 15.71 10.14 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.486 ' HG2' ' CB ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -115.46 -10.4 11.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.73 ' HG ' ' CZ2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -90.09 -18.89 0.23 Allowed Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -179.747 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.837 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 30.1 Cg_endo -65.43 84.44 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 CA-C-N 120.905 1.359 . . . . 0.0 111.468 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.487 ' O ' HD13 ' A' ' 210' ' ' LEU . 47.1 t -70.56 108.15 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.148 -178.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -79.98 84.5 5.72 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.705 ' HB2' ' O ' ' A' ' 230' ' ' ALA . 4.7 mp -74.93 136.01 41.4 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 118.742 0.701 . . . . 0.0 109.325 178.528 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . 178.38 -177.02 48.33 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.773 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.538 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 0.5 OUTLIER -71.52 -74.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.092 -0.554 . . . . 0.0 111.638 -179.536 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.571 ' CG2' ' H ' ' A' ' 214' ' ' SER . 7.6 p -117.0 -145.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.88 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.571 ' H ' ' CG2' ' A' ' 213' ' ' VAL . 0.6 OUTLIER 61.0 -179.38 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 121.98 -0.45 . . . . 0.0 109.905 -179.578 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 21.5 Cg_exo -66.4 24.2 0.1 OUTLIER 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.646 2.231 . . . . 0.0 113.765 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.528 ' HA ' ' HG3' ' A' ' 209' ' ' LYS . 68.2 m -53.0 152.05 4.31 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 120.617 0.246 . . . . 0.0 110.848 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.426 ' N ' ' HG2' ' A' ' 209' ' ' LYS . 0.6 OUTLIER -84.14 -29.25 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.379 179.742 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.444 ' HA ' HD21 ' A' ' 218' ' ' LEU . 36.1 mt -115.65 132.53 56.6 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.136 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -87.96 81.65 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.682 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.8 mm? -100.3 64.09 1.16 Allowed 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.538 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -60.78 35.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -177.097 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.558 ' HB3' ' HG2' ' A' ' 224' ' ' GLU . 3.1 t70 -87.94 125.44 34.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 76.8 p -39.73 -30.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.558 ' HG2' ' HB3' ' A' ' 222' ' ' ASP . 9.8 pt-20 -51.88 -42.23 62.53 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.989 0.424 . . . . 0.0 110.838 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.58 HG21 ' HA2' ' A' ' 211' ' ' GLY . 2.7 p -96.87 106.17 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.835 179.017 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.5 t -47.22 -68.56 0.18 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.452 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -128.32 -45.1 0.2 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 178.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.631 ' HA ' ' HA3' ' A' ' 211' ' ' GLY . 0.4 OUTLIER -143.45 127.65 17.64 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.087 -0.557 . . . . 0.0 109.555 178.953 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.813 ' CE1' ' HB3' ' A' ' 248' ' ' SER . 1.2 t60 -92.12 -55.19 3.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.534 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.705 ' O ' ' HB2' ' A' ' 210' ' ' LEU . . . -155.35 150.76 27.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.68 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -131.88 179.87 5.82 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.979 179.428 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.837 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.0 mt -126.93 139.4 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.847 179.157 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.83 129.98 5.52 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.915 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 5.4 p90 -111.61 151.6 28.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -175.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 239' ' ' PHE . 1.5 t-20 -73.32 126.8 30.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 112.493 -2.14 . . . . 0.0 111.007 177.69 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.5 t -89.19 -29.73 19.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.0 m -77.95 -30.95 50.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.699 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.446 ' O ' ' CG ' ' A' ' 239' ' ' PHE . 1.5 tptm -108.23 -2.32 19.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.598 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.446 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 27.9 p90 43.44 42.39 3.81 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.37 140.35 52.78 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.579 0.704 . . . . 0.0 110.382 178.507 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.787 ' HA ' ' HB3' ' A' ' 234' ' ' TRP . 2.9 m95 -89.45 121.96 32.18 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.078 -179.393 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.0 mt-10 -140.51 151.18 44.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.004 0.907 . . . . 0.0 113.196 -178.258 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 3.8 pp -117.36 156.51 27.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.125 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.476 HG22 ' CD1' ' A' ' 269' ' ' TRP . 1.3 p -128.91 162.92 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.719 0.295 . . . . 0.0 111.746 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -92.17 156.43 17.34 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.438 0.637 . . . . 0.0 111.367 179.481 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.67 ' O ' ' N ' ' A' ' 248' ' ' SER . 0.0 OUTLIER -127.86 87.8 2.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.768 179.174 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 249' ' ' LEU . . . 55.29 -46.83 0.01 OUTLIER Glycine 0 C--N 1.341 0.818 0 CA-C-O 121.402 0.446 . . . . 0.0 113.948 179.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.813 ' HB3' ' CE1' ' A' ' 229' ' ' HIS . 4.1 m -38.81 85.26 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' A' ' 249' ' ' LEU . 8.7 tp -55.5 2.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 -178.49 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.579 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . 3.8 m120 -71.67 15.92 0.13 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.568 1.531 . . . . 0.0 111.511 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 249' ' ' LEU . . . 42.49 84.64 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.111 179.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -47.43 156.45 0.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.714 0.257 . . . . 0.0 110.593 179.406 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.556 HD21 ' O ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -144.8 128.94 17.66 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.05 0.453 . . . . 0.0 111.384 178.729 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.437 ' CG2' HG13 ' A' ' 281' ' ' ILE . 85.2 t -104.77 132.06 52.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.681 178.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 52.13 41.63 30.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.134 0.492 . . . . 0.0 110.15 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.62 24.49 11.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.969 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 9.6 m80 -127.39 108.71 11.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.037 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 3.3 t -58.56 97.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.148 0.499 . . . . 0.0 111.558 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.537 ' CG1' HG22 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -78.66 -54.74 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.717 -179.171 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.532 ' N ' HG12 ' A' ' 259' ' ' ILE . 6.9 p . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.9 tptt . . . . . 0 CA--C 1.515 -0.403 0 CA-C-O 121.229 0.538 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.476 ' CD1' HG22 ' A' ' 244' ' ' VAL . 18.6 t-105 -67.72 -27.91 67.21 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.068 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.65 154.44 18.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.98 179.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.45 150.74 41.77 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.599 0.238 . . . . 0.0 110.624 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.39 144.54 31.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.36 2.04 . . . . 0.0 112.076 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 92.8 t -132.15 131.87 61.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.163 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.7 pm0 -80.74 132.87 35.58 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.229 -178.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 291' ' ' VAL . 0.0 OUTLIER -96.82 165.13 12.26 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.526 -179.74 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.6 162.14 36.21 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 20.3 p -69.97 132.84 46.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.253 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 277' ' ' SER . 42.7 m-20 82.98 -8.51 1.15 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.975 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -62.1 -168.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.193 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.503 ' CG2' ' HD1' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -161.11 120.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.406 178.341 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.4 OUTLIER -105.08 157.66 5.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.072 179.742 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.556 ' O ' HD21 ' A' ' 253' ' ' LEU . 1.7 m -143.02 120.7 11.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.605 ' HB2' ' CD2' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -117.7 47.1 1.61 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.298 -178.449 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.2 -137.13 3.68 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 119.418 -1.373 . . . . 0.0 113.044 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 12.1 t -90.01 -36.32 15.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.836 0.351 . . . . 0.0 110.598 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -151.92 0.91 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.866 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 24.5 m -75.65 105.22 6.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.62 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 2.1 mtpt -122.99 127.51 48.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 111.246 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.453 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -107.69 133.59 52.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.537 -178.717 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.503 ' HD1' ' CG2' ' A' ' 280' ' ' ILE . 2.0 t80 -77.38 131.16 37.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.897 0.379 . . . . 0.0 110.098 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.592 ' HA ' HD13 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -103.05 117.87 49.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.304 -178.906 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.629 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -137.6 141.66 41.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.033 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 6.2 mt -136.27 133.0 49.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.735 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 22.7 t -133.18 158.78 41.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.963 0.411 . . . . 0.0 111.264 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.7 150.34 21.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.654 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.705 -179.972 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 1.5 m . . . . . 0 N--CA 1.462 0.132 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.575 ' CB ' ' CZ ' ' A' ' 183' ' ' PHE . 90.8 m95 -156.97 146.78 20.74 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.583 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.532 HD11 HG12 ' A' ' 293' ' ' ILE . 0.2 OUTLIER -122.8 106.45 10.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 113.64 -1.618 . . . . 0.0 106.797 176.155 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.575 ' CZ ' ' CB ' ' A' ' 181' ' ' TRP . 1.8 m-85 -105.83 138.53 41.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.936 0.874 . . . . 0.0 113.007 -177.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.631 ' CD2' ' N ' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -135.63 146.57 48.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.067 177.406 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 1.6 tt0 -140.9 127.4 20.02 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -176.841 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.626 ' CG1' HD11 ' A' ' 220' ' ' LEU . 10.7 t -62.14 116.51 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.173 178.363 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.567 HG22 ' HB3' ' A' ' 288' ' ' LYS . 6.1 tt -97.22 -22.47 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.516 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.737 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.28 91.21 0.69 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.84 -177.64 35.08 Favored Glycine 0 C--O 1.228 -0.224 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 178.161 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.488 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 84.4 Cg_endo -76.99 32.72 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.907 1.738 . . . . 0.0 111.802 178.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.747 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -161.47 28.74 0.13 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.617 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -47.74 111.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.379 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.94 10.06 2.94 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.683 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 191' ' ' ALA . 0.4 OUTLIER -101.39 105.38 16.41 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.983 0.897 . . . . 0.0 109.944 178.837 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.467 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 8.5 mt-30 -105.83 156.19 18.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.715 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.616 ' CE1' HD11 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -149.44 147.2 27.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.299 179.716 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 183' ' ' PHE . . . -149.02 158.29 44.07 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.587 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.716 HG22 ' HA ' ' A' ' 206' ' ' LEU . 9.8 p -159.96 148.57 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.655 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 180' ' ' SER . 2.1 m120 -85.49 140.72 30.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.863 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.929 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 9.8 m -56.71 -10.93 1.14 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.635 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.2 t -97.14 9.07 43.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.797 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.64 ' OG ' ' HG2' ' A' ' 205' ' ' LYS . 0.1 OUTLIER -96.53 103.14 15.03 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.932 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.509 ' O ' HD13 ' A' ' 206' ' ' LEU . 1.9 m -62.98 -89.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.62 13.25 7.25 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.981 -0.449 . . . . 0.0 111.642 -179.098 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.64 ' HG2' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -111.51 -2.61 15.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.645 -179.447 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.852 ' C ' HD21 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -100.35 -27.67 0.23 Allowed Pre-proline 0 C--O 1.232 0.15 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.867 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 206' ' ' LEU . 9.7 Cg_endo -54.1 100.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.867 0 CA-C-N 121.329 1.51 . . . . 0.0 111.11 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.609 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 59.5 t -68.46 155.22 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.273 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.566 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -135.87 90.48 2.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 -179.164 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.9 OUTLIER -81.45 127.77 33.16 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.638 -179.99 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.586 ' HA2' HG22 ' A' ' 225' ' ' VAL . . . -172.56 171.44 44.32 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.066 -179.623 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.812 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 5.3 ttm180 -67.04 -74.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.297 0.57 . . . . 0.0 111.774 -179.625 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 214' ' ' SER . 9.4 p -124.15 -138.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.278 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.599 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 0.7 OUTLIER 59.74 179.26 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 119.131 0.878 . . . . 0.0 109.606 -179.966 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 38.4 Cg_endo -67.43 25.86 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.039 1.826 . . . . 0.0 113.758 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -58.43 152.7 17.3 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.686 0.279 . . . . 0.0 110.695 179.471 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -79.94 -32.0 40.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.379 . . . . 0.0 110.117 179.484 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.723 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.2 mt -106.48 129.05 54.51 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.373 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.655 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -92.71 81.47 4.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.791 0.329 . . . . 0.0 111.502 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.723 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 2.5 mm? -108.48 62.22 0.61 Allowed 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.812 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 10.2 pttt -51.91 55.8 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -177.482 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 220' ' ' LEU . 22.1 t0 -100.62 149.64 23.55 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.759 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 29.5 t -64.47 -34.61 78.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.477 -179.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.457 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 0.0 OUTLIER -48.9 -39.94 27.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.442 -179.591 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.63 HG12 ' HB2' ' A' ' 212' ' ' ARG . 2.3 p -103.45 89.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.448 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -34.82 -45.77 0.27 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.705 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.37 -53.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.535 ' HB2' ' SD ' ' A' ' 246' ' ' MET . 0.0 OUTLIER -144.71 135.2 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.194 0.521 . . . . 0.0 109.667 178.73 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.679 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.8 OUTLIER -104.2 -56.08 2.25 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.284 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.448 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -141.76 172.42 12.71 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.506 0.669 . . . . 0.0 112.485 -178.27 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.609 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 1.5 pt20 -158.52 173.46 16.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.319 179.648 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 9.8 mt -134.31 151.58 32.37 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.481 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -162.01 148.18 13.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.713 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.929 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 2.5 p90 -130.17 163.24 27.09 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.369 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.47 123.79 50.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.256 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 24.1 t -84.01 -1.77 55.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.099 179.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.5 m -80.8 -33.74 34.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.599 0.714 . . . . 0.0 109.984 179.15 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 19.5 tptm -129.41 16.3 6.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.95 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.408 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 9.0 p90 40.05 60.3 1.76 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.476 0.655 . . . . 0.0 109.545 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.2 OUTLIER -123.81 138.55 54.48 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.364 179.661 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.639 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -117.2 114.77 24.13 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.123 178.761 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 35.3 mt-10 -130.83 141.88 50.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.757 0.789 . . . . 0.0 112.373 -177.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.8 pp -108.26 152.6 24.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.125 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.52 HG22 ' CD1' ' A' ' 269' ' ' TRP . 0.7 OUTLIER -123.44 162.24 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.573 -179.404 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.676 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 1.1 m-20 -111.28 101.09 9.6 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.914 178.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.845 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -84.94 106.5 16.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.971 0.415 . . . . 0.0 109.924 179.347 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 48.19 67.31 1.65 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.803 -178.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.04 74.6 8.08 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.7 HD12 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -51.34 -56.26 14.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.611 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.7 ' H ' HD12 ' A' ' 249' ' ' LEU . 1.2 t-20 -71.07 -25.96 62.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.167 0.508 . . . . 0.0 110.965 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 89.49 136.79 6.15 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.483 -0.78 . . . . 0.0 113.753 179.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 282' ' ' THR . 24.1 m -100.71 155.68 17.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.117 179.284 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -146.57 145.45 30.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.087 0.47 . . . . 0.0 111.615 179.623 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.55 ' N ' HD13 ' A' ' 259' ' ' ILE . 45.6 t -114.09 131.19 66.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.345 179.026 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.61 ' HA ' HG13 ' A' ' 280' ' ' ILE . 11.1 p30 51.37 39.68 24.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.517 -178.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 256' ' ' SER . . . . . 0.502 ' N ' HD12 ' A' ' 280' ' ' ILE . 4.4 p 72.17 37.11 1.01 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.692 179.107 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.84 117.0 6.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.069 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 83.8 p -64.68 87.6 0.06 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.504 0.669 . . . . 0.0 110.655 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.676 HG12 ' HG ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -83.89 -17.9 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.82 -177.952 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.676 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 20.3 m . . . . . 0 C--N 1.329 -0.285 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -177.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.435 ' CD ' ' HA2' ' A' ' 270' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.375 0 CA-C-O 121.095 0.474 . . . . 0.0 112.032 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.845 ' CZ3' ' HB2' ' A' ' 246' ' ' MET . 46.1 t-105 -70.01 -24.46 63.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.361 179.526 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.435 ' HA2' ' CD ' ' A' ' 268' ' ' LYS . . . 70.88 170.74 9.99 Favored Glycine 0 CA--C 1.512 -0.141 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.932 178.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -102.62 146.66 32.78 Favored Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.221 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 51.3 Cg_exo -54.14 121.75 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.04 1.827 . . . . 0.0 112.574 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 70.1 t -99.22 133.15 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -78.46 123.73 27.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.622 -178.89 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.712 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -89.12 165.12 14.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.656 179.752 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.54 161.57 38.78 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.404 -0.518 . . . . 0.0 112.273 -179.117 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.2 OUTLIER -62.3 124.44 20.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.359 179.361 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 277' ' ' SER . 10.1 m-20 88.58 7.71 0.14 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.499 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.7 OUTLIER -79.01 -169.33 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.361 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.682 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -160.04 129.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.059 178.163 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.587 ' O ' ' HG2' ' A' ' 288' ' ' LYS . 0.8 OUTLIER -109.84 152.31 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.669 178.783 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 252' ' ' THR . 0.2 OUTLIER -138.54 126.77 22.86 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.925 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.679 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -120.03 40.56 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.201 -178.794 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 177.57 -131.3 1.76 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.613 -1.279 . . . . 0.0 113.533 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.1 t -89.28 -43.9 10.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 110.797 -179.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.9 t -146.58 -1.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.439 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.9 m -68.99 99.9 1.14 Allowed 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.35 179.054 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.641 ' HD3' ' HB ' ' A' ' 280' ' ' ILE . 1.3 ttmt -118.34 131.0 56.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.459 -178.572 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -114.03 132.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 121.381 -0.128 . . . . 0.0 111.085 -179.486 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.682 ' HD1' HG23 ' A' ' 280' ' ' ILE . 1.1 t80 -77.35 142.22 39.46 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 110.647 -178.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.42 HG12 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -110.39 115.97 51.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.631 -179.268 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -138.72 153.21 48.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.085 -179.629 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.532 HG12 HD11 ' A' ' 182' ' ' LEU . 3.8 mt -144.23 120.72 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.345 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.03 158.57 39.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.947 0.403 . . . . 0.0 110.975 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.4 p -101.34 -173.49 2.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.671 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.523 -0.084 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.692 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 23.8 m95 -145.83 131.44 18.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.9 OUTLIER -115.13 124.04 50.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.703 176.551 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.692 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 7.5 m-85 -124.64 133.82 53.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.39 0.614 . . . . 0.0 110.776 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.633 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -139.75 149.35 43.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.9 178.289 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.555 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 13.1 tt0 -141.23 128.4 20.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.448 HG13 ' CD1' ' A' ' 220' ' ' LEU . 48.2 t -65.52 112.65 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.385 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' LYS . 5.6 tt -97.25 -21.64 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -176.075 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.834 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -157.96 92.38 1.18 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.564 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.626 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.1 -163.69 16.37 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.498 ' HD3' ' OD2' ' A' ' 222' ' ' ASP . 91.6 Cg_endo -85.73 28.6 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.96 2.44 . . . . 0.0 110.971 178.277 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.599 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -160.22 23.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.981 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.626 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.6 mt -39.57 109.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 111.675 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.32 10.12 3.11 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.902 -1.142 . . . . 0.0 113.438 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER -96.65 129.12 44.1 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.754 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.555 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 15.8 mt-30 -128.96 151.5 49.61 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.264 -178.367 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.608 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -145.14 145.4 31.37 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.18 179.943 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -149.74 154.44 38.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.893 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.426 ' CG2' ' HA ' ' A' ' 206' ' ' LEU . 7.5 p -164.89 153.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 110.818 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 180' ' ' SER . 4.3 m120 -90.19 149.4 22.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.64 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.501 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 49.2 p -65.5 -9.22 24.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.691 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 2.3 t -96.64 25.33 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.461 0.648 . . . . 0.0 110.098 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.475 ' HB3' ' CG ' ' A' ' 205' ' ' LYS . 35.8 m -104.3 119.14 38.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.432 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 70.2 m -66.71 -84.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.968 -179.122 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 47.7 m -105.12 26.78 8.9 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.475 ' CG ' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -117.85 -14.49 10.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.788 0.328 . . . . 0.0 111.141 179.596 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.661 ' N ' ' HD2' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -81.4 -38.03 0.92 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.163 -179.527 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 206' ' ' LEU . 9.7 Cg_endo -54.11 102.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 120.875 1.05 . . . . 0.0 111.676 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.546 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 40.8 t -68.91 159.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.206 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 41.0 mtmt -140.6 95.62 2.89 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.471 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.455 HD13 ' C ' ' A' ' 230' ' ' ALA . 0.4 OUTLIER -83.84 123.94 30.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.382 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.538 ' HA3' ' OG ' ' A' ' 216' ' ' SER . . . -159.55 163.09 33.35 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.195 -179.423 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.775 ' HD2' ' HB ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -60.15 -91.05 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.302 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.427 ' H ' ' HB3' ' A' ' 212' ' ' ARG . 7.5 p -116.37 -15.15 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 0.0 110.938 -179.27 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.775 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 52.9 m -51.78 174.04 0.12 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.783 178.59 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 19.3 Cg_endo -58.36 7.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.062 1.841 . . . . 0.0 112.942 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.541 ' H ' ' C ' ' A' ' 214' ' ' SER . 17.8 m -45.81 157.42 0.11 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.949 0.405 . . . . 0.0 111.479 179.648 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.535 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -71.06 -32.28 68.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.896 -179.256 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 12.0 mt -106.52 129.57 54.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.028 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.46 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -90.31 85.8 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 111.689 -179.563 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.749 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.3 mm? -105.28 83.72 2.01 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 44.17 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.67 ' CA ' ' HD3' ' A' ' 212' ' ' ARG . 0.7 OUTLIER -76.56 167.34 22.01 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 122.255 -0.278 . . . . 0.0 110.554 179.318 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.4 p -95.27 -0.97 52.4 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 179.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.22 -27.25 13.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.917 0.78 . . . . 0.0 112.763 -176.891 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.775 ' HB ' ' HD2' ' A' ' 212' ' ' ARG . 32.7 t -92.97 91.3 3.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.055 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.98 -41.77 3.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.378 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.39 -57.51 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.055 179.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.439 ' HB2' ' HG2' ' A' ' 246' ' ' MET . 8.0 mttt -146.38 130.55 17.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.003 0.43 . . . . 0.0 111.151 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.518 ' ND1' HG23 ' A' ' 225' ' ' VAL . 1.4 t60 -90.59 -57.92 2.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.458 178.021 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.455 ' C ' HD13 ' A' ' 210' ' ' LEU . . . -147.67 -175.0 4.69 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.638 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.635 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -163.7 177.53 8.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.396 179.648 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 17.7 mt -137.82 147.53 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.301 0.572 . . . . 0.0 112.51 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.48 147.16 13.88 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.131 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.827 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.6 p90 -137.79 165.66 25.9 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -178.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.572 ' HB2' ' HD2' ' A' ' 240' ' ' LYS . 1.4 m-80 -117.57 133.65 55.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.204 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.1 m -89.52 4.9 47.74 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.609 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.6 m -77.83 -37.5 48.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.821 0.819 . . . . 0.0 109.653 178.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 6.1 tptm -126.26 14.98 7.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.261 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 238' ' ' LYS . 18.6 p90 41.68 61.22 1.93 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.933 0.873 . . . . 0.0 108.673 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.827 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -128.5 145.97 50.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.259 -179.855 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.645 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -128.92 125.53 37.74 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.021 -178.914 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 9.5 pt-20 -138.53 146.91 42.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.842 0.83 . . . . 0.0 113.116 -178.254 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 2.4 pp -112.19 152.11 28.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.773 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.622 HG12 ' CZ3' ' A' ' 269' ' ' TRP . 7.3 p -117.06 163.82 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.42 0.152 . . . . 0.0 110.962 -179.158 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.468 ' OD2' ' HA3' ' A' ' 270' ' ' GLY . 0.0 OUTLIER -107.33 105.95 16.15 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.52 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 2.3 tpt -78.43 103.68 8.53 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.129 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.3 65.07 3.81 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.005 -178.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.9 p -68.21 53.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.761 HD23 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.55 -50.61 72.53 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.297 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.761 ' N ' HD23 ' A' ' 249' ' ' LEU . 6.1 t-20 -79.19 -34.78 42.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.053 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.413 ' O ' HD21 ' A' ' 253' ' ' LEU . . . 89.84 102.1 1.11 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.238 179.732 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 258' ' ' SER . 0.5 OUTLIER -56.88 163.99 1.73 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.893 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.668 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -154.31 136.59 14.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.424 0.63 . . . . 0.0 112.458 179.99 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.419 ' CG2' HG12 ' A' ' 281' ' ' ILE . 53.3 t -109.15 133.55 53.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.244 178.464 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.514 ' HA ' HG13 ' A' ' 280' ' ' ILE . 14.4 p30 49.56 33.9 6.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.177 0.513 . . . . 0.0 110.695 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 4.1 m 76.83 27.79 0.72 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.83 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . 0.402 ' O ' HG21 ' A' ' 259' ' ' ILE . 0.0 OUTLIER -129.65 110.12 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.147 179.494 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 252' ' ' THR . 86.5 p -62.97 84.71 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.171 0.51 . . . . 0.0 111.748 -179.275 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.545 ' CG1' HG23 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -79.82 -8.19 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.12 -179.481 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 2.0 m . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.622 ' CZ3' HG12 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -76.12 -26.05 55.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.87 -178.159 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.468 ' HA3' ' OD2' ' A' ' 245' ' ' ASP . . . 61.85 -173.54 7.61 Favored Glycine 0 CA--C 1.515 0.093 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.266 -179.081 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -108.36 148.16 37.07 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 117.846 0.823 . . . . 0.0 111.239 -179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.685 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 31.9 Cg_exo -60.06 122.57 11.59 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.08 2.52 . . . . 0.0 114.008 -178.751 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 71.4 t -98.95 138.01 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.656 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.2 mp0 -83.03 127.48 33.6 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.987 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.5 ' H ' ' CD1' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.32 164.16 13.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.776 179.81 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -141.76 158.11 44.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.268 0.556 . . . . 0.0 112.181 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 10.8 p -55.39 128.55 34.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.928 179.532 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 81.13 8.49 1.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.693 179.829 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.518 ' O ' HG21 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -88.4 137.17 32.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.001 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.514 HG13 ' HA ' ' A' ' 255' ' ' ASN . 1.0 OUTLIER -97.43 129.62 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.664 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.71 ' O ' ' CG2' ' A' ' 281' ' ' ILE . 0.4 OUTLIER -112.39 94.39 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -178.748 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.668 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 7.0 m -82.94 142.49 31.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.495 ' HB2' ' CD2' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -134.76 47.43 2.37 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.04 -179.865 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.85 -125.23 1.1 Allowed Glycine 0 C--N 1.329 0.194 0 C-N-CA 119.879 -1.153 . . . . 0.0 113.469 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.5 t -95.64 -45.32 7.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.717 0.294 . . . . 0.0 110.747 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.66 -0.17 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.812 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.834 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 25.5 m -75.4 102.13 5.04 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.621 0.248 . . . . 0.0 111.345 -179.885 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.645 ' O ' HG23 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -122.44 131.43 53.87 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.498 0.666 . . . . 0.0 111.044 179.792 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.81 131.76 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.54 -177.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.0 OUTLIER -76.95 132.49 39.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.694 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 279' ' ' ASP . 2.5 t -110.89 117.35 54.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.634 -178.124 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.2 OUTLIER -136.73 150.99 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.847 -179.464 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.452 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 3.1 mt -143.21 127.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.366 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.61 153.34 43.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.813 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 5.0 m -85.94 168.07 14.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.137 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 -179.989 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.198 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.675 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 3.2 m95 -143.52 130.88 20.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.4 OUTLIER -122.08 130.28 53.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.017 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 0.2 OUTLIER -133.18 146.22 51.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.77 0.795 . . . . 0.0 111.393 179.979 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -146.84 153.32 40.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.009 178.955 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.511 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 0.1 OUTLIER -142.02 133.35 26.44 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.183 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.791 ' HA ' HG22 ' A' ' 289' ' ' VAL . 40.0 t -66.4 116.04 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.017 0.436 . . . . 0.0 110.148 177.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.2 tt -97.45 -24.16 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.83 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -160.11 93.55 1.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.677 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.91 -173.25 30.34 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 178.357 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.603 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 96.9 Cg_endo -80.16 32.65 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 CA-C-N 119.452 1.626 . . . . 0.0 111.587 178.684 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.559 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -162.95 23.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.627 178.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.677 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.8 mt -39.41 114.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 127.56 10.54 3.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.519 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.759 HD12 HD12 ' A' ' 220' ' ' LEU . 0.1 OUTLIER -99.66 131.16 45.83 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.964 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.511 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 20.9 mt-30 -128.01 153.89 46.24 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.358 -178.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.703 ' CD2' ' HB3' ' A' ' 217' ' ' ASP . 0.0 OUTLIER -145.57 146.03 31.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.165 178.968 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.56 144.51 29.62 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.273 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.689 HG22 ' HA ' ' A' ' 206' ' ' LEU . 10.2 p -146.51 147.81 17.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.332 0.587 . . . . 0.0 110.816 179.281 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 180' ' ' SER . 21.4 p30 -95.07 150.47 20.15 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.265 -179.45 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.494 ' N ' ' HZ2' ' A' ' 234' ' ' TRP . 48.2 t -70.67 1.04 5.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.474 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.441 ' H ' HG21 ' A' ' 201' ' ' THR . 0.0 OUTLIER -104.17 11.63 34.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.25 0.548 . . . . 0.0 110.784 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.4 m -91.3 132.13 36.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.059 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.47 -77.41 0.39 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.261 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.5 m -101.68 20.62 15.87 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.735 0.303 . . . . 0.0 111.59 -179.287 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -123.16 -15.03 7.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.942 0.401 . . . . 0.0 110.807 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.713 HD13 ' CE2' ' A' ' 234' ' ' TRP . 6.9 tt -59.08 -60.51 10.31 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.405 -179.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -42.59 98.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.629 2.219 . . . . 0.0 113.016 -178.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 59.7 t -68.04 163.57 2.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.326 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.712 ' O ' ' HB2' ' A' ' 217' ' ' ASP . 0.5 OUTLIER -142.64 115.09 8.49 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.222 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.702 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -116.67 145.88 43.13 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.657 -0.652 . . . . 0.0 111.236 178.145 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.427 ' HA2' HG23 ' A' ' 225' ' ' VAL . . . 170.85 -174.74 44.7 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.753 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.663 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -65.11 -77.4 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.054 0.454 . . . . 0.0 111.85 -178.89 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.564 ' HB ' ' HE ' ' A' ' 212' ' ' ARG . 13.7 p -128.28 -138.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.234 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.735 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 5.0 m 67.39 173.59 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 118.897 0.771 . . . . 0.0 109.378 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.735 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 40.0 Cg_endo -66.59 18.15 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.907 1.738 . . . . 0.0 112.694 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 214' ' ' SER . 1.9 m -54.91 178.68 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.721 0.296 . . . . 0.0 110.739 179.851 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.712 ' HB2' ' O ' ' A' ' 209' ' ' LYS . 14.0 m-20 -100.98 -35.87 9.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.469 -179.591 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.702 ' HB2' ' HA ' ' A' ' 210' ' ' LEU . 6.2 mt -100.39 129.08 46.32 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.231 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.468 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -95.04 79.19 3.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.633 0.254 . . . . 0.0 110.634 -179.736 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.759 HD12 HD12 ' A' ' 194' ' ' LEU . 3.0 mm? -100.74 66.37 1.2 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.74 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.663 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 1.8 pttt -50.22 69.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.825 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 220' ' ' LEU . 2.5 t0 -124.72 140.05 53.29 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.214 0.53 . . . . 0.0 110.05 178.104 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.9 t -54.96 -40.34 69.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.437 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -41.94 -42.97 2.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.364 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.784 ' HB ' ' HD1' ' A' ' 229' ' ' HIS . 2.4 p -102.36 79.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.215 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -33.05 -42.43 0.08 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.114 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.17 -55.79 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.035 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 246' ' ' MET . 30.4 mtmm -145.17 129.46 17.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.156 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.784 ' HD1' ' HB ' ' A' ' 225' ' ' VAL . 0.1 OUTLIER -93.88 -53.53 3.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.118 179.702 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.696 ' HB3' HG23 ' A' ' 252' ' ' THR . . . -151.33 -179.22 7.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.683 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.638 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.4 OUTLIER -161.2 -178.01 6.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.295 178.404 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 23.7 mt -140.52 148.67 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.17 0.509 . . . . 0.0 111.482 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.68 137.2 8.7 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.735 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.874 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 3.2 p90 -131.62 166.46 21.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . 0.5 ' CB ' ' HD2' ' A' ' 240' ' ' LYS . 11.0 t-20 -116.43 134.17 55.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.868 -1.514 . . . . 0.0 112.953 -178.671 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.5 t -90.53 -1.1 57.88 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.946 178.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.4 m -77.02 -28.95 55.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.718 0.771 . . . . 0.0 110.015 178.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.45 15.09 3.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.693 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.4 p90 41.9 58.97 2.69 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.874 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -126.34 145.87 50.26 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.712 -179.612 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.684 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -129.51 124.86 35.0 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.035 -178.935 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -139.71 142.7 36.86 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.758 0.79 . . . . 0.0 112.78 -178.181 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 1.8 pp -108.07 156.38 19.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.221 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.67 HG23 ' CE3' ' A' ' 269' ' ' TRP . 5.1 p -124.47 163.24 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.592 ' CG ' ' HB3' ' A' ' 260' ' ' SER . 6.6 m-20 -107.91 125.47 51.53 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.152 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.764 ' HE3' ' N ' ' A' ' 246' ' ' MET . 0.0 OUTLIER -85.77 94.28 9.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.738 178.374 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 47.74 68.4 1.22 Allowed Glycine 0 C--N 1.329 0.16 0 C-N-CA 119.544 -1.312 . . . . 0.0 110.475 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 85.8 p -64.32 58.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.685 HD11 ' N ' ' A' ' 250' ' ' ASN . 1.2 tm? -54.26 -60.63 3.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.224 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.685 ' N ' HD11 ' A' ' 249' ' ' LEU . 1.1 t-20 -71.1 -30.16 66.18 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.006 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.429 ' O ' HD23 ' A' ' 253' ' ' LEU . . . 100.48 118.66 4.28 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.672 178.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.696 HG23 ' HB3' ' A' ' 230' ' ' ALA . 1.4 m -92.74 105.59 17.7 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -98.75 139.25 34.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 112.367 -178.279 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.542 ' N ' HD11 ' A' ' 259' ' ' ILE . 41.4 t -109.61 127.42 66.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.953 178.126 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.597 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 7.2 t-20 55.01 38.34 30.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.082 0.468 . . . . 0.0 110.248 -178.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.38 34.96 12.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.594 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . 0.437 ' O ' HG21 ' A' ' 259' ' ' ILE . 0.5 OUTLIER -140.96 113.18 7.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.522 -179.84 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 83.7 p -58.9 88.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.533 0.683 . . . . 0.0 110.562 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.784 HD13 ' H ' ' A' ' 259' ' ' ILE . 0.2 OUTLIER -88.67 -21.8 6.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.222 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.592 ' HB3' ' CG ' ' A' ' 245' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.457 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.415 0.626 . . . . 0.0 112.38 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.67 ' CE3' HG23 ' A' ' 244' ' ' VAL . 83.7 m95 -80.33 -20.58 43.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.306 178.371 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.489 ' HA3' ' HG ' ' A' ' 260' ' ' SER . . . 68.87 174.96 10.09 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -177.326 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.69 125.27 65.6 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 118.141 0.971 . . . . 0.0 110.52 -179.486 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.1 Cg_exo -35.25 119.63 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.807 2.338 . . . . 0.0 111.638 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 97.7 t -101.15 136.6 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.671 -177.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 11.9 mt-10 -82.4 128.38 34.19 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.868 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.661 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.17 165.2 13.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.992 -179.464 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.657 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.08 159.03 43.05 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.671 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 84.9 p -62.89 130.71 46.0 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.426 179.188 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.671 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.5 OUTLIER 83.66 -0.66 1.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.122 -179.237 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.657 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -71.07 -170.27 0.44 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.597 ' CD1' ' HA ' ' A' ' 255' ' ' ASN . 0.8 OUTLIER -162.07 124.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 177.349 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -99.27 150.28 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.149 176.363 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.681 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 1.8 m -134.68 122.2 21.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.662 0.744 . . . . 0.0 109.357 178.091 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.644 ' CD2' HD22 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -122.13 136.93 54.97 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.593 179.598 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.463 ' HA2' ' CG ' ' A' ' 250' ' ' ASN . . . 88.11 -132.4 11.19 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.315 179.522 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.8 t -100.03 -33.43 10.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.445 0.164 . . . . 0.0 111.18 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -152.79 8.21 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.751 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.83 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 12.7 m -74.53 102.43 4.51 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.043 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.538 ' HD3' ' HB ' ' A' ' 280' ' ' ILE . 15.6 ttmt -120.04 125.37 48.16 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.63 -179.311 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 186' ' ' VAL . 1.0 OUTLIER -107.4 135.57 45.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.607 179.701 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.58 ' HD1' HG21 ' A' ' 280' ' ' ILE . 2.2 t80 -78.13 136.67 37.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.615 -179.393 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.587 HG12 ' HB2' ' A' ' 275' ' ' LEU . 1.8 t -105.45 114.86 46.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.393 -179.569 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -133.87 138.82 45.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.162 -179.636 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.454 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 14.2 mt -135.74 143.22 37.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 7.6 t -146.29 153.25 40.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.431 ' HA ' ' HG ' ' A' ' 180' ' ' SER . 78.2 p -86.16 162.51 18.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.312 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 179.97 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.645 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.226 -0.151 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.698 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 22.0 m95 -144.29 130.9 20.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.642 ' HB3' ' CZ3' ' A' ' 234' ' ' TRP . 0.4 OUTLIER -121.44 107.95 13.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.035 177.883 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.698 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 0.9 OUTLIER -106.88 140.13 40.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.864 0.84 . . . . 0.0 112.081 -179.565 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.655 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -133.48 144.11 49.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.165 177.401 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.584 ' C ' HG11 ' A' ' 289' ' ' VAL . 16.1 tt0 -137.74 125.79 22.86 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.673 HG12 HD12 ' A' ' 220' ' ' LEU . 9.6 t -65.52 112.26 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.578 177.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.737 HG21 ' O ' ' A' ' 288' ' ' LYS . 7.4 tt -95.03 -22.44 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.102 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.863 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.85 93.75 0.56 Allowed 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 119.742 -0.783 . . . . 0.0 112.691 -179.331 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.733 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.63 -171.05 27.18 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 178.257 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.698 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 93.6 Cg_endo -79.41 30.57 0.47 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.053 1.835 . . . . 0.0 111.77 178.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.59 27.29 0.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 178.314 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.733 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -41.2 107.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.818 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 8.17 2.26 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.741 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.582 ' CD1' HD13 ' A' ' 220' ' ' LEU . 0.1 OUTLIER -97.59 132.99 42.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.939 0.876 . . . . 0.0 108.705 177.878 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.546 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 17.8 mt-30 -133.22 152.9 51.94 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.211 -1.358 . . . . 0.0 110.193 -178.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.655 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -148.25 148.31 30.33 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.097 -179.757 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.439 ' C ' ' HZ3' ' A' ' 181' ' ' TRP . . . -147.42 140.07 24.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.337 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.781 HG23 ' HA ' ' A' ' 206' ' ' LEU . 5.2 p -143.29 149.6 18.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.427 0.632 . . . . 0.0 110.458 178.435 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 180' ' ' SER . 4.5 p30 -95.8 151.83 19.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.758 -179.516 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.525 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 80.5 p -67.41 -1.33 4.63 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -178.542 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.6 15.49 22.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.941 0.4 . . . . 0.0 111.27 179.265 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.52 143.93 26.66 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.064 179.26 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.0 m -89.04 -94.46 0.1 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.354 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.86 31.01 2.47 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.302 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.64 -11.73 8.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 110.751 179.18 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.781 ' HA ' HG23 ' A' ' 198' ' ' VAL . 4.7 tt -67.5 -58.04 9.27 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.591 -179.152 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -41.93 90.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.639 2.226 . . . . 0.0 112.438 -178.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 196' ' ' HIS . 2.2 t -71.56 91.0 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.209 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.405 ' HA ' ' HG3' ' A' ' 231' ' ' GLN . 12.2 mtmt -69.96 87.2 0.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 2.0 mp -74.55 128.67 36.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.807 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . -177.78 -177.33 46.51 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.486 -179.551 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.921 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.2 OUTLIER -57.18 -93.2 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.017 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 214' ' ' SER . 11.5 p -158.3 158.75 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.355 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.952 ' HB2' ' HD3' ' A' ' 215' ' ' PRO . 24.4 m 103.16 -74.06 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.831 179.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.952 ' HD3' ' HB2' ' A' ' 214' ' ' SER . 95.9 Cg_endo -96.01 -35.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.079 1.853 . . . . 0.0 113.182 179.545 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.463 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 0.9 OUTLIER -57.02 145.87 29.05 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.142 0.496 . . . . 0.0 112.209 -178.958 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.04 -33.06 69.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.454 179.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.761 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.6 mt -100.21 135.24 41.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.557 178.284 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.503 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -93.64 73.5 4.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.951 -178.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.921 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.1 mm? -99.48 94.69 6.54 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.776 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . 0.698 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 28.0 pttt -65.11 53.63 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.232 0.539 . . . . 0.0 110.048 178.406 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 220' ' ' LEU . 4.1 m-20 -87.81 116.2 25.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.223 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 11.5 p -60.51 -15.53 28.07 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.877 -179.347 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.534 ' HG2' ' HB3' ' A' ' 222' ' ' ASP . 0.0 OUTLIER -79.22 -21.33 46.41 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.576 0.227 . . . . 0.0 110.838 179.686 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.941 ' HB ' ' HD1' ' A' ' 229' ' ' HIS . 2.8 p -107.61 80.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.16 -30.22 0.74 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 111.188 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -145.87 -59.66 0.02 OUTLIER Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.194 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.846 ' HB2' ' HG3' ' A' ' 246' ' ' MET . 0.3 OUTLIER -144.49 133.59 22.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.785 0.326 . . . . 0.0 110.354 -179.824 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.941 ' HD1' ' HB ' ' A' ' 225' ' ' VAL . 0.4 OUTLIER -93.43 -58.7 2.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.738 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 210' ' ' LEU . . . -147.45 165.48 30.13 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.788 -178.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 17.9 tt0 -143.11 157.44 44.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.657 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 23.7 mt -121.54 145.75 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.918 179.53 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.68 ' HA ' HD23 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -161.79 160.58 28.46 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.28 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.773 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 3.6 p90 -149.68 165.73 31.5 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -117.31 133.6 55.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.854 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -0.12 57.32 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.107 179.093 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -76.15 -20.15 57.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.659 0.742 . . . . 0.0 110.052 178.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.635 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 7.5 tptm -151.6 20.58 0.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.596 -178.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 23.8 p90 41.01 57.81 2.67 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.391 0.615 . . . . 0.0 109.926 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.773 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.8 OUTLIER -120.63 137.5 54.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.938 179.352 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.701 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -120.49 122.25 40.23 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.95 179.963 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 1.0 OUTLIER -139.37 142.25 37.56 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.941 0.876 . . . . 0.0 112.784 -178.391 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.812 HD21 HD13 ' A' ' 281' ' ' ILE . 3.0 pp -110.31 155.09 22.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.691 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.827 HG12 ' CZ3' ' A' ' 269' ' ' TRP . 5.0 p -117.33 163.02 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 122.239 -0.288 . . . . 0.0 111.102 -179.452 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 260' ' ' SER . 0.0 OUTLIER -105.95 113.09 26.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.318 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.846 ' HG3' ' HB2' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -81.39 105.77 12.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.665 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 54.35 65.6 3.37 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.71 -178.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.504 ' HG ' ' HA2' ' A' ' 251' ' ' GLY . 0.3 OUTLIER -66.76 49.79 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.905 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.584 ' N ' HD11 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -58.11 -47.67 82.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.702 178.431 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.517 ' H ' HD11 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.38 -33.09 37.44 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.014 -179.159 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.504 ' HA2' ' HG ' ' A' ' 248' ' ' SER . . . 92.02 85.4 1.49 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.122 -178.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.627 ' HB ' ' OG ' ' A' ' 260' ' ' SER . 2.9 m -46.55 168.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.641 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.626 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -154.97 136.2 13.99 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 119.9 -0.72 . . . . 0.0 112.749 179.381 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.526 ' CG2' HG13 ' A' ' 281' ' ' ILE . 67.1 t -115.16 130.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.154 178.481 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . 0.539 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 1.1 t-20 56.16 37.68 29.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.106 0.479 . . . . 0.0 109.932 -179.25 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.67 25.69 9.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.637 -179.488 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -128.02 101.35 6.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.675 179.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 252' ' ' THR . 10.4 t -53.51 92.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.327 0.584 . . . . 0.0 111.167 -179.71 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.593 ' CG1' HG23 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -88.88 -9.14 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.004 -178.284 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.627 ' OG ' ' HB ' ' A' ' 252' ' ' THR . 25.2 m . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.359 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp . . . . . 0 CA--C 1.543 0.683 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.827 ' CZ3' HG12 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -80.31 -23.13 40.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.785 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.463 ' HA3' ' OD2' ' A' ' 245' ' ' ASP . . . 62.0 -175.74 6.39 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.241 -0.981 . . . . 0.0 110.929 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -105.6 141.74 23.29 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 117.983 0.891 . . . . 0.0 111.141 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.692 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.1 Cg_exo -51.97 123.14 11.8 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.856 2.371 . . . . 0.0 113.517 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.593 HG23 ' CG1' ' A' ' 259' ' ' ILE . 95.2 t -100.9 140.91 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.272 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.1 mt-10 -86.92 129.24 34.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.745 -179.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.686 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -95.41 164.67 12.72 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.93 -179.516 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.601 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.67 157.4 45.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.618 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 29.3 t -61.02 129.44 41.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.25 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 277' ' ' SER . 5.8 m-20 82.43 -1.15 1.38 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.519 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.611 ' O ' HG21 ' A' ' 291' ' ' VAL . 0.1 OUTLIER -79.11 137.86 37.67 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.079 179.473 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.574 ' O ' HD13 ' A' ' 280' ' ' ILE . 1.1 pp -102.08 127.11 55.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.04 179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.812 HD13 HD21 ' A' ' 243' ' ' LEU . 0.4 OUTLIER -105.96 159.54 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.995 0.426 . . . . 0.0 111.287 178.971 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.626 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.9 m -145.54 122.91 11.62 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.149 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.518 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -119.01 47.93 1.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.833 -179.44 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.03 -134.9 3.1 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.85 -1.167 . . . . 0.0 113.042 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 1.8 t -87.8 -51.62 5.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 0.0 110.382 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.59 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -137.86 -2.19 1.93 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.292 179.337 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.863 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.6 m -70.92 102.77 2.47 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.885 0.374 . . . . 0.0 111.103 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.737 ' O ' HG21 ' A' ' 187' ' ' ILE . 0.4 OUTLIER -121.27 128.55 52.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.922 -179.215 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.683 HG22 ' CG2' ' A' ' 281' ' ' ILE . 0.0 OUTLIER -108.3 133.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.087 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.1 t80 -76.43 134.78 39.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.682 -179.221 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.611 HG21 ' O ' ' A' ' 279' ' ' ASP . 0.6 OUTLIER -104.38 113.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.044 -179.988 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -129.06 141.86 51.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.749 -179.785 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.567 HD11 ' CE3' ' A' ' 241' ' ' TRP . 6.6 mt -137.63 138.17 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.286 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.29 131.56 16.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.695 0.283 . . . . 0.0 111.071 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 23.8 p -79.77 143.19 34.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.091 0.472 . . . . 0.0 111.193 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.628 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.229 0.538 . . . . 0.0 110.75 . . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 181' ' ' TRP . . . . . 0.683 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 37.0 m95 -148.16 139.44 23.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.38 -178.069 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.54 ' CD2' ' HZ3' ' A' ' 234' ' ' TRP . 0.9 OUTLIER -114.9 120.98 41.78 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.049 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 183' ' ' PHE . . . . . 0.683 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 2.3 m-85 -121.56 135.41 55.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.445 0.641 . . . . 0.0 110.358 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -140.57 148.36 40.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.355 179.211 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 1.7 tt0 -137.56 124.46 21.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.2 -177.556 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.579 ' CG1' HD11 ' A' ' 220' ' ' LEU . 40.3 t -63.05 108.74 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.379 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.453 HD13 HG23 ' A' ' 187' ' ' ILE . 10.9 tt -87.92 -26.64 5.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -176.118 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.866 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -158.8 96.31 1.35 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.443 -179.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.602 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.49 173.91 39.66 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 178.546 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.463 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 37.6 Cg_endo -69.47 32.92 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 121.823 1.682 . . . . 0.0 111.266 178.141 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 191' ' ' ALA . . . . . 0.632 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -160.65 20.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.308 179.497 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.602 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.1 mt -38.94 108.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.721 0.296 . . . . 0.0 111.761 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.31 8.07 2.1 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.154 -1.022 . . . . 0.0 113.018 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.703 HD13 ' O ' ' A' ' 219' ' ' ALA . 0.8 OUTLIER -101.47 112.89 25.57 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.917 0.865 . . . . 0.0 109.74 178.75 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.441 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 5.7 mt-30 -114.65 154.69 27.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.565 -179.149 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.549 ' CD2' ' HB3' ' A' ' 217' ' ' ASP . 0.0 OUTLIER -147.84 148.08 30.5 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.381 0.61 . . . . 0.0 111.154 179.636 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -144.01 152.27 40.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.044 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.582 ' CG2' ' HA ' ' A' ' 206' ' ' LEU . 8.1 p -167.03 150.29 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.0 111.278 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 199' ' ' ASN . . . . . 0.64 ' HA ' ' O ' ' A' ' 180' ' ' SER . 1.0 OUTLIER -92.46 155.28 17.95 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.369 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.647 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 3.6 m -56.3 -48.74 76.06 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.522 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' A' ' 201' ' ' THR . 0.0 OUTLIER -67.66 14.11 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.251 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 202' ' ' SER . . . . . 0.528 ' HB2' ' O ' ' A' ' 199' ' ' ASN . 0.3 OUTLIER -91.99 118.89 31.2 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 110.005 179.2 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -67.14 -107.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.4 m -80.98 21.02 0.73 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.5 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -114.17 -19.23 11.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 178.944 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.759 HD21 ' CE3' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -70.71 -33.78 3.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.274 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 38.6 Cg_exo -55.47 101.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 121.016 1.144 . . . . 0.0 111.721 179.538 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.421 HG13 HD12 ' A' ' 184' ' ' LEU . 49.0 t -84.78 90.9 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.694 -179.163 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.609 ' HD2' ' HA ' ' A' ' 216' ' ' SER . 11.9 mttt -71.01 109.11 4.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.008 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.6 mp -94.38 131.78 39.68 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.013 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -179.55 -176.39 47.1 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.057 -179.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . 0.955 ' HB2' HG12 ' A' ' 225' ' ' VAL . 30.6 ttt-85 -80.76 -69.64 0.59 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.639 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 213' ' ' VAL . 9.1 p -141.88 118.8 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 0.0 110.529 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 214' ' ' SER . . . . . 0.564 ' C ' ' H ' ' A' ' 216' ' ' SER . 0.0 OUTLIER 168.9 176.85 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.735 -178.973 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 214' ' ' SER . 41.1 Cg_endo -67.47 23.5 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 121.831 1.687 . . . . 0.0 112.243 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 216' ' ' SER . . . . . 0.609 ' HA ' ' HD2' ' A' ' 209' ' ' LYS . 1.1 m -62.62 -151.77 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.438 179.806 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.549 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 52.1 m-20 -130.9 -34.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.957 0.408 . . . . 0.0 110.466 179.643 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.682 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 4.0 mt -103.71 125.33 50.12 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 177.111 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.703 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -94.08 87.67 5.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.863 0.364 . . . . 0.0 110.223 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.77 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.0 mm? -110.45 92.42 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.168 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.48 36.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.214 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.836 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -64.67 111.88 2.95 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.076 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.5 p -53.02 -19.15 2.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.562 0.22 . . . . 0.0 111.322 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.452 ' O ' HD13 ' A' ' 249' ' ' LEU . 3.0 pm0 -75.36 -28.69 59.64 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.929 179.674 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 225' ' ' VAL . . . . . 0.955 HG12 ' HB2' ' A' ' 212' ' ' ARG . 2.8 p -97.41 92.42 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.042 178.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.1 m -40.96 -40.71 1.47 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.371 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.4 -54.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.53 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . 0.65 ' HB3' ' HG3' ' A' ' 246' ' ' MET . 0.1 OUTLIER -144.25 126.69 15.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.749 0.309 . . . . 0.0 110.539 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 229' ' ' HIS . . . . . 0.603 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.6 OUTLIER -96.54 -51.64 4.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.961 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.476 ' C ' HD11 ' A' ' 210' ' ' LEU . . . -142.42 165.44 27.41 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . 0.475 ' CG ' ' HA ' ' A' ' 209' ' ' LYS . 1.3 tm0? -149.89 160.88 43.23 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.597 179.471 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.9 mt -124.9 144.43 34.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 CA-C-O 121.271 0.557 . . . . 0.0 111.744 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.38 164.3 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.118 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 234' ' ' TRP . . . . . 0.813 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.8 p90 -157.58 167.46 30.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -115.0 131.72 56.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.542 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.49 -0.61 57.62 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.27 179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.1 m -73.6 -21.79 60.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.696 0.76 . . . . 0.0 110.168 178.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 239' ' ' PHE . 6.2 tptt -150.87 23.79 0.76 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.377 -178.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 238' ' ' LYS . 8.9 p90 38.31 60.48 1.28 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.521 0.677 . . . . 0.0 109.533 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.813 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -121.7 136.53 54.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.727 179.683 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 241' ' ' TRP . . . . . 0.68 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.2 OUTLIER -118.65 130.58 55.94 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.771 -179.905 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.458 ' CB ' ' O ' ' A' ' 273' ' ' VAL . 0.8 OUTLIER -137.09 132.7 34.47 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.427 0.632 . . . . 0.0 111.115 -177.815 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . 0.737 HD13 ' N ' ' A' ' 244' ' ' VAL . 0.2 OUTLIER -110.08 136.97 48.49 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.131 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.737 ' N ' HD13 ' A' ' 243' ' ' LEU . 4.2 p -122.6 162.82 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 120.733 0.301 . . . . 0.0 110.359 -179.735 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.666 ' HB2' ' CA ' ' A' ' 270' ' ' GLY . 12.2 m-20 -99.38 149.1 23.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.182 0.515 . . . . 0.0 111.707 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.65 ' HG3' ' HB3' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -116.34 95.0 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.424 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 51.33 60.81 6.84 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.812 -177.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.489 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 0.3 OUTLIER -72.86 72.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.858 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 250' ' ' ASN . 1.2 pp -54.33 -57.54 10.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.26 0.552 . . . . 0.0 110.189 178.86 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.629 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.5 OUTLIER -69.52 -25.97 64.29 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.774 -179.712 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 248' ' ' SER . . . 89.94 132.11 4.73 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.779 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 282' ' ' THR . 79.7 m -92.59 151.62 20.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.58 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.0 OUTLIER -144.76 128.56 17.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.939 0.399 . . . . 0.0 111.659 -179.989 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . 0.407 ' CG2' ' CD1' ' A' ' 259' ' ' ILE . 50.1 t -101.44 131.95 48.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.251 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 49.12 31.85 3.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.149 0.499 . . . . 0.0 110.557 -178.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 78.04 36.89 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.33 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.2 120.45 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.938 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 258' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 252' ' ' THR . 72.4 p -67.28 85.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.42 0.628 . . . . 0.0 110.91 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . 0.534 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.1 OUTLIER -80.12 -15.42 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.636 -178.629 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.522 ' O ' ' HA2' ' A' ' 270' ' ' GLY . 2.8 m . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 269' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 . . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 269' ' ' TRP . . . . . 0.634 ' CZ3' ' HB3' ' A' ' 246' ' ' MET . 26.7 t-105 -85.19 78.68 9.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.275 -177.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.666 ' CA ' ' HB2' ' A' ' 245' ' ' ASP . . . 36.04 -160.87 0.01 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 118.984 2.354 . . . . 0.0 118.984 172.176 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.11 94.24 3.53 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 111.418 -2.391 . . . . 0.0 105.99 175.11 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.41 ' HD3' ' CG2' ' A' ' 244' ' ' VAL . 1.0 OUTLIER -24.4 109.01 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.872 3.048 . . . . 0.0 115.929 -176.912 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 273' ' ' VAL . . . . . 0.534 HG21 ' HB ' ' A' ' 259' ' ' ILE . 17.5 t -115.95 159.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.314 179.128 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 81.9 mm-40 -94.19 130.98 40.21 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 241' ' ' TRP . 0.4 OUTLIER -94.33 161.51 14.21 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.089 -177.258 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.51 155.27 45.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.287 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 25.7 t -61.73 134.73 57.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.852 179.301 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.2 OUTLIER 83.66 7.25 0.66 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.925 -179.418 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 279' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.7 OUTLIER -82.92 126.93 33.03 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.358 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . 0.445 ' CG2' ' CD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -100.38 132.02 46.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 119.619 -0.833 . . . . 0.0 111.161 -179.524 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 281' ' ' ILE . . . . . 0.447 ' CD1' ' CG1' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -107.41 156.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.336 179.184 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 252' ' ' THR . 9.3 m -144.51 116.64 8.39 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 283' ' ' LEU . . . . . 0.603 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -120.01 49.52 1.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.523 -178.307 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 179.97 -142.24 5.03 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.106 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.6 t -87.7 -37.11 16.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.998 0.428 . . . . 0.0 110.211 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -152.72 3.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.238 179.706 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.866 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.3 m -77.54 106.11 9.11 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 117.753 0.252 . . . . 0.0 111.102 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.59 ' HG2' ' OG1' ' A' ' 282' ' ' THR . 2.9 mtpt -127.98 133.36 49.17 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.364 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.447 ' CG1' ' CD1' ' A' ' 281' ' ' ILE . 8.7 p -113.32 136.51 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.345 -179.386 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 290' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 3.1 t80 -77.98 133.06 38.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 279' ' ' ASP . 2.6 t -113.69 124.7 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.466 -178.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.511 ' O ' HD11 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -143.53 153.05 42.19 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.891 -179.744 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.523 HD11 ' CD2' ' A' ' 241' ' ' TRP . 1.5 mt -139.69 129.83 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.43 160.04 35.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 111.142 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 295' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 180' ' ' SER . 0.3 OUTLIER -99.02 174.31 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.665 179.578 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -179.691 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.414 ' HA ' ' CG2' ' A' ' 201' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.765 0.317 . . . . 0.0 110.882 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.538 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.39 84.02 1.14 Allowed Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 27.0 t -165.08 -72.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.2 OUTLIER -139.25 -178.92 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.7 m95 -150.52 134.22 16.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 197' ' ' ALA . 2.7 tp -119.99 139.96 51.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.49 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.608 ' O ' HD13 ' A' ' 184' ' ' LEU . 4.4 m-85 -138.94 137.94 36.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.441 0.639 . . . . 0.0 110.043 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.709 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 5.2 mp -132.7 151.45 51.97 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.019 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.433 ' C ' HG12 ' A' ' 289' ' ' VAL . 0.7 OUTLIER -144.11 122.37 12.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.473 HG23 ' CD1' ' A' ' 194' ' ' LEU . 42.1 t -64.6 118.75 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.436 ' CG2' ' HB3' ' A' ' 288' ' ' LYS . 3.7 tt -97.96 -23.94 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.75 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -161.85 92.41 0.85 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.541 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.541 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.58 -173.78 30.65 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.418 ' HG3' ' CA ' ' A' ' 222' ' ' ASP . 74.3 Cg_endo -79.88 30.58 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.179 1.919 . . . . 0.0 111.822 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.552 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -162.28 23.95 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.627 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.541 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.9 mt -39.63 113.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.072 0.463 . . . . 0.0 111.699 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.9 9.63 2.45 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.524 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.611 HD13 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -99.37 135.08 41.3 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.288 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.709 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 27.1 mt-30 -129.67 147.46 51.46 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.217 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.663 ' CG ' HG13 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -136.26 130.05 32.44 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.599 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 182' ' ' LEU . . . -144.63 166.02 26.37 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.942 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.759 HG23 ' HA ' ' A' ' 206' ' ' LEU . 3.2 p -175.21 157.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.098 0.475 . . . . 0.0 111.073 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 180' ' ' SER . 65.8 m-80 -90.92 149.13 22.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.872 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.49 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 54.8 p -66.82 -3.29 6.47 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.709 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.538 HG21 ' N ' ' A' ' 178' ' ' GLY . 0.1 OUTLIER -102.45 5.45 39.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.741 0.305 . . . . 0.0 111.444 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -87.35 127.34 35.2 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.04 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.5 t -90.56 -87.3 0.19 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.53 11.59 6.85 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.12 -11.0 9.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.917 0.389 . . . . 0.0 110.875 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.759 ' HA ' HG23 ' A' ' 198' ' ' VAL . 6.5 tt -70.11 -57.76 5.78 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.528 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -42.83 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.29 1.993 . . . . 0.0 112.745 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.663 HG13 ' CG ' ' A' ' 196' ' ' HIS . 99.2 t -69.59 164.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.183 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.62 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 3.8 mtmm -139.64 95.03 2.85 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 230' ' ' ALA . 1.3 mp -83.78 127.32 33.72 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.471 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -169.11 172.05 43.22 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.02 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.582 ' CG ' ' HA ' ' A' ' 221' ' ' LYS . 3.0 ttt85 -71.46 -76.16 0.11 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.408 ' O ' ' CG1' ' A' ' 213' ' ' VAL . 11.7 p -133.66 110.18 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.135 0.493 . . . . 0.0 110.991 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.459 ' HB2' ' HD2' ' A' ' 215' ' ' PRO . 0.0 OUTLIER 171.4 179.81 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.592 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 214' ' ' SER . 45.2 Cg_exo -56.65 -3.42 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 121.946 1.764 . . . . 0.0 112.478 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.498 ' HA ' ' HB3' ' A' ' 209' ' ' LYS . 0.4 OUTLIER -43.24 158.62 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.971 0.415 . . . . 0.0 111.535 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.471 ' HB3' HG11 ' A' ' 208' ' ' VAL . 21.5 t0 -83.68 -30.46 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.289 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.473 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 18.7 mt -113.88 127.99 56.22 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.611 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -88.62 84.78 6.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.487 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.7 mm? -100.94 66.74 1.17 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.582 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 0.4 OUTLIER -62.07 54.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.494 ' HB3' ' HG3' ' A' ' 224' ' ' GLU . 19.8 t0 -105.33 125.5 51.05 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.1 p -40.15 -31.83 0.15 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.494 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 0.0 OUTLIER -53.32 -40.36 64.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.795 0.331 . . . . 0.0 111.11 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.544 ' O ' ' HB2' ' A' ' 212' ' ' ARG . 2.5 p -99.89 96.33 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 83.1 p -41.63 -51.86 3.92 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.047 0.451 . . . . 0.0 111.145 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -142.72 -54.07 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.31 128.67 21.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 109.964 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.579 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.2 OUTLIER -94.62 -56.88 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.211 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.492 ' O ' HD13 ' A' ' 210' ' ' LEU . . . -150.45 177.24 10.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.37 0.605 . . . . 0.0 112.469 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.62 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.7 OUTLIER -157.93 178.67 9.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.152 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 4.8 mt -133.23 145.58 33.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.434 0.635 . . . . 0.0 111.734 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.94 131.37 5.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.914 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 16.3 p90 -125.3 167.02 15.48 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.99 133.43 56.04 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.233 -1.349 . . . . 0.0 112.503 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 48.0 t -91.52 0.44 57.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.11 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.2 m -79.01 -46.3 18.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.833 0.825 . . . . 0.0 109.457 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.413 ' C ' ' CG ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -111.77 9.53 20.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.936 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.413 ' CG ' ' C ' ' A' ' 238' ' ' LYS . 10.2 p90 43.75 65.9 0.92 Allowed 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.593 0.711 . . . . 0.0 109.924 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.914 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -135.61 145.82 47.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.269 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.725 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.9 OUTLIER -121.37 114.4 21.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.601 -1.182 . . . . 0.0 109.935 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.685 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 24.1 mt-10 -131.36 146.46 52.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.956 0.884 . . . . 0.0 113.156 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 1.6 pp -110.98 153.61 25.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.935 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.509 ' CG2' ' CD1' ' A' ' 269' ' ' TRP . 1.4 p -122.71 162.23 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.452 ' OD1' ' HB ' ' A' ' 252' ' ' THR . 5.2 m-20 -112.6 100.62 8.87 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.986 0.422 . . . . 0.0 111.988 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.673 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -78.15 106.11 9.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.678 178.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 49.19 65.0 2.96 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.252 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.411 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 0.0 OUTLIER -71.35 64.32 0.39 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.651 HD11 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -48.39 -62.32 1.55 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.023 0.439 . . . . 0.0 110.166 178.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.526 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . 0.4 OUTLIER -77.02 -31.71 56.56 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.854 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.555 ' HA3' ' ND1' ' A' ' 261' ' ' HIS . . . 99.19 149.09 24.06 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.172 -0.922 . . . . 0.0 114.006 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.485 HG22 HG23 ' A' ' 281' ' ' ILE . 2.9 m -115.95 107.63 15.22 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.722 0.409 . . . . 0.0 110.57 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.563 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -98.52 128.87 45.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.122 0.487 . . . . 0.0 111.554 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.44 HG23 HD13 ' A' ' 259' ' ' ILE . 91.9 t -99.7 134.02 40.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.678 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.1 p30 47.93 38.01 8.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.279 0.561 . . . . 0.0 110.068 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.0 t 67.51 36.69 3.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.731 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.64 111.81 5.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.245 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.567 ' CB ' ' NE2' ' A' ' 261' ' ' HIS . 60.0 p -58.17 87.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.134 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.511 HD11 HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -88.97 -18.18 7.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.844 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 9.7 t -130.87 -10.17 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.68 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 7.4 p80 -110.99 44.26 0.22 Allowed Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 176.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.844 ' HD3' ' C ' ' A' ' 260' ' ' SER . 10.6 Cg_exo -74.37 -4.95 16.21 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.11 1.873 . . . . 0.0 113.859 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 266' ' ' SER . 8.8 t0 -135.76 100.55 4.5 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.108 0.48 . . . . 0.0 111.872 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.2 -85.78 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.924 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -38.93 -29.55 0.09 OUTLIER Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.536 -0.364 . . . . 0.0 113.672 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 263' ' ' ASP . 0.3 OUTLIER -65.28 -40.56 94.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.5 22.52 0.75 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -54.87 154.67 4.98 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.408 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.673 ' CZ3' ' HB2' ' A' ' 246' ' ' MET . 38.4 t-105 -67.91 -23.32 65.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.276 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 73.38 167.76 13.51 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.748 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -102.68 143.77 27.28 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.5 Cg_exo -51.32 121.45 8.42 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.308 2.006 . . . . 0.0 113.12 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.685 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 70.2 t -96.42 132.15 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.606 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.3 125.65 29.67 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.408 -178.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -94.59 165.5 12.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.51 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.1 162.87 35.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.207 0.527 . . . . 0.0 112.418 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.56 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 13.4 p -60.61 128.55 37.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.428 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.8 m-20 86.05 7.84 0.33 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.279 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -75.89 -171.46 1.64 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.452 ' CG2' ' HD1' ' A' ' 290' ' ' TYR . 0.4 OUTLIER -160.73 133.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.102 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -111.63 149.85 14.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.987 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.563 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -139.33 112.4 8.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.622 ' N ' HD12 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -110.77 45.01 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.059 -177.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.33 -132.29 2.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 119.321 -1.419 . . . . 0.0 113.64 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 10.9 t -89.87 -43.68 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.654 0.264 . . . . 0.0 110.529 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.2 t -148.37 -0.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.75 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 25.8 m -69.04 102.57 1.65 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.257 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 2.5 ttmt -121.01 127.01 51.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.664 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -109.77 132.69 57.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.294 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.1 t80 -76.86 137.05 38.93 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.872 0.368 . . . . 0.0 110.194 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.563 ' HA ' ' CD1' ' A' ' 184' ' ' LEU . 1.3 t -106.04 115.75 48.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.262 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.79 142.6 50.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.912 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.444 HG12 HD11 ' A' ' 182' ' ' LEU . 6.4 mt -139.0 115.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.157 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.77 154.18 45.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 110.924 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 88.7 p -87.95 -173.2 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.726 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.52 116.19 2.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.52 101.38 13.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.982 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.592 ' HB2' ' CG2' ' A' ' 201' ' ' THR . 57.6 mt . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 120.6 0.238 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.674 ' N ' HG23 ' A' ' 201' ' ' THR . . . 104.32 99.79 2.58 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.916 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.543 ' HB3' ' HB3' ' A' ' 200' ' ' SER . 1.1 m -179.54 -89.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.499 0.19 . . . . 0.0 111.16 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.9 OUTLIER -139.53 179.95 6.26 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 2.7 m95 -141.07 132.29 26.49 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.649 HD23 ' CZ3' ' A' ' 234' ' ' TRP . 3.0 tp -121.94 133.56 54.84 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.116 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 2.4 m-85 -129.71 132.19 46.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.677 0.751 . . . . 0.0 110.246 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.733 ' HB3' ' CE1' ' A' ' 196' ' ' HIS . 4.5 mm? -117.97 140.68 49.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.832 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.529 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.7 OUTLIER -137.35 118.48 14.45 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.625 ' HA ' HG11 ' A' ' 289' ' ' VAL . 5.7 t -67.15 103.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.164 0.507 . . . . 0.0 109.657 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.448 HG21 ' HG2' ' A' ' 288' ' ' LYS . 7.0 tt -87.38 -20.84 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.839 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.54 97.02 0.4 Allowed 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.496 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.554 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.85 -169.57 25.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.55 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 87.1 Cg_endo -81.13 30.12 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.12 1.88 . . . . 0.0 111.313 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.559 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.48 24.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.372 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.554 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.8 mt -39.65 106.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.805 0.336 . . . . 0.0 111.851 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.62 2.42 2.55 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.469 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER -98.02 167.93 10.59 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.637 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.8 mt-30 -159.97 149.21 17.72 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.371 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.733 ' CE1' ' HB3' ' A' ' 184' ' ' LEU . 1.7 p-80 -135.42 128.66 31.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.341 0.591 . . . . 0.0 109.93 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 182' ' ' LEU . . . -143.24 163.03 34.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.475 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.665 HG21 ' HA ' ' A' ' 206' ' ' LEU . 6.1 p -173.2 157.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.041 0.448 . . . . 0.0 111.066 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.7 OUTLIER -90.41 153.47 20.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.988 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.543 ' HB3' ' HB3' ' A' ' 179' ' ' SER . 12.4 t -69.49 -6.07 28.19 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.218 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.674 HG23 ' N ' ' A' ' 178' ' ' GLY . 0.6 OUTLIER -99.35 7.6 45.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.862 -179.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.404 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 1.0 OUTLIER -86.41 138.56 31.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.797 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.0 m -90.22 -85.67 0.21 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.02 22.77 9.84 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.404 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 3.0 pttt -119.67 -11.85 9.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.868 0.365 . . . . 0.0 110.87 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.665 ' HA ' HG21 ' A' ' 198' ' ' VAL . 7.7 tt -71.22 -58.52 3.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -42.86 97.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.575 2.184 . . . . 0.0 113.127 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.585 HG11 ' CD2' ' A' ' 196' ' ' HIS . 60.9 t -69.07 164.78 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 17.5 mtpt -138.08 96.57 3.22 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.634 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.6 OUTLIER -84.3 125.37 32.2 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.88 166.97 38.38 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.418 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.777 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 9.9 ttt180 -69.33 -77.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.28 110.95 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.386 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.599 ' CB ' ' HD2' ' A' ' 215' ' ' PRO . 0.3 OUTLIER 171.98 -178.61 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.778 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.599 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 24.0 Cg_endo -61.68 12.64 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.002 1.801 . . . . 0.0 113.02 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.541 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -57.51 -173.61 0.01 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.91 0.386 . . . . 0.0 111.265 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -104.79 -30.04 10.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.09 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.701 HD12 ' CE1' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -110.95 133.66 53.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.072 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -98.45 82.23 2.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.162 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.777 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.8 mm? -103.73 83.5 2.14 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.55 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 24.6 pttt -58.94 65.04 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.766 0.317 . . . . 0.0 111.61 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 220' ' ' LEU . 6.7 m-20 -93.48 144.01 25.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.446 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.7 t -85.76 -4.14 59.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.519 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 12.7 pm0 -101.24 -16.29 17.02 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 61.9 t -97.93 77.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.893 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -34.03 -50.87 0.4 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.98 0.419 . . . . 0.0 111.535 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.4 -49.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.573 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.441 ' HG2' ' OG ' ' A' ' 216' ' ' SER . 1.6 mtmm -144.08 129.73 19.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.443 . . . . 0.0 110.915 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.539 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 3.1 t60 -96.32 -55.97 2.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.578 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.47 ' C ' HD13 ' A' ' 210' ' ' LEU . . . -148.57 177.49 9.44 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.647 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -156.58 173.17 17.32 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.932 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 35.6 mt -132.77 145.16 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.199 0.523 . . . . 0.0 112.225 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.476 ' N ' HG22 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -160.62 148.66 16.21 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.796 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 8.1 p90 -140.88 165.57 27.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.728 1.011 . . . . 0.0 113.728 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -117.35 133.95 55.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.726 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 10.2 t -90.58 2.02 56.21 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.333 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 4.5 m -76.28 -25.88 55.35 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.71 0.767 . . . . 0.0 110.238 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -145.87 23.47 1.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.123 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 238' ' ' LYS . 15.6 p90 36.97 62.16 0.82 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.51 0.671 . . . . 0.0 110.194 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.796 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -124.97 141.12 52.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.456 178.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.68 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -124.61 123.24 39.63 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.664 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.6 pt-20 -137.09 143.4 42.55 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.935 0.874 . . . . 0.0 112.826 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.647 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 1.4 pp -111.2 150.68 29.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.431 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.5 HG12 ' HG3' ' A' ' 231' ' ' GLN . 0.3 OUTLIER -117.78 162.79 15.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.5 ' CG ' ' HB2' ' A' ' 260' ' ' SER . 1.8 m-20 -112.03 105.79 14.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.547 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -73.32 99.18 2.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.463 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.63 64.49 4.17 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.504 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -68.5 64.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.629 HD11 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -55.42 -51.85 65.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.622 178.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.547 ' N ' HD23 ' A' ' 249' ' ' LEU . 0.3 OUTLIER -74.31 -31.71 62.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 110.914 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.458 ' O ' HD21 ' A' ' 253' ' ' LEU . . . 90.89 90.09 1.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.017 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 1.9 m -46.24 159.2 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.798 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -149.64 137.82 20.54 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.432 0.634 . . . . 0.0 111.85 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.423 ' N ' HD11 ' A' ' 259' ' ' ILE . 99.7 t -112.15 128.2 68.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.608 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.478 ' HA ' HD11 ' A' ' 280' ' ' ILE . 0.3 OUTLIER 56.18 44.61 24.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.129 0.49 . . . . 0.0 110.209 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 m 62.35 24.7 14.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.991 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -130.65 110.51 11.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.42 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 8.7 t -58.79 98.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.512 0.672 . . . . 0.0 111.747 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.602 ' CG1' HG22 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -77.52 -37.68 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.216 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.904 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 42.1 t -59.8 170.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.461 ' O ' ' N ' ' A' ' 263' ' ' ASP . 0.1 OUTLIER -88.87 97.52 0.9 Allowed Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 119.305 0.957 . . . . 0.0 108.714 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.904 ' HD3' ' O ' ' A' ' 260' ' ' SER . 83.8 Cg_exo -55.43 79.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.578 0 C-N-CA 123.197 2.598 . . . . 0.0 112.997 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 261' ' ' HIS . 0.7 OUTLIER -133.88 86.23 2.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.315 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.418 ' CD2' ' H ' ' A' ' 264' ' ' LEU . 0.0 OUTLIER -47.33 -30.77 3.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.338 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.04 -41.85 6.51 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.332 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.408 ' HB2' ' CB ' ' A' ' 263' ' ' ASP . 20.4 m -61.91 -39.75 93.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.925 0.393 . . . . 0.0 111.961 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 46.58 22.6 0.18 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.896 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -53.91 153.58 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.196 0.522 . . . . 0.0 111.725 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.547 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 42.5 t-105 -65.92 -24.85 66.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.217 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.66 159.87 12.44 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.7 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -94.29 142.11 24.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.661 0.267 . . . . 0.0 110.543 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -48.44 113.73 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.502 2.134 . . . . 0.0 112.901 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.602 HG22 ' CG1' ' A' ' 259' ' ' ILE . 85.0 t -94.19 136.14 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -84.36 128.34 34.52 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.7 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.551 HD11 HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -94.0 165.8 12.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.198 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.0 156.59 46.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 60.1 p -60.86 130.38 46.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.987 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.0 OUTLIER 81.28 -2.95 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.406 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.622 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -77.91 138.98 39.19 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.126 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.478 HD11 ' HA ' ' A' ' 255' ' ' ASN . 0.9 OUTLIER -99.0 123.48 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.345 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.494 HG23 HD11 ' A' ' 281' ' ' ILE . 0.3 OUTLIER -103.4 158.79 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.189 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.798 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 47.5 m -151.06 130.3 12.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.539 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -123.74 42.3 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -177.17 -134.53 2.02 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.578 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.7 t -90.59 -47.87 7.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.702 0.287 . . . . 0.0 110.703 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.55 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -139.37 0.93 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 179.234 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.839 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.7 m -75.85 101.03 4.97 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.527 0.204 . . . . 0.0 111.182 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.529 ' HB3' ' OG1' ' A' ' 282' ' ' THR . 0.0 OUTLIER -120.38 129.56 53.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.231 0.539 . . . . 0.0 111.47 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.652 HG13 ' HE1' ' A' ' 196' ' ' HIS . 0.2 OUTLIER -109.84 132.53 57.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.649 -178.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 278' ' ' ASP . 1.4 t80 -77.46 133.35 38.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.981 0.42 . . . . 0.0 110.353 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.583 ' HA ' HD13 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -102.46 114.27 41.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.008 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.39 133.73 53.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.525 HD12 ' CE3' ' A' ' 241' ' ' TRP . 3.7 mt -132.72 134.66 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.377 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.51 165.67 30.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 111.129 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 13.7 m -97.74 177.79 5.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.781 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -159.36 116.49 2.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -75.66 86.44 2.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.484 ' HB2' ' CG2' ' A' ' 201' ' ' THR . 3.7 mm? . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 120.566 0.222 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.497 ' N ' HG23 ' A' ' 201' ' ' THR . . . 99.39 106.28 2.7 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.792 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.476 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 0.2 OUTLIER -179.81 -86.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.585 0.231 . . . . 0.0 110.549 178.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -140.26 -178.53 5.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.9 m95 -143.59 132.35 22.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 1.2 tp -120.88 134.86 55.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.246 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.549 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 5.7 m-85 -133.42 138.77 46.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.706 0.765 . . . . 0.0 109.823 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.601 ' HB3' ' CE1' ' A' ' 196' ' ' HIS . 4.1 mm? -122.09 139.1 54.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.906 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.15 114.95 13.66 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 289' ' ' VAL . 11.2 t -64.33 102.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.074 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 188' ' ' ALA . 15.1 tt -83.59 -28.43 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.768 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -162.08 99.66 1.08 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.424 ' H ' ' CG1' ' A' ' 192' ' ' ILE . . . -162.18 -169.91 26.21 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.638 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 87.6 Cg_endo -83.67 30.85 0.52 Allowed 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.52 2.147 . . . . 0.0 111.748 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.451 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -162.83 24.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.303 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.424 ' CG1' ' H ' ' A' ' 189' ' ' GLY . 8.4 mt -39.32 108.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.471 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.98 3.4 2.56 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.48 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.542 ' CD1' HD12 ' A' ' 220' ' ' LEU . 0.0 OUTLIER -97.42 169.43 9.75 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 117.636 0.718 . . . . 0.0 109.14 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.1 mt-30 -160.06 147.63 16.54 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.563 -178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.802 ' CE1' HD12 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -135.87 129.04 31.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.88 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.52 170.04 16.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.003 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.647 HG11 ' HG ' ' A' ' 206' ' ' LEU . 8.5 p -177.4 153.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.2 0.524 . . . . 0.0 112.244 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 180' ' ' SER . 5.9 t-20 -88.48 150.54 23.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.969 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.49 ' HA ' ' CE2' ' A' ' 234' ' ' TRP . 5.9 t -68.69 -4.85 17.23 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.347 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.497 HG23 ' N ' ' A' ' 178' ' ' GLY . 0.6 OUTLIER -101.04 20.34 15.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.808 0.337 . . . . 0.0 111.744 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.24 112.46 25.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.775 0.321 . . . . 0.0 110.363 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 16.5 m -72.72 -89.93 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 45.6 t -89.32 14.51 10.96 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 111.511 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 13.9 pttt -125.75 54.5 1.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.65 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 10.3 tt -143.58 -56.3 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.755 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 5.5 Cg_exo -41.36 100.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.995 1.796 . . . . 0.0 112.791 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.443 ' O ' ' CB ' ' A' ' 231' ' ' GLN . 87.8 t -67.96 163.9 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.996 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.641 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 31.5 mtmt -135.77 96.31 3.4 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.676 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.5 OUTLIER -83.28 128.34 34.41 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.091 178.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -173.59 174.85 46.27 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.745 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.5 OUTLIER -69.04 -72.32 0.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.996 0.427 . . . . 0.0 111.873 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.59 ' CG2' ' H ' ' A' ' 214' ' ' SER . 10.1 p -128.86 -142.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.728 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.59 ' H ' ' CG2' ' A' ' 213' ' ' VAL . 2.5 m 66.9 -179.42 0.04 OUTLIER Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 118.441 0.564 . . . . 0.0 110.228 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.535 ' CD ' ' HB3' ' A' ' 214' ' ' SER . 22.6 Cg_exo -65.31 7.75 0.28 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.656 2.238 . . . . 0.0 113.558 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.6 m -48.87 173.16 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.714 0.292 . . . . 0.0 110.909 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.06 -31.43 13.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.252 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.802 HD12 ' CE1' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -104.06 133.65 48.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.831 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -100.48 74.99 1.74 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 0.0 110.804 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.729 ' O ' ' N ' ' A' ' 222' ' ' ASP . 2.8 mm? -99.85 80.0 2.28 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.638 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -53.26 67.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 110.802 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.729 ' N ' ' O ' ' A' ' 220' ' ' LEU . 1.7 m-20 -99.65 128.67 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.402 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.7 p -73.46 -4.8 35.96 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.295 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -93.03 -25.0 18.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.698 0.285 . . . . 0.0 111.258 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 212' ' ' ARG . 3.4 p -105.49 85.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -32.39 -46.49 0.13 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.628 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.95 -52.37 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.616 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -141.79 128.78 20.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.139 0.495 . . . . 0.0 110.618 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.553 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 3.8 t60 -100.41 -56.26 2.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.281 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -139.38 172.88 12.16 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -162.53 174.49 12.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.276 179.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.755 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.0 mt -130.79 144.81 36.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.577 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.85 163.44 34.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.612 ' CE3' HD13 ' A' ' 206' ' ' LEU . 0.7 OUTLIER -96.86 150.63 20.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.337 -1.301 . . . . 0.0 114.255 -176.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 239' ' ' PHE . 0.8 OUTLIER -118.91 94.14 4.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.217 -1.356 . . . . 0.0 107.716 175.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 13.8 p -78.16 -25.44 47.25 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 32.3 m -74.24 -21.06 59.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.584 0.707 . . . . 0.0 109.713 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 33.0 tptt -123.01 6.23 9.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.344 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 235' ' ' ASN . 13.0 p90 36.98 43.55 0.31 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 120.713 0.292 . . . . 0.0 111.003 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.455 ' HG2' ' N ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -115.19 174.97 5.71 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.183 0.516 . . . . 0.0 109.697 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.541 ' CE3' ' CD1' ' A' ' 293' ' ' ILE . 0.0 OUTLIER -127.95 119.64 25.96 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.866 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 0.0 OUTLIER -143.13 152.34 41.71 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.946 0.879 . . . . 0.0 112.851 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 3.4 pp -116.79 154.04 31.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.765 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.532 ' CG2' ' CD1' ' A' ' 269' ' ' TRP . 3.3 p -121.3 163.7 18.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.669 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 269' ' ' TRP . 1.0 OUTLIER -106.09 101.4 10.89 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.151 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.546 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -70.6 97.46 1.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.728 177.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 52.33 64.65 3.85 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.213 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.439 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -76.32 66.89 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -178.036 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.718 HD21 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -54.77 -49.97 69.59 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.718 ' N ' HD21 ' A' ' 249' ' ' LEU . 2.6 t-20 -72.19 -30.19 64.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.971 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.425 ' O ' HD22 ' A' ' 253' ' ' LEU . . . 91.81 85.06 1.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.836 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.416 ' HB ' ' OD1' ' A' ' 245' ' ' ASP . 1.8 m -46.03 158.61 0.09 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.51 0.155 . . . . 0.0 111.077 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.57 HD21 ' O ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -149.83 137.26 19.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 111.808 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.424 ' HB ' HG23 ' A' ' 259' ' ' ILE . 75.2 t -111.28 132.2 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.014 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.517 ' HA ' HG13 ' A' ' 280' ' ' ILE . 0.5 OUTLIER 55.2 41.78 31.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 110.306 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 75.6 m 63.43 33.9 13.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.561 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.16 109.76 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 3.1 t -55.82 94.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 260' ' ' SER . 0.4 OUTLIER -79.85 -20.59 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.04 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.739 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 6.3 t -68.71 166.9 16.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 175.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.531 ' O ' ' N ' ' A' ' 263' ' ' ASP . 8.4 m80 -68.34 104.53 0.72 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 120.328 1.422 . . . . 0.0 109.241 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.739 ' HD3' ' O ' ' A' ' 260' ' ' SER . 96.8 Cg_exo -53.34 79.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.893 2.395 . . . . 0.0 112.284 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 261' ' ' HIS . 71.4 m-20 -79.34 -176.65 5.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.642 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 264' ' ' LEU . 1.9 mm? -112.68 -47.38 3.07 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.652 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -154.68 23.9 0.64 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.252 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 267' ' ' ARG . 0.4 OUTLIER -64.14 -69.86 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.419 0.688 . . . . 0.0 112.357 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.0 OUTLIER 85.59 15.12 0.15 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.244 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -53.05 160.64 0.96 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.061 0.458 . . . . 0.0 111.185 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.546 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 36.0 t-105 -71.9 -26.52 62.35 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 75.3 164.28 13.39 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.743 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -98.5 146.14 31.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.723 0.297 . . . . 0.0 110.469 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.502 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 89.2 Cg_exo -48.83 142.55 18.97 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 122.725 2.283 . . . . 0.0 113.072 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 86.9 t -124.89 136.25 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 10.5 mt-10 -84.37 132.82 34.55 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.844 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.498 ' H ' ' CD1' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -97.05 165.98 11.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.396 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.64 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.13 158.34 44.05 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 93.2 p -60.61 129.25 40.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.063 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 277' ' ' SER . 38.5 m-20 82.47 -0.06 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.838 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.64 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.9 OUTLIER -68.29 -170.08 0.17 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.529 HG23 ' CD1' ' A' ' 290' ' ' TYR . 1.0 OUTLIER -161.02 124.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.076 177.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -105.55 155.39 6.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.122 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.57 ' O ' HD21 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -141.62 123.28 15.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.553 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -116.37 38.07 3.52 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.766 -178.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 178.68 -122.04 0.79 Allowed Glycine 0 N--CA 1.454 -0.141 0 C-N-CA 119.042 -1.551 . . . . 0.0 114.22 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.7 t -95.17 -51.72 4.5 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -141.54 2.17 1.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.72 -0.392 . . . . 0.0 112.007 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.768 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.9 m -72.57 104.77 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.806 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 0.4 OUTLIER -120.47 127.25 52.05 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.829 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.502 HG11 ' CE1' ' A' ' 196' ' ' HIS . 0.3 OUTLIER -110.03 130.07 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.796 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.529 ' CD1' HG23 ' A' ' 280' ' ' ILE . 1.6 t80 -77.42 133.57 38.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.306 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.51 ' HA ' HD12 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -101.12 116.25 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.488 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.34 135.81 48.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.77 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.541 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 13.6 mt -134.08 142.11 41.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.738 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.0 m -152.79 160.91 43.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 111.089 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.96 175.23 6.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -120.92 116.36 24.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -85.0 86.41 7.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.743 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.839 179.942 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.462 ' HA ' ' CG2' ' A' ' 201' ' ' THR . 35.7 mt . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.723 0.297 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 201' ' ' THR . . . 115.77 92.85 1.81 Allowed Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.959 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.1 m -176.42 -78.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.001 0.429 . . . . 0.0 110.049 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -137.6 -173.33 3.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.654 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.5 m95 -150.4 132.95 15.72 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.547 ' HG ' HD12 ' A' ' 184' ' ' LEU . 5.0 tp -116.25 130.22 56.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.807 176.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.654 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 4.6 m-85 -127.17 134.65 50.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.57 0.7 . . . . 0.0 110.564 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.634 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.1 mp -133.25 146.97 51.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.901 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 8.5 tt0 -142.21 124.76 15.77 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.476 ' HA ' HG13 ' A' ' 289' ' ' VAL . 11.8 t -62.09 119.8 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.459 HG21 ' O ' ' A' ' 288' ' ' LYS . 4.3 tt -101.05 -22.78 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.803 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.91 93.56 0.72 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.514 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.96 -170.35 26.58 Favored Glycine 0 CA--C 1.518 0.244 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.566 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 89.5 Cg_endo -81.32 30.3 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.032 1.822 . . . . 0.0 111.55 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.526 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -160.96 22.9 0.13 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.744 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.514 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.0 mt -39.77 109.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.916 0.389 . . . . 0.0 111.602 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.97 8.95 2.02 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.613 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.584 HD13 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -98.36 153.8 18.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.614 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.634 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 5.9 mt-30 -150.08 148.77 29.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.591 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.631 ' ND1' HG12 ' A' ' 208' ' ' VAL . 2.0 p80 -138.5 132.64 31.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.268 0.556 . . . . 0.0 110.47 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.73 169.93 18.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.746 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.513 HG11 ' CH2' ' A' ' 234' ' ' TRP . 2.7 p -177.64 157.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.197 0.522 . . . . 0.0 110.749 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 180' ' ' SER . 5.9 m120 -90.47 147.59 23.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.781 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.517 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 30.5 m -60.66 -6.17 1.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.92 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.462 ' CG2' ' HA ' ' A' ' 177' ' ' LEU . 9.1 t -102.34 32.19 3.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.154 0.502 . . . . 0.0 111.106 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.429 ' HB2' ' HG2' ' A' ' 205' ' ' LYS . 77.9 p -110.54 132.32 54.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.893 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.484 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 56.9 m -85.57 -84.31 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.8 21.72 14.08 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.484 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -115.88 -8.95 11.89 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.765 178.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' A' ' 233' ' ' THR . 4.0 tt -69.8 -57.0 6.97 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.688 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.2 Cg_endo -43.32 86.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.797 2.331 . . . . 0.0 113.761 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.631 HG12 ' ND1' ' A' ' 196' ' ' HIS . 57.6 t -70.16 99.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.775 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 216' ' ' SER . 0.0 OUTLIER -69.48 87.26 0.46 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.664 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.0 OUTLIER -69.14 127.4 32.98 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.461 ' HA2' HG23 ' A' ' 225' ' ' VAL . . . -168.38 169.97 41.87 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.638 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.825 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -53.02 -95.84 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.788 -0.706 . . . . 0.0 112.606 -178.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.65 -7.69 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 O-C-N 122.187 -0.321 . . . . 0.0 111.812 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 216' ' ' SER . 0.3 OUTLIER -55.44 -177.22 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.493 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 53.1 Cg_exo -55.8 -1.21 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.397 2.065 . . . . 0.0 113.073 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -44.71 166.28 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.938 0.399 . . . . 0.0 111.432 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -83.93 -32.59 25.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.26 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.668 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 0.9 OUTLIER -105.46 131.88 52.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.584 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -97.48 82.76 3.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.768 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.668 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 2.9 mm? -104.47 64.53 0.75 Allowed 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.825 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -53.59 66.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.068 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.644 ' N ' ' O ' ' A' ' 220' ' ' LEU . 4.8 t0 -121.82 139.92 53.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.206 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.4 p -53.24 -31.33 42.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.624 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.557 ' CG ' ' HB3' ' A' ' 222' ' ' ASP . 2.9 pt-20 -49.6 -41.72 42.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.096 0.474 . . . . 0.0 110.147 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.563 ' O ' ' HB2' ' A' ' 212' ' ' ARG . 2.6 p -103.18 110.93 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.68 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.4 t -56.03 -56.07 25.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.233 0.539 . . . . 0.0 109.823 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -137.08 -51.91 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.539 ' CB ' ' HG2' ' A' ' 246' ' ' MET . 0.7 OUTLIER -141.35 125.65 17.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.167 0.508 . . . . 0.0 109.889 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.602 ' CE1' ' HB3' ' A' ' 250' ' ' ASN . 0.5 OUTLIER -92.45 -60.64 1.78 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.3 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -145.23 173.76 11.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 24.6 tt0 -153.28 161.78 42.0 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.688 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.6 mt -124.13 147.86 28.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.802 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.554 ' HA ' HD23 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.25 163.23 33.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.818 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 3.1 p90 -153.86 165.32 36.44 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.49 ' HB2' ' HD2' ' A' ' 240' ' ' LYS . 20.4 m-20 -117.44 133.47 55.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.311 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.49 3.04 55.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.091 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.2 m -76.99 -30.14 55.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.071 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 38.0 tptt -139.89 22.01 2.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.789 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 238' ' ' LYS . 15.5 p90 37.74 62.94 0.84 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.523 0.678 . . . . 0.0 110.16 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.818 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -125.47 142.32 51.57 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.7 178.251 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.722 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -129.15 123.23 31.59 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.957 -179.036 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 4.1 pt-20 -141.26 151.56 43.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.258 1.028 . . . . 0.0 113.323 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.554 ' CD2' HG13 ' A' ' 281' ' ' ILE . 2.2 pp -113.5 158.83 20.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.031 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.497 HG13 ' CZ2' ' A' ' 269' ' ' TRP . 4.1 p -136.82 162.35 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.844 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -81.89 123.61 28.99 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.539 ' HG2' ' CB ' ' A' ' 228' ' ' LYS . 10.4 tpt -76.77 32.42 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.47 50.31 32.67 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.707 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 5.5 t -99.05 179.1 4.72 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 110.912 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.699 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -105.89 -29.54 9.92 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.699 ' H ' HD13 ' A' ' 249' ' ' LEU . 1.3 t-20 -75.31 -35.9 61.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.311 0.577 . . . . 0.0 112.244 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 262' ' ' PRO . . . 93.29 166.72 38.21 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.017 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.439 ' C ' HD11 ' A' ' 259' ' ' ILE . 7.6 m -120.89 160.59 23.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.51 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.654 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -146.32 121.02 9.84 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.257 0.551 . . . . 0.0 111.117 179.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 61.6 t -97.49 129.01 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.046 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.425 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 2.5 m-20 53.85 42.62 31.68 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.191 0.52 . . . . 0.0 110.282 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 15.8 m 65.02 22.26 12.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.952 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.52 101.48 7.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.23 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 26.3 p -54.74 101.05 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.075 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.542 HG12 ' N ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -78.81 -52.41 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.751 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.713 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 0.8 OUTLIER -58.15 174.94 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.444 ' CG ' ' HD3' ' A' ' 268' ' ' LYS . 14.4 m170 -105.38 88.42 2.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 118.203 0.456 . . . . 0.0 110.146 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.713 ' HD3' ' O ' ' A' ' 260' ' ' SER . 42.1 Cg_endo -93.29 32.19 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.069 2.513 . . . . 0.0 112.754 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -79.2 -126.8 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.641 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.527 HD23 ' N ' ' A' ' 264' ' ' LEU . 0.3 OUTLIER -45.01 -63.13 0.99 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 168.94 37.25 0.02 OUTLIER Glycine 0 CA--C 1.517 0.208 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.99 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 1.8 m -59.48 -32.6 70.41 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 248' ' ' SER . 5.0 ttp-105 44.13 21.56 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.782 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.444 ' HD3' ' CG ' ' A' ' 261' ' ' HIS . 8.0 ptmt -61.28 151.76 31.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.995 0.518 . . . . 0.0 111.561 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.525 ' HZ3' ' CE ' ' A' ' 246' ' ' MET . 7.0 t-105 -66.2 -26.09 67.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.043 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.432 ' O ' ' HD1' ' A' ' 269' ' ' TRP . . . 73.11 168.76 13.85 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.622 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.75 145.72 30.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.569 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 50.6 Cg_exo -53.24 110.55 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.483 2.122 . . . . 0.0 112.967 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 90.1 t -89.4 132.24 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 4.1 mt-10 -79.59 126.12 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.711 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.54 ' H ' HD12 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.9 166.19 12.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.98 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.4 158.69 43.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.233 0.54 . . . . 0.0 112.39 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.6 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 42.7 p -56.51 127.5 31.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.349 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 277' ' ' SER . 73.6 m-20 82.67 1.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.859 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 69.4 m-20 -78.87 133.84 36.95 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.507 ' HB ' ' HD3' ' A' ' 288' ' ' LYS . 0.8 OUTLIER -94.28 125.21 46.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.694 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.554 HG13 ' CD2' ' A' ' 243' ' ' LEU . 0.3 OUTLIER -105.14 155.8 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.137 178.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.654 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -148.73 132.52 16.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.54 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -128.34 53.1 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.432 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 169.1 -129.84 1.94 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 119.596 -1.287 . . . . 0.0 113.613 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.0 t -95.76 -47.85 6.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.335 0.112 . . . . 0.0 110.92 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.7 t -139.88 -6.25 1.29 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.335 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.803 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 29.3 m -69.11 101.25 1.4 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.781 0.325 . . . . 0.0 110.279 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.576 ' HG3' ' OG1' ' A' ' 282' ' ' THR . 20.4 ttmt -118.65 126.45 51.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.067 0.46 . . . . 0.0 111.576 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.476 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -110.79 131.91 60.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.424 -178.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.4 t80 -77.18 137.46 38.88 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.076 0.465 . . . . 0.0 109.942 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.19 112.27 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.022 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -126.55 139.42 53.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.069 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.534 HD11 ' CE3' ' A' ' 241' ' ' TRP . 3.4 mt -136.26 132.22 49.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.73 152.78 45.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.46 159.31 15.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.61 121.21 31.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.925 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 297' ' ' ASN . 2.6 p-10 -80.37 86.34 5.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.875 179.934 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.463 ' HA ' ' CG2' ' A' ' 201' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.692 0.282 . . . . 0.0 110.715 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.4 94.15 1.92 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.1 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.476 ' HB3' ' OG ' ' A' ' 200' ' ' SER . 2.9 m -169.49 -72.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.2 OUTLIER -138.03 -179.15 5.6 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 9.8 m95 -147.89 133.34 18.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 3.6 tp -118.65 132.97 56.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.722 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 9.2 m-85 -128.32 126.0 39.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.669 0.747 . . . . 0.0 110.165 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.612 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 4.2 mm? -108.81 133.74 52.45 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.675 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.4 OUTLIER -129.9 108.02 9.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.455 ' CG1' HD11 ' A' ' 220' ' ' LEU . 40.8 t -60.97 104.98 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.443 HD13 HG23 ' A' ' 187' ' ' ILE . 12.4 tt -89.28 -24.85 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -175.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.704 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.8 96.66 0.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.538 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.627 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.11 -168.64 24.32 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.466 ' HB2' ' CG ' ' A' ' 221' ' ' LYS . 93.2 Cg_endo -82.91 30.53 0.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.243 1.962 . . . . 0.0 110.97 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.442 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.95 23.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.624 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.627 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.0 mt -39.34 109.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.89 6.33 2.89 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.717 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 219' ' ' ALA . 0.0 OUTLIER -100.14 139.66 35.48 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 117.841 0.821 . . . . 0.0 109.117 178.189 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 29.8 mt-30 -134.38 151.22 51.08 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.787 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.416 ' CD2' ' CG1' ' A' ' 208' ' ' VAL . 59.4 t60 -144.92 138.96 27.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.569 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -145.75 166.12 26.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.639 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 206' ' ' LEU . 7.9 p -169.22 152.66 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.731 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 180' ' ' SER . 2.8 m120 -88.93 144.57 26.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.972 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.518 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 97.8 p -60.32 -7.72 2.17 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.595 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.463 ' CG2' ' HA ' ' A' ' 177' ' ' LEU . 7.6 t -98.49 24.53 7.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.912 0.387 . . . . 0.0 110.685 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.416 ' HB3' ' HG2' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -106.04 119.02 38.11 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.362 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.1 t -71.68 -77.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.0 m -105.0 23.07 14.18 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.416 ' HG2' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -119.7 -10.38 9.58 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.578 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.782 HD22 ' CE3' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -82.11 -32.37 0.59 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.105 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.625 ' HD3' HD12 ' A' ' 206' ' ' LEU . 29.9 Cg_exo -59.23 100.46 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.14 1.227 . . . . 0.0 111.733 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 4.9 t -68.62 160.65 4.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.54 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.8 OUTLIER -137.4 86.48 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.4 OUTLIER -77.67 125.81 29.91 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.963 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.05 172.98 45.07 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.767 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 16.2 ttt-85 -71.62 -70.66 0.31 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.325 -0.438 . . . . 0.0 112.145 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.515 ' CG2' ' H ' ' A' ' 214' ' ' SER . 9.3 p -125.59 -149.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.952 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.515 ' H ' ' CG2' ' A' ' 213' ' ' VAL . 1.0 OUTLIER 66.94 -178.0 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 58.8 Cg_endo -73.85 45.73 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 121.807 1.671 . . . . 0.0 112.702 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.35 165.92 24.17 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.445 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.36 -38.46 13.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.161 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.725 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 3.1 mt -105.82 129.94 53.89 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.533 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -93.46 79.38 4.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.904 0.383 . . . . 0.0 111.173 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.725 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -101.55 83.95 2.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.466 ' CG ' ' HB2' ' A' ' 190' ' ' PRO . 3.5 pttp -60.2 59.72 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.981 0.42 . . . . 0.0 111.81 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 220' ' ' LEU . 0.3 OUTLIER -89.1 126.7 35.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 37.2 p -67.04 -7.53 23.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.218 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -87.31 -22.52 25.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.095 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 212' ' ' ARG . 2.6 p -106.54 83.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.3 p -35.0 -41.42 0.14 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.69 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.35 -57.6 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.608 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.3 OUTLIER -138.81 130.81 28.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.211 0.529 . . . . 0.0 110.316 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.597 ' O ' ' N ' ' A' ' 246' ' ' MET . 2.2 t60 -101.07 -56.45 2.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.888 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.446 ' C ' HD11 ' A' ' 210' ' ' LEU . . . -147.35 173.21 12.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.249 0.547 . . . . 0.0 112.273 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.691 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -156.3 179.85 8.84 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.824 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.44 ' CG2' HD12 ' A' ' 275' ' ' LEU . 19.8 mt -139.23 149.68 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.544 0.688 . . . . 0.0 112.436 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.89 160.67 31.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.782 ' CE3' HD22 ' A' ' 206' ' ' LEU . 5.3 p90 -149.58 165.51 32.02 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -116.49 132.98 56.53 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.138 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.07 0.27 57.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.867 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.16 -29.38 48.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.699 0.761 . . . . 0.0 109.963 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.418 ' HD3' ' HD3' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -138.44 23.12 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.129 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 238' ' ' LYS . 23.1 p90 37.0 59.09 1.11 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.355 0.597 . . . . 0.0 110.115 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.719 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 1.2 mptp? -122.72 141.37 51.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.105 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.687 ' CE3' ' CE3' ' A' ' 234' ' ' TRP . 2.1 m95 -124.46 121.61 35.33 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.912 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.8 pt-20 -138.57 144.86 40.05 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.8 pp -111.46 152.57 27.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.369 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.689 HG12 ' CZ3' ' A' ' 269' ' ' TRP . 6.1 p -123.41 165.1 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 122.859 0.464 . . . . 0.0 110.586 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.841 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 5.1 t0 -107.39 116.6 32.22 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.83 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -75.76 99.12 4.31 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 267' ' ' ARG . . . 57.46 69.05 1.39 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.578 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 56.0 p -61.5 43.54 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.577 HD23 ' HB2' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.6 -54.19 49.68 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.622 0.646 . . . . 0.0 109.911 178.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.577 ' HB2' HD23 ' A' ' 249' ' ' LEU . 2.1 t-20 -77.87 -38.12 46.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.244 0.545 . . . . 0.0 110.672 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.545 ' CA ' ' HB2' ' A' ' 261' ' ' HIS . . . 93.79 96.87 1.54 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.13 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.87 165.17 0.97 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.645 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -150.97 140.02 21.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.285 0.564 . . . . 0.0 111.455 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 93.1 t -114.33 132.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.788 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.562 ' HA ' HG13 ' A' ' 280' ' ' ILE . 16.9 t-20 53.43 42.22 32.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.126 0.489 . . . . 0.0 110.28 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.2 p 63.52 32.35 14.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.835 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -138.88 110.32 7.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 52.4 p -60.12 88.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.431 0.634 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.492 HG12 HG11 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -90.75 -7.57 10.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.601 -178.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.841 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 38.9 m -105.7 -17.54 14.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.65 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 3.6 t-160 -108.75 23.58 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 72.4 Cg_exo -42.66 -46.95 8.06 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.915 1.743 . . . . 0.0 112.501 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.72 93.07 3.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.294 0.568 . . . . 0.0 110.316 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.511 ' CD2' ' H ' ' A' ' 264' ' ' LEU . 0.2 OUTLIER -47.98 -43.39 29.58 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.166 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -37.44 -31.63 0.07 OUTLIER Glycine 0 C--N 1.329 0.15 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.387 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.508 ' C ' ' H ' ' A' ' 268' ' ' LYS . 52.0 m -75.97 -68.67 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.477 ' O ' ' HA2' ' A' ' 247' ' ' GLY . 1.6 tpp180 71.57 -19.63 0.25 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 266' ' ' SER . 0.0 OUTLIER -73.36 -134.93 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -176.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.83 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 0.0 OUTLIER -75.36 -25.38 57.65 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.646 -178.21 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.2 -174.55 7.47 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.581 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -111.94 157.71 38.84 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 117.482 0.641 . . . . 0.0 110.866 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.68 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 21.3 Cg_exo -66.91 138.23 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.86 2.374 . . . . 0.0 113.892 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.68 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 74.3 t -114.51 142.28 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.0 mm-40 -85.28 127.12 34.2 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 118.803 -1.159 . . . . 0.0 112.316 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.45 ' C ' ' CD2' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -95.05 164.85 12.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.018 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.1 160.0 41.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.57 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 80.1 p -59.77 132.24 53.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.509 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.5 OUTLIER 84.01 7.46 0.6 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.285 -179.51 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.656 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 3.0 m-20 -79.72 -167.31 1.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.562 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -160.34 134.92 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.301 177.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -107.09 157.21 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.985 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.645 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.7 OUTLIER -149.18 117.81 6.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.578 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -115.57 43.9 1.98 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.976 -178.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 172.28 -123.39 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 119.209 -1.472 . . . . 0.0 113.741 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.0 t -92.88 -51.16 5.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.586 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -143.6 -3.63 0.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 40.4 m -67.09 104.03 1.32 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 117.811 0.278 . . . . 0.0 110.807 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 3.6 mtpt -125.49 134.66 51.96 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.498 -0.481 . . . . 0.0 112.264 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 186' ' ' VAL . 9.6 p -112.98 136.92 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.289 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.436 ' HD1' HG22 ' A' ' 280' ' ' ILE . 2.0 t80 -77.66 137.06 38.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.249 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.98 110.48 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.625 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -129.99 134.57 47.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.586 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 4.6 mt -133.15 143.14 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.7 t -150.35 157.17 42.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.0 110.813 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 2.8 m -87.65 -176.94 5.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -154.89 116.3 4.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -158.63 103.61 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.794 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.66 ' HB2' ' HA ' ' A' ' 201' ' ' THR . 2.3 mm? . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.452 0.168 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 201' ' ' THR . . . 112.5 128.27 4.98 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.19 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.566 ' O ' ' HB3' ' A' ' 296' ' ' GLN . 22.4 m -95.05 94.58 8.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.9 0.381 . . . . 0.0 111.647 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 16.0 m -144.97 179.12 7.55 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.1 m95 -143.01 135.18 27.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 3.5 tp -118.29 123.5 45.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.502 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 3.3 m-85 -123.63 134.85 53.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.681 0.753 . . . . 0.0 110.679 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.74 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.0 OUTLIER -135.48 145.39 47.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.497 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.582 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 39.8 tt0 -140.11 127.39 21.2 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.624 HG11 HD13 ' A' ' 220' ' ' LEU . 16.9 t -64.97 107.72 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.512 HG21 ' HG2' ' A' ' 288' ' ' LYS . 6.5 tt -91.47 -21.51 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.822 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.55 94.56 0.7 Allowed 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.671 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.14 -177.99 35.65 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.511 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 88.2 Cg_endo -76.84 31.84 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 CA-C-N 119.591 1.696 . . . . 0.0 111.579 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.543 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.57 23.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.336 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.671 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.5 mt -39.81 111.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.85 6.89 2.45 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.011 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.605 HD11 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -98.72 154.59 17.86 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.74 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.3 mt-30 -151.66 148.67 28.22 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.213 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.621 ' CD2' ' HB2' ' A' ' 184' ' ' LEU . 1.1 p80 -136.31 130.74 33.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.308 0.575 . . . . 0.0 109.828 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.97 163.72 35.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.243 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.457 HG11 ' CD2' ' A' ' 206' ' ' LEU . 9.4 p -174.28 160.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.292 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 180' ' ' SER . 7.3 m120 -87.86 146.02 25.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.601 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 9.3 t -62.84 -5.26 2.67 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.854 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.66 ' HA ' ' HB2' ' A' ' 177' ' ' LEU . 2.7 t -91.82 34.79 0.98 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.039 0.447 . . . . 0.0 110.617 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.93 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 8.5 m -137.25 92.88 2.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.249 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 11.3 t -66.68 -73.3 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.392 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.0 t -89.93 -2.06 58.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.93 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.1 OUTLIER -115.63 47.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.132 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -152.28 -26.65 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.768 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 33.0 Cg_exo -55.05 102.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 CA-C-N 121.02 1.4 . . . . 0.0 111.739 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 217' ' ' ASP . 17.1 t -68.34 165.78 2.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.086 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 1.5 mtpt -134.99 88.38 2.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.151 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.582 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.8 OUTLIER -75.75 128.29 34.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.543 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -175.3 176.62 47.3 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.155 -1.021 . . . . 0.0 113.556 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.632 ' CG ' ' HA ' ' A' ' 221' ' ' LYS . 6.1 ttt180 -71.47 -72.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.876 0.47 . . . . 0.0 111.477 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 214' ' ' SER . 8.0 p -125.49 -139.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.648 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.643 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.3 OUTLIER 61.78 -179.92 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 118.894 0.77 . . . . 0.0 109.928 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 47.0 Cg_endo -70.46 31.24 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.836 1.691 . . . . 0.0 113.205 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.448 ' H ' ' C ' ' A' ' 214' ' ' SER . 3.9 m -65.03 157.71 27.63 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.796 0.331 . . . . 0.0 110.837 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.502 ' HB3' HG13 ' A' ' 208' ' ' VAL . 0.4 OUTLIER -85.4 -30.36 23.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.533 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.761 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.6 mt -110.01 133.51 53.11 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.605 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -94.95 77.32 3.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.522 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.761 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -100.44 66.88 1.29 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.632 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 0.3 OUTLIER -61.59 45.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -177.293 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.519 ' O ' HG12 ' A' ' 225' ' ' VAL . 10.3 t0 -94.1 124.05 37.87 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.4 t -39.55 -32.07 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.228 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.501 ' O ' HD12 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -52.11 -37.42 54.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 110.366 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.543 HG21 ' HA2' ' A' ' 211' ' ' GLY . 4.3 p -103.51 102.14 13.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.496 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.41 ' O ' ' HD2' ' A' ' 212' ' ' ARG . 78.6 p -45.17 -62.2 1.35 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.08 0.466 . . . . 0.0 111.032 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -132.19 -50.58 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.643 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 0.1 OUTLIER -143.05 131.25 21.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.015 -0.592 . . . . 0.0 109.782 178.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.625 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.3 t60 -95.82 -55.58 2.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.327 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.425 ' C ' HD13 ' A' ' 210' ' ' LEU . . . -143.65 172.81 12.3 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -157.48 177.66 11.18 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.727 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.768 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.0 mt -135.78 150.17 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.885 0.374 . . . . 0.0 111.985 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.59 163.71 37.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.217 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.566 ' CZ3' HD22 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -91.92 149.46 21.54 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 240' ' ' LYS . 7.9 t-20 -119.78 80.83 1.64 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 5.9 p -68.61 -19.97 64.47 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 82.5 m -81.21 -32.16 33.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.425 0.631 . . . . 0.0 110.885 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.531 ' HD3' ' HD3' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -117.7 15.29 14.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.889 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.417 ' C ' ' O ' ' A' ' 238' ' ' LYS . 10.0 p90 38.9 71.98 0.15 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.531 ' HD3' ' HD3' ' A' ' 238' ' ' LYS . 6.0 mptt -137.84 148.21 45.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.445 -1.252 . . . . 0.0 112.375 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.672 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.5 OUTLIER -116.97 104.73 11.57 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.5 mt-10 -126.26 146.8 49.86 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 2.5 pp -116.12 149.76 38.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.767 -1.56 . . . . 0.0 110.984 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.655 HG23 ' CD1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -118.87 162.31 17.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.547 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 248' ' ' SER . 11.5 m-20 -115.6 99.26 7.21 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.172 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.798 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.36 108.81 9.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.207 0.527 . . . . 0.0 110.588 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 51.61 62.5 5.48 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.114 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 5.8 t -80.6 76.17 7.46 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.661 HD11 ' H ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -57.47 -48.83 78.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.527 ' N ' ' CD2' ' A' ' 249' ' ' LEU . 0.2 OUTLIER -74.68 -28.02 60.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.414 -179.188 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 87.3 99.05 0.86 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.858 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 282' ' ' THR . 4.9 m -60.31 159.22 10.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.359 0.123 . . . . 0.0 110.77 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.683 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -148.09 124.51 10.97 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.027 0.442 . . . . 0.0 111.374 179.064 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 90.9 t -101.26 132.02 47.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.819 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.425 ' HA ' HG13 ' A' ' 280' ' ' ILE . 32.0 t-20 51.27 39.58 24.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.069 0.461 . . . . 0.0 110.29 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 1.6 t 65.82 22.14 11.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.51 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -121.45 100.49 7.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.007 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 59.9 p -51.84 97.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.072 0.463 . . . . 0.0 112.19 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.542 HG12 ' N ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -78.14 -54.21 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.874 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.542 ' N ' HG12 ' A' ' 259' ' ' ILE . 2.0 t -46.21 160.48 0.07 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.526 ' CE1' ' HD3' ' A' ' 268' ' ' LYS . 59.3 m-70 -53.51 107.38 0.84 Allowed Pre-proline 0 C--N 1.327 -0.379 0 O-C-N 121.676 -0.64 . . . . 0.0 111.811 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.85 14.19 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.079 2.519 . . . . 0.0 112.188 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 261' ' ' HIS . 0.9 OUTLIER -103.21 112.47 25.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.981 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.85 164.71 9.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.364 0.602 . . . . 0.0 112.355 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.31 -20.09 2.75 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.747 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.569 ' O ' ' HB2' ' A' ' 267' ' ' ARG . 0.6 OUTLIER -75.93 -77.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.981 0.391 . . . . 0.0 111.633 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.569 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.0 OUTLIER 85.2 17.0 0.14 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.965 0.412 . . . . 0.0 111.206 -179.188 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.526 ' HD3' ' CE1' ' A' ' 261' ' ' HIS . 15.2 mtpt -50.65 153.98 1.5 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.283 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.798 ' CZ3' ' HB2' ' A' ' 246' ' ' MET . 36.8 t-105 -66.19 -26.58 67.46 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.438 ' HA2' ' CD2' ' A' ' 261' ' ' HIS . . . 76.92 160.88 11.58 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.911 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -94.56 146.47 31.52 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.88 147.87 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.166 1.911 . . . . 0.0 111.503 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 85.9 t -132.14 127.18 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.672 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.01 128.08 33.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.154 -178.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.53 HD13 ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -93.11 164.38 13.28 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.957 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.707 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.02 159.23 42.64 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 57.2 p -62.48 132.1 51.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.245 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 81.8 -0.89 1.56 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.013 -179.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.707 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -71.97 -167.02 0.26 Allowed 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.425 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -162.7 133.37 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.444 177.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -109.9 156.18 10.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.483 178.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.683 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 5.8 m -147.42 112.82 5.59 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.642 HD11 ' N ' ' A' ' 283' ' ' LEU . 0.0 OUTLIER -112.1 46.43 1.16 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.614 -177.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -178.79 -129.74 1.34 Allowed Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 119.654 -1.26 . . . . 0.0 113.882 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' THR . . . . . 0.417 ' H ' ' HG3' ' A' ' 224' ' ' GLU . 5.4 t -97.59 -41.05 8.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.0 110.501 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.608 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -149.25 3.09 0.58 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.835 179.239 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.822 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 57.3 m -77.06 104.66 7.67 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.512 ' HG2' HG21 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -127.02 133.51 50.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.343 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -110.82 136.76 45.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.311 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 4.0 t80 -76.41 135.22 39.45 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.472 ' CG1' ' HB2' ' A' ' 275' ' ' LEU . 2.3 t -103.37 113.51 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.099 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.471 ' HD2' ' H ' ' A' ' 293' ' ' ILE . 6.7 tpt180 -126.43 145.5 50.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.471 ' H ' ' HD2' ' A' ' 292' ' ' ARG . 7.1 mt -143.32 116.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.908 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 6.1 t -125.48 155.76 40.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 0.0 110.725 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.02 162.25 24.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.204 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.566 ' HB3' ' O ' ' A' ' 179' ' ' SER . 5.5 tp60 -94.11 135.3 35.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.952 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -86.57 86.05 7.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.96 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.861 ' HA ' HG23 ' A' ' 201' ' ' THR . 3.2 mp . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.607 0.241 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.54 64.76 0.39 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.786 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.609 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 0.3 OUTLIER -137.21 -77.81 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.875 0.369 . . . . 0.0 110.021 179.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.4 OUTLIER -135.25 179.31 6.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.237 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.67 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.0 m95 -144.02 127.77 17.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.552 ' HB3' ' CZ3' ' A' ' 234' ' ' TRP . 1.2 tp -120.07 129.68 54.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.392 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.67 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 1.2 m-85 -130.25 135.8 48.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.786 0.803 . . . . 0.0 111.814 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -132.03 148.65 52.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.963 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.583 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 26.5 tt0 -140.64 124.96 17.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.593 ' HA ' HG12 ' A' ' 289' ' ' VAL . 17.4 t -60.8 108.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.925 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.731 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.2 tt -92.38 -18.38 7.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.777 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.53 93.6 0.34 Allowed 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.589 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.689 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.03 -172.06 27.84 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.605 ' O ' ' HG2' ' A' ' 221' ' ' LYS . 83.5 Cg_endo -80.41 29.06 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.232 1.954 . . . . 0.0 111.61 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.494 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.75 27.13 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.689 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.1 mt -41.76 111.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 112.136 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 8.16 2.26 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.11 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.637 HD11 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -101.18 136.28 41.29 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.697 0.761 . . . . 0.0 109.057 178.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.583 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 7.9 mt-30 -136.17 155.81 49.6 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.494 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.578 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -148.84 147.58 28.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.355 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.531 ' C ' ' HZ3' ' A' ' 181' ' ' TRP . . . -151.25 149.48 29.45 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.619 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' A' ' 206' ' ' LEU . 5.2 p -153.77 153.83 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.432 0.634 . . . . 0.0 111.542 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.62 ' HA ' ' O ' ' A' ' 180' ' ' SER . 6.3 m-80 -91.27 148.57 22.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.679 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.607 ' OG ' ' HB3' ' A' ' 179' ' ' SER . 32.8 p -66.31 -0.63 2.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.861 HG23 ' HA ' ' A' ' 177' ' ' LEU . 2.1 t -103.17 26.78 7.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.432 0.634 . . . . 0.0 110.457 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 55.8 p -114.32 123.22 48.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.692 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.432 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 22.9 m -91.07 -80.88 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.3 t -82.34 6.46 16.93 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.432 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -117.26 -12.13 10.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.958 0.408 . . . . 0.0 110.939 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.763 HD11 ' CE2' ' A' ' 234' ' ' TRP . 6.8 tt -68.0 -60.97 4.58 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.295 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.608 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.6 Cg_endo -42.6 99.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.32 2.014 . . . . 0.0 112.571 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.872 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 2.3 t -67.38 160.44 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.438 ' N ' ' CG1' ' A' ' 208' ' ' VAL . 3.7 mtpt -133.83 93.11 3.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.0 OUTLIER -84.5 121.89 28.23 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.75 167.48 38.54 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.527 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.877 ' HB2' HG11 ' A' ' 225' ' ' VAL . 0.1 OUTLIER -57.42 -88.18 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.402 ' O ' HG21 ' A' ' 213' ' ' VAL . 13.1 p -126.89 -10.61 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 111.62 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.574 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.6 OUTLIER -52.34 179.78 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.461 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 36.1 Cg_exo -60.05 10.83 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.417 2.078 . . . . 0.0 113.202 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.531 ' H ' ' C ' ' A' ' 214' ' ' SER . 1.0 OUTLIER -52.39 -178.11 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.16 0.505 . . . . 0.0 111.461 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -99.24 -31.42 11.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.51 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.714 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.6 mt -104.33 127.61 52.01 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.637 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -94.27 82.24 4.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.91 0.386 . . . . 0.0 111.889 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.842 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.9 mm? -102.68 91.49 4.22 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 6.5 ptpt -61.53 60.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.147 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 220' ' ' LEU . 3.3 m-20 -93.15 146.59 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.702 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 54.2 p -86.77 -18.46 31.04 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.56 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.401 ' HB2' ' CG ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -79.48 -18.65 51.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.76 0.314 . . . . 0.0 111.466 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.877 HG11 ' HB2' ' A' ' 212' ' ' ARG . 3.0 p -109.37 81.45 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.023 0.44 . . . . 0.0 110.583 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.8 p -37.71 -39.45 0.34 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.514 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.37 -55.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.947 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.574 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 0.6 OUTLIER -140.75 130.82 24.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.115 0.483 . . . . 0.0 110.782 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.654 ' HD1' ' HB ' ' A' ' 225' ' ' VAL . 0.8 OUTLIER -96.57 -57.02 2.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.442 179.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.452 ' C ' HD11 ' A' ' 210' ' ' LEU . . . -151.57 175.81 11.96 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.555 0.693 . . . . 0.0 112.449 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.872 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -152.52 173.32 15.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.974 -179.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 9.0 mt -125.03 143.37 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.913 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.24 129.07 4.25 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.766 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 4.5 p90 -119.32 166.43 13.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.754 0.788 . . . . 0.0 112.624 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -113.66 133.25 55.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.201 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.44 -1.83 52.92 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.088 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.8 m -78.83 -23.86 44.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.518 0.675 . . . . 0.0 109.937 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.492 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 13.9 tptt -141.82 16.61 2.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.373 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 15.3 p90 42.83 60.44 2.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.537 0.684 . . . . 0.0 109.774 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.766 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 2.0 mptp? -124.08 141.25 52.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.91 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.631 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -124.68 127.02 46.65 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.316 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.805 ' HG2' ' HG3' ' A' ' 274' ' ' GLU . 24.5 mt-10 -134.87 139.85 45.35 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.487 ' CD2' HG12 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -92.37 143.1 26.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.738 -1.574 . . . . 0.0 107.45 177.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.593 HG22 ' CD1' ' A' ' 269' ' ' TRP . 1.3 p -140.16 161.64 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.272 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.711 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 10.5 t0 -84.93 135.03 34.23 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 120.881 0.372 . . . . 0.0 110.716 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.486 ' HG3' ' HG2' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -89.74 31.33 0.95 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.18 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.56 47.45 56.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.418 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.46 175.21 6.65 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.915 0.358 . . . . 0.0 111.077 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.716 HD11 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -101.67 -30.08 11.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.737 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.716 ' H ' HD11 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -75.82 -33.29 60.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.467 0.651 . . . . 0.0 111.579 -178.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.492 ' O ' ' NE2' ' A' ' 229' ' ' HIS . . . 93.27 160.47 35.38 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.769 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.417 HG23 ' CB ' ' A' ' 230' ' ' ALA . 7.6 m -117.98 157.37 26.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.049 -0.575 . . . . 0.0 110.763 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.625 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -144.87 141.82 29.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.041 0.448 . . . . 0.0 110.681 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.404 ' CG2' HG12 ' A' ' 259' ' ' ILE . 60.0 t -114.89 128.99 71.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.053 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.525 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 40.6 t30 55.93 48.68 17.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.099 0.476 . . . . 0.0 110.24 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 18.7 m 56.33 29.12 14.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.66 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . 0.4 ' O ' ' N ' ' A' ' 259' ' ' ILE . 1.7 t60 -133.3 103.4 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.816 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.574 ' HA ' ' HB3' ' A' ' 253' ' ' LEU . 64.8 p -55.03 89.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.286 0.565 . . . . 0.0 110.877 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.499 HD13 ' C ' ' A' ' 259' ' ' ILE . 2.6 pp -94.66 -8.19 9.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.229 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.711 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 3.3 m -118.9 -22.08 7.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -176.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.623 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 22.1 p-80 -111.12 38.12 0.15 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.623 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 39.2 Cg_exo -59.14 -16.04 31.47 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.474 1.449 . . . . 0.0 112.904 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -130.33 94.93 3.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.299 0.571 . . . . 0.0 111.418 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.737 ' H ' HD21 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -57.4 169.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.246 179.055 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 66.2 -19.05 0.18 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.686 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.591 ' H ' ' C ' ' A' ' 264' ' ' LEU . 7.8 p -77.27 -36.35 54.45 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 49.3 27.23 1.82 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.113 0.483 . . . . 0.0 110.804 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.425 ' NZ ' ' HA2' ' A' ' 270' ' ' GLY . 0.1 OUTLIER -69.64 164.36 23.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.07 -179.362 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.593 ' CD1' HG22 ' A' ' 244' ' ' VAL . 19.5 t-105 -78.29 -18.79 54.8 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.299 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.425 ' HA2' ' NZ ' ' A' ' 268' ' ' LYS . . . 71.78 173.29 18.31 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.33 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -105.0 138.31 19.47 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -50.28 111.43 0.53 Allowed 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.602 2.202 . . . . 0.0 113.316 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 39.6 t -97.97 139.53 19.97 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.805 ' HG3' ' HG2' ' A' ' 242' ' ' GLU . 1.7 mp0 -80.1 124.79 29.06 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.593 HD22 ' HB2' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -91.81 165.98 12.99 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.99 177.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.71 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.72 159.19 42.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 13.7 t -59.88 128.33 36.38 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.958 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 277' ' ' SER . 12.8 m-20 87.98 5.77 0.24 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.885 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.71 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -80.94 -163.29 0.57 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 255' ' ' ASN . 0.7 OUTLIER -161.52 131.02 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.365 177.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -104.46 156.3 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.117 0.484 . . . . 0.0 110.018 178.163 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.625 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 3.2 m -147.43 114.41 6.15 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.581 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -114.92 44.4 1.79 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.143 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.87 -131.54 1.79 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.585 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.6 t -92.36 -51.35 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.703 0.287 . . . . 0.0 110.522 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.584 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -138.58 -0.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.577 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.777 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 29.9 m -70.26 103.06 2.26 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.643 0.258 . . . . 0.0 110.953 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.731 ' O ' HG22 ' A' ' 187' ' ' ILE . 1.3 mtpp -126.01 137.78 53.68 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.349 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.593 HG12 ' HA ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -115.54 134.81 57.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.457 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.572 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.1 t80 -76.5 141.23 41.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.26 109.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.422 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -124.29 141.28 52.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.606 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.505 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 9.3 mt -138.76 133.16 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.02 156.46 43.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.733 0.301 . . . . 0.0 111.001 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.32 -174.75 4.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.031 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.444 ' OE1' ' HB3' ' A' ' 297' ' ' ASN . 2.6 tp-100 -158.44 116.39 2.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.922 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . 0.559 ' HB3' ' HB2' ' A' ' 297' ' ' ASN . 3.8 p30 -164.7 109.74 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.842 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.927 -179.936 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.455 ' HA ' ' CG2' ' A' ' 201' ' ' THR . 1.1 mp . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.616 0.246 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.527 ' N ' HG23 ' A' ' 201' ' ' THR . . . 115.45 64.63 0.39 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.72 -0.753 . . . . 0.0 113.581 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.481 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 0.2 OUTLIER -133.8 -70.02 0.53 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.932 0.396 . . . . 0.0 110.319 178.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.582 ' HB2' ' OG ' ' A' ' 200' ' ' SER . 0.8 OUTLIER -138.79 -175.42 4.13 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.716 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 14.1 m95 -148.12 134.01 19.08 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.733 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 2.2 tp -112.98 119.78 39.11 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.458 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.716 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 5.6 m-85 -117.12 127.43 54.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.677 0.751 . . . . 0.0 110.66 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.614 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -118.28 134.62 54.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.676 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.553 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 2.3 tt0 -131.06 112.3 12.78 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.528 ' CG2' HD11 ' A' ' 220' ' ' LEU . 18.8 t -61.99 107.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 188' ' ' ALA . 11.0 tt -88.53 -26.01 5.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.729 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.31 98.35 0.71 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.418 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.564 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.1 -162.06 12.8 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.464 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 88.5 Cg_endo -86.59 27.93 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.677 2.251 . . . . 0.0 111.324 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.715 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -162.07 25.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.418 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.564 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.9 mt -39.63 107.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.52 5.47 2.28 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.203 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 191' ' ' ALA . 0.9 OUTLIER -102.81 133.7 47.44 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.544 0.687 . . . . 0.0 110.076 179.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.8 mt-30 -131.13 153.96 48.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.763 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.555 ' NE2' ' HB3' ' A' ' 217' ' ' ASP . 1.6 t-80 -144.28 138.66 28.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.134 0.492 . . . . 0.0 110.832 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.733 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.92 156.08 44.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.591 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.475 HG22 ' HA ' ' A' ' 206' ' ' LEU . 12.3 p -157.69 149.01 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.348 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.5 OUTLIER -91.65 140.56 29.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.317 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.582 ' OG ' ' HB2' ' A' ' 180' ' ' SER . 0.9 OUTLIER -62.23 -6.88 3.46 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.527 HG23 ' N ' ' A' ' 178' ' ' GLY . 0.9 OUTLIER -93.76 28.55 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.323 0.582 . . . . 0.0 110.742 179.216 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.748 ' OG ' ' HB3' ' A' ' 206' ' ' LEU . 89.2 p -101.02 140.87 34.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.358 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -70.94 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 111.315 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.41 33.04 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.004 0.43 . . . . 0.0 110.752 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -117.15 4.13 12.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.862 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.748 ' HB3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -98.69 -19.19 0.21 Allowed Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.691 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 10.8 Cg_endo -58.14 97.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 CA-C-N 120.836 1.334 . . . . 0.0 111.058 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 58.5 t -67.64 164.07 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.276 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.3 OUTLIER -139.73 86.0 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.509 -178.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.481 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.0 OUTLIER -74.94 130.38 39.28 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.869 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -176.13 178.57 47.53 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.588 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 15.5 ttt180 -76.48 -67.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.53 ' CG2' ' H ' ' A' ' 214' ' ' SER . 9.8 p -125.99 -145.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.53 ' H ' ' CG2' ' A' ' 213' ' ' VAL . 1.1 p 64.78 179.9 0.04 OUTLIER Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 57.7 Cg_endo -73.15 39.37 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.913 1.742 . . . . 0.0 112.597 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 214' ' ' SER . 3.2 p -70.05 151.98 44.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.836 0.35 . . . . 0.0 110.553 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.555 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 2.8 m-20 -75.62 -38.15 59.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.086 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.645 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.6 mt -103.21 130.33 50.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.603 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -98.72 86.28 3.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.841 0.353 . . . . 0.0 111.078 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.677 ' O ' ' N ' ' A' ' 222' ' ' ASP . 2.3 mm? -108.03 69.66 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -47.75 72.82 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.919 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.677 ' N ' ' O ' ' A' ' 220' ' ' LEU . 41.8 t0 -101.58 137.45 39.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.468 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.0 p -76.89 -3.98 41.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.348 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -99.73 -22.39 15.4 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 90.4 t -96.73 76.37 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.419 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 225' ' ' VAL . 49.0 m -31.5 -48.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.999 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.6 -58.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.81 131.39 23.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.2 0.524 . . . . 0.0 110.336 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.605 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.6 t60 -99.5 -54.88 2.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.175 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.475 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -141.65 175.54 9.61 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.633 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -165.88 176.94 7.48 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.578 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.691 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.4 mt -135.27 148.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.682 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.17 164.11 38.01 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.46 ' CH2' ' CZ3' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -89.32 146.15 24.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -176.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.484 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 0.9 OUTLIER -119.33 81.28 1.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.515 175.023 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.7 p -64.77 -20.64 66.47 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.1 m -80.91 -30.87 35.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.33 0.586 . . . . 0.0 110.334 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.543 ' HD2' ' HE2' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -108.59 5.25 24.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.064 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 235' ' ' ASN . 2.8 p90 38.48 42.73 0.58 Allowed 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.245 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.543 ' HE2' ' HD2' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -118.64 173.95 6.55 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.279 0.562 . . . . 0.0 109.503 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.643 ' HZ3' ' HB2' ' A' ' 182' ' ' LEU . 2.0 m0 -121.88 113.41 19.6 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 13.7 pt-20 -133.26 149.13 51.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.8 pp -115.05 152.15 32.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.06 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.512 HG23 ' CD1' ' A' ' 269' ' ' TRP . 0.7 OUTLIER -118.98 163.12 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 248' ' ' SER . 0.4 OUTLIER -104.73 110.66 23.08 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.59 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.82 100.49 5.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.656 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.73 63.44 5.12 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.499 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 3.1 p -67.33 55.74 0.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.51 -46.52 80.51 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.685 ' N ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -78.91 -35.62 43.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.559 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 89.71 87.4 1.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.89 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.447 ' N ' ' HB3' ' A' ' 260' ' ' SER . 0.2 OUTLIER -45.24 164.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.47 0.176 . . . . 0.0 111.288 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.609 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -151.84 134.17 15.24 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.213 0.53 . . . . 0.0 111.686 178.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 96.6 t -110.65 137.61 42.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.225 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.415 ' HA ' HD11 ' A' ' 280' ' ' ILE . 3.1 p-10 49.45 35.41 8.09 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.207 0.527 . . . . 0.0 110.173 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 14.6 m 69.44 29.33 4.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.442 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -131.5 102.22 5.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.349 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 8.8 t -53.39 87.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.698 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.489 ' HB ' HG12 ' A' ' 273' ' ' VAL . 0.0 OUTLIER -90.18 6.86 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.932 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.453 ' C ' ' CD ' ' A' ' 262' ' ' PRO . 2.4 t -99.21 -17.11 18.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.678 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 0.0 OUTLIER -103.31 14.77 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 87.9 Cg_exo -48.1 -50.02 12.81 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.326 1.35 . . . . 0.0 110.186 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -75.72 79.59 2.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 113.211 -1.813 . . . . 0.0 110.627 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -55.33 134.2 49.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.443 . . . . 0.0 111.223 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 85.21 -4.87 84.86 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.611 ' C ' ' H ' ' A' ' 268' ' ' LYS . 99.2 p -79.14 -67.9 0.71 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.044 0.422 . . . . 0.0 111.704 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 266' ' ' SER . 1.0 OUTLIER 68.63 -20.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.802 0.728 . . . . 0.0 111.854 -178.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.611 ' H ' ' C ' ' A' ' 266' ' ' SER . 25.6 ttpt -74.33 -129.47 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.59 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 3.4 t-105 -82.73 -29.14 29.99 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.72 -174.52 8.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.532 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -101.54 137.87 19.72 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.397 0.598 . . . . 0.0 110.497 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 75.6 Cg_exo -51.63 122.9 11.11 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.704 2.269 . . . . 0.0 113.621 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 98.7 t -94.12 141.11 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -82.93 130.13 35.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.033 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.702 HD11 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -96.46 163.25 13.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.895 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.31 160.33 41.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.296 0.569 . . . . 0.0 112.487 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 38.3 t -59.89 125.63 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.609 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 290' ' ' TYR . 14.8 m-20 85.97 0.77 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.736 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 2.3 m-20 -82.06 133.7 35.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.722 HG23 ' HD1' ' A' ' 290' ' ' TYR . 1.0 OUTLIER -101.91 130.36 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.992 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.56 ' O ' ' HG2' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -99.46 155.15 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.998 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.609 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -144.83 118.97 9.44 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.605 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -114.87 44.53 1.76 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.2 -122.93 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 119.277 -1.44 . . . . 0.0 113.843 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.2 t -93.44 -51.74 4.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.142 . . . . 0.0 111.188 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -142.65 -2.63 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.729 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 35.7 m -65.94 102.39 0.78 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 117.853 0.297 . . . . 0.0 110.614 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 281' ' ' ILE . 0.1 OUTLIER -117.63 123.73 46.87 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.752 -178.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.48 HG12 HG21 ' A' ' 281' ' ' ILE . 2.5 p -108.41 134.08 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.636 0.255 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.722 ' HD1' HG23 ' A' ' 280' ' ' ILE . 1.4 t80 -77.65 130.26 36.62 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 279' ' ' ASP . 2.2 t -104.01 115.91 46.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.894 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -129.3 146.64 51.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.576 -179.151 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.522 ' CG2' ' CZ3' ' A' ' 241' ' ' TRP . 9.1 mt -139.78 140.77 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.52 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.6 t -152.3 161.44 42.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.373 . . . . 0.0 111.29 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 54.5 p -102.97 141.52 35.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.533 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -112.39 146.92 37.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.772 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -127.41 86.88 2.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.109 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.475 ' O ' ' CG2' ' A' ' 201' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.769 0.319 . . . . 0.0 110.179 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.635 ' HA3' ' CG2' ' A' ' 201' ' ' THR . . . 116.51 -138.12 14.15 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.535 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.456 ' C ' ' HB3' ' A' ' 296' ' ' GLN . 2.5 m -165.81 38.85 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.233 -0.484 . . . . 0.0 111.507 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 73.1 m -163.62 163.15 24.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.415 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 49.0 m95 -156.82 143.02 18.1 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.744 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.4 OUTLIER -118.79 106.16 12.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 14.2 m-85 -101.91 136.44 41.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.997 0.903 . . . . 0.0 112.179 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.529 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.4 OUTLIER -126.74 136.21 52.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.404 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.412 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 4.3 tm-20 -133.34 116.53 16.21 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.556 ' CG1' HD13 ' A' ' 220' ' ' LEU . 18.4 t -62.53 116.15 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 288' ' ' LYS . 9.2 tt -96.63 -23.21 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.722 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.39 91.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.54 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.632 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.86 -174.75 32.12 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.53 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 60.4 Cg_endo -75.34 27.56 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.371 2.047 . . . . 0.0 111.568 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.698 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -161.4 31.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.94 0.4 . . . . 0.0 110.0 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.632 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.1 mt -47.8 107.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.622 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.93 7.16 2.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.122 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.698 HD13 ' O ' ' A' ' 191' ' ' ALA . 0.6 OUTLIER -101.44 112.18 24.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.802 0.81 . . . . 0.0 109.906 179.151 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.0 mt-30 -111.03 152.62 26.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.554 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.435 ' CG ' HG11 ' A' ' 208' ' ' VAL . 1.1 t-80 -144.04 136.56 26.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.744 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -142.06 165.18 28.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.64 HG23 ' HA ' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -165.04 148.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.528 179.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 180' ' ' SER . 18.2 t-20 -88.57 137.18 32.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.474 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.57 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 32.4 t -49.32 -14.36 0.09 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.887 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.635 ' CG2' ' HA3' ' A' ' 178' ' ' GLY . 2.0 t -102.11 7.32 41.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -103.78 114.07 28.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.885 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 2.7 m -91.26 -67.39 0.86 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.69 -5.49 2.76 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.7 -1.81 11.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.126 -0.359 . . . . 0.0 111.313 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.64 ' HA ' HG23 ' A' ' 198' ' ' VAL . 1.3 tt -71.58 -61.66 2.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.4 Cg_endo -44.01 84.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.45 2.1 . . . . 0.0 113.276 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 206' ' ' LEU . 88.0 t -74.53 92.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.746 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.468 ' N ' ' HB2' ' A' ' 217' ' ' ASP . 0.7 OUTLIER -69.36 98.59 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.501 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.4 mp -82.65 128.79 34.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.778 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -179.11 179.37 48.91 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.899 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.835 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.0 OUTLIER -68.06 -76.39 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.548 ' CG2' ' H ' ' A' ' 214' ' ' SER . 8.0 p -126.57 -141.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.39 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.548 ' H ' ' CG2' ' A' ' 213' ' ' VAL . 0.1 OUTLIER 64.72 -175.88 0.03 OUTLIER Pre-proline 0 C--O 1.232 0.135 0 CA-C-N 118.314 0.506 . . . . 0.0 110.247 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 21.8 Cg_exo -65.66 10.03 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.745 2.297 . . . . 0.0 113.423 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 214' ' ' SER . 39.4 m -48.83 169.03 0.02 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.741 0.305 . . . . 0.0 111.092 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.468 ' HB2' ' N ' ' A' ' 209' ' ' LYS . 1.7 m-20 -95.48 -34.81 11.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.343 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.783 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 5.0 mt -105.81 127.31 53.02 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.522 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -92.57 80.02 4.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.724 0.297 . . . . 0.0 110.711 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.835 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.7 mm? -103.7 92.71 4.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -60.1 58.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.674 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 220' ' ' LEU . 5.5 t0 -92.72 124.88 37.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.349 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.7 p -69.05 -10.5 57.88 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.108 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.57 -24.76 33.81 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.783 0.325 . . . . 0.0 110.928 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 222' ' ' ASP . 3.0 p -108.41 79.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.1 m -35.17 -36.16 0.05 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.737 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.23 -58.01 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.976 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -143.19 132.48 23.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.135 0.493 . . . . 0.0 110.556 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.526 ' O ' ' N ' ' A' ' 246' ' ' MET . 0.6 OUTLIER -102.16 -57.0 2.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.376 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -141.83 171.21 14.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.192 0.52 . . . . 0.0 112.036 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 1.0 OUTLIER -152.54 159.36 43.29 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.486 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.565 HG12 ' HB3' ' A' ' 243' ' ' LEU . 19.4 mt -123.73 145.73 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.432 0.634 . . . . 0.0 111.87 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.418 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -161.41 150.51 16.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.8 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 3.2 p90 -138.76 165.64 26.46 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.12 132.43 56.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.792 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 73.4 m -88.99 2.09 54.5 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.872 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 21.4 m -78.63 -19.48 52.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.643 0.735 . . . . 0.0 110.276 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -150.73 23.63 0.78 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.496 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.2 p90 37.44 59.58 1.18 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.214 0.53 . . . . 0.0 110.446 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.8 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -128.63 143.12 50.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.673 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.665 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -123.42 122.5 38.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.774 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.671 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.8 pt-20 -134.18 142.35 47.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.698 0.761 . . . . 0.0 112.354 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.565 ' HB3' HG12 ' A' ' 232' ' ' ILE . 2.4 pp -107.82 152.76 23.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.784 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.558 HG23 ' CD1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -115.75 162.24 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.663 0.268 . . . . 0.0 110.963 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.512 ' HB3' ' OG ' ' A' ' 260' ' ' SER . 1.2 m-20 -106.22 111.05 23.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.596 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.93 103.42 6.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.203 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.87 70.59 0.92 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.51 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.2 m -62.0 40.96 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.724 HD23 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.52 -52.54 64.37 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.793 -0.567 . . . . 0.0 109.881 178.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.724 ' N ' HD23 ' A' ' 249' ' ' LEU . 2.7 m120 -80.32 -39.36 28.83 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.145 0.498 . . . . 0.0 111.681 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 88.89 87.36 1.23 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.804 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.675 ' N ' ' HB3' ' A' ' 260' ' ' SER . 2.9 m -45.44 170.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.279 0.232 . . . . 0.0 110.553 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.547 HD22 ' O ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -149.11 133.66 17.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.205 0.526 . . . . 0.0 111.461 177.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' A' ' 257' ' ' HIS . 86.0 t -109.83 133.11 56.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.083 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.467 ' HA ' HG13 ' A' ' 280' ' ' ILE . 3.3 m-20 51.11 44.41 28.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.174 0.512 . . . . 0.0 110.07 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 m 64.18 26.93 13.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.763 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . 0.497 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.1 OUTLIER -129.75 115.67 17.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.208 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 5.8 t -67.46 89.82 0.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.03 0.443 . . . . 0.0 111.548 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 257' ' ' HIS . 0.1 OUTLIER -89.36 0.33 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.431 -178.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.675 ' HB3' ' N ' ' A' ' 252' ' ' THR . 14.0 t -100.08 -16.69 17.78 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.687 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 0.8 OUTLIER -103.23 16.87 0.05 OUTLIER Pre-proline 0 N--CA 1.454 -0.266 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 43.8 Cg_endo -90.84 40.82 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.874 1.716 . . . . 0.0 111.144 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -151.56 85.58 1.32 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.986 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -69.72 -37.83 76.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.066 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -88.05 -3.83 79.03 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.489 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.608 ' C ' ' H ' ' A' ' 268' ' ' LYS . 3.1 m -97.84 -70.33 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.5 OUTLIER 67.68 -19.15 0.13 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.476 0.655 . . . . 0.0 112.061 -178.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.608 ' H ' ' C ' ' A' ' 266' ' ' SER . 0.1 OUTLIER -72.9 -129.09 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.536 -177.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.596 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 1.4 t-105 -77.68 -15.7 58.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.92 0.488 . . . . 0.0 112.232 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 59.94 -174.19 4.53 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.488 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -107.18 134.07 20.06 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.905 0.852 . . . . 0.0 110.494 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 96.4 Cg_exo -45.0 125.08 6.41 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.771 2.314 . . . . 0.0 113.521 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.671 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 74.9 t -98.77 129.3 49.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.665 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.13 128.65 34.79 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.46 -178.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.466 HD23 ' OD2' ' A' ' 279' ' ' ASP . 0.6 OUTLIER -87.27 163.5 16.82 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.031 -178.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -137.82 145.86 42.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.395 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 2.9 t -56.64 126.0 24.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.017 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.2 m-20 90.27 4.52 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.344 0.657 . . . . 0.0 111.949 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.472 ' OD2' ' HB ' ' A' ' 291' ' ' VAL . 0.6 OUTLIER -79.91 -164.51 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.522 HG21 ' HA ' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -162.3 136.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.406 178.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.46 ' O ' ' HG2' ' A' ' 288' ' ' LYS . 0.1 OUTLIER -108.46 156.64 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.607 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.665 ' OG1' ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -145.81 117.27 8.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.399 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.515 ' HB2' ' CB ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -113.07 44.61 1.49 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.79 -133.26 2.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.433 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.8 t -88.45 -49.44 6.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.643 0.259 . . . . 0.0 110.956 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.6 t -139.68 -7.3 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.722 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 49.0 m -63.97 101.31 0.38 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.665 ' HG3' ' OG1' ' A' ' 282' ' ' THR . 1.7 ttmt -118.8 129.51 55.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.637 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 289' ' ' VAL . 0.3 OUTLIER -106.98 128.49 61.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.542 0.21 . . . . 0.0 111.52 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.522 ' HA ' HG21 ' A' ' 280' ' ' ILE . 7.1 t80 -76.79 136.99 39.0 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.472 ' HB ' ' OD2' ' A' ' 279' ' ' ASP . 8.0 t -113.89 115.17 48.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.535 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.61 142.32 39.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.773 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.542 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 0.5 OUTLIER -129.89 147.24 33.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.501 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.67 129.54 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 0.0 111.482 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 8.7 p -81.42 159.37 24.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.58 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.456 ' HB3' ' C ' ' A' ' 179' ' ' SER . 3.7 tp-100 -110.9 119.42 39.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.687 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.87 92.15 3.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.289 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.868 179.701 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.858 ' HA ' HG21 ' A' ' 201' ' ' THR . 2.0 mp . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.653 0.263 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.561 ' N ' HG23 ' A' ' 201' ' ' THR . . . 110.97 79.6 1.04 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.261 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 77.2 p -149.5 -74.07 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.063 0.459 . . . . 0.0 109.851 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 295' ' ' SER . 0.6 OUTLIER -142.87 -175.53 4.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.946 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.686 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.5 m95 -143.24 131.62 22.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.634 ' HB2' ' CZ3' ' A' ' 241' ' ' TRP . 3.4 tp -114.07 128.41 56.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.943 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.686 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 1.4 m-85 -130.27 129.94 43.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.747 0.784 . . . . 0.0 111.588 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.638 HD21 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -130.84 146.36 52.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.775 176.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.513 ' C ' HG12 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -140.19 127.21 20.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.456 -0.497 . . . . 0.0 112.308 -177.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.629 HG23 HD13 ' A' ' 220' ' ' LEU . 9.7 t -64.5 106.06 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.459 HG23 HD11 ' A' ' 187' ' ' ILE . 10.1 tt -90.6 -19.01 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.801 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.63 95.02 0.62 Allowed 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.268 -0.573 . . . . 0.0 112.466 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.659 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.2 -179.54 37.75 Favored Glycine 0 C--O 1.228 -0.26 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.56 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 58.9 Cg_endo -74.6 30.17 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 CA-C-N 119.433 1.617 . . . . 0.0 111.269 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.668 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -160.2 26.38 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.659 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.0 mt -42.11 108.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.07 7.57 1.75 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.099 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.668 HD13 ' O ' ' A' ' 191' ' ' ALA . 1.1 mp -100.86 119.72 39.08 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.139 0.971 . . . . 0.0 109.818 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.439 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 8.1 mt-30 -122.54 153.64 38.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.208 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.638 ' CD2' HD21 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -146.67 145.42 30.02 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.059 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.516 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -150.22 143.46 24.99 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.517 HG12 ' HG ' ' A' ' 206' ' ' LEU . 12.0 p -149.01 149.94 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.418 0.628 . . . . 0.0 111.309 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -87.72 148.14 24.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.356 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.541 ' CB ' ' HZ2' ' A' ' 234' ' ' TRP . 1.0 OUTLIER -65.55 -7.64 15.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.387 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.858 HG21 ' HA ' ' A' ' 177' ' ' LEU . 3.1 t -92.35 5.62 49.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.95 0.405 . . . . 0.0 111.209 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.613 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -94.93 113.68 25.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.57 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.8 m -60.1 -108.46 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.2 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.8 m -78.58 25.52 0.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.613 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.54 -10.55 10.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.93 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.529 ' HB3' ' HD3' ' A' ' 207' ' ' PRO . 9.0 tt -77.06 -49.22 2.45 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.557 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 206' ' ' LEU . 52.9 Cg_exo -46.48 100.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.467 1.445 . . . . 0.0 111.653 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.848 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 4.7 t -66.83 163.33 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.513 ' O ' ' HB3' ' A' ' 216' ' ' SER . 0.0 OUTLIER -138.38 92.55 2.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.851 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 230' ' ' ALA . 1.0 OUTLIER -83.91 127.32 33.76 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.402 ' HA2' HG22 ' A' ' 225' ' ' VAL . . . -173.31 178.11 45.41 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.136 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.98 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 8.5 ttt180 -63.38 -86.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.67 -4.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.624 ' HB2' ' CD ' ' A' ' 215' ' ' PRO . 67.5 p -53.76 -178.85 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.624 ' CD ' ' HB2' ' A' ' 214' ' ' SER . 32.6 Cg_exo -61.08 17.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.307 2.004 . . . . 0.0 112.709 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 214' ' ' SER . 6.4 m -58.39 -178.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.218 0.532 . . . . 0.0 111.619 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.1 -31.92 11.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.506 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.647 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.1 mt -103.46 124.89 49.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.62 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.623 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -94.67 86.42 4.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.795 0.331 . . . . 0.0 110.465 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.98 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.7 mm? -109.62 96.6 6.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -64.28 51.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.56 ' HA ' ' HG3' ' A' ' 190' ' ' PRO . 0.3 OUTLIER -84.9 138.14 32.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.2 p -78.95 -11.09 59.99 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.121 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -84.39 -20.34 32.06 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.769 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.694 HG23 ' N ' ' A' ' 229' ' ' HIS . 7.5 p -113.91 69.79 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-O 120.872 0.367 . . . . 0.0 110.069 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -35.2 -33.28 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.193 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 225' ' ' VAL . . . -144.1 -67.75 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.361 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.509 ' HD3' ' HG ' ' A' ' 216' ' ' SER . 6.8 mttp -140.38 128.48 22.23 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.32 0.581 . . . . 0.0 111.176 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.694 ' N ' HG23 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -95.8 -60.69 1.59 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.508 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.591 ' O ' ' HB2' ' A' ' 210' ' ' LEU . . . -150.35 163.02 39.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.904 -177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.848 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -138.76 -179.14 5.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.908 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 14.8 mt -131.1 141.55 45.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.012 0.435 . . . . 0.0 110.81 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.94 133.48 5.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.758 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.8 p90 -124.41 165.72 17.23 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.82 133.61 55.85 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.827 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 31.4 p -92.97 3.04 56.44 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.469 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 89.8 m -80.85 -27.99 36.25 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.42 0.629 . . . . 0.0 110.065 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.453 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 4.6 tptt -137.09 19.19 2.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.02 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.414 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 27.9 p90 40.43 60.03 1.94 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.5 0.667 . . . . 0.0 109.861 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.758 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -125.12 143.63 50.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.322 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.634 ' CZ3' ' HB2' ' A' ' 182' ' ' LEU . 11.6 m0 -123.79 125.16 44.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.497 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 1.1 pt-20 -129.06 134.87 48.28 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.635 HD11 ' N ' ' A' ' 244' ' ' VAL . 0.1 OUTLIER -107.0 124.74 50.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.048 177.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.635 ' N ' HD11 ' A' ' 243' ' ' LEU . 4.8 p -126.39 164.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 O-C-N 122.111 -0.368 . . . . 0.0 111.609 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 260' ' ' SER . 15.9 t0 -88.53 127.8 35.54 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.712 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -84.51 44.44 1.04 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.411 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.46 57.26 11.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.64 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.677 ' HB3' ' HA ' ' A' ' 229' ' ' HIS . 56.1 p -99.87 148.29 24.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.81 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.739 HD12 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -79.44 -37.67 36.47 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.961 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.739 ' H ' HD12 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -74.01 -31.25 62.86 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.844 0.354 . . . . 0.0 111.494 -179.066 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 95.3 163.96 34.68 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.946 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.413 HG22 ' N ' ' A' ' 253' ' ' LEU . 25.0 m -125.22 156.61 38.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.84 0.353 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 281' ' ' ILE . 0.1 OUTLIER -148.68 126.41 11.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.987 0.423 . . . . 0.0 111.41 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 36.0 t -102.25 127.64 55.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.735 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 53.14 41.22 32.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 110.34 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 16.6 m 62.99 20.22 12.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.404 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.06 90.97 3.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.92 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 96.1 p -45.79 97.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.596 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.562 HG12 ' N ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -78.63 -52.65 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.248 179.185 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.562 ' N ' HG12 ' A' ' 259' ' ' ILE . 19.7 p -52.24 162.99 0.43 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 268' ' ' LYS . 0.4 OUTLIER -56.73 109.31 1.61 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.933 179.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -59.44 -3.89 2.14 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.464 2.11 . . . . 0.0 112.942 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.4 101.88 9.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.192 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 264' ' ' LEU . 9.6 mt -48.24 -25.46 1.54 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -93.12 -11.21 58.91 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.892 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 1.9 m -81.26 -35.91 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.712 ' HG2' ' HA ' ' A' ' 249' ' ' LEU . 15.3 mtm180 44.85 22.38 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 261' ' ' HIS . 2.5 mttt -62.49 157.77 19.49 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.27 0.628 . . . . 0.0 112.102 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.712 ' CE3' ' HA ' ' A' ' 246' ' ' MET . 0.4 OUTLIER -72.86 -24.95 60.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.157 -0.928 . . . . 0.0 108.662 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.59 ' O ' ' HD1' ' A' ' 269' ' ' TRP . . . 79.52 166.17 31.93 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.747 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -89.74 138.64 27.93 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.397 0.598 . . . . 0.0 109.929 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.75 108.63 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.504 2.136 . . . . 0.0 112.753 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 40.0 t -102.0 147.24 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.674 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 20.9 mm-40 -85.53 130.21 34.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.51 0.671 . . . . 0.0 112.766 -177.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.421 ' C ' HD21 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -95.74 164.51 12.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.934 179.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.686 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.15 159.4 42.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 23.9 p -57.92 129.32 41.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.327 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.476 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.8 m-20 87.93 7.74 0.18 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.287 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.686 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.7 OUTLIER -80.72 -164.28 0.7 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.423 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.5 OUTLIER -162.27 135.17 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 177.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.582 HG21 ' HG ' ' A' ' 243' ' ' LEU . 0.1 OUTLIER -123.6 93.76 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 287' ' ' THR . 0.6 OUTLIER -79.0 121.96 25.59 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.553 ' HB3' ' CD2' ' A' ' 229' ' ' HIS . 0.3 OUTLIER -106.69 50.03 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.459 -0.497 . . . . 0.0 112.254 -178.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 162.54 -115.94 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 119.571 -1.299 . . . . 0.0 113.807 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 1.2 t -96.1 -57.62 2.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.594 0.235 . . . . 0.0 110.727 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -135.32 0.33 2.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.916 179.766 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.801 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 45.1 m -75.12 102.94 5.1 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 121.353 -0.139 . . . . 0.0 111.248 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 282' ' ' THR . 3.4 ptpt -129.08 135.46 48.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.222 0.534 . . . . 0.0 112.091 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.56 HG11 ' HA ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -108.49 135.63 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.046 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.2 t80 -77.0 137.93 39.3 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.415 HG21 ' C ' ' A' ' 279' ' ' ASP . 0.1 OUTLIER -106.68 110.79 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.78 -178.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.39 140.6 50.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.775 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.483 ' CG2' ' CH2' ' A' ' 241' ' ' TRP . 32.3 mt -138.63 134.37 42.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.1 t -152.47 161.76 42.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 111.207 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.5 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 36.6 p -104.86 157.97 16.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.819 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -117.22 116.25 26.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.772 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.51 86.41 6.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.525 ' HB3' HD21 ' A' ' 199' ' ' ASN . 2.6 mp . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.835 0.35 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.64 99.11 2.19 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.532 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' A' ' 201' ' ' THR . 13.6 p -179.59 -77.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.766 0.317 . . . . 0.0 110.483 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.718 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 20.9 m -135.27 157.99 45.5 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.0 m95 -127.59 132.29 49.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 292' ' ' ARG . 2.2 tp -117.72 129.88 55.98 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.244 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 11.2 m-85 -125.95 133.15 51.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.681 0.753 . . . . 0.0 110.436 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.731 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 3.3 mt -123.84 141.37 52.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.889 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.476 ' C ' HG13 ' A' ' 289' ' ' VAL . 6.8 tt0 -134.8 111.3 9.8 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.622 ' CG1' HD12 ' A' ' 220' ' ' LEU . 8.8 t -58.64 117.98 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.49 HD13 HG23 ' A' ' 187' ' ' ILE . 5.6 tt -101.91 -24.41 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -175.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.76 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -155.86 91.2 1.27 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.994 0.815 . . . . 0.0 112.479 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -162.64 -165.89 20.48 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.41 ' HG3' ' CG ' ' A' ' 222' ' ' ASP . 58.6 Cg_endo -92.43 33.1 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.971 2.447 . . . . 0.0 111.509 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.672 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -162.34 29.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.459 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.584 HD11 ' N ' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -47.87 111.12 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.052 0.453 . . . . 0.0 111.322 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.12 4.52 2.58 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.666 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.672 HD11 ' O ' ' A' ' 191' ' ' ALA . 0.8 OUTLIER -102.33 118.9 37.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.599 0.714 . . . . 0.0 109.578 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.731 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.0 mt-30 -114.68 149.85 36.11 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.785 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.529 ' NE2' ' HB3' ' A' ' 217' ' ' ASP . 1.0 OUTLIER -138.48 133.26 32.47 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.102 178.436 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.59 156.62 43.36 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.399 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' A' ' 206' ' ' LEU . 4.5 p -162.19 156.37 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.625 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.718 ' HA ' ' O ' ' A' ' 180' ' ' SER . 46.2 m-20 -94.78 145.73 24.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.619 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.473 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 28.3 p -58.34 -0.31 0.09 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.081 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.51 HG21 ' HA ' ' A' ' 177' ' ' LEU . 1.4 t -106.72 14.4 26.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.857 0.36 . . . . 0.0 111.301 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.428 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -106.33 124.53 49.73 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.179 179.362 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 m -87.48 -83.03 0.21 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 26.2 m -84.09 13.27 5.25 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.428 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.03 -14.31 9.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.015 0.436 . . . . 0.0 110.624 178.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.594 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.6 tt -65.69 -55.32 24.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.802 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.8 Cg_endo -42.84 92.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.653 2.235 . . . . 0.0 113.453 -178.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 231' ' ' GLN . 41.6 t -71.46 90.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.708 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.551 ' N ' ' HB2' ' A' ' 217' ' ' ASP . 0.7 OUTLIER -68.16 78.81 0.24 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.713 HD21 HD22 ' A' ' 218' ' ' LEU . 3.1 mp -65.35 129.55 40.13 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.975 -0.453 . . . . 0.0 110.043 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . -173.59 171.62 44.62 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.46 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.613 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -70.56 -74.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.893 0.477 . . . . 0.0 112.074 -179.155 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.654 HG22 ' H ' ' A' ' 214' ' ' SER . 9.9 p -124.28 -142.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.363 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.654 ' H ' HG22 ' A' ' 213' ' ' VAL . 1.9 m 60.5 173.25 0.06 OUTLIER Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 118.972 0.805 . . . . 0.0 109.616 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.596 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 37.5 Cg_endo -65.71 28.58 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.076 1.851 . . . . 0.0 113.064 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.531 ' H ' ' C ' ' A' ' 214' ' ' SER . 8.1 m -57.47 167.01 1.09 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.749 0.309 . . . . 0.0 110.756 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.551 ' HB2' ' N ' ' A' ' 209' ' ' LYS . 9.7 m-20 -89.0 -43.01 11.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.874 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.713 HD22 HD21 ' A' ' 210' ' ' LEU . 3.4 tp -99.07 131.63 44.97 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.559 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -95.68 75.75 3.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.954 0.407 . . . . 0.0 110.785 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.622 HD12 ' CG1' ' A' ' 186' ' ' VAL . 2.6 mm? -103.96 62.87 0.76 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.613 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 2.2 pttt -54.57 57.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 220' ' ' LEU . 10.0 t0 -88.75 153.81 20.78 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.2 p -73.18 -4.72 34.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.499 ' HG3' ' HA3' ' A' ' 284' ' ' GLY . 1.4 pt-20 -91.74 -21.79 20.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.977 0.418 . . . . 0.0 110.26 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -96.94 102.88 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.083 179.089 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 73.0 m -53.18 -49.26 67.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.468 0.651 . . . . 0.0 109.885 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 228' ' ' LYS . . . -148.34 -50.62 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.522 ' HD2' ' HD2' ' A' ' 209' ' ' LYS . 8.1 mttm -145.87 134.74 22.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.082 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.559 ' HD2' ' HB2' ' A' ' 283' ' ' LEU . 0.0 OUTLIER -101.18 -53.84 2.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.181 179.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.449 ' C ' ' HG3' ' A' ' 231' ' ' GLN . . . -148.97 170.32 18.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.774 ' O ' HD11 ' A' ' 243' ' ' LEU . 0.0 OUTLIER -152.68 170.24 20.75 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.764 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.802 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.7 mt -121.06 143.62 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.483 0.659 . . . . 0.0 111.814 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.478 ' HA ' HD23 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.14 126.3 4.2 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.775 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 10.5 p90 -120.32 166.85 12.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.528 HD22 ' HB2' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -115.58 133.58 55.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.02 -179.042 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.27 -0.88 52.49 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.71 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 18.6 m -78.97 -39.33 34.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.904 0.859 . . . . 0.0 109.382 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.585 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 10.0 tptm -117.8 10.08 13.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.21 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 10.6 p90 44.92 63.83 1.58 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.42 0.629 . . . . 0.0 109.772 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.775 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 2.1 mptp? -130.69 140.56 50.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.092 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.66 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 1.8 m95 -121.41 124.01 43.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.942 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 6.7 pt-20 -138.29 147.17 43.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.784 ' HG ' HG13 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -95.25 151.34 19.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 112.859 -1.973 . . . . 0.0 108.474 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.502 HG23 ' CD1' ' A' ' 269' ' ' TRP . 2.2 p -145.57 161.79 12.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.867 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 17.4 t0 -84.25 139.44 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.561 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.02 30.56 0.58 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.0 41.02 97.51 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.646 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 9.5 t -86.54 172.28 10.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 111.264 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.677 HD11 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -96.95 -30.95 12.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.809 179.283 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.677 ' H ' HD11 ' A' ' 249' ' ' LEU . 0.8 OUTLIER -75.53 -29.65 59.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.805 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.502 ' HA3' ' CG ' ' A' ' 261' ' ' HIS . . . 85.62 152.55 19.14 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.742 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 253' ' ' LEU . 87.6 m -108.94 154.73 21.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.463 -0.368 . . . . 0.0 110.772 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -138.06 136.43 36.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.159 178.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.463 ' HB ' HG12 ' A' ' 259' ' ' ILE . 89.6 t -107.6 127.45 63.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.971 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.582 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 27.2 t-20 56.56 50.54 12.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.376 0.608 . . . . 0.0 109.985 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.56 32.51 17.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.927 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . 0.415 ' O ' ' N ' ' A' ' 259' ' ' ILE . 0.1 OUTLIER -137.95 111.54 8.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.823 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.556 ' CB ' ' CE1' ' A' ' 261' ' ' HIS . 78.3 p -60.41 83.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.306 0.574 . . . . 0.0 110.34 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.463 HG12 ' HB ' ' A' ' 254' ' ' VAL . 2.6 pp -87.85 -9.49 10.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.815 -178.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.626 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 0.1 OUTLIER -119.99 -21.65 7.02 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.199 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.618 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 34.2 p-80 -112.07 40.88 0.2 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.626 ' HD3' ' C ' ' A' ' 260' ' ' SER . 38.2 Cg_exo -57.65 -24.92 65.21 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.848 1.698 . . . . 0.0 113.33 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 266' ' ' SER . 57.0 m-20 -118.76 110.18 16.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.198 0.523 . . . . 0.0 111.898 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.61 156.92 33.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.982 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 75.18 -17.45 3.04 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.84 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.554 ' HB2' ' O ' ' A' ' 263' ' ' ASP . 0.4 OUTLIER -75.69 -38.69 58.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.976 0.417 . . . . 0.0 111.445 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 248' ' ' SER . 0.6 OUTLIER 53.07 24.8 3.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.988 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -65.77 165.38 12.87 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.781 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.521 ' CZ2' ' OE1' ' A' ' 231' ' ' GLN . 7.7 t-105 -81.02 -16.93 51.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.541 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 72.22 174.22 22.85 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.462 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -105.59 137.15 19.22 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.153 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.24 115.75 2.08 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.654 2.236 . . . . 0.0 113.789 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 80.9 t -103.96 135.18 42.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.586 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -75.56 127.8 33.88 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -176.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.626 HD11 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.29 164.65 13.45 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.517 178.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.82 159.3 42.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 28.3 t -61.38 129.28 40.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.367 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 277' ' ' SER . 0.4 OUTLIER 83.74 6.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.387 -178.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 16.0 t0 -81.1 -165.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 255' ' ' ASN . 0.8 OUTLIER -160.4 126.39 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.368 178.129 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.784 HG13 ' HG ' ' A' ' 243' ' ' LEU . 0.2 OUTLIER -100.58 148.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.663 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 13.9 m -140.53 136.81 33.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.612 0.72 . . . . 0.0 111.56 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.639 ' O ' ' HB ' ' A' ' 287' ' ' THR . 0.0 OUTLIER -136.95 134.78 37.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.359 178.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.499 ' HA3' ' HG3' ' A' ' 224' ' ' GLU . . . 95.64 -137.91 13.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.346 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 11.6 t -99.33 -30.16 12.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.898 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -156.53 5.14 0.16 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.76 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 7.4 m -73.47 107.14 5.58 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.881 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 282' ' ' THR . 11.6 ttmm -127.81 134.83 49.47 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.17 0.509 . . . . 0.0 111.807 -178.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.476 HG13 ' C ' ' A' ' 185' ' ' GLU . 16.7 t -115.44 135.38 55.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.809 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.541 ' CD1' HG23 ' A' ' 280' ' ' ILE . 2.5 t80 -76.9 137.98 39.45 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.122 0.487 . . . . 0.0 110.666 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.11 112.23 37.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.718 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.503 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -129.26 138.45 51.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.872 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 4.1 mt -138.78 122.36 19.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.23 162.34 32.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 110.835 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.6 -165.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.988 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -144.34 115.84 8.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.767 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -104.23 86.56 2.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.983 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.887 179.911 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.566 ' HB2' HG22 ' A' ' 201' ' ' THR . 73.8 mt . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.489 ' N ' HG22 ' A' ' 201' ' ' THR . . . 113.88 101.06 2.43 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.706 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 200' ' ' SER . 0.8 OUTLIER -178.42 -89.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.61 0.205 . . . . 0.0 111.167 179.12 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.611 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -142.24 -171.91 3.48 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.0 m95 -145.56 130.34 18.11 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.633 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 4.0 tp -119.82 136.56 54.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.059 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 3.5 m-85 -134.16 130.23 37.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.762 0.792 . . . . 0.0 109.809 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.622 HD13 ' HA ' ' A' ' 291' ' ' VAL . 3.7 mm? -116.98 139.43 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.276 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -135.49 111.96 9.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 194' ' ' LEU . 14.3 t -60.58 110.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.459 ' CG2' ' HG3' ' A' ' 288' ' ' LYS . 9.0 tt -92.64 -19.28 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.756 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.9 95.21 0.34 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.88 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.613 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.63 -173.25 30.06 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.504 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 94.6 Cg_endo -81.43 31.8 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 121.926 1.751 . . . . 0.0 110.91 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -160.83 24.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.077 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.613 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.3 mt -40.84 108.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.863 0.364 . . . . 0.0 111.979 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.62 6.03 2.13 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.375 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -95.94 143.86 26.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.605 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 16.6 mt-30 -139.88 147.12 40.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.421 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.58 ' CD2' HG13 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -136.82 131.05 32.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.392 0.615 . . . . 0.0 110.421 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.93 152.76 43.83 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.019 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.473 HG13 ' CH2' ' A' ' 234' ' ' TRP . 5.3 p -166.38 156.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.196 0.522 . . . . 0.0 110.937 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 180' ' ' SER . 1.2 m120 -93.38 147.31 23.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.405 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.527 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 1.4 t -64.58 -3.22 2.92 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.978 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 177' ' ' LEU . 3.5 t -89.15 12.15 16.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.775 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -95.2 144.32 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.946 0.403 . . . . 0.0 111.238 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.53 -60.89 1.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.082 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.57 25.39 4.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.331 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.42 -1.05 12.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.764 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.634 ' N ' ' CD ' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -94.57 -22.96 0.24 Allowed Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 206' ' ' LEU . 22.2 Cg_exo -61.57 94.29 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.113 1.209 . . . . 0.0 111.384 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.58 HG13 ' CD2' ' A' ' 196' ' ' HIS . 45.5 t -80.61 102.06 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.34 0.591 . . . . 0.0 111.254 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 216' ' ' SER . 0.0 OUTLIER -69.46 97.22 0.97 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.624 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.5 mp -75.85 125.3 28.82 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.463 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -169.2 171.97 43.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.385 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.789 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 4.8 ttt180 -58.53 -90.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 10.6 p -127.5 -9.57 4.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.579 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.1 OUTLIER -53.82 -173.86 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.713 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 27.0 Cg_exo -62.42 3.89 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.438 2.092 . . . . 0.0 112.877 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.509 ' HA ' ' HB3' ' A' ' 209' ' ' LYS . 0.9 OUTLIER -49.76 165.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.895 0.378 . . . . 0.0 111.577 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.402 ' HB2' ' N ' ' A' ' 209' ' ' LYS . 3.4 m-20 -86.01 -31.36 22.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.679 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.746 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 2.9 mt -107.93 130.8 55.01 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.615 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -92.26 79.83 5.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.816 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.789 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.1 mm? -103.81 86.24 2.57 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.694 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 7.4 ptpt -59.51 20.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.608 ' H ' ' C ' ' A' ' 220' ' ' LEU . 6.3 t0 -48.99 125.73 11.03 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.2 t -63.41 -12.23 29.17 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.436 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 285' ' ' THR . 0.1 OUTLIER -82.49 -17.24 45.84 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.779 0.323 . . . . 0.0 110.544 179.159 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.701 ' O ' ' HB2' ' A' ' 212' ' ' ARG . 7.4 p -108.83 94.5 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.065 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.14 -45.22 16.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.036 0.446 . . . . 0.0 110.836 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.43 -50.38 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.476 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.579 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 7.0 mttt -139.41 126.55 21.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.111 0.482 . . . . 0.0 110.466 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.679 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.5 t60 -100.54 -58.07 1.98 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.752 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.445 ' C ' HD13 ' A' ' 210' ' ' LEU . . . -141.1 173.15 11.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.812 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.537 ' O ' HD12 ' A' ' 243' ' ' LEU . 61.2 tt0 -151.98 154.3 35.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.302 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.0 mt -111.96 140.6 30.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-O 121.197 0.522 . . . . 0.0 111.276 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.35 149.87 17.61 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.718 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 4.0 p90 -139.47 166.34 24.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -115.42 132.77 56.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.138 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.7 m -92.81 -1.07 57.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.949 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.3 m -77.58 -28.19 51.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.674 0.749 . . . . 0.0 109.876 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.32 19.18 2.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.804 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.7 p90 39.84 62.09 1.31 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.578 0.704 . . . . 0.0 109.56 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.718 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 1.4 mptm? -122.91 138.95 54.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.902 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.567 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -123.43 122.35 38.05 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.492 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 7.8 pt-20 -130.68 145.53 51.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 122.388 1.09 . . . . 0.0 113.872 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.649 ' HG ' HG13 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -102.24 138.44 39.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.988 178.103 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.472 HG22 ' CD1' ' A' ' 269' ' ' TRP . 3.7 p -133.47 162.42 39.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.78 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.474 ' HB2' ' CB ' ' A' ' 260' ' ' SER . 25.1 t0 -88.16 139.66 30.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.311 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.517 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -86.98 32.54 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.102 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.86 47.92 77.51 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.916 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.45 -178.55 5.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.72 HD12 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -106.0 -28.32 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.139 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.72 ' H ' HD12 ' A' ' 249' ' ' LEU . 8.1 t-20 -75.37 -36.07 61.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.127 0.489 . . . . 0.0 111.622 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.12 116.24 1.71 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.825 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.544 HG21 ' H ' ' A' ' 253' ' ' LEU . 16.7 m -70.98 165.29 23.75 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.655 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -149.28 128.85 13.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.314 0.578 . . . . 0.0 111.394 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.434 HG22 ' CG2' ' A' ' 259' ' ' ILE . 86.1 t -105.57 132.81 51.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.453 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 280' ' ' ILE . 12.2 p30 50.08 39.31 18.92 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.094 0.473 . . . . 0.0 110.084 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.95 27.68 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.534 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.74 103.18 6.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.243 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 7.6 t -51.46 95.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.61 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.501 ' HB ' ' CG2' ' A' ' 273' ' ' VAL . 0.2 OUTLIER -77.72 -23.01 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.416 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.474 ' CB ' ' HB2' ' A' ' 245' ' ' ASP . 24.7 p -74.37 169.19 18.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.429 ' C ' ' H ' ' A' ' 263' ' ' ASP . 0.2 OUTLIER -56.01 106.15 0.63 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 119.514 1.052 . . . . 0.0 111.086 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 260' ' ' SER . 7.4 Cg_exo -74.5 17.91 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.004 2.469 . . . . 0.0 112.01 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.483 ' O ' ' HB3' ' A' ' 266' ' ' SER . 27.7 t70 -103.64 122.89 45.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.227 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 42.6 mt -55.56 148.64 15.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.527 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.47 -22.57 4.56 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.464 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.557 ' C ' ' H ' ' A' ' 268' ' ' LYS . 2.0 t -95.12 76.43 3.48 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.074 0.95 . . . . 0.0 109.129 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 6.2 mtm105 -74.55 33.56 0.09 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.132 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.557 ' H ' ' C ' ' A' ' 266' ' ' SER . 19.0 mttt -61.73 161.9 9.42 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.517 ' CE3' ' HA ' ' A' ' 246' ' ' MET . 13.0 t-105 -72.96 -18.92 61.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.98 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 75.9 168.91 26.54 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.403 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -99.66 134.64 20.94 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.116 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.17 108.76 0.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.608 2.206 . . . . 0.0 113.687 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.501 ' CG2' ' HB ' ' A' ' 259' ' ' ILE . 81.3 t -100.38 141.65 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 0.0 OUTLIER -83.03 129.3 35.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.07 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.457 ' C ' ' CD2' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.91 165.72 12.52 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.022 178.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.49 161.99 36.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.3 OUTLIER -60.24 130.33 46.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.126 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 277' ' ' SER . 18.0 m-20 82.86 3.08 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.952 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.606 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 2.6 t0 -75.1 -162.56 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.522 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.5 OUTLIER -161.73 127.96 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.994 178.371 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.649 HG13 ' HG ' ' A' ' 243' ' ' LEU . 0.2 OUTLIER -107.78 157.29 8.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.302 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.655 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 5.6 m -150.64 134.94 17.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.679 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -129.27 47.56 2.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.12 -125.69 1.04 Allowed Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 119.493 -1.337 . . . . 0.0 113.638 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' THR . . . . . 0.451 ' N ' ' HG3' ' A' ' 224' ' ' GLU . 3.8 t -99.98 -37.23 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 0.0 110.823 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -149.74 -10.12 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.756 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 87.2 m -66.34 106.06 1.61 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 117.77 0.259 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 0.1 OUTLIER -131.55 139.04 49.14 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.39 0.614 . . . . 0.0 111.619 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 186' ' ' VAL . 4.5 t -116.77 136.54 53.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.329 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.522 ' HD1' HG23 ' A' ' 280' ' ' ILE . 1.8 t80 -76.75 136.09 39.02 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 109.917 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.622 ' HA ' HD13 ' A' ' 184' ' ' LEU . 1.8 t -102.52 110.96 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.659 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.409 ' C ' HG13 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -123.35 137.93 54.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.538 HD11 ' CE3' ' A' ' 241' ' ' TRP . 2.5 mt -137.62 117.93 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.42 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.5 146.63 47.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.897 0.38 . . . . 0.0 111.226 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.75 167.7 14.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.873 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -113.99 125.6 54.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -164.28 86.49 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.951 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.486 ' HB3' ' CG ' ' A' ' 199' ' ' ASN . 3.4 mp . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 120.333 0.111 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.653 ' HA3' ' CG2' ' A' ' 201' ' ' THR . . . 116.13 162.36 13.09 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.972 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.787 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 16.4 p -89.53 23.83 2.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.212 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 25.1 m -147.81 140.42 24.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.168 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.714 ' HB3' ' CE1' ' A' ' 183' ' ' PHE . 3.7 m95 -142.77 133.48 25.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.448 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.5 OUTLIER -121.82 130.31 53.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.714 ' CE1' ' HB3' ' A' ' 181' ' ' TRP . 0.7 OUTLIER -132.28 143.14 49.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.712 0.768 . . . . 0.0 111.308 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.639 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -137.9 148.69 45.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.402 177.522 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.452 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 9.0 tt0 -137.77 125.11 21.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.968 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.575 HG13 HD13 ' A' ' 220' ' ' LEU . 18.9 t -64.69 119.6 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.509 ' CG2' ' HB3' ' A' ' 288' ' ' LYS . 3.8 tp -104.15 -23.41 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.809 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -159.2 91.8 1.04 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.47 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.579 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.71 -171.66 28.07 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.468 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 73.2 Cg_endo -81.43 31.26 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.878 1.719 . . . . 0.0 111.664 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.496 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -162.4 25.32 0.11 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.582 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.579 HG12 ' H ' ' A' ' 189' ' ' GLY . 7.5 mt -43.13 114.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.77 7.23 3.43 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.277 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -98.69 132.57 43.97 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.452 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 20.3 mt-30 -130.58 151.9 50.54 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.665 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.627 ' HB3' HD21 ' A' ' 184' ' ' LEU . 1.4 t60 -143.23 139.79 30.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.255 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -131.84 148.08 52.53 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.05 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.768 HG21 ' HA ' ' A' ' 206' ' ' LEU . 11.8 p -159.16 141.77 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.513 ' OD1' ' CH2' ' A' ' 181' ' ' TRP . 3.1 m120 -88.03 161.55 17.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.013 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.488 ' HB2' ' NE1' ' A' ' 234' ' ' TRP . 60.0 p -68.78 -48.64 63.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.342 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.653 ' CG2' ' HA3' ' A' ' 178' ' ' GLY . 0.0 OUTLIER -62.23 1.84 0.29 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.579 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -83.04 129.7 35.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -89.72 -95.88 0.11 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.12 11.19 2.42 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.579 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -116.49 -17.79 10.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.684 0.278 . . . . 0.0 110.765 179.352 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.824 HD23 ' O ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -76.93 -42.93 2.81 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.769 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 6.2 Cg_endo -51.89 96.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.209 1.11 . . . . 0.0 112.118 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.653 ' O ' ' HG3' ' A' ' 231' ' ' GLN . 78.5 t -67.36 151.19 10.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -128.29 93.61 3.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.7 OUTLIER -84.76 127.88 34.33 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.306 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.437 ' HA2' HG23 ' A' ' 225' ' ' VAL . . . -173.39 174.21 45.97 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.02 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.581 ' CG ' ' HA ' ' A' ' 221' ' ' LYS . 2.0 ttm180 -69.98 -75.03 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.812 0.445 . . . . 0.0 111.834 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 214' ' ' SER . 9.2 p -121.82 -145.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.524 ' CB ' ' HD2' ' A' ' 215' ' ' PRO . 0.3 OUTLIER 65.91 179.03 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 118.731 0.696 . . . . 0.0 109.85 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 49.7 Cg_endo -69.58 28.7 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.089 1.859 . . . . 0.0 113.435 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 214' ' ' SER . 6.3 m -61.96 160.57 12.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.699 0.285 . . . . 0.0 110.679 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.77 -31.27 21.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.754 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 4.8 mt -111.49 133.13 53.99 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.606 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -92.52 76.46 5.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.415 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.754 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.1 mm? -97.99 62.52 1.58 Allowed 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.581 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 8.2 pttt -59.56 50.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.468 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 22.6 t0 -97.32 124.4 41.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 t -39.82 -27.88 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.614 ' HG2' ' HA2' ' A' ' 284' ' ' GLY . 0.4 OUTLIER -60.8 -39.9 90.62 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.097 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 212' ' ' ARG . 1.7 p -97.75 93.93 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.0 m -35.29 -62.05 0.41 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.105 0.479 . . . . 0.0 111.445 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 228' ' ' LYS . . . -133.33 -47.76 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 227' ' ' GLY . 3.6 mttt -144.19 127.3 16.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.493 -0.354 . . . . 0.0 110.172 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.47 ' O ' ' N ' ' A' ' 246' ' ' MET . 4.4 t60 -96.09 -55.67 2.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.637 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -140.12 159.65 41.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.411 0.624 . . . . 0.0 112.614 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.653 ' HG3' ' O ' ' A' ' 208' ' ' VAL . 0.1 OUTLIER -145.72 161.96 38.7 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.704 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.769 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.6 mt -124.13 149.4 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.515 ' HA ' HD13 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -153.8 162.03 41.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.661 178.032 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.488 ' NE1' ' HB2' ' A' ' 200' ' ' SER . 0.6 OUTLIER -98.39 157.39 16.23 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -176.074 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 240' ' ' LYS . 2.0 t-20 -121.55 71.46 0.97 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.156 -1.384 . . . . 0.0 107.478 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 p -56.48 -19.44 15.38 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.9 m -75.54 -21.39 57.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.463 0.649 . . . . 0.0 110.567 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.517 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 0.3 OUTLIER -137.19 17.84 2.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.374 -179.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 239' ' ' PHE . 19.7 p90 42.67 68.0 0.54 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -130.19 144.48 51.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.295 -179.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.521 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -119.29 102.96 9.07 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.569 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.5 pt-20 -125.96 144.71 50.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.107 0.956 . . . . 0.0 113.002 -177.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 2.6 pp -115.94 149.96 37.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.681 -1.599 . . . . 0.0 111.208 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.525 ' CG2' ' CD1' ' A' ' 269' ' ' TRP . 2.0 p -113.99 163.06 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.657 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 260' ' ' SER . 6.1 m-20 -112.25 101.84 10.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.511 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -65.56 96.46 0.26 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.417 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.59 69.88 1.13 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.356 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.413 ' CB ' ' HB2' ' A' ' 260' ' ' SER . 0.4 OUTLIER -65.4 57.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.583 HD11 ' N ' ' A' ' 250' ' ' ASN . 0.8 OUTLIER -53.38 -57.72 9.62 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.31 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.583 ' N ' HD11 ' A' ' 249' ' ' LEU . 0.7 OUTLIER -78.77 -30.1 45.42 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.264 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.459 ' O ' HD23 ' A' ' 253' ' ' LEU . . . 92.07 125.82 3.67 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.513 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.442 ' O ' HG12 ' A' ' 259' ' ' ILE . 25.7 m -88.67 114.96 25.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.155 0.182 . . . . 0.0 110.601 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -103.98 130.51 51.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.278 0.561 . . . . 0.0 112.512 -178.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.434 HG23 ' CG1' ' A' ' 281' ' ' ILE . 33.1 t -108.55 131.95 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.63 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 280' ' ' ILE . 3.3 t-20 52.15 32.01 9.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.125 0.488 . . . . 0.0 109.877 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.8 m 68.82 21.04 7.84 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.686 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -120.49 93.35 4.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.802 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 21.7 p -43.79 97.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.356 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 260' ' ' SER . 14.4 pt -77.29 -53.88 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.508 ' N ' HG13 ' A' ' 259' ' ' ILE . 36.9 p -45.8 160.44 0.06 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.494 ' C ' ' H ' ' A' ' 263' ' ' ASP . 48.9 p-80 -55.43 108.05 1.06 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 118.597 0.635 . . . . 0.0 111.673 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.53 22.39 0.34 Allowed 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.863 2.375 . . . . 0.0 111.63 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 261' ' ' HIS . 0.1 OUTLIER -107.49 112.1 24.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.355 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.75 164.58 14.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.299 0.571 . . . . 0.0 112.237 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.01 -22.46 4.29 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.178 -0.919 . . . . 0.0 114.269 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.616 ' O ' ' HB2' ' A' ' 267' ' ' ARG . 36.8 m -81.49 -71.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.318 0.559 . . . . 0.0 112.335 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.616 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.8 OUTLIER 79.52 17.7 0.8 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.153 -179.022 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -46.85 156.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.525 ' CD1' ' CG2' ' A' ' 244' ' ' VAL . 28.2 t-105 -67.17 -24.87 65.92 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 79.97 157.81 14.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.099 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -96.6 140.94 22.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -46.39 119.0 2.8 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.575 2.184 . . . . 0.0 112.788 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 84.9 t -100.91 136.22 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -85.0 128.6 34.7 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.97 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.681 ' H ' HD12 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.48 165.58 12.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.08 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -137.43 155.61 49.13 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.564 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 89.0 p -63.78 133.21 53.06 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.258 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.564 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.0 OUTLIER 79.27 -4.99 2.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.254 -178.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 3.5 t70 -67.61 -167.24 0.06 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.538 ' HB ' ' HE3' ' A' ' 288' ' ' LYS . 0.7 OUTLIER -162.09 131.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.645 178.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -104.02 148.13 9.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.139 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.669 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 1.6 m -138.89 116.95 11.71 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.456 ' O ' ' HB ' ' A' ' 287' ' ' THR . 0.1 OUTLIER -113.44 136.54 52.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.444 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.614 ' HA2' ' HG2' ' A' ' 224' ' ' GLU . . . 82.91 -129.14 8.88 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.666 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 t -95.11 -31.65 13.46 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -159.67 8.15 0.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.577 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.809 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 14.9 m -69.51 99.26 1.23 Allowed 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.542 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 0.2 OUTLIER -111.86 115.26 28.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.456 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.434 ' O ' HG12 ' A' ' 289' ' ' VAL . 4.4 p -103.17 131.03 52.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 122.205 -0.31 . . . . 0.0 110.827 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.639 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.2 t80 -76.22 132.49 39.94 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.56 114.62 43.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.652 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.505 ' HD2' ' H ' ' A' ' 293' ' ' ILE . 5.6 tpt180 -132.0 143.85 50.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.235 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.515 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 8.8 mt -143.13 122.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.697 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.79 159.1 38.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.941 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 9.7 m -89.29 -179.12 5.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.787 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 2.8 tp60 -115.4 120.66 40.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.484 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -77.37 88.42 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.316 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.738 179.702 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.51 HD23 ' CH2' ' A' ' 181' ' ' TRP . 1.3 mp . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 121.184 0.516 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.81 ' HA3' HG21 ' A' ' 201' ' ' THR . . . 70.75 165.6 6.03 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.817 -0.629 . . . . 0.0 113.353 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.702 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 0.3 OUTLIER -87.94 33.21 0.72 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.887 -0.656 . . . . 0.0 111.978 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.449 ' HB3' ' OG ' ' A' ' 200' ' ' SER . 0.5 OUTLIER -142.75 135.27 27.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.498 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 10.9 m95 -147.09 142.06 26.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.849 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.507 ' HB2' ' CZ3' ' A' ' 241' ' ' TRP . 1.5 tp -125.96 122.72 36.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 1.4 m-85 -121.31 141.23 51.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.795 0.807 . . . . 0.0 111.313 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.64 ' CD2' ' N ' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -139.65 149.01 43.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.526 178.668 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.472 ' C ' HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -139.52 125.98 20.36 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.476 ' CG1' HD11 ' A' ' 220' ' ' LEU . 21.7 t -62.06 116.48 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.599 ' CG2' ' HG3' ' A' ' 288' ' ' LYS . 5.5 tt -100.03 -19.34 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.839 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.54 91.9 0.6 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.659 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -160.9 -171.12 26.43 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.654 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 64.0 Cg_endo -81.59 32.54 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.006 1.804 . . . . 0.0 111.311 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.49 22.12 0.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.574 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.659 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.4 mt -39.81 111.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.08 7.65 3.19 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.109 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 219' ' ' ALA . 0.2 OUTLIER -96.24 131.9 42.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.425 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 14.1 mt-30 -129.07 151.11 50.11 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.465 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.579 ' NE2' HD12 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -146.87 148.14 31.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.771 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.23 144.73 34.88 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.778 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.595 ' CG2' ' HA ' ' A' ' 206' ' ' LEU . 2.1 p -147.66 139.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.393 0.616 . . . . 0.0 111.437 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.564 HD21 HG23 ' A' ' 201' ' ' THR . 2.6 p-10 -92.65 148.36 22.13 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.768 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.553 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 61.5 m -66.19 -1.12 2.95 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.81 HG21 ' HA3' ' A' ' 178' ' ' GLY . 0.1 OUTLIER -111.38 11.66 21.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.054 0.454 . . . . 0.0 111.0 178.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.692 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -106.74 120.04 40.94 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.746 178.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -76.41 0.45 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.5 t -62.93 1.51 0.41 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.435 ' HG2' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -122.15 -10.19 8.58 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.083 -0.385 . . . . 0.0 110.814 178.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.693 ' CD2' ' HA ' ' A' ' 233' ' ' THR . 5.1 tt -62.09 -63.38 4.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.606 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.7 Cg_endo -43.03 88.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.412 2.075 . . . . 0.0 113.174 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.539 ' O ' ' CG1' ' A' ' 208' ' ' VAL . 1.7 t -69.51 85.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.461 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 216' ' ' SER . 1.3 mtpt -69.82 97.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.5 mp -82.93 127.94 33.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -167.35 167.61 40.0 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.571 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.876 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 4.7 ttt180 -56.54 -90.75 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 14.0 p -124.01 -9.89 6.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.69 0.281 . . . . 0.0 111.477 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.552 ' C ' ' H ' ' A' ' 216' ' ' SER . 0.6 OUTLIER -50.88 178.94 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.217 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 21.0 Cg_endo -63.51 13.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.661 1.574 . . . . 0.0 112.493 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 214' ' ' SER . 16.3 m -52.82 166.96 0.17 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 111.193 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -84.75 -26.09 27.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.761 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.715 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.2 mt -111.53 130.99 55.55 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.633 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -94.96 82.09 3.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.726 0.298 . . . . 0.0 111.355 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.715 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -102.14 63.85 0.92 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.876 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -51.9 72.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.445 -178.728 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.654 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 3.4 t0 -127.49 137.18 52.59 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-O 120.992 0.425 . . . . 0.0 110.774 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 43.9 t -51.31 -36.84 44.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.477 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.61 ' CD ' ' HA3' ' A' ' 284' ' ' GLY . 2.4 pt-20 -44.71 -45.71 9.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.015 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 212' ' ' ARG . 2.2 p -102.29 107.68 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.655 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.63 -51.7 20.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.224 0.535 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.94 -46.67 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.404 ' NZ ' ' HG2' ' A' ' 215' ' ' PRO . 0.1 OUTLIER -136.64 120.63 17.62 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.705 ' CD2' ' HB3' ' A' ' 283' ' ' LEU . 5.4 t60 -92.2 -61.1 1.68 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.702 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.593 ' CB ' HG23 ' A' ' 252' ' ' THR . . . -140.08 176.84 8.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.526 0.679 . . . . 0.0 112.315 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.594 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 10.6 tt0 -159.19 162.69 36.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.909 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.538 HG12 ' HB3' ' A' ' 243' ' ' LEU . 54.4 mt -124.72 144.31 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.563 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.693 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.87 163.41 32.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.12 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.865 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 12.1 p90 -154.91 166.59 33.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -115.47 133.14 56.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.304 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.48 -2.87 57.94 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.295 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.5 m -76.43 -26.03 55.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.768 0.794 . . . . 0.0 110.231 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 239' ' ' PHE . 10.9 tptt -138.8 21.91 2.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.648 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.432 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 7.7 p90 35.48 60.09 0.76 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.638 0.732 . . . . 0.0 109.722 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.865 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.1 OUTLIER -125.09 141.0 52.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.126 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.756 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 1.3 m95 -122.25 126.51 48.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.395 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.4 pt-20 -143.2 144.52 32.21 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.808 0.813 . . . . 0.0 113.142 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.594 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 2.5 pp -111.09 152.08 27.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.776 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.509 HG21 ' CD1' ' A' ' 269' ' ' TRP . 2.8 p -121.32 163.18 19.48 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.617 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 248' ' ' SER . 2.6 m-20 -105.27 104.41 14.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.509 ' HG2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -71.4 97.26 1.59 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.428 177.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.09 65.67 3.23 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.312 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 0.2 OUTLIER -70.32 59.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.583 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -54.35 -52.69 60.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.338 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.583 ' H ' HD13 ' A' ' 249' ' ' LEU . 25.5 m-20 -74.37 -30.98 62.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.933 0.397 . . . . 0.0 111.304 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 95.55 99.56 1.79 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.19 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.593 HG23 ' CB ' ' A' ' 230' ' ' ALA . 1.6 m -64.97 114.85 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.021 -0.105 . . . . 0.0 110.993 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 258' ' ' SER . 2.4 mt -101.57 130.02 47.78 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.489 -0.484 . . . . 0.0 112.009 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.416 ' CG2' ' CD1' ' A' ' 259' ' ' ILE . 99.0 t -105.48 127.66 60.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.635 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 1.8 t30 55.14 40.75 31.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 110.215 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.12 32.1 21.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -138.83 107.93 6.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.795 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.422 ' HB3' HD22 ' A' ' 253' ' ' LEU . 25.0 p -55.15 91.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.541 0.686 . . . . 0.0 111.45 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 252' ' ' THR . 0.2 OUTLIER -78.56 -23.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.788 -178.413 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.715 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 13.9 t -80.75 -174.26 4.65 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 263' ' ' ASP . 1.7 t-160 -103.41 78.63 0.29 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 119.248 0.931 . . . . 0.0 110.047 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.715 ' HD3' ' O ' ' A' ' 260' ' ' SER . 16.1 Cg_exo -43.21 84.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.388 2.725 . . . . 0.0 113.539 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 261' ' ' HIS . 1.0 OUTLIER -124.73 94.1 4.09 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.034 179.231 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.59 HD23 ' H ' ' A' ' 264' ' ' LEU . 1.6 mm? -47.6 -40.47 19.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.454 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.17 -27.05 53.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.446 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 263' ' ' ASP . 10.5 p -78.87 -44.19 23.39 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.486 ' HD3' ' HB3' ' A' ' 249' ' ' LEU . 0.5 OUTLIER 49.9 25.55 1.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.048 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.39 159.9 4.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.436 0.636 . . . . 0.0 112.076 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.509 ' CD1' HG21 ' A' ' 244' ' ' VAL . 20.5 t-105 -72.82 -22.58 60.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.598 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 74.44 163.63 10.21 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.574 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -99.99 150.63 37.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.3 . . . . 0.0 110.397 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.61 145.4 17.2 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.411 2.074 . . . . 0.0 112.514 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 93.6 t -130.87 130.22 64.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.728 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 3.2 mp0 -80.83 129.02 34.31 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.877 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.425 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -94.02 166.7 12.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.935 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.614 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.62 159.62 41.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.151 0.5 . . . . 0.0 112.014 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 0.1 OUTLIER -62.0 129.4 40.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.143 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 277' ' ' SER . 0.3 OUTLIER 86.73 1.52 0.52 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.309 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -72.72 -170.98 0.76 Allowed 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.635 ' CD1' ' HA ' ' A' ' 255' ' ' ASN . 1.0 OUTLIER -163.22 122.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 176.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.574 HG13 HG13 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -97.12 156.12 3.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.156 177.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 288' ' ' LYS . 21.3 m -141.51 114.68 8.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.705 ' HB3' ' CD2' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -113.8 141.48 47.25 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.335 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.61 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 84.52 -133.32 11.73 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.126 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 286' ' ' THR . 9.9 t -97.93 -36.03 10.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.658 0.266 . . . . 0.0 111.516 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -152.37 7.49 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.839 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 25.8 m -76.78 101.16 5.73 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.838 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.599 ' HG3' ' CG2' ' A' ' 187' ' ' ILE . 0.0 OUTLIER -124.54 134.39 53.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.072 -179.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.574 HG13 HG13 ' A' ' 281' ' ' ILE . 9.1 p -113.53 139.61 38.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.876 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.625 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.8 t80 -76.55 132.17 39.36 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.765 0.317 . . . . 0.0 110.232 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 6.1 t -103.01 112.01 34.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.479 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.47 138.11 51.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 111.338 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 13.3 mt -132.89 139.79 48.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.431 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 40.7 m -155.49 164.21 38.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.913 0.387 . . . . 0.0 111.423 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.26 -173.22 2.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.683 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.702 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 11.8 tp60 -112.55 134.49 54.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.727 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -150.98 92.97 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.687 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.024 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.526 ' HA ' HG22 ' A' ' 201' ' ' THR . 5.1 mp . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.738 0.304 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.467 ' H ' HG21 ' A' ' 201' ' ' THR . . . 107.81 60.81 0.56 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.92 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 23.5 p -125.96 -60.12 1.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 110.387 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 200' ' ' SER . 0.1 OUTLIER -142.56 -174.36 4.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.626 179.125 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.633 ' O ' HG22 ' A' ' 293' ' ' ILE . 3.2 m95 -148.57 138.97 22.58 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.545 -0.462 . . . . 0.0 112.203 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.512 HD12 HG12 ' A' ' 293' ' ' ILE . 0.3 OUTLIER -123.77 140.71 52.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.96 178.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 6.2 m-85 -137.7 140.54 40.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.535 0.684 . . . . 0.0 110.442 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.794 ' HB3' ' CE1' ' A' ' 196' ' ' HIS . 4.0 mm? -123.96 140.95 52.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.889 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -135.35 116.7 14.61 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.614 HG13 HD12 ' A' ' 220' ' ' LEU . 6.0 t -66.98 98.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.476 HG21 ' HG3' ' A' ' 288' ' ' LYS . 9.0 tt -82.03 -24.5 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.812 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -166.24 98.9 0.62 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.593 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.49 -169.15 25.46 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.493 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 98.0 Cg_endo -80.13 29.67 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.358 2.038 . . . . 0.0 110.642 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.532 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.13 25.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.593 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.6 mt -40.82 106.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.969 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.43 2.65 2.88 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.898 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.604 ' CD1' HD13 ' A' ' 220' ' ' LEU . 0.0 OUTLIER -96.73 165.19 12.25 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 118.106 0.953 . . . . 0.0 108.692 177.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 5.0 mt-30 -156.72 146.18 20.6 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.063 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.794 ' CE1' ' HB3' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -136.12 128.43 30.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.183 0.516 . . . . 0.0 109.852 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 182' ' ' LEU . . . -130.8 165.1 23.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.899 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.678 HG13 ' HG ' ' A' ' 206' ' ' LEU . 11.9 p -175.25 143.86 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 121.327 0.584 . . . . 0.0 112.264 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -85.78 147.96 26.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.382 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.484 ' HB3' ' OG ' ' A' ' 180' ' ' SER . 15.3 t -62.65 -9.42 8.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.526 HG22 ' HA ' ' A' ' 177' ' ' LEU . 2.9 t -95.04 36.85 1.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.973 0.416 . . . . 0.0 111.882 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.484 ' OG ' HD11 ' A' ' 206' ' ' LEU . 4.7 p -128.59 108.74 10.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.403 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 3.4 m -70.71 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.228 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.7 m -86.99 8.37 23.58 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.401 ' CG ' ' HB2' ' A' ' 202' ' ' SER . 9.0 pttt -118.41 52.74 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.702 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 8.2 tt -143.77 -52.4 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.896 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 3.7 Cg_exo -40.57 93.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.41 2.074 . . . . 0.0 113.384 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 231' ' ' GLN . 59.8 t -73.25 107.91 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.923 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.573 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 19.5 mtmt -77.91 90.99 4.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.446 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.598 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.8 OUTLIER -78.51 136.75 37.65 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . 164.63 -161.22 34.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.964 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.707 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.0 OUTLIER -73.65 171.72 12.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.393 -0.404 . . . . 0.0 111.487 -179.521 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.87 110.95 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 122.2 1.0 . . . . 0.0 111.833 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 215' ' ' PRO . 12.4 p -171.11 -163.0 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 113.435 -1.711 . . . . 0.0 107.864 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 62.3 Cg_exo -51.8 -12.0 1.05 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.475 1.45 . . . . 0.0 112.665 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.405 ' OG ' ' HG2' ' A' ' 228' ' ' LYS . 0.1 OUTLIER -51.45 -178.36 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.962 0.411 . . . . 0.0 111.714 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.41 -37.72 8.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.697 HD12 ' CE1' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -100.47 140.53 34.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.641 179.087 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -103.06 78.18 1.62 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.892 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.9 mm? -102.49 91.72 4.36 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.493 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 1.5 ptpt -66.44 56.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.962 0.411 . . . . 0.0 110.653 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 220' ' ' LEU . 0.3 OUTLIER -88.96 123.35 33.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.518 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.0 p -66.25 -7.11 16.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.664 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.87 -24.47 23.66 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.759 0.314 . . . . 0.0 110.699 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 212' ' ' ARG . 7.2 p -100.66 93.4 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.02 0.438 . . . . 0.0 110.835 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.15 -38.71 18.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.053 0.454 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.13 -57.53 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.786 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.533 ' HA ' ' HA3' ' A' ' 211' ' ' GLY . 25.4 mtmm -143.7 129.02 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.421 0.629 . . . . 0.0 111.688 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.491 ' HE1' ' HB2' ' A' ' 250' ' ' ASN . 2.0 t60 -89.84 -61.82 1.6 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.154 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.561 ' C ' ' HE3' ' A' ' 246' ' ' MET . . . -140.72 171.17 14.47 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.8 OUTLIER -157.88 168.89 25.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.24 179.013 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.896 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 8.0 mt -125.39 138.16 55.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.604 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.48 163.64 32.4 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.471 ' CZ3' HD12 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -96.25 148.0 23.19 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.448 ' HB2' ' HD3' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -119.53 71.99 0.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.276 174.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.7 p -54.11 -21.13 7.86 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 46.3 m -73.72 -27.86 61.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.632 0.73 . . . . 0.0 109.33 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 20.0 tptt -116.31 6.29 13.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.465 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 235' ' ' ASN . 8.0 p90 37.05 49.56 0.83 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.885 0.374 . . . . 0.0 110.669 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.448 ' HD3' ' HB2' ' A' ' 235' ' ' ASN . 0.0 OUTLIER -119.8 176.21 5.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 0.0 109.78 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.58 ' HB2' HD21 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -124.61 110.0 13.88 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 0.7 OUTLIER -132.15 151.2 51.91 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.589 HD21 HD12 ' A' ' 281' ' ' ILE . 3.3 pp -119.16 152.65 36.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.579 -1.646 . . . . 0.0 111.456 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.541 HG21 ' CE3' ' A' ' 269' ' ' TRP . 4.7 p -119.33 162.6 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.139 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 13.6 m-20 -118.86 121.8 40.85 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.662 ' HB3' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -93.83 107.85 19.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.957 178.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.507 ' HA2' ' HB3' ' A' ' 267' ' ' ARG . . . 48.59 62.34 4.51 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.374 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.23 74.75 0.23 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -59.66 -48.77 80.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.859 178.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.624 ' N ' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -78.7 -39.51 36.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.048 0.451 . . . . 0.0 110.851 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.707 ' HA3' ' HB3' ' A' ' 262' ' ' PRO . . . 97.05 93.0 1.87 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.359 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.516 HG21 ' CD1' ' A' ' 281' ' ' ILE . 1.9 m -47.29 156.59 0.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.297 -0.261 . . . . 0.0 110.297 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.551 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -148.12 130.23 15.45 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.179 0.514 . . . . 0.0 111.521 179.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.422 ' CG2' HG23 ' A' ' 259' ' ' ILE . 55.5 t -104.14 130.04 55.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.829 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.472 ' HA ' HD11 ' A' ' 280' ' ' ILE . 6.1 t-20 55.09 42.33 30.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.048 0.451 . . . . 0.0 110.329 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.15 23.1 12.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.992 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.7 112.03 15.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.373 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 253' ' ' LEU . 85.9 p -63.12 99.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.431 0.634 . . . . 0.0 112.174 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.505 HG12 ' N ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -79.45 -47.68 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.774 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.709 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 4.7 t -56.06 171.74 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.458 ' CD2' ' HD3' ' A' ' 268' ' ' LYS . 0.5 OUTLIER -102.75 92.05 3.24 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.249 0.477 . . . . 0.0 110.104 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' A' ' 260' ' ' SER . 17.3 Cg_endo -95.54 32.09 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.808 3.006 . . . . 0.0 112.946 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -78.69 -134.35 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.585 ' N ' HD21 ' A' ' 264' ' ' LEU . 0.0 OUTLIER -44.26 -100.85 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.409 ' N ' HD21 ' A' ' 264' ' ' LEU . . . -150.35 37.53 0.91 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.548 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 268' ' ' LYS . 47.4 t -63.39 -32.78 74.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.782 0.325 . . . . 0.0 111.704 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.507 ' HB3' ' HA2' ' A' ' 247' ' ' GLY . 31.1 mmt-85 41.22 20.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.422 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 261' ' ' HIS . 11.2 ptmt -60.33 157.46 13.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.701 0.8 . . . . 0.0 112.521 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.662 ' CH2' ' HB3' ' A' ' 246' ' ' MET . 2.8 m95 -63.77 -30.31 71.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.234 -0.893 . . . . 0.0 108.768 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 72.53 165.13 8.13 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.15 122.86 72.35 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.701 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 34.2 Cg_exo -31.05 111.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.21 2.607 . . . . 0.0 112.846 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.478 ' HB ' HD13 ' A' ' 243' ' ' LEU . 62.5 t -87.58 130.18 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.388 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 0.0 OUTLIER -78.3 131.71 37.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.977 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.666 ' H ' HD12 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -98.0 164.26 12.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.121 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.85 152.67 45.3 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.641 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.9 OUTLIER -54.62 130.89 41.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.362 179.031 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.641 ' HB2' ' O ' ' A' ' 277' ' ' SER . 9.0 m-20 82.17 -3.65 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.738 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.2 m-20 -77.24 141.15 40.15 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.744 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' A' ' 255' ' ' ASN . 0.9 OUTLIER -100.72 124.79 54.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 119.789 -0.765 . . . . 0.0 109.728 178.541 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.687 ' O ' ' CG2' ' A' ' 281' ' ' ILE . 0.3 OUTLIER -110.46 94.61 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -82.49 138.38 34.35 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.524 -0.735 . . . . 0.0 109.589 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.462 ' HB3' HG23 ' A' ' 252' ' ' THR . 0.0 OUTLIER -130.39 53.1 1.97 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.372 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 168.16 -122.5 1.03 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.494 -1.336 . . . . 0.0 113.43 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.5 t -98.0 -44.8 6.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.636 0.255 . . . . 0.0 110.675 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -147.64 1.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.812 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.1 m -79.32 104.75 10.15 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.605 ' HA ' ' HA ' ' A' ' 282' ' ' THR . 9.0 ptpt -126.19 131.02 52.08 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.796 0.807 . . . . 0.0 111.931 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.428 HG12 ' CE1' ' A' ' 196' ' ' HIS . 14.9 t -106.2 132.1 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.758 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.538 ' CZ ' ' HA ' ' A' ' 278' ' ' ASP . 1.7 t80 -77.17 130.89 37.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.637 ' HA ' HD11 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -100.75 113.64 37.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.734 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.523 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -131.09 136.16 48.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.742 0.306 . . . . 0.0 110.82 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 181' ' ' TRP . 2.4 mt -135.46 139.65 46.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 3.2 m -142.81 156.09 44.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.776 0.322 . . . . 0.0 111.14 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.3 m -85.73 159.22 19.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -86.82 145.53 26.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.786 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -144.72 95.04 2.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.996 179.921 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.618 ' HA ' HG23 ' A' ' 201' ' ' THR . 2.6 mp . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.621 0.248 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.56 ' N ' HG23 ' A' ' 201' ' ' THR . . . 115.12 97.59 2.15 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.231 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.488 ' OG ' HG22 ' A' ' 201' ' ' THR . 0.1 OUTLIER -170.77 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.4 OUTLIER -134.42 175.25 9.69 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.039 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.643 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.6 m95 -145.29 131.77 19.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.594 HD12 ' O ' ' A' ' 292' ' ' ARG . 5.1 tp -118.12 128.2 54.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.214 177.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.643 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 1.1 m-85 -128.99 138.57 52.03 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.553 0.692 . . . . 0.0 110.799 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.774 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.5 mp -140.89 153.01 45.51 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.586 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.524 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 23.3 tt0 -144.61 124.85 13.73 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.511 HG11 HD12 ' A' ' 220' ' ' LEU . 22.0 t -59.49 113.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 6.7 tt -97.02 -20.76 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.722 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -157.76 91.27 1.12 Allowed 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.327 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.693 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.76 178.57 38.45 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.45 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 71.9 Cg_endo -75.4 32.13 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 121.79 1.66 . . . . 0.0 111.185 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 189' ' ' GLY . . . -163.94 28.92 0.08 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.966 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.693 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.7 mt -43.55 119.75 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.112 0.482 . . . . 0.0 112.239 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.24 -48.46 0.92 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.726 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.593 HD13 ' O ' ' A' ' 219' ' ' ALA . 0.7 OUTLIER -40.9 143.84 0.33 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.302 0.573 . . . . 0.0 110.752 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.774 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 20.8 mt-30 -141.64 152.03 43.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.776 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.598 ' CE1' HD13 ' A' ' 218' ' ' LEU . 3.9 p-80 -139.63 131.59 27.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.268 0.556 . . . . 0.0 109.635 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.86 153.6 40.34 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.38 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.94 HG23 ' HA ' ' A' ' 206' ' ' LEU . 7.2 p -160.92 161.24 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.349 0.595 . . . . 0.0 111.725 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.432 ' N ' ' CG2' ' A' ' 198' ' ' VAL . 1.4 t-20 -98.59 143.33 29.11 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.705 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.483 ' HA ' ' HE1' ' A' ' 234' ' ' TRP . 16.2 t -60.76 1.48 0.14 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.618 HG23 ' HA ' ' A' ' 177' ' ' LEU . 1.3 t -107.09 -8.08 16.65 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.601 0.36 . . . . 0.0 111.562 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -69.05 118.13 11.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.027 0.441 . . . . 0.0 110.452 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 72.8 m -66.42 -101.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.1 m -91.41 20.1 5.55 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.24 -9.0 11.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.205 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.94 ' HA ' HG23 ' A' ' 198' ' ' VAL . 7.8 tt -67.74 -61.21 4.55 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.644 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -43.28 101.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.005 1.803 . . . . 0.0 112.395 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.917 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 98.7 t -67.26 165.52 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 217' ' ' ASP . 15.7 mtmt -136.9 90.12 2.51 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.572 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.5 OUTLIER -79.97 123.91 28.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.138 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . -165.98 167.69 39.35 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.391 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.682 ' HB2' ' CG1' ' A' ' 225' ' ' VAL . 4.7 ttt-85 -66.36 -73.01 0.14 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.701 HG13 ' HG2' ' A' ' 215' ' ' PRO . 15.0 p -79.39 159.42 4.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.447 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 1.0 OUTLIER -31.07 -52.78 0.42 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -178.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.701 ' HG2' HG13 ' A' ' 213' ' ' VAL . 2.9 Cg_endo -42.52 -24.76 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.205 1.936 . . . . 0.0 113.153 -177.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.431 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -83.93 156.51 22.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -69.96 -36.24 75.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.564 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.804 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 2.0 mt -103.68 134.35 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.593 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -90.31 73.32 7.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.562 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.804 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -97.15 68.39 2.25 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.557 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 2.2 pttt -60.71 39.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.546 ' O ' HG12 ' A' ' 225' ' ' VAL . 12.4 t0 -90.23 131.23 36.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.5 p -46.51 -33.57 4.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.207 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.528 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 1.1 pp20? -52.21 -32.03 34.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.341 . . . . 0.0 111.233 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.728 ' HB ' ' HD1' ' A' ' 229' ' ' HIS . 2.1 p -104.33 97.72 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.54 -46.99 14.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.203 0.525 . . . . 0.0 110.574 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.32 -50.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.431 ' HB3' ' HG3' ' A' ' 246' ' ' MET . 3.6 mptp? -140.85 127.01 19.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.237 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.728 ' HD1' ' HB ' ' A' ' 225' ' ' VAL . 0.2 OUTLIER -94.55 -55.22 3.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.631 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.569 ' HB1' HG22 ' A' ' 252' ' ' THR . . . -151.87 177.0 10.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.286 0.565 . . . . 0.0 111.996 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.917 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 3.9 mt-30 -156.84 -178.01 7.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.222 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.7 HD12 HD11 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -125.36 141.76 44.28 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.249 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.24 127.18 3.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.827 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.8 p90 -124.92 167.53 14.56 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -112.62 133.16 54.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.137 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.22 -1.96 50.58 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.515 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.7 m -80.55 -35.04 34.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.588 0.709 . . . . 0.0 109.593 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.519 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 33.8 tptt -121.91 10.4 10.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.596 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 24.4 p90 45.18 63.04 1.89 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.495 0.664 . . . . 0.0 109.694 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.827 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.2 OUTLIER -129.14 138.18 51.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.121 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.687 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -119.91 126.75 51.67 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.731 179.043 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 272' ' ' PRO . 27.1 mt-10 -142.58 146.35 34.5 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 232' ' ' ILE . 0.3 OUTLIER -97.92 150.94 20.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.767 -1.561 . . . . 0.0 109.486 178.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.495 HG11 ' CZ2' ' A' ' 269' ' ' TRP . 4.5 p -141.67 162.85 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.901 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.603 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 18.8 t70 -84.63 138.82 32.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.412 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.534 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -88.92 31.63 0.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.722 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.47 50.48 59.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.769 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.632 ' HB2' ' HA ' ' A' ' 229' ' ' HIS . 32.6 t -92.6 168.97 10.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.836 0.35 . . . . 0.0 111.146 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 250' ' ' ASN . 3.1 pp -93.01 -43.82 8.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.439 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.58 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.8 OUTLIER -68.32 -19.03 64.65 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.546 0.689 . . . . 0.0 109.921 -178.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.567 ' HA3' ' CG ' ' A' ' 261' ' ' HIS . . . 76.27 147.75 2.24 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.364 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.569 HG22 ' HB1' ' A' ' 230' ' ' ALA . 6.0 m -103.66 152.29 21.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.608 0.242 . . . . 0.0 110.99 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -140.13 138.88 35.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.053 177.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.422 ' CG2' ' CD1' ' A' ' 259' ' ' ILE . 95.5 t -110.03 133.62 54.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.956 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 280' ' ' ILE . 14.7 p30 52.98 38.32 26.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.332 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.47 36.87 2.11 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.436 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . 0.459 ' O ' HG21 ' A' ' 259' ' ' ILE . 20.0 t-80 -148.29 117.53 6.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 91.9 p -63.5 86.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.251 0.548 . . . . 0.0 110.275 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.573 ' CG1' HG23 ' A' ' 273' ' ' VAL . 0.1 OUTLIER -84.92 -13.08 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.229 -178.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.757 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 1.5 t -124.34 -16.87 6.26 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.649 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 57.2 t60 -111.35 43.74 0.22 Allowed Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.757 ' HD3' ' C ' ' A' ' 260' ' ' SER . 22.8 Cg_exo -66.05 -2.05 6.2 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.042 1.828 . . . . 0.0 113.506 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.693 ' O ' ' HB2' ' A' ' 266' ' ' SER . 38.2 m-20 -135.87 101.1 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.446 0.641 . . . . 0.0 111.167 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.415 ' CD2' ' H ' ' A' ' 264' ' ' LEU . 0.4 OUTLIER -63.31 147.54 50.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.266 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.53 -31.49 2.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.56 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.693 ' HB2' ' O ' ' A' ' 263' ' ' ASP . 2.9 m -59.83 -42.0 92.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.129 0.49 . . . . 0.0 111.571 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 53.72 28.06 7.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.947 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -68.96 168.3 13.99 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.472 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.534 ' CE3' ' HA ' ' A' ' 246' ' ' MET . 14.7 t-105 -84.61 -19.59 32.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.705 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 64.25 -172.98 16.1 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.782 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.467 ' HB2' ' HD2' ' A' ' 272' ' ' PRO . 29.2 p30 -110.38 158.97 33.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 117.524 0.662 . . . . 0.0 110.304 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.584 ' HB2' ' HB2' ' A' ' 242' ' ' GLU . 58.7 Cg_endo -72.99 114.3 4.0 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.296 1.997 . . . . 0.0 113.628 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.573 HG23 ' CG1' ' A' ' 259' ' ' ILE . 66.9 t -97.38 138.53 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 2.3 pm0 -76.24 123.45 25.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.131 0.967 . . . . 0.0 113.572 -176.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.746 ' H ' HD12 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -90.87 163.96 14.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.525 -1.671 . . . . 0.0 109.167 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.628 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -146.87 162.75 38.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 26.3 t -60.34 127.77 33.41 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.849 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 86.09 7.85 0.32 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.273 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -83.61 -166.66 1.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -161.48 128.84 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.603 177.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.686 ' CG2' HG11 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -99.28 147.13 7.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.591 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.71 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 0.6 OUTLIER -134.17 125.57 28.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.627 0.727 . . . . 0.0 110.226 178.158 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.458 ' O ' ' HB ' ' A' ' 287' ' ' THR . 0.1 OUTLIER -125.72 131.61 52.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.897 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.407 ' HA3' ' CG ' ' A' ' 224' ' ' GLU . . . 86.26 -127.95 8.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.143 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 t -96.94 -30.67 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -160.46 5.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.722 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 7.2 m -64.69 99.67 0.34 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.898 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 0.0 OUTLIER -117.97 125.21 49.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -177.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.686 HG11 ' CG2' ' A' ' 281' ' ' ILE . 6.3 p -113.26 136.47 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.224 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.48 ' HD1' ' CG2' ' A' ' 280' ' ' ILE . 1.0 OUTLIER -78.19 140.54 38.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.884 0.373 . . . . 0.0 110.373 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 277' ' ' SER . 0.4 OUTLIER -108.82 114.13 45.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.046 -179.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.594 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.9 OUTLIER -130.05 140.99 50.77 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.812 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.548 HD12 ' CE3' ' A' ' 241' ' ' TRP . 11.6 mt -138.95 119.87 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.81 149.99 52.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 0.0 111.268 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.86 164.07 16.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.4 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.415 HE21 ' HA ' ' A' ' 296' ' ' GLN . 0.0 OUTLIER -117.19 137.64 52.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.981 0.42 . . . . 0.0 111.486 -179.773 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . 0.469 ' N ' ' ND2' ' A' ' 297' ' ' ASN . 0.4 OUTLIER -119.54 87.35 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.022 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.916 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.504 ' N ' ' CD2' ' A' ' 177' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.767 0.318 . . . . 0.0 110.896 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.65 -123.71 6.02 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.434 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 90.5 p -179.24 103.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.841 0.353 . . . . 0.0 111.041 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.599 ' N ' ' HB3' ' A' ' 296' ' ' GLN . 0.1 OUTLIER -174.62 165.8 3.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.508 0.671 . . . . 0.0 112.167 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 1.2 m95 -137.22 135.71 37.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.188 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 1.1 tp -126.66 133.97 50.84 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.508 ' N ' HD11 ' A' ' 182' ' ' LEU . 2.0 m-85 -133.42 137.1 45.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.63 0.728 . . . . 0.0 110.447 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.533 ' HB3' ' CE1' ' A' ' 196' ' ' HIS . 4.3 mm? -119.62 139.72 51.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.414 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -134.49 112.25 10.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.479 ' HA ' HG21 ' A' ' 289' ' ' VAL . 40.6 t -60.1 98.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.132 0.492 . . . . 0.0 109.907 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.477 ' O ' HD13 ' A' ' 192' ' ' ILE . 11.5 tt -77.04 -23.2 14.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.929 -177.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.784 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -167.96 99.95 0.46 Allowed 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.9 -177.0 34.59 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.638 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 64.0 Cg_endo -79.82 34.5 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.96 1.773 . . . . 0.0 111.573 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.462 ' HB3' HD13 ' A' ' 220' ' ' LEU . . . -162.99 26.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 187' ' ' ILE . 0.7 OUTLIER -39.16 106.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.908 0.385 . . . . 0.0 110.592 -179.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.89 3.41 1.74 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.105 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.614 HD12 HD13 ' A' ' 220' ' ' LEU . 0.1 OUTLIER -99.31 141.74 31.7 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 117.724 0.762 . . . . 0.0 109.296 177.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 22.2 mt-30 -137.05 147.88 46.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.802 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.581 ' CE1' ' CD1' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -137.41 128.09 26.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.021 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -148.13 164.58 33.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 206' ' ' LEU . 3.5 p -171.19 158.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.336 0.589 . . . . 0.0 110.798 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.441 ' OD1' ' CZ2' ' A' ' 181' ' ' TRP . 8.0 m120 -88.14 146.77 25.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.268 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.839 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 2.6 t -66.65 -3.85 7.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.901 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.5 ' HA ' ' HB2' ' A' ' 177' ' ' LEU . 1.4 t -93.44 36.9 1.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.159 0.504 . . . . 0.0 110.44 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.502 ' O ' HD11 ' A' ' 206' ' ' LEU . 15.4 m -131.25 96.37 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.073 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.426 ' N ' ' HG ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -55.9 -76.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.799 -178.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.91 12.33 34.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 111.465 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.418 ' CG ' ' HB3' ' A' ' 202' ' ' SER . 10.4 pttt -118.42 52.18 1.04 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.048 0.452 . . . . 0.0 110.539 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.996 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -147.76 -30.44 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.996 ' HD2' ' H ' ' A' ' 206' ' ' LEU . 3.1 Cg_endo -45.38 99.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 121.088 1.424 . . . . 0.0 112.078 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 231' ' ' GLN . 61.9 t -68.76 160.77 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.872 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.734 ' HB2' ' HB2' ' A' ' 217' ' ' ASP . 13.6 mtpp -136.8 127.74 27.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.805 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.553 HD11 ' N ' ' A' ' 210' ' ' LEU . 0.0 OUTLIER -126.61 148.32 49.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.127 0.489 . . . . 0.0 111.496 178.429 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . 153.45 -157.07 27.15 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.633 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -69.2 157.06 37.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.641 0.258 . . . . 0.0 111.355 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.419 ' O ' ' CB ' ' A' ' 214' ' ' SER . 7.2 p -77.42 123.43 34.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.777 0.799 . . . . 0.0 113.127 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.705 ' CB ' ' HD3' ' A' ' 215' ' ' PRO . 0.8 OUTLIER 160.27 -81.7 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 114.176 -1.374 . . . . 0.0 109.718 178.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.705 ' HD3' ' CB ' ' A' ' 214' ' ' SER . 16.6 Cg_endo -98.28 -14.4 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.255 1.97 . . . . 0.0 113.254 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.2 174.05 11.12 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.734 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.5 OUTLIER -88.49 -36.4 16.47 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.935 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.77 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 10.7 mt -94.04 132.69 38.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 191' ' ' ALA . . . -95.36 72.59 3.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.927 0.394 . . . . 0.0 110.0 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.77 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.1 mm? -96.23 88.05 4.68 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.638 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 8.0 ptpt -57.63 63.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 0.0 110.849 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 220' ' ' LEU . 2.0 m-20 -95.59 149.64 21.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.989 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.0 t -90.93 -5.8 54.97 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.11 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.448 ' HG3' ' CA ' ' A' ' 284' ' ' GLY . 4.5 pm0 -93.88 -21.13 19.43 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.564 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.671 ' O ' ' HB2' ' A' ' 212' ' ' ARG . 3.1 p -111.85 82.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.7 t -34.76 -44.35 0.21 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.835 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.11 -48.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.876 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -145.5 131.14 18.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.97 0.414 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.586 ' CD2' ' HB2' ' A' ' 283' ' ' LEU . 7.0 t60 -102.77 -49.81 3.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.447 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.523 ' CB ' HD23 ' A' ' 210' ' ' LEU . . . -147.65 179.08 7.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.204 0.526 . . . . 0.0 112.389 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.533 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -162.38 172.92 14.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.663 -179.349 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.707 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 10.9 mt -129.05 149.09 33.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.567 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.87 155.44 25.66 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.839 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 4.8 p90 -137.94 156.4 47.9 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.29 123.28 49.02 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.028 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 p -84.06 -4.32 58.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.515 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.0 m -77.8 -22.25 50.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.325 0.583 . . . . 0.0 110.392 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -144.47 20.71 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.855 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 17.6 p90 40.82 64.88 0.88 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.461 0.648 . . . . 0.0 109.811 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.614 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 10.5 mptt -128.31 141.4 51.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.058 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.707 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 4.8 m95 -120.69 117.25 27.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.211 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.3 mt-10 -133.93 141.78 47.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.779 0.8 . . . . 0.0 113.11 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 2.2 pp -108.13 154.0 22.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.658 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.451 HG22 ' CD1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -125.51 163.28 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.75 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 1.9 t0 -97.92 156.94 16.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.651 0.739 . . . . 0.0 112.502 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.562 ' N ' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -130.66 90.55 2.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.348 178.681 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 49.18 69.16 1.08 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.288 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.431 ' O ' ' CE1' ' A' ' 261' ' ' HIS . 0.1 OUTLIER -79.68 70.44 6.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.097 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.552 HD12 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.74 -51.44 67.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.944 178.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.552 ' H ' HD12 ' A' ' 249' ' ' LEU . 1.1 p-10 -72.74 -33.27 66.27 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.303 0.573 . . . . 0.0 110.977 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.534 ' HA2' ' CG ' ' A' ' 261' ' ' HIS . . . 100.95 101.19 2.46 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.922 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 258' ' ' SER . 11.3 m -64.9 160.12 21.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.532 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -156.55 153.86 29.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.301 0.572 . . . . 0.0 112.418 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.51 ' N ' HD12 ' A' ' 259' ' ' ILE . 78.0 t -129.99 130.47 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.268 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.586 ' HA ' HD11 ' A' ' 280' ' ' ILE . 54.1 t30 59.21 38.58 23.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.027 0.442 . . . . 0.0 110.319 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.1 36.58 5.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.041 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -148.61 118.92 7.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.998 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 25.1 p -62.67 94.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.383 0.611 . . . . 0.0 110.456 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 273' ' ' VAL . 0.1 OUTLIER -95.6 -17.98 6.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 0.6 OUTLIER -112.96 -14.03 13.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.602 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.62 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 8.9 t60 -107.6 24.02 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 86.4 Cg_exo -47.29 -17.75 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.563 1.509 . . . . 0.0 112.335 179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.504 ' HB3' ' CB ' ' A' ' 266' ' ' SER . 0.9 OUTLIER -79.64 92.27 5.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.156 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 13.0 mt -47.21 -95.8 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -82.9 8.9 61.45 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.593 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.504 ' CB ' ' HB3' ' A' ' 263' ' ' ASP . 0.5 OUTLIER -72.64 -52.66 14.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 266' ' ' SER . 8.1 mmt85 74.17 14.7 3.77 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.594 0.711 . . . . 0.0 109.458 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.501 ' HB2' ' CG ' ' A' ' 263' ' ' ASP . 4.7 mtpt -49.8 164.41 0.1 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.366 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.516 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 39.5 t-105 -71.46 -25.64 62.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.6 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.03 160.92 27.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.764 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -98.34 151.7 37.62 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.792 0.329 . . . . 0.0 111.142 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 32.5 Cg_exo -58.63 115.9 2.87 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.894 2.396 . . . . 0.0 113.479 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 78.4 t -99.76 138.16 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.707 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.2 pp20? -83.71 129.41 34.95 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.229 -0.988 . . . . 0.0 112.174 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.507 ' H ' ' CD1' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -94.32 164.32 13.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.755 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.528 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.06 160.01 41.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.282 0.563 . . . . 0.0 112.074 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.662 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 6.1 p -61.61 131.01 48.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.127 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.662 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.2 m-20 85.21 5.68 0.51 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.873 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.528 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.9 m-20 -79.11 -168.07 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.641 ' N ' ' CD1' ' A' ' 280' ' ' ILE . 0.1 OUTLIER -160.36 128.21 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.1 OUTLIER -103.25 154.49 5.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.162 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.532 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -142.17 116.93 9.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.586 ' HB2' ' CD2' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -114.72 40.62 2.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 -178.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.448 ' CA ' ' HG3' ' A' ' 224' ' ' GLU . . . 179.37 -130.99 1.6 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 119.57 -1.3 . . . . 0.0 113.555 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 5.0 t -92.09 -49.49 6.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.595 0.235 . . . . 0.0 111.21 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -139.75 0.67 1.83 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.784 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.5 m -72.58 103.66 3.62 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.248 -0.181 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.667 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 10.9 mtpt -121.45 129.55 53.04 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.667 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 186' ' ' VAL . 0.4 OUTLIER -107.83 129.71 61.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.539 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.477 ' CE2' ' HA ' ' A' ' 278' ' ' ASP . 4.4 t80 -77.52 137.2 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.491 ' HA ' HD11 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -104.69 114.01 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.626 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.11 129.73 42.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.664 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 16.8 mt -126.84 139.24 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.546 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.66 142.64 50.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.672 0.272 . . . . 0.0 110.388 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 41.1 p -79.7 150.52 30.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.07 0.462 . . . . 0.0 110.864 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.599 ' HB3' ' N ' ' A' ' 180' ' ' SER . 2.8 tp-100 -118.14 133.32 56.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.491 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -135.34 88.17 2.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.849 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.511 ' HA ' HG22 ' A' ' 201' ' ' THR . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.676 0.274 . . . . 0.0 110.791 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.8 103.9 2.42 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.382 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.541 ' N ' HD22 ' A' ' 199' ' ' ASN . 0.6 OUTLIER -179.9 -71.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.076 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.98 -179.5 6.11 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.0 m95 -149.0 133.88 18.0 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.9 OUTLIER -119.23 133.13 55.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.045 177.014 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 6.2 m-85 -132.44 137.24 47.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.776 0.798 . . . . 0.0 110.975 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.753 ' HB3' ' CE1' ' A' ' 196' ' ' HIS . 4.5 mm? -120.97 140.52 51.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.494 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.467 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 3.6 tt0 -134.93 114.3 12.39 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -178.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.814 ' HA ' HG12 ' A' ' 289' ' ' VAL . 2.6 t -59.52 110.33 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.327 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 187' ' ' ILE . 10.2 tt -95.61 -23.77 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.735 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.84 95.09 0.7 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.441 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.527 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.4 -178.07 35.96 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.467 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 73.0 Cg_endo -78.52 32.36 0.45 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.153 1.902 . . . . 0.0 111.642 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.489 ' HB2' HD12 ' A' ' 220' ' ' LEU . . . -161.77 22.63 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.187 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.527 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -40.24 108.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.65 5.01 1.53 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.788 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.528 ' CD1' HD11 ' A' ' 220' ' ' LEU . 0.1 OUTLIER -100.41 170.04 8.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 22.1 mt-30 -159.92 148.74 17.46 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.928 0.394 . . . . 0.0 111.6 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.753 ' CE1' ' HB3' ' A' ' 184' ' ' LEU . 0.7 OUTLIER -134.27 124.76 26.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.469 0.652 . . . . 0.0 109.467 178.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 182' ' ' LEU . . . -145.22 168.66 19.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.357 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.749 HG21 ' HA ' ' A' ' 206' ' ' LEU . 2.3 p -178.03 160.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.424 0.631 . . . . 0.0 111.529 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.541 HD22 ' N ' ' A' ' 179' ' ' SER . 0.7 OUTLIER -96.1 148.62 22.5 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.974 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.477 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 13.3 p -65.46 -1.18 2.33 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 177' ' ' LEU . 0.6 OUTLIER -109.73 10.52 24.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.795 0.331 . . . . 0.0 111.44 179.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.407 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -87.9 137.83 31.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.057 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 61.1 m -90.14 -88.29 0.17 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 43.9 m -93.47 20.18 7.55 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.407 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.2 OUTLIER -118.05 -11.57 10.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.059 0.456 . . . . 0.0 110.742 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.749 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.8 tt -74.15 -60.59 1.43 Allowed Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.828 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.529 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 2.0 Cg_endo -42.99 99.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.338 2.025 . . . . 0.0 112.639 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.599 ' O ' ' CB ' ' A' ' 231' ' ' GLN . 99.1 t -69.26 158.39 6.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.971 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.678 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 16.4 mtpt -138.25 77.86 1.65 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.635 HD21 ' CD2' ' A' ' 218' ' ' LEU . 3.7 mp -65.5 122.39 17.08 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.116 -0.365 . . . . 0.0 110.655 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . -164.32 166.37 37.72 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.941 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.789 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.2 OUTLIER -67.12 -70.83 0.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -177.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.641 HG23 ' HD2' ' A' ' 215' ' ' PRO . 14.9 p -78.48 157.34 4.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.487 ' N ' HG23 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -30.07 -54.89 0.34 Allowed Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.641 ' HD2' HG23 ' A' ' 213' ' ' VAL . 55.0 Cg_exo -36.83 -30.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.854 2.37 . . . . 0.0 113.133 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.441 ' CB ' ' HA3' ' A' ' 211' ' ' GLY . 0.9 OUTLIER -81.91 154.92 25.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.616 0.246 . . . . 0.0 110.512 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.556 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -69.24 -40.53 77.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.328 . . . . 0.0 110.194 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.659 HD23 ' CE1' ' A' ' 196' ' ' HIS . 2.6 tp -97.47 130.16 44.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.487 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -90.04 76.84 6.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.01 0.433 . . . . 0.0 110.963 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.789 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.5 mm? -106.69 90.64 3.39 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.44 ' CG ' ' HB2' ' A' ' 190' ' ' PRO . 4.6 pttt -64.0 36.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 220' ' ' LEU . 26.5 t0 -65.65 132.89 49.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.9 p -73.55 -4.53 34.55 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.255 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -18.73 24.24 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.717 0.294 . . . . 0.0 110.545 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.552 ' CG1' ' HB2' ' A' ' 212' ' ' ARG . 5.4 p -107.58 86.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.172 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.23 -42.95 0.49 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.346 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.39 -49.91 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 246' ' ' MET . 0.0 OUTLIER -143.5 135.32 26.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.461 . . . . 0.0 110.016 179.259 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.577 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.1 t60 -106.12 -52.95 2.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -148.34 176.04 10.59 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.678 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -159.17 178.51 9.93 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.881 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 243' ' ' LEU . 18.7 mt -137.22 147.63 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 121.471 0.653 . . . . 0.0 112.405 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.431 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -161.65 158.5 26.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.781 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 7.0 p90 -147.48 166.81 26.13 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -116.0 133.58 55.88 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.352 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 82.1 p -93.23 1.19 57.17 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.262 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.0 m -79.31 -37.92 36.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.888 0.851 . . . . 0.0 109.652 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.455 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 50.5 tptt -124.9 13.58 8.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.068 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.3 p90 42.47 61.27 2.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.528 0.68 . . . . 0.0 109.87 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.781 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.4 OUTLIER -125.32 137.57 54.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.146 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.688 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -118.95 120.33 36.97 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.062 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 6.9 mt-10 -138.32 144.04 40.22 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.836 0.827 . . . . 0.0 112.629 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 1.5 pp -105.01 152.02 23.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.474 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.48 HG13 ' HG3' ' A' ' 231' ' ' GLN . 4.3 p -122.37 163.36 20.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.462 ' OD1' ' HB ' ' A' ' 252' ' ' THR . 0.3 OUTLIER -105.96 156.43 18.39 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.659 ' HA ' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -80.97 149.17 29.46 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.18 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.481 ' HA2' ' C ' ' A' ' 268' ' ' LYS . . . -53.21 10.84 0.01 OUTLIER Glycine 0 C--N 1.317 -0.508 0 N-CA-C 115.569 0.988 . . . . 0.0 115.569 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 246' ' ' MET . 0.6 OUTLIER -89.4 130.48 35.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.025 1.412 . . . . 0.0 110.77 179.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.536 HD22 ' O ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -57.16 6.04 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.48 ' N ' HD12 ' A' ' 249' ' ' LEU . 4.9 m-20 -70.0 -40.25 75.4 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 119.666 1.121 . . . . 0.0 109.847 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 72.57 119.02 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.126 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 258' ' ' SER . 76.7 m -73.5 172.07 12.0 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.305 0.242 . . . . 0.0 110.457 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.616 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -144.4 121.23 11.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.174 0.512 . . . . 0.0 110.567 177.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.427 HG23 HG12 ' A' ' 259' ' ' ILE . 89.9 t -97.15 134.97 32.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.759 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 280' ' ' ILE . 11.9 p30 49.58 34.54 7.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.147 0.499 . . . . 0.0 110.104 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.55 36.64 1.24 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.831 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -144.61 112.49 6.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.646 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 77.7 p -61.03 85.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 110.811 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.511 ' HB ' HG22 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -84.98 -13.29 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.263 -179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.468 ' N ' HD11 ' A' ' 259' ' ' ILE . 17.0 p -100.01 -14.21 18.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.639 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 0.3 OUTLIER -109.76 24.54 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.442 177.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 84.1 Cg_exo -45.98 -48.22 13.05 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.986 1.791 . . . . 0.0 112.963 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.56 100.01 6.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.119 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 19.2 mt -48.24 -24.83 1.29 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.113 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -49.4 -28.23 9.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.314 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.613 ' C ' ' H ' ' A' ' 268' ' ' LYS . 10.1 m -89.27 -67.41 0.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.368 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.421 ' HG2' ' CB ' ' A' ' 249' ' ' LEU . 13.4 mtm180 68.81 -22.51 0.14 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.25 0.548 . . . . 0.0 112.333 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.613 ' H ' ' C ' ' A' ' 266' ' ' SER . 0.0 OUTLIER -68.73 -136.39 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.205 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.659 ' CZ3' ' HA ' ' A' ' 246' ' ' MET . 11.6 t-105 -71.54 -16.38 62.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.06 -175.92 4.96 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -109.51 151.15 42.02 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 117.857 0.829 . . . . 0.0 110.95 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 34.6 Cg_exo -60.27 117.65 4.43 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.777 2.318 . . . . 0.0 113.463 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 97.6 t -95.49 137.06 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.59 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.5 OUTLIER -83.36 125.04 31.23 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.864 -179.013 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.441 ' C ' ' CD2' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -90.25 164.33 14.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.566 179.176 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.7 157.37 45.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.258 0.551 . . . . 0.0 112.043 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 68.3 p -58.21 127.81 33.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.483 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 84.24 8.84 0.5 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.418 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.6 t0 -83.18 -165.54 1.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.487 ' CG2' ' HD1' ' A' ' 290' ' ' TYR . 0.5 OUTLIER -162.36 134.45 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.592 177.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -108.57 156.6 9.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.67 178.471 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.616 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.3 m -146.52 113.8 6.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.577 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -114.64 47.8 1.21 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.589 -178.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 172.58 -125.14 1.13 Allowed Glycine 0 CA--C 1.517 0.205 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.453 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.5 t -96.9 -47.13 5.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.644 0.259 . . . . 0.0 111.244 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -144.83 -6.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.735 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 61.6 m -64.93 103.44 0.72 Allowed 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.432 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 2.8 mtpt -124.78 134.53 52.75 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.034 0.445 . . . . 0.0 111.259 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.814 HG12 ' HA ' ' A' ' 186' ' ' VAL . 0.1 OUTLIER -114.97 134.24 58.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.69 -178.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.487 ' HD1' ' CG2' ' A' ' 280' ' ' ILE . 2.3 t80 -76.98 139.49 40.12 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.971 0.415 . . . . 0.0 110.261 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.618 ' HA ' HD11 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -106.32 113.13 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.846 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.91 144.86 50.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.516 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.456 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 11.5 mt -144.15 116.81 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.443 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.1 m -123.74 147.52 47.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.951 0.405 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 70.4 m -80.8 -178.31 6.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -150.05 116.13 5.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -148.49 97.01 2.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.965 179.877 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.599 ' HA ' HG22 ' A' ' 201' ' ' THR . 1.1 mp . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.769 0.319 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.98 82.14 0.96 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.233 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 31.8 t -161.02 -76.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 109.979 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.7 OUTLIER -141.5 -176.14 4.63 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.387 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 6.6 m95 -147.2 132.32 18.3 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.679 HD22 ' HZ3' ' A' ' 234' ' ' TRP . 6.1 tp -117.86 127.47 53.9 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.092 176.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 16.9 m-85 -125.74 136.5 53.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.676 0.751 . . . . 0.0 110.932 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.75 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.4 mp -138.13 149.84 46.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.917 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.513 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 12.9 tt0 -145.09 127.09 15.52 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.437 ' HA ' HG12 ' A' ' 289' ' ' VAL . 13.4 t -64.07 114.87 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.438 HG23 ' CB ' ' A' ' 288' ' ' LYS . 8.7 tt -99.01 -20.17 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.79 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.74 91.39 0.56 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.421 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.749 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.82 -172.68 29.53 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.663 ' HB2' ' HD2' ' A' ' 221' ' ' LYS . 70.7 Cg_endo -77.0 26.84 0.44 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.121 1.881 . . . . 0.0 111.931 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 189' ' ' GLY . . . -162.0 29.91 0.12 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.114 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.749 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.3 mt -42.84 116.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.46 -51.78 0.76 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.341 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -38.56 149.43 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.282 0.563 . . . . 0.0 111.215 -178.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.75 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.6 mt-30 -148.63 149.97 32.44 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.813 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.598 ' ND1' HD12 ' A' ' 184' ' ' LEU . 2.0 p80 -136.93 126.95 25.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.251 0.548 . . . . 0.0 109.847 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.6 161.26 38.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.476 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.46 HG11 ' CH2' ' A' ' 234' ' ' TRP . 4.0 p -172.61 160.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 111.812 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 180' ' ' SER . 29.9 m-80 -88.74 150.12 23.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.24 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.549 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 40.6 t -64.08 -9.01 13.78 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.623 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 177' ' ' LEU . 1.8 t -101.18 34.47 2.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.209 0.528 . . . . 0.0 111.061 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.403 ' HB2' ' CG ' ' A' ' 205' ' ' LYS . 35.9 p -116.13 129.74 56.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.634 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.0 m -90.33 -86.93 0.19 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.0 m -86.8 14.24 7.5 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.403 ' CG ' ' HB2' ' A' ' 202' ' ' SER . 0.0 OUTLIER -115.83 -13.46 11.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.995 0.426 . . . . 0.0 110.412 178.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.602 ' HB3' ' CD ' ' A' ' 207' ' ' PRO . 6.4 tt -70.4 -60.29 3.4 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.314 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.602 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.0 OUTLIER -43.51 97.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.562 2.175 . . . . 0.0 113.47 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.71 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 98.9 t -68.32 163.16 3.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.535 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 3.6 mtpp -139.66 85.81 2.07 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.606 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.5 OUTLIER -73.67 126.43 30.29 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.163 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.449 ' HA3' ' OG ' ' A' ' 216' ' ' SER . . . -170.09 173.15 44.12 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.943 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.783 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.2 OUTLIER -70.58 -75.12 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.742 HG23 ' HD2' ' A' ' 215' ' ' PRO . 11.3 p -78.99 160.13 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -176.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.484 ' N ' ' HD2' ' A' ' 215' ' ' PRO . 0.6 OUTLIER -27.68 -52.59 0.23 Allowed Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -178.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.742 ' HD2' HG23 ' A' ' 213' ' ' VAL . 5.0 Cg_exo -38.5 -29.77 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.634 2.223 . . . . 0.0 112.962 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.449 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 0.7 OUTLIER -82.98 151.24 25.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.648 179.011 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -31.03 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.108 0.48 . . . . 0.0 109.967 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.769 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 0.8 OUTLIER -105.74 131.24 53.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.234 178.591 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.611 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -91.23 77.75 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.84 0.353 . . . . 0.0 111.808 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.783 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.2 mm? -101.26 87.09 3.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.663 ' HD2' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -59.65 24.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.108 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.765 ' HB2' HG13 ' A' ' 225' ' ' VAL . 5.7 m-20 -54.48 115.04 1.9 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.805 0.336 . . . . 0.0 110.791 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 t -56.31 -16.21 5.17 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.45 ' O ' ' CD1' ' A' ' 249' ' ' LEU . 1.9 pm0 -83.19 -23.51 32.82 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.765 HG13 ' HB2' ' A' ' 222' ' ' ASP . 2.4 p -97.18 92.26 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 0.0 110.084 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 36.1 m -37.89 -48.18 1.12 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.271 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.06 -50.1 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.698 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.401 ' HD3' ' CB ' ' A' ' 216' ' ' SER . 0.4 OUTLIER -141.26 125.87 17.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.424 0.63 . . . . 0.0 110.738 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.504 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.9 t60 -89.8 -62.17 1.53 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.6 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.488 ' C ' HD13 ' A' ' 210' ' ' LEU . . . -145.32 178.01 8.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.39 -178.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.71 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -160.81 178.25 9.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.659 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.501 HG12 ' HB3' ' A' ' 243' ' ' LEU . 6.5 mt -138.85 149.92 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.149 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.421 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -161.24 143.49 12.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.091 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.783 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 5.2 p90 -131.89 165.25 24.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.65 133.78 55.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.645 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 95.5 p -91.75 0.71 57.47 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.264 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.8 m -77.72 -32.33 52.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.7 0.762 . . . . 0.0 109.825 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.518 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -134.78 16.22 3.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.308 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.416 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 17.8 p90 43.73 62.46 1.91 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.459 0.647 . . . . 0.0 109.609 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.783 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 5.1 mptt -125.86 140.58 52.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.207 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.667 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -125.21 118.0 25.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.37 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.561 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.7 pt-20 -133.97 148.09 51.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.994 0.902 . . . . 0.0 112.821 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.613 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 1.3 pp -112.19 149.71 31.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.925 -1.488 . . . . 0.0 110.843 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.476 ' CG2' ' HB3' ' A' ' 269' ' ' TRP . 0.8 OUTLIER -124.46 160.86 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 9.2 m-20 -110.7 108.66 18.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.536 ' CE ' ' HG2' ' A' ' 231' ' ' GLN . 1.8 ptp -86.38 106.85 17.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 50.25 62.73 4.84 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.173 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.8 p -79.14 71.35 5.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.706 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -55.08 -56.64 17.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.844 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.586 ' N ' HD23 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -73.35 -27.11 61.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 111.017 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.546 ' HA2' ' HB2' ' A' ' 261' ' ' HIS . . . 91.16 135.22 6.37 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.81 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 282' ' ' THR . 3.5 m -97.3 156.84 16.26 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.673 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -149.04 139.17 22.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.077 0.465 . . . . 0.0 111.297 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.83 133.02 56.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.266 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.686 ' HA ' HG13 ' A' ' 280' ' ' ILE . 11.4 p30 53.02 38.07 26.36 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.256 0.551 . . . . 0.0 110.689 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.2 m 70.68 36.75 1.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.876 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.01 113.18 6.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.947 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 69.0 p -63.82 82.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.471 0.653 . . . . 0.0 110.384 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.529 ' HB ' HG23 ' A' ' 273' ' ' VAL . 0.4 OUTLIER -81.31 -10.75 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.73 -178.141 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.615 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 15.4 m -122.98 -13.89 7.72 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.681 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 41.7 t-80 -111.51 35.62 0.12 Allowed Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.681 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 37.8 Cg_exo -58.91 -29.07 89.32 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.919 1.746 . . . . 0.0 113.917 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.81 111.14 19.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.491 0.662 . . . . 0.0 111.324 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.716 HD22 ' H ' ' A' ' 264' ' ' LEU . 0.3 OUTLIER -69.99 160.01 32.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.665 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 74.23 -28.47 0.99 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.923 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 264' ' ' LEU . 4.2 m -65.72 -38.49 89.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.517 ' HD3' ' HA ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER 54.02 24.58 4.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.037 -178.235 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -81.35 171.93 14.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.013 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.609 ' HA ' ' O ' ' A' ' 245' ' ' ASP . 0.5 OUTLIER -79.71 -6.17 56.67 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.709 179.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 74.85 -106.93 2.17 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 119.485 -1.34 . . . . 0.0 109.759 -177.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.589 ' O ' HG21 ' A' ' 273' ' ' VAL . 0.7 OUTLIER -152.14 125.1 4.1 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.67 174.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 84.9 Cg_exo -38.66 102.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.723 1.616 . . . . 0.0 110.04 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 271' ' ' ASN . 45.3 t -93.08 139.04 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.299 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.4 mm-40 -84.55 127.5 34.08 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.255 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.604 HD11 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.56 164.76 13.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.37 179.531 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.616 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.85 161.24 39.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 1.5 m -62.27 131.93 51.0 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.778 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.575 ' HB2' ' O ' ' A' ' 277' ' ' SER . 34.6 m-20 80.16 -0.2 2.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.414 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.616 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -71.73 -164.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.686 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.9 OUTLIER -157.13 123.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.161 177.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.579 HG21 ' CG2' ' A' ' 289' ' ' VAL . 0.3 OUTLIER -104.89 157.73 5.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.945 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.673 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 2.9 m -150.38 126.58 10.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.504 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -121.85 49.96 1.49 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 175.26 -134.26 2.67 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.496 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.5 t -89.44 -38.63 13.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.119 0.485 . . . . 0.0 109.805 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -151.65 -5.63 0.25 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.11 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.79 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 26.3 m -66.63 99.95 0.64 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.196 0.522 . . . . 0.0 111.353 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.442 ' C ' ' CG2' ' A' ' 289' ' ' VAL . 17.0 mttt -99.13 178.93 4.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.592 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.579 ' CG2' HG21 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -162.72 120.0 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.088 177.489 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.604 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.7 t80 -75.76 136.98 40.28 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.53 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -107.2 111.36 35.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.183 -178.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.497 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 9.0 tpt85 -128.24 144.14 51.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.458 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.456 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 20.9 mt -143.01 123.75 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.26 153.46 46.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.696 0.284 . . . . 0.0 110.533 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 73.1 m -80.63 174.95 11.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.821 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.89 133.82 49.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.93 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -155.97 87.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.775 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.946 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.443 ' HB3' ' ND2' ' A' ' 199' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.639 0.257 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.842 ' HA3' HG22 ' A' ' 201' ' ' THR . . . 115.88 -115.45 3.38 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.911 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 17.8 p -166.13 26.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.8 m -160.07 160.06 32.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 121.244 -0.183 . . . . 0.0 110.875 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 17.8 m95 -151.09 148.8 28.75 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.632 HD22 ' HZ3' ' A' ' 234' ' ' TRP . 0.1 OUTLIER -128.36 127.57 42.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.021 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 2.3 m-85 -125.69 142.09 51.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.908 0.861 . . . . 0.0 112.531 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.634 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -137.66 147.44 44.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.022 176.421 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.477 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -139.56 129.45 24.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.505 HG13 HD12 ' A' ' 220' ' ' LEU . 26.9 t -66.41 116.18 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 288' ' ' LYS . 4.7 tt -99.01 -22.2 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.879 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -160.63 92.54 0.96 Allowed 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.665 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.4 -169.8 25.19 Favored Glycine 0 CA--C 1.516 0.116 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.61 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 96.3 Cg_endo -81.02 28.45 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.042 1.828 . . . . 0.0 111.631 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.51 24.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.912 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.665 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.5 mt -39.53 114.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.876 0.37 . . . . 0.0 111.954 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.24 7.74 4.34 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.924 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.723 HD11 ' O ' ' A' ' 219' ' ' ALA . 0.1 OUTLIER -97.12 128.25 43.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.477 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 10.8 mt-30 -127.71 150.84 49.6 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.022 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.628 ' HB3' HD23 ' A' ' 184' ' ' LEU . 1.0 OUTLIER -141.62 142.05 33.43 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.83 179.387 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -132.5 136.33 46.59 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.189 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.564 ' CG2' ' HG ' ' A' ' 206' ' ' LEU . 12.3 p -141.39 130.92 24.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.487 0.66 . . . . 0.0 111.863 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.443 ' ND2' ' HB3' ' A' ' 177' ' ' LEU . 8.8 p30 -85.88 145.56 27.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.949 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.425 ' HB2' ' CZ2' ' A' ' 234' ' ' TRP . 12.2 t -63.55 -3.55 2.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.69 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.842 HG22 ' HA3' ' A' ' 178' ' ' GLY . 0.5 OUTLIER -105.52 6.46 32.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -179.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.464 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -85.69 130.59 34.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.0 110.289 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.9 t -90.65 -90.16 0.16 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 24.7 p -84.51 14.81 4.17 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -123.49 -14.39 7.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.036 0.446 . . . . 0.0 110.522 179.038 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.58 ' HB3' ' CD ' ' A' ' 207' ' ' PRO . 7.8 tt -65.61 -62.53 4.36 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.706 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -43.17 99.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.36 2.04 . . . . 0.0 112.584 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.585 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 87.3 t -68.36 164.71 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.902 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.619 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 25.5 mtmt -141.41 94.57 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.501 HD13 ' C ' ' A' ' 230' ' ' ALA . 0.6 OUTLIER -87.96 131.03 34.76 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.28 173.65 45.31 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.993 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.647 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 12.2 ttt180 -71.15 -74.96 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.808 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 10.2 p -140.54 110.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.462 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.57 ' C ' ' H ' ' A' ' 216' ' ' SER . 0.3 OUTLIER 178.61 179.89 0.23 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.962 -179.026 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 37.0 Cg_endo -66.1 25.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 121.907 1.738 . . . . 0.0 112.331 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.57 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -68.21 -172.93 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.966 0.412 . . . . 0.0 111.242 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.407 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 13.3 m-20 -104.7 -29.48 10.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.474 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.562 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 5.7 mt -112.64 131.68 55.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.723 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -98.25 87.72 3.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.567 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 222' ' ' ASP . 3.0 mm? -103.72 59.65 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.647 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -53.2 73.19 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.22 -178.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.61 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 7.0 t0 -116.58 143.11 46.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.003 0.43 . . . . 0.0 110.311 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.5 t -63.5 -5.3 3.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.541 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.592 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 0.1 OUTLIER -86.79 -30.73 21.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 109.869 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.594 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 0.1 OUTLIER -95.62 107.68 19.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.601 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -49.38 71.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.137 0.494 . . . . 0.0 110.297 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 228' ' ' LYS . . . -148.1 -51.06 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.468 ' HG2' ' HG ' ' A' ' 216' ' ' SER . 0.1 OUTLIER -145.81 125.11 13.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.013 0.435 . . . . 0.0 110.479 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.569 ' HB2' ' CG1' ' A' ' 225' ' ' VAL . 2.5 t60 -84.56 -58.95 2.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.196 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.501 ' C ' HD13 ' A' ' 210' ' ' LEU . . . -152.23 175.53 12.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.498 -177.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.619 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -155.55 179.96 8.68 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.817 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.706 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.5 mt -135.79 149.44 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.41 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.404 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -153.69 164.35 38.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.632 ' HZ3' HD22 ' A' ' 182' ' ' LEU . 0.6 OUTLIER -93.33 153.43 18.55 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.018 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 239' ' ' PHE . 2.3 m-20 -119.35 71.02 0.85 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.722 -1.581 . . . . 0.0 106.975 174.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.1 p -53.87 -23.24 11.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.9 m -74.38 -27.12 60.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.549 0.69 . . . . 0.0 109.235 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.504 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -117.25 8.66 13.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.334 178.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 235' ' ' ASN . 2.7 p90 38.38 39.47 0.29 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.622 0.248 . . . . 0.0 111.039 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.44 ' HD2' ' HB3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -112.27 179.96 3.85 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.423 0.63 . . . . 0.0 110.009 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.628 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -131.02 115.0 15.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.917 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 14.0 pt-20 -137.65 151.72 48.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.4 pp -116.34 153.85 31.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.053 -1.431 . . . . 0.0 111.802 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.534 HG13 ' HG3' ' A' ' 231' ' ' GLN . 2.1 p -121.7 162.69 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.672 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.758 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 8.3 t0 -102.49 116.88 33.52 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -77.53 98.0 5.21 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.488 ' O ' HD12 ' A' ' 249' ' ' LEU . . . 56.2 70.18 1.05 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.704 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.5 p -62.87 48.15 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.584 HD21 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.58 -49.81 73.76 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.231 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.584 ' N ' HD21 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.5 -39.02 28.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.529 ' CA ' ' HB2' ' A' ' 261' ' ' HIS . . . 93.52 93.39 1.54 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.614 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.558 HG23 ' CD1' ' A' ' 281' ' ' ILE . 20.0 m -50.2 164.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 258' ' ' SER . 0.2 OUTLIER -150.29 139.7 21.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.328 0.585 . . . . 0.0 111.303 179.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.512 HG21 HD13 ' A' ' 281' ' ' ILE . 70.3 t -114.37 137.13 48.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.748 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.666 ' HA ' HG13 ' A' ' 280' ' ' ILE . 23.4 p30 47.69 34.98 4.06 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.307 0.575 . . . . 0.0 110.421 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' SER . . . . . 0.47 ' N ' HD13 ' A' ' 280' ' ' ILE . 0.1 OUTLIER 72.87 35.35 1.02 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.481 -179.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . 0.432 ' O ' HG21 ' A' ' 259' ' ' ILE . 64.5 t-80 -137.56 111.42 8.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.714 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 5.4 t -63.05 84.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.454 0.645 . . . . 0.0 110.992 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.545 ' CG1' HG23 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -84.28 -8.49 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.724 -178.523 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.758 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 21.4 m -101.75 -23.9 14.14 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.574 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 0.2 OUTLIER -109.68 33.0 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 178.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 71.0 Cg_exo -47.63 -55.04 4.33 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.526 1.484 . . . . 0.0 111.782 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -111.89 102.4 10.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.175 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.437 ' HA ' ' CE1' ' A' ' 261' ' ' HIS . 34.6 mt -52.96 -22.6 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.538 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -50.23 -24.64 7.14 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.873 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.583 ' C ' ' H ' ' A' ' 268' ' ' LYS . 0.3 OUTLIER -91.82 -63.28 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.746 -0.267 . . . . 0.0 111.599 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER 67.79 -17.8 0.15 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.286 0.494 . . . . 0.0 112.144 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.583 ' H ' ' C ' ' A' ' 266' ' ' SER . 13.2 ttpt -76.23 -125.08 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.595 ' HA ' ' O ' ' A' ' 245' ' ' ASP . 12.2 t-105 -83.66 -27.46 29.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.435 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.79 -178.29 5.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.203 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -105.09 146.89 33.57 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.106 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.635 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 71.8 Cg_exo -49.88 148.99 11.8 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.594 2.196 . . . . 0.0 112.857 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 69.2 t -129.86 136.31 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.4 mp0 -81.53 128.14 33.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 118.794 -1.162 . . . . 0.0 112.052 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.508 ' H ' HD12 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.0 165.93 12.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.027 178.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.666 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.28 161.73 37.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.673 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 3.7 p -62.64 130.04 43.24 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.281 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 277' ' ' SER . 30.9 m-20 81.87 -1.48 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.449 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.681 ' O ' HG21 ' A' ' 280' ' ' ILE . 0.2 OUTLIER -70.8 -162.83 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.681 HG21 ' O ' ' A' ' 279' ' ' ASP . 0.9 OUTLIER -159.97 129.09 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.226 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.718 ' O ' ' CG2' ' A' ' 281' ' ' ILE . 0.3 OUTLIER -117.3 93.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.519 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 288' ' ' LYS . 1.8 m -79.56 129.51 34.54 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.559 ' HB3' ' CD2' ' A' ' 229' ' ' HIS . 0.5 OUTLIER -118.92 50.53 1.2 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.424 -178.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.508 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 162.73 -119.01 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 119.198 -1.477 . . . . 0.0 113.673 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 1.7 t -95.51 -58.75 2.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.374 0.131 . . . . 0.0 111.159 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -134.08 -1.28 2.97 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.762 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.879 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 40.4 m -72.51 102.14 3.15 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 282' ' ' THR . 12.7 ttmt -119.4 123.36 43.92 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.104 0.478 . . . . 0.0 111.286 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 1.1 t -103.01 129.86 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.964 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.634 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 0.6 OUTLIER -77.36 133.85 38.62 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.659 -0.416 . . . . 0.0 109.912 -179.309 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.494 ' CG1' ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -103.44 112.81 38.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.633 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -130.59 141.14 50.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.949 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.525 HG12 HD11 ' A' ' 182' ' ' LEU . 2.1 mt -138.98 143.2 32.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.8 t -151.67 164.23 37.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.1 -169.87 2.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.428 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -123.25 122.0 37.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.77 0.319 . . . . 0.0 111.067 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -81.98 90.75 6.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.019 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.57 ' HA ' HG21 ' A' ' 201' ' ' THR . 1.5 mp . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.664 0.269 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 116.02 87.33 1.36 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.33 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 5.9 p -165.28 -71.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.449 . . . . 0.0 109.896 179.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.6 OUTLIER -141.76 -176.81 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.459 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.664 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.9 m95 -147.65 130.58 16.21 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 184' ' ' LEU . 5.2 tp -113.27 124.37 52.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.058 177.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.664 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 6.5 m-85 -123.39 130.27 52.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.713 0.768 . . . . 0.0 110.791 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.748 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.2 mp -131.6 142.61 49.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.346 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.613 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 24.6 tt0 -140.2 124.8 18.08 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.272 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.743 HG21 HD12 ' A' ' 194' ' ' LEU . 11.1 t -61.33 113.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.013 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.6 tt -97.05 -20.46 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.69 95.01 0.71 Allowed 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.919 -179.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.7 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.32 -175.81 33.74 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 178.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.509 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 96.3 Cg_endo -79.23 30.95 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.782 1.655 . . . . 0.0 110.966 178.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.516 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -161.81 24.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.7 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.2 mt -39.55 113.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.75 11.26 2.98 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.3 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.743 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -100.67 155.89 17.63 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.823 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.748 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 27.2 mt-30 -150.61 151.3 32.35 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.801 -177.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.738 ' CE1' HD12 ' A' ' 218' ' ' LEU . 3.7 p-80 -138.56 128.62 25.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.08 164.43 30.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.407 -179.099 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.818 HG23 ' HA ' ' A' ' 206' ' ' LEU . 5.9 p -172.84 156.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.4 0.619 . . . . 0.0 111.726 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.519 ' N ' HG22 ' A' ' 198' ' ' VAL . 3.3 m120 -91.52 144.76 25.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.395 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.455 ' HB2' ' CZ2' ' A' ' 234' ' ' TRP . 3.2 t -61.37 -4.52 1.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.455 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.57 HG21 ' HA ' ' A' ' 177' ' ' LEU . 4.9 t -102.08 0.54 35.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.561 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -75.12 138.27 41.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.418 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.2 m -87.18 -89.08 0.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.2 18.8 17.8 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.777 0.323 . . . . 0.0 111.722 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -6.88 11.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.525 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.818 ' HA ' HG23 ' A' ' 198' ' ' VAL . 7.5 tt -75.6 -62.53 0.77 Allowed Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.782 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.8 Cg_endo -42.7 99.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.254 1.969 . . . . 0.0 112.765 -178.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.599 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 43.1 t -69.54 165.31 2.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.757 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.554 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 4.3 mtpp -135.18 90.19 2.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.8 OUTLIER -78.11 124.93 28.62 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.891 -179.945 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.711 ' HA2' HG23 ' A' ' 225' ' ' VAL . . . 177.01 -173.72 46.52 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.823 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.74 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.6 OUTLIER -60.32 155.92 16.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.583 0.23 . . . . 0.0 110.936 -179.755 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 219' ' ' ALA . 10.0 p -77.29 119.43 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.892 0.854 . . . . 0.0 113.204 -176.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.739 ' CB ' ' HD3' ' A' ' 215' ' ' PRO . 0.6 OUTLIER 160.88 -75.99 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.709 178.92 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.739 ' HD3' ' CB ' ' A' ' 214' ' ' SER . 42.9 Cg_endo -100.9 -14.82 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.653 2.235 . . . . 0.0 112.837 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.457 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 1.2 m -80.21 157.29 26.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.003 0.43 . . . . 0.0 111.758 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.7 OUTLIER -73.16 -37.23 66.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.805 178.898 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.789 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.7 mt -98.06 134.85 40.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.583 178.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.494 ' HB2' HG23 ' A' ' 213' ' ' VAL . . . -89.39 76.21 7.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.003 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.789 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 2.8 mm? -109.36 94.68 5.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.046 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.509 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -64.71 24.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.656 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.591 ' H ' ' C ' ' A' ' 220' ' ' LEU . 0.4 OUTLIER -55.75 116.05 2.71 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.222 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.4 t -58.73 -20.38 48.6 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.823 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.535 ' CG ' ' HB2' ' A' ' 250' ' ' ASN . 2.3 tp10 -75.11 -19.57 59.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 0.0 110.812 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.711 HG23 ' HA2' ' A' ' 211' ' ' GLY . 5.8 p -124.37 64.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.921 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 10.1 p -46.12 -31.93 2.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.834 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -125.69 -78.86 0.32 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.375 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -139.29 131.0 27.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.076 0.465 . . . . 0.0 110.74 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.677 ' N ' HG21 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -99.59 -55.94 2.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.637 178.908 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 245' ' ' ASP . . . -148.97 164.9 33.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.542 0.687 . . . . 0.0 112.563 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.599 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -149.97 -178.24 6.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.522 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.782 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.1 mt -135.9 151.86 29.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 121.071 0.463 . . . . 0.0 112.198 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.23 163.69 39.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.163 178.213 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.586 ' CE3' HD22 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -91.4 152.66 20.31 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -176.286 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 239' ' ' PHE . 26.8 t-20 -120.58 72.29 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.8 t -59.77 -15.83 23.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -175.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 90.7 m -84.33 -35.58 23.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.44 0.638 . . . . 0.0 110.625 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.464 ' HE3' ' CE1' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -112.6 11.83 19.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.355 179.881 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.464 ' CE1' ' HE3' ' A' ' 238' ' ' LYS . 12.5 p90 42.25 69.55 0.36 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 2.0 mptp? -136.96 147.29 46.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.296 -178.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.611 ' N ' ' CD1' ' A' ' 241' ' ' TRP . 0.5 OUTLIER -114.14 103.46 11.14 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 178.656 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 27.6 mt-10 -125.08 143.63 50.82 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.104 0.954 . . . . 0.0 113.286 -176.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 1.4 pp -109.0 151.59 26.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.296 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.515 ' CG2' ' HB2' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -125.06 154.09 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.182 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.565 ' C ' ' HB3' ' A' ' 269' ' ' TRP . 5.5 m-20 -117.04 100.49 7.78 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.596 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -64.17 106.64 1.11 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.012 178.332 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.72 68.32 1.75 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.577 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 267' ' ' ARG . 52.2 p -76.87 61.04 1.86 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.624 HD11 ' N ' ' A' ' 250' ' ' ASN . 1.6 tm? -49.84 -60.01 3.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.149 0.5 . . . . 0.0 110.139 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.624 ' N ' HD11 ' A' ' 249' ' ' LEU . 4.1 t-20 -69.72 -22.34 63.4 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.832 -179.243 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.429 ' O ' HD22 ' A' ' 253' ' ' LEU . . . 81.67 84.57 0.76 Allowed Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.549 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.627 ' HB ' ' OG ' ' A' ' 260' ' ' SER . 55.7 m -46.46 164.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.555 0.178 . . . . 0.0 110.641 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 258' ' ' SER . 0.1 OUTLIER -148.38 126.69 12.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.26 0.552 . . . . 0.0 112.103 179.033 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.41 HG23 HG12 ' A' ' 259' ' ' ILE . 99.8 t -101.95 129.27 53.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.359 178.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.443 ' HA ' HD11 ' A' ' 280' ' ' ILE . 52.6 t-20 53.35 43.06 31.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.138 0.494 . . . . 0.0 110.195 -179.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.36 31.02 17.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.062 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . 0.406 ' O ' ' N ' ' A' ' 259' ' ' ILE . 0.1 OUTLIER -136.73 106.83 6.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.558 179.648 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 60.1 p -57.6 87.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.267 0.556 . . . . 0.0 110.76 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.505 HD13 ' C ' ' A' ' 259' ' ' ILE . 1.0 OUTLIER -88.34 -2.38 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.37 -178.961 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.627 ' OG ' ' HB ' ' A' ' 252' ' ' THR . 1.4 m -99.09 -13.54 19.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.683 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 2.1 t60 -107.24 15.68 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 179.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 84.8 Cg_exo -47.78 -37.59 28.41 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.596 1.531 . . . . 0.0 110.327 179.018 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' ' 266' ' ' SER . 77.4 m-20 -76.59 98.74 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.25 -1.795 . . . . 0.0 111.064 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 92.3 mt -66.21 133.33 50.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.739 0.305 . . . . 0.0 110.794 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.45 5.65 82.68 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.676 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.568 ' HB2' ' O ' ' A' ' 263' ' ' ASP . 0.5 OUTLIER -85.74 -60.29 2.06 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 122.905 -0.173 . . . . 0.0 111.168 -179.862 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.581 ' HD3' ' HA ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER 73.87 -2.87 2.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 111.256 -178.479 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.531 ' HD3' ' CD1' ' A' ' 269' ' ' TRP . 2.7 ptpt -91.26 -143.55 0.18 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -176.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.596 ' CE3' ' HA ' ' A' ' 246' ' ' MET . 0.0 OUTLIER -95.0 -10.81 29.8 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 179.556 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.481 ' H ' ' HG3' ' A' ' 268' ' ' LYS . . . 58.06 -148.37 36.43 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 118.833 -1.651 . . . . 0.0 111.171 -178.048 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -96.36 126.51 43.58 Favored Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.507 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 4.0 Cg_exo -38.74 120.69 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.983 2.456 . . . . 0.0 111.887 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.47 ' CG2' ' HB ' ' A' ' 259' ' ' ILE . 48.5 t -94.36 135.3 29.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.921 -177.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -81.7 127.16 32.63 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.545 0.688 . . . . 0.0 110.984 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.596 ' HB2' HG13 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.49 162.63 14.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.96 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.11 156.76 45.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.047 0.451 . . . . 0.0 112.054 -179.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.649 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 29.7 p -59.05 128.76 38.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.649 ' HB2' ' O ' ' A' ' 277' ' ' SER . 30.7 m-20 87.13 2.45 0.44 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.143 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -75.78 -166.08 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.528 HG21 ' HD1' ' A' ' 290' ' ' TYR . 0.7 OUTLIER -161.51 130.82 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.085 178.208 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -112.22 156.97 13.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.052 0.453 . . . . 0.0 111.321 178.436 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.472 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.9 m -141.7 119.17 11.58 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.314 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.427 ' HB3' ' CD2' ' A' ' 229' ' ' HIS . 0.7 OUTLIER -111.84 47.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.898 -178.253 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 167.22 -128.14 1.69 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 119.621 -1.276 . . . . 0.0 113.796 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.8 t -89.9 -46.65 8.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.622 0.249 . . . . 0.0 111.137 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 188' ' ' ALA . 3.5 t -144.0 -7.36 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.728 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 47.6 m -64.15 103.21 0.59 Allowed 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 5.5 mtpt -124.72 133.05 53.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 111.318 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.635 HG11 ' HA ' ' A' ' 186' ' ' VAL . 0.1 OUTLIER -112.21 135.5 51.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.564 -179.311 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.4 t80 -77.05 139.29 39.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.596 HG13 ' HB2' ' A' ' 275' ' ' LEU . 0.7 OUTLIER -110.28 114.11 46.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.544 -178.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.521 ' HD2' ' H ' ' A' ' 293' ' ' ILE . 11.8 tpt180 -127.65 148.28 50.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.801 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.521 ' H ' ' HD2' ' A' ' 292' ' ' ARG . 14.3 mt -141.13 113.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.58 156.09 45.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.762 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 22.8 m -90.51 162.04 15.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.873 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -86.61 135.04 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.032 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.56 86.48 6.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.004 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.961 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.606 ' C ' HG23 ' A' ' 201' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 121.177 0.513 . . . . 0.0 111.323 . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.711 ' HA3' HG22 ' A' ' 201' ' ' THR . . . 65.02 172.11 3.16 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.682 0.601 . . . . 0.0 113.689 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.889 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 40.2 t -110.43 42.12 1.63 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.408 -0.896 . . . . 0.0 112.403 -178.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 1.4 t -151.09 145.6 25.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 111.206 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.703 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 9.9 m95 -149.53 137.79 20.64 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.29 -178.307 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 1.2 tp -119.85 131.05 55.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.703 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 1.7 m-85 -130.32 141.12 50.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.83 0.824 . . . . 0.0 111.595 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.62 ' CD2' ' N ' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -139.46 152.73 47.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.994 178.079 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.513 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 17.7 tt0 -143.56 126.25 16.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.551 ' HA ' HG13 ' A' ' 289' ' ' VAL . 10.9 t -62.01 115.52 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.464 ' CG2' ' HG3' ' A' ' 288' ' ' LYS . 6.2 tt -100.56 -22.11 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -176.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.805 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -161.58 91.03 0.81 Allowed 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.601 -178.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.562 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.89 -170.54 26.76 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 178.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.492 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 91.6 Cg_endo -81.81 29.34 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.253 1.969 . . . . 0.0 111.589 178.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 194' ' ' LEU . . . -162.05 27.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.562 HG12 ' H ' ' A' ' 189' ' ' GLY . 7.8 mt -45.38 112.11 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 111.506 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.47 6.05 2.17 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.223 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 219' ' ' ALA . 0.2 OUTLIER -98.47 138.94 34.95 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.703 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.513 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 17.1 mt-30 -137.92 153.08 49.53 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.515 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.608 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 0.1 OUTLIER -147.83 147.76 30.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.634 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -147.56 166.67 26.64 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.991 -179.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.582 ' CG2' ' HA ' ' A' ' 206' ' ' LEU . 5.7 p -171.82 147.92 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.535 0.683 . . . . 0.0 111.984 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.554 ' N ' HG21 ' A' ' 198' ' ' VAL . 0.8 OUTLIER -93.11 147.87 22.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.693 179.219 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.46 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 24.8 p -65.88 -2.23 3.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.255 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.711 HG22 ' HA3' ' A' ' 178' ' ' GLY . 0.1 OUTLIER -102.77 -4.17 25.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.032 179.661 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.6 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -94.27 125.51 38.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.548 179.871 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 62.2 p -91.54 -81.28 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.12 3.21 0.63 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.458 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -120.87 -8.32 9.42 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.128 -0.358 . . . . 0.0 111.573 179.851 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.6 ' HB2' ' O ' ' A' ' 202' ' ' SER . 6.6 tt -71.9 -61.25 2.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.562 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.7 Cg_endo -43.75 96.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.967 1.778 . . . . 0.0 112.764 -178.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.88 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 3.4 t -68.62 157.85 6.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.95 179.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 217' ' ' ASP . 4.5 mtmm -135.71 93.48 2.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.607 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.497 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.0 OUTLIER -86.86 123.19 31.71 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.735 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -168.14 169.72 41.6 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.504 -179.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.857 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 14.7 ttt180 -72.01 -74.4 0.16 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.014 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.6 p -138.94 115.08 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.528 ' C ' ' H ' ' A' ' 216' ' ' SER . 0.3 OUTLIER 169.18 -176.29 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.1 -179.578 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 16.4 Cg_exo -67.96 23.26 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.47 2.113 . . . . 0.0 112.589 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.528 ' H ' ' C ' ' A' ' 214' ' ' SER . 3.5 m -64.23 -150.43 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.987 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.8 OUTLIER -132.16 -34.04 1.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.486 179.809 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.703 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.1 mt -105.47 126.08 51.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.516 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -92.09 83.1 5.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.887 0.375 . . . . 0.0 111.432 -179.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.857 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.3 mm? -104.69 89.44 3.19 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.069 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.427 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.1 OUTLIER -64.0 38.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.618 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 220' ' ' LEU . 12.6 t0 -64.18 123.32 18.79 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.18 179.191 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 60.1 p -67.45 -4.33 10.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.871 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -19.02 18.11 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.468 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 225' ' ' VAL . 79.0 t -93.81 81.98 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.49 178.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -38.68 -48.01 1.42 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.441 -179.038 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.58 -55.38 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.667 ' HB2' ' HG3' ' A' ' 246' ' ' MET . 0.2 OUTLIER -140.93 128.31 21.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.998 0.427 . . . . 0.0 110.772 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.59 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.7 OUTLIER -98.22 -59.71 1.7 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.46 179.088 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.465 ' C ' HD11 ' A' ' 210' ' ' LEU . . . -149.22 170.89 17.43 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.88 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 1.7 mt-30 -151.58 173.64 14.39 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.745 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.535 HD12 HG12 ' A' ' 208' ' ' VAL . 3.5 mt -127.03 143.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.519 0.676 . . . . 0.0 112.19 179.063 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.74 127.34 3.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.711 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 5.7 p90 -118.08 166.05 13.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.96 132.87 56.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.058 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.09 -0.26 57.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.453 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 19.8 m -79.02 -36.76 40.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.731 0.777 . . . . 0.0 109.521 178.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.38 17.4 7.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.476 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 12.8 p90 41.12 59.2 2.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.463 0.649 . . . . 0.0 110.014 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.711 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.97 138.4 54.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.624 179.872 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.603 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.71 120.02 32.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.89 179.571 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 21.8 mt-10 -132.97 144.03 49.85 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.679 ' HG ' HD11 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -89.03 146.8 24.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.959 -1.928 . . . . 0.0 108.4 178.064 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.514 HG12 ' CZ3' ' A' ' 269' ' ' TRP . 6.0 p -122.32 163.47 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 118.718 0.69 . . . . 0.0 109.316 178.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.526 ' CG ' ' HA ' ' A' ' 260' ' ' SER . 2.0 m-20 -118.84 110.14 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.725 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -79.82 105.15 10.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.466 178.148 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.29 69.38 1.28 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.205 -179.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.01 45.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.609 HD21 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -58.37 -54.03 51.61 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.781 -0.575 . . . . 0.0 109.846 178.38 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.609 ' N ' HD21 ' A' ' 249' ' ' LEU . 1.4 m-20 -79.12 -34.11 43.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.003 0.43 . . . . 0.0 110.627 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 260' ' ' SER . . . 87.46 98.42 0.88 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.774 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 282' ' ' THR . 3.1 m -61.07 170.56 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.479 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.699 HD21 ' O ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -153.25 127.0 8.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.433 178.54 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.484 ' CG2' HG12 ' A' ' 259' ' ' ILE . 86.1 t -103.44 130.58 53.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.522 178.347 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.506 ' HA ' HG13 ' A' ' 280' ' ' ILE . 23.8 t-20 54.03 48.8 20.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.096 0.474 . . . . 0.0 110.216 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.84 23.51 8.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -127.74 105.71 8.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.257 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 86.7 p -55.62 86.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.488 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.484 HG12 ' CG2' ' A' ' 254' ' ' VAL . 2.9 pp -86.15 20.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.332 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.933 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 78.5 p -94.49 -20.85 19.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.344 -178.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.628 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 0.0 OUTLIER -108.35 47.35 0.18 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.636 178.157 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.933 ' HD3' ' C ' ' A' ' 260' ' ' SER . 3.0 Cg_exo -82.6 26.46 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.668 2.245 . . . . 0.0 111.763 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 261' ' ' HIS . 1.5 m-20 -137.68 -159.22 0.93 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.438 ' CD2' ' N ' ' A' ' 264' ' ' LEU . 1.4 mm? -113.63 -49.96 2.86 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 118.445 0.566 . . . . 0.0 110.509 177.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -141.02 26.96 2.46 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.123 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.608 ' C ' ' H ' ' A' ' 268' ' ' LYS . 66.1 p -65.68 -62.78 1.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.516 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 266' ' ' SER . 0.0 OUTLIER 68.02 -23.68 0.13 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.831 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.608 ' H ' ' C ' ' A' ' 266' ' ' SER . 5.3 ttmt -68.7 -127.15 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.692 -177.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.725 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 0.0 OUTLIER -79.67 -14.58 58.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.149 -178.994 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 59.62 -172.34 5.09 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -178.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -113.68 131.94 22.81 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 118.242 1.021 . . . . 0.0 110.178 179.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.439 ' HB3' ' HB2' ' A' ' 242' ' ' GLU . 80.0 Cg_exo -44.83 119.92 2.59 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.809 2.339 . . . . 0.0 114.055 -178.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.477 ' CG2' ' HB ' ' A' ' 259' ' ' ILE . 49.3 t -104.14 133.02 49.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.588 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -75.15 128.11 34.75 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -176.678 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.451 ' C ' ' CD2' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.44 165.09 13.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 113.86 -1.518 . . . . 0.0 108.864 178.088 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.52 158.43 44.01 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.57 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.69 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 5.5 p -58.25 130.09 45.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.652 178.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.69 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.1 m-20 85.55 7.15 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.831 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.8 m-20 -78.78 -169.52 1.79 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.631 HG21 ' O ' ' A' ' 279' ' ' ASP . 0.5 OUTLIER -160.78 129.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 177.488 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.679 HD11 ' HG ' ' A' ' 243' ' ' LEU . 1.0 OUTLIER -106.15 157.05 6.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.809 0.337 . . . . 0.0 111.394 179.762 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.699 ' O ' HD21 ' A' ' 253' ' ' LEU . 1.7 m -145.98 116.71 7.66 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.59 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -110.65 45.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.087 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 170.87 -128.81 1.68 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 119.317 -1.42 . . . . 0.0 114.201 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 t -86.49 -48.33 8.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.78 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.2 t -146.43 -4.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.805 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 17.0 m -66.92 104.29 1.33 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.25 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 1.3 ptmt -126.81 135.84 51.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 0.0 111.581 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.551 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.1 OUTLIER -111.92 135.18 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.093 -178.927 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 4.6 t80 -76.89 138.84 39.99 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.049 -179.438 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.91 112.09 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.753 -178.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -137.34 145.55 43.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.88 179.866 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 181' ' ' TRP . 1.3 mt -135.82 145.79 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.634 -179.388 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.01 139.68 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.988 0.423 . . . . 0.0 111.494 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.51 165.97 22.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.975 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.889 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 51.6 tp60 -95.7 159.61 14.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.984 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -83.53 86.34 7.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.059 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -179.963 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.421 ' HA ' ' CG2' ' A' ' 201' ' ' THR . 2.9 mp . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.762 0.315 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.436 ' N ' HG22 ' A' ' 201' ' ' THR . . . 115.61 103.09 2.39 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.843 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 39.4 t -179.29 -76.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.974 0.416 . . . . 0.0 109.892 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 3.1 m -139.23 174.92 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.716 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.1 m95 -140.06 130.41 25.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.3 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.5 OUTLIER -119.87 131.51 55.28 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.151 177.719 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.716 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 0.4 OUTLIER -135.92 145.68 46.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.891 0.853 . . . . 0.0 111.263 -179.858 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.632 HD21 ' HB3' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -144.14 149.8 37.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.837 178.588 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.427 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 1.3 tt0 -137.03 124.82 22.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.019 -177.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.548 ' CG2' HD11 ' A' ' 220' ' ' LEU . 40.1 t -64.21 116.3 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.49 HG23 ' HG2' ' A' ' 288' ' ' LYS . 8.7 tt -99.94 -23.3 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -175.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.865 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -155.42 91.21 1.3 Allowed 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.494 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.498 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.27 -177.11 35.94 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.524 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 74.0 Cg_endo -77.98 31.79 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.08 1.853 . . . . 0.0 111.788 178.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.623 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -161.64 21.52 0.12 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.794 178.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.498 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.7 mt -39.63 113.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 0.0 111.656 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.7 7.96 2.9 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.901 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.623 HD12 ' O ' ' A' ' 191' ' ' ALA . 0.6 OUTLIER -99.34 109.19 21.83 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.814 0.816 . . . . 0.0 109.749 178.771 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.427 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 16.4 mt-30 -111.39 153.79 25.55 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.727 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.632 ' HB3' HD21 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -146.43 146.41 30.58 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.88 179.921 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.31 153.4 40.5 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.769 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.496 HG13 ' HG ' ' A' ' 206' ' ' LEU . 14.8 p -155.35 146.48 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.349 0.595 . . . . 0.0 111.82 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.8 OUTLIER -85.06 145.81 27.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.546 178.128 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.452 ' HA ' ' CE2' ' A' ' 234' ' ' TRP . 5.7 t -63.15 -6.97 4.82 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.11 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 178' ' ' GLY . 3.7 t -101.95 42.84 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.302 0.572 . . . . 0.0 111.323 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.431 ' HB2' ' CG ' ' A' ' 205' ' ' LYS . 6.3 p -135.0 106.27 6.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.523 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.7 m -76.02 -87.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.83 5.32 7.98 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.436 ' O ' ' CG ' ' A' ' 205' ' ' LYS . 2.4 pttt -122.48 56.27 1.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.68 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 7.9 tt -146.34 -53.84 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.925 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 3.4 Cg_exo -40.59 96.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.374 2.049 . . . . 0.0 113.076 -177.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 231' ' ' GLN . 61.7 t -74.96 97.83 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.337 0.062 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.167 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.674 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 6.0 mtmm -69.69 93.41 0.72 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.7 OUTLIER -78.53 129.55 34.97 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.611 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 179.55 -177.27 48.16 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.097 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.864 ' HB3' ' O ' ' A' ' 226' ' ' SER . 55.5 ttt180 -82.4 -68.66 0.68 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.094 0.558 . . . . 0.0 112.448 -178.518 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.545 ' CG2' ' H ' ' A' ' 214' ' ' SER . 9.6 p -116.9 -151.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.099 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.545 ' H ' ' CG2' ' A' ' 213' ' ' VAL . 0.5 OUTLIER 66.37 173.31 0.08 OUTLIER Pre-proline 0 C--O 1.231 0.118 0 O-C-N 122.125 -0.36 . . . . 0.0 110.264 -179.806 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 72.0 Cg_endo -74.27 40.63 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.475 2.116 . . . . 0.0 113.336 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 209' ' ' LYS . 0.6 OUTLIER -71.56 168.01 18.53 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.616 0.246 . . . . 0.0 110.347 179.365 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.488 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 1.8 m-20 -85.02 -34.36 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.371 . . . . 0.0 110.605 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.67 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.8 mt -101.83 127.68 48.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.593 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -97.36 82.11 3.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.935 0.398 . . . . 0.0 110.992 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.705 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.5 mm? -105.97 73.36 0.99 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.184 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.28 60.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.609 ' N ' ' HG3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -107.26 127.79 53.85 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.961 0.41 . . . . 0.0 110.188 178.615 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.3 p -48.24 -24.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.454 0.645 . . . . 0.0 111.58 178.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.527 ' O ' ' CG2' ' A' ' 225' ' ' VAL . 0.2 OUTLIER -109.92 73.2 0.83 Allowed 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.215 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.719 HG11 ' O ' ' A' ' 225' ' ' VAL . 1.9 t 169.72 3.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 113.08 -1.873 . . . . 0.0 108.626 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.864 ' O ' ' HB3' ' A' ' 212' ' ' ARG . 0.3 OUTLIER -7.23 -116.47 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.628 1.571 . . . . 0.0 114.635 -179.297 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.465 ' H ' ' HB3' ' A' ' 226' ' ' SER . . . -52.49 -89.54 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.029 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.644 ' O ' ' O ' ' A' ' 246' ' ' MET . 6.5 mttm -146.96 138.76 24.38 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.07 0.462 . . . . 0.0 109.95 179.591 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.576 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.1 OUTLIER -96.21 -59.94 1.73 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.58 -179.626 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.506 ' C ' HD11 ' A' ' 210' ' ' LEU . . . -149.19 177.66 9.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.621 0.724 . . . . 0.0 112.474 -178.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.674 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 3.8 pt20 -159.36 172.8 17.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.422 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.925 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 4.9 mt -126.77 143.82 38.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.308 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.49 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -145.5 162.53 37.17 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.721 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.472 ' CE3' ' CD1' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -92.33 152.84 19.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.471 -177.05 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -119.29 71.33 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 175.16 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 17.8 p -54.61 -23.97 19.29 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -176.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.8 m -74.77 -22.15 58.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.556 0.693 . . . . 0.0 109.343 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 22.5 tptt -122.98 8.95 9.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.4 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 235' ' ' ASN . 8.0 p90 39.92 42.93 1.15 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.332 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.515 ' HD2' ' HB3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -120.42 -179.02 3.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.489 0.662 . . . . 0.0 110.58 -179.643 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.988 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -131.86 119.82 21.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.783 -179.309 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 6.0 pt-20 -139.84 152.36 46.43 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.776 0.798 . . . . 0.0 113.099 -178.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.631 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 2.8 pp -111.16 153.29 25.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.775 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -123.14 162.34 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.55 -179.432 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.658 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 2.2 t0 -95.4 100.36 12.14 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 120.777 0.322 . . . . 0.0 111.508 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.644 ' O ' ' O ' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -87.09 90.57 8.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.041 178.964 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.676 ' HA2' ' HG3' ' A' ' 267' ' ' ARG . . . 48.01 70.67 0.69 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.933 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.414 ' OG ' ' CD2' ' A' ' 229' ' ' HIS . 3.2 t -95.6 78.23 3.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.473 HD11 ' C ' ' A' ' 249' ' ' LEU . 1.6 tm? -52.75 -58.85 5.53 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.142 0.496 . . . . 0.0 109.776 177.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.472 ' HB3' ' HE2' ' A' ' 229' ' ' HIS . 0.2 OUTLIER -68.33 -29.25 67.95 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.92 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.498 ' O ' ' CD2' ' A' ' 229' ' ' HIS . . . 101.32 156.43 26.89 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.726 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 46.7 m -124.86 155.18 39.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.819 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.587 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -150.06 145.6 26.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.036 0.446 . . . . 0.0 111.558 179.621 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.412 HG12 ' OD1' ' A' ' 279' ' ' ASP . 75.2 t -116.9 138.3 47.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.095 178.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.481 ' HA ' HG13 ' A' ' 280' ' ' ILE . 3.8 p-10 49.0 37.08 9.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.211 0.529 . . . . 0.0 110.471 -178.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.06 36.85 1.33 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.127 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.45 116.8 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.075 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 51.7 p -62.09 90.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.298 0.571 . . . . 0.0 110.746 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.413 ' HB ' HG23 ' A' ' 273' ' ' VAL . 0.1 OUTLIER -92.98 -11.79 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.352 -177.758 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.748 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 0.2 OUTLIER -122.01 -19.44 6.64 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.509 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.648 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 14.6 t-80 -110.7 42.59 0.2 Allowed Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.748 ' HD3' ' C ' ' A' ' 260' ' ' SER . 23.2 Cg_exo -65.86 -27.61 51.29 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 121.887 1.725 . . . . 0.0 113.546 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -119.73 95.78 4.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.804 0.335 . . . . 0.0 111.052 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.637 ' C ' ' H ' ' A' ' 266' ' ' SER . 0.6 OUTLIER -61.7 173.65 0.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.757 179.001 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 64.41 -19.44 0.1 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.494 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 264' ' ' LEU . 0.5 OUTLIER -80.2 -35.13 36.76 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 122.806 0.442 . . . . 0.0 111.703 -179.738 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.676 ' HG3' ' HA2' ' A' ' 247' ' ' GLY . 0.0 OUTLIER 44.77 21.95 0.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.38 -179.331 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -62.94 165.83 6.39 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 123.715 0.806 . . . . 0.0 112.392 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.658 ' HA ' ' O ' ' A' ' 245' ' ' ASP . 30.9 t-105 -77.34 -24.81 50.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.354 178.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 63.02 -179.01 5.66 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.322 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -107.82 134.15 20.18 Favored Pre-proline 0 C--N 1.332 -0.17 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.511 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 1.3 Cg_endo -44.93 136.64 9.84 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.166 2.577 . . . . 0.0 113.926 -178.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 62.2 t -109.21 129.43 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.0 pt-20 -74.31 132.24 41.89 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.417 -178.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.2 mt -89.1 163.22 15.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.973 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -135.81 144.33 45.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.729 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.599 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 6.4 m -55.92 131.9 48.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.189 178.042 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 84.58 1.76 0.82 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.133 -179.26 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 3.2 t70 -72.96 -166.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.481 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -160.4 133.49 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.896 178.542 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 289' ' ' VAL . 0.2 OUTLIER -110.94 156.57 12.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.061 0.458 . . . . 0.0 111.286 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.587 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 3.0 m -148.89 123.5 9.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.576 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -120.95 39.58 3.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.457 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -176.1 -136.42 2.35 Favored Glycine 0 C--N 1.328 0.095 0 C-N-CA 119.331 -1.414 . . . . 0.0 113.702 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 285' ' ' THR . . . . . 0.414 HG21 ' HG3' ' A' ' 224' ' ' GLU . 14.1 t -87.15 -48.85 7.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.588 0.232 . . . . 0.0 110.695 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.412 ' O ' ' HD2' ' A' ' 288' ' ' LYS . 1.3 t -140.25 2.32 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.319 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.865 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 31.7 m -74.93 102.09 4.66 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.69 0.281 . . . . 0.0 110.261 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.49 ' HG2' HG23 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -123.51 133.2 54.04 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.31 0.576 . . . . 0.0 110.918 -179.874 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.464 ' N ' ' O ' ' A' ' 281' ' ' ILE . 1.2 t -107.9 130.61 60.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.372 -178.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.5 t80 -76.15 136.7 39.79 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 110.309 -178.189 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.446 HG21 ' HA ' ' A' ' 280' ' ' ILE . 3.5 t -102.25 107.81 22.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.196 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.32 122.4 37.62 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.988 HD12 ' CE3' ' A' ' 241' ' ' TRP . 1.2 mt -132.58 146.51 32.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.7 t -152.2 166.13 32.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 111.146 -179.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 7.0 m -94.57 159.77 14.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.631 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -113.7 116.05 28.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.926 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -95.5 107.18 19.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.472 ' HB3' ' CG ' ' A' ' 199' ' ' ASN . 5.2 mp . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.731 0.3 . . . . 0.0 110.527 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.752 ' HA3' HG22 ' A' ' 201' ' ' THR . . . 77.09 166.86 26.55 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.093 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.627 ' HA ' ' CB ' ' A' ' 296' ' ' GLN . 0.5 OUTLIER -93.92 41.02 1.08 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.147 -0.527 . . . . 0.0 112.196 -179.419 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.5 OUTLIER -146.49 140.69 26.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.068 0.461 . . . . 0.0 110.935 179.761 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.663 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.3 m95 -146.88 139.45 24.96 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.13 -178.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 8.8 tp -116.88 124.53 49.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.634 178.053 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 5.7 m-85 -123.87 131.54 53.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.775 0.798 . . . . 0.0 110.197 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.739 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.0 OUTLIER -131.45 142.69 50.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.331 -179.69 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.605 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 2.9 tt0 -139.39 124.68 19.06 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.705 ' HA ' HG12 ' A' ' 289' ' ' VAL . 10.5 t -62.95 104.84 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.102 0.477 . . . . 0.0 110.462 178.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 288' ' ' LYS . 10.6 tt -87.03 -24.26 6.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 -177.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.725 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -166.64 98.62 0.57 Allowed 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.874 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.656 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.9 -175.04 32.51 Favored Glycine 0 N--CA 1.452 -0.272 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 178.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.546 ' O ' ' HG2' ' A' ' 221' ' ' LYS . 89.1 Cg_endo -77.31 28.71 0.43 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.099 1.866 . . . . 0.0 111.533 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.562 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -162.15 27.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.656 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.4 mt -39.97 111.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.453 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.58 6.56 2.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.257 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER -99.51 162.2 13.16 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.883 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.739 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 12.7 mt-30 -156.59 149.67 24.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.076 -178.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.643 ' CE1' HD13 ' A' ' 218' ' ' LEU . 4.0 p-80 -136.98 129.06 29.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.67 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -139.12 164.62 29.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.075 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.79 HG12 ' HG ' ' A' ' 206' ' ' LEU . 10.1 p -175.32 155.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.56 0.695 . . . . 0.0 112.704 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 180' ' ' SER . 4.0 m-80 -90.39 147.8 23.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.832 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.589 ' HA ' ' CE2' ' A' ' 234' ' ' TRP . 65.2 m -56.03 -49.92 72.37 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.107 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.752 HG22 ' HA3' ' A' ' 178' ' ' GLY . 0.1 OUTLIER -62.93 5.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.607 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.77 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.3 OUTLIER -87.19 105.14 17.0 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.294 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.83 -107.48 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.2 m -70.48 6.23 1.48 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 205' ' ' LYS . 8.9 pttt -120.32 55.98 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.212 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.79 ' HG ' HG12 ' A' ' 198' ' ' VAL . 8.0 tt -149.15 -59.87 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.761 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 4.5 Cg_exo -41.09 99.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.185 1.923 . . . . 0.0 112.189 -177.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 31.9 t -68.82 166.88 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.015 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.605 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -139.38 92.1 2.55 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.63 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.612 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.6 OUTLIER -76.79 125.24 28.95 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.324 178.895 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -166.22 168.59 39.97 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.64 -179.122 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 1.5 ttt85 -60.72 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 213' ' ' VAL . 12.4 p -133.42 -12.4 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 0.0 111.735 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.653 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 1.4 m -49.85 176.5 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.732 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 28.4 Cg_endo -62.03 18.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.134 1.89 . . . . 0.0 112.667 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.59 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.6 OUTLIER -58.59 -178.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 111.31 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -96.57 -31.55 12.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.138 179.238 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.696 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.4 mt -104.66 131.42 52.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.619 178.609 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.504 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -98.09 82.5 2.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.596 -179.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.824 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.3 mm? -102.2 86.37 2.83 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -60.07 67.83 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.856 179.865 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.629 ' N ' ' O ' ' A' ' 220' ' ' LEU . 5.3 t0 -97.77 151.17 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.232 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.5 p -90.38 -9.79 46.31 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.194 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.64 -20.64 24.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.427 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.494 ' CG1' ' HB2' ' A' ' 212' ' ' ARG . 3.6 p -107.26 86.76 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.4 m -37.62 -42.23 0.53 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.413 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.33 -55.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.498 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.9 OUTLIER -140.42 133.37 29.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.996 0.427 . . . . 0.0 109.93 179.122 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.576 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.9 t60 -98.27 -54.21 3.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.281 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.442 ' C ' HD13 ' A' ' 210' ' ' LEU . . . -146.56 177.24 9.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 112.212 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.616 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -163.72 175.8 10.19 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.475 -179.822 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.761 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.9 mt -132.8 148.96 31.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.757 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.427 ' O ' ' OE2' ' A' ' 242' ' ' GLU . 0.1 OUTLIER -149.8 164.65 34.75 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.56 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.74 ' HE3' HD23 ' A' ' 206' ' ' LEU . 0.4 OUTLIER -110.55 112.96 25.22 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.285 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.37 82.89 4.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.6 t -61.65 -9.2 5.63 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -176.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 55.2 m -74.7 -32.98 62.33 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.17 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.529 ' HG2' ' HG2' ' A' ' 240' ' ' LYS . 5.4 tptm -110.54 0.22 17.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.245 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 17.4 p90 41.32 47.86 3.1 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.087 0.47 . . . . 0.0 110.272 179.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.57 ' HE2' ' HG2' ' A' ' 242' ' ' GLU . 0.0 OUTLIER -119.88 170.34 9.33 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.574 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.603 ' CZ3' ' HB2' ' A' ' 182' ' ' LEU . 1.3 m0 -119.4 108.58 14.75 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.57 ' HG2' ' HE2' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -133.89 147.65 51.16 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.4 pp -111.92 152.16 28.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.357 -1.747 . . . . 0.0 110.59 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.521 HG22 ' CD1' ' A' ' 269' ' ' TRP . 1.2 p -117.99 162.92 15.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.558 0.218 . . . . 0.0 110.527 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.615 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -103.18 111.25 23.53 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -177.983 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.594 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -79.36 95.72 5.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.692 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.73 64.0 4.7 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.023 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.48 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 21.8 p -64.59 50.34 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.321 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.621 ' N ' HD13 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -55.56 -50.74 69.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.872 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.497 ' HB3' ' HE2' ' A' ' 229' ' ' HIS . 5.1 t30 -77.72 -37.15 50.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.469 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.1 85.91 1.35 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.218 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.538 ' N ' ' HB3' ' A' ' 260' ' ' SER . 0.5 OUTLIER -45.69 166.56 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 119.87 -0.11 . . . . 0.0 110.789 179.137 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.653 ' O ' ' HA ' ' A' ' 281' ' ' ILE . 0.2 OUTLIER -150.83 127.23 10.69 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.089 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.47 ' CG2' HG13 ' A' ' 281' ' ' ILE . 99.5 t -107.39 131.32 57.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.646 178.295 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.458 ' HA ' HD11 ' A' ' 280' ' ' ILE . 7.8 t-20 57.57 40.15 27.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.232 0.539 . . . . 0.0 109.852 -179.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 7.9 p 61.53 24.78 14.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.445 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.42 97.64 4.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.604 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -46.4 93.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.6 -179.605 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.648 HD11 ' C ' ' A' ' 259' ' ' ILE . 0.0 OUTLIER -94.87 6.23 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.452 -178.855 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.568 ' N ' HD11 ' A' ' 259' ' ' ILE . 2.0 t -99.23 -19.52 17.07 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.159 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.644 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 0.6 OUTLIER -106.78 21.43 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 50.9 Cg_exo -51.27 -43.35 49.58 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.184 1.256 . . . . 0.0 109.622 178.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 266' ' ' SER . 33.1 p30 -75.87 81.71 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 112.296 -2.229 . . . . 0.0 110.924 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -54.92 134.04 48.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.616 -179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 78.73 -4.49 60.58 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.647 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 268' ' ' LYS . 3.6 m -83.06 -63.04 1.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.049 0.424 . . . . 0.0 111.682 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.432 ' HA ' ' HG ' ' A' ' 248' ' ' SER . 0.0 OUTLIER 68.39 -12.79 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.649 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 266' ' ' SER . 3.5 ttmm -80.52 -130.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.615 ' HA ' ' O ' ' A' ' 245' ' ' ASP . 1.8 t-105 -80.7 -30.89 36.31 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.17 -171.55 7.8 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.14 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -106.5 134.9 19.6 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 117.65 0.725 . . . . 0.0 111.158 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.567 ' HB3' ' OE1' ' A' ' 242' ' ' GLU . 84.2 Cg_exo -43.03 124.11 3.52 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.214 2.61 . . . . 0.0 113.74 -178.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 87.9 t -99.27 139.28 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.4 OUTLIER -86.45 131.05 34.29 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 119.099 -1.041 . . . . 0.0 111.979 -178.954 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.678 ' H ' HD12 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -96.59 163.91 12.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.496 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.5 158.48 43.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 8.5 t -61.55 131.44 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.803 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.609 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.7 m-20 85.4 -1.94 0.82 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.18 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -71.34 -166.78 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.44 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.717 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.8 OUTLIER -161.37 128.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.454 177.299 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.708 ' CG2' HG23 ' A' ' 289' ' ' VAL . 1.0 OUTLIER -108.74 155.13 9.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.706 179.23 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.607 ' OG1' ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -142.2 121.82 13.37 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.551 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.576 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -113.71 45.18 1.48 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.145 -178.008 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 170.26 -123.13 1.03 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 119.2 -1.476 . . . . 0.0 114.114 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.0 t -91.59 -54.8 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.186 . . . . 0.0 111.273 -179.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.573 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -139.94 -3.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.471 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.725 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 26.9 m -67.57 103.0 1.25 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.853 0.297 . . . . 0.0 110.58 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.657 ' O ' HG23 ' A' ' 187' ' ' ILE . 7.9 ttmt -118.39 130.98 56.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.708 HG23 ' CG2' ' A' ' 281' ' ' ILE . 0.0 OUTLIER -113.43 133.02 60.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.653 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.717 ' HD1' HG23 ' A' ' 280' ' ' ILE . 4.4 t80 -76.34 136.16 39.54 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.014 0.435 . . . . 0.0 110.031 -178.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 275' ' ' LEU . 1.0 OUTLIER -103.46 110.68 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.404 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.19 135.24 55.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.508 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.561 ' CG2' ' CZ3' ' A' ' 241' ' ' TRP . 16.0 mt -131.41 133.51 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.867 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.3 m -156.58 159.98 39.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 110.798 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 52.1 m -86.97 177.54 7.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.845 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.627 ' CB ' ' HA ' ' A' ' 179' ' ' SER . 0.0 OUTLIER -81.27 126.27 31.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -148.42 86.38 1.54 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 -179.912 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.633 ' C ' HG22 ' A' ' 201' ' ' THR . 1.2 mt . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.067 0.46 . . . . 0.0 111.748 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.443 ' HA3' HG21 ' A' ' 201' ' ' THR . . . 64.24 -123.61 28.14 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 115.725 -0.67 . . . . 0.0 114.747 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.483 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 0.1 OUTLIER -179.02 48.03 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.804 -0.698 . . . . 0.0 111.273 -178.675 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 13.4 t -159.56 156.78 28.66 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.789 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 15.8 m95 -150.48 146.71 26.8 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.8 OUTLIER -122.26 134.54 54.68 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.922 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 13.3 m-85 -130.25 136.86 49.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.67 0.747 . . . . 0.0 110.466 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.592 HD13 ' HA ' ' A' ' 291' ' ' VAL . 2.4 mm? -123.4 138.91 54.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.049 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.55 117.15 15.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 194' ' ' LEU . 27.0 t -65.59 118.2 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.001 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.456 HG22 ' HB2' ' A' ' 288' ' ' LYS . 5.2 tt -98.04 -26.89 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -176.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.866 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -158.01 94.34 1.31 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.616 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.76 -174.58 31.81 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 178.255 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.441 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 85.2 Cg_endo -80.6 32.09 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.02 1.813 . . . . 0.0 110.785 178.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.583 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.26 21.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.749 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.616 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.1 mt -38.99 113.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 111.612 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.95 5.9 4.66 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.76 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 191' ' ' ALA . 0.2 OUTLIER -93.29 139.87 30.16 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.111 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 12.4 mt-30 -133.26 143.55 49.17 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.662 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.523 ' CD2' ' HB2' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -134.83 128.55 32.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.772 -179.537 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -140.82 162.81 34.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.773 -179.195 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.606 HG23 ' HA ' ' A' ' 206' ' ' LEU . 12.3 p -173.3 153.03 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.413 178.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.481 ' ND2' HG23 ' A' ' 201' ' ' THR . 0.3 OUTLIER -90.74 145.59 24.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.919 179.52 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.915 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 0.1 OUTLIER -62.59 -2.2 1.03 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.203 179.517 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.633 HG22 ' C ' ' A' ' 177' ' ' LEU . 1.2 t -101.63 13.74 34.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.827 0.346 . . . . 0.0 110.8 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.486 ' CB ' ' HG2' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -103.96 117.34 34.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.166 179.761 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.4 m -76.92 -84.29 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.9 t -90.4 15.71 10.14 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.486 ' HG2' ' CB ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -115.46 -10.4 11.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.73 ' HG ' ' CZ2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -90.09 -18.89 0.23 Allowed Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -179.747 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.837 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 30.1 Cg_endo -65.43 84.44 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 CA-C-N 120.905 1.359 . . . . 0.0 111.468 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.487 ' O ' HD13 ' A' ' 210' ' ' LEU . 47.1 t -70.56 108.15 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.148 -178.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.68 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -79.98 84.5 5.72 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.705 ' HB2' ' O ' ' A' ' 230' ' ' ALA . 4.7 mp -74.93 136.01 41.4 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 118.742 0.701 . . . . 0.0 109.325 178.528 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . 178.38 -177.02 48.33 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.773 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.538 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 0.5 OUTLIER -71.52 -74.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.092 -0.554 . . . . 0.0 111.638 -179.536 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.571 ' CG2' ' H ' ' A' ' 214' ' ' SER . 7.6 p -117.0 -145.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.88 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.571 ' H ' ' CG2' ' A' ' 213' ' ' VAL . 0.6 OUTLIER 61.0 -179.38 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 121.98 -0.45 . . . . 0.0 109.905 -179.578 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 21.5 Cg_exo -66.4 24.2 0.1 OUTLIER 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.646 2.231 . . . . 0.0 113.765 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.528 ' HA ' ' HG3' ' A' ' 209' ' ' LYS . 68.2 m -53.0 152.05 4.31 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 120.617 0.246 . . . . 0.0 110.848 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.426 ' N ' ' HG2' ' A' ' 209' ' ' LYS . 0.6 OUTLIER -84.14 -29.25 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.379 179.742 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.444 ' HA ' HD21 ' A' ' 218' ' ' LEU . 36.1 mt -115.65 132.53 56.6 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.136 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -87.96 81.65 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.682 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.8 mm? -100.3 64.09 1.16 Allowed 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.538 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -60.78 35.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -177.097 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.558 ' HB3' ' HG2' ' A' ' 224' ' ' GLU . 3.1 t70 -87.94 125.44 34.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 76.8 p -39.73 -30.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.558 ' HG2' ' HB3' ' A' ' 222' ' ' ASP . 9.8 pt-20 -51.88 -42.23 62.53 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.989 0.424 . . . . 0.0 110.838 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.58 HG21 ' HA2' ' A' ' 211' ' ' GLY . 2.7 p -96.87 106.17 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.835 179.017 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.5 t -47.22 -68.56 0.18 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.452 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -128.32 -45.1 0.2 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 178.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.631 ' HA ' ' HA3' ' A' ' 211' ' ' GLY . 0.4 OUTLIER -143.45 127.65 17.64 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.087 -0.557 . . . . 0.0 109.555 178.953 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.813 ' CE1' ' HB3' ' A' ' 248' ' ' SER . 1.2 t60 -92.12 -55.19 3.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.534 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.705 ' O ' ' HB2' ' A' ' 210' ' ' LEU . . . -155.35 150.76 27.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.68 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -131.88 179.87 5.82 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.979 179.428 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.837 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.0 mt -126.93 139.4 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.847 179.157 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.83 129.98 5.52 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.915 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 5.4 p90 -111.61 151.6 28.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -175.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 239' ' ' PHE . 1.5 t-20 -73.32 126.8 30.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 112.493 -2.14 . . . . 0.0 111.007 177.69 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.5 t -89.19 -29.73 19.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.0 m -77.95 -30.95 50.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.699 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.446 ' O ' ' CG ' ' A' ' 239' ' ' PHE . 1.5 tptm -108.23 -2.32 19.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.598 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.446 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 27.9 p90 43.44 42.39 3.81 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.37 140.35 52.78 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.579 0.704 . . . . 0.0 110.382 178.507 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.787 ' HA ' ' HB3' ' A' ' 234' ' ' TRP . 2.9 m95 -89.45 121.96 32.18 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.078 -179.393 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.0 mt-10 -140.51 151.18 44.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.004 0.907 . . . . 0.0 113.196 -178.258 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 3.8 pp -117.36 156.51 27.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.125 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.476 HG22 ' CD1' ' A' ' 269' ' ' TRP . 1.3 p -128.91 162.92 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.719 0.295 . . . . 0.0 111.746 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -92.17 156.43 17.34 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.438 0.637 . . . . 0.0 111.367 179.481 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.67 ' O ' ' N ' ' A' ' 248' ' ' SER . 0.0 OUTLIER -127.86 87.8 2.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.768 179.174 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.508 ' O ' ' HG3' ' A' ' 267' ' ' ARG . . . 55.29 -46.83 0.01 OUTLIER Glycine 0 C--N 1.341 0.818 0 CA-C-O 121.402 0.446 . . . . 0.0 113.948 179.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.813 ' HB3' ' CE1' ' A' ' 229' ' ' HIS . 4.1 m -38.81 85.26 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.599 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.633 ' O ' ' HG ' ' A' ' 249' ' ' LEU . 8.7 tp -55.5 2.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 -178.49 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.579 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . 3.8 m120 -71.67 15.92 0.13 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.568 1.531 . . . . 0.0 111.511 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 249' ' ' LEU . . . 42.49 84.64 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.111 179.606 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -47.43 156.45 0.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.714 0.257 . . . . 0.0 110.593 179.406 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.556 HD21 ' O ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -144.8 128.94 17.66 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.05 0.453 . . . . 0.0 111.384 178.729 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.437 ' CG2' HG13 ' A' ' 281' ' ' ILE . 85.2 t -104.77 132.06 52.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.681 178.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 52.13 41.63 30.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.134 0.492 . . . . 0.0 110.15 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.62 24.49 11.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.969 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 9.6 m80 -127.39 108.71 11.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.037 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 3.3 t -58.56 97.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.148 0.499 . . . . 0.0 111.558 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.537 ' CG1' HG22 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -78.66 -54.74 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.717 -179.171 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.532 ' N ' HG12 ' A' ' 259' ' ' ILE . 6.9 p -51.43 165.99 0.14 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' A' ' 263' ' ' ASP . 23.1 p-80 -57.48 109.54 1.84 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 118.591 0.632 . . . . 0.0 112.059 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.24 21.68 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.039 2.493 . . . . 0.0 111.781 178.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 261' ' ' HIS . 2.1 m-20 -100.17 117.74 35.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.63 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 264' ' ' LEU . 3.8 mm? -69.12 155.93 39.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.285 -179.114 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 71.71 -10.96 3.62 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.927 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 268' ' ' LYS . 0.4 OUTLIER -80.48 -30.92 37.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.944 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 247' ' ' GLY . 0.0 OUTLIER 42.58 17.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.45 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 266' ' ' SER . 6.9 tptt -53.4 153.21 4.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.229 0.538 . . . . 0.0 110.993 -178.752 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.476 ' CD1' HG22 ' A' ' 244' ' ' VAL . 18.6 t-105 -67.72 -27.91 67.21 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.068 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.65 154.44 18.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.98 179.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.45 150.74 41.77 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.599 0.238 . . . . 0.0 110.624 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.39 144.54 31.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.36 2.04 . . . . 0.0 112.076 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 92.8 t -132.15 131.87 61.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.163 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.7 pm0 -80.74 132.87 35.58 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.229 -178.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 291' ' ' VAL . 0.0 OUTLIER -96.82 165.13 12.26 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.526 -179.74 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.6 162.14 36.21 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 20.3 p -69.97 132.84 46.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.253 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 277' ' ' SER . 42.7 m-20 82.98 -8.51 1.15 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.975 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -62.1 -168.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.193 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.503 ' CG2' ' HD1' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -161.11 120.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.406 178.341 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.4 OUTLIER -105.08 157.66 5.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.072 179.742 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.556 ' O ' HD21 ' A' ' 253' ' ' LEU . 1.7 m -143.02 120.7 11.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.605 ' HB2' ' CD2' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -117.7 47.1 1.61 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.298 -178.449 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.2 -137.13 3.68 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 119.418 -1.373 . . . . 0.0 113.044 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 12.1 t -90.01 -36.32 15.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.836 0.351 . . . . 0.0 110.598 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -151.92 0.91 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.866 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 24.5 m -75.65 105.22 6.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.62 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 281' ' ' ILE . 2.1 mtpt -122.99 127.51 48.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 111.246 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.453 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -107.69 133.59 52.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.537 -178.717 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.503 ' HD1' ' CG2' ' A' ' 280' ' ' ILE . 2.0 t80 -77.38 131.16 37.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.897 0.379 . . . . 0.0 110.098 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.592 ' HA ' HD13 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -103.05 117.87 49.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.304 -178.906 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.629 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -137.6 141.66 41.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.033 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 6.2 mt -136.27 133.0 49.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.735 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 22.7 t -133.18 158.78 41.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.963 0.411 . . . . 0.0 111.264 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.7 150.34 21.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.654 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.483 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 9.1 tp-100 -109.7 139.16 45.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.705 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -86.05 104.44 15.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.381 -179.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.899 179.599 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.573 ' O ' ' OG1' ' A' ' 201' ' ' THR . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 CA-C-O 120.798 0.332 . . . . 0.0 111.517 . . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.419 ' O ' ' CG2' ' A' ' 201' ' ' THR . . . 117.08 103.27 2.27 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.193 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 2.1 t -70.87 101.31 2.11 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.593 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 1.5 m -145.93 164.6 31.51 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.575 ' CB ' ' CZ ' ' A' ' 183' ' ' PHE . 90.8 m95 -156.97 146.78 20.74 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.583 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.532 HD11 HG12 ' A' ' 293' ' ' ILE . 0.2 OUTLIER -122.8 106.45 10.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 113.64 -1.618 . . . . 0.0 106.797 176.155 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.575 ' CZ ' ' CB ' ' A' ' 181' ' ' TRP . 1.8 m-85 -105.83 138.53 41.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.936 0.874 . . . . 0.0 113.007 -177.685 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -135.63 146.57 48.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.067 177.406 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 1.6 tt0 -140.9 127.4 20.02 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -176.841 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.626 ' CG1' HD11 ' A' ' 220' ' ' LEU . 10.7 t -62.14 116.51 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.173 178.363 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.567 HG22 ' HB3' ' A' ' 288' ' ' LYS . 6.1 tt -97.22 -22.47 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.516 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.737 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.28 91.21 0.69 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.84 -177.64 35.08 Favored Glycine 0 C--O 1.228 -0.224 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 178.161 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.488 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 84.4 Cg_endo -76.99 32.72 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.907 1.738 . . . . 0.0 111.802 178.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.747 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -161.47 28.74 0.13 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.617 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -47.74 111.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.379 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.94 10.06 2.94 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.683 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.747 HD13 ' O ' ' A' ' 191' ' ' ALA . 0.4 OUTLIER -101.39 105.38 16.41 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.983 0.897 . . . . 0.0 109.944 178.837 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.467 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 8.5 mt-30 -105.83 156.19 18.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.715 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.616 ' CE1' HD11 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -149.44 147.2 27.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.299 179.716 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.489 ' HB2' ' CD2' ' A' ' 183' ' ' PHE . . . -149.02 158.29 44.07 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.587 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.716 HG22 ' HA ' ' A' ' 206' ' ' LEU . 9.8 p -159.96 148.57 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.655 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 180' ' ' SER . 2.1 m120 -85.49 140.72 30.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.863 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.929 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 9.8 m -56.71 -10.93 1.14 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.635 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 177' ' ' LEU . 4.2 t -97.14 9.07 43.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.797 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.64 ' OG ' ' HG2' ' A' ' 205' ' ' LYS . 0.1 OUTLIER -96.53 103.14 15.03 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.932 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.509 ' O ' HD13 ' A' ' 206' ' ' LEU . 1.9 m -62.98 -89.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.62 13.25 7.25 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.981 -0.449 . . . . 0.0 111.642 -179.098 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.64 ' HG2' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -111.51 -2.61 15.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.645 -179.447 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.852 HD21 ' C ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -100.35 -27.67 0.23 Allowed Pre-proline 0 C--O 1.232 0.15 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.867 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 206' ' ' LEU . 9.7 Cg_endo -54.1 100.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.867 0 CA-C-N 121.329 1.51 . . . . 0.0 111.11 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.609 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 59.5 t -68.46 155.22 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.273 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.566 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -135.87 90.48 2.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 -179.164 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.9 OUTLIER -81.45 127.77 33.16 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.638 -179.99 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.586 ' HA2' HG22 ' A' ' 225' ' ' VAL . . . -172.56 171.44 44.32 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.066 -179.623 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.812 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 5.3 ttm180 -67.04 -74.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.297 0.57 . . . . 0.0 111.774 -179.625 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.497 HG12 ' N ' ' A' ' 214' ' ' SER . 9.4 p -124.15 -138.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.278 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.599 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 0.7 OUTLIER 59.74 179.26 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 119.131 0.878 . . . . 0.0 109.606 -179.966 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 38.4 Cg_endo -67.43 25.86 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.039 1.826 . . . . 0.0 113.758 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -58.43 152.7 17.3 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.686 0.279 . . . . 0.0 110.695 179.471 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -79.94 -32.0 40.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.379 . . . . 0.0 110.117 179.484 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.723 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.2 mt -106.48 129.05 54.51 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.373 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.655 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -92.71 81.47 4.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.791 0.329 . . . . 0.0 111.502 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.723 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 2.5 mm? -108.48 62.22 0.61 Allowed 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.812 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 10.2 pttt -51.91 55.8 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -177.482 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 220' ' ' LEU . 22.1 t0 -100.62 149.64 23.55 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.759 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 29.5 t -64.47 -34.61 78.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.477 -179.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.457 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 0.0 OUTLIER -48.9 -39.94 27.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.442 -179.591 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.63 HG12 ' HB2' ' A' ' 212' ' ' ARG . 2.3 p -103.45 89.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.448 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -34.82 -45.77 0.27 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.705 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.37 -53.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.535 ' HB2' ' SD ' ' A' ' 246' ' ' MET . 0.0 OUTLIER -144.71 135.2 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.194 0.521 . . . . 0.0 109.667 178.73 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.679 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.8 OUTLIER -104.2 -56.08 2.25 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.284 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.448 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -141.76 172.42 12.71 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.506 0.669 . . . . 0.0 112.485 -178.27 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.609 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 1.5 pt20 -158.52 173.46 16.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.319 179.648 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 9.8 mt -134.31 151.58 32.37 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.481 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -162.01 148.18 13.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.713 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.929 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 2.5 p90 -130.17 163.24 27.09 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.369 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.47 123.79 50.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.256 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 24.1 t -84.01 -1.77 55.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.099 179.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.5 m -80.8 -33.74 34.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.599 0.714 . . . . 0.0 109.984 179.15 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 19.5 tptm -129.41 16.3 6.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.95 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.408 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 9.0 p90 40.05 60.3 1.76 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.476 0.655 . . . . 0.0 109.545 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.574 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.2 OUTLIER -123.81 138.55 54.48 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.364 179.661 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.639 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -117.2 114.77 24.13 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.123 178.761 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 35.3 mt-10 -130.83 141.88 50.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.757 0.789 . . . . 0.0 112.373 -177.85 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.8 pp -108.26 152.6 24.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.125 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.52 HG22 ' CD1' ' A' ' 269' ' ' TRP . 0.7 OUTLIER -123.44 162.24 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.573 -179.404 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.676 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 1.1 m-20 -111.28 101.09 9.6 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.914 178.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.845 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -84.94 106.5 16.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.971 0.415 . . . . 0.0 109.924 179.347 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.517 ' HA2' ' HG3' ' A' ' 267' ' ' ARG . . . 48.19 67.31 1.65 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.803 -178.813 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.561 ' O ' ' CE1' ' A' ' 261' ' ' HIS . 0.3 OUTLIER -89.04 74.6 8.08 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.42 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.7 HD12 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -51.34 -56.26 14.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.611 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.7 ' H ' HD12 ' A' ' 249' ' ' LEU . 1.2 t-20 -71.07 -25.96 62.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.167 0.508 . . . . 0.0 110.965 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.57 ' HA3' ' CD2' ' A' ' 261' ' ' HIS . . . 89.49 136.79 6.15 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.483 -0.78 . . . . 0.0 113.753 179.479 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 282' ' ' THR . 24.1 m -100.71 155.68 17.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.117 179.284 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -146.57 145.45 30.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.087 0.47 . . . . 0.0 111.615 179.623 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.55 ' N ' HD13 ' A' ' 259' ' ' ILE . 45.6 t -114.09 131.19 66.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.345 179.026 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.61 ' HA ' HG13 ' A' ' 280' ' ' ILE . 11.1 p30 51.37 39.68 24.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.517 -178.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 256' ' ' SER . . . . . 0.502 ' N ' HD12 ' A' ' 280' ' ' ILE . 4.4 p 72.17 37.11 1.01 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.692 179.107 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.84 117.0 6.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.069 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 83.8 p -64.68 87.6 0.06 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.504 0.669 . . . . 0.0 110.655 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.676 HG12 ' HG ' ' A' ' 260' ' ' SER . 0.2 OUTLIER -83.89 -17.9 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.82 -177.952 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.74 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 20.3 m -120.21 -14.99 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -177.388 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.654 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 67.9 t60 -110.41 41.37 0.17 Allowed Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 177.429 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.74 ' HD3' ' C ' ' A' ' 260' ' ' SER . 23.6 Cg_exo -64.92 -4.38 8.7 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.546 1.497 . . . . 0.0 113.273 -179.345 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.458 ' CG ' ' HB2' ' A' ' 266' ' ' SER . 14.8 t0 -138.82 99.79 3.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.283 0.563 . . . . 0.0 111.501 -179.861 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.623 ' HA ' ' CE1' ' A' ' 261' ' ' HIS . 0.1 OUTLIER -50.58 -79.95 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.494 -178.962 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -46.35 -20.75 0.6 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.818 -0.706 . . . . 0.0 114.001 -178.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.458 ' HB2' ' CG ' ' A' ' 263' ' ' ASP . 0.4 OUTLIER -70.01 -42.44 73.02 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.301 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.517 ' HG3' ' HA2' ' A' ' 247' ' ' GLY . 2.2 ttt180 50.77 24.95 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 110.114 -179.169 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.435 ' CD ' ' HA2' ' A' ' 270' ' ' GLY . 0.6 OUTLIER -58.16 156.24 9.98 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.032 -178.838 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.845 ' CZ3' ' HB2' ' A' ' 246' ' ' MET . 46.1 t-105 -70.01 -24.46 63.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.361 179.526 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.435 ' HA2' ' CD ' ' A' ' 268' ' ' LYS . . . 70.88 170.74 9.99 Favored Glycine 0 CA--C 1.512 -0.141 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.932 178.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -102.62 146.66 32.78 Favored Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.221 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.636 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 51.3 Cg_exo -54.14 121.75 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.04 1.827 . . . . 0.0 112.574 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 70.1 t -99.22 133.15 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -78.46 123.73 27.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.622 -178.89 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.712 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -89.12 165.12 14.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.656 179.752 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.54 161.57 38.78 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.404 -0.518 . . . . 0.0 112.273 -179.117 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.2 OUTLIER -62.3 124.44 20.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.359 179.361 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 277' ' ' SER . 10.1 m-20 88.58 7.71 0.14 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.499 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.7 OUTLIER -79.01 -169.33 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.361 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.682 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -160.04 129.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.059 178.163 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.587 ' O ' ' HG2' ' A' ' 288' ' ' LYS . 0.8 OUTLIER -109.84 152.31 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.669 178.783 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 252' ' ' THR . 0.2 OUTLIER -138.54 126.77 22.86 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.925 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.679 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -120.03 40.56 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.201 -178.794 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 177.57 -131.3 1.76 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.613 -1.279 . . . . 0.0 113.533 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.1 t -89.28 -43.9 10.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 110.797 -179.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.9 t -146.58 -1.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.439 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.737 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.9 m -68.99 99.9 1.14 Allowed 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.35 179.054 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.641 ' HD3' ' HB ' ' A' ' 280' ' ' ILE . 1.3 ttmt -118.34 131.0 56.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.459 -178.572 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -114.03 132.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 121.381 -0.128 . . . . 0.0 111.085 -179.486 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.682 ' HD1' HG23 ' A' ' 280' ' ' ILE . 1.1 t80 -77.35 142.22 39.46 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 110.647 -178.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.42 HG12 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -110.39 115.97 51.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.631 -179.268 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -138.72 153.21 48.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.085 -179.629 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.532 HG12 HD11 ' A' ' 182' ' ' LEU . 3.8 mt -144.23 120.72 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.345 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.03 158.57 39.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.947 0.403 . . . . 0.0 110.975 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.4 p -101.34 -173.49 2.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.671 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.17 130.62 54.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -164.14 95.89 0.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.806 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.864 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.494 ' HA ' HG21 ' A' ' 201' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.588 0.233 . . . . 0.0 110.452 . . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.67 60.29 0.35 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.83 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.414 ' HB2' HG23 ' A' ' 201' ' ' THR . 1.3 m -128.52 -70.28 0.69 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -136.11 -176.1 4.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.085 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.692 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 23.8 m95 -145.83 131.44 18.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.9 OUTLIER -115.13 124.04 50.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.703 176.551 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.692 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 7.5 m-85 -124.64 133.82 53.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.39 0.614 . . . . 0.0 110.776 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.633 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -139.75 149.35 43.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.9 178.289 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.555 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 13.1 tt0 -141.23 128.4 20.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.448 HG13 ' CD1' ' A' ' 220' ' ' LEU . 48.2 t -65.52 112.65 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.385 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' LYS . 5.6 tt -97.25 -21.64 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -176.075 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.834 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -157.96 92.38 1.18 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.564 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.626 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.1 -163.69 16.37 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.498 ' HD3' ' OD2' ' A' ' 222' ' ' ASP . 91.6 Cg_endo -85.73 28.6 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.96 2.44 . . . . 0.0 110.971 178.277 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.599 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -160.22 23.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.981 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.626 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.6 mt -39.57 109.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 111.675 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.32 10.12 3.11 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.902 -1.142 . . . . 0.0 113.438 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER -96.65 129.12 44.1 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.754 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.555 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 15.8 mt-30 -128.96 151.5 49.61 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.264 -178.367 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.608 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -145.14 145.4 31.37 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.18 179.943 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -149.74 154.44 38.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.893 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.426 ' CG2' ' HA ' ' A' ' 206' ' ' LEU . 7.5 p -164.89 153.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 110.818 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 180' ' ' SER . 4.3 m120 -90.19 149.4 22.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.64 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.501 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 49.2 p -65.5 -9.22 24.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.691 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.494 HG21 ' HA ' ' A' ' 177' ' ' LEU . 2.3 t -96.64 25.33 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.461 0.648 . . . . 0.0 110.098 178.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.475 ' HB3' ' CG ' ' A' ' 205' ' ' LYS . 35.8 m -104.3 119.14 38.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.432 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 70.2 m -66.71 -84.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.968 -179.122 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 47.7 m -105.12 26.78 8.9 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.475 ' CG ' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -117.85 -14.49 10.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.788 0.328 . . . . 0.0 111.141 179.596 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.661 ' N ' ' HD2' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -81.4 -38.03 0.92 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.163 -179.527 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 206' ' ' LEU . 9.7 Cg_endo -54.11 102.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 120.875 1.05 . . . . 0.0 111.676 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.546 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 40.8 t -68.91 159.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.206 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 41.0 mtmt -140.6 95.62 2.89 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.471 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.455 HD13 ' C ' ' A' ' 230' ' ' ALA . 0.4 OUTLIER -83.84 123.94 30.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.382 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.538 ' HA3' ' OG ' ' A' ' 216' ' ' SER . . . -159.55 163.09 33.35 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.195 -179.423 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.775 ' HD2' ' HB ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -60.15 -91.05 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.302 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.427 ' H ' ' HB3' ' A' ' 212' ' ' ARG . 7.5 p -116.37 -15.15 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 0.0 110.938 -179.27 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.775 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 52.9 m -51.78 174.04 0.12 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.783 178.59 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 19.3 Cg_endo -58.36 7.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.062 1.841 . . . . 0.0 112.942 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.541 ' H ' ' C ' ' A' ' 214' ' ' SER . 17.8 m -45.81 157.42 0.11 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.949 0.405 . . . . 0.0 111.479 179.648 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.535 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -71.06 -32.28 68.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.896 -179.256 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.468 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 12.0 mt -106.52 129.57 54.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.028 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.46 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -90.31 85.8 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 111.689 -179.563 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.749 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.3 mm? -105.28 83.72 2.01 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 44.17 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.67 ' CA ' ' HD3' ' A' ' 212' ' ' ARG . 0.7 OUTLIER -76.56 167.34 22.01 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 122.255 -0.278 . . . . 0.0 110.554 179.318 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.4 p -95.27 -0.97 52.4 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 179.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.22 -27.25 13.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.917 0.78 . . . . 0.0 112.763 -176.891 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.775 ' HB ' ' HD2' ' A' ' 212' ' ' ARG . 32.7 t -92.97 91.3 3.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.055 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.98 -41.77 3.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.378 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.39 -57.51 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.055 179.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.439 ' HB2' ' HG2' ' A' ' 246' ' ' MET . 8.0 mttt -146.38 130.55 17.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.003 0.43 . . . . 0.0 111.151 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.518 ' ND1' HG23 ' A' ' 225' ' ' VAL . 1.4 t60 -90.59 -57.92 2.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.458 178.021 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.455 ' C ' HD13 ' A' ' 210' ' ' LEU . . . -147.67 -175.0 4.69 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.638 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.635 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -163.7 177.53 8.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.396 179.648 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 17.7 mt -137.82 147.53 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.301 0.572 . . . . 0.0 112.51 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.48 147.16 13.88 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.131 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.827 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.6 p90 -137.79 165.66 25.9 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -178.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.572 ' HB2' ' HD2' ' A' ' 240' ' ' LYS . 1.4 m-80 -117.57 133.65 55.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.204 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.1 m -89.52 4.9 47.74 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.609 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.6 m -77.83 -37.5 48.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.821 0.819 . . . . 0.0 109.653 178.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 6.1 tptm -126.26 14.98 7.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.261 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 238' ' ' LYS . 18.6 p90 41.68 61.22 1.93 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.933 0.873 . . . . 0.0 108.673 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.827 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -128.5 145.97 50.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.259 -179.855 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.645 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -128.92 125.53 37.74 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.021 -178.914 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 9.5 pt-20 -138.53 146.91 42.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.842 0.83 . . . . 0.0 113.116 -178.254 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 2.4 pp -112.19 152.11 28.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.773 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.622 HG12 ' CZ3' ' A' ' 269' ' ' TRP . 7.3 p -117.06 163.82 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.42 0.152 . . . . 0.0 110.962 -179.158 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.468 ' OD2' ' HA3' ' A' ' 270' ' ' GLY . 0.0 OUTLIER -107.33 105.95 16.15 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.52 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 2.3 tpt -78.43 103.68 8.53 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.129 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 267' ' ' ARG . . . 55.3 65.07 3.81 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.005 -178.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.9 p -68.21 53.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.761 HD23 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.55 -50.61 72.53 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.297 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.761 ' N ' HD23 ' A' ' 249' ' ' LEU . 6.1 t-20 -79.19 -34.78 42.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.053 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.413 ' O ' HD21 ' A' ' 253' ' ' LEU . . . 89.84 102.1 1.11 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.238 179.732 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 258' ' ' SER . 0.5 OUTLIER -56.88 163.99 1.73 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.893 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.668 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -154.31 136.59 14.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.424 0.63 . . . . 0.0 112.458 179.99 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.419 ' CG2' HG12 ' A' ' 281' ' ' ILE . 53.3 t -109.15 133.55 53.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.244 178.464 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.514 ' HA ' HG13 ' A' ' 280' ' ' ILE . 14.4 p30 49.56 33.9 6.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.177 0.513 . . . . 0.0 110.695 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 4.1 m 76.83 27.79 0.72 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.83 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . 0.402 ' O ' HG21 ' A' ' 259' ' ' ILE . 0.0 OUTLIER -129.65 110.12 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.147 179.494 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 252' ' ' THR . 86.5 p -62.97 84.71 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.171 0.51 . . . . 0.0 111.748 -179.275 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.545 ' CG1' HG23 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -79.82 -8.19 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.12 -179.481 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 2.0 m -91.42 -13.71 31.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.666 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 2.8 t-160 -105.99 16.57 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.82 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 71.1 Cg_exo -49.51 -44.83 33.47 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.399 1.4 . . . . 0.0 110.338 178.72 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 266' ' ' SER . 29.0 p-10 -76.02 95.4 3.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 113.308 -1.769 . . . . 0.0 111.177 -179.377 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.403 ' N ' HD21 ' A' ' 264' ' ' LEU . 3.7 mm? -70.09 139.15 52.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.584 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 78.58 -1.64 71.24 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.907 -179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.599 ' O ' ' HB2' ' A' ' 267' ' ' ARG . 0.4 OUTLIER -82.51 -72.93 0.42 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.957 0.378 . . . . 0.0 110.888 -179.751 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.0 OUTLIER 73.48 -21.35 0.26 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.307 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' A' ' 266' ' ' SER . 0.0 OUTLIER -72.94 -132.89 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -176.881 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.622 ' CZ3' HG12 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -76.12 -26.05 55.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.87 -178.159 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.468 ' HA3' ' OD2' ' A' ' 245' ' ' ASP . . . 61.85 -173.54 7.61 Favored Glycine 0 CA--C 1.515 0.093 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.266 -179.081 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -108.36 148.16 37.07 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 117.846 0.823 . . . . 0.0 111.239 -179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.685 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 31.9 Cg_exo -60.06 122.57 11.59 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.08 2.52 . . . . 0.0 114.008 -178.751 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 71.4 t -98.95 138.01 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.656 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.2 mp0 -83.03 127.48 33.6 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.987 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.5 ' H ' ' CD1' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.32 164.16 13.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.776 179.81 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -141.76 158.11 44.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.268 0.556 . . . . 0.0 112.181 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 10.8 p -55.39 128.55 34.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.928 179.532 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 81.13 8.49 1.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.693 179.829 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.518 ' O ' HG21 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -88.4 137.17 32.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.001 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.514 HG13 ' HA ' ' A' ' 255' ' ' ASN . 1.0 OUTLIER -97.43 129.62 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.664 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.71 ' O ' ' CG2' ' A' ' 281' ' ' ILE . 0.4 OUTLIER -112.39 94.39 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -178.748 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.668 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 7.0 m -82.94 142.49 31.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.495 ' HB2' ' CD2' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -134.76 47.43 2.37 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.04 -179.865 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.85 -125.23 1.1 Allowed Glycine 0 C--N 1.329 0.194 0 C-N-CA 119.879 -1.153 . . . . 0.0 113.469 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.5 t -95.64 -45.32 7.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.717 0.294 . . . . 0.0 110.747 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.66 -0.17 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.812 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.834 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 25.5 m -75.4 102.13 5.04 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.621 0.248 . . . . 0.0 111.345 -179.885 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.645 ' O ' HG23 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -122.44 131.43 53.87 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.498 0.666 . . . . 0.0 111.044 179.792 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.81 131.76 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.54 -177.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.0 OUTLIER -76.95 132.49 39.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.694 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 279' ' ' ASP . 2.5 t -110.89 117.35 54.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.634 -178.124 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.2 OUTLIER -136.73 150.99 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.847 -179.464 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.452 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 3.1 mt -143.21 127.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.366 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.61 153.34 43.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.813 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 5.0 m -85.94 168.07 14.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.137 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -114.28 117.81 32.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -80.85 89.85 5.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.953 179.854 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.686 ' HB2' HG23 ' A' ' 201' ' ' THR . 19.9 mt . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 120.447 0.165 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.557 ' N ' HG22 ' A' ' 201' ' ' THR . . . 98.37 94.34 1.99 Allowed Glycine 0 C--N 1.341 0.807 0 C-N-CA 121.151 -0.547 . . . . 0.0 114.112 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.686 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 4.6 t -178.98 -91.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.675 0.238 . . . . 0.0 111.143 179.194 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -137.22 179.93 6.1 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.577 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.675 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 3.2 m95 -143.52 130.88 20.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.4 OUTLIER -122.08 130.28 53.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.017 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 0.2 OUTLIER -133.18 146.22 51.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.77 0.795 . . . . 0.0 111.393 179.979 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -146.84 153.32 40.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.009 178.955 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.511 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 0.1 OUTLIER -142.02 133.35 26.44 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.183 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.791 ' HA ' HG22 ' A' ' 289' ' ' VAL . 40.0 t -66.4 116.04 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.017 0.436 . . . . 0.0 110.148 177.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 5.2 tt -97.45 -24.16 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.83 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -160.11 93.55 1.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.677 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.91 -173.25 30.34 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 178.357 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.603 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 96.9 Cg_endo -80.16 32.65 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 CA-C-N 119.452 1.626 . . . . 0.0 111.587 178.684 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.559 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -162.95 23.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.627 178.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.677 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.8 mt -39.41 114.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 127.56 10.54 3.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.519 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.759 HD12 HD12 ' A' ' 220' ' ' LEU . 0.1 OUTLIER -99.66 131.16 45.83 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.964 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.511 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 20.9 mt-30 -128.01 153.89 46.24 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.358 -178.392 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.703 ' CD2' ' HB3' ' A' ' 217' ' ' ASP . 0.0 OUTLIER -145.57 146.03 31.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.165 178.968 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.56 144.51 29.62 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.273 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.689 HG22 ' HA ' ' A' ' 206' ' ' LEU . 10.2 p -146.51 147.81 17.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.332 0.587 . . . . 0.0 110.816 179.281 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 180' ' ' SER . 21.4 p30 -95.07 150.47 20.15 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.265 -179.45 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.494 ' N ' ' HZ2' ' A' ' 234' ' ' TRP . 48.2 t -70.67 1.04 5.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.474 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.686 ' HB ' ' HB2' ' A' ' 179' ' ' SER . 0.0 OUTLIER -104.17 11.63 34.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.25 0.548 . . . . 0.0 110.784 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.4 m -91.3 132.13 36.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.059 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.47 -77.41 0.39 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.261 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.5 m -101.68 20.62 15.87 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.735 0.303 . . . . 0.0 111.59 -179.287 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.441 ' HE3' HD13 ' A' ' 177' ' ' LEU . 7.3 pttt -123.16 -15.03 7.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.942 0.401 . . . . 0.0 110.807 179.447 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.713 HD13 ' CE2' ' A' ' 234' ' ' TRP . 6.9 tt -59.08 -60.51 10.31 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.405 -179.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -42.59 98.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.629 2.219 . . . . 0.0 113.016 -178.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 59.7 t -68.04 163.57 2.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.326 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.712 ' O ' ' HB2' ' A' ' 217' ' ' ASP . 0.5 OUTLIER -142.64 115.09 8.49 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.222 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.702 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 0.0 OUTLIER -116.67 145.88 43.13 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.657 -0.652 . . . . 0.0 111.236 178.145 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.427 ' HA2' HG23 ' A' ' 225' ' ' VAL . . . 170.85 -174.74 44.7 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.753 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.663 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -65.11 -77.4 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.054 0.454 . . . . 0.0 111.85 -178.89 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.564 ' HB ' ' HE ' ' A' ' 212' ' ' ARG . 13.7 p -128.28 -138.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.234 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.735 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 5.0 m 67.39 173.59 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 118.897 0.771 . . . . 0.0 109.378 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.735 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 40.0 Cg_endo -66.59 18.15 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.907 1.738 . . . . 0.0 112.694 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.522 ' H ' ' C ' ' A' ' 214' ' ' SER . 1.9 m -54.91 178.68 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.721 0.296 . . . . 0.0 110.739 179.851 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.712 ' HB2' ' O ' ' A' ' 209' ' ' LYS . 14.0 m-20 -100.98 -35.87 9.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.469 -179.591 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.702 ' HB2' ' HA ' ' A' ' 210' ' ' LEU . 6.2 mt -100.39 129.08 46.32 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.231 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.468 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -95.04 79.19 3.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.633 0.254 . . . . 0.0 110.634 -179.736 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.759 HD12 HD12 ' A' ' 194' ' ' LEU . 3.0 mm? -100.74 66.37 1.2 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.74 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.663 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 1.8 pttt -50.22 69.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.825 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 220' ' ' LEU . 2.5 t0 -124.72 140.05 53.29 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.214 0.53 . . . . 0.0 110.05 178.104 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.9 t -54.96 -40.34 69.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.437 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -41.94 -42.97 2.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.364 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.784 ' HB ' ' HD1' ' A' ' 229' ' ' HIS . 2.4 p -102.36 79.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.215 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -33.05 -42.43 0.08 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.114 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.17 -55.79 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.035 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 246' ' ' MET . 30.4 mtmm -145.17 129.46 17.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.156 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.784 ' HD1' ' HB ' ' A' ' 225' ' ' VAL . 0.1 OUTLIER -93.88 -53.53 3.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.118 179.702 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.696 ' HB3' HG23 ' A' ' 252' ' ' THR . . . -151.33 -179.22 7.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.683 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.638 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.4 OUTLIER -161.2 -178.01 6.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.295 178.404 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 23.7 mt -140.52 148.67 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.17 0.509 . . . . 0.0 111.482 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.68 137.2 8.7 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.735 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.874 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 3.2 p90 -131.62 166.46 21.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.616 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.5 ' CB ' ' HD2' ' A' ' 240' ' ' LYS . 11.0 t-20 -116.43 134.17 55.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.868 -1.514 . . . . 0.0 112.953 -178.671 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.5 t -90.53 -1.1 57.88 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.946 178.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.4 m -77.02 -28.95 55.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.718 0.771 . . . . 0.0 110.015 178.509 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.45 15.09 3.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.693 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.4 p90 41.9 58.97 2.69 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.874 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -126.34 145.87 50.26 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.712 -179.612 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.684 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -129.51 124.86 35.0 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.035 -178.935 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -139.71 142.7 36.86 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.758 0.79 . . . . 0.0 112.78 -178.181 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.638 ' HB2' ' O ' ' A' ' 231' ' ' GLN . 1.8 pp -108.07 156.38 19.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.221 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.67 HG23 ' CE3' ' A' ' 269' ' ' TRP . 5.1 p -124.47 163.24 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.592 ' CG ' ' HB3' ' A' ' 260' ' ' SER . 6.6 m-20 -107.91 125.47 51.53 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.152 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.764 ' N ' ' HE3' ' A' ' 246' ' ' MET . 0.0 OUTLIER -85.77 94.28 9.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.738 178.374 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 47.74 68.4 1.22 Allowed Glycine 0 C--N 1.329 0.16 0 C-N-CA 119.544 -1.312 . . . . 0.0 110.475 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 261' ' ' HIS . 85.8 p -64.32 58.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.685 HD11 ' N ' ' A' ' 250' ' ' ASN . 1.2 tm? -54.26 -60.63 3.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.224 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.685 ' N ' HD11 ' A' ' 249' ' ' LEU . 1.1 t-20 -71.1 -30.16 66.18 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.006 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.476 ' CA ' ' CG ' ' A' ' 261' ' ' HIS . . . 100.48 118.66 4.28 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.672 178.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.696 HG23 ' HB3' ' A' ' 230' ' ' ALA . 1.4 m -92.74 105.59 17.7 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -98.75 139.25 34.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 112.367 -178.279 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.542 ' N ' HD11 ' A' ' 259' ' ' ILE . 41.4 t -109.61 127.42 66.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.953 178.126 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.597 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 7.2 t-20 55.01 38.34 30.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.082 0.468 . . . . 0.0 110.248 -178.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.38 34.96 12.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.594 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . 0.437 ' O ' HG21 ' A' ' 259' ' ' ILE . 0.5 OUTLIER -140.96 113.18 7.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.522 -179.84 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.467 ' CB ' ' NE2' ' A' ' 261' ' ' HIS . 83.7 p -58.9 88.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.533 0.683 . . . . 0.0 110.562 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.784 HD13 ' H ' ' A' ' 259' ' ' ILE . 0.2 OUTLIER -88.67 -21.8 6.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.222 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.78 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 0.1 OUTLIER -127.73 -12.89 5.38 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.457 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.655 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 16.6 p80 -110.51 43.04 0.2 Allowed Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 177.53 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.78 ' HD3' ' C ' ' A' ' 260' ' ' SER . 21.8 Cg_exo -66.93 -4.45 11.39 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.86 1.707 . . . . 0.0 113.564 -178.839 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 266' ' ' SER . 5.0 m-20 -137.46 97.44 3.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.318 . . . . 0.0 111.291 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.469 ' N ' HD22 ' A' ' 264' ' ' LEU . 4.3 mm? -56.12 -55.85 28.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.242 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.3 -18.23 34.94 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.022 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 263' ' ' ASP . 34.9 m -81.97 -35.95 28.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.955 0.407 . . . . 0.0 111.957 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 24.9 ttp180 48.99 26.0 1.23 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.198 0.523 . . . . 0.0 110.304 -178.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 169.94 12.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.38 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.67 ' CE3' HG23 ' A' ' 244' ' ' VAL . 83.7 m95 -80.33 -20.58 43.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.306 178.371 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.489 ' HA3' ' HG ' ' A' ' 260' ' ' SER . . . 68.87 174.96 10.09 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -177.326 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.69 125.27 65.6 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 118.141 0.971 . . . . 0.0 110.52 -179.486 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.593 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.1 Cg_exo -35.25 119.63 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.807 2.338 . . . . 0.0 111.638 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 97.7 t -101.15 136.6 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.671 -177.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 11.9 mt-10 -82.4 128.38 34.19 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.868 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.661 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.17 165.2 13.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.992 -179.464 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.657 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.08 159.03 43.05 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.671 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 84.9 p -62.89 130.71 46.0 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.426 179.188 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.671 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.5 OUTLIER 83.66 -0.66 1.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.122 -179.237 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.657 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -71.07 -170.27 0.44 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.597 ' CD1' ' HA ' ' A' ' 255' ' ' ASN . 0.8 OUTLIER -162.07 124.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 177.349 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 288' ' ' LYS . 0.0 OUTLIER -99.27 150.28 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.149 176.363 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.681 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 1.8 m -134.68 122.2 21.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.662 0.744 . . . . 0.0 109.357 178.091 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.644 ' CD2' HD22 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -122.13 136.93 54.97 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.593 179.598 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.463 ' HA2' ' CG ' ' A' ' 250' ' ' ASN . . . 88.11 -132.4 11.19 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.315 179.522 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.8 t -100.03 -33.43 10.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.445 0.164 . . . . 0.0 111.18 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -152.79 8.21 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.751 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.83 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 12.7 m -74.53 102.43 4.51 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.043 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.538 ' HD3' ' HB ' ' A' ' 280' ' ' ILE . 15.6 ttmt -120.04 125.37 48.16 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.63 -179.311 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 186' ' ' VAL . 1.0 OUTLIER -107.4 135.57 45.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.607 179.701 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.58 ' HD1' HG21 ' A' ' 280' ' ' ILE . 2.2 t80 -78.13 136.67 37.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.615 -179.393 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.587 HG12 ' HB2' ' A' ' 275' ' ' LEU . 1.8 t -105.45 114.86 46.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.393 -179.569 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -133.87 138.82 45.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.162 -179.636 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.454 ' CD1' ' CE3' ' A' ' 241' ' ' TRP . 14.2 mt -135.74 143.22 37.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 7.6 t -146.29 153.25 40.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.431 ' HA ' ' HG ' ' A' ' 180' ' ' SER . 78.2 p -86.16 162.51 18.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.312 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -106.05 125.31 50.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . 0.454 ' H ' ' ND2' ' A' ' 297' ' ' ASN . 2.9 p30 -78.87 88.28 4.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.088 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.459 HD23 HD22 ' A' ' 199' ' ' ASN . 1.0 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.93 57.69 0.33 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.429 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.553 ' HB2' HG21 ' A' ' 201' ' ' THR . 11.7 m -128.61 -69.02 0.73 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.833 0.349 . . . . 0.0 110.401 178.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.645 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.5 OUTLIER -135.21 178.23 7.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.406 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.698 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 22.0 m95 -144.29 130.9 20.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.642 ' HB3' ' CZ3' ' A' ' 234' ' ' TRP . 0.4 OUTLIER -121.44 107.95 13.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.035 177.883 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.698 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 0.9 OUTLIER -106.88 140.13 40.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.864 0.84 . . . . 0.0 112.081 -179.565 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.655 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -133.48 144.11 49.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.165 177.401 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.584 ' C ' HG11 ' A' ' 289' ' ' VAL . 16.1 tt0 -137.74 125.79 22.86 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.673 HG12 HD12 ' A' ' 220' ' ' LEU . 9.6 t -65.52 112.26 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.578 177.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.737 HG21 ' O ' ' A' ' 288' ' ' LYS . 7.4 tt -95.03 -22.44 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.102 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.863 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.85 93.75 0.56 Allowed 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 119.742 -0.783 . . . . 0.0 112.691 -179.331 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.733 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.63 -171.05 27.18 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 178.257 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.698 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 93.6 Cg_endo -79.41 30.57 0.47 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.053 1.835 . . . . 0.0 111.77 178.948 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.531 ' O ' ' HG ' ' A' ' 194' ' ' LEU . . . -161.59 27.29 0.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 178.314 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.733 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -41.2 107.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.818 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 8.17 2.26 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.741 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.582 ' CD1' HD13 ' A' ' 220' ' ' LEU . 0.1 OUTLIER -97.59 132.99 42.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.939 0.876 . . . . 0.0 108.705 177.878 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.546 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 17.8 mt-30 -133.22 152.9 51.94 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.211 -1.358 . . . . 0.0 110.193 -178.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.655 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -148.25 148.31 30.33 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.097 -179.757 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.439 ' C ' ' HZ3' ' A' ' 181' ' ' TRP . . . -147.42 140.07 24.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.337 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.781 HG23 ' HA ' ' A' ' 206' ' ' LEU . 5.2 p -143.29 149.6 18.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.427 0.632 . . . . 0.0 110.458 178.435 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 180' ' ' SER . 4.5 p30 -95.8 151.83 19.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.758 -179.516 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.525 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 80.5 p -67.41 -1.33 4.63 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -178.542 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.553 HG21 ' HB2' ' A' ' 179' ' ' SER . 0.6 OUTLIER -109.6 15.49 22.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.941 0.4 . . . . 0.0 111.27 179.265 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.52 143.93 26.66 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.064 179.26 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.0 m -89.04 -94.46 0.1 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.354 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.86 31.01 2.47 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.302 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.64 -11.73 8.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 110.751 179.18 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.781 ' HA ' HG23 ' A' ' 198' ' ' VAL . 4.7 tt -67.5 -58.04 9.27 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.591 -179.152 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -41.93 90.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.639 2.226 . . . . 0.0 112.438 -178.7 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 196' ' ' HIS . 2.2 t -71.56 91.0 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.209 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.405 ' HA ' ' HG3' ' A' ' 231' ' ' GLN . 12.2 mtmt -69.96 87.2 0.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 2.0 mp -74.55 128.67 36.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.807 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . -177.78 -177.33 46.51 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.486 -179.551 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.921 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.2 OUTLIER -57.18 -93.2 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.017 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 214' ' ' SER . 11.5 p -158.3 158.75 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.355 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.952 ' HB2' ' HD3' ' A' ' 215' ' ' PRO . 24.4 m 103.16 -74.06 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.831 179.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.952 ' HD3' ' HB2' ' A' ' 214' ' ' SER . 95.9 Cg_endo -96.01 -35.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.079 1.853 . . . . 0.0 113.182 179.545 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.463 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 0.9 OUTLIER -57.02 145.87 29.05 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.142 0.496 . . . . 0.0 112.209 -178.958 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.04 -33.06 69.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.454 179.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.761 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 1.6 mt -100.21 135.24 41.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.557 178.284 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.503 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -93.64 73.5 4.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.951 -178.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.921 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.1 mm? -99.48 94.69 6.54 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.776 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.698 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 28.0 pttt -65.11 53.63 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.232 0.539 . . . . 0.0 110.048 178.406 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 220' ' ' LEU . 4.1 m-20 -87.81 116.2 25.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.223 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 11.5 p -60.51 -15.53 28.07 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.877 -179.347 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.534 ' HG2' ' HB3' ' A' ' 222' ' ' ASP . 0.0 OUTLIER -79.22 -21.33 46.41 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.576 0.227 . . . . 0.0 110.838 179.686 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.941 ' HB ' ' HD1' ' A' ' 229' ' ' HIS . 2.8 p -107.61 80.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.16 -30.22 0.74 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 111.188 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -145.87 -59.66 0.02 OUTLIER Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.194 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.846 ' HB2' ' HG3' ' A' ' 246' ' ' MET . 0.3 OUTLIER -144.49 133.59 22.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.785 0.326 . . . . 0.0 110.354 -179.824 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.941 ' HD1' ' HB ' ' A' ' 225' ' ' VAL . 0.4 OUTLIER -93.43 -58.7 2.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.738 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 210' ' ' LEU . . . -147.45 165.48 30.13 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.788 -178.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.572 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 17.9 tt0 -143.11 157.44 44.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.657 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 23.7 mt -121.54 145.75 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.918 179.53 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.68 ' HA ' HD23 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -161.79 160.58 28.46 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.28 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.773 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 3.6 p90 -149.68 165.73 31.5 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -117.31 133.6 55.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.854 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -0.12 57.32 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.107 179.093 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -76.15 -20.15 57.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.659 0.742 . . . . 0.0 110.052 178.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.635 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 7.5 tptm -151.6 20.58 0.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.596 -178.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 23.8 p90 41.01 57.81 2.67 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.391 0.615 . . . . 0.0 109.926 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.773 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.8 OUTLIER -120.63 137.5 54.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.938 179.352 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.701 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -120.49 122.25 40.23 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.95 179.963 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 1.0 OUTLIER -139.37 142.25 37.56 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.941 0.876 . . . . 0.0 112.784 -178.391 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.812 HD21 HD13 ' A' ' 281' ' ' ILE . 3.0 pp -110.31 155.09 22.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.691 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.827 HG12 ' CZ3' ' A' ' 269' ' ' TRP . 5.0 p -117.33 163.02 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 122.239 -0.288 . . . . 0.0 111.102 -179.452 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 260' ' ' SER . 0.0 OUTLIER -105.95 113.09 26.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.318 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.846 ' HG3' ' HB2' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -81.39 105.77 12.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.665 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 267' ' ' ARG . . . 54.35 65.6 3.37 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.71 -178.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.504 ' HG ' ' HA2' ' A' ' 251' ' ' GLY . 0.3 OUTLIER -66.76 49.79 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.905 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.584 ' N ' HD11 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -58.11 -47.67 82.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.702 178.431 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.517 ' H ' HD11 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.38 -33.09 37.44 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.014 -179.159 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.504 ' HA2' ' HG ' ' A' ' 248' ' ' SER . . . 92.02 85.4 1.49 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.122 -178.851 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.627 ' HB ' ' OG ' ' A' ' 260' ' ' SER . 2.9 m -46.55 168.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.641 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.626 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -154.97 136.2 13.99 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 119.9 -0.72 . . . . 0.0 112.749 179.381 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.526 ' CG2' HG13 ' A' ' 281' ' ' ILE . 67.1 t -115.16 130.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.154 178.481 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . 0.539 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 1.1 t-20 56.16 37.68 29.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.106 0.479 . . . . 0.0 109.932 -179.25 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.67 25.69 9.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.637 -179.488 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -128.02 101.35 6.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.675 179.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 252' ' ' THR . 10.4 t -53.51 92.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.327 0.584 . . . . 0.0 111.167 -179.71 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.593 ' CG1' HG23 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -88.88 -9.14 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.004 -178.284 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.627 ' OG ' ' HB ' ' A' ' 252' ' ' THR . 25.2 m -92.04 -12.81 32.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.359 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.711 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 1.6 t-160 -106.35 22.53 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.711 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 31.3 Cg_exo -57.44 -44.82 38.97 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.288 1.325 . . . . 0.0 110.184 178.688 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.55 84.15 2.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.293 -179.176 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.445 ' H ' HD21 ' A' ' 264' ' ' LEU . 2.0 pt? -59.62 132.06 52.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.796 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.86 -13.11 61.83 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.883 -179.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.568 ' C ' ' H ' ' A' ' 268' ' ' LYS . 0.1 OUTLIER -72.56 -69.25 0.42 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 119.362 -0.351 . . . . 0.0 111.024 -179.855 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.3 OUTLIER 70.19 -20.98 0.18 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.671 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.568 ' H ' ' C ' ' A' ' 266' ' ' SER . 4.1 mtpp -73.82 -127.08 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.018 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.827 ' CZ3' HG12 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -80.31 -23.13 40.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.785 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.463 ' HA3' ' OD2' ' A' ' 245' ' ' ASP . . . 62.0 -175.74 6.39 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.241 -0.981 . . . . 0.0 110.929 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -105.6 141.74 23.29 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 117.983 0.891 . . . . 0.0 111.141 -179.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.692 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.1 Cg_exo -51.97 123.14 11.8 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.856 2.371 . . . . 0.0 113.517 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.593 HG23 ' CG1' ' A' ' 259' ' ' ILE . 95.2 t -100.9 140.91 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.272 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.1 mt-10 -86.92 129.24 34.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.745 -179.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.686 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -95.41 164.67 12.72 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.93 -179.516 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.601 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.67 157.4 45.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.905 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.618 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 29.3 t -61.02 129.44 41.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.25 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 277' ' ' SER . 5.8 m-20 82.43 -1.15 1.38 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.519 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.611 ' O ' HG21 ' A' ' 291' ' ' VAL . 0.1 OUTLIER -79.11 137.86 37.67 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.079 179.473 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.574 ' O ' HD13 ' A' ' 280' ' ' ILE . 1.1 pp -102.08 127.11 55.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.04 179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.812 HD13 HD21 ' A' ' 243' ' ' LEU . 0.4 OUTLIER -105.96 159.54 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.995 0.426 . . . . 0.0 111.287 178.971 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.626 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.9 m -145.54 122.91 11.62 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.149 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.518 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -119.01 47.93 1.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.833 -179.44 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.03 -134.9 3.1 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.85 -1.167 . . . . 0.0 113.042 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 1.8 t -87.8 -51.62 5.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 0.0 110.382 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.59 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -137.86 -2.19 1.93 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.292 179.337 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.863 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.6 m -70.92 102.77 2.47 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.885 0.374 . . . . 0.0 111.103 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.737 ' O ' HG21 ' A' ' 187' ' ' ILE . 0.4 OUTLIER -121.27 128.55 52.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.922 -179.215 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.683 HG22 ' CG2' ' A' ' 281' ' ' ILE . 0.0 OUTLIER -108.3 133.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.087 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.1 t80 -76.43 134.78 39.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.682 -179.221 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.611 HG21 ' O ' ' A' ' 279' ' ' ASP . 0.6 OUTLIER -104.38 113.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.044 -179.988 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -129.06 141.86 51.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.749 -179.785 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.567 HD11 ' CE3' ' A' ' 241' ' ' TRP . 6.6 mt -137.63 138.17 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.286 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.29 131.56 16.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.695 0.283 . . . . 0.0 111.071 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 23.8 p -79.77 143.19 34.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.091 0.472 . . . . 0.0 111.193 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.04 147.33 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.628 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -141.81 94.51 2.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.973 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 . . . . . 0 C--O 1.234 0.267 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.818 179.826 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.556 ' HB3' ' CG ' ' A' ' 199' ' ' ASN . 1.0 OUTLIER . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.375 0.131 . . . . 0.0 110.782 . . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.678 ' HA3' ' CG2' ' A' ' 201' ' ' THR . . . 117.2 158.93 11.28 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.837 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.843 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 0.4 OUTLIER -89.11 29.06 1.1 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.304 -0.448 . . . . 0.0 111.806 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.3 OUTLIER -153.58 146.97 24.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.229 0.538 . . . . 0.0 110.75 179.84 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' TRP . . . . . 0.683 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 37.0 m95 -148.16 139.44 23.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.38 -178.069 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.54 ' CD2' ' HZ3' ' A' ' 234' ' ' TRP . 0.9 OUTLIER -114.9 120.98 41.78 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.049 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 183' ' ' PHE . . . . . 0.683 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 2.3 m-85 -121.56 135.41 55.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.445 0.641 . . . . 0.0 110.358 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -140.57 148.36 40.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.355 179.211 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 1.7 tt0 -137.56 124.46 21.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.2 -177.556 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.579 ' CG1' HD11 ' A' ' 220' ' ' LEU . 40.3 t -63.05 108.74 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.379 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.453 HD13 HG23 ' A' ' 187' ' ' ILE . 10.9 tt -87.92 -26.64 5.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -176.118 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.866 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -158.8 96.31 1.35 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.443 -179.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.602 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.49 173.91 39.66 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 178.546 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.463 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 37.6 Cg_endo -69.47 32.92 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 121.823 1.682 . . . . 0.0 111.266 178.141 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.632 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -160.65 20.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.308 179.497 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.602 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.1 mt -38.94 108.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.721 0.296 . . . . 0.0 111.761 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.31 8.07 2.1 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.154 -1.022 . . . . 0.0 113.018 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.703 HD13 ' O ' ' A' ' 219' ' ' ALA . 0.8 OUTLIER -101.47 112.89 25.57 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.917 0.865 . . . . 0.0 109.74 178.75 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.441 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 5.7 mt-30 -114.65 154.69 27.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.565 -179.149 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.549 ' CD2' ' HB3' ' A' ' 217' ' ' ASP . 0.0 OUTLIER -147.84 148.08 30.5 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.381 0.61 . . . . 0.0 111.154 179.636 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -144.01 152.27 40.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.044 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.582 ' CG2' ' HA ' ' A' ' 206' ' ' LEU . 8.1 p -167.03 150.29 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.0 111.278 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.64 ' HA ' ' O ' ' A' ' 180' ' ' SER . 1.0 OUTLIER -92.46 155.28 17.95 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.369 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.647 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 3.6 m -56.3 -48.74 76.06 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.522 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.678 ' CG2' ' HA3' ' A' ' 178' ' ' GLY . 0.0 OUTLIER -67.66 14.11 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.251 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 202' ' ' SER . . . . . 0.528 ' HB2' ' O ' ' A' ' 199' ' ' ASN . 0.3 OUTLIER -91.99 118.89 31.2 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 110.005 179.2 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -67.14 -107.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.4 m -80.98 21.02 0.73 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.5 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -114.17 -19.23 11.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 178.944 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.759 HD21 ' CE3' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -70.71 -33.78 3.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.274 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 38.6 Cg_exo -55.47 101.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 121.016 1.144 . . . . 0.0 111.721 179.538 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.421 HG13 HD12 ' A' ' 184' ' ' LEU . 49.0 t -84.78 90.9 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.694 -179.163 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.609 ' HD2' ' HA ' ' A' ' 216' ' ' SER . 11.9 mttt -71.01 109.11 4.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.008 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 1.6 mp -94.38 131.78 39.68 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.013 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -179.55 -176.39 47.1 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.057 -179.575 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . 0.955 ' HB2' HG12 ' A' ' 225' ' ' VAL . 30.6 ttt-85 -80.76 -69.64 0.59 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.639 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 213' ' ' VAL . 9.1 p -141.88 118.8 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 0.0 110.529 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 214' ' ' SER . . . . . 0.564 ' C ' ' H ' ' A' ' 216' ' ' SER . 0.0 OUTLIER 168.9 176.85 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.735 -178.973 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 214' ' ' SER . 41.1 Cg_endo -67.47 23.5 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 121.831 1.687 . . . . 0.0 112.243 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 216' ' ' SER . . . . . 0.609 ' HA ' ' HD2' ' A' ' 209' ' ' LYS . 1.1 m -62.62 -151.77 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.438 179.806 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.549 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 52.1 m-20 -130.9 -34.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.957 0.408 . . . . 0.0 110.466 179.643 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.682 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 4.0 mt -103.71 125.33 50.12 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 177.111 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.703 ' O ' HD13 ' A' ' 194' ' ' LEU . . . -94.08 87.67 5.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.863 0.364 . . . . 0.0 110.223 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.77 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.0 mm? -110.45 92.42 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.168 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.48 36.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.214 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.836 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -64.67 111.88 2.95 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.076 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.5 p -53.02 -19.15 2.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.562 0.22 . . . . 0.0 111.322 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.452 ' O ' HD13 ' A' ' 249' ' ' LEU . 3.0 pm0 -75.36 -28.69 59.64 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.929 179.674 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.955 HG12 ' HB2' ' A' ' 212' ' ' ARG . 2.8 p -97.41 92.42 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.042 178.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.1 m -40.96 -40.71 1.47 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.371 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.4 -54.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.53 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . 0.65 ' HB3' ' HG3' ' A' ' 246' ' ' MET . 0.1 OUTLIER -144.25 126.69 15.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.749 0.309 . . . . 0.0 110.539 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.603 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.6 OUTLIER -96.54 -51.64 4.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.961 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.476 ' C ' HD11 ' A' ' 210' ' ' LEU . . . -142.42 165.44 27.41 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . 0.475 ' CG ' ' HA ' ' A' ' 209' ' ' LYS . 1.3 tm0? -149.89 160.88 43.23 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.597 179.471 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.9 mt -124.9 144.43 34.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 CA-C-O 121.271 0.557 . . . . 0.0 111.744 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.38 164.3 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.118 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 234' ' ' TRP . . . . . 0.813 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.8 p90 -157.58 167.46 30.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -115.0 131.72 56.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.542 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.49 -0.61 57.62 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.27 179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.1 m -73.6 -21.79 60.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.696 0.76 . . . . 0.0 110.168 178.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 239' ' ' PHE . 6.2 tptt -150.87 23.79 0.76 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.377 -178.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 238' ' ' LYS . 8.9 p90 38.31 60.48 1.28 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.521 0.677 . . . . 0.0 109.533 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.813 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -121.7 136.53 54.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.727 179.683 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 241' ' ' TRP . . . . . 0.68 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.2 OUTLIER -118.65 130.58 55.94 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.771 -179.905 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.458 ' CB ' ' O ' ' A' ' 273' ' ' VAL . 0.8 OUTLIER -137.09 132.7 34.47 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.427 0.632 . . . . 0.0 111.115 -177.815 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.737 HD13 ' N ' ' A' ' 244' ' ' VAL . 0.2 OUTLIER -110.08 136.97 48.49 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.131 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.737 ' N ' HD13 ' A' ' 243' ' ' LEU . 4.2 p -122.6 162.82 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 120.733 0.301 . . . . 0.0 110.359 -179.735 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.666 ' HB2' ' CA ' ' A' ' 270' ' ' GLY . 12.2 m-20 -99.38 149.1 23.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.182 0.515 . . . . 0.0 111.707 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.65 ' HG3' ' HB3' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -116.34 95.0 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.424 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 51.33 60.81 6.84 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.812 -177.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.489 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 0.3 OUTLIER -72.86 72.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.858 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 250' ' ' ASN . 1.2 pp -54.33 -57.54 10.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.26 0.552 . . . . 0.0 110.189 178.86 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.629 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.5 OUTLIER -69.52 -25.97 64.29 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.774 -179.712 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 248' ' ' SER . . . 89.94 132.11 4.73 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.779 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 282' ' ' THR . 79.7 m -92.59 151.62 20.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.58 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.0 OUTLIER -144.76 128.56 17.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.939 0.399 . . . . 0.0 111.659 -179.989 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.407 ' CG2' ' CD1' ' A' ' 259' ' ' ILE . 50.1 t -101.44 131.95 48.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.251 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 49.12 31.85 3.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.149 0.499 . . . . 0.0 110.557 -178.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 78.04 36.89 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.33 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -148.2 120.45 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.938 179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 252' ' ' THR . 72.4 p -67.28 85.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.42 0.628 . . . . 0.0 110.91 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . 0.534 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.1 OUTLIER -80.12 -15.42 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.636 -178.629 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.522 ' O ' ' HA2' ' A' ' 270' ' ' GLY . 2.8 m -101.61 -10.8 19.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.497 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . 0.666 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 10.0 t-80 -106.76 18.06 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 179.498 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 262' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 95.7 Cg_exo -45.01 -29.13 3.58 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.578 1.519 . . . . 0.0 111.264 179.167 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.61 ' O ' ' HB2' ' A' ' 266' ' ' SER . 0.4 OUTLIER -76.64 92.24 3.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.051 -179.654 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 95.3 mt -48.12 129.97 15.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.041 0.448 . . . . 0.0 111.887 -179.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 74.08 21.87 78.55 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.279 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.621 ' C ' ' H ' ' A' ' 268' ' ' LYS . 0.1 OUTLIER -78.74 -68.57 0.64 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.018 0.409 . . . . 0.0 111.374 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 267' ' ' ARG . . . . . 0.519 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.1 OUTLIER 66.38 -17.8 0.11 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.256 -0.577 . . . . 0.0 112.412 -179.173 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.621 ' H ' ' C ' ' A' ' 266' ' ' SER . 0.2 OUTLIER -81.09 -138.49 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -175.981 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 269' ' ' TRP . . . . . 0.634 ' CZ3' ' HB3' ' A' ' 246' ' ' MET . 26.7 t-105 -85.19 78.68 9.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.275 -177.494 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.666 ' CA ' ' HB2' ' A' ' 245' ' ' ASP . . . 36.04 -160.87 0.01 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 118.984 2.354 . . . . 0.0 118.984 172.176 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.11 94.24 3.53 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 111.418 -2.391 . . . . 0.0 105.99 175.11 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.41 ' HD3' ' CG2' ' A' ' 244' ' ' VAL . 1.0 OUTLIER -24.4 109.01 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.872 3.048 . . . . 0.0 115.929 -176.912 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 273' ' ' VAL . . . . . 0.534 HG21 ' HB ' ' A' ' 259' ' ' ILE . 17.5 t -115.95 159.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.314 179.128 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 81.9 mm-40 -94.19 130.98 40.21 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 241' ' ' TRP . 0.4 OUTLIER -94.33 161.51 14.21 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.089 -177.258 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.51 155.27 45.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.287 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 25.7 t -61.73 134.73 57.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.852 179.301 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.2 OUTLIER 83.66 7.25 0.66 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.925 -179.418 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 279' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.7 OUTLIER -82.92 126.93 33.03 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.358 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . 0.445 ' CG2' ' CD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -100.38 132.02 46.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 119.619 -0.833 . . . . 0.0 111.161 -179.524 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 281' ' ' ILE . . . . . 0.447 ' CD1' ' CG1' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -107.41 156.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.336 179.184 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 252' ' ' THR . 9.3 m -144.51 116.64 8.39 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 283' ' ' LEU . . . . . 0.603 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -120.01 49.52 1.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.523 -178.307 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 179.97 -142.24 5.03 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.106 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.6 t -87.7 -37.11 16.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.998 0.428 . . . . 0.0 110.211 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -152.72 3.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.238 179.706 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.866 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.3 m -77.54 106.11 9.11 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 117.753 0.252 . . . . 0.0 111.102 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.59 ' HG2' ' OG1' ' A' ' 282' ' ' THR . 2.9 mtpt -127.98 133.36 49.17 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.364 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.447 ' CG1' ' CD1' ' A' ' 281' ' ' ILE . 8.7 p -113.32 136.51 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.345 -179.386 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 290' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 3.1 t80 -77.98 133.06 38.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 279' ' ' ASP . 2.6 t -113.69 124.7 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.466 -178.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.511 ' O ' HD11 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -143.53 153.05 42.19 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.891 -179.744 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.523 HD11 ' CD2' ' A' ' 241' ' ' TRP . 1.5 mt -139.69 129.83 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.43 160.04 35.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 111.142 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 295' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 180' ' ' SER . 0.3 OUTLIER -99.02 174.31 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.665 179.578 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 296' ' ' GLN . . . . . 0.843 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 3.5 tp-100 -109.99 116.09 30.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -179.691 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -117.69 86.38 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.878 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.5 ' N ' ' HG ' ' A' ' 200' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.521 -0.141 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.7 m95 -150.52 134.22 16.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 184' ' ' LEU . 2.7 tp -119.99 139.96 51.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.49 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.762 ' O ' HD12 ' A' ' 184' ' ' LEU . 4.4 m-85 -138.94 137.94 36.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.441 0.639 . . . . 0.0 110.043 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.792 HD13 HD11 ' A' ' 182' ' ' LEU . 5.2 mp -132.7 151.45 51.97 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.019 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.11 122.37 12.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.872 HG21 HD12 ' A' ' 194' ' ' LEU . 42.1 t -64.6 118.75 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 288' ' ' LYS . 3.7 tt -97.96 -23.94 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.758 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -161.85 92.41 0.85 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.541 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.603 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.58 -173.78 30.65 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.447 ' HG3' ' CA ' ' A' ' 222' ' ' ASP . 74.3 Cg_endo -79.88 30.58 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.179 1.919 . . . . 0.0 111.822 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.865 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.28 23.95 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.627 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.603 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.9 mt -39.63 113.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.072 0.463 . . . . 0.0 111.699 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.9 9.63 2.45 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.524 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.872 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -99.37 135.08 41.3 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.288 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.702 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 27.1 mt-30 -129.67 147.46 51.46 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.217 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.941 ' CE1' HG21 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -136.26 130.05 32.44 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.599 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 182' ' ' LEU . . . -144.63 166.02 26.37 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.942 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.83 HG13 ' CH2' ' A' ' 234' ' ' TRP . 3.2 p -175.21 157.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.098 0.475 . . . . 0.0 111.073 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.554 ' ND2' ' CD1' ' A' ' 181' ' ' TRP . 24.8 m120 -90.92 149.13 22.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.872 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.528 ' CB ' ' HE1' ' A' ' 234' ' ' TRP . 54.8 p -66.82 -3.29 6.47 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.709 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.45 5.45 39.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.741 0.305 . . . . 0.0 111.444 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -87.35 127.34 35.2 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.04 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.5 t -90.56 -87.3 0.19 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.53 11.59 6.85 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.12 -11.0 9.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.917 0.389 . . . . 0.0 110.875 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.793 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.5 tt -70.11 -57.76 5.78 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -42.83 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.29 1.993 . . . . 0.0 112.745 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.941 HG21 ' CE1' ' A' ' 196' ' ' HIS . 99.2 t -69.59 164.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.183 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.664 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 3.8 mtmm -139.64 95.03 2.85 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.901 HD23 HD12 ' A' ' 218' ' ' LEU . 1.3 mp -83.78 127.32 33.72 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.488 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -169.11 172.05 43.22 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.02 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.984 ' HB2' HG13 ' A' ' 225' ' ' VAL . 3.0 ttt85 -71.46 -76.16 0.11 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 213' ' ' VAL . 11.7 p -133.66 110.18 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.135 0.493 . . . . 0.0 110.991 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.497 ' HB2' ' HD2' ' A' ' 215' ' ' PRO . 0.0 OUTLIER 171.4 179.81 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.592 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 214' ' ' SER . 45.2 Cg_exo -56.65 -3.42 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 121.946 1.764 . . . . 0.0 112.478 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.535 ' HA ' ' HB3' ' A' ' 209' ' ' LYS . 0.4 OUTLIER -43.24 158.62 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.971 0.415 . . . . 0.0 111.535 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -83.68 -30.46 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.289 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.901 HD12 HD23 ' A' ' 210' ' ' LEU . 18.7 mt -113.88 127.99 56.22 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -88.62 84.78 6.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.487 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.718 HD21 ' HB3' ' A' ' 218' ' ' LEU . 1.7 mm? -100.94 66.74 1.17 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.604 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 0.4 OUTLIER -62.07 54.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 220' ' ' LEU . 19.8 t0 -105.33 125.5 51.05 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.1 p -40.15 -31.83 0.15 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.49 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 0.0 OUTLIER -53.32 -40.36 64.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.795 0.331 . . . . 0.0 111.11 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.984 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.5 p -99.89 96.33 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 83.1 p -41.63 -51.86 3.92 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.047 0.451 . . . . 0.0 111.145 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -142.72 -54.07 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.31 128.67 21.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 109.964 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.602 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.1 OUTLIER -94.62 -56.88 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.211 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -150.45 177.24 10.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.37 0.605 . . . . 0.0 112.469 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.743 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.7 OUTLIER -157.93 178.67 9.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.152 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 4.8 mt -133.23 145.58 33.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.434 0.635 . . . . 0.0 111.734 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.94 131.37 5.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.939 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 16.3 p90 -125.3 167.02 15.48 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.99 133.43 56.04 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.233 -1.349 . . . . 0.0 112.503 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 48.0 t -91.52 0.44 57.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.11 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.2 m -79.01 -46.3 18.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.833 0.825 . . . . 0.0 109.457 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.413 ' C ' ' CG ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -111.77 9.53 20.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.936 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.413 ' CG ' ' C ' ' A' ' 238' ' ' LYS . 10.2 p90 43.75 65.9 0.92 Allowed 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.593 0.711 . . . . 0.0 109.924 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.939 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -135.61 145.82 47.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.269 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.76 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.9 OUTLIER -121.37 114.4 21.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.601 -1.182 . . . . 0.0 109.935 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.673 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 24.1 mt-10 -131.36 146.46 52.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.956 0.884 . . . . 0.0 113.156 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.771 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.6 pp -110.98 153.61 25.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.935 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 269' ' ' TRP . 1.4 p -122.71 162.23 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.41 ' CG ' ' HB3' ' A' ' 260' ' ' SER . 5.2 m-20 -112.6 100.62 8.87 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.986 0.422 . . . . 0.0 111.988 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.697 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -78.15 106.11 9.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.678 178.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 49.19 65.0 2.96 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.252 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.446 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 0.0 OUTLIER -71.35 64.32 0.39 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.673 HD12 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -48.39 -62.32 1.55 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.023 0.439 . . . . 0.0 110.166 178.439 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.486 ' H ' ' CD1' ' A' ' 249' ' ' LEU . 0.4 OUTLIER -77.02 -31.71 56.56 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.854 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 248' ' ' SER . . . 99.19 149.09 24.06 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.172 -0.922 . . . . 0.0 114.006 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 282' ' ' THR . 2.9 m -115.95 107.63 15.22 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.722 0.409 . . . . 0.0 110.57 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.621 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.1 OUTLIER -98.52 128.87 45.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.122 0.487 . . . . 0.0 111.554 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.647 HG23 HD11 ' A' ' 259' ' ' ILE . 91.9 t -99.7 134.02 40.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.678 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 255' ' ' ASN . 0.9 OUTLIER 47.93 38.01 8.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.279 0.561 . . . . 0.0 110.068 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.0 t 67.51 36.69 3.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.731 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.64 111.81 5.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.245 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 60.0 p -58.17 87.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.134 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.765 HG12 HG11 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -88.97 -18.18 7.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.747 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.549 ' N ' HD12 ' A' ' 259' ' ' ILE . 9.7 t . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.008 0.432 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.741 ' CD1' HG21 ' A' ' 244' ' ' VAL . 38.4 t-105 -67.91 -23.32 65.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.276 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 73.38 167.76 13.51 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.748 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -102.68 143.77 27.28 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.614 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.5 Cg_exo -51.32 121.45 8.42 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.308 2.006 . . . . 0.0 113.12 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.765 HG11 HG12 ' A' ' 259' ' ' ILE . 70.2 t -96.42 132.15 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.3 125.65 29.67 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.408 -178.23 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.841 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -94.59 165.5 12.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.51 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.551 ' HB3' ' OD1' ' A' ' 279' ' ' ASP . . . -144.1 162.87 35.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.207 0.527 . . . . 0.0 112.418 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.554 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 13.4 p -60.61 128.55 37.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.428 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.8 m-20 86.05 7.84 0.33 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.279 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.551 ' OD1' ' HB3' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -75.89 -171.46 1.64 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.4 OUTLIER -160.73 133.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.102 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.698 HD12 ' CG2' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -111.63 149.85 14.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.987 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.571 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -139.33 112.4 8.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.233 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.746 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -110.77 45.01 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.059 -177.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.33 -132.29 2.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 119.321 -1.419 . . . . 0.0 113.64 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 10.9 t -89.87 -43.68 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.654 0.264 . . . . 0.0 110.529 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.2 t -148.37 -0.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.758 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 25.8 m -69.04 102.57 1.65 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.257 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.658 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.5 ttmt -121.01 127.01 51.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.664 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.698 ' CG2' HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -109.77 132.69 57.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.294 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.462 ' HD1' ' CG2' ' A' ' 280' ' ' ILE . 2.1 t80 -76.86 137.05 38.93 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.872 0.368 . . . . 0.0 110.194 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.677 HG13 HD11 ' A' ' 184' ' ' LEU . 1.3 t -106.04 115.75 48.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.262 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.74 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -129.79 142.6 50.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.912 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.841 HD11 HD23 ' A' ' 275' ' ' LEU . 6.4 mt -139.0 115.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.157 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.77 154.18 45.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 110.924 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 88.7 p -87.95 -173.2 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.726 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.565 ' NE1' ' ND2' ' A' ' 199' ' ' ASN . 2.7 m95 -141.07 132.29 26.49 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.9 HD11 ' CD2' ' A' ' 184' ' ' LEU . 3.0 tp -121.94 133.56 54.84 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.116 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.779 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.4 m-85 -129.71 132.19 46.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.677 0.751 . . . . 0.0 110.246 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.9 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.5 mm? -117.97 140.68 49.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.832 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.7 OUTLIER -137.35 118.48 14.45 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.324 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.874 HG21 HD12 ' A' ' 194' ' ' LEU . 5.7 t -67.15 103.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.164 0.507 . . . . 0.0 109.657 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.884 HG22 ' O ' ' A' ' 288' ' ' LYS . 7.0 tt -87.38 -20.84 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.859 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.54 97.02 0.4 Allowed 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.496 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.601 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.85 -169.57 25.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.598 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 87.1 Cg_endo -81.13 30.12 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.12 1.88 . . . . 0.0 111.313 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.874 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.48 24.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.372 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.601 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.8 mt -39.65 106.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.805 0.336 . . . . 0.0 111.851 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.62 2.42 2.55 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.469 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.874 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -98.02 167.93 10.59 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.8 mt-30 -159.97 149.21 17.72 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.371 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.887 ' CE1' HD21 ' A' ' 210' ' ' LEU . 1.1 p80 -135.42 128.66 31.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.341 0.591 . . . . 0.0 109.93 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.24 163.03 34.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.475 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.955 HG21 ' HA ' ' A' ' 206' ' ' LEU . 6.1 p -173.2 157.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.041 0.448 . . . . 0.0 111.066 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.565 ' ND2' ' NE1' ' A' ' 181' ' ' TRP . 0.3 OUTLIER -90.41 153.47 20.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.988 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.525 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 12.4 t -69.49 -6.07 28.19 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.218 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.35 7.6 45.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.862 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.424 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 1.0 OUTLIER -86.41 138.56 31.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.797 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.0 m -90.22 -85.67 0.21 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.02 22.77 9.84 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.424 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 3.0 pttt -119.67 -11.85 9.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.868 0.365 . . . . 0.0 110.87 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.955 ' HA ' HG21 ' A' ' 198' ' ' VAL . 7.7 tt -71.22 -58.52 3.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -42.86 97.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.575 2.184 . . . . 0.0 113.127 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 209' ' ' LYS . 60.9 t -69.07 164.78 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 208' ' ' VAL . 17.5 mtpt -138.08 96.57 3.22 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.992 HD23 HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -84.3 125.37 32.2 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.88 166.97 38.38 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.418 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.886 ' HD3' HG12 ' A' ' 213' ' ' VAL . 9.9 ttt180 -69.33 -77.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.886 HG12 ' HD3' ' A' ' 212' ' ' ARG . 8.8 p -138.28 110.95 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.386 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.616 ' CB ' ' HD2' ' A' ' 215' ' ' PRO . 0.3 OUTLIER 171.98 -178.61 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.778 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.616 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 24.0 Cg_endo -61.68 12.64 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.002 1.801 . . . . 0.0 113.02 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -57.51 -173.61 0.01 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.91 0.386 . . . . 0.0 111.265 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -104.79 -30.04 10.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.09 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.992 HD12 HD23 ' A' ' 210' ' ' LEU . 0.4 OUTLIER -110.95 133.66 53.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.072 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -98.45 82.23 2.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.162 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.779 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.8 mm? -103.73 83.5 2.14 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.598 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 24.6 pttt -58.94 65.04 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.766 0.317 . . . . 0.0 111.61 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' A' ' 220' ' ' LEU . 6.7 m-20 -93.48 144.01 25.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.446 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.7 t -85.76 -4.14 59.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.519 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.495 ' OE2' HG22 ' A' ' 285' ' ' THR . 12.7 pm0 -101.24 -16.29 17.02 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 61.9 t -97.93 77.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.893 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -34.03 -50.87 0.4 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.98 0.419 . . . . 0.0 111.535 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.4 -49.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.573 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.468 ' HG2' ' OG ' ' A' ' 216' ' ' SER . 1.6 mtmm -144.08 129.73 19.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.443 . . . . 0.0 110.915 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.554 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 9.2 t-80 -96.32 -55.97 2.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.578 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -148.57 177.49 9.44 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.666 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -156.58 173.17 17.32 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.932 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 35.6 mt -132.77 145.16 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.199 0.523 . . . . 0.0 112.225 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.418 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -160.62 148.66 16.21 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.386 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.817 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 8.1 p90 -140.88 165.57 27.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.728 1.011 . . . . 0.0 113.728 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.4 ' HB2' ' CD ' ' A' ' 240' ' ' LYS . 1.1 m120 -117.35 133.95 55.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.726 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 10.2 t -90.58 2.02 56.21 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.333 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 4.5 m -76.28 -25.88 55.35 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.71 0.767 . . . . 0.0 110.238 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -145.87 23.47 1.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.123 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 238' ' ' LYS . 15.6 p90 36.97 62.16 0.82 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.51 0.671 . . . . 0.0 110.194 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.817 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -124.97 141.12 52.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.456 178.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.713 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -124.61 123.24 39.63 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.664 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.6 pt-20 -137.09 143.4 42.55 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.935 0.874 . . . . 0.0 112.826 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.795 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.4 pp -111.2 150.68 29.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.431 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.661 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -117.78 162.79 15.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.495 ' CG ' ' HB2' ' A' ' 260' ' ' SER . 1.8 m-20 -112.03 105.79 14.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.555 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -73.32 99.18 2.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.463 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.63 64.49 4.17 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.504 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -68.5 64.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.496 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.902 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.42 -51.85 65.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.622 178.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.902 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.3 OUTLIER -74.31 -31.71 62.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 110.914 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.89 90.09 1.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.017 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.602 HG22 ' CD1' ' A' ' 281' ' ' ILE . 1.9 m -46.24 159.2 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.835 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -149.64 137.82 20.54 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.432 0.634 . . . . 0.0 111.85 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 1.07 HG23 HD12 ' A' ' 259' ' ' ILE . 99.7 t -112.15 128.2 68.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.608 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.18 44.61 24.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.129 0.49 . . . . 0.0 110.209 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 m 62.35 24.7 14.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.991 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -130.65 110.51 11.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.42 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 8.7 t -58.79 98.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.512 0.672 . . . . 0.0 111.747 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 1.07 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -77.52 -37.68 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.216 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.495 ' HB2' ' CG ' ' A' ' 245' ' ' ASP . 42.1 t . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.0 mttt . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.196 0.522 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.661 ' NE1' HG11 ' A' ' 244' ' ' VAL . 42.5 t-105 -65.92 -24.85 66.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.217 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.66 159.87 12.44 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.7 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -94.29 142.11 24.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.661 0.267 . . . . 0.0 110.543 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 76.0 Cg_exo -48.44 113.73 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.502 2.134 . . . . 0.0 112.901 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.616 HG21 ' CG1' ' A' ' 259' ' ' ILE . 85.0 t -94.19 136.14 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -84.36 128.34 34.52 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.7 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.873 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -94.0 165.8 12.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.198 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.0 156.59 46.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 60.1 p -60.86 130.38 46.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.987 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.0 OUTLIER 81.28 -2.95 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.406 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.893 ' O ' HG23 ' A' ' 291' ' ' VAL . 0.1 OUTLIER -77.91 138.98 39.19 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.126 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.46 ' H ' HG13 ' A' ' 280' ' ' ILE . 0.9 OUTLIER -99.0 123.48 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.345 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.73 HG12 HG22 ' A' ' 254' ' ' VAL . 0.3 OUTLIER -103.4 158.79 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.189 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.835 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 47.5 m -151.06 130.3 12.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.659 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -123.74 42.3 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -177.17 -134.53 2.02 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.578 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.495 HG22 ' OE2' ' A' ' 224' ' ' GLU . 4.7 t -90.59 -47.87 7.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.702 0.287 . . . . 0.0 110.703 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.55 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -139.37 0.93 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 179.234 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.859 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.7 m -75.85 101.03 4.97 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.527 0.204 . . . . 0.0 111.182 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.884 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -120.38 129.56 53.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.231 0.539 . . . . 0.0 111.47 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -109.84 132.53 57.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.649 -178.585 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 278' ' ' ASP . 1.4 t80 -77.46 133.35 38.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.981 0.42 . . . . 0.0 110.353 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.2 OUTLIER -102.46 114.27 41.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.008 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.517 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -124.39 133.73 53.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.868 HD11 HD23 ' A' ' 275' ' ' LEU . 3.7 mt -132.72 134.66 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.377 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.51 165.67 30.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 111.129 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 13.7 m -97.74 177.79 5.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.781 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 179.967 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.143 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.9 m95 -143.59 132.35 22.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.936 HD11 ' CD2' ' A' ' 184' ' ' LEU . 1.2 tp -120.88 134.86 55.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.246 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.913 ' N ' HD12 ' A' ' 182' ' ' LEU . 5.7 m-85 -133.42 138.77 46.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.706 0.765 . . . . 0.0 109.823 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.936 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.1 mm? -122.09 139.1 54.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.906 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.15 114.95 13.66 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.959 HG21 HD12 ' A' ' 194' ' ' LEU . 11.2 t -64.33 102.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.074 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.926 HG22 ' O ' ' A' ' 288' ' ' LYS . 15.1 tt -83.59 -28.43 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.784 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -162.08 99.66 1.08 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.467 ' H ' ' CG1' ' A' ' 192' ' ' ILE . . . -162.18 -169.91 26.21 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.673 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 87.6 Cg_endo -83.67 30.85 0.52 Allowed 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.52 2.147 . . . . 0.0 111.748 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.938 ' HB1' HD21 ' A' ' 194' ' ' LEU . . . -162.83 24.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.303 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 188' ' ' ALA . 8.4 mt -39.32 108.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.471 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.98 3.4 2.56 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.48 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.959 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -97.42 169.43 9.75 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 117.636 0.718 . . . . 0.0 109.14 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.1 mt-30 -160.06 147.63 16.54 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.563 -178.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.948 ' CE1' HD11 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -135.87 129.04 31.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.88 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.52 170.04 16.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.003 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.789 HG21 ' HG ' ' A' ' 206' ' ' LEU . 8.5 p -177.4 153.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.2 0.524 . . . . 0.0 112.244 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 180' ' ' SER . 5.9 t-20 -88.48 150.54 23.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.969 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.479 ' HA ' ' CE2' ' A' ' 234' ' ' TRP . 5.9 t -68.69 -4.85 17.23 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.347 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.533 HG22 ' OD1' ' A' ' 199' ' ' ASN . 0.6 OUTLIER -101.04 20.34 15.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.808 0.337 . . . . 0.0 111.744 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -103.24 112.46 25.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.775 0.321 . . . . 0.0 110.363 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 16.5 m -72.72 -89.93 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 45.6 t -89.32 14.51 10.96 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 111.511 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 13.9 pttt -125.75 54.5 1.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.789 ' HG ' HG21 ' A' ' 198' ' ' VAL . 10.3 tt -143.58 -56.3 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.794 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 5.5 Cg_exo -41.36 100.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.995 1.796 . . . . 0.0 112.791 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 209' ' ' LYS . 87.8 t -67.96 163.9 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.996 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 31.5 mtmt -135.77 96.31 3.4 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.823 HD23 HD12 ' A' ' 218' ' ' LEU . 0.5 OUTLIER -83.28 128.34 34.41 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.091 178.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.476 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -173.59 174.85 46.27 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.745 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 1.003 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -69.04 -72.32 0.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.996 0.427 . . . . 0.0 111.873 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.881 HG22 ' H ' ' A' ' 214' ' ' SER . 10.1 p -128.86 -142.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.728 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.881 ' H ' HG22 ' A' ' 213' ' ' VAL . 2.5 m 66.9 -179.42 0.04 OUTLIER Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 118.441 0.564 . . . . 0.0 110.228 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.551 ' CD ' ' HB3' ' A' ' 214' ' ' SER . 22.6 Cg_exo -65.31 7.75 0.28 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.656 2.238 . . . . 0.0 113.558 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.6 m -48.87 173.16 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.714 0.292 . . . . 0.0 110.909 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.06 -31.43 13.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.252 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.948 HD11 ' CE1' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -104.06 133.65 48.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.831 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 191' ' ' ALA . . . -100.48 74.99 1.74 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 0.0 110.804 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.92 HD21 HD13 ' A' ' 218' ' ' LEU . 2.8 mm? -99.85 80.0 2.28 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.673 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -53.26 67.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 110.802 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.729 ' N ' ' O ' ' A' ' 220' ' ' LEU . 1.7 m-20 -99.65 128.67 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.402 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.7 p -73.46 -4.8 35.96 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.295 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.566 ' O ' HD11 ' A' ' 249' ' ' LEU . 6.0 pm0 -93.03 -25.0 18.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.698 0.285 . . . . 0.0 111.258 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 1.003 HG13 ' HB2' ' A' ' 212' ' ' ARG . 3.4 p -105.49 85.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -32.39 -46.49 0.13 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.628 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.95 -52.37 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.616 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -141.79 128.78 20.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.139 0.495 . . . . 0.0 110.618 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.575 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 9.4 t-80 -100.41 -56.26 2.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.281 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.53 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -139.38 172.88 12.16 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.694 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -162.53 174.49 12.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.276 179.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.794 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.0 mt -130.79 144.81 36.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.577 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.85 163.44 34.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.667 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.7 OUTLIER -96.86 150.63 20.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.337 -1.301 . . . . 0.0 114.255 -176.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 239' ' ' PHE . 0.8 OUTLIER -118.91 94.14 4.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.217 -1.356 . . . . 0.0 107.716 175.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 13.8 p -78.16 -25.44 47.25 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 32.3 m -74.24 -21.06 59.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.584 0.707 . . . . 0.0 109.713 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 33.0 tptt -123.01 6.23 9.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.344 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 235' ' ' ASN . 13.0 p90 36.98 43.55 0.31 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 120.713 0.292 . . . . 0.0 111.003 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -115.19 174.97 5.71 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.183 0.516 . . . . 0.0 109.697 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.565 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -127.95 119.64 25.96 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.866 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 0.0 OUTLIER -143.13 152.34 41.71 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.946 0.879 . . . . 0.0 112.851 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.864 HD22 HD12 ' A' ' 281' ' ' ILE . 3.4 pp -116.79 154.04 31.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.765 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.753 HG21 ' CD1' ' A' ' 269' ' ' TRP . 3.3 p -121.3 163.7 18.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.669 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 269' ' ' TRP . 1.0 OUTLIER -106.09 101.4 10.89 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.151 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.558 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -70.6 97.46 1.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.728 177.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 52.33 64.65 3.85 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.213 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -76.32 66.89 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -178.036 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.846 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -54.77 -49.97 69.59 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.846 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -72.19 -30.19 64.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.971 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 91.81 85.06 1.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.836 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.509 ' C ' HD23 ' A' ' 253' ' ' LEU . 1.8 m -46.03 158.61 0.09 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.51 0.155 . . . . 0.0 111.077 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.635 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -149.83 137.26 19.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 111.808 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.762 HG22 HG13 ' A' ' 281' ' ' ILE . 75.2 t -111.28 132.2 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.014 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.52 ' HA ' HG13 ' A' ' 280' ' ' ILE . 1.4 t30 55.2 41.78 31.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 110.306 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 75.6 m 63.43 33.9 13.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.561 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.16 109.76 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 3.1 t -55.82 94.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.665 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.4 OUTLIER -79.85 -20.59 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.04 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.642 ' N ' HD12 ' A' ' 259' ' ' ILE . 6.3 t . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 10.3 mttt . . . . . 0 CA--C 1.516 -0.335 0 CA-C-O 121.061 0.458 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.753 ' CD1' HG21 ' A' ' 244' ' ' VAL . 36.0 t-105 -71.9 -26.52 62.35 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 75.3 164.28 13.39 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.743 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -98.5 146.14 31.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.723 0.297 . . . . 0.0 110.469 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 89.2 Cg_exo -48.83 142.55 18.97 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 122.725 2.283 . . . . 0.0 113.072 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.665 HG21 ' HB ' ' A' ' 259' ' ' ILE . 86.9 t -124.89 136.25 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 10.5 mt-10 -84.37 132.82 34.55 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.844 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.973 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -97.05 165.98 11.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.396 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.13 158.34 44.05 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 93.2 p -60.61 129.25 40.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.063 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.462 ' HA ' ' CE2' ' A' ' 290' ' ' TYR . 38.5 m-20 82.47 -0.06 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.838 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 280' ' ' ILE . 0.9 OUTLIER -68.29 -170.08 0.17 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 279' ' ' ASP . 1.0 OUTLIER -161.02 124.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.076 177.737 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.864 HD12 HD22 ' A' ' 243' ' ' LEU . 0.2 OUTLIER -105.55 155.39 6.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.122 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 287' ' ' THR . 0.2 OUTLIER -141.62 123.28 15.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.216 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.693 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -116.37 38.07 3.52 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.766 -178.166 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.4 ' HA3' ' HG3' ' A' ' 224' ' ' GLU . . . 178.68 -122.04 0.79 Allowed Glycine 0 N--CA 1.454 -0.141 0 C-N-CA 119.042 -1.551 . . . . 0.0 114.22 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.466 HG22 ' OE1' ' A' ' 224' ' ' GLU . 4.7 t -95.17 -51.72 4.5 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -141.54 2.17 1.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.72 -0.392 . . . . 0.0 112.007 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.784 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.9 m -72.57 104.77 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.806 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.926 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.4 OUTLIER -120.47 127.25 52.05 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.829 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.3 OUTLIER -110.03 130.07 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.796 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.471 ' CD1' ' CG2' ' A' ' 280' ' ' ILE . 1.6 t80 -77.42 133.57 38.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.306 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.973 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -101.12 116.25 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.488 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.34 135.81 48.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.77 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.729 HD11 HD23 ' A' ' 275' ' ' LEU . 13.6 mt -134.08 142.11 41.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.738 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.0 m -152.79 160.91 43.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 111.089 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.96 175.23 6.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.5 m95 -150.4 132.95 15.72 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 292' ' ' ARG . 5.0 tp -116.25 130.22 56.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.807 176.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 4.6 m-85 -127.17 134.65 50.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.57 0.7 . . . . 0.0 110.564 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.913 HD13 ' ND1' ' A' ' 196' ' ' HIS . 1.1 mp -133.25 146.97 51.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.901 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.435 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 8.5 tt0 -142.21 124.76 15.77 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.92 HG21 HD12 ' A' ' 194' ' ' LEU . 11.8 t -62.09 119.8 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.719 HG22 ' O ' ' A' ' 288' ' ' LYS . 4.3 tt -101.05 -22.78 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.814 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.91 93.56 0.72 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.578 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.96 -170.35 26.58 Favored Glycine 0 CA--C 1.518 0.244 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.587 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 89.5 Cg_endo -81.32 30.3 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.032 1.822 . . . . 0.0 111.55 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.896 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -160.96 22.9 0.13 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.744 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.578 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.0 mt -39.77 109.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.916 0.389 . . . . 0.0 111.602 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.97 8.95 2.02 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.613 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.92 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -98.36 153.8 18.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.614 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 5.9 mt-30 -150.08 148.77 29.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.591 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.913 ' ND1' HD13 ' A' ' 184' ' ' LEU . 2.0 p80 -138.5 132.64 31.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.268 0.556 . . . . 0.0 110.47 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.73 169.93 18.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.746 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.626 HG13 ' CH2' ' A' ' 234' ' ' TRP . 2.7 p -177.64 157.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.197 0.522 . . . . 0.0 110.749 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.517 ' HA ' ' O ' ' A' ' 180' ' ' SER . 5.9 m120 -90.47 147.59 23.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.781 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.523 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 30.5 m -60.66 -6.17 1.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.92 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 9.1 t -102.34 32.19 3.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.154 0.502 . . . . 0.0 111.106 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.469 ' HB2' ' HG2' ' A' ' 205' ' ' LYS . 77.9 p -110.54 132.32 54.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.893 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' SER . . . . . 0.547 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 56.9 m -85.57 -84.31 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.8 21.72 14.08 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.547 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -115.88 -8.95 11.89 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.765 178.669 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.865 HD11 ' CE2' ' A' ' 234' ' ' TRP . 4.0 tt -69.8 -57.0 6.97 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.2 Cg_endo -43.32 86.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.797 2.331 . . . . 0.0 113.761 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.789 HG11 ' CG ' ' A' ' 196' ' ' HIS . 57.6 t -70.16 99.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.775 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 216' ' ' SER . 0.0 OUTLIER -69.48 87.26 0.46 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.199 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.029 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -69.14 127.4 32.98 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.48 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -168.38 169.97 41.87 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.638 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.855 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -53.02 -95.84 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.788 -0.706 . . . . 0.0 112.606 -178.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.639 HG12 ' HD3' ' A' ' 212' ' ' ARG . 10.9 p -127.65 -7.69 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 O-C-N 122.187 -0.321 . . . . 0.0 111.812 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.469 ' CB ' ' CD ' ' A' ' 215' ' ' PRO . 0.3 OUTLIER -55.44 -177.22 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.493 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 53.1 Cg_exo -55.8 -1.21 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.397 2.065 . . . . 0.0 113.073 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -44.71 166.28 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.938 0.399 . . . . 0.0 111.432 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -83.93 -32.59 25.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.26 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.029 HD12 HD23 ' A' ' 210' ' ' LEU . 0.9 OUTLIER -105.46 131.88 52.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.407 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -97.48 82.76 3.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.768 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.687 HD21 HD13 ' A' ' 218' ' ' LEU . 2.9 mm? -104.47 64.53 0.75 Allowed 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.855 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -53.59 66.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.068 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.644 ' N ' ' O ' ' A' ' 220' ' ' LEU . 4.8 t0 -121.82 139.92 53.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.206 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.4 p -53.24 -31.33 42.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.624 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.56 ' CG ' ' HB3' ' A' ' 222' ' ' ASP . 2.9 pt-20 -49.6 -41.72 42.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.096 0.474 . . . . 0.0 110.147 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.6 p -103.18 110.93 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.68 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.4 t -56.03 -56.07 25.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.233 0.539 . . . . 0.0 109.823 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -137.08 -51.91 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.57 ' CB ' ' HG2' ' A' ' 246' ' ' MET . 0.7 OUTLIER -141.35 125.65 17.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.167 0.508 . . . . 0.0 109.889 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.634 ' CE1' ' HB3' ' A' ' 250' ' ' ASN . 0.5 OUTLIER -92.45 -60.64 1.78 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.3 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -145.23 173.76 11.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.677 ' HA ' HD12 ' A' ' 210' ' ' LEU . 24.6 tt0 -153.28 161.78 42.0 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.6 mt -124.13 147.86 28.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.802 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.716 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.25 163.23 33.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.865 ' CE2' HD11 ' A' ' 206' ' ' LEU . 3.1 p90 -153.86 165.32 36.44 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.513 ' HB2' ' HD2' ' A' ' 240' ' ' LYS . 20.4 m-20 -117.44 133.47 55.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.311 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.49 3.04 55.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.091 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.2 m -76.99 -30.14 55.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.071 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 38.0 tptt -139.89 22.01 2.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.789 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 238' ' ' LYS . 15.5 p90 37.74 62.94 0.84 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.523 0.678 . . . . 0.0 110.16 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.839 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -125.47 142.32 51.57 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.7 178.251 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.769 ' CE3' HD13 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -129.15 123.23 31.59 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.957 -179.036 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.1 pt-20 -141.26 151.56 43.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.258 1.028 . . . . 0.0 113.323 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.644 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.2 pp -113.5 158.83 20.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.031 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.83 HG21 ' NE1' ' A' ' 269' ' ' TRP . 4.1 p -136.82 162.35 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.844 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.412 ' N ' HG22 ' A' ' 244' ' ' VAL . 14.3 t70 -81.89 123.61 28.99 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.57 ' HG2' ' CB ' ' A' ' 228' ' ' LYS . 10.4 tpt -76.77 32.42 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.47 50.31 32.67 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.707 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' A' ' 229' ' ' HIS . 5.5 t -99.05 179.1 4.72 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 110.912 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.697 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -105.89 -29.54 9.92 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.697 ' H ' HD13 ' A' ' 249' ' ' LEU . 1.3 t-20 -75.31 -35.9 61.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.311 0.577 . . . . 0.0 112.244 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.535 ' O ' ' NE2' ' A' ' 229' ' ' HIS . . . 93.29 166.72 38.21 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.017 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.586 ' HB ' HD11 ' A' ' 259' ' ' ILE . 7.6 m -120.89 160.59 23.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.51 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.708 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -146.32 121.02 9.84 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.257 0.551 . . . . 0.0 111.117 179.02 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.886 HG23 HD12 ' A' ' 259' ' ' ILE . 61.6 t -97.49 129.01 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.046 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.473 ' HA ' HD12 ' A' ' 280' ' ' ILE . 2.5 m-20 53.85 42.62 31.68 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.191 0.52 . . . . 0.0 110.282 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 15.8 m 65.02 22.26 12.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.952 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER -123.52 101.48 7.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.23 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 26.3 p -54.74 101.05 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.075 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.886 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -78.81 -52.41 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.751 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.542 ' N ' HG12 ' A' ' 259' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.83 ' NE1' HG21 ' A' ' 244' ' ' VAL . 7.0 t-105 -66.2 -26.09 67.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.043 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' GLY . . . . . 0.433 ' O ' ' HD1' ' A' ' 269' ' ' TRP . . . 73.11 168.76 13.85 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.622 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.75 145.72 30.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.569 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 50.6 Cg_exo -53.24 110.55 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.483 2.122 . . . . 0.0 112.967 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.817 HG21 ' HB ' ' A' ' 259' ' ' ILE . 90.1 t -89.4 132.24 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.1 mt-10 -79.59 126.12 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.711 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.972 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -93.9 166.19 12.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.98 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.609 ' HB3' ' OD2' ' A' ' 279' ' ' ASP . . . -143.4 158.69 43.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.233 0.54 . . . . 0.0 112.39 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 42.7 p -56.51 127.5 31.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.349 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.607 ' HB2' ' O ' ' A' ' 277' ' ' SER . 73.6 m-20 82.67 1.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.859 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 291' ' ' VAL . 69.4 m-20 -78.87 133.84 36.95 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.53 ' HB ' ' HD3' ' A' ' 288' ' ' LYS . 0.8 OUTLIER -94.28 125.21 46.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.694 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.566 HD13 ' H ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -105.14 155.8 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.137 178.403 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.681 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -148.73 132.52 16.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.721 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -128.34 53.1 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.444 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 169.1 -129.84 1.94 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 119.596 -1.287 . . . . 0.0 113.613 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.0 t -95.76 -47.85 6.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.335 0.112 . . . . 0.0 110.92 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.7 t -139.88 -6.25 1.29 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.335 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.814 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 29.3 m -69.11 101.25 1.4 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.781 0.325 . . . . 0.0 110.279 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.719 ' O ' HG22 ' A' ' 187' ' ' ILE . 20.4 ttmt -118.65 126.45 51.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.067 0.46 . . . . 0.0 111.576 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -110.79 131.91 60.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.424 -178.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.4 t80 -77.18 137.46 38.88 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.076 0.465 . . . . 0.0 109.942 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.923 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.5 t -105.19 112.27 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.022 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.797 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -126.55 139.42 53.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.069 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.972 HD11 HD23 ' A' ' 275' ' ' LEU . 3.4 mt -136.26 132.22 49.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.73 152.78 45.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.46 159.31 15.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.925 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.556 ' N ' ' HG ' ' A' ' 200' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.523 -0.075 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 9.8 m95 -147.89 133.34 18.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.812 HD11 ' CD2' ' A' ' 184' ' ' LEU . 3.6 tp -118.65 132.97 56.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.722 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.666 ' N ' HD12 ' A' ' 182' ' ' LEU . 9.2 m-85 -128.32 126.0 39.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.669 0.747 . . . . 0.0 110.165 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.812 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.2 mm? -108.81 133.74 52.45 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.675 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.565 ' C ' HG23 ' A' ' 289' ' ' VAL . 0.4 OUTLIER -129.9 108.02 9.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.83 HG21 HD12 ' A' ' 194' ' ' LEU . 40.8 t -60.97 104.98 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 288' ' ' LYS . 12.4 tt -89.28 -24.85 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -175.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.72 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.8 96.66 0.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.538 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.677 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.11 -168.64 24.32 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.478 ' HB2' ' CG ' ' A' ' 221' ' ' LYS . 93.2 Cg_endo -82.91 30.53 0.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.243 1.962 . . . . 0.0 110.97 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.947 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.95 23.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.624 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.677 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.0 mt -39.34 109.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.89 6.33 2.89 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.717 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.947 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER -100.14 139.66 35.48 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 117.841 0.821 . . . . 0.0 109.117 178.189 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 29.8 mt-30 -134.38 151.22 51.08 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.787 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.661 ' NE2' HG22 ' A' ' 208' ' ' VAL . 59.4 t60 -144.92 138.96 27.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.569 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -145.75 166.12 26.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.639 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.8 HG13 ' CH2' ' A' ' 234' ' ' TRP . 7.9 p -169.22 152.66 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.731 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 180' ' ' SER . 2.8 m120 -88.93 144.57 26.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.972 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.556 ' HG ' ' N ' ' A' ' 180' ' ' SER . 97.8 p -60.32 -7.72 2.17 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.595 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 7.6 t -98.49 24.53 7.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.912 0.387 . . . . 0.0 110.685 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.434 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -106.04 119.02 38.11 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.362 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.1 t -71.68 -77.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.0 m -105.0 23.07 14.18 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -119.7 -10.38 9.58 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.578 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.987 ' O ' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -82.11 -32.37 0.59 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.105 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 206' ' ' LEU . 29.9 Cg_exo -59.23 100.46 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.14 1.227 . . . . 0.0 111.733 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.724 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 4.9 t -68.62 160.65 4.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.8 OUTLIER -137.4 86.48 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.011 HD23 HD12 ' A' ' 218' ' ' LEU . 0.4 OUTLIER -77.67 125.81 29.91 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.963 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.05 172.98 45.07 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.767 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.959 ' HB2' HG13 ' A' ' 225' ' ' VAL . 16.2 ttt-85 -71.62 -70.66 0.31 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.325 -0.438 . . . . 0.0 112.145 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.81 HG22 ' H ' ' A' ' 214' ' ' SER . 9.3 p -125.59 -149.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.952 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.81 ' H ' HG22 ' A' ' 213' ' ' VAL . 1.0 OUTLIER 66.94 -178.0 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 58.8 Cg_endo -73.85 45.73 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 121.807 1.671 . . . . 0.0 112.702 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.35 165.92 24.17 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.445 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.36 -38.46 13.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.161 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.011 HD12 HD23 ' A' ' 210' ' ' LEU . 3.1 mt -105.82 129.94 53.89 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -93.46 79.38 4.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.904 0.383 . . . . 0.0 111.173 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.754 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -101.55 83.95 2.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.478 ' CG ' ' HB2' ' A' ' 190' ' ' PRO . 3.5 pttp -60.2 59.72 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.981 0.42 . . . . 0.0 111.81 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.876 ' HB2' HG12 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -89.1 126.7 35.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 37.2 p -67.04 -7.53 23.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.218 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -87.31 -22.52 25.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.095 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.959 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.6 p -106.54 83.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.3 p -35.0 -41.42 0.14 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.69 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.35 -57.6 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.608 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.3 OUTLIER -138.81 130.81 28.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.211 0.529 . . . . 0.0 110.316 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.61 ' HB3' ' HB2' ' A' ' 283' ' ' LEU . 1.9 t-80 -101.07 -56.45 2.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.888 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.528 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -147.35 173.21 12.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.249 0.547 . . . . 0.0 112.273 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.724 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -156.3 179.85 8.84 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.824 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.458 HG12 ' HB3' ' A' ' 243' ' ' LEU . 19.8 mt -139.23 149.68 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.544 0.688 . . . . 0.0 112.436 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.89 160.67 31.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.8 ' CH2' HG13 ' A' ' 198' ' ' VAL . 5.3 p90 -149.58 165.51 32.02 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -116.49 132.98 56.53 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.138 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.07 0.27 57.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.867 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.16 -29.38 48.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.699 0.761 . . . . 0.0 109.963 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.444 ' HD3' ' HD3' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -138.44 23.12 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.129 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 238' ' ' LYS . 23.1 p90 37.0 59.09 1.11 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.355 0.597 . . . . 0.0 110.115 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.74 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 1.2 mptp? -122.72 141.37 51.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.105 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.687 ' CE3' ' CE3' ' A' ' 234' ' ' TRP . 2.1 m95 -124.46 121.61 35.33 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.912 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.8 pt-20 -138.57 144.86 40.05 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.731 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.8 pp -111.46 152.57 27.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.369 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.847 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 6.1 p -123.41 165.1 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 122.859 0.464 . . . . 0.0 110.586 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.852 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 5.1 t0 -107.39 116.6 32.22 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.851 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -75.76 99.12 4.31 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.444 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' 249' ' ' LEU . . . 57.46 69.05 1.39 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.578 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 56.0 p -61.5 43.54 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 1.014 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.6 -54.19 49.68 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.622 0.646 . . . . 0.0 109.911 178.353 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 1.014 ' N ' HD22 ' A' ' 249' ' ' LEU . 2.1 t-20 -77.87 -38.12 46.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.244 0.545 . . . . 0.0 110.672 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 93.79 96.87 1.54 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.13 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.55 ' C ' HD23 ' A' ' 253' ' ' LEU . 0.7 OUTLIER -55.87 165.17 0.97 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.349 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.662 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -150.97 140.02 21.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.285 0.564 . . . . 0.0 111.455 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.586 HG23 HD11 ' A' ' 259' ' ' ILE . 93.1 t -114.33 132.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.788 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.57 ' HA ' HG13 ' A' ' 280' ' ' ILE . 16.9 t-20 53.43 42.22 32.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.126 0.489 . . . . 0.0 110.28 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.2 p 63.52 32.35 14.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.835 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -138.88 110.32 7.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 52.4 p -60.12 88.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.431 0.634 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.82 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -90.75 -7.57 10.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.601 -178.586 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.852 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 38.9 m . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.851 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 0.0 OUTLIER -75.36 -25.38 57.65 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.646 -178.21 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.2 -174.55 7.47 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.581 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -111.94 157.71 38.84 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 117.482 0.641 . . . . 0.0 110.866 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.731 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 21.3 Cg_exo -66.91 138.23 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.86 2.374 . . . . 0.0 113.892 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.82 HG21 ' HB ' ' A' ' 259' ' ' ILE . 74.3 t -114.51 142.28 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.0 mm-40 -85.28 127.12 34.2 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 118.803 -1.159 . . . . 0.0 112.316 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.874 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -95.05 164.85 12.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.018 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.1 160.0 41.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.588 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 80.1 p -59.77 132.24 53.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.509 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.5 OUTLIER 84.01 7.46 0.6 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.285 -179.51 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.659 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 3.0 m-20 -79.72 -167.31 1.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.57 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -160.34 134.92 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.301 177.773 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 1.036 HG22 HG12 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -107.09 157.21 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.985 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.69 HG23 ' CG ' ' A' ' 288' ' ' LYS . 0.7 OUTLIER -149.18 117.81 6.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.662 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -115.57 43.9 1.98 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.976 -178.065 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 172.28 -123.39 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 119.209 -1.472 . . . . 0.0 113.741 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.0 t -92.88 -51.16 5.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.586 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -143.6 -3.63 0.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 40.4 m -67.09 104.03 1.32 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 117.811 0.278 . . . . 0.0 110.807 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.781 ' O ' HG22 ' A' ' 187' ' ' ILE . 3.6 mtpt -125.49 134.66 51.96 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.498 -0.481 . . . . 0.0 112.264 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 1.036 HG12 HG22 ' A' ' 281' ' ' ILE . 9.6 p -112.98 136.92 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.289 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.443 ' HD1' HG22 ' A' ' 280' ' ' ILE . 2.0 t80 -77.66 137.06 38.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.249 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -103.98 110.48 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.625 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -129.99 134.57 47.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.586 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.685 HD11 HD23 ' A' ' 275' ' ' LEU . 4.6 mt -133.15 143.14 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.7 t -150.35 157.17 42.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.0 110.813 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 2.8 m -87.65 -176.94 5.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 16.0 m . . . . . 0 N--CA 1.457 -0.099 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.1 m95 -143.01 135.18 27.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 3.5 tp -118.29 123.5 45.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.502 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 3.3 m-85 -123.63 134.85 53.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.681 0.753 . . . . 0.0 110.679 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.999 HD13 ' CE1' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -135.48 145.39 47.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.497 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.557 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 39.8 tt0 -140.11 127.39 21.2 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.869 HG21 HD12 ' A' ' 194' ' ' LEU . 16.9 t -64.97 107.72 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.5 tt -91.47 -21.51 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.834 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.55 94.56 0.7 Allowed 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.722 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.14 -177.99 35.65 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.534 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 88.2 Cg_endo -76.84 31.84 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 CA-C-N 119.591 1.696 . . . . 0.0 111.579 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.831 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.57 23.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.336 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.722 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.5 mt -39.81 111.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.85 6.89 2.45 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.011 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.869 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -98.72 154.59 17.86 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.736 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.3 mt-30 -151.66 148.67 28.22 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.213 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.999 ' CE1' HD13 ' A' ' 184' ' ' LEU . 1.1 p80 -136.31 130.74 33.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.308 0.575 . . . . 0.0 109.828 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.97 163.72 35.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.243 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' A' ' 206' ' ' LEU . 9.4 p -174.28 160.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.292 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 180' ' ' SER . 7.3 m120 -87.86 146.02 25.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.601 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.416 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 9.3 t -62.84 -5.26 2.67 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.854 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.553 HG22 ' HB3' ' A' ' 199' ' ' ASN . 2.7 t -91.82 34.79 0.98 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.039 0.447 . . . . 0.0 110.617 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.961 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 8.5 m -137.25 92.88 2.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.249 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 11.3 t -66.68 -73.3 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.392 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.0 t -89.93 -2.06 58.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.961 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.1 OUTLIER -115.63 47.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.132 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.857 ' H ' ' CD ' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -152.28 -26.65 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.857 ' CD ' ' H ' ' A' ' 206' ' ' LEU . 33.0 Cg_exo -55.05 102.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 CA-C-N 121.02 1.4 . . . . 0.0 111.739 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.588 HG11 ' ND1' ' A' ' 196' ' ' HIS . 17.1 t -68.34 165.78 2.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.086 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.568 ' N ' HG12 ' A' ' 208' ' ' VAL . 1.5 mtpt -134.99 88.38 2.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.151 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.072 HD23 HD12 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -75.75 128.29 34.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.563 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -175.3 176.62 47.3 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.155 -1.021 . . . . 0.0 113.556 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 1.005 ' HB2' HG13 ' A' ' 225' ' ' VAL . 6.1 ttt180 -71.47 -72.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.876 0.47 . . . . 0.0 111.477 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.657 HG22 ' H ' ' A' ' 214' ' ' SER . 8.0 p -125.49 -139.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.648 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.684 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.3 OUTLIER 61.78 -179.92 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 118.894 0.77 . . . . 0.0 109.928 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 47.0 Cg_endo -70.46 31.24 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.836 1.691 . . . . 0.0 113.205 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 214' ' ' SER . 3.9 m -65.03 157.71 27.63 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.796 0.331 . . . . 0.0 110.837 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.4 -30.36 23.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.533 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.072 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -110.01 133.51 53.11 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -94.95 77.32 3.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.522 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.785 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -100.44 66.88 1.29 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.647 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 0.3 OUTLIER -61.59 45.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -177.293 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.534 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 10.3 t0 -94.1 124.05 37.87 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.4 t -39.55 -32.07 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.228 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.867 ' O ' HD11 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -52.11 -37.42 54.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 110.366 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 1.005 HG13 ' HB2' ' A' ' 212' ' ' ARG . 4.3 p -103.51 102.14 13.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.496 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.437 ' O ' ' HD2' ' A' ' 212' ' ' ARG . 78.6 p -45.17 -62.2 1.35 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.08 0.466 . . . . 0.0 111.032 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -132.19 -50.58 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.684 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 0.1 OUTLIER -143.05 131.25 21.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.015 -0.592 . . . . 0.0 109.782 178.229 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.649 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.3 t60 -95.82 -55.58 2.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.327 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -143.65 172.81 12.3 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.578 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -157.48 177.66 11.18 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.727 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.792 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.0 mt -135.78 150.17 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.885 0.374 . . . . 0.0 111.985 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.59 163.71 37.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.217 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.613 ' CE3' HD21 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -91.92 149.46 21.54 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.497 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.432 ' HB3' ' CB ' ' A' ' 240' ' ' LYS . 7.9 t-20 -119.78 80.83 1.64 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 5.9 p -68.61 -19.97 64.47 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 82.5 m -81.21 -32.16 33.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.425 0.631 . . . . 0.0 110.885 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.583 ' HD3' ' HD3' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -117.7 15.29 14.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.889 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.417 ' C ' ' O ' ' A' ' 238' ' ' LYS . 10.0 p90 38.9 71.98 0.15 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.583 ' HD3' ' HD3' ' A' ' 238' ' ' LYS . 6.0 mptt -137.84 148.21 45.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.445 -1.252 . . . . 0.0 112.375 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.71 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.5 OUTLIER -116.97 104.73 11.57 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.5 mt-10 -126.26 146.8 49.86 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.5 pp -116.12 149.76 38.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.767 -1.56 . . . . 0.0 110.984 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.691 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -118.87 162.31 17.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.547 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 248' ' ' SER . 11.5 m-20 -115.6 99.26 7.21 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.172 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.822 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.36 108.81 9.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.207 0.527 . . . . 0.0 110.588 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 51.61 62.5 5.48 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.114 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 5.8 t -80.6 76.17 7.46 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.972 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.47 -48.83 78.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.972 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -74.68 -28.02 60.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.414 -179.188 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.522 ' O ' HD23 ' A' ' 253' ' ' LEU . . . 87.3 99.05 0.86 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.858 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.563 ' C ' HD23 ' A' ' 253' ' ' LEU . 4.9 m -60.31 159.22 10.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.359 0.123 . . . . 0.0 110.77 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.715 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -148.09 124.51 10.97 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.027 0.442 . . . . 0.0 111.374 179.064 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.887 HG22 HG23 ' A' ' 281' ' ' ILE . 90.9 t -101.26 132.02 47.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.819 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.428 ' HA ' HG13 ' A' ' 280' ' ' ILE . 32.0 t-20 51.27 39.58 24.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.069 0.461 . . . . 0.0 110.29 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 1.6 t 65.82 22.14 11.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.51 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -121.45 100.49 7.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.007 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 59.9 p -51.84 97.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.072 0.463 . . . . 0.0 112.19 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.928 HG21 HG11 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -78.14 -54.21 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.874 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.544 ' N ' HG12 ' A' ' 259' ' ' ILE . 2.0 t . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.932 0.396 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.822 ' CZ3' ' HB2' ' A' ' 246' ' ' MET . 36.8 t-105 -66.19 -26.58 67.46 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 76.92 160.88 11.58 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.911 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -94.56 146.47 31.52 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.88 147.87 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.166 1.911 . . . . 0.0 111.503 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.928 HG11 HG21 ' A' ' 259' ' ' ILE . 85.9 t -132.14 127.18 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.71 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.01 128.08 33.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.154 -178.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 1.022 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -93.11 164.38 13.28 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.957 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.02 159.23 42.64 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 57.2 p -62.48 132.1 51.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.245 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 81.8 -0.89 1.56 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.013 -179.108 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.72 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -71.97 -167.02 0.26 Allowed 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.6 OUTLIER -162.7 133.37 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.444 177.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.887 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -109.9 156.18 10.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.483 178.416 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.715 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 5.8 m -147.42 112.82 5.59 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.779 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -112.1 46.43 1.16 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.614 -177.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -178.79 -129.74 1.34 Allowed Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 119.654 -1.26 . . . . 0.0 113.882 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.641 HG22 ' HG3' ' A' ' 224' ' ' GLU . 5.4 t -97.59 -41.05 8.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.0 110.501 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.608 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -149.25 3.09 0.58 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.835 179.239 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.834 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 57.3 m -77.06 104.66 7.67 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.745 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -127.02 133.51 50.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.343 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.85 ' CG2' HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -110.82 136.76 45.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.311 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 4.0 t80 -76.41 135.22 39.45 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 1.022 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.3 t -103.37 113.51 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.099 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 293' ' ' ILE . 6.7 tpt180 -126.43 145.5 50.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.705 HD11 HD23 ' A' ' 275' ' ' LEU . 7.1 mt -143.32 116.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.908 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 6.1 t -125.48 155.76 40.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 0.0 110.725 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.02 162.25 24.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.204 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 296' ' ' GLN . 5.5 tp60 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.952 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.251 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.678 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.0 m95 -144.02 127.77 17.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.871 HD11 ' CD1' ' A' ' 184' ' ' LEU . 1.2 tp -120.07 129.68 54.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.392 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.852 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.2 m-85 -130.25 135.8 48.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.786 0.803 . . . . 0.0 111.814 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.991 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -132.03 148.65 52.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.963 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.606 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 26.5 tt0 -140.64 124.96 17.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.709 HG21 HD12 ' A' ' 194' ' ' LEU . 17.4 t -60.8 108.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.925 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.2 tt -92.38 -18.38 7.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.798 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.53 93.6 0.34 Allowed 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.589 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.736 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.03 -172.06 27.84 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.621 ' O ' ' HG2' ' A' ' 221' ' ' LYS . 83.5 Cg_endo -80.41 29.06 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.232 1.954 . . . . 0.0 111.61 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.847 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.75 27.13 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.736 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.1 mt -41.76 111.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 112.136 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 8.16 2.26 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.11 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.847 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -101.18 136.28 41.29 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.697 0.761 . . . . 0.0 109.057 178.049 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.606 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 7.9 mt-30 -136.17 155.81 49.6 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.494 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.991 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -148.84 147.58 28.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.355 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.544 ' C ' ' HZ3' ' A' ' 181' ' ' TRP . . . -151.25 149.48 29.45 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.619 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.927 HG13 ' CH2' ' A' ' 234' ' ' TRP . 5.2 p -153.77 153.83 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.432 0.634 . . . . 0.0 111.542 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 180' ' ' SER . 7.8 m120 -91.27 148.57 22.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.679 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.516 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 32.8 p -66.31 -0.63 2.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 2.1 t -103.17 26.78 7.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.432 0.634 . . . . 0.0 110.457 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.627 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 55.8 p -114.32 123.22 48.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.692 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' SER . . . . . 0.497 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 22.9 m -91.07 -80.88 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.3 t -82.34 6.46 16.93 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.497 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -117.26 -12.13 10.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.958 0.408 . . . . 0.0 110.939 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.747 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.8 tt -68.0 -60.97 4.58 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.295 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.619 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.6 Cg_endo -42.6 99.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.32 2.014 . . . . 0.0 112.571 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.895 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 2.3 t -67.38 160.44 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.438 ' N ' ' CG1' ' A' ' 208' ' ' VAL . 3.7 mtpt -133.83 93.11 3.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.026 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -84.5 121.89 28.23 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.75 167.48 38.54 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.527 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.934 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.1 OUTLIER -57.42 -88.18 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.27 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.586 HG12 ' HD3' ' A' ' 212' ' ' ARG . 13.1 p -126.89 -10.61 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 111.62 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.609 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.6 OUTLIER -52.34 179.78 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.461 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 36.1 Cg_exo -60.05 10.83 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.417 2.078 . . . . 0.0 113.202 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 214' ' ' SER . 1.0 OUTLIER -52.39 -178.11 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.16 0.505 . . . . 0.0 111.461 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 209' ' ' LYS . 17.6 m-20 -99.24 -31.42 11.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.51 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.026 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -104.33 127.61 52.01 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -94.27 82.24 4.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.91 0.386 . . . . 0.0 111.889 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.857 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.9 mm? -102.68 91.49 4.22 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 6.5 ptpt -61.53 60.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.147 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 220' ' ' LEU . 3.3 m-20 -93.15 146.59 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.702 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 54.2 p -86.77 -18.46 31.04 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.56 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.569 ' OE1' HG22 ' A' ' 285' ' ' THR . 0.0 OUTLIER -79.48 -18.65 51.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.76 0.314 . . . . 0.0 111.466 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.934 HG13 ' HB2' ' A' ' 212' ' ' ARG . 3.0 p -109.37 81.45 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.023 0.44 . . . . 0.0 110.583 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.8 p -37.71 -39.45 0.34 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.514 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.37 -55.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.947 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.609 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 0.6 OUTLIER -140.75 130.82 24.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.115 0.483 . . . . 0.0 110.782 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.603 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.8 OUTLIER -96.57 -57.02 2.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.442 179.039 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 244' ' ' VAL . . . -151.57 175.81 11.96 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.555 0.693 . . . . 0.0 112.449 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.895 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -152.52 173.32 15.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.974 -179.302 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 9.0 mt -125.03 143.37 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.913 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.24 129.07 4.25 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.927 ' CH2' HG13 ' A' ' 198' ' ' VAL . 4.5 p90 -119.32 166.43 13.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.754 0.788 . . . . 0.0 112.624 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 240' ' ' LYS . 1.9 m-20 -113.66 133.25 55.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.201 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.44 -1.83 52.92 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.088 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.8 m -78.83 -23.86 44.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.518 0.675 . . . . 0.0 109.937 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.518 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 13.9 tptt -141.82 16.61 2.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.373 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 15.3 p90 42.83 60.44 2.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.537 0.684 . . . . 0.0 109.774 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.785 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 2.0 mptp? -124.08 141.25 52.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.91 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.663 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -124.68 127.02 46.65 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.316 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.835 ' HG2' ' HG3' ' A' ' 274' ' ' GLU . 24.5 mt-10 -134.87 139.85 45.35 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.824 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -92.37 143.1 26.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.738 -1.574 . . . . 0.0 107.45 177.182 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.517 ' O ' ' HB1' ' A' ' 230' ' ' ALA . 1.3 p -140.16 161.64 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.272 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.714 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 10.5 t0 -84.93 135.03 34.23 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 120.881 0.372 . . . . 0.0 110.716 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.538 ' HG3' ' HG2' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -89.74 31.33 0.95 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.18 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.56 47.45 56.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.418 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.46 175.21 6.65 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.915 0.358 . . . . 0.0 111.077 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.694 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -101.67 -30.08 11.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.737 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.694 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -75.82 -33.29 60.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.467 0.651 . . . . 0.0 111.579 -178.753 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.492 ' O ' ' NE2' ' A' ' 229' ' ' HIS . . . 93.27 160.47 35.38 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.769 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 260' ' ' SER . 7.6 m -117.98 157.37 26.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.049 -0.575 . . . . 0.0 110.763 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.682 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -144.87 141.82 29.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.041 0.448 . . . . 0.0 110.681 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.564 HG23 HD11 ' A' ' 259' ' ' ILE . 60.0 t -114.89 128.99 71.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.053 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.658 ' HA ' HD12 ' A' ' 280' ' ' ILE . 40.6 t30 55.93 48.68 17.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.099 0.476 . . . . 0.0 110.24 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 18.7 m 56.33 29.12 14.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.66 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.401 ' O ' HG23 ' A' ' 259' ' ' ILE . 1.7 t60 -133.3 103.4 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.816 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.585 ' HA ' ' HB3' ' A' ' 253' ' ' LEU . 64.8 p -55.03 89.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.286 0.565 . . . . 0.0 110.877 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.93 ' HB ' HG21 ' A' ' 273' ' ' VAL . 2.6 pp -94.66 -8.19 9.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.229 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.714 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 3.3 m . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.434 ' NZ ' ' HA2' ' A' ' 270' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.196 0.522 . . . . 0.0 112.07 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.561 ' CH2' ' NE2' ' A' ' 231' ' ' GLN . 19.5 t-105 -78.29 -18.79 54.8 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.299 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' GLY . . . . . 0.434 ' HA2' ' NZ ' ' A' ' 268' ' ' LYS . . . 71.78 173.29 18.31 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.33 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -105.0 138.31 19.47 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -50.28 111.43 0.53 Allowed 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.602 2.202 . . . . 0.0 113.316 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.93 HG21 ' HB ' ' A' ' 259' ' ' ILE . 39.6 t -97.97 139.53 19.97 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.835 ' HG3' ' HG2' ' A' ' 242' ' ' GLU . 1.7 mp0 -80.1 124.79 29.06 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.869 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -91.81 165.98 12.99 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.99 177.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.721 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.72 159.19 42.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 13.7 t -59.88 128.33 36.38 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.958 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 277' ' ' SER . 12.8 m-20 87.98 5.77 0.24 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.885 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.721 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -80.94 -163.29 0.57 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.7 OUTLIER -161.52 131.02 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.365 177.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.867 HD12 ' CG2' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -104.46 156.3 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.117 0.484 . . . . 0.0 110.018 178.163 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.682 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 3.2 m -147.43 114.41 6.15 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.743 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.92 44.4 1.79 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.143 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.87 -131.54 1.79 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.585 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.569 HG22 ' OE1' ' A' ' 224' ' ' GLU . 2.6 t -92.36 -51.35 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.703 0.287 . . . . 0.0 110.522 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.584 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -138.58 -0.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.577 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.798 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 29.9 m -70.26 103.06 2.26 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.643 0.258 . . . . 0.0 110.953 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.679 ' O ' HG22 ' A' ' 187' ' ' ILE . 1.3 mtpp -126.01 137.78 53.68 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.349 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.867 ' CG2' HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -115.54 134.81 57.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.457 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.645 ' HD1' HG23 ' A' ' 280' ' ' ILE . 2.1 t80 -76.5 141.23 41.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.548 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -107.26 109.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.422 -179.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.416 ' O ' HD12 ' A' ' 182' ' ' LEU . 4.9 tpt180 -124.29 141.28 52.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.606 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.547 HG12 HD13 ' A' ' 182' ' ' LEU . 9.3 mt -138.76 133.16 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.02 156.46 43.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.733 0.301 . . . . 0.0 111.001 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.32 -174.75 4.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.031 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.922 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.577 ' HB2' ' OG ' ' A' ' 200' ' ' SER . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.137 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.734 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 14.1 m95 -148.12 134.01 19.08 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.738 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 2.2 tp -112.98 119.78 39.11 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.458 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.734 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 5.6 m-85 -117.12 127.43 54.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.677 0.751 . . . . 0.0 110.66 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -118.28 134.62 54.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.676 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.541 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 2.3 tt0 -131.06 112.3 12.78 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.911 HG21 HD11 ' A' ' 220' ' ' LEU . 18.8 t -61.99 107.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.889 HG22 ' O ' ' A' ' 288' ' ' LYS . 11.0 tt -88.53 -26.01 5.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.743 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.31 98.35 0.71 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.418 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.1 -162.06 12.8 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.466 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 88.5 Cg_endo -86.59 27.93 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.677 2.251 . . . . 0.0 111.324 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.872 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -162.07 25.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.418 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.604 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.9 mt -39.63 107.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.52 5.47 2.28 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.203 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.872 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.9 OUTLIER -102.81 133.7 47.44 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.544 0.687 . . . . 0.0 110.076 179.126 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.8 mt-30 -131.13 153.96 48.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.763 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.568 ' NE2' ' HB3' ' A' ' 217' ' ' ASP . 1.6 t-80 -144.28 138.66 28.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.134 0.492 . . . . 0.0 110.832 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.738 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.92 156.08 44.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.591 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.795 HG21 ' CB ' ' A' ' 206' ' ' LEU . 12.3 p -157.69 149.01 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.348 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.5 OUTLIER -91.65 140.56 29.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.317 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.577 ' OG ' ' HB2' ' A' ' 180' ' ' SER . 0.9 OUTLIER -62.23 -6.88 3.46 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.035 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.76 28.55 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.323 0.582 . . . . 0.0 110.742 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.766 ' OG ' ' HB3' ' A' ' 206' ' ' LEU . 89.2 p -101.02 140.87 34.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.358 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -70.94 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 111.315 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.41 33.04 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.004 0.43 . . . . 0.0 110.752 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -117.15 4.13 12.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.862 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.989 HD13 ' HD3' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -98.69 -19.19 0.21 Allowed Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.989 ' HD3' HD13 ' A' ' 206' ' ' LEU . 10.8 Cg_endo -58.14 97.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 CA-C-N 120.836 1.334 . . . . 0.0 111.058 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 58.5 t -67.64 164.07 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.276 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.66 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.3 OUTLIER -139.73 86.0 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.509 -178.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.041 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -74.94 130.38 39.28 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.869 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.432 ' HA2' HG11 ' A' ' 225' ' ' VAL . . . -176.13 178.57 47.53 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.588 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 15.5 ttt180 -76.48 -67.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.816 HG22 ' H ' ' A' ' 214' ' ' SER . 9.8 p -125.99 -145.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 213' ' ' VAL . 1.1 p 64.78 179.9 0.04 OUTLIER Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 57.7 Cg_endo -73.15 39.37 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.913 1.742 . . . . 0.0 112.597 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.2 p -70.05 151.98 44.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.836 0.35 . . . . 0.0 110.553 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.568 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 2.8 m-20 -75.62 -38.15 59.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.086 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.041 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -103.21 130.33 50.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.6 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -98.72 86.28 3.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.841 0.353 . . . . 0.0 111.078 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.911 HD11 HG21 ' A' ' 186' ' ' VAL . 2.3 mm? -108.03 69.66 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.41 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 6.7 pttt -47.75 72.82 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.919 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.677 ' N ' ' O ' ' A' ' 220' ' ' LEU . 41.8 t0 -101.58 137.45 39.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.468 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.0 p -76.89 -3.98 41.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.348 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -99.73 -22.39 15.4 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 90.4 t -96.73 76.37 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.419 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 225' ' ' VAL . 49.0 m -31.5 -48.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.999 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.6 -58.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.1 OUTLIER -141.81 131.39 23.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.2 0.524 . . . . 0.0 110.336 179.073 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.627 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.6 t60 -99.5 -54.88 2.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.175 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -141.65 175.54 9.61 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.72 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -165.88 176.94 7.48 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.578 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.4 mt -135.27 148.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.682 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.17 164.11 38.01 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.46 ' CH2' ' CZ3' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -89.32 146.15 24.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -176.166 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.532 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 0.9 OUTLIER -119.33 81.28 1.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.515 175.023 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.7 p -64.77 -20.64 66.47 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.1 m -80.91 -30.87 35.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.33 0.586 . . . . 0.0 110.334 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.598 ' HD2' ' HE2' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -108.59 5.25 24.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.064 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 235' ' ' ASN . 2.8 p90 38.48 42.73 0.58 Allowed 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.245 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.598 ' HE2' ' HD2' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -118.64 173.95 6.55 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.279 0.562 . . . . 0.0 109.503 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.696 ' CZ3' HG23 ' A' ' 293' ' ' ILE . 2.0 m0 -121.88 113.41 19.6 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 13.7 pt-20 -133.26 149.13 51.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.715 ' O ' HD12 ' A' ' 243' ' ' LEU . 3.8 pp -115.05 152.15 32.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.06 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.868 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.7 OUTLIER -118.98 163.12 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 248' ' ' SER . 0.4 OUTLIER -104.73 110.66 23.08 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.163 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.601 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.82 100.49 5.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.656 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.73 63.44 5.12 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.541 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 3.1 p -67.33 55.74 0.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.771 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.51 -46.52 80.51 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.771 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -78.91 -35.62 43.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.559 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 89.71 87.4 1.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.89 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.525 ' C ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -45.24 164.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.47 0.176 . . . . 0.0 111.288 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.613 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -151.84 134.17 15.24 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.213 0.53 . . . . 0.0 111.686 178.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.629 HG23 ' CG1' ' A' ' 259' ' ' ILE . 96.6 t -110.65 137.61 42.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.225 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 49.45 35.41 8.09 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.207 0.527 . . . . 0.0 110.173 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 14.6 m 69.44 29.33 4.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.442 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -131.5 102.22 5.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.349 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 8.8 t -53.39 87.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.698 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.766 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.0 OUTLIER -90.18 6.86 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.932 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.457 ' HB3' ' N ' ' A' ' 252' ' ' THR . 2.4 t . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.868 ' NE1' HG11 ' A' ' 244' ' ' VAL . 3.4 t-105 -82.73 -29.14 29.99 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.72 -174.52 8.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.532 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -101.54 137.87 19.72 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.397 0.598 . . . . 0.0 110.497 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 75.6 Cg_exo -51.63 122.9 11.11 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.704 2.269 . . . . 0.0 113.621 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.766 HG21 ' HB ' ' A' ' 259' ' ' ILE . 98.7 t -94.12 141.11 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -82.93 130.13 35.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.033 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.792 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -96.46 163.25 13.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.895 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.31 160.33 41.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.296 0.569 . . . . 0.0 112.487 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 38.3 t -59.89 125.63 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.609 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.522 ' HA ' ' CZ ' ' A' ' 290' ' ' TYR . 14.8 m-20 85.97 0.77 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.736 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.662 ' O ' HG23 ' A' ' 291' ' ' VAL . 2.3 m-20 -82.06 133.7 35.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.703 HG23 ' HD1' ' A' ' 290' ' ' TYR . 1.0 OUTLIER -101.91 130.36 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.992 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 1.054 HG22 HG12 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -99.46 155.15 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.998 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.613 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -144.83 118.97 9.44 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.67 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.87 44.53 1.76 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.2 -122.93 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 119.277 -1.44 . . . . 0.0 113.843 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.2 t -93.44 -51.74 4.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.142 . . . . 0.0 111.188 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -142.65 -2.63 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.743 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 35.7 m -65.94 102.39 0.78 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 117.853 0.297 . . . . 0.0 110.614 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.889 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -117.63 123.73 46.87 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.752 -178.601 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 1.054 HG12 HG22 ' A' ' 281' ' ' ILE . 2.5 p -108.41 134.08 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.636 0.255 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.703 ' HD1' HG23 ' A' ' 280' ' ' ILE . 1.4 t80 -77.65 130.26 36.62 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.2 t -104.01 115.91 46.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.894 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.601 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -129.3 146.64 51.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.576 -179.151 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.792 HD11 HD23 ' A' ' 275' ' ' LEU . 9.1 mt -139.78 140.77 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.52 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.6 t -152.3 161.44 42.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.373 . . . . 0.0 111.29 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 54.5 p -102.97 141.52 35.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.533 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.772 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 73.1 m . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.752 0.311 . . . . 0.0 111.415 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 49.0 m95 -156.82 143.02 18.1 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.752 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.4 OUTLIER -118.79 106.16 12.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.427 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 14.2 m-85 -101.91 136.44 41.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.997 0.903 . . . . 0.0 112.179 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.529 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.4 OUTLIER -126.74 136.21 52.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.404 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -133.34 116.53 16.21 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.975 HG21 HD11 ' A' ' 220' ' ' LEU . 18.4 t -62.53 116.15 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.2 tt -96.63 -23.21 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.39 91.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.54 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.685 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.86 -174.75 32.12 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.567 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 60.4 Cg_endo -75.34 27.56 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.371 2.047 . . . . 0.0 111.568 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.898 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -161.4 31.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.94 0.4 . . . . 0.0 110.0 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.685 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.1 mt -47.8 107.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.622 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.93 7.16 2.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.122 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 186' ' ' VAL . 0.6 OUTLIER -101.44 112.18 24.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.802 0.81 . . . . 0.0 109.906 179.151 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.0 mt-30 -111.03 152.62 26.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.554 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.527 ' O ' HD12 ' A' ' 184' ' ' LEU . 1.1 t-80 -144.04 136.56 26.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.752 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -142.06 165.18 28.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.882 HG13 ' CH2' ' A' ' 234' ' ' TRP . 0.6 OUTLIER -165.04 148.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.528 179.121 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 180' ' ' SER . 18.2 t-20 -88.57 137.18 32.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.474 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.589 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 32.4 t -49.32 -14.36 0.09 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.887 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.44 HG22 ' OD1' ' A' ' 199' ' ' ASN . 2.0 t -102.11 7.32 41.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -103.78 114.07 28.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.885 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 2.7 m -91.26 -67.39 0.86 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.69 -5.49 2.76 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.7 -1.81 11.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.126 -0.359 . . . . 0.0 111.313 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.9 HD21 ' CE3' ' A' ' 234' ' ' TRP . 1.3 tt -71.58 -61.66 2.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.4 Cg_endo -44.01 84.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.45 2.1 . . . . 0.0 113.276 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 206' ' ' LEU . 88.0 t -74.53 92.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.746 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.47 ' N ' ' HB2' ' A' ' 217' ' ' ASP . 0.7 OUTLIER -69.36 98.59 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.054 HD23 HD12 ' A' ' 218' ' ' LEU . 1.4 mp -82.65 128.79 34.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.778 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -179.11 179.37 48.91 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.899 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.909 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -68.06 -76.39 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.815 HG22 ' H ' ' A' ' 214' ' ' SER . 8.0 p -126.57 -141.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.39 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.815 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.1 OUTLIER 64.72 -175.88 0.03 OUTLIER Pre-proline 0 C--O 1.232 0.135 0 CA-C-N 118.314 0.506 . . . . 0.0 110.247 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 21.8 Cg_exo -65.66 10.03 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.745 2.297 . . . . 0.0 113.423 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 39.4 m -48.83 169.03 0.02 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.741 0.305 . . . . 0.0 111.092 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.47 ' HB2' ' N ' ' A' ' 209' ' ' LYS . 1.7 m-20 -95.48 -34.81 11.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.343 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.054 HD12 HD23 ' A' ' 210' ' ' LEU . 5.0 mt -105.81 127.31 53.02 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.62 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -92.57 80.02 4.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.724 0.297 . . . . 0.0 110.711 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.975 HD11 HG21 ' A' ' 186' ' ' VAL . 2.7 mm? -103.7 92.71 4.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.406 ' C ' ' HG2' ' A' ' 190' ' ' PRO . 1.3 mtmt -60.1 58.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.674 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.928 ' HB3' HG12 ' A' ' 225' ' ' VAL . 5.5 t0 -92.72 124.88 37.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.349 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.7 p -69.05 -10.5 57.88 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.108 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.402 ' HG3' ' OD1' ' A' ' 250' ' ' ASN . 0.8 OUTLIER -82.57 -24.76 33.81 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.783 0.325 . . . . 0.0 110.928 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.928 HG12 ' HB3' ' A' ' 222' ' ' ASP . 3.0 p -108.41 79.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.1 m -35.17 -36.16 0.05 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.737 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.23 -58.01 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.976 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.492 ' C ' HG23 ' A' ' 225' ' ' VAL . 2.6 mtpp -143.19 132.48 23.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.135 0.493 . . . . 0.0 110.556 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.541 ' CB ' ' HB2' ' A' ' 283' ' ' LEU . 0.6 OUTLIER -102.16 -57.0 2.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.376 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -141.83 171.21 14.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.192 0.52 . . . . 0.0 112.036 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.783 ' HA ' HD12 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -152.54 159.36 43.29 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.486 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.616 HG12 ' HB3' ' A' ' 243' ' ' LEU . 19.4 mt -123.73 145.73 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.432 0.634 . . . . 0.0 111.87 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.852 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -161.41 150.51 16.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.9 ' CE3' HD21 ' A' ' 206' ' ' LEU . 3.2 p90 -138.76 165.64 26.46 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.12 132.43 56.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.792 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 73.4 m -88.99 2.09 54.5 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.872 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 21.4 m -78.63 -19.48 52.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.643 0.735 . . . . 0.0 110.276 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -150.73 23.63 0.78 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.496 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.2 p90 37.44 59.58 1.18 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.214 0.53 . . . . 0.0 110.446 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.822 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -128.63 143.12 50.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.673 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.694 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -123.42 122.5 38.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.774 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.8 pt-20 -134.18 142.35 47.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.698 0.761 . . . . 0.0 112.354 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.4 pp -107.82 152.76 23.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.784 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.856 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -115.75 162.24 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.663 0.268 . . . . 0.0 110.963 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.519 ' HB3' ' OG ' ' A' ' 260' ' ' SER . 1.2 m-20 -106.22 111.05 23.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.605 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.93 103.42 6.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.203 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.87 70.59 0.92 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.51 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.2 m -62.0 40.96 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.878 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.52 -52.54 64.37 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.793 -0.567 . . . . 0.0 109.881 178.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.878 ' H ' HD13 ' A' ' 249' ' ' LEU . 2.7 m120 -80.32 -39.36 28.83 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.145 0.498 . . . . 0.0 111.681 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 88.89 87.36 1.23 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.804 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.693 ' N ' ' HB3' ' A' ' 260' ' ' SER . 2.9 m -45.44 170.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.279 0.232 . . . . 0.0 110.553 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -149.11 133.66 17.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.205 0.526 . . . . 0.0 111.461 177.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.876 HG23 ' CD1' ' A' ' 259' ' ' ILE . 86.0 t -109.83 133.11 56.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.083 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.464 ' HA ' HG13 ' A' ' 280' ' ' ILE . 3.3 m-20 51.11 44.41 28.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.174 0.512 . . . . 0.0 110.07 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 m 64.18 26.93 13.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.763 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.441 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.1 OUTLIER -129.75 115.67 17.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.208 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 5.8 t -67.46 89.82 0.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.03 0.443 . . . . 0.0 111.548 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.876 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -89.36 0.33 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.431 -178.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.693 ' HB3' ' N ' ' A' ' 252' ' ' THR . 14.0 t . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.452 ' HD2' ' H ' ' A' ' 269' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.856 ' NE1' HG11 ' A' ' 244' ' ' VAL . 1.4 t-105 -77.68 -15.7 58.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.92 0.488 . . . . 0.0 112.232 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 59.94 -174.19 4.53 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.488 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -107.18 134.07 20.06 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.905 0.852 . . . . 0.0 110.494 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 96.4 Cg_exo -45.0 125.08 6.41 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.771 2.314 . . . . 0.0 113.521 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.806 HG21 ' CG1' ' A' ' 259' ' ' ILE . 74.9 t -98.77 129.3 49.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.13 128.65 34.79 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.46 -178.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.986 HD22 HG11 ' A' ' 291' ' ' VAL . 0.6 OUTLIER -87.27 163.5 16.82 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.031 -178.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.408 ' HA ' ' HZ3' ' A' ' 241' ' ' TRP . . . -137.82 145.86 42.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.395 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 2.9 t -56.64 126.0 24.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.017 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.2 m-20 90.27 4.52 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.344 0.657 . . . . 0.0 111.949 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' ' 280' ' ' ILE . 0.6 OUTLIER -79.91 -164.51 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.789 HG22 ' HA ' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -162.3 136.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.406 178.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.935 HG22 HG12 ' A' ' 289' ' ' VAL . 0.1 OUTLIER -108.46 156.64 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.607 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.693 ' OG1' ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -145.81 117.27 8.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.399 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.699 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -113.07 44.61 1.49 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.79 -133.26 2.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.433 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 286' ' ' THR . 6.8 t -88.45 -49.44 6.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.643 0.259 . . . . 0.0 110.956 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.6 t -139.68 -7.3 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.728 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 49.0 m -63.97 101.31 0.38 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.693 ' HG3' ' OG1' ' A' ' 282' ' ' THR . 1.7 ttmt -118.8 129.51 55.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.637 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.935 HG12 HG22 ' A' ' 281' ' ' ILE . 0.3 OUTLIER -106.98 128.49 61.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.542 0.21 . . . . 0.0 111.52 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.789 ' HA ' HG22 ' A' ' 280' ' ' ILE . 7.1 t80 -76.79 136.99 39.0 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.986 HG11 HD22 ' A' ' 275' ' ' LEU . 8.0 t -113.89 115.17 48.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.535 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.61 142.32 39.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.773 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.552 HD12 ' CE3' ' A' ' 241' ' ' TRP . 0.5 OUTLIER -129.89 147.24 33.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.501 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.67 129.54 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 0.0 111.482 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 8.7 p -81.42 159.37 24.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.58 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.687 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 295' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.458 -0.059 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.7 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.5 m95 -143.24 131.62 22.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.799 HD11 ' CD1' ' A' ' 184' ' ' LEU . 3.4 tp -114.07 128.41 56.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.943 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.783 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.4 m-85 -130.27 129.94 43.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.747 0.784 . . . . 0.0 111.588 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.983 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -130.84 146.36 52.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.775 176.714 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.525 ' C ' HG12 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -140.19 127.21 20.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.456 -0.497 . . . . 0.0 112.308 -177.72 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.879 HG21 HD11 ' A' ' 220' ' ' LEU . 9.7 t -64.5 106.06 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.1 tt -90.6 -19.01 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.819 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.63 95.02 0.62 Allowed 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.268 -0.573 . . . . 0.0 112.466 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.71 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.2 -179.54 37.75 Favored Glycine 0 C--O 1.228 -0.26 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.597 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 58.9 Cg_endo -74.6 30.17 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 CA-C-N 119.433 1.617 . . . . 0.0 111.269 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.791 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -160.2 26.38 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.71 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.0 mt -42.11 108.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.07 7.57 1.75 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.099 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.845 ' O ' HG23 ' A' ' 186' ' ' VAL . 1.1 mp -100.86 119.72 39.08 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.139 0.971 . . . . 0.0 109.818 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 8.1 mt-30 -122.54 153.64 38.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.208 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.983 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -146.67 145.42 30.02 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.059 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -150.22 143.46 24.99 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.892 HG21 ' HA ' ' A' ' 206' ' ' LEU . 12.0 p -149.01 149.94 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.418 0.628 . . . . 0.0 111.309 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.516 ' HB3' HG22 ' A' ' 201' ' ' THR . 33.8 m120 -87.72 148.14 24.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.356 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.561 ' CB ' ' HZ2' ' A' ' 234' ' ' TRP . 1.0 OUTLIER -65.55 -7.64 15.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.387 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 199' ' ' ASN . 3.1 t -92.35 5.62 49.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.95 0.405 . . . . 0.0 111.209 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.668 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -94.93 113.68 25.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.57 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.8 m -60.1 -108.46 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.2 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.8 m -78.58 25.52 0.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.54 -10.55 10.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.93 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.892 ' HA ' HG21 ' A' ' 198' ' ' VAL . 9.0 tt -77.06 -49.22 2.45 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.557 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 206' ' ' LEU . 52.9 Cg_exo -46.48 100.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.467 1.445 . . . . 0.0 111.653 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.874 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 4.7 t -66.83 163.33 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 216' ' ' SER . 0.0 OUTLIER -138.38 92.55 2.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.851 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.055 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -83.91 127.32 33.76 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.423 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.513 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -173.31 178.11 45.41 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.136 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 1.003 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 8.5 ttt180 -63.38 -86.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.605 HG12 ' HD3' ' A' ' 212' ' ' ARG . 14.5 p -133.67 -4.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.631 ' HB2' ' CD ' ' A' ' 215' ' ' PRO . 67.5 p -53.76 -178.85 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.631 ' CD ' ' HB2' ' A' ' 214' ' ' SER . 32.6 Cg_exo -61.08 17.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.307 2.004 . . . . 0.0 112.709 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 214' ' ' SER . 6.4 m -58.39 -178.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.218 0.532 . . . . 0.0 111.619 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.1 -31.92 11.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.506 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.055 HD12 HD23 ' A' ' 210' ' ' LEU . 1.1 mt -103.46 124.89 49.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.62 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.596 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -94.67 86.42 4.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.795 0.331 . . . . 0.0 110.465 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 1.003 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.7 mm? -109.62 96.6 6.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -64.28 51.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.897 ' HB2' HG12 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -84.9 138.14 32.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.2 p -78.95 -11.09 59.99 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.121 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.437 ' CG ' ' HA3' ' A' ' 284' ' ' GLY . 0.0 OUTLIER -84.39 -20.34 32.06 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.769 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.897 HG12 ' HB2' ' A' ' 222' ' ' ASP . 7.5 p -113.91 69.79 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-O 120.872 0.367 . . . . 0.0 110.069 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -35.2 -33.28 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.193 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 225' ' ' VAL . . . -144.1 -67.75 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.361 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -140.38 128.48 22.23 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.32 0.581 . . . . 0.0 111.176 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 248' ' ' SER . 0.3 OUTLIER -95.8 -60.69 1.59 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.508 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.675 ' HB3' ' CD2' ' A' ' 283' ' ' LEU . . . -150.35 163.02 39.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.904 -177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.98 ' O ' HD13 ' A' ' 243' ' ' LEU . 0.0 OUTLIER -138.76 -179.14 5.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.908 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.952 HG12 HD22 ' A' ' 243' ' ' LEU . 14.8 mt -131.1 141.55 45.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.012 0.435 . . . . 0.0 110.81 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.94 133.48 5.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.886 ' CZ2' HD11 ' A' ' 206' ' ' LEU . 1.8 p90 -124.41 165.72 17.23 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.82 133.61 55.85 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.827 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 31.4 p -92.97 3.04 56.44 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.469 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 89.8 m -80.85 -27.99 36.25 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.42 0.629 . . . . 0.0 110.065 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 4.6 tptt -137.09 19.19 2.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.02 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.433 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 27.9 p90 40.43 60.03 1.94 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.5 0.667 . . . . 0.0 109.861 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.77 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -125.12 143.63 50.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.322 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.824 ' CH2' HG23 ' A' ' 293' ' ' ILE . 11.6 m0 -123.79 125.16 44.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.497 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 1.1 pt-20 -129.06 134.87 48.28 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.98 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.1 OUTLIER -107.0 124.74 50.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.048 177.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.761 HG11 ' CZ2' ' A' ' 269' ' ' TRP . 4.8 p -126.39 164.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 O-C-N 122.111 -0.368 . . . . 0.0 111.609 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 260' ' ' SER . 15.9 t0 -88.53 127.8 35.54 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.728 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -84.51 44.44 1.04 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.411 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 269' ' ' TRP . . . 65.46 57.26 11.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.64 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.716 ' HB3' ' HA ' ' A' ' 229' ' ' HIS . 56.1 p -99.87 148.29 24.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.81 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.762 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -79.44 -37.67 36.47 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.961 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.762 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -74.01 -31.25 62.86 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.844 0.354 . . . . 0.0 111.494 -179.066 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 95.3 163.96 34.68 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.946 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.724 ' C ' HD23 ' A' ' 253' ' ' LEU . 25.0 m -125.22 156.61 38.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.84 0.353 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.724 HD23 ' C ' ' A' ' 252' ' ' THR . 0.1 OUTLIER -148.68 126.41 11.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.987 0.423 . . . . 0.0 111.41 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 1.048 HG23 HD12 ' A' ' 259' ' ' ILE . 36.0 t -102.25 127.64 55.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.735 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 53.14 41.22 32.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 110.34 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 16.6 m 62.99 20.22 12.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.404 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.06 90.97 3.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.92 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 96.1 p -45.79 97.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.596 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 1.048 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -78.63 -52.65 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.248 179.185 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.568 ' N ' HG12 ' A' ' 259' ' ' ILE . 19.7 p . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 2.5 mttt . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.38 0.61 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.761 ' CZ2' HG11 ' A' ' 244' ' ' VAL . 0.4 OUTLIER -72.86 -24.95 60.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.157 -0.928 . . . . 0.0 108.662 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 270' ' ' GLY . . . . . 0.596 ' O ' ' HD1' ' A' ' 269' ' ' TRP . . . 79.52 166.17 31.93 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.747 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 273' ' ' VAL . 8.7 m-20 -89.74 138.64 27.93 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.397 0.598 . . . . 0.0 109.929 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.409 ' HB2' ' OE1' ' A' ' 242' ' ' GLU . 9.7 Cg_endo -52.75 108.63 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.504 2.136 . . . . 0.0 112.753 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 40.0 t -102.0 147.24 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.674 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 20.9 mm-40 -85.53 130.21 34.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.51 0.671 . . . . 0.0 112.766 -177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.829 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -95.74 164.51 12.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.934 179.289 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.15 159.4 42.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 23.9 p -57.92 129.32 41.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.327 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.8 m-20 87.93 7.74 0.18 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.287 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.7 OUTLIER -80.72 -164.28 0.7 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.5 OUTLIER -162.27 135.17 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 177.209 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.877 ' CG2' HG22 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -123.6 93.76 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 287' ' ' THR . 0.6 OUTLIER -79.0 121.96 25.59 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.685 HD23 HG23 ' A' ' 252' ' ' THR . 0.3 OUTLIER -106.69 50.03 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.459 -0.497 . . . . 0.0 112.254 -178.049 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 162.54 -115.94 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 119.571 -1.299 . . . . 0.0 113.807 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 286' ' ' THR . 1.2 t -96.1 -57.62 2.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.594 0.235 . . . . 0.0 110.727 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -135.32 0.33 2.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.916 179.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.819 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 45.1 m -75.12 102.94 5.1 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 121.353 -0.139 . . . . 0.0 111.248 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.747 ' O ' HG22 ' A' ' 187' ' ' ILE . 3.4 ptpt -129.08 135.46 48.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.222 0.534 . . . . 0.0 112.091 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.871 HG23 HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -108.49 135.63 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.046 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.2 t80 -77.0 137.93 39.3 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 279' ' ' ASP . 0.1 OUTLIER -106.68 110.79 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.78 -178.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.519 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -119.39 140.6 50.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.775 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.824 HG23 ' CH2' ' A' ' 241' ' ' TRP . 32.3 mt -138.63 134.37 42.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.1 t -152.47 161.76 42.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 111.207 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 36.6 p -104.86 157.97 16.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.819 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.772 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.711 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 20.9 m . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.0 m95 -127.59 132.29 49.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.781 HD23 ' HZ3' ' A' ' 234' ' ' TRP . 2.2 tp -117.72 129.88 55.98 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.244 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.734 ' N ' HD12 ' A' ' 182' ' ' LEU . 11.2 m-85 -125.95 133.15 51.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.681 0.753 . . . . 0.0 110.436 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.799 HD11 HD12 ' A' ' 232' ' ' ILE . 3.3 mt -123.84 141.37 52.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.889 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -134.8 111.3 9.8 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 194' ' ' LEU . 8.8 t -58.64 117.98 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.6 tt -101.91 -24.41 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -175.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.758 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -155.86 91.2 1.27 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.994 0.815 . . . . 0.0 112.479 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -162.64 -165.89 20.48 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.43 ' HG3' ' CG ' ' A' ' 222' ' ' ASP . 58.6 Cg_endo -92.43 33.1 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.971 2.447 . . . . 0.0 111.509 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.842 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -162.34 29.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.459 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.689 HD11 ' N ' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -47.87 111.12 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.052 0.453 . . . . 0.0 111.322 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.12 4.52 2.58 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.666 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.883 ' O ' HG23 ' A' ' 186' ' ' VAL . 0.8 OUTLIER -102.33 118.9 37.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.599 0.714 . . . . 0.0 109.578 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.734 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.0 mt-30 -114.68 149.85 36.11 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.785 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.534 ' NE2' ' HB3' ' A' ' 217' ' ' ASP . 1.0 OUTLIER -138.48 133.26 32.47 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.102 178.436 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.59 156.62 43.36 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.399 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 206' ' ' LEU . 4.5 p -162.19 156.37 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.625 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.711 ' HA ' ' O ' ' A' ' 180' ' ' SER . 3.1 m120 -94.78 145.73 24.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.619 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.659 ' HG ' ' N ' ' A' ' 180' ' ' SER . 28.3 p -58.34 -0.31 0.09 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.081 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 199' ' ' ASN . 1.4 t -106.72 14.4 26.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.857 0.36 . . . . 0.0 111.301 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.453 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -106.33 124.53 49.73 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.179 179.362 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 m -87.48 -83.03 0.21 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 26.2 m -84.09 13.27 5.25 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.453 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.03 -14.31 9.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.015 0.436 . . . . 0.0 110.624 178.645 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.775 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.6 tt -65.69 -55.32 24.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.827 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.8 Cg_endo -42.84 92.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.653 2.235 . . . . 0.0 113.453 -178.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 231' ' ' GLN . 41.6 t -71.46 90.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.708 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.561 ' N ' ' HB2' ' A' ' 217' ' ' ASP . 0.7 OUTLIER -68.16 78.81 0.24 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 231' ' ' GLN . 3.1 mp -65.35 129.55 40.13 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.975 -0.453 . . . . 0.0 110.043 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . -173.59 171.62 44.62 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.46 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.66 ' HB2' ' HB ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -70.56 -74.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.893 0.477 . . . . 0.0 112.074 -179.155 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.647 HG22 ' H ' ' A' ' 214' ' ' SER . 9.9 p -124.28 -142.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.363 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.647 ' H ' HG22 ' A' ' 213' ' ' VAL . 1.9 m 60.5 173.25 0.06 OUTLIER Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 118.972 0.805 . . . . 0.0 109.616 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 37.5 Cg_endo -65.71 28.58 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.076 1.851 . . . . 0.0 113.064 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 214' ' ' SER . 8.1 m -57.47 167.01 1.09 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.749 0.309 . . . . 0.0 110.756 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.561 ' HB2' ' N ' ' A' ' 209' ' ' LYS . 9.7 m-20 -89.0 -43.01 11.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.874 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.814 HD23 HD21 ' A' ' 220' ' ' LEU . 3.4 tp -99.07 131.63 44.97 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.74 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -95.68 75.75 3.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.954 0.407 . . . . 0.0 110.785 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.817 HD11 HG21 ' A' ' 186' ' ' VAL . 2.6 mm? -103.96 62.87 0.76 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.645 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 2.2 pttt -54.57 57.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 220' ' ' LEU . 10.0 t0 -88.75 153.81 20.78 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.2 p -73.18 -4.72 34.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.505 ' HG3' ' HA3' ' A' ' 284' ' ' GLY . 1.4 pt-20 -91.74 -21.79 20.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.977 0.418 . . . . 0.0 110.26 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.784 HG13 ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -96.94 102.88 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.083 179.089 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 73.0 m -53.18 -49.26 67.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.468 0.651 . . . . 0.0 109.885 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 228' ' ' LYS . . . -148.34 -50.62 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.552 ' HD2' ' HD2' ' A' ' 209' ' ' LYS . 8.1 mttm -145.87 134.74 22.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.082 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.784 ' CG ' HG13 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -101.18 -53.84 2.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.181 179.173 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.652 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -148.97 170.32 18.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.865 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -152.68 170.24 20.75 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.764 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.827 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.7 mt -121.06 143.62 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.483 0.659 . . . . 0.0 111.814 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.591 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.14 126.3 4.2 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.799 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 10.5 p90 -120.32 166.85 12.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.485 HD22 ' CB ' ' A' ' 240' ' ' LYS . 16.3 p30 -115.58 133.58 55.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.02 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.27 -0.88 52.49 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.71 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 18.6 m -78.97 -39.33 34.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.904 0.859 . . . . 0.0 109.382 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.608 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 10.0 tptm -117.8 10.08 13.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.21 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 10.6 p90 44.92 63.83 1.58 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.42 0.629 . . . . 0.0 109.772 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.799 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 2.1 mptp? -130.69 140.56 50.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.092 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.691 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 1.8 m95 -121.41 124.01 43.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.942 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 6.7 pt-20 -138.29 147.17 43.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.782 ' HG ' HG13 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -95.25 151.34 19.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 112.859 -1.973 . . . . 0.0 108.474 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.486 HG21 ' HE1' ' A' ' 269' ' ' TRP . 2.2 p -145.57 161.79 12.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.867 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 17.4 t0 -84.25 139.44 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.561 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.417 ' HE2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -85.02 30.56 0.58 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.0 41.02 97.51 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.646 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.459 ' HB2' ' HA ' ' A' ' 229' ' ' HIS . 9.5 t -86.54 172.28 10.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 111.264 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.69 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -96.95 -30.95 12.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.809 179.283 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.69 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.8 OUTLIER -75.53 -29.65 59.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.805 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 85.62 152.55 19.14 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.742 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.652 HG21 ' HB2' ' A' ' 230' ' ' ALA . 87.6 m -108.94 154.73 21.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.463 -0.368 . . . . 0.0 110.772 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.759 ' O ' HD13 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -138.06 136.43 36.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.159 178.342 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.974 HG22 HD11 ' A' ' 281' ' ' ILE . 89.6 t -107.6 127.45 63.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.971 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 1.01 ' HA ' HD12 ' A' ' 280' ' ' ILE . 27.2 t-20 56.56 50.54 12.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.376 0.608 . . . . 0.0 109.985 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.56 32.51 17.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.927 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.415 ' O ' ' N ' ' A' ' 259' ' ' ILE . 0.1 OUTLIER -137.95 111.54 8.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.823 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.464 ' HA ' ' HB3' ' A' ' 253' ' ' LEU . 78.3 p -60.41 83.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.306 0.574 . . . . 0.0 110.34 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.979 ' HB ' HG21 ' A' ' 273' ' ' VAL . 2.6 pp -87.85 -9.49 10.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.815 -178.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.562 ' HB2' HD12 ' A' ' 259' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp . . . . . 0 C--O 1.232 0.176 0 CA-C-O 121.263 0.554 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.634 ' CZ2' ' NE2' ' A' ' 231' ' ' GLN . 7.7 t-105 -81.02 -16.93 51.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.541 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 72.22 174.22 22.85 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.462 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -105.59 137.15 19.22 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.153 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.24 115.75 2.08 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.654 2.236 . . . . 0.0 113.789 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.979 HG21 ' HB ' ' A' ' 259' ' ' ILE . 80.9 t -103.96 135.18 42.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -75.56 127.8 33.88 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -176.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.847 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.29 164.65 13.45 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.517 178.528 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.82 159.3 42.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 28.3 t -61.38 129.28 40.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.367 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 277' ' ' SER . 0.4 OUTLIER 83.74 6.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.387 -178.829 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 16.0 t0 -81.1 -165.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 1.01 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.8 OUTLIER -160.4 126.39 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.368 178.129 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.974 HD11 HG22 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -100.58 148.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.774 ' C ' HD13 ' A' ' 283' ' ' LEU . 13.9 m -140.53 136.81 33.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.612 0.72 . . . . 0.0 111.56 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.774 HD13 ' C ' ' A' ' 282' ' ' THR . 0.0 OUTLIER -136.95 134.78 37.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.359 178.287 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 224' ' ' GLU . . . 95.64 -137.91 13.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.346 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.459 HG22 ' OE1' ' A' ' 224' ' ' GLU . 11.6 t -99.33 -30.16 12.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.898 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -156.53 5.14 0.16 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.758 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 7.4 m -73.47 107.14 5.58 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.881 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.718 ' O ' HG22 ' A' ' 187' ' ' ILE . 11.6 ttmm -127.81 134.83 49.47 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.17 0.509 . . . . 0.0 111.807 -178.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 16.7 t -115.44 135.38 55.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.809 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.596 ' CD1' HG23 ' A' ' 280' ' ' ILE . 2.5 t80 -76.9 137.98 39.45 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.122 0.487 . . . . 0.0 110.666 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.847 HG11 ' HB2' ' A' ' 275' ' ' LEU . 3.7 t -105.11 112.23 37.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.718 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.464 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -129.26 138.45 51.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.872 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.672 HD11 HD23 ' A' ' 275' ' ' LEU . 4.1 mt -138.78 122.36 19.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.23 162.34 32.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 110.835 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.6 -165.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.988 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.767 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.17 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.0 m95 -145.56 130.34 18.11 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.914 HD11 ' CD2' ' A' ' 184' ' ' LEU . 4.0 tp -119.82 136.56 54.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.059 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.763 ' N ' HD12 ' A' ' 182' ' ' LEU . 3.5 m-85 -134.16 130.23 37.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.762 0.792 . . . . 0.0 109.809 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.914 ' CD2' HD11 ' A' ' 182' ' ' LEU . 3.7 mm? -116.98 139.43 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.276 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.529 ' C ' HG13 ' A' ' 289' ' ' VAL . 3.5 tt0 -135.49 111.96 9.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.871 HG21 HD12 ' A' ' 194' ' ' LEU . 14.3 t -60.58 110.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.0 tt -92.64 -19.28 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.767 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.9 95.21 0.34 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.88 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.673 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.63 -173.25 30.06 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.553 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 94.6 Cg_endo -81.43 31.8 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 121.926 1.751 . . . . 0.0 110.91 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.879 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -160.83 24.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.077 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.673 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.3 mt -40.84 108.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.863 0.364 . . . . 0.0 111.979 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.62 6.03 2.13 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.375 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.879 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -95.94 143.86 26.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 16.6 mt-30 -139.88 147.12 40.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.421 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.936 ' ND1' HG21 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -136.82 131.05 32.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.392 0.615 . . . . 0.0 110.421 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.643 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.93 152.76 43.83 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.019 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.815 HG13 ' CH2' ' A' ' 234' ' ' TRP . 5.3 p -166.38 156.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.196 0.522 . . . . 0.0 110.937 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 180' ' ' SER . 1.2 m120 -93.38 147.31 23.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.405 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.53 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 1.4 t -64.58 -3.22 2.92 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.978 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 199' ' ' ASN . 3.5 t -89.15 12.15 16.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.775 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.469 ' HG ' ' HB3' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -95.2 144.32 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.946 0.403 . . . . 0.0 111.238 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.53 -60.89 1.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.082 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.57 25.39 4.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.331 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.409 ' HG2' ' OG ' ' A' ' 202' ' ' SER . 0.2 OUTLIER -115.42 -1.05 12.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.764 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.96 ' O ' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -94.57 -22.96 0.24 Allowed Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.551 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 206' ' ' LEU . 22.2 Cg_exo -61.57 94.29 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.113 1.209 . . . . 0.0 111.384 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.936 HG21 ' ND1' ' A' ' 196' ' ' HIS . 45.5 t -80.61 102.06 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.34 0.591 . . . . 0.0 111.254 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 216' ' ' SER . 0.0 OUTLIER -69.46 97.22 0.97 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.624 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.077 HD23 HD12 ' A' ' 218' ' ' LEU . 1.5 mp -75.85 125.3 28.82 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.446 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -169.2 171.97 43.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.385 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.892 ' HB2' HG13 ' A' ' 225' ' ' VAL . 4.8 ttt180 -58.53 -90.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.478 ' O ' HG22 ' A' ' 213' ' ' VAL . 10.6 p -127.5 -9.57 4.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.622 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.1 OUTLIER -53.82 -173.86 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.713 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 27.0 Cg_exo -62.42 3.89 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.438 2.092 . . . . 0.0 112.877 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.543 ' HA ' ' HB3' ' A' ' 209' ' ' LYS . 0.9 OUTLIER -49.76 165.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.895 0.378 . . . . 0.0 111.577 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.539 ' HB3' HG13 ' A' ' 208' ' ' VAL . 3.4 m-20 -86.01 -31.36 22.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.679 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.077 HD12 HD23 ' A' ' 210' ' ' LEU . 2.9 mt -107.93 130.8 55.01 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -92.26 79.83 5.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.816 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.796 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.1 mm? -103.81 86.24 2.57 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.739 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 7.4 ptpt -59.51 20.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.607 ' HB3' HG12 ' A' ' 225' ' ' VAL . 6.3 t0 -48.99 125.73 11.03 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.2 t -63.41 -12.23 29.17 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.436 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 285' ' ' THR . 0.1 OUTLIER -82.49 -17.24 45.84 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.779 0.323 . . . . 0.0 110.544 179.159 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.892 HG13 ' HB2' ' A' ' 212' ' ' ARG . 7.4 p -108.83 94.5 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.065 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.14 -45.22 16.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.036 0.446 . . . . 0.0 110.836 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.43 -50.38 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.476 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.622 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 7.0 mttt -139.41 126.55 21.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.111 0.482 . . . . 0.0 110.466 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.704 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.5 t60 -100.54 -58.07 1.98 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.752 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -141.1 173.15 11.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.812 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.808 ' HA ' HD12 ' A' ' 210' ' ' LEU . 10.7 tt0 -151.98 154.3 35.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.302 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.0 mt -111.96 140.6 30.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-O 121.197 0.522 . . . . 0.0 111.276 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.415 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.35 149.87 17.61 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.28 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.815 ' CH2' HG13 ' A' ' 198' ' ' VAL . 4.0 p90 -139.47 166.34 24.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -115.42 132.77 56.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.138 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.7 m -92.81 -1.07 57.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.949 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.3 m -77.58 -28.19 51.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.674 0.749 . . . . 0.0 109.876 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.408 ' HB3' ' HD3' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -139.32 19.18 2.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.804 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.7 p90 39.84 62.09 1.31 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.578 0.704 . . . . 0.0 109.56 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.742 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 1.4 mptm? -122.91 138.95 54.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.902 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.657 ' CE3' HD13 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -123.43 122.35 38.05 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.492 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 7.8 pt-20 -130.68 145.53 51.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 122.388 1.09 . . . . 0.0 113.872 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -102.24 138.44 39.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.988 178.103 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.728 HG21 ' NE1' ' A' ' 269' ' ' TRP . 3.7 p -133.47 162.42 39.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.78 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.479 ' HB2' ' CB ' ' A' ' 260' ' ' SER . 25.1 t0 -88.16 139.66 30.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.311 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.532 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -86.98 32.54 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.102 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.86 47.92 77.51 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.916 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.45 -178.55 5.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.738 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -106.0 -28.32 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.139 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.738 ' H ' HD13 ' A' ' 249' ' ' LEU . 8.1 t-20 -75.37 -36.07 61.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.127 0.489 . . . . 0.0 111.622 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.12 116.24 1.71 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.825 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.645 ' C ' HD23 ' A' ' 253' ' ' LEU . 16.7 m -70.98 165.29 23.75 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.708 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -149.28 128.85 13.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.314 0.578 . . . . 0.0 111.394 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 1.046 HG23 HD12 ' A' ' 259' ' ' ILE . 86.1 t -105.57 132.81 51.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.453 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 255' ' ' ASN . 1.7 p-10 50.08 39.31 18.92 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.094 0.473 . . . . 0.0 110.084 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.95 27.68 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.534 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 0.4 OUTLIER -129.74 103.18 6.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.243 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 7.6 t -51.46 95.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.61 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 1.046 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -77.72 -23.01 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.416 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.479 ' CB ' ' HB2' ' A' ' 245' ' ' ASP . 24.7 p . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 19.0 mttt . . . . . 0 CA--C 1.521 -0.165 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.728 ' NE1' HG21 ' A' ' 244' ' ' VAL . 13.0 t-105 -72.96 -18.92 61.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.98 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 75.9 168.91 26.54 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.403 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -99.66 134.64 20.94 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.116 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.17 108.76 0.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.608 2.206 . . . . 0.0 113.687 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 259' ' ' ILE . 81.3 t -100.38 141.65 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 0.0 OUTLIER -83.03 129.3 35.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.07 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.772 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.91 165.72 12.52 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.022 178.243 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.49 161.99 36.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.3 OUTLIER -60.24 130.33 46.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.126 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 277' ' ' SER . 18.0 m-20 82.86 3.08 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.952 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.637 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 2.6 t0 -75.1 -162.56 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.547 HG23 ' CD1' ' A' ' 290' ' ' TYR . 0.5 OUTLIER -161.73 127.96 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.994 178.371 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.651 HG13 ' HG ' ' A' ' 243' ' ' LEU . 0.2 OUTLIER -107.78 157.29 8.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.302 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.708 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 5.6 m -150.64 134.94 17.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -129.27 47.56 2.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.337 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.12 -125.69 1.04 Allowed Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 119.493 -1.337 . . . . 0.0 113.638 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.47 ' N ' ' HG3' ' A' ' 224' ' ' GLU . 3.8 t -99.98 -37.23 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 0.0 110.823 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -149.74 -10.12 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.767 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 87.2 m -66.34 106.06 1.61 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 117.77 0.259 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.636 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -131.55 139.04 49.14 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.39 0.614 . . . . 0.0 111.619 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.63 HG13 ' N ' ' A' ' 186' ' ' VAL . 4.5 t -116.77 136.54 53.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.329 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.621 ' O ' HD13 ' A' ' 184' ' ' LEU . 1.8 t80 -76.75 136.09 39.02 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 109.917 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 275' ' ' LEU . 1.8 t -102.52 110.96 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.659 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.632 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -123.35 137.93 54.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.657 HD13 ' CE3' ' A' ' 241' ' ' TRP . 2.5 mt -137.62 117.93 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.42 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.5 146.63 47.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.897 0.38 . . . . 0.0 111.226 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.75 167.7 14.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.873 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.957 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 25.1 m . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 121.235 0.54 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.733 ' HB3' ' CE1' ' A' ' 183' ' ' PHE . 3.7 m95 -142.77 133.48 25.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.448 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.918 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.5 OUTLIER -121.82 130.31 53.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.918 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.7 OUTLIER -132.28 143.14 49.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.712 0.768 . . . . 0.0 111.308 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.803 ' CD1' HD11 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -137.9 148.69 45.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.402 177.522 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.478 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 9.0 tt0 -137.77 125.11 21.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.968 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.726 HG21 HD12 ' A' ' 194' ' ' LEU . 18.9 t -64.69 119.6 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.803 HG22 ' O ' ' A' ' 288' ' ' LYS . 3.8 tp -104.15 -23.41 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.817 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -159.2 91.8 1.04 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.47 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.631 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.71 -171.66 28.07 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.496 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 73.2 Cg_endo -81.43 31.26 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.878 1.719 . . . . 0.0 111.664 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.789 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.4 25.32 0.11 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.582 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.631 HG12 ' H ' ' A' ' 189' ' ' GLY . 7.5 mt -43.13 114.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.77 7.23 3.43 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.277 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.789 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -98.69 132.57 43.97 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.173 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.478 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 20.3 mt-30 -130.58 151.9 50.54 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.665 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.709 ' O ' HD22 ' A' ' 184' ' ' LEU . 1.4 t60 -143.23 139.79 30.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.255 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -131.84 148.08 52.53 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.05 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.848 HG21 ' HA ' ' A' ' 206' ' ' LEU . 11.8 p -159.16 141.77 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.513 ' OD1' ' CH2' ' A' ' 181' ' ' TRP . 3.1 m120 -88.03 161.55 17.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.013 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.517 ' HB2' ' NE1' ' A' ' 234' ' ' TRP . 60.0 p -68.78 -48.64 63.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.342 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.23 1.84 0.29 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.63 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -83.04 129.7 35.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -89.72 -95.88 0.11 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.12 11.19 2.42 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -116.49 -17.79 10.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.684 0.278 . . . . 0.0 110.765 179.352 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.862 ' O ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -76.93 -42.93 2.81 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.801 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 6.2 Cg_endo -51.89 96.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.209 1.11 . . . . 0.0 112.118 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.67 ' O ' ' HG3' ' A' ' 231' ' ' GLN . 78.5 t -67.36 151.19 10.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -128.29 93.61 3.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.04 HD23 HD12 ' A' ' 218' ' ' LEU . 0.7 OUTLIER -84.76 127.88 34.33 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.306 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.514 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -173.39 174.21 45.97 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.02 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.906 ' HB2' HG13 ' A' ' 225' ' ' VAL . 2.0 ttm180 -69.98 -75.03 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.812 0.445 . . . . 0.0 111.834 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.668 HG22 ' H ' ' A' ' 214' ' ' SER . 9.2 p -121.82 -145.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.668 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.3 OUTLIER 65.91 179.03 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 118.731 0.696 . . . . 0.0 109.85 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 49.7 Cg_endo -69.58 28.7 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.089 1.859 . . . . 0.0 113.435 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 214' ' ' SER . 6.3 m -61.96 160.57 12.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.699 0.285 . . . . 0.0 110.679 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.77 -31.27 21.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.04 HD12 HD23 ' A' ' 210' ' ' LEU . 4.8 mt -111.49 133.13 53.99 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -92.52 76.46 5.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.415 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.783 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.1 mm? -97.99 62.52 1.58 Allowed 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.598 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 8.2 pttt -59.56 50.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 220' ' ' LEU . 22.6 t0 -97.32 124.4 41.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 t -39.82 -27.88 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.642 ' HG2' ' HA2' ' A' ' 284' ' ' GLY . 0.4 OUTLIER -60.8 -39.9 90.62 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.097 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.906 HG13 ' HB2' ' A' ' 212' ' ' ARG . 1.7 p -97.75 93.93 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.0 m -35.29 -62.05 0.41 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.105 0.479 . . . . 0.0 111.445 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 228' ' ' LYS . . . -133.33 -47.76 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 227' ' ' GLY . 3.6 mttt -144.19 127.3 16.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.493 -0.354 . . . . 0.0 110.172 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.478 ' O ' ' N ' ' A' ' 246' ' ' MET . 2.0 t-80 -96.09 -55.67 2.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.637 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 210' ' ' LEU . . . -140.12 159.65 41.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.411 0.624 . . . . 0.0 112.614 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.67 ' HG3' ' O ' ' A' ' 208' ' ' VAL . 0.1 OUTLIER -145.72 161.96 38.7 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.704 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.801 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.6 mt -124.13 149.4 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.8 162.03 41.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.661 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.675 ' CE3' HD21 ' A' ' 206' ' ' LEU . 0.6 OUTLIER -98.39 157.39 16.23 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -176.074 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 240' ' ' LYS . 2.0 t-20 -121.55 71.46 0.97 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.156 -1.384 . . . . 0.0 107.478 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 p -56.48 -19.44 15.38 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.9 m -75.54 -21.39 57.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.463 0.649 . . . . 0.0 110.567 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.53 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 0.3 OUTLIER -137.19 17.84 2.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.374 -179.04 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.407 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 19.7 p90 42.67 68.0 0.54 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 235' ' ' ASN . 0.2 OUTLIER -130.19 144.48 51.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.295 -179.311 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.56 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -119.29 102.96 9.07 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.5 pt-20 -125.96 144.71 50.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.107 0.956 . . . . 0.0 113.002 -177.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 1.005 HD11 HD11 ' A' ' 259' ' ' ILE . 2.6 pp -115.94 149.96 37.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.681 -1.599 . . . . 0.0 111.208 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.754 HG21 ' CD1' ' A' ' 269' ' ' TRP . 2.0 p -113.99 163.06 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.657 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.494 ' OD2' ' HA ' ' A' ' 260' ' ' SER . 6.1 m-20 -112.25 101.84 10.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.521 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -65.56 96.46 0.26 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.417 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.59 69.88 1.13 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.356 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 260' ' ' SER . 0.4 OUTLIER -65.4 57.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.529 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 250' ' ' ASN . 0.8 OUTLIER -53.38 -57.72 9.62 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.31 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.593 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.7 OUTLIER -78.77 -30.1 45.42 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.264 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.429 ' O ' HD23 ' A' ' 253' ' ' LEU . . . 92.07 125.82 3.67 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.513 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.465 ' O ' HG12 ' A' ' 259' ' ' ILE . 25.7 m -88.67 114.96 25.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.155 0.182 . . . . 0.0 110.601 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -103.98 130.51 51.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.278 0.561 . . . . 0.0 112.512 -178.684 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.88 ' CG2' HD13 ' A' ' 259' ' ' ILE . 33.1 t -108.55 131.95 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.63 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 280' ' ' ILE . 3.3 t-20 52.15 32.01 9.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.125 0.488 . . . . 0.0 109.877 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.8 m 68.82 21.04 7.84 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.686 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -120.49 93.35 4.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.802 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 21.7 p -43.79 97.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.356 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 1.005 HD11 HD11 ' A' ' 243' ' ' LEU . 14.4 pt -77.29 -53.88 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' HG13 ' A' ' 259' ' ' ILE . 36.9 p . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt . . . . . 0 CA--C 1.518 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.754 ' CD1' HG21 ' A' ' 244' ' ' VAL . 28.2 t-105 -67.17 -24.87 65.92 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 79.97 157.81 14.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.099 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -96.6 140.94 22.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 85.8 Cg_exo -46.39 119.0 2.8 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.575 2.184 . . . . 0.0 112.788 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.854 ' HB ' HD12 ' A' ' 259' ' ' ILE . 84.9 t -100.91 136.22 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -85.0 128.6 34.7 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.97 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.926 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.48 165.58 12.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.08 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -137.43 155.61 49.13 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.582 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 89.0 p -63.78 133.21 53.06 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.258 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.582 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.0 OUTLIER 79.27 -4.99 2.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.254 -178.512 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.654 ' O ' HG23 ' A' ' 280' ' ' ILE . 3.5 t70 -67.61 -167.24 0.06 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.654 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.7 OUTLIER -162.09 131.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.645 178.233 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.943 HG22 HG12 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -104.02 148.13 9.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.139 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.667 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 1.6 m -138.89 116.95 11.71 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.482 ' O ' ' HB ' ' A' ' 287' ' ' THR . 0.1 OUTLIER -113.44 136.54 52.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.444 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.642 ' HA2' ' HG2' ' A' ' 224' ' ' GLU . . . 82.91 -129.14 8.88 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.666 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 t -95.11 -31.65 13.46 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -159.67 8.15 0.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.577 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 14.9 m -69.51 99.26 1.23 Allowed 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.542 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.803 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -111.86 115.26 28.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.456 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.943 HG12 HG22 ' A' ' 281' ' ' ILE . 4.4 p -103.17 131.03 52.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 122.205 -0.31 . . . . 0.0 110.827 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.2 t80 -76.22 132.49 39.94 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.926 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.6 t -103.56 114.62 43.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.652 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.52 ' HD2' ' H ' ' A' ' 293' ' ' ILE . 5.6 tpt180 -132.0 143.85 50.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.235 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.753 HD11 HD23 ' A' ' 275' ' ' LEU . 8.8 mt -143.13 122.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.697 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.79 159.1 38.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.941 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 9.7 m -89.29 -179.12 5.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.484 -179.749 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.458 ' HB3' ' OG ' ' A' ' 200' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 10.9 m95 -147.09 142.06 26.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.849 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.789 HD11 ' CD1' ' A' ' 184' ' ' LEU . 1.5 tp -125.96 122.72 36.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.701 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.4 m-85 -121.31 141.23 51.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.795 0.807 . . . . 0.0 111.313 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.971 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -139.65 149.01 43.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.526 178.668 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.523 ' C ' HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -139.52 125.98 20.36 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.789 HG21 HD12 ' A' ' 194' ' ' LEU . 21.7 t -62.06 116.48 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.909 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.5 tt -100.03 -19.34 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.851 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.54 91.9 0.6 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.719 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -160.9 -171.12 26.43 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.68 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 64.0 Cg_endo -81.59 32.54 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.006 1.804 . . . . 0.0 111.311 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.845 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.49 22.12 0.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.574 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.719 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.4 mt -39.81 111.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.08 7.65 3.19 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.109 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.845 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.2 OUTLIER -96.24 131.9 42.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.441 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 9.6 mt-30 -129.07 151.11 50.11 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.465 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.971 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -146.87 148.14 31.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.771 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.23 144.73 34.88 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.778 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.931 HG21 ' HA ' ' A' ' 206' ' ' LEU . 2.1 p -147.66 139.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.393 0.616 . . . . 0.0 111.437 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.422 ' ND2' ' H ' ' A' ' 199' ' ' ASN . 1.3 p30 -92.65 148.36 22.13 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.768 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.568 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 61.5 m -66.19 -1.12 2.95 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.38 11.66 21.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.054 0.454 . . . . 0.0 111.0 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.705 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -106.74 120.04 40.94 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.746 178.71 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -76.41 0.45 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.5 t -62.93 1.51 0.41 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -122.15 -10.19 8.58 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.083 -0.385 . . . . 0.0 110.814 178.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.931 ' HA ' HG21 ' A' ' 198' ' ' VAL . 5.1 tt -62.09 -63.38 4.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.618 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.7 Cg_endo -43.03 88.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.412 2.075 . . . . 0.0 113.174 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 208' ' ' VAL . 1.7 t -69.51 85.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.461 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 216' ' ' SER . 1.3 mtpt -69.82 97.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.134 HD23 HD12 ' A' ' 218' ' ' LEU . 1.5 mp -82.93 127.94 33.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.424 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -167.35 167.61 40.0 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.571 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.924 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 4.7 ttt180 -56.54 -90.75 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.696 HG12 ' HD3' ' A' ' 212' ' ' ARG . 14.0 p -124.01 -9.89 6.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.69 0.281 . . . . 0.0 111.477 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.545 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 0.6 OUTLIER -50.88 178.94 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.217 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 21.0 Cg_endo -63.51 13.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.661 1.574 . . . . 0.0 112.493 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.532 ' H ' ' C ' ' A' ' 214' ' ' SER . 16.3 m -52.82 166.96 0.17 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 111.193 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -84.75 -26.09 27.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.761 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.134 HD12 HD23 ' A' ' 210' ' ' LEU . 1.2 mt -111.53 130.99 55.55 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -94.96 82.09 3.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.726 0.298 . . . . 0.0 111.355 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.77 HD21 HD13 ' A' ' 218' ' ' LEU . 3.2 mm? -102.14 63.85 0.92 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.924 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -51.9 72.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.445 -178.728 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.68 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 3.4 t0 -127.49 137.18 52.59 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-O 120.992 0.425 . . . . 0.0 110.774 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 43.9 t -51.31 -36.84 44.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.477 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.628 ' CD ' ' HA3' ' A' ' 284' ' ' GLY . 2.4 pt-20 -44.71 -45.71 9.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.015 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.879 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.2 p -102.29 107.68 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.655 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.63 -51.7 20.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.224 0.535 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.94 -46.67 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.41 ' NZ ' ' HG2' ' A' ' 215' ' ' PRO . 0.1 OUTLIER -136.64 120.63 17.62 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.67 ' CE1' ' HB3' ' A' ' 283' ' ' LEU . 44.3 t-80 -92.2 -61.1 1.68 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.702 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -140.08 176.84 8.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.526 0.679 . . . . 0.0 112.315 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.738 ' HA ' HD12 ' A' ' 210' ' ' LEU . 10.6 tt0 -159.19 162.69 36.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.909 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.593 HG12 ' HB3' ' A' ' 243' ' ' LEU . 54.4 mt -124.72 144.31 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.563 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.716 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.87 163.41 32.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.12 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.886 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 12.1 p90 -154.91 166.59 33.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -115.47 133.14 56.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.304 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.48 -2.87 57.94 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.295 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.5 m -76.43 -26.03 55.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.768 0.794 . . . . 0.0 110.231 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 239' ' ' PHE . 10.9 tptt -138.8 21.91 2.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.648 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.445 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 7.7 p90 35.48 60.09 0.76 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.638 0.732 . . . . 0.0 109.722 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.886 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.1 OUTLIER -125.09 141.0 52.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.126 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.792 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 1.3 m95 -122.25 126.51 48.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.395 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.4 pt-20 -143.2 144.52 32.21 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.808 0.813 . . . . 0.0 113.142 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.659 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.5 pp -111.09 152.08 27.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.776 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.692 HG21 ' CD1' ' A' ' 269' ' ' TRP . 2.8 p -121.32 163.18 19.48 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.617 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 248' ' ' SER . 2.6 m-20 -105.27 104.41 14.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.512 ' HG2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -71.4 97.26 1.59 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.428 177.755 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.09 65.67 3.23 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.312 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 0.2 OUTLIER -70.32 59.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 1.016 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -54.35 -52.69 60.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.338 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 1.016 ' N ' HD22 ' A' ' 249' ' ' LEU . 2.5 m120 -74.37 -30.98 62.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.933 0.397 . . . . 0.0 111.304 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 95.55 99.56 1.79 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.19 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.808 HG23 HD12 ' A' ' 283' ' ' LEU . 1.6 m -64.97 114.85 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.021 -0.105 . . . . 0.0 110.993 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 258' ' ' SER . 2.4 mt -101.57 130.02 47.78 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.489 -0.484 . . . . 0.0 112.009 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.913 HG23 HD12 ' A' ' 259' ' ' ILE . 99.0 t -105.48 127.66 60.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.859 ' HA ' HD12 ' A' ' 280' ' ' ILE . 1.8 t30 55.14 40.75 31.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 110.215 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.12 32.1 21.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.532 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.6 OUTLIER -138.83 107.93 6.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.795 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.469 ' HB3' HD22 ' A' ' 253' ' ' LEU . 25.0 p -55.15 91.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.541 0.686 . . . . 0.0 111.45 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.965 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -78.56 -23.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.788 -178.413 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.471 ' HB2' ' CG ' ' A' ' 245' ' ' ASP . 13.9 t . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.436 0.636 . . . . 0.0 112.076 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.692 ' CD1' HG21 ' A' ' 244' ' ' VAL . 20.5 t-105 -72.82 -22.58 60.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.598 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 74.44 163.63 10.21 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.574 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -99.99 150.63 37.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.3 . . . . 0.0 110.397 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.61 145.4 17.2 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.411 2.074 . . . . 0.0 112.514 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.965 HG21 ' CG1' ' A' ' 259' ' ' ILE . 93.6 t -130.87 130.22 64.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.771 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 3.2 mp0 -80.83 129.02 34.31 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.877 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.869 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -94.02 166.7 12.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.935 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.629 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.62 159.62 41.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.151 0.5 . . . . 0.0 112.014 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 0.1 OUTLIER -62.0 129.4 40.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.143 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 277' ' ' SER . 0.3 OUTLIER 86.73 1.52 0.52 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.309 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.629 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -72.72 -170.98 0.76 Allowed 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.859 HD12 ' HA ' ' A' ' 255' ' ' ASN . 1.0 OUTLIER -163.22 122.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 176.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.825 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -97.12 156.12 3.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.156 177.071 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 288' ' ' LYS . 21.3 m -141.51 114.68 8.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.912 HD22 ' O ' ' A' ' 287' ' ' THR . 0.0 OUTLIER -113.8 141.48 47.25 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.335 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.628 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 84.52 -133.32 11.73 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.126 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 t -97.93 -36.03 10.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.658 0.266 . . . . 0.0 111.516 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -152.37 7.49 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.912 ' O ' HD22 ' A' ' 283' ' ' LEU . 25.8 m -76.78 101.16 5.73 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.838 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.909 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -124.54 134.39 53.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.072 -179.641 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.523 HG23 ' C ' ' A' ' 185' ' ' GLU . 9.1 p -113.53 139.61 38.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.876 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.8 t80 -76.55 132.17 39.36 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.765 0.317 . . . . 0.0 110.232 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 275' ' ' LEU . 6.1 t -103.01 112.01 34.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.479 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.52 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.4 OUTLIER -129.47 138.11 51.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 111.338 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.869 HD11 HD23 ' A' ' 275' ' ' LEU . 13.3 mt -132.89 139.79 48.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.431 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 40.7 m -155.49 164.21 38.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.913 0.387 . . . . 0.0 111.423 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.26 -173.22 2.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.683 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.727 -179.858 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.514 ' OG ' ' HB3' ' A' ' 200' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.523 -0.075 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 3.2 m95 -148.57 138.97 22.58 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.545 -0.462 . . . . 0.0 112.203 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.972 HD11 ' CD2' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -123.77 140.71 52.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.96 178.167 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.845 ' N ' HD12 ' A' ' 182' ' ' LEU . 6.2 m-85 -137.7 140.54 40.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.535 0.684 . . . . 0.0 110.442 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.972 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.0 mm? -123.96 140.95 52.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.889 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.519 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -135.35 116.7 14.61 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.981 HG21 HD12 ' A' ' 194' ' ' LEU . 6.0 t -66.98 98.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.0 tt -82.03 -24.5 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.843 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -166.24 98.9 0.62 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.685 ' HA3' HG23 ' A' ' 287' ' ' THR . . . -162.49 -169.15 25.46 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.545 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 98.0 Cg_endo -80.13 29.67 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.358 2.038 . . . . 0.0 110.642 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.795 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.13 25.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.637 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.6 mt -40.82 106.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.969 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.43 2.65 2.88 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.898 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.981 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -96.73 165.19 12.25 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 118.106 0.953 . . . . 0.0 108.692 177.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 5.0 mt-30 -156.72 146.18 20.6 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.063 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.923 ' CD2' HG11 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -136.12 128.43 30.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.183 0.516 . . . . 0.0 109.852 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 182' ' ' LEU . . . -130.8 165.1 23.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.899 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.613 HG11 ' HG ' ' A' ' 206' ' ' LEU . 11.9 p -175.25 143.86 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 121.327 0.584 . . . . 0.0 112.264 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.404 ' HB2' HG22 ' A' ' 201' ' ' THR . 14.0 p30 -85.78 147.96 26.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.382 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.514 ' HB3' ' OG ' ' A' ' 180' ' ' SER . 15.3 t -62.65 -9.42 8.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 199' ' ' ASN . 2.9 t -95.04 36.85 1.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.973 0.416 . . . . 0.0 111.882 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.427 ' HB2' ' CG ' ' A' ' 205' ' ' LYS . 4.7 p -128.59 108.74 10.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.403 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 3.4 m -70.71 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.228 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.7 m -86.99 8.37 23.58 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.427 ' CG ' ' HB2' ' A' ' 202' ' ' SER . 9.0 pttt -118.41 52.74 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.796 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 8.2 tt -143.77 -52.4 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.943 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 3.7 Cg_exo -40.57 93.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.41 2.074 . . . . 0.0 113.384 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.923 HG11 ' CD2' ' A' ' 196' ' ' HIS . 59.8 t -73.25 107.91 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.923 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.624 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 19.5 mtmt -77.91 90.99 4.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.446 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.964 HD23 HD12 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -78.51 136.75 37.65 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . 164.63 -161.22 34.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.964 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.714 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.0 OUTLIER -73.65 171.72 12.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.393 -0.404 . . . . 0.0 111.487 -179.521 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 213' ' ' VAL . 7.2 p -73.87 110.95 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 122.2 1.0 . . . . 0.0 111.833 -176.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 215' ' ' PRO . 12.4 p -171.11 -163.0 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 113.435 -1.711 . . . . 0.0 107.864 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 62.3 Cg_exo -51.8 -12.0 1.05 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.475 1.45 . . . . 0.0 112.665 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.421 ' OG ' ' HG2' ' A' ' 228' ' ' LYS . 0.1 OUTLIER -51.45 -178.36 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.962 0.411 . . . . 0.0 111.714 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.41 -37.72 8.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.964 HD12 HD23 ' A' ' 210' ' ' LEU . 0.4 OUTLIER -100.47 140.53 34.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.641 179.087 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -103.06 78.18 1.62 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.892 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.772 HD21 HD13 ' A' ' 218' ' ' LEU . 2.9 mm? -102.49 91.72 4.36 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.545 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 1.5 ptpt -66.44 56.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.962 0.411 . . . . 0.0 110.653 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.551 ' HB3' HG12 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -88.96 123.35 33.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.518 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.0 p -66.25 -7.11 16.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.664 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.515 ' O ' HD11 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -87.87 -24.47 23.66 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.759 0.314 . . . . 0.0 110.699 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 225' ' ' VAL . 7.2 p -100.66 93.4 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.02 0.438 . . . . 0.0 110.835 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.15 -38.71 18.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.053 0.454 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.13 -57.53 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.786 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 211' ' ' GLY . 25.4 mtmm -143.7 129.02 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.421 0.629 . . . . 0.0 111.688 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.454 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 2.2 t-80 -89.84 -61.82 1.6 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.154 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.564 ' C ' ' HE3' ' A' ' 246' ' ' MET . . . -140.72 171.17 14.47 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.663 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.8 OUTLIER -157.88 168.89 25.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.24 179.013 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.943 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 8.0 mt -125.39 138.16 55.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.604 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.48 163.64 32.4 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.671 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -96.25 148.0 23.19 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.491 ' HB2' ' HD3' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -119.53 71.99 0.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.276 174.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.7 p -54.11 -21.13 7.86 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 46.3 m -73.72 -27.86 61.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.632 0.73 . . . . 0.0 109.33 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.433 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 20.0 tptt -116.31 6.29 13.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.465 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 235' ' ' ASN . 8.0 p90 37.05 49.56 0.83 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.885 0.374 . . . . 0.0 110.669 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 235' ' ' ASN . 0.0 OUTLIER -119.8 176.21 5.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 0.0 109.78 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.839 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -124.61 110.0 13.88 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 0.7 OUTLIER -132.15 151.2 51.91 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.147 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.703 ' O ' HD12 ' A' ' 243' ' ' LEU . 3.3 pp -119.16 152.65 36.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.579 -1.646 . . . . 0.0 111.456 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.592 HG13 ' HE1' ' A' ' 246' ' ' MET . 4.7 p -119.33 162.6 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.139 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 13.6 m-20 -118.86 121.8 40.85 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.677 ' HB3' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -93.83 107.85 19.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.957 178.578 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 48.59 62.34 4.51 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.374 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.23 74.75 0.23 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.809 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -59.66 -48.77 80.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.859 178.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.809 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -78.7 -39.51 36.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.048 0.451 . . . . 0.0 110.851 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 97.05 93.0 1.87 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.359 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.61 HG22 ' CD1' ' A' ' 281' ' ' ILE . 1.9 m -47.29 156.59 0.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.297 -0.261 . . . . 0.0 110.297 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -148.12 130.23 15.45 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.179 0.514 . . . . 0.0 111.521 179.586 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.974 HG23 HD12 ' A' ' 259' ' ' ILE . 55.5 t -104.14 130.04 55.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.829 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 55.09 42.33 30.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.048 0.451 . . . . 0.0 110.329 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.15 23.1 12.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.992 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.7 112.03 15.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.373 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 85.9 p -63.12 99.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.431 0.634 . . . . 0.0 112.174 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.974 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -79.45 -47.68 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.774 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.501 ' N ' HG12 ' A' ' 259' ' ' ILE . 4.7 t . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.677 ' CH2' ' HB3' ' A' ' 246' ' ' MET . 2.8 m95 -63.77 -30.31 71.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.234 -0.893 . . . . 0.0 108.768 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 72.53 165.13 8.13 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.15 122.86 72.35 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.701 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 34.2 Cg_exo -31.05 111.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.21 2.607 . . . . 0.0 112.846 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.714 HG11 HG21 ' A' ' 259' ' ' ILE . 62.5 t -87.58 130.18 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.388 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -78.3 131.71 37.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.977 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.727 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -98.0 164.26 12.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.121 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.85 152.67 45.3 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.647 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.9 OUTLIER -54.62 130.89 41.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.362 179.031 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 277' ' ' SER . 9.0 m-20 82.17 -3.65 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.738 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.951 ' O ' HG23 ' A' ' 291' ' ' VAL . 1.2 m-20 -77.24 141.15 40.15 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.744 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.513 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -100.72 124.79 54.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 119.789 -0.765 . . . . 0.0 109.728 178.541 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.791 HG12 HG22 ' A' ' 254' ' ' VAL . 0.3 OUTLIER -110.46 94.61 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.324 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -82.49 138.38 34.35 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.524 -0.735 . . . . 0.0 109.589 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.753 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -130.39 53.1 1.97 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.372 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 168.16 -122.5 1.03 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.494 -1.336 . . . . 0.0 113.43 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.5 t -98.0 -44.8 6.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.636 0.255 . . . . 0.0 110.675 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -147.64 1.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.1 m -79.32 104.75 10.15 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.785 ' O ' HG22 ' A' ' 187' ' ' ILE . 9.0 ptpt -126.19 131.02 52.08 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.796 0.807 . . . . 0.0 111.931 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.621 HG11 ' CE1' ' A' ' 196' ' ' HIS . 14.9 t -106.2 132.1 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.758 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 278' ' ' ASP . 1.7 t80 -77.17 130.89 37.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.951 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.2 OUTLIER -100.75 113.64 37.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.734 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -131.09 136.16 48.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.742 0.306 . . . . 0.0 110.82 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.839 HD12 ' CE3' ' A' ' 241' ' ' TRP . 2.4 mt -135.46 139.65 46.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 3.2 m -142.81 156.09 44.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.776 0.322 . . . . 0.0 111.14 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.3 m -85.73 159.22 19.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.786 -179.991 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.111 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.652 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.6 m95 -145.29 131.77 19.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.672 HD23 ' HZ3' ' A' ' 234' ' ' TRP . 5.1 tp -118.12 128.2 54.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.214 177.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 1.1 m-85 -128.99 138.57 52.03 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.553 0.692 . . . . 0.0 110.799 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.77 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.5 mp -140.89 153.01 45.51 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.586 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.604 ' C ' HG23 ' A' ' 289' ' ' VAL . 23.3 tt0 -144.61 124.85 13.73 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.674 ' N ' HG23 ' A' ' 289' ' ' VAL . 22.0 t -59.49 113.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.7 tt -97.02 -20.76 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -176.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.719 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -157.76 91.27 1.12 Allowed 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.327 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.757 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.76 178.57 38.45 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.477 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 71.9 Cg_endo -75.4 32.13 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 121.79 1.66 . . . . 0.0 111.185 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.719 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -163.94 28.92 0.08 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.966 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.757 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.7 mt -43.55 119.75 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.112 0.482 . . . . 0.0 112.239 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.24 -48.46 0.92 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.726 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.719 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.7 OUTLIER -40.9 143.84 0.33 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.302 0.573 . . . . 0.0 110.752 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.77 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 5.2 mt-30 -141.64 152.03 43.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.776 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.998 ' CE1' HD21 ' A' ' 210' ' ' LEU . 1.8 p80 -139.63 131.59 27.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.268 0.556 . . . . 0.0 109.635 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.86 153.6 40.34 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.38 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.9 HG21 ' HA ' ' A' ' 206' ' ' LEU . 7.2 p -160.92 161.24 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.349 0.595 . . . . 0.0 111.725 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.569 ' N ' HG22 ' A' ' 198' ' ' VAL . 1.4 t-20 -98.59 143.33 29.11 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.705 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.496 ' HA ' ' HE1' ' A' ' 234' ' ' TRP . 16.2 t -60.76 1.48 0.14 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 1.3 t -107.09 -8.08 16.65 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.601 0.36 . . . . 0.0 111.562 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.495 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -69.05 118.13 11.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.027 0.441 . . . . 0.0 110.452 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 72.8 m -66.42 -101.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.1 m -91.41 20.1 5.55 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.24 -9.0 11.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.205 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.9 ' HA ' HG21 ' A' ' 198' ' ' VAL . 7.8 tt -67.74 -61.21 4.55 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.681 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -43.28 101.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.005 1.803 . . . . 0.0 112.395 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.94 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 98.7 t -67.26 165.52 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.564 ' N ' HG12 ' A' ' 208' ' ' VAL . 15.7 mtmt -136.9 90.12 2.51 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.998 HD21 ' CE1' ' A' ' 196' ' ' HIS . 0.5 OUTLIER -79.97 123.91 28.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.138 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . -165.98 167.69 39.35 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.391 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 1.094 ' HB2' HG13 ' A' ' 225' ' ' VAL . 4.7 ttt-85 -66.36 -73.01 0.14 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.738 HG13 ' HG2' ' A' ' 215' ' ' PRO . 15.0 p -79.39 159.42 4.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 213' ' ' VAL . 1.0 OUTLIER -31.07 -52.78 0.42 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -178.032 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.738 ' HG2' HG13 ' A' ' 213' ' ' VAL . 2.9 Cg_endo -42.52 -24.76 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.205 1.936 . . . . 0.0 113.153 -177.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.429 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -83.93 156.51 22.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.892 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -69.96 -36.24 75.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.564 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.992 HD12 HD23 ' A' ' 210' ' ' LEU . 2.0 mt -103.68 134.35 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.427 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -90.31 73.32 7.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.562 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.838 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -97.15 68.39 2.25 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.594 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 2.2 pttt -60.71 39.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.52 ' HB3' ' HG3' ' A' ' 224' ' ' GLU . 12.4 t0 -90.23 131.23 36.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.5 p -46.51 -33.57 4.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.207 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 1.1 pp20? -52.21 -32.03 34.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.341 . . . . 0.0 111.233 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 1.094 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.1 p -104.33 97.72 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.54 -46.99 14.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.203 0.525 . . . . 0.0 110.574 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.32 -50.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.428 ' HB2' ' SD ' ' A' ' 246' ' ' MET . 3.6 mptp? -140.85 127.01 19.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.237 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.653 ' HA ' ' HB2' ' A' ' 248' ' ' SER . 0.2 OUTLIER -94.55 -55.22 3.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.631 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -151.87 177.0 10.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.286 0.565 . . . . 0.0 111.996 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.94 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 3.9 mt-30 -156.84 -178.01 7.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.222 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.858 HG12 HD11 ' A' ' 243' ' ' LEU . 0.9 OUTLIER -125.36 141.76 44.28 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.249 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.24 127.18 3.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.85 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.8 p90 -124.92 167.53 14.56 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -112.62 133.16 54.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.137 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.22 -1.96 50.58 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.515 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.7 m -80.55 -35.04 34.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.588 0.709 . . . . 0.0 109.593 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.529 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 33.8 tptt -121.91 10.4 10.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.596 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 24.4 p90 45.18 63.04 1.89 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.495 0.664 . . . . 0.0 109.694 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.85 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.2 OUTLIER -129.14 138.18 51.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.121 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.724 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -119.91 126.75 51.67 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.731 179.043 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 272' ' ' PRO . 27.1 mt-10 -142.58 146.35 34.5 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.859 HD23 ' CD1' ' A' ' 281' ' ' ILE . 0.3 OUTLIER -97.92 150.94 20.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.767 -1.561 . . . . 0.0 109.486 178.601 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.613 HG21 ' NE1' ' A' ' 269' ' ' TRP . 4.5 p -141.67 162.85 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.901 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.606 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 18.8 t70 -84.63 138.82 32.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.412 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.547 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -88.92 31.63 0.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.722 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.47 50.48 59.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.769 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.653 ' HB2' ' HA ' ' A' ' 229' ' ' HIS . 32.6 t -92.6 168.97 10.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.836 0.35 . . . . 0.0 111.146 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 250' ' ' ASN . 3.1 pp -93.01 -43.82 8.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.439 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.592 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.8 OUTLIER -68.32 -19.03 64.65 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.546 0.689 . . . . 0.0 109.921 -178.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 76.27 147.75 2.24 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.364 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.727 HG23 HD23 ' A' ' 283' ' ' LEU . 6.0 m -103.66 152.29 21.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.608 0.242 . . . . 0.0 110.99 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -140.13 138.88 35.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.053 177.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.851 HG23 ' CD1' ' A' ' 259' ' ' ILE . 95.5 t -110.03 133.62 54.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.956 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.873 ' HA ' HD12 ' A' ' 280' ' ' ILE . 0.7 OUTLIER 52.98 38.32 26.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.332 -178.586 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.47 36.87 2.11 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.436 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.633 ' O ' HG23 ' A' ' 259' ' ' ILE . 20.0 t-80 -148.29 117.53 6.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 91.9 p -63.5 86.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.251 0.548 . . . . 0.0 110.275 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -84.92 -13.08 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.229 -178.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.606 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 1.5 t . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.7 mttt . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.082 0.467 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.613 ' NE1' HG21 ' A' ' 244' ' ' VAL . 14.7 t-105 -84.61 -19.59 32.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.705 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 64.25 -172.98 16.1 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.782 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.487 ' HB2' ' HD2' ' A' ' 272' ' ' PRO . 29.2 p30 -110.38 158.97 33.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 117.524 0.662 . . . . 0.0 110.304 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.621 ' HB2' ' HB2' ' A' ' 242' ' ' GLU . 58.7 Cg_endo -72.99 114.3 4.0 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.296 1.997 . . . . 0.0 113.628 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.724 HG21 ' HB ' ' A' ' 259' ' ' ILE . 66.9 t -97.38 138.53 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.3 pm0 -76.24 123.45 25.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.131 0.967 . . . . 0.0 113.572 -176.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.85 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -90.87 163.96 14.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.525 -1.671 . . . . 0.0 109.167 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.639 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -146.87 162.75 38.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.634 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 26.3 t -60.34 127.77 33.41 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.849 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.634 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 86.09 7.85 0.32 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.273 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.639 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -83.61 -166.66 1.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.857 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -161.48 128.84 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.603 177.246 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.859 ' CD1' HD23 ' A' ' 243' ' ' LEU . 0.0 OUTLIER -99.28 147.13 7.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.591 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.716 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 0.6 OUTLIER -134.17 125.57 28.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.627 0.727 . . . . 0.0 110.226 178.158 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.727 HD23 HG23 ' A' ' 252' ' ' THR . 0.1 OUTLIER -125.72 131.61 52.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.897 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 224' ' ' GLU . . . 86.26 -127.95 8.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.143 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 t -96.94 -30.67 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -160.46 5.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 7.2 m -64.69 99.67 0.34 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.898 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.812 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -117.97 125.21 49.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -177.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.783 HG12 HG22 ' A' ' 281' ' ' ILE . 6.3 p -113.26 136.47 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.224 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.671 ' HD1' HG23 ' A' ' 280' ' ' ILE . 1.0 OUTLIER -78.19 140.54 38.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.884 0.373 . . . . 0.0 110.373 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -108.82 114.13 45.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.046 -179.49 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.603 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.9 OUTLIER -130.05 140.99 50.77 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.812 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.667 HG12 HD13 ' A' ' 182' ' ' LEU . 11.6 mt -138.95 119.87 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 181' ' ' TRP . 0.1 OUTLIER -130.81 149.99 52.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 0.0 111.268 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.86 164.07 16.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.4 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.981 0.42 . . . . 0.0 111.486 -179.773 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.615 ' N ' ' HB3' ' A' ' 296' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 121.508 0.671 . . . . 0.0 112.167 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 1.2 m95 -137.22 135.71 37.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.188 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.937 HD11 ' CD2' ' A' ' 184' ' ' LEU . 1.1 tp -126.66 133.97 50.84 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.883 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.0 m-85 -133.42 137.1 45.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.63 0.728 . . . . 0.0 110.447 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.937 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.3 mm? -119.62 139.72 51.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.414 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -134.49 112.25 10.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 220' ' ' LEU . 40.6 t -60.1 98.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.132 0.492 . . . . 0.0 109.907 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.815 HG22 ' O ' ' A' ' 288' ' ' LYS . 11.5 tt -77.04 -23.2 14.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.929 -177.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.802 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -167.96 99.95 0.46 Allowed 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.492 ' HA3' HG23 ' A' ' 287' ' ' THR . . . -161.9 -177.0 34.59 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.679 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 64.0 Cg_endo -79.82 34.5 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.96 1.773 . . . . 0.0 111.573 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.987 ' HB3' HD13 ' A' ' 220' ' ' LEU . . . -162.99 26.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 192' ' ' ILE . 0.7 OUTLIER -39.16 106.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.908 0.385 . . . . 0.0 110.592 -179.709 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.89 3.41 1.74 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.105 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.911 HD21 ' HB1' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -99.31 141.74 31.7 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 117.724 0.762 . . . . 0.0 109.296 177.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 22.2 mt-30 -137.05 147.88 46.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.802 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 1.203 ' CD2' HD21 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -137.41 128.09 26.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.021 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -148.13 164.58 33.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.582 HG13 ' CH2' ' A' ' 234' ' ' TRP . 3.5 p -171.19 158.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.336 0.589 . . . . 0.0 110.798 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.722 ' HB3' HG22 ' A' ' 201' ' ' THR . 8.0 m120 -88.14 146.77 25.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.268 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.848 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 2.6 t -66.65 -3.85 7.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.901 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 199' ' ' ASN . 1.4 t -93.44 36.9 1.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.159 0.504 . . . . 0.0 110.44 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.811 ' O ' HD12 ' A' ' 206' ' ' LEU . 15.4 m -131.25 96.37 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.073 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.9 -76.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.799 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.91 12.33 34.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 111.465 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 10.4 pttt -118.42 52.18 1.04 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.048 0.452 . . . . 0.0 110.539 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 1.067 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -147.76 -30.44 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 1.067 ' HD2' ' H ' ' A' ' 206' ' ' LEU . 3.1 Cg_endo -45.38 99.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 121.088 1.424 . . . . 0.0 112.078 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 209' ' ' LYS . 61.9 t -68.76 160.77 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.872 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.753 ' HB2' ' HB2' ' A' ' 217' ' ' ASP . 13.6 mtpp -136.8 127.74 27.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.805 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.821 HD21 ' HB3' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -126.61 148.32 49.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.127 0.489 . . . . 0.0 111.496 178.429 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . 153.45 -157.07 27.15 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.633 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.683 ' HB2' ' O ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -69.2 157.06 37.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.641 0.258 . . . . 0.0 111.355 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.568 ' HB ' ' HB1' ' A' ' 219' ' ' ALA . 7.2 p -77.42 123.43 34.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.777 0.799 . . . . 0.0 113.127 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.739 ' CB ' ' HD3' ' A' ' 215' ' ' PRO . 0.8 OUTLIER 160.27 -81.7 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 114.176 -1.374 . . . . 0.0 109.718 178.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.739 ' HD3' ' CB ' ' A' ' 214' ' ' SER . 16.6 Cg_endo -98.28 -14.4 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.255 1.97 . . . . 0.0 113.254 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.2 174.05 11.12 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.753 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.5 OUTLIER -88.49 -36.4 16.47 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.935 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.203 HD21 ' CD2' ' A' ' 196' ' ' HIS . 10.7 mt -94.04 132.69 38.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.568 ' HB1' ' HB ' ' A' ' 213' ' ' VAL . . . -95.36 72.59 3.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.927 0.394 . . . . 0.0 110.0 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.987 HD13 ' HB3' ' A' ' 191' ' ' ALA . 3.1 mm? -96.23 88.05 4.68 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.679 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 8.0 ptpt -57.63 63.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 0.0 110.849 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 220' ' ' LEU . 2.0 m-20 -95.59 149.64 21.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.989 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.0 t -90.93 -5.8 54.97 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.11 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.46 ' O ' HD11 ' A' ' 249' ' ' LEU . 4.5 pm0 -93.88 -21.13 19.43 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.564 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.683 ' O ' ' HB2' ' A' ' 212' ' ' ARG . 3.1 p -111.85 82.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.7 t -34.76 -44.35 0.21 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.835 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.11 -48.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.876 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -145.5 131.14 18.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.97 0.414 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' A' ' 246' ' ' MET . 1.6 t-80 -102.77 -49.81 3.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.447 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.821 ' HB3' HD21 ' A' ' 210' ' ' LEU . . . -147.65 179.08 7.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.204 0.526 . . . . 0.0 112.389 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -162.38 172.92 14.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.663 -179.349 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.743 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 10.9 mt -129.05 149.09 33.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.567 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.451 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -159.87 155.44 25.66 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.283 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.848 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 4.8 p90 -137.94 156.4 47.9 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.29 123.28 49.02 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.028 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 p -84.06 -4.32 58.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.515 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.0 m -77.8 -22.25 50.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.325 0.583 . . . . 0.0 110.392 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -144.47 20.71 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.855 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 17.6 p90 40.82 64.88 0.88 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.461 0.648 . . . . 0.0 109.811 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.635 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 10.5 mptt -128.31 141.4 51.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.058 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.745 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 4.8 m95 -120.69 117.25 27.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.211 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.3 mt-10 -133.93 141.78 47.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.779 0.8 . . . . 0.0 113.11 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.702 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.2 pp -108.13 154.0 22.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.658 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.609 HG11 ' HE1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -125.51 163.28 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.75 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 1.9 t0 -97.92 156.94 16.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.651 0.739 . . . . 0.0 112.502 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.562 ' N ' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -130.66 90.55 2.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.348 178.681 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 49.18 69.16 1.08 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.288 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.68 70.44 6.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.988 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.74 -51.44 67.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.944 178.208 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.988 ' N ' HD22 ' A' ' 249' ' ' LEU . 1.1 p-10 -72.74 -33.27 66.27 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.303 0.573 . . . . 0.0 110.977 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 100.95 101.19 2.46 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.922 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.613 ' C ' HD23 ' A' ' 253' ' ' LEU . 11.3 m -64.9 160.12 21.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 252' ' ' THR . 0.2 OUTLIER -156.55 153.86 29.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.301 0.572 . . . . 0.0 112.418 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.878 HG22 HG13 ' A' ' 281' ' ' ILE . 78.0 t -129.99 130.47 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.268 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.594 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 54.1 t30 59.21 38.58 23.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.027 0.442 . . . . 0.0 110.319 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.1 36.58 5.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.041 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.72 ' O ' HG23 ' A' ' 259' ' ' ILE . 12.2 m80 -148.61 118.92 7.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.998 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 252' ' ' THR . 25.1 p -62.67 94.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.383 0.611 . . . . 0.0 110.456 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.824 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -95.6 -17.98 6.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.125 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.563 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt . . . . . 0 CA--C 1.516 -0.361 0 CA-C-O 121.439 0.637 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.609 ' HE1' HG11 ' A' ' 244' ' ' VAL . 39.5 t-105 -71.46 -25.64 62.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.6 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.03 160.92 27.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.764 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -98.34 151.7 37.62 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.792 0.329 . . . . 0.0 111.142 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.644 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 32.5 Cg_exo -58.63 115.9 2.87 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.894 2.396 . . . . 0.0 113.479 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.68 HG21 HG12 ' A' ' 259' ' ' ILE . 78.4 t -99.76 138.16 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.745 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.2 pp20? -83.71 129.41 34.95 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.229 -0.988 . . . . 0.0 112.174 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.963 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -94.32 164.32 13.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.755 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.06 160.01 41.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.282 0.563 . . . . 0.0 112.074 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.681 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 6.1 p -61.61 131.01 48.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.127 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.681 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.2 m-20 85.21 5.68 0.51 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.873 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.9 m-20 -79.11 -168.07 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.917 HD13 ' N ' ' A' ' 280' ' ' ILE . 0.1 OUTLIER -160.36 128.21 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.878 HG13 HG22 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -103.25 154.49 5.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.162 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.714 HG23 ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -142.17 116.93 9.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.658 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.65 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.72 40.62 2.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 -178.572 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.447 ' CA ' ' HG3' ' A' ' 224' ' ' GLU . . . 179.37 -130.99 1.6 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 119.57 -1.3 . . . . 0.0 113.555 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 5.0 t -92.09 -49.49 6.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.595 0.235 . . . . 0.0 111.21 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -139.75 0.67 1.83 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.802 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.5 m -72.58 103.66 3.62 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.248 -0.181 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.815 ' O ' HG22 ' A' ' 187' ' ' ILE . 10.9 mtpt -121.45 129.55 53.04 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.667 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.701 HG13 HD12 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -107.83 129.71 61.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.539 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 278' ' ' ASP . 4.4 t80 -77.52 137.2 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.888 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -104.69 114.01 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.626 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.11 129.73 42.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.664 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.804 HD11 ' CD2' ' A' ' 275' ' ' LEU . 16.8 mt -126.84 139.24 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.546 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.66 142.64 50.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.672 0.272 . . . . 0.0 110.388 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 41.1 p -79.7 150.52 30.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.07 0.462 . . . . 0.0 110.864 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' GLN . . . . . 0.615 ' HB3' ' N ' ' A' ' 180' ' ' SER . 2.8 tp-100 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.491 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.129 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.0 m95 -149.0 133.88 18.0 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.943 HD11 ' CD2' ' A' ' 184' ' ' LEU . 0.9 OUTLIER -119.23 133.13 55.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.045 177.014 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.927 ' N ' HD12 ' A' ' 182' ' ' LEU . 6.2 m-85 -132.44 137.24 47.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.776 0.798 . . . . 0.0 110.975 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.943 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.5 mm? -120.97 140.52 51.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.494 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 3.6 tt0 -134.93 114.3 12.39 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -178.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.647 HG21 HD12 ' A' ' 194' ' ' LEU . 2.6 t -59.52 110.33 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.327 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.849 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.2 tt -95.61 -23.77 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.744 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.84 95.09 0.7 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.441 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.585 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.4 -178.07 35.96 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.5 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 73.0 Cg_endo -78.52 32.36 0.45 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.153 1.902 . . . . 0.0 111.642 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.875 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.77 22.63 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.187 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.585 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -40.24 108.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.65 5.01 1.53 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.788 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.875 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -100.41 170.04 8.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 22.1 mt-30 -159.92 148.74 17.46 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.928 0.394 . . . . 0.0 111.6 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.68 ' CE1' ' HB3' ' A' ' 184' ' ' LEU . 0.4 OUTLIER -134.27 124.76 26.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.469 0.652 . . . . 0.0 109.467 178.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -145.22 168.66 19.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.357 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.792 HG13 ' CH2' ' A' ' 234' ' ' TRP . 2.3 p -178.03 160.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.424 0.631 . . . . 0.0 111.529 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.65 ' OD1' HG22 ' A' ' 201' ' ' THR . 4.1 t-20 -96.1 148.62 22.5 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.974 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.479 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 13.3 p -65.46 -1.18 2.33 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.65 HG22 ' OD1' ' A' ' 199' ' ' ASN . 0.6 OUTLIER -109.73 10.52 24.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.795 0.331 . . . . 0.0 111.44 179.738 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.432 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -87.9 137.83 31.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.057 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 61.1 m -90.14 -88.29 0.17 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 43.9 m -93.47 20.18 7.55 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.432 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.2 OUTLIER -118.05 -11.57 10.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.059 0.456 . . . . 0.0 110.742 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.736 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.8 tt -74.15 -60.59 1.43 Allowed Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.828 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 2.0 Cg_endo -42.99 99.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.338 2.025 . . . . 0.0 112.639 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 99.1 t -69.26 158.39 6.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.971 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 16.4 mtpt -138.25 77.86 1.65 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' A' ' 231' ' ' GLN . 3.7 mp -65.5 122.39 17.08 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.116 -0.365 . . . . 0.0 110.655 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . -164.32 166.37 37.72 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.941 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 1.07 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -67.12 -70.83 0.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -177.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.749 HG22 ' HD2' ' A' ' 215' ' ' PRO . 14.9 p -78.48 157.34 4.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -30.07 -54.89 0.34 Allowed Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.749 ' HD2' HG22 ' A' ' 213' ' ' VAL . 55.0 Cg_exo -36.83 -30.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.854 2.37 . . . . 0.0 113.133 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.437 ' CB ' ' HA3' ' A' ' 211' ' ' GLY . 0.9 OUTLIER -81.91 154.92 25.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.616 0.246 . . . . 0.0 110.512 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.571 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -69.24 -40.53 77.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.328 . . . . 0.0 110.194 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.742 ' HB3' HD23 ' A' ' 220' ' ' LEU . 2.6 tp -97.47 130.16 44.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.561 ' C ' HD22 ' A' ' 220' ' ' LEU . . . -90.04 76.84 6.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.01 0.433 . . . . 0.0 110.963 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.792 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.5 mm? -106.69 90.64 3.39 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.445 ' CG ' ' HB2' ' A' ' 190' ' ' PRO . 4.6 pttt -64.0 36.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.873 ' HB3' HG12 ' A' ' 225' ' ' VAL . 26.5 t0 -65.65 132.89 49.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.9 p -73.55 -4.53 34.55 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.255 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -18.73 24.24 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.717 0.294 . . . . 0.0 110.545 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 1.07 HG13 ' HB2' ' A' ' 212' ' ' ARG . 5.4 p -107.58 86.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.172 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.23 -42.95 0.49 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.346 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.39 -49.91 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 246' ' ' MET . 0.0 OUTLIER -143.5 135.32 26.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.461 . . . . 0.0 110.016 179.259 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.601 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.1 t60 -106.12 -52.95 2.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -148.34 176.04 10.59 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.808 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -159.17 178.51 9.93 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.881 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 18.7 mt -137.22 147.63 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 121.471 0.653 . . . . 0.0 112.405 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.455 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -161.65 158.5 26.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.807 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 7.0 p90 -147.48 166.81 26.13 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -116.0 133.58 55.88 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.352 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 82.1 p -93.23 1.19 57.17 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.262 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.0 m -79.31 -37.92 36.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.888 0.851 . . . . 0.0 109.652 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 50.5 tptt -124.9 13.58 8.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.068 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.3 p90 42.47 61.27 2.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.528 0.68 . . . . 0.0 109.87 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.807 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.4 OUTLIER -125.32 137.57 54.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.146 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.725 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -118.95 120.33 36.97 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.062 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 6.9 mt-10 -138.32 144.04 40.22 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.836 0.827 . . . . 0.0 112.629 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.784 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.5 pp -105.01 152.02 23.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.474 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 269' ' ' TRP . 4.3 p -122.37 163.36 20.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.406 ' OD1' ' HB ' ' A' ' 252' ' ' THR . 0.3 OUTLIER -105.96 156.43 18.39 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.676 ' HA ' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -80.97 149.17 29.46 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.18 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.5 ' HA2' ' C ' ' A' ' 268' ' ' LYS . . . -53.21 10.84 0.01 OUTLIER Glycine 0 C--N 1.317 -0.508 0 N-CA-C 115.569 0.988 . . . . 0.0 115.569 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 246' ' ' MET . 0.6 OUTLIER -89.4 130.48 35.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.025 1.412 . . . . 0.0 110.77 179.056 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.669 ' C ' HD13 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -57.16 6.04 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.66 ' N ' HD13 ' A' ' 249' ' ' LEU . 4.9 m-20 -70.0 -40.25 75.4 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 119.666 1.121 . . . . 0.0 109.847 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 72.57 119.02 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.126 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.64 ' C ' HD23 ' A' ' 253' ' ' LEU . 76.7 m -73.5 172.07 12.0 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.305 0.242 . . . . 0.0 110.457 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.661 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -144.4 121.23 11.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.174 0.512 . . . . 0.0 110.567 177.772 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 259' ' ' ILE . 89.9 t -97.15 134.97 32.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.759 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 255' ' ' ASN . 1.2 p-10 49.58 34.54 7.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.147 0.499 . . . . 0.0 110.104 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.55 36.64 1.24 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.831 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -144.61 112.49 6.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.646 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 77.7 p -61.03 85.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 110.811 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.923 HG12 HG11 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -84.98 -13.29 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.263 -179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.55 ' N ' HD12 ' A' ' 259' ' ' ILE . 17.0 p . . . . . 0 C--N 1.329 -0.315 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.5 ' C ' ' HA2' ' A' ' 247' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.72 ' O ' HG22 ' A' ' 244' ' ' VAL . 11.6 t-105 -71.54 -16.38 62.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.06 -175.92 4.96 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -109.51 151.15 42.02 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 117.857 0.829 . . . . 0.0 110.95 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 34.6 Cg_exo -60.27 117.65 4.43 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.777 2.318 . . . . 0.0 113.463 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.923 HG11 HG12 ' A' ' 259' ' ' ILE . 97.6 t -95.49 137.06 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.5 OUTLIER -83.36 125.04 31.23 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.864 -179.013 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.947 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -90.25 164.33 14.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.566 179.176 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.7 157.37 45.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.258 0.551 . . . . 0.0 112.043 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.493 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 68.3 p -58.21 127.81 33.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.483 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 84.24 8.84 0.5 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.418 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.6 t0 -83.18 -165.54 1.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.519 HG23 ' CD1' ' A' ' 290' ' ' TYR . 0.5 OUTLIER -162.36 134.45 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.592 177.728 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.897 HD12 HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -108.57 156.6 9.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.67 178.471 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.661 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.3 m -146.52 113.8 6.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.755 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.64 47.8 1.21 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.589 -178.025 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 172.58 -125.14 1.13 Allowed Glycine 0 CA--C 1.517 0.205 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.453 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.5 t -96.9 -47.13 5.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.644 0.259 . . . . 0.0 111.244 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -144.83 -6.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 61.6 m -64.93 103.44 0.72 Allowed 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.432 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.849 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.8 mtpt -124.78 134.53 52.75 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.034 0.445 . . . . 0.0 111.259 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.897 HG23 HD12 ' A' ' 281' ' ' ILE . 0.1 OUTLIER -114.97 134.24 58.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.69 -178.808 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.524 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.3 t80 -76.98 139.49 40.12 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.971 0.415 . . . . 0.0 110.261 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.947 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -106.32 113.13 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.846 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.91 144.86 50.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.516 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.709 HD11 ' CD2' ' A' ' 275' ' ' LEU . 11.5 mt -144.15 116.81 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.443 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.1 m -123.74 147.52 47.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.951 0.405 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 70.4 m -80.8 -178.31 6.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.7 OUTLIER . . . . . 0 CA--C 1.521 -0.139 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.567 ' O ' HG23 ' A' ' 293' ' ' ILE . 6.6 m95 -147.2 132.32 18.3 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.604 HD23 ' HZ3' ' A' ' 234' ' ' TRP . 6.1 tp -117.86 127.47 53.9 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.092 176.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 16.9 m-85 -125.74 136.5 53.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.676 0.751 . . . . 0.0 110.932 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.845 HD13 ' ND1' ' A' ' 196' ' ' HIS . 1.4 mp -138.13 149.84 46.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.917 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.486 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 12.9 tt0 -145.09 127.09 15.52 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.613 HG21 HD12 ' A' ' 194' ' ' LEU . 13.4 t -64.07 114.87 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.505 HG22 ' CB ' ' A' ' 288' ' ' LYS . 8.7 tt -99.01 -20.17 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.808 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.74 91.39 0.56 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.421 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.808 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.82 -172.68 29.53 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.689 ' HB2' ' HD2' ' A' ' 221' ' ' LYS . 70.7 Cg_endo -77.0 26.84 0.44 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.121 1.881 . . . . 0.0 111.931 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.821 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.0 29.91 0.12 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.114 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.808 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.3 mt -42.84 116.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.46 -51.78 0.76 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.341 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.821 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -38.56 149.43 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.282 0.563 . . . . 0.0 111.215 -178.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.745 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 4.9 mt-30 -148.63 149.97 32.44 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.813 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.845 ' ND1' HD13 ' A' ' 184' ' ' LEU . 2.0 p80 -136.93 126.95 25.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.251 0.548 . . . . 0.0 109.847 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.6 161.26 38.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.476 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.909 HG13 ' CH2' ' A' ' 234' ' ' TRP . 4.0 p -172.61 160.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 111.812 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 180' ' ' SER . 29.9 m-80 -88.74 150.12 23.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.24 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.566 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 40.6 t -64.08 -9.01 13.78 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.623 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 1.8 t -101.18 34.47 2.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.209 0.528 . . . . 0.0 111.061 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.44 ' HB2' ' HG2' ' A' ' 205' ' ' LYS . 35.9 p -116.13 129.74 56.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.634 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' SER . . . . . 0.446 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 4.0 m -90.33 -86.93 0.19 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.0 m -86.8 14.24 7.5 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.446 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -115.83 -13.46 11.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.995 0.426 . . . . 0.0 110.412 178.643 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.773 HD11 ' CE2' ' A' ' 234' ' ' TRP . 6.4 tt -70.4 -60.29 3.4 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.314 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.609 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.0 OUTLIER -43.51 97.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.562 2.175 . . . . 0.0 113.47 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.74 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 98.9 t -68.32 163.16 3.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 3.6 mtpp -139.66 85.81 2.07 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.06 HD23 HD12 ' A' ' 218' ' ' LEU . 0.5 OUTLIER -73.67 126.43 30.29 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.163 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.447 ' HA3' ' OG ' ' A' ' 216' ' ' SER . . . -170.09 173.15 44.12 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.943 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 1.059 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -70.58 -75.12 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.922 HG13 ' HG2' ' A' ' 215' ' ' PRO . 11.3 p -78.99 160.13 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -176.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.507 ' N ' HG22 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -27.68 -52.59 0.23 Allowed Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -178.492 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.922 ' HG2' HG13 ' A' ' 213' ' ' VAL . 5.0 Cg_exo -38.5 -29.77 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.634 2.223 . . . . 0.0 112.962 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.447 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 0.7 OUTLIER -82.98 151.24 25.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.648 179.011 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -31.03 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.108 0.48 . . . . 0.0 109.967 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.06 HD12 HD23 ' A' ' 210' ' ' LEU . 0.8 OUTLIER -105.74 131.24 53.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.234 178.591 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -91.23 77.75 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.84 0.353 . . . . 0.0 111.808 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.793 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -101.26 87.09 3.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.689 ' HD2' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -59.65 24.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.108 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.619 ' H ' ' C ' ' A' ' 220' ' ' LEU . 5.7 m-20 -54.48 115.04 1.9 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.805 0.336 . . . . 0.0 110.791 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 t -56.31 -16.21 5.17 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.804 ' O ' HD11 ' A' ' 249' ' ' LEU . 1.9 pm0 -83.19 -23.51 32.82 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 1.059 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.4 p -97.18 92.26 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 0.0 110.084 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 36.1 m -37.89 -48.18 1.12 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.271 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.06 -50.1 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.698 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.415 ' HD3' ' CB ' ' A' ' 216' ' ' SER . 0.4 OUTLIER -141.26 125.87 17.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.424 0.63 . . . . 0.0 110.738 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.519 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 6.7 t-80 -89.8 -62.17 1.53 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.6 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -145.32 178.01 8.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.39 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.74 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -160.81 178.25 9.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.659 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.551 HG12 ' HB3' ' A' ' 243' ' ' LEU . 6.5 mt -138.85 149.92 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.149 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.427 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -161.24 143.49 12.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.091 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.909 ' CH2' HG13 ' A' ' 198' ' ' VAL . 5.2 p90 -131.89 165.25 24.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.65 133.78 55.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.645 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 95.5 p -91.75 0.71 57.47 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.264 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.8 m -77.72 -32.33 52.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.7 0.762 . . . . 0.0 109.825 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.541 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -134.78 16.22 3.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.308 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.416 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 17.8 p90 43.73 62.46 1.91 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.459 0.647 . . . . 0.0 109.609 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.802 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 5.1 mptt -125.86 140.58 52.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.207 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.717 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -125.21 118.0 25.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.37 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.7 pt-20 -133.97 148.09 51.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.994 0.902 . . . . 0.0 112.821 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.838 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.3 pp -112.19 149.71 31.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.925 -1.488 . . . . 0.0 110.843 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 1.032 HG22 ' HB3' ' A' ' 269' ' ' TRP . 0.8 OUTLIER -124.46 160.86 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.617 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 9.2 m-20 -110.7 108.66 18.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.547 ' CE ' ' HG2' ' A' ' 231' ' ' GLN . 1.8 ptp -86.38 106.85 17.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 50.25 62.73 4.84 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.173 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.405 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 2.8 p -79.14 71.35 5.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.866 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.08 -56.64 17.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.844 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.866 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -73.35 -27.11 61.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 111.017 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 248' ' ' SER . . . 91.16 135.22 6.37 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.81 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.569 HG22 ' CD1' ' A' ' 281' ' ' ILE . 3.5 m -97.3 156.84 16.26 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.687 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -149.04 139.17 22.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.077 0.465 . . . . 0.0 111.297 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.628 HG23 HD11 ' A' ' 259' ' ' ILE . 48.9 t -109.83 133.02 56.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.266 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.692 ' HA ' HG13 ' A' ' 280' ' ' ILE . 0.7 OUTLIER 53.02 38.07 26.36 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.256 0.551 . . . . 0.0 110.689 -179.173 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.2 m 70.68 36.75 1.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.876 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.01 113.18 6.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.947 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 69.0 p -63.82 82.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.471 0.653 . . . . 0.0 110.384 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.78 HG12 HG11 ' A' ' 273' ' ' VAL . 0.4 OUTLIER -81.31 -10.75 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.73 -178.141 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.499 ' N ' HD12 ' A' ' 259' ' ' ILE . 15.4 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 270' ' ' GLY . 2.6 ptmm? . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.583 0.23 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 1.032 ' HB3' HG22 ' A' ' 244' ' ' VAL . 0.5 OUTLIER -79.71 -6.17 56.67 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.709 179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 270' ' ' GLY . . . . . 0.449 ' H ' ' HG3' ' A' ' 268' ' ' LYS . . . 74.85 -106.93 2.17 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 119.485 -1.34 . . . . 0.0 109.759 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 273' ' ' VAL . 0.7 OUTLIER -152.14 125.1 4.1 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.67 174.553 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 84.9 Cg_exo -38.66 102.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.723 1.616 . . . . 0.0 110.04 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.78 HG11 HG12 ' A' ' 259' ' ' ILE . 45.3 t -93.08 139.04 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.299 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.717 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.4 mm-40 -84.55 127.5 34.08 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.255 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.983 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.56 164.76 13.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.37 179.531 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.633 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.85 161.24 39.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.579 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 1.5 m -62.27 131.93 51.0 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.778 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' A' ' 277' ' ' SER . 34.6 m-20 80.16 -0.2 2.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.414 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -71.73 -164.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.701 HG22 ' HD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -157.13 123.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.161 177.856 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.737 HG22 HG23 ' A' ' 289' ' ' VAL . 0.3 OUTLIER -104.89 157.73 5.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.945 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.687 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 2.9 m -150.38 126.58 10.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.713 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -121.85 49.96 1.49 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.871 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 175.26 -134.26 2.67 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.496 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.422 HG22 ' OE2' ' A' ' 224' ' ' GLU . 9.5 t -89.44 -38.63 13.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.119 0.485 . . . . 0.0 109.805 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -151.65 -5.63 0.25 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.11 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.808 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 26.3 m -66.63 99.95 0.64 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.196 0.522 . . . . 0.0 111.353 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.563 ' O ' HG22 ' A' ' 289' ' ' VAL . 17.0 mttt -99.13 178.93 4.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.592 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.737 HG23 HG22 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -162.72 120.0 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.088 177.489 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.701 ' HD1' HG22 ' A' ' 280' ' ' ILE . 1.7 t80 -75.76 136.98 40.28 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.53 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.983 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -107.2 111.36 35.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.183 -178.541 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 9.0 tpt85 -128.24 144.14 51.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.458 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.609 HD12 ' CZ3' ' A' ' 241' ' ' TRP . 20.9 mt -143.01 123.75 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.26 153.46 46.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.696 0.284 . . . . 0.0 110.533 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 73.1 m -80.63 174.95 11.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.821 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.93 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.308 0.099 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 17.8 m95 -151.09 148.8 28.75 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.893 HD11 ' CD1' ' A' ' 184' ' ' LEU . 0.1 OUTLIER -128.36 127.57 42.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.021 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.845 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.3 m-85 -125.69 142.09 51.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.908 0.861 . . . . 0.0 112.531 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.893 ' CD1' HD11 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -137.66 147.44 44.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.022 176.421 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -139.56 129.45 24.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.759 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.827 HG21 HD12 ' A' ' 194' ' ' LEU . 26.9 t -66.41 116.18 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 288' ' ' LYS . 4.7 tt -99.01 -22.2 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.887 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -160.63 92.54 0.96 Allowed 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.714 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.4 -169.8 25.19 Favored Glycine 0 CA--C 1.516 0.116 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.635 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 96.3 Cg_endo -81.02 28.45 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.042 1.828 . . . . 0.0 111.631 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.836 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.51 24.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.912 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.714 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.5 mt -39.53 114.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.876 0.37 . . . . 0.0 111.954 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.24 7.74 4.34 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.924 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.836 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -97.12 128.25 43.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.124 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 10.8 mt-30 -127.71 150.84 49.6 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.022 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.726 ' O ' HD22 ' A' ' 184' ' ' LEU . 1.0 OUTLIER -141.62 142.05 33.43 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.83 179.387 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -132.5 136.33 46.59 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.189 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.655 HG21 ' HG ' ' A' ' 206' ' ' LEU . 12.3 p -141.39 130.92 24.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.487 0.66 . . . . 0.0 111.863 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -85.88 145.56 27.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.949 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.452 ' HG ' ' HE1' ' A' ' 234' ' ' TRP . 12.2 t -63.55 -3.55 2.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.69 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.52 6.46 32.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.504 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -85.69 130.59 34.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.0 110.289 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.9 t -90.65 -90.16 0.16 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 24.7 p -84.51 14.81 4.17 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.504 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -123.49 -14.39 7.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.036 0.446 . . . . 0.0 110.522 179.038 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.655 ' HG ' HG21 ' A' ' 198' ' ' VAL . 7.8 tt -65.61 -62.53 4.36 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.75 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -43.17 99.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.36 2.04 . . . . 0.0 112.584 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 87.3 t -68.36 164.71 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.902 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 25.5 mtmt -141.41 94.57 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.049 HD23 HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -87.96 131.03 34.76 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.28 173.65 45.31 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.993 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.876 ' HD3' HG12 ' A' ' 213' ' ' VAL . 12.2 ttt180 -71.15 -74.96 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.808 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.876 HG12 ' HD3' ' A' ' 212' ' ' ARG . 10.2 p -140.54 110.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.462 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.578 ' CB ' ' HD2' ' A' ' 215' ' ' PRO . 0.3 OUTLIER 178.61 179.89 0.23 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.962 -179.026 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 37.0 Cg_endo -66.1 25.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 121.907 1.738 . . . . 0.0 112.331 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -68.21 -172.93 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.966 0.412 . . . . 0.0 111.242 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.425 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 13.3 m-20 -104.7 -29.48 10.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.474 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.049 HD12 HD23 ' A' ' 210' ' ' LEU . 5.7 mt -112.64 131.68 55.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -98.25 87.72 3.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.567 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.661 HD11 ' CG2' ' A' ' 186' ' ' VAL . 3.0 mm? -103.72 59.65 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.681 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -53.2 73.19 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.22 -178.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.635 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 7.0 t0 -116.58 143.11 46.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.003 0.43 . . . . 0.0 110.311 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.5 t -63.5 -5.3 3.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.541 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.697 ' HG2' HG22 ' A' ' 285' ' ' THR . 0.1 OUTLIER -86.79 -30.73 21.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 109.869 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 0.1 OUTLIER -95.62 107.68 19.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.601 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -49.38 71.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.137 0.494 . . . . 0.0 110.297 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 228' ' ' LYS . . . -148.1 -51.06 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.1 OUTLIER -145.81 125.11 13.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.013 0.435 . . . . 0.0 110.479 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.574 ' HB2' ' CG1' ' A' ' 225' ' ' VAL . 1.6 t-80 -84.56 -58.95 2.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.196 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.902 ' HB3' HD22 ' A' ' 283' ' ' LEU . . . -152.23 175.53 12.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.498 -177.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.731 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -155.55 179.96 8.68 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.817 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.75 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.5 mt -135.79 149.44 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.41 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.4 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -153.69 164.35 38.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.635 ' CD2' HD11 ' A' ' 206' ' ' LEU . 0.6 OUTLIER -93.33 153.43 18.55 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.018 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 239' ' ' PHE . 2.3 m-20 -119.35 71.02 0.85 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.722 -1.581 . . . . 0.0 106.975 174.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.1 p -53.87 -23.24 11.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.9 m -74.38 -27.12 60.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.549 0.69 . . . . 0.0 109.235 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -117.25 8.66 13.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.334 178.763 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 235' ' ' ASN . 2.7 p90 38.38 39.47 0.29 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.622 0.248 . . . . 0.0 111.039 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -112.27 179.96 3.85 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.423 0.63 . . . . 0.0 110.009 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.784 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -131.02 115.0 15.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.917 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 14.0 pt-20 -137.65 151.72 48.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.692 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.4 pp -116.34 153.85 31.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.053 -1.431 . . . . 0.0 111.802 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.805 HG21 ' CD1' ' A' ' 269' ' ' TRP . 2.1 p -121.7 162.69 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.672 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.775 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 8.3 t0 -102.49 116.88 33.52 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -77.53 98.0 5.21 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.215 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 56.2 70.18 1.05 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.704 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.5 p -62.87 48.15 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.973 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.58 -49.81 73.76 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.231 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.973 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.5 -39.02 28.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 93.52 93.39 1.54 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.614 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' THR . . . . . 1.06 HG23 HD23 ' A' ' 283' ' ' LEU . 20.0 m -50.2 164.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.689 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -150.29 139.7 21.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.328 0.585 . . . . 0.0 111.303 179.151 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.872 HG22 HG12 ' A' ' 281' ' ' ILE . 70.3 t -114.37 137.13 48.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.748 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.677 ' HA ' HG13 ' A' ' 280' ' ' ILE . 23.4 p30 47.69 34.98 4.06 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.307 0.575 . . . . 0.0 110.421 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 72.87 35.35 1.02 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.481 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 259' ' ' ILE . 64.5 t-80 -137.56 111.42 8.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.714 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 5.4 t -63.05 84.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.454 0.645 . . . . 0.0 110.992 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.868 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -84.28 -8.49 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.724 -178.523 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.775 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 21.4 m . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.614 ' HE3' ' HB2' ' A' ' 269' ' ' TRP . 13.2 ttpt . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.805 ' CD1' HG21 ' A' ' 244' ' ' VAL . 12.2 t-105 -83.66 -27.46 29.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.435 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.79 -178.29 5.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.203 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -105.09 146.89 33.57 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.106 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.692 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 71.8 Cg_exo -49.88 148.99 11.8 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.594 2.196 . . . . 0.0 112.857 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.841 HG11 HG13 ' A' ' 259' ' ' ILE . 69.2 t -129.86 136.31 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.4 mp0 -81.53 128.14 33.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 118.794 -1.162 . . . . 0.0 112.052 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 1.031 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -93.0 165.93 12.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.027 178.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.683 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.28 161.73 37.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.682 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 3.7 p -62.64 130.04 43.24 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.281 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' A' ' 277' ' ' SER . 30.9 m-20 81.87 -1.48 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.449 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.683 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.2 OUTLIER -70.8 -162.83 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.822 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.723 HG22 ' HD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -159.97 129.09 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.226 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.872 HG12 HG22 ' A' ' 254' ' ' VAL . 0.3 OUTLIER -117.3 93.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.519 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 288' ' ' LYS . 1.8 m -79.56 129.51 34.54 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 1.06 HD23 HG23 ' A' ' 252' ' ' THR . 0.5 OUTLIER -118.92 50.53 1.2 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.424 -178.669 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.528 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 162.73 -119.01 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 119.198 -1.477 . . . . 0.0 113.673 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.697 HG22 ' HG2' ' A' ' 224' ' ' GLU . 1.7 t -95.51 -58.75 2.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.374 0.131 . . . . 0.0 111.159 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.494 ' H ' HG23 ' A' ' 285' ' ' THR . 1.3 t -134.08 -1.28 2.97 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.762 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.887 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 40.4 m -72.51 102.14 3.15 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.697 ' O ' HG22 ' A' ' 187' ' ' ILE . 12.7 ttmt -119.4 123.36 43.92 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.104 0.478 . . . . 0.0 111.286 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 1.1 t -103.01 129.86 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.964 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.723 ' HD1' HG22 ' A' ' 280' ' ' ILE . 0.6 OUTLIER -77.36 133.85 38.62 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.659 -0.416 . . . . 0.0 109.912 -179.309 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 1.031 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -103.44 112.81 38.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.633 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -130.59 141.14 50.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.949 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.784 HD12 ' CE3' ' A' ' 241' ' ' TRP . 2.1 mt -138.98 143.2 32.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.8 t -151.67 164.23 37.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.1 -169.87 2.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.428 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.77 0.319 . . . . 0.0 111.067 -179.81 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.672 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.9 m95 -147.65 130.58 16.21 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.419 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.57 ' HB2' ' HZ3' ' A' ' 241' ' ' TRP . 5.2 tp -113.27 124.37 52.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.058 177.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.672 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 6.5 m-85 -123.39 130.27 52.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.713 0.768 . . . . 0.0 110.791 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 196' ' ' HIS . 1.2 mp -131.6 142.61 49.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.346 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.573 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 24.6 tt0 -140.2 124.8 18.08 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.272 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.767 HG21 HD12 ' A' ' 194' ' ' LEU . 11.1 t -61.33 113.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.013 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 288' ' ' LYS . 8.6 tt -97.05 -20.46 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.518 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.739 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.69 95.01 0.71 Allowed 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.919 -179.138 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.767 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.32 -175.81 33.74 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 178.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.547 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 96.3 Cg_endo -79.23 30.95 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.782 1.655 . . . . 0.0 110.966 178.235 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.941 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.81 24.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.767 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.2 mt -39.55 113.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.75 11.26 2.98 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.3 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.941 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -100.67 155.89 17.63 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.823 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.744 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 8.7 mt-30 -150.61 151.3 32.35 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.801 -177.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.96 ' CE1' HD21 ' A' ' 210' ' ' LEU . 1.7 p80 -138.56 128.62 25.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.08 164.43 30.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.407 -179.099 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.828 HG21 ' HA ' ' A' ' 206' ' ' LEU . 5.9 p -172.84 156.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.4 0.619 . . . . 0.0 111.726 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.505 ' N ' HG22 ' A' ' 198' ' ' VAL . 3.3 m120 -91.52 144.76 25.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.395 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.455 ' HB2' ' CZ2' ' A' ' 234' ' ' TRP . 3.2 t -61.37 -4.52 1.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.455 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.9 t -102.08 0.54 35.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.593 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -75.12 138.27 41.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.418 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.2 m -87.18 -89.08 0.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.137 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.2 18.8 17.8 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.777 0.323 . . . . 0.0 111.722 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -6.88 11.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.525 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.828 ' HA ' HG21 ' A' ' 198' ' ' VAL . 7.5 tt -75.6 -62.53 0.77 Allowed Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.597 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.795 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.8 Cg_endo -42.7 99.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.254 1.969 . . . . 0.0 112.765 -178.034 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.628 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 43.1 t -69.54 165.31 2.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.757 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 4.3 mtpp -135.18 90.19 2.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.028 HD23 HD12 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -78.11 124.93 28.62 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.891 -179.945 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.56 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . 177.01 -173.72 46.52 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.823 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.755 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.6 OUTLIER -60.32 155.92 16.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.583 0.23 . . . . 0.0 110.936 -179.755 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 213' ' ' VAL . 10.0 p -77.29 119.43 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.892 0.854 . . . . 0.0 113.204 -176.439 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.759 ' CB ' ' HD3' ' A' ' 215' ' ' PRO . 0.6 OUTLIER 160.88 -75.99 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.709 178.92 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.759 ' HD3' ' CB ' ' A' ' 214' ' ' SER . 42.9 Cg_endo -100.9 -14.82 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.653 2.235 . . . . 0.0 112.837 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.447 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 1.2 m -80.21 157.29 26.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.003 0.43 . . . . 0.0 111.758 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.524 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.7 OUTLIER -73.16 -37.23 66.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.805 178.898 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.028 HD12 HD23 ' A' ' 210' ' ' LEU . 1.7 mt -98.06 134.85 40.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.583 178.453 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.736 ' HB3' HD22 ' A' ' 194' ' ' LEU . . . -89.39 76.21 7.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.003 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.807 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 2.8 mm? -109.36 94.68 5.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.046 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.547 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -64.71 24.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.656 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.944 ' HB3' HG12 ' A' ' 225' ' ' VAL . 0.4 OUTLIER -55.75 116.05 2.71 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.222 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.4 t -58.73 -20.38 48.6 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.823 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.545 ' CG ' ' HB2' ' A' ' 250' ' ' ASN . 2.3 tp10 -75.11 -19.57 59.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 0.0 110.812 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.944 HG12 ' HB3' ' A' ' 222' ' ' ASP . 5.8 p -124.37 64.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.921 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 10.1 p -46.12 -31.93 2.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.834 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -125.69 -78.86 0.32 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.375 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -139.29 131.0 27.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.076 0.465 . . . . 0.0 110.74 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 245' ' ' ASP . 0.0 OUTLIER -99.59 -55.94 2.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.637 178.908 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.636 ' HB2' ' OD2' ' A' ' 245' ' ' ASP . . . -148.97 164.9 33.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.542 0.687 . . . . 0.0 112.563 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.628 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -149.97 -178.24 6.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.522 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.795 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.1 mt -135.9 151.86 29.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 121.071 0.463 . . . . 0.0 112.198 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.23 163.69 39.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.163 178.213 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.784 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -91.4 152.66 20.31 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -176.286 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 239' ' ' PHE . 26.8 t-20 -120.58 72.29 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.07 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.8 t -59.77 -15.83 23.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -175.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 90.7 m -84.33 -35.58 23.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.44 0.638 . . . . 0.0 110.625 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.486 ' HE3' ' CE1' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -112.6 11.83 19.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.355 179.881 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.486 ' CE1' ' HE3' ' A' ' 238' ' ' LYS . 12.5 p90 42.25 69.55 0.36 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 2.0 mptp? -136.96 147.29 46.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.296 -178.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.735 ' CZ3' HG23 ' A' ' 293' ' ' ILE . 0.5 OUTLIER -114.14 103.46 11.14 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 178.656 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 27.6 mt-10 -125.08 143.63 50.82 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.104 0.954 . . . . 0.0 113.286 -176.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.81 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.4 pp -109.0 151.59 26.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.296 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 1.018 HG22 ' HB2' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -125.06 154.09 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.182 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.636 ' OD2' ' HB2' ' A' ' 230' ' ' ALA . 5.5 m-20 -117.04 100.49 7.78 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.228 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.607 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -64.17 106.64 1.11 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.012 178.332 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.72 68.32 1.75 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.577 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 52.2 p -76.87 61.04 1.86 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 250' ' ' ASN . 1.6 tm? -49.84 -60.01 3.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.149 0.5 . . . . 0.0 110.139 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.545 ' HB2' ' CG ' ' A' ' 224' ' ' GLU . 4.1 t-20 -69.72 -22.34 63.4 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.832 -179.243 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 81.67 84.57 0.76 Allowed Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.549 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.769 ' C ' HD23 ' A' ' 253' ' ' LEU . 55.7 m -46.46 164.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.555 0.178 . . . . 0.0 110.641 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.769 HD23 ' C ' ' A' ' 252' ' ' THR . 0.1 OUTLIER -148.38 126.69 12.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.26 0.552 . . . . 0.0 112.103 179.033 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.745 HG23 HD11 ' A' ' 259' ' ' ILE . 99.8 t -101.95 129.27 53.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.359 178.343 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 52.6 t-20 53.35 43.06 31.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.138 0.494 . . . . 0.0 110.195 -179.038 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.36 31.02 17.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.062 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.406 ' O ' ' N ' ' A' ' 259' ' ' ILE . 0.1 OUTLIER -136.73 106.83 6.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.558 179.648 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 60.1 p -57.6 87.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.267 0.556 . . . . 0.0 110.76 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.785 ' HB ' HG21 ' A' ' 273' ' ' VAL . 1.0 OUTLIER -88.34 -2.38 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.37 -178.961 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.651 ' OG ' ' HB ' ' A' ' 252' ' ' THR . 1.4 m . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.558 ' HD3' ' CD1' ' A' ' 269' ' ' TRP . 2.7 ptpt . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 1.018 ' HB2' HG22 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -95.0 -10.81 29.8 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 179.556 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 270' ' ' GLY . . . . . 0.522 ' H ' ' HG3' ' A' ' 268' ' ' LYS . . . 58.06 -148.37 36.43 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 118.833 -1.651 . . . . 0.0 111.171 -178.048 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -96.36 126.51 43.58 Favored Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.507 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 4.0 Cg_exo -38.74 120.69 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.983 2.456 . . . . 0.0 111.887 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.785 HG21 ' HB ' ' A' ' 259' ' ' ILE . 48.5 t -94.36 135.3 29.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.921 -177.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -81.7 127.16 32.63 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.545 0.688 . . . . 0.0 110.984 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.924 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.49 162.63 14.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.96 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.11 156.76 45.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.047 0.451 . . . . 0.0 112.054 -179.17 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.655 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 29.7 p -59.05 128.76 38.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.655 ' HB2' ' O ' ' A' ' 277' ' ' SER . 30.7 m-20 87.13 2.45 0.44 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.143 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -75.78 -166.08 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.523 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.7 OUTLIER -161.51 130.82 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.085 178.208 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.65 HD12 HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -112.22 156.97 13.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.052 0.453 . . . . 0.0 111.321 178.436 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.658 HG23 ' CG ' ' A' ' 288' ' ' LYS . 1.9 m -141.7 119.17 11.58 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.314 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.617 HD23 ' CG2' ' A' ' 252' ' ' THR . 0.7 OUTLIER -111.84 47.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.898 -178.253 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 167.22 -128.14 1.69 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 119.621 -1.276 . . . . 0.0 113.796 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.8 t -89.9 -46.65 8.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.622 0.249 . . . . 0.0 111.137 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 188' ' ' ALA . 3.5 t -144.0 -7.36 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 47.6 m -64.15 103.21 0.59 Allowed 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.757 ' O ' HG22 ' A' ' 187' ' ' ILE . 5.5 mtpt -124.72 133.05 53.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 111.318 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.65 HG23 HD12 ' A' ' 281' ' ' ILE . 0.1 OUTLIER -112.21 135.5 51.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.564 -179.311 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.4 t80 -77.05 139.29 39.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.7 OUTLIER -110.28 114.11 46.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.544 -178.875 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 11.8 tpt180 -127.65 148.28 50.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.801 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.735 HG23 ' CZ3' ' A' ' 241' ' ' TRP . 14.3 mt -141.13 113.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.58 156.09 45.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.762 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 22.8 m -90.51 162.04 15.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.873 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.032 -179.869 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 1.4 t . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.711 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 9.9 m95 -149.53 137.79 20.64 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.29 -178.307 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.951 HD12 ' N ' ' A' ' 183' ' ' PHE . 1.2 tp -119.85 131.05 55.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.466 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.951 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.7 m-85 -130.32 141.12 50.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.83 0.824 . . . . 0.0 111.595 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.989 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -139.46 152.73 47.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.994 178.079 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 17.7 tt0 -143.56 126.25 16.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.591 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.729 HG21 HD12 ' A' ' 194' ' ' LEU . 10.9 t -62.01 115.52 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.2 tt -100.56 -22.11 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -176.034 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.816 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -161.58 91.03 0.81 Allowed 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.601 -178.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.611 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.89 -170.54 26.76 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 178.671 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.524 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 91.6 Cg_endo -81.81 29.34 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.253 1.969 . . . . 0.0 111.589 178.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.821 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.05 27.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.611 HG12 ' H ' ' A' ' 189' ' ' GLY . 7.8 mt -45.38 112.11 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 111.506 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.47 6.05 2.17 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.223 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.821 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.2 OUTLIER -98.47 138.94 34.95 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.703 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.539 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 17.1 mt-30 -137.92 153.08 49.53 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.515 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.989 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -147.83 147.76 30.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.634 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -147.56 166.67 26.64 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.991 -179.241 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 1.015 HG21 ' HA ' ' A' ' 206' ' ' LEU . 5.7 p -171.82 147.92 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.535 0.683 . . . . 0.0 111.984 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.466 ' OD1' ' CZ2' ' A' ' 181' ' ' TRP . 0.8 OUTLIER -93.11 147.87 22.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.693 179.219 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 24.8 p -65.88 -2.23 3.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.255 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.77 -4.17 25.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.032 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.623 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -94.27 125.51 38.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.548 179.871 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 203' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 207' ' ' PRO . 62.2 p -91.54 -81.28 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.642 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.12 3.21 0.63 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.704 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.475 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -120.87 -8.32 9.42 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.128 -0.358 . . . . 0.0 111.573 179.851 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 1.015 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.6 tt -71.9 -61.25 2.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.413 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.572 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.7 Cg_endo -43.75 96.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.967 1.778 . . . . 0.0 112.764 -178.464 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.903 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 3.4 t -68.62 157.85 6.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.95 179.068 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 217' ' ' ASP . 4.5 mtmm -135.71 93.48 2.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.607 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.042 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -86.86 123.19 31.71 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.735 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -168.14 169.72 41.6 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.504 -179.355 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.864 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 14.7 ttt180 -72.01 -74.4 0.16 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.014 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 213' ' ' VAL . 8.6 p -138.94 115.08 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 216' ' ' SER . 0.3 OUTLIER 169.18 -176.29 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.1 -179.578 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 16.4 Cg_exo -67.96 23.26 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.47 2.113 . . . . 0.0 112.589 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 214' ' ' SER . 3.5 m -64.23 -150.43 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.987 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.8 OUTLIER -132.16 -34.04 1.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.486 179.809 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.042 HD12 HD23 ' A' ' 210' ' ' LEU . 1.1 mt -105.47 126.08 51.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.227 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -92.09 83.1 5.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.887 0.375 . . . . 0.0 111.432 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.864 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.3 mm? -104.69 89.44 3.19 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.069 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.472 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.1 OUTLIER -64.0 38.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.618 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.524 ' HA ' ' HG3' ' A' ' 190' ' ' PRO . 12.6 t0 -64.18 123.32 18.79 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.18 179.191 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 60.1 p -67.45 -4.33 10.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.871 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -19.02 18.11 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.468 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.673 HG22 ' ND1' ' A' ' 229' ' ' HIS . 79.0 t -93.81 81.98 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.49 178.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -38.68 -48.01 1.42 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.441 -179.038 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.58 -55.38 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.693 ' HB2' ' HG3' ' A' ' 246' ' ' MET . 0.2 OUTLIER -140.93 128.31 21.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.998 0.427 . . . . 0.0 110.772 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.673 ' ND1' HG22 ' A' ' 225' ' ' VAL . 0.7 OUTLIER -98.22 -59.71 1.7 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.46 179.088 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 244' ' ' VAL . . . -149.22 170.89 17.43 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.903 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 1.7 mt-30 -151.58 173.64 14.39 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.745 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.546 HG12 HD22 ' A' ' 243' ' ' LEU . 3.5 mt -127.03 143.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.519 0.676 . . . . 0.0 112.19 179.063 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.74 127.34 3.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.942 ' CH2' HG13 ' A' ' 198' ' ' VAL . 5.7 p90 -118.08 166.05 13.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.96 132.87 56.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.058 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.09 -0.26 57.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.453 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 19.8 m -79.02 -36.76 40.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.731 0.777 . . . . 0.0 109.521 178.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.38 17.4 7.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.476 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 12.8 p90 41.12 59.2 2.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.463 0.649 . . . . 0.0 110.014 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.735 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.97 138.4 54.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.624 179.872 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.64 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.71 120.02 32.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.89 179.571 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 21.8 mt-10 -132.97 144.03 49.85 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.851 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.2 OUTLIER -89.03 146.8 24.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.959 -1.928 . . . . 0.0 108.4 178.064 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.721 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 6.0 p -122.32 163.47 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 118.718 0.69 . . . . 0.0 109.316 178.486 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.53 ' CG ' ' HA ' ' A' ' 260' ' ' SER . 2.0 m-20 -118.84 110.14 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.737 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -79.82 105.15 10.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.466 178.148 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.29 69.38 1.28 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.205 -179.029 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.01 45.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.285 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.905 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -58.37 -54.03 51.61 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.781 -0.575 . . . . 0.0 109.846 178.38 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.905 ' H ' HD13 ' A' ' 249' ' ' LEU . 1.4 m-20 -79.12 -34.11 43.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.003 0.43 . . . . 0.0 110.627 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 260' ' ' SER . . . 87.46 98.42 0.88 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.774 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.542 ' C ' HD23 ' A' ' 253' ' ' LEU . 3.1 m -61.07 170.56 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.479 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -153.25 127.0 8.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.433 178.54 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.554 HG22 HG13 ' A' ' 281' ' ' ILE . 86.1 t -103.44 130.58 53.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.522 178.347 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.51 ' HA ' HG13 ' A' ' 280' ' ' ILE . 23.8 t-20 54.03 48.8 20.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.096 0.474 . . . . 0.0 110.216 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.84 23.51 8.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -127.74 105.71 8.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.257 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 86.7 p -55.62 86.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.488 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.802 ' HB ' HG21 ' A' ' 273' ' ' VAL . 2.9 pp -86.15 20.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.332 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.53 ' HA ' ' CG ' ' A' ' 245' ' ' ASP . 78.5 p . . . . . 0 N--CA 1.451 -0.397 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.344 -178.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.737 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 0.0 OUTLIER -79.67 -14.58 58.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.149 -178.994 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 59.62 -172.34 5.09 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -178.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -113.68 131.94 22.81 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 118.242 1.021 . . . . 0.0 110.178 179.102 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.49 ' HB3' ' HB2' ' A' ' 242' ' ' GLU . 80.0 Cg_exo -44.83 119.92 2.59 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.809 2.339 . . . . 0.0 114.055 -178.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.802 HG21 ' HB ' ' A' ' 259' ' ' ILE . 49.3 t -104.14 133.02 49.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -75.15 128.11 34.75 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -176.678 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.828 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.44 165.09 13.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 113.86 -1.518 . . . . 0.0 108.864 178.088 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.52 158.43 44.01 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.57 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.705 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 5.5 p -58.25 130.09 45.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.652 178.287 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.705 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.1 m-20 85.55 7.15 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.831 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.675 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.8 m-20 -78.78 -169.52 1.79 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.5 OUTLIER -160.78 129.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 177.488 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.863 ' CG2' HG23 ' A' ' 289' ' ' VAL . 1.0 OUTLIER -106.15 157.05 6.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.809 0.337 . . . . 0.0 111.394 179.762 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.531 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.7 m -145.98 116.71 7.66 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.807 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.66 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -110.65 45.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.087 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 170.87 -128.81 1.68 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 119.317 -1.42 . . . . 0.0 114.201 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 t -86.49 -48.33 8.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.78 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.2 t -146.43 -4.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.6 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.816 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 17.0 m -66.92 104.29 1.33 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.25 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.749 ' O ' HG22 ' A' ' 187' ' ' ILE . 1.3 ptmt -126.81 135.84 51.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 0.0 111.581 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.863 HG23 ' CG2' ' A' ' 281' ' ' ILE . 0.1 OUTLIER -111.92 135.18 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.093 -178.927 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 4.6 t80 -76.89 138.84 39.99 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.049 -179.438 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.401 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -109.91 112.09 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.753 -178.545 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -137.34 145.55 43.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.88 179.866 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.679 HG12 HD13 ' A' ' 182' ' ' LEU . 1.3 mt -135.82 145.79 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.634 -179.388 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.01 139.68 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.988 0.423 . . . . 0.0 111.494 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.51 165.97 22.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.975 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.984 -179.572 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.591 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 3.1 m . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.727 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.1 m95 -140.06 130.41 25.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.3 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.945 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.5 OUTLIER -119.87 131.51 55.28 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.151 177.719 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.945 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.4 OUTLIER -135.92 145.68 46.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.891 0.853 . . . . 0.0 111.263 -179.858 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.675 HD21 ' HB3' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -144.14 149.8 37.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.837 178.588 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 1.3 tt0 -137.03 124.82 22.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.019 -177.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.911 HG21 HD11 ' A' ' 220' ' ' LEU . 40.1 t -64.21 116.3 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.922 HG22 ' O ' ' A' ' 288' ' ' LYS . 8.7 tt -99.94 -23.3 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -175.579 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.88 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -155.42 91.21 1.3 Allowed 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.494 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.559 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.27 -177.11 35.94 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.292 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.542 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 74.0 Cg_endo -77.98 31.79 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.08 1.853 . . . . 0.0 111.788 178.352 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.829 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -161.64 21.52 0.12 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.794 178.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.559 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.7 mt -39.63 113.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 0.0 111.656 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.7 7.96 2.9 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.901 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.829 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.6 OUTLIER -99.34 109.19 21.83 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.814 0.816 . . . . 0.0 109.749 178.771 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.453 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 16.4 mt-30 -111.39 153.79 25.55 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.727 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.675 ' HB3' HD21 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -146.43 146.41 30.58 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.88 179.921 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.31 153.4 40.5 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.769 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.785 HG21 ' HG ' ' A' ' 206' ' ' LEU . 14.8 p -155.35 146.48 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.349 0.595 . . . . 0.0 111.82 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.591 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.8 OUTLIER -85.06 145.81 27.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.546 178.128 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.445 ' HB2' ' CZ2' ' A' ' 234' ' ' TRP . 5.7 t -63.15 -6.97 4.82 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.11 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 199' ' ' ASN . 3.7 t -101.95 42.84 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.302 0.572 . . . . 0.0 111.323 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.461 ' HB2' ' CG ' ' A' ' 205' ' ' LYS . 6.3 p -135.0 106.27 6.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.523 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.7 m -76.02 -87.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.83 5.32 7.98 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.461 ' CG ' ' HB2' ' A' ' 202' ' ' SER . 2.4 pttt -122.48 56.27 1.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.89 HD11 ' CE3' ' A' ' 234' ' ' TRP . 7.9 tt -146.34 -53.84 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.975 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 3.4 Cg_exo -40.59 96.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.374 2.049 . . . . 0.0 113.076 -177.656 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 231' ' ' GLN . 61.7 t -74.96 97.83 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.337 0.062 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.167 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.729 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 6.0 mtmm -69.69 93.41 0.72 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.108 HD23 HD12 ' A' ' 218' ' ' LEU . 0.7 OUTLIER -78.53 129.55 34.97 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.611 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 179.55 -177.27 48.16 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.097 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.909 ' HB2' HG12 ' A' ' 225' ' ' VAL . 55.5 ttt180 -82.4 -68.66 0.68 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.094 0.558 . . . . 0.0 112.448 -178.518 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.864 HG22 ' H ' ' A' ' 214' ' ' SER . 9.6 p -116.9 -151.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.099 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.864 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.5 OUTLIER 66.37 173.31 0.08 OUTLIER Pre-proline 0 C--O 1.231 0.118 0 O-C-N 122.125 -0.36 . . . . 0.0 110.264 -179.806 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 72.0 Cg_endo -74.27 40.63 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.475 2.116 . . . . 0.0 113.336 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 209' ' ' LYS . 0.6 OUTLIER -71.56 168.01 18.53 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.616 0.246 . . . . 0.0 110.347 179.365 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 1.8 m-20 -85.02 -34.36 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.371 . . . . 0.0 110.605 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.108 HD12 HD23 ' A' ' 210' ' ' LEU . 1.8 mt -101.83 127.68 48.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.652 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -97.36 82.11 3.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.935 0.398 . . . . 0.0 110.992 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.911 HD11 HG21 ' A' ' 186' ' ' VAL . 2.5 mm? -105.97 73.36 0.99 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.184 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.28 60.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.623 ' N ' ' HG3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -107.26 127.79 53.85 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.961 0.41 . . . . 0.0 110.188 178.615 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.3 p -48.24 -24.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.454 0.645 . . . . 0.0 111.58 178.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.914 ' O ' HG23 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -109.92 73.2 0.83 Allowed 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.215 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 224' ' ' GLU . 1.9 t 169.72 3.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 113.08 -1.873 . . . . 0.0 108.626 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.886 ' O ' ' HB3' ' A' ' 212' ' ' ARG . 0.3 OUTLIER -7.23 -116.47 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.628 1.571 . . . . 0.0 114.635 -179.297 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.518 ' H ' ' HB3' ' A' ' 226' ' ' SER . . . -52.49 -89.54 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.029 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.644 ' O ' ' O ' ' A' ' 246' ' ' MET . 6.5 mttm -146.96 138.76 24.38 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.07 0.462 . . . . 0.0 109.95 179.591 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.636 ' CE1' ' HB3' ' A' ' 250' ' ' ASN . 0.2 OUTLIER -96.21 -59.94 1.73 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.58 -179.626 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -149.19 177.66 9.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.621 0.724 . . . . 0.0 112.474 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.729 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 3.8 pt20 -159.36 172.8 17.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.422 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.975 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 4.9 mt -126.77 143.82 38.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.308 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.485 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -145.5 162.53 37.17 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.721 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.89 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.6 OUTLIER -92.33 152.84 19.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.471 -177.05 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 239' ' ' PHE . 1.9 t-20 -119.29 71.33 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 175.16 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 17.8 p -54.61 -23.97 19.29 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -176.907 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.8 m -74.77 -22.15 58.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.556 0.693 . . . . 0.0 109.343 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 22.5 tptt -122.98 8.95 9.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.4 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 235' ' ' ASN . 8.0 p90 39.92 42.93 1.15 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.332 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -120.42 -179.02 3.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.489 0.662 . . . . 0.0 110.58 -179.643 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 1.039 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -131.86 119.82 21.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.783 -179.309 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 6.0 pt-20 -139.84 152.36 46.43 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.776 0.798 . . . . 0.0 113.099 -178.063 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.8 pp -111.16 153.29 25.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.775 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.796 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -123.14 162.34 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.55 -179.432 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.666 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 2.2 t0 -95.4 100.36 12.14 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 120.777 0.322 . . . . 0.0 111.508 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.644 ' O ' ' O ' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -87.09 90.57 8.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.041 178.964 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 48.01 70.67 0.69 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.933 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.414 ' HB2' ' CG ' ' A' ' 245' ' ' ASP . 3.2 t -95.6 78.23 3.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.098 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.578 HD13 ' C ' ' A' ' 249' ' ' LEU . 1.6 tm? -52.75 -58.85 5.53 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.142 0.496 . . . . 0.0 109.776 177.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.636 ' HB3' ' CE1' ' A' ' 229' ' ' HIS . 0.2 OUTLIER -68.33 -29.25 67.95 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.92 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.538 ' O ' ' CE1' ' A' ' 229' ' ' HIS . . . 101.32 156.43 26.89 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.726 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.551 ' C ' HD23 ' A' ' 253' ' ' LEU . 46.7 m -124.86 155.18 39.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.819 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -150.06 145.6 26.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.036 0.446 . . . . 0.0 111.558 179.621 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.858 HG23 ' CD1' ' A' ' 259' ' ' ILE . 75.2 t -116.9 138.3 47.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.095 178.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.483 ' HA ' HG13 ' A' ' 280' ' ' ILE . 3.8 p-10 49.0 37.08 9.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.211 0.529 . . . . 0.0 110.471 -178.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.06 36.85 1.33 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.127 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.708 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.1 OUTLIER -146.45 116.8 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.075 -179.916 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 51.7 p -62.09 90.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.298 0.571 . . . . 0.0 110.746 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.861 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.1 OUTLIER -92.98 -11.79 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.352 -177.758 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.451 ' HB3' ' CG ' ' A' ' 245' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.509 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? . . . . . 0 CA--C 1.517 -0.327 0 CA-C-O 121.375 0.607 . . . . 0.0 112.392 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.796 ' NE1' HG11 ' A' ' 244' ' ' VAL . 30.9 t-105 -77.34 -24.81 50.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.354 178.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 63.02 -179.01 5.66 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.322 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -107.82 134.15 20.18 Favored Pre-proline 0 C--N 1.332 -0.17 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.511 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 1.3 Cg_endo -44.93 136.64 9.84 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.166 2.577 . . . . 0.0 113.926 -178.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.861 HG21 ' CG1' ' A' ' 259' ' ' ILE . 62.2 t -109.21 129.43 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.0 pt-20 -74.31 132.24 41.89 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.417 -178.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.829 HD22 HG11 ' A' ' 291' ' ' VAL . 1.2 mt -89.1 163.22 15.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.973 -178.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -135.81 144.33 45.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.729 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 6.4 m -55.92 131.9 48.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.189 178.042 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 84.58 1.76 0.82 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.133 -179.26 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 3.2 t70 -72.96 -166.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.6 OUTLIER -160.4 133.49 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.896 178.542 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.65 HG12 HG22 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -110.94 156.57 12.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.061 0.458 . . . . 0.0 111.286 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.605 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 3.0 m -148.89 123.5 9.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.729 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.752 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -120.95 39.58 3.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.457 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -176.1 -136.42 2.35 Favored Glycine 0 C--N 1.328 0.095 0 C-N-CA 119.331 -1.414 . . . . 0.0 113.702 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.644 HG22 ' HG3' ' A' ' 224' ' ' GLU . 14.1 t -87.15 -48.85 7.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.588 0.232 . . . . 0.0 110.695 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.435 ' O ' ' HD2' ' A' ' 288' ' ' LYS . 1.3 t -140.25 2.32 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.319 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 31.7 m -74.93 102.09 4.66 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.69 0.281 . . . . 0.0 110.261 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.922 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -123.51 133.2 54.04 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.31 0.576 . . . . 0.0 110.918 -179.874 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.517 HG23 HG22 ' A' ' 281' ' ' ILE . 1.2 t -107.9 130.61 60.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.372 -178.578 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.5 t80 -76.15 136.7 39.79 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 110.309 -178.189 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.829 HG11 HD22 ' A' ' 275' ' ' LEU . 3.5 t -102.25 107.81 22.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.196 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.32 122.4 37.62 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 1.039 HD12 ' CE3' ' A' ' 241' ' ' TRP . 1.2 mt -132.58 146.51 32.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.7 t -152.2 166.13 32.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 111.146 -179.5 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 7.0 m -94.57 159.77 14.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.631 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.926 179.776 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 121.068 0.461 . . . . 0.0 110.935 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.3 m95 -146.88 139.45 24.96 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.13 -178.676 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 8.8 tp -116.88 124.53 49.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.634 178.053 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 5.7 m-85 -123.87 131.54 53.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.775 0.798 . . . . 0.0 110.197 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.825 HD13 ' ND1' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -131.45 142.69 50.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.331 -179.69 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.584 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 2.9 tt0 -139.39 124.68 19.06 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.873 HG21 HD12 ' A' ' 194' ' ' LEU . 10.5 t -62.95 104.84 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.102 0.477 . . . . 0.0 110.462 178.332 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.6 tt -87.03 -24.26 6.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 -177.33 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.738 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -166.64 98.62 0.57 Allowed 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.874 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.714 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.9 -175.04 32.51 Favored Glycine 0 N--CA 1.452 -0.272 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 178.714 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.563 ' O ' ' HG2' ' A' ' 221' ' ' LYS . 89.1 Cg_endo -77.31 28.71 0.43 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.099 1.866 . . . . 0.0 111.533 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.85 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.15 27.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.714 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.4 mt -39.97 111.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.453 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.58 6.56 2.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.257 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.873 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -99.51 162.2 13.16 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.883 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.735 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 12.7 mt-30 -156.59 149.67 24.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.076 -178.177 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.825 ' ND1' HD13 ' A' ' 184' ' ' LEU . 1.8 p80 -136.98 129.06 29.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.674 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -139.12 164.62 29.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.075 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.588 HG21 ' HG ' ' A' ' 206' ' ' LEU . 10.1 p -175.32 155.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.56 0.695 . . . . 0.0 112.704 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.626 ' O ' HD12 ' A' ' 206' ' ' LEU . 5.6 m120 -90.39 147.8 23.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.832 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.596 ' HA ' ' CE2' ' A' ' 234' ' ' TRP . 65.2 m -56.03 -49.92 72.37 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.107 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.93 5.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.607 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.797 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.3 OUTLIER -87.19 105.14 17.0 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.294 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 203' ' ' SER . . . . . 0.445 ' HB3' ' H ' ' A' ' 204' ' ' SER . 1.0 OUTLIER -67.83 -107.48 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.099 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.445 ' H ' ' HB3' ' A' ' 203' ' ' SER . 3.2 m -70.48 6.23 1.48 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.128 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.488 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 8.9 pttt -120.32 55.98 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.212 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.829 HD11 ' CE3' ' A' ' 234' ' ' TRP . 8.0 tt -149.15 -59.87 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.515 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.791 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 4.5 Cg_exo -41.09 99.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.185 1.923 . . . . 0.0 112.189 -177.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 31.9 t -68.82 166.88 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.015 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -139.38 92.1 2.55 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.63 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.077 HD23 HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -76.79 125.24 28.95 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.324 178.895 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -166.22 168.59 39.97 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.64 -179.122 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.996 ' HB2' HG13 ' A' ' 225' ' ' VAL . 1.5 ttt85 -60.72 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.397 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.619 HG12 ' HD3' ' A' ' 212' ' ' ARG . 12.4 p -133.42 -12.4 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 0.0 111.735 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.639 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 1.4 m -49.85 176.5 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.732 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.639 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 28.4 Cg_endo -62.03 18.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.134 1.89 . . . . 0.0 112.667 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.57 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.6 OUTLIER -58.59 -178.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 111.31 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -96.57 -31.55 12.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.138 179.238 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.077 HD12 HD23 ' A' ' 210' ' ' LEU . 1.4 mt -104.66 131.42 52.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.619 178.609 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -98.09 82.5 2.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.596 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.831 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.3 mm? -102.2 86.37 2.83 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.264 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -60.07 67.83 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.856 179.865 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.921 ' HB3' HG12 ' A' ' 225' ' ' VAL . 5.3 t0 -97.77 151.17 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.232 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.5 p -90.38 -9.79 46.31 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.194 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.64 -20.64 24.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.427 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.996 HG13 ' HB2' ' A' ' 212' ' ' ARG . 3.6 p -107.26 86.76 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.041 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.4 m -37.62 -42.23 0.53 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.413 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.33 -55.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.491 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.9 OUTLIER -140.42 133.37 29.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.996 0.427 . . . . 0.0 109.93 179.122 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.6 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.9 t60 -98.27 -54.21 3.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.281 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.415 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -146.56 177.24 9.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 112.212 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.645 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -163.72 175.8 10.19 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.475 -179.822 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.791 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.9 mt -132.8 148.96 31.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.757 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 207' ' ' PRO . 0.1 OUTLIER -149.8 164.65 34.75 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.56 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.829 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.4 OUTLIER -110.55 112.96 25.22 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.285 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.37 82.89 4.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.28 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.6 t -61.65 -9.2 5.63 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -176.942 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 55.2 m -74.7 -32.98 62.33 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.17 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.58 ' HG2' ' HG2' ' A' ' 240' ' ' LYS . 5.4 tptm -110.54 0.22 17.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.245 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 17.4 p90 41.32 47.86 3.1 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.087 0.47 . . . . 0.0 110.272 179.572 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.617 ' HE2' ' HG2' ' A' ' 242' ' ' GLU . 0.0 OUTLIER -119.88 170.34 9.33 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.574 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 1.004 ' CZ3' HG23 ' A' ' 293' ' ' ILE . 1.3 m0 -119.4 108.58 14.75 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.83 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.617 ' HG2' ' HE2' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -133.89 147.65 51.16 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.912 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.744 ' O ' HD12 ' A' ' 243' ' ' LEU . 3.4 pp -111.92 152.16 28.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.357 -1.747 . . . . 0.0 110.59 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.834 HG21 ' CD1' ' A' ' 269' ' ' TRP . 1.2 p -117.99 162.92 15.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.558 0.218 . . . . 0.0 110.527 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -103.18 111.25 23.53 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -177.983 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.606 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -79.36 95.72 5.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.692 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.73 64.0 4.7 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.023 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 21.8 p -64.59 50.34 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.321 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.877 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.56 -50.74 69.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.872 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.877 ' H ' HD13 ' A' ' 249' ' ' LEU . 5.1 t30 -77.72 -37.15 50.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.469 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.1 85.91 1.35 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.218 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.548 ' N ' ' HB3' ' A' ' 260' ' ' SER . 0.5 OUTLIER -45.69 166.56 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 119.87 -0.11 . . . . 0.0 110.789 179.137 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 281' ' ' ILE . 0.2 OUTLIER -150.83 127.23 10.69 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.089 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.771 HG22 HG13 ' A' ' 281' ' ' ILE . 99.5 t -107.39 131.32 57.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.646 178.295 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 58.6 t30 57.57 40.15 27.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.232 0.539 . . . . 0.0 109.852 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 7.9 p 61.53 24.78 14.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.445 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.42 97.64 4.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.604 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -46.4 93.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.6 -179.605 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.83 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.0 OUTLIER -94.87 6.23 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.452 -178.855 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.548 ' HB3' ' N ' ' A' ' 252' ' ' THR . 2.0 t . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.159 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.834 ' CD1' HG21 ' A' ' 244' ' ' VAL . 1.8 t-105 -80.7 -30.89 36.31 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.17 -171.55 7.8 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.14 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -106.5 134.9 19.6 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 117.65 0.725 . . . . 0.0 111.158 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 84.2 Cg_exo -43.03 124.11 3.52 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.214 2.61 . . . . 0.0 113.74 -178.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.83 HG21 ' HB ' ' A' ' 259' ' ' ILE . 87.9 t -99.27 139.28 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.4 OUTLIER -86.45 131.05 34.29 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 119.099 -1.041 . . . . 0.0 111.979 -178.954 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.948 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -96.59 163.91 12.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.496 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.657 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.5 158.48 43.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 8.5 t -61.55 131.44 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.803 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.61 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.7 m-20 85.4 -1.94 0.82 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.18 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.657 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -71.34 -166.78 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.44 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.59 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.8 OUTLIER -161.37 128.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.454 177.299 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.771 HG13 HG22 ' A' ' 254' ' ' VAL . 1.0 OUTLIER -108.74 155.13 9.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.706 179.23 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.629 ' OG1' ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -142.2 121.82 13.37 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.551 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.72 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -113.71 45.18 1.48 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.145 -178.008 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 170.26 -123.13 1.03 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 119.2 -1.476 . . . . 0.0 114.114 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.0 t -91.59 -54.8 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.186 . . . . 0.0 111.273 -179.207 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.573 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -139.94 -3.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.471 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 26.9 m -67.57 103.0 1.25 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.853 0.297 . . . . 0.0 110.58 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.662 ' O ' HG22 ' A' ' 187' ' ' ILE . 7.9 ttmt -118.39 130.98 56.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.672 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -113.43 133.02 60.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.653 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.59 ' HD1' HG23 ' A' ' 280' ' ' ILE . 4.4 t80 -76.34 136.16 39.54 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.014 0.435 . . . . 0.0 110.031 -178.567 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.948 HG11 ' HB2' ' A' ' 275' ' ' LEU . 1.0 OUTLIER -103.46 110.68 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.404 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.19 135.24 55.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.508 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 1.004 HG23 ' CZ3' ' A' ' 241' ' ' TRP . 16.0 mt -131.41 133.51 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.867 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.3 m -156.58 159.98 39.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 110.798 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 52.1 m -86.97 177.54 7.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.845 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 120.639 0.257 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 15.8 m95 -150.48 146.71 26.8 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.638 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.896 HD11 ' CD2' ' A' ' 184' ' ' LEU . 0.8 OUTLIER -122.26 134.54 54.68 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.922 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.841 ' N ' HD12 ' A' ' 182' ' ' LEU . 13.3 m-85 -130.25 136.86 49.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.67 0.747 . . . . 0.0 110.466 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.896 ' CD2' HD11 ' A' ' 182' ' ' LEU . 2.4 mm? -123.4 138.91 54.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.049 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.55 117.15 15.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.796 HG21 HD12 ' A' ' 194' ' ' LEU . 27.0 t -65.59 118.2 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.001 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.768 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.2 tt -98.04 -26.89 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -176.576 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.883 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -158.01 94.34 1.31 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.677 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.76 -174.58 31.81 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 178.255 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.462 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 85.2 Cg_endo -80.6 32.09 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.02 1.813 . . . . 0.0 110.785 178.248 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.796 ' HB1' HD21 ' A' ' 194' ' ' LEU . . . -161.26 21.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.749 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.677 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.1 mt -38.99 113.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 111.612 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.95 5.9 4.66 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.76 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.796 HD12 HG21 ' A' ' 186' ' ' VAL . 0.2 OUTLIER -93.29 139.87 30.16 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.111 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 12.4 mt-30 -133.26 143.55 49.17 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.662 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.886 ' CG ' HG11 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -134.83 128.55 32.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.772 -179.537 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -140.82 162.81 34.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.773 -179.195 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.708 HG21 ' HA ' ' A' ' 206' ' ' LEU . 12.3 p -173.3 153.03 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.413 178.674 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.588 ' HB2' HG22 ' A' ' 201' ' ' THR . 3.0 p30 -90.74 145.59 24.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.919 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.939 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 0.1 OUTLIER -62.59 -2.2 1.03 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.203 179.517 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.588 HG22 ' HB2' ' A' ' 199' ' ' ASN . 1.2 t -101.63 13.74 34.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.827 0.346 . . . . 0.0 110.8 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.514 ' CB ' ' HG2' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -103.96 117.34 34.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.166 179.761 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.4 m -76.92 -84.29 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.551 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.9 t -90.4 15.71 10.14 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.514 ' HG2' ' CB ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -115.46 -10.4 11.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.912 HD13 ' HD3' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -90.09 -18.89 0.23 Allowed Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -179.747 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.912 ' HD3' HD13 ' A' ' 206' ' ' LEU . 30.1 Cg_endo -65.43 84.44 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 CA-C-N 120.905 1.359 . . . . 0.0 111.468 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.886 HG11 ' CG ' ' A' ' 196' ' ' HIS . 47.1 t -70.56 108.15 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.148 -178.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.742 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -79.98 84.5 5.72 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.72 ' HB2' ' O ' ' A' ' 230' ' ' ALA . 4.7 mp -74.93 136.01 41.4 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 118.742 0.701 . . . . 0.0 109.325 178.528 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.672 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . 178.38 -177.02 48.33 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.773 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 1.068 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -71.52 -74.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.092 -0.554 . . . . 0.0 111.638 -179.536 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.848 HG22 ' H ' ' A' ' 214' ' ' SER . 7.6 p -117.0 -145.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.88 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.848 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.6 OUTLIER 61.0 -179.38 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 121.98 -0.45 . . . . 0.0 109.905 -179.578 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 21.5 Cg_exo -66.4 24.2 0.1 OUTLIER 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.646 2.231 . . . . 0.0 113.765 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.558 ' HA ' ' HG3' ' A' ' 209' ' ' LYS . 68.2 m -53.0 152.05 4.31 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 120.617 0.246 . . . . 0.0 110.848 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.53 ' HB3' HG13 ' A' ' 208' ' ' VAL . 0.6 OUTLIER -84.14 -29.25 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.379 179.742 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.67 ' HB3' HD21 ' A' ' 220' ' ' LEU . 36.1 mt -115.65 132.53 56.6 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.136 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -87.96 81.65 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.682 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.672 ' N ' HD22 ' A' ' 220' ' ' LEU . 1.8 mm? -100.3 64.09 1.16 Allowed 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.845 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.559 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -60.78 35.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -177.097 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 224' ' ' GLU . 3.1 t70 -87.94 125.44 34.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.645 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 76.8 p -39.73 -30.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 222' ' ' ASP . 9.8 pt-20 -51.88 -42.23 62.53 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.989 0.424 . . . . 0.0 110.838 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 1.068 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.7 p -96.87 106.17 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.835 179.017 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.5 t -47.22 -68.56 0.18 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.452 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -128.32 -45.1 0.2 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 178.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.672 ' HA ' ' HA3' ' A' ' 211' ' ' GLY . 0.4 OUTLIER -143.45 127.65 17.64 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.087 -0.557 . . . . 0.0 109.555 178.953 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.832 ' CE1' ' HB3' ' A' ' 248' ' ' SER . 1.2 t60 -92.12 -55.19 3.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.534 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' A' ' 210' ' ' LEU . . . -155.35 150.76 27.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.742 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -131.88 179.87 5.82 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.979 179.428 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.866 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.0 mt -126.93 139.4 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.847 179.157 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.747 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -159.83 129.98 5.52 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.383 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.939 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 5.4 p90 -111.61 151.6 28.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -175.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 239' ' ' PHE . 1.5 t-20 -73.32 126.8 30.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 112.493 -2.14 . . . . 0.0 111.007 177.69 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.5 t -89.19 -29.73 19.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.462 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.0 m -77.95 -30.95 50.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.699 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.446 ' O ' ' CG ' ' A' ' 239' ' ' PHE . 1.5 tptm -108.23 -2.32 19.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.598 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 235' ' ' ASN . 27.9 p90 43.44 42.39 3.81 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.37 140.35 52.78 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.579 0.704 . . . . 0.0 110.382 178.507 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.843 ' HA ' ' HB3' ' A' ' 234' ' ' TRP . 2.9 m95 -89.45 121.96 32.18 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.078 -179.393 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.0 mt-10 -140.51 151.18 44.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.004 0.907 . . . . 0.0 113.196 -178.258 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.612 ' CD2' HD12 ' A' ' 281' ' ' ILE . 3.8 pp -117.36 156.51 27.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.125 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.614 HG11 ' HE1' ' A' ' 269' ' ' TRP . 1.3 p -128.91 162.92 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.719 0.295 . . . . 0.0 111.746 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -92.17 156.43 17.34 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.438 0.637 . . . . 0.0 111.367 179.481 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.694 ' O ' ' N ' ' A' ' 248' ' ' SER . 0.0 OUTLIER -127.86 87.8 2.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.768 179.174 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 249' ' ' LEU . . . 55.29 -46.83 0.01 OUTLIER Glycine 0 C--N 1.341 0.818 0 CA-C-O 121.402 0.446 . . . . 0.0 113.948 179.221 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.832 ' HB3' ' CE1' ' A' ' 229' ' ' HIS . 4.1 m -38.81 85.26 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.599 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.65 ' O ' ' HG ' ' A' ' 249' ' ' LEU . 8.7 tp -55.5 2.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 -178.49 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.587 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . 3.8 m120 -71.67 15.92 0.13 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.568 1.531 . . . . 0.0 111.511 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 249' ' ' LEU . . . 42.49 84.64 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.111 179.606 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.473 ' C ' HD23 ' A' ' 253' ' ' LEU . 1.0 OUTLIER -47.43 156.45 0.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.714 0.257 . . . . 0.0 110.593 179.406 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.612 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -144.8 128.94 17.66 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.05 0.453 . . . . 0.0 111.384 178.729 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.946 HG23 HD12 ' A' ' 259' ' ' ILE . 85.2 t -104.77 132.06 52.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.681 178.635 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 3.9 t30 52.13 41.63 30.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.134 0.492 . . . . 0.0 110.15 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.62 24.49 11.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.969 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 9.6 m80 -127.39 108.71 11.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.037 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 3.3 t -58.56 97.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.148 0.499 . . . . 0.0 111.558 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.946 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -78.66 -54.74 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.717 -179.171 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.542 ' N ' HG12 ' A' ' 259' ' ' ILE . 6.9 p . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.9 tptt . . . . . 0 CA--C 1.515 -0.403 0 CA-C-O 121.229 0.538 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.614 ' HE1' HG11 ' A' ' 244' ' ' VAL . 18.6 t-105 -67.72 -27.91 67.21 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.068 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.65 154.44 18.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.98 179.27 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.45 150.74 41.77 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.599 0.238 . . . . 0.0 110.624 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.39 144.54 31.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.36 2.04 . . . . 0.0 112.076 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.795 HG11 HG21 ' A' ' 259' ' ' ILE . 92.8 t -132.15 131.87 61.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.163 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.7 pm0 -80.74 132.87 35.58 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.229 -178.517 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 1.031 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -96.82 165.13 12.26 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.526 -179.74 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.6 162.14 36.21 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.656 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 20.3 p -69.97 132.84 46.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.253 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 277' ' ' SER . 42.7 m-20 82.98 -8.51 1.15 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.975 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -62.1 -168.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.193 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.51 ' CG2' ' HD1' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -161.11 120.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.406 178.341 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.871 HG13 HG22 ' A' ' 254' ' ' VAL . 0.4 OUTLIER -105.08 157.66 5.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.072 179.742 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.661 HG23 ' CG ' ' A' ' 288' ' ' LYS . 1.7 m -143.02 120.7 11.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.64 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.661 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -117.7 47.1 1.61 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.298 -178.449 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.2 -137.13 3.68 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 119.418 -1.373 . . . . 0.0 113.044 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 12.1 t -90.01 -36.32 15.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.836 0.351 . . . . 0.0 110.598 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -151.92 0.91 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.883 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 24.5 m -75.65 105.22 6.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.62 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.768 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.1 mtpt -122.99 127.51 48.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 111.246 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.491 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -107.69 133.59 52.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.537 -178.717 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.675 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.0 t80 -77.38 131.16 37.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.897 0.379 . . . . 0.0 110.098 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 1.031 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -103.05 117.87 49.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.304 -178.906 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.656 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -137.6 141.66 41.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.033 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.739 HD11 HD23 ' A' ' 275' ' ' LEU . 6.2 mt -136.27 133.0 49.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.735 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 22.7 t -133.18 158.78 41.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.963 0.411 . . . . 0.0 111.264 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.7 150.34 21.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.654 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.705 -179.972 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 1.5 m . . . . . 0 N--CA 1.462 0.132 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.575 ' CB ' ' CZ ' ' A' ' 183' ' ' PHE . 90.8 m95 -156.97 146.78 20.74 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.583 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.771 HD11 ' CD1' ' A' ' 184' ' ' LEU . 0.2 OUTLIER -122.8 106.45 10.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 113.64 -1.618 . . . . 0.0 106.797 176.155 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.575 ' CZ ' ' CB ' ' A' ' 181' ' ' TRP . 1.8 m-85 -105.83 138.53 41.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.936 0.874 . . . . 0.0 113.007 -177.685 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.913 ' N ' HD22 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -135.63 146.57 48.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.067 177.406 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.488 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 1.6 tt0 -140.9 127.4 20.02 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -176.841 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.972 HG21 HD11 ' A' ' 220' ' ' LEU . 10.7 t -62.14 116.51 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.173 178.363 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.1 tt -97.22 -22.47 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.516 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.748 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.28 91.21 0.69 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.84 -177.64 35.08 Favored Glycine 0 C--O 1.228 -0.224 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 178.161 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.52 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 84.4 Cg_endo -76.99 32.72 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.907 1.738 . . . . 0.0 111.802 178.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.9 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -161.47 28.74 0.13 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.672 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -47.74 111.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.379 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.94 10.06 2.94 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.683 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.9 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.4 OUTLIER -101.39 105.38 16.41 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.983 0.897 . . . . 0.0 109.944 178.837 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.488 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 8.5 mt-30 -105.83 156.19 18.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.715 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.871 ' ND1' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -149.44 147.2 27.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.299 179.716 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.457 ' HB2' ' HD2' ' A' ' 183' ' ' PHE . . . -149.02 158.29 44.07 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.587 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.74 HG21 ' HA ' ' A' ' 206' ' ' LEU . 9.8 p -159.96 148.57 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.655 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 180' ' ' SER . 2.1 m120 -85.49 140.72 30.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.863 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.954 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 9.8 m -56.71 -10.93 1.14 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.635 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.2 t -97.14 9.07 43.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.797 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.89 ' O ' HD12 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -96.53 103.14 15.03 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.932 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 203' ' ' SER . . . . . 0.413 ' O ' ' CD1' ' A' ' 206' ' ' LEU . 1.9 m -62.98 -89.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.828 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.62 13.25 7.25 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.981 -0.449 . . . . 0.0 111.642 -179.098 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.667 ' HG2' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -111.51 -2.61 15.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.645 -179.447 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 1.058 HD13 ' HD3' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -100.35 -27.67 0.23 Allowed Pre-proline 0 C--O 1.232 0.15 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.867 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 1.058 ' HD3' HD13 ' A' ' 206' ' ' LEU . 9.7 Cg_endo -54.1 100.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.867 0 CA-C-N 121.329 1.51 . . . . 0.0 111.11 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 59.5 t -68.46 155.22 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.273 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.608 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -135.87 90.48 2.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 -179.164 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.067 HD23 HD12 ' A' ' 218' ' ' LEU . 0.9 OUTLIER -81.45 127.77 33.16 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.638 -179.99 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.565 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -172.56 171.44 44.32 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.066 -179.623 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.986 ' HB2' HG13 ' A' ' 225' ' ' VAL . 5.3 ttm180 -67.04 -74.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.297 0.57 . . . . 0.0 111.774 -179.625 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.679 HG22 ' H ' ' A' ' 214' ' ' SER . 9.4 p -124.15 -138.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.278 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.679 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.7 OUTLIER 59.74 179.26 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 119.131 0.878 . . . . 0.0 109.606 -179.966 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.658 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 38.4 Cg_endo -67.43 25.86 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.039 1.826 . . . . 0.0 113.758 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -58.43 152.7 17.3 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.686 0.279 . . . . 0.0 110.695 179.471 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -79.94 -32.0 40.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.379 . . . . 0.0 110.117 179.484 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.067 HD12 HD23 ' A' ' 210' ' ' LEU . 1.2 mt -106.48 129.05 54.51 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.373 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.638 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -92.71 81.47 4.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.791 0.329 . . . . 0.0 111.502 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.972 HD11 HG21 ' A' ' 186' ' ' VAL . 2.5 mm? -108.48 62.22 0.61 Allowed 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.969 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.846 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 10.2 pttt -51.91 55.8 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -177.482 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 220' ' ' LEU . 22.1 t0 -100.62 149.64 23.55 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.759 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 29.5 t -64.47 -34.61 78.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.477 -179.764 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.526 ' O ' HD11 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -48.9 -39.94 27.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.442 -179.591 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.986 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.3 p -103.45 89.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.448 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -34.82 -45.77 0.27 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.705 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.37 -53.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.422 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.559 ' HB2' ' SD ' ' A' ' 246' ' ' MET . 0.0 OUTLIER -144.71 135.2 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.194 0.521 . . . . 0.0 109.667 178.73 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.708 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.4 OUTLIER -104.2 -56.08 2.25 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.284 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -141.76 172.42 12.71 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.506 0.669 . . . . 0.0 112.485 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.703 ' HG3' HG12 ' A' ' 244' ' ' VAL . 1.5 pt20 -158.52 173.46 16.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.319 179.648 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 9.8 mt -134.31 151.58 32.37 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.422 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -162.01 148.18 13.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.713 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.954 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 2.5 p90 -130.17 163.24 27.09 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.369 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.47 123.79 50.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.256 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 24.1 t -84.01 -1.77 55.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.099 179.443 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.5 m -80.8 -33.74 34.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.599 0.714 . . . . 0.0 109.984 179.15 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 19.5 tptm -129.41 16.3 6.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.95 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.417 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 9.0 p90 40.05 60.3 1.76 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.476 0.655 . . . . 0.0 109.545 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.597 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.2 OUTLIER -123.81 138.55 54.48 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.364 179.661 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.68 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -117.2 114.77 24.13 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.123 178.761 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 35.3 mt-10 -130.83 141.88 50.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.757 0.789 . . . . 0.0 112.373 -177.85 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.749 HD22 HD12 ' A' ' 281' ' ' ILE . 3.8 pp -108.26 152.6 24.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.125 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.703 HG12 ' HG3' ' A' ' 231' ' ' GLN . 0.7 OUTLIER -123.44 162.24 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.573 -179.404 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.706 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 1.1 m-20 -111.28 101.09 9.6 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.914 178.899 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.871 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -84.94 106.5 16.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.971 0.415 . . . . 0.0 109.924 179.347 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 48.19 67.31 1.65 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.803 -178.813 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.04 74.6 8.08 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.42 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.853 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -51.34 -56.26 14.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.611 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.853 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -71.07 -25.96 62.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.167 0.508 . . . . 0.0 110.965 -179.892 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.469 ' N ' ' HE1' ' A' ' 229' ' ' HIS . . . 89.49 136.79 6.15 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.483 -0.78 . . . . 0.0 113.753 179.479 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.59 ' C ' HD23 ' A' ' 253' ' ' LEU . 24.1 m -100.71 155.68 17.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.117 179.284 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.666 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -146.57 145.45 30.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.087 0.47 . . . . 0.0 111.615 179.623 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.841 HG23 ' CD1' ' A' ' 259' ' ' ILE . 45.6 t -114.09 131.19 66.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.345 179.026 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.611 ' HA ' HG13 ' A' ' 280' ' ' ILE . 1.3 p-10 51.37 39.68 24.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.517 -178.669 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 4.4 p 72.17 37.11 1.01 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.692 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.552 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.5 OUTLIER -148.84 117.0 6.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.069 179.949 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 83.8 p -64.68 87.6 0.06 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.504 0.669 . . . . 0.0 110.655 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.927 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -83.89 -17.9 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.82 -177.952 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.706 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 20.3 m . . . . . 0 C--N 1.329 -0.285 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -177.388 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 270' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.375 0 CA-C-O 121.095 0.474 . . . . 0.0 112.032 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.871 ' CZ3' ' HB2' ' A' ' 246' ' ' MET . 46.1 t-105 -70.01 -24.46 63.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.361 179.526 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 270' ' ' GLY . . . . . 0.461 ' H ' ' HD3' ' A' ' 268' ' ' LYS . . . 70.88 170.74 9.99 Favored Glycine 0 CA--C 1.512 -0.141 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.932 178.911 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -102.62 146.66 32.78 Favored Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.221 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.695 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 51.3 Cg_exo -54.14 121.75 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.04 1.827 . . . . 0.0 112.574 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.927 HG21 ' CG1' ' A' ' 259' ' ' ILE . 70.1 t -99.22 133.15 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.66 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -78.46 123.73 27.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.622 -178.89 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.871 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -89.12 165.12 14.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.656 179.752 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.54 161.57 38.78 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.404 -0.518 . . . . 0.0 112.273 -179.117 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.2 OUTLIER -62.3 124.44 20.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.359 179.361 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 277' ' ' SER . 10.1 m-20 88.58 7.71 0.14 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.499 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.7 OUTLIER -79.01 -169.33 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.361 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.673 ' HB ' ' HD3' ' A' ' 288' ' ' LYS . 0.9 OUTLIER -160.04 129.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.059 178.163 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.905 HG22 HG23 ' A' ' 289' ' ' VAL . 0.8 OUTLIER -109.84 152.31 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.669 178.783 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 252' ' ' THR . 0.2 OUTLIER -138.54 126.77 22.86 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.925 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.708 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -120.03 40.56 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.201 -178.794 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 177.57 -131.3 1.76 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.613 -1.279 . . . . 0.0 113.533 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.1 t -89.28 -43.9 10.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 110.797 -179.628 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.9 t -146.58 -1.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.439 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.748 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.9 m -68.99 99.9 1.14 Allowed 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.35 179.054 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.811 ' O ' HG22 ' A' ' 187' ' ' ILE . 1.3 ttmt -118.34 131.0 56.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.459 -178.572 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.905 HG23 HG22 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -114.03 132.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 121.381 -0.128 . . . . 0.0 111.085 -179.486 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.64 ' HD1' HG22 ' A' ' 280' ' ' ILE . 1.1 t80 -77.35 142.22 39.46 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 110.647 -178.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.871 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -110.39 115.97 51.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.631 -179.268 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -138.72 153.21 48.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.085 -179.629 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.459 HD12 ' CZ3' ' A' ' 241' ' ' TRP . 3.8 mt -144.23 120.72 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.345 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.03 158.57 39.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.947 0.403 . . . . 0.0 110.975 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.4 p -101.34 -173.49 2.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.671 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.523 -0.084 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.701 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 23.8 m95 -145.83 131.44 18.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.9 OUTLIER -115.13 124.04 50.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.703 176.551 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.737 ' N ' HD12 ' A' ' 182' ' ' LEU . 7.5 m-85 -124.64 133.82 53.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.39 0.614 . . . . 0.0 110.776 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.633 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -139.75 149.35 43.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.9 178.289 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.58 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 13.1 tt0 -141.23 128.4 20.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.499 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 1.119 HG21 HD12 ' A' ' 194' ' ' LEU . 48.2 t -65.52 112.65 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.385 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.6 tt -97.25 -21.64 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -176.075 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.853 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -157.96 92.38 1.18 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.564 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.676 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.1 -163.69 16.37 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.523 ' HD3' ' OD2' ' A' ' 222' ' ' ASP . 91.6 Cg_endo -85.73 28.6 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.96 2.44 . . . . 0.0 110.971 178.277 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.86 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -160.22 23.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.981 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.676 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.6 mt -39.57 109.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 111.675 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.32 10.12 3.11 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.902 -1.142 . . . . 0.0 113.438 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 1.119 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -96.65 129.12 44.1 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.754 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.58 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 15.8 mt-30 -128.96 151.5 49.61 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.264 -178.367 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.608 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -145.14 145.4 31.37 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.18 179.943 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -149.74 154.44 38.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.893 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.806 HG21 ' HA ' ' A' ' 206' ' ' LEU . 7.5 p -164.89 153.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 110.818 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' A' ' 180' ' ' SER . 4.3 m120 -90.19 149.4 22.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.64 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.514 ' CA ' ' HZ2' ' A' ' 234' ' ' TRP . 49.2 p -65.5 -9.22 24.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.691 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 2.3 t -96.64 25.33 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.461 0.648 . . . . 0.0 110.098 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.475 ' HB3' ' CG ' ' A' ' 205' ' ' LYS . 35.8 m -104.3 119.14 38.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.432 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 70.2 m -66.71 -84.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.968 -179.122 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 47.7 m -105.12 26.78 8.9 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.475 ' CG ' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -117.85 -14.49 10.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.788 0.328 . . . . 0.0 111.141 179.596 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.941 ' O ' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -81.4 -38.03 0.92 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.163 -179.527 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.781 ' N ' HD13 ' A' ' 206' ' ' LEU . 9.7 Cg_endo -54.11 102.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 120.875 1.05 . . . . 0.0 111.676 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 40.8 t -68.91 159.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.206 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 41.0 mtmt -140.6 95.62 2.89 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.471 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.934 HD23 HD12 ' A' ' 218' ' ' LEU . 0.4 OUTLIER -83.84 123.94 30.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.382 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.545 ' HA3' ' OG ' ' A' ' 216' ' ' SER . . . -159.55 163.09 33.35 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.195 -179.423 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.797 ' HD2' ' HB ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -60.15 -91.05 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.302 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.434 ' H ' ' HB3' ' A' ' 212' ' ' ARG . 7.5 p -116.37 -15.15 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 0.0 110.938 -179.27 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.789 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 52.9 m -51.78 174.04 0.12 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.783 178.59 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.789 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 19.3 Cg_endo -58.36 7.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.062 1.841 . . . . 0.0 112.942 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.545 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 17.8 m -45.81 157.42 0.11 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.949 0.405 . . . . 0.0 111.479 179.648 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.539 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -71.06 -32.28 68.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.896 -179.256 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.934 HD12 HD23 ' A' ' 210' ' ' LEU . 12.0 mt -106.52 129.57 54.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.028 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -90.31 85.8 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 111.689 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.765 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.3 mm? -105.28 83.72 2.01 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 44.17 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.693 ' CA ' ' HD3' ' A' ' 212' ' ' ARG . 0.7 OUTLIER -76.56 167.34 22.01 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 122.255 -0.278 . . . . 0.0 110.554 179.318 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.4 p -95.27 -0.97 52.4 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 179.295 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.22 -27.25 13.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.917 0.78 . . . . 0.0 112.763 -176.891 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 0.835 HG22 ' CD2' ' A' ' 229' ' ' HIS . 32.7 t -92.97 91.3 3.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.055 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.98 -41.77 3.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.378 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.39 -57.51 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.055 179.721 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.464 ' HB2' ' HG2' ' A' ' 246' ' ' MET . 8.0 mttt -146.38 130.55 17.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.003 0.43 . . . . 0.0 111.151 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.835 ' CD2' HG22 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -90.59 -57.92 2.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.458 178.021 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -147.67 -175.0 4.69 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.638 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.661 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -163.7 177.53 8.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.396 179.648 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 17.7 mt -137.82 147.53 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.301 0.572 . . . . 0.0 112.51 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.48 147.16 13.88 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.131 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.85 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.6 p90 -137.79 165.66 25.9 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -178.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.582 ' HB2' ' HD2' ' A' ' 240' ' ' LYS . 1.4 m-80 -117.57 133.65 55.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.204 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.1 m -89.52 4.9 47.74 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.609 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.6 m -77.83 -37.5 48.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.821 0.819 . . . . 0.0 109.653 178.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 6.1 tptm -126.26 14.98 7.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.261 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 238' ' ' LYS . 18.6 p90 41.68 61.22 1.93 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.933 0.873 . . . . 0.0 108.673 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.85 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -128.5 145.97 50.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.259 -179.855 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.726 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -128.92 125.53 37.74 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.021 -178.914 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 9.5 pt-20 -138.53 146.91 42.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.842 0.83 . . . . 0.0 113.116 -178.254 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.4 pp -112.19 152.11 28.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.773 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.808 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 7.3 p -117.06 163.82 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.42 0.152 . . . . 0.0 110.962 -179.158 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.48 ' OD2' ' HA3' ' A' ' 270' ' ' GLY . 0.0 OUTLIER -107.33 105.95 16.15 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.52 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.55 ' CE ' ' HA ' ' A' ' 246' ' ' MET . 2.3 tpt -78.43 103.68 8.53 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.129 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.3 65.07 3.81 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.005 -178.695 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.9 p -68.21 53.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.676 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.792 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.55 -50.61 72.53 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.297 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.792 ' N ' HD22 ' A' ' 249' ' ' LEU . 6.1 t-20 -79.19 -34.78 42.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.053 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 89.84 102.1 1.11 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.238 179.732 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.69 HG23 ' HB3' ' A' ' 283' ' ' LEU . 0.5 OUTLIER -56.88 163.99 1.73 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.893 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.735 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -154.31 136.59 14.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.424 0.63 . . . . 0.0 112.458 179.99 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 1.015 HG23 HD12 ' A' ' 259' ' ' ILE . 53.3 t -109.15 133.55 53.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.244 178.464 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.52 ' HA ' HG13 ' A' ' 280' ' ' ILE . 0.7 OUTLIER 49.56 33.9 6.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.177 0.513 . . . . 0.0 110.695 -179.577 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 4.1 m 76.83 27.79 0.72 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.83 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.489 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.0 OUTLIER -129.65 110.12 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.147 179.494 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 252' ' ' THR . 86.5 p -62.97 84.71 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.171 0.51 . . . . 0.0 111.748 -179.275 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 1.015 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -79.82 -8.19 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.12 -179.481 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 2.0 m . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.641 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.808 ' CZ3' HG13 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -76.12 -26.05 55.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.87 -178.159 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 270' ' ' GLY . . . . . 0.48 ' HA3' ' OD2' ' A' ' 245' ' ' ASP . . . 61.85 -173.54 7.61 Favored Glycine 0 CA--C 1.515 0.093 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.266 -179.081 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 272' ' ' PRO . 23.0 m-20 -108.36 148.16 37.07 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 117.846 0.823 . . . . 0.0 111.239 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.727 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 31.9 Cg_exo -60.06 122.57 11.59 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.08 2.52 . . . . 0.0 114.008 -178.751 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.607 HG21 ' HB ' ' A' ' 259' ' ' ILE . 71.4 t -98.95 138.01 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.656 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.2 mp0 -83.03 127.48 33.6 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.987 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.94 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.32 164.16 13.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.776 179.81 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -141.76 158.11 44.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.268 0.556 . . . . 0.0 112.181 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 10.8 p -55.39 128.55 34.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.928 179.532 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 81.13 8.49 1.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.693 179.829 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.511 ' OD2' ' HB ' ' A' ' 291' ' ' VAL . 0.0 OUTLIER -88.4 137.17 32.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.001 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.675 HG22 ' HD1' ' A' ' 290' ' ' TYR . 1.0 OUTLIER -97.43 129.62 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.664 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.956 HG12 HG22 ' A' ' 254' ' ' VAL . 0.4 OUTLIER -112.39 94.39 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -178.748 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.697 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 7.0 m -82.94 142.49 31.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.935 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.699 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -134.76 47.43 2.37 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.04 -179.865 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.85 -125.23 1.1 Allowed Glycine 0 C--N 1.329 0.194 0 C-N-CA 119.879 -1.153 . . . . 0.0 113.469 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.5 t -95.64 -45.32 7.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.717 0.294 . . . . 0.0 110.747 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.66 -0.17 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.812 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.853 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 25.5 m -75.4 102.13 5.04 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.621 0.248 . . . . 0.0 111.345 -179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.722 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -122.44 131.43 53.87 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.498 0.666 . . . . 0.0 111.044 179.792 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.43 HG23 HD11 ' A' ' 283' ' ' LEU . 2.4 t -107.81 131.76 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.54 -177.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.675 ' HD1' HG22 ' A' ' 280' ' ' ILE . 1.0 OUTLIER -76.95 132.49 39.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.694 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.511 ' HB ' ' OD2' ' A' ' 279' ' ' ASP . 2.5 t -110.89 117.35 54.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.634 -178.124 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.2 OUTLIER -136.73 150.99 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.847 -179.464 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.726 HD12 ' CE3' ' A' ' 241' ' ' TRP . 3.1 mt -143.21 127.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.366 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.61 153.34 43.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.813 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 5.0 m -85.94 168.07 14.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.137 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 -179.989 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.198 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.687 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 3.2 m95 -143.52 130.88 20.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.713 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.929 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.4 OUTLIER -122.08 130.28 53.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.017 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.929 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -133.18 146.22 51.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.77 0.795 . . . . 0.0 111.393 179.979 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -146.84 153.32 40.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.009 178.955 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.535 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 0.1 OUTLIER -142.02 133.35 26.44 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.183 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.912 HG11 HD11 ' A' ' 220' ' ' LEU . 40.0 t -66.4 116.04 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.017 0.436 . . . . 0.0 110.148 177.862 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.868 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.2 tt -97.45 -24.16 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.09 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.848 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -160.11 93.55 1.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.733 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.91 -173.25 30.34 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 178.357 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.624 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 96.9 Cg_endo -80.16 32.65 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 CA-C-N 119.452 1.626 . . . . 0.0 111.587 178.684 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.812 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.95 23.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.627 178.846 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.733 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.8 mt -39.41 114.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 127.56 10.54 3.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.519 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.812 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -99.66 131.16 45.83 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.964 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.535 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 12.7 mt-30 -128.01 153.89 46.24 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.358 -178.392 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.723 ' CD2' ' HB3' ' A' ' 217' ' ' ASP . 0.0 OUTLIER -145.57 146.03 31.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.165 178.968 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.56 144.51 29.62 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.273 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.995 HG21 ' HA ' ' A' ' 206' ' ' LEU . 10.2 p -146.51 147.81 17.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.332 0.587 . . . . 0.0 110.816 179.281 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.581 ' OD1' HG23 ' A' ' 201' ' ' THR . 21.4 p30 -95.07 150.47 20.15 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.265 -179.45 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.509 ' N ' ' HZ2' ' A' ' 234' ' ' TRP . 48.2 t -70.67 1.04 5.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.474 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.581 HG23 ' OD1' ' A' ' 199' ' ' ASN . 0.0 OUTLIER -104.17 11.63 34.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.25 0.548 . . . . 0.0 110.784 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.4 m -91.3 132.13 36.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.059 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.47 -77.41 0.39 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.261 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.5 m -101.68 20.62 15.87 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.735 0.303 . . . . 0.0 111.59 -179.287 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -123.16 -15.03 7.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.942 0.401 . . . . 0.0 110.807 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.995 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.9 tt -59.08 -60.51 10.31 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.405 -179.598 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.778 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -42.59 98.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.629 2.219 . . . . 0.0 113.016 -178.65 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.561 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 59.7 t -68.04 163.57 2.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.326 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.732 ' O ' ' HB2' ' A' ' 217' ' ' ASP . 0.5 OUTLIER -142.64 115.09 8.49 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.222 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.964 HD21 ' HB3' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -116.67 145.88 43.13 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.657 -0.652 . . . . 0.0 111.236 178.145 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . 170.85 -174.74 44.7 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.753 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 1.088 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -65.11 -77.4 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.054 0.454 . . . . 0.0 111.85 -178.89 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.809 HG22 ' H ' ' A' ' 214' ' ' SER . 13.7 p -128.28 -138.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.234 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.809 ' H ' HG22 ' A' ' 213' ' ' VAL . 5.0 m 67.39 173.59 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 118.897 0.771 . . . . 0.0 109.378 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 40.0 Cg_endo -66.59 18.15 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.907 1.738 . . . . 0.0 112.694 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 214' ' ' SER . 1.9 m -54.91 178.68 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.721 0.296 . . . . 0.0 110.739 179.851 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.732 ' HB2' ' O ' ' A' ' 209' ' ' LYS . 14.0 m-20 -100.98 -35.87 9.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.469 -179.591 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.685 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 6.2 mt -100.39 129.08 46.32 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.231 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.448 ' O ' ' CB ' ' A' ' 191' ' ' ALA . . . -95.04 79.19 3.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.633 0.254 . . . . 0.0 110.634 -179.736 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.912 HD11 HG11 ' A' ' 186' ' ' VAL . 3.0 mm? -100.74 66.37 1.2 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.74 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.718 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 1.8 pttt -50.22 69.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.825 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 220' ' ' LEU . 2.5 t0 -124.72 140.05 53.29 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.214 0.53 . . . . 0.0 110.05 178.104 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.9 t -54.96 -40.34 69.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.437 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.419 ' HB3' ' HA2' ' A' ' 284' ' ' GLY . 2.4 mm-40 -41.94 -42.97 2.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.364 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 1.088 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.4 p -102.36 79.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.215 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -33.05 -42.43 0.08 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.114 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.17 -55.79 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.035 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 246' ' ' MET . 30.4 mtmm -145.17 129.46 17.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.156 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.544 ' HB3' HD22 ' A' ' 283' ' ' LEU . 0.1 OUTLIER -93.88 -53.53 3.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.118 179.702 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.964 ' HB3' HD21 ' A' ' 210' ' ' LEU . . . -151.33 -179.22 7.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.683 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.842 ' HG2' ' HE1' ' A' ' 246' ' ' MET . 0.4 OUTLIER -161.2 -178.01 6.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.295 178.404 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.778 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 23.7 mt -140.52 148.67 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.17 0.509 . . . . 0.0 111.482 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.68 137.2 8.7 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.735 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.96 ' CH2' HG13 ' A' ' 198' ' ' VAL . 3.2 p90 -131.62 166.46 21.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.616 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 235' ' ' ASN . . . . . 0.548 ' H ' ' HD2' ' A' ' 240' ' ' LYS . 11.0 t-20 -116.43 134.17 55.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.868 -1.514 . . . . 0.0 112.953 -178.671 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.5 t -90.53 -1.1 57.88 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.946 178.445 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.4 m -77.02 -28.95 55.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.718 0.771 . . . . 0.0 110.015 178.509 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.45 15.09 3.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.693 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.4 p90 41.9 58.97 2.69 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.895 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -126.34 145.87 50.26 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.712 -179.612 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.716 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -129.51 124.86 35.0 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.035 -178.935 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -139.71 142.7 36.86 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.758 0.79 . . . . 0.0 112.78 -178.181 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.8 pp -108.07 156.38 19.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.221 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.499 HG22 ' HE3' ' A' ' 269' ' ' TRP . 5.1 p -124.47 163.24 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.613 ' CG ' ' HB3' ' A' ' 260' ' ' SER . 6.6 m-20 -107.91 125.47 51.53 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.152 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.842 ' HE1' ' HG2' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -85.77 94.28 9.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.738 178.374 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 47.74 68.4 1.22 Allowed Glycine 0 C--N 1.329 0.16 0 C-N-CA 119.544 -1.312 . . . . 0.0 110.475 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 85.8 p -64.32 58.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.531 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 250' ' ' ASN . 1.2 tm? -54.26 -60.63 3.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.224 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.567 ' N ' HD13 ' A' ' 249' ' ' LEU . 1.1 t-20 -71.1 -30.16 66.18 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.006 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 248' ' ' SER . . . 100.48 118.66 4.28 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.672 178.954 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.914 HG23 HD23 ' A' ' 283' ' ' LEU . 1.4 m -92.74 105.59 17.7 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.653 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -98.75 139.25 34.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 112.367 -178.279 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.85 HG22 HG23 ' A' ' 281' ' ' ILE . 41.4 t -109.61 127.42 66.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.953 178.126 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.843 ' HA ' HD12 ' A' ' 280' ' ' ILE . 7.2 t-20 55.01 38.34 30.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.082 0.468 . . . . 0.0 110.248 -178.655 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.38 34.96 12.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.594 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.725 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.5 OUTLIER -140.96 113.18 7.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.522 -179.84 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 83.7 p -58.9 88.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.533 0.683 . . . . 0.0 110.562 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.934 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -88.67 -21.8 6.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.222 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.613 ' HB3' ' CG ' ' A' ' 245' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.457 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.415 0.626 . . . . 0.0 112.38 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.596 ' CH2' ' HG3' ' A' ' 246' ' ' MET . 83.7 m95 -80.33 -20.58 43.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.306 178.371 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 68.87 174.96 10.09 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -177.326 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.69 125.27 65.6 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 118.141 0.971 . . . . 0.0 110.52 -179.486 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.1 Cg_exo -35.25 119.63 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.807 2.338 . . . . 0.0 111.638 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.934 HG21 ' CG1' ' A' ' 259' ' ' ILE . 97.7 t -101.15 136.6 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.671 -177.675 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 11.9 mt-10 -82.4 128.38 34.19 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.868 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.987 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.17 165.2 13.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.992 -179.464 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.08 159.03 43.05 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.789 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.689 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 84.9 p -62.89 130.71 46.0 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.426 179.188 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.5 OUTLIER 83.66 -0.66 1.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.122 -179.237 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -71.07 -170.27 0.44 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.843 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.8 OUTLIER -162.07 124.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 177.349 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.85 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -99.27 150.28 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.149 176.363 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.688 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 1.8 m -134.68 122.2 21.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.662 0.744 . . . . 0.0 109.357 178.091 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.914 HD23 HG23 ' A' ' 252' ' ' THR . 0.0 OUTLIER -122.13 136.93 54.97 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.593 179.598 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.472 ' HA2' ' CG ' ' A' ' 250' ' ' ASN . . . 88.11 -132.4 11.19 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.315 179.522 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.8 t -100.03 -33.43 10.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.445 0.164 . . . . 0.0 111.18 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -152.79 8.21 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.751 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.848 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 12.7 m -74.53 102.43 4.51 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.043 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.868 ' O ' HG22 ' A' ' 187' ' ' ILE . 15.6 ttmt -120.04 125.37 48.16 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.63 -179.311 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 184' ' ' LEU . 1.0 OUTLIER -107.4 135.57 45.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.607 179.701 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.653 ' HD1' HG23 ' A' ' 280' ' ' ILE . 2.2 t80 -78.13 136.67 37.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.615 -179.393 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.987 HG11 ' HB2' ' A' ' 275' ' ' LEU . 1.8 t -105.45 114.86 46.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.393 -179.569 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -133.87 138.82 45.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.162 -179.636 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.762 HD11 HD23 ' A' ' 275' ' ' LEU . 14.2 mt -135.74 143.22 37.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 7.6 t -146.29 153.25 40.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 78.2 p -86.16 162.51 18.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.312 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 41.2 tp60 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 179.97 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.226 -0.151 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.716 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 22.0 m95 -144.29 130.9 20.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.864 HD23 ' CZ3' ' A' ' 234' ' ' TRP . 0.4 OUTLIER -121.44 107.95 13.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.035 177.883 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.716 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 0.9 OUTLIER -106.88 140.13 40.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.864 0.84 . . . . 0.0 112.081 -179.565 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.894 ' N ' HD22 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -133.48 144.11 49.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.165 177.401 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 16.1 tt0 -137.74 125.79 22.86 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.829 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.947 HG21 HD12 ' A' ' 194' ' ' LEU . 9.6 t -65.52 112.26 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.578 177.819 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 288' ' ' LYS . 7.4 tt -95.03 -22.44 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.102 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.88 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.85 93.75 0.56 Allowed 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 119.742 -0.783 . . . . 0.0 112.691 -179.331 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.776 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.63 -171.05 27.18 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 178.257 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.762 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 93.6 Cg_endo -79.41 30.57 0.47 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.053 1.835 . . . . 0.0 111.77 178.948 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.865 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.59 27.29 0.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 178.314 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.776 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -41.2 107.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.818 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 8.17 2.26 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.741 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.947 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -97.59 132.99 42.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.939 0.876 . . . . 0.0 108.705 177.878 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.57 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 17.8 mt-30 -133.22 152.9 51.94 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.211 -1.358 . . . . 0.0 110.193 -178.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.872 ' CG ' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -148.25 148.31 30.33 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.097 -179.757 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.453 ' C ' ' HZ3' ' A' ' 181' ' ' TRP . . . -147.42 140.07 24.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.337 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.91 HG13 ' CH2' ' A' ' 234' ' ' TRP . 5.2 p -143.29 149.6 18.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.427 0.632 . . . . 0.0 110.458 178.435 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 180' ' ' SER . 4.5 p30 -95.8 151.83 19.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.758 -179.516 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.563 ' HG ' ' N ' ' A' ' 180' ' ' SER . 80.5 p -67.41 -1.33 4.63 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -178.542 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.6 15.49 22.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.941 0.4 . . . . 0.0 111.27 179.265 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.52 143.93 26.66 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.064 179.26 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.0 m -89.04 -94.46 0.1 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.354 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.86 31.01 2.47 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.302 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.64 -11.73 8.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 110.751 179.18 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.774 ' HA ' HG21 ' A' ' 198' ' ' VAL . 4.7 tt -67.5 -58.04 9.27 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.591 -179.152 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -41.93 90.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.639 2.226 . . . . 0.0 112.438 -178.7 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.684 ' O ' HG12 ' A' ' 208' ' ' VAL . 2.2 t -71.56 91.0 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.209 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 231' ' ' GLN . 12.2 mtmt -69.96 87.2 0.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.757 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.987 HD23 HD12 ' A' ' 218' ' ' LEU . 2.0 mp -74.55 128.67 36.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.807 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . -177.78 -177.33 46.51 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.486 -179.551 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 0.961 ' HD3' HG12 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -57.18 -93.2 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.017 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.961 HG12 ' HD3' ' A' ' 212' ' ' ARG . 11.5 p -158.3 158.75 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.355 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.998 ' HB2' ' HD3' ' A' ' 215' ' ' PRO . 24.4 m 103.16 -74.06 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.831 179.812 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.998 ' HD3' ' HB2' ' A' ' 214' ' ' SER . 95.9 Cg_endo -96.01 -35.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.079 1.853 . . . . 0.0 113.182 179.545 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.448 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 0.9 OUTLIER -57.02 145.87 29.05 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.142 0.496 . . . . 0.0 112.209 -178.958 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.04 -33.06 69.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.454 179.049 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.987 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -100.21 135.24 41.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.557 178.284 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -93.64 73.5 4.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.951 -178.98 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.93 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.1 mm? -99.48 94.69 6.54 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.776 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.762 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 28.0 pttt -65.11 53.63 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.232 0.539 . . . . 0.0 110.048 178.406 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 220' ' ' LEU . 4.1 m-20 -87.81 116.2 25.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.223 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 11.5 p -60.51 -15.53 28.07 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.877 -179.347 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 222' ' ' ASP . 0.0 OUTLIER -79.22 -21.33 46.41 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.576 0.227 . . . . 0.0 110.838 179.686 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 1.012 ' HB ' ' HD1' ' A' ' 229' ' ' HIS . 2.8 p -107.61 80.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.16 -30.22 0.74 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 111.188 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -145.87 -59.66 0.02 OUTLIER Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.194 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.867 ' HB2' ' HG3' ' A' ' 246' ' ' MET . 0.3 OUTLIER -144.49 133.59 22.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.785 0.326 . . . . 0.0 110.354 -179.824 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 1.012 ' HD1' ' HB ' ' A' ' 225' ' ' VAL . 0.4 OUTLIER -93.43 -58.7 2.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.738 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 210' ' ' LEU . . . -147.45 165.48 30.13 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.788 -178.59 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.724 ' HA ' HD12 ' A' ' 210' ' ' LEU . 17.9 tt0 -143.11 157.44 44.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.657 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.695 HG13 HD11 ' A' ' 210' ' ' LEU . 23.7 mt -121.54 145.75 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.918 179.53 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.724 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -161.79 160.58 28.46 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.28 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.91 ' CH2' HG13 ' A' ' 198' ' ' VAL . 3.6 p90 -149.68 165.73 31.5 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -117.31 133.6 55.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.854 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -0.12 57.32 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.107 179.093 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -76.15 -20.15 57.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.659 0.742 . . . . 0.0 110.052 178.858 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.661 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 7.5 tptm -151.6 20.58 0.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.596 -178.919 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 23.8 p90 41.01 57.81 2.67 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.391 0.615 . . . . 0.0 109.926 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.792 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.8 OUTLIER -120.63 137.5 54.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.938 179.352 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.734 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -120.49 122.25 40.23 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.95 179.963 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 1.0 OUTLIER -139.37 142.25 37.56 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.941 0.876 . . . . 0.0 112.784 -178.391 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.753 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.0 pp -110.31 155.09 22.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.691 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.909 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 5.0 p -117.33 163.02 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 122.239 -0.288 . . . . 0.0 111.102 -179.452 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 260' ' ' SER . 0.0 OUTLIER -105.95 113.09 26.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.318 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.867 ' HG3' ' HB2' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -81.39 105.77 12.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.665 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 54.35 65.6 3.37 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.71 -178.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.76 49.79 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.905 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.772 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -58.11 -47.67 82.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.702 178.431 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.772 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.38 -33.09 37.44 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.014 -179.159 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.529 ' N ' HD22 ' A' ' 250' ' ' ASN . . . 92.02 85.4 1.49 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.122 -178.851 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 258' ' ' SER . 2.9 m -46.55 168.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.641 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.665 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.3 OUTLIER -154.97 136.2 13.99 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 119.9 -0.72 . . . . 0.0 112.749 179.381 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 1.038 HG22 HG13 ' A' ' 281' ' ' ILE . 67.1 t -115.16 130.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.154 178.481 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 255' ' ' ASN . . . . . 0.674 ' HA ' HD12 ' A' ' 280' ' ' ILE . 1.1 t-20 56.16 37.68 29.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.106 0.479 . . . . 0.0 109.932 -179.25 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.67 25.69 9.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.637 -179.488 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.694 ' O ' HG23 ' A' ' 259' ' ' ILE . 3.1 t-80 -128.02 101.35 6.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.675 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 252' ' ' THR . 10.4 t -53.51 92.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.327 0.584 . . . . 0.0 111.167 -179.71 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.961 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -88.88 -9.14 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.004 -178.284 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 25.2 m . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.359 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp . . . . . 0 CA--C 1.543 0.683 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.909 ' CZ3' HG13 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -80.31 -23.13 40.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.785 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 270' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' A' ' 245' ' ' ASP . . . 62.0 -175.74 6.39 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.241 -0.981 . . . . 0.0 110.929 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 272' ' ' PRO . 1.7 m-20 -105.6 141.74 23.29 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 117.983 0.891 . . . . 0.0 111.141 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.753 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.1 Cg_exo -51.97 123.14 11.8 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.856 2.371 . . . . 0.0 113.517 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.622 HG11 HG13 ' A' ' 259' ' ' ILE . 95.2 t -100.9 140.91 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.272 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.1 mt-10 -86.92 129.24 34.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.745 -179.17 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.869 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -95.41 164.67 12.72 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.93 -179.516 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.67 157.4 45.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.905 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 29.3 t -61.02 129.44 41.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.25 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.621 ' HB2' ' O ' ' A' ' 277' ' ' SER . 5.8 m-20 82.43 -1.15 1.38 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.519 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.725 ' O ' HG23 ' A' ' 291' ' ' VAL . 0.1 OUTLIER -79.11 137.86 37.67 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.079 179.473 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 255' ' ' ASN . 1.1 pp -102.08 127.11 55.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.04 179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 1.038 HG13 HG22 ' A' ' 254' ' ' VAL . 0.4 OUTLIER -105.96 159.54 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.995 0.426 . . . . 0.0 111.287 178.971 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.649 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.9 m -145.54 122.91 11.62 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.149 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.657 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -119.01 47.93 1.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.833 -179.44 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.03 -134.9 3.1 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.85 -1.167 . . . . 0.0 113.042 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.51 HG22 ' OE1' ' A' ' 224' ' ' GLU . 1.8 t -87.8 -51.62 5.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 0.0 110.382 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.59 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -137.86 -2.19 1.93 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.292 179.337 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.6 m -70.92 102.77 2.47 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.885 0.374 . . . . 0.0 111.103 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.816 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.4 OUTLIER -121.27 128.55 52.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.922 -179.215 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.719 HG23 ' CG2' ' A' ' 281' ' ' ILE . 0.0 OUTLIER -108.3 133.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.087 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.1 t80 -76.43 134.78 39.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.682 -179.221 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.869 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -104.38 113.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.044 -179.988 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -129.06 141.86 51.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.749 -179.785 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.761 HD11 HD23 ' A' ' 275' ' ' LEU . 6.6 mt -137.63 138.17 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.286 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.29 131.56 16.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.695 0.283 . . . . 0.0 111.071 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.408 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 23.8 p -79.77 143.19 34.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.091 0.472 . . . . 0.0 111.193 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.628 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.229 0.538 . . . . 0.0 110.75 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 181' ' ' TRP . . . . . 0.702 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 37.0 m95 -148.16 139.44 23.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.38 -178.069 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.9 OUTLIER -114.9 120.98 41.78 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.049 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 183' ' ' PHE . . . . . 0.725 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.3 m-85 -121.56 135.41 55.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.445 0.641 . . . . 0.0 110.358 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -140.57 148.36 40.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.355 179.211 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.647 ' C ' HG23 ' A' ' 289' ' ' VAL . 1.7 tt0 -137.56 124.46 21.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.2 -177.556 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 1.014 HG21 HD11 ' A' ' 220' ' ' LEU . 40.3 t -63.05 108.74 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.379 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.9 tt -87.92 -26.64 5.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -176.118 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.886 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -158.8 96.31 1.35 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.443 -179.85 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.676 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.49 173.91 39.66 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 178.546 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.51 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 37.6 Cg_endo -69.47 32.92 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 121.823 1.682 . . . . 0.0 111.266 178.141 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 191' ' ' ALA . . . . . 0.831 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -160.65 20.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.308 179.497 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.676 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.1 mt -38.94 108.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.721 0.296 . . . . 0.0 111.761 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.31 8.07 2.1 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.154 -1.022 . . . . 0.0 113.018 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.831 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.8 OUTLIER -101.47 112.89 25.57 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.917 0.865 . . . . 0.0 109.74 178.75 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.469 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 5.7 mt-30 -114.65 154.69 27.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.565 -179.149 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.564 ' CD2' ' HB3' ' A' ' 217' ' ' ASP . 0.0 OUTLIER -147.84 148.08 30.5 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.381 0.61 . . . . 0.0 111.154 179.636 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -144.01 152.27 40.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.044 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 1.053 HG21 ' HA ' ' A' ' 206' ' ' LEU . 8.1 p -167.03 150.29 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.0 111.278 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 199' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 180' ' ' SER . 1.0 OUTLIER -92.46 155.28 17.95 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.369 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.675 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 3.6 m -56.3 -48.74 76.06 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.522 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' A' ' 201' ' ' THR . 0.0 OUTLIER -67.66 14.11 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.251 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 202' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' A' ' 199' ' ' ASN . 0.3 OUTLIER -91.99 118.89 31.2 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 110.005 179.2 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -67.14 -107.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.523 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.4 m -80.98 21.02 0.73 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.559 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.527 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -114.17 -19.23 11.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 178.944 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 1.053 ' HA ' HG21 ' A' ' 198' ' ' VAL . 0.0 OUTLIER -70.71 -33.78 3.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.274 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 38.6 Cg_exo -55.47 101.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 121.016 1.144 . . . . 0.0 111.721 179.538 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.433 HG11 HD11 ' A' ' 184' ' ' LEU . 49.0 t -84.78 90.9 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.694 -179.163 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.637 ' HD2' ' HA ' ' A' ' 216' ' ' SER . 11.9 mttt -71.01 109.11 4.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.008 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.105 HD23 HD12 ' A' ' 218' ' ' LEU . 1.6 mp -94.38 131.78 39.68 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.013 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -179.55 -176.39 47.1 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.057 -179.575 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 212' ' ' ARG . . . . . 1.002 ' HB2' HG13 ' A' ' 225' ' ' VAL . 30.6 ttt-85 -80.76 -69.64 0.59 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.639 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 213' ' ' VAL . 9.1 p -141.88 118.8 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 0.0 110.529 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 214' ' ' SER . . . . . 0.604 ' HB2' ' HD2' ' A' ' 215' ' ' PRO . 0.0 OUTLIER 168.9 176.85 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.735 -178.973 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 214' ' ' SER . 41.1 Cg_endo -67.47 23.5 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 121.831 1.687 . . . . 0.0 112.243 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 216' ' ' SER . . . . . 0.637 ' HA ' ' HD2' ' A' ' 209' ' ' LYS . 1.1 m -62.62 -151.77 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.438 179.806 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.564 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 52.1 m-20 -130.9 -34.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.957 0.408 . . . . 0.0 110.466 179.643 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.105 HD12 HD23 ' A' ' 210' ' ' LEU . 4.0 mt -103.71 125.33 50.12 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 177.111 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.582 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -94.08 87.67 5.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.863 0.364 . . . . 0.0 110.223 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 1.014 HD11 HG21 ' A' ' 186' ' ' VAL . 2.0 mm? -110.45 92.42 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.168 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 221' ' ' LYS . . . . . 0.411 ' HA ' ' HG3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -62.48 36.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.214 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.905 ' HB2' HG12 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -64.67 111.88 2.95 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.076 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.5 p -53.02 -19.15 2.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.562 0.22 . . . . 0.0 111.322 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.789 ' O ' HD21 ' A' ' 249' ' ' LEU . 3.0 pm0 -75.36 -28.69 59.64 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.929 179.674 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 225' ' ' VAL . . . . . 1.002 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.8 p -97.41 92.42 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.042 178.809 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.1 m -40.96 -40.71 1.47 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.371 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.4 -54.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.53 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 228' ' ' LYS . . . . . 0.659 ' HB3' ' HG3' ' A' ' 246' ' ' MET . 0.1 OUTLIER -144.25 126.69 15.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.749 0.309 . . . . 0.0 110.539 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 229' ' ' HIS . . . . . 0.63 ' C ' ' HG2' ' A' ' 246' ' ' MET . 0.6 OUTLIER -96.54 -51.64 4.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.961 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.781 ' HB1' HD11 ' A' ' 243' ' ' LEU . . . -142.42 165.44 27.41 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.888 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 231' ' ' GLN . . . . . 0.835 ' HA ' HD12 ' A' ' 210' ' ' LEU . 1.3 tm0? -149.89 160.88 43.23 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.597 179.471 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.675 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.9 mt -124.9 144.43 34.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 CA-C-O 121.271 0.557 . . . . 0.0 111.744 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.707 HG22 ' OE1' ' A' ' 231' ' ' GLN . 0.1 OUTLIER -161.38 164.3 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.118 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 234' ' ' TRP . . . . . 0.835 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.8 p90 -157.58 167.46 30.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.796 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -115.0 131.72 56.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.542 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.49 -0.61 57.62 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.27 179.589 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.1 m -73.6 -21.79 60.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.696 0.76 . . . . 0.0 110.168 178.656 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 239' ' ' PHE . 6.2 tptt -150.87 23.79 0.76 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.377 -178.814 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 238' ' ' LYS . 8.9 p90 38.31 60.48 1.28 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.521 0.677 . . . . 0.0 109.533 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.835 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -121.7 136.53 54.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.727 179.683 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 241' ' ' TRP . . . . . 0.713 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.2 OUTLIER -118.65 130.58 55.94 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.771 -179.905 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.458 ' CB ' ' O ' ' A' ' 273' ' ' VAL . 0.8 OUTLIER -137.09 132.7 34.47 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.427 0.632 . . . . 0.0 111.115 -177.815 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.825 HD21 HG21 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -110.08 136.97 48.49 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.131 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.769 ' N ' HD12 ' A' ' 243' ' ' LEU . 4.2 p -122.6 162.82 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 120.733 0.301 . . . . 0.0 110.359 -179.735 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.691 ' HB2' ' CA ' ' A' ' 270' ' ' GLY . 12.2 m-20 -99.38 149.1 23.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.182 0.515 . . . . 0.0 111.707 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.659 ' HG3' ' HB3' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -116.34 95.0 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.424 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 51.33 60.81 6.84 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.812 -177.707 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.5 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 0.3 OUTLIER -72.86 72.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.858 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.789 HD21 ' O ' ' A' ' 224' ' ' GLU . 1.2 pp -54.33 -57.54 10.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.26 0.552 . . . . 0.0 110.189 178.86 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.643 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.5 OUTLIER -69.52 -25.97 64.29 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.774 -179.712 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.5 ' HA2' ' HB2' ' A' ' 248' ' ' SER . . . 89.94 132.11 4.73 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.779 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.736 ' C ' HD23 ' A' ' 253' ' ' LEU . 79.7 m -92.59 151.62 20.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 252' ' ' THR . 0.0 OUTLIER -144.76 128.56 17.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.939 0.399 . . . . 0.0 111.659 -179.989 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 254' ' ' VAL . . . . . 0.852 HG22 HG23 ' A' ' 281' ' ' ILE . 50.1 t -101.44 131.95 48.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.251 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 49.12 31.85 3.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.149 0.499 . . . . 0.0 110.557 -178.97 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 78.04 36.89 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.33 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.503 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.5 OUTLIER -148.2 120.45 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.938 179.784 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 258' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 252' ' ' THR . 72.4 p -67.28 85.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.42 0.628 . . . . 0.0 110.91 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 259' ' ' ILE . . . . . 0.767 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -80.12 -15.42 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.636 -178.629 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.527 ' O ' ' HA2' ' A' ' 270' ' ' GLY . 2.8 m . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.497 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 269' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 269' ' ' TRP . . . . . 0.649 ' CE3' ' HA ' ' A' ' 246' ' ' MET . 26.7 t-105 -85.19 78.68 9.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.275 -177.494 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 270' ' ' GLY . . . . . 0.691 ' CA ' ' HB2' ' A' ' 245' ' ' ASP . . . 36.04 -160.87 0.01 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 118.984 2.354 . . . . 0.0 118.984 172.176 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.11 94.24 3.53 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 111.418 -2.391 . . . . 0.0 105.99 175.11 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.426 ' HD3' HG23 ' A' ' 244' ' ' VAL . 1.0 OUTLIER -24.4 109.01 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.872 3.048 . . . . 0.0 115.929 -176.912 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 273' ' ' VAL . . . . . 0.667 HG21 HG12 ' A' ' 259' ' ' ILE . 17.5 t -115.95 159.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.314 179.128 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.502 ' N ' HG12 ' A' ' 273' ' ' VAL . 81.9 mm-40 -94.19 130.98 40.21 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.261 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -94.33 161.51 14.21 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.089 -177.258 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.587 ' H ' HD23 ' A' ' 275' ' ' LEU . . . -142.51 155.27 45.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.287 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 25.7 t -61.73 134.73 57.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.852 179.301 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 278' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.2 OUTLIER 83.66 7.25 0.66 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.925 -179.418 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 279' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 291' ' ' VAL . 0.7 OUTLIER -82.92 126.93 33.03 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.358 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -100.38 132.02 46.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 119.619 -0.833 . . . . 0.0 111.161 -179.524 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 281' ' ' ILE . . . . . 0.852 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -107.41 156.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.336 179.184 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 252' ' ' THR . 9.3 m -144.51 116.64 8.39 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.967 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 283' ' ' LEU . . . . . 0.75 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -120.01 49.52 1.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.523 -178.307 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 179.97 -142.24 5.03 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.106 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.6 t -87.7 -37.11 16.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.998 0.428 . . . . 0.0 110.211 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -152.72 3.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.238 179.706 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.886 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.3 m -77.54 106.11 9.11 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 117.753 0.252 . . . . 0.0 111.102 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.81 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.9 mtpt -127.98 133.36 49.17 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.364 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.693 ' CG1' HD12 ' A' ' 281' ' ' ILE . 8.7 p -113.32 136.51 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.345 -179.386 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 290' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 3.1 t80 -77.98 133.06 38.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 279' ' ' ASP . 2.6 t -113.69 124.7 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.466 -178.733 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.417 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -143.53 153.05 42.19 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.891 -179.744 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.713 HD12 ' CE3' ' A' ' 241' ' ' TRP . 1.5 mt -139.69 129.83 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.43 160.04 35.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 111.142 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 295' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 180' ' ' SER . 0.3 OUTLIER -99.02 174.31 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.665 179.578 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -179.691 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.619 ' HA ' HG23 ' A' ' 201' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.765 0.317 . . . . 0.0 110.882 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.567 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.39 84.02 1.14 Allowed Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.402 ' HG ' ' HG ' ' A' ' 200' ' ' SER . 27.0 t -165.08 -72.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.2 OUTLIER -139.25 -178.92 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.25 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.7 m95 -150.52 134.22 16.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 184' ' ' LEU . 2.7 tp -119.99 139.96 51.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.49 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.762 ' O ' HD12 ' A' ' 184' ' ' LEU . 4.4 m-85 -138.94 137.94 36.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.441 0.639 . . . . 0.0 110.043 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.792 HD13 HD11 ' A' ' 182' ' ' LEU . 5.2 mp -132.7 151.45 51.97 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.019 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.11 122.37 12.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.872 HG21 HD12 ' A' ' 194' ' ' LEU . 42.1 t -64.6 118.75 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 288' ' ' LYS . 3.7 tt -97.96 -23.94 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.758 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -161.85 92.41 0.85 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.541 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.603 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.58 -173.78 30.65 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.447 ' HG3' ' CA ' ' A' ' 222' ' ' ASP . 74.3 Cg_endo -79.88 30.58 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.179 1.919 . . . . 0.0 111.822 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.865 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.28 23.95 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.627 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.603 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.9 mt -39.63 113.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.072 0.463 . . . . 0.0 111.699 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.9 9.63 2.45 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.524 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.872 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -99.37 135.08 41.3 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.288 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.702 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 27.1 mt-30 -129.67 147.46 51.46 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.217 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.941 ' CE1' HG21 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -136.26 130.05 32.44 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.599 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 182' ' ' LEU . . . -144.63 166.02 26.37 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.942 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.83 HG13 ' CH2' ' A' ' 234' ' ' TRP . 3.2 p -175.21 157.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.098 0.475 . . . . 0.0 111.073 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.554 ' ND2' ' CD1' ' A' ' 181' ' ' TRP . 24.8 m120 -90.92 149.13 22.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.872 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.528 ' CB ' ' HE1' ' A' ' 234' ' ' TRP . 54.8 p -66.82 -3.29 6.47 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.709 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.619 HG23 ' HA ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -102.45 5.45 39.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.741 0.305 . . . . 0.0 111.444 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -87.35 127.34 35.2 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.04 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.5 t -90.56 -87.3 0.19 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.53 11.59 6.85 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.12 -11.0 9.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.917 0.389 . . . . 0.0 110.875 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.793 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.5 tt -70.11 -57.76 5.78 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -42.83 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.29 1.993 . . . . 0.0 112.745 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.941 HG21 ' CE1' ' A' ' 196' ' ' HIS . 99.2 t -69.59 164.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.183 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.664 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 3.8 mtmm -139.64 95.03 2.85 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.901 HD23 HD12 ' A' ' 218' ' ' LEU . 1.3 mp -83.78 127.32 33.72 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.488 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -169.11 172.05 43.22 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.02 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.984 ' HB2' HG13 ' A' ' 225' ' ' VAL . 3.0 ttt85 -71.46 -76.16 0.11 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 213' ' ' VAL . 11.7 p -133.66 110.18 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.135 0.493 . . . . 0.0 110.991 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.497 ' HB2' ' HD2' ' A' ' 215' ' ' PRO . 0.0 OUTLIER 171.4 179.81 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.592 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 214' ' ' SER . 45.2 Cg_exo -56.65 -3.42 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 121.946 1.764 . . . . 0.0 112.478 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.535 ' HA ' ' HB3' ' A' ' 209' ' ' LYS . 0.4 OUTLIER -43.24 158.62 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.971 0.415 . . . . 0.0 111.535 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -83.68 -30.46 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.289 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.901 HD12 HD23 ' A' ' 210' ' ' LEU . 18.7 mt -113.88 127.99 56.22 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -88.62 84.78 6.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.487 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.718 HD21 ' HB3' ' A' ' 218' ' ' LEU . 1.7 mm? -100.94 66.74 1.17 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.604 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 0.4 OUTLIER -62.07 54.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 220' ' ' LEU . 19.8 t0 -105.33 125.5 51.05 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.1 p -40.15 -31.83 0.15 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.49 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 0.0 OUTLIER -53.32 -40.36 64.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.795 0.331 . . . . 0.0 111.11 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.984 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.5 p -99.89 96.33 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 83.1 p -41.63 -51.86 3.92 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.047 0.451 . . . . 0.0 111.145 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -142.72 -54.07 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.31 128.67 21.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 109.964 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.602 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.1 OUTLIER -94.62 -56.88 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.211 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -150.45 177.24 10.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.37 0.605 . . . . 0.0 112.469 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.743 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.7 OUTLIER -157.93 178.67 9.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.152 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 4.8 mt -133.23 145.58 33.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.434 0.635 . . . . 0.0 111.734 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.94 131.37 5.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.939 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 16.3 p90 -125.3 167.02 15.48 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.99 133.43 56.04 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.233 -1.349 . . . . 0.0 112.503 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 48.0 t -91.52 0.44 57.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.11 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.2 m -79.01 -46.3 18.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.833 0.825 . . . . 0.0 109.457 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.413 ' C ' ' CG ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -111.77 9.53 20.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.936 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.413 ' CG ' ' C ' ' A' ' 238' ' ' LYS . 10.2 p90 43.75 65.9 0.92 Allowed 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.593 0.711 . . . . 0.0 109.924 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.939 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -135.61 145.82 47.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.269 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.76 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.9 OUTLIER -121.37 114.4 21.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.601 -1.182 . . . . 0.0 109.935 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.673 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 24.1 mt-10 -131.36 146.46 52.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.956 0.884 . . . . 0.0 113.156 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.771 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.6 pp -110.98 153.61 25.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.935 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 269' ' ' TRP . 1.4 p -122.71 162.23 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.41 ' CG ' ' HB3' ' A' ' 260' ' ' SER . 5.2 m-20 -112.6 100.62 8.87 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.986 0.422 . . . . 0.0 111.988 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.697 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -78.15 106.11 9.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.678 178.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 49.19 65.0 2.96 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.252 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.446 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 0.0 OUTLIER -71.35 64.32 0.39 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.673 HD12 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -48.39 -62.32 1.55 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.023 0.439 . . . . 0.0 110.166 178.439 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.486 ' H ' ' CD1' ' A' ' 249' ' ' LEU . 0.4 OUTLIER -77.02 -31.71 56.56 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.854 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.574 ' HA3' ' ND1' ' A' ' 261' ' ' HIS . . . 99.19 149.09 24.06 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.172 -0.922 . . . . 0.0 114.006 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 282' ' ' THR . 2.9 m -115.95 107.63 15.22 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.722 0.409 . . . . 0.0 110.57 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.621 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.1 OUTLIER -98.52 128.87 45.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.122 0.487 . . . . 0.0 111.554 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.647 HG23 HD11 ' A' ' 259' ' ' ILE . 91.9 t -99.7 134.02 40.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.678 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 255' ' ' ASN . 0.9 OUTLIER 47.93 38.01 8.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.279 0.561 . . . . 0.0 110.068 -178.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.0 t 67.51 36.69 3.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.731 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.64 111.81 5.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.245 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.567 ' CB ' ' NE2' ' A' ' 261' ' ' HIS . 60.0 p -58.17 87.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.134 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.765 HG12 HG11 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -88.97 -18.18 7.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.886 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 9.7 t -130.87 -10.17 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.701 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 7.4 p80 -110.99 44.26 0.22 Allowed Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 176.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.886 ' HD3' ' C ' ' A' ' 260' ' ' SER . 10.6 Cg_exo -74.37 -4.95 16.21 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.11 1.873 . . . . 0.0 113.859 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 266' ' ' SER . 8.8 t0 -135.76 100.55 4.5 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.108 0.48 . . . . 0.0 111.872 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.443 HD22 ' H ' ' A' ' 264' ' ' LEU . 3.5 mm? -54.2 -85.78 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.924 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -38.93 -29.55 0.09 OUTLIER Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.536 -0.364 . . . . 0.0 113.672 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.485 ' HB2' ' HB3' ' A' ' 263' ' ' ASP . 0.3 OUTLIER -65.28 -40.56 94.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.5 22.52 0.75 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -54.87 154.67 4.98 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.408 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.741 ' CD1' HG21 ' A' ' 244' ' ' VAL . 38.4 t-105 -67.91 -23.32 65.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.276 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 73.38 167.76 13.51 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.748 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -102.68 143.77 27.28 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.614 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.5 Cg_exo -51.32 121.45 8.42 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.308 2.006 . . . . 0.0 113.12 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.765 HG11 HG12 ' A' ' 259' ' ' ILE . 70.2 t -96.42 132.15 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.3 125.65 29.67 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.408 -178.23 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.841 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -94.59 165.5 12.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.51 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.551 ' HB3' ' OD1' ' A' ' 279' ' ' ASP . . . -144.1 162.87 35.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.207 0.527 . . . . 0.0 112.418 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.554 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 13.4 p -60.61 128.55 37.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.428 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.8 m-20 86.05 7.84 0.33 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.279 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.551 ' OD1' ' HB3' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -75.89 -171.46 1.64 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.4 OUTLIER -160.73 133.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.102 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.698 HD12 ' CG2' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -111.63 149.85 14.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.987 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.571 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -139.33 112.4 8.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.233 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.746 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -110.77 45.01 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.059 -177.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.33 -132.29 2.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 119.321 -1.419 . . . . 0.0 113.64 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 10.9 t -89.87 -43.68 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.654 0.264 . . . . 0.0 110.529 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.2 t -148.37 -0.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.758 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 25.8 m -69.04 102.57 1.65 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.257 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.658 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.5 ttmt -121.01 127.01 51.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.664 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.698 ' CG2' HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -109.77 132.69 57.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.294 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.462 ' HD1' ' CG2' ' A' ' 280' ' ' ILE . 2.1 t80 -76.86 137.05 38.93 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.872 0.368 . . . . 0.0 110.194 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.677 HG13 HD11 ' A' ' 184' ' ' LEU . 1.3 t -106.04 115.75 48.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.262 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.74 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -129.79 142.6 50.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.912 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.841 HD11 HD23 ' A' ' 275' ' ' LEU . 6.4 mt -139.0 115.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.157 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.77 154.18 45.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 110.924 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 88.7 p -87.95 -173.2 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.726 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.52 116.19 2.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.52 101.38 13.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.982 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.613 ' HB2' HG23 ' A' ' 201' ' ' THR . 57.6 mt . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 120.6 0.238 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.886 ' N ' HG21 ' A' ' 201' ' ' THR . . . 104.32 99.79 2.58 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.916 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.563 ' HB3' ' HB3' ' A' ' 200' ' ' SER . 1.1 m -179.54 -89.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.499 0.19 . . . . 0.0 111.16 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.9 OUTLIER -139.53 179.95 6.26 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.565 ' NE1' ' ND2' ' A' ' 199' ' ' ASN . 2.7 m95 -141.07 132.29 26.49 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.9 HD11 ' CD2' ' A' ' 184' ' ' LEU . 3.0 tp -121.94 133.56 54.84 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.116 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.779 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.4 m-85 -129.71 132.19 46.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.677 0.751 . . . . 0.0 110.246 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.9 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.5 mm? -117.97 140.68 49.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.832 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.7 OUTLIER -137.35 118.48 14.45 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.324 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.874 HG21 HD12 ' A' ' 194' ' ' LEU . 5.7 t -67.15 103.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.164 0.507 . . . . 0.0 109.657 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.884 HG22 ' O ' ' A' ' 288' ' ' LYS . 7.0 tt -87.38 -20.84 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.859 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.54 97.02 0.4 Allowed 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.496 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.601 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.85 -169.57 25.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.598 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 87.1 Cg_endo -81.13 30.12 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.12 1.88 . . . . 0.0 111.313 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.874 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.48 24.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.372 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.601 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.8 mt -39.65 106.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.805 0.336 . . . . 0.0 111.851 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.62 2.42 2.55 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.469 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.874 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER -98.02 167.93 10.59 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.8 mt-30 -159.97 149.21 17.72 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.371 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.887 ' CE1' HD21 ' A' ' 210' ' ' LEU . 1.1 p80 -135.42 128.66 31.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.341 0.591 . . . . 0.0 109.93 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.24 163.03 34.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.475 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.955 HG21 ' HA ' ' A' ' 206' ' ' LEU . 6.1 p -173.2 157.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.041 0.448 . . . . 0.0 111.066 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.565 ' ND2' ' NE1' ' A' ' 181' ' ' TRP . 0.3 OUTLIER -90.41 153.47 20.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.988 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.563 ' HB3' ' HB3' ' A' ' 179' ' ' SER . 12.4 t -69.49 -6.07 28.19 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.218 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.886 HG21 ' N ' ' A' ' 178' ' ' GLY . 0.6 OUTLIER -99.35 7.6 45.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.862 -179.408 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.424 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 1.0 OUTLIER -86.41 138.56 31.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.797 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.0 m -90.22 -85.67 0.21 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.02 22.77 9.84 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.424 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 3.0 pttt -119.67 -11.85 9.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.868 0.365 . . . . 0.0 110.87 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.955 ' HA ' HG21 ' A' ' 198' ' ' VAL . 7.7 tt -71.22 -58.52 3.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -42.86 97.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.575 2.184 . . . . 0.0 113.127 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 209' ' ' LYS . 60.9 t -69.07 164.78 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 208' ' ' VAL . 17.5 mtpt -138.08 96.57 3.22 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.992 HD23 HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -84.3 125.37 32.2 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.88 166.97 38.38 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.418 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.886 ' HD3' HG12 ' A' ' 213' ' ' VAL . 9.9 ttt180 -69.33 -77.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.886 HG12 ' HD3' ' A' ' 212' ' ' ARG . 8.8 p -138.28 110.95 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.386 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.616 ' CB ' ' HD2' ' A' ' 215' ' ' PRO . 0.3 OUTLIER 171.98 -178.61 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.778 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.616 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 24.0 Cg_endo -61.68 12.64 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.002 1.801 . . . . 0.0 113.02 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -57.51 -173.61 0.01 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.91 0.386 . . . . 0.0 111.265 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -104.79 -30.04 10.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.09 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.992 HD12 HD23 ' A' ' 210' ' ' LEU . 0.4 OUTLIER -110.95 133.66 53.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.072 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -98.45 82.23 2.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.162 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.779 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.8 mm? -103.73 83.5 2.14 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.598 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 24.6 pttt -58.94 65.04 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.766 0.317 . . . . 0.0 111.61 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' A' ' 220' ' ' LEU . 6.7 m-20 -93.48 144.01 25.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.446 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.7 t -85.76 -4.14 59.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.519 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.495 ' OE2' HG22 ' A' ' 285' ' ' THR . 12.7 pm0 -101.24 -16.29 17.02 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 61.9 t -97.93 77.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.893 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -34.03 -50.87 0.4 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.98 0.419 . . . . 0.0 111.535 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.4 -49.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.573 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.468 ' HG2' ' OG ' ' A' ' 216' ' ' SER . 1.6 mtmm -144.08 129.73 19.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.443 . . . . 0.0 110.915 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.554 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 9.2 t-80 -96.32 -55.97 2.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.578 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -148.57 177.49 9.44 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.666 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -156.58 173.17 17.32 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.932 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 35.6 mt -132.77 145.16 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.199 0.523 . . . . 0.0 112.225 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.418 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -160.62 148.66 16.21 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.386 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.817 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 8.1 p90 -140.88 165.57 27.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.728 1.011 . . . . 0.0 113.728 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.4 ' HB2' ' CD ' ' A' ' 240' ' ' LYS . 1.1 m120 -117.35 133.95 55.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.726 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 10.2 t -90.58 2.02 56.21 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.333 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 4.5 m -76.28 -25.88 55.35 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.71 0.767 . . . . 0.0 110.238 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -145.87 23.47 1.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.123 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 238' ' ' LYS . 15.6 p90 36.97 62.16 0.82 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.51 0.671 . . . . 0.0 110.194 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.817 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -124.97 141.12 52.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.456 178.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.713 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -124.61 123.24 39.63 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.664 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.6 pt-20 -137.09 143.4 42.55 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.935 0.874 . . . . 0.0 112.826 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.795 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.4 pp -111.2 150.68 29.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.431 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.661 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -117.78 162.79 15.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.495 ' CG ' ' HB2' ' A' ' 260' ' ' SER . 1.8 m-20 -112.03 105.79 14.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.555 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -73.32 99.18 2.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.463 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.63 64.49 4.17 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.504 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -68.5 64.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.496 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.902 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.42 -51.85 65.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.622 178.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.902 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.3 OUTLIER -74.31 -31.71 62.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 110.914 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.89 90.09 1.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.017 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.602 HG22 ' CD1' ' A' ' 281' ' ' ILE . 1.9 m -46.24 159.2 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.835 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -149.64 137.82 20.54 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.432 0.634 . . . . 0.0 111.85 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 1.07 HG23 HD12 ' A' ' 259' ' ' ILE . 99.7 t -112.15 128.2 68.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.608 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.18 44.61 24.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.129 0.49 . . . . 0.0 110.209 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 m 62.35 24.7 14.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.991 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -130.65 110.51 11.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.42 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 8.7 t -58.79 98.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.512 0.672 . . . . 0.0 111.747 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 1.07 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -77.52 -37.68 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.216 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.913 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 42.1 t -59.8 170.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.461 ' O ' ' N ' ' A' ' 263' ' ' ASP . 0.1 OUTLIER -88.87 97.52 0.9 Allowed Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 119.305 0.957 . . . . 0.0 108.714 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.913 ' HD3' ' O ' ' A' ' 260' ' ' SER . 83.8 Cg_exo -55.43 79.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.578 0 C-N-CA 123.197 2.598 . . . . 0.0 112.997 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 261' ' ' HIS . 0.7 OUTLIER -133.88 86.23 2.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.315 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.726 HD22 ' H ' ' A' ' 264' ' ' LEU . 0.0 OUTLIER -47.33 -30.77 3.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.338 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.04 -41.85 6.51 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.332 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.412 ' CB ' ' HB3' ' A' ' 263' ' ' ASP . 20.4 m -61.91 -39.75 93.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.925 0.393 . . . . 0.0 111.961 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 267' ' ' ARG . 5.4 mmt180 46.58 22.6 0.18 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.896 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -53.91 153.58 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.196 0.522 . . . . 0.0 111.725 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.661 ' NE1' HG11 ' A' ' 244' ' ' VAL . 42.5 t-105 -65.92 -24.85 66.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.217 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.66 159.87 12.44 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.7 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -94.29 142.11 24.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.661 0.267 . . . . 0.0 110.543 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 76.0 Cg_exo -48.44 113.73 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.502 2.134 . . . . 0.0 112.901 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.616 HG21 ' CG1' ' A' ' 259' ' ' ILE . 85.0 t -94.19 136.14 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -84.36 128.34 34.52 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.7 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.873 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -94.0 165.8 12.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.198 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.0 156.59 46.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 60.1 p -60.86 130.38 46.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.987 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.0 OUTLIER 81.28 -2.95 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.406 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.893 ' O ' HG23 ' A' ' 291' ' ' VAL . 0.1 OUTLIER -77.91 138.98 39.19 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.126 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 280' ' ' ILE . 0.9 OUTLIER -99.0 123.48 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.345 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.73 HG12 HG22 ' A' ' 254' ' ' VAL . 0.3 OUTLIER -103.4 158.79 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.189 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.835 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 47.5 m -151.06 130.3 12.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.659 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -123.74 42.3 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -177.17 -134.53 2.02 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.578 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.495 HG22 ' OE2' ' A' ' 224' ' ' GLU . 4.7 t -90.59 -47.87 7.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.702 0.287 . . . . 0.0 110.703 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.55 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -139.37 0.93 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 179.234 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.859 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.7 m -75.85 101.03 4.97 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.527 0.204 . . . . 0.0 111.182 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.884 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -120.38 129.56 53.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.231 0.539 . . . . 0.0 111.47 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -109.84 132.53 57.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.649 -178.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 278' ' ' ASP . 1.4 t80 -77.46 133.35 38.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.981 0.42 . . . . 0.0 110.353 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.2 OUTLIER -102.46 114.27 41.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.008 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.517 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -124.39 133.73 53.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.868 HD11 HD23 ' A' ' 275' ' ' LEU . 3.7 mt -132.72 134.66 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.377 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.51 165.67 30.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 111.129 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 13.7 m -97.74 177.79 5.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.781 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -159.36 116.49 2.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -75.66 86.44 2.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.63 ' HB2' HG23 ' A' ' 201' ' ' THR . 3.7 mm? . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 120.566 0.222 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.595 ' N ' HG21 ' A' ' 201' ' ' THR . . . 99.39 106.28 2.7 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.792 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.494 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 0.2 OUTLIER -179.81 -86.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.585 0.231 . . . . 0.0 110.549 178.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -140.26 -178.53 5.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.9 m95 -143.59 132.35 22.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.936 HD11 ' CD2' ' A' ' 184' ' ' LEU . 1.2 tp -120.88 134.86 55.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.246 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.913 ' N ' HD12 ' A' ' 182' ' ' LEU . 5.7 m-85 -133.42 138.77 46.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.706 0.765 . . . . 0.0 109.823 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.936 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.1 mm? -122.09 139.1 54.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.906 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.15 114.95 13.66 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.959 HG21 HD12 ' A' ' 194' ' ' LEU . 11.2 t -64.33 102.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.074 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.926 HG22 ' O ' ' A' ' 288' ' ' LYS . 15.1 tt -83.59 -28.43 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.784 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -162.08 99.66 1.08 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.467 ' H ' ' CG1' ' A' ' 192' ' ' ILE . . . -162.18 -169.91 26.21 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.673 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 87.6 Cg_endo -83.67 30.85 0.52 Allowed 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.52 2.147 . . . . 0.0 111.748 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.938 ' HB1' HD21 ' A' ' 194' ' ' LEU . . . -162.83 24.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.303 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 188' ' ' ALA . 8.4 mt -39.32 108.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.471 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.98 3.4 2.56 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.48 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.959 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -97.42 169.43 9.75 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 117.636 0.718 . . . . 0.0 109.14 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.1 mt-30 -160.06 147.63 16.54 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.563 -178.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.948 ' CE1' HD11 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -135.87 129.04 31.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.88 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.52 170.04 16.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.003 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.789 HG21 ' HG ' ' A' ' 206' ' ' LEU . 8.5 p -177.4 153.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.2 0.524 . . . . 0.0 112.244 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 180' ' ' SER . 5.9 t-20 -88.48 150.54 23.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.969 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.479 ' HA ' ' CE2' ' A' ' 234' ' ' TRP . 5.9 t -68.69 -4.85 17.23 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.347 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.63 HG23 ' HB2' ' A' ' 177' ' ' LEU . 0.6 OUTLIER -101.04 20.34 15.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.808 0.337 . . . . 0.0 111.744 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -103.24 112.46 25.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.775 0.321 . . . . 0.0 110.363 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 16.5 m -72.72 -89.93 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 45.6 t -89.32 14.51 10.96 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 111.511 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 13.9 pttt -125.75 54.5 1.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.789 ' HG ' HG21 ' A' ' 198' ' ' VAL . 10.3 tt -143.58 -56.3 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.794 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 5.5 Cg_exo -41.36 100.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.995 1.796 . . . . 0.0 112.791 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 209' ' ' LYS . 87.8 t -67.96 163.9 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.996 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 31.5 mtmt -135.77 96.31 3.4 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.823 HD23 HD12 ' A' ' 218' ' ' LEU . 0.5 OUTLIER -83.28 128.34 34.41 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.091 178.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.476 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -173.59 174.85 46.27 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.745 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 1.003 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -69.04 -72.32 0.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.996 0.427 . . . . 0.0 111.873 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.881 HG22 ' H ' ' A' ' 214' ' ' SER . 10.1 p -128.86 -142.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.728 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.881 ' H ' HG22 ' A' ' 213' ' ' VAL . 2.5 m 66.9 -179.42 0.04 OUTLIER Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 118.441 0.564 . . . . 0.0 110.228 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.551 ' CD ' ' HB3' ' A' ' 214' ' ' SER . 22.6 Cg_exo -65.31 7.75 0.28 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.656 2.238 . . . . 0.0 113.558 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.6 m -48.87 173.16 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.714 0.292 . . . . 0.0 110.909 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.06 -31.43 13.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.252 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.948 HD11 ' CE1' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -104.06 133.65 48.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.831 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 191' ' ' ALA . . . -100.48 74.99 1.74 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 0.0 110.804 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.92 HD21 HD13 ' A' ' 218' ' ' LEU . 2.8 mm? -99.85 80.0 2.28 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.673 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -53.26 67.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 110.802 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.729 ' N ' ' O ' ' A' ' 220' ' ' LEU . 1.7 m-20 -99.65 128.67 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.402 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.7 p -73.46 -4.8 35.96 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.295 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.566 ' O ' HD11 ' A' ' 249' ' ' LEU . 6.0 pm0 -93.03 -25.0 18.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.698 0.285 . . . . 0.0 111.258 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.003 HG13 ' HB2' ' A' ' 212' ' ' ARG . 3.4 p -105.49 85.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -32.39 -46.49 0.13 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.628 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.95 -52.37 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.616 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -141.79 128.78 20.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.139 0.495 . . . . 0.0 110.618 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.575 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 9.4 t-80 -100.41 -56.26 2.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.281 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.53 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -139.38 172.88 12.16 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.694 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -162.53 174.49 12.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.276 179.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.794 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.0 mt -130.79 144.81 36.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.577 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.85 163.44 34.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.667 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.7 OUTLIER -96.86 150.63 20.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.337 -1.301 . . . . 0.0 114.255 -176.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 239' ' ' PHE . 0.8 OUTLIER -118.91 94.14 4.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.217 -1.356 . . . . 0.0 107.716 175.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 13.8 p -78.16 -25.44 47.25 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 32.3 m -74.24 -21.06 59.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.584 0.707 . . . . 0.0 109.713 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 33.0 tptt -123.01 6.23 9.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.344 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 235' ' ' ASN . 13.0 p90 36.98 43.55 0.31 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 120.713 0.292 . . . . 0.0 111.003 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -115.19 174.97 5.71 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.183 0.516 . . . . 0.0 109.697 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.565 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -127.95 119.64 25.96 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.866 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 0.0 OUTLIER -143.13 152.34 41.71 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.946 0.879 . . . . 0.0 112.851 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.864 HD22 HD12 ' A' ' 281' ' ' ILE . 3.4 pp -116.79 154.04 31.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.765 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.753 HG21 ' CD1' ' A' ' 269' ' ' TRP . 3.3 p -121.3 163.7 18.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.669 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 269' ' ' TRP . 1.0 OUTLIER -106.09 101.4 10.89 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.151 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.558 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -70.6 97.46 1.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.728 177.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 52.33 64.65 3.85 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.213 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -76.32 66.89 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -178.036 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.846 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -54.77 -49.97 69.59 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.846 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -72.19 -30.19 64.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.971 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 91.81 85.06 1.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.836 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.509 ' C ' HD23 ' A' ' 253' ' ' LEU . 1.8 m -46.03 158.61 0.09 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.51 0.155 . . . . 0.0 111.077 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.635 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -149.83 137.26 19.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 111.808 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.762 HG22 HG13 ' A' ' 281' ' ' ILE . 75.2 t -111.28 132.2 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.014 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.52 ' HA ' HG13 ' A' ' 280' ' ' ILE . 1.4 t30 55.2 41.78 31.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 110.306 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 75.6 m 63.43 33.9 13.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.561 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.16 109.76 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 3.1 t -55.82 94.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.665 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.4 OUTLIER -79.85 -20.59 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.04 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.73 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 6.3 t -68.71 166.9 16.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 175.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.531 ' O ' ' N ' ' A' ' 263' ' ' ASP . 8.4 m80 -68.34 104.53 0.72 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 120.328 1.422 . . . . 0.0 109.241 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.73 ' HD3' ' O ' ' A' ' 260' ' ' SER . 96.8 Cg_exo -53.34 79.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.893 2.395 . . . . 0.0 112.284 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.55 ' C ' HD22 ' A' ' 264' ' ' LEU . 71.4 m-20 -79.34 -176.65 5.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.642 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.55 HD22 ' C ' ' A' ' 263' ' ' ASP . 1.9 mm? -112.68 -47.38 3.07 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.652 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -154.68 23.9 0.64 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.252 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 267' ' ' ARG . 0.4 OUTLIER -64.14 -69.86 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.419 0.688 . . . . 0.0 112.357 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.0 OUTLIER 85.59 15.12 0.15 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.244 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -53.05 160.64 0.96 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.061 0.458 . . . . 0.0 111.185 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.753 ' CD1' HG21 ' A' ' 244' ' ' VAL . 36.0 t-105 -71.9 -26.52 62.35 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 75.3 164.28 13.39 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.743 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -98.5 146.14 31.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.723 0.297 . . . . 0.0 110.469 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 89.2 Cg_exo -48.83 142.55 18.97 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 122.725 2.283 . . . . 0.0 113.072 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.665 HG21 ' HB ' ' A' ' 259' ' ' ILE . 86.9 t -124.89 136.25 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 10.5 mt-10 -84.37 132.82 34.55 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.844 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.973 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -97.05 165.98 11.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.396 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.13 158.34 44.05 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 93.2 p -60.61 129.25 40.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.063 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.462 ' HA ' ' CE2' ' A' ' 290' ' ' TYR . 38.5 m-20 82.47 -0.06 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.838 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 280' ' ' ILE . 0.9 OUTLIER -68.29 -170.08 0.17 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 279' ' ' ASP . 1.0 OUTLIER -161.02 124.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.076 177.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.864 HD12 HD22 ' A' ' 243' ' ' LEU . 0.2 OUTLIER -105.55 155.39 6.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.122 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 287' ' ' THR . 0.2 OUTLIER -141.62 123.28 15.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.216 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.693 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -116.37 38.07 3.52 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.766 -178.166 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.4 ' HA3' ' HG3' ' A' ' 224' ' ' GLU . . . 178.68 -122.04 0.79 Allowed Glycine 0 N--CA 1.454 -0.141 0 C-N-CA 119.042 -1.551 . . . . 0.0 114.22 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.466 HG22 ' OE1' ' A' ' 224' ' ' GLU . 4.7 t -95.17 -51.72 4.5 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -141.54 2.17 1.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.72 -0.392 . . . . 0.0 112.007 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.784 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.9 m -72.57 104.77 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.806 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.926 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.4 OUTLIER -120.47 127.25 52.05 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.829 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.3 OUTLIER -110.03 130.07 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.796 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.471 ' CD1' ' CG2' ' A' ' 280' ' ' ILE . 1.6 t80 -77.42 133.57 38.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.306 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.973 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -101.12 116.25 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.488 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.34 135.81 48.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.77 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.729 HD11 HD23 ' A' ' 275' ' ' LEU . 13.6 mt -134.08 142.11 41.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.738 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.0 m -152.79 160.91 43.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 111.089 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.96 175.23 6.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -120.92 116.36 24.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -85.0 86.41 7.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.743 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.839 179.942 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.669 ' HA ' HG23 ' A' ' 201' ' ' THR . 35.7 mt . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.723 0.297 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.461 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.77 92.85 1.81 Allowed Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.959 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.1 m -176.42 -78.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.001 0.429 . . . . 0.0 110.049 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -137.6 -173.33 3.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.5 m95 -150.4 132.95 15.72 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 292' ' ' ARG . 5.0 tp -116.25 130.22 56.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.807 176.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 4.6 m-85 -127.17 134.65 50.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.57 0.7 . . . . 0.0 110.564 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.913 HD13 ' ND1' ' A' ' 196' ' ' HIS . 1.1 mp -133.25 146.97 51.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.901 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.435 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 8.5 tt0 -142.21 124.76 15.77 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.92 HG21 HD12 ' A' ' 194' ' ' LEU . 11.8 t -62.09 119.8 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.719 HG22 ' O ' ' A' ' 288' ' ' LYS . 4.3 tt -101.05 -22.78 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.814 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.91 93.56 0.72 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.578 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.96 -170.35 26.58 Favored Glycine 0 CA--C 1.518 0.244 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.587 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 89.5 Cg_endo -81.32 30.3 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.032 1.822 . . . . 0.0 111.55 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.896 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -160.96 22.9 0.13 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.744 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.578 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.0 mt -39.77 109.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.916 0.389 . . . . 0.0 111.602 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.97 8.95 2.02 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.613 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.92 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -98.36 153.8 18.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.614 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 5.9 mt-30 -150.08 148.77 29.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.591 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.913 ' ND1' HD13 ' A' ' 184' ' ' LEU . 2.0 p80 -138.5 132.64 31.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.268 0.556 . . . . 0.0 110.47 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.73 169.93 18.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.746 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.626 HG13 ' CH2' ' A' ' 234' ' ' TRP . 2.7 p -177.64 157.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.197 0.522 . . . . 0.0 110.749 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.631 ' HB2' HD22 ' A' ' 177' ' ' LEU . 5.9 m120 -90.47 147.59 23.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.781 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.523 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 30.5 m -60.66 -6.17 1.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.92 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.669 HG23 ' HA ' ' A' ' 177' ' ' LEU . 9.1 t -102.34 32.19 3.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.154 0.502 . . . . 0.0 111.106 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.469 ' HB2' ' HG2' ' A' ' 205' ' ' LYS . 77.9 p -110.54 132.32 54.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.893 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.547 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 56.9 m -85.57 -84.31 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.8 21.72 14.08 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.547 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -115.88 -8.95 11.89 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.765 178.669 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.865 HD11 ' CE2' ' A' ' 234' ' ' TRP . 4.0 tt -69.8 -57.0 6.97 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.2 Cg_endo -43.32 86.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.797 2.331 . . . . 0.0 113.761 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.789 HG11 ' CG ' ' A' ' 196' ' ' HIS . 57.6 t -70.16 99.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.775 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 216' ' ' SER . 0.0 OUTLIER -69.48 87.26 0.46 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.199 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.029 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -69.14 127.4 32.98 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.48 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -168.38 169.97 41.87 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.638 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.855 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -53.02 -95.84 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.788 -0.706 . . . . 0.0 112.606 -178.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.639 HG12 ' HD3' ' A' ' 212' ' ' ARG . 10.9 p -127.65 -7.69 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 O-C-N 122.187 -0.321 . . . . 0.0 111.812 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.469 ' CB ' ' CD ' ' A' ' 215' ' ' PRO . 0.3 OUTLIER -55.44 -177.22 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.493 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 53.1 Cg_exo -55.8 -1.21 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.397 2.065 . . . . 0.0 113.073 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -44.71 166.28 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.938 0.399 . . . . 0.0 111.432 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -83.93 -32.59 25.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.26 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.029 HD12 HD23 ' A' ' 210' ' ' LEU . 0.9 OUTLIER -105.46 131.88 52.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -97.48 82.76 3.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.768 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.687 HD21 HD13 ' A' ' 218' ' ' LEU . 2.9 mm? -104.47 64.53 0.75 Allowed 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.855 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -53.59 66.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.068 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.644 ' N ' ' O ' ' A' ' 220' ' ' LEU . 4.8 t0 -121.82 139.92 53.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.206 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.4 p -53.24 -31.33 42.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.624 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.56 ' CG ' ' HB3' ' A' ' 222' ' ' ASP . 2.9 pt-20 -49.6 -41.72 42.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.096 0.474 . . . . 0.0 110.147 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.6 p -103.18 110.93 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.68 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.4 t -56.03 -56.07 25.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.233 0.539 . . . . 0.0 109.823 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -137.08 -51.91 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.57 ' CB ' ' HG2' ' A' ' 246' ' ' MET . 0.7 OUTLIER -141.35 125.65 17.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.167 0.508 . . . . 0.0 109.889 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.634 ' CE1' ' HB3' ' A' ' 250' ' ' ASN . 0.5 OUTLIER -92.45 -60.64 1.78 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.3 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -145.23 173.76 11.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.677 ' HA ' HD12 ' A' ' 210' ' ' LEU . 24.6 tt0 -153.28 161.78 42.0 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.6 mt -124.13 147.86 28.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.802 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.716 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.25 163.23 33.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.865 ' CE2' HD11 ' A' ' 206' ' ' LEU . 3.1 p90 -153.86 165.32 36.44 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.513 ' HB2' ' HD2' ' A' ' 240' ' ' LYS . 20.4 m-20 -117.44 133.47 55.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.311 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.49 3.04 55.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.091 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.2 m -76.99 -30.14 55.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.071 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 38.0 tptt -139.89 22.01 2.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.789 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 238' ' ' LYS . 15.5 p90 37.74 62.94 0.84 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.523 0.678 . . . . 0.0 110.16 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.839 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -125.47 142.32 51.57 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.7 178.251 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.769 ' CE3' HD13 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -129.15 123.23 31.59 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.957 -179.036 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.1 pt-20 -141.26 151.56 43.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.258 1.028 . . . . 0.0 113.323 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.644 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.2 pp -113.5 158.83 20.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.031 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.83 HG21 ' NE1' ' A' ' 269' ' ' TRP . 4.1 p -136.82 162.35 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.844 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.412 ' N ' HG22 ' A' ' 244' ' ' VAL . 14.3 t70 -81.89 123.61 28.99 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.57 ' HG2' ' CB ' ' A' ' 228' ' ' LYS . 10.4 tpt -76.77 32.42 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.47 50.31 32.67 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.707 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 5.5 t -99.05 179.1 4.72 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 110.912 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.697 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -105.89 -29.54 9.92 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.697 ' H ' HD13 ' A' ' 249' ' ' LEU . 1.3 t-20 -75.31 -35.9 61.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.311 0.577 . . . . 0.0 112.244 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 262' ' ' PRO . . . 93.29 166.72 38.21 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.017 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.586 ' HB ' HD11 ' A' ' 259' ' ' ILE . 7.6 m -120.89 160.59 23.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.51 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.708 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.3 OUTLIER -146.32 121.02 9.84 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.257 0.551 . . . . 0.0 111.117 179.02 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.886 HG23 HD12 ' A' ' 259' ' ' ILE . 61.6 t -97.49 129.01 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.046 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.473 ' HA ' HD12 ' A' ' 280' ' ' ILE . 2.5 m-20 53.85 42.62 31.68 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.191 0.52 . . . . 0.0 110.282 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 15.8 m 65.02 22.26 12.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.952 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER -123.52 101.48 7.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.23 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 26.3 p -54.74 101.05 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.075 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.886 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -78.81 -52.41 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.751 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.738 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 0.8 OUTLIER -58.15 174.94 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.195 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.466 ' CG ' ' HD3' ' A' ' 268' ' ' LYS . 14.4 m170 -105.38 88.42 2.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 118.203 0.456 . . . . 0.0 110.146 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.738 ' HD3' ' O ' ' A' ' 260' ' ' SER . 42.1 Cg_endo -93.29 32.19 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.069 2.513 . . . . 0.0 112.754 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -79.2 -126.8 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.641 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.577 ' N ' HD23 ' A' ' 264' ' ' LEU . 0.3 OUTLIER -45.01 -63.13 0.99 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.412 ' N ' ' HG ' ' A' ' 264' ' ' LEU . . . 168.94 37.25 0.02 OUTLIER Glycine 0 CA--C 1.517 0.208 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.99 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 1.8 m -59.48 -32.6 70.41 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 248' ' ' SER . 5.0 ttp-105 44.13 21.56 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.782 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.466 ' HD3' ' CG ' ' A' ' 261' ' ' HIS . 8.0 ptmt -61.28 151.76 31.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.995 0.518 . . . . 0.0 111.561 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.83 ' NE1' HG21 ' A' ' 244' ' ' VAL . 7.0 t-105 -66.2 -26.09 67.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.043 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.433 ' O ' ' HD1' ' A' ' 269' ' ' TRP . . . 73.11 168.76 13.85 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.622 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.75 145.72 30.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.569 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 50.6 Cg_exo -53.24 110.55 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.483 2.122 . . . . 0.0 112.967 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.817 HG21 ' HB ' ' A' ' 259' ' ' ILE . 90.1 t -89.4 132.24 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.1 mt-10 -79.59 126.12 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.711 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.972 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -93.9 166.19 12.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.98 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.609 ' HB3' ' OD2' ' A' ' 279' ' ' ASP . . . -143.4 158.69 43.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.233 0.54 . . . . 0.0 112.39 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 42.7 p -56.51 127.5 31.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.349 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.607 ' HB2' ' O ' ' A' ' 277' ' ' SER . 73.6 m-20 82.67 1.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.859 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 291' ' ' VAL . 69.4 m-20 -78.87 133.84 36.95 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.53 ' HB ' ' HD3' ' A' ' 288' ' ' LYS . 0.8 OUTLIER -94.28 125.21 46.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.694 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.566 HD13 ' H ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -105.14 155.8 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.137 178.403 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.681 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -148.73 132.52 16.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.721 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -128.34 53.1 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.444 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 169.1 -129.84 1.94 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 119.596 -1.287 . . . . 0.0 113.613 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.0 t -95.76 -47.85 6.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.335 0.112 . . . . 0.0 110.92 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.7 t -139.88 -6.25 1.29 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.335 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.814 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 29.3 m -69.11 101.25 1.4 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.781 0.325 . . . . 0.0 110.279 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.719 ' O ' HG22 ' A' ' 187' ' ' ILE . 20.4 ttmt -118.65 126.45 51.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.067 0.46 . . . . 0.0 111.576 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -110.79 131.91 60.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.424 -178.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.4 t80 -77.18 137.46 38.88 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.076 0.465 . . . . 0.0 109.942 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.923 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.5 t -105.19 112.27 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.022 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.797 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -126.55 139.42 53.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.069 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.972 HD11 HD23 ' A' ' 275' ' ' LEU . 3.4 mt -136.26 132.22 49.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.73 152.78 45.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.46 159.31 15.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.61 121.21 31.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.925 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 297' ' ' ASN . 2.6 p-10 -80.37 86.34 5.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.875 179.934 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.583 ' HA ' HG23 ' A' ' 201' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.692 0.282 . . . . 0.0 110.715 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.577 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.4 94.15 1.92 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.1 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.504 ' HB3' ' OG ' ' A' ' 200' ' ' SER . 2.9 m -169.49 -72.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.2 OUTLIER -138.03 -179.15 5.6 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.152 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 9.8 m95 -147.89 133.34 18.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.812 HD11 ' CD2' ' A' ' 184' ' ' LEU . 3.6 tp -118.65 132.97 56.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.722 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.666 ' N ' HD12 ' A' ' 182' ' ' LEU . 9.2 m-85 -128.32 126.0 39.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.669 0.747 . . . . 0.0 110.165 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.812 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.2 mm? -108.81 133.74 52.45 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.675 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.565 ' C ' HG23 ' A' ' 289' ' ' VAL . 0.4 OUTLIER -129.9 108.02 9.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.83 HG21 HD12 ' A' ' 194' ' ' LEU . 40.8 t -60.97 104.98 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 288' ' ' LYS . 12.4 tt -89.28 -24.85 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -175.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.72 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.8 96.66 0.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.538 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.677 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.11 -168.64 24.32 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.478 ' HB2' ' CG ' ' A' ' 221' ' ' LYS . 93.2 Cg_endo -82.91 30.53 0.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.243 1.962 . . . . 0.0 110.97 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.947 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.95 23.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.624 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.677 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.0 mt -39.34 109.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.89 6.33 2.89 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.717 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.947 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER -100.14 139.66 35.48 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 117.841 0.821 . . . . 0.0 109.117 178.189 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 29.8 mt-30 -134.38 151.22 51.08 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.787 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.661 ' NE2' HG22 ' A' ' 208' ' ' VAL . 59.4 t60 -144.92 138.96 27.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.569 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -145.75 166.12 26.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.639 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.8 HG13 ' CH2' ' A' ' 234' ' ' TRP . 7.9 p -169.22 152.66 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.731 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 180' ' ' SER . 2.8 m120 -88.93 144.57 26.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.972 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.526 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 97.8 p -60.32 -7.72 2.17 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.595 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.583 HG23 ' HA ' ' A' ' 177' ' ' LEU . 7.6 t -98.49 24.53 7.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.912 0.387 . . . . 0.0 110.685 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.434 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -106.04 119.02 38.11 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.362 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.1 t -71.68 -77.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.0 m -105.0 23.07 14.18 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -119.7 -10.38 9.58 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.578 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.987 ' O ' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -82.11 -32.37 0.59 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.105 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 206' ' ' LEU . 29.9 Cg_exo -59.23 100.46 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.14 1.227 . . . . 0.0 111.733 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.724 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 4.9 t -68.62 160.65 4.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.8 OUTLIER -137.4 86.48 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.011 HD23 HD12 ' A' ' 218' ' ' LEU . 0.4 OUTLIER -77.67 125.81 29.91 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.963 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.05 172.98 45.07 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.767 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.959 ' HB2' HG13 ' A' ' 225' ' ' VAL . 16.2 ttt-85 -71.62 -70.66 0.31 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.325 -0.438 . . . . 0.0 112.145 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.81 HG22 ' H ' ' A' ' 214' ' ' SER . 9.3 p -125.59 -149.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.952 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.81 ' H ' HG22 ' A' ' 213' ' ' VAL . 1.0 OUTLIER 66.94 -178.0 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 58.8 Cg_endo -73.85 45.73 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 121.807 1.671 . . . . 0.0 112.702 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.35 165.92 24.17 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.445 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.36 -38.46 13.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.161 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.011 HD12 HD23 ' A' ' 210' ' ' LEU . 3.1 mt -105.82 129.94 53.89 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -93.46 79.38 4.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.904 0.383 . . . . 0.0 111.173 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.754 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -101.55 83.95 2.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.478 ' CG ' ' HB2' ' A' ' 190' ' ' PRO . 3.5 pttp -60.2 59.72 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.981 0.42 . . . . 0.0 111.81 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.876 ' HB2' HG12 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -89.1 126.7 35.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 37.2 p -67.04 -7.53 23.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.218 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -87.31 -22.52 25.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.095 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.959 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.6 p -106.54 83.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.3 p -35.0 -41.42 0.14 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.69 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.35 -57.6 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.608 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.3 OUTLIER -138.81 130.81 28.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.211 0.529 . . . . 0.0 110.316 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.61 ' HB3' ' HB2' ' A' ' 283' ' ' LEU . 1.9 t-80 -101.07 -56.45 2.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.888 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.528 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -147.35 173.21 12.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.249 0.547 . . . . 0.0 112.273 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.724 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -156.3 179.85 8.84 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.824 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.458 HG12 ' HB3' ' A' ' 243' ' ' LEU . 19.8 mt -139.23 149.68 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.544 0.688 . . . . 0.0 112.436 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.89 160.67 31.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.8 ' CH2' HG13 ' A' ' 198' ' ' VAL . 5.3 p90 -149.58 165.51 32.02 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -116.49 132.98 56.53 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.138 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.07 0.27 57.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.867 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.16 -29.38 48.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.699 0.761 . . . . 0.0 109.963 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.444 ' HD3' ' HD3' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -138.44 23.12 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.129 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 238' ' ' LYS . 23.1 p90 37.0 59.09 1.11 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.355 0.597 . . . . 0.0 110.115 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.74 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 1.2 mptp? -122.72 141.37 51.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.105 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.687 ' CE3' ' CE3' ' A' ' 234' ' ' TRP . 2.1 m95 -124.46 121.61 35.33 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.912 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.8 pt-20 -138.57 144.86 40.05 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.731 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.8 pp -111.46 152.57 27.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.369 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.847 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 6.1 p -123.41 165.1 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 122.859 0.464 . . . . 0.0 110.586 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.852 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 5.1 t0 -107.39 116.6 32.22 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.851 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -75.76 99.12 4.31 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.444 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 267' ' ' ARG . . . 57.46 69.05 1.39 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.578 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 56.0 p -61.5 43.54 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 1.014 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.6 -54.19 49.68 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.622 0.646 . . . . 0.0 109.911 178.353 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 1.014 ' N ' HD22 ' A' ' 249' ' ' LEU . 2.1 t-20 -77.87 -38.12 46.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.244 0.545 . . . . 0.0 110.672 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.552 ' CA ' ' HB2' ' A' ' 261' ' ' HIS . . . 93.79 96.87 1.54 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.13 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.55 ' C ' HD23 ' A' ' 253' ' ' LEU . 0.7 OUTLIER -55.87 165.17 0.97 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.349 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.662 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -150.97 140.02 21.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.285 0.564 . . . . 0.0 111.455 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.586 HG23 HD11 ' A' ' 259' ' ' ILE . 93.1 t -114.33 132.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.788 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.57 ' HA ' HG13 ' A' ' 280' ' ' ILE . 16.9 t-20 53.43 42.22 32.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.126 0.489 . . . . 0.0 110.28 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.2 p 63.52 32.35 14.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.835 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -138.88 110.32 7.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 52.4 p -60.12 88.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.431 0.634 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.82 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -90.75 -7.57 10.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.601 -178.586 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.852 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 38.9 m -105.7 -17.54 14.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.65 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 3.6 t-160 -108.75 23.58 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 72.4 Cg_exo -42.66 -46.95 8.06 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.915 1.743 . . . . 0.0 112.501 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.72 93.07 3.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.294 0.568 . . . . 0.0 110.316 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.884 ' H ' HD23 ' A' ' 264' ' ' LEU . 0.2 OUTLIER -47.98 -43.39 29.58 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.166 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -37.44 -31.63 0.07 OUTLIER Glycine 0 C--N 1.329 0.15 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.387 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 268' ' ' LYS . 52.0 m -75.97 -68.67 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.48 ' O ' ' HA2' ' A' ' 247' ' ' GLY . 1.6 tpp180 71.57 -19.63 0.25 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 266' ' ' SER . 0.0 OUTLIER -73.36 -134.93 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -176.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.851 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 0.0 OUTLIER -75.36 -25.38 57.65 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.646 -178.21 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.2 -174.55 7.47 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.581 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -111.94 157.71 38.84 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 117.482 0.641 . . . . 0.0 110.866 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.731 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 21.3 Cg_exo -66.91 138.23 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.86 2.374 . . . . 0.0 113.892 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.82 HG21 ' HB ' ' A' ' 259' ' ' ILE . 74.3 t -114.51 142.28 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.0 mm-40 -85.28 127.12 34.2 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 118.803 -1.159 . . . . 0.0 112.316 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.874 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -95.05 164.85 12.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.018 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.1 160.0 41.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.588 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 80.1 p -59.77 132.24 53.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.509 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.5 OUTLIER 84.01 7.46 0.6 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.285 -179.51 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.659 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 3.0 m-20 -79.72 -167.31 1.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.57 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -160.34 134.92 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.301 177.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 1.036 HG22 HG12 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -107.09 157.21 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.985 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.69 HG23 ' CG ' ' A' ' 288' ' ' LYS . 0.7 OUTLIER -149.18 117.81 6.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.662 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -115.57 43.9 1.98 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.976 -178.065 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 172.28 -123.39 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 119.209 -1.472 . . . . 0.0 113.741 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.0 t -92.88 -51.16 5.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.586 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -143.6 -3.63 0.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 40.4 m -67.09 104.03 1.32 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 117.811 0.278 . . . . 0.0 110.807 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.781 ' O ' HG22 ' A' ' 187' ' ' ILE . 3.6 mtpt -125.49 134.66 51.96 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.498 -0.481 . . . . 0.0 112.264 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 1.036 HG12 HG22 ' A' ' 281' ' ' ILE . 9.6 p -112.98 136.92 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.289 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.443 ' HD1' HG22 ' A' ' 280' ' ' ILE . 2.0 t80 -77.66 137.06 38.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.249 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -103.98 110.48 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.625 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -129.99 134.57 47.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.586 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.685 HD11 HD23 ' A' ' 275' ' ' LEU . 4.6 mt -133.15 143.14 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.7 t -150.35 157.17 42.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.0 110.813 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 2.8 m -87.65 -176.94 5.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -154.89 116.3 4.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.63 103.61 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.794 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.671 ' HB2' ' HA ' ' A' ' 201' ' ' THR . 2.3 mm? . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.452 0.168 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 201' ' ' THR . . . 112.5 128.27 4.98 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.19 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' A' ' 296' ' ' GLN . 22.4 m -95.05 94.58 8.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.9 0.381 . . . . 0.0 111.647 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 16.0 m -144.97 179.12 7.55 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.1 m95 -143.01 135.18 27.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 3.5 tp -118.29 123.5 45.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.502 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 3.3 m-85 -123.63 134.85 53.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.681 0.753 . . . . 0.0 110.679 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.999 HD13 ' CE1' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -135.48 145.39 47.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.497 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.557 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 39.8 tt0 -140.11 127.39 21.2 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.869 HG21 HD12 ' A' ' 194' ' ' LEU . 16.9 t -64.97 107.72 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.5 tt -91.47 -21.51 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.834 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.55 94.56 0.7 Allowed 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.722 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.14 -177.99 35.65 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.534 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 88.2 Cg_endo -76.84 31.84 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 CA-C-N 119.591 1.696 . . . . 0.0 111.579 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.831 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.57 23.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.336 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.722 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.5 mt -39.81 111.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.85 6.89 2.45 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.011 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.869 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -98.72 154.59 17.86 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.736 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.3 mt-30 -151.66 148.67 28.22 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.213 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.999 ' CE1' HD13 ' A' ' 184' ' ' LEU . 1.1 p80 -136.31 130.74 33.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.308 0.575 . . . . 0.0 109.828 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.97 163.72 35.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.243 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' A' ' 206' ' ' LEU . 9.4 p -174.28 160.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.292 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 180' ' ' SER . 7.3 m120 -87.86 146.02 25.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.601 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.416 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 9.3 t -62.84 -5.26 2.67 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.854 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.671 ' HA ' ' HB2' ' A' ' 177' ' ' LEU . 2.7 t -91.82 34.79 0.98 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.039 0.447 . . . . 0.0 110.617 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.961 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 8.5 m -137.25 92.88 2.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.249 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 11.3 t -66.68 -73.3 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.392 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.0 t -89.93 -2.06 58.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.961 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.1 OUTLIER -115.63 47.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.132 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.857 ' H ' ' CD ' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -152.28 -26.65 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.857 ' CD ' ' H ' ' A' ' 206' ' ' LEU . 33.0 Cg_exo -55.05 102.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 CA-C-N 121.02 1.4 . . . . 0.0 111.739 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.588 HG11 ' ND1' ' A' ' 196' ' ' HIS . 17.1 t -68.34 165.78 2.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.086 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.568 ' N ' HG12 ' A' ' 208' ' ' VAL . 1.5 mtpt -134.99 88.38 2.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.151 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.072 HD23 HD12 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -75.75 128.29 34.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.563 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -175.3 176.62 47.3 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.155 -1.021 . . . . 0.0 113.556 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 1.005 ' HB2' HG13 ' A' ' 225' ' ' VAL . 6.1 ttt180 -71.47 -72.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.876 0.47 . . . . 0.0 111.477 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.657 HG22 ' H ' ' A' ' 214' ' ' SER . 8.0 p -125.49 -139.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.648 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.684 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.3 OUTLIER 61.78 -179.92 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 118.894 0.77 . . . . 0.0 109.928 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 47.0 Cg_endo -70.46 31.24 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.836 1.691 . . . . 0.0 113.205 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 214' ' ' SER . 3.9 m -65.03 157.71 27.63 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.796 0.331 . . . . 0.0 110.837 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.4 -30.36 23.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.533 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.072 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -110.01 133.51 53.11 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -94.95 77.32 3.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.522 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.785 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -100.44 66.88 1.29 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.647 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 0.3 OUTLIER -61.59 45.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -177.293 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.534 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 10.3 t0 -94.1 124.05 37.87 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.4 t -39.55 -32.07 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.228 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.867 ' O ' HD11 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -52.11 -37.42 54.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 110.366 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.005 HG13 ' HB2' ' A' ' 212' ' ' ARG . 4.3 p -103.51 102.14 13.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.496 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.437 ' O ' ' HD2' ' A' ' 212' ' ' ARG . 78.6 p -45.17 -62.2 1.35 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.08 0.466 . . . . 0.0 111.032 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -132.19 -50.58 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.684 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 0.1 OUTLIER -143.05 131.25 21.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.015 -0.592 . . . . 0.0 109.782 178.229 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.649 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.3 t60 -95.82 -55.58 2.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.327 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -143.65 172.81 12.3 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.578 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -157.48 177.66 11.18 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.727 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.792 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.0 mt -135.78 150.17 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.885 0.374 . . . . 0.0 111.985 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.59 163.71 37.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.217 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.613 ' CE3' HD21 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -91.92 149.46 21.54 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.497 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.432 ' HB3' ' CB ' ' A' ' 240' ' ' LYS . 7.9 t-20 -119.78 80.83 1.64 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 5.9 p -68.61 -19.97 64.47 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 82.5 m -81.21 -32.16 33.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.425 0.631 . . . . 0.0 110.885 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.583 ' HD3' ' HD3' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -117.7 15.29 14.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.889 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.417 ' C ' ' O ' ' A' ' 238' ' ' LYS . 10.0 p90 38.9 71.98 0.15 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.583 ' HD3' ' HD3' ' A' ' 238' ' ' LYS . 6.0 mptt -137.84 148.21 45.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.445 -1.252 . . . . 0.0 112.375 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.71 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.5 OUTLIER -116.97 104.73 11.57 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.5 mt-10 -126.26 146.8 49.86 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.5 pp -116.12 149.76 38.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.767 -1.56 . . . . 0.0 110.984 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.691 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -118.87 162.31 17.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.547 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 248' ' ' SER . 11.5 m-20 -115.6 99.26 7.21 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.172 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.822 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.36 108.81 9.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.207 0.527 . . . . 0.0 110.588 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 51.61 62.5 5.48 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.114 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 5.8 t -80.6 76.17 7.46 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.972 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.47 -48.83 78.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.972 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -74.68 -28.02 60.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.414 -179.188 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.522 ' O ' HD23 ' A' ' 253' ' ' LEU . . . 87.3 99.05 0.86 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.858 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.563 ' C ' HD23 ' A' ' 253' ' ' LEU . 4.9 m -60.31 159.22 10.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.359 0.123 . . . . 0.0 110.77 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.715 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -148.09 124.51 10.97 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.027 0.442 . . . . 0.0 111.374 179.064 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.887 HG22 HG23 ' A' ' 281' ' ' ILE . 90.9 t -101.26 132.02 47.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.819 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.428 ' HA ' HG13 ' A' ' 280' ' ' ILE . 32.0 t-20 51.27 39.58 24.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.069 0.461 . . . . 0.0 110.29 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 1.6 t 65.82 22.14 11.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.51 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -121.45 100.49 7.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.007 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 59.9 p -51.84 97.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.072 0.463 . . . . 0.0 112.19 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.928 HG21 HG11 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -78.14 -54.21 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.874 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.544 ' N ' HG12 ' A' ' 259' ' ' ILE . 2.0 t -46.21 160.48 0.07 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.527 ' CE1' ' HA2' ' A' ' 270' ' ' GLY . 72.0 m80 -53.51 107.38 0.84 Allowed Pre-proline 0 C--N 1.327 -0.379 0 O-C-N 121.676 -0.64 . . . . 0.0 111.811 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.85 14.19 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.079 2.519 . . . . 0.0 112.188 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 261' ' ' HIS . 0.9 OUTLIER -103.21 112.47 25.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.981 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.85 164.71 9.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.364 0.602 . . . . 0.0 112.355 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.31 -20.09 2.75 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.747 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.572 ' O ' ' HB2' ' A' ' 267' ' ' ARG . 0.6 OUTLIER -75.93 -77.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.981 0.391 . . . . 0.0 111.633 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.0 OUTLIER 85.2 17.0 0.14 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.965 0.412 . . . . 0.0 111.206 -179.188 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' A' ' 266' ' ' SER . 15.2 mtpt -50.65 153.98 1.5 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.283 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.822 ' CZ3' ' HB2' ' A' ' 246' ' ' MET . 36.8 t-105 -66.19 -26.58 67.46 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.527 ' HA2' ' CE1' ' A' ' 261' ' ' HIS . . . 76.92 160.88 11.58 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.911 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -94.56 146.47 31.52 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.88 147.87 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.166 1.911 . . . . 0.0 111.503 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.928 HG11 HG21 ' A' ' 259' ' ' ILE . 85.9 t -132.14 127.18 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.71 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.01 128.08 33.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.154 -178.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 1.022 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -93.11 164.38 13.28 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.957 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.02 159.23 42.64 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 57.2 p -62.48 132.1 51.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.245 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 81.8 -0.89 1.56 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.013 -179.108 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.72 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -71.97 -167.02 0.26 Allowed 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.6 OUTLIER -162.7 133.37 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.444 177.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.887 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -109.9 156.18 10.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.483 178.416 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.715 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 5.8 m -147.42 112.82 5.59 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.779 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -112.1 46.43 1.16 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.614 -177.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -178.79 -129.74 1.34 Allowed Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 119.654 -1.26 . . . . 0.0 113.882 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.641 HG22 ' HG3' ' A' ' 224' ' ' GLU . 5.4 t -97.59 -41.05 8.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.0 110.501 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.608 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -149.25 3.09 0.58 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.835 179.239 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.834 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 57.3 m -77.06 104.66 7.67 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.745 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -127.02 133.51 50.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.343 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.85 ' CG2' HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -110.82 136.76 45.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.311 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 4.0 t80 -76.41 135.22 39.45 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 1.022 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.3 t -103.37 113.51 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.099 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 293' ' ' ILE . 6.7 tpt180 -126.43 145.5 50.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.705 HD11 HD23 ' A' ' 275' ' ' LEU . 7.1 mt -143.32 116.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.908 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 6.1 t -125.48 155.76 40.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 0.0 110.725 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.02 162.25 24.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.204 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.594 ' HB3' ' O ' ' A' ' 179' ' ' SER . 5.5 tp60 -94.11 135.3 35.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.952 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -86.57 86.05 7.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.96 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.464 ' HA ' ' CG2' ' A' ' 201' ' ' THR . 3.2 mp . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.607 0.241 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.442 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.54 64.76 0.39 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.786 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.636 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 0.3 OUTLIER -137.21 -77.81 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.875 0.369 . . . . 0.0 110.021 179.253 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.4 OUTLIER -135.25 179.31 6.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.237 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.678 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.0 m95 -144.02 127.77 17.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.871 HD11 ' CD1' ' A' ' 184' ' ' LEU . 1.2 tp -120.07 129.68 54.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.392 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.852 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.2 m-85 -130.25 135.8 48.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.786 0.803 . . . . 0.0 111.814 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.991 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -132.03 148.65 52.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.963 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.606 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 26.5 tt0 -140.64 124.96 17.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.709 HG21 HD12 ' A' ' 194' ' ' LEU . 17.4 t -60.8 108.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.925 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.2 tt -92.38 -18.38 7.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.798 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.53 93.6 0.34 Allowed 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.589 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.736 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.03 -172.06 27.84 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.621 ' O ' ' HG2' ' A' ' 221' ' ' LYS . 83.5 Cg_endo -80.41 29.06 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.232 1.954 . . . . 0.0 111.61 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.847 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.75 27.13 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.736 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.1 mt -41.76 111.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 112.136 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 8.16 2.26 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.11 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.847 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -101.18 136.28 41.29 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.697 0.761 . . . . 0.0 109.057 178.049 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.606 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 7.9 mt-30 -136.17 155.81 49.6 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.494 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.991 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -148.84 147.58 28.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.355 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.544 ' C ' ' HZ3' ' A' ' 181' ' ' TRP . . . -151.25 149.48 29.45 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.619 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.927 HG13 ' CH2' ' A' ' 234' ' ' TRP . 5.2 p -153.77 153.83 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.432 0.634 . . . . 0.0 111.542 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 180' ' ' SER . 7.8 m120 -91.27 148.57 22.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.679 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 179' ' ' SER . 32.8 p -66.31 -0.63 2.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.636 ' HB ' ' HB2' ' A' ' 179' ' ' SER . 2.1 t -103.17 26.78 7.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.432 0.634 . . . . 0.0 110.457 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.627 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 55.8 p -114.32 123.22 48.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.692 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.497 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 22.9 m -91.07 -80.88 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.3 t -82.34 6.46 16.93 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.497 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -117.26 -12.13 10.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.958 0.408 . . . . 0.0 110.939 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.747 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.8 tt -68.0 -60.97 4.58 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.295 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.619 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.6 Cg_endo -42.6 99.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.32 2.014 . . . . 0.0 112.571 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.895 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 2.3 t -67.38 160.44 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.438 ' N ' ' CG1' ' A' ' 208' ' ' VAL . 3.7 mtpt -133.83 93.11 3.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.026 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -84.5 121.89 28.23 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.75 167.48 38.54 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.527 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.934 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.1 OUTLIER -57.42 -88.18 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.27 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.586 HG12 ' HD3' ' A' ' 212' ' ' ARG . 13.1 p -126.89 -10.61 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 111.62 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.609 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.6 OUTLIER -52.34 179.78 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.461 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 36.1 Cg_exo -60.05 10.83 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.417 2.078 . . . . 0.0 113.202 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 214' ' ' SER . 1.0 OUTLIER -52.39 -178.11 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.16 0.505 . . . . 0.0 111.461 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 209' ' ' LYS . 17.6 m-20 -99.24 -31.42 11.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.51 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.026 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -104.33 127.61 52.01 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -94.27 82.24 4.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.91 0.386 . . . . 0.0 111.889 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.857 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.9 mm? -102.68 91.49 4.22 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 6.5 ptpt -61.53 60.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.147 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 220' ' ' LEU . 3.3 m-20 -93.15 146.59 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.702 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 54.2 p -86.77 -18.46 31.04 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.56 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.569 ' OE1' HG22 ' A' ' 285' ' ' THR . 0.0 OUTLIER -79.48 -18.65 51.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.76 0.314 . . . . 0.0 111.466 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.934 HG13 ' HB2' ' A' ' 212' ' ' ARG . 3.0 p -109.37 81.45 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.023 0.44 . . . . 0.0 110.583 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.8 p -37.71 -39.45 0.34 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.514 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.37 -55.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.947 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.609 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 0.6 OUTLIER -140.75 130.82 24.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.115 0.483 . . . . 0.0 110.782 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.603 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.8 OUTLIER -96.57 -57.02 2.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.442 179.039 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 244' ' ' VAL . . . -151.57 175.81 11.96 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.555 0.693 . . . . 0.0 112.449 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.895 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 0.4 OUTLIER -152.52 173.32 15.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.974 -179.302 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 9.0 mt -125.03 143.37 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.913 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.24 129.07 4.25 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.927 ' CH2' HG13 ' A' ' 198' ' ' VAL . 4.5 p90 -119.32 166.43 13.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.754 0.788 . . . . 0.0 112.624 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 240' ' ' LYS . 1.9 m-20 -113.66 133.25 55.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.201 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.44 -1.83 52.92 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.088 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.8 m -78.83 -23.86 44.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.518 0.675 . . . . 0.0 109.937 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.518 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 13.9 tptt -141.82 16.61 2.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.373 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 15.3 p90 42.83 60.44 2.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.537 0.684 . . . . 0.0 109.774 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.785 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 2.0 mptp? -124.08 141.25 52.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.91 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.663 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -124.68 127.02 46.65 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.316 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.835 ' HG2' ' HG3' ' A' ' 274' ' ' GLU . 24.5 mt-10 -134.87 139.85 45.35 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.824 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -92.37 143.1 26.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.738 -1.574 . . . . 0.0 107.45 177.182 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.517 ' O ' ' HB1' ' A' ' 230' ' ' ALA . 1.3 p -140.16 161.64 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.272 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.714 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 10.5 t0 -84.93 135.03 34.23 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 120.881 0.372 . . . . 0.0 110.716 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.538 ' HG3' ' HG2' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -89.74 31.33 0.95 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.18 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.56 47.45 56.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.418 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.46 175.21 6.65 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.915 0.358 . . . . 0.0 111.077 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.694 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -101.67 -30.08 11.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.737 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.694 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -75.82 -33.29 60.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.467 0.651 . . . . 0.0 111.579 -178.753 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.499 ' CA ' ' HB3' ' A' ' 261' ' ' HIS . . . 93.27 160.47 35.38 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.769 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 260' ' ' SER . 7.6 m -117.98 157.37 26.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.049 -0.575 . . . . 0.0 110.763 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.682 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -144.87 141.82 29.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.041 0.448 . . . . 0.0 110.681 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.564 HG23 HD11 ' A' ' 259' ' ' ILE . 60.0 t -114.89 128.99 71.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.053 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.658 ' HA ' HD12 ' A' ' 280' ' ' ILE . 40.6 t30 55.93 48.68 17.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.099 0.476 . . . . 0.0 110.24 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 18.7 m 56.33 29.12 14.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.66 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.401 ' O ' HG23 ' A' ' 259' ' ' ILE . 1.7 t60 -133.3 103.4 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.816 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.585 ' HA ' ' HB3' ' A' ' 253' ' ' LEU . 64.8 p -55.03 89.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.286 0.565 . . . . 0.0 110.877 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.93 ' HB ' HG21 ' A' ' 273' ' ' VAL . 2.6 pp -94.66 -8.19 9.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.229 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.714 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 3.3 m -118.9 -22.08 7.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -176.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.647 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 22.1 p-80 -111.12 38.12 0.15 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.661 ' HD3' ' C ' ' A' ' 260' ' ' SER . 39.2 Cg_exo -59.14 -16.04 31.47 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.474 1.449 . . . . 0.0 112.904 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -130.33 94.93 3.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.299 0.571 . . . . 0.0 111.418 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.827 ' H ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -57.4 169.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.246 179.055 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 66.2 -19.05 0.18 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.686 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 264' ' ' LEU . 7.8 p -77.27 -36.35 54.45 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 49.3 27.23 1.82 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.113 0.483 . . . . 0.0 110.804 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.434 ' NZ ' ' HA2' ' A' ' 270' ' ' GLY . 0.1 OUTLIER -69.64 164.36 23.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.07 -179.362 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.561 ' CH2' ' NE2' ' A' ' 231' ' ' GLN . 19.5 t-105 -78.29 -18.79 54.8 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.299 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.434 ' HA2' ' NZ ' ' A' ' 268' ' ' LYS . . . 71.78 173.29 18.31 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.33 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -105.0 138.31 19.47 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -50.28 111.43 0.53 Allowed 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.602 2.202 . . . . 0.0 113.316 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.93 HG21 ' HB ' ' A' ' 259' ' ' ILE . 39.6 t -97.97 139.53 19.97 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.835 ' HG3' ' HG2' ' A' ' 242' ' ' GLU . 1.7 mp0 -80.1 124.79 29.06 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.869 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -91.81 165.98 12.99 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.99 177.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.721 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.72 159.19 42.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 13.7 t -59.88 128.33 36.38 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.958 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 277' ' ' SER . 12.8 m-20 87.98 5.77 0.24 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.885 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.721 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -80.94 -163.29 0.57 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.7 OUTLIER -161.52 131.02 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.365 177.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.867 HD12 ' CG2' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -104.46 156.3 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.117 0.484 . . . . 0.0 110.018 178.163 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.682 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 3.2 m -147.43 114.41 6.15 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.743 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.92 44.4 1.79 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.143 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.87 -131.54 1.79 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.585 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.569 HG22 ' OE1' ' A' ' 224' ' ' GLU . 2.6 t -92.36 -51.35 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.703 0.287 . . . . 0.0 110.522 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.584 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -138.58 -0.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.577 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.798 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 29.9 m -70.26 103.06 2.26 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.643 0.258 . . . . 0.0 110.953 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.679 ' O ' HG22 ' A' ' 187' ' ' ILE . 1.3 mtpp -126.01 137.78 53.68 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.349 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.867 ' CG2' HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -115.54 134.81 57.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.457 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.645 ' HD1' HG23 ' A' ' 280' ' ' ILE . 2.1 t80 -76.5 141.23 41.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.548 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -107.26 109.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.422 -179.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.416 ' O ' HD12 ' A' ' 182' ' ' LEU . 4.9 tpt180 -124.29 141.28 52.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.606 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.547 HG12 HD13 ' A' ' 182' ' ' LEU . 9.3 mt -138.76 133.16 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.02 156.46 43.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.733 0.301 . . . . 0.0 111.001 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.32 -174.75 4.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.031 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -158.44 116.39 2.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -164.7 109.74 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.842 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.927 -179.936 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.579 ' HA ' HG23 ' A' ' 201' ' ' THR . 1.1 mp . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.616 0.246 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.548 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.45 64.63 0.39 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.72 -0.753 . . . . 0.0 113.581 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 0.2 OUTLIER -133.8 -70.02 0.53 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.932 0.396 . . . . 0.0 110.319 178.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.577 ' HB2' ' OG ' ' A' ' 200' ' ' SER . 0.8 OUTLIER -138.79 -175.42 4.13 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.734 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 14.1 m95 -148.12 134.01 19.08 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.738 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 2.2 tp -112.98 119.78 39.11 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.458 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.734 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 5.6 m-85 -117.12 127.43 54.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.677 0.751 . . . . 0.0 110.66 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -118.28 134.62 54.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.676 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.541 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 2.3 tt0 -131.06 112.3 12.78 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.911 HG21 HD11 ' A' ' 220' ' ' LEU . 18.8 t -61.99 107.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.889 HG22 ' O ' ' A' ' 288' ' ' LYS . 11.0 tt -88.53 -26.01 5.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.743 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.31 98.35 0.71 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.418 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.1 -162.06 12.8 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.466 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 88.5 Cg_endo -86.59 27.93 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.677 2.251 . . . . 0.0 111.324 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.872 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -162.07 25.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.418 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.604 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.9 mt -39.63 107.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.52 5.47 2.28 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.203 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.872 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.9 OUTLIER -102.81 133.7 47.44 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.544 0.687 . . . . 0.0 110.076 179.126 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.8 mt-30 -131.13 153.96 48.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.763 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.568 ' NE2' ' HB3' ' A' ' 217' ' ' ASP . 1.6 t-80 -144.28 138.66 28.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.134 0.492 . . . . 0.0 110.832 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.738 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.92 156.08 44.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.591 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.795 HG21 ' CB ' ' A' ' 206' ' ' LEU . 12.3 p -157.69 149.01 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.348 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.569 ' OD1' HD23 ' A' ' 177' ' ' LEU . 0.5 OUTLIER -91.65 140.56 29.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.317 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.577 ' OG ' ' HB2' ' A' ' 180' ' ' SER . 0.9 OUTLIER -62.23 -6.88 3.46 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.579 HG23 ' HA ' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -93.76 28.55 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.323 0.582 . . . . 0.0 110.742 179.216 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.766 ' OG ' ' HB3' ' A' ' 206' ' ' LEU . 89.2 p -101.02 140.87 34.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.358 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -70.94 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 111.315 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.41 33.04 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.004 0.43 . . . . 0.0 110.752 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -117.15 4.13 12.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.862 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.989 HD13 ' HD3' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -98.69 -19.19 0.21 Allowed Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.989 ' HD3' HD13 ' A' ' 206' ' ' LEU . 10.8 Cg_endo -58.14 97.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 CA-C-N 120.836 1.334 . . . . 0.0 111.058 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 58.5 t -67.64 164.07 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.276 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.66 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.3 OUTLIER -139.73 86.0 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.509 -178.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.041 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -74.94 130.38 39.28 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.869 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.432 ' HA2' HG11 ' A' ' 225' ' ' VAL . . . -176.13 178.57 47.53 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.588 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 15.5 ttt180 -76.48 -67.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.816 HG22 ' H ' ' A' ' 214' ' ' SER . 9.8 p -125.99 -145.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 213' ' ' VAL . 1.1 p 64.78 179.9 0.04 OUTLIER Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 57.7 Cg_endo -73.15 39.37 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.913 1.742 . . . . 0.0 112.597 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.2 p -70.05 151.98 44.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.836 0.35 . . . . 0.0 110.553 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.568 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 2.8 m-20 -75.62 -38.15 59.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.086 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.041 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -103.21 130.33 50.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.6 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -98.72 86.28 3.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.841 0.353 . . . . 0.0 111.078 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.911 HD11 HG21 ' A' ' 186' ' ' VAL . 2.3 mm? -108.03 69.66 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.41 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 6.7 pttt -47.75 72.82 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.919 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.677 ' N ' ' O ' ' A' ' 220' ' ' LEU . 41.8 t0 -101.58 137.45 39.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.468 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.0 p -76.89 -3.98 41.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.348 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -99.73 -22.39 15.4 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 90.4 t -96.73 76.37 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.419 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 225' ' ' VAL . 49.0 m -31.5 -48.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.999 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.6 -58.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.1 OUTLIER -141.81 131.39 23.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.2 0.524 . . . . 0.0 110.336 179.073 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.627 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.6 t60 -99.5 -54.88 2.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.175 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -141.65 175.54 9.61 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.72 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -165.88 176.94 7.48 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.578 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.4 mt -135.27 148.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.682 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.17 164.11 38.01 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.46 ' CH2' ' CZ3' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -89.32 146.15 24.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -176.166 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.532 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 0.9 OUTLIER -119.33 81.28 1.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.515 175.023 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.7 p -64.77 -20.64 66.47 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.1 m -80.91 -30.87 35.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.33 0.586 . . . . 0.0 110.334 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.598 ' HD2' ' HE2' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -108.59 5.25 24.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.064 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 235' ' ' ASN . 2.8 p90 38.48 42.73 0.58 Allowed 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.245 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.598 ' HE2' ' HD2' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -118.64 173.95 6.55 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.279 0.562 . . . . 0.0 109.503 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.696 ' CZ3' HG23 ' A' ' 293' ' ' ILE . 2.0 m0 -121.88 113.41 19.6 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 13.7 pt-20 -133.26 149.13 51.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.715 ' O ' HD12 ' A' ' 243' ' ' LEU . 3.8 pp -115.05 152.15 32.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.06 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.868 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.7 OUTLIER -118.98 163.12 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 248' ' ' SER . 0.4 OUTLIER -104.73 110.66 23.08 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.163 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.601 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.82 100.49 5.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.656 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.73 63.44 5.12 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.541 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 3.1 p -67.33 55.74 0.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.771 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.51 -46.52 80.51 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.771 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -78.91 -35.62 43.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.559 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 89.71 87.4 1.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.89 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.525 ' C ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -45.24 164.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.47 0.176 . . . . 0.0 111.288 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.613 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -151.84 134.17 15.24 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.213 0.53 . . . . 0.0 111.686 178.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.629 HG23 ' CG1' ' A' ' 259' ' ' ILE . 96.6 t -110.65 137.61 42.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.225 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 49.45 35.41 8.09 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.207 0.527 . . . . 0.0 110.173 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 14.6 m 69.44 29.33 4.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.442 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -131.5 102.22 5.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.349 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 8.8 t -53.39 87.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.698 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.766 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.0 OUTLIER -90.18 6.86 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.932 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.457 ' HB3' ' N ' ' A' ' 252' ' ' THR . 2.4 t -99.21 -17.11 18.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.678 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 0.2 OUTLIER -103.31 14.77 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 87.9 Cg_exo -48.1 -50.02 12.81 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.326 1.35 . . . . 0.0 110.186 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 266' ' ' SER . 28.6 m-20 -75.72 79.59 2.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 113.211 -1.813 . . . . 0.0 110.627 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 264' ' ' LEU . 2.4 pt? -55.33 134.2 49.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.443 . . . . 0.0 111.223 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 85.21 -4.87 84.86 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.586 ' C ' ' H ' ' A' ' 268' ' ' LYS . 99.2 p -79.14 -67.9 0.71 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.044 0.422 . . . . 0.0 111.704 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.564 ' HB2' ' O ' ' A' ' 266' ' ' SER . 1.0 OUTLIER 68.63 -20.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.802 0.728 . . . . 0.0 111.854 -178.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.586 ' H ' ' C ' ' A' ' 266' ' ' SER . 25.6 ttpt -74.33 -129.47 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.868 ' NE1' HG11 ' A' ' 244' ' ' VAL . 3.4 t-105 -82.73 -29.14 29.99 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.72 -174.52 8.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.532 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -101.54 137.87 19.72 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.397 0.598 . . . . 0.0 110.497 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 75.6 Cg_exo -51.63 122.9 11.11 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.704 2.269 . . . . 0.0 113.621 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.766 HG21 ' HB ' ' A' ' 259' ' ' ILE . 98.7 t -94.12 141.11 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -82.93 130.13 35.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.033 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.792 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -96.46 163.25 13.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.895 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.31 160.33 41.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.296 0.569 . . . . 0.0 112.487 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 38.3 t -59.89 125.63 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.609 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.522 ' HA ' ' CZ ' ' A' ' 290' ' ' TYR . 14.8 m-20 85.97 0.77 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.736 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.662 ' O ' HG23 ' A' ' 291' ' ' VAL . 2.3 m-20 -82.06 133.7 35.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.703 HG23 ' HD1' ' A' ' 290' ' ' TYR . 1.0 OUTLIER -101.91 130.36 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.992 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 1.054 HG22 HG12 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -99.46 155.15 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.998 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.613 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -144.83 118.97 9.44 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.67 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.87 44.53 1.76 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.2 -122.93 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 119.277 -1.44 . . . . 0.0 113.843 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.2 t -93.44 -51.74 4.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.142 . . . . 0.0 111.188 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -142.65 -2.63 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.743 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 35.7 m -65.94 102.39 0.78 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 117.853 0.297 . . . . 0.0 110.614 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.889 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -117.63 123.73 46.87 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.752 -178.601 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 1.054 HG12 HG22 ' A' ' 281' ' ' ILE . 2.5 p -108.41 134.08 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.636 0.255 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.703 ' HD1' HG23 ' A' ' 280' ' ' ILE . 1.4 t80 -77.65 130.26 36.62 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.2 t -104.01 115.91 46.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.894 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.601 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -129.3 146.64 51.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.576 -179.151 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.792 HD11 HD23 ' A' ' 275' ' ' LEU . 9.1 mt -139.78 140.77 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.52 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.6 t -152.3 161.44 42.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.373 . . . . 0.0 111.29 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 54.5 p -102.97 141.52 35.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.533 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -112.39 146.92 37.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.772 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -127.41 86.88 2.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.109 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.475 ' O ' ' CG2' ' A' ' 201' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.769 0.319 . . . . 0.0 110.179 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.731 ' HA3' HG21 ' A' ' 201' ' ' THR . . . 116.51 -138.12 14.15 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.535 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.475 ' C ' ' HB3' ' A' ' 296' ' ' GLN . 2.5 m -165.81 38.85 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.233 -0.484 . . . . 0.0 111.507 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 73.1 m -163.62 163.15 24.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.415 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 49.0 m95 -156.82 143.02 18.1 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.752 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.4 OUTLIER -118.79 106.16 12.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.427 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 14.2 m-85 -101.91 136.44 41.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.997 0.903 . . . . 0.0 112.179 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.529 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.4 OUTLIER -126.74 136.21 52.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.404 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -133.34 116.53 16.21 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.975 HG21 HD11 ' A' ' 220' ' ' LEU . 18.4 t -62.53 116.15 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.2 tt -96.63 -23.21 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.39 91.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.54 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.685 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.86 -174.75 32.12 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.567 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 60.4 Cg_endo -75.34 27.56 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.371 2.047 . . . . 0.0 111.568 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.898 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -161.4 31.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.94 0.4 . . . . 0.0 110.0 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.685 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.1 mt -47.8 107.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.622 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.93 7.16 2.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.122 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 186' ' ' VAL . 0.6 OUTLIER -101.44 112.18 24.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.802 0.81 . . . . 0.0 109.906 179.151 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.0 mt-30 -111.03 152.62 26.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.554 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.527 ' O ' HD12 ' A' ' 184' ' ' LEU . 1.1 t-80 -144.04 136.56 26.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.752 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -142.06 165.18 28.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.882 HG13 ' CH2' ' A' ' 234' ' ' TRP . 0.6 OUTLIER -165.04 148.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.528 179.121 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 180' ' ' SER . 18.2 t-20 -88.57 137.18 32.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.474 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.589 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 32.4 t -49.32 -14.36 0.09 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.887 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.731 HG21 ' HA3' ' A' ' 178' ' ' GLY . 2.0 t -102.11 7.32 41.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -103.78 114.07 28.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.885 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 2.7 m -91.26 -67.39 0.86 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.69 -5.49 2.76 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.7 -1.81 11.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.126 -0.359 . . . . 0.0 111.313 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.9 HD21 ' CE3' ' A' ' 234' ' ' TRP . 1.3 tt -71.58 -61.66 2.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.4 Cg_endo -44.01 84.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.45 2.1 . . . . 0.0 113.276 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 206' ' ' LEU . 88.0 t -74.53 92.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.746 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.47 ' N ' ' HB2' ' A' ' 217' ' ' ASP . 0.7 OUTLIER -69.36 98.59 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.054 HD23 HD12 ' A' ' 218' ' ' LEU . 1.4 mp -82.65 128.79 34.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.778 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -179.11 179.37 48.91 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.899 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.909 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -68.06 -76.39 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.815 HG22 ' H ' ' A' ' 214' ' ' SER . 8.0 p -126.57 -141.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.39 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.815 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.1 OUTLIER 64.72 -175.88 0.03 OUTLIER Pre-proline 0 C--O 1.232 0.135 0 CA-C-N 118.314 0.506 . . . . 0.0 110.247 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 21.8 Cg_exo -65.66 10.03 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.745 2.297 . . . . 0.0 113.423 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 39.4 m -48.83 169.03 0.02 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.741 0.305 . . . . 0.0 111.092 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.47 ' HB2' ' N ' ' A' ' 209' ' ' LYS . 1.7 m-20 -95.48 -34.81 11.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.343 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.054 HD12 HD23 ' A' ' 210' ' ' LEU . 5.0 mt -105.81 127.31 53.02 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.62 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -92.57 80.02 4.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.724 0.297 . . . . 0.0 110.711 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.975 HD11 HG21 ' A' ' 186' ' ' VAL . 2.7 mm? -103.7 92.71 4.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.406 ' C ' ' HG2' ' A' ' 190' ' ' PRO . 1.3 mtmt -60.1 58.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.674 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.928 ' HB3' HG12 ' A' ' 225' ' ' VAL . 5.5 t0 -92.72 124.88 37.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.349 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.7 p -69.05 -10.5 57.88 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.108 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.402 ' HG3' ' OD1' ' A' ' 250' ' ' ASN . 0.8 OUTLIER -82.57 -24.76 33.81 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.783 0.325 . . . . 0.0 110.928 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.928 HG12 ' HB3' ' A' ' 222' ' ' ASP . 3.0 p -108.41 79.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.1 m -35.17 -36.16 0.05 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.737 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.23 -58.01 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.976 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.492 ' C ' HG23 ' A' ' 225' ' ' VAL . 2.6 mtpp -143.19 132.48 23.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.135 0.493 . . . . 0.0 110.556 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.541 ' CB ' ' HB2' ' A' ' 283' ' ' LEU . 0.6 OUTLIER -102.16 -57.0 2.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.376 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -141.83 171.21 14.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.192 0.52 . . . . 0.0 112.036 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.783 ' HA ' HD12 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -152.54 159.36 43.29 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.486 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.616 HG12 ' HB3' ' A' ' 243' ' ' LEU . 19.4 mt -123.73 145.73 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.432 0.634 . . . . 0.0 111.87 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.852 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -161.41 150.51 16.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.9 ' CE3' HD21 ' A' ' 206' ' ' LEU . 3.2 p90 -138.76 165.64 26.46 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.12 132.43 56.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.792 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 73.4 m -88.99 2.09 54.5 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.872 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 21.4 m -78.63 -19.48 52.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.643 0.735 . . . . 0.0 110.276 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -150.73 23.63 0.78 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.496 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.2 p90 37.44 59.58 1.18 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.214 0.53 . . . . 0.0 110.446 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.822 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -128.63 143.12 50.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.673 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.694 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -123.42 122.5 38.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.774 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.8 pt-20 -134.18 142.35 47.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.698 0.761 . . . . 0.0 112.354 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.4 pp -107.82 152.76 23.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.784 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.856 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -115.75 162.24 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.663 0.268 . . . . 0.0 110.963 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.519 ' HB3' ' OG ' ' A' ' 260' ' ' SER . 1.2 m-20 -106.22 111.05 23.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.605 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.93 103.42 6.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.203 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.87 70.59 0.92 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.51 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.2 m -62.0 40.96 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.878 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.52 -52.54 64.37 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.793 -0.567 . . . . 0.0 109.881 178.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.878 ' H ' HD13 ' A' ' 249' ' ' LEU . 2.7 m120 -80.32 -39.36 28.83 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.145 0.498 . . . . 0.0 111.681 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 88.89 87.36 1.23 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.804 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.693 ' N ' ' HB3' ' A' ' 260' ' ' SER . 2.9 m -45.44 170.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.279 0.232 . . . . 0.0 110.553 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -149.11 133.66 17.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.205 0.526 . . . . 0.0 111.461 177.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.876 HG23 ' CD1' ' A' ' 259' ' ' ILE . 86.0 t -109.83 133.11 56.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.083 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.464 ' HA ' HG13 ' A' ' 280' ' ' ILE . 3.3 m-20 51.11 44.41 28.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.174 0.512 . . . . 0.0 110.07 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 m 64.18 26.93 13.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.763 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.441 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.1 OUTLIER -129.75 115.67 17.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.208 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 5.8 t -67.46 89.82 0.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.03 0.443 . . . . 0.0 111.548 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.876 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -89.36 0.33 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.431 -178.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.693 ' HB3' ' N ' ' A' ' 252' ' ' THR . 14.0 t -100.08 -16.69 17.78 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.7 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 0.8 OUTLIER -103.23 16.87 0.05 OUTLIER Pre-proline 0 N--CA 1.454 -0.266 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.7 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 43.8 Cg_endo -90.84 40.82 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.874 1.716 . . . . 0.0 111.144 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -151.56 85.58 1.32 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.986 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 264' ' ' LEU . 3.4 mm? -69.72 -37.83 76.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.066 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -88.05 -3.83 79.03 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.489 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 268' ' ' LYS . 3.1 m -97.84 -70.33 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.5 OUTLIER 67.68 -19.15 0.13 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.476 0.655 . . . . 0.0 112.061 -178.469 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 266' ' ' SER . 0.1 OUTLIER -72.9 -129.09 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.536 -177.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.856 ' NE1' HG11 ' A' ' 244' ' ' VAL . 1.4 t-105 -77.68 -15.7 58.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.92 0.488 . . . . 0.0 112.232 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 59.94 -174.19 4.53 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.488 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -107.18 134.07 20.06 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.905 0.852 . . . . 0.0 110.494 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 96.4 Cg_exo -45.0 125.08 6.41 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.771 2.314 . . . . 0.0 113.521 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.806 HG21 ' CG1' ' A' ' 259' ' ' ILE . 74.9 t -98.77 129.3 49.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.13 128.65 34.79 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.46 -178.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.986 HD22 HG11 ' A' ' 291' ' ' VAL . 0.6 OUTLIER -87.27 163.5 16.82 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.031 -178.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.408 ' HA ' ' HZ3' ' A' ' 241' ' ' TRP . . . -137.82 145.86 42.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.395 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 2.9 t -56.64 126.0 24.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.017 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.2 m-20 90.27 4.52 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.344 0.657 . . . . 0.0 111.949 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' ' 280' ' ' ILE . 0.6 OUTLIER -79.91 -164.51 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.789 HG22 ' HA ' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -162.3 136.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.406 178.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.935 HG22 HG12 ' A' ' 289' ' ' VAL . 0.1 OUTLIER -108.46 156.64 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.607 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.693 ' OG1' ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -145.81 117.27 8.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.399 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.699 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -113.07 44.61 1.49 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.79 -133.26 2.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.433 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 286' ' ' THR . 6.8 t -88.45 -49.44 6.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.643 0.259 . . . . 0.0 110.956 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.6 t -139.68 -7.3 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.728 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 49.0 m -63.97 101.31 0.38 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.693 ' HG3' ' OG1' ' A' ' 282' ' ' THR . 1.7 ttmt -118.8 129.51 55.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.637 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.935 HG12 HG22 ' A' ' 281' ' ' ILE . 0.3 OUTLIER -106.98 128.49 61.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.542 0.21 . . . . 0.0 111.52 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.789 ' HA ' HG22 ' A' ' 280' ' ' ILE . 7.1 t80 -76.79 136.99 39.0 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.986 HG11 HD22 ' A' ' 275' ' ' LEU . 8.0 t -113.89 115.17 48.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.535 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.61 142.32 39.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.773 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.552 HD12 ' CE3' ' A' ' 241' ' ' TRP . 0.5 OUTLIER -129.89 147.24 33.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.501 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.67 129.54 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 0.0 111.482 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 8.7 p -81.42 159.37 24.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.58 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.475 ' HB3' ' C ' ' A' ' 179' ' ' SER . 3.7 tp-100 -110.9 119.42 39.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.687 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -75.87 92.15 3.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.289 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.868 179.701 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.523 ' HA ' ' CG2' ' A' ' 201' ' ' THR . 2.0 mp . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.653 0.263 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.653 ' N ' HG21 ' A' ' 201' ' ' THR . . . 110.97 79.6 1.04 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.261 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 77.2 p -149.5 -74.07 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.063 0.459 . . . . 0.0 109.851 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 295' ' ' SER . 0.6 OUTLIER -142.87 -175.53 4.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.946 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.7 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.5 m95 -143.24 131.62 22.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.799 HD11 ' CD1' ' A' ' 184' ' ' LEU . 3.4 tp -114.07 128.41 56.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.943 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.783 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.4 m-85 -130.27 129.94 43.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.747 0.784 . . . . 0.0 111.588 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.983 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -130.84 146.36 52.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.775 176.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.525 ' C ' HG12 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -140.19 127.21 20.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.456 -0.497 . . . . 0.0 112.308 -177.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.879 HG21 HD11 ' A' ' 220' ' ' LEU . 9.7 t -64.5 106.06 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.1 tt -90.6 -19.01 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.819 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.63 95.02 0.62 Allowed 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.268 -0.573 . . . . 0.0 112.466 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.71 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.2 -179.54 37.75 Favored Glycine 0 C--O 1.228 -0.26 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.597 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 58.9 Cg_endo -74.6 30.17 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 CA-C-N 119.433 1.617 . . . . 0.0 111.269 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.791 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -160.2 26.38 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.71 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.0 mt -42.11 108.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.07 7.57 1.75 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.099 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.845 ' O ' HG23 ' A' ' 186' ' ' VAL . 1.1 mp -100.86 119.72 39.08 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.139 0.971 . . . . 0.0 109.818 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 8.1 mt-30 -122.54 153.64 38.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.208 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.983 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -146.67 145.42 30.02 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.059 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -150.22 143.46 24.99 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.892 HG21 ' HA ' ' A' ' 206' ' ' LEU . 12.0 p -149.01 149.94 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.418 0.628 . . . . 0.0 111.309 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.516 ' HB3' HG22 ' A' ' 201' ' ' THR . 33.8 m120 -87.72 148.14 24.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.356 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.561 ' CB ' ' HZ2' ' A' ' 234' ' ' TRP . 1.0 OUTLIER -65.55 -7.64 15.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.387 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.653 HG21 ' N ' ' A' ' 178' ' ' GLY . 3.1 t -92.35 5.62 49.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.95 0.405 . . . . 0.0 111.209 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.668 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -94.93 113.68 25.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.57 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.8 m -60.1 -108.46 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.2 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.8 m -78.58 25.52 0.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.54 -10.55 10.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.93 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.892 ' HA ' HG21 ' A' ' 198' ' ' VAL . 9.0 tt -77.06 -49.22 2.45 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.557 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 206' ' ' LEU . 52.9 Cg_exo -46.48 100.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.467 1.445 . . . . 0.0 111.653 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.874 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 4.7 t -66.83 163.33 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 216' ' ' SER . 0.0 OUTLIER -138.38 92.55 2.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.851 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.055 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -83.91 127.32 33.76 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.423 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.513 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -173.31 178.11 45.41 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.136 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 1.003 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 8.5 ttt180 -63.38 -86.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.605 HG12 ' HD3' ' A' ' 212' ' ' ARG . 14.5 p -133.67 -4.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.631 ' HB2' ' CD ' ' A' ' 215' ' ' PRO . 67.5 p -53.76 -178.85 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.631 ' CD ' ' HB2' ' A' ' 214' ' ' SER . 32.6 Cg_exo -61.08 17.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.307 2.004 . . . . 0.0 112.709 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 214' ' ' SER . 6.4 m -58.39 -178.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.218 0.532 . . . . 0.0 111.619 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.1 -31.92 11.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.506 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.055 HD12 HD23 ' A' ' 210' ' ' LEU . 1.1 mt -103.46 124.89 49.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.62 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.596 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -94.67 86.42 4.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.795 0.331 . . . . 0.0 110.465 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 1.003 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.7 mm? -109.62 96.6 6.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -64.28 51.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.897 ' HB2' HG12 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -84.9 138.14 32.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.2 p -78.95 -11.09 59.99 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.121 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.437 ' CG ' ' HA3' ' A' ' 284' ' ' GLY . 0.0 OUTLIER -84.39 -20.34 32.06 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.769 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.897 HG12 ' HB2' ' A' ' 222' ' ' ASP . 7.5 p -113.91 69.79 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-O 120.872 0.367 . . . . 0.0 110.069 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -35.2 -33.28 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.193 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 225' ' ' VAL . . . -144.1 -67.75 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.361 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -140.38 128.48 22.23 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.32 0.581 . . . . 0.0 111.176 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 248' ' ' SER . 0.3 OUTLIER -95.8 -60.69 1.59 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.508 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.675 ' HB3' ' CD2' ' A' ' 283' ' ' LEU . . . -150.35 163.02 39.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.904 -177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.98 ' O ' HD13 ' A' ' 243' ' ' LEU . 0.0 OUTLIER -138.76 -179.14 5.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.908 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.952 HG12 HD22 ' A' ' 243' ' ' LEU . 14.8 mt -131.1 141.55 45.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.012 0.435 . . . . 0.0 110.81 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.94 133.48 5.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.886 ' CZ2' HD11 ' A' ' 206' ' ' LEU . 1.8 p90 -124.41 165.72 17.23 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.82 133.61 55.85 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.827 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 31.4 p -92.97 3.04 56.44 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.469 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 89.8 m -80.85 -27.99 36.25 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.42 0.629 . . . . 0.0 110.065 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 4.6 tptt -137.09 19.19 2.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.02 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.433 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 27.9 p90 40.43 60.03 1.94 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.5 0.667 . . . . 0.0 109.861 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.77 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -125.12 143.63 50.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.322 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.824 ' CH2' HG23 ' A' ' 293' ' ' ILE . 11.6 m0 -123.79 125.16 44.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.497 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 1.1 pt-20 -129.06 134.87 48.28 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.98 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.1 OUTLIER -107.0 124.74 50.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.048 177.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.761 HG11 ' CZ2' ' A' ' 269' ' ' TRP . 4.8 p -126.39 164.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 O-C-N 122.111 -0.368 . . . . 0.0 111.609 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 260' ' ' SER . 15.9 t0 -88.53 127.8 35.54 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.728 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -84.51 44.44 1.04 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.411 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 269' ' ' TRP . . . 65.46 57.26 11.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.64 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.716 ' HB3' ' HA ' ' A' ' 229' ' ' HIS . 56.1 p -99.87 148.29 24.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.81 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.762 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -79.44 -37.67 36.47 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.961 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.762 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -74.01 -31.25 62.86 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.844 0.354 . . . . 0.0 111.494 -179.066 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 95.3 163.96 34.68 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.946 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.724 ' C ' HD23 ' A' ' 253' ' ' LEU . 25.0 m -125.22 156.61 38.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.84 0.353 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.724 HD23 ' C ' ' A' ' 252' ' ' THR . 0.1 OUTLIER -148.68 126.41 11.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.987 0.423 . . . . 0.0 111.41 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 1.048 HG23 HD12 ' A' ' 259' ' ' ILE . 36.0 t -102.25 127.64 55.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.735 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 53.14 41.22 32.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 110.34 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 16.6 m 62.99 20.22 12.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.404 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.06 90.97 3.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.92 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 96.1 p -45.79 97.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.596 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 1.048 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -78.63 -52.65 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.248 179.185 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.568 ' N ' HG12 ' A' ' 259' ' ' ILE . 19.7 p -52.24 162.99 0.43 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 268' ' ' LYS . 0.4 OUTLIER -56.73 109.31 1.61 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.933 179.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -59.44 -3.89 2.14 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.464 2.11 . . . . 0.0 112.942 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.4 101.88 9.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.192 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 264' ' ' LEU . 9.6 mt -48.24 -25.46 1.54 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -93.12 -11.21 58.91 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.892 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 1.9 m -81.26 -35.91 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.727 ' HG2' ' HA ' ' A' ' 249' ' ' LEU . 15.3 mtm180 44.85 22.38 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 261' ' ' HIS . 2.5 mttt -62.49 157.77 19.49 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.27 0.628 . . . . 0.0 112.102 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.761 ' CZ2' HG11 ' A' ' 244' ' ' VAL . 0.4 OUTLIER -72.86 -24.95 60.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.157 -0.928 . . . . 0.0 108.662 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.596 ' O ' ' HD1' ' A' ' 269' ' ' TRP . . . 79.52 166.17 31.93 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.747 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 273' ' ' VAL . 8.7 m-20 -89.74 138.64 27.93 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.397 0.598 . . . . 0.0 109.929 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.409 ' HB2' ' OE1' ' A' ' 242' ' ' GLU . 9.7 Cg_endo -52.75 108.63 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.504 2.136 . . . . 0.0 112.753 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 40.0 t -102.0 147.24 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.674 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 20.9 mm-40 -85.53 130.21 34.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.51 0.671 . . . . 0.0 112.766 -177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.829 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -95.74 164.51 12.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.934 179.289 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.15 159.4 42.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 23.9 p -57.92 129.32 41.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.327 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.8 m-20 87.93 7.74 0.18 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.287 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.7 OUTLIER -80.72 -164.28 0.7 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.5 OUTLIER -162.27 135.17 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 177.209 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.877 ' CG2' HG22 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -123.6 93.76 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 287' ' ' THR . 0.6 OUTLIER -79.0 121.96 25.59 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.685 HD23 HG23 ' A' ' 252' ' ' THR . 0.3 OUTLIER -106.69 50.03 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.459 -0.497 . . . . 0.0 112.254 -178.049 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 162.54 -115.94 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 119.571 -1.299 . . . . 0.0 113.807 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 286' ' ' THR . 1.2 t -96.1 -57.62 2.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.594 0.235 . . . . 0.0 110.727 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -135.32 0.33 2.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.916 179.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.819 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 45.1 m -75.12 102.94 5.1 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 121.353 -0.139 . . . . 0.0 111.248 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.747 ' O ' HG22 ' A' ' 187' ' ' ILE . 3.4 ptpt -129.08 135.46 48.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.222 0.534 . . . . 0.0 112.091 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.871 HG23 HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -108.49 135.63 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.046 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.2 t80 -77.0 137.93 39.3 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 279' ' ' ASP . 0.1 OUTLIER -106.68 110.79 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.78 -178.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.519 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -119.39 140.6 50.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.775 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.824 HG23 ' CH2' ' A' ' 241' ' ' TRP . 32.3 mt -138.63 134.37 42.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.1 t -152.47 161.76 42.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 111.207 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 36.6 p -104.86 157.97 16.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.819 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -117.22 116.25 26.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.772 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.51 86.41 6.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.578 ' HA ' HG23 ' A' ' 201' ' ' THR . 2.6 mp . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.835 0.35 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.569 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.64 99.11 2.19 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.532 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 13.6 p -179.59 -77.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.766 0.317 . . . . 0.0 110.483 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.711 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 20.9 m -135.27 157.99 45.5 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.0 m95 -127.59 132.29 49.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.781 HD23 ' HZ3' ' A' ' 234' ' ' TRP . 2.2 tp -117.72 129.88 55.98 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.244 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.734 ' N ' HD12 ' A' ' 182' ' ' LEU . 11.2 m-85 -125.95 133.15 51.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.681 0.753 . . . . 0.0 110.436 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.799 HD11 HD12 ' A' ' 232' ' ' ILE . 3.3 mt -123.84 141.37 52.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.889 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -134.8 111.3 9.8 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 194' ' ' LEU . 8.8 t -58.64 117.98 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.6 tt -101.91 -24.41 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -175.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.758 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -155.86 91.2 1.27 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.994 0.815 . . . . 0.0 112.479 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -162.64 -165.89 20.48 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.43 ' HG3' ' CG ' ' A' ' 222' ' ' ASP . 58.6 Cg_endo -92.43 33.1 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.971 2.447 . . . . 0.0 111.509 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.842 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -162.34 29.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.459 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.689 HD11 ' N ' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -47.87 111.12 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.052 0.453 . . . . 0.0 111.322 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.12 4.52 2.58 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.666 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.883 ' O ' HG23 ' A' ' 186' ' ' VAL . 0.8 OUTLIER -102.33 118.9 37.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.599 0.714 . . . . 0.0 109.578 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.734 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.0 mt-30 -114.68 149.85 36.11 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.785 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.534 ' NE2' ' HB3' ' A' ' 217' ' ' ASP . 1.0 OUTLIER -138.48 133.26 32.47 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.102 178.436 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.59 156.62 43.36 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.399 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 206' ' ' LEU . 4.5 p -162.19 156.37 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.625 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.711 ' HA ' ' O ' ' A' ' 180' ' ' SER . 3.1 m120 -94.78 145.73 24.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.619 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.502 ' CB ' ' HE1' ' A' ' 234' ' ' TRP . 28.3 p -58.34 -0.31 0.09 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.081 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.578 HG23 ' HA ' ' A' ' 177' ' ' LEU . 1.4 t -106.72 14.4 26.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.857 0.36 . . . . 0.0 111.301 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.453 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -106.33 124.53 49.73 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.179 179.362 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 m -87.48 -83.03 0.21 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 26.2 m -84.09 13.27 5.25 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.453 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.03 -14.31 9.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.015 0.436 . . . . 0.0 110.624 178.645 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.775 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.6 tt -65.69 -55.32 24.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.827 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.8 Cg_endo -42.84 92.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.653 2.235 . . . . 0.0 113.453 -178.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 231' ' ' GLN . 41.6 t -71.46 90.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.708 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.561 ' N ' ' HB2' ' A' ' 217' ' ' ASP . 0.7 OUTLIER -68.16 78.81 0.24 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 231' ' ' GLN . 3.1 mp -65.35 129.55 40.13 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.975 -0.453 . . . . 0.0 110.043 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . -173.59 171.62 44.62 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.46 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.66 ' HB2' ' HB ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -70.56 -74.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.893 0.477 . . . . 0.0 112.074 -179.155 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.647 HG22 ' H ' ' A' ' 214' ' ' SER . 9.9 p -124.28 -142.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.363 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.647 ' H ' HG22 ' A' ' 213' ' ' VAL . 1.9 m 60.5 173.25 0.06 OUTLIER Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 118.972 0.805 . . . . 0.0 109.616 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 37.5 Cg_endo -65.71 28.58 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.076 1.851 . . . . 0.0 113.064 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 214' ' ' SER . 8.1 m -57.47 167.01 1.09 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.749 0.309 . . . . 0.0 110.756 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.561 ' HB2' ' N ' ' A' ' 209' ' ' LYS . 9.7 m-20 -89.0 -43.01 11.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.874 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.814 HD23 HD21 ' A' ' 220' ' ' LEU . 3.4 tp -99.07 131.63 44.97 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.74 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -95.68 75.75 3.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.954 0.407 . . . . 0.0 110.785 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.817 HD11 HG21 ' A' ' 186' ' ' VAL . 2.6 mm? -103.96 62.87 0.76 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.645 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 2.2 pttt -54.57 57.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 220' ' ' LEU . 10.0 t0 -88.75 153.81 20.78 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.2 p -73.18 -4.72 34.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.505 ' HG3' ' HA3' ' A' ' 284' ' ' GLY . 1.4 pt-20 -91.74 -21.79 20.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.977 0.418 . . . . 0.0 110.26 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.784 HG13 ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -96.94 102.88 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.083 179.089 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 73.0 m -53.18 -49.26 67.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.468 0.651 . . . . 0.0 109.885 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 228' ' ' LYS . . . -148.34 -50.62 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.552 ' HD2' ' HD2' ' A' ' 209' ' ' LYS . 8.1 mttm -145.87 134.74 22.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.082 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.784 ' CG ' HG13 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -101.18 -53.84 2.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.181 179.173 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.652 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -148.97 170.32 18.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.865 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -152.68 170.24 20.75 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.764 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.827 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.7 mt -121.06 143.62 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.483 0.659 . . . . 0.0 111.814 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.591 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.14 126.3 4.2 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.799 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 10.5 p90 -120.32 166.85 12.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.485 HD22 ' CB ' ' A' ' 240' ' ' LYS . 16.3 p30 -115.58 133.58 55.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.02 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.27 -0.88 52.49 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.71 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 18.6 m -78.97 -39.33 34.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.904 0.859 . . . . 0.0 109.382 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.608 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 10.0 tptm -117.8 10.08 13.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.21 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 10.6 p90 44.92 63.83 1.58 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.42 0.629 . . . . 0.0 109.772 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.799 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 2.1 mptp? -130.69 140.56 50.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.092 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.691 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 1.8 m95 -121.41 124.01 43.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.942 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 6.7 pt-20 -138.29 147.17 43.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.782 ' HG ' HG13 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -95.25 151.34 19.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 112.859 -1.973 . . . . 0.0 108.474 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.486 HG21 ' HE1' ' A' ' 269' ' ' TRP . 2.2 p -145.57 161.79 12.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.867 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 17.4 t0 -84.25 139.44 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.561 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.417 ' HE2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -85.02 30.56 0.58 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.0 41.02 97.51 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.646 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.521 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 9.5 t -86.54 172.28 10.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 111.264 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.69 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -96.95 -30.95 12.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.809 179.283 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.69 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.8 OUTLIER -75.53 -29.65 59.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.805 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.521 ' HA3' ' CG ' ' A' ' 261' ' ' HIS . . . 85.62 152.55 19.14 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.742 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.652 HG21 ' HB2' ' A' ' 230' ' ' ALA . 87.6 m -108.94 154.73 21.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.463 -0.368 . . . . 0.0 110.772 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.759 ' O ' HD13 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -138.06 136.43 36.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.159 178.342 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.974 HG22 HD11 ' A' ' 281' ' ' ILE . 89.6 t -107.6 127.45 63.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.971 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 1.01 ' HA ' HD12 ' A' ' 280' ' ' ILE . 27.2 t-20 56.56 50.54 12.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.376 0.608 . . . . 0.0 109.985 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.56 32.51 17.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.927 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.415 ' O ' ' N ' ' A' ' 259' ' ' ILE . 0.1 OUTLIER -137.95 111.54 8.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.823 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.556 ' CB ' ' CE1' ' A' ' 261' ' ' HIS . 78.3 p -60.41 83.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.306 0.574 . . . . 0.0 110.34 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.979 ' HB ' HG21 ' A' ' 273' ' ' VAL . 2.6 pp -87.85 -9.49 10.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.815 -178.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.674 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 0.1 OUTLIER -119.99 -21.65 7.02 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.199 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.643 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 34.2 p-80 -112.07 40.88 0.2 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.674 ' HD3' ' C ' ' A' ' 260' ' ' SER . 38.2 Cg_exo -57.65 -24.92 65.21 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.848 1.698 . . . . 0.0 113.33 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 266' ' ' SER . 57.0 m-20 -118.76 110.18 16.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.198 0.523 . . . . 0.0 111.898 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.61 156.92 33.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.982 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 75.18 -17.45 3.04 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.84 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' A' ' 263' ' ' ASP . 0.4 OUTLIER -75.69 -38.69 58.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.976 0.417 . . . . 0.0 111.445 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 248' ' ' SER . 0.6 OUTLIER 53.07 24.8 3.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.988 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -65.77 165.38 12.87 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.781 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.634 ' CZ2' ' NE2' ' A' ' 231' ' ' GLN . 7.7 t-105 -81.02 -16.93 51.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.541 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 72.22 174.22 22.85 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.462 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -105.59 137.15 19.22 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.153 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.24 115.75 2.08 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.654 2.236 . . . . 0.0 113.789 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.979 HG21 ' HB ' ' A' ' 259' ' ' ILE . 80.9 t -103.96 135.18 42.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -75.56 127.8 33.88 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -176.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.847 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.29 164.65 13.45 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.517 178.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.82 159.3 42.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 28.3 t -61.38 129.28 40.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.367 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 277' ' ' SER . 0.4 OUTLIER 83.74 6.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.387 -178.829 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 16.0 t0 -81.1 -165.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 1.01 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.8 OUTLIER -160.4 126.39 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.368 178.129 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.974 HD11 HG22 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -100.58 148.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.774 ' C ' HD13 ' A' ' 283' ' ' LEU . 13.9 m -140.53 136.81 33.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.612 0.72 . . . . 0.0 111.56 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.774 HD13 ' C ' ' A' ' 282' ' ' THR . 0.0 OUTLIER -136.95 134.78 37.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.359 178.287 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 224' ' ' GLU . . . 95.64 -137.91 13.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.346 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.459 HG22 ' OE1' ' A' ' 224' ' ' GLU . 11.6 t -99.33 -30.16 12.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.898 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -156.53 5.14 0.16 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.758 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 7.4 m -73.47 107.14 5.58 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.881 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.718 ' O ' HG22 ' A' ' 187' ' ' ILE . 11.6 ttmm -127.81 134.83 49.47 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.17 0.509 . . . . 0.0 111.807 -178.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 16.7 t -115.44 135.38 55.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.809 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.596 ' CD1' HG23 ' A' ' 280' ' ' ILE . 2.5 t80 -76.9 137.98 39.45 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.122 0.487 . . . . 0.0 110.666 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.847 HG11 ' HB2' ' A' ' 275' ' ' LEU . 3.7 t -105.11 112.23 37.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.718 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.464 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -129.26 138.45 51.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.872 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.672 HD11 HD23 ' A' ' 275' ' ' LEU . 4.1 mt -138.78 122.36 19.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.23 162.34 32.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 110.835 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.6 -165.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.988 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -144.34 115.84 8.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.767 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -104.23 86.56 2.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.983 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.887 179.911 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.56 ' HB2' ' OG1' ' A' ' 201' ' ' THR . 73.8 mt . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.744 ' N ' HG21 ' A' ' 201' ' ' THR . . . 113.88 101.06 2.43 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.706 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.416 ' HB2' ' N ' ' A' ' 201' ' ' THR . 0.8 OUTLIER -178.42 -89.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.61 0.205 . . . . 0.0 111.167 179.12 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -142.24 -171.91 3.48 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.0 m95 -145.56 130.34 18.11 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.914 HD11 ' CD2' ' A' ' 184' ' ' LEU . 4.0 tp -119.82 136.56 54.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.059 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.763 ' N ' HD12 ' A' ' 182' ' ' LEU . 3.5 m-85 -134.16 130.23 37.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.762 0.792 . . . . 0.0 109.809 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.914 ' CD2' HD11 ' A' ' 182' ' ' LEU . 3.7 mm? -116.98 139.43 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.276 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.529 ' C ' HG13 ' A' ' 289' ' ' VAL . 3.5 tt0 -135.49 111.96 9.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.871 HG21 HD12 ' A' ' 194' ' ' LEU . 14.3 t -60.58 110.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.0 tt -92.64 -19.28 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.767 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.9 95.21 0.34 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.88 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.673 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.63 -173.25 30.06 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.553 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 94.6 Cg_endo -81.43 31.8 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 121.926 1.751 . . . . 0.0 110.91 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.879 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -160.83 24.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.077 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.673 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.3 mt -40.84 108.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.863 0.364 . . . . 0.0 111.979 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.62 6.03 2.13 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.375 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.879 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -95.94 143.86 26.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 16.6 mt-30 -139.88 147.12 40.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.421 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.936 ' ND1' HG21 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -136.82 131.05 32.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.392 0.615 . . . . 0.0 110.421 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.643 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.93 152.76 43.83 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.019 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.815 HG13 ' CH2' ' A' ' 234' ' ' TRP . 5.3 p -166.38 156.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.196 0.522 . . . . 0.0 110.937 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 180' ' ' SER . 1.2 m120 -93.38 147.31 23.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.405 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.53 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 1.4 t -64.58 -3.22 2.92 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.978 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.744 HG21 ' N ' ' A' ' 178' ' ' GLY . 3.5 t -89.15 12.15 16.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.775 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.469 ' HG ' ' HB3' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -95.2 144.32 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.946 0.403 . . . . 0.0 111.238 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.53 -60.89 1.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.082 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.57 25.39 4.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.331 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.409 ' HG2' ' OG ' ' A' ' 202' ' ' SER . 0.2 OUTLIER -115.42 -1.05 12.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.764 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.96 ' O ' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -94.57 -22.96 0.24 Allowed Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.551 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 206' ' ' LEU . 22.2 Cg_exo -61.57 94.29 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.113 1.209 . . . . 0.0 111.384 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.936 HG21 ' ND1' ' A' ' 196' ' ' HIS . 45.5 t -80.61 102.06 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.34 0.591 . . . . 0.0 111.254 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 216' ' ' SER . 0.0 OUTLIER -69.46 97.22 0.97 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.624 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.077 HD23 HD12 ' A' ' 218' ' ' LEU . 1.5 mp -75.85 125.3 28.82 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.446 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -169.2 171.97 43.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.385 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.892 ' HB2' HG13 ' A' ' 225' ' ' VAL . 4.8 ttt180 -58.53 -90.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.478 ' O ' HG22 ' A' ' 213' ' ' VAL . 10.6 p -127.5 -9.57 4.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.622 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.1 OUTLIER -53.82 -173.86 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.713 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 27.0 Cg_exo -62.42 3.89 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.438 2.092 . . . . 0.0 112.877 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.543 ' HA ' ' HB3' ' A' ' 209' ' ' LYS . 0.9 OUTLIER -49.76 165.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.895 0.378 . . . . 0.0 111.577 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.539 ' HB3' HG13 ' A' ' 208' ' ' VAL . 3.4 m-20 -86.01 -31.36 22.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.679 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.077 HD12 HD23 ' A' ' 210' ' ' LEU . 2.9 mt -107.93 130.8 55.01 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -92.26 79.83 5.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.816 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.796 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.1 mm? -103.81 86.24 2.57 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.739 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 7.4 ptpt -59.51 20.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.607 ' HB3' HG12 ' A' ' 225' ' ' VAL . 6.3 t0 -48.99 125.73 11.03 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.2 t -63.41 -12.23 29.17 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.436 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 285' ' ' THR . 0.1 OUTLIER -82.49 -17.24 45.84 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.779 0.323 . . . . 0.0 110.544 179.159 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.892 HG13 ' HB2' ' A' ' 212' ' ' ARG . 7.4 p -108.83 94.5 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.065 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.14 -45.22 16.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.036 0.446 . . . . 0.0 110.836 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.43 -50.38 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.476 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.622 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 7.0 mttt -139.41 126.55 21.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.111 0.482 . . . . 0.0 110.466 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.704 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.5 t60 -100.54 -58.07 1.98 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.752 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -141.1 173.15 11.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.812 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.808 ' HA ' HD12 ' A' ' 210' ' ' LEU . 10.7 tt0 -151.98 154.3 35.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.302 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.0 mt -111.96 140.6 30.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-O 121.197 0.522 . . . . 0.0 111.276 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.415 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.35 149.87 17.61 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.28 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.815 ' CH2' HG13 ' A' ' 198' ' ' VAL . 4.0 p90 -139.47 166.34 24.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -115.42 132.77 56.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.138 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.7 m -92.81 -1.07 57.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.949 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.3 m -77.58 -28.19 51.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.674 0.749 . . . . 0.0 109.876 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.408 ' HB3' ' HD3' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -139.32 19.18 2.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.804 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.7 p90 39.84 62.09 1.31 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.578 0.704 . . . . 0.0 109.56 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.742 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 1.4 mptm? -122.91 138.95 54.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.902 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.657 ' CE3' HD13 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -123.43 122.35 38.05 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.492 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 7.8 pt-20 -130.68 145.53 51.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 122.388 1.09 . . . . 0.0 113.872 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -102.24 138.44 39.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.988 178.103 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.728 HG21 ' NE1' ' A' ' 269' ' ' TRP . 3.7 p -133.47 162.42 39.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.78 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.479 ' HB2' ' CB ' ' A' ' 260' ' ' SER . 25.1 t0 -88.16 139.66 30.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.311 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.532 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -86.98 32.54 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.102 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.86 47.92 77.51 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.916 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.45 -178.55 5.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.738 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -106.0 -28.32 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.139 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.738 ' H ' HD13 ' A' ' 249' ' ' LEU . 8.1 t-20 -75.37 -36.07 61.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.127 0.489 . . . . 0.0 111.622 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.12 116.24 1.71 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.825 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.645 ' C ' HD23 ' A' ' 253' ' ' LEU . 16.7 m -70.98 165.29 23.75 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.708 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -149.28 128.85 13.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.314 0.578 . . . . 0.0 111.394 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 1.046 HG23 HD12 ' A' ' 259' ' ' ILE . 86.1 t -105.57 132.81 51.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.453 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 255' ' ' ASN . 1.7 p-10 50.08 39.31 18.92 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.094 0.473 . . . . 0.0 110.084 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.95 27.68 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.534 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 0.4 OUTLIER -129.74 103.18 6.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.243 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 7.6 t -51.46 95.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.61 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 1.046 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -77.72 -23.01 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.416 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.479 ' CB ' ' HB2' ' A' ' 245' ' ' ASP . 24.7 p -74.37 169.19 18.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.408 ' C ' ' H ' ' A' ' 263' ' ' ASP . 0.2 OUTLIER -56.01 106.15 0.63 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 119.514 1.052 . . . . 0.0 111.086 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.5 17.91 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.004 2.469 . . . . 0.0 112.01 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 266' ' ' SER . 27.7 t70 -103.64 122.89 45.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.227 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 42.6 mt -55.56 148.64 15.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.527 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.47 -22.57 4.56 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.464 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 268' ' ' LYS . 2.0 t -95.12 76.43 3.48 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.074 0.95 . . . . 0.0 109.129 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 6.2 mtm105 -74.55 33.56 0.09 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.132 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 266' ' ' SER . 19.0 mttt -61.73 161.9 9.42 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.728 ' NE1' HG21 ' A' ' 244' ' ' VAL . 13.0 t-105 -72.96 -18.92 61.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.98 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 75.9 168.91 26.54 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.403 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -99.66 134.64 20.94 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.116 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.17 108.76 0.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.608 2.206 . . . . 0.0 113.687 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 259' ' ' ILE . 81.3 t -100.38 141.65 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 0.0 OUTLIER -83.03 129.3 35.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.07 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.772 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.91 165.72 12.52 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.022 178.243 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.49 161.99 36.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.3 OUTLIER -60.24 130.33 46.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.126 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 277' ' ' SER . 18.0 m-20 82.86 3.08 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.952 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.637 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 2.6 t0 -75.1 -162.56 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.547 HG23 ' CD1' ' A' ' 290' ' ' TYR . 0.5 OUTLIER -161.73 127.96 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.994 178.371 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.651 HG13 ' HG ' ' A' ' 243' ' ' LEU . 0.2 OUTLIER -107.78 157.29 8.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.302 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.708 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 5.6 m -150.64 134.94 17.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -129.27 47.56 2.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.337 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.12 -125.69 1.04 Allowed Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 119.493 -1.337 . . . . 0.0 113.638 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.47 ' N ' ' HG3' ' A' ' 224' ' ' GLU . 3.8 t -99.98 -37.23 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 0.0 110.823 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -149.74 -10.12 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.767 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 87.2 m -66.34 106.06 1.61 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 117.77 0.259 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.636 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -131.55 139.04 49.14 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.39 0.614 . . . . 0.0 111.619 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.63 HG13 ' N ' ' A' ' 186' ' ' VAL . 4.5 t -116.77 136.54 53.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.329 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.621 ' O ' HD13 ' A' ' 184' ' ' LEU . 1.8 t80 -76.75 136.09 39.02 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 109.917 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 275' ' ' LEU . 1.8 t -102.52 110.96 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.659 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.632 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -123.35 137.93 54.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.657 HD13 ' CE3' ' A' ' 241' ' ' TRP . 2.5 mt -137.62 117.93 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.42 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.5 146.63 47.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.897 0.38 . . . . 0.0 111.226 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.75 167.7 14.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.873 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -113.99 125.6 54.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -164.28 86.49 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.951 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.509 ' HB3' ' CG ' ' A' ' 199' ' ' ASN . 3.4 mp . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 120.333 0.111 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.68 ' HA3' ' CG2' ' A' ' 201' ' ' THR . . . 116.13 162.36 13.09 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.972 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.833 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 16.4 p -89.53 23.83 2.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.212 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 25.1 m -147.81 140.42 24.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.168 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.733 ' HB3' ' CE1' ' A' ' 183' ' ' PHE . 3.7 m95 -142.77 133.48 25.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.448 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.918 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.5 OUTLIER -121.82 130.31 53.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.918 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.7 OUTLIER -132.28 143.14 49.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.712 0.768 . . . . 0.0 111.308 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.803 ' CD1' HD11 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -137.9 148.69 45.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.402 177.522 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.478 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 9.0 tt0 -137.77 125.11 21.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.968 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.726 HG21 HD12 ' A' ' 194' ' ' LEU . 18.9 t -64.69 119.6 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.803 HG22 ' O ' ' A' ' 288' ' ' LYS . 3.8 tp -104.15 -23.41 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.817 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -159.2 91.8 1.04 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.47 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.631 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.71 -171.66 28.07 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.496 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 73.2 Cg_endo -81.43 31.26 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.878 1.719 . . . . 0.0 111.664 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.789 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.4 25.32 0.11 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.582 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.631 HG12 ' H ' ' A' ' 189' ' ' GLY . 7.5 mt -43.13 114.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.77 7.23 3.43 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.277 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.789 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -98.69 132.57 43.97 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.173 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.478 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 20.3 mt-30 -130.58 151.9 50.54 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.665 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.709 ' O ' HD22 ' A' ' 184' ' ' LEU . 1.4 t60 -143.23 139.79 30.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.255 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -131.84 148.08 52.53 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.05 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.848 HG21 ' HA ' ' A' ' 206' ' ' LEU . 11.8 p -159.16 141.77 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.513 ' OD1' ' CH2' ' A' ' 181' ' ' TRP . 3.1 m120 -88.03 161.55 17.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.013 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.517 ' HB2' ' NE1' ' A' ' 234' ' ' TRP . 60.0 p -68.78 -48.64 63.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.342 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.68 ' CG2' ' HA3' ' A' ' 178' ' ' GLY . 0.0 OUTLIER -62.23 1.84 0.29 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.63 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -83.04 129.7 35.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -89.72 -95.88 0.11 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.12 11.19 2.42 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -116.49 -17.79 10.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.684 0.278 . . . . 0.0 110.765 179.352 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.862 ' O ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -76.93 -42.93 2.81 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.801 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 6.2 Cg_endo -51.89 96.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.209 1.11 . . . . 0.0 112.118 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.67 ' O ' ' HG3' ' A' ' 231' ' ' GLN . 78.5 t -67.36 151.19 10.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -128.29 93.61 3.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.04 HD23 HD12 ' A' ' 218' ' ' LEU . 0.7 OUTLIER -84.76 127.88 34.33 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.306 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.514 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -173.39 174.21 45.97 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.02 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.906 ' HB2' HG13 ' A' ' 225' ' ' VAL . 2.0 ttm180 -69.98 -75.03 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.812 0.445 . . . . 0.0 111.834 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.668 HG22 ' H ' ' A' ' 214' ' ' SER . 9.2 p -121.82 -145.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.668 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.3 OUTLIER 65.91 179.03 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 118.731 0.696 . . . . 0.0 109.85 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 49.7 Cg_endo -69.58 28.7 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.089 1.859 . . . . 0.0 113.435 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 214' ' ' SER . 6.3 m -61.96 160.57 12.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.699 0.285 . . . . 0.0 110.679 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.77 -31.27 21.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.04 HD12 HD23 ' A' ' 210' ' ' LEU . 4.8 mt -111.49 133.13 53.99 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -92.52 76.46 5.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.415 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.783 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.1 mm? -97.99 62.52 1.58 Allowed 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.598 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 8.2 pttt -59.56 50.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 220' ' ' LEU . 22.6 t0 -97.32 124.4 41.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 t -39.82 -27.88 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.642 ' HG2' ' HA2' ' A' ' 284' ' ' GLY . 0.4 OUTLIER -60.8 -39.9 90.62 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.097 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.906 HG13 ' HB2' ' A' ' 212' ' ' ARG . 1.7 p -97.75 93.93 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.0 m -35.29 -62.05 0.41 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.105 0.479 . . . . 0.0 111.445 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 228' ' ' LYS . . . -133.33 -47.76 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 227' ' ' GLY . 3.6 mttt -144.19 127.3 16.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.493 -0.354 . . . . 0.0 110.172 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.478 ' O ' ' N ' ' A' ' 246' ' ' MET . 2.0 t-80 -96.09 -55.67 2.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.637 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 210' ' ' LEU . . . -140.12 159.65 41.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.411 0.624 . . . . 0.0 112.614 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.67 ' HG3' ' O ' ' A' ' 208' ' ' VAL . 0.1 OUTLIER -145.72 161.96 38.7 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.704 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.801 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.6 mt -124.13 149.4 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.8 162.03 41.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.661 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.675 ' CE3' HD21 ' A' ' 206' ' ' LEU . 0.6 OUTLIER -98.39 157.39 16.23 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -176.074 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 240' ' ' LYS . 2.0 t-20 -121.55 71.46 0.97 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.156 -1.384 . . . . 0.0 107.478 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 p -56.48 -19.44 15.38 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.9 m -75.54 -21.39 57.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.463 0.649 . . . . 0.0 110.567 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.53 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 0.3 OUTLIER -137.19 17.84 2.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.374 -179.04 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.407 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 19.7 p90 42.67 68.0 0.54 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 235' ' ' ASN . 0.2 OUTLIER -130.19 144.48 51.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.295 -179.311 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.56 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -119.29 102.96 9.07 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.5 pt-20 -125.96 144.71 50.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.107 0.956 . . . . 0.0 113.002 -177.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 1.005 HD11 HD11 ' A' ' 259' ' ' ILE . 2.6 pp -115.94 149.96 37.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.681 -1.599 . . . . 0.0 111.208 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.754 HG21 ' CD1' ' A' ' 269' ' ' TRP . 2.0 p -113.99 163.06 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.657 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.494 ' OD2' ' HA ' ' A' ' 260' ' ' SER . 6.1 m-20 -112.25 101.84 10.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.521 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -65.56 96.46 0.26 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.417 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.59 69.88 1.13 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.356 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 260' ' ' SER . 0.4 OUTLIER -65.4 57.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.529 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 250' ' ' ASN . 0.8 OUTLIER -53.38 -57.72 9.62 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.31 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.593 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.7 OUTLIER -78.77 -30.1 45.42 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.264 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.429 ' O ' HD23 ' A' ' 253' ' ' LEU . . . 92.07 125.82 3.67 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.513 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.465 ' O ' HG12 ' A' ' 259' ' ' ILE . 25.7 m -88.67 114.96 25.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.155 0.182 . . . . 0.0 110.601 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -103.98 130.51 51.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.278 0.561 . . . . 0.0 112.512 -178.684 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.88 ' CG2' HD13 ' A' ' 259' ' ' ILE . 33.1 t -108.55 131.95 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.63 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 280' ' ' ILE . 3.3 t-20 52.15 32.01 9.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.125 0.488 . . . . 0.0 109.877 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.8 m 68.82 21.04 7.84 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.686 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -120.49 93.35 4.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.802 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 21.7 p -43.79 97.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.356 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 1.005 HD11 HD11 ' A' ' 243' ' ' LEU . 14.4 pt -77.29 -53.88 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' HG13 ' A' ' 259' ' ' ILE . 36.9 p -45.8 160.44 0.06 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.513 ' CE1' ' H ' ' A' ' 267' ' ' ARG . 17.9 p80 -55.43 108.05 1.06 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 118.597 0.635 . . . . 0.0 111.673 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.53 22.39 0.34 Allowed 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.863 2.375 . . . . 0.0 111.63 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 261' ' ' HIS . 0.1 OUTLIER -107.49 112.1 24.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.355 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.75 164.58 14.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.299 0.571 . . . . 0.0 112.237 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.01 -22.46 4.29 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.178 -0.919 . . . . 0.0 114.269 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' A' ' 267' ' ' ARG . 36.8 m -81.49 -71.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.318 0.559 . . . . 0.0 112.335 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.8 OUTLIER 79.52 17.7 0.8 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.153 -179.022 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -46.85 156.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.754 ' CD1' HG21 ' A' ' 244' ' ' VAL . 28.2 t-105 -67.17 -24.87 65.92 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 79.97 157.81 14.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.099 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -96.6 140.94 22.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 85.8 Cg_exo -46.39 119.0 2.8 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.575 2.184 . . . . 0.0 112.788 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.854 ' HB ' HD12 ' A' ' 259' ' ' ILE . 84.9 t -100.91 136.22 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -85.0 128.6 34.7 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.97 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.926 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.48 165.58 12.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.08 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -137.43 155.61 49.13 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.582 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 89.0 p -63.78 133.21 53.06 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.258 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.582 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.0 OUTLIER 79.27 -4.99 2.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.254 -178.512 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.654 ' O ' HG23 ' A' ' 280' ' ' ILE . 3.5 t70 -67.61 -167.24 0.06 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.654 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.7 OUTLIER -162.09 131.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.645 178.233 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.943 HG22 HG12 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -104.02 148.13 9.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.139 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.667 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 1.6 m -138.89 116.95 11.71 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.482 ' O ' ' HB ' ' A' ' 287' ' ' THR . 0.1 OUTLIER -113.44 136.54 52.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.444 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.642 ' HA2' ' HG2' ' A' ' 224' ' ' GLU . . . 82.91 -129.14 8.88 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.666 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 t -95.11 -31.65 13.46 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -159.67 8.15 0.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.577 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 14.9 m -69.51 99.26 1.23 Allowed 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.542 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.803 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -111.86 115.26 28.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.456 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.943 HG12 HG22 ' A' ' 281' ' ' ILE . 4.4 p -103.17 131.03 52.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 122.205 -0.31 . . . . 0.0 110.827 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.2 t80 -76.22 132.49 39.94 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.926 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.6 t -103.56 114.62 43.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.652 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.52 ' HD2' ' H ' ' A' ' 293' ' ' ILE . 5.6 tpt180 -132.0 143.85 50.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.235 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.753 HD11 HD23 ' A' ' 275' ' ' LEU . 8.8 mt -143.13 122.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.697 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.79 159.1 38.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.941 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 9.7 m -89.29 -179.12 5.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.833 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 2.8 tp60 -115.4 120.66 40.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.484 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -77.37 88.42 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.316 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.738 179.702 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.629 HD23 ' CZ2' ' A' ' 181' ' ' TRP . 1.3 mp . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 121.184 0.516 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.738 ' HA3' HG21 ' A' ' 201' ' ' THR . . . 70.75 165.6 6.03 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.817 -0.629 . . . . 0.0 113.353 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.746 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 0.3 OUTLIER -87.94 33.21 0.72 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.887 -0.656 . . . . 0.0 111.978 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.458 ' HB3' ' OG ' ' A' ' 200' ' ' SER . 0.5 OUTLIER -142.75 135.27 27.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.498 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 10.9 m95 -147.09 142.06 26.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.849 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.789 HD11 ' CD1' ' A' ' 184' ' ' LEU . 1.5 tp -125.96 122.72 36.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.701 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.4 m-85 -121.31 141.23 51.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.795 0.807 . . . . 0.0 111.313 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.971 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -139.65 149.01 43.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.526 178.668 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.523 ' C ' HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -139.52 125.98 20.36 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.789 HG21 HD12 ' A' ' 194' ' ' LEU . 21.7 t -62.06 116.48 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.909 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.5 tt -100.03 -19.34 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.851 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.54 91.9 0.6 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.719 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -160.9 -171.12 26.43 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.68 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 64.0 Cg_endo -81.59 32.54 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.006 1.804 . . . . 0.0 111.311 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.845 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.49 22.12 0.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.574 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.719 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.4 mt -39.81 111.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.08 7.65 3.19 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.109 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.845 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.2 OUTLIER -96.24 131.9 42.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.441 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 9.6 mt-30 -129.07 151.11 50.11 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.465 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.971 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -146.87 148.14 31.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.771 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.23 144.73 34.88 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.778 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.931 HG21 ' HA ' ' A' ' 206' ' ' LEU . 2.1 p -147.66 139.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.393 0.616 . . . . 0.0 111.437 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.45 ' ND2' ' HG ' ' A' ' 177' ' ' LEU . 1.3 p30 -92.65 148.36 22.13 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.768 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.568 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 61.5 m -66.19 -1.12 2.95 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.738 HG21 ' HA3' ' A' ' 178' ' ' GLY . 0.1 OUTLIER -111.38 11.66 21.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.054 0.454 . . . . 0.0 111.0 178.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.705 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -106.74 120.04 40.94 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.746 178.71 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -76.41 0.45 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.5 t -62.93 1.51 0.41 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -122.15 -10.19 8.58 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.083 -0.385 . . . . 0.0 110.814 178.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.931 ' HA ' HG21 ' A' ' 198' ' ' VAL . 5.1 tt -62.09 -63.38 4.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.618 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.7 Cg_endo -43.03 88.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.412 2.075 . . . . 0.0 113.174 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.741 ' O ' HG12 ' A' ' 208' ' ' VAL . 1.7 t -69.51 85.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.461 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 216' ' ' SER . 1.3 mtpt -69.82 97.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.134 HD23 HD12 ' A' ' 218' ' ' LEU . 1.5 mp -82.93 127.94 33.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.424 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -167.35 167.61 40.0 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.571 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.924 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 4.7 ttt180 -56.54 -90.75 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.696 HG12 ' HD3' ' A' ' 212' ' ' ARG . 14.0 p -124.01 -9.89 6.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.69 0.281 . . . . 0.0 111.477 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.545 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 0.6 OUTLIER -50.88 178.94 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.217 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 21.0 Cg_endo -63.51 13.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.661 1.574 . . . . 0.0 112.493 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.532 ' H ' ' C ' ' A' ' 214' ' ' SER . 16.3 m -52.82 166.96 0.17 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 111.193 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -84.75 -26.09 27.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.761 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.134 HD12 HD23 ' A' ' 210' ' ' LEU . 1.2 mt -111.53 130.99 55.55 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -94.96 82.09 3.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.726 0.298 . . . . 0.0 111.355 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.77 HD21 HD13 ' A' ' 218' ' ' LEU . 3.2 mm? -102.14 63.85 0.92 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.924 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -51.9 72.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.445 -178.728 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.68 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 3.4 t0 -127.49 137.18 52.59 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-O 120.992 0.425 . . . . 0.0 110.774 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 43.9 t -51.31 -36.84 44.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.477 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.628 ' CD ' ' HA3' ' A' ' 284' ' ' GLY . 2.4 pt-20 -44.71 -45.71 9.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.015 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.879 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.2 p -102.29 107.68 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.655 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.63 -51.7 20.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.224 0.535 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.94 -46.67 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.41 ' NZ ' ' HG2' ' A' ' 215' ' ' PRO . 0.1 OUTLIER -136.64 120.63 17.62 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.67 ' CE1' ' HB3' ' A' ' 283' ' ' LEU . 44.3 t-80 -92.2 -61.1 1.68 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.702 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -140.08 176.84 8.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.526 0.679 . . . . 0.0 112.315 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.738 ' HA ' HD12 ' A' ' 210' ' ' LEU . 10.6 tt0 -159.19 162.69 36.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.909 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.593 HG12 ' HB3' ' A' ' 243' ' ' LEU . 54.4 mt -124.72 144.31 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.563 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.716 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.87 163.41 32.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.12 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.886 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 12.1 p90 -154.91 166.59 33.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -115.47 133.14 56.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.304 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.48 -2.87 57.94 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.295 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.5 m -76.43 -26.03 55.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.768 0.794 . . . . 0.0 110.231 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 239' ' ' PHE . 10.9 tptt -138.8 21.91 2.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.648 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.445 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 7.7 p90 35.48 60.09 0.76 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.638 0.732 . . . . 0.0 109.722 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.886 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.1 OUTLIER -125.09 141.0 52.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.126 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.792 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 1.3 m95 -122.25 126.51 48.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.395 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.4 pt-20 -143.2 144.52 32.21 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.808 0.813 . . . . 0.0 113.142 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.659 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.5 pp -111.09 152.08 27.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.776 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.692 HG21 ' CD1' ' A' ' 269' ' ' TRP . 2.8 p -121.32 163.18 19.48 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.617 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 248' ' ' SER . 2.6 m-20 -105.27 104.41 14.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.512 ' HG2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -71.4 97.26 1.59 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.428 177.755 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.09 65.67 3.23 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.312 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 0.2 OUTLIER -70.32 59.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 1.016 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -54.35 -52.69 60.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.338 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 1.016 ' N ' HD22 ' A' ' 249' ' ' LEU . 2.5 m120 -74.37 -30.98 62.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.933 0.397 . . . . 0.0 111.304 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 95.55 99.56 1.79 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.19 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.808 HG23 HD12 ' A' ' 283' ' ' LEU . 1.6 m -64.97 114.85 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.021 -0.105 . . . . 0.0 110.993 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 258' ' ' SER . 2.4 mt -101.57 130.02 47.78 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.489 -0.484 . . . . 0.0 112.009 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.913 HG23 HD12 ' A' ' 259' ' ' ILE . 99.0 t -105.48 127.66 60.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.859 ' HA ' HD12 ' A' ' 280' ' ' ILE . 1.8 t30 55.14 40.75 31.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 110.215 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.12 32.1 21.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.532 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.6 OUTLIER -138.83 107.93 6.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.795 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.469 ' HB3' HD22 ' A' ' 253' ' ' LEU . 25.0 p -55.15 91.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.541 0.686 . . . . 0.0 111.45 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.965 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -78.56 -23.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.788 -178.413 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.756 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 13.9 t -80.75 -174.26 4.65 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 263' ' ' ASP . 1.7 t-160 -103.41 78.63 0.29 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 119.248 0.931 . . . . 0.0 110.047 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.756 ' HD3' ' O ' ' A' ' 260' ' ' SER . 16.1 Cg_exo -43.21 84.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.388 2.725 . . . . 0.0 113.539 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 266' ' ' SER . 1.0 OUTLIER -124.73 94.1 4.09 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.034 179.231 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.814 HD22 ' H ' ' A' ' 264' ' ' LEU . 1.6 mm? -47.6 -40.47 19.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.454 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.17 -27.05 53.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.446 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 263' ' ' ASP . 10.5 p -78.87 -44.19 23.39 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.505 ' HD3' ' HB3' ' A' ' 249' ' ' LEU . 0.5 OUTLIER 49.9 25.55 1.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.048 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.39 159.9 4.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.436 0.636 . . . . 0.0 112.076 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.692 ' CD1' HG21 ' A' ' 244' ' ' VAL . 20.5 t-105 -72.82 -22.58 60.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.598 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 74.44 163.63 10.21 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.574 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -99.99 150.63 37.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.3 . . . . 0.0 110.397 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.61 145.4 17.2 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.411 2.074 . . . . 0.0 112.514 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.965 HG21 ' CG1' ' A' ' 259' ' ' ILE . 93.6 t -130.87 130.22 64.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.771 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 3.2 mp0 -80.83 129.02 34.31 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.877 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.869 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -94.02 166.7 12.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.935 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.629 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.62 159.62 41.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.151 0.5 . . . . 0.0 112.014 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 0.1 OUTLIER -62.0 129.4 40.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.143 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 277' ' ' SER . 0.3 OUTLIER 86.73 1.52 0.52 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.309 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.629 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -72.72 -170.98 0.76 Allowed 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.859 HD12 ' HA ' ' A' ' 255' ' ' ASN . 1.0 OUTLIER -163.22 122.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 176.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.825 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -97.12 156.12 3.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.156 177.071 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 288' ' ' LYS . 21.3 m -141.51 114.68 8.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.912 HD22 ' O ' ' A' ' 287' ' ' THR . 0.0 OUTLIER -113.8 141.48 47.25 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.335 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.628 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 84.52 -133.32 11.73 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.126 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 t -97.93 -36.03 10.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.658 0.266 . . . . 0.0 111.516 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -152.37 7.49 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.912 ' O ' HD22 ' A' ' 283' ' ' LEU . 25.8 m -76.78 101.16 5.73 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.838 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.909 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -124.54 134.39 53.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.072 -179.641 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.523 HG23 ' C ' ' A' ' 185' ' ' GLU . 9.1 p -113.53 139.61 38.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.876 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.8 t80 -76.55 132.17 39.36 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.765 0.317 . . . . 0.0 110.232 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 275' ' ' LEU . 6.1 t -103.01 112.01 34.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.479 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.52 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.4 OUTLIER -129.47 138.11 51.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 111.338 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.869 HD11 HD23 ' A' ' 275' ' ' LEU . 13.3 mt -132.89 139.79 48.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.431 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 40.7 m -155.49 164.21 38.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.913 0.387 . . . . 0.0 111.423 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.26 -173.22 2.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.683 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.746 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 11.8 tp60 -112.55 134.49 54.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.727 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -150.98 92.97 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.687 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.024 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.564 ' HA ' HG21 ' A' ' 201' ' ' THR . 5.1 mp . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.738 0.304 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.552 ' H ' HG21 ' A' ' 201' ' ' THR . . . 107.81 60.81 0.56 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.92 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 23.5 p -125.96 -60.12 1.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 110.387 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.514 ' OG ' ' HB3' ' A' ' 200' ' ' SER . 0.1 OUTLIER -142.56 -174.36 4.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.626 179.125 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 3.2 m95 -148.57 138.97 22.58 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.545 -0.462 . . . . 0.0 112.203 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.972 HD11 ' CD2' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -123.77 140.71 52.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.96 178.167 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.845 ' N ' HD12 ' A' ' 182' ' ' LEU . 6.2 m-85 -137.7 140.54 40.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.535 0.684 . . . . 0.0 110.442 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.972 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.0 mm? -123.96 140.95 52.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.889 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.519 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -135.35 116.7 14.61 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.981 HG21 HD12 ' A' ' 194' ' ' LEU . 6.0 t -66.98 98.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.0 tt -82.03 -24.5 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.843 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -166.24 98.9 0.62 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.685 ' HA3' HG23 ' A' ' 287' ' ' THR . . . -162.49 -169.15 25.46 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.545 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 98.0 Cg_endo -80.13 29.67 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.358 2.038 . . . . 0.0 110.642 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.795 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.13 25.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.637 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.6 mt -40.82 106.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.969 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.43 2.65 2.88 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.898 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.981 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -96.73 165.19 12.25 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 118.106 0.953 . . . . 0.0 108.692 177.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 5.0 mt-30 -156.72 146.18 20.6 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.063 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.923 ' CD2' HG11 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -136.12 128.43 30.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.183 0.516 . . . . 0.0 109.852 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 182' ' ' LEU . . . -130.8 165.1 23.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.899 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.613 HG11 ' HG ' ' A' ' 206' ' ' LEU . 11.9 p -175.25 143.86 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 121.327 0.584 . . . . 0.0 112.264 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.404 ' HB2' HG22 ' A' ' 201' ' ' THR . 0.4 OUTLIER -85.78 147.96 26.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.382 178.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.514 ' HB3' ' OG ' ' A' ' 180' ' ' SER . 15.3 t -62.65 -9.42 8.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.564 HG21 ' HA ' ' A' ' 177' ' ' LEU . 2.9 t -95.04 36.85 1.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.973 0.416 . . . . 0.0 111.882 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.427 ' HB2' ' CG ' ' A' ' 205' ' ' LYS . 4.7 p -128.59 108.74 10.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.403 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 3.4 m -70.71 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.228 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.7 m -86.99 8.37 23.58 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.427 ' CG ' ' HB2' ' A' ' 202' ' ' SER . 9.0 pttt -118.41 52.74 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.796 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 8.2 tt -143.77 -52.4 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.943 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 3.7 Cg_exo -40.57 93.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.41 2.074 . . . . 0.0 113.384 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.923 HG11 ' CD2' ' A' ' 196' ' ' HIS . 59.8 t -73.25 107.91 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.923 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.624 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 19.5 mtmt -77.91 90.99 4.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.446 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.964 HD23 HD12 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -78.51 136.75 37.65 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . 164.63 -161.22 34.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.964 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.714 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.0 OUTLIER -73.65 171.72 12.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.393 -0.404 . . . . 0.0 111.487 -179.521 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 213' ' ' VAL . 7.2 p -73.87 110.95 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 122.2 1.0 . . . . 0.0 111.833 -176.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 215' ' ' PRO . 12.4 p -171.11 -163.0 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 113.435 -1.711 . . . . 0.0 107.864 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 62.3 Cg_exo -51.8 -12.0 1.05 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.475 1.45 . . . . 0.0 112.665 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.421 ' OG ' ' HG2' ' A' ' 228' ' ' LYS . 0.1 OUTLIER -51.45 -178.36 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.962 0.411 . . . . 0.0 111.714 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.41 -37.72 8.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.964 HD12 HD23 ' A' ' 210' ' ' LEU . 0.4 OUTLIER -100.47 140.53 34.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.641 179.087 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -103.06 78.18 1.62 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.892 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.772 HD21 HD13 ' A' ' 218' ' ' LEU . 2.9 mm? -102.49 91.72 4.36 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.545 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 1.5 ptpt -66.44 56.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.962 0.411 . . . . 0.0 110.653 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.551 ' HB3' HG12 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -88.96 123.35 33.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.518 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.0 p -66.25 -7.11 16.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.664 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.515 ' O ' HD11 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -87.87 -24.47 23.66 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.759 0.314 . . . . 0.0 110.699 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 225' ' ' VAL . 7.2 p -100.66 93.4 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.02 0.438 . . . . 0.0 110.835 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.15 -38.71 18.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.053 0.454 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.13 -57.53 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.786 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 211' ' ' GLY . 25.4 mtmm -143.7 129.02 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.421 0.629 . . . . 0.0 111.688 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.454 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 2.2 t-80 -89.84 -61.82 1.6 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.154 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.564 ' C ' ' HE3' ' A' ' 246' ' ' MET . . . -140.72 171.17 14.47 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.663 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.8 OUTLIER -157.88 168.89 25.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.24 179.013 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.943 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 8.0 mt -125.39 138.16 55.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.604 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.48 163.64 32.4 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.671 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -96.25 148.0 23.19 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.491 ' HB2' ' HD3' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -119.53 71.99 0.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.276 174.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.7 p -54.11 -21.13 7.86 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 46.3 m -73.72 -27.86 61.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.632 0.73 . . . . 0.0 109.33 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.433 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 20.0 tptt -116.31 6.29 13.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.465 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 235' ' ' ASN . 8.0 p90 37.05 49.56 0.83 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.885 0.374 . . . . 0.0 110.669 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 235' ' ' ASN . 0.0 OUTLIER -119.8 176.21 5.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 0.0 109.78 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.839 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -124.61 110.0 13.88 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 0.7 OUTLIER -132.15 151.2 51.91 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.147 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.703 ' O ' HD12 ' A' ' 243' ' ' LEU . 3.3 pp -119.16 152.65 36.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.579 -1.646 . . . . 0.0 111.456 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.592 HG13 ' HE1' ' A' ' 246' ' ' MET . 4.7 p -119.33 162.6 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.139 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 13.6 m-20 -118.86 121.8 40.85 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.677 ' HB3' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -93.83 107.85 19.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.957 178.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 267' ' ' ARG . . . 48.59 62.34 4.51 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.374 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.23 74.75 0.23 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.809 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -59.66 -48.77 80.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.859 178.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.809 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -78.7 -39.51 36.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.048 0.451 . . . . 0.0 110.851 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.736 ' HA3' ' HB3' ' A' ' 262' ' ' PRO . . . 97.05 93.0 1.87 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.359 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.61 HG22 ' CD1' ' A' ' 281' ' ' ILE . 1.9 m -47.29 156.59 0.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.297 -0.261 . . . . 0.0 110.297 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.715 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -148.12 130.23 15.45 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.179 0.514 . . . . 0.0 111.521 179.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.974 HG23 HD12 ' A' ' 259' ' ' ILE . 55.5 t -104.14 130.04 55.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.829 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 55.09 42.33 30.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.048 0.451 . . . . 0.0 110.329 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.15 23.1 12.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.992 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.7 112.03 15.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.373 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 85.9 p -63.12 99.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.431 0.634 . . . . 0.0 112.174 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.974 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -79.45 -47.68 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.774 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.714 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 4.7 t -56.06 171.74 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.469 ' CD2' ' HD3' ' A' ' 268' ' ' LYS . 0.5 OUTLIER -102.75 92.05 3.24 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.249 0.477 . . . . 0.0 110.104 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.736 ' HB3' ' HA3' ' A' ' 251' ' ' GLY . 17.3 Cg_endo -95.54 32.09 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.808 3.006 . . . . 0.0 112.946 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.512 ' HB3' HD22 ' A' ' 264' ' ' LEU . 10.1 t0 -78.69 -134.35 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.763 ' N ' HD22 ' A' ' 264' ' ' LEU . 0.0 OUTLIER -44.26 -100.85 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.606 ' H ' HD23 ' A' ' 264' ' ' LEU . . . -150.35 37.53 0.91 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.548 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.492 ' H ' HD23 ' A' ' 264' ' ' LEU . 47.4 t -63.39 -32.78 74.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.782 0.325 . . . . 0.0 111.704 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.534 ' HB3' ' HA2' ' A' ' 247' ' ' GLY . 31.1 mmt-85 41.22 20.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.422 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.469 ' HD3' ' CD2' ' A' ' 261' ' ' HIS . 11.2 ptmt -60.33 157.46 13.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.701 0.8 . . . . 0.0 112.521 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.677 ' CH2' ' HB3' ' A' ' 246' ' ' MET . 2.8 m95 -63.77 -30.31 71.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.234 -0.893 . . . . 0.0 108.768 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 72.53 165.13 8.13 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.15 122.86 72.35 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.701 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 34.2 Cg_exo -31.05 111.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.21 2.607 . . . . 0.0 112.846 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.714 HG11 HG21 ' A' ' 259' ' ' ILE . 62.5 t -87.58 130.18 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.388 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -78.3 131.71 37.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.977 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.727 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -98.0 164.26 12.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.121 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.85 152.67 45.3 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.647 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.9 OUTLIER -54.62 130.89 41.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.362 179.031 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 277' ' ' SER . 9.0 m-20 82.17 -3.65 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.738 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.951 ' O ' HG23 ' A' ' 291' ' ' VAL . 1.2 m-20 -77.24 141.15 40.15 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.744 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.513 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -100.72 124.79 54.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 119.789 -0.765 . . . . 0.0 109.728 178.541 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.791 HG12 HG22 ' A' ' 254' ' ' VAL . 0.3 OUTLIER -110.46 94.61 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.324 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -82.49 138.38 34.35 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.524 -0.735 . . . . 0.0 109.589 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.753 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -130.39 53.1 1.97 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.372 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 168.16 -122.5 1.03 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.494 -1.336 . . . . 0.0 113.43 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.5 t -98.0 -44.8 6.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.636 0.255 . . . . 0.0 110.675 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -147.64 1.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.1 m -79.32 104.75 10.15 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.785 ' O ' HG22 ' A' ' 187' ' ' ILE . 9.0 ptpt -126.19 131.02 52.08 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.796 0.807 . . . . 0.0 111.931 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.621 HG11 ' CE1' ' A' ' 196' ' ' HIS . 14.9 t -106.2 132.1 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.758 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 278' ' ' ASP . 1.7 t80 -77.17 130.89 37.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.951 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.2 OUTLIER -100.75 113.64 37.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.734 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -131.09 136.16 48.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.742 0.306 . . . . 0.0 110.82 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.839 HD12 ' CE3' ' A' ' 241' ' ' TRP . 2.4 mt -135.46 139.65 46.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 3.2 m -142.81 156.09 44.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.776 0.322 . . . . 0.0 111.14 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.3 m -85.73 159.22 19.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -86.82 145.53 26.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.786 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -144.72 95.04 2.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.996 179.921 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.507 ' HA ' ' CG2' ' A' ' 201' ' ' THR . 2.6 mp . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.621 0.248 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.667 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.12 97.59 2.15 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.231 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.77 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.42 175.25 9.69 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.652 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.6 m95 -145.29 131.77 19.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.672 HD23 ' HZ3' ' A' ' 234' ' ' TRP . 5.1 tp -118.12 128.2 54.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.214 177.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 1.1 m-85 -128.99 138.57 52.03 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.553 0.692 . . . . 0.0 110.799 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.77 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.5 mp -140.89 153.01 45.51 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.586 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.604 ' C ' HG23 ' A' ' 289' ' ' VAL . 23.3 tt0 -144.61 124.85 13.73 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.674 ' N ' HG23 ' A' ' 289' ' ' VAL . 22.0 t -59.49 113.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.7 tt -97.02 -20.76 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -176.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.719 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -157.76 91.27 1.12 Allowed 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.327 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.757 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.76 178.57 38.45 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.477 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 71.9 Cg_endo -75.4 32.13 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 121.79 1.66 . . . . 0.0 111.185 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.719 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -163.94 28.92 0.08 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.966 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.757 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.7 mt -43.55 119.75 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.112 0.482 . . . . 0.0 112.239 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.24 -48.46 0.92 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.726 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.719 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.7 OUTLIER -40.9 143.84 0.33 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.302 0.573 . . . . 0.0 110.752 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.77 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 5.2 mt-30 -141.64 152.03 43.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.776 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.998 ' CE1' HD21 ' A' ' 210' ' ' LEU . 1.8 p80 -139.63 131.59 27.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.268 0.556 . . . . 0.0 109.635 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.86 153.6 40.34 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.38 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.9 HG21 ' HA ' ' A' ' 206' ' ' LEU . 7.2 p -160.92 161.24 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.349 0.595 . . . . 0.0 111.725 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.569 ' N ' HG22 ' A' ' 198' ' ' VAL . 1.4 t-20 -98.59 143.33 29.11 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.705 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.496 ' HA ' ' HE1' ' A' ' 234' ' ' TRP . 16.2 t -60.76 1.48 0.14 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.667 HG21 ' N ' ' A' ' 178' ' ' GLY . 1.3 t -107.09 -8.08 16.65 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.601 0.36 . . . . 0.0 111.562 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.495 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -69.05 118.13 11.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.027 0.441 . . . . 0.0 110.452 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 72.8 m -66.42 -101.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.1 m -91.41 20.1 5.55 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.24 -9.0 11.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.205 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.9 ' HA ' HG21 ' A' ' 198' ' ' VAL . 7.8 tt -67.74 -61.21 4.55 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.681 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -43.28 101.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.005 1.803 . . . . 0.0 112.395 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.94 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 98.7 t -67.26 165.52 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.564 ' N ' HG12 ' A' ' 208' ' ' VAL . 15.7 mtmt -136.9 90.12 2.51 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.998 HD21 ' CE1' ' A' ' 196' ' ' HIS . 0.5 OUTLIER -79.97 123.91 28.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.138 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . -165.98 167.69 39.35 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.391 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 1.094 ' HB2' HG13 ' A' ' 225' ' ' VAL . 4.7 ttt-85 -66.36 -73.01 0.14 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.738 HG13 ' HG2' ' A' ' 215' ' ' PRO . 15.0 p -79.39 159.42 4.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 213' ' ' VAL . 1.0 OUTLIER -31.07 -52.78 0.42 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -178.032 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.738 ' HG2' HG13 ' A' ' 213' ' ' VAL . 2.9 Cg_endo -42.52 -24.76 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.205 1.936 . . . . 0.0 113.153 -177.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.429 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -83.93 156.51 22.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -69.96 -36.24 75.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.564 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.992 HD12 HD23 ' A' ' 210' ' ' LEU . 2.0 mt -103.68 134.35 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.427 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -90.31 73.32 7.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.562 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.838 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -97.15 68.39 2.25 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.594 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 2.2 pttt -60.71 39.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.52 ' HB3' ' HG3' ' A' ' 224' ' ' GLU . 12.4 t0 -90.23 131.23 36.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.5 p -46.51 -33.57 4.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.207 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 1.1 pp20? -52.21 -32.03 34.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.341 . . . . 0.0 111.233 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.094 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.1 p -104.33 97.72 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.54 -46.99 14.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.203 0.525 . . . . 0.0 110.574 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.32 -50.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.428 ' HB2' ' SD ' ' A' ' 246' ' ' MET . 3.6 mptp? -140.85 127.01 19.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.237 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.653 ' HA ' ' HB2' ' A' ' 248' ' ' SER . 0.2 OUTLIER -94.55 -55.22 3.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.631 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -151.87 177.0 10.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.286 0.565 . . . . 0.0 111.996 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.94 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 3.9 mt-30 -156.84 -178.01 7.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.222 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.858 HG12 HD11 ' A' ' 243' ' ' LEU . 0.9 OUTLIER -125.36 141.76 44.28 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.249 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.24 127.18 3.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.85 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.8 p90 -124.92 167.53 14.56 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -112.62 133.16 54.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.137 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.22 -1.96 50.58 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.515 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.7 m -80.55 -35.04 34.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.588 0.709 . . . . 0.0 109.593 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.529 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 33.8 tptt -121.91 10.4 10.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.596 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 24.4 p90 45.18 63.04 1.89 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.495 0.664 . . . . 0.0 109.694 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.85 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.2 OUTLIER -129.14 138.18 51.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.121 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.724 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -119.91 126.75 51.67 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.731 179.043 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 272' ' ' PRO . 27.1 mt-10 -142.58 146.35 34.5 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.859 HD23 ' CD1' ' A' ' 281' ' ' ILE . 0.3 OUTLIER -97.92 150.94 20.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.767 -1.561 . . . . 0.0 109.486 178.601 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.613 HG21 ' NE1' ' A' ' 269' ' ' TRP . 4.5 p -141.67 162.85 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.901 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.606 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 18.8 t70 -84.63 138.82 32.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.412 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.547 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -88.92 31.63 0.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.722 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.47 50.48 59.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.769 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.653 ' HB2' ' HA ' ' A' ' 229' ' ' HIS . 32.6 t -92.6 168.97 10.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.836 0.35 . . . . 0.0 111.146 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 250' ' ' ASN . 3.1 pp -93.01 -43.82 8.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.439 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.592 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.8 OUTLIER -68.32 -19.03 64.65 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.546 0.689 . . . . 0.0 109.921 -178.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.596 ' HA3' ' CG ' ' A' ' 261' ' ' HIS . . . 76.27 147.75 2.24 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.364 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.727 HG23 HD23 ' A' ' 283' ' ' LEU . 6.0 m -103.66 152.29 21.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.608 0.242 . . . . 0.0 110.99 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -140.13 138.88 35.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.053 177.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.851 HG23 ' CD1' ' A' ' 259' ' ' ILE . 95.5 t -110.03 133.62 54.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.956 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.873 ' HA ' HD12 ' A' ' 280' ' ' ILE . 0.7 OUTLIER 52.98 38.32 26.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.332 -178.586 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.47 36.87 2.11 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.436 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.633 ' O ' HG23 ' A' ' 259' ' ' ILE . 20.0 t-80 -148.29 117.53 6.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 91.9 p -63.5 86.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.251 0.548 . . . . 0.0 110.275 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -84.92 -13.08 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.229 -178.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.801 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 1.5 t -124.34 -16.87 6.26 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.668 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 57.2 t60 -111.35 43.74 0.22 Allowed Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.801 ' HD3' ' C ' ' A' ' 260' ' ' SER . 22.8 Cg_exo -66.05 -2.05 6.2 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.042 1.828 . . . . 0.0 113.506 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.701 ' O ' ' HB2' ' A' ' 266' ' ' SER . 38.2 m-20 -135.87 101.1 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.446 0.641 . . . . 0.0 111.167 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.853 ' H ' HD23 ' A' ' 264' ' ' LEU . 0.4 OUTLIER -63.31 147.54 50.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.266 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.53 -31.49 2.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.56 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.701 ' HB2' ' O ' ' A' ' 263' ' ' ASP . 2.9 m -59.83 -42.0 92.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.129 0.49 . . . . 0.0 111.571 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 248' ' ' SER . 30.4 ttp180 53.72 28.06 7.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.947 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -68.96 168.3 13.99 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.472 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.613 ' NE1' HG21 ' A' ' 244' ' ' VAL . 14.7 t-105 -84.61 -19.59 32.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.705 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 64.25 -172.98 16.1 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.782 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.487 ' HB2' ' HD2' ' A' ' 272' ' ' PRO . 29.2 p30 -110.38 158.97 33.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 117.524 0.662 . . . . 0.0 110.304 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.621 ' HB2' ' HB2' ' A' ' 242' ' ' GLU . 58.7 Cg_endo -72.99 114.3 4.0 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.296 1.997 . . . . 0.0 113.628 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.724 HG21 ' HB ' ' A' ' 259' ' ' ILE . 66.9 t -97.38 138.53 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.3 pm0 -76.24 123.45 25.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.131 0.967 . . . . 0.0 113.572 -176.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.85 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -90.87 163.96 14.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.525 -1.671 . . . . 0.0 109.167 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.639 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -146.87 162.75 38.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.634 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 26.3 t -60.34 127.77 33.41 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.849 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.634 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 86.09 7.85 0.32 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.273 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.639 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -83.61 -166.66 1.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -161.48 128.84 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.603 177.246 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.859 ' CD1' HD23 ' A' ' 243' ' ' LEU . 0.0 OUTLIER -99.28 147.13 7.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.591 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.716 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 0.6 OUTLIER -134.17 125.57 28.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.627 0.727 . . . . 0.0 110.226 178.158 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.727 HD23 HG23 ' A' ' 252' ' ' THR . 0.1 OUTLIER -125.72 131.61 52.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.897 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 224' ' ' GLU . . . 86.26 -127.95 8.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.143 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 t -96.94 -30.67 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -160.46 5.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 7.2 m -64.69 99.67 0.34 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.898 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.812 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -117.97 125.21 49.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -177.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.783 HG12 HG22 ' A' ' 281' ' ' ILE . 6.3 p -113.26 136.47 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.224 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.671 ' HD1' HG23 ' A' ' 280' ' ' ILE . 1.0 OUTLIER -78.19 140.54 38.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.884 0.373 . . . . 0.0 110.373 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -108.82 114.13 45.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.046 -179.49 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.603 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.9 OUTLIER -130.05 140.99 50.77 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.812 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.667 HG12 HD13 ' A' ' 182' ' ' LEU . 11.6 mt -138.95 119.87 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 181' ' ' TRP . 0.1 OUTLIER -130.81 149.99 52.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 0.0 111.268 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.86 164.07 16.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.4 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -117.19 137.64 52.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.981 0.42 . . . . 0.0 111.486 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -119.54 87.35 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.022 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.916 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.514 ' N ' HD22 ' A' ' 177' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.767 0.318 . . . . 0.0 110.896 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.65 -123.71 6.02 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.434 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 90.5 p -179.24 103.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.841 0.353 . . . . 0.0 111.041 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.615 ' N ' ' HB3' ' A' ' 296' ' ' GLN . 0.1 OUTLIER -174.62 165.8 3.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.508 0.671 . . . . 0.0 112.167 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 1.2 m95 -137.22 135.71 37.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.188 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.937 HD11 ' CD2' ' A' ' 184' ' ' LEU . 1.1 tp -126.66 133.97 50.84 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.883 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.0 m-85 -133.42 137.1 45.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.63 0.728 . . . . 0.0 110.447 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.937 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.3 mm? -119.62 139.72 51.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.414 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -134.49 112.25 10.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 220' ' ' LEU . 40.6 t -60.1 98.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.132 0.492 . . . . 0.0 109.907 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.815 HG22 ' O ' ' A' ' 288' ' ' LYS . 11.5 tt -77.04 -23.2 14.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.929 -177.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.802 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -167.96 99.95 0.46 Allowed 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.492 ' HA3' HG23 ' A' ' 287' ' ' THR . . . -161.9 -177.0 34.59 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.679 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 64.0 Cg_endo -79.82 34.5 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.96 1.773 . . . . 0.0 111.573 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.987 ' HB3' HD13 ' A' ' 220' ' ' LEU . . . -162.99 26.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 192' ' ' ILE . 0.7 OUTLIER -39.16 106.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.908 0.385 . . . . 0.0 110.592 -179.709 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.89 3.41 1.74 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.105 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.911 HD21 ' HB1' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -99.31 141.74 31.7 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 117.724 0.762 . . . . 0.0 109.296 177.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 22.2 mt-30 -137.05 147.88 46.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.802 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 1.203 ' CD2' HD21 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -137.41 128.09 26.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.021 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -148.13 164.58 33.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.582 HG13 ' CH2' ' A' ' 234' ' ' TRP . 3.5 p -171.19 158.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.336 0.589 . . . . 0.0 110.798 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.722 ' HB3' HG22 ' A' ' 201' ' ' THR . 8.0 m120 -88.14 146.77 25.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.268 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.848 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 2.6 t -66.65 -3.85 7.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.901 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 199' ' ' ASN . 1.4 t -93.44 36.9 1.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.159 0.504 . . . . 0.0 110.44 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.811 ' O ' HD12 ' A' ' 206' ' ' LEU . 15.4 m -131.25 96.37 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.073 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.433 ' N ' ' HG ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -55.9 -76.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.799 -178.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.91 12.33 34.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 111.465 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 10.4 pttt -118.42 52.18 1.04 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.048 0.452 . . . . 0.0 110.539 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 1.067 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -147.76 -30.44 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 1.067 ' HD2' ' H ' ' A' ' 206' ' ' LEU . 3.1 Cg_endo -45.38 99.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 121.088 1.424 . . . . 0.0 112.078 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 209' ' ' LYS . 61.9 t -68.76 160.77 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.872 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.753 ' HB2' ' HB2' ' A' ' 217' ' ' ASP . 13.6 mtpp -136.8 127.74 27.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.805 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.821 HD21 ' HB3' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -126.61 148.32 49.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.127 0.489 . . . . 0.0 111.496 178.429 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . 153.45 -157.07 27.15 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.633 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.683 ' HB2' ' O ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -69.2 157.06 37.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.641 0.258 . . . . 0.0 111.355 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.568 ' HB ' ' HB1' ' A' ' 219' ' ' ALA . 7.2 p -77.42 123.43 34.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.777 0.799 . . . . 0.0 113.127 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.739 ' CB ' ' HD3' ' A' ' 215' ' ' PRO . 0.8 OUTLIER 160.27 -81.7 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 114.176 -1.374 . . . . 0.0 109.718 178.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.739 ' HD3' ' CB ' ' A' ' 214' ' ' SER . 16.6 Cg_endo -98.28 -14.4 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.255 1.97 . . . . 0.0 113.254 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.2 174.05 11.12 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.753 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.5 OUTLIER -88.49 -36.4 16.47 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.935 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.203 HD21 ' CD2' ' A' ' 196' ' ' HIS . 10.7 mt -94.04 132.69 38.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.568 ' HB1' ' HB ' ' A' ' 213' ' ' VAL . . . -95.36 72.59 3.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.927 0.394 . . . . 0.0 110.0 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.987 HD13 ' HB3' ' A' ' 191' ' ' ALA . 3.1 mm? -96.23 88.05 4.68 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.679 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 8.0 ptpt -57.63 63.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 0.0 110.849 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 220' ' ' LEU . 2.0 m-20 -95.59 149.64 21.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.989 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.0 t -90.93 -5.8 54.97 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.11 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.46 ' O ' HD11 ' A' ' 249' ' ' LEU . 4.5 pm0 -93.88 -21.13 19.43 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.564 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.683 ' O ' ' HB2' ' A' ' 212' ' ' ARG . 3.1 p -111.85 82.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.7 t -34.76 -44.35 0.21 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.835 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.11 -48.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.876 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -145.5 131.14 18.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.97 0.414 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' A' ' 246' ' ' MET . 1.6 t-80 -102.77 -49.81 3.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.447 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.821 ' HB3' HD21 ' A' ' 210' ' ' LEU . . . -147.65 179.08 7.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.204 0.526 . . . . 0.0 112.389 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -162.38 172.92 14.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.663 -179.349 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.743 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 10.9 mt -129.05 149.09 33.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.567 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.451 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -159.87 155.44 25.66 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.283 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.848 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 4.8 p90 -137.94 156.4 47.9 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.29 123.28 49.02 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.028 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 p -84.06 -4.32 58.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.515 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.0 m -77.8 -22.25 50.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.325 0.583 . . . . 0.0 110.392 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -144.47 20.71 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.855 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 17.6 p90 40.82 64.88 0.88 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.461 0.648 . . . . 0.0 109.811 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.635 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 10.5 mptt -128.31 141.4 51.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.058 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.745 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 4.8 m95 -120.69 117.25 27.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.211 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.3 mt-10 -133.93 141.78 47.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.779 0.8 . . . . 0.0 113.11 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.702 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.2 pp -108.13 154.0 22.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.658 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.609 HG11 ' HE1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -125.51 163.28 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.75 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 1.9 t0 -97.92 156.94 16.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.651 0.739 . . . . 0.0 112.502 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.562 ' N ' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -130.66 90.55 2.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.348 178.681 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 49.18 69.16 1.08 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.288 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.474 ' O ' ' CE1' ' A' ' 261' ' ' HIS . 0.1 OUTLIER -79.68 70.44 6.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.097 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.988 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.74 -51.44 67.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.944 178.208 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.988 ' N ' HD22 ' A' ' 249' ' ' LEU . 1.1 p-10 -72.74 -33.27 66.27 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.303 0.573 . . . . 0.0 110.977 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.563 ' HA2' ' CG ' ' A' ' 261' ' ' HIS . . . 100.95 101.19 2.46 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.922 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.613 ' C ' HD23 ' A' ' 253' ' ' LEU . 11.3 m -64.9 160.12 21.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 252' ' ' THR . 0.2 OUTLIER -156.55 153.86 29.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.301 0.572 . . . . 0.0 112.418 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.878 HG22 HG13 ' A' ' 281' ' ' ILE . 78.0 t -129.99 130.47 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.268 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.594 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 54.1 t30 59.21 38.58 23.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.027 0.442 . . . . 0.0 110.319 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.1 36.58 5.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.041 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.72 ' O ' HG23 ' A' ' 259' ' ' ILE . 12.2 m80 -148.61 118.92 7.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.998 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 252' ' ' THR . 25.1 p -62.67 94.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.383 0.611 . . . . 0.0 110.456 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.824 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -95.6 -17.98 6.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.125 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.563 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 0.6 OUTLIER -112.96 -14.03 13.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.602 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.635 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 12.1 t-160 -107.6 24.02 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.635 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 86.4 Cg_exo -47.29 -17.75 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.563 1.509 . . . . 0.0 112.335 179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.521 ' CG ' ' HB2' ' A' ' 268' ' ' LYS . 0.9 OUTLIER -79.64 92.27 5.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.156 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 264' ' ' LEU . 13.0 mt -47.21 -95.8 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -82.9 8.9 61.45 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.593 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.507 ' CB ' ' HB3' ' A' ' 263' ' ' ASP . 0.5 OUTLIER -72.64 -52.66 14.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 266' ' ' SER . 8.1 mmt85 74.17 14.7 3.77 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.594 0.711 . . . . 0.0 109.458 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.521 ' HB2' ' CG ' ' A' ' 263' ' ' ASP . 4.7 mtpt -49.8 164.41 0.1 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.366 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.609 ' HE1' HG11 ' A' ' 244' ' ' VAL . 39.5 t-105 -71.46 -25.64 62.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.6 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.03 160.92 27.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.764 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -98.34 151.7 37.62 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.792 0.329 . . . . 0.0 111.142 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.644 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 32.5 Cg_exo -58.63 115.9 2.87 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.894 2.396 . . . . 0.0 113.479 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.68 HG21 HG12 ' A' ' 259' ' ' ILE . 78.4 t -99.76 138.16 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.745 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.2 pp20? -83.71 129.41 34.95 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.229 -0.988 . . . . 0.0 112.174 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.963 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -94.32 164.32 13.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.755 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.06 160.01 41.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.282 0.563 . . . . 0.0 112.074 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.681 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 6.1 p -61.61 131.01 48.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.127 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.681 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.2 m-20 85.21 5.68 0.51 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.873 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.9 m-20 -79.11 -168.07 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.917 HD13 ' N ' ' A' ' 280' ' ' ILE . 0.1 OUTLIER -160.36 128.21 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.878 HG13 HG22 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -103.25 154.49 5.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.162 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.714 HG23 ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -142.17 116.93 9.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.658 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.65 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.72 40.62 2.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 -178.572 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.447 ' CA ' ' HG3' ' A' ' 224' ' ' GLU . . . 179.37 -130.99 1.6 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 119.57 -1.3 . . . . 0.0 113.555 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 5.0 t -92.09 -49.49 6.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.595 0.235 . . . . 0.0 111.21 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -139.75 0.67 1.83 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.802 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.5 m -72.58 103.66 3.62 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.248 -0.181 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.815 ' O ' HG22 ' A' ' 187' ' ' ILE . 10.9 mtpt -121.45 129.55 53.04 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.667 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.701 HG13 HD12 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -107.83 129.71 61.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.539 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 278' ' ' ASP . 4.4 t80 -77.52 137.2 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.888 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -104.69 114.01 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.626 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.11 129.73 42.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.664 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.804 HD11 ' CD2' ' A' ' 275' ' ' LEU . 16.8 mt -126.84 139.24 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.546 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.66 142.64 50.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.672 0.272 . . . . 0.0 110.388 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 41.1 p -79.7 150.52 30.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.07 0.462 . . . . 0.0 110.864 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.615 ' HB3' ' N ' ' A' ' 180' ' ' SER . 2.8 tp-100 -118.14 133.32 56.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.491 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -135.34 88.17 2.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.849 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.711 ' HA ' HG23 ' A' ' 201' ' ' THR . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.676 0.274 . . . . 0.0 110.791 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.475 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.8 103.9 2.42 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.382 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.478 ' HB3' ' OG ' ' A' ' 200' ' ' SER . 0.6 OUTLIER -179.9 -71.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.076 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.98 -179.5 6.11 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.0 m95 -149.0 133.88 18.0 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.943 HD11 ' CD2' ' A' ' 184' ' ' LEU . 0.9 OUTLIER -119.23 133.13 55.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.045 177.014 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.927 ' N ' HD12 ' A' ' 182' ' ' LEU . 6.2 m-85 -132.44 137.24 47.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.776 0.798 . . . . 0.0 110.975 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.943 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.5 mm? -120.97 140.52 51.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.494 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 3.6 tt0 -134.93 114.3 12.39 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -178.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.647 HG21 HD12 ' A' ' 194' ' ' LEU . 2.6 t -59.52 110.33 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.327 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.849 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.2 tt -95.61 -23.77 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.744 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.84 95.09 0.7 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.441 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.585 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.4 -178.07 35.96 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.5 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 73.0 Cg_endo -78.52 32.36 0.45 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.153 1.902 . . . . 0.0 111.642 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.875 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.77 22.63 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.187 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.585 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -40.24 108.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.65 5.01 1.53 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.788 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.875 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -100.41 170.04 8.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 22.1 mt-30 -159.92 148.74 17.46 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.928 0.394 . . . . 0.0 111.6 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.68 ' CE1' ' HB3' ' A' ' 184' ' ' LEU . 0.4 OUTLIER -134.27 124.76 26.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.469 0.652 . . . . 0.0 109.467 178.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -145.22 168.66 19.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.357 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.792 HG13 ' CH2' ' A' ' 234' ' ' TRP . 2.3 p -178.03 160.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.424 0.631 . . . . 0.0 111.529 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.65 ' OD1' HG22 ' A' ' 201' ' ' THR . 4.1 t-20 -96.1 148.62 22.5 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.974 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.479 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 13.3 p -65.46 -1.18 2.33 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.711 HG23 ' HA ' ' A' ' 177' ' ' LEU . 0.6 OUTLIER -109.73 10.52 24.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.795 0.331 . . . . 0.0 111.44 179.738 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.432 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -87.9 137.83 31.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.057 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 61.1 m -90.14 -88.29 0.17 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 43.9 m -93.47 20.18 7.55 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.432 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.2 OUTLIER -118.05 -11.57 10.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.059 0.456 . . . . 0.0 110.742 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.736 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.8 tt -74.15 -60.59 1.43 Allowed Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.828 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 2.0 Cg_endo -42.99 99.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.338 2.025 . . . . 0.0 112.639 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 99.1 t -69.26 158.39 6.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.971 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 16.4 mtpt -138.25 77.86 1.65 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' A' ' 231' ' ' GLN . 3.7 mp -65.5 122.39 17.08 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.116 -0.365 . . . . 0.0 110.655 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . -164.32 166.37 37.72 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.941 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 1.07 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -67.12 -70.83 0.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -177.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.749 HG22 ' HD2' ' A' ' 215' ' ' PRO . 14.9 p -78.48 157.34 4.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -30.07 -54.89 0.34 Allowed Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.749 ' HD2' HG22 ' A' ' 213' ' ' VAL . 55.0 Cg_exo -36.83 -30.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.854 2.37 . . . . 0.0 113.133 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.437 ' CB ' ' HA3' ' A' ' 211' ' ' GLY . 0.9 OUTLIER -81.91 154.92 25.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.616 0.246 . . . . 0.0 110.512 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.571 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -69.24 -40.53 77.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.328 . . . . 0.0 110.194 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.742 ' HB3' HD23 ' A' ' 220' ' ' LEU . 2.6 tp -97.47 130.16 44.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.561 ' C ' HD22 ' A' ' 220' ' ' LEU . . . -90.04 76.84 6.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.01 0.433 . . . . 0.0 110.963 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.792 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.5 mm? -106.69 90.64 3.39 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.445 ' CG ' ' HB2' ' A' ' 190' ' ' PRO . 4.6 pttt -64.0 36.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.873 ' HB3' HG12 ' A' ' 225' ' ' VAL . 26.5 t0 -65.65 132.89 49.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.9 p -73.55 -4.53 34.55 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.255 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -18.73 24.24 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.717 0.294 . . . . 0.0 110.545 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.07 HG13 ' HB2' ' A' ' 212' ' ' ARG . 5.4 p -107.58 86.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.172 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.23 -42.95 0.49 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.346 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.39 -49.91 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 246' ' ' MET . 0.0 OUTLIER -143.5 135.32 26.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.461 . . . . 0.0 110.016 179.259 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.601 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.1 t60 -106.12 -52.95 2.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -148.34 176.04 10.59 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.808 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -159.17 178.51 9.93 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.881 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 18.7 mt -137.22 147.63 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 121.471 0.653 . . . . 0.0 112.405 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.455 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -161.65 158.5 26.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.807 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 7.0 p90 -147.48 166.81 26.13 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -116.0 133.58 55.88 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.352 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 82.1 p -93.23 1.19 57.17 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.262 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.0 m -79.31 -37.92 36.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.888 0.851 . . . . 0.0 109.652 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 50.5 tptt -124.9 13.58 8.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.068 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.3 p90 42.47 61.27 2.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.528 0.68 . . . . 0.0 109.87 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.807 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.4 OUTLIER -125.32 137.57 54.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.146 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.725 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -118.95 120.33 36.97 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.062 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 6.9 mt-10 -138.32 144.04 40.22 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.836 0.827 . . . . 0.0 112.629 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.784 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.5 pp -105.01 152.02 23.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.474 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 269' ' ' TRP . 4.3 p -122.37 163.36 20.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.406 ' OD1' ' HB ' ' A' ' 252' ' ' THR . 0.3 OUTLIER -105.96 156.43 18.39 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.676 ' HA ' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -80.97 149.17 29.46 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.18 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.5 ' HA2' ' C ' ' A' ' 268' ' ' LYS . . . -53.21 10.84 0.01 OUTLIER Glycine 0 C--N 1.317 -0.508 0 N-CA-C 115.569 0.988 . . . . 0.0 115.569 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 246' ' ' MET . 0.6 OUTLIER -89.4 130.48 35.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.025 1.412 . . . . 0.0 110.77 179.056 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.669 ' C ' HD13 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -57.16 6.04 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.66 ' N ' HD13 ' A' ' 249' ' ' LEU . 4.9 m-20 -70.0 -40.25 75.4 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 119.666 1.121 . . . . 0.0 109.847 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 72.57 119.02 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.126 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.64 ' C ' HD23 ' A' ' 253' ' ' LEU . 76.7 m -73.5 172.07 12.0 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.305 0.242 . . . . 0.0 110.457 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.661 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -144.4 121.23 11.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.174 0.512 . . . . 0.0 110.567 177.772 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 259' ' ' ILE . 89.9 t -97.15 134.97 32.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.759 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 255' ' ' ASN . 1.2 p-10 49.58 34.54 7.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.147 0.499 . . . . 0.0 110.104 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.55 36.64 1.24 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.831 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -144.61 112.49 6.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.646 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 77.7 p -61.03 85.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 110.811 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.923 HG12 HG11 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -84.98 -13.29 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.263 -179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.55 ' N ' HD12 ' A' ' 259' ' ' ILE . 17.0 p -100.01 -14.21 18.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.639 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 0.3 OUTLIER -109.76 24.54 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.442 177.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 84.1 Cg_exo -45.98 -48.22 13.05 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.986 1.791 . . . . 0.0 112.963 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.56 100.01 6.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.119 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 19.2 mt -48.24 -24.83 1.29 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.113 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -49.4 -28.23 9.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.314 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.587 ' C ' ' H ' ' A' ' 268' ' ' LYS . 10.1 m -89.27 -67.41 0.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.368 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.429 ' HG2' ' CB ' ' A' ' 249' ' ' LEU . 13.4 mtm180 68.81 -22.51 0.14 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.25 0.548 . . . . 0.0 112.333 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 266' ' ' SER . 0.0 OUTLIER -68.73 -136.39 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.205 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.72 ' O ' HG22 ' A' ' 244' ' ' VAL . 11.6 t-105 -71.54 -16.38 62.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.06 -175.92 4.96 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -109.51 151.15 42.02 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 117.857 0.829 . . . . 0.0 110.95 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 34.6 Cg_exo -60.27 117.65 4.43 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.777 2.318 . . . . 0.0 113.463 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.923 HG11 HG12 ' A' ' 259' ' ' ILE . 97.6 t -95.49 137.06 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.5 OUTLIER -83.36 125.04 31.23 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.864 -179.013 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.947 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -90.25 164.33 14.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.566 179.176 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.7 157.37 45.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.258 0.551 . . . . 0.0 112.043 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.493 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 68.3 p -58.21 127.81 33.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.483 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 84.24 8.84 0.5 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.418 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.6 t0 -83.18 -165.54 1.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.519 HG23 ' CD1' ' A' ' 290' ' ' TYR . 0.5 OUTLIER -162.36 134.45 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.592 177.728 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.897 HD12 HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -108.57 156.6 9.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.67 178.471 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.661 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.3 m -146.52 113.8 6.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.755 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.64 47.8 1.21 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.589 -178.025 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 172.58 -125.14 1.13 Allowed Glycine 0 CA--C 1.517 0.205 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.453 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.5 t -96.9 -47.13 5.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.644 0.259 . . . . 0.0 111.244 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -144.83 -6.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 61.6 m -64.93 103.44 0.72 Allowed 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.432 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.849 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.8 mtpt -124.78 134.53 52.75 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.034 0.445 . . . . 0.0 111.259 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.897 HG23 HD12 ' A' ' 281' ' ' ILE . 0.1 OUTLIER -114.97 134.24 58.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.69 -178.808 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.524 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.3 t80 -76.98 139.49 40.12 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.971 0.415 . . . . 0.0 110.261 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.947 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -106.32 113.13 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.846 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.91 144.86 50.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.516 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.709 HD11 ' CD2' ' A' ' 275' ' ' LEU . 11.5 mt -144.15 116.81 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.443 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.1 m -123.74 147.52 47.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.951 0.405 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 70.4 m -80.8 -178.31 6.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -150.05 116.13 5.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -148.49 97.01 2.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.965 179.877 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.597 ' HA ' HG23 ' A' ' 201' ' ' THR . 1.1 mp . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.769 0.319 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.538 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.98 82.14 0.96 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.233 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 31.8 t -161.02 -76.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 109.979 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.7 OUTLIER -141.5 -176.14 4.63 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.387 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.567 ' O ' HG23 ' A' ' 293' ' ' ILE . 6.6 m95 -147.2 132.32 18.3 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.604 HD23 ' HZ3' ' A' ' 234' ' ' TRP . 6.1 tp -117.86 127.47 53.9 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.092 176.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 16.9 m-85 -125.74 136.5 53.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.676 0.751 . . . . 0.0 110.932 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.845 HD13 ' ND1' ' A' ' 196' ' ' HIS . 1.4 mp -138.13 149.84 46.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.917 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.486 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 12.9 tt0 -145.09 127.09 15.52 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.613 HG21 HD12 ' A' ' 194' ' ' LEU . 13.4 t -64.07 114.87 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.505 HG22 ' CB ' ' A' ' 288' ' ' LYS . 8.7 tt -99.01 -20.17 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.808 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.74 91.39 0.56 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.421 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.808 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.82 -172.68 29.53 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.689 ' HB2' ' HD2' ' A' ' 221' ' ' LYS . 70.7 Cg_endo -77.0 26.84 0.44 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.121 1.881 . . . . 0.0 111.931 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.821 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.0 29.91 0.12 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.114 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.808 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.3 mt -42.84 116.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.46 -51.78 0.76 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.341 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.821 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -38.56 149.43 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.282 0.563 . . . . 0.0 111.215 -178.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.745 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 4.9 mt-30 -148.63 149.97 32.44 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.813 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.845 ' ND1' HD13 ' A' ' 184' ' ' LEU . 2.0 p80 -136.93 126.95 25.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.251 0.548 . . . . 0.0 109.847 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.6 161.26 38.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.476 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.909 HG13 ' CH2' ' A' ' 234' ' ' TRP . 4.0 p -172.61 160.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 111.812 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 180' ' ' SER . 11.6 m120 -88.74 150.12 23.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.24 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.566 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 40.6 t -64.08 -9.01 13.78 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.623 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.597 HG23 ' HA ' ' A' ' 177' ' ' LEU . 1.8 t -101.18 34.47 2.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.209 0.528 . . . . 0.0 111.061 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.44 ' HB2' ' HG2' ' A' ' 205' ' ' LYS . 35.9 p -116.13 129.74 56.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.634 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.446 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 4.0 m -90.33 -86.93 0.19 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.0 m -86.8 14.24 7.5 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.446 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -115.83 -13.46 11.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.995 0.426 . . . . 0.0 110.412 178.643 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.773 HD11 ' CE2' ' A' ' 234' ' ' TRP . 6.4 tt -70.4 -60.29 3.4 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.314 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.609 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.0 OUTLIER -43.51 97.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.562 2.175 . . . . 0.0 113.47 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.74 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 98.9 t -68.32 163.16 3.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 3.6 mtpp -139.66 85.81 2.07 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.06 HD23 HD12 ' A' ' 218' ' ' LEU . 0.5 OUTLIER -73.67 126.43 30.29 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.163 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.447 ' HA3' ' OG ' ' A' ' 216' ' ' SER . . . -170.09 173.15 44.12 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.943 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 1.059 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -70.58 -75.12 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.922 HG13 ' HG2' ' A' ' 215' ' ' PRO . 11.3 p -78.99 160.13 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -176.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.507 ' N ' HG22 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -27.68 -52.59 0.23 Allowed Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -178.492 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.922 ' HG2' HG13 ' A' ' 213' ' ' VAL . 5.0 Cg_exo -38.5 -29.77 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.634 2.223 . . . . 0.0 112.962 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.447 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 0.7 OUTLIER -82.98 151.24 25.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.648 179.011 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -31.03 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.108 0.48 . . . . 0.0 109.967 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.06 HD12 HD23 ' A' ' 210' ' ' LEU . 0.8 OUTLIER -105.74 131.24 53.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.234 178.591 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -91.23 77.75 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.84 0.353 . . . . 0.0 111.808 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.793 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -101.26 87.09 3.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.689 ' HD2' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -59.65 24.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.108 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.619 ' H ' ' C ' ' A' ' 220' ' ' LEU . 5.7 m-20 -54.48 115.04 1.9 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.805 0.336 . . . . 0.0 110.791 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 t -56.31 -16.21 5.17 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.804 ' O ' HD11 ' A' ' 249' ' ' LEU . 1.9 pm0 -83.19 -23.51 32.82 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.059 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.4 p -97.18 92.26 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 0.0 110.084 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 36.1 m -37.89 -48.18 1.12 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.271 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.06 -50.1 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.698 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.415 ' HD3' ' CB ' ' A' ' 216' ' ' SER . 0.4 OUTLIER -141.26 125.87 17.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.424 0.63 . . . . 0.0 110.738 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.519 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 6.7 t-80 -89.8 -62.17 1.53 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.6 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -145.32 178.01 8.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.39 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.74 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -160.81 178.25 9.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.659 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.551 HG12 ' HB3' ' A' ' 243' ' ' LEU . 6.5 mt -138.85 149.92 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.149 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.427 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -161.24 143.49 12.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.091 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.909 ' CH2' HG13 ' A' ' 198' ' ' VAL . 5.2 p90 -131.89 165.25 24.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.65 133.78 55.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.645 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 95.5 p -91.75 0.71 57.47 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.264 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.8 m -77.72 -32.33 52.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.7 0.762 . . . . 0.0 109.825 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.541 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -134.78 16.22 3.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.308 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.416 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 17.8 p90 43.73 62.46 1.91 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.459 0.647 . . . . 0.0 109.609 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.802 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 5.1 mptt -125.86 140.58 52.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.207 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.717 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -125.21 118.0 25.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.37 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.7 pt-20 -133.97 148.09 51.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.994 0.902 . . . . 0.0 112.821 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.838 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.3 pp -112.19 149.71 31.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.925 -1.488 . . . . 0.0 110.843 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 1.032 HG22 ' HB3' ' A' ' 269' ' ' TRP . 0.8 OUTLIER -124.46 160.86 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.617 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 9.2 m-20 -110.7 108.66 18.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.547 ' CE ' ' HG2' ' A' ' 231' ' ' GLN . 1.8 ptp -86.38 106.85 17.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 50.25 62.73 4.84 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.173 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.405 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 2.8 p -79.14 71.35 5.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.866 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.08 -56.64 17.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.844 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.866 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -73.35 -27.11 61.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 111.017 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 261' ' ' HIS . . . 91.16 135.22 6.37 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.81 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.569 HG22 ' CD1' ' A' ' 281' ' ' ILE . 3.5 m -97.3 156.84 16.26 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.687 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -149.04 139.17 22.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.077 0.465 . . . . 0.0 111.297 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.628 HG23 HD11 ' A' ' 259' ' ' ILE . 48.9 t -109.83 133.02 56.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.266 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.692 ' HA ' HG13 ' A' ' 280' ' ' ILE . 0.7 OUTLIER 53.02 38.07 26.36 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.256 0.551 . . . . 0.0 110.689 -179.173 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.2 m 70.68 36.75 1.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.876 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.01 113.18 6.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.947 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 69.0 p -63.82 82.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.471 0.653 . . . . 0.0 110.384 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.78 HG12 HG11 ' A' ' 273' ' ' VAL . 0.4 OUTLIER -81.31 -10.75 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.73 -178.141 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.664 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 15.4 m -122.98 -13.89 7.72 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.711 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 41.7 t-80 -111.51 35.62 0.12 Allowed Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.711 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 37.8 Cg_exo -58.91 -29.07 89.32 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.919 1.746 . . . . 0.0 113.917 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.81 111.14 19.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.491 0.662 . . . . 0.0 111.324 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.792 ' H ' HD23 ' A' ' 264' ' ' LEU . 0.3 OUTLIER -69.99 160.01 32.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.665 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 74.23 -28.47 0.99 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.923 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 264' ' ' LEU . 4.2 m -65.72 -38.49 89.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.569 ' HD3' ' HA ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER 54.02 24.58 4.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.037 -178.235 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 270' ' ' GLY . 2.6 ptmm? -81.35 171.93 14.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.013 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 1.032 ' HB3' HG22 ' A' ' 244' ' ' VAL . 0.5 OUTLIER -79.71 -6.17 56.67 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.709 179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.449 ' H ' ' HG3' ' A' ' 268' ' ' LYS . . . 74.85 -106.93 2.17 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 119.485 -1.34 . . . . 0.0 109.759 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 273' ' ' VAL . 0.7 OUTLIER -152.14 125.1 4.1 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.67 174.553 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 84.9 Cg_exo -38.66 102.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.723 1.616 . . . . 0.0 110.04 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.78 HG11 HG12 ' A' ' 259' ' ' ILE . 45.3 t -93.08 139.04 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.299 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.717 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.4 mm-40 -84.55 127.5 34.08 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.255 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.983 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.56 164.76 13.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.37 179.531 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.633 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.85 161.24 39.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.579 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 1.5 m -62.27 131.93 51.0 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.778 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' A' ' 277' ' ' SER . 34.6 m-20 80.16 -0.2 2.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.414 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -71.73 -164.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.701 HG22 ' HD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -157.13 123.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.161 177.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.737 HG22 HG23 ' A' ' 289' ' ' VAL . 0.3 OUTLIER -104.89 157.73 5.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.945 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.687 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 2.9 m -150.38 126.58 10.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.713 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -121.85 49.96 1.49 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 175.26 -134.26 2.67 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.496 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.422 HG22 ' OE2' ' A' ' 224' ' ' GLU . 9.5 t -89.44 -38.63 13.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.119 0.485 . . . . 0.0 109.805 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -151.65 -5.63 0.25 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.11 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.808 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 26.3 m -66.63 99.95 0.64 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.196 0.522 . . . . 0.0 111.353 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.563 ' O ' HG22 ' A' ' 289' ' ' VAL . 17.0 mttt -99.13 178.93 4.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.592 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.737 HG23 HG22 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -162.72 120.0 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.088 177.489 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.701 ' HD1' HG22 ' A' ' 280' ' ' ILE . 1.7 t80 -75.76 136.98 40.28 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.53 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.983 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -107.2 111.36 35.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.183 -178.541 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 9.0 tpt85 -128.24 144.14 51.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.458 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.609 HD12 ' CZ3' ' A' ' 241' ' ' TRP . 20.9 mt -143.01 123.75 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.26 153.46 46.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.696 0.284 . . . . 0.0 110.533 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 73.1 m -80.63 174.95 11.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.821 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.89 133.82 49.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.93 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -155.97 87.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.775 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.946 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.461 ' HB3' ' ND2' ' A' ' 199' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.639 0.257 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 1.006 ' HA3' HG21 ' A' ' 201' ' ' THR . . . 115.88 -115.45 3.38 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.911 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 17.8 p -166.13 26.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.8 m -160.07 160.06 32.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 121.244 -0.183 . . . . 0.0 110.875 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 17.8 m95 -151.09 148.8 28.75 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.893 HD11 ' CD1' ' A' ' 184' ' ' LEU . 0.1 OUTLIER -128.36 127.57 42.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.021 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.845 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.3 m-85 -125.69 142.09 51.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.908 0.861 . . . . 0.0 112.531 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.893 ' CD1' HD11 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -137.66 147.44 44.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.022 176.421 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -139.56 129.45 24.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.759 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.827 HG21 HD12 ' A' ' 194' ' ' LEU . 26.9 t -66.41 116.18 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 288' ' ' LYS . 4.7 tt -99.01 -22.2 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.887 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -160.63 92.54 0.96 Allowed 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.714 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.4 -169.8 25.19 Favored Glycine 0 CA--C 1.516 0.116 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.635 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 96.3 Cg_endo -81.02 28.45 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.042 1.828 . . . . 0.0 111.631 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.836 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.51 24.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.912 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.714 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.5 mt -39.53 114.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.876 0.37 . . . . 0.0 111.954 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.24 7.74 4.34 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.924 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.836 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -97.12 128.25 43.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.124 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 10.8 mt-30 -127.71 150.84 49.6 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.022 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.726 ' O ' HD22 ' A' ' 184' ' ' LEU . 1.0 OUTLIER -141.62 142.05 33.43 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.83 179.387 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -132.5 136.33 46.59 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.189 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.655 HG21 ' HG ' ' A' ' 206' ' ' LEU . 12.3 p -141.39 130.92 24.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.487 0.66 . . . . 0.0 111.863 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.461 ' ND2' ' HB3' ' A' ' 177' ' ' LEU . 8.8 p30 -85.88 145.56 27.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.949 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.452 ' HG ' ' HE1' ' A' ' 234' ' ' TRP . 12.2 t -63.55 -3.55 2.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.69 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' THR . . . . . 1.006 HG21 ' HA3' ' A' ' 178' ' ' GLY . 0.5 OUTLIER -105.52 6.46 32.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -179.507 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.504 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -85.69 130.59 34.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.0 110.289 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.9 t -90.65 -90.16 0.16 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 24.7 p -84.51 14.81 4.17 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.504 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -123.49 -14.39 7.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.036 0.446 . . . . 0.0 110.522 179.038 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.655 ' HG ' HG21 ' A' ' 198' ' ' VAL . 7.8 tt -65.61 -62.53 4.36 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.75 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -43.17 99.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.36 2.04 . . . . 0.0 112.584 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 87.3 t -68.36 164.71 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.902 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 25.5 mtmt -141.41 94.57 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.049 HD23 HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -87.96 131.03 34.76 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.28 173.65 45.31 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.993 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.876 ' HD3' HG12 ' A' ' 213' ' ' VAL . 12.2 ttt180 -71.15 -74.96 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.808 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.876 HG12 ' HD3' ' A' ' 212' ' ' ARG . 10.2 p -140.54 110.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.462 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.578 ' CB ' ' HD2' ' A' ' 215' ' ' PRO . 0.3 OUTLIER 178.61 179.89 0.23 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.962 -179.026 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 37.0 Cg_endo -66.1 25.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 121.907 1.738 . . . . 0.0 112.331 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -68.21 -172.93 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.966 0.412 . . . . 0.0 111.242 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.425 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 13.3 m-20 -104.7 -29.48 10.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.474 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.049 HD12 HD23 ' A' ' 210' ' ' LEU . 5.7 mt -112.64 131.68 55.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -98.25 87.72 3.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.567 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.661 HD11 ' CG2' ' A' ' 186' ' ' VAL . 3.0 mm? -103.72 59.65 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.681 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -53.2 73.19 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.22 -178.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.635 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 7.0 t0 -116.58 143.11 46.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.003 0.43 . . . . 0.0 110.311 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.5 t -63.5 -5.3 3.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.541 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.697 ' HG2' HG22 ' A' ' 285' ' ' THR . 0.1 OUTLIER -86.79 -30.73 21.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 109.869 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 0.1 OUTLIER -95.62 107.68 19.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.601 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -49.38 71.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.137 0.494 . . . . 0.0 110.297 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 228' ' ' LYS . . . -148.1 -51.06 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.1 OUTLIER -145.81 125.11 13.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.013 0.435 . . . . 0.0 110.479 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.574 ' HB2' ' CG1' ' A' ' 225' ' ' VAL . 1.6 t-80 -84.56 -58.95 2.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.196 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.902 ' HB3' HD22 ' A' ' 283' ' ' LEU . . . -152.23 175.53 12.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.498 -177.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.731 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -155.55 179.96 8.68 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.817 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.75 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.5 mt -135.79 149.44 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.41 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.4 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -153.69 164.35 38.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.635 ' CD2' HD11 ' A' ' 206' ' ' LEU . 0.6 OUTLIER -93.33 153.43 18.55 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.018 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 239' ' ' PHE . 2.3 m-20 -119.35 71.02 0.85 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.722 -1.581 . . . . 0.0 106.975 174.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.1 p -53.87 -23.24 11.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.9 m -74.38 -27.12 60.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.549 0.69 . . . . 0.0 109.235 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.512 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -117.25 8.66 13.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.334 178.763 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 235' ' ' ASN . 2.7 p90 38.38 39.47 0.29 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.622 0.248 . . . . 0.0 111.039 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -112.27 179.96 3.85 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.423 0.63 . . . . 0.0 110.009 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.784 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -131.02 115.0 15.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.917 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 14.0 pt-20 -137.65 151.72 48.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.692 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.4 pp -116.34 153.85 31.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.053 -1.431 . . . . 0.0 111.802 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.805 HG21 ' CD1' ' A' ' 269' ' ' TRP . 2.1 p -121.7 162.69 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.672 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.775 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 8.3 t0 -102.49 116.88 33.52 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -77.53 98.0 5.21 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.215 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 56.2 70.18 1.05 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.704 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.5 p -62.87 48.15 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.973 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.58 -49.81 73.76 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.231 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.973 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.5 -39.02 28.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 261' ' ' HIS . . . 93.52 93.39 1.54 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.614 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' THR . . . . . 1.06 HG23 HD23 ' A' ' 283' ' ' LEU . 20.0 m -50.2 164.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.689 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -150.29 139.7 21.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.328 0.585 . . . . 0.0 111.303 179.151 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.872 HG22 HG12 ' A' ' 281' ' ' ILE . 70.3 t -114.37 137.13 48.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.748 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.677 ' HA ' HG13 ' A' ' 280' ' ' ILE . 23.4 p30 47.69 34.98 4.06 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.307 0.575 . . . . 0.0 110.421 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 72.87 35.35 1.02 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.481 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 259' ' ' ILE . 64.5 t-80 -137.56 111.42 8.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.714 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 5.4 t -63.05 84.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.454 0.645 . . . . 0.0 110.992 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.868 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -84.28 -8.49 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.724 -178.523 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.775 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 21.4 m -101.75 -23.9 14.14 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.607 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 0.2 OUTLIER -109.68 33.0 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 178.787 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.607 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 71.0 Cg_exo -47.63 -55.04 4.33 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.526 1.484 . . . . 0.0 111.782 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -111.89 102.4 10.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.175 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.445 ' HA ' ' CE1' ' A' ' 261' ' ' HIS . 34.6 mt -52.96 -22.6 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.538 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -50.23 -24.64 7.14 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.873 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 268' ' ' LYS . 0.3 OUTLIER -91.82 -63.28 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.746 -0.267 . . . . 0.0 111.599 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER 67.79 -17.8 0.15 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.286 0.494 . . . . 0.0 112.144 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.614 ' HE3' ' HB2' ' A' ' 269' ' ' TRP . 13.2 ttpt -76.23 -125.08 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.805 ' CD1' HG21 ' A' ' 244' ' ' VAL . 12.2 t-105 -83.66 -27.46 29.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.435 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.79 -178.29 5.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.203 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -105.09 146.89 33.57 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.106 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.692 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 71.8 Cg_exo -49.88 148.99 11.8 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.594 2.196 . . . . 0.0 112.857 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.841 HG11 HG13 ' A' ' 259' ' ' ILE . 69.2 t -129.86 136.31 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.4 mp0 -81.53 128.14 33.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 118.794 -1.162 . . . . 0.0 112.052 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 1.031 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -93.0 165.93 12.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.027 178.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.683 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.28 161.73 37.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.682 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 3.7 p -62.64 130.04 43.24 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.281 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' A' ' 277' ' ' SER . 30.9 m-20 81.87 -1.48 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.449 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.683 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.2 OUTLIER -70.8 -162.83 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.822 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.723 HG22 ' HD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -159.97 129.09 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.226 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.872 HG12 HG22 ' A' ' 254' ' ' VAL . 0.3 OUTLIER -117.3 93.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.519 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 288' ' ' LYS . 1.8 m -79.56 129.51 34.54 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 1.06 HD23 HG23 ' A' ' 252' ' ' THR . 0.5 OUTLIER -118.92 50.53 1.2 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.424 -178.669 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.528 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 162.73 -119.01 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 119.198 -1.477 . . . . 0.0 113.673 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.697 HG22 ' HG2' ' A' ' 224' ' ' GLU . 1.7 t -95.51 -58.75 2.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.374 0.131 . . . . 0.0 111.159 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.494 ' H ' HG23 ' A' ' 285' ' ' THR . 1.3 t -134.08 -1.28 2.97 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.762 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.887 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 40.4 m -72.51 102.14 3.15 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.697 ' O ' HG22 ' A' ' 187' ' ' ILE . 12.7 ttmt -119.4 123.36 43.92 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.104 0.478 . . . . 0.0 111.286 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 1.1 t -103.01 129.86 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.964 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.723 ' HD1' HG22 ' A' ' 280' ' ' ILE . 0.6 OUTLIER -77.36 133.85 38.62 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.659 -0.416 . . . . 0.0 109.912 -179.309 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 1.031 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -103.44 112.81 38.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.633 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -130.59 141.14 50.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.949 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.784 HD12 ' CE3' ' A' ' 241' ' ' TRP . 2.1 mt -138.98 143.2 32.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.8 t -151.67 164.23 37.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.1 -169.87 2.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.428 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -123.25 122.0 37.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.77 0.319 . . . . 0.0 111.067 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -81.98 90.75 6.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.019 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.65 ' HA ' HG23 ' A' ' 201' ' ' THR . 1.5 mp . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.664 0.269 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.578 ' N ' HG21 ' A' ' 201' ' ' THR . . . 116.02 87.33 1.36 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.33 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.448 ' OG ' HG22 ' A' ' 201' ' ' THR . 5.9 p -165.28 -71.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.449 . . . . 0.0 109.896 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.6 OUTLIER -141.76 -176.81 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.459 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.672 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.9 m95 -147.65 130.58 16.21 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.419 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.57 ' HB2' ' HZ3' ' A' ' 241' ' ' TRP . 5.2 tp -113.27 124.37 52.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.058 177.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.672 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 6.5 m-85 -123.39 130.27 52.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.713 0.768 . . . . 0.0 110.791 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 196' ' ' HIS . 1.2 mp -131.6 142.61 49.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.346 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.573 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 24.6 tt0 -140.2 124.8 18.08 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.272 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.767 HG21 HD12 ' A' ' 194' ' ' LEU . 11.1 t -61.33 113.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.013 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 288' ' ' LYS . 8.6 tt -97.05 -20.46 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.518 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.739 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.69 95.01 0.71 Allowed 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.919 -179.138 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.767 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.32 -175.81 33.74 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 178.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.547 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 96.3 Cg_endo -79.23 30.95 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.782 1.655 . . . . 0.0 110.966 178.235 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.941 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.81 24.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.767 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.2 mt -39.55 113.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.75 11.26 2.98 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.3 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.941 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -100.67 155.89 17.63 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.823 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.744 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 8.7 mt-30 -150.61 151.3 32.35 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.801 -177.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.96 ' CE1' HD21 ' A' ' 210' ' ' LEU . 1.7 p80 -138.56 128.62 25.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.08 164.43 30.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.407 -179.099 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.828 HG21 ' HA ' ' A' ' 206' ' ' LEU . 5.9 p -172.84 156.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.4 0.619 . . . . 0.0 111.726 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.505 ' N ' HG22 ' A' ' 198' ' ' VAL . 3.3 m120 -91.52 144.76 25.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.395 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.455 ' HB2' ' CZ2' ' A' ' 234' ' ' TRP . 3.2 t -61.37 -4.52 1.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.455 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.65 HG23 ' HA ' ' A' ' 177' ' ' LEU . 4.9 t -102.08 0.54 35.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.593 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -75.12 138.27 41.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.418 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.2 m -87.18 -89.08 0.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.2 18.8 17.8 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.777 0.323 . . . . 0.0 111.722 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -6.88 11.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.525 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.828 ' HA ' HG21 ' A' ' 198' ' ' VAL . 7.5 tt -75.6 -62.53 0.77 Allowed Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.597 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.795 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.8 Cg_endo -42.7 99.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.254 1.969 . . . . 0.0 112.765 -178.034 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.628 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 43.1 t -69.54 165.31 2.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.757 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 4.3 mtpp -135.18 90.19 2.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.028 HD23 HD12 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -78.11 124.93 28.62 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.891 -179.945 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.56 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . 177.01 -173.72 46.52 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.823 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.755 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.6 OUTLIER -60.32 155.92 16.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.583 0.23 . . . . 0.0 110.936 -179.755 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 213' ' ' VAL . 10.0 p -77.29 119.43 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.892 0.854 . . . . 0.0 113.204 -176.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.759 ' CB ' ' HD3' ' A' ' 215' ' ' PRO . 0.6 OUTLIER 160.88 -75.99 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.709 178.92 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.759 ' HD3' ' CB ' ' A' ' 214' ' ' SER . 42.9 Cg_endo -100.9 -14.82 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.653 2.235 . . . . 0.0 112.837 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.447 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 1.2 m -80.21 157.29 26.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.003 0.43 . . . . 0.0 111.758 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.524 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.7 OUTLIER -73.16 -37.23 66.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.805 178.898 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.028 HD12 HD23 ' A' ' 210' ' ' LEU . 1.7 mt -98.06 134.85 40.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.583 178.453 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.736 ' HB3' HD22 ' A' ' 194' ' ' LEU . . . -89.39 76.21 7.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.003 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.807 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 2.8 mm? -109.36 94.68 5.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.046 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.547 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -64.71 24.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.656 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.944 ' HB3' HG12 ' A' ' 225' ' ' VAL . 0.4 OUTLIER -55.75 116.05 2.71 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.222 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.4 t -58.73 -20.38 48.6 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.823 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.545 ' CG ' ' HB2' ' A' ' 250' ' ' ASN . 2.3 tp10 -75.11 -19.57 59.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 0.0 110.812 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.944 HG12 ' HB3' ' A' ' 222' ' ' ASP . 5.8 p -124.37 64.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.921 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 10.1 p -46.12 -31.93 2.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.834 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -125.69 -78.86 0.32 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.375 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -139.29 131.0 27.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.076 0.465 . . . . 0.0 110.74 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 245' ' ' ASP . 0.0 OUTLIER -99.59 -55.94 2.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.637 178.908 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.636 ' HB2' ' OD2' ' A' ' 245' ' ' ASP . . . -148.97 164.9 33.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.542 0.687 . . . . 0.0 112.563 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.628 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -149.97 -178.24 6.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.522 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.795 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.1 mt -135.9 151.86 29.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 121.071 0.463 . . . . 0.0 112.198 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.23 163.69 39.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.163 178.213 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.784 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -91.4 152.66 20.31 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -176.286 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 239' ' ' PHE . 26.8 t-20 -120.58 72.29 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.07 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.8 t -59.77 -15.83 23.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -175.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 90.7 m -84.33 -35.58 23.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.44 0.638 . . . . 0.0 110.625 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.486 ' HE3' ' CE1' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -112.6 11.83 19.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.355 179.881 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.486 ' CE1' ' HE3' ' A' ' 238' ' ' LYS . 12.5 p90 42.25 69.55 0.36 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 2.0 mptp? -136.96 147.29 46.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.296 -178.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.735 ' CZ3' HG23 ' A' ' 293' ' ' ILE . 0.5 OUTLIER -114.14 103.46 11.14 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 178.656 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 27.6 mt-10 -125.08 143.63 50.82 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.104 0.954 . . . . 0.0 113.286 -176.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.81 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.4 pp -109.0 151.59 26.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.296 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 1.018 HG22 ' HB2' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -125.06 154.09 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.182 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.636 ' OD2' ' HB2' ' A' ' 230' ' ' ALA . 5.5 m-20 -117.04 100.49 7.78 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.228 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.607 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -64.17 106.64 1.11 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.012 178.332 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.72 68.32 1.75 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.577 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 267' ' ' ARG . 52.2 p -76.87 61.04 1.86 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.618 ' HA ' ' HD3' ' A' ' 267' ' ' ARG . 1.6 tm? -49.84 -60.01 3.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.149 0.5 . . . . 0.0 110.139 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.545 ' HB2' ' CG ' ' A' ' 224' ' ' GLU . 4.1 t-20 -69.72 -22.34 63.4 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.832 -179.243 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 81.67 84.57 0.76 Allowed Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.549 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.769 ' C ' HD23 ' A' ' 253' ' ' LEU . 55.7 m -46.46 164.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.555 0.178 . . . . 0.0 110.641 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.769 HD23 ' C ' ' A' ' 252' ' ' THR . 0.1 OUTLIER -148.38 126.69 12.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.26 0.552 . . . . 0.0 112.103 179.033 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.745 HG23 HD11 ' A' ' 259' ' ' ILE . 99.8 t -101.95 129.27 53.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.359 178.343 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 52.6 t-20 53.35 43.06 31.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.138 0.494 . . . . 0.0 110.195 -179.038 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.36 31.02 17.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.062 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.406 ' O ' ' N ' ' A' ' 259' ' ' ILE . 0.1 OUTLIER -136.73 106.83 6.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.558 179.648 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 60.1 p -57.6 87.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.267 0.556 . . . . 0.0 110.76 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.785 ' HB ' HG21 ' A' ' 273' ' ' VAL . 1.0 OUTLIER -88.34 -2.38 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.37 -178.961 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.651 ' OG ' ' HB ' ' A' ' 252' ' ' THR . 1.4 m -99.09 -13.54 19.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.683 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 2.1 t60 -107.24 15.68 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 179.361 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 84.8 Cg_exo -47.78 -37.59 28.41 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.596 1.531 . . . . 0.0 110.327 179.018 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.584 ' O ' ' HB2' ' A' ' 266' ' ' SER . 77.4 m-20 -76.59 98.74 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.25 -1.795 . . . . 0.0 111.064 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 92.3 mt -66.21 133.33 50.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.739 0.305 . . . . 0.0 110.794 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.45 5.65 82.68 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.676 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.584 ' HB2' ' O ' ' A' ' 263' ' ' ASP . 0.5 OUTLIER -85.74 -60.29 2.06 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 122.905 -0.173 . . . . 0.0 111.168 -179.862 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.618 ' HD3' ' HA ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER 73.87 -2.87 2.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 111.256 -178.479 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.558 ' HD3' ' CD1' ' A' ' 269' ' ' TRP . 2.7 ptpt -91.26 -143.55 0.18 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -176.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 1.018 ' HB2' HG22 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -95.0 -10.81 29.8 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 179.556 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.522 ' H ' ' HG3' ' A' ' 268' ' ' LYS . . . 58.06 -148.37 36.43 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 118.833 -1.651 . . . . 0.0 111.171 -178.048 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -96.36 126.51 43.58 Favored Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.507 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 4.0 Cg_exo -38.74 120.69 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.983 2.456 . . . . 0.0 111.887 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.785 HG21 ' HB ' ' A' ' 259' ' ' ILE . 48.5 t -94.36 135.3 29.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.921 -177.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -81.7 127.16 32.63 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.545 0.688 . . . . 0.0 110.984 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.924 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.49 162.63 14.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.96 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.11 156.76 45.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.047 0.451 . . . . 0.0 112.054 -179.17 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.655 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 29.7 p -59.05 128.76 38.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.655 ' HB2' ' O ' ' A' ' 277' ' ' SER . 30.7 m-20 87.13 2.45 0.44 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.143 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -75.78 -166.08 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.523 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.7 OUTLIER -161.51 130.82 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.085 178.208 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.65 HD12 HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -112.22 156.97 13.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.052 0.453 . . . . 0.0 111.321 178.436 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.658 HG23 ' CG ' ' A' ' 288' ' ' LYS . 1.9 m -141.7 119.17 11.58 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.314 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.617 HD23 ' CG2' ' A' ' 252' ' ' THR . 0.7 OUTLIER -111.84 47.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.898 -178.253 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 167.22 -128.14 1.69 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 119.621 -1.276 . . . . 0.0 113.796 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.8 t -89.9 -46.65 8.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.622 0.249 . . . . 0.0 111.137 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 188' ' ' ALA . 3.5 t -144.0 -7.36 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 47.6 m -64.15 103.21 0.59 Allowed 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.757 ' O ' HG22 ' A' ' 187' ' ' ILE . 5.5 mtpt -124.72 133.05 53.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 111.318 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.65 HG23 HD12 ' A' ' 281' ' ' ILE . 0.1 OUTLIER -112.21 135.5 51.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.564 -179.311 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.4 t80 -77.05 139.29 39.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.7 OUTLIER -110.28 114.11 46.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.544 -178.875 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 11.8 tpt180 -127.65 148.28 50.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.801 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.735 HG23 ' CZ3' ' A' ' 241' ' ' TRP . 14.3 mt -141.13 113.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.58 156.09 45.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.762 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 22.8 m -90.51 162.04 15.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.873 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -86.61 135.04 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.032 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.56 86.48 6.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.004 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.961 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.754 ' C ' HG21 ' A' ' 201' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 121.177 0.513 . . . . 0.0 111.323 . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.63 ' N ' HG21 ' A' ' 201' ' ' THR . . . 65.02 172.11 3.16 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.682 0.601 . . . . 0.0 113.689 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.941 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 40.2 t -110.43 42.12 1.63 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.408 -0.896 . . . . 0.0 112.403 -178.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 1.4 t -151.09 145.6 25.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 111.206 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.711 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 9.9 m95 -149.53 137.79 20.64 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.29 -178.307 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.951 HD12 ' N ' ' A' ' 183' ' ' PHE . 1.2 tp -119.85 131.05 55.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.466 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.951 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.7 m-85 -130.32 141.12 50.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.83 0.824 . . . . 0.0 111.595 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.989 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -139.46 152.73 47.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.994 178.079 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 17.7 tt0 -143.56 126.25 16.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.591 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.729 HG21 HD12 ' A' ' 194' ' ' LEU . 10.9 t -62.01 115.52 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.2 tt -100.56 -22.11 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -176.034 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.816 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -161.58 91.03 0.81 Allowed 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.601 -178.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.611 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.89 -170.54 26.76 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 178.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.524 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 91.6 Cg_endo -81.81 29.34 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.253 1.969 . . . . 0.0 111.589 178.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.821 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.05 27.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.611 HG12 ' H ' ' A' ' 189' ' ' GLY . 7.8 mt -45.38 112.11 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 111.506 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.47 6.05 2.17 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.223 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.821 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.2 OUTLIER -98.47 138.94 34.95 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.703 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.539 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 17.1 mt-30 -137.92 153.08 49.53 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.515 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.989 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -147.83 147.76 30.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.634 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -147.56 166.67 26.64 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.991 -179.241 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 1.015 HG21 ' HA ' ' A' ' 206' ' ' LEU . 5.7 p -171.82 147.92 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.535 0.683 . . . . 0.0 111.984 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.466 ' OD1' ' CZ2' ' A' ' 181' ' ' TRP . 0.8 OUTLIER -93.11 147.87 22.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.693 179.219 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 24.8 p -65.88 -2.23 3.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.255 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.754 HG21 ' C ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -102.77 -4.17 25.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.032 179.661 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.623 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -94.27 125.51 38.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.548 179.871 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 207' ' ' PRO . 62.2 p -91.54 -81.28 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.12 3.21 0.63 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.704 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.475 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -120.87 -8.32 9.42 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.128 -0.358 . . . . 0.0 111.573 179.851 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 1.015 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.6 tt -71.9 -61.25 2.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.413 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.572 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.7 Cg_endo -43.75 96.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.967 1.778 . . . . 0.0 112.764 -178.464 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.903 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 3.4 t -68.62 157.85 6.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.95 179.068 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 217' ' ' ASP . 4.5 mtmm -135.71 93.48 2.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.607 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.042 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -86.86 123.19 31.71 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.735 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -168.14 169.72 41.6 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.504 -179.355 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.864 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 14.7 ttt180 -72.01 -74.4 0.16 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.014 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 213' ' ' VAL . 8.6 p -138.94 115.08 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 216' ' ' SER . 0.3 OUTLIER 169.18 -176.29 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.1 -179.578 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 16.4 Cg_exo -67.96 23.26 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.47 2.113 . . . . 0.0 112.589 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 214' ' ' SER . 3.5 m -64.23 -150.43 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.987 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.8 OUTLIER -132.16 -34.04 1.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.486 179.809 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.042 HD12 HD23 ' A' ' 210' ' ' LEU . 1.1 mt -105.47 126.08 51.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.227 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -92.09 83.1 5.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.887 0.375 . . . . 0.0 111.432 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.864 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.3 mm? -104.69 89.44 3.19 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.069 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.472 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.1 OUTLIER -64.0 38.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.618 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.524 ' HA ' ' HG3' ' A' ' 190' ' ' PRO . 12.6 t0 -64.18 123.32 18.79 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.18 179.191 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 60.1 p -67.45 -4.33 10.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.871 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -19.02 18.11 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.468 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.673 HG22 ' ND1' ' A' ' 229' ' ' HIS . 79.0 t -93.81 81.98 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.49 178.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -38.68 -48.01 1.42 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.441 -179.038 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.58 -55.38 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.693 ' HB2' ' HG3' ' A' ' 246' ' ' MET . 0.2 OUTLIER -140.93 128.31 21.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.998 0.427 . . . . 0.0 110.772 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.673 ' ND1' HG22 ' A' ' 225' ' ' VAL . 0.7 OUTLIER -98.22 -59.71 1.7 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.46 179.088 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 244' ' ' VAL . . . -149.22 170.89 17.43 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.495 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.903 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 1.7 mt-30 -151.58 173.64 14.39 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.745 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.546 HG12 HD22 ' A' ' 243' ' ' LEU . 3.5 mt -127.03 143.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.519 0.676 . . . . 0.0 112.19 179.063 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.74 127.34 3.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.942 ' CH2' HG13 ' A' ' 198' ' ' VAL . 5.7 p90 -118.08 166.05 13.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.96 132.87 56.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.058 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.09 -0.26 57.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.453 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 19.8 m -79.02 -36.76 40.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.731 0.777 . . . . 0.0 109.521 178.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.38 17.4 7.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.476 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 12.8 p90 41.12 59.2 2.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.463 0.649 . . . . 0.0 110.014 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.735 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.97 138.4 54.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.624 179.872 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.64 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.71 120.02 32.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.89 179.571 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 21.8 mt-10 -132.97 144.03 49.85 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.851 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.2 OUTLIER -89.03 146.8 24.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.959 -1.928 . . . . 0.0 108.4 178.064 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.721 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 6.0 p -122.32 163.47 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 118.718 0.69 . . . . 0.0 109.316 178.486 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.53 ' CG ' ' HA ' ' A' ' 260' ' ' SER . 2.0 m-20 -118.84 110.14 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.737 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -79.82 105.15 10.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.466 178.148 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.29 69.38 1.28 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.205 -179.029 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.01 45.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.285 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.905 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -58.37 -54.03 51.61 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.781 -0.575 . . . . 0.0 109.846 178.38 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.905 ' H ' HD13 ' A' ' 249' ' ' LEU . 1.4 m-20 -79.12 -34.11 43.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.003 0.43 . . . . 0.0 110.627 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 260' ' ' SER . . . 87.46 98.42 0.88 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.774 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.542 ' C ' HD23 ' A' ' 253' ' ' LEU . 3.1 m -61.07 170.56 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.479 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -153.25 127.0 8.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.433 178.54 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.554 HG22 HG13 ' A' ' 281' ' ' ILE . 86.1 t -103.44 130.58 53.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.522 178.347 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.51 ' HA ' HG13 ' A' ' 280' ' ' ILE . 23.8 t-20 54.03 48.8 20.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.096 0.474 . . . . 0.0 110.216 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.84 23.51 8.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -127.74 105.71 8.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.257 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 86.7 p -55.62 86.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.488 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.802 ' HB ' HG21 ' A' ' 273' ' ' VAL . 2.9 pp -86.15 20.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.332 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.958 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 78.5 p -94.49 -20.85 19.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.344 -178.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.643 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 0.0 OUTLIER -108.35 47.35 0.18 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.636 178.157 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.958 ' HD3' ' C ' ' A' ' 260' ' ' SER . 3.0 Cg_exo -82.6 26.46 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.668 2.245 . . . . 0.0 111.763 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.595 ' C ' HD22 ' A' ' 264' ' ' LEU . 1.5 m-20 -137.68 -159.22 0.93 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.425 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.595 HD22 ' C ' ' A' ' 263' ' ' ASP . 1.4 mm? -113.63 -49.96 2.86 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 118.445 0.566 . . . . 0.0 110.509 177.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -141.02 26.96 2.46 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.123 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.575 ' C ' ' H ' ' A' ' 268' ' ' LYS . 66.1 p -65.68 -62.78 1.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.516 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 266' ' ' SER . 0.0 OUTLIER 68.02 -23.68 0.13 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.831 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.575 ' H ' ' C ' ' A' ' 266' ' ' SER . 5.3 ttmt -68.7 -127.15 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.692 -177.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.737 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 0.0 OUTLIER -79.67 -14.58 58.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.149 -178.994 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 59.62 -172.34 5.09 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -178.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -113.68 131.94 22.81 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 118.242 1.021 . . . . 0.0 110.178 179.102 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.49 ' HB3' ' HB2' ' A' ' 242' ' ' GLU . 80.0 Cg_exo -44.83 119.92 2.59 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.809 2.339 . . . . 0.0 114.055 -178.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.802 HG21 ' HB ' ' A' ' 259' ' ' ILE . 49.3 t -104.14 133.02 49.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -75.15 128.11 34.75 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -176.678 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.828 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.44 165.09 13.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 113.86 -1.518 . . . . 0.0 108.864 178.088 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.52 158.43 44.01 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.57 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.705 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 5.5 p -58.25 130.09 45.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.652 178.287 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.705 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.1 m-20 85.55 7.15 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.831 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.675 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.8 m-20 -78.78 -169.52 1.79 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.5 OUTLIER -160.78 129.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 177.488 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.863 ' CG2' HG23 ' A' ' 289' ' ' VAL . 1.0 OUTLIER -106.15 157.05 6.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.809 0.337 . . . . 0.0 111.394 179.762 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.531 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.7 m -145.98 116.71 7.66 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.66 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -110.65 45.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.087 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 170.87 -128.81 1.68 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 119.317 -1.42 . . . . 0.0 114.201 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 t -86.49 -48.33 8.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.78 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.2 t -146.43 -4.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.6 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.816 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 17.0 m -66.92 104.29 1.33 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.25 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.749 ' O ' HG22 ' A' ' 187' ' ' ILE . 1.3 ptmt -126.81 135.84 51.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 0.0 111.581 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.863 HG23 ' CG2' ' A' ' 281' ' ' ILE . 0.1 OUTLIER -111.92 135.18 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.093 -178.927 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 4.6 t80 -76.89 138.84 39.99 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.049 -179.438 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.401 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -109.91 112.09 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.753 -178.545 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -137.34 145.55 43.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.88 179.866 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.679 HG12 HD13 ' A' ' 182' ' ' LEU . 1.3 mt -135.82 145.79 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.634 -179.388 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.01 139.68 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.988 0.423 . . . . 0.0 111.494 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.51 165.97 22.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.975 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.941 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 51.6 tp60 -95.7 159.61 14.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.984 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -83.53 86.34 7.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.059 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -179.963 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.511 ' HA ' HG23 ' A' ' 201' ' ' THR . 2.9 mp . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.762 0.315 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.586 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.61 103.09 2.39 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.843 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 39.4 t -179.29 -76.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.974 0.416 . . . . 0.0 109.892 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.591 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 3.1 m -139.23 174.92 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.352 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.727 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.1 m95 -140.06 130.41 25.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.3 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.945 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.5 OUTLIER -119.87 131.51 55.28 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.151 177.719 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.945 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.4 OUTLIER -135.92 145.68 46.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.891 0.853 . . . . 0.0 111.263 -179.858 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.675 HD21 ' HB3' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -144.14 149.8 37.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.837 178.588 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 1.3 tt0 -137.03 124.82 22.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.019 -177.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.911 HG21 HD11 ' A' ' 220' ' ' LEU . 40.1 t -64.21 116.3 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.922 HG22 ' O ' ' A' ' 288' ' ' LYS . 8.7 tt -99.94 -23.3 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -175.579 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.88 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -155.42 91.21 1.3 Allowed 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.494 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.559 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.27 -177.11 35.94 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.542 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 74.0 Cg_endo -77.98 31.79 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.08 1.853 . . . . 0.0 111.788 178.352 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.829 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -161.64 21.52 0.12 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.794 178.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.559 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.7 mt -39.63 113.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 0.0 111.656 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.7 7.96 2.9 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.901 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.829 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.6 OUTLIER -99.34 109.19 21.83 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.814 0.816 . . . . 0.0 109.749 178.771 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.453 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 16.4 mt-30 -111.39 153.79 25.55 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.727 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.675 ' HB3' HD21 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -146.43 146.41 30.58 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.88 179.921 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.31 153.4 40.5 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.769 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.785 HG21 ' HG ' ' A' ' 206' ' ' LEU . 14.8 p -155.35 146.48 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.349 0.595 . . . . 0.0 111.82 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.591 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.8 OUTLIER -85.06 145.81 27.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.546 178.128 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.445 ' HB2' ' CZ2' ' A' ' 234' ' ' TRP . 5.7 t -63.15 -6.97 4.82 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.11 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.586 HG21 ' N ' ' A' ' 178' ' ' GLY . 3.7 t -101.95 42.84 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.302 0.572 . . . . 0.0 111.323 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.461 ' HB2' ' CG ' ' A' ' 205' ' ' LYS . 6.3 p -135.0 106.27 6.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.523 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.7 m -76.02 -87.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.83 5.32 7.98 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.461 ' CG ' ' HB2' ' A' ' 202' ' ' SER . 2.4 pttt -122.48 56.27 1.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.89 HD11 ' CE3' ' A' ' 234' ' ' TRP . 7.9 tt -146.34 -53.84 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.975 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 3.4 Cg_exo -40.59 96.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.374 2.049 . . . . 0.0 113.076 -177.656 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 231' ' ' GLN . 61.7 t -74.96 97.83 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.337 0.062 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.167 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.729 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 6.0 mtmm -69.69 93.41 0.72 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.108 HD23 HD12 ' A' ' 218' ' ' LEU . 0.7 OUTLIER -78.53 129.55 34.97 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.611 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 179.55 -177.27 48.16 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.097 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.909 ' HB2' HG12 ' A' ' 225' ' ' VAL . 55.5 ttt180 -82.4 -68.66 0.68 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.094 0.558 . . . . 0.0 112.448 -178.518 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.864 HG22 ' H ' ' A' ' 214' ' ' SER . 9.6 p -116.9 -151.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.099 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.864 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.5 OUTLIER 66.37 173.31 0.08 OUTLIER Pre-proline 0 C--O 1.231 0.118 0 O-C-N 122.125 -0.36 . . . . 0.0 110.264 -179.806 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 72.0 Cg_endo -74.27 40.63 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.475 2.116 . . . . 0.0 113.336 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 209' ' ' LYS . 0.6 OUTLIER -71.56 168.01 18.53 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.616 0.246 . . . . 0.0 110.347 179.365 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 1.8 m-20 -85.02 -34.36 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.371 . . . . 0.0 110.605 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.108 HD12 HD23 ' A' ' 210' ' ' LEU . 1.8 mt -101.83 127.68 48.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.652 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -97.36 82.11 3.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.935 0.398 . . . . 0.0 110.992 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.911 HD11 HG21 ' A' ' 186' ' ' VAL . 2.5 mm? -105.97 73.36 0.99 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.184 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.28 60.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.623 ' N ' ' HG3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -107.26 127.79 53.85 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.961 0.41 . . . . 0.0 110.188 178.615 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.3 p -48.24 -24.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.454 0.645 . . . . 0.0 111.58 178.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.914 ' O ' HG23 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -109.92 73.2 0.83 Allowed 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.215 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 224' ' ' GLU . 1.9 t 169.72 3.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 113.08 -1.873 . . . . 0.0 108.626 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.886 ' O ' ' HB3' ' A' ' 212' ' ' ARG . 0.3 OUTLIER -7.23 -116.47 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.628 1.571 . . . . 0.0 114.635 -179.297 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.518 ' H ' ' HB3' ' A' ' 226' ' ' SER . . . -52.49 -89.54 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.029 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.644 ' O ' ' O ' ' A' ' 246' ' ' MET . 6.5 mttm -146.96 138.76 24.38 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.07 0.462 . . . . 0.0 109.95 179.591 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.636 ' CE1' ' HB3' ' A' ' 250' ' ' ASN . 0.2 OUTLIER -96.21 -59.94 1.73 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.58 -179.626 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -149.19 177.66 9.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.621 0.724 . . . . 0.0 112.474 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.729 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 3.8 pt20 -159.36 172.8 17.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.422 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.975 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 4.9 mt -126.77 143.82 38.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.308 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.485 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -145.5 162.53 37.17 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.721 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.89 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.6 OUTLIER -92.33 152.84 19.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.471 -177.05 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 239' ' ' PHE . 1.9 t-20 -119.29 71.33 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 175.16 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 17.8 p -54.61 -23.97 19.29 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -176.907 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.8 m -74.77 -22.15 58.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.556 0.693 . . . . 0.0 109.343 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 22.5 tptt -122.98 8.95 9.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.4 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 235' ' ' ASN . 8.0 p90 39.92 42.93 1.15 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.332 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -120.42 -179.02 3.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.489 0.662 . . . . 0.0 110.58 -179.643 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 1.039 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -131.86 119.82 21.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.783 -179.309 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 6.0 pt-20 -139.84 152.36 46.43 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.776 0.798 . . . . 0.0 113.099 -178.063 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.8 pp -111.16 153.29 25.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.775 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.796 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -123.14 162.34 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.55 -179.432 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.666 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 2.2 t0 -95.4 100.36 12.14 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 120.777 0.322 . . . . 0.0 111.508 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.644 ' O ' ' O ' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -87.09 90.57 8.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.041 178.964 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.719 ' HA2' ' HG3' ' A' ' 267' ' ' ARG . . . 48.01 70.67 0.69 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.933 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.414 ' HB2' ' CG ' ' A' ' 245' ' ' ASP . 3.2 t -95.6 78.23 3.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.098 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.578 HD13 ' C ' ' A' ' 249' ' ' LEU . 1.6 tm? -52.75 -58.85 5.53 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.142 0.496 . . . . 0.0 109.776 177.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.636 ' HB3' ' CE1' ' A' ' 229' ' ' HIS . 0.2 OUTLIER -68.33 -29.25 67.95 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.92 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.538 ' O ' ' CE1' ' A' ' 229' ' ' HIS . . . 101.32 156.43 26.89 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.726 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.551 ' C ' HD23 ' A' ' 253' ' ' LEU . 46.7 m -124.86 155.18 39.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.819 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -150.06 145.6 26.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.036 0.446 . . . . 0.0 111.558 179.621 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.858 HG23 ' CD1' ' A' ' 259' ' ' ILE . 75.2 t -116.9 138.3 47.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.095 178.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.483 ' HA ' HG13 ' A' ' 280' ' ' ILE . 3.8 p-10 49.0 37.08 9.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.211 0.529 . . . . 0.0 110.471 -178.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.06 36.85 1.33 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.127 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.708 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.1 OUTLIER -146.45 116.8 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.075 -179.916 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 51.7 p -62.09 90.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.298 0.571 . . . . 0.0 110.746 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.861 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.1 OUTLIER -92.98 -11.79 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.352 -177.758 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.793 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 0.2 OUTLIER -122.01 -19.44 6.64 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.509 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.668 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 14.6 t-80 -110.7 42.59 0.2 Allowed Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.793 ' HD3' ' C ' ' A' ' 260' ' ' SER . 23.2 Cg_exo -65.86 -27.61 51.29 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 121.887 1.725 . . . . 0.0 113.546 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -119.73 95.78 4.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.804 0.335 . . . . 0.0 111.052 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.731 ' H ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -61.7 173.65 0.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.757 179.001 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 64.41 -19.44 0.1 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.494 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.604 ' H ' ' C ' ' A' ' 264' ' ' LEU . 0.5 OUTLIER -80.2 -35.13 36.76 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 122.806 0.442 . . . . 0.0 111.703 -179.738 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.719 ' HG3' ' HA2' ' A' ' 247' ' ' GLY . 0.0 OUTLIER 44.77 21.95 0.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.38 -179.331 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -62.94 165.83 6.39 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 123.715 0.806 . . . . 0.0 112.392 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.796 ' NE1' HG11 ' A' ' 244' ' ' VAL . 30.9 t-105 -77.34 -24.81 50.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.354 178.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 63.02 -179.01 5.66 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.322 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -107.82 134.15 20.18 Favored Pre-proline 0 C--N 1.332 -0.17 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.511 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 1.3 Cg_endo -44.93 136.64 9.84 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.166 2.577 . . . . 0.0 113.926 -178.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.861 HG21 ' CG1' ' A' ' 259' ' ' ILE . 62.2 t -109.21 129.43 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.0 pt-20 -74.31 132.24 41.89 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.417 -178.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.829 HD22 HG11 ' A' ' 291' ' ' VAL . 1.2 mt -89.1 163.22 15.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.973 -178.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -135.81 144.33 45.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.729 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 6.4 m -55.92 131.9 48.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.189 178.042 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 84.58 1.76 0.82 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.133 -179.26 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 3.2 t70 -72.96 -166.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.6 OUTLIER -160.4 133.49 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.896 178.542 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.65 HG12 HG22 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -110.94 156.57 12.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.061 0.458 . . . . 0.0 111.286 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.605 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 3.0 m -148.89 123.5 9.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.729 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.752 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -120.95 39.58 3.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.457 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -176.1 -136.42 2.35 Favored Glycine 0 C--N 1.328 0.095 0 C-N-CA 119.331 -1.414 . . . . 0.0 113.702 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.644 HG22 ' HG3' ' A' ' 224' ' ' GLU . 14.1 t -87.15 -48.85 7.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.588 0.232 . . . . 0.0 110.695 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.435 ' O ' ' HD2' ' A' ' 288' ' ' LYS . 1.3 t -140.25 2.32 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.319 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 31.7 m -74.93 102.09 4.66 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.69 0.281 . . . . 0.0 110.261 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.922 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -123.51 133.2 54.04 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.31 0.576 . . . . 0.0 110.918 -179.874 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.517 HG23 HG22 ' A' ' 281' ' ' ILE . 1.2 t -107.9 130.61 60.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.372 -178.578 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.5 t80 -76.15 136.7 39.79 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 110.309 -178.189 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.829 HG11 HD22 ' A' ' 275' ' ' LEU . 3.5 t -102.25 107.81 22.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.196 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.32 122.4 37.62 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 1.039 HD12 ' CE3' ' A' ' 241' ' ' TRP . 1.2 mt -132.58 146.51 32.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.7 t -152.2 166.13 32.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 111.146 -179.5 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 7.0 m -94.57 159.77 14.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.631 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -113.7 116.05 28.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.926 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -95.5 107.18 19.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.625 HD23 ' OD1' ' A' ' 199' ' ' ASN . 5.2 mp . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.731 0.3 . . . . 0.0 110.527 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.707 ' HA3' ' CG2' ' A' ' 201' ' ' THR . . . 77.09 166.86 26.55 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.093 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.659 ' HA ' ' CB ' ' A' ' 296' ' ' GLN . 0.5 OUTLIER -93.92 41.02 1.08 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.147 -0.527 . . . . 0.0 112.196 -179.419 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.5 OUTLIER -146.49 140.69 26.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.068 0.461 . . . . 0.0 110.935 179.761 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.3 m95 -146.88 139.45 24.96 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.13 -178.676 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 8.8 tp -116.88 124.53 49.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.634 178.053 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 5.7 m-85 -123.87 131.54 53.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.775 0.798 . . . . 0.0 110.197 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.825 HD13 ' ND1' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -131.45 142.69 50.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.331 -179.69 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.584 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 2.9 tt0 -139.39 124.68 19.06 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.873 HG21 HD12 ' A' ' 194' ' ' LEU . 10.5 t -62.95 104.84 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.102 0.477 . . . . 0.0 110.462 178.332 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.6 tt -87.03 -24.26 6.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 -177.33 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.738 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -166.64 98.62 0.57 Allowed 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.874 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.714 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.9 -175.04 32.51 Favored Glycine 0 N--CA 1.452 -0.272 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 178.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.563 ' O ' ' HG2' ' A' ' 221' ' ' LYS . 89.1 Cg_endo -77.31 28.71 0.43 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.099 1.866 . . . . 0.0 111.533 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.85 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.15 27.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.714 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.4 mt -39.97 111.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.453 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.58 6.56 2.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.257 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.873 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -99.51 162.2 13.16 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.883 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.735 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 12.7 mt-30 -156.59 149.67 24.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.076 -178.177 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.825 ' ND1' HD13 ' A' ' 184' ' ' LEU . 1.8 p80 -136.98 129.06 29.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -139.12 164.62 29.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.075 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.588 HG21 ' HG ' ' A' ' 206' ' ' LEU . 10.1 p -175.32 155.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.56 0.695 . . . . 0.0 112.704 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.626 ' O ' HD12 ' A' ' 206' ' ' LEU . 5.6 m120 -90.39 147.8 23.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.832 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.596 ' HA ' ' CE2' ' A' ' 234' ' ' TRP . 65.2 m -56.03 -49.92 72.37 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.107 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.707 ' CG2' ' HA3' ' A' ' 178' ' ' GLY . 0.1 OUTLIER -62.93 5.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.607 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.797 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.3 OUTLIER -87.19 105.14 17.0 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.294 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.445 ' HB3' ' H ' ' A' ' 204' ' ' SER . 1.0 OUTLIER -67.83 -107.48 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.099 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.445 ' H ' ' HB3' ' A' ' 203' ' ' SER . 3.2 m -70.48 6.23 1.48 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.128 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.488 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 8.9 pttt -120.32 55.98 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.212 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.829 HD11 ' CE3' ' A' ' 234' ' ' TRP . 8.0 tt -149.15 -59.87 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.515 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.791 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 4.5 Cg_exo -41.09 99.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.185 1.923 . . . . 0.0 112.189 -177.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.645 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 31.9 t -68.82 166.88 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.015 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -139.38 92.1 2.55 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.63 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.077 HD23 HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -76.79 125.24 28.95 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.324 178.895 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -166.22 168.59 39.97 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.64 -179.122 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.996 ' HB2' HG13 ' A' ' 225' ' ' VAL . 1.5 ttt85 -60.72 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.397 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.619 HG12 ' HD3' ' A' ' 212' ' ' ARG . 12.4 p -133.42 -12.4 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 0.0 111.735 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.639 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 1.4 m -49.85 176.5 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.732 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.639 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 28.4 Cg_endo -62.03 18.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.134 1.89 . . . . 0.0 112.667 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.57 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.6 OUTLIER -58.59 -178.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 111.31 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -96.57 -31.55 12.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.138 179.238 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.077 HD12 HD23 ' A' ' 210' ' ' LEU . 1.4 mt -104.66 131.42 52.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.619 178.609 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -98.09 82.5 2.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.596 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.831 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.3 mm? -102.2 86.37 2.83 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.264 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -60.07 67.83 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.856 179.865 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.921 ' HB3' HG12 ' A' ' 225' ' ' VAL . 5.3 t0 -97.77 151.17 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.232 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.5 p -90.38 -9.79 46.31 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.194 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.64 -20.64 24.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.427 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.996 HG13 ' HB2' ' A' ' 212' ' ' ARG . 3.6 p -107.26 86.76 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.041 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.4 m -37.62 -42.23 0.53 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.413 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.33 -55.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.491 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.9 OUTLIER -140.42 133.37 29.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.996 0.427 . . . . 0.0 109.93 179.122 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.6 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.9 t60 -98.27 -54.21 3.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.281 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.415 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -146.56 177.24 9.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 112.212 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.645 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -163.72 175.8 10.19 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.475 -179.822 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.791 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.9 mt -132.8 148.96 31.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.757 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 207' ' ' PRO . 0.1 OUTLIER -149.8 164.65 34.75 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.56 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.829 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.4 OUTLIER -110.55 112.96 25.22 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.285 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.37 82.89 4.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.28 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.6 t -61.65 -9.2 5.63 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -176.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 55.2 m -74.7 -32.98 62.33 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.17 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.58 ' HG2' ' HG2' ' A' ' 240' ' ' LYS . 5.4 tptm -110.54 0.22 17.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.245 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 17.4 p90 41.32 47.86 3.1 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.087 0.47 . . . . 0.0 110.272 179.572 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.617 ' HE2' ' HG2' ' A' ' 242' ' ' GLU . 0.0 OUTLIER -119.88 170.34 9.33 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.574 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 1.004 ' CZ3' HG23 ' A' ' 293' ' ' ILE . 1.3 m0 -119.4 108.58 14.75 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.617 ' HG2' ' HE2' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -133.89 147.65 51.16 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.912 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.744 ' O ' HD12 ' A' ' 243' ' ' LEU . 3.4 pp -111.92 152.16 28.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.357 -1.747 . . . . 0.0 110.59 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.834 HG21 ' CD1' ' A' ' 269' ' ' TRP . 1.2 p -117.99 162.92 15.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.558 0.218 . . . . 0.0 110.527 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -103.18 111.25 23.53 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -177.983 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.606 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -79.36 95.72 5.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.692 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.73 64.0 4.7 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.023 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 21.8 p -64.59 50.34 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.321 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.877 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.56 -50.74 69.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.872 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.877 ' H ' HD13 ' A' ' 249' ' ' LEU . 5.1 t30 -77.72 -37.15 50.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.469 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.1 85.91 1.35 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.218 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.548 ' N ' ' HB3' ' A' ' 260' ' ' SER . 0.5 OUTLIER -45.69 166.56 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 119.87 -0.11 . . . . 0.0 110.789 179.137 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 281' ' ' ILE . 0.2 OUTLIER -150.83 127.23 10.69 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.089 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.771 HG22 HG13 ' A' ' 281' ' ' ILE . 99.5 t -107.39 131.32 57.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.646 178.295 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 58.6 t30 57.57 40.15 27.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.232 0.539 . . . . 0.0 109.852 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 7.9 p 61.53 24.78 14.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.445 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.42 97.64 4.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.604 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -46.4 93.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.6 -179.605 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.83 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.0 OUTLIER -94.87 6.23 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.452 -178.855 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.548 ' HB3' ' N ' ' A' ' 252' ' ' THR . 2.0 t -99.23 -19.52 17.07 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.159 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.666 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 0.6 OUTLIER -106.78 21.43 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.666 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 50.9 Cg_exo -51.27 -43.35 49.58 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.184 1.256 . . . . 0.0 109.622 178.387 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 266' ' ' SER . 33.1 p30 -75.87 81.71 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 112.296 -2.229 . . . . 0.0 110.924 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.719 ' H ' HD23 ' A' ' 264' ' ' LEU . 1.5 pt? -54.92 134.04 48.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.616 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 78.73 -4.49 60.58 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.647 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 263' ' ' ASP . 3.6 m -83.06 -63.04 1.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.049 0.424 . . . . 0.0 111.682 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.39 -12.79 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 266' ' ' SER . 3.5 ttmm -80.52 -130.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.834 ' CD1' HG21 ' A' ' 244' ' ' VAL . 1.8 t-105 -80.7 -30.89 36.31 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.17 -171.55 7.8 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.14 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -106.5 134.9 19.6 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 117.65 0.725 . . . . 0.0 111.158 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 84.2 Cg_exo -43.03 124.11 3.52 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.214 2.61 . . . . 0.0 113.74 -178.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.83 HG21 ' HB ' ' A' ' 259' ' ' ILE . 87.9 t -99.27 139.28 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.4 OUTLIER -86.45 131.05 34.29 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 119.099 -1.041 . . . . 0.0 111.979 -178.954 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.948 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -96.59 163.91 12.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.496 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.657 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.5 158.48 43.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 8.5 t -61.55 131.44 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.803 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.61 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.7 m-20 85.4 -1.94 0.82 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.18 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.657 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -71.34 -166.78 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.44 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.59 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.8 OUTLIER -161.37 128.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.454 177.299 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.771 HG13 HG22 ' A' ' 254' ' ' VAL . 1.0 OUTLIER -108.74 155.13 9.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.706 179.23 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.629 ' OG1' ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -142.2 121.82 13.37 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.551 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.72 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -113.71 45.18 1.48 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.145 -178.008 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 170.26 -123.13 1.03 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 119.2 -1.476 . . . . 0.0 114.114 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.0 t -91.59 -54.8 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.186 . . . . 0.0 111.273 -179.207 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.573 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -139.94 -3.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.471 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 26.9 m -67.57 103.0 1.25 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.853 0.297 . . . . 0.0 110.58 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.662 ' O ' HG22 ' A' ' 187' ' ' ILE . 7.9 ttmt -118.39 130.98 56.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.672 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -113.43 133.02 60.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.653 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.59 ' HD1' HG23 ' A' ' 280' ' ' ILE . 4.4 t80 -76.34 136.16 39.54 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.014 0.435 . . . . 0.0 110.031 -178.567 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.948 HG11 ' HB2' ' A' ' 275' ' ' LEU . 1.0 OUTLIER -103.46 110.68 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.404 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.19 135.24 55.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.508 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 1.004 HG23 ' CZ3' ' A' ' 241' ' ' TRP . 16.0 mt -131.41 133.51 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.867 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.3 m -156.58 159.98 39.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 110.798 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 52.1 m -86.97 177.54 7.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.845 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.659 ' CB ' ' HA ' ' A' ' 179' ' ' SER . 0.0 OUTLIER -81.27 126.27 31.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -148.42 86.38 1.54 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 -179.912 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.821 ' C ' HG21 ' A' ' 201' ' ' THR . 1.2 mt . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.067 0.46 . . . . 0.0 111.748 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.564 ' N ' HG21 ' A' ' 201' ' ' THR . . . 64.24 -123.61 28.14 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 115.725 -0.67 . . . . 0.0 114.747 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 0.1 OUTLIER -179.02 48.03 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.804 -0.698 . . . . 0.0 111.273 -178.675 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 13.4 t -159.56 156.78 28.66 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.789 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 15.8 m95 -150.48 146.71 26.8 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.638 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.896 HD11 ' CD2' ' A' ' 184' ' ' LEU . 0.8 OUTLIER -122.26 134.54 54.68 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.922 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.841 ' N ' HD12 ' A' ' 182' ' ' LEU . 13.3 m-85 -130.25 136.86 49.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.67 0.747 . . . . 0.0 110.466 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.896 ' CD2' HD11 ' A' ' 182' ' ' LEU . 2.4 mm? -123.4 138.91 54.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.049 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.55 117.15 15.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.796 HG21 HD12 ' A' ' 194' ' ' LEU . 27.0 t -65.59 118.2 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.001 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.768 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.2 tt -98.04 -26.89 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -176.576 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.883 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -158.01 94.34 1.31 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.677 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.76 -174.58 31.81 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 178.255 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.462 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 85.2 Cg_endo -80.6 32.09 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.02 1.813 . . . . 0.0 110.785 178.248 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.796 ' HB1' HD21 ' A' ' 194' ' ' LEU . . . -161.26 21.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.749 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.677 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.1 mt -38.99 113.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 111.612 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.95 5.9 4.66 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.76 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.796 HD12 HG21 ' A' ' 186' ' ' VAL . 0.2 OUTLIER -93.29 139.87 30.16 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.111 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 12.4 mt-30 -133.26 143.55 49.17 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.662 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.886 ' CG ' HG11 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -134.83 128.55 32.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.772 -179.537 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -140.82 162.81 34.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.773 -179.195 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.708 HG21 ' HA ' ' A' ' 206' ' ' LEU . 12.3 p -173.3 153.03 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.413 178.674 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.588 ' HB2' HG22 ' A' ' 201' ' ' THR . 3.0 p30 -90.74 145.59 24.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.919 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.939 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 0.1 OUTLIER -62.59 -2.2 1.03 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.203 179.517 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.821 HG21 ' C ' ' A' ' 177' ' ' LEU . 1.2 t -101.63 13.74 34.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.827 0.346 . . . . 0.0 110.8 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.514 ' CB ' ' HG2' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -103.96 117.34 34.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.166 179.761 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.4 m -76.92 -84.29 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.9 t -90.4 15.71 10.14 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.514 ' HG2' ' CB ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -115.46 -10.4 11.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.912 HD13 ' HD3' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -90.09 -18.89 0.23 Allowed Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -179.747 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.912 ' HD3' HD13 ' A' ' 206' ' ' LEU . 30.1 Cg_endo -65.43 84.44 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 CA-C-N 120.905 1.359 . . . . 0.0 111.468 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.886 HG11 ' CG ' ' A' ' 196' ' ' HIS . 47.1 t -70.56 108.15 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.148 -178.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.742 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -79.98 84.5 5.72 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.72 ' HB2' ' O ' ' A' ' 230' ' ' ALA . 4.7 mp -74.93 136.01 41.4 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 118.742 0.701 . . . . 0.0 109.325 178.528 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.672 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . 178.38 -177.02 48.33 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.773 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 1.068 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -71.52 -74.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.092 -0.554 . . . . 0.0 111.638 -179.536 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.848 HG22 ' H ' ' A' ' 214' ' ' SER . 7.6 p -117.0 -145.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.88 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.848 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.6 OUTLIER 61.0 -179.38 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 121.98 -0.45 . . . . 0.0 109.905 -179.578 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 21.5 Cg_exo -66.4 24.2 0.1 OUTLIER 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.646 2.231 . . . . 0.0 113.765 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.558 ' HA ' ' HG3' ' A' ' 209' ' ' LYS . 68.2 m -53.0 152.05 4.31 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 120.617 0.246 . . . . 0.0 110.848 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.53 ' HB3' HG13 ' A' ' 208' ' ' VAL . 0.6 OUTLIER -84.14 -29.25 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.379 179.742 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.67 ' HB3' HD21 ' A' ' 220' ' ' LEU . 36.1 mt -115.65 132.53 56.6 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.136 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -87.96 81.65 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.682 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.672 ' N ' HD22 ' A' ' 220' ' ' LEU . 1.8 mm? -100.3 64.09 1.16 Allowed 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.845 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.559 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -60.78 35.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -177.097 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 224' ' ' GLU . 3.1 t70 -87.94 125.44 34.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 76.8 p -39.73 -30.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 222' ' ' ASP . 9.8 pt-20 -51.88 -42.23 62.53 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.989 0.424 . . . . 0.0 110.838 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.068 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.7 p -96.87 106.17 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.835 179.017 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.5 t -47.22 -68.56 0.18 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.452 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -128.32 -45.1 0.2 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 178.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.672 ' HA ' ' HA3' ' A' ' 211' ' ' GLY . 0.4 OUTLIER -143.45 127.65 17.64 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.087 -0.557 . . . . 0.0 109.555 178.953 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.832 ' CE1' ' HB3' ' A' ' 248' ' ' SER . 1.2 t60 -92.12 -55.19 3.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.534 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' A' ' 210' ' ' LEU . . . -155.35 150.76 27.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.742 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.0 OUTLIER -131.88 179.87 5.82 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.979 179.428 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.866 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.0 mt -126.93 139.4 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.847 179.157 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.747 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -159.83 129.98 5.52 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.383 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.939 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 5.4 p90 -111.61 151.6 28.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -175.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 239' ' ' PHE . 1.5 t-20 -73.32 126.8 30.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 112.493 -2.14 . . . . 0.0 111.007 177.69 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.5 t -89.19 -29.73 19.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.462 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.0 m -77.95 -30.95 50.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.699 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.446 ' O ' ' CG ' ' A' ' 239' ' ' PHE . 1.5 tptm -108.23 -2.32 19.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.598 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 235' ' ' ASN . 27.9 p90 43.44 42.39 3.81 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.37 140.35 52.78 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.579 0.704 . . . . 0.0 110.382 178.507 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.843 ' HA ' ' HB3' ' A' ' 234' ' ' TRP . 2.9 m95 -89.45 121.96 32.18 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.078 -179.393 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.0 mt-10 -140.51 151.18 44.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.004 0.907 . . . . 0.0 113.196 -178.258 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.612 ' CD2' HD12 ' A' ' 281' ' ' ILE . 3.8 pp -117.36 156.51 27.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.125 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.614 HG11 ' HE1' ' A' ' 269' ' ' TRP . 1.3 p -128.91 162.92 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.719 0.295 . . . . 0.0 111.746 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -92.17 156.43 17.34 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.438 0.637 . . . . 0.0 111.367 179.481 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.694 ' O ' ' N ' ' A' ' 248' ' ' SER . 0.0 OUTLIER -127.86 87.8 2.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.768 179.174 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 267' ' ' ARG . . . 55.29 -46.83 0.01 OUTLIER Glycine 0 C--N 1.341 0.818 0 CA-C-O 121.402 0.446 . . . . 0.0 113.948 179.221 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.832 ' HB3' ' CE1' ' A' ' 229' ' ' HIS . 4.1 m -38.81 85.26 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.599 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.65 ' O ' ' HG ' ' A' ' 249' ' ' LEU . 8.7 tp -55.5 2.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 -178.49 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.587 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . 3.8 m120 -71.67 15.92 0.13 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.568 1.531 . . . . 0.0 111.511 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 249' ' ' LEU . . . 42.49 84.64 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.111 179.606 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.473 ' C ' HD23 ' A' ' 253' ' ' LEU . 1.0 OUTLIER -47.43 156.45 0.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.714 0.257 . . . . 0.0 110.593 179.406 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.612 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -144.8 128.94 17.66 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.05 0.453 . . . . 0.0 111.384 178.729 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.946 HG23 HD12 ' A' ' 259' ' ' ILE . 85.2 t -104.77 132.06 52.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.681 178.635 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 3.9 t30 52.13 41.63 30.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.134 0.492 . . . . 0.0 110.15 -179.501 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.62 24.49 11.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.969 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 9.6 m80 -127.39 108.71 11.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.037 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 3.3 t -58.56 97.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.148 0.499 . . . . 0.0 111.558 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.946 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -78.66 -54.74 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.717 -179.171 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.542 ' N ' HG12 ' A' ' 259' ' ' ILE . 6.9 p -51.43 165.99 0.14 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.441 ' O ' ' CG ' ' A' ' 261' ' ' HIS . 23.1 p-80 -57.48 109.54 1.84 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 118.591 0.632 . . . . 0.0 112.059 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 261' ' ' HIS . 6.8 Cg_exo -75.24 21.68 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.039 2.493 . . . . 0.0 111.781 178.731 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 261' ' ' HIS . 2.1 m-20 -100.17 117.74 35.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.63 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.536 ' HA ' HD11 ' A' ' 249' ' ' LEU . 3.8 mm? -69.12 155.93 39.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.285 -179.114 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 71.71 -10.96 3.62 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.927 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 268' ' ' LYS . 0.4 OUTLIER -80.48 -30.92 37.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.944 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 247' ' ' GLY . 0.0 OUTLIER 42.58 17.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.45 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 266' ' ' SER . 6.9 tptt -53.4 153.21 4.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.229 0.538 . . . . 0.0 110.993 -178.752 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.614 ' HE1' HG11 ' A' ' 244' ' ' VAL . 18.6 t-105 -67.72 -27.91 67.21 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.068 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.65 154.44 18.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.98 179.27 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.45 150.74 41.77 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.599 0.238 . . . . 0.0 110.624 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.39 144.54 31.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.36 2.04 . . . . 0.0 112.076 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.795 HG11 HG21 ' A' ' 259' ' ' ILE . 92.8 t -132.15 131.87 61.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.163 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.7 pm0 -80.74 132.87 35.58 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.229 -178.517 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 1.031 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -96.82 165.13 12.26 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.526 -179.74 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.6 162.14 36.21 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.656 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 20.3 p -69.97 132.84 46.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.253 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 277' ' ' SER . 42.7 m-20 82.98 -8.51 1.15 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.975 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -62.1 -168.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.193 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.51 ' CG2' ' HD1' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -161.11 120.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.406 178.341 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.871 HG13 HG22 ' A' ' 254' ' ' VAL . 0.4 OUTLIER -105.08 157.66 5.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.072 179.742 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.661 HG23 ' CG ' ' A' ' 288' ' ' LYS . 1.7 m -143.02 120.7 11.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.64 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.661 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -117.7 47.1 1.61 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.298 -178.449 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.2 -137.13 3.68 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 119.418 -1.373 . . . . 0.0 113.044 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 12.1 t -90.01 -36.32 15.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.836 0.351 . . . . 0.0 110.598 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -151.92 0.91 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.883 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 24.5 m -75.65 105.22 6.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.62 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.768 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.1 mtpt -122.99 127.51 48.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 111.246 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.491 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -107.69 133.59 52.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.537 -178.717 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.675 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.0 t80 -77.38 131.16 37.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.897 0.379 . . . . 0.0 110.098 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 1.031 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -103.05 117.87 49.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.304 -178.906 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.656 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -137.6 141.66 41.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.033 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.739 HD11 HD23 ' A' ' 275' ' ' LEU . 6.2 mt -136.27 133.0 49.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.735 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 22.7 t -133.18 158.78 41.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.963 0.411 . . . . 0.0 111.264 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.7 150.34 21.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.654 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 9.1 tp-100 -109.7 139.16 45.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.705 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -86.05 104.44 15.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.381 -179.459 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.899 179.599 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.577 ' HB3' ' OG1' ' A' ' 201' ' ' THR . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 CA-C-O 120.798 0.332 . . . . 0.0 111.517 . . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.419 ' O ' ' CG2' ' A' ' 201' ' ' THR . . . 117.08 103.27 2.27 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.193 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 2.1 t -70.87 101.31 2.11 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.34 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 1.5 m -145.93 164.6 31.51 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.575 ' CB ' ' CZ ' ' A' ' 183' ' ' PHE . 90.8 m95 -156.97 146.78 20.74 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.583 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.771 HD11 ' CD1' ' A' ' 184' ' ' LEU . 0.2 OUTLIER -122.8 106.45 10.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 113.64 -1.618 . . . . 0.0 106.797 176.155 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.575 ' CZ ' ' CB ' ' A' ' 181' ' ' TRP . 1.8 m-85 -105.83 138.53 41.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.936 0.874 . . . . 0.0 113.007 -177.685 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.913 ' N ' HD22 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -135.63 146.57 48.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.067 177.406 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.488 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 1.6 tt0 -140.9 127.4 20.02 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -176.841 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.972 HG21 HD11 ' A' ' 220' ' ' LEU . 10.7 t -62.14 116.51 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.173 178.363 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.1 tt -97.22 -22.47 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.516 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.748 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.28 91.21 0.69 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.84 -177.64 35.08 Favored Glycine 0 C--O 1.228 -0.224 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 178.161 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.52 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 84.4 Cg_endo -76.99 32.72 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.907 1.738 . . . . 0.0 111.802 178.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.9 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -161.47 28.74 0.13 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.672 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -47.74 111.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.379 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.94 10.06 2.94 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.683 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.9 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.4 OUTLIER -101.39 105.38 16.41 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.983 0.897 . . . . 0.0 109.944 178.837 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.488 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 8.5 mt-30 -105.83 156.19 18.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.715 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.871 ' ND1' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -149.44 147.2 27.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.299 179.716 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.457 ' HB2' ' HD2' ' A' ' 183' ' ' PHE . . . -149.02 158.29 44.07 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.587 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.74 HG21 ' HA ' ' A' ' 206' ' ' LEU . 9.8 p -159.96 148.57 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.655 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 180' ' ' SER . 2.1 m120 -85.49 140.72 30.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.863 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.954 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 9.8 m -56.71 -10.93 1.14 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.635 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 177' ' ' LEU . 4.2 t -97.14 9.07 43.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.797 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.89 ' O ' HD12 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -96.53 103.14 15.03 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.932 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.413 ' O ' ' CD1' ' A' ' 206' ' ' LEU . 1.9 m -62.98 -89.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.828 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.62 13.25 7.25 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.981 -0.449 . . . . 0.0 111.642 -179.098 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.667 ' HG2' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -111.51 -2.61 15.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.645 -179.447 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 1.058 HD13 ' HD3' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -100.35 -27.67 0.23 Allowed Pre-proline 0 C--O 1.232 0.15 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.867 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 1.058 ' HD3' HD13 ' A' ' 206' ' ' LEU . 9.7 Cg_endo -54.1 100.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.867 0 CA-C-N 121.329 1.51 . . . . 0.0 111.11 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 59.5 t -68.46 155.22 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.273 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.608 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -135.87 90.48 2.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 -179.164 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.067 HD23 HD12 ' A' ' 218' ' ' LEU . 0.9 OUTLIER -81.45 127.77 33.16 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.638 -179.99 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.565 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -172.56 171.44 44.32 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.066 -179.623 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.986 ' HB2' HG13 ' A' ' 225' ' ' VAL . 5.3 ttm180 -67.04 -74.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.297 0.57 . . . . 0.0 111.774 -179.625 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.679 HG22 ' H ' ' A' ' 214' ' ' SER . 9.4 p -124.15 -138.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.278 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.679 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.7 OUTLIER 59.74 179.26 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 119.131 0.878 . . . . 0.0 109.606 -179.966 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.658 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 38.4 Cg_endo -67.43 25.86 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.039 1.826 . . . . 0.0 113.758 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -58.43 152.7 17.3 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.686 0.279 . . . . 0.0 110.695 179.471 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -79.94 -32.0 40.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.379 . . . . 0.0 110.117 179.484 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.067 HD12 HD23 ' A' ' 210' ' ' LEU . 1.2 mt -106.48 129.05 54.51 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.373 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.638 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -92.71 81.47 4.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.791 0.329 . . . . 0.0 111.502 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.972 HD11 HG21 ' A' ' 186' ' ' VAL . 2.5 mm? -108.48 62.22 0.61 Allowed 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.846 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 10.2 pttt -51.91 55.8 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -177.482 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 220' ' ' LEU . 22.1 t0 -100.62 149.64 23.55 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.759 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 29.5 t -64.47 -34.61 78.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.477 -179.764 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.526 ' O ' HD11 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -48.9 -39.94 27.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.442 -179.591 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.986 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.3 p -103.45 89.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.448 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -34.82 -45.77 0.27 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.705 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.37 -53.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.422 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.559 ' HB2' ' SD ' ' A' ' 246' ' ' MET . 0.0 OUTLIER -144.71 135.2 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.194 0.521 . . . . 0.0 109.667 178.73 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.708 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.4 OUTLIER -104.2 -56.08 2.25 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.284 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -141.76 172.42 12.71 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.506 0.669 . . . . 0.0 112.485 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.703 ' HG3' HG12 ' A' ' 244' ' ' VAL . 1.5 pt20 -158.52 173.46 16.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.319 179.648 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 9.8 mt -134.31 151.58 32.37 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.422 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -162.01 148.18 13.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.713 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.954 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 2.5 p90 -130.17 163.24 27.09 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.369 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.47 123.79 50.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.256 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 24.1 t -84.01 -1.77 55.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.099 179.443 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.5 m -80.8 -33.74 34.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.599 0.714 . . . . 0.0 109.984 179.15 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 19.5 tptm -129.41 16.3 6.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.95 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.417 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 9.0 p90 40.05 60.3 1.76 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.476 0.655 . . . . 0.0 109.545 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.597 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.2 OUTLIER -123.81 138.55 54.48 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.364 179.661 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.68 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -117.2 114.77 24.13 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.123 178.761 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 35.3 mt-10 -130.83 141.88 50.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.757 0.789 . . . . 0.0 112.373 -177.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.749 HD22 HD12 ' A' ' 281' ' ' ILE . 3.8 pp -108.26 152.6 24.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.125 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.703 HG12 ' HG3' ' A' ' 231' ' ' GLN . 0.7 OUTLIER -123.44 162.24 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.573 -179.404 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.706 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 1.1 m-20 -111.28 101.09 9.6 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.914 178.899 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.871 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -84.94 106.5 16.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.971 0.415 . . . . 0.0 109.924 179.347 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.556 ' HA2' ' HG3' ' A' ' 267' ' ' ARG . . . 48.19 67.31 1.65 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.803 -178.813 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.51 ' O ' ' CD2' ' A' ' 261' ' ' HIS . 0.3 OUTLIER -89.04 74.6 8.08 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.42 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.853 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -51.34 -56.26 14.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.611 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.853 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -71.07 -25.96 62.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.167 0.508 . . . . 0.0 110.965 -179.892 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.589 ' HA2' ' CG ' ' A' ' 261' ' ' HIS . . . 89.49 136.79 6.15 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.483 -0.78 . . . . 0.0 113.753 179.479 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.59 ' C ' HD23 ' A' ' 253' ' ' LEU . 24.1 m -100.71 155.68 17.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.117 179.284 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.666 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -146.57 145.45 30.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.087 0.47 . . . . 0.0 111.615 179.623 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.841 HG23 ' CD1' ' A' ' 259' ' ' ILE . 45.6 t -114.09 131.19 66.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.345 179.026 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.611 ' HA ' HG13 ' A' ' 280' ' ' ILE . 1.3 p-10 51.37 39.68 24.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.517 -178.669 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 4.4 p 72.17 37.11 1.01 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.692 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.552 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.5 OUTLIER -148.84 117.0 6.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.069 179.949 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 83.8 p -64.68 87.6 0.06 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.504 0.669 . . . . 0.0 110.655 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.927 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -83.89 -17.9 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.82 -177.952 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.785 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 20.3 m -120.21 -14.99 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -177.388 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.683 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 16.8 t-80 -110.41 41.37 0.17 Allowed Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 177.429 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.785 ' HD3' ' C ' ' A' ' 260' ' ' SER . 23.6 Cg_exo -64.92 -4.38 8.7 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.546 1.497 . . . . 0.0 113.273 -179.345 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.472 ' CG ' ' HB2' ' A' ' 266' ' ' SER . 14.8 t0 -138.82 99.79 3.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.283 0.563 . . . . 0.0 111.501 -179.861 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.651 ' H ' HD23 ' A' ' 264' ' ' LEU . 0.1 OUTLIER -50.58 -79.95 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.494 -178.962 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -46.35 -20.75 0.6 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.818 -0.706 . . . . 0.0 114.001 -178.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.472 ' HB2' ' CG ' ' A' ' 263' ' ' ASP . 0.4 OUTLIER -70.01 -42.44 73.02 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.301 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.556 ' HG3' ' HA2' ' A' ' 247' ' ' GLY . 2.2 ttt180 50.77 24.95 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 110.114 -179.169 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 270' ' ' GLY . 0.6 OUTLIER -58.16 156.24 9.98 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.032 -178.838 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.871 ' CZ3' ' HB2' ' A' ' 246' ' ' MET . 46.1 t-105 -70.01 -24.46 63.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.361 179.526 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.461 ' H ' ' HD3' ' A' ' 268' ' ' LYS . . . 70.88 170.74 9.99 Favored Glycine 0 CA--C 1.512 -0.141 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.932 178.911 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -102.62 146.66 32.78 Favored Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.221 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.695 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 51.3 Cg_exo -54.14 121.75 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.04 1.827 . . . . 0.0 112.574 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.927 HG21 ' CG1' ' A' ' 259' ' ' ILE . 70.1 t -99.22 133.15 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.66 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -78.46 123.73 27.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.622 -178.89 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.871 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -89.12 165.12 14.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.656 179.752 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.54 161.57 38.78 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.404 -0.518 . . . . 0.0 112.273 -179.117 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.2 OUTLIER -62.3 124.44 20.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.359 179.361 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 277' ' ' SER . 10.1 m-20 88.58 7.71 0.14 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.499 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.7 OUTLIER -79.01 -169.33 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.361 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.673 ' HB ' ' HD3' ' A' ' 288' ' ' LYS . 0.9 OUTLIER -160.04 129.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.059 178.163 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.905 HG22 HG23 ' A' ' 289' ' ' VAL . 0.8 OUTLIER -109.84 152.31 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.669 178.783 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 252' ' ' THR . 0.2 OUTLIER -138.54 126.77 22.86 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.925 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.708 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -120.03 40.56 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.201 -178.794 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 177.57 -131.3 1.76 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.613 -1.279 . . . . 0.0 113.533 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.1 t -89.28 -43.9 10.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 110.797 -179.628 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.9 t -146.58 -1.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.439 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.748 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.9 m -68.99 99.9 1.14 Allowed 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.35 179.054 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.811 ' O ' HG22 ' A' ' 187' ' ' ILE . 1.3 ttmt -118.34 131.0 56.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.459 -178.572 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.905 HG23 HG22 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -114.03 132.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 121.381 -0.128 . . . . 0.0 111.085 -179.486 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.64 ' HD1' HG22 ' A' ' 280' ' ' ILE . 1.1 t80 -77.35 142.22 39.46 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 110.647 -178.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.871 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -110.39 115.97 51.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.631 -179.268 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -138.72 153.21 48.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.085 -179.629 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.459 HD12 ' CZ3' ' A' ' 241' ' ' TRP . 3.8 mt -144.23 120.72 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.345 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.03 158.57 39.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.947 0.403 . . . . 0.0 110.975 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.4 p -101.34 -173.49 2.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.671 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.17 130.62 54.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -164.14 95.89 0.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.806 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.864 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.736 ' HA ' HG23 ' A' ' 201' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.588 0.233 . . . . 0.0 110.452 . . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.67 60.29 0.35 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.83 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.419 ' HB3' ' OG ' ' A' ' 200' ' ' SER . 1.3 m -128.52 -70.28 0.69 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.561 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -136.11 -176.1 4.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.085 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.701 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 23.8 m95 -145.83 131.44 18.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.9 OUTLIER -115.13 124.04 50.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.703 176.551 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.737 ' N ' HD12 ' A' ' 182' ' ' LEU . 7.5 m-85 -124.64 133.82 53.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.39 0.614 . . . . 0.0 110.776 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.633 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -139.75 149.35 43.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.9 178.289 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.58 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 13.1 tt0 -141.23 128.4 20.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.499 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 1.119 HG21 HD12 ' A' ' 194' ' ' LEU . 48.2 t -65.52 112.65 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.385 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.6 tt -97.25 -21.64 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -176.075 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.853 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -157.96 92.38 1.18 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.564 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.676 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.1 -163.69 16.37 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.523 ' HD3' ' OD2' ' A' ' 222' ' ' ASP . 91.6 Cg_endo -85.73 28.6 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.96 2.44 . . . . 0.0 110.971 178.277 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.86 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -160.22 23.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.981 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.676 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.6 mt -39.57 109.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 111.675 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.32 10.12 3.11 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.902 -1.142 . . . . 0.0 113.438 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 1.119 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -96.65 129.12 44.1 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.754 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.58 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 15.8 mt-30 -128.96 151.5 49.61 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.264 -178.367 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.608 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -145.14 145.4 31.37 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.18 179.943 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -149.74 154.44 38.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.893 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.806 HG21 ' HA ' ' A' ' 206' ' ' LEU . 7.5 p -164.89 153.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 110.818 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' A' ' 180' ' ' SER . 4.3 m120 -90.19 149.4 22.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.64 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.514 ' CA ' ' HZ2' ' A' ' 234' ' ' TRP . 49.2 p -65.5 -9.22 24.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.691 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.736 HG23 ' HA ' ' A' ' 177' ' ' LEU . 2.3 t -96.64 25.33 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.461 0.648 . . . . 0.0 110.098 178.598 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.475 ' HB3' ' CG ' ' A' ' 205' ' ' LYS . 35.8 m -104.3 119.14 38.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.432 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 70.2 m -66.71 -84.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.968 -179.122 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 47.7 m -105.12 26.78 8.9 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.475 ' CG ' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -117.85 -14.49 10.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.788 0.328 . . . . 0.0 111.141 179.596 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.941 HD22 ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -81.4 -38.03 0.92 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.163 -179.527 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.781 ' N ' HD13 ' A' ' 206' ' ' LEU . 9.7 Cg_endo -54.11 102.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 120.875 1.05 . . . . 0.0 111.676 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 40.8 t -68.91 159.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.206 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 41.0 mtmt -140.6 95.62 2.89 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.471 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.934 HD23 HD12 ' A' ' 218' ' ' LEU . 0.4 OUTLIER -83.84 123.94 30.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.382 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.545 ' HA3' ' OG ' ' A' ' 216' ' ' SER . . . -159.55 163.09 33.35 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.195 -179.423 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.797 ' HD2' ' HB ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -60.15 -91.05 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.302 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.434 ' H ' ' HB3' ' A' ' 212' ' ' ARG . 7.5 p -116.37 -15.15 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 0.0 110.938 -179.27 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.789 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 52.9 m -51.78 174.04 0.12 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.783 178.59 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.789 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 19.3 Cg_endo -58.36 7.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.062 1.841 . . . . 0.0 112.942 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.545 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 17.8 m -45.81 157.42 0.11 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.949 0.405 . . . . 0.0 111.479 179.648 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.539 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -71.06 -32.28 68.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.896 -179.256 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.934 HD12 HD23 ' A' ' 210' ' ' LEU . 12.0 mt -106.52 129.57 54.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.028 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -90.31 85.8 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 111.689 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.765 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.3 mm? -105.28 83.72 2.01 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 44.17 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.693 ' CA ' ' HD3' ' A' ' 212' ' ' ARG . 0.7 OUTLIER -76.56 167.34 22.01 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 122.255 -0.278 . . . . 0.0 110.554 179.318 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.4 p -95.27 -0.97 52.4 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 179.295 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.22 -27.25 13.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.917 0.78 . . . . 0.0 112.763 -176.891 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.835 HG22 ' CD2' ' A' ' 229' ' ' HIS . 32.7 t -92.97 91.3 3.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.055 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.98 -41.77 3.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.378 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.39 -57.51 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.055 179.721 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.464 ' HB2' ' HG2' ' A' ' 246' ' ' MET . 8.0 mttt -146.38 130.55 17.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.003 0.43 . . . . 0.0 111.151 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.835 ' CD2' HG22 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -90.59 -57.92 2.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.458 178.021 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -147.67 -175.0 4.69 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.638 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.661 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -163.7 177.53 8.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.396 179.648 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 17.7 mt -137.82 147.53 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.301 0.572 . . . . 0.0 112.51 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.48 147.16 13.88 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.131 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.85 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.6 p90 -137.79 165.66 25.9 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -178.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.582 ' HB2' ' HD2' ' A' ' 240' ' ' LYS . 1.4 m-80 -117.57 133.65 55.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.204 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.1 m -89.52 4.9 47.74 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.609 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.6 m -77.83 -37.5 48.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.821 0.819 . . . . 0.0 109.653 178.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 6.1 tptm -126.26 14.98 7.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.261 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 238' ' ' LYS . 18.6 p90 41.68 61.22 1.93 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.933 0.873 . . . . 0.0 108.673 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.85 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -128.5 145.97 50.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.259 -179.855 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.726 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -128.92 125.53 37.74 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.021 -178.914 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 9.5 pt-20 -138.53 146.91 42.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.842 0.83 . . . . 0.0 113.116 -178.254 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.4 pp -112.19 152.11 28.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.773 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.808 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 7.3 p -117.06 163.82 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.42 0.152 . . . . 0.0 110.962 -179.158 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.48 ' OD2' ' HA3' ' A' ' 270' ' ' GLY . 0.0 OUTLIER -107.33 105.95 16.15 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.52 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.55 ' CE ' ' HA ' ' A' ' 246' ' ' MET . 2.3 tpt -78.43 103.68 8.53 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.129 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 267' ' ' ARG . . . 55.3 65.07 3.81 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.005 -178.695 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.9 p -68.21 53.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.676 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.792 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.55 -50.61 72.53 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.297 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.792 ' N ' HD22 ' A' ' 249' ' ' LEU . 6.1 t-20 -79.19 -34.78 42.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.053 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 89.84 102.1 1.11 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.238 179.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.69 HG23 ' HB3' ' A' ' 283' ' ' LEU . 0.5 OUTLIER -56.88 163.99 1.73 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.893 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.735 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.3 OUTLIER -154.31 136.59 14.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.424 0.63 . . . . 0.0 112.458 179.99 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 1.015 HG23 HD12 ' A' ' 259' ' ' ILE . 53.3 t -109.15 133.55 53.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.244 178.464 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.52 ' HA ' HG13 ' A' ' 280' ' ' ILE . 0.7 OUTLIER 49.56 33.9 6.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.177 0.513 . . . . 0.0 110.695 -179.577 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 4.1 m 76.83 27.79 0.72 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.83 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.489 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.0 OUTLIER -129.65 110.12 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.147 179.494 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 252' ' ' THR . 86.5 p -62.97 84.71 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.171 0.51 . . . . 0.0 111.748 -179.275 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 1.015 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -79.82 -8.19 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.12 -179.481 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 2.0 m -91.42 -13.71 31.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.641 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.671 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 2.8 t-160 -105.99 16.57 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.82 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.671 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 71.1 Cg_exo -49.51 -44.83 33.47 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.399 1.4 . . . . 0.0 110.338 178.72 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 266' ' ' SER . 29.0 p-10 -76.02 95.4 3.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 113.308 -1.769 . . . . 0.0 111.177 -179.377 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.09 139.15 52.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.584 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 78.58 -1.64 71.24 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.907 -179.737 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' A' ' 267' ' ' ARG . 0.4 OUTLIER -82.51 -72.93 0.42 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.957 0.378 . . . . 0.0 110.888 -179.751 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.617 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.0 OUTLIER 73.48 -21.35 0.26 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.307 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.494 ' HD3' ' CB ' ' A' ' 266' ' ' SER . 0.0 OUTLIER -72.94 -132.89 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -176.881 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.808 ' CZ3' HG13 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -76.12 -26.05 55.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.87 -178.159 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.48 ' HA3' ' OD2' ' A' ' 245' ' ' ASP . . . 61.85 -173.54 7.61 Favored Glycine 0 CA--C 1.515 0.093 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.266 -179.081 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 272' ' ' PRO . 23.0 m-20 -108.36 148.16 37.07 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 117.846 0.823 . . . . 0.0 111.239 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.727 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 31.9 Cg_exo -60.06 122.57 11.59 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.08 2.52 . . . . 0.0 114.008 -178.751 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.607 HG21 ' HB ' ' A' ' 259' ' ' ILE . 71.4 t -98.95 138.01 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.656 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.2 mp0 -83.03 127.48 33.6 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.987 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.94 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.32 164.16 13.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.776 179.81 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -141.76 158.11 44.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.268 0.556 . . . . 0.0 112.181 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 10.8 p -55.39 128.55 34.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.928 179.532 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 81.13 8.49 1.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.693 179.829 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.511 ' OD2' ' HB ' ' A' ' 291' ' ' VAL . 0.0 OUTLIER -88.4 137.17 32.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.001 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.675 HG22 ' HD1' ' A' ' 290' ' ' TYR . 1.0 OUTLIER -97.43 129.62 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.664 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.956 HG12 HG22 ' A' ' 254' ' ' VAL . 0.4 OUTLIER -112.39 94.39 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -178.748 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.697 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 7.0 m -82.94 142.49 31.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.935 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.699 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -134.76 47.43 2.37 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.04 -179.865 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.85 -125.23 1.1 Allowed Glycine 0 C--N 1.329 0.194 0 C-N-CA 119.879 -1.153 . . . . 0.0 113.469 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.5 t -95.64 -45.32 7.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.717 0.294 . . . . 0.0 110.747 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.66 -0.17 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.812 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.853 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 25.5 m -75.4 102.13 5.04 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.621 0.248 . . . . 0.0 111.345 -179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.722 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -122.44 131.43 53.87 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.498 0.666 . . . . 0.0 111.044 179.792 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.43 HG23 HD11 ' A' ' 283' ' ' LEU . 2.4 t -107.81 131.76 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.54 -177.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.675 ' HD1' HG22 ' A' ' 280' ' ' ILE . 1.0 OUTLIER -76.95 132.49 39.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.694 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.511 ' HB ' ' OD2' ' A' ' 279' ' ' ASP . 2.5 t -110.89 117.35 54.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.634 -178.124 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.2 OUTLIER -136.73 150.99 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.847 -179.464 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.726 HD12 ' CE3' ' A' ' 241' ' ' TRP . 3.1 mt -143.21 127.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.366 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.61 153.34 43.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.813 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 5.0 m -85.94 168.07 14.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.137 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -114.28 117.81 32.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -80.85 89.85 5.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.953 179.854 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.567 ' C ' HG21 ' A' ' 201' ' ' THR . 19.9 mt . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 120.447 0.165 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.945 ' N ' HG21 ' A' ' 201' ' ' THR . . . 98.37 94.34 1.99 Allowed Glycine 0 C--N 1.341 0.807 0 C-N-CA 121.151 -0.547 . . . . 0.0 114.112 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.751 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 4.6 t -178.98 -91.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.675 0.238 . . . . 0.0 111.143 179.194 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -137.22 179.93 6.1 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.577 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.687 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 3.2 m95 -143.52 130.88 20.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.713 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.929 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.4 OUTLIER -122.08 130.28 53.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.017 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.929 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -133.18 146.22 51.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.77 0.795 . . . . 0.0 111.393 179.979 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -146.84 153.32 40.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.009 178.955 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.535 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 0.1 OUTLIER -142.02 133.35 26.44 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.183 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.912 HG11 HD11 ' A' ' 220' ' ' LEU . 40.0 t -66.4 116.04 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.017 0.436 . . . . 0.0 110.148 177.862 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.868 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.2 tt -97.45 -24.16 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.09 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.848 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -160.11 93.55 1.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.733 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.91 -173.25 30.34 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 178.357 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.624 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 96.9 Cg_endo -80.16 32.65 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 CA-C-N 119.452 1.626 . . . . 0.0 111.587 178.684 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.812 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.95 23.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.627 178.846 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.733 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.8 mt -39.41 114.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 127.56 10.54 3.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.519 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.812 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -99.66 131.16 45.83 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.964 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.535 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 12.7 mt-30 -128.01 153.89 46.24 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.358 -178.392 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.723 ' CD2' ' HB3' ' A' ' 217' ' ' ASP . 0.0 OUTLIER -145.57 146.03 31.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.165 178.968 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.56 144.51 29.62 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.273 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.995 HG21 ' HA ' ' A' ' 206' ' ' LEU . 10.2 p -146.51 147.81 17.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.332 0.587 . . . . 0.0 110.816 179.281 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.581 ' OD1' HG23 ' A' ' 201' ' ' THR . 21.4 p30 -95.07 150.47 20.15 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.265 -179.45 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.509 ' N ' ' HZ2' ' A' ' 234' ' ' TRP . 48.2 t -70.67 1.04 5.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.474 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.945 HG21 ' N ' ' A' ' 178' ' ' GLY . 0.0 OUTLIER -104.17 11.63 34.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.25 0.548 . . . . 0.0 110.784 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.4 m -91.3 132.13 36.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.059 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.47 -77.41 0.39 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.261 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.5 m -101.68 20.62 15.87 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.735 0.303 . . . . 0.0 111.59 -179.287 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -123.16 -15.03 7.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.942 0.401 . . . . 0.0 110.807 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.995 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.9 tt -59.08 -60.51 10.31 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.405 -179.598 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.778 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -42.59 98.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.629 2.219 . . . . 0.0 113.016 -178.65 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.561 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 59.7 t -68.04 163.57 2.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.326 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.732 ' O ' ' HB2' ' A' ' 217' ' ' ASP . 0.5 OUTLIER -142.64 115.09 8.49 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.222 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.964 HD21 ' HB3' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -116.67 145.88 43.13 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.657 -0.652 . . . . 0.0 111.236 178.145 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . 170.85 -174.74 44.7 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.753 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 1.088 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -65.11 -77.4 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.054 0.454 . . . . 0.0 111.85 -178.89 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.809 HG22 ' H ' ' A' ' 214' ' ' SER . 13.7 p -128.28 -138.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.234 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.809 ' H ' HG22 ' A' ' 213' ' ' VAL . 5.0 m 67.39 173.59 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 118.897 0.771 . . . . 0.0 109.378 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 40.0 Cg_endo -66.59 18.15 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.907 1.738 . . . . 0.0 112.694 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 214' ' ' SER . 1.9 m -54.91 178.68 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.721 0.296 . . . . 0.0 110.739 179.851 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.732 ' HB2' ' O ' ' A' ' 209' ' ' LYS . 14.0 m-20 -100.98 -35.87 9.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.469 -179.591 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.685 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 6.2 mt -100.39 129.08 46.32 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.231 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.448 ' O ' ' CB ' ' A' ' 191' ' ' ALA . . . -95.04 79.19 3.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.633 0.254 . . . . 0.0 110.634 -179.736 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.912 HD11 HG11 ' A' ' 186' ' ' VAL . 3.0 mm? -100.74 66.37 1.2 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.74 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.718 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 1.8 pttt -50.22 69.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.825 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 220' ' ' LEU . 2.5 t0 -124.72 140.05 53.29 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.214 0.53 . . . . 0.0 110.05 178.104 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.9 t -54.96 -40.34 69.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.437 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.419 ' HB3' ' HA2' ' A' ' 284' ' ' GLY . 2.4 mm-40 -41.94 -42.97 2.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.364 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.088 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.4 p -102.36 79.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.215 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -33.05 -42.43 0.08 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.114 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.17 -55.79 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.035 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 246' ' ' MET . 30.4 mtmm -145.17 129.46 17.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.156 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.544 ' HB3' HD22 ' A' ' 283' ' ' LEU . 0.1 OUTLIER -93.88 -53.53 3.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.118 179.702 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.964 ' HB3' HD21 ' A' ' 210' ' ' LEU . . . -151.33 -179.22 7.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.683 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.842 ' HG2' ' HE1' ' A' ' 246' ' ' MET . 0.4 OUTLIER -161.2 -178.01 6.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.295 178.404 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.778 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 23.7 mt -140.52 148.67 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.17 0.509 . . . . 0.0 111.482 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.68 137.2 8.7 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.735 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.96 ' CH2' HG13 ' A' ' 198' ' ' VAL . 3.2 p90 -131.62 166.46 21.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.616 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.548 ' H ' ' HD2' ' A' ' 240' ' ' LYS . 11.0 t-20 -116.43 134.17 55.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.868 -1.514 . . . . 0.0 112.953 -178.671 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.5 t -90.53 -1.1 57.88 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.946 178.445 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.4 m -77.02 -28.95 55.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.718 0.771 . . . . 0.0 110.015 178.509 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.45 15.09 3.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.693 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.4 p90 41.9 58.97 2.69 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.895 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -126.34 145.87 50.26 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.712 -179.612 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.716 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -129.51 124.86 35.0 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.035 -178.935 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -139.71 142.7 36.86 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.758 0.79 . . . . 0.0 112.78 -178.181 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.8 pp -108.07 156.38 19.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.221 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.499 HG22 ' HE3' ' A' ' 269' ' ' TRP . 5.1 p -124.47 163.24 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.613 ' CG ' ' HB3' ' A' ' 260' ' ' SER . 6.6 m-20 -107.91 125.47 51.53 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.152 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.842 ' HE1' ' HG2' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -85.77 94.28 9.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.738 178.374 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 47.74 68.4 1.22 Allowed Glycine 0 C--N 1.329 0.16 0 C-N-CA 119.544 -1.312 . . . . 0.0 110.475 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.529 ' HB2' ' HB3' ' A' ' 261' ' ' HIS . 85.8 p -64.32 58.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.531 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 250' ' ' ASN . 1.2 tm? -54.26 -60.63 3.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.224 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.567 ' N ' HD13 ' A' ' 249' ' ' LEU . 1.1 t-20 -71.1 -30.16 66.18 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.006 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.476 ' CA ' ' CG ' ' A' ' 261' ' ' HIS . . . 100.48 118.66 4.28 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.672 178.954 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.914 HG23 HD23 ' A' ' 283' ' ' LEU . 1.4 m -92.74 105.59 17.7 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.653 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -98.75 139.25 34.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 112.367 -178.279 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.85 HG22 HG23 ' A' ' 281' ' ' ILE . 41.4 t -109.61 127.42 66.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.953 178.126 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.843 ' HA ' HD12 ' A' ' 280' ' ' ILE . 7.2 t-20 55.01 38.34 30.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.082 0.468 . . . . 0.0 110.248 -178.655 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.38 34.96 12.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.594 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.725 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.5 OUTLIER -140.96 113.18 7.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.522 -179.84 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.467 ' CB ' ' NE2' ' A' ' 261' ' ' HIS . 83.7 p -58.9 88.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.533 0.683 . . . . 0.0 110.562 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.934 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -88.67 -21.8 6.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.222 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.819 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 0.1 OUTLIER -127.73 -12.89 5.38 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.457 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.676 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 16.6 p80 -110.51 43.04 0.2 Allowed Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 177.53 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.819 ' HD3' ' C ' ' A' ' 260' ' ' SER . 21.8 Cg_exo -66.93 -4.45 11.39 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.86 1.707 . . . . 0.0 113.564 -178.839 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.433 ' HB3' ' OG ' ' A' ' 266' ' ' SER . 5.0 m-20 -137.46 97.44 3.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.318 . . . . 0.0 111.291 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 264' ' ' LEU . 4.3 mm? -56.12 -55.85 28.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.242 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.3 -18.23 34.94 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.022 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.433 ' OG ' ' HB3' ' A' ' 263' ' ' ASP . 34.9 m -81.97 -35.95 28.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.955 0.407 . . . . 0.0 111.957 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 24.9 ttp180 48.99 26.0 1.23 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.198 0.523 . . . . 0.0 110.304 -178.724 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 169.94 12.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.38 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.596 ' CH2' ' HG3' ' A' ' 246' ' ' MET . 83.7 m95 -80.33 -20.58 43.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.306 178.371 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 68.87 174.96 10.09 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -177.326 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.69 125.27 65.6 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 118.141 0.971 . . . . 0.0 110.52 -179.486 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.1 Cg_exo -35.25 119.63 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.807 2.338 . . . . 0.0 111.638 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.934 HG21 ' CG1' ' A' ' 259' ' ' ILE . 97.7 t -101.15 136.6 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.671 -177.675 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 11.9 mt-10 -82.4 128.38 34.19 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.868 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.987 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.17 165.2 13.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.992 -179.464 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.08 159.03 43.05 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.789 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.689 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 84.9 p -62.89 130.71 46.0 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.426 179.188 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.5 OUTLIER 83.66 -0.66 1.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.122 -179.237 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -71.07 -170.27 0.44 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.843 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.8 OUTLIER -162.07 124.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 177.349 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.85 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -99.27 150.28 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.149 176.363 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.688 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 1.8 m -134.68 122.2 21.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.662 0.744 . . . . 0.0 109.357 178.091 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.914 HD23 HG23 ' A' ' 252' ' ' THR . 0.0 OUTLIER -122.13 136.93 54.97 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.593 179.598 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.472 ' HA2' ' CG ' ' A' ' 250' ' ' ASN . . . 88.11 -132.4 11.19 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.315 179.522 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.8 t -100.03 -33.43 10.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.445 0.164 . . . . 0.0 111.18 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -152.79 8.21 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.751 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.848 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 12.7 m -74.53 102.43 4.51 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.043 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.868 ' O ' HG22 ' A' ' 187' ' ' ILE . 15.6 ttmt -120.04 125.37 48.16 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.63 -179.311 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 184' ' ' LEU . 1.0 OUTLIER -107.4 135.57 45.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.607 179.701 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.653 ' HD1' HG23 ' A' ' 280' ' ' ILE . 2.2 t80 -78.13 136.67 37.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.615 -179.393 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.987 HG11 ' HB2' ' A' ' 275' ' ' LEU . 1.8 t -105.45 114.86 46.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.393 -179.569 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -133.87 138.82 45.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.162 -179.636 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.762 HD11 HD23 ' A' ' 275' ' ' LEU . 14.2 mt -135.74 143.22 37.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 7.6 t -146.29 153.25 40.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 78.2 p -86.16 162.51 18.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.312 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 41.2 tp60 -106.05 125.31 50.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -78.87 88.28 4.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.088 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.728 ' HA ' HG23 ' A' ' 201' ' ' THR . 1.0 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.93 57.69 0.33 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.429 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.441 ' HB2' HG22 ' A' ' 201' ' ' THR . 11.7 m -128.61 -69.02 0.73 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.833 0.349 . . . . 0.0 110.401 178.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.5 OUTLIER -135.21 178.23 7.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.406 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.716 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 22.0 m95 -144.29 130.9 20.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.864 HD23 ' CZ3' ' A' ' 234' ' ' TRP . 0.4 OUTLIER -121.44 107.95 13.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.035 177.883 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.716 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 0.9 OUTLIER -106.88 140.13 40.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.864 0.84 . . . . 0.0 112.081 -179.565 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.894 ' N ' HD22 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -133.48 144.11 49.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.165 177.401 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 16.1 tt0 -137.74 125.79 22.86 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.829 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.947 HG21 HD12 ' A' ' 194' ' ' LEU . 9.6 t -65.52 112.26 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.578 177.819 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 288' ' ' LYS . 7.4 tt -95.03 -22.44 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.102 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.88 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.85 93.75 0.56 Allowed 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 119.742 -0.783 . . . . 0.0 112.691 -179.331 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.776 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.63 -171.05 27.18 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 178.257 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.762 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 93.6 Cg_endo -79.41 30.57 0.47 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.053 1.835 . . . . 0.0 111.77 178.948 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.865 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.59 27.29 0.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 178.314 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.776 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -41.2 107.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.818 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 8.17 2.26 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.741 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.947 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -97.59 132.99 42.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.939 0.876 . . . . 0.0 108.705 177.878 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.57 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 17.8 mt-30 -133.22 152.9 51.94 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.211 -1.358 . . . . 0.0 110.193 -178.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.872 ' CG ' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -148.25 148.31 30.33 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.097 -179.757 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.453 ' C ' ' HZ3' ' A' ' 181' ' ' TRP . . . -147.42 140.07 24.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.337 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.91 HG13 ' CH2' ' A' ' 234' ' ' TRP . 5.2 p -143.29 149.6 18.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.427 0.632 . . . . 0.0 110.458 178.435 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.8 OUTLIER -95.8 151.83 19.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.758 -179.516 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.542 ' HA ' ' HE1' ' A' ' 234' ' ' TRP . 80.5 p -67.41 -1.33 4.63 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -178.542 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.728 HG23 ' HA ' ' A' ' 177' ' ' LEU . 0.6 OUTLIER -109.6 15.49 22.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.941 0.4 . . . . 0.0 111.27 179.265 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.52 143.93 26.66 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.064 179.26 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.0 m -89.04 -94.46 0.1 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.354 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.86 31.01 2.47 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.302 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.64 -11.73 8.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 110.751 179.18 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.774 ' HA ' HG21 ' A' ' 198' ' ' VAL . 4.7 tt -67.5 -58.04 9.27 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.591 -179.152 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -41.93 90.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.639 2.226 . . . . 0.0 112.438 -178.7 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.684 ' O ' HG12 ' A' ' 208' ' ' VAL . 2.2 t -71.56 91.0 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.209 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 231' ' ' GLN . 12.2 mtmt -69.96 87.2 0.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.757 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.987 HD23 HD12 ' A' ' 218' ' ' LEU . 2.0 mp -74.55 128.67 36.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.807 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . -177.78 -177.33 46.51 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.486 -179.551 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 0.961 ' HD3' HG12 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -57.18 -93.2 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.017 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.961 HG12 ' HD3' ' A' ' 212' ' ' ARG . 11.5 p -158.3 158.75 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.355 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.998 ' HB2' ' HD3' ' A' ' 215' ' ' PRO . 24.4 m 103.16 -74.06 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.831 179.812 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.998 ' HD3' ' HB2' ' A' ' 214' ' ' SER . 95.9 Cg_endo -96.01 -35.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.079 1.853 . . . . 0.0 113.182 179.545 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.448 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 0.9 OUTLIER -57.02 145.87 29.05 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.142 0.496 . . . . 0.0 112.209 -178.958 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.04 -33.06 69.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.454 179.049 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.987 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -100.21 135.24 41.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.557 178.284 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -93.64 73.5 4.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.951 -178.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.93 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.1 mm? -99.48 94.69 6.54 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.776 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.762 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 28.0 pttt -65.11 53.63 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.232 0.539 . . . . 0.0 110.048 178.406 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 220' ' ' LEU . 4.1 m-20 -87.81 116.2 25.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.223 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 11.5 p -60.51 -15.53 28.07 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.877 -179.347 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 222' ' ' ASP . 0.0 OUTLIER -79.22 -21.33 46.41 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.576 0.227 . . . . 0.0 110.838 179.686 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.012 ' HB ' ' HD1' ' A' ' 229' ' ' HIS . 2.8 p -107.61 80.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.16 -30.22 0.74 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 111.188 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -145.87 -59.66 0.02 OUTLIER Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.194 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.867 ' HB2' ' HG3' ' A' ' 246' ' ' MET . 0.3 OUTLIER -144.49 133.59 22.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.785 0.326 . . . . 0.0 110.354 -179.824 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 1.012 ' HD1' ' HB ' ' A' ' 225' ' ' VAL . 0.4 OUTLIER -93.43 -58.7 2.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.738 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 210' ' ' LEU . . . -147.45 165.48 30.13 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.788 -178.59 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.724 ' HA ' HD12 ' A' ' 210' ' ' LEU . 17.9 tt0 -143.11 157.44 44.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.657 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.695 HG13 HD11 ' A' ' 210' ' ' LEU . 23.7 mt -121.54 145.75 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.918 179.53 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.724 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -161.79 160.58 28.46 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.28 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.91 ' CH2' HG13 ' A' ' 198' ' ' VAL . 3.6 p90 -149.68 165.73 31.5 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -117.31 133.6 55.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.854 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -0.12 57.32 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.107 179.093 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -76.15 -20.15 57.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.659 0.742 . . . . 0.0 110.052 178.858 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.661 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 7.5 tptm -151.6 20.58 0.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.596 -178.919 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 23.8 p90 41.01 57.81 2.67 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.391 0.615 . . . . 0.0 109.926 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.792 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.8 OUTLIER -120.63 137.5 54.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.938 179.352 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.734 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -120.49 122.25 40.23 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.95 179.963 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 1.0 OUTLIER -139.37 142.25 37.56 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.941 0.876 . . . . 0.0 112.784 -178.391 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.753 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.0 pp -110.31 155.09 22.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.691 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.909 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 5.0 p -117.33 163.02 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 122.239 -0.288 . . . . 0.0 111.102 -179.452 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 260' ' ' SER . 0.0 OUTLIER -105.95 113.09 26.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.318 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.867 ' HG3' ' HB2' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -81.39 105.77 12.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.665 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 267' ' ' ARG . . . 54.35 65.6 3.37 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.71 -178.826 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.76 49.79 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.905 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.772 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -58.11 -47.67 82.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.702 178.431 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.772 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.38 -33.09 37.44 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.014 -179.159 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.529 ' N ' HD22 ' A' ' 250' ' ' ASN . . . 92.02 85.4 1.49 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.122 -178.851 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 258' ' ' SER . 2.9 m -46.55 168.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.641 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.665 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.3 OUTLIER -154.97 136.2 13.99 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 119.9 -0.72 . . . . 0.0 112.749 179.381 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 1.038 HG22 HG13 ' A' ' 281' ' ' ILE . 67.1 t -115.16 130.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.154 178.481 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 255' ' ' ASN . . . . . 0.674 ' HA ' HD12 ' A' ' 280' ' ' ILE . 1.1 t-20 56.16 37.68 29.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.106 0.479 . . . . 0.0 109.932 -179.25 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.67 25.69 9.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.637 -179.488 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.694 ' O ' HG23 ' A' ' 259' ' ' ILE . 3.1 t-80 -128.02 101.35 6.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.675 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 252' ' ' THR . 10.4 t -53.51 92.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.327 0.584 . . . . 0.0 111.167 -179.71 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.961 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -88.88 -9.14 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.004 -178.284 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 25.2 m -92.04 -12.81 32.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.359 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.742 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 1.6 t-160 -106.35 22.53 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.742 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 31.3 Cg_exo -57.44 -44.82 38.97 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.288 1.325 . . . . 0.0 110.184 178.688 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.55 84.15 2.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.293 -179.176 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.639 ' H ' HD23 ' A' ' 264' ' ' LEU . 2.0 pt? -59.62 132.06 52.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.796 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.86 -13.11 61.83 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.883 -179.305 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.571 ' O ' ' HB2' ' A' ' 267' ' ' ARG . 0.1 OUTLIER -72.56 -69.25 0.42 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 119.362 -0.351 . . . . 0.0 111.024 -179.855 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.3 OUTLIER 70.19 -20.98 0.18 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.671 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 266' ' ' SER . 4.1 mtpp -73.82 -127.08 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.018 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.909 ' CZ3' HG13 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -80.31 -23.13 40.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.785 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' A' ' 245' ' ' ASP . . . 62.0 -175.74 6.39 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.241 -0.981 . . . . 0.0 110.929 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 272' ' ' PRO . 1.7 m-20 -105.6 141.74 23.29 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 117.983 0.891 . . . . 0.0 111.141 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.753 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.1 Cg_exo -51.97 123.14 11.8 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.856 2.371 . . . . 0.0 113.517 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.622 HG11 HG13 ' A' ' 259' ' ' ILE . 95.2 t -100.9 140.91 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.272 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.1 mt-10 -86.92 129.24 34.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.745 -179.17 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.869 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -95.41 164.67 12.72 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.93 -179.516 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.67 157.4 45.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.905 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 29.3 t -61.02 129.44 41.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.25 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.621 ' HB2' ' O ' ' A' ' 277' ' ' SER . 5.8 m-20 82.43 -1.15 1.38 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.519 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.725 ' O ' HG23 ' A' ' 291' ' ' VAL . 0.1 OUTLIER -79.11 137.86 37.67 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.079 179.473 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 255' ' ' ASN . 1.1 pp -102.08 127.11 55.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.04 179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 1.038 HG13 HG22 ' A' ' 254' ' ' VAL . 0.4 OUTLIER -105.96 159.54 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.995 0.426 . . . . 0.0 111.287 178.971 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.649 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.9 m -145.54 122.91 11.62 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.149 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.657 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -119.01 47.93 1.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.833 -179.44 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.03 -134.9 3.1 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.85 -1.167 . . . . 0.0 113.042 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.51 HG22 ' OE1' ' A' ' 224' ' ' GLU . 1.8 t -87.8 -51.62 5.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 0.0 110.382 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.59 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -137.86 -2.19 1.93 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.292 179.337 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.6 m -70.92 102.77 2.47 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.885 0.374 . . . . 0.0 111.103 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.816 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.4 OUTLIER -121.27 128.55 52.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.922 -179.215 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.719 HG23 ' CG2' ' A' ' 281' ' ' ILE . 0.0 OUTLIER -108.3 133.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.087 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.1 t80 -76.43 134.78 39.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.682 -179.221 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.869 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -104.38 113.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.044 -179.988 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -129.06 141.86 51.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.749 -179.785 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.761 HD11 HD23 ' A' ' 275' ' ' LEU . 6.6 mt -137.63 138.17 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.286 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.29 131.56 16.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.695 0.283 . . . . 0.0 111.071 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.408 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 23.8 p -79.77 143.19 34.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.091 0.472 . . . . 0.0 111.193 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.04 147.33 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.628 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -141.81 94.51 2.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.973 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 . . . . . 0 C--O 1.234 0.267 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.818 179.826 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.578 ' HB3' ' CG ' ' A' ' 199' ' ' ASN . 1.0 OUTLIER . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.375 0.131 . . . . 0.0 110.782 . . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.711 ' HA3' ' CG2' ' A' ' 201' ' ' THR . . . 117.2 158.93 11.28 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.837 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.89 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 0.4 OUTLIER -89.11 29.06 1.1 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.304 -0.448 . . . . 0.0 111.806 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.3 OUTLIER -153.58 146.97 24.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.229 0.538 . . . . 0.0 110.75 179.84 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 181' ' ' TRP . . . . . 0.702 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 37.0 m95 -148.16 139.44 23.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.38 -178.069 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.9 OUTLIER -114.9 120.98 41.78 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.049 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 183' ' ' PHE . . . . . 0.725 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.3 m-85 -121.56 135.41 55.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.445 0.641 . . . . 0.0 110.358 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -140.57 148.36 40.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.355 179.211 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.647 ' C ' HG23 ' A' ' 289' ' ' VAL . 1.7 tt0 -137.56 124.46 21.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.2 -177.556 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 1.014 HG21 HD11 ' A' ' 220' ' ' LEU . 40.3 t -63.05 108.74 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.379 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.9 tt -87.92 -26.64 5.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -176.118 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.886 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -158.8 96.31 1.35 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.443 -179.85 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.676 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.49 173.91 39.66 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 178.546 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.51 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 37.6 Cg_endo -69.47 32.92 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 121.823 1.682 . . . . 0.0 111.266 178.141 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.831 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -160.65 20.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.308 179.497 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.676 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.1 mt -38.94 108.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.721 0.296 . . . . 0.0 111.761 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.31 8.07 2.1 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.154 -1.022 . . . . 0.0 113.018 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.831 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.8 OUTLIER -101.47 112.89 25.57 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.917 0.865 . . . . 0.0 109.74 178.75 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.469 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 5.7 mt-30 -114.65 154.69 27.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.565 -179.149 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.564 ' CD2' ' HB3' ' A' ' 217' ' ' ASP . 0.0 OUTLIER -147.84 148.08 30.5 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.381 0.61 . . . . 0.0 111.154 179.636 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -144.01 152.27 40.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.044 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 1.053 HG21 ' HA ' ' A' ' 206' ' ' LEU . 8.1 p -167.03 150.29 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.0 111.278 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 180' ' ' SER . 1.0 OUTLIER -92.46 155.28 17.95 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.369 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.675 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 3.6 m -56.3 -48.74 76.06 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.522 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.711 ' CG2' ' HA3' ' A' ' 178' ' ' GLY . 0.0 OUTLIER -67.66 14.11 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.251 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 202' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' A' ' 199' ' ' ASN . 0.3 OUTLIER -91.99 118.89 31.2 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 110.005 179.2 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -67.14 -107.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.523 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.4 m -80.98 21.02 0.73 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.559 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.527 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -114.17 -19.23 11.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 178.944 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 1.053 ' HA ' HG21 ' A' ' 198' ' ' VAL . 0.0 OUTLIER -70.71 -33.78 3.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.274 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 38.6 Cg_exo -55.47 101.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 121.016 1.144 . . . . 0.0 111.721 179.538 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.433 HG11 HD11 ' A' ' 184' ' ' LEU . 49.0 t -84.78 90.9 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.694 -179.163 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.637 ' HD2' ' HA ' ' A' ' 216' ' ' SER . 11.9 mttt -71.01 109.11 4.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.008 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.105 HD23 HD12 ' A' ' 218' ' ' LEU . 1.6 mp -94.38 131.78 39.68 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.013 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -179.55 -176.39 47.1 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.057 -179.575 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 212' ' ' ARG . . . . . 1.002 ' HB2' HG13 ' A' ' 225' ' ' VAL . 30.6 ttt-85 -80.76 -69.64 0.59 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.639 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 213' ' ' VAL . 9.1 p -141.88 118.8 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 0.0 110.529 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 214' ' ' SER . . . . . 0.604 ' HB2' ' HD2' ' A' ' 215' ' ' PRO . 0.0 OUTLIER 168.9 176.85 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.735 -178.973 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 214' ' ' SER . 41.1 Cg_endo -67.47 23.5 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 121.831 1.687 . . . . 0.0 112.243 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 216' ' ' SER . . . . . 0.637 ' HA ' ' HD2' ' A' ' 209' ' ' LYS . 1.1 m -62.62 -151.77 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.438 179.806 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.564 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 52.1 m-20 -130.9 -34.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.957 0.408 . . . . 0.0 110.466 179.643 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.105 HD12 HD23 ' A' ' 210' ' ' LEU . 4.0 mt -103.71 125.33 50.12 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 177.111 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.582 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -94.08 87.67 5.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.863 0.364 . . . . 0.0 110.223 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 1.014 HD11 HG21 ' A' ' 186' ' ' VAL . 2.0 mm? -110.45 92.42 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.168 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.411 ' HA ' ' HG3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -62.48 36.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.214 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.905 ' HB2' HG12 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -64.67 111.88 2.95 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.076 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.5 p -53.02 -19.15 2.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.562 0.22 . . . . 0.0 111.322 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.789 ' O ' HD21 ' A' ' 249' ' ' LEU . 3.0 pm0 -75.36 -28.69 59.64 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.929 179.674 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 1.002 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.8 p -97.41 92.42 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.042 178.809 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.1 m -40.96 -40.71 1.47 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.371 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.4 -54.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.53 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 228' ' ' LYS . . . . . 0.659 ' HB3' ' HG3' ' A' ' 246' ' ' MET . 0.1 OUTLIER -144.25 126.69 15.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.749 0.309 . . . . 0.0 110.539 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 229' ' ' HIS . . . . . 0.63 ' C ' ' HG2' ' A' ' 246' ' ' MET . 0.6 OUTLIER -96.54 -51.64 4.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.961 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.781 ' HB1' HD11 ' A' ' 243' ' ' LEU . . . -142.42 165.44 27.41 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.888 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 231' ' ' GLN . . . . . 0.835 ' HA ' HD12 ' A' ' 210' ' ' LEU . 1.3 tm0? -149.89 160.88 43.23 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.597 179.471 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.675 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.9 mt -124.9 144.43 34.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 CA-C-O 121.271 0.557 . . . . 0.0 111.744 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.707 HG22 ' OE1' ' A' ' 231' ' ' GLN . 0.1 OUTLIER -161.38 164.3 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.118 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 234' ' ' TRP . . . . . 0.835 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.8 p90 -157.58 167.46 30.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.796 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -115.0 131.72 56.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.542 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.49 -0.61 57.62 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.27 179.589 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.1 m -73.6 -21.79 60.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.696 0.76 . . . . 0.0 110.168 178.656 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 239' ' ' PHE . 6.2 tptt -150.87 23.79 0.76 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.377 -178.814 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 238' ' ' LYS . 8.9 p90 38.31 60.48 1.28 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.521 0.677 . . . . 0.0 109.533 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.835 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -121.7 136.53 54.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.727 179.683 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 241' ' ' TRP . . . . . 0.713 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.2 OUTLIER -118.65 130.58 55.94 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.771 -179.905 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.458 ' CB ' ' O ' ' A' ' 273' ' ' VAL . 0.8 OUTLIER -137.09 132.7 34.47 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.427 0.632 . . . . 0.0 111.115 -177.815 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.825 HD21 HG21 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -110.08 136.97 48.49 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.131 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.769 ' N ' HD12 ' A' ' 243' ' ' LEU . 4.2 p -122.6 162.82 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 120.733 0.301 . . . . 0.0 110.359 -179.735 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.691 ' HB2' ' CA ' ' A' ' 270' ' ' GLY . 12.2 m-20 -99.38 149.1 23.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.182 0.515 . . . . 0.0 111.707 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.659 ' HG3' ' HB3' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -116.34 95.0 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.424 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 51.33 60.81 6.84 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.812 -177.707 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.5 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 0.3 OUTLIER -72.86 72.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.858 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.789 HD21 ' O ' ' A' ' 224' ' ' GLU . 1.2 pp -54.33 -57.54 10.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.26 0.552 . . . . 0.0 110.189 178.86 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.643 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.5 OUTLIER -69.52 -25.97 64.29 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.774 -179.712 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.5 ' HA2' ' HB2' ' A' ' 248' ' ' SER . . . 89.94 132.11 4.73 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.779 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.736 ' C ' HD23 ' A' ' 253' ' ' LEU . 79.7 m -92.59 151.62 20.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 252' ' ' THR . 0.0 OUTLIER -144.76 128.56 17.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.939 0.399 . . . . 0.0 111.659 -179.989 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.852 HG22 HG23 ' A' ' 281' ' ' ILE . 50.1 t -101.44 131.95 48.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.251 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 49.12 31.85 3.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.149 0.499 . . . . 0.0 110.557 -178.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 78.04 36.89 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.33 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.503 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.5 OUTLIER -148.2 120.45 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.938 179.784 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 252' ' ' THR . 72.4 p -67.28 85.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.42 0.628 . . . . 0.0 110.91 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 259' ' ' ILE . . . . . 0.767 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -80.12 -15.42 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.636 -178.629 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.527 ' O ' ' HA2' ' A' ' 270' ' ' GLY . 2.8 m -101.61 -10.8 19.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.497 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 261' ' ' HIS . . . . . 0.666 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 10.0 t-80 -106.76 18.06 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 179.498 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 262' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 95.7 Cg_exo -45.01 -29.13 3.58 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.578 1.519 . . . . 0.0 111.264 179.167 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.619 ' O ' ' HB2' ' A' ' 266' ' ' SER . 0.4 OUTLIER -76.64 92.24 3.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.051 -179.654 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 95.3 mt -48.12 129.97 15.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.041 0.448 . . . . 0.0 111.887 -179.275 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 74.08 21.87 78.55 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.279 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.619 ' HB2' ' O ' ' A' ' 263' ' ' ASP . 0.1 OUTLIER -78.74 -68.57 0.64 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.018 0.409 . . . . 0.0 111.374 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 267' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.1 OUTLIER 66.38 -17.8 0.11 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.256 -0.577 . . . . 0.0 112.412 -179.173 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.581 ' H ' ' C ' ' A' ' 266' ' ' SER . 0.2 OUTLIER -81.09 -138.49 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -175.981 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 269' ' ' TRP . . . . . 0.649 ' CE3' ' HA ' ' A' ' 246' ' ' MET . 26.7 t-105 -85.19 78.68 9.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.275 -177.494 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.691 ' CA ' ' HB2' ' A' ' 245' ' ' ASP . . . 36.04 -160.87 0.01 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 118.984 2.354 . . . . 0.0 118.984 172.176 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.11 94.24 3.53 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 111.418 -2.391 . . . . 0.0 105.99 175.11 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.426 ' HD3' HG23 ' A' ' 244' ' ' VAL . 1.0 OUTLIER -24.4 109.01 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.872 3.048 . . . . 0.0 115.929 -176.912 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 273' ' ' VAL . . . . . 0.667 HG21 HG12 ' A' ' 259' ' ' ILE . 17.5 t -115.95 159.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.314 179.128 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.502 ' N ' HG12 ' A' ' 273' ' ' VAL . 81.9 mm-40 -94.19 130.98 40.21 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.261 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -94.33 161.51 14.21 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.089 -177.258 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.587 ' H ' HD23 ' A' ' 275' ' ' LEU . . . -142.51 155.27 45.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.287 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 25.7 t -61.73 134.73 57.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.852 179.301 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 278' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.2 OUTLIER 83.66 7.25 0.66 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.925 -179.418 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 279' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 291' ' ' VAL . 0.7 OUTLIER -82.92 126.93 33.03 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.358 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -100.38 132.02 46.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 119.619 -0.833 . . . . 0.0 111.161 -179.524 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 281' ' ' ILE . . . . . 0.852 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -107.41 156.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.336 179.184 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 252' ' ' THR . 9.3 m -144.51 116.64 8.39 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 283' ' ' LEU . . . . . 0.75 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -120.01 49.52 1.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.523 -178.307 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 179.97 -142.24 5.03 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.106 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.6 t -87.7 -37.11 16.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.998 0.428 . . . . 0.0 110.211 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -152.72 3.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.238 179.706 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.886 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.3 m -77.54 106.11 9.11 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 117.753 0.252 . . . . 0.0 111.102 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.81 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.9 mtpt -127.98 133.36 49.17 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.364 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.693 ' CG1' HD12 ' A' ' 281' ' ' ILE . 8.7 p -113.32 136.51 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.345 -179.386 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 290' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 3.1 t80 -77.98 133.06 38.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 279' ' ' ASP . 2.6 t -113.69 124.7 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.466 -178.733 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.417 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -143.53 153.05 42.19 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.891 -179.744 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.713 HD12 ' CE3' ' A' ' 241' ' ' TRP . 1.5 mt -139.69 129.83 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.43 160.04 35.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 111.142 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 295' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 180' ' ' SER . 0.3 OUTLIER -99.02 174.31 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.665 179.578 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 296' ' ' GLN . . . . . 0.89 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 3.5 tp-100 -109.99 116.09 30.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -179.691 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -117.69 86.38 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.878 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.5 ' N ' ' HG ' ' A' ' 200' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.521 -0.141 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.7 m95 -150.52 134.22 16.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 184' ' ' LEU . 2.7 tp -119.99 139.96 51.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.49 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.762 ' O ' HD12 ' A' ' 184' ' ' LEU . 4.4 m-85 -138.94 137.94 36.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.441 0.639 . . . . 0.0 110.043 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.883 HD22 ' CE1' ' A' ' 196' ' ' HIS . 5.2 mp -132.7 151.45 51.97 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.019 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.11 122.37 12.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.872 HG21 HD12 ' A' ' 194' ' ' LEU . 42.1 t -64.6 118.75 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 288' ' ' LYS . 3.7 tt -97.96 -23.94 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.758 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -161.85 92.41 0.85 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.541 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.603 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.58 -173.78 30.65 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.447 ' HG3' ' CA ' ' A' ' 222' ' ' ASP . 74.3 Cg_endo -79.88 30.58 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.179 1.919 . . . . 0.0 111.822 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.865 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.28 23.95 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.627 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.603 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.9 mt -39.63 113.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.072 0.463 . . . . 0.0 111.699 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.9 9.63 2.45 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.524 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.872 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -99.37 135.08 41.3 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.702 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 27.1 mt-30 -129.67 147.46 51.46 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.217 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.944 ' CD2' HG21 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -136.26 130.05 32.44 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.599 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 182' ' ' LEU . . . -144.63 166.02 26.37 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.942 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.83 HG13 ' CH2' ' A' ' 234' ' ' TRP . 3.2 p -175.21 157.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.098 0.475 . . . . 0.0 111.073 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.483 ' N ' HG22 ' A' ' 198' ' ' VAL . 65.8 m-80 -90.92 149.13 22.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.872 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.528 ' CB ' ' HE1' ' A' ' 234' ' ' TRP . 54.8 p -66.82 -3.29 6.47 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.709 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.45 5.45 39.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.741 0.305 . . . . 0.0 111.444 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -87.35 127.34 35.2 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.04 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.5 t -90.56 -87.3 0.19 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.53 11.59 6.85 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.12 -11.0 9.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.917 0.389 . . . . 0.0 110.875 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.793 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.5 tt -70.11 -57.76 5.78 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -42.83 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.29 1.993 . . . . 0.0 112.745 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.944 HG21 ' CD2' ' A' ' 196' ' ' HIS . 99.2 t -69.59 164.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.183 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.664 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 3.8 mtmm -139.64 95.03 2.85 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.901 HD23 HD12 ' A' ' 218' ' ' LEU . 1.3 mp -83.78 127.32 33.72 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.488 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -169.11 172.05 43.22 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.02 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.984 ' HB2' HG13 ' A' ' 225' ' ' VAL . 3.0 ttt85 -71.46 -76.16 0.11 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 213' ' ' VAL . 11.7 p -133.66 110.18 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.135 0.493 . . . . 0.0 110.991 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.497 ' HB2' ' HD2' ' A' ' 215' ' ' PRO . 0.0 OUTLIER 171.4 179.81 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.592 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 214' ' ' SER . 45.2 Cg_exo -56.65 -3.42 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 121.946 1.764 . . . . 0.0 112.478 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.535 ' HA ' ' HB3' ' A' ' 209' ' ' LYS . 0.4 OUTLIER -43.24 158.62 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.971 0.415 . . . . 0.0 111.535 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -83.68 -30.46 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.289 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.901 HD12 HD23 ' A' ' 210' ' ' LEU . 18.7 mt -113.88 127.99 56.22 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -88.62 84.78 6.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.487 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.718 HD21 ' HB3' ' A' ' 218' ' ' LEU . 1.7 mm? -100.94 66.74 1.17 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.604 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 0.4 OUTLIER -62.07 54.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 220' ' ' LEU . 19.8 t0 -105.33 125.5 51.05 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.1 p -40.15 -31.83 0.15 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.49 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 0.0 OUTLIER -53.32 -40.36 64.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.795 0.331 . . . . 0.0 111.11 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.984 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.5 p -99.89 96.33 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 83.1 p -41.63 -51.86 3.92 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.047 0.451 . . . . 0.0 111.145 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -142.72 -54.07 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.31 128.67 21.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 109.964 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.602 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.2 OUTLIER -94.62 -56.88 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.211 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -150.45 177.24 10.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.37 0.605 . . . . 0.0 112.469 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.743 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.7 OUTLIER -157.93 178.67 9.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.152 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 4.8 mt -133.23 145.58 33.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.434 0.635 . . . . 0.0 111.734 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.94 131.37 5.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.939 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 16.3 p90 -125.3 167.02 15.48 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.99 133.43 56.04 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.233 -1.349 . . . . 0.0 112.503 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 48.0 t -91.52 0.44 57.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.11 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.2 m -79.01 -46.3 18.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.833 0.825 . . . . 0.0 109.457 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.413 ' C ' ' CG ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -111.77 9.53 20.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.936 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.413 ' CG ' ' C ' ' A' ' 238' ' ' LYS . 10.2 p90 43.75 65.9 0.92 Allowed 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.593 0.711 . . . . 0.0 109.924 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.939 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -135.61 145.82 47.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.269 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.76 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.9 OUTLIER -121.37 114.4 21.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.601 -1.182 . . . . 0.0 109.935 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.673 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 24.1 mt-10 -131.36 146.46 52.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.956 0.884 . . . . 0.0 113.156 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.771 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.6 pp -110.98 153.61 25.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.935 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 269' ' ' TRP . 1.4 p -122.71 162.23 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.41 ' CG ' ' HB3' ' A' ' 260' ' ' SER . 5.2 m-20 -112.6 100.62 8.87 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.986 0.422 . . . . 0.0 111.988 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.697 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -78.15 106.11 9.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.678 178.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 49.19 65.0 2.96 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.252 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.446 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 0.0 OUTLIER -71.35 64.32 0.39 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.673 HD12 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -48.39 -62.32 1.55 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.023 0.439 . . . . 0.0 110.166 178.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.556 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . 0.4 OUTLIER -77.02 -31.71 56.56 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.854 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 248' ' ' SER . . . 99.19 149.09 24.06 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.172 -0.922 . . . . 0.0 114.006 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 282' ' ' THR . 2.9 m -115.95 107.63 15.22 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.722 0.409 . . . . 0.0 110.57 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.621 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.1 OUTLIER -98.52 128.87 45.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.122 0.487 . . . . 0.0 111.554 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.647 HG23 HD11 ' A' ' 259' ' ' ILE . 91.9 t -99.7 134.02 40.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.678 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.473 HD22 HG12 ' A' ' 254' ' ' VAL . 16.1 p30 47.93 38.01 8.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.279 0.561 . . . . 0.0 110.068 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.0 t 67.51 36.69 3.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.731 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.64 111.81 5.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.245 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 60.0 p -58.17 87.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.134 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.765 HG12 HG11 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -88.97 -18.18 7.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.549 ' N ' HD12 ' A' ' 259' ' ' ILE . 9.7 t . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.008 0.432 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.741 ' CD1' HG21 ' A' ' 244' ' ' VAL . 38.4 t-105 -67.91 -23.32 65.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.276 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 73.38 167.76 13.51 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.748 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -102.68 143.77 27.28 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.614 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.5 Cg_exo -51.32 121.45 8.42 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.308 2.006 . . . . 0.0 113.12 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.765 HG11 HG12 ' A' ' 259' ' ' ILE . 70.2 t -96.42 132.15 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.3 125.65 29.67 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.408 -178.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.841 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -94.59 165.5 12.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.51 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.551 ' HB3' ' OD1' ' A' ' 279' ' ' ASP . . . -144.1 162.87 35.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.207 0.527 . . . . 0.0 112.418 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.554 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 13.4 p -60.61 128.55 37.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.428 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.8 m-20 86.05 7.84 0.33 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.279 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.551 ' OD1' ' HB3' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -75.89 -171.46 1.64 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.4 OUTLIER -160.73 133.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.102 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.698 HD12 ' CG2' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -111.63 149.85 14.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.987 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.571 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -139.33 112.4 8.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.746 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -110.77 45.01 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.059 -177.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.33 -132.29 2.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 119.321 -1.419 . . . . 0.0 113.64 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 10.9 t -89.87 -43.68 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.654 0.264 . . . . 0.0 110.529 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.2 t -148.37 -0.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.758 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 25.8 m -69.04 102.57 1.65 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.257 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.658 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.5 ttmt -121.01 127.01 51.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.664 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.698 ' CG2' HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -109.77 132.69 57.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.294 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.462 ' HD1' ' CG2' ' A' ' 280' ' ' ILE . 2.1 t80 -76.86 137.05 38.93 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.872 0.368 . . . . 0.0 110.194 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.677 HG13 HD11 ' A' ' 184' ' ' LEU . 1.3 t -106.04 115.75 48.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.262 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.74 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -129.79 142.6 50.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.912 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.841 HD11 HD23 ' A' ' 275' ' ' LEU . 6.4 mt -139.0 115.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.157 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.77 154.18 45.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 110.924 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 88.7 p -87.95 -173.2 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.726 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 2.7 m95 -141.07 132.29 26.49 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.9 HD11 ' CD2' ' A' ' 184' ' ' LEU . 3.0 tp -121.94 133.56 54.84 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.116 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.779 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.4 m-85 -129.71 132.19 46.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.677 0.751 . . . . 0.0 110.246 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.9 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.5 mm? -117.97 140.68 49.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.832 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.7 OUTLIER -137.35 118.48 14.45 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.874 HG21 HD12 ' A' ' 194' ' ' LEU . 5.7 t -67.15 103.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.164 0.507 . . . . 0.0 109.657 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.884 HG22 ' O ' ' A' ' 288' ' ' LYS . 7.0 tt -87.38 -20.84 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.859 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.54 97.02 0.4 Allowed 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.496 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.601 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.85 -169.57 25.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.598 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 87.1 Cg_endo -81.13 30.12 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.12 1.88 . . . . 0.0 111.313 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.874 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.48 24.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.372 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.601 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.8 mt -39.65 106.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.805 0.336 . . . . 0.0 111.851 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.62 2.42 2.55 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.469 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.874 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -98.02 167.93 10.59 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.8 mt-30 -159.97 149.21 17.72 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.371 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.781 ' HE1' HG11 ' A' ' 289' ' ' VAL . 1.7 p-80 -135.42 128.66 31.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.341 0.591 . . . . 0.0 109.93 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.24 163.03 34.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.475 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.955 HG21 ' HA ' ' A' ' 206' ' ' LEU . 6.1 p -173.2 157.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.041 0.448 . . . . 0.0 111.066 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.7 OUTLIER -90.41 153.47 20.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.988 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.525 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 12.4 t -69.49 -6.07 28.19 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.218 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.35 7.6 45.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.862 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.424 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 1.0 OUTLIER -86.41 138.56 31.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.797 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.0 m -90.22 -85.67 0.21 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.02 22.77 9.84 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.424 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 3.0 pttt -119.67 -11.85 9.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.868 0.365 . . . . 0.0 110.87 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.955 ' HA ' HG21 ' A' ' 198' ' ' VAL . 7.7 tt -71.22 -58.52 3.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -42.86 97.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.575 2.184 . . . . 0.0 113.127 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.743 HG11 ' CD2' ' A' ' 196' ' ' HIS . 60.9 t -69.07 164.78 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 208' ' ' VAL . 17.5 mtpt -138.08 96.57 3.22 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.992 HD23 HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -84.3 125.37 32.2 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.88 166.97 38.38 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.418 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.886 ' HD3' HG12 ' A' ' 213' ' ' VAL . 9.9 ttt180 -69.33 -77.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.886 HG12 ' HD3' ' A' ' 212' ' ' ARG . 8.8 p -138.28 110.95 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.386 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.616 ' CB ' ' HD2' ' A' ' 215' ' ' PRO . 0.3 OUTLIER 171.98 -178.61 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.778 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.616 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 24.0 Cg_endo -61.68 12.64 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.002 1.801 . . . . 0.0 113.02 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -57.51 -173.61 0.01 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.91 0.386 . . . . 0.0 111.265 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -104.79 -30.04 10.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.09 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.992 HD12 HD23 ' A' ' 210' ' ' LEU . 0.4 OUTLIER -110.95 133.66 53.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.072 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -98.45 82.23 2.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.162 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.779 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.8 mm? -103.73 83.5 2.14 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.598 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 24.6 pttt -58.94 65.04 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.766 0.317 . . . . 0.0 111.61 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' A' ' 220' ' ' LEU . 6.7 m-20 -93.48 144.01 25.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.446 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.7 t -85.76 -4.14 59.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.519 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.495 ' OE2' HG22 ' A' ' 285' ' ' THR . 12.7 pm0 -101.24 -16.29 17.02 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 61.9 t -97.93 77.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.893 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -34.03 -50.87 0.4 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.98 0.419 . . . . 0.0 111.535 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.4 -49.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.573 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.468 ' HG2' ' OG ' ' A' ' 216' ' ' SER . 1.6 mtmm -144.08 129.73 19.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.443 . . . . 0.0 110.915 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.554 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 3.1 t60 -96.32 -55.97 2.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.578 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -148.57 177.49 9.44 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.666 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -156.58 173.17 17.32 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.932 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 35.6 mt -132.77 145.16 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.199 0.523 . . . . 0.0 112.225 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.418 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -160.62 148.66 16.21 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.817 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 8.1 p90 -140.88 165.57 27.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.728 1.011 . . . . 0.0 113.728 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.4 ' HB2' ' CD ' ' A' ' 240' ' ' LYS . 1.1 m120 -117.35 133.95 55.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.726 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 10.2 t -90.58 2.02 56.21 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.333 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 4.5 m -76.28 -25.88 55.35 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.71 0.767 . . . . 0.0 110.238 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -145.87 23.47 1.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.123 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 238' ' ' LYS . 15.6 p90 36.97 62.16 0.82 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.51 0.671 . . . . 0.0 110.194 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.817 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -124.97 141.12 52.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.456 178.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.713 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -124.61 123.24 39.63 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.664 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.6 pt-20 -137.09 143.4 42.55 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.935 0.874 . . . . 0.0 112.826 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.795 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.4 pp -111.2 150.68 29.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.431 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.661 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -117.78 162.79 15.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.495 ' CG ' ' HB2' ' A' ' 260' ' ' SER . 1.8 m-20 -112.03 105.79 14.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.555 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -73.32 99.18 2.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.463 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.63 64.49 4.17 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.504 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -68.5 64.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.902 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.42 -51.85 65.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.622 178.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.902 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.3 OUTLIER -74.31 -31.71 62.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 110.914 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.89 90.09 1.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.017 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.602 HG22 ' CD1' ' A' ' 281' ' ' ILE . 1.9 m -46.24 159.2 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.835 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -149.64 137.82 20.54 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.432 0.634 . . . . 0.0 111.85 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 1.07 HG23 HD12 ' A' ' 259' ' ' ILE . 99.7 t -112.15 128.2 68.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.608 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.18 44.61 24.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.129 0.49 . . . . 0.0 110.209 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 m 62.35 24.7 14.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.991 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -130.65 110.51 11.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.42 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 8.7 t -58.79 98.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.512 0.672 . . . . 0.0 111.747 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 1.07 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -77.52 -37.68 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.216 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.495 ' HB2' ' CG ' ' A' ' 245' ' ' ASP . 42.1 t . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.0 mttt . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 121.196 0.522 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.661 ' NE1' HG11 ' A' ' 244' ' ' VAL . 42.5 t-105 -65.92 -24.85 66.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.217 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.66 159.87 12.44 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.7 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -94.29 142.11 24.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.661 0.267 . . . . 0.0 110.543 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 76.0 Cg_exo -48.44 113.73 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.502 2.134 . . . . 0.0 112.901 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.616 HG21 ' CG1' ' A' ' 259' ' ' ILE . 85.0 t -94.19 136.14 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -84.36 128.34 34.52 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.7 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.873 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -94.0 165.8 12.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.198 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.0 156.59 46.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 60.1 p -60.86 130.38 46.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.987 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.0 OUTLIER 81.28 -2.95 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.406 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.893 ' O ' HG23 ' A' ' 291' ' ' VAL . 0.1 OUTLIER -77.91 138.98 39.19 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.126 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.46 ' H ' HG13 ' A' ' 280' ' ' ILE . 0.9 OUTLIER -99.0 123.48 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.345 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.73 HG12 HG22 ' A' ' 254' ' ' VAL . 0.3 OUTLIER -103.4 158.79 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.189 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.835 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 47.5 m -151.06 130.3 12.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.659 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -123.74 42.3 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -177.17 -134.53 2.02 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.578 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.495 HG22 ' OE2' ' A' ' 224' ' ' GLU . 4.7 t -90.59 -47.87 7.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.702 0.287 . . . . 0.0 110.703 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.55 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -139.37 0.93 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 179.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.859 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.7 m -75.85 101.03 4.97 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.527 0.204 . . . . 0.0 111.182 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.884 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -120.38 129.56 53.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.231 0.539 . . . . 0.0 111.47 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.781 HG11 ' HE1' ' A' ' 196' ' ' HIS . 0.2 OUTLIER -109.84 132.53 57.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.649 -178.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 278' ' ' ASP . 1.4 t80 -77.46 133.35 38.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.981 0.42 . . . . 0.0 110.353 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.2 OUTLIER -102.46 114.27 41.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.008 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.517 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -124.39 133.73 53.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.868 HD11 HD23 ' A' ' 275' ' ' LEU . 3.7 mt -132.72 134.66 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.377 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.51 165.67 30.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 111.129 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 13.7 m -97.74 177.79 5.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.781 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 179.967 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.226 -0.143 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.9 m95 -143.59 132.35 22.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.936 HD11 ' CD2' ' A' ' 184' ' ' LEU . 1.2 tp -120.88 134.86 55.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.246 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.913 ' N ' HD12 ' A' ' 182' ' ' LEU . 5.7 m-85 -133.42 138.77 46.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.706 0.765 . . . . 0.0 109.823 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.936 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.1 mm? -122.09 139.1 54.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.906 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.15 114.95 13.66 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.959 HG21 HD12 ' A' ' 194' ' ' LEU . 11.2 t -64.33 102.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.074 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.926 HG22 ' O ' ' A' ' 288' ' ' LYS . 15.1 tt -83.59 -28.43 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.784 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -162.08 99.66 1.08 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.467 ' H ' ' CG1' ' A' ' 192' ' ' ILE . . . -162.18 -169.91 26.21 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.673 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 87.6 Cg_endo -83.67 30.85 0.52 Allowed 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.52 2.147 . . . . 0.0 111.748 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.938 ' HB1' HD21 ' A' ' 194' ' ' LEU . . . -162.83 24.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.303 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 188' ' ' ALA . 8.4 mt -39.32 108.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.471 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.98 3.4 2.56 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.48 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.959 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -97.42 169.43 9.75 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 117.636 0.718 . . . . 0.0 109.14 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.1 mt-30 -160.06 147.63 16.54 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.563 -178.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.948 ' CE1' HD11 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -135.87 129.04 31.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.88 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.52 170.04 16.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.003 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.789 HG21 ' HG ' ' A' ' 206' ' ' LEU . 8.5 p -177.4 153.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.2 0.524 . . . . 0.0 112.244 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 180' ' ' SER . 5.9 t-20 -88.48 150.54 23.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.969 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.479 ' HA ' ' CE2' ' A' ' 234' ' ' TRP . 5.9 t -68.69 -4.85 17.23 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.347 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.533 HG22 ' OD1' ' A' ' 199' ' ' ASN . 0.6 OUTLIER -101.04 20.34 15.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.808 0.337 . . . . 0.0 111.744 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -103.24 112.46 25.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.775 0.321 . . . . 0.0 110.363 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 16.5 m -72.72 -89.93 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 45.6 t -89.32 14.51 10.96 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 111.511 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 13.9 pttt -125.75 54.5 1.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.789 ' HG ' HG21 ' A' ' 198' ' ' VAL . 10.3 tt -143.58 -56.3 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.794 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 5.5 Cg_exo -41.36 100.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.995 1.796 . . . . 0.0 112.791 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 209' ' ' LYS . 87.8 t -67.96 163.9 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.996 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 31.5 mtmt -135.77 96.31 3.4 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.823 HD23 HD12 ' A' ' 218' ' ' LEU . 0.5 OUTLIER -83.28 128.34 34.41 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.091 178.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.476 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -173.59 174.85 46.27 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.745 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 1.003 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -69.04 -72.32 0.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.996 0.427 . . . . 0.0 111.873 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.881 HG22 ' H ' ' A' ' 214' ' ' SER . 10.1 p -128.86 -142.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.728 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.881 ' H ' HG22 ' A' ' 213' ' ' VAL . 2.5 m 66.9 -179.42 0.04 OUTLIER Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 118.441 0.564 . . . . 0.0 110.228 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.551 ' CD ' ' HB3' ' A' ' 214' ' ' SER . 22.6 Cg_exo -65.31 7.75 0.28 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.656 2.238 . . . . 0.0 113.558 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.6 m -48.87 173.16 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.714 0.292 . . . . 0.0 110.909 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.06 -31.43 13.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.252 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.948 HD11 ' CE1' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -104.06 133.65 48.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.831 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 191' ' ' ALA . . . -100.48 74.99 1.74 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 0.0 110.804 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.92 HD21 HD13 ' A' ' 218' ' ' LEU . 2.8 mm? -99.85 80.0 2.28 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.673 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -53.26 67.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 110.802 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.729 ' N ' ' O ' ' A' ' 220' ' ' LEU . 1.7 m-20 -99.65 128.67 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.402 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.7 p -73.46 -4.8 35.96 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.295 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.566 ' O ' HD11 ' A' ' 249' ' ' LEU . 6.0 pm0 -93.03 -25.0 18.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.698 0.285 . . . . 0.0 111.258 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 1.003 HG13 ' HB2' ' A' ' 212' ' ' ARG . 3.4 p -105.49 85.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -32.39 -46.49 0.13 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.628 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.95 -52.37 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.616 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -141.79 128.78 20.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.139 0.495 . . . . 0.0 110.618 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.575 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 3.8 t60 -100.41 -56.26 2.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.281 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.53 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -139.38 172.88 12.16 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.694 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -162.53 174.49 12.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.276 179.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.794 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.0 mt -130.79 144.81 36.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.577 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.85 163.44 34.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.667 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.7 OUTLIER -96.86 150.63 20.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.337 -1.301 . . . . 0.0 114.255 -176.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 239' ' ' PHE . 0.8 OUTLIER -118.91 94.14 4.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.217 -1.356 . . . . 0.0 107.716 175.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 13.8 p -78.16 -25.44 47.25 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 32.3 m -74.24 -21.06 59.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.584 0.707 . . . . 0.0 109.713 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 33.0 tptt -123.01 6.23 9.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.344 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 235' ' ' ASN . 13.0 p90 36.98 43.55 0.31 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 120.713 0.292 . . . . 0.0 111.003 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -115.19 174.97 5.71 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.183 0.516 . . . . 0.0 109.697 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.565 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -127.95 119.64 25.96 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.866 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 0.0 OUTLIER -143.13 152.34 41.71 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.946 0.879 . . . . 0.0 112.851 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.864 HD22 HD12 ' A' ' 281' ' ' ILE . 3.4 pp -116.79 154.04 31.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.765 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.753 HG21 ' CD1' ' A' ' 269' ' ' TRP . 3.3 p -121.3 163.7 18.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.669 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 269' ' ' TRP . 1.0 OUTLIER -106.09 101.4 10.89 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.151 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.558 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -70.6 97.46 1.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.728 177.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 52.33 64.65 3.85 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.213 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -76.32 66.89 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -178.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.846 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -54.77 -49.97 69.59 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.846 ' N ' HD22 ' A' ' 249' ' ' LEU . 2.6 t-20 -72.19 -30.19 64.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.971 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 91.81 85.06 1.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.836 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.509 ' C ' HD23 ' A' ' 253' ' ' LEU . 1.8 m -46.03 158.61 0.09 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.51 0.155 . . . . 0.0 111.077 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.635 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -149.83 137.26 19.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 111.808 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.762 HG22 HG13 ' A' ' 281' ' ' ILE . 75.2 t -111.28 132.2 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.014 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.52 ' HA ' HG13 ' A' ' 280' ' ' ILE . 0.5 OUTLIER 55.2 41.78 31.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 110.306 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 75.6 m 63.43 33.9 13.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.561 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.16 109.76 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 3.1 t -55.82 94.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.665 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.4 OUTLIER -79.85 -20.59 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.04 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.642 ' N ' HD12 ' A' ' 259' ' ' ILE . 6.3 t . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 10.3 mttt . . . . . 0 CA--C 1.516 -0.335 0 CA-C-O 121.061 0.458 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.753 ' CD1' HG21 ' A' ' 244' ' ' VAL . 36.0 t-105 -71.9 -26.52 62.35 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 75.3 164.28 13.39 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.743 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -98.5 146.14 31.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.723 0.297 . . . . 0.0 110.469 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 89.2 Cg_exo -48.83 142.55 18.97 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 122.725 2.283 . . . . 0.0 113.072 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.665 HG21 ' HB ' ' A' ' 259' ' ' ILE . 86.9 t -124.89 136.25 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 10.5 mt-10 -84.37 132.82 34.55 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.844 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.973 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -97.05 165.98 11.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.396 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.13 158.34 44.05 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 93.2 p -60.61 129.25 40.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.063 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.462 ' HA ' ' CE2' ' A' ' 290' ' ' TYR . 38.5 m-20 82.47 -0.06 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.838 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 280' ' ' ILE . 0.9 OUTLIER -68.29 -170.08 0.17 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 279' ' ' ASP . 1.0 OUTLIER -161.02 124.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.076 177.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.864 HD12 HD22 ' A' ' 243' ' ' LEU . 0.2 OUTLIER -105.55 155.39 6.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.122 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 287' ' ' THR . 0.2 OUTLIER -141.62 123.28 15.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.216 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.693 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -116.37 38.07 3.52 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.766 -178.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.4 ' HA3' ' HG3' ' A' ' 224' ' ' GLU . . . 178.68 -122.04 0.79 Allowed Glycine 0 N--CA 1.454 -0.141 0 C-N-CA 119.042 -1.551 . . . . 0.0 114.22 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.466 HG22 ' OE1' ' A' ' 224' ' ' GLU . 4.7 t -95.17 -51.72 4.5 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -141.54 2.17 1.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.72 -0.392 . . . . 0.0 112.007 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.784 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.9 m -72.57 104.77 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.806 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.926 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.4 OUTLIER -120.47 127.25 52.05 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.829 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.3 OUTLIER -110.03 130.07 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.796 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.471 ' CD1' ' CG2' ' A' ' 280' ' ' ILE . 1.6 t80 -77.42 133.57 38.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.306 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.973 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -101.12 116.25 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.488 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.34 135.81 48.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.77 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.729 HD11 HD23 ' A' ' 275' ' ' LEU . 13.6 mt -134.08 142.11 41.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.738 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.0 m -152.79 160.91 43.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 111.089 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.96 175.23 6.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -179.965 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.118 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.5 m95 -150.4 132.95 15.72 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 292' ' ' ARG . 5.0 tp -116.25 130.22 56.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.807 176.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 4.6 m-85 -127.17 134.65 50.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.57 0.7 . . . . 0.0 110.564 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.913 HD13 ' ND1' ' A' ' 196' ' ' HIS . 1.1 mp -133.25 146.97 51.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.901 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.435 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 8.5 tt0 -142.21 124.76 15.77 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.92 HG21 HD12 ' A' ' 194' ' ' LEU . 11.8 t -62.09 119.8 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.719 HG22 ' O ' ' A' ' 288' ' ' LYS . 4.3 tt -101.05 -22.78 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.814 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.91 93.56 0.72 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.578 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.96 -170.35 26.58 Favored Glycine 0 CA--C 1.518 0.244 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.587 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 89.5 Cg_endo -81.32 30.3 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.032 1.822 . . . . 0.0 111.55 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.896 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -160.96 22.9 0.13 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.744 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.578 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.0 mt -39.77 109.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.916 0.389 . . . . 0.0 111.602 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.97 8.95 2.02 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.613 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.92 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -98.36 153.8 18.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 5.9 mt-30 -150.08 148.77 29.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.591 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.913 ' ND1' HD13 ' A' ' 184' ' ' LEU . 2.0 p80 -138.5 132.64 31.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.268 0.556 . . . . 0.0 110.47 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.73 169.93 18.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.746 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.626 HG13 ' CH2' ' A' ' 234' ' ' TRP . 2.7 p -177.64 157.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.197 0.522 . . . . 0.0 110.749 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.517 ' HA ' ' O ' ' A' ' 180' ' ' SER . 5.9 m120 -90.47 147.59 23.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.781 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.523 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 30.5 m -60.66 -6.17 1.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.92 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 9.1 t -102.34 32.19 3.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.154 0.502 . . . . 0.0 111.106 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.469 ' HB2' ' HG2' ' A' ' 205' ' ' LYS . 77.9 p -110.54 132.32 54.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.893 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . 0.547 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 56.9 m -85.57 -84.31 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.8 21.72 14.08 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.547 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -115.88 -8.95 11.89 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.765 178.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.865 HD11 ' CE2' ' A' ' 234' ' ' TRP . 4.0 tt -69.8 -57.0 6.97 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.2 Cg_endo -43.32 86.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.797 2.331 . . . . 0.0 113.761 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.789 HG11 ' CG ' ' A' ' 196' ' ' HIS . 57.6 t -70.16 99.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.775 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 216' ' ' SER . 0.0 OUTLIER -69.48 87.26 0.46 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.029 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -69.14 127.4 32.98 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.48 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -168.38 169.97 41.87 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.638 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.855 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -53.02 -95.84 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.788 -0.706 . . . . 0.0 112.606 -178.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.639 HG12 ' HD3' ' A' ' 212' ' ' ARG . 10.9 p -127.65 -7.69 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 O-C-N 122.187 -0.321 . . . . 0.0 111.812 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.469 ' CB ' ' CD ' ' A' ' 215' ' ' PRO . 0.3 OUTLIER -55.44 -177.22 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.493 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 53.1 Cg_exo -55.8 -1.21 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.397 2.065 . . . . 0.0 113.073 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -44.71 166.28 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.938 0.399 . . . . 0.0 111.432 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -83.93 -32.59 25.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.26 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.029 HD12 HD23 ' A' ' 210' ' ' LEU . 0.9 OUTLIER -105.46 131.88 52.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -97.48 82.76 3.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.768 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.687 HD21 HD13 ' A' ' 218' ' ' LEU . 2.9 mm? -104.47 64.53 0.75 Allowed 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.855 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -53.59 66.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.068 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.644 ' N ' ' O ' ' A' ' 220' ' ' LEU . 4.8 t0 -121.82 139.92 53.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.206 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.4 p -53.24 -31.33 42.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.624 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.56 ' CG ' ' HB3' ' A' ' 222' ' ' ASP . 2.9 pt-20 -49.6 -41.72 42.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.096 0.474 . . . . 0.0 110.147 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.6 p -103.18 110.93 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.68 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.4 t -56.03 -56.07 25.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.233 0.539 . . . . 0.0 109.823 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -137.08 -51.91 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.57 ' CB ' ' HG2' ' A' ' 246' ' ' MET . 0.7 OUTLIER -141.35 125.65 17.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.167 0.508 . . . . 0.0 109.889 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.634 ' CE1' ' HB3' ' A' ' 250' ' ' ASN . 0.5 OUTLIER -92.45 -60.64 1.78 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.3 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -145.23 173.76 11.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.677 ' HA ' HD12 ' A' ' 210' ' ' LEU . 24.6 tt0 -153.28 161.78 42.0 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.6 mt -124.13 147.86 28.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.802 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.716 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.25 163.23 33.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.865 ' CE2' HD11 ' A' ' 206' ' ' LEU . 3.1 p90 -153.86 165.32 36.44 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.513 ' HB2' ' HD2' ' A' ' 240' ' ' LYS . 20.4 m-20 -117.44 133.47 55.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.311 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.49 3.04 55.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.091 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.2 m -76.99 -30.14 55.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.071 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 38.0 tptt -139.89 22.01 2.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.789 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 238' ' ' LYS . 15.5 p90 37.74 62.94 0.84 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.523 0.678 . . . . 0.0 110.16 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.839 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -125.47 142.32 51.57 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.7 178.251 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.769 ' CE3' HD13 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -129.15 123.23 31.59 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.957 -179.036 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.1 pt-20 -141.26 151.56 43.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.258 1.028 . . . . 0.0 113.323 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.644 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.2 pp -113.5 158.83 20.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.031 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.83 HG21 ' NE1' ' A' ' 269' ' ' TRP . 4.1 p -136.82 162.35 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.844 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.412 ' N ' HG22 ' A' ' 244' ' ' VAL . 14.3 t70 -81.89 123.61 28.99 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.57 ' HG2' ' CB ' ' A' ' 228' ' ' LYS . 10.4 tpt -76.77 32.42 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.47 50.31 32.67 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.707 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' A' ' 229' ' ' HIS . 5.5 t -99.05 179.1 4.72 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 110.912 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.697 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -105.89 -29.54 9.92 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.697 ' H ' HD13 ' A' ' 249' ' ' LEU . 1.3 t-20 -75.31 -35.9 61.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.311 0.577 . . . . 0.0 112.244 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.535 ' O ' ' NE2' ' A' ' 229' ' ' HIS . . . 93.29 166.72 38.21 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.017 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.586 ' HB ' HD11 ' A' ' 259' ' ' ILE . 7.6 m -120.89 160.59 23.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.51 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.708 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -146.32 121.02 9.84 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.257 0.551 . . . . 0.0 111.117 179.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.886 HG23 HD12 ' A' ' 259' ' ' ILE . 61.6 t -97.49 129.01 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.046 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.473 ' HA ' HD12 ' A' ' 280' ' ' ILE . 2.5 m-20 53.85 42.62 31.68 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.191 0.52 . . . . 0.0 110.282 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 15.8 m 65.02 22.26 12.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.952 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER -123.52 101.48 7.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.23 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 26.3 p -54.74 101.05 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.075 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.886 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -78.81 -52.41 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.751 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.542 ' N ' HG12 ' A' ' 259' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 121.183 0.516 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.83 ' NE1' HG21 ' A' ' 244' ' ' VAL . 7.0 t-105 -66.2 -26.09 67.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.043 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . 0.433 ' O ' ' HD1' ' A' ' 269' ' ' TRP . . . 73.11 168.76 13.85 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.622 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.75 145.72 30.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.569 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 50.6 Cg_exo -53.24 110.55 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.483 2.122 . . . . 0.0 112.967 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.817 HG21 ' HB ' ' A' ' 259' ' ' ILE . 90.1 t -89.4 132.24 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.1 mt-10 -79.59 126.12 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.711 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.972 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -93.9 166.19 12.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.98 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.609 ' HB3' ' OD2' ' A' ' 279' ' ' ASP . . . -143.4 158.69 43.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.233 0.54 . . . . 0.0 112.39 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 42.7 p -56.51 127.5 31.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.349 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.607 ' HB2' ' O ' ' A' ' 277' ' ' SER . 73.6 m-20 82.67 1.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.859 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 291' ' ' VAL . 69.4 m-20 -78.87 133.84 36.95 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.53 ' HB ' ' HD3' ' A' ' 288' ' ' LYS . 0.8 OUTLIER -94.28 125.21 46.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.694 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.566 HD13 ' H ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -105.14 155.8 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.137 178.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.681 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -148.73 132.52 16.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.721 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -128.34 53.1 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.444 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 169.1 -129.84 1.94 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 119.596 -1.287 . . . . 0.0 113.613 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.0 t -95.76 -47.85 6.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.335 0.112 . . . . 0.0 110.92 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.7 t -139.88 -6.25 1.29 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.335 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.814 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 29.3 m -69.11 101.25 1.4 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.781 0.325 . . . . 0.0 110.279 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.719 ' O ' HG22 ' A' ' 187' ' ' ILE . 20.4 ttmt -118.65 126.45 51.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.067 0.46 . . . . 0.0 111.576 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -110.79 131.91 60.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.424 -178.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.4 t80 -77.18 137.46 38.88 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.076 0.465 . . . . 0.0 109.942 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.923 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.5 t -105.19 112.27 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.022 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.797 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -126.55 139.42 53.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.069 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.972 HD11 HD23 ' A' ' 275' ' ' LEU . 3.4 mt -136.26 132.22 49.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.73 152.78 45.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.46 159.31 15.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.925 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.556 ' N ' ' HG ' ' A' ' 200' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.523 -0.075 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 9.8 m95 -147.89 133.34 18.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.812 HD11 ' CD2' ' A' ' 184' ' ' LEU . 3.6 tp -118.65 132.97 56.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.722 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.666 ' N ' HD12 ' A' ' 182' ' ' LEU . 9.2 m-85 -128.32 126.0 39.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.669 0.747 . . . . 0.0 110.165 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.812 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.2 mm? -108.81 133.74 52.45 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.675 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.565 ' C ' HG23 ' A' ' 289' ' ' VAL . 0.4 OUTLIER -129.9 108.02 9.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.83 HG21 HD12 ' A' ' 194' ' ' LEU . 40.8 t -60.97 104.98 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 288' ' ' LYS . 12.4 tt -89.28 -24.85 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -175.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.72 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.8 96.66 0.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.538 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.677 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.11 -168.64 24.32 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.478 ' HB2' ' CG ' ' A' ' 221' ' ' LYS . 93.2 Cg_endo -82.91 30.53 0.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.243 1.962 . . . . 0.0 110.97 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.947 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.95 23.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.624 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.677 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.0 mt -39.34 109.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.89 6.33 2.89 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.717 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.947 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER -100.14 139.66 35.48 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 117.841 0.821 . . . . 0.0 109.117 178.189 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 29.8 mt-30 -134.38 151.22 51.08 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.787 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.661 ' NE2' HG22 ' A' ' 208' ' ' VAL . 59.4 t60 -144.92 138.96 27.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.569 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -145.75 166.12 26.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.639 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.8 HG13 ' CH2' ' A' ' 234' ' ' TRP . 7.9 p -169.22 152.66 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.731 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 180' ' ' SER . 2.8 m120 -88.93 144.57 26.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.972 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.556 ' HG ' ' N ' ' A' ' 180' ' ' SER . 97.8 p -60.32 -7.72 2.17 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.595 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 7.6 t -98.49 24.53 7.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.912 0.387 . . . . 0.0 110.685 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.434 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -106.04 119.02 38.11 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.362 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.1 t -71.68 -77.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.0 m -105.0 23.07 14.18 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -119.7 -10.38 9.58 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.578 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.987 ' O ' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -82.11 -32.37 0.59 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.105 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 206' ' ' LEU . 29.9 Cg_exo -59.23 100.46 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.14 1.227 . . . . 0.0 111.733 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.724 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 4.9 t -68.62 160.65 4.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.8 OUTLIER -137.4 86.48 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.011 HD23 HD12 ' A' ' 218' ' ' LEU . 0.4 OUTLIER -77.67 125.81 29.91 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.963 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.05 172.98 45.07 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.767 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.959 ' HB2' HG13 ' A' ' 225' ' ' VAL . 16.2 ttt-85 -71.62 -70.66 0.31 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.325 -0.438 . . . . 0.0 112.145 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.81 HG22 ' H ' ' A' ' 214' ' ' SER . 9.3 p -125.59 -149.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.952 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.81 ' H ' HG22 ' A' ' 213' ' ' VAL . 1.0 OUTLIER 66.94 -178.0 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 58.8 Cg_endo -73.85 45.73 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 121.807 1.671 . . . . 0.0 112.702 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.35 165.92 24.17 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.445 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.36 -38.46 13.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.161 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.011 HD12 HD23 ' A' ' 210' ' ' LEU . 3.1 mt -105.82 129.94 53.89 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -93.46 79.38 4.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.904 0.383 . . . . 0.0 111.173 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.754 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -101.55 83.95 2.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.478 ' CG ' ' HB2' ' A' ' 190' ' ' PRO . 3.5 pttp -60.2 59.72 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.981 0.42 . . . . 0.0 111.81 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.876 ' HB2' HG12 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -89.1 126.7 35.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 37.2 p -67.04 -7.53 23.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.218 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -87.31 -22.52 25.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.095 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.959 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.6 p -106.54 83.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.3 p -35.0 -41.42 0.14 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.69 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.35 -57.6 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.608 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.3 OUTLIER -138.81 130.81 28.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.211 0.529 . . . . 0.0 110.316 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.61 ' HB3' ' HB2' ' A' ' 283' ' ' LEU . 2.2 t60 -101.07 -56.45 2.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.888 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.528 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -147.35 173.21 12.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.249 0.547 . . . . 0.0 112.273 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.724 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -156.3 179.85 8.84 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.824 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.458 HG12 ' HB3' ' A' ' 243' ' ' LEU . 19.8 mt -139.23 149.68 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.544 0.688 . . . . 0.0 112.436 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.89 160.67 31.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.8 ' CH2' HG13 ' A' ' 198' ' ' VAL . 5.3 p90 -149.58 165.51 32.02 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -116.49 132.98 56.53 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.138 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.07 0.27 57.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.867 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.16 -29.38 48.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.699 0.761 . . . . 0.0 109.963 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.444 ' HD3' ' HD3' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -138.44 23.12 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.129 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 238' ' ' LYS . 23.1 p90 37.0 59.09 1.11 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.355 0.597 . . . . 0.0 110.115 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.74 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 1.2 mptp? -122.72 141.37 51.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.105 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.687 ' CE3' ' CE3' ' A' ' 234' ' ' TRP . 2.1 m95 -124.46 121.61 35.33 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.912 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.8 pt-20 -138.57 144.86 40.05 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.731 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.8 pp -111.46 152.57 27.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.369 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.847 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 6.1 p -123.41 165.1 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 122.859 0.464 . . . . 0.0 110.586 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.852 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 5.1 t0 -107.39 116.6 32.22 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.851 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -75.76 99.12 4.31 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' 249' ' ' LEU . . . 57.46 69.05 1.39 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.578 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 56.0 p -61.5 43.54 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 1.014 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.6 -54.19 49.68 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.622 0.646 . . . . 0.0 109.911 178.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 1.014 ' N ' HD22 ' A' ' 249' ' ' LEU . 2.1 t-20 -77.87 -38.12 46.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.244 0.545 . . . . 0.0 110.672 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 93.79 96.87 1.54 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.13 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.55 ' C ' HD23 ' A' ' 253' ' ' LEU . 0.7 OUTLIER -55.87 165.17 0.97 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.662 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -150.97 140.02 21.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.285 0.564 . . . . 0.0 111.455 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.586 HG23 HD11 ' A' ' 259' ' ' ILE . 93.1 t -114.33 132.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.788 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.57 ' HA ' HG13 ' A' ' 280' ' ' ILE . 16.9 t-20 53.43 42.22 32.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.126 0.489 . . . . 0.0 110.28 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.2 p 63.52 32.35 14.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.835 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -138.88 110.32 7.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 52.4 p -60.12 88.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.431 0.634 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.82 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -90.75 -7.57 10.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.601 -178.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.852 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 38.9 m . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.851 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 0.0 OUTLIER -75.36 -25.38 57.65 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.646 -178.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.2 -174.55 7.47 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.581 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -111.94 157.71 38.84 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 117.482 0.641 . . . . 0.0 110.866 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.731 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 21.3 Cg_exo -66.91 138.23 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.86 2.374 . . . . 0.0 113.892 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.82 HG21 ' HB ' ' A' ' 259' ' ' ILE . 74.3 t -114.51 142.28 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.0 mm-40 -85.28 127.12 34.2 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 118.803 -1.159 . . . . 0.0 112.316 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.874 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -95.05 164.85 12.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.018 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.1 160.0 41.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.588 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 80.1 p -59.77 132.24 53.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.509 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.5 OUTLIER 84.01 7.46 0.6 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.285 -179.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.659 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 3.0 m-20 -79.72 -167.31 1.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.57 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -160.34 134.92 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.301 177.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 1.036 HG22 HG12 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -107.09 157.21 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.985 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.69 HG23 ' CG ' ' A' ' 288' ' ' LYS . 0.7 OUTLIER -149.18 117.81 6.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.662 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -115.57 43.9 1.98 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.976 -178.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 172.28 -123.39 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 119.209 -1.472 . . . . 0.0 113.741 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.0 t -92.88 -51.16 5.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.586 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -143.6 -3.63 0.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 40.4 m -67.09 104.03 1.32 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 117.811 0.278 . . . . 0.0 110.807 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.781 ' O ' HG22 ' A' ' 187' ' ' ILE . 3.6 mtpt -125.49 134.66 51.96 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.498 -0.481 . . . . 0.0 112.264 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 1.036 HG12 HG22 ' A' ' 281' ' ' ILE . 9.6 p -112.98 136.92 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.289 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.443 ' HD1' HG22 ' A' ' 280' ' ' ILE . 2.0 t80 -77.66 137.06 38.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.249 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -103.98 110.48 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.625 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -129.99 134.57 47.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.586 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.685 HD11 HD23 ' A' ' 275' ' ' LEU . 4.6 mt -133.15 143.14 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.7 t -150.35 157.17 42.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.0 110.813 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 2.8 m -87.65 -176.94 5.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 16.0 m . . . . . 0 N--CA 1.457 -0.099 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.1 m95 -143.01 135.18 27.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 3.5 tp -118.29 123.5 45.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.502 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 3.3 m-85 -123.63 134.85 53.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.681 0.753 . . . . 0.0 110.679 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.999 HD13 ' CE1' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -135.48 145.39 47.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.497 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.557 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 39.8 tt0 -140.11 127.39 21.2 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.869 HG21 HD12 ' A' ' 194' ' ' LEU . 16.9 t -64.97 107.72 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.5 tt -91.47 -21.51 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.834 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.55 94.56 0.7 Allowed 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.722 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.14 -177.99 35.65 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.534 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 88.2 Cg_endo -76.84 31.84 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 CA-C-N 119.591 1.696 . . . . 0.0 111.579 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.831 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.57 23.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.336 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.722 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.5 mt -39.81 111.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.85 6.89 2.45 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.011 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.869 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -98.72 154.59 17.86 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.736 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.3 mt-30 -151.66 148.67 28.22 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.213 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.999 ' CE1' HD13 ' A' ' 184' ' ' LEU . 1.1 p80 -136.31 130.74 33.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.308 0.575 . . . . 0.0 109.828 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.97 163.72 35.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.243 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' A' ' 206' ' ' LEU . 9.4 p -174.28 160.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.292 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 180' ' ' SER . 7.3 m120 -87.86 146.02 25.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.601 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.416 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 9.3 t -62.84 -5.26 2.67 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.854 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.553 HG22 ' HB3' ' A' ' 199' ' ' ASN . 2.7 t -91.82 34.79 0.98 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.039 0.447 . . . . 0.0 110.617 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.961 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 8.5 m -137.25 92.88 2.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.249 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 11.3 t -66.68 -73.3 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.392 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.0 t -89.93 -2.06 58.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.961 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.1 OUTLIER -115.63 47.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.132 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.857 ' H ' ' CD ' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -152.28 -26.65 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.857 ' CD ' ' H ' ' A' ' 206' ' ' LEU . 33.0 Cg_exo -55.05 102.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 CA-C-N 121.02 1.4 . . . . 0.0 111.739 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.588 HG11 ' ND1' ' A' ' 196' ' ' HIS . 17.1 t -68.34 165.78 2.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.086 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.568 ' N ' HG12 ' A' ' 208' ' ' VAL . 1.5 mtpt -134.99 88.38 2.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.151 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.072 HD23 HD12 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -75.75 128.29 34.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.563 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -175.3 176.62 47.3 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.155 -1.021 . . . . 0.0 113.556 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 1.005 ' HB2' HG13 ' A' ' 225' ' ' VAL . 6.1 ttt180 -71.47 -72.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.876 0.47 . . . . 0.0 111.477 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.657 HG22 ' H ' ' A' ' 214' ' ' SER . 8.0 p -125.49 -139.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.648 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.684 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.3 OUTLIER 61.78 -179.92 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 118.894 0.77 . . . . 0.0 109.928 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 47.0 Cg_endo -70.46 31.24 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.836 1.691 . . . . 0.0 113.205 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 214' ' ' SER . 3.9 m -65.03 157.71 27.63 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.796 0.331 . . . . 0.0 110.837 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.4 -30.36 23.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.533 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.072 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -110.01 133.51 53.11 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -94.95 77.32 3.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.522 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.785 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -100.44 66.88 1.29 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.647 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 0.3 OUTLIER -61.59 45.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -177.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.534 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 10.3 t0 -94.1 124.05 37.87 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.4 t -39.55 -32.07 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.228 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.867 ' O ' HD11 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -52.11 -37.42 54.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 110.366 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 1.005 HG13 ' HB2' ' A' ' 212' ' ' ARG . 4.3 p -103.51 102.14 13.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.496 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.437 ' O ' ' HD2' ' A' ' 212' ' ' ARG . 78.6 p -45.17 -62.2 1.35 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.08 0.466 . . . . 0.0 111.032 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -132.19 -50.58 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.684 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 0.1 OUTLIER -143.05 131.25 21.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.015 -0.592 . . . . 0.0 109.782 178.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.649 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.3 t60 -95.82 -55.58 2.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.327 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -143.65 172.81 12.3 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.578 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -157.48 177.66 11.18 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.727 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.792 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.0 mt -135.78 150.17 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.885 0.374 . . . . 0.0 111.985 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.59 163.71 37.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.217 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.613 ' CE3' HD21 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -91.92 149.46 21.54 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.432 ' HB3' ' CB ' ' A' ' 240' ' ' LYS . 7.9 t-20 -119.78 80.83 1.64 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 5.9 p -68.61 -19.97 64.47 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 82.5 m -81.21 -32.16 33.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.425 0.631 . . . . 0.0 110.885 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.583 ' HD3' ' HD3' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -117.7 15.29 14.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.889 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.417 ' C ' ' O ' ' A' ' 238' ' ' LYS . 10.0 p90 38.9 71.98 0.15 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.583 ' HD3' ' HD3' ' A' ' 238' ' ' LYS . 6.0 mptt -137.84 148.21 45.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.445 -1.252 . . . . 0.0 112.375 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.71 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.5 OUTLIER -116.97 104.73 11.57 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.5 mt-10 -126.26 146.8 49.86 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.5 pp -116.12 149.76 38.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.767 -1.56 . . . . 0.0 110.984 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.691 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -118.87 162.31 17.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.547 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 248' ' ' SER . 11.5 m-20 -115.6 99.26 7.21 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.172 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.822 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.36 108.81 9.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.207 0.527 . . . . 0.0 110.588 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 51.61 62.5 5.48 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.114 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 5.8 t -80.6 76.17 7.46 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.972 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.47 -48.83 78.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.972 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -74.68 -28.02 60.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.414 -179.188 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.522 ' O ' HD23 ' A' ' 253' ' ' LEU . . . 87.3 99.05 0.86 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.858 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.563 ' C ' HD23 ' A' ' 253' ' ' LEU . 4.9 m -60.31 159.22 10.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.359 0.123 . . . . 0.0 110.77 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.715 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -148.09 124.51 10.97 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.027 0.442 . . . . 0.0 111.374 179.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.887 HG22 HG23 ' A' ' 281' ' ' ILE . 90.9 t -101.26 132.02 47.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.819 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.428 ' HA ' HG13 ' A' ' 280' ' ' ILE . 32.0 t-20 51.27 39.58 24.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.069 0.461 . . . . 0.0 110.29 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 1.6 t 65.82 22.14 11.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.51 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -121.45 100.49 7.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.007 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 59.9 p -51.84 97.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.072 0.463 . . . . 0.0 112.19 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.928 HG21 HG11 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -78.14 -54.21 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.874 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.544 ' N ' HG12 ' A' ' 259' ' ' ILE . 2.0 t . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.932 0.396 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.822 ' CZ3' ' HB2' ' A' ' 246' ' ' MET . 36.8 t-105 -66.19 -26.58 67.46 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 76.92 160.88 11.58 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.911 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -94.56 146.47 31.52 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.88 147.87 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.166 1.911 . . . . 0.0 111.503 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.928 HG11 HG21 ' A' ' 259' ' ' ILE . 85.9 t -132.14 127.18 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.71 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.01 128.08 33.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.154 -178.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 1.022 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -93.11 164.38 13.28 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.957 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.02 159.23 42.64 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 57.2 p -62.48 132.1 51.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.245 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 81.8 -0.89 1.56 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.013 -179.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.72 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -71.97 -167.02 0.26 Allowed 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.6 OUTLIER -162.7 133.37 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.444 177.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.887 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -109.9 156.18 10.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.483 178.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.715 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 5.8 m -147.42 112.82 5.59 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.779 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -112.1 46.43 1.16 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.614 -177.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -178.79 -129.74 1.34 Allowed Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 119.654 -1.26 . . . . 0.0 113.882 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.641 HG22 ' HG3' ' A' ' 224' ' ' GLU . 5.4 t -97.59 -41.05 8.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.0 110.501 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.608 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -149.25 3.09 0.58 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.835 179.239 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.834 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 57.3 m -77.06 104.66 7.67 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.745 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -127.02 133.51 50.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.343 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.85 ' CG2' HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -110.82 136.76 45.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.311 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 4.0 t80 -76.41 135.22 39.45 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 1.022 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.3 t -103.37 113.51 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.099 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 293' ' ' ILE . 6.7 tpt180 -126.43 145.5 50.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.705 HD11 HD23 ' A' ' 275' ' ' LEU . 7.1 mt -143.32 116.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.908 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 6.1 t -125.48 155.76 40.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 0.0 110.725 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.02 162.25 24.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.204 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 296' ' ' GLN . 5.5 tp60 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.952 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.251 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.678 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.0 m95 -144.02 127.77 17.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.871 HD11 ' CD1' ' A' ' 184' ' ' LEU . 1.2 tp -120.07 129.68 54.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.392 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.852 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.2 m-85 -130.25 135.8 48.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.786 0.803 . . . . 0.0 111.814 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.991 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -132.03 148.65 52.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.963 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.606 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 26.5 tt0 -140.64 124.96 17.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.709 HG21 HD12 ' A' ' 194' ' ' LEU . 17.4 t -60.8 108.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.925 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.2 tt -92.38 -18.38 7.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.798 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.53 93.6 0.34 Allowed 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.589 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.736 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.03 -172.06 27.84 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.621 ' O ' ' HG2' ' A' ' 221' ' ' LYS . 83.5 Cg_endo -80.41 29.06 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.232 1.954 . . . . 0.0 111.61 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.847 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.75 27.13 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.736 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.1 mt -41.76 111.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 112.136 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 8.16 2.26 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.11 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.847 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -101.18 136.28 41.29 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.697 0.761 . . . . 0.0 109.057 178.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.606 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 7.9 mt-30 -136.17 155.81 49.6 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.494 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.991 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -148.84 147.58 28.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.355 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.544 ' C ' ' HZ3' ' A' ' 181' ' ' TRP . . . -151.25 149.48 29.45 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.619 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.927 HG13 ' CH2' ' A' ' 234' ' ' TRP . 5.2 p -153.77 153.83 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.432 0.634 . . . . 0.0 111.542 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 180' ' ' SER . 6.3 m-80 -91.27 148.57 22.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.679 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.516 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 32.8 p -66.31 -0.63 2.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 2.1 t -103.17 26.78 7.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.432 0.634 . . . . 0.0 110.457 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.627 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 55.8 p -114.32 123.22 48.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.692 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . 0.497 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 22.9 m -91.07 -80.88 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.3 t -82.34 6.46 16.93 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.497 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -117.26 -12.13 10.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.958 0.408 . . . . 0.0 110.939 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.747 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.8 tt -68.0 -60.97 4.58 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.295 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.619 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.6 Cg_endo -42.6 99.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.32 2.014 . . . . 0.0 112.571 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.895 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 2.3 t -67.38 160.44 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.438 ' N ' ' CG1' ' A' ' 208' ' ' VAL . 3.7 mtpt -133.83 93.11 3.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.026 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -84.5 121.89 28.23 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.75 167.48 38.54 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.527 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.934 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.1 OUTLIER -57.42 -88.18 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.586 HG12 ' HD3' ' A' ' 212' ' ' ARG . 13.1 p -126.89 -10.61 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 111.62 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.609 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.6 OUTLIER -52.34 179.78 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.461 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 36.1 Cg_exo -60.05 10.83 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.417 2.078 . . . . 0.0 113.202 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 214' ' ' SER . 1.0 OUTLIER -52.39 -178.11 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.16 0.505 . . . . 0.0 111.461 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 209' ' ' LYS . 17.6 m-20 -99.24 -31.42 11.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.51 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.026 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -104.33 127.61 52.01 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -94.27 82.24 4.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.91 0.386 . . . . 0.0 111.889 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.857 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.9 mm? -102.68 91.49 4.22 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 6.5 ptpt -61.53 60.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.147 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 220' ' ' LEU . 3.3 m-20 -93.15 146.59 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.702 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 54.2 p -86.77 -18.46 31.04 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.56 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.569 ' OE1' HG22 ' A' ' 285' ' ' THR . 0.0 OUTLIER -79.48 -18.65 51.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.76 0.314 . . . . 0.0 111.466 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.934 HG13 ' HB2' ' A' ' 212' ' ' ARG . 3.0 p -109.37 81.45 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.023 0.44 . . . . 0.0 110.583 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.8 p -37.71 -39.45 0.34 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.514 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.37 -55.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.947 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.609 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 0.6 OUTLIER -140.75 130.82 24.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.115 0.483 . . . . 0.0 110.782 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.603 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.8 OUTLIER -96.57 -57.02 2.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.442 179.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 244' ' ' VAL . . . -151.57 175.81 11.96 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.555 0.693 . . . . 0.0 112.449 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.895 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -152.52 173.32 15.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.974 -179.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 9.0 mt -125.03 143.37 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.913 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.24 129.07 4.25 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.927 ' CH2' HG13 ' A' ' 198' ' ' VAL . 4.5 p90 -119.32 166.43 13.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.754 0.788 . . . . 0.0 112.624 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 240' ' ' LYS . 1.9 m-20 -113.66 133.25 55.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.201 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.44 -1.83 52.92 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.088 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.8 m -78.83 -23.86 44.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.518 0.675 . . . . 0.0 109.937 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.518 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 13.9 tptt -141.82 16.61 2.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.373 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 15.3 p90 42.83 60.44 2.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.537 0.684 . . . . 0.0 109.774 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.785 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 2.0 mptp? -124.08 141.25 52.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.91 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.663 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -124.68 127.02 46.65 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.316 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.835 ' HG2' ' HG3' ' A' ' 274' ' ' GLU . 24.5 mt-10 -134.87 139.85 45.35 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.824 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -92.37 143.1 26.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.738 -1.574 . . . . 0.0 107.45 177.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.517 ' O ' ' HB1' ' A' ' 230' ' ' ALA . 1.3 p -140.16 161.64 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.272 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.714 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 10.5 t0 -84.93 135.03 34.23 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 120.881 0.372 . . . . 0.0 110.716 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.538 ' HG3' ' HG2' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -89.74 31.33 0.95 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.18 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.56 47.45 56.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.418 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.46 175.21 6.65 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.915 0.358 . . . . 0.0 111.077 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.694 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -101.67 -30.08 11.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.737 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.694 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -75.82 -33.29 60.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.467 0.651 . . . . 0.0 111.579 -178.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.492 ' O ' ' NE2' ' A' ' 229' ' ' HIS . . . 93.27 160.47 35.38 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.769 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 260' ' ' SER . 7.6 m -117.98 157.37 26.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.049 -0.575 . . . . 0.0 110.763 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.682 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -144.87 141.82 29.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.041 0.448 . . . . 0.0 110.681 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.564 HG23 HD11 ' A' ' 259' ' ' ILE . 60.0 t -114.89 128.99 71.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.053 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.658 ' HA ' HD12 ' A' ' 280' ' ' ILE . 40.6 t30 55.93 48.68 17.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.099 0.476 . . . . 0.0 110.24 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 18.7 m 56.33 29.12 14.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.66 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.401 ' O ' HG23 ' A' ' 259' ' ' ILE . 1.7 t60 -133.3 103.4 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.816 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.585 ' HA ' ' HB3' ' A' ' 253' ' ' LEU . 64.8 p -55.03 89.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.286 0.565 . . . . 0.0 110.877 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.93 ' HB ' HG21 ' A' ' 273' ' ' VAL . 2.6 pp -94.66 -8.19 9.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.229 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.714 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 3.3 m . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.434 ' NZ ' ' HA2' ' A' ' 270' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.196 0.522 . . . . 0.0 112.07 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.432 ' CZ3' ' HE3' ' A' ' 246' ' ' MET . 19.5 t-105 -78.29 -18.79 54.8 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.299 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . 0.434 ' HA2' ' NZ ' ' A' ' 268' ' ' LYS . . . 71.78 173.29 18.31 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.33 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -105.0 138.31 19.47 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -50.28 111.43 0.53 Allowed 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.602 2.202 . . . . 0.0 113.316 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.93 HG21 ' HB ' ' A' ' 259' ' ' ILE . 39.6 t -97.97 139.53 19.97 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.835 ' HG3' ' HG2' ' A' ' 242' ' ' GLU . 1.7 mp0 -80.1 124.79 29.06 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.869 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -91.81 165.98 12.99 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.99 177.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.721 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.72 159.19 42.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 13.7 t -59.88 128.33 36.38 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.958 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 277' ' ' SER . 12.8 m-20 87.98 5.77 0.24 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.885 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.721 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -80.94 -163.29 0.57 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.7 OUTLIER -161.52 131.02 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.365 177.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.867 HD12 ' CG2' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -104.46 156.3 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.117 0.484 . . . . 0.0 110.018 178.163 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.682 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 3.2 m -147.43 114.41 6.15 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.743 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.92 44.4 1.79 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.143 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.87 -131.54 1.79 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.585 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.569 HG22 ' OE1' ' A' ' 224' ' ' GLU . 2.6 t -92.36 -51.35 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.703 0.287 . . . . 0.0 110.522 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.584 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -138.58 -0.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.577 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.798 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 29.9 m -70.26 103.06 2.26 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.643 0.258 . . . . 0.0 110.953 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.679 ' O ' HG22 ' A' ' 187' ' ' ILE . 1.3 mtpp -126.01 137.78 53.68 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.349 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.867 ' CG2' HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -115.54 134.81 57.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.457 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.645 ' HD1' HG23 ' A' ' 280' ' ' ILE . 2.1 t80 -76.5 141.23 41.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.548 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -107.26 109.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.422 -179.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.416 ' O ' HD12 ' A' ' 182' ' ' LEU . 4.9 tpt180 -124.29 141.28 52.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.606 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.547 HG12 HD13 ' A' ' 182' ' ' LEU . 9.3 mt -138.76 133.16 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.02 156.46 43.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.733 0.301 . . . . 0.0 111.001 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.32 -174.75 4.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.031 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.922 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.577 ' HB2' ' OG ' ' A' ' 200' ' ' SER . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.137 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.734 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 14.1 m95 -148.12 134.01 19.08 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.738 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 2.2 tp -112.98 119.78 39.11 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.458 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.734 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 5.6 m-85 -117.12 127.43 54.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.677 0.751 . . . . 0.0 110.66 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -118.28 134.62 54.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.676 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.541 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 2.3 tt0 -131.06 112.3 12.78 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.911 HG21 HD11 ' A' ' 220' ' ' LEU . 18.8 t -61.99 107.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.889 HG22 ' O ' ' A' ' 288' ' ' LYS . 11.0 tt -88.53 -26.01 5.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.743 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.31 98.35 0.71 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.418 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.1 -162.06 12.8 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.466 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 88.5 Cg_endo -86.59 27.93 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.677 2.251 . . . . 0.0 111.324 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.872 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -162.07 25.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.418 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.604 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.9 mt -39.63 107.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.52 5.47 2.28 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.203 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.872 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.9 OUTLIER -102.81 133.7 47.44 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.544 0.687 . . . . 0.0 110.076 179.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.8 mt-30 -131.13 153.96 48.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.763 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.568 ' NE2' ' HB3' ' A' ' 217' ' ' ASP . 1.6 t-80 -144.28 138.66 28.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.134 0.492 . . . . 0.0 110.832 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.738 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.92 156.08 44.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.591 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.795 HG21 ' CB ' ' A' ' 206' ' ' LEU . 12.3 p -157.69 149.01 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.348 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.5 OUTLIER -91.65 140.56 29.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.317 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.577 ' OG ' ' HB2' ' A' ' 180' ' ' SER . 0.9 OUTLIER -62.23 -6.88 3.46 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.76 28.55 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.323 0.582 . . . . 0.0 110.742 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.766 ' OG ' ' HB3' ' A' ' 206' ' ' LEU . 89.2 p -101.02 140.87 34.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.358 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -70.94 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 111.315 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.41 33.04 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.004 0.43 . . . . 0.0 110.752 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -117.15 4.13 12.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.862 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.989 HD13 ' HD3' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -98.69 -19.19 0.21 Allowed Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.989 ' HD3' HD13 ' A' ' 206' ' ' LEU . 10.8 Cg_endo -58.14 97.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 CA-C-N 120.836 1.334 . . . . 0.0 111.058 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 58.5 t -67.64 164.07 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.276 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.66 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.3 OUTLIER -139.73 86.0 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.509 -178.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.041 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -74.94 130.38 39.28 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.869 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.432 ' HA2' HG11 ' A' ' 225' ' ' VAL . . . -176.13 178.57 47.53 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.588 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 15.5 ttt180 -76.48 -67.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.816 HG22 ' H ' ' A' ' 214' ' ' SER . 9.8 p -125.99 -145.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 213' ' ' VAL . 1.1 p 64.78 179.9 0.04 OUTLIER Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 57.7 Cg_endo -73.15 39.37 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.913 1.742 . . . . 0.0 112.597 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.2 p -70.05 151.98 44.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.836 0.35 . . . . 0.0 110.553 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.568 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 2.8 m-20 -75.62 -38.15 59.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.086 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.041 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -103.21 130.33 50.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.6 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -98.72 86.28 3.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.841 0.353 . . . . 0.0 111.078 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.911 HD11 HG21 ' A' ' 186' ' ' VAL . 2.3 mm? -108.03 69.66 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.41 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 6.7 pttt -47.75 72.82 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.919 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.677 ' N ' ' O ' ' A' ' 220' ' ' LEU . 41.8 t0 -101.58 137.45 39.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.468 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.0 p -76.89 -3.98 41.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.348 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -99.73 -22.39 15.4 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 90.4 t -96.73 76.37 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.419 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 225' ' ' VAL . 49.0 m -31.5 -48.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.999 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.6 -58.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.1 OUTLIER -141.81 131.39 23.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.2 0.524 . . . . 0.0 110.336 179.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.627 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.6 t60 -99.5 -54.88 2.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.175 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -141.65 175.54 9.61 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.72 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -165.88 176.94 7.48 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.578 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.4 mt -135.27 148.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.682 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.17 164.11 38.01 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.46 ' CH2' ' CZ3' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -89.32 146.15 24.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -176.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.532 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 0.9 OUTLIER -119.33 81.28 1.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.515 175.023 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.7 p -64.77 -20.64 66.47 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.1 m -80.91 -30.87 35.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.33 0.586 . . . . 0.0 110.334 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.598 ' HD2' ' HE2' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -108.59 5.25 24.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.064 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 235' ' ' ASN . 2.8 p90 38.48 42.73 0.58 Allowed 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.245 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.598 ' HE2' ' HD2' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -118.64 173.95 6.55 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.279 0.562 . . . . 0.0 109.503 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.696 ' CZ3' HG23 ' A' ' 293' ' ' ILE . 2.0 m0 -121.88 113.41 19.6 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 13.7 pt-20 -133.26 149.13 51.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.715 ' O ' HD12 ' A' ' 243' ' ' LEU . 3.8 pp -115.05 152.15 32.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.06 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.868 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.7 OUTLIER -118.98 163.12 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 248' ' ' SER . 0.4 OUTLIER -104.73 110.66 23.08 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.601 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.82 100.49 5.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.656 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.73 63.44 5.12 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.541 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 3.1 p -67.33 55.74 0.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.771 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.51 -46.52 80.51 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.771 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -78.91 -35.62 43.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.559 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 89.71 87.4 1.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.89 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.525 ' C ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -45.24 164.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.47 0.176 . . . . 0.0 111.288 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.613 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -151.84 134.17 15.24 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.213 0.53 . . . . 0.0 111.686 178.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.629 HG23 ' CG1' ' A' ' 259' ' ' ILE . 96.6 t -110.65 137.61 42.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.225 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 49.45 35.41 8.09 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.207 0.527 . . . . 0.0 110.173 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 14.6 m 69.44 29.33 4.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.442 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -131.5 102.22 5.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.349 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 8.8 t -53.39 87.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.698 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.766 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.0 OUTLIER -90.18 6.86 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.932 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.457 ' HB3' ' N ' ' A' ' 252' ' ' THR . 2.4 t . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.868 ' NE1' HG11 ' A' ' 244' ' ' VAL . 3.4 t-105 -82.73 -29.14 29.99 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.72 -174.52 8.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.532 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -101.54 137.87 19.72 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.397 0.598 . . . . 0.0 110.497 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 75.6 Cg_exo -51.63 122.9 11.11 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.704 2.269 . . . . 0.0 113.621 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.766 HG21 ' HB ' ' A' ' 259' ' ' ILE . 98.7 t -94.12 141.11 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -82.93 130.13 35.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.033 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.792 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -96.46 163.25 13.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.895 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.31 160.33 41.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.296 0.569 . . . . 0.0 112.487 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 38.3 t -59.89 125.63 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.609 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.522 ' HA ' ' CZ ' ' A' ' 290' ' ' TYR . 14.8 m-20 85.97 0.77 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.736 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.662 ' O ' HG23 ' A' ' 291' ' ' VAL . 2.3 m-20 -82.06 133.7 35.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.703 HG23 ' HD1' ' A' ' 290' ' ' TYR . 1.0 OUTLIER -101.91 130.36 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.992 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 1.054 HG22 HG12 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -99.46 155.15 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.998 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.613 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -144.83 118.97 9.44 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.67 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.87 44.53 1.76 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.2 -122.93 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 119.277 -1.44 . . . . 0.0 113.843 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.2 t -93.44 -51.74 4.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.142 . . . . 0.0 111.188 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -142.65 -2.63 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.743 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 35.7 m -65.94 102.39 0.78 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 117.853 0.297 . . . . 0.0 110.614 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.889 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -117.63 123.73 46.87 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.752 -178.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 1.054 HG12 HG22 ' A' ' 281' ' ' ILE . 2.5 p -108.41 134.08 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.636 0.255 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.703 ' HD1' HG23 ' A' ' 280' ' ' ILE . 1.4 t80 -77.65 130.26 36.62 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.2 t -104.01 115.91 46.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.894 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.601 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -129.3 146.64 51.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.576 -179.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.792 HD11 HD23 ' A' ' 275' ' ' LEU . 9.1 mt -139.78 140.77 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.52 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.6 t -152.3 161.44 42.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.373 . . . . 0.0 111.29 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 54.5 p -102.97 141.52 35.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.533 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.772 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 73.1 m . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 120.752 0.311 . . . . 0.0 111.415 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 49.0 m95 -156.82 143.02 18.1 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.752 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.4 OUTLIER -118.79 106.16 12.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 14.2 m-85 -101.91 136.44 41.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.997 0.903 . . . . 0.0 112.179 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.529 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.4 OUTLIER -126.74 136.21 52.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.404 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -133.34 116.53 16.21 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.975 HG21 HD11 ' A' ' 220' ' ' LEU . 18.4 t -62.53 116.15 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.2 tt -96.63 -23.21 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.39 91.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.54 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.685 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.86 -174.75 32.12 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.567 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 60.4 Cg_endo -75.34 27.56 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.371 2.047 . . . . 0.0 111.568 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.898 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -161.4 31.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.94 0.4 . . . . 0.0 110.0 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.685 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.1 mt -47.8 107.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.622 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.93 7.16 2.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.122 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 186' ' ' VAL . 0.6 OUTLIER -101.44 112.18 24.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.802 0.81 . . . . 0.0 109.906 179.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.0 mt-30 -111.03 152.62 26.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.554 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.527 ' O ' HD12 ' A' ' 184' ' ' LEU . 1.1 t-80 -144.04 136.56 26.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.752 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -142.06 165.18 28.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.882 HG13 ' CH2' ' A' ' 234' ' ' TRP . 0.6 OUTLIER -165.04 148.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.528 179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 180' ' ' SER . 18.2 t-20 -88.57 137.18 32.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.474 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.589 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 32.4 t -49.32 -14.36 0.09 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.887 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.44 HG22 ' OD1' ' A' ' 199' ' ' ASN . 2.0 t -102.11 7.32 41.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -103.78 114.07 28.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.885 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 2.7 m -91.26 -67.39 0.86 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.69 -5.49 2.76 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.7 -1.81 11.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.126 -0.359 . . . . 0.0 111.313 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.9 HD21 ' CE3' ' A' ' 234' ' ' TRP . 1.3 tt -71.58 -61.66 2.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.4 Cg_endo -44.01 84.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.45 2.1 . . . . 0.0 113.276 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 206' ' ' LEU . 88.0 t -74.53 92.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.746 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.47 ' N ' ' HB2' ' A' ' 217' ' ' ASP . 0.7 OUTLIER -69.36 98.59 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.054 HD23 HD12 ' A' ' 218' ' ' LEU . 1.4 mp -82.65 128.79 34.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.778 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -179.11 179.37 48.91 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.899 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.909 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -68.06 -76.39 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.815 HG22 ' H ' ' A' ' 214' ' ' SER . 8.0 p -126.57 -141.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.39 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.815 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.1 OUTLIER 64.72 -175.88 0.03 OUTLIER Pre-proline 0 C--O 1.232 0.135 0 CA-C-N 118.314 0.506 . . . . 0.0 110.247 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 21.8 Cg_exo -65.66 10.03 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.745 2.297 . . . . 0.0 113.423 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 39.4 m -48.83 169.03 0.02 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.741 0.305 . . . . 0.0 111.092 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.47 ' HB2' ' N ' ' A' ' 209' ' ' LYS . 1.7 m-20 -95.48 -34.81 11.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.343 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.054 HD12 HD23 ' A' ' 210' ' ' LEU . 5.0 mt -105.81 127.31 53.02 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.62 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -92.57 80.02 4.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.724 0.297 . . . . 0.0 110.711 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.975 HD11 HG21 ' A' ' 186' ' ' VAL . 2.7 mm? -103.7 92.71 4.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.406 ' C ' ' HG2' ' A' ' 190' ' ' PRO . 1.3 mtmt -60.1 58.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.674 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.928 ' HB3' HG12 ' A' ' 225' ' ' VAL . 5.5 t0 -92.72 124.88 37.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.349 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.7 p -69.05 -10.5 57.88 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.108 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.402 ' HG3' ' OD1' ' A' ' 250' ' ' ASN . 0.8 OUTLIER -82.57 -24.76 33.81 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.783 0.325 . . . . 0.0 110.928 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.928 HG12 ' HB3' ' A' ' 222' ' ' ASP . 3.0 p -108.41 79.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.1 m -35.17 -36.16 0.05 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.737 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.23 -58.01 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.976 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.492 ' C ' HG23 ' A' ' 225' ' ' VAL . 2.6 mtpp -143.19 132.48 23.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.135 0.493 . . . . 0.0 110.556 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.541 ' CB ' ' HB2' ' A' ' 283' ' ' LEU . 0.6 OUTLIER -102.16 -57.0 2.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.376 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -141.83 171.21 14.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.192 0.52 . . . . 0.0 112.036 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.783 ' HA ' HD12 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -152.54 159.36 43.29 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.486 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.616 HG12 ' HB3' ' A' ' 243' ' ' LEU . 19.4 mt -123.73 145.73 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.432 0.634 . . . . 0.0 111.87 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.852 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -161.41 150.51 16.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.9 ' CE3' HD21 ' A' ' 206' ' ' LEU . 3.2 p90 -138.76 165.64 26.46 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.12 132.43 56.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.792 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 73.4 m -88.99 2.09 54.5 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.872 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 21.4 m -78.63 -19.48 52.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.643 0.735 . . . . 0.0 110.276 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -150.73 23.63 0.78 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.496 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.2 p90 37.44 59.58 1.18 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.214 0.53 . . . . 0.0 110.446 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.822 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -128.63 143.12 50.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.673 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.694 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -123.42 122.5 38.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.774 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.8 pt-20 -134.18 142.35 47.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.698 0.761 . . . . 0.0 112.354 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.4 pp -107.82 152.76 23.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.784 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.856 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -115.75 162.24 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.663 0.268 . . . . 0.0 110.963 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.519 ' HB3' ' OG ' ' A' ' 260' ' ' SER . 1.2 m-20 -106.22 111.05 23.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.605 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.93 103.42 6.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.203 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.87 70.59 0.92 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.51 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.2 m -62.0 40.96 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.878 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.52 -52.54 64.37 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.793 -0.567 . . . . 0.0 109.881 178.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.878 ' H ' HD13 ' A' ' 249' ' ' LEU . 2.7 m120 -80.32 -39.36 28.83 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.145 0.498 . . . . 0.0 111.681 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 88.89 87.36 1.23 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.804 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.693 ' N ' ' HB3' ' A' ' 260' ' ' SER . 2.9 m -45.44 170.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.279 0.232 . . . . 0.0 110.553 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -149.11 133.66 17.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.205 0.526 . . . . 0.0 111.461 177.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.876 HG23 ' CD1' ' A' ' 259' ' ' ILE . 86.0 t -109.83 133.11 56.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.083 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.464 ' HA ' HG13 ' A' ' 280' ' ' ILE . 3.3 m-20 51.11 44.41 28.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.174 0.512 . . . . 0.0 110.07 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 m 64.18 26.93 13.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.763 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.441 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.1 OUTLIER -129.75 115.67 17.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.208 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 5.8 t -67.46 89.82 0.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.03 0.443 . . . . 0.0 111.548 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.876 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -89.36 0.33 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.431 -178.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.693 ' HB3' ' N ' ' A' ' 252' ' ' THR . 14.0 t . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.452 ' HD2' ' H ' ' A' ' 269' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.856 ' NE1' HG11 ' A' ' 244' ' ' VAL . 1.4 t-105 -77.68 -15.7 58.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.92 0.488 . . . . 0.0 112.232 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 59.94 -174.19 4.53 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.488 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -107.18 134.07 20.06 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.905 0.852 . . . . 0.0 110.494 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 96.4 Cg_exo -45.0 125.08 6.41 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.771 2.314 . . . . 0.0 113.521 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.806 HG21 ' CG1' ' A' ' 259' ' ' ILE . 74.9 t -98.77 129.3 49.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.13 128.65 34.79 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.46 -178.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.986 HD22 HG11 ' A' ' 291' ' ' VAL . 0.6 OUTLIER -87.27 163.5 16.82 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.031 -178.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.408 ' HA ' ' HZ3' ' A' ' 241' ' ' TRP . . . -137.82 145.86 42.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.395 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 2.9 t -56.64 126.0 24.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.017 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.2 m-20 90.27 4.52 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.344 0.657 . . . . 0.0 111.949 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' ' 280' ' ' ILE . 0.6 OUTLIER -79.91 -164.51 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.789 HG22 ' HA ' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -162.3 136.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.406 178.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.935 HG22 HG12 ' A' ' 289' ' ' VAL . 0.1 OUTLIER -108.46 156.64 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.607 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.693 ' OG1' ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -145.81 117.27 8.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.699 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -113.07 44.61 1.49 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.79 -133.26 2.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.433 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 286' ' ' THR . 6.8 t -88.45 -49.44 6.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.643 0.259 . . . . 0.0 110.956 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.6 t -139.68 -7.3 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.728 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 49.0 m -63.97 101.31 0.38 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.693 ' HG3' ' OG1' ' A' ' 282' ' ' THR . 1.7 ttmt -118.8 129.51 55.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.637 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.935 HG12 HG22 ' A' ' 281' ' ' ILE . 0.3 OUTLIER -106.98 128.49 61.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.542 0.21 . . . . 0.0 111.52 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.789 ' HA ' HG22 ' A' ' 280' ' ' ILE . 7.1 t80 -76.79 136.99 39.0 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.986 HG11 HD22 ' A' ' 275' ' ' LEU . 8.0 t -113.89 115.17 48.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.535 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.61 142.32 39.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.773 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.552 HD12 ' CE3' ' A' ' 241' ' ' TRP . 0.5 OUTLIER -129.89 147.24 33.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.501 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.67 129.54 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 0.0 111.482 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 8.7 p -81.42 159.37 24.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.58 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.687 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 295' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.458 -0.059 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.7 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.5 m95 -143.24 131.62 22.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.799 HD11 ' CD1' ' A' ' 184' ' ' LEU . 3.4 tp -114.07 128.41 56.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.943 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.783 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.4 m-85 -130.27 129.94 43.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.747 0.784 . . . . 0.0 111.588 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.983 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -130.84 146.36 52.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.775 176.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.525 ' C ' HG12 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -140.19 127.21 20.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.456 -0.497 . . . . 0.0 112.308 -177.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.879 HG21 HD11 ' A' ' 220' ' ' LEU . 9.7 t -64.5 106.06 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.1 tt -90.6 -19.01 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.819 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.63 95.02 0.62 Allowed 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.268 -0.573 . . . . 0.0 112.466 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.71 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.2 -179.54 37.75 Favored Glycine 0 C--O 1.228 -0.26 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.597 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 58.9 Cg_endo -74.6 30.17 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 CA-C-N 119.433 1.617 . . . . 0.0 111.269 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.791 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -160.2 26.38 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.71 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.0 mt -42.11 108.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.07 7.57 1.75 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.099 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.845 ' O ' HG23 ' A' ' 186' ' ' VAL . 1.1 mp -100.86 119.72 39.08 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.139 0.971 . . . . 0.0 109.818 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 8.1 mt-30 -122.54 153.64 38.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.208 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.983 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -146.67 145.42 30.02 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.059 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -150.22 143.46 24.99 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.892 HG21 ' HA ' ' A' ' 206' ' ' LEU . 12.0 p -149.01 149.94 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.418 0.628 . . . . 0.0 111.309 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.516 ' HB3' HG22 ' A' ' 201' ' ' THR . 71.9 m-80 -87.72 148.14 24.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.356 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.561 ' CB ' ' HZ2' ' A' ' 234' ' ' TRP . 1.0 OUTLIER -65.55 -7.64 15.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.387 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 199' ' ' ASN . 3.1 t -92.35 5.62 49.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.95 0.405 . . . . 0.0 111.209 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.668 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -94.93 113.68 25.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.57 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.8 m -60.1 -108.46 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.2 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.8 m -78.58 25.52 0.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.54 -10.55 10.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.93 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.892 ' HA ' HG21 ' A' ' 198' ' ' VAL . 9.0 tt -77.06 -49.22 2.45 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.557 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 206' ' ' LEU . 52.9 Cg_exo -46.48 100.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.467 1.445 . . . . 0.0 111.653 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.874 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 4.7 t -66.83 163.33 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 216' ' ' SER . 0.0 OUTLIER -138.38 92.55 2.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.851 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.055 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -83.91 127.32 33.76 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.513 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -173.31 178.11 45.41 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.136 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 1.003 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 8.5 ttt180 -63.38 -86.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.605 HG12 ' HD3' ' A' ' 212' ' ' ARG . 14.5 p -133.67 -4.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.631 ' HB2' ' CD ' ' A' ' 215' ' ' PRO . 67.5 p -53.76 -178.85 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.631 ' CD ' ' HB2' ' A' ' 214' ' ' SER . 32.6 Cg_exo -61.08 17.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.307 2.004 . . . . 0.0 112.709 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 214' ' ' SER . 6.4 m -58.39 -178.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.218 0.532 . . . . 0.0 111.619 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.1 -31.92 11.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.506 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.055 HD12 HD23 ' A' ' 210' ' ' LEU . 1.1 mt -103.46 124.89 49.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.62 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.596 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -94.67 86.42 4.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.795 0.331 . . . . 0.0 110.465 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 1.003 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.7 mm? -109.62 96.6 6.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -64.28 51.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.897 ' HB2' HG12 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -84.9 138.14 32.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.2 p -78.95 -11.09 59.99 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.121 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.437 ' CG ' ' HA3' ' A' ' 284' ' ' GLY . 0.0 OUTLIER -84.39 -20.34 32.06 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.769 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.897 HG12 ' HB2' ' A' ' 222' ' ' ASP . 7.5 p -113.91 69.79 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-O 120.872 0.367 . . . . 0.0 110.069 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -35.2 -33.28 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.193 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 225' ' ' VAL . . . -144.1 -67.75 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.361 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -140.38 128.48 22.23 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.32 0.581 . . . . 0.0 111.176 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 248' ' ' SER . 0.3 OUTLIER -95.8 -60.69 1.59 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.508 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.675 ' HB3' ' CD2' ' A' ' 283' ' ' LEU . . . -150.35 163.02 39.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.904 -177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.98 ' O ' HD13 ' A' ' 243' ' ' LEU . 0.0 OUTLIER -138.76 -179.14 5.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.908 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.952 HG12 HD22 ' A' ' 243' ' ' LEU . 14.8 mt -131.1 141.55 45.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.012 0.435 . . . . 0.0 110.81 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.94 133.48 5.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.886 ' CZ2' HD11 ' A' ' 206' ' ' LEU . 1.8 p90 -124.41 165.72 17.23 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.82 133.61 55.85 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.827 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 31.4 p -92.97 3.04 56.44 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.469 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 89.8 m -80.85 -27.99 36.25 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.42 0.629 . . . . 0.0 110.065 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 4.6 tptt -137.09 19.19 2.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.02 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.433 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 27.9 p90 40.43 60.03 1.94 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.5 0.667 . . . . 0.0 109.861 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.77 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -125.12 143.63 50.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.322 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.824 ' CH2' HG23 ' A' ' 293' ' ' ILE . 11.6 m0 -123.79 125.16 44.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.497 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 1.1 pt-20 -129.06 134.87 48.28 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.98 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.1 OUTLIER -107.0 124.74 50.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.048 177.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.761 HG11 ' CZ2' ' A' ' 269' ' ' TRP . 4.8 p -126.39 164.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 O-C-N 122.111 -0.368 . . . . 0.0 111.609 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 260' ' ' SER . 15.9 t0 -88.53 127.8 35.54 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.728 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -84.51 44.44 1.04 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.411 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 269' ' ' TRP . . . 65.46 57.26 11.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.64 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.716 ' HB3' ' HA ' ' A' ' 229' ' ' HIS . 56.1 p -99.87 148.29 24.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.81 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.762 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -79.44 -37.67 36.47 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.961 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.762 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -74.01 -31.25 62.86 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.844 0.354 . . . . 0.0 111.494 -179.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 95.3 163.96 34.68 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.946 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.724 ' C ' HD23 ' A' ' 253' ' ' LEU . 25.0 m -125.22 156.61 38.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.84 0.353 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.724 HD23 ' C ' ' A' ' 252' ' ' THR . 0.1 OUTLIER -148.68 126.41 11.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.987 0.423 . . . . 0.0 111.41 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 1.048 HG23 HD12 ' A' ' 259' ' ' ILE . 36.0 t -102.25 127.64 55.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.735 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 53.14 41.22 32.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 110.34 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 16.6 m 62.99 20.22 12.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.404 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.06 90.97 3.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.92 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 96.1 p -45.79 97.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.596 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 1.048 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -78.63 -52.65 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.248 179.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.568 ' N ' HG12 ' A' ' 259' ' ' ILE . 19.7 p . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 2.5 mttt . . . . . 0 CA--C 1.517 -0.29 0 CA-C-O 121.38 0.61 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.761 ' CZ2' HG11 ' A' ' 244' ' ' VAL . 0.4 OUTLIER -72.86 -24.95 60.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.157 -0.928 . . . . 0.0 108.662 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . 0.596 ' O ' ' HD1' ' A' ' 269' ' ' TRP . . . 79.52 166.17 31.93 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.747 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 273' ' ' VAL . 8.7 m-20 -89.74 138.64 27.93 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.397 0.598 . . . . 0.0 109.929 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.409 ' HB2' ' OE1' ' A' ' 242' ' ' GLU . 9.7 Cg_endo -52.75 108.63 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.504 2.136 . . . . 0.0 112.753 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 40.0 t -102.0 147.24 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.674 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 20.9 mm-40 -85.53 130.21 34.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.51 0.671 . . . . 0.0 112.766 -177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.829 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -95.74 164.51 12.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.934 179.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.15 159.4 42.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 23.9 p -57.92 129.32 41.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.327 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.8 m-20 87.93 7.74 0.18 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.287 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.7 OUTLIER -80.72 -164.28 0.7 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.5 OUTLIER -162.27 135.17 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 177.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.877 ' CG2' HG22 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -123.6 93.76 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 287' ' ' THR . 0.6 OUTLIER -79.0 121.96 25.59 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.685 HD23 HG23 ' A' ' 252' ' ' THR . 0.3 OUTLIER -106.69 50.03 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.459 -0.497 . . . . 0.0 112.254 -178.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 162.54 -115.94 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 119.571 -1.299 . . . . 0.0 113.807 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 286' ' ' THR . 1.2 t -96.1 -57.62 2.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.594 0.235 . . . . 0.0 110.727 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -135.32 0.33 2.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.916 179.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.819 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 45.1 m -75.12 102.94 5.1 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 121.353 -0.139 . . . . 0.0 111.248 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.747 ' O ' HG22 ' A' ' 187' ' ' ILE . 3.4 ptpt -129.08 135.46 48.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.222 0.534 . . . . 0.0 112.091 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.871 HG23 HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -108.49 135.63 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.046 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.2 t80 -77.0 137.93 39.3 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 279' ' ' ASP . 0.1 OUTLIER -106.68 110.79 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.78 -178.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.519 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -119.39 140.6 50.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.775 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.824 HG23 ' CH2' ' A' ' 241' ' ' TRP . 32.3 mt -138.63 134.37 42.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.1 t -152.47 161.76 42.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 111.207 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 36.6 p -104.86 157.97 16.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.819 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.772 -179.929 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.711 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 20.9 m . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.0 m95 -127.59 132.29 49.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.781 HD23 ' HZ3' ' A' ' 234' ' ' TRP . 2.2 tp -117.72 129.88 55.98 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.244 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.734 ' N ' HD12 ' A' ' 182' ' ' LEU . 11.2 m-85 -125.95 133.15 51.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.681 0.753 . . . . 0.0 110.436 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.799 HD11 HD12 ' A' ' 232' ' ' ILE . 3.3 mt -123.84 141.37 52.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.889 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -134.8 111.3 9.8 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 194' ' ' LEU . 8.8 t -58.64 117.98 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.6 tt -101.91 -24.41 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -175.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.758 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -155.86 91.2 1.27 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.994 0.815 . . . . 0.0 112.479 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -162.64 -165.89 20.48 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.43 ' HG3' ' CG ' ' A' ' 222' ' ' ASP . 58.6 Cg_endo -92.43 33.1 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.971 2.447 . . . . 0.0 111.509 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.842 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -162.34 29.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.459 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.689 HD11 ' N ' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -47.87 111.12 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.052 0.453 . . . . 0.0 111.322 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.12 4.52 2.58 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.666 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.883 ' O ' HG23 ' A' ' 186' ' ' VAL . 0.8 OUTLIER -102.33 118.9 37.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.599 0.714 . . . . 0.0 109.578 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.734 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.0 mt-30 -114.68 149.85 36.11 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.785 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.534 ' NE2' ' HB3' ' A' ' 217' ' ' ASP . 1.0 OUTLIER -138.48 133.26 32.47 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.102 178.436 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.59 156.62 43.36 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.399 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 206' ' ' LEU . 4.5 p -162.19 156.37 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.625 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.711 ' HA ' ' O ' ' A' ' 180' ' ' SER . 46.2 m-20 -94.78 145.73 24.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.619 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.659 ' HG ' ' N ' ' A' ' 180' ' ' SER . 28.3 p -58.34 -0.31 0.09 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.081 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 199' ' ' ASN . 1.4 t -106.72 14.4 26.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.857 0.36 . . . . 0.0 111.301 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.453 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -106.33 124.53 49.73 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.179 179.362 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 m -87.48 -83.03 0.21 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 26.2 m -84.09 13.27 5.25 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.453 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.03 -14.31 9.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.015 0.436 . . . . 0.0 110.624 178.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.775 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.6 tt -65.69 -55.32 24.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.827 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.8 Cg_endo -42.84 92.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.653 2.235 . . . . 0.0 113.453 -178.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 231' ' ' GLN . 41.6 t -71.46 90.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.708 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.561 ' N ' ' HB2' ' A' ' 217' ' ' ASP . 0.7 OUTLIER -68.16 78.81 0.24 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 231' ' ' GLN . 3.1 mp -65.35 129.55 40.13 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.975 -0.453 . . . . 0.0 110.043 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . -173.59 171.62 44.62 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.46 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.66 ' HB2' ' HB ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -70.56 -74.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.893 0.477 . . . . 0.0 112.074 -179.155 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.647 HG22 ' H ' ' A' ' 214' ' ' SER . 9.9 p -124.28 -142.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.363 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.647 ' H ' HG22 ' A' ' 213' ' ' VAL . 1.9 m 60.5 173.25 0.06 OUTLIER Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 118.972 0.805 . . . . 0.0 109.616 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 37.5 Cg_endo -65.71 28.58 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.076 1.851 . . . . 0.0 113.064 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 214' ' ' SER . 8.1 m -57.47 167.01 1.09 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.749 0.309 . . . . 0.0 110.756 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.561 ' HB2' ' N ' ' A' ' 209' ' ' LYS . 9.7 m-20 -89.0 -43.01 11.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.874 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.814 HD23 HD21 ' A' ' 220' ' ' LEU . 3.4 tp -99.07 131.63 44.97 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.74 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -95.68 75.75 3.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.954 0.407 . . . . 0.0 110.785 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.817 HD11 HG21 ' A' ' 186' ' ' VAL . 2.6 mm? -103.96 62.87 0.76 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.645 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 2.2 pttt -54.57 57.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 220' ' ' LEU . 10.0 t0 -88.75 153.81 20.78 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.2 p -73.18 -4.72 34.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.505 ' HG3' ' HA3' ' A' ' 284' ' ' GLY . 1.4 pt-20 -91.74 -21.79 20.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.977 0.418 . . . . 0.0 110.26 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.784 HG13 ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -96.94 102.88 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.083 179.089 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 73.0 m -53.18 -49.26 67.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.468 0.651 . . . . 0.0 109.885 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 228' ' ' LYS . . . -148.34 -50.62 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.552 ' HD2' ' HD2' ' A' ' 209' ' ' LYS . 8.1 mttm -145.87 134.74 22.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.082 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.784 ' CG ' HG13 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -101.18 -53.84 2.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.181 179.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.652 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -148.97 170.32 18.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.865 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -152.68 170.24 20.75 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.764 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.827 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.7 mt -121.06 143.62 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.483 0.659 . . . . 0.0 111.814 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.591 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.14 126.3 4.2 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.799 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 10.5 p90 -120.32 166.85 12.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.546 HD21 ' HB2' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -115.58 133.58 55.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.02 -179.042 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.27 -0.88 52.49 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.71 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 18.6 m -78.97 -39.33 34.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.904 0.859 . . . . 0.0 109.382 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.608 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 10.0 tptm -117.8 10.08 13.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.21 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 10.6 p90 44.92 63.83 1.58 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.42 0.629 . . . . 0.0 109.772 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.799 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 2.1 mptp? -130.69 140.56 50.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.092 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.691 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 1.8 m95 -121.41 124.01 43.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.942 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 6.7 pt-20 -138.29 147.17 43.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.782 ' HG ' HG13 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -95.25 151.34 19.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 112.859 -1.973 . . . . 0.0 108.474 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.486 HG21 ' HE1' ' A' ' 269' ' ' TRP . 2.2 p -145.57 161.79 12.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.867 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 17.4 t0 -84.25 139.44 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.561 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.417 ' HE2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -85.02 30.56 0.58 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.0 41.02 97.51 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.646 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.459 ' HB2' ' HA ' ' A' ' 229' ' ' HIS . 9.5 t -86.54 172.28 10.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 111.264 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.69 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -96.95 -30.95 12.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.809 179.283 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.69 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.8 OUTLIER -75.53 -29.65 59.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.805 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 85.62 152.55 19.14 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.742 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.652 HG21 ' HB2' ' A' ' 230' ' ' ALA . 87.6 m -108.94 154.73 21.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.463 -0.368 . . . . 0.0 110.772 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.759 ' O ' HD13 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -138.06 136.43 36.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.159 178.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.974 HG22 HD11 ' A' ' 281' ' ' ILE . 89.6 t -107.6 127.45 63.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.971 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 1.01 ' HA ' HD12 ' A' ' 280' ' ' ILE . 27.2 t-20 56.56 50.54 12.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.376 0.608 . . . . 0.0 109.985 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.56 32.51 17.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.927 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.415 ' O ' ' N ' ' A' ' 259' ' ' ILE . 0.1 OUTLIER -137.95 111.54 8.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.823 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.464 ' HA ' ' HB3' ' A' ' 253' ' ' LEU . 78.3 p -60.41 83.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.306 0.574 . . . . 0.0 110.34 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.979 ' HB ' HG21 ' A' ' 273' ' ' VAL . 2.6 pp -87.85 -9.49 10.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.815 -178.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.562 ' HB2' HD12 ' A' ' 259' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp . . . . . 0 C--O 1.232 0.176 0 CA-C-O 121.263 0.554 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.521 ' CZ2' ' OE1' ' A' ' 231' ' ' GLN . 7.7 t-105 -81.02 -16.93 51.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.541 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 72.22 174.22 22.85 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.462 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -105.59 137.15 19.22 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.153 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.24 115.75 2.08 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.654 2.236 . . . . 0.0 113.789 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.979 HG21 ' HB ' ' A' ' 259' ' ' ILE . 80.9 t -103.96 135.18 42.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -75.56 127.8 33.88 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -176.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.847 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.29 164.65 13.45 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.517 178.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.82 159.3 42.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 28.3 t -61.38 129.28 40.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.367 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 277' ' ' SER . 0.4 OUTLIER 83.74 6.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.387 -178.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 16.0 t0 -81.1 -165.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 1.01 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.8 OUTLIER -160.4 126.39 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.368 178.129 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.974 HD11 HG22 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -100.58 148.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.774 ' C ' HD13 ' A' ' 283' ' ' LEU . 13.9 m -140.53 136.81 33.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.612 0.72 . . . . 0.0 111.56 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.774 HD13 ' C ' ' A' ' 282' ' ' THR . 0.0 OUTLIER -136.95 134.78 37.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.359 178.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 224' ' ' GLU . . . 95.64 -137.91 13.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.346 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.459 HG22 ' OE1' ' A' ' 224' ' ' GLU . 11.6 t -99.33 -30.16 12.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.898 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -156.53 5.14 0.16 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.758 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 7.4 m -73.47 107.14 5.58 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.881 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.718 ' O ' HG22 ' A' ' 187' ' ' ILE . 11.6 ttmm -127.81 134.83 49.47 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.17 0.509 . . . . 0.0 111.807 -178.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 16.7 t -115.44 135.38 55.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.809 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.596 ' CD1' HG23 ' A' ' 280' ' ' ILE . 2.5 t80 -76.9 137.98 39.45 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.122 0.487 . . . . 0.0 110.666 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.847 HG11 ' HB2' ' A' ' 275' ' ' LEU . 3.7 t -105.11 112.23 37.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.718 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.464 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -129.26 138.45 51.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.872 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.672 HD11 HD23 ' A' ' 275' ' ' LEU . 4.1 mt -138.78 122.36 19.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.23 162.34 32.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 110.835 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.6 -165.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.988 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.767 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.17 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.0 m95 -145.56 130.34 18.11 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.914 HD11 ' CD2' ' A' ' 184' ' ' LEU . 4.0 tp -119.82 136.56 54.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.059 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.763 ' N ' HD12 ' A' ' 182' ' ' LEU . 3.5 m-85 -134.16 130.23 37.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.762 0.792 . . . . 0.0 109.809 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.914 ' CD2' HD11 ' A' ' 182' ' ' LEU . 3.7 mm? -116.98 139.43 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.276 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.529 ' C ' HG13 ' A' ' 289' ' ' VAL . 3.5 tt0 -135.49 111.96 9.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.871 HG21 HD12 ' A' ' 194' ' ' LEU . 14.3 t -60.58 110.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.0 tt -92.64 -19.28 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.767 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.9 95.21 0.34 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.88 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.673 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.63 -173.25 30.06 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.553 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 94.6 Cg_endo -81.43 31.8 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 121.926 1.751 . . . . 0.0 110.91 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.879 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -160.83 24.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.077 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.673 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.3 mt -40.84 108.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.863 0.364 . . . . 0.0 111.979 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.62 6.03 2.13 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.375 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.879 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -95.94 143.86 26.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 16.6 mt-30 -139.88 147.12 40.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.421 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.936 ' ND1' HG21 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -136.82 131.05 32.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.392 0.615 . . . . 0.0 110.421 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.643 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.93 152.76 43.83 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.019 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.815 HG13 ' CH2' ' A' ' 234' ' ' TRP . 5.3 p -166.38 156.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.196 0.522 . . . . 0.0 110.937 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 180' ' ' SER . 1.2 m120 -93.38 147.31 23.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.405 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.53 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 1.4 t -64.58 -3.22 2.92 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.978 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 199' ' ' ASN . 3.5 t -89.15 12.15 16.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.775 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.469 ' HG ' ' HB3' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -95.2 144.32 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.946 0.403 . . . . 0.0 111.238 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.53 -60.89 1.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.082 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.57 25.39 4.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.331 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.409 ' HG2' ' OG ' ' A' ' 202' ' ' SER . 0.2 OUTLIER -115.42 -1.05 12.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.764 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.96 ' O ' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -94.57 -22.96 0.24 Allowed Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 206' ' ' LEU . 22.2 Cg_exo -61.57 94.29 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.113 1.209 . . . . 0.0 111.384 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.936 HG21 ' ND1' ' A' ' 196' ' ' HIS . 45.5 t -80.61 102.06 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.34 0.591 . . . . 0.0 111.254 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 216' ' ' SER . 0.0 OUTLIER -69.46 97.22 0.97 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.624 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.077 HD23 HD12 ' A' ' 218' ' ' LEU . 1.5 mp -75.85 125.3 28.82 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.446 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -169.2 171.97 43.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.385 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.892 ' HB2' HG13 ' A' ' 225' ' ' VAL . 4.8 ttt180 -58.53 -90.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.478 ' O ' HG22 ' A' ' 213' ' ' VAL . 10.6 p -127.5 -9.57 4.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.622 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.1 OUTLIER -53.82 -173.86 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.713 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 27.0 Cg_exo -62.42 3.89 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.438 2.092 . . . . 0.0 112.877 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.543 ' HA ' ' HB3' ' A' ' 209' ' ' LYS . 0.9 OUTLIER -49.76 165.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.895 0.378 . . . . 0.0 111.577 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.539 ' HB3' HG13 ' A' ' 208' ' ' VAL . 3.4 m-20 -86.01 -31.36 22.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.679 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.077 HD12 HD23 ' A' ' 210' ' ' LEU . 2.9 mt -107.93 130.8 55.01 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -92.26 79.83 5.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.816 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.796 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.1 mm? -103.81 86.24 2.57 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.739 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 7.4 ptpt -59.51 20.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.607 ' HB3' HG12 ' A' ' 225' ' ' VAL . 6.3 t0 -48.99 125.73 11.03 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.2 t -63.41 -12.23 29.17 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.436 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 285' ' ' THR . 0.1 OUTLIER -82.49 -17.24 45.84 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.779 0.323 . . . . 0.0 110.544 179.159 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.892 HG13 ' HB2' ' A' ' 212' ' ' ARG . 7.4 p -108.83 94.5 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.065 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.14 -45.22 16.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.036 0.446 . . . . 0.0 110.836 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.43 -50.38 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.476 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.622 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 7.0 mttt -139.41 126.55 21.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.111 0.482 . . . . 0.0 110.466 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.704 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.5 t60 -100.54 -58.07 1.98 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.752 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -141.1 173.15 11.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.812 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.808 ' HA ' HD12 ' A' ' 210' ' ' LEU . 61.2 tt0 -151.98 154.3 35.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.302 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.0 mt -111.96 140.6 30.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-O 121.197 0.522 . . . . 0.0 111.276 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.415 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.35 149.87 17.61 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.815 ' CH2' HG13 ' A' ' 198' ' ' VAL . 4.0 p90 -139.47 166.34 24.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -115.42 132.77 56.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.138 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.7 m -92.81 -1.07 57.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.949 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.3 m -77.58 -28.19 51.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.674 0.749 . . . . 0.0 109.876 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.408 ' HB3' ' HD3' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -139.32 19.18 2.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.804 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.7 p90 39.84 62.09 1.31 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.578 0.704 . . . . 0.0 109.56 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.742 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 1.4 mptm? -122.91 138.95 54.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.902 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.657 ' CE3' HD13 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -123.43 122.35 38.05 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.492 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 7.8 pt-20 -130.68 145.53 51.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 122.388 1.09 . . . . 0.0 113.872 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -102.24 138.44 39.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.988 178.103 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.728 HG21 ' NE1' ' A' ' 269' ' ' TRP . 3.7 p -133.47 162.42 39.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.78 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.479 ' HB2' ' CB ' ' A' ' 260' ' ' SER . 25.1 t0 -88.16 139.66 30.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.311 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.532 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -86.98 32.54 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.102 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.86 47.92 77.51 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.916 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.45 -178.55 5.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.738 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -106.0 -28.32 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.139 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.738 ' H ' HD13 ' A' ' 249' ' ' LEU . 8.1 t-20 -75.37 -36.07 61.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.127 0.489 . . . . 0.0 111.622 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.12 116.24 1.71 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.825 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.645 ' C ' HD23 ' A' ' 253' ' ' LEU . 16.7 m -70.98 165.29 23.75 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.708 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -149.28 128.85 13.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.314 0.578 . . . . 0.0 111.394 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 1.046 HG23 HD12 ' A' ' 259' ' ' ILE . 86.1 t -105.57 132.81 51.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.453 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.618 HD22 HG12 ' A' ' 254' ' ' VAL . 12.2 p30 50.08 39.31 18.92 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.094 0.473 . . . . 0.0 110.084 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.95 27.68 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.534 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 0.4 OUTLIER -129.74 103.18 6.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.243 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 7.6 t -51.46 95.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.61 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 1.046 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -77.72 -23.01 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.416 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.479 ' CB ' ' HB2' ' A' ' 245' ' ' ASP . 24.7 p . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 19.0 mttt . . . . . 0 CA--C 1.521 -0.165 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.728 ' NE1' HG21 ' A' ' 244' ' ' VAL . 13.0 t-105 -72.96 -18.92 61.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.98 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 75.9 168.91 26.54 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.403 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -99.66 134.64 20.94 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.116 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.17 108.76 0.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.608 2.206 . . . . 0.0 113.687 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 259' ' ' ILE . 81.3 t -100.38 141.65 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 0.0 OUTLIER -83.03 129.3 35.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.07 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.772 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.91 165.72 12.52 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.022 178.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.49 161.99 36.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.3 OUTLIER -60.24 130.33 46.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.126 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 277' ' ' SER . 18.0 m-20 82.86 3.08 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.952 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.637 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 2.6 t0 -75.1 -162.56 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.547 HG23 ' CD1' ' A' ' 290' ' ' TYR . 0.5 OUTLIER -161.73 127.96 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.994 178.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.651 HG13 ' HG ' ' A' ' 243' ' ' LEU . 0.2 OUTLIER -107.78 157.29 8.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.302 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.708 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 5.6 m -150.64 134.94 17.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -129.27 47.56 2.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.337 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.12 -125.69 1.04 Allowed Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 119.493 -1.337 . . . . 0.0 113.638 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.47 ' N ' ' HG3' ' A' ' 224' ' ' GLU . 3.8 t -99.98 -37.23 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 0.0 110.823 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -149.74 -10.12 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.767 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 87.2 m -66.34 106.06 1.61 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 117.77 0.259 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.636 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -131.55 139.04 49.14 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.39 0.614 . . . . 0.0 111.619 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.63 HG13 ' N ' ' A' ' 186' ' ' VAL . 4.5 t -116.77 136.54 53.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.329 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.621 ' O ' HD13 ' A' ' 184' ' ' LEU . 1.8 t80 -76.75 136.09 39.02 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 109.917 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 275' ' ' LEU . 1.8 t -102.52 110.96 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.659 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.632 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -123.35 137.93 54.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.657 HD13 ' CE3' ' A' ' 241' ' ' TRP . 2.5 mt -137.62 117.93 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.42 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.5 146.63 47.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.897 0.38 . . . . 0.0 111.226 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.75 167.7 14.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.873 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.957 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 25.1 m . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 121.235 0.54 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.733 ' HB3' ' CE1' ' A' ' 183' ' ' PHE . 3.7 m95 -142.77 133.48 25.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.448 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.918 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.5 OUTLIER -121.82 130.31 53.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.918 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.7 OUTLIER -132.28 143.14 49.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.712 0.768 . . . . 0.0 111.308 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.803 ' CD1' HD11 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -137.9 148.69 45.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.402 177.522 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.478 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 9.0 tt0 -137.77 125.11 21.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.968 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.726 HG21 HD12 ' A' ' 194' ' ' LEU . 18.9 t -64.69 119.6 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.803 HG22 ' O ' ' A' ' 288' ' ' LYS . 3.8 tp -104.15 -23.41 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.817 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -159.2 91.8 1.04 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.47 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.631 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.71 -171.66 28.07 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.496 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 73.2 Cg_endo -81.43 31.26 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.878 1.719 . . . . 0.0 111.664 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.789 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.4 25.32 0.11 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.582 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.631 HG12 ' H ' ' A' ' 189' ' ' GLY . 7.5 mt -43.13 114.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.77 7.23 3.43 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.277 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.789 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -98.69 132.57 43.97 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.478 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 20.3 mt-30 -130.58 151.9 50.54 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.665 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.709 ' O ' HD22 ' A' ' 184' ' ' LEU . 1.4 t60 -143.23 139.79 30.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.255 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -131.84 148.08 52.53 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.05 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.848 HG21 ' HA ' ' A' ' 206' ' ' LEU . 11.8 p -159.16 141.77 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.513 ' OD1' ' CH2' ' A' ' 181' ' ' TRP . 3.1 m120 -88.03 161.55 17.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.013 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.517 ' HB2' ' NE1' ' A' ' 234' ' ' TRP . 60.0 p -68.78 -48.64 63.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.342 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.23 1.84 0.29 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.63 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -83.04 129.7 35.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -89.72 -95.88 0.11 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.12 11.19 2.42 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -116.49 -17.79 10.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.684 0.278 . . . . 0.0 110.765 179.352 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.862 ' O ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -76.93 -42.93 2.81 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.801 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 6.2 Cg_endo -51.89 96.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.209 1.11 . . . . 0.0 112.118 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.67 ' O ' ' HG3' ' A' ' 231' ' ' GLN . 78.5 t -67.36 151.19 10.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -128.29 93.61 3.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.04 HD23 HD12 ' A' ' 218' ' ' LEU . 0.7 OUTLIER -84.76 127.88 34.33 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.306 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.514 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -173.39 174.21 45.97 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.02 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.906 ' HB2' HG13 ' A' ' 225' ' ' VAL . 2.0 ttm180 -69.98 -75.03 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.812 0.445 . . . . 0.0 111.834 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.668 HG22 ' H ' ' A' ' 214' ' ' SER . 9.2 p -121.82 -145.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.668 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.3 OUTLIER 65.91 179.03 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 118.731 0.696 . . . . 0.0 109.85 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 49.7 Cg_endo -69.58 28.7 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.089 1.859 . . . . 0.0 113.435 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 214' ' ' SER . 6.3 m -61.96 160.57 12.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.699 0.285 . . . . 0.0 110.679 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.77 -31.27 21.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.04 HD12 HD23 ' A' ' 210' ' ' LEU . 4.8 mt -111.49 133.13 53.99 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -92.52 76.46 5.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.415 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.783 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.1 mm? -97.99 62.52 1.58 Allowed 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.598 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 8.2 pttt -59.56 50.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 220' ' ' LEU . 22.6 t0 -97.32 124.4 41.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 t -39.82 -27.88 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.642 ' HG2' ' HA2' ' A' ' 284' ' ' GLY . 0.4 OUTLIER -60.8 -39.9 90.62 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.097 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.906 HG13 ' HB2' ' A' ' 212' ' ' ARG . 1.7 p -97.75 93.93 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.0 m -35.29 -62.05 0.41 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.105 0.479 . . . . 0.0 111.445 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 228' ' ' LYS . . . -133.33 -47.76 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 227' ' ' GLY . 3.6 mttt -144.19 127.3 16.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.493 -0.354 . . . . 0.0 110.172 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.478 ' O ' ' N ' ' A' ' 246' ' ' MET . 4.4 t60 -96.09 -55.67 2.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.637 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 210' ' ' LEU . . . -140.12 159.65 41.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.411 0.624 . . . . 0.0 112.614 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.67 ' HG3' ' O ' ' A' ' 208' ' ' VAL . 0.1 OUTLIER -145.72 161.96 38.7 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.704 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.801 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.6 mt -124.13 149.4 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.8 162.03 41.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.661 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.675 ' CE3' HD21 ' A' ' 206' ' ' LEU . 0.6 OUTLIER -98.39 157.39 16.23 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -176.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 240' ' ' LYS . 2.0 t-20 -121.55 71.46 0.97 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.156 -1.384 . . . . 0.0 107.478 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 p -56.48 -19.44 15.38 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.9 m -75.54 -21.39 57.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.463 0.649 . . . . 0.0 110.567 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.53 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 0.3 OUTLIER -137.19 17.84 2.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.374 -179.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.407 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 19.7 p90 42.67 68.0 0.54 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 235' ' ' ASN . 0.2 OUTLIER -130.19 144.48 51.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.295 -179.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.56 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -119.29 102.96 9.07 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.5 pt-20 -125.96 144.71 50.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.107 0.956 . . . . 0.0 113.002 -177.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 1.005 HD11 HD11 ' A' ' 259' ' ' ILE . 2.6 pp -115.94 149.96 37.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.681 -1.599 . . . . 0.0 111.208 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.754 HG21 ' CD1' ' A' ' 269' ' ' TRP . 2.0 p -113.99 163.06 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.657 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.494 ' OD2' ' HA ' ' A' ' 260' ' ' SER . 6.1 m-20 -112.25 101.84 10.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.521 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -65.56 96.46 0.26 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.417 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.59 69.88 1.13 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.356 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 260' ' ' SER . 0.4 OUTLIER -65.4 57.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 250' ' ' ASN . 0.8 OUTLIER -53.38 -57.72 9.62 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.31 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.593 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.7 OUTLIER -78.77 -30.1 45.42 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.264 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.429 ' O ' HD23 ' A' ' 253' ' ' LEU . . . 92.07 125.82 3.67 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.513 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.465 ' O ' HG12 ' A' ' 259' ' ' ILE . 25.7 m -88.67 114.96 25.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.155 0.182 . . . . 0.0 110.601 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -103.98 130.51 51.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.278 0.561 . . . . 0.0 112.512 -178.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.88 ' CG2' HD13 ' A' ' 259' ' ' ILE . 33.1 t -108.55 131.95 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.63 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 280' ' ' ILE . 3.3 t-20 52.15 32.01 9.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.125 0.488 . . . . 0.0 109.877 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.8 m 68.82 21.04 7.84 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.686 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -120.49 93.35 4.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.802 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 21.7 p -43.79 97.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.356 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 1.005 HD11 HD11 ' A' ' 243' ' ' LEU . 14.4 pt -77.29 -53.88 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' HG13 ' A' ' 259' ' ' ILE . 36.9 p . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt . . . . . 0 CA--C 1.518 -0.277 0 CA-C-O 120.896 0.379 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.754 ' CD1' HG21 ' A' ' 244' ' ' VAL . 28.2 t-105 -67.17 -24.87 65.92 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 79.97 157.81 14.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.099 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -96.6 140.94 22.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 85.8 Cg_exo -46.39 119.0 2.8 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.575 2.184 . . . . 0.0 112.788 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.854 ' HB ' HD12 ' A' ' 259' ' ' ILE . 84.9 t -100.91 136.22 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -85.0 128.6 34.7 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.97 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.926 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.48 165.58 12.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.08 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -137.43 155.61 49.13 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.582 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 89.0 p -63.78 133.21 53.06 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.258 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.582 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.0 OUTLIER 79.27 -4.99 2.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.254 -178.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.654 ' O ' HG23 ' A' ' 280' ' ' ILE . 3.5 t70 -67.61 -167.24 0.06 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.654 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.7 OUTLIER -162.09 131.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.645 178.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.943 HG22 HG12 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -104.02 148.13 9.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.667 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 1.6 m -138.89 116.95 11.71 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.482 ' O ' ' HB ' ' A' ' 287' ' ' THR . 0.1 OUTLIER -113.44 136.54 52.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.444 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.642 ' HA2' ' HG2' ' A' ' 224' ' ' GLU . . . 82.91 -129.14 8.88 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.666 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 t -95.11 -31.65 13.46 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -159.67 8.15 0.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.577 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 14.9 m -69.51 99.26 1.23 Allowed 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.542 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.803 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -111.86 115.26 28.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.456 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.943 HG12 HG22 ' A' ' 281' ' ' ILE . 4.4 p -103.17 131.03 52.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 122.205 -0.31 . . . . 0.0 110.827 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.2 t80 -76.22 132.49 39.94 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.926 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.6 t -103.56 114.62 43.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.652 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.52 ' HD2' ' H ' ' A' ' 293' ' ' ILE . 5.6 tpt180 -132.0 143.85 50.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.235 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.753 HD11 HD23 ' A' ' 275' ' ' LEU . 8.8 mt -143.13 122.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.697 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.79 159.1 38.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.941 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 9.7 m -89.29 -179.12 5.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.484 -179.749 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.458 ' HB3' ' OG ' ' A' ' 200' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 10.9 m95 -147.09 142.06 26.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.849 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.789 HD11 ' CD1' ' A' ' 184' ' ' LEU . 1.5 tp -125.96 122.72 36.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.701 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.4 m-85 -121.31 141.23 51.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.795 0.807 . . . . 0.0 111.313 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.971 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -139.65 149.01 43.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.526 178.668 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.523 ' C ' HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -139.52 125.98 20.36 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.789 HG21 HD12 ' A' ' 194' ' ' LEU . 21.7 t -62.06 116.48 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.909 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.5 tt -100.03 -19.34 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.851 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.54 91.9 0.6 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.719 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -160.9 -171.12 26.43 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.68 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 64.0 Cg_endo -81.59 32.54 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.006 1.804 . . . . 0.0 111.311 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.845 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.49 22.12 0.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.574 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.719 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.4 mt -39.81 111.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.08 7.65 3.19 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.109 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.845 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.2 OUTLIER -96.24 131.9 42.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.441 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 14.1 mt-30 -129.07 151.11 50.11 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.465 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.971 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -146.87 148.14 31.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.771 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.23 144.73 34.88 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.778 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.931 HG21 ' HA ' ' A' ' 206' ' ' LEU . 2.1 p -147.66 139.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.393 0.616 . . . . 0.0 111.437 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.54 HD22 HG23 ' A' ' 201' ' ' THR . 2.6 p-10 -92.65 148.36 22.13 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.768 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.568 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 61.5 m -66.19 -1.12 2.95 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.54 HG23 HD22 ' A' ' 199' ' ' ASN . 0.1 OUTLIER -111.38 11.66 21.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.054 0.454 . . . . 0.0 111.0 178.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.705 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -106.74 120.04 40.94 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.746 178.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -76.41 0.45 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.5 t -62.93 1.51 0.41 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -122.15 -10.19 8.58 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.083 -0.385 . . . . 0.0 110.814 178.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.931 ' HA ' HG21 ' A' ' 198' ' ' VAL . 5.1 tt -62.09 -63.38 4.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.618 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.7 Cg_endo -43.03 88.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.412 2.075 . . . . 0.0 113.174 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 208' ' ' VAL . 1.7 t -69.51 85.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.461 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 216' ' ' SER . 1.3 mtpt -69.82 97.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.134 HD23 HD12 ' A' ' 218' ' ' LEU . 1.5 mp -82.93 127.94 33.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.424 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -167.35 167.61 40.0 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.571 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.924 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 4.7 ttt180 -56.54 -90.75 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.696 HG12 ' HD3' ' A' ' 212' ' ' ARG . 14.0 p -124.01 -9.89 6.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.69 0.281 . . . . 0.0 111.477 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.545 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 0.6 OUTLIER -50.88 178.94 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.217 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 21.0 Cg_endo -63.51 13.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.661 1.574 . . . . 0.0 112.493 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.532 ' H ' ' C ' ' A' ' 214' ' ' SER . 16.3 m -52.82 166.96 0.17 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 111.193 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -84.75 -26.09 27.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.761 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.134 HD12 HD23 ' A' ' 210' ' ' LEU . 1.2 mt -111.53 130.99 55.55 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -94.96 82.09 3.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.726 0.298 . . . . 0.0 111.355 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.77 HD21 HD13 ' A' ' 218' ' ' LEU . 3.2 mm? -102.14 63.85 0.92 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.924 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -51.9 72.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.445 -178.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.68 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 3.4 t0 -127.49 137.18 52.59 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-O 120.992 0.425 . . . . 0.0 110.774 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 43.9 t -51.31 -36.84 44.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.477 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.628 ' CD ' ' HA3' ' A' ' 284' ' ' GLY . 2.4 pt-20 -44.71 -45.71 9.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.015 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.879 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.2 p -102.29 107.68 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.655 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.63 -51.7 20.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.224 0.535 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.94 -46.67 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.41 ' NZ ' ' HG2' ' A' ' 215' ' ' PRO . 0.1 OUTLIER -136.64 120.63 17.62 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.733 ' CD2' ' HB3' ' A' ' 283' ' ' LEU . 5.4 t60 -92.2 -61.1 1.68 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.702 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -140.08 176.84 8.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.526 0.679 . . . . 0.0 112.315 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.738 ' HA ' HD12 ' A' ' 210' ' ' LEU . 10.6 tt0 -159.19 162.69 36.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.909 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.593 HG12 ' HB3' ' A' ' 243' ' ' LEU . 54.4 mt -124.72 144.31 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.563 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.716 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.87 163.41 32.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.12 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.886 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 12.1 p90 -154.91 166.59 33.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -115.47 133.14 56.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.304 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.48 -2.87 57.94 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.295 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.5 m -76.43 -26.03 55.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.768 0.794 . . . . 0.0 110.231 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 239' ' ' PHE . 10.9 tptt -138.8 21.91 2.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.648 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.445 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 7.7 p90 35.48 60.09 0.76 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.638 0.732 . . . . 0.0 109.722 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.886 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.1 OUTLIER -125.09 141.0 52.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.126 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.792 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 1.3 m95 -122.25 126.51 48.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.395 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.4 pt-20 -143.2 144.52 32.21 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.808 0.813 . . . . 0.0 113.142 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.659 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.5 pp -111.09 152.08 27.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.776 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.692 HG21 ' CD1' ' A' ' 269' ' ' TRP . 2.8 p -121.32 163.18 19.48 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.617 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 248' ' ' SER . 2.6 m-20 -105.27 104.41 14.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.512 ' HG2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -71.4 97.26 1.59 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.428 177.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.09 65.67 3.23 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.312 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 0.2 OUTLIER -70.32 59.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 1.016 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -54.35 -52.69 60.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.338 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 1.016 ' N ' HD22 ' A' ' 249' ' ' LEU . 25.5 m-20 -74.37 -30.98 62.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.933 0.397 . . . . 0.0 111.304 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 95.55 99.56 1.79 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.19 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.808 HG23 HD12 ' A' ' 283' ' ' LEU . 1.6 m -64.97 114.85 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.021 -0.105 . . . . 0.0 110.993 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 258' ' ' SER . 2.4 mt -101.57 130.02 47.78 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.489 -0.484 . . . . 0.0 112.009 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.913 HG23 HD12 ' A' ' 259' ' ' ILE . 99.0 t -105.48 127.66 60.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.859 ' HA ' HD12 ' A' ' 280' ' ' ILE . 1.8 t30 55.14 40.75 31.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 110.215 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.12 32.1 21.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.532 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.6 OUTLIER -138.83 107.93 6.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.795 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.469 ' HB3' HD22 ' A' ' 253' ' ' LEU . 25.0 p -55.15 91.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.541 0.686 . . . . 0.0 111.45 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.965 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -78.56 -23.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.788 -178.413 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.471 ' HB2' ' CG ' ' A' ' 245' ' ' ASP . 13.9 t . . . . . 0 C--N 1.321 -0.665 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.436 0.636 . . . . 0.0 112.076 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.692 ' CD1' HG21 ' A' ' 244' ' ' VAL . 20.5 t-105 -72.82 -22.58 60.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.598 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 74.44 163.63 10.21 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.574 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -99.99 150.63 37.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.3 . . . . 0.0 110.397 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.61 145.4 17.2 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.411 2.074 . . . . 0.0 112.514 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.965 HG21 ' CG1' ' A' ' 259' ' ' ILE . 93.6 t -130.87 130.22 64.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.771 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 3.2 mp0 -80.83 129.02 34.31 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.877 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.869 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -94.02 166.7 12.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.935 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.629 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.62 159.62 41.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.151 0.5 . . . . 0.0 112.014 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 0.1 OUTLIER -62.0 129.4 40.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.143 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 277' ' ' SER . 0.3 OUTLIER 86.73 1.52 0.52 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.309 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.629 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -72.72 -170.98 0.76 Allowed 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.859 HD12 ' HA ' ' A' ' 255' ' ' ASN . 1.0 OUTLIER -163.22 122.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 176.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.825 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -97.12 156.12 3.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.156 177.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 288' ' ' LYS . 21.3 m -141.51 114.68 8.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.912 HD22 ' O ' ' A' ' 287' ' ' THR . 0.0 OUTLIER -113.8 141.48 47.25 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.335 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.628 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 84.52 -133.32 11.73 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.126 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 t -97.93 -36.03 10.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.658 0.266 . . . . 0.0 111.516 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -152.37 7.49 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.912 ' O ' HD22 ' A' ' 283' ' ' LEU . 25.8 m -76.78 101.16 5.73 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.838 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.909 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -124.54 134.39 53.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.072 -179.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.523 HG23 ' C ' ' A' ' 185' ' ' GLU . 9.1 p -113.53 139.61 38.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.876 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.8 t80 -76.55 132.17 39.36 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.765 0.317 . . . . 0.0 110.232 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 275' ' ' LEU . 6.1 t -103.01 112.01 34.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.479 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.52 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.4 OUTLIER -129.47 138.11 51.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 111.338 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.869 HD11 HD23 ' A' ' 275' ' ' LEU . 13.3 mt -132.89 139.79 48.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.431 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 40.7 m -155.49 164.21 38.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.913 0.387 . . . . 0.0 111.423 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.26 -173.22 2.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.683 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 11.8 tp60 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.727 -179.858 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.514 ' OG ' ' HB3' ' A' ' 200' ' ' SER . 0.1 OUTLIER . . . . . 0 CA--C 1.523 -0.075 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 3.2 m95 -148.57 138.97 22.58 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.545 -0.462 . . . . 0.0 112.203 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.972 HD11 ' CD2' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -123.77 140.71 52.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.96 178.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.845 ' N ' HD12 ' A' ' 182' ' ' LEU . 6.2 m-85 -137.7 140.54 40.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.535 0.684 . . . . 0.0 110.442 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.972 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.0 mm? -123.96 140.95 52.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.889 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.519 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -135.35 116.7 14.61 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.981 HG21 HD12 ' A' ' 194' ' ' LEU . 6.0 t -66.98 98.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.0 tt -82.03 -24.5 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.843 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -166.24 98.9 0.62 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.685 ' HA3' HG23 ' A' ' 287' ' ' THR . . . -162.49 -169.15 25.46 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.545 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 98.0 Cg_endo -80.13 29.67 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.358 2.038 . . . . 0.0 110.642 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.795 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.13 25.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.637 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.6 mt -40.82 106.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.969 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.43 2.65 2.88 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.898 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.981 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -96.73 165.19 12.25 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 118.106 0.953 . . . . 0.0 108.692 177.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 5.0 mt-30 -156.72 146.18 20.6 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.063 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.923 ' CD2' HG11 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -136.12 128.43 30.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.183 0.516 . . . . 0.0 109.852 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 182' ' ' LEU . . . -130.8 165.1 23.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.899 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.613 HG11 ' HG ' ' A' ' 206' ' ' LEU . 11.9 p -175.25 143.86 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 121.327 0.584 . . . . 0.0 112.264 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.404 ' HB2' HG22 ' A' ' 201' ' ' THR . 14.0 p30 -85.78 147.96 26.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.382 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.514 ' HB3' ' OG ' ' A' ' 180' ' ' SER . 15.3 t -62.65 -9.42 8.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 199' ' ' ASN . 2.9 t -95.04 36.85 1.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.973 0.416 . . . . 0.0 111.882 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.427 ' HB2' ' CG ' ' A' ' 205' ' ' LYS . 4.7 p -128.59 108.74 10.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.403 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 3.4 m -70.71 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.228 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.7 m -86.99 8.37 23.58 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.427 ' CG ' ' HB2' ' A' ' 202' ' ' SER . 9.0 pttt -118.41 52.74 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.796 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 8.2 tt -143.77 -52.4 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.943 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 3.7 Cg_exo -40.57 93.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.41 2.074 . . . . 0.0 113.384 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.923 HG11 ' CD2' ' A' ' 196' ' ' HIS . 59.8 t -73.25 107.91 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.923 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.624 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 19.5 mtmt -77.91 90.99 4.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.446 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.964 HD23 HD12 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -78.51 136.75 37.65 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . 164.63 -161.22 34.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.964 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.714 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.0 OUTLIER -73.65 171.72 12.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.393 -0.404 . . . . 0.0 111.487 -179.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 213' ' ' VAL . 7.2 p -73.87 110.95 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 122.2 1.0 . . . . 0.0 111.833 -176.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 215' ' ' PRO . 12.4 p -171.11 -163.0 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 113.435 -1.711 . . . . 0.0 107.864 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 62.3 Cg_exo -51.8 -12.0 1.05 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.475 1.45 . . . . 0.0 112.665 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.421 ' OG ' ' HG2' ' A' ' 228' ' ' LYS . 0.1 OUTLIER -51.45 -178.36 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.962 0.411 . . . . 0.0 111.714 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.41 -37.72 8.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.964 HD12 HD23 ' A' ' 210' ' ' LEU . 0.4 OUTLIER -100.47 140.53 34.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.641 179.087 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -103.06 78.18 1.62 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.892 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.772 HD21 HD13 ' A' ' 218' ' ' LEU . 2.9 mm? -102.49 91.72 4.36 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.545 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 1.5 ptpt -66.44 56.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.962 0.411 . . . . 0.0 110.653 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.551 ' HB3' HG12 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -88.96 123.35 33.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.518 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.0 p -66.25 -7.11 16.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.664 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.515 ' O ' HD11 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -87.87 -24.47 23.66 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.759 0.314 . . . . 0.0 110.699 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 225' ' ' VAL . 7.2 p -100.66 93.4 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.02 0.438 . . . . 0.0 110.835 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.15 -38.71 18.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.053 0.454 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.13 -57.53 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.786 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 211' ' ' GLY . 25.4 mtmm -143.7 129.02 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.421 0.629 . . . . 0.0 111.688 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.517 ' HE1' ' HB2' ' A' ' 250' ' ' ASN . 2.0 t60 -89.84 -61.82 1.6 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.154 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.564 ' C ' ' HE3' ' A' ' 246' ' ' MET . . . -140.72 171.17 14.47 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.663 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.8 OUTLIER -157.88 168.89 25.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.24 179.013 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.943 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 8.0 mt -125.39 138.16 55.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.604 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.48 163.64 32.4 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.671 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -96.25 148.0 23.19 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.491 ' HB2' ' HD3' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -119.53 71.99 0.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.276 174.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.7 p -54.11 -21.13 7.86 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 46.3 m -73.72 -27.86 61.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.632 0.73 . . . . 0.0 109.33 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.433 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 20.0 tptt -116.31 6.29 13.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.465 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 235' ' ' ASN . 8.0 p90 37.05 49.56 0.83 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.885 0.374 . . . . 0.0 110.669 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 235' ' ' ASN . 0.0 OUTLIER -119.8 176.21 5.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 0.0 109.78 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.839 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -124.61 110.0 13.88 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 0.7 OUTLIER -132.15 151.2 51.91 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.703 ' O ' HD12 ' A' ' 243' ' ' LEU . 3.3 pp -119.16 152.65 36.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.579 -1.646 . . . . 0.0 111.456 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.592 HG13 ' HE1' ' A' ' 246' ' ' MET . 4.7 p -119.33 162.6 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.139 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 13.6 m-20 -118.86 121.8 40.85 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.677 ' HB3' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -93.83 107.85 19.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.957 178.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 48.59 62.34 4.51 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.374 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.23 74.75 0.23 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.809 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -59.66 -48.77 80.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.859 178.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.809 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -78.7 -39.51 36.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.048 0.451 . . . . 0.0 110.851 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 97.05 93.0 1.87 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.359 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.61 HG22 ' CD1' ' A' ' 281' ' ' ILE . 1.9 m -47.29 156.59 0.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.297 -0.261 . . . . 0.0 110.297 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -148.12 130.23 15.45 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.179 0.514 . . . . 0.0 111.521 179.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.974 HG23 HD12 ' A' ' 259' ' ' ILE . 55.5 t -104.14 130.04 55.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.829 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 55.09 42.33 30.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.048 0.451 . . . . 0.0 110.329 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.15 23.1 12.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.992 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.7 112.03 15.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.373 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 85.9 p -63.12 99.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.431 0.634 . . . . 0.0 112.174 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.974 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -79.45 -47.68 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.774 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.501 ' N ' HG12 ' A' ' 259' ' ' ILE . 4.7 t . . . . . 0 C--N 1.327 -0.377 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.677 ' CH2' ' HB3' ' A' ' 246' ' ' MET . 2.8 m95 -63.77 -30.31 71.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.234 -0.893 . . . . 0.0 108.768 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 72.53 165.13 8.13 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.15 122.86 72.35 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.701 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 34.2 Cg_exo -31.05 111.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.21 2.607 . . . . 0.0 112.846 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.714 HG11 HG21 ' A' ' 259' ' ' ILE . 62.5 t -87.58 130.18 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.388 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -78.3 131.71 37.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.977 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.727 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -98.0 164.26 12.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.121 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.85 152.67 45.3 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.647 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.9 OUTLIER -54.62 130.89 41.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.362 179.031 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 277' ' ' SER . 9.0 m-20 82.17 -3.65 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.738 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.951 ' O ' HG23 ' A' ' 291' ' ' VAL . 1.2 m-20 -77.24 141.15 40.15 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.744 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.513 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -100.72 124.79 54.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 119.789 -0.765 . . . . 0.0 109.728 178.541 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.791 HG12 HG22 ' A' ' 254' ' ' VAL . 0.3 OUTLIER -110.46 94.61 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -82.49 138.38 34.35 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.524 -0.735 . . . . 0.0 109.589 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.753 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -130.39 53.1 1.97 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.372 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 168.16 -122.5 1.03 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.494 -1.336 . . . . 0.0 113.43 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.5 t -98.0 -44.8 6.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.636 0.255 . . . . 0.0 110.675 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -147.64 1.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.1 m -79.32 104.75 10.15 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.785 ' O ' HG22 ' A' ' 187' ' ' ILE . 9.0 ptpt -126.19 131.02 52.08 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.796 0.807 . . . . 0.0 111.931 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.621 HG11 ' CE1' ' A' ' 196' ' ' HIS . 14.9 t -106.2 132.1 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.758 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 278' ' ' ASP . 1.7 t80 -77.17 130.89 37.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.951 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.2 OUTLIER -100.75 113.64 37.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.734 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -131.09 136.16 48.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.742 0.306 . . . . 0.0 110.82 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.839 HD12 ' CE3' ' A' ' 241' ' ' TRP . 2.4 mt -135.46 139.65 46.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 3.2 m -142.81 156.09 44.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.776 0.322 . . . . 0.0 111.14 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.3 m -85.73 159.22 19.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.786 -179.991 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.111 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.652 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.6 m95 -145.29 131.77 19.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.672 HD23 ' HZ3' ' A' ' 234' ' ' TRP . 5.1 tp -118.12 128.2 54.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.214 177.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 1.1 m-85 -128.99 138.57 52.03 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.553 0.692 . . . . 0.0 110.799 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.77 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.5 mp -140.89 153.01 45.51 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.586 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.604 ' C ' HG23 ' A' ' 289' ' ' VAL . 23.3 tt0 -144.61 124.85 13.73 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.674 ' N ' HG23 ' A' ' 289' ' ' VAL . 22.0 t -59.49 113.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.7 tt -97.02 -20.76 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -176.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.719 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -157.76 91.27 1.12 Allowed 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.327 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.757 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.76 178.57 38.45 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.477 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 71.9 Cg_endo -75.4 32.13 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 121.79 1.66 . . . . 0.0 111.185 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.719 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -163.94 28.92 0.08 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.966 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.757 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.7 mt -43.55 119.75 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.112 0.482 . . . . 0.0 112.239 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.24 -48.46 0.92 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.726 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.719 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.7 OUTLIER -40.9 143.84 0.33 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.302 0.573 . . . . 0.0 110.752 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.77 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 20.8 mt-30 -141.64 152.03 43.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.776 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.818 ' HE1' HG21 ' A' ' 289' ' ' VAL . 3.9 p-80 -139.63 131.59 27.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.268 0.556 . . . . 0.0 109.635 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.86 153.6 40.34 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.38 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.9 HG21 ' HA ' ' A' ' 206' ' ' LEU . 7.2 p -160.92 161.24 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.349 0.595 . . . . 0.0 111.725 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.569 ' N ' HG22 ' A' ' 198' ' ' VAL . 1.4 t-20 -98.59 143.33 29.11 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.705 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.496 ' HA ' ' HE1' ' A' ' 234' ' ' TRP . 16.2 t -60.76 1.48 0.14 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 1.3 t -107.09 -8.08 16.65 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.601 0.36 . . . . 0.0 111.562 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.495 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -69.05 118.13 11.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.027 0.441 . . . . 0.0 110.452 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 72.8 m -66.42 -101.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.1 m -91.41 20.1 5.55 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.24 -9.0 11.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.205 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.9 ' HA ' HG21 ' A' ' 198' ' ' VAL . 7.8 tt -67.74 -61.21 4.55 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.681 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -43.28 101.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.005 1.803 . . . . 0.0 112.395 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.94 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 98.7 t -67.26 165.52 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.564 ' N ' HG12 ' A' ' 208' ' ' VAL . 15.7 mtmt -136.9 90.12 2.51 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.992 HD23 HD12 ' A' ' 218' ' ' LEU . 0.5 OUTLIER -79.97 123.91 28.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.138 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . -165.98 167.69 39.35 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.391 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 1.094 ' HB2' HG13 ' A' ' 225' ' ' VAL . 4.7 ttt-85 -66.36 -73.01 0.14 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.738 HG13 ' HG2' ' A' ' 215' ' ' PRO . 15.0 p -79.39 159.42 4.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 213' ' ' VAL . 1.0 OUTLIER -31.07 -52.78 0.42 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -178.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.738 ' HG2' HG13 ' A' ' 213' ' ' VAL . 2.9 Cg_endo -42.52 -24.76 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.205 1.936 . . . . 0.0 113.153 -177.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.429 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -83.93 156.51 22.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -69.96 -36.24 75.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.564 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.992 HD12 HD23 ' A' ' 210' ' ' LEU . 2.0 mt -103.68 134.35 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.427 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -90.31 73.32 7.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.562 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.838 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -97.15 68.39 2.25 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.594 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 2.2 pttt -60.71 39.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.52 ' HB3' ' HG3' ' A' ' 224' ' ' GLU . 12.4 t0 -90.23 131.23 36.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.5 p -46.51 -33.57 4.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.207 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 1.1 pp20? -52.21 -32.03 34.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.341 . . . . 0.0 111.233 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 1.094 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.1 p -104.33 97.72 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.54 -46.99 14.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.203 0.525 . . . . 0.0 110.574 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.32 -50.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.428 ' HB2' ' SD ' ' A' ' 246' ' ' MET . 3.6 mptp? -140.85 127.01 19.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.237 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.653 ' HA ' ' HB2' ' A' ' 248' ' ' SER . 0.2 OUTLIER -94.55 -55.22 3.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.631 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -151.87 177.0 10.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.286 0.565 . . . . 0.0 111.996 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.94 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 3.9 mt-30 -156.84 -178.01 7.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.222 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.858 HG12 HD11 ' A' ' 243' ' ' LEU . 0.9 OUTLIER -125.36 141.76 44.28 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.249 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.24 127.18 3.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.85 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.8 p90 -124.92 167.53 14.56 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -112.62 133.16 54.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.137 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.22 -1.96 50.58 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.515 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.7 m -80.55 -35.04 34.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.588 0.709 . . . . 0.0 109.593 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.529 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 33.8 tptt -121.91 10.4 10.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.596 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 24.4 p90 45.18 63.04 1.89 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.495 0.664 . . . . 0.0 109.694 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.85 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.2 OUTLIER -129.14 138.18 51.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.121 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.724 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -119.91 126.75 51.67 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.731 179.043 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 272' ' ' PRO . 27.1 mt-10 -142.58 146.35 34.5 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.859 HD23 ' CD1' ' A' ' 281' ' ' ILE . 0.3 OUTLIER -97.92 150.94 20.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.767 -1.561 . . . . 0.0 109.486 178.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.613 HG21 ' NE1' ' A' ' 269' ' ' TRP . 4.5 p -141.67 162.85 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.901 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.606 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 18.8 t70 -84.63 138.82 32.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.412 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.547 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -88.92 31.63 0.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.722 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.47 50.48 59.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.769 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.653 ' HB2' ' HA ' ' A' ' 229' ' ' HIS . 32.6 t -92.6 168.97 10.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.836 0.35 . . . . 0.0 111.146 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 250' ' ' ASN . 3.1 pp -93.01 -43.82 8.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.439 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.592 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.8 OUTLIER -68.32 -19.03 64.65 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.546 0.689 . . . . 0.0 109.921 -178.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 76.27 147.75 2.24 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.364 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.727 HG23 HD23 ' A' ' 283' ' ' LEU . 6.0 m -103.66 152.29 21.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.608 0.242 . . . . 0.0 110.99 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -140.13 138.88 35.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.053 177.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.851 HG23 ' CD1' ' A' ' 259' ' ' ILE . 95.5 t -110.03 133.62 54.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.956 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.873 ' HA ' HD12 ' A' ' 280' ' ' ILE . 14.7 p30 52.98 38.32 26.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.332 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.47 36.87 2.11 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.436 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.633 ' O ' HG23 ' A' ' 259' ' ' ILE . 20.0 t-80 -148.29 117.53 6.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 91.9 p -63.5 86.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.251 0.548 . . . . 0.0 110.275 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -84.92 -13.08 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.229 -178.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.606 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 1.5 t . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.7 mttt . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.082 0.467 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.613 ' NE1' HG21 ' A' ' 244' ' ' VAL . 14.7 t-105 -84.61 -19.59 32.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.705 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 64.25 -172.98 16.1 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.782 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.487 ' HB2' ' HD2' ' A' ' 272' ' ' PRO . 29.2 p30 -110.38 158.97 33.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 117.524 0.662 . . . . 0.0 110.304 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.621 ' HB2' ' HB2' ' A' ' 242' ' ' GLU . 58.7 Cg_endo -72.99 114.3 4.0 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.296 1.997 . . . . 0.0 113.628 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.724 HG21 ' HB ' ' A' ' 259' ' ' ILE . 66.9 t -97.38 138.53 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.3 pm0 -76.24 123.45 25.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.131 0.967 . . . . 0.0 113.572 -176.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.85 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -90.87 163.96 14.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.525 -1.671 . . . . 0.0 109.167 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.639 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -146.87 162.75 38.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.634 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 26.3 t -60.34 127.77 33.41 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.849 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.634 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 86.09 7.85 0.32 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.273 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.639 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -83.61 -166.66 1.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -161.48 128.84 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.603 177.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.859 ' CD1' HD23 ' A' ' 243' ' ' LEU . 0.0 OUTLIER -99.28 147.13 7.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.716 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 0.6 OUTLIER -134.17 125.57 28.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.627 0.727 . . . . 0.0 110.226 178.158 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.727 HD23 HG23 ' A' ' 252' ' ' THR . 0.1 OUTLIER -125.72 131.61 52.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.897 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 224' ' ' GLU . . . 86.26 -127.95 8.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.143 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 t -96.94 -30.67 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -160.46 5.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 7.2 m -64.69 99.67 0.34 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.898 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.812 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -117.97 125.21 49.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -177.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.818 HG21 ' HE1' ' A' ' 196' ' ' HIS . 6.3 p -113.26 136.47 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.224 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.671 ' HD1' HG23 ' A' ' 280' ' ' ILE . 1.0 OUTLIER -78.19 140.54 38.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.884 0.373 . . . . 0.0 110.373 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -108.82 114.13 45.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.046 -179.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.603 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.9 OUTLIER -130.05 140.99 50.77 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.812 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.667 HG12 HD13 ' A' ' 182' ' ' LEU . 11.6 mt -138.95 119.87 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 181' ' ' TRP . 0.1 OUTLIER -130.81 149.99 52.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 0.0 111.268 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.86 164.07 16.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.4 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.433 HE21 ' HA ' ' A' ' 296' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.981 0.42 . . . . 0.0 111.486 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.615 ' N ' ' HB3' ' A' ' 296' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.461 0.104 0 CA-C-O 121.508 0.671 . . . . 0.0 112.167 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 1.2 m95 -137.22 135.71 37.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.188 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.937 HD11 ' CD2' ' A' ' 184' ' ' LEU . 1.1 tp -126.66 133.97 50.84 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.883 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.0 m-85 -133.42 137.1 45.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.63 0.728 . . . . 0.0 110.447 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.937 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.3 mm? -119.62 139.72 51.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.414 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -134.49 112.25 10.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 220' ' ' LEU . 40.6 t -60.1 98.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.132 0.492 . . . . 0.0 109.907 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.815 HG22 ' O ' ' A' ' 288' ' ' LYS . 11.5 tt -77.04 -23.2 14.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.929 -177.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.802 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -167.96 99.95 0.46 Allowed 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.492 ' HA3' HG23 ' A' ' 287' ' ' THR . . . -161.9 -177.0 34.59 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.679 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 64.0 Cg_endo -79.82 34.5 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.96 1.773 . . . . 0.0 111.573 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.987 ' HB3' HD13 ' A' ' 220' ' ' LEU . . . -162.99 26.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 192' ' ' ILE . 0.7 OUTLIER -39.16 106.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.908 0.385 . . . . 0.0 110.592 -179.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.89 3.41 1.74 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.105 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.911 HD21 ' HB1' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -99.31 141.74 31.7 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 117.724 0.762 . . . . 0.0 109.296 177.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 22.2 mt-30 -137.05 147.88 46.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.802 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 1.003 ' ND1' HD21 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -137.41 128.09 26.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.021 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -148.13 164.58 33.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.582 HG13 ' CH2' ' A' ' 234' ' ' TRP . 3.5 p -171.19 158.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.336 0.589 . . . . 0.0 110.798 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.722 ' HB3' HG22 ' A' ' 201' ' ' THR . 8.0 m120 -88.14 146.77 25.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.268 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.848 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 2.6 t -66.65 -3.85 7.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.901 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 199' ' ' ASN . 1.4 t -93.44 36.9 1.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.159 0.504 . . . . 0.0 110.44 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.811 ' O ' HD12 ' A' ' 206' ' ' LEU . 15.4 m -131.25 96.37 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.073 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.9 -76.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.799 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.91 12.33 34.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 111.465 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 10.4 pttt -118.42 52.18 1.04 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.048 0.452 . . . . 0.0 110.539 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 1.067 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -147.76 -30.44 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 1.067 ' HD2' ' H ' ' A' ' 206' ' ' LEU . 3.1 Cg_endo -45.38 99.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 121.088 1.424 . . . . 0.0 112.078 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.583 HG11 ' CD2' ' A' ' 196' ' ' HIS . 61.9 t -68.76 160.77 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.872 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.753 ' HB2' ' HB2' ' A' ' 217' ' ' ASP . 13.6 mtpp -136.8 127.74 27.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.805 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.821 HD21 ' HB3' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -126.61 148.32 49.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.127 0.489 . . . . 0.0 111.496 178.429 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . 153.45 -157.07 27.15 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.633 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.683 ' HB2' ' O ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -69.2 157.06 37.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.641 0.258 . . . . 0.0 111.355 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.568 ' HB ' ' HB1' ' A' ' 219' ' ' ALA . 7.2 p -77.42 123.43 34.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.777 0.799 . . . . 0.0 113.127 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.739 ' CB ' ' HD3' ' A' ' 215' ' ' PRO . 0.8 OUTLIER 160.27 -81.7 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 114.176 -1.374 . . . . 0.0 109.718 178.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.739 ' HD3' ' CB ' ' A' ' 214' ' ' SER . 16.6 Cg_endo -98.28 -14.4 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.255 1.97 . . . . 0.0 113.254 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.2 174.05 11.12 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.753 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.5 OUTLIER -88.49 -36.4 16.47 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.935 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.003 HD21 ' ND1' ' A' ' 196' ' ' HIS . 10.7 mt -94.04 132.69 38.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.568 ' HB1' ' HB ' ' A' ' 213' ' ' VAL . . . -95.36 72.59 3.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.927 0.394 . . . . 0.0 110.0 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.987 HD13 ' HB3' ' A' ' 191' ' ' ALA . 3.1 mm? -96.23 88.05 4.68 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.679 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 8.0 ptpt -57.63 63.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 0.0 110.849 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 220' ' ' LEU . 2.0 m-20 -95.59 149.64 21.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.989 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.0 t -90.93 -5.8 54.97 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.11 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.46 ' O ' HD11 ' A' ' 249' ' ' LEU . 4.5 pm0 -93.88 -21.13 19.43 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.564 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.683 ' O ' ' HB2' ' A' ' 212' ' ' ARG . 3.1 p -111.85 82.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.7 t -34.76 -44.35 0.21 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.835 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.11 -48.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.876 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -145.5 131.14 18.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.97 0.414 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.606 ' CD2' ' HB2' ' A' ' 283' ' ' LEU . 7.0 t60 -102.77 -49.81 3.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.447 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.821 ' HB3' HD21 ' A' ' 210' ' ' LEU . . . -147.65 179.08 7.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.204 0.526 . . . . 0.0 112.389 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -162.38 172.92 14.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.663 -179.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.743 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 10.9 mt -129.05 149.09 33.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.567 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.451 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -159.87 155.44 25.66 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.848 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 4.8 p90 -137.94 156.4 47.9 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.29 123.28 49.02 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.028 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 p -84.06 -4.32 58.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.515 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.0 m -77.8 -22.25 50.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.325 0.583 . . . . 0.0 110.392 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -144.47 20.71 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.855 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 17.6 p90 40.82 64.88 0.88 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.461 0.648 . . . . 0.0 109.811 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.635 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 10.5 mptt -128.31 141.4 51.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.058 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.745 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 4.8 m95 -120.69 117.25 27.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.211 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.3 mt-10 -133.93 141.78 47.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.779 0.8 . . . . 0.0 113.11 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.702 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.2 pp -108.13 154.0 22.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.658 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.609 HG11 ' HE1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -125.51 163.28 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.75 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 1.9 t0 -97.92 156.94 16.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.651 0.739 . . . . 0.0 112.502 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.562 ' N ' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -130.66 90.55 2.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.348 178.681 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 49.18 69.16 1.08 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.288 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.68 70.44 6.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.988 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.74 -51.44 67.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.944 178.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.988 ' N ' HD22 ' A' ' 249' ' ' LEU . 1.1 p-10 -72.74 -33.27 66.27 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.303 0.573 . . . . 0.0 110.977 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 100.95 101.19 2.46 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.922 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.613 ' C ' HD23 ' A' ' 253' ' ' LEU . 11.3 m -64.9 160.12 21.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 252' ' ' THR . 0.2 OUTLIER -156.55 153.86 29.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.301 0.572 . . . . 0.0 112.418 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.878 HG22 HG13 ' A' ' 281' ' ' ILE . 78.0 t -129.99 130.47 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.268 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.594 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 54.1 t30 59.21 38.58 23.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.027 0.442 . . . . 0.0 110.319 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.1 36.58 5.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.041 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.72 ' O ' HG23 ' A' ' 259' ' ' ILE . 12.2 m80 -148.61 118.92 7.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.998 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 252' ' ' THR . 25.1 p -62.67 94.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.383 0.611 . . . . 0.0 110.456 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.824 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -95.6 -17.98 6.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.563 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 0.6 OUTLIER . . . . . 0 C--N 1.324 -0.504 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt . . . . . 0 CA--C 1.516 -0.361 0 CA-C-O 121.439 0.637 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.609 ' HE1' HG11 ' A' ' 244' ' ' VAL . 39.5 t-105 -71.46 -25.64 62.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.6 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.03 160.92 27.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.764 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -98.34 151.7 37.62 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.792 0.329 . . . . 0.0 111.142 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.644 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 32.5 Cg_exo -58.63 115.9 2.87 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.894 2.396 . . . . 0.0 113.479 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.68 HG21 HG12 ' A' ' 259' ' ' ILE . 78.4 t -99.76 138.16 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.745 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.2 pp20? -83.71 129.41 34.95 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.229 -0.988 . . . . 0.0 112.174 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.963 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -94.32 164.32 13.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.755 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.06 160.01 41.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.282 0.563 . . . . 0.0 112.074 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.681 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 6.1 p -61.61 131.01 48.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.127 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.681 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.2 m-20 85.21 5.68 0.51 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.873 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.9 m-20 -79.11 -168.07 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.917 HD13 ' N ' ' A' ' 280' ' ' ILE . 0.1 OUTLIER -160.36 128.21 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.878 HG13 HG22 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -103.25 154.49 5.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.162 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.714 HG23 ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -142.17 116.93 9.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.65 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.72 40.62 2.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 -178.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.447 ' CA ' ' HG3' ' A' ' 224' ' ' GLU . . . 179.37 -130.99 1.6 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 119.57 -1.3 . . . . 0.0 113.555 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 5.0 t -92.09 -49.49 6.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.595 0.235 . . . . 0.0 111.21 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -139.75 0.67 1.83 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.802 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.5 m -72.58 103.66 3.62 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.248 -0.181 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.815 ' O ' HG22 ' A' ' 187' ' ' ILE . 10.9 mtpt -121.45 129.55 53.04 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.667 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.701 HG13 HD12 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -107.83 129.71 61.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.539 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 278' ' ' ASP . 4.4 t80 -77.52 137.2 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.888 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -104.69 114.01 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.626 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.11 129.73 42.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.664 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.804 HD11 ' CD2' ' A' ' 275' ' ' LEU . 16.8 mt -126.84 139.24 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.546 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.66 142.64 50.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.672 0.272 . . . . 0.0 110.388 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 41.1 p -79.7 150.52 30.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.07 0.462 . . . . 0.0 110.864 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . 0.615 ' HB3' ' N ' ' A' ' 180' ' ' SER . 2.8 tp-100 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.491 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.129 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.0 m95 -149.0 133.88 18.0 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.943 HD11 ' CD2' ' A' ' 184' ' ' LEU . 0.9 OUTLIER -119.23 133.13 55.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.045 177.014 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.927 ' N ' HD12 ' A' ' 182' ' ' LEU . 6.2 m-85 -132.44 137.24 47.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.776 0.798 . . . . 0.0 110.975 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.943 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.5 mm? -120.97 140.52 51.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.494 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 3.6 tt0 -134.93 114.3 12.39 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -178.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.647 HG21 HD12 ' A' ' 194' ' ' LEU . 2.6 t -59.52 110.33 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.327 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.849 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.2 tt -95.61 -23.77 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.744 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.84 95.09 0.7 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.441 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.585 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.4 -178.07 35.96 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.5 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 73.0 Cg_endo -78.52 32.36 0.45 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.153 1.902 . . . . 0.0 111.642 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.875 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.77 22.63 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.187 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.585 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -40.24 108.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.65 5.01 1.53 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.788 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.875 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -100.41 170.04 8.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 22.1 mt-30 -159.92 148.74 17.46 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.928 0.394 . . . . 0.0 111.6 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.785 ' CE1' ' HB3' ' A' ' 184' ' ' LEU . 0.7 OUTLIER -134.27 124.76 26.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.469 0.652 . . . . 0.0 109.467 178.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -145.22 168.66 19.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.357 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.792 HG13 ' CH2' ' A' ' 234' ' ' TRP . 2.3 p -178.03 160.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.424 0.631 . . . . 0.0 111.529 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.799 ' ND2' HG22 ' A' ' 201' ' ' THR . 0.7 OUTLIER -96.1 148.62 22.5 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.974 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.479 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 13.3 p -65.46 -1.18 2.33 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.799 HG22 ' ND2' ' A' ' 199' ' ' ASN . 0.6 OUTLIER -109.73 10.52 24.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.795 0.331 . . . . 0.0 111.44 179.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.432 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -87.9 137.83 31.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.057 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 61.1 m -90.14 -88.29 0.17 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 43.9 m -93.47 20.18 7.55 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.432 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.2 OUTLIER -118.05 -11.57 10.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.059 0.456 . . . . 0.0 110.742 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.736 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.8 tt -74.15 -60.59 1.43 Allowed Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.828 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 2.0 Cg_endo -42.99 99.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.338 2.025 . . . . 0.0 112.639 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.675 HG11 ' CD2' ' A' ' 196' ' ' HIS . 99.1 t -69.26 158.39 6.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.971 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 16.4 mtpt -138.25 77.86 1.65 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' A' ' 231' ' ' GLN . 3.7 mp -65.5 122.39 17.08 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.116 -0.365 . . . . 0.0 110.655 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . -164.32 166.37 37.72 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.941 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 1.07 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -67.12 -70.83 0.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -177.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.749 HG22 ' HD2' ' A' ' 215' ' ' PRO . 14.9 p -78.48 157.34 4.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -30.07 -54.89 0.34 Allowed Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.749 ' HD2' HG22 ' A' ' 213' ' ' VAL . 55.0 Cg_exo -36.83 -30.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.854 2.37 . . . . 0.0 113.133 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.437 ' CB ' ' HA3' ' A' ' 211' ' ' GLY . 0.9 OUTLIER -81.91 154.92 25.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.616 0.246 . . . . 0.0 110.512 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.571 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -69.24 -40.53 77.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.328 . . . . 0.0 110.194 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.742 ' HB3' HD23 ' A' ' 220' ' ' LEU . 2.6 tp -97.47 130.16 44.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.561 ' C ' HD22 ' A' ' 220' ' ' LEU . . . -90.04 76.84 6.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.01 0.433 . . . . 0.0 110.963 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.792 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.5 mm? -106.69 90.64 3.39 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.445 ' CG ' ' HB2' ' A' ' 190' ' ' PRO . 4.6 pttt -64.0 36.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.873 ' HB3' HG12 ' A' ' 225' ' ' VAL . 26.5 t0 -65.65 132.89 49.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.9 p -73.55 -4.53 34.55 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.255 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -18.73 24.24 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.717 0.294 . . . . 0.0 110.545 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 1.07 HG13 ' HB2' ' A' ' 212' ' ' ARG . 5.4 p -107.58 86.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.172 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.23 -42.95 0.49 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.346 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.39 -49.91 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 246' ' ' MET . 0.0 OUTLIER -143.5 135.32 26.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.461 . . . . 0.0 110.016 179.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.601 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.1 t60 -106.12 -52.95 2.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -148.34 176.04 10.59 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.808 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -159.17 178.51 9.93 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.881 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 18.7 mt -137.22 147.63 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 121.471 0.653 . . . . 0.0 112.405 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.455 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -161.65 158.5 26.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.807 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 7.0 p90 -147.48 166.81 26.13 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -116.0 133.58 55.88 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.352 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 82.1 p -93.23 1.19 57.17 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.262 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.0 m -79.31 -37.92 36.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.888 0.851 . . . . 0.0 109.652 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 50.5 tptt -124.9 13.58 8.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.068 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.3 p90 42.47 61.27 2.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.528 0.68 . . . . 0.0 109.87 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.807 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.4 OUTLIER -125.32 137.57 54.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.146 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.725 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -118.95 120.33 36.97 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.062 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 6.9 mt-10 -138.32 144.04 40.22 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.836 0.827 . . . . 0.0 112.629 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.784 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.5 pp -105.01 152.02 23.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.474 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 269' ' ' TRP . 4.3 p -122.37 163.36 20.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.406 ' OD1' ' HB ' ' A' ' 252' ' ' THR . 0.3 OUTLIER -105.96 156.43 18.39 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.676 ' HA ' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -80.97 149.17 29.46 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.5 ' HA2' ' C ' ' A' ' 268' ' ' LYS . . . -53.21 10.84 0.01 OUTLIER Glycine 0 C--N 1.317 -0.508 0 N-CA-C 115.569 0.988 . . . . 0.0 115.569 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 246' ' ' MET . 0.6 OUTLIER -89.4 130.48 35.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.025 1.412 . . . . 0.0 110.77 179.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.669 ' C ' HD13 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -57.16 6.04 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.66 ' N ' HD13 ' A' ' 249' ' ' LEU . 4.9 m-20 -70.0 -40.25 75.4 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 119.666 1.121 . . . . 0.0 109.847 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 72.57 119.02 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.126 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.64 ' C ' HD23 ' A' ' 253' ' ' LEU . 76.7 m -73.5 172.07 12.0 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.305 0.242 . . . . 0.0 110.457 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.661 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -144.4 121.23 11.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.174 0.512 . . . . 0.0 110.567 177.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 259' ' ' ILE . 89.9 t -97.15 134.97 32.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.759 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.447 HD22 HG12 ' A' ' 254' ' ' VAL . 11.9 p30 49.58 34.54 7.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.147 0.499 . . . . 0.0 110.104 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.55 36.64 1.24 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.831 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -144.61 112.49 6.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.646 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 77.7 p -61.03 85.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 110.811 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.923 HG12 HG11 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -84.98 -13.29 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.263 -179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.55 ' N ' HD12 ' A' ' 259' ' ' ILE . 17.0 p . . . . . 0 C--N 1.329 -0.315 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.5 ' C ' ' HA2' ' A' ' 247' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.72 ' O ' HG22 ' A' ' 244' ' ' VAL . 11.6 t-105 -71.54 -16.38 62.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.06 -175.92 4.96 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -109.51 151.15 42.02 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 117.857 0.829 . . . . 0.0 110.95 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 34.6 Cg_exo -60.27 117.65 4.43 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.777 2.318 . . . . 0.0 113.463 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.923 HG11 HG12 ' A' ' 259' ' ' ILE . 97.6 t -95.49 137.06 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.5 OUTLIER -83.36 125.04 31.23 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.864 -179.013 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.947 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -90.25 164.33 14.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.566 179.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.7 157.37 45.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.258 0.551 . . . . 0.0 112.043 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.493 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 68.3 p -58.21 127.81 33.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.483 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 84.24 8.84 0.5 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.418 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.6 t0 -83.18 -165.54 1.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.519 HG23 ' CD1' ' A' ' 290' ' ' TYR . 0.5 OUTLIER -162.36 134.45 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.592 177.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.897 HD12 HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -108.57 156.6 9.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.67 178.471 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.661 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.3 m -146.52 113.8 6.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.755 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.64 47.8 1.21 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.589 -178.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 172.58 -125.14 1.13 Allowed Glycine 0 CA--C 1.517 0.205 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.453 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.5 t -96.9 -47.13 5.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.644 0.259 . . . . 0.0 111.244 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -144.83 -6.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 61.6 m -64.93 103.44 0.72 Allowed 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.432 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.849 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.8 mtpt -124.78 134.53 52.75 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.034 0.445 . . . . 0.0 111.259 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.897 HG23 HD12 ' A' ' 281' ' ' ILE . 0.1 OUTLIER -114.97 134.24 58.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.69 -178.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.524 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.3 t80 -76.98 139.49 40.12 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.971 0.415 . . . . 0.0 110.261 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.947 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -106.32 113.13 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.846 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.91 144.86 50.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.516 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.709 HD11 ' CD2' ' A' ' 275' ' ' LEU . 11.5 mt -144.15 116.81 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.443 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.1 m -123.74 147.52 47.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.951 0.405 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 70.4 m -80.8 -178.31 6.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.7 OUTLIER . . . . . 0 CA--C 1.521 -0.139 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.567 ' O ' HG23 ' A' ' 293' ' ' ILE . 6.6 m95 -147.2 132.32 18.3 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.604 HD23 ' HZ3' ' A' ' 234' ' ' TRP . 6.1 tp -117.86 127.47 53.9 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.092 176.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 16.9 m-85 -125.74 136.5 53.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.676 0.751 . . . . 0.0 110.932 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.845 HD13 ' ND1' ' A' ' 196' ' ' HIS . 1.4 mp -138.13 149.84 46.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.917 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.486 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 12.9 tt0 -145.09 127.09 15.52 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.613 HG21 HD12 ' A' ' 194' ' ' LEU . 13.4 t -64.07 114.87 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.505 HG22 ' CB ' ' A' ' 288' ' ' LYS . 8.7 tt -99.01 -20.17 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.808 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.74 91.39 0.56 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.421 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.808 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.82 -172.68 29.53 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.689 ' HB2' ' HD2' ' A' ' 221' ' ' LYS . 70.7 Cg_endo -77.0 26.84 0.44 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.121 1.881 . . . . 0.0 111.931 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.821 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.0 29.91 0.12 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.114 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.808 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.3 mt -42.84 116.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.46 -51.78 0.76 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.341 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.821 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -38.56 149.43 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.282 0.563 . . . . 0.0 111.215 -178.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.745 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.6 mt-30 -148.63 149.97 32.44 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.813 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.845 ' ND1' HD13 ' A' ' 184' ' ' LEU . 2.0 p80 -136.93 126.95 25.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.251 0.548 . . . . 0.0 109.847 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.6 161.26 38.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.476 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.909 HG13 ' CH2' ' A' ' 234' ' ' TRP . 4.0 p -172.61 160.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 111.812 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 180' ' ' SER . 29.9 m-80 -88.74 150.12 23.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.24 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.566 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 40.6 t -64.08 -9.01 13.78 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.623 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 1.8 t -101.18 34.47 2.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.209 0.528 . . . . 0.0 111.061 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.44 ' HB2' ' HG2' ' A' ' 205' ' ' LYS . 35.9 p -116.13 129.74 56.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.634 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . 0.446 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 4.0 m -90.33 -86.93 0.19 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.0 m -86.8 14.24 7.5 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.446 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -115.83 -13.46 11.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.995 0.426 . . . . 0.0 110.412 178.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.773 HD11 ' CE2' ' A' ' 234' ' ' TRP . 6.4 tt -70.4 -60.29 3.4 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.314 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.609 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.0 OUTLIER -43.51 97.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.562 2.175 . . . . 0.0 113.47 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.74 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 98.9 t -68.32 163.16 3.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 3.6 mtpp -139.66 85.81 2.07 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.06 HD23 HD12 ' A' ' 218' ' ' LEU . 0.5 OUTLIER -73.67 126.43 30.29 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.163 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.447 ' HA3' ' OG ' ' A' ' 216' ' ' SER . . . -170.09 173.15 44.12 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.943 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 1.059 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -70.58 -75.12 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.922 HG13 ' HG2' ' A' ' 215' ' ' PRO . 11.3 p -78.99 160.13 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -176.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.507 ' N ' HG22 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -27.68 -52.59 0.23 Allowed Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -178.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.922 ' HG2' HG13 ' A' ' 213' ' ' VAL . 5.0 Cg_exo -38.5 -29.77 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.634 2.223 . . . . 0.0 112.962 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.447 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 0.7 OUTLIER -82.98 151.24 25.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.648 179.011 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -31.03 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.108 0.48 . . . . 0.0 109.967 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.06 HD12 HD23 ' A' ' 210' ' ' LEU . 0.8 OUTLIER -105.74 131.24 53.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.234 178.591 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -91.23 77.75 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.84 0.353 . . . . 0.0 111.808 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.793 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -101.26 87.09 3.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.689 ' HD2' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -59.65 24.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.108 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.619 ' H ' ' C ' ' A' ' 220' ' ' LEU . 5.7 m-20 -54.48 115.04 1.9 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.805 0.336 . . . . 0.0 110.791 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 t -56.31 -16.21 5.17 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.804 ' O ' HD11 ' A' ' 249' ' ' LEU . 1.9 pm0 -83.19 -23.51 32.82 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 1.059 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.4 p -97.18 92.26 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 0.0 110.084 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 36.1 m -37.89 -48.18 1.12 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.271 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.06 -50.1 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.698 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.415 ' HD3' ' CB ' ' A' ' 216' ' ' SER . 0.4 OUTLIER -141.26 125.87 17.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.424 0.63 . . . . 0.0 110.738 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.519 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.9 t60 -89.8 -62.17 1.53 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.6 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -145.32 178.01 8.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.39 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.74 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -160.81 178.25 9.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.659 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.551 HG12 ' HB3' ' A' ' 243' ' ' LEU . 6.5 mt -138.85 149.92 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.149 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.427 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -161.24 143.49 12.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.091 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.909 ' CH2' HG13 ' A' ' 198' ' ' VAL . 5.2 p90 -131.89 165.25 24.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.65 133.78 55.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.645 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 95.5 p -91.75 0.71 57.47 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.264 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.8 m -77.72 -32.33 52.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.7 0.762 . . . . 0.0 109.825 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.541 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -134.78 16.22 3.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.308 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.416 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 17.8 p90 43.73 62.46 1.91 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.459 0.647 . . . . 0.0 109.609 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.802 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 5.1 mptt -125.86 140.58 52.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.207 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.717 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -125.21 118.0 25.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.37 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.7 pt-20 -133.97 148.09 51.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.994 0.902 . . . . 0.0 112.821 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.838 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.3 pp -112.19 149.71 31.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.925 -1.488 . . . . 0.0 110.843 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 1.032 HG22 ' HB3' ' A' ' 269' ' ' TRP . 0.8 OUTLIER -124.46 160.86 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.617 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 9.2 m-20 -110.7 108.66 18.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.547 ' CE ' ' HG2' ' A' ' 231' ' ' GLN . 1.8 ptp -86.38 106.85 17.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 50.25 62.73 4.84 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.173 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.405 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 2.8 p -79.14 71.35 5.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.866 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.08 -56.64 17.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.844 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.866 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -73.35 -27.11 61.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 111.017 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 248' ' ' SER . . . 91.16 135.22 6.37 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.81 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.569 HG22 ' CD1' ' A' ' 281' ' ' ILE . 3.5 m -97.3 156.84 16.26 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.687 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -149.04 139.17 22.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.077 0.465 . . . . 0.0 111.297 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.628 HG23 HD11 ' A' ' 259' ' ' ILE . 48.9 t -109.83 133.02 56.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.266 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.692 ' HA ' HG13 ' A' ' 280' ' ' ILE . 11.4 p30 53.02 38.07 26.36 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.256 0.551 . . . . 0.0 110.689 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.2 m 70.68 36.75 1.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.876 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.01 113.18 6.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.947 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 69.0 p -63.82 82.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.471 0.653 . . . . 0.0 110.384 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.78 HG12 HG11 ' A' ' 273' ' ' VAL . 0.4 OUTLIER -81.31 -10.75 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.73 -178.141 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.499 ' N ' HD12 ' A' ' 259' ' ' ILE . 15.4 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 270' ' ' GLY . 2.6 ptmm? . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.583 0.23 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 1.032 ' HB3' HG22 ' A' ' 244' ' ' VAL . 0.5 OUTLIER -79.71 -6.17 56.67 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.709 179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . 0.449 ' H ' ' HG3' ' A' ' 268' ' ' LYS . . . 74.85 -106.93 2.17 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 119.485 -1.34 . . . . 0.0 109.759 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 273' ' ' VAL . 0.7 OUTLIER -152.14 125.1 4.1 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.67 174.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 84.9 Cg_exo -38.66 102.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.723 1.616 . . . . 0.0 110.04 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.78 HG11 HG12 ' A' ' 259' ' ' ILE . 45.3 t -93.08 139.04 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.299 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.717 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.4 mm-40 -84.55 127.5 34.08 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.255 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.983 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.56 164.76 13.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.37 179.531 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.633 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.85 161.24 39.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.579 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 1.5 m -62.27 131.93 51.0 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.778 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' A' ' 277' ' ' SER . 34.6 m-20 80.16 -0.2 2.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.414 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -71.73 -164.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.701 HG22 ' HD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -157.13 123.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.161 177.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.737 HG22 HG23 ' A' ' 289' ' ' VAL . 0.3 OUTLIER -104.89 157.73 5.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.945 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.687 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 2.9 m -150.38 126.58 10.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.713 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -121.85 49.96 1.49 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 175.26 -134.26 2.67 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.496 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.422 HG22 ' OE2' ' A' ' 224' ' ' GLU . 9.5 t -89.44 -38.63 13.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.119 0.485 . . . . 0.0 109.805 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -151.65 -5.63 0.25 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.11 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.808 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 26.3 m -66.63 99.95 0.64 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.196 0.522 . . . . 0.0 111.353 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.563 ' O ' HG22 ' A' ' 289' ' ' VAL . 17.0 mttt -99.13 178.93 4.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.592 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.737 HG23 HG22 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -162.72 120.0 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.088 177.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.701 ' HD1' HG22 ' A' ' 280' ' ' ILE . 1.7 t80 -75.76 136.98 40.28 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.53 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.983 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -107.2 111.36 35.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.183 -178.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 9.0 tpt85 -128.24 144.14 51.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.458 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.609 HD12 ' CZ3' ' A' ' 241' ' ' TRP . 20.9 mt -143.01 123.75 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.26 153.46 46.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.696 0.284 . . . . 0.0 110.533 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 73.1 m -80.63 174.95 11.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.821 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.93 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.308 0.099 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 17.8 m95 -151.09 148.8 28.75 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.893 HD11 ' CD1' ' A' ' 184' ' ' LEU . 0.1 OUTLIER -128.36 127.57 42.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.021 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.845 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.3 m-85 -125.69 142.09 51.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.908 0.861 . . . . 0.0 112.531 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.893 ' CD1' HD11 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -137.66 147.44 44.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.022 176.421 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -139.56 129.45 24.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.827 HG21 HD12 ' A' ' 194' ' ' LEU . 26.9 t -66.41 116.18 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 288' ' ' LYS . 4.7 tt -99.01 -22.2 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.887 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -160.63 92.54 0.96 Allowed 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.714 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.4 -169.8 25.19 Favored Glycine 0 CA--C 1.516 0.116 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.635 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 96.3 Cg_endo -81.02 28.45 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.042 1.828 . . . . 0.0 111.631 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.836 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.51 24.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.912 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.714 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.5 mt -39.53 114.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.876 0.37 . . . . 0.0 111.954 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.24 7.74 4.34 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.924 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.836 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -97.12 128.25 43.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 10.8 mt-30 -127.71 150.84 49.6 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.022 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.726 ' O ' HD22 ' A' ' 184' ' ' LEU . 1.0 OUTLIER -141.62 142.05 33.43 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.83 179.387 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -132.5 136.33 46.59 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.189 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.655 HG21 ' HG ' ' A' ' 206' ' ' LEU . 12.3 p -141.39 130.92 24.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.487 0.66 . . . . 0.0 111.863 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -85.88 145.56 27.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.949 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.452 ' HG ' ' HE1' ' A' ' 234' ' ' TRP . 12.2 t -63.55 -3.55 2.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.69 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.52 6.46 32.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.504 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -85.69 130.59 34.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.0 110.289 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.9 t -90.65 -90.16 0.16 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 24.7 p -84.51 14.81 4.17 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.504 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -123.49 -14.39 7.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.036 0.446 . . . . 0.0 110.522 179.038 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.655 ' HG ' HG21 ' A' ' 198' ' ' VAL . 7.8 tt -65.61 -62.53 4.36 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.75 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -43.17 99.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.36 2.04 . . . . 0.0 112.584 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 87.3 t -68.36 164.71 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.902 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 25.5 mtmt -141.41 94.57 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.049 HD23 HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -87.96 131.03 34.76 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.28 173.65 45.31 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.993 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.876 ' HD3' HG12 ' A' ' 213' ' ' VAL . 12.2 ttt180 -71.15 -74.96 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.808 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.876 HG12 ' HD3' ' A' ' 212' ' ' ARG . 10.2 p -140.54 110.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.462 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.578 ' CB ' ' HD2' ' A' ' 215' ' ' PRO . 0.3 OUTLIER 178.61 179.89 0.23 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.962 -179.026 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 37.0 Cg_endo -66.1 25.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 121.907 1.738 . . . . 0.0 112.331 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -68.21 -172.93 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.966 0.412 . . . . 0.0 111.242 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.425 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 13.3 m-20 -104.7 -29.48 10.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.474 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.049 HD12 HD23 ' A' ' 210' ' ' LEU . 5.7 mt -112.64 131.68 55.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -98.25 87.72 3.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.567 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.661 HD11 ' CG2' ' A' ' 186' ' ' VAL . 3.0 mm? -103.72 59.65 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.681 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -53.2 73.19 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.22 -178.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.635 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 7.0 t0 -116.58 143.11 46.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.003 0.43 . . . . 0.0 110.311 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.5 t -63.5 -5.3 3.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.541 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.697 ' HG2' HG22 ' A' ' 285' ' ' THR . 0.1 OUTLIER -86.79 -30.73 21.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 109.869 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 0.1 OUTLIER -95.62 107.68 19.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.601 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -49.38 71.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.137 0.494 . . . . 0.0 110.297 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 228' ' ' LYS . . . -148.1 -51.06 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.1 OUTLIER -145.81 125.11 13.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.013 0.435 . . . . 0.0 110.479 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.574 ' HB2' ' CG1' ' A' ' 225' ' ' VAL . 2.5 t60 -84.56 -58.95 2.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.196 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.902 ' HB3' HD22 ' A' ' 283' ' ' LEU . . . -152.23 175.53 12.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.498 -177.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.731 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -155.55 179.96 8.68 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.817 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.75 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.5 mt -135.79 149.44 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.41 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.4 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -153.69 164.35 38.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.635 ' CD2' HD11 ' A' ' 206' ' ' LEU . 0.6 OUTLIER -93.33 153.43 18.55 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.018 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 239' ' ' PHE . 2.3 m-20 -119.35 71.02 0.85 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.722 -1.581 . . . . 0.0 106.975 174.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.1 p -53.87 -23.24 11.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.9 m -74.38 -27.12 60.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.549 0.69 . . . . 0.0 109.235 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -117.25 8.66 13.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.334 178.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 235' ' ' ASN . 2.7 p90 38.38 39.47 0.29 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.622 0.248 . . . . 0.0 111.039 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -112.27 179.96 3.85 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.423 0.63 . . . . 0.0 110.009 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.784 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -131.02 115.0 15.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.917 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 14.0 pt-20 -137.65 151.72 48.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.692 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.4 pp -116.34 153.85 31.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.053 -1.431 . . . . 0.0 111.802 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.805 HG21 ' CD1' ' A' ' 269' ' ' TRP . 2.1 p -121.7 162.69 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.672 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.775 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 8.3 t0 -102.49 116.88 33.52 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -77.53 98.0 5.21 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 56.2 70.18 1.05 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.704 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.5 p -62.87 48.15 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.973 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.58 -49.81 73.76 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.231 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.973 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.5 -39.02 28.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 93.52 93.39 1.54 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.614 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 1.06 HG23 HD23 ' A' ' 283' ' ' LEU . 20.0 m -50.2 164.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.689 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -150.29 139.7 21.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.328 0.585 . . . . 0.0 111.303 179.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.872 HG22 HG12 ' A' ' 281' ' ' ILE . 70.3 t -114.37 137.13 48.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.748 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.677 ' HA ' HG13 ' A' ' 280' ' ' ILE . 23.4 p30 47.69 34.98 4.06 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.307 0.575 . . . . 0.0 110.421 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 72.87 35.35 1.02 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.481 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 259' ' ' ILE . 64.5 t-80 -137.56 111.42 8.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.714 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 5.4 t -63.05 84.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.454 0.645 . . . . 0.0 110.992 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.868 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -84.28 -8.49 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.724 -178.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.775 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 21.4 m . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.614 ' HE3' ' HB2' ' A' ' 269' ' ' TRP . 13.2 ttpt . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.805 ' CD1' HG21 ' A' ' 244' ' ' VAL . 12.2 t-105 -83.66 -27.46 29.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.435 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.79 -178.29 5.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.203 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -105.09 146.89 33.57 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.106 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.692 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 71.8 Cg_exo -49.88 148.99 11.8 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.594 2.196 . . . . 0.0 112.857 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.841 HG11 HG13 ' A' ' 259' ' ' ILE . 69.2 t -129.86 136.31 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.4 mp0 -81.53 128.14 33.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 118.794 -1.162 . . . . 0.0 112.052 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 1.031 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -93.0 165.93 12.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.027 178.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.683 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.28 161.73 37.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.682 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 3.7 p -62.64 130.04 43.24 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.281 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' A' ' 277' ' ' SER . 30.9 m-20 81.87 -1.48 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.449 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.683 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.2 OUTLIER -70.8 -162.83 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.723 HG22 ' HD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -159.97 129.09 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.226 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.872 HG12 HG22 ' A' ' 254' ' ' VAL . 0.3 OUTLIER -117.3 93.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 288' ' ' LYS . 1.8 m -79.56 129.51 34.54 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 1.06 HD23 HG23 ' A' ' 252' ' ' THR . 0.5 OUTLIER -118.92 50.53 1.2 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.424 -178.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.528 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 162.73 -119.01 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 119.198 -1.477 . . . . 0.0 113.673 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.697 HG22 ' HG2' ' A' ' 224' ' ' GLU . 1.7 t -95.51 -58.75 2.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.374 0.131 . . . . 0.0 111.159 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.494 ' H ' HG23 ' A' ' 285' ' ' THR . 1.3 t -134.08 -1.28 2.97 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.762 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.887 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 40.4 m -72.51 102.14 3.15 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.697 ' O ' HG22 ' A' ' 187' ' ' ILE . 12.7 ttmt -119.4 123.36 43.92 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.104 0.478 . . . . 0.0 111.286 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 1.1 t -103.01 129.86 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.964 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.723 ' HD1' HG22 ' A' ' 280' ' ' ILE . 0.6 OUTLIER -77.36 133.85 38.62 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.659 -0.416 . . . . 0.0 109.912 -179.309 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 1.031 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -103.44 112.81 38.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.633 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -130.59 141.14 50.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.949 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.784 HD12 ' CE3' ' A' ' 241' ' ' TRP . 2.1 mt -138.98 143.2 32.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.8 t -151.67 164.23 37.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.1 -169.87 2.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.428 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.77 0.319 . . . . 0.0 111.067 -179.81 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.672 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.9 m95 -147.65 130.58 16.21 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.57 ' HB2' ' HZ3' ' A' ' 241' ' ' TRP . 5.2 tp -113.27 124.37 52.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.058 177.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.672 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 6.5 m-85 -123.39 130.27 52.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.713 0.768 . . . . 0.0 110.791 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.837 HD13 ' CD2' ' A' ' 196' ' ' HIS . 1.2 mp -131.6 142.61 49.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.346 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.573 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 24.6 tt0 -140.2 124.8 18.08 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.272 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.767 HG21 HD12 ' A' ' 194' ' ' LEU . 11.1 t -61.33 113.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 288' ' ' LYS . 8.6 tt -97.05 -20.46 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.739 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.69 95.01 0.71 Allowed 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.919 -179.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.767 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.32 -175.81 33.74 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 178.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.547 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 96.3 Cg_endo -79.23 30.95 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.782 1.655 . . . . 0.0 110.966 178.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.941 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.81 24.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.767 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.2 mt -39.55 113.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.75 11.26 2.98 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.3 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.941 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -100.67 155.89 17.63 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.823 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.744 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 27.2 mt-30 -150.61 151.3 32.35 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.801 -177.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.837 ' CD2' HD13 ' A' ' 184' ' ' LEU . 3.7 p-80 -138.56 128.62 25.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.08 164.43 30.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.407 -179.099 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.828 HG21 ' HA ' ' A' ' 206' ' ' LEU . 5.9 p -172.84 156.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.4 0.619 . . . . 0.0 111.726 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.505 ' N ' HG22 ' A' ' 198' ' ' VAL . 3.3 m120 -91.52 144.76 25.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.395 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.455 ' HB2' ' CZ2' ' A' ' 234' ' ' TRP . 3.2 t -61.37 -4.52 1.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.455 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.9 t -102.08 0.54 35.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.593 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -75.12 138.27 41.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.418 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.2 m -87.18 -89.08 0.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.2 18.8 17.8 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.777 0.323 . . . . 0.0 111.722 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -6.88 11.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.525 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.828 ' HA ' HG21 ' A' ' 198' ' ' VAL . 7.5 tt -75.6 -62.53 0.77 Allowed Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.795 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.8 Cg_endo -42.7 99.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.254 1.969 . . . . 0.0 112.765 -178.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.73 HG11 ' CD2' ' A' ' 196' ' ' HIS . 43.1 t -69.54 165.31 2.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.757 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 4.3 mtpp -135.18 90.19 2.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.028 HD23 HD12 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -78.11 124.93 28.62 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.891 -179.945 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.56 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . 177.01 -173.72 46.52 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.823 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.755 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.6 OUTLIER -60.32 155.92 16.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.583 0.23 . . . . 0.0 110.936 -179.755 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 213' ' ' VAL . 10.0 p -77.29 119.43 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.892 0.854 . . . . 0.0 113.204 -176.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.759 ' CB ' ' HD3' ' A' ' 215' ' ' PRO . 0.6 OUTLIER 160.88 -75.99 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.709 178.92 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.759 ' HD3' ' CB ' ' A' ' 214' ' ' SER . 42.9 Cg_endo -100.9 -14.82 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.653 2.235 . . . . 0.0 112.837 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.447 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 1.2 m -80.21 157.29 26.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.003 0.43 . . . . 0.0 111.758 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.524 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.7 OUTLIER -73.16 -37.23 66.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.805 178.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.028 HD12 HD23 ' A' ' 210' ' ' LEU . 1.7 mt -98.06 134.85 40.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.583 178.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.736 ' HB3' HD22 ' A' ' 194' ' ' LEU . . . -89.39 76.21 7.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.003 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.807 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 2.8 mm? -109.36 94.68 5.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.547 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -64.71 24.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.656 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.944 ' HB3' HG12 ' A' ' 225' ' ' VAL . 0.4 OUTLIER -55.75 116.05 2.71 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.222 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.4 t -58.73 -20.38 48.6 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.823 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.545 ' CG ' ' HB2' ' A' ' 250' ' ' ASN . 2.3 tp10 -75.11 -19.57 59.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 0.0 110.812 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.944 HG12 ' HB3' ' A' ' 222' ' ' ASP . 5.8 p -124.37 64.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.921 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 10.1 p -46.12 -31.93 2.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.834 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -125.69 -78.86 0.32 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.375 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -139.29 131.0 27.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.076 0.465 . . . . 0.0 110.74 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 245' ' ' ASP . 0.3 OUTLIER -99.59 -55.94 2.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.637 178.908 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.636 ' HB2' ' OD2' ' A' ' 245' ' ' ASP . . . -148.97 164.9 33.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.542 0.687 . . . . 0.0 112.563 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.628 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -149.97 -178.24 6.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.522 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.795 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.1 mt -135.9 151.86 29.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 121.071 0.463 . . . . 0.0 112.198 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.23 163.69 39.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.163 178.213 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.784 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -91.4 152.66 20.31 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -176.286 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 239' ' ' PHE . 26.8 t-20 -120.58 72.29 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.8 t -59.77 -15.83 23.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -175.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 90.7 m -84.33 -35.58 23.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.44 0.638 . . . . 0.0 110.625 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.486 ' HE3' ' CE1' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -112.6 11.83 19.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.355 179.881 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.486 ' CE1' ' HE3' ' A' ' 238' ' ' LYS . 12.5 p90 42.25 69.55 0.36 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 2.0 mptp? -136.96 147.29 46.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.296 -178.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.735 ' CZ3' HG23 ' A' ' 293' ' ' ILE . 0.5 OUTLIER -114.14 103.46 11.14 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 178.656 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 27.6 mt-10 -125.08 143.63 50.82 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.104 0.954 . . . . 0.0 113.286 -176.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.81 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.4 pp -109.0 151.59 26.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.296 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 1.018 HG22 ' HB2' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -125.06 154.09 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.182 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.636 ' OD2' ' HB2' ' A' ' 230' ' ' ALA . 5.5 m-20 -117.04 100.49 7.78 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.607 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -64.17 106.64 1.11 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.012 178.332 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.72 68.32 1.75 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.577 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 52.2 p -76.87 61.04 1.86 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 250' ' ' ASN . 1.6 tm? -49.84 -60.01 3.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.149 0.5 . . . . 0.0 110.139 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.545 ' HB2' ' CG ' ' A' ' 224' ' ' GLU . 4.1 t-20 -69.72 -22.34 63.4 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.832 -179.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 81.67 84.57 0.76 Allowed Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.549 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.769 ' C ' HD23 ' A' ' 253' ' ' LEU . 55.7 m -46.46 164.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.555 0.178 . . . . 0.0 110.641 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.769 HD23 ' C ' ' A' ' 252' ' ' THR . 0.1 OUTLIER -148.38 126.69 12.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.26 0.552 . . . . 0.0 112.103 179.033 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.745 HG23 HD11 ' A' ' 259' ' ' ILE . 99.8 t -101.95 129.27 53.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.359 178.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 52.6 t-20 53.35 43.06 31.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.138 0.494 . . . . 0.0 110.195 -179.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.36 31.02 17.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.062 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.406 ' O ' ' N ' ' A' ' 259' ' ' ILE . 0.1 OUTLIER -136.73 106.83 6.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.558 179.648 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 60.1 p -57.6 87.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.267 0.556 . . . . 0.0 110.76 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.785 ' HB ' HG21 ' A' ' 273' ' ' VAL . 1.0 OUTLIER -88.34 -2.38 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.37 -178.961 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.651 ' OG ' ' HB ' ' A' ' 252' ' ' THR . 1.4 m . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.558 ' HD3' ' CD1' ' A' ' 269' ' ' TRP . 2.7 ptpt . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 1.018 ' HB2' HG22 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -95.0 -10.81 29.8 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 179.556 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . 0.522 ' H ' ' HG3' ' A' ' 268' ' ' LYS . . . 58.06 -148.37 36.43 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 118.833 -1.651 . . . . 0.0 111.171 -178.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -96.36 126.51 43.58 Favored Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.507 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 4.0 Cg_exo -38.74 120.69 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.983 2.456 . . . . 0.0 111.887 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.785 HG21 ' HB ' ' A' ' 259' ' ' ILE . 48.5 t -94.36 135.3 29.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.921 -177.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -81.7 127.16 32.63 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.545 0.688 . . . . 0.0 110.984 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.924 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.49 162.63 14.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.96 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.11 156.76 45.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.047 0.451 . . . . 0.0 112.054 -179.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.655 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 29.7 p -59.05 128.76 38.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.655 ' HB2' ' O ' ' A' ' 277' ' ' SER . 30.7 m-20 87.13 2.45 0.44 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.143 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -75.78 -166.08 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.523 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.7 OUTLIER -161.51 130.82 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.085 178.208 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.65 HD12 HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -112.22 156.97 13.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.052 0.453 . . . . 0.0 111.321 178.436 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.658 HG23 ' CG ' ' A' ' 288' ' ' LYS . 1.9 m -141.7 119.17 11.58 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.314 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.617 HD23 ' CG2' ' A' ' 252' ' ' THR . 0.7 OUTLIER -111.84 47.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.898 -178.253 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 167.22 -128.14 1.69 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 119.621 -1.276 . . . . 0.0 113.796 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.8 t -89.9 -46.65 8.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.622 0.249 . . . . 0.0 111.137 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 188' ' ' ALA . 3.5 t -144.0 -7.36 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 47.6 m -64.15 103.21 0.59 Allowed 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.757 ' O ' HG22 ' A' ' 187' ' ' ILE . 5.5 mtpt -124.72 133.05 53.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 111.318 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.65 HG23 HD12 ' A' ' 281' ' ' ILE . 0.1 OUTLIER -112.21 135.5 51.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.564 -179.311 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.4 t80 -77.05 139.29 39.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.7 OUTLIER -110.28 114.11 46.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.544 -178.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 11.8 tpt180 -127.65 148.28 50.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.801 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.735 HG23 ' CZ3' ' A' ' 241' ' ' TRP . 14.3 mt -141.13 113.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.58 156.09 45.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.762 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 22.8 m -90.51 162.04 15.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.873 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.032 -179.869 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 1.4 t . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.711 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 9.9 m95 -149.53 137.79 20.64 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.29 -178.307 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.951 HD12 ' N ' ' A' ' 183' ' ' PHE . 1.2 tp -119.85 131.05 55.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.951 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.7 m-85 -130.32 141.12 50.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.83 0.824 . . . . 0.0 111.595 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.989 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -139.46 152.73 47.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.994 178.079 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 17.7 tt0 -143.56 126.25 16.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.729 HG21 HD12 ' A' ' 194' ' ' LEU . 10.9 t -62.01 115.52 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.2 tt -100.56 -22.11 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -176.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.816 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -161.58 91.03 0.81 Allowed 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.601 -178.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.611 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.89 -170.54 26.76 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 178.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.524 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 91.6 Cg_endo -81.81 29.34 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.253 1.969 . . . . 0.0 111.589 178.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.821 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.05 27.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.611 HG12 ' H ' ' A' ' 189' ' ' GLY . 7.8 mt -45.38 112.11 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 111.506 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.47 6.05 2.17 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.223 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.821 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.2 OUTLIER -98.47 138.94 34.95 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.703 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.539 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 17.1 mt-30 -137.92 153.08 49.53 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.515 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.989 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -147.83 147.76 30.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.634 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -147.56 166.67 26.64 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.991 -179.241 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 1.015 HG21 ' HA ' ' A' ' 206' ' ' LEU . 5.7 p -171.82 147.92 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.535 0.683 . . . . 0.0 111.984 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.466 ' OD1' ' CZ2' ' A' ' 181' ' ' TRP . 0.8 OUTLIER -93.11 147.87 22.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.693 179.219 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 24.8 p -65.88 -2.23 3.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.255 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.77 -4.17 25.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.032 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.623 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -94.27 125.51 38.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.548 179.871 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 207' ' ' PRO . 62.2 p -91.54 -81.28 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.12 3.21 0.63 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.475 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -120.87 -8.32 9.42 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.128 -0.358 . . . . 0.0 111.573 179.851 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 1.015 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.6 tt -71.9 -61.25 2.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.572 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.7 Cg_endo -43.75 96.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.967 1.778 . . . . 0.0 112.764 -178.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.903 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 3.4 t -68.62 157.85 6.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.95 179.068 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 217' ' ' ASP . 4.5 mtmm -135.71 93.48 2.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.042 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -86.86 123.19 31.71 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.735 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -168.14 169.72 41.6 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.504 -179.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.864 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 14.7 ttt180 -72.01 -74.4 0.16 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.014 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 213' ' ' VAL . 8.6 p -138.94 115.08 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 216' ' ' SER . 0.3 OUTLIER 169.18 -176.29 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.1 -179.578 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 16.4 Cg_exo -67.96 23.26 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.47 2.113 . . . . 0.0 112.589 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 214' ' ' SER . 3.5 m -64.23 -150.43 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.987 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.8 OUTLIER -132.16 -34.04 1.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.486 179.809 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.042 HD12 HD23 ' A' ' 210' ' ' LEU . 1.1 mt -105.47 126.08 51.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -92.09 83.1 5.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.887 0.375 . . . . 0.0 111.432 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.864 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.3 mm? -104.69 89.44 3.19 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.472 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.1 OUTLIER -64.0 38.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.618 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.524 ' HA ' ' HG3' ' A' ' 190' ' ' PRO . 12.6 t0 -64.18 123.32 18.79 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.18 179.191 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 60.1 p -67.45 -4.33 10.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.871 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -19.02 18.11 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.673 HG22 ' ND1' ' A' ' 229' ' ' HIS . 79.0 t -93.81 81.98 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.49 178.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -38.68 -48.01 1.42 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.441 -179.038 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.58 -55.38 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.693 ' HB2' ' HG3' ' A' ' 246' ' ' MET . 0.2 OUTLIER -140.93 128.31 21.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.998 0.427 . . . . 0.0 110.772 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.673 ' ND1' HG22 ' A' ' 225' ' ' VAL . 0.7 OUTLIER -98.22 -59.71 1.7 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.46 179.088 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 244' ' ' VAL . . . -149.22 170.89 17.43 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.903 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 1.7 mt-30 -151.58 173.64 14.39 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.745 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.546 HG12 HD22 ' A' ' 243' ' ' LEU . 3.5 mt -127.03 143.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.519 0.676 . . . . 0.0 112.19 179.063 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.74 127.34 3.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.942 ' CH2' HG13 ' A' ' 198' ' ' VAL . 5.7 p90 -118.08 166.05 13.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.96 132.87 56.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.058 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.09 -0.26 57.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.453 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 19.8 m -79.02 -36.76 40.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.731 0.777 . . . . 0.0 109.521 178.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.38 17.4 7.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.476 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 12.8 p90 41.12 59.2 2.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.463 0.649 . . . . 0.0 110.014 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.735 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.97 138.4 54.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.624 179.872 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.64 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.71 120.02 32.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.89 179.571 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 21.8 mt-10 -132.97 144.03 49.85 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.851 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.2 OUTLIER -89.03 146.8 24.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.959 -1.928 . . . . 0.0 108.4 178.064 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.721 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 6.0 p -122.32 163.47 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 118.718 0.69 . . . . 0.0 109.316 178.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.53 ' CG ' ' HA ' ' A' ' 260' ' ' SER . 2.0 m-20 -118.84 110.14 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.737 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -79.82 105.15 10.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.466 178.148 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.29 69.38 1.28 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.205 -179.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.01 45.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.905 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -58.37 -54.03 51.61 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.781 -0.575 . . . . 0.0 109.846 178.38 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.905 ' H ' HD13 ' A' ' 249' ' ' LEU . 1.4 m-20 -79.12 -34.11 43.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.003 0.43 . . . . 0.0 110.627 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 260' ' ' SER . . . 87.46 98.42 0.88 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.774 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.542 ' C ' HD23 ' A' ' 253' ' ' LEU . 3.1 m -61.07 170.56 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.479 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -153.25 127.0 8.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.433 178.54 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.554 HG22 HG13 ' A' ' 281' ' ' ILE . 86.1 t -103.44 130.58 53.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.522 178.347 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.51 ' HA ' HG13 ' A' ' 280' ' ' ILE . 23.8 t-20 54.03 48.8 20.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.096 0.474 . . . . 0.0 110.216 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.84 23.51 8.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -127.74 105.71 8.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.257 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 86.7 p -55.62 86.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.488 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.802 ' HB ' HG21 ' A' ' 273' ' ' VAL . 2.9 pp -86.15 20.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.332 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.53 ' HA ' ' CG ' ' A' ' 245' ' ' ASP . 78.5 p . . . . . 0 N--CA 1.451 -0.397 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.344 -178.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.737 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 0.0 OUTLIER -79.67 -14.58 58.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.149 -178.994 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 59.62 -172.34 5.09 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -178.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -113.68 131.94 22.81 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 118.242 1.021 . . . . 0.0 110.178 179.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.49 ' HB3' ' HB2' ' A' ' 242' ' ' GLU . 80.0 Cg_exo -44.83 119.92 2.59 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.809 2.339 . . . . 0.0 114.055 -178.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.802 HG21 ' HB ' ' A' ' 259' ' ' ILE . 49.3 t -104.14 133.02 49.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -75.15 128.11 34.75 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -176.678 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.828 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.44 165.09 13.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 113.86 -1.518 . . . . 0.0 108.864 178.088 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.52 158.43 44.01 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.57 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.705 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 5.5 p -58.25 130.09 45.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.652 178.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.705 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.1 m-20 85.55 7.15 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.831 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.675 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.8 m-20 -78.78 -169.52 1.79 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.5 OUTLIER -160.78 129.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 177.488 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.863 ' CG2' HG23 ' A' ' 289' ' ' VAL . 1.0 OUTLIER -106.15 157.05 6.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.809 0.337 . . . . 0.0 111.394 179.762 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.531 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.7 m -145.98 116.71 7.66 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.66 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -110.65 45.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.087 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 170.87 -128.81 1.68 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 119.317 -1.42 . . . . 0.0 114.201 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 t -86.49 -48.33 8.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.78 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.2 t -146.43 -4.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.816 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 17.0 m -66.92 104.29 1.33 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.25 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.749 ' O ' HG22 ' A' ' 187' ' ' ILE . 1.3 ptmt -126.81 135.84 51.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 0.0 111.581 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.863 HG23 ' CG2' ' A' ' 281' ' ' ILE . 0.1 OUTLIER -111.92 135.18 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.093 -178.927 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 4.6 t80 -76.89 138.84 39.99 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.049 -179.438 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.401 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -109.91 112.09 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.753 -178.545 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -137.34 145.55 43.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.88 179.866 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.679 HG12 HD13 ' A' ' 182' ' ' LEU . 1.3 mt -135.82 145.79 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.634 -179.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.01 139.68 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.988 0.423 . . . . 0.0 111.494 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.51 165.97 22.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.975 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.984 -179.572 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.591 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 3.1 m . . . . . 0 CA--C 1.52 -0.197 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.727 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.1 m95 -140.06 130.41 25.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.945 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.5 OUTLIER -119.87 131.51 55.28 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.151 177.719 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.945 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.4 OUTLIER -135.92 145.68 46.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.891 0.853 . . . . 0.0 111.263 -179.858 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.675 HD21 ' HB3' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -144.14 149.8 37.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.837 178.588 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 1.3 tt0 -137.03 124.82 22.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.019 -177.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.911 HG21 HD11 ' A' ' 220' ' ' LEU . 40.1 t -64.21 116.3 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.922 HG22 ' O ' ' A' ' 288' ' ' LYS . 8.7 tt -99.94 -23.3 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -175.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.88 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -155.42 91.21 1.3 Allowed 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.494 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.559 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.27 -177.11 35.94 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.542 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 74.0 Cg_endo -77.98 31.79 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.08 1.853 . . . . 0.0 111.788 178.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.829 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -161.64 21.52 0.12 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.794 178.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.559 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.7 mt -39.63 113.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 0.0 111.656 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.7 7.96 2.9 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.901 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.829 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.6 OUTLIER -99.34 109.19 21.83 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.814 0.816 . . . . 0.0 109.749 178.771 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.453 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 16.4 mt-30 -111.39 153.79 25.55 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.727 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.675 ' HB3' HD21 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -146.43 146.41 30.58 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.88 179.921 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.31 153.4 40.5 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.769 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.785 HG21 ' HG ' ' A' ' 206' ' ' LEU . 14.8 p -155.35 146.48 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.349 0.595 . . . . 0.0 111.82 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.591 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.8 OUTLIER -85.06 145.81 27.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.546 178.128 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.445 ' HB2' ' CZ2' ' A' ' 234' ' ' TRP . 5.7 t -63.15 -6.97 4.82 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.11 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.499 HG22 ' HB3' ' A' ' 199' ' ' ASN . 3.7 t -101.95 42.84 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.302 0.572 . . . . 0.0 111.323 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.461 ' HB2' ' CG ' ' A' ' 205' ' ' LYS . 6.3 p -135.0 106.27 6.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.523 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.7 m -76.02 -87.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.83 5.32 7.98 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.461 ' CG ' ' HB2' ' A' ' 202' ' ' SER . 2.4 pttt -122.48 56.27 1.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.89 HD11 ' CE3' ' A' ' 234' ' ' TRP . 7.9 tt -146.34 -53.84 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.975 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 3.4 Cg_exo -40.59 96.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.374 2.049 . . . . 0.0 113.076 -177.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 231' ' ' GLN . 61.7 t -74.96 97.83 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.337 0.062 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.167 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.729 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 6.0 mtmm -69.69 93.41 0.72 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.108 HD23 HD12 ' A' ' 218' ' ' LEU . 0.7 OUTLIER -78.53 129.55 34.97 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.611 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 179.55 -177.27 48.16 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.097 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.909 ' HB2' HG12 ' A' ' 225' ' ' VAL . 55.5 ttt180 -82.4 -68.66 0.68 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.094 0.558 . . . . 0.0 112.448 -178.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.864 HG22 ' H ' ' A' ' 214' ' ' SER . 9.6 p -116.9 -151.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.099 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.864 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.5 OUTLIER 66.37 173.31 0.08 OUTLIER Pre-proline 0 C--O 1.231 0.118 0 O-C-N 122.125 -0.36 . . . . 0.0 110.264 -179.806 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 72.0 Cg_endo -74.27 40.63 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.475 2.116 . . . . 0.0 113.336 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 209' ' ' LYS . 0.6 OUTLIER -71.56 168.01 18.53 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.616 0.246 . . . . 0.0 110.347 179.365 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 1.8 m-20 -85.02 -34.36 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.371 . . . . 0.0 110.605 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.108 HD12 HD23 ' A' ' 210' ' ' LEU . 1.8 mt -101.83 127.68 48.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.652 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -97.36 82.11 3.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.935 0.398 . . . . 0.0 110.992 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.911 HD11 HG21 ' A' ' 186' ' ' VAL . 2.5 mm? -105.97 73.36 0.99 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.184 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.28 60.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.623 ' N ' ' HG3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -107.26 127.79 53.85 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.961 0.41 . . . . 0.0 110.188 178.615 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.3 p -48.24 -24.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.454 0.645 . . . . 0.0 111.58 178.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.914 ' O ' HG23 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -109.92 73.2 0.83 Allowed 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.215 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 224' ' ' GLU . 1.9 t 169.72 3.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 113.08 -1.873 . . . . 0.0 108.626 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.886 ' O ' ' HB3' ' A' ' 212' ' ' ARG . 0.3 OUTLIER -7.23 -116.47 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.628 1.571 . . . . 0.0 114.635 -179.297 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.518 ' H ' ' HB3' ' A' ' 226' ' ' SER . . . -52.49 -89.54 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.029 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.644 ' O ' ' O ' ' A' ' 246' ' ' MET . 6.5 mttm -146.96 138.76 24.38 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.07 0.462 . . . . 0.0 109.95 179.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.602 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.1 OUTLIER -96.21 -59.94 1.73 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.58 -179.626 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -149.19 177.66 9.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.621 0.724 . . . . 0.0 112.474 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.729 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 3.8 pt20 -159.36 172.8 17.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.422 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.975 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 4.9 mt -126.77 143.82 38.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.308 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.485 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -145.5 162.53 37.17 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.721 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.89 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.6 OUTLIER -92.33 152.84 19.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.471 -177.05 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -119.29 71.33 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 175.16 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 17.8 p -54.61 -23.97 19.29 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -176.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.8 m -74.77 -22.15 58.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.556 0.693 . . . . 0.0 109.343 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 22.5 tptt -122.98 8.95 9.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.4 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 235' ' ' ASN . 8.0 p90 39.92 42.93 1.15 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.332 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -120.42 -179.02 3.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.489 0.662 . . . . 0.0 110.58 -179.643 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 1.039 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -131.86 119.82 21.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.783 -179.309 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 6.0 pt-20 -139.84 152.36 46.43 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.776 0.798 . . . . 0.0 113.099 -178.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.8 pp -111.16 153.29 25.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.775 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.796 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -123.14 162.34 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.55 -179.432 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.666 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 2.2 t0 -95.4 100.36 12.14 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 120.777 0.322 . . . . 0.0 111.508 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.644 ' O ' ' O ' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -87.09 90.57 8.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.041 178.964 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 48.01 70.67 0.69 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.933 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.414 ' OG ' ' CD2' ' A' ' 229' ' ' HIS . 3.2 t -95.6 78.23 3.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.578 HD13 ' C ' ' A' ' 249' ' ' LEU . 1.6 tm? -52.75 -58.85 5.53 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.142 0.496 . . . . 0.0 109.776 177.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.568 ' N ' HD13 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -68.33 -29.25 67.95 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.92 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.498 ' O ' ' CD2' ' A' ' 229' ' ' HIS . . . 101.32 156.43 26.89 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.726 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.551 ' C ' HD23 ' A' ' 253' ' ' LEU . 46.7 m -124.86 155.18 39.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.819 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -150.06 145.6 26.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.036 0.446 . . . . 0.0 111.558 179.621 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.858 HG23 ' CD1' ' A' ' 259' ' ' ILE . 75.2 t -116.9 138.3 47.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.095 178.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.483 ' HA ' HG13 ' A' ' 280' ' ' ILE . 3.8 p-10 49.0 37.08 9.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.211 0.529 . . . . 0.0 110.471 -178.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.06 36.85 1.33 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.127 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.708 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.1 OUTLIER -146.45 116.8 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.075 -179.916 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 51.7 p -62.09 90.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.298 0.571 . . . . 0.0 110.746 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.861 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.1 OUTLIER -92.98 -11.79 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.352 -177.758 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.451 ' HB3' ' CG ' ' A' ' 245' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? . . . . . 0 CA--C 1.517 -0.327 0 CA-C-O 121.375 0.607 . . . . 0.0 112.392 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.796 ' NE1' HG11 ' A' ' 244' ' ' VAL . 30.9 t-105 -77.34 -24.81 50.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.354 178.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 63.02 -179.01 5.66 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.322 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -107.82 134.15 20.18 Favored Pre-proline 0 C--N 1.332 -0.17 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.511 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 1.3 Cg_endo -44.93 136.64 9.84 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.166 2.577 . . . . 0.0 113.926 -178.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.861 HG21 ' CG1' ' A' ' 259' ' ' ILE . 62.2 t -109.21 129.43 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.0 pt-20 -74.31 132.24 41.89 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.417 -178.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.829 HD22 HG11 ' A' ' 291' ' ' VAL . 1.2 mt -89.1 163.22 15.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.973 -178.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -135.81 144.33 45.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.729 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 6.4 m -55.92 131.9 48.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.189 178.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 84.58 1.76 0.82 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.133 -179.26 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 3.2 t70 -72.96 -166.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.6 OUTLIER -160.4 133.49 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.896 178.542 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.65 HG12 HG22 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -110.94 156.57 12.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.061 0.458 . . . . 0.0 111.286 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.605 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 3.0 m -148.89 123.5 9.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.752 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -120.95 39.58 3.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.457 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -176.1 -136.42 2.35 Favored Glycine 0 C--N 1.328 0.095 0 C-N-CA 119.331 -1.414 . . . . 0.0 113.702 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.644 HG22 ' HG3' ' A' ' 224' ' ' GLU . 14.1 t -87.15 -48.85 7.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.588 0.232 . . . . 0.0 110.695 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.435 ' O ' ' HD2' ' A' ' 288' ' ' LYS . 1.3 t -140.25 2.32 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.319 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 31.7 m -74.93 102.09 4.66 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.69 0.281 . . . . 0.0 110.261 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.922 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -123.51 133.2 54.04 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.31 0.576 . . . . 0.0 110.918 -179.874 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.517 HG23 HG22 ' A' ' 281' ' ' ILE . 1.2 t -107.9 130.61 60.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.372 -178.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.5 t80 -76.15 136.7 39.79 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 110.309 -178.189 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.829 HG11 HD22 ' A' ' 275' ' ' LEU . 3.5 t -102.25 107.81 22.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.196 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.32 122.4 37.62 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 1.039 HD12 ' CE3' ' A' ' 241' ' ' TRP . 1.2 mt -132.58 146.51 32.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.7 t -152.2 166.13 32.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 111.146 -179.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 7.0 m -94.57 159.77 14.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.631 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.926 179.776 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 121.068 0.461 . . . . 0.0 110.935 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.3 m95 -146.88 139.45 24.96 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.13 -178.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 8.8 tp -116.88 124.53 49.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.634 178.053 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 5.7 m-85 -123.87 131.54 53.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.775 0.798 . . . . 0.0 110.197 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 1.018 HD13 ' CD2' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -131.45 142.69 50.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.331 -179.69 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.584 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 2.9 tt0 -139.39 124.68 19.06 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.873 HG21 HD12 ' A' ' 194' ' ' LEU . 10.5 t -62.95 104.84 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.102 0.477 . . . . 0.0 110.462 178.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.6 tt -87.03 -24.26 6.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 -177.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.738 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -166.64 98.62 0.57 Allowed 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.874 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.714 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.9 -175.04 32.51 Favored Glycine 0 N--CA 1.452 -0.272 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 178.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.563 ' O ' ' HG2' ' A' ' 221' ' ' LYS . 89.1 Cg_endo -77.31 28.71 0.43 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.099 1.866 . . . . 0.0 111.533 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.85 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.15 27.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.714 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.4 mt -39.97 111.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.453 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.58 6.56 2.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.257 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.873 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -99.51 162.2 13.16 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.883 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.735 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 12.7 mt-30 -156.59 149.67 24.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.076 -178.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 1.018 ' CD2' HD13 ' A' ' 184' ' ' LEU . 4.0 p-80 -136.98 129.06 29.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -139.12 164.62 29.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.075 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.588 HG21 ' HG ' ' A' ' 206' ' ' LEU . 10.1 p -175.32 155.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.56 0.695 . . . . 0.0 112.704 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.626 ' O ' HD12 ' A' ' 206' ' ' LEU . 4.0 m-80 -90.39 147.8 23.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.832 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.596 ' HA ' ' CE2' ' A' ' 234' ' ' TRP . 65.2 m -56.03 -49.92 72.37 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.107 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.93 5.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.797 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.3 OUTLIER -87.19 105.14 17.0 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.294 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . 0.445 ' HB3' ' H ' ' A' ' 204' ' ' SER . 1.0 OUTLIER -67.83 -107.48 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.099 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.445 ' H ' ' HB3' ' A' ' 203' ' ' SER . 3.2 m -70.48 6.23 1.48 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.128 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.488 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 8.9 pttt -120.32 55.98 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.212 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.829 HD11 ' CE3' ' A' ' 234' ' ' TRP . 8.0 tt -149.15 -59.87 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.791 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 4.5 Cg_exo -41.09 99.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.185 1.923 . . . . 0.0 112.189 -177.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.755 HG11 ' CD2' ' A' ' 196' ' ' HIS . 31.9 t -68.82 166.88 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.015 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -139.38 92.1 2.55 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.63 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.077 HD23 HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -76.79 125.24 28.95 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.324 178.895 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -166.22 168.59 39.97 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.64 -179.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.996 ' HB2' HG13 ' A' ' 225' ' ' VAL . 1.5 ttt85 -60.72 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.619 HG12 ' HD3' ' A' ' 212' ' ' ARG . 12.4 p -133.42 -12.4 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 0.0 111.735 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.639 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 1.4 m -49.85 176.5 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.732 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.639 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 28.4 Cg_endo -62.03 18.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.134 1.89 . . . . 0.0 112.667 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.57 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.6 OUTLIER -58.59 -178.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 111.31 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -96.57 -31.55 12.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.138 179.238 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.077 HD12 HD23 ' A' ' 210' ' ' LEU . 1.4 mt -104.66 131.42 52.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.619 178.609 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -98.09 82.5 2.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.596 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.831 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.3 mm? -102.2 86.37 2.83 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -60.07 67.83 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.856 179.865 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.921 ' HB3' HG12 ' A' ' 225' ' ' VAL . 5.3 t0 -97.77 151.17 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.232 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.5 p -90.38 -9.79 46.31 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.194 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.64 -20.64 24.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.427 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.996 HG13 ' HB2' ' A' ' 212' ' ' ARG . 3.6 p -107.26 86.76 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.4 m -37.62 -42.23 0.53 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.413 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.33 -55.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.9 OUTLIER -140.42 133.37 29.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.996 0.427 . . . . 0.0 109.93 179.122 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.6 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.9 t60 -98.27 -54.21 3.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.281 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.415 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -146.56 177.24 9.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 112.212 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.728 ' NE2' HG12 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -163.72 175.8 10.19 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.475 -179.822 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.791 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.9 mt -132.8 148.96 31.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.757 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 207' ' ' PRO . 0.1 OUTLIER -149.8 164.65 34.75 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.56 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.829 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.4 OUTLIER -110.55 112.96 25.22 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.285 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.37 82.89 4.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.6 t -61.65 -9.2 5.63 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -176.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 55.2 m -74.7 -32.98 62.33 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.17 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.58 ' HG2' ' HG2' ' A' ' 240' ' ' LYS . 5.4 tptm -110.54 0.22 17.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.245 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 17.4 p90 41.32 47.86 3.1 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.087 0.47 . . . . 0.0 110.272 179.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.617 ' HE2' ' HG2' ' A' ' 242' ' ' GLU . 0.0 OUTLIER -119.88 170.34 9.33 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.574 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 1.004 ' CZ3' HG23 ' A' ' 293' ' ' ILE . 1.3 m0 -119.4 108.58 14.75 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.617 ' HG2' ' HE2' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -133.89 147.65 51.16 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.744 ' O ' HD12 ' A' ' 243' ' ' LEU . 3.4 pp -111.92 152.16 28.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.357 -1.747 . . . . 0.0 110.59 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.834 HG21 ' CD1' ' A' ' 269' ' ' TRP . 1.2 p -117.99 162.92 15.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.558 0.218 . . . . 0.0 110.527 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -103.18 111.25 23.53 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -177.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.606 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -79.36 95.72 5.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.692 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.73 64.0 4.7 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.023 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 21.8 p -64.59 50.34 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.321 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.877 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.56 -50.74 69.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.872 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.877 ' H ' HD13 ' A' ' 249' ' ' LEU . 5.1 t30 -77.72 -37.15 50.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.469 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.1 85.91 1.35 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.218 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.548 ' N ' ' HB3' ' A' ' 260' ' ' SER . 0.5 OUTLIER -45.69 166.56 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 119.87 -0.11 . . . . 0.0 110.789 179.137 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 281' ' ' ILE . 0.2 OUTLIER -150.83 127.23 10.69 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.089 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.771 HG22 HG13 ' A' ' 281' ' ' ILE . 99.5 t -107.39 131.32 57.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.646 178.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 57.57 40.15 27.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.232 0.539 . . . . 0.0 109.852 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 7.9 p 61.53 24.78 14.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.445 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.42 97.64 4.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.604 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -46.4 93.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.6 -179.605 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.83 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.0 OUTLIER -94.87 6.23 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.452 -178.855 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.548 ' HB3' ' N ' ' A' ' 252' ' ' THR . 2.0 t . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.159 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.834 ' CD1' HG21 ' A' ' 244' ' ' VAL . 1.8 t-105 -80.7 -30.89 36.31 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.17 -171.55 7.8 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.14 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -106.5 134.9 19.6 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 117.65 0.725 . . . . 0.0 111.158 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 84.2 Cg_exo -43.03 124.11 3.52 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.214 2.61 . . . . 0.0 113.74 -178.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.83 HG21 ' HB ' ' A' ' 259' ' ' ILE . 87.9 t -99.27 139.28 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.4 OUTLIER -86.45 131.05 34.29 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 119.099 -1.041 . . . . 0.0 111.979 -178.954 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.948 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -96.59 163.91 12.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.496 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.657 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.5 158.48 43.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 8.5 t -61.55 131.44 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.803 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.61 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.7 m-20 85.4 -1.94 0.82 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.18 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.657 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -71.34 -166.78 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.44 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.59 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.8 OUTLIER -161.37 128.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.454 177.299 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.771 HG13 HG22 ' A' ' 254' ' ' VAL . 1.0 OUTLIER -108.74 155.13 9.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.706 179.23 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.629 ' OG1' ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -142.2 121.82 13.37 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.551 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.72 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -113.71 45.18 1.48 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.145 -178.008 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 170.26 -123.13 1.03 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 119.2 -1.476 . . . . 0.0 114.114 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.0 t -91.59 -54.8 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.186 . . . . 0.0 111.273 -179.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.573 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -139.94 -3.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.471 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 26.9 m -67.57 103.0 1.25 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.853 0.297 . . . . 0.0 110.58 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.662 ' O ' HG22 ' A' ' 187' ' ' ILE . 7.9 ttmt -118.39 130.98 56.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.672 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -113.43 133.02 60.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.653 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.59 ' HD1' HG23 ' A' ' 280' ' ' ILE . 4.4 t80 -76.34 136.16 39.54 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.014 0.435 . . . . 0.0 110.031 -178.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.948 HG11 ' HB2' ' A' ' 275' ' ' LEU . 1.0 OUTLIER -103.46 110.68 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.404 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.19 135.24 55.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.508 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 1.004 HG23 ' CZ3' ' A' ' 241' ' ' TRP . 16.0 mt -131.41 133.51 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.867 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.3 m -156.58 159.98 39.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 110.798 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 52.1 m -86.97 177.54 7.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.845 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -179.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 120.639 0.257 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 15.8 m95 -150.48 146.71 26.8 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.896 HD11 ' CD2' ' A' ' 184' ' ' LEU . 0.8 OUTLIER -122.26 134.54 54.68 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.841 ' N ' HD12 ' A' ' 182' ' ' LEU . 13.3 m-85 -130.25 136.86 49.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.67 0.747 . . . . 0.0 110.466 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.896 ' CD2' HD11 ' A' ' 182' ' ' LEU . 2.4 mm? -123.4 138.91 54.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.049 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.55 117.15 15.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.796 HG21 HD12 ' A' ' 194' ' ' LEU . 27.0 t -65.59 118.2 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.001 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.768 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.2 tt -98.04 -26.89 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -176.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.883 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -158.01 94.34 1.31 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.677 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.76 -174.58 31.81 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 178.255 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.462 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 85.2 Cg_endo -80.6 32.09 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.02 1.813 . . . . 0.0 110.785 178.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.796 ' HB1' HD21 ' A' ' 194' ' ' LEU . . . -161.26 21.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.749 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.677 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.1 mt -38.99 113.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 111.612 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.95 5.9 4.66 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.76 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.796 HD12 HG21 ' A' ' 186' ' ' VAL . 0.2 OUTLIER -93.29 139.87 30.16 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.111 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 12.4 mt-30 -133.26 143.55 49.17 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.662 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.886 ' CG ' HG11 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -134.83 128.55 32.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.772 -179.537 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -140.82 162.81 34.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.773 -179.195 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.708 HG21 ' HA ' ' A' ' 206' ' ' LEU . 12.3 p -173.3 153.03 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.413 178.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.588 ' HB2' HG22 ' A' ' 201' ' ' THR . 0.3 OUTLIER -90.74 145.59 24.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.919 179.52 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.939 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 0.1 OUTLIER -62.59 -2.2 1.03 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.203 179.517 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.588 HG22 ' HB2' ' A' ' 199' ' ' ASN . 1.2 t -101.63 13.74 34.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.827 0.346 . . . . 0.0 110.8 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.514 ' CB ' ' HG2' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -103.96 117.34 34.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.166 179.761 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.4 m -76.92 -84.29 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.9 t -90.4 15.71 10.14 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.514 ' HG2' ' CB ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -115.46 -10.4 11.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.912 HD13 ' HD3' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -90.09 -18.89 0.23 Allowed Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -179.747 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.912 ' HD3' HD13 ' A' ' 206' ' ' LEU . 30.1 Cg_endo -65.43 84.44 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 CA-C-N 120.905 1.359 . . . . 0.0 111.468 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.886 HG11 ' CG ' ' A' ' 196' ' ' HIS . 47.1 t -70.56 108.15 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.148 -178.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.742 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -79.98 84.5 5.72 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.72 ' HB2' ' O ' ' A' ' 230' ' ' ALA . 4.7 mp -74.93 136.01 41.4 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 118.742 0.701 . . . . 0.0 109.325 178.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.672 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . 178.38 -177.02 48.33 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.773 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 1.068 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -71.52 -74.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.092 -0.554 . . . . 0.0 111.638 -179.536 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.848 HG22 ' H ' ' A' ' 214' ' ' SER . 7.6 p -117.0 -145.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.88 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.848 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.6 OUTLIER 61.0 -179.38 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 121.98 -0.45 . . . . 0.0 109.905 -179.578 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 21.5 Cg_exo -66.4 24.2 0.1 OUTLIER 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.646 2.231 . . . . 0.0 113.765 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.558 ' HA ' ' HG3' ' A' ' 209' ' ' LYS . 68.2 m -53.0 152.05 4.31 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 120.617 0.246 . . . . 0.0 110.848 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.53 ' HB3' HG13 ' A' ' 208' ' ' VAL . 0.6 OUTLIER -84.14 -29.25 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.379 179.742 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.67 ' HB3' HD21 ' A' ' 220' ' ' LEU . 36.1 mt -115.65 132.53 56.6 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.136 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -87.96 81.65 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.682 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.672 ' N ' HD22 ' A' ' 220' ' ' LEU . 1.8 mm? -100.3 64.09 1.16 Allowed 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.559 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -60.78 35.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -177.097 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 224' ' ' GLU . 3.1 t70 -87.94 125.44 34.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 76.8 p -39.73 -30.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 222' ' ' ASP . 9.8 pt-20 -51.88 -42.23 62.53 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.989 0.424 . . . . 0.0 110.838 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 1.068 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.7 p -96.87 106.17 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.835 179.017 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.5 t -47.22 -68.56 0.18 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.452 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -128.32 -45.1 0.2 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 178.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.672 ' HA ' ' HA3' ' A' ' 211' ' ' GLY . 0.4 OUTLIER -143.45 127.65 17.64 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.087 -0.557 . . . . 0.0 109.555 178.953 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.832 ' CE1' ' HB3' ' A' ' 248' ' ' SER . 1.2 t60 -92.12 -55.19 3.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.534 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' A' ' 210' ' ' LEU . . . -155.35 150.76 27.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.742 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -131.88 179.87 5.82 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.979 179.428 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.866 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.0 mt -126.93 139.4 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.847 179.157 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.747 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -159.83 129.98 5.52 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.383 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.939 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 5.4 p90 -111.61 151.6 28.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -175.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 239' ' ' PHE . 1.5 t-20 -73.32 126.8 30.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 112.493 -2.14 . . . . 0.0 111.007 177.69 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.5 t -89.19 -29.73 19.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.0 m -77.95 -30.95 50.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.699 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.446 ' O ' ' CG ' ' A' ' 239' ' ' PHE . 1.5 tptm -108.23 -2.32 19.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.598 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 235' ' ' ASN . 27.9 p90 43.44 42.39 3.81 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.37 140.35 52.78 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.579 0.704 . . . . 0.0 110.382 178.507 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.843 ' HA ' ' HB3' ' A' ' 234' ' ' TRP . 2.9 m95 -89.45 121.96 32.18 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.078 -179.393 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.0 mt-10 -140.51 151.18 44.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.004 0.907 . . . . 0.0 113.196 -178.258 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.612 ' CD2' HD12 ' A' ' 281' ' ' ILE . 3.8 pp -117.36 156.51 27.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.125 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.614 HG11 ' HE1' ' A' ' 269' ' ' TRP . 1.3 p -128.91 162.92 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.719 0.295 . . . . 0.0 111.746 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -92.17 156.43 17.34 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.438 0.637 . . . . 0.0 111.367 179.481 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.694 ' O ' ' N ' ' A' ' 248' ' ' SER . 0.0 OUTLIER -127.86 87.8 2.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.768 179.174 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 249' ' ' LEU . . . 55.29 -46.83 0.01 OUTLIER Glycine 0 C--N 1.341 0.818 0 CA-C-O 121.402 0.446 . . . . 0.0 113.948 179.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.832 ' HB3' ' CE1' ' A' ' 229' ' ' HIS . 4.1 m -38.81 85.26 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.65 ' O ' ' HG ' ' A' ' 249' ' ' LEU . 8.7 tp -55.5 2.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 -178.49 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.587 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . 3.8 m120 -71.67 15.92 0.13 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.568 1.531 . . . . 0.0 111.511 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 249' ' ' LEU . . . 42.49 84.64 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.111 179.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.473 ' C ' HD23 ' A' ' 253' ' ' LEU . 1.0 OUTLIER -47.43 156.45 0.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.714 0.257 . . . . 0.0 110.593 179.406 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.612 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -144.8 128.94 17.66 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.05 0.453 . . . . 0.0 111.384 178.729 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.946 HG23 HD12 ' A' ' 259' ' ' ILE . 85.2 t -104.77 132.06 52.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.681 178.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 52.13 41.63 30.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.134 0.492 . . . . 0.0 110.15 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.62 24.49 11.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.969 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 9.6 m80 -127.39 108.71 11.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.037 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 3.3 t -58.56 97.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.148 0.499 . . . . 0.0 111.558 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.946 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -78.66 -54.74 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.717 -179.171 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.542 ' N ' HG12 ' A' ' 259' ' ' ILE . 6.9 p . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.9 tptt . . . . . 0 CA--C 1.515 -0.403 0 CA-C-O 121.229 0.538 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.614 ' HE1' HG11 ' A' ' 244' ' ' VAL . 18.6 t-105 -67.72 -27.91 67.21 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.068 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.65 154.44 18.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.98 179.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.45 150.74 41.77 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.599 0.238 . . . . 0.0 110.624 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.39 144.54 31.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.36 2.04 . . . . 0.0 112.076 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.795 HG11 HG21 ' A' ' 259' ' ' ILE . 92.8 t -132.15 131.87 61.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.163 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.7 pm0 -80.74 132.87 35.58 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.229 -178.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 1.031 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -96.82 165.13 12.26 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.526 -179.74 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.6 162.14 36.21 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.656 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 20.3 p -69.97 132.84 46.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.253 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 277' ' ' SER . 42.7 m-20 82.98 -8.51 1.15 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.975 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -62.1 -168.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.193 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.51 ' CG2' ' HD1' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -161.11 120.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.406 178.341 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.871 HG13 HG22 ' A' ' 254' ' ' VAL . 0.4 OUTLIER -105.08 157.66 5.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.072 179.742 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.661 HG23 ' CG ' ' A' ' 288' ' ' LYS . 1.7 m -143.02 120.7 11.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.661 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -117.7 47.1 1.61 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.298 -178.449 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.2 -137.13 3.68 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 119.418 -1.373 . . . . 0.0 113.044 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 12.1 t -90.01 -36.32 15.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.836 0.351 . . . . 0.0 110.598 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -151.92 0.91 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.883 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 24.5 m -75.65 105.22 6.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.62 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.768 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.1 mtpt -122.99 127.51 48.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 111.246 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.491 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -107.69 133.59 52.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.537 -178.717 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.675 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.0 t80 -77.38 131.16 37.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.897 0.379 . . . . 0.0 110.098 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 1.031 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -103.05 117.87 49.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.304 -178.906 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.656 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -137.6 141.66 41.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.033 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.739 HD11 HD23 ' A' ' 275' ' ' LEU . 6.2 mt -136.27 133.0 49.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.735 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 22.7 t -133.18 158.78 41.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.963 0.411 . . . . 0.0 111.264 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.7 150.34 21.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.654 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.705 -179.972 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 1.5 m . . . . . 0 N--CA 1.462 0.132 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.575 ' CB ' ' CZ ' ' A' ' 183' ' ' PHE . 90.8 m95 -156.97 146.78 20.74 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.771 HD11 ' CD1' ' A' ' 184' ' ' LEU . 0.2 OUTLIER -122.8 106.45 10.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 113.64 -1.618 . . . . 0.0 106.797 176.155 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.575 ' CZ ' ' CB ' ' A' ' 181' ' ' TRP . 1.8 m-85 -105.83 138.53 41.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.936 0.874 . . . . 0.0 113.007 -177.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.913 ' N ' HD22 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -135.63 146.57 48.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.067 177.406 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.488 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 1.6 tt0 -140.9 127.4 20.02 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -176.841 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.972 HG21 HD11 ' A' ' 220' ' ' LEU . 10.7 t -62.14 116.51 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.173 178.363 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.1 tt -97.22 -22.47 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.748 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.28 91.21 0.69 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.84 -177.64 35.08 Favored Glycine 0 C--O 1.228 -0.224 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 178.161 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.52 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 84.4 Cg_endo -76.99 32.72 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.907 1.738 . . . . 0.0 111.802 178.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.9 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -161.47 28.74 0.13 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.672 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -47.74 111.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.379 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.94 10.06 2.94 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.683 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.9 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.4 OUTLIER -101.39 105.38 16.41 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.983 0.897 . . . . 0.0 109.944 178.837 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.488 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 8.5 mt-30 -105.83 156.19 18.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.715 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.871 ' ND1' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -149.44 147.2 27.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.299 179.716 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.457 ' HB2' ' HD2' ' A' ' 183' ' ' PHE . . . -149.02 158.29 44.07 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.587 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.74 HG21 ' HA ' ' A' ' 206' ' ' LEU . 9.8 p -159.96 148.57 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.655 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 180' ' ' SER . 2.1 m120 -85.49 140.72 30.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.863 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.954 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 9.8 m -56.71 -10.93 1.14 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.635 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.2 t -97.14 9.07 43.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.797 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.89 ' O ' HD12 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -96.53 103.14 15.03 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.932 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . 0.413 ' O ' ' CD1' ' A' ' 206' ' ' LEU . 1.9 m -62.98 -89.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.62 13.25 7.25 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.981 -0.449 . . . . 0.0 111.642 -179.098 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.667 ' HG2' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -111.51 -2.61 15.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.645 -179.447 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 1.058 HD13 ' HD3' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -100.35 -27.67 0.23 Allowed Pre-proline 0 C--O 1.232 0.15 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.867 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 1.058 ' HD3' HD13 ' A' ' 206' ' ' LEU . 9.7 Cg_endo -54.1 100.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.867 0 CA-C-N 121.329 1.51 . . . . 0.0 111.11 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 59.5 t -68.46 155.22 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.273 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.608 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -135.87 90.48 2.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 -179.164 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.067 HD23 HD12 ' A' ' 218' ' ' LEU . 0.9 OUTLIER -81.45 127.77 33.16 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.638 -179.99 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.565 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -172.56 171.44 44.32 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.066 -179.623 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.986 ' HB2' HG13 ' A' ' 225' ' ' VAL . 5.3 ttm180 -67.04 -74.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.297 0.57 . . . . 0.0 111.774 -179.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.679 HG22 ' H ' ' A' ' 214' ' ' SER . 9.4 p -124.15 -138.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.278 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.679 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.7 OUTLIER 59.74 179.26 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 119.131 0.878 . . . . 0.0 109.606 -179.966 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.658 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 38.4 Cg_endo -67.43 25.86 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.039 1.826 . . . . 0.0 113.758 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -58.43 152.7 17.3 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.686 0.279 . . . . 0.0 110.695 179.471 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -79.94 -32.0 40.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.379 . . . . 0.0 110.117 179.484 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.067 HD12 HD23 ' A' ' 210' ' ' LEU . 1.2 mt -106.48 129.05 54.51 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.373 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.638 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -92.71 81.47 4.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.791 0.329 . . . . 0.0 111.502 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.972 HD11 HG21 ' A' ' 186' ' ' VAL . 2.5 mm? -108.48 62.22 0.61 Allowed 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.846 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 10.2 pttt -51.91 55.8 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -177.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 220' ' ' LEU . 22.1 t0 -100.62 149.64 23.55 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 29.5 t -64.47 -34.61 78.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.477 -179.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.526 ' O ' HD11 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -48.9 -39.94 27.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.442 -179.591 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.986 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.3 p -103.45 89.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.448 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -34.82 -45.77 0.27 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.705 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.37 -53.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.559 ' HB2' ' SD ' ' A' ' 246' ' ' MET . 0.0 OUTLIER -144.71 135.2 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.194 0.521 . . . . 0.0 109.667 178.73 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.708 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.8 OUTLIER -104.2 -56.08 2.25 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.284 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -141.76 172.42 12.71 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.506 0.669 . . . . 0.0 112.485 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.703 ' HG3' HG12 ' A' ' 244' ' ' VAL . 1.5 pt20 -158.52 173.46 16.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.319 179.648 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 9.8 mt -134.31 151.58 32.37 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.422 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -162.01 148.18 13.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.713 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.954 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 2.5 p90 -130.17 163.24 27.09 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.369 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.47 123.79 50.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.256 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 24.1 t -84.01 -1.77 55.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.099 179.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.5 m -80.8 -33.74 34.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.599 0.714 . . . . 0.0 109.984 179.15 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 19.5 tptm -129.41 16.3 6.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.95 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.417 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 9.0 p90 40.05 60.3 1.76 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.476 0.655 . . . . 0.0 109.545 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.597 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.2 OUTLIER -123.81 138.55 54.48 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.364 179.661 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.68 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -117.2 114.77 24.13 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.123 178.761 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 35.3 mt-10 -130.83 141.88 50.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.757 0.789 . . . . 0.0 112.373 -177.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.749 HD22 HD12 ' A' ' 281' ' ' ILE . 3.8 pp -108.26 152.6 24.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.125 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.703 HG12 ' HG3' ' A' ' 231' ' ' GLN . 0.7 OUTLIER -123.44 162.24 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.573 -179.404 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.706 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 1.1 m-20 -111.28 101.09 9.6 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.914 178.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.871 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -84.94 106.5 16.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.971 0.415 . . . . 0.0 109.924 179.347 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 48.19 67.31 1.65 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.803 -178.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.04 74.6 8.08 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.42 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.853 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -51.34 -56.26 14.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.611 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.853 ' N ' HD22 ' A' ' 249' ' ' LEU . 1.2 t-20 -71.07 -25.96 62.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.167 0.508 . . . . 0.0 110.965 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.418 ' N ' ' HE2' ' A' ' 229' ' ' HIS . . . 89.49 136.79 6.15 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.483 -0.78 . . . . 0.0 113.753 179.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.59 ' C ' HD23 ' A' ' 253' ' ' LEU . 24.1 m -100.71 155.68 17.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.117 179.284 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.666 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -146.57 145.45 30.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.087 0.47 . . . . 0.0 111.615 179.623 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.841 HG23 ' CD1' ' A' ' 259' ' ' ILE . 45.6 t -114.09 131.19 66.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.345 179.026 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.766 HD22 HG12 ' A' ' 254' ' ' VAL . 11.1 p30 51.37 39.68 24.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.517 -178.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 4.4 p 72.17 37.11 1.01 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.692 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.552 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.5 OUTLIER -148.84 117.0 6.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.069 179.949 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 83.8 p -64.68 87.6 0.06 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.504 0.669 . . . . 0.0 110.655 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.927 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -83.89 -17.9 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.82 -177.952 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.706 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 20.3 m . . . . . 0 C--N 1.329 -0.285 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -177.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 270' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.375 0 CA-C-O 121.095 0.474 . . . . 0.0 112.032 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.871 ' CZ3' ' HB2' ' A' ' 246' ' ' MET . 46.1 t-105 -70.01 -24.46 63.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.361 179.526 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . 0.461 ' H ' ' HD3' ' A' ' 268' ' ' LYS . . . 70.88 170.74 9.99 Favored Glycine 0 CA--C 1.512 -0.141 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.932 178.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -102.62 146.66 32.78 Favored Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.221 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.695 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 51.3 Cg_exo -54.14 121.75 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.04 1.827 . . . . 0.0 112.574 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.927 HG21 ' CG1' ' A' ' 259' ' ' ILE . 70.1 t -99.22 133.15 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -78.46 123.73 27.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.622 -178.89 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.871 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -89.12 165.12 14.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.656 179.752 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.54 161.57 38.78 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.404 -0.518 . . . . 0.0 112.273 -179.117 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.2 OUTLIER -62.3 124.44 20.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.359 179.361 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 277' ' ' SER . 10.1 m-20 88.58 7.71 0.14 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.499 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.7 OUTLIER -79.01 -169.33 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.361 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.673 ' HB ' ' HD3' ' A' ' 288' ' ' LYS . 0.9 OUTLIER -160.04 129.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.059 178.163 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.905 HG22 HG23 ' A' ' 289' ' ' VAL . 0.8 OUTLIER -109.84 152.31 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.669 178.783 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 252' ' ' THR . 0.2 OUTLIER -138.54 126.77 22.86 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.925 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.708 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -120.03 40.56 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.201 -178.794 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 177.57 -131.3 1.76 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.613 -1.279 . . . . 0.0 113.533 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.1 t -89.28 -43.9 10.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 110.797 -179.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.9 t -146.58 -1.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.439 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.748 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.9 m -68.99 99.9 1.14 Allowed 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.35 179.054 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.811 ' O ' HG22 ' A' ' 187' ' ' ILE . 1.3 ttmt -118.34 131.0 56.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.459 -178.572 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.905 HG23 HG22 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -114.03 132.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 121.381 -0.128 . . . . 0.0 111.085 -179.486 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.64 ' HD1' HG22 ' A' ' 280' ' ' ILE . 1.1 t80 -77.35 142.22 39.46 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 110.647 -178.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.871 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -110.39 115.97 51.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.631 -179.268 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -138.72 153.21 48.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.085 -179.629 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.459 HD12 ' CZ3' ' A' ' 241' ' ' TRP . 3.8 mt -144.23 120.72 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.345 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.03 158.57 39.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.947 0.403 . . . . 0.0 110.975 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.4 p -101.34 -173.49 2.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.671 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 179.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.523 -0.084 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.701 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 23.8 m95 -145.83 131.44 18.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.9 OUTLIER -115.13 124.04 50.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.703 176.551 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.737 ' N ' HD12 ' A' ' 182' ' ' LEU . 7.5 m-85 -124.64 133.82 53.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.39 0.614 . . . . 0.0 110.776 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.633 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -139.75 149.35 43.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.9 178.289 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.58 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 13.1 tt0 -141.23 128.4 20.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 1.119 HG21 HD12 ' A' ' 194' ' ' LEU . 48.2 t -65.52 112.65 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.385 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.6 tt -97.25 -21.64 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -176.075 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.853 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -157.96 92.38 1.18 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.564 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.676 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.1 -163.69 16.37 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.523 ' HD3' ' OD2' ' A' ' 222' ' ' ASP . 91.6 Cg_endo -85.73 28.6 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.96 2.44 . . . . 0.0 110.971 178.277 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.86 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -160.22 23.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.981 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.676 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.6 mt -39.57 109.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 111.675 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.32 10.12 3.11 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.902 -1.142 . . . . 0.0 113.438 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 1.119 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -96.65 129.12 44.1 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.754 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.58 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 15.8 mt-30 -128.96 151.5 49.61 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.264 -178.367 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.608 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -145.14 145.4 31.37 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.18 179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -149.74 154.44 38.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.893 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.806 HG21 ' HA ' ' A' ' 206' ' ' LEU . 7.5 p -164.89 153.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 110.818 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' A' ' 180' ' ' SER . 4.3 m120 -90.19 149.4 22.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.64 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.514 ' CA ' ' HZ2' ' A' ' 234' ' ' TRP . 49.2 p -65.5 -9.22 24.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.691 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 2.3 t -96.64 25.33 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.461 0.648 . . . . 0.0 110.098 178.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.475 ' HB3' ' CG ' ' A' ' 205' ' ' LYS . 35.8 m -104.3 119.14 38.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.432 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 70.2 m -66.71 -84.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.968 -179.122 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 47.7 m -105.12 26.78 8.9 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.475 ' CG ' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -117.85 -14.49 10.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.788 0.328 . . . . 0.0 111.141 179.596 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.941 ' O ' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -81.4 -38.03 0.92 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.163 -179.527 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.781 ' N ' HD13 ' A' ' 206' ' ' LEU . 9.7 Cg_endo -54.11 102.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 120.875 1.05 . . . . 0.0 111.676 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 40.8 t -68.91 159.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.206 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 41.0 mtmt -140.6 95.62 2.89 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.471 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.934 HD23 HD12 ' A' ' 218' ' ' LEU . 0.4 OUTLIER -83.84 123.94 30.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.382 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.545 ' HA3' ' OG ' ' A' ' 216' ' ' SER . . . -159.55 163.09 33.35 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.195 -179.423 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.797 ' HD2' ' HB ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -60.15 -91.05 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.302 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.434 ' H ' ' HB3' ' A' ' 212' ' ' ARG . 7.5 p -116.37 -15.15 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 0.0 110.938 -179.27 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.789 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 52.9 m -51.78 174.04 0.12 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.783 178.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.789 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 19.3 Cg_endo -58.36 7.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.062 1.841 . . . . 0.0 112.942 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.545 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 17.8 m -45.81 157.42 0.11 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.949 0.405 . . . . 0.0 111.479 179.648 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.539 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -71.06 -32.28 68.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.896 -179.256 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.934 HD12 HD23 ' A' ' 210' ' ' LEU . 12.0 mt -106.52 129.57 54.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.028 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -90.31 85.8 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 111.689 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.765 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.3 mm? -105.28 83.72 2.01 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 44.17 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.693 ' CA ' ' HD3' ' A' ' 212' ' ' ARG . 0.7 OUTLIER -76.56 167.34 22.01 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 122.255 -0.278 . . . . 0.0 110.554 179.318 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.4 p -95.27 -0.97 52.4 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 179.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.22 -27.25 13.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.917 0.78 . . . . 0.0 112.763 -176.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 0.797 ' HB ' ' HD2' ' A' ' 212' ' ' ARG . 32.7 t -92.97 91.3 3.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.055 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.98 -41.77 3.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.378 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.39 -57.51 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.055 179.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.464 ' HB2' ' HG2' ' A' ' 246' ' ' MET . 8.0 mttt -146.38 130.55 17.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.003 0.43 . . . . 0.0 111.151 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.635 ' ND1' HG22 ' A' ' 225' ' ' VAL . 1.4 t60 -90.59 -57.92 2.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.458 178.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -147.67 -175.0 4.69 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.661 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -163.7 177.53 8.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.396 179.648 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 17.7 mt -137.82 147.53 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.301 0.572 . . . . 0.0 112.51 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.48 147.16 13.88 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.131 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.85 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.6 p90 -137.79 165.66 25.9 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -178.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.582 ' HB2' ' HD2' ' A' ' 240' ' ' LYS . 1.4 m-80 -117.57 133.65 55.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.204 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.1 m -89.52 4.9 47.74 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.609 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.6 m -77.83 -37.5 48.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.821 0.819 . . . . 0.0 109.653 178.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 6.1 tptm -126.26 14.98 7.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.261 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 238' ' ' LYS . 18.6 p90 41.68 61.22 1.93 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.933 0.873 . . . . 0.0 108.673 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.85 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -128.5 145.97 50.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.259 -179.855 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.726 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -128.92 125.53 37.74 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.021 -178.914 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 9.5 pt-20 -138.53 146.91 42.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.842 0.83 . . . . 0.0 113.116 -178.254 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.4 pp -112.19 152.11 28.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.773 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.808 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 7.3 p -117.06 163.82 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.42 0.152 . . . . 0.0 110.962 -179.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.48 ' OD2' ' HA3' ' A' ' 270' ' ' GLY . 0.0 OUTLIER -107.33 105.95 16.15 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.52 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.55 ' CE ' ' HA ' ' A' ' 246' ' ' MET . 2.3 tpt -78.43 103.68 8.53 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.129 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.3 65.07 3.81 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.005 -178.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.9 p -68.21 53.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.792 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.55 -50.61 72.53 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.297 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.792 ' N ' HD22 ' A' ' 249' ' ' LEU . 6.1 t-20 -79.19 -34.78 42.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.053 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 89.84 102.1 1.11 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.238 179.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.69 HG23 ' HB3' ' A' ' 283' ' ' LEU . 0.5 OUTLIER -56.88 163.99 1.73 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.893 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.735 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -154.31 136.59 14.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.424 0.63 . . . . 0.0 112.458 179.99 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 1.015 HG23 HD12 ' A' ' 259' ' ' ILE . 53.3 t -109.15 133.55 53.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.244 178.464 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.52 ' HA ' HG13 ' A' ' 280' ' ' ILE . 14.4 p30 49.56 33.9 6.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.177 0.513 . . . . 0.0 110.695 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 4.1 m 76.83 27.79 0.72 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.83 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.489 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.0 OUTLIER -129.65 110.12 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.147 179.494 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 252' ' ' THR . 86.5 p -62.97 84.71 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.171 0.51 . . . . 0.0 111.748 -179.275 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 1.015 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -79.82 -8.19 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.12 -179.481 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 2.0 m . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.808 ' CZ3' HG13 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -76.12 -26.05 55.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.87 -178.159 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . 0.48 ' HA3' ' OD2' ' A' ' 245' ' ' ASP . . . 61.85 -173.54 7.61 Favored Glycine 0 CA--C 1.515 0.093 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.266 -179.081 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 272' ' ' PRO . 23.0 m-20 -108.36 148.16 37.07 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 117.846 0.823 . . . . 0.0 111.239 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.727 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 31.9 Cg_exo -60.06 122.57 11.59 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.08 2.52 . . . . 0.0 114.008 -178.751 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.607 HG21 ' HB ' ' A' ' 259' ' ' ILE . 71.4 t -98.95 138.01 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.656 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.2 mp0 -83.03 127.48 33.6 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.987 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.94 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.32 164.16 13.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.776 179.81 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -141.76 158.11 44.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.268 0.556 . . . . 0.0 112.181 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 10.8 p -55.39 128.55 34.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.928 179.532 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 81.13 8.49 1.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.693 179.829 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.511 ' OD2' ' HB ' ' A' ' 291' ' ' VAL . 0.0 OUTLIER -88.4 137.17 32.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.001 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.675 HG22 ' HD1' ' A' ' 290' ' ' TYR . 1.0 OUTLIER -97.43 129.62 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.664 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.956 HG12 HG22 ' A' ' 254' ' ' VAL . 0.4 OUTLIER -112.39 94.39 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -178.748 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.697 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 7.0 m -82.94 142.49 31.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.699 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -134.76 47.43 2.37 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.04 -179.865 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.85 -125.23 1.1 Allowed Glycine 0 C--N 1.329 0.194 0 C-N-CA 119.879 -1.153 . . . . 0.0 113.469 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.5 t -95.64 -45.32 7.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.717 0.294 . . . . 0.0 110.747 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.66 -0.17 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.812 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.853 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 25.5 m -75.4 102.13 5.04 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.621 0.248 . . . . 0.0 111.345 -179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.722 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -122.44 131.43 53.87 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.498 0.666 . . . . 0.0 111.044 179.792 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.43 HG23 HD11 ' A' ' 283' ' ' LEU . 2.4 t -107.81 131.76 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.54 -177.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.675 ' HD1' HG22 ' A' ' 280' ' ' ILE . 1.0 OUTLIER -76.95 132.49 39.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.694 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.511 ' HB ' ' OD2' ' A' ' 279' ' ' ASP . 2.5 t -110.89 117.35 54.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.634 -178.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.2 OUTLIER -136.73 150.99 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.847 -179.464 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.726 HD12 ' CE3' ' A' ' 241' ' ' TRP . 3.1 mt -143.21 127.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.366 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.61 153.34 43.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.813 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 5.0 m -85.94 168.07 14.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.137 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 -179.989 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.198 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.687 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 3.2 m95 -143.52 130.88 20.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.929 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.4 OUTLIER -122.08 130.28 53.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.017 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.929 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -133.18 146.22 51.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.77 0.795 . . . . 0.0 111.393 179.979 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -146.84 153.32 40.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.009 178.955 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.535 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 0.1 OUTLIER -142.02 133.35 26.44 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.183 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.912 HG11 HD11 ' A' ' 220' ' ' LEU . 40.0 t -66.4 116.04 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.017 0.436 . . . . 0.0 110.148 177.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.868 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.2 tt -97.45 -24.16 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.09 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.848 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -160.11 93.55 1.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.733 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.91 -173.25 30.34 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 178.357 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.624 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 96.9 Cg_endo -80.16 32.65 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 CA-C-N 119.452 1.626 . . . . 0.0 111.587 178.684 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.812 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.95 23.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.627 178.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.733 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.8 mt -39.41 114.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 127.56 10.54 3.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.519 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.812 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -99.66 131.16 45.83 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.964 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.535 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 20.9 mt-30 -128.01 153.89 46.24 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.358 -178.392 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.723 ' CD2' ' HB3' ' A' ' 217' ' ' ASP . 0.0 OUTLIER -145.57 146.03 31.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.165 178.968 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.56 144.51 29.62 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.273 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.995 HG21 ' HA ' ' A' ' 206' ' ' LEU . 10.2 p -146.51 147.81 17.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.332 0.587 . . . . 0.0 110.816 179.281 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.581 ' OD1' HG23 ' A' ' 201' ' ' THR . 21.4 p30 -95.07 150.47 20.15 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.265 -179.45 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.509 ' N ' ' HZ2' ' A' ' 234' ' ' TRP . 48.2 t -70.67 1.04 5.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.474 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.581 HG23 ' OD1' ' A' ' 199' ' ' ASN . 0.0 OUTLIER -104.17 11.63 34.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.25 0.548 . . . . 0.0 110.784 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.4 m -91.3 132.13 36.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.059 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.47 -77.41 0.39 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.261 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.5 m -101.68 20.62 15.87 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.735 0.303 . . . . 0.0 111.59 -179.287 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -123.16 -15.03 7.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.942 0.401 . . . . 0.0 110.807 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.995 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.9 tt -59.08 -60.51 10.31 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.405 -179.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.778 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -42.59 98.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.629 2.219 . . . . 0.0 113.016 -178.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.561 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 59.7 t -68.04 163.57 2.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.732 ' O ' ' HB2' ' A' ' 217' ' ' ASP . 0.5 OUTLIER -142.64 115.09 8.49 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.222 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.964 HD21 ' HB3' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -116.67 145.88 43.13 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.657 -0.652 . . . . 0.0 111.236 178.145 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . 170.85 -174.74 44.7 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.753 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 1.088 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -65.11 -77.4 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.054 0.454 . . . . 0.0 111.85 -178.89 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.809 HG22 ' H ' ' A' ' 214' ' ' SER . 13.7 p -128.28 -138.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.234 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.809 ' H ' HG22 ' A' ' 213' ' ' VAL . 5.0 m 67.39 173.59 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 118.897 0.771 . . . . 0.0 109.378 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 40.0 Cg_endo -66.59 18.15 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.907 1.738 . . . . 0.0 112.694 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 214' ' ' SER . 1.9 m -54.91 178.68 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.721 0.296 . . . . 0.0 110.739 179.851 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.732 ' HB2' ' O ' ' A' ' 209' ' ' LYS . 14.0 m-20 -100.98 -35.87 9.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.469 -179.591 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.685 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 6.2 mt -100.39 129.08 46.32 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.231 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.448 ' O ' ' CB ' ' A' ' 191' ' ' ALA . . . -95.04 79.19 3.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.633 0.254 . . . . 0.0 110.634 -179.736 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.912 HD11 HG11 ' A' ' 186' ' ' VAL . 3.0 mm? -100.74 66.37 1.2 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.74 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.718 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 1.8 pttt -50.22 69.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.825 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 220' ' ' LEU . 2.5 t0 -124.72 140.05 53.29 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.214 0.53 . . . . 0.0 110.05 178.104 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.9 t -54.96 -40.34 69.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.437 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.419 ' HB3' ' HA2' ' A' ' 284' ' ' GLY . 2.4 mm-40 -41.94 -42.97 2.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.364 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 1.088 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.4 p -102.36 79.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.215 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -33.05 -42.43 0.08 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.114 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.17 -55.79 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.035 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 246' ' ' MET . 30.4 mtmm -145.17 129.46 17.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.156 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.544 ' HB3' HD22 ' A' ' 283' ' ' LEU . 0.1 OUTLIER -93.88 -53.53 3.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.118 179.702 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.964 ' HB3' HD21 ' A' ' 210' ' ' LEU . . . -151.33 -179.22 7.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.842 ' HG2' ' HE1' ' A' ' 246' ' ' MET . 0.4 OUTLIER -161.2 -178.01 6.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.295 178.404 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.778 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 23.7 mt -140.52 148.67 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.17 0.509 . . . . 0.0 111.482 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.68 137.2 8.7 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.96 ' CH2' HG13 ' A' ' 198' ' ' VAL . 3.2 p90 -131.62 166.46 21.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . 0.548 ' H ' ' HD2' ' A' ' 240' ' ' LYS . 11.0 t-20 -116.43 134.17 55.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.868 -1.514 . . . . 0.0 112.953 -178.671 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.5 t -90.53 -1.1 57.88 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.946 178.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.4 m -77.02 -28.95 55.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.718 0.771 . . . . 0.0 110.015 178.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.45 15.09 3.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.693 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.4 p90 41.9 58.97 2.69 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.895 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -126.34 145.87 50.26 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.712 -179.612 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.716 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -129.51 124.86 35.0 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.035 -178.935 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -139.71 142.7 36.86 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.758 0.79 . . . . 0.0 112.78 -178.181 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.8 pp -108.07 156.38 19.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.221 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.499 HG22 ' HE3' ' A' ' 269' ' ' TRP . 5.1 p -124.47 163.24 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.613 ' CG ' ' HB3' ' A' ' 260' ' ' SER . 6.6 m-20 -107.91 125.47 51.53 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.152 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.842 ' HE1' ' HG2' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -85.77 94.28 9.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.738 178.374 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 47.74 68.4 1.22 Allowed Glycine 0 C--N 1.329 0.16 0 C-N-CA 119.544 -1.312 . . . . 0.0 110.475 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 85.8 p -64.32 58.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 250' ' ' ASN . 1.2 tm? -54.26 -60.63 3.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.224 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.567 ' N ' HD13 ' A' ' 249' ' ' LEU . 1.1 t-20 -71.1 -30.16 66.18 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.006 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 248' ' ' SER . . . 100.48 118.66 4.28 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.672 178.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.914 HG23 HD23 ' A' ' 283' ' ' LEU . 1.4 m -92.74 105.59 17.7 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -98.75 139.25 34.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 112.367 -178.279 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.85 HG22 HG23 ' A' ' 281' ' ' ILE . 41.4 t -109.61 127.42 66.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.953 178.126 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.843 ' HA ' HD12 ' A' ' 280' ' ' ILE . 7.2 t-20 55.01 38.34 30.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.082 0.468 . . . . 0.0 110.248 -178.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.38 34.96 12.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.594 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.725 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.5 OUTLIER -140.96 113.18 7.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.522 -179.84 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 83.7 p -58.9 88.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.533 0.683 . . . . 0.0 110.562 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.934 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -88.67 -21.8 6.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.222 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.613 ' HB3' ' CG ' ' A' ' 245' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.457 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.415 0.626 . . . . 0.0 112.38 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.596 ' CH2' ' HG3' ' A' ' 246' ' ' MET . 83.7 m95 -80.33 -20.58 43.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.306 178.371 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 68.87 174.96 10.09 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -177.326 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.69 125.27 65.6 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 118.141 0.971 . . . . 0.0 110.52 -179.486 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.1 Cg_exo -35.25 119.63 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.807 2.338 . . . . 0.0 111.638 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.934 HG21 ' CG1' ' A' ' 259' ' ' ILE . 97.7 t -101.15 136.6 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.671 -177.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 11.9 mt-10 -82.4 128.38 34.19 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.868 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.987 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.17 165.2 13.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.992 -179.464 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.08 159.03 43.05 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.689 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 84.9 p -62.89 130.71 46.0 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.426 179.188 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.5 OUTLIER 83.66 -0.66 1.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.122 -179.237 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -71.07 -170.27 0.44 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.843 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.8 OUTLIER -162.07 124.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 177.349 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.85 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -99.27 150.28 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.149 176.363 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.688 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 1.8 m -134.68 122.2 21.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.662 0.744 . . . . 0.0 109.357 178.091 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.914 HD23 HG23 ' A' ' 252' ' ' THR . 0.0 OUTLIER -122.13 136.93 54.97 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.593 179.598 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.472 ' HA2' ' CG ' ' A' ' 250' ' ' ASN . . . 88.11 -132.4 11.19 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.315 179.522 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.8 t -100.03 -33.43 10.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.445 0.164 . . . . 0.0 111.18 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -152.79 8.21 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.751 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.848 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 12.7 m -74.53 102.43 4.51 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.043 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.868 ' O ' HG22 ' A' ' 187' ' ' ILE . 15.6 ttmt -120.04 125.37 48.16 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.63 -179.311 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 184' ' ' LEU . 1.0 OUTLIER -107.4 135.57 45.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.607 179.701 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.653 ' HD1' HG23 ' A' ' 280' ' ' ILE . 2.2 t80 -78.13 136.67 37.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.615 -179.393 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.987 HG11 ' HB2' ' A' ' 275' ' ' LEU . 1.8 t -105.45 114.86 46.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.393 -179.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -133.87 138.82 45.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.162 -179.636 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.762 HD11 HD23 ' A' ' 275' ' ' LEU . 14.2 mt -135.74 143.22 37.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 7.6 t -146.29 153.25 40.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 78.2 p -86.16 162.51 18.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.312 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 179.97 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.226 -0.151 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.716 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 22.0 m95 -144.29 130.9 20.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.864 HD23 ' CZ3' ' A' ' 234' ' ' TRP . 0.4 OUTLIER -121.44 107.95 13.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.035 177.883 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.716 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 0.9 OUTLIER -106.88 140.13 40.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.864 0.84 . . . . 0.0 112.081 -179.565 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 1.008 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -133.48 144.11 49.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.165 177.401 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 16.1 tt0 -137.74 125.79 22.86 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.947 HG21 HD12 ' A' ' 194' ' ' LEU . 9.6 t -65.52 112.26 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.578 177.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 288' ' ' LYS . 7.4 tt -95.03 -22.44 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.102 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.88 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.85 93.75 0.56 Allowed 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 119.742 -0.783 . . . . 0.0 112.691 -179.331 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.776 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.63 -171.05 27.18 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 178.257 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.762 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 93.6 Cg_endo -79.41 30.57 0.47 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.053 1.835 . . . . 0.0 111.77 178.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.865 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.59 27.29 0.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 178.314 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.776 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -41.2 107.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.818 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 8.17 2.26 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.741 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.947 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -97.59 132.99 42.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.939 0.876 . . . . 0.0 108.705 177.878 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.57 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 17.8 mt-30 -133.22 152.9 51.94 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.211 -1.358 . . . . 0.0 110.193 -178.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 1.008 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -148.25 148.31 30.33 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.097 -179.757 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.453 ' C ' ' HZ3' ' A' ' 181' ' ' TRP . . . -147.42 140.07 24.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.337 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.91 HG13 ' CH2' ' A' ' 234' ' ' TRP . 5.2 p -143.29 149.6 18.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.427 0.632 . . . . 0.0 110.458 178.435 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 180' ' ' SER . 4.5 p30 -95.8 151.83 19.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.758 -179.516 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.563 ' HG ' ' N ' ' A' ' 180' ' ' SER . 80.5 p -67.41 -1.33 4.63 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -178.542 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.6 15.49 22.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.941 0.4 . . . . 0.0 111.27 179.265 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.52 143.93 26.66 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.064 179.26 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.0 m -89.04 -94.46 0.1 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.354 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.86 31.01 2.47 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.302 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.64 -11.73 8.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 110.751 179.18 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.774 ' HA ' HG21 ' A' ' 198' ' ' VAL . 4.7 tt -67.5 -58.04 9.27 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.591 -179.152 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -41.93 90.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.639 2.226 . . . . 0.0 112.438 -178.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.684 ' O ' HG12 ' A' ' 208' ' ' VAL . 2.2 t -71.56 91.0 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.209 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 231' ' ' GLN . 12.2 mtmt -69.96 87.2 0.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.987 HD23 HD12 ' A' ' 218' ' ' LEU . 2.0 mp -74.55 128.67 36.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . -177.78 -177.33 46.51 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.486 -179.551 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 0.961 ' HD3' HG12 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -57.18 -93.2 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.017 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.961 HG12 ' HD3' ' A' ' 212' ' ' ARG . 11.5 p -158.3 158.75 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.355 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.998 ' HB2' ' HD3' ' A' ' 215' ' ' PRO . 24.4 m 103.16 -74.06 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.831 179.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.998 ' HD3' ' HB2' ' A' ' 214' ' ' SER . 95.9 Cg_endo -96.01 -35.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.079 1.853 . . . . 0.0 113.182 179.545 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.448 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 0.9 OUTLIER -57.02 145.87 29.05 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.142 0.496 . . . . 0.0 112.209 -178.958 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.04 -33.06 69.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.454 179.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.987 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -100.21 135.24 41.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.557 178.284 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -93.64 73.5 4.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.951 -178.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.93 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.1 mm? -99.48 94.69 6.54 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.776 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.762 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 28.0 pttt -65.11 53.63 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.232 0.539 . . . . 0.0 110.048 178.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 220' ' ' LEU . 4.1 m-20 -87.81 116.2 25.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.223 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 11.5 p -60.51 -15.53 28.07 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.877 -179.347 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 222' ' ' ASP . 0.0 OUTLIER -79.22 -21.33 46.41 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.576 0.227 . . . . 0.0 110.838 179.686 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 1.012 ' HB ' ' HD1' ' A' ' 229' ' ' HIS . 2.8 p -107.61 80.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.16 -30.22 0.74 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 111.188 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -145.87 -59.66 0.02 OUTLIER Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.194 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.867 ' HB2' ' HG3' ' A' ' 246' ' ' MET . 0.3 OUTLIER -144.49 133.59 22.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.785 0.326 . . . . 0.0 110.354 -179.824 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 1.012 ' HD1' ' HB ' ' A' ' 225' ' ' VAL . 0.4 OUTLIER -93.43 -58.7 2.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.738 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 210' ' ' LEU . . . -147.45 165.48 30.13 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.788 -178.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.724 ' HA ' HD12 ' A' ' 210' ' ' LEU . 17.9 tt0 -143.11 157.44 44.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.657 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.695 HG13 HD11 ' A' ' 210' ' ' LEU . 23.7 mt -121.54 145.75 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.918 179.53 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.724 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -161.79 160.58 28.46 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.28 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.91 ' CH2' HG13 ' A' ' 198' ' ' VAL . 3.6 p90 -149.68 165.73 31.5 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -117.31 133.6 55.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.854 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -0.12 57.32 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.107 179.093 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -76.15 -20.15 57.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.659 0.742 . . . . 0.0 110.052 178.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.661 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 7.5 tptm -151.6 20.58 0.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.596 -178.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 23.8 p90 41.01 57.81 2.67 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.391 0.615 . . . . 0.0 109.926 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.792 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.8 OUTLIER -120.63 137.5 54.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.938 179.352 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.734 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -120.49 122.25 40.23 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.95 179.963 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 1.0 OUTLIER -139.37 142.25 37.56 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.941 0.876 . . . . 0.0 112.784 -178.391 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.753 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.0 pp -110.31 155.09 22.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.691 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.909 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 5.0 p -117.33 163.02 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 122.239 -0.288 . . . . 0.0 111.102 -179.452 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 260' ' ' SER . 0.0 OUTLIER -105.95 113.09 26.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.318 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.867 ' HG3' ' HB2' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -81.39 105.77 12.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.665 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 54.35 65.6 3.37 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.71 -178.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.76 49.79 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.772 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -58.11 -47.67 82.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.702 178.431 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.772 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.38 -33.09 37.44 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.014 -179.159 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.529 ' N ' HD22 ' A' ' 250' ' ' ASN . . . 92.02 85.4 1.49 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.122 -178.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 258' ' ' SER . 2.9 m -46.55 168.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.641 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.665 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.3 OUTLIER -154.97 136.2 13.99 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 119.9 -0.72 . . . . 0.0 112.749 179.381 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 1.038 HG22 HG13 ' A' ' 281' ' ' ILE . 67.1 t -115.16 130.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.154 178.481 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . 0.674 ' HA ' HD12 ' A' ' 280' ' ' ILE . 1.1 t-20 56.16 37.68 29.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.106 0.479 . . . . 0.0 109.932 -179.25 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.67 25.69 9.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.637 -179.488 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.694 ' O ' HG23 ' A' ' 259' ' ' ILE . 3.1 t-80 -128.02 101.35 6.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.675 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 252' ' ' THR . 10.4 t -53.51 92.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.327 0.584 . . . . 0.0 111.167 -179.71 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.961 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -88.88 -9.14 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.004 -178.284 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 25.2 m . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.359 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp . . . . . 0 CA--C 1.543 0.683 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.909 ' CZ3' HG13 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -80.31 -23.13 40.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.785 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' A' ' 245' ' ' ASP . . . 62.0 -175.74 6.39 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.241 -0.981 . . . . 0.0 110.929 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 272' ' ' PRO . 1.7 m-20 -105.6 141.74 23.29 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 117.983 0.891 . . . . 0.0 111.141 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.753 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.1 Cg_exo -51.97 123.14 11.8 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.856 2.371 . . . . 0.0 113.517 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.622 HG11 HG13 ' A' ' 259' ' ' ILE . 95.2 t -100.9 140.91 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.272 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.1 mt-10 -86.92 129.24 34.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.745 -179.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.869 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -95.41 164.67 12.72 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.93 -179.516 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.67 157.4 45.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 29.3 t -61.02 129.44 41.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.25 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.621 ' HB2' ' O ' ' A' ' 277' ' ' SER . 5.8 m-20 82.43 -1.15 1.38 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.519 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.725 ' O ' HG23 ' A' ' 291' ' ' VAL . 0.1 OUTLIER -79.11 137.86 37.67 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.079 179.473 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 255' ' ' ASN . 1.1 pp -102.08 127.11 55.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.04 179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 1.038 HG13 HG22 ' A' ' 254' ' ' VAL . 0.4 OUTLIER -105.96 159.54 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.995 0.426 . . . . 0.0 111.287 178.971 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.649 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.9 m -145.54 122.91 11.62 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.149 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.657 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -119.01 47.93 1.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.833 -179.44 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.03 -134.9 3.1 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.85 -1.167 . . . . 0.0 113.042 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.51 HG22 ' OE1' ' A' ' 224' ' ' GLU . 1.8 t -87.8 -51.62 5.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 0.0 110.382 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.59 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -137.86 -2.19 1.93 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.292 179.337 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.6 m -70.92 102.77 2.47 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.885 0.374 . . . . 0.0 111.103 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.816 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.4 OUTLIER -121.27 128.55 52.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.922 -179.215 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.719 HG23 ' CG2' ' A' ' 281' ' ' ILE . 0.0 OUTLIER -108.3 133.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.087 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.1 t80 -76.43 134.78 39.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.682 -179.221 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.869 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -104.38 113.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.044 -179.988 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -129.06 141.86 51.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.749 -179.785 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.761 HD11 HD23 ' A' ' 275' ' ' LEU . 6.6 mt -137.63 138.17 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.286 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.29 131.56 16.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.695 0.283 . . . . 0.0 111.071 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.408 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 23.8 p -79.77 143.19 34.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.091 0.472 . . . . 0.0 111.193 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.628 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.3 OUTLIER . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.229 0.538 . . . . 0.0 110.75 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 181' ' ' TRP . . . . . 0.702 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 37.0 m95 -148.16 139.44 23.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.38 -178.069 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.9 OUTLIER -114.9 120.98 41.78 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.049 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 183' ' ' PHE . . . . . 0.725 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.3 m-85 -121.56 135.41 55.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.445 0.641 . . . . 0.0 110.358 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -140.57 148.36 40.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.355 179.211 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.647 ' C ' HG23 ' A' ' 289' ' ' VAL . 1.7 tt0 -137.56 124.46 21.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.2 -177.556 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 1.014 HG21 HD11 ' A' ' 220' ' ' LEU . 40.3 t -63.05 108.74 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.379 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.9 tt -87.92 -26.64 5.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -176.118 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.886 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -158.8 96.31 1.35 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.443 -179.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.676 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.49 173.91 39.66 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 178.546 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.51 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 37.6 Cg_endo -69.47 32.92 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 121.823 1.682 . . . . 0.0 111.266 178.141 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 191' ' ' ALA . . . . . 0.831 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -160.65 20.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.308 179.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.676 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.1 mt -38.94 108.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.721 0.296 . . . . 0.0 111.761 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.31 8.07 2.1 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.154 -1.022 . . . . 0.0 113.018 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.831 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.8 OUTLIER -101.47 112.89 25.57 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.917 0.865 . . . . 0.0 109.74 178.75 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.469 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 5.7 mt-30 -114.65 154.69 27.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.565 -179.149 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.564 ' CD2' ' HB3' ' A' ' 217' ' ' ASP . 0.0 OUTLIER -147.84 148.08 30.5 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.381 0.61 . . . . 0.0 111.154 179.636 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -144.01 152.27 40.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.044 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 1.053 HG21 ' HA ' ' A' ' 206' ' ' LEU . 8.1 p -167.03 150.29 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.0 111.278 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 199' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 180' ' ' SER . 1.0 OUTLIER -92.46 155.28 17.95 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.369 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.675 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 3.6 m -56.3 -48.74 76.06 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.522 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' A' ' 201' ' ' THR . 0.0 OUTLIER -67.66 14.11 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.251 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' A' ' 199' ' ' ASN . 0.3 OUTLIER -91.99 118.89 31.2 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 110.005 179.2 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -67.14 -107.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.4 m -80.98 21.02 0.73 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.527 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -114.17 -19.23 11.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 178.944 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 1.053 ' HA ' HG21 ' A' ' 198' ' ' VAL . 0.0 OUTLIER -70.71 -33.78 3.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.274 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 38.6 Cg_exo -55.47 101.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 121.016 1.144 . . . . 0.0 111.721 179.538 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.433 HG11 HD11 ' A' ' 184' ' ' LEU . 49.0 t -84.78 90.9 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.694 -179.163 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.637 ' HD2' ' HA ' ' A' ' 216' ' ' SER . 11.9 mttt -71.01 109.11 4.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.008 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.105 HD23 HD12 ' A' ' 218' ' ' LEU . 1.6 mp -94.38 131.78 39.68 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.013 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -179.55 -176.39 47.1 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.057 -179.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . 1.002 ' HB2' HG13 ' A' ' 225' ' ' VAL . 30.6 ttt-85 -80.76 -69.64 0.59 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.639 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 213' ' ' VAL . 9.1 p -141.88 118.8 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 0.0 110.529 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . 0.604 ' HB2' ' HD2' ' A' ' 215' ' ' PRO . 0.0 OUTLIER 168.9 176.85 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.735 -178.973 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 214' ' ' SER . 41.1 Cg_endo -67.47 23.5 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 121.831 1.687 . . . . 0.0 112.243 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 216' ' ' SER . . . . . 0.637 ' HA ' ' HD2' ' A' ' 209' ' ' LYS . 1.1 m -62.62 -151.77 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.438 179.806 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.564 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 52.1 m-20 -130.9 -34.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.957 0.408 . . . . 0.0 110.466 179.643 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.105 HD12 HD23 ' A' ' 210' ' ' LEU . 4.0 mt -103.71 125.33 50.12 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 177.111 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.582 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -94.08 87.67 5.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.863 0.364 . . . . 0.0 110.223 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 1.014 HD11 HG21 ' A' ' 186' ' ' VAL . 2.0 mm? -110.45 92.42 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 221' ' ' LYS . . . . . 0.411 ' HA ' ' HG3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -62.48 36.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.214 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.905 ' HB2' HG12 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -64.67 111.88 2.95 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.076 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.5 p -53.02 -19.15 2.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.562 0.22 . . . . 0.0 111.322 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.789 ' O ' HD21 ' A' ' 249' ' ' LEU . 3.0 pm0 -75.36 -28.69 59.64 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.929 179.674 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 225' ' ' VAL . . . . . 1.002 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.8 p -97.41 92.42 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.042 178.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.1 m -40.96 -40.71 1.47 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.371 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.4 -54.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.53 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . 0.659 ' HB3' ' HG3' ' A' ' 246' ' ' MET . 0.1 OUTLIER -144.25 126.69 15.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.749 0.309 . . . . 0.0 110.539 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 229' ' ' HIS . . . . . 0.63 ' C ' ' HG2' ' A' ' 246' ' ' MET . 0.6 OUTLIER -96.54 -51.64 4.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.961 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.781 ' HB1' HD11 ' A' ' 243' ' ' LEU . . . -142.42 165.44 27.41 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . 0.835 ' HA ' HD12 ' A' ' 210' ' ' LEU . 1.3 tm0? -149.89 160.88 43.23 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.597 179.471 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.675 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.9 mt -124.9 144.43 34.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 CA-C-O 121.271 0.557 . . . . 0.0 111.744 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.707 HG22 ' OE1' ' A' ' 231' ' ' GLN . 0.1 OUTLIER -161.38 164.3 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.118 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 234' ' ' TRP . . . . . 0.835 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.8 p90 -157.58 167.46 30.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.796 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -115.0 131.72 56.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.542 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.49 -0.61 57.62 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.27 179.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.1 m -73.6 -21.79 60.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.696 0.76 . . . . 0.0 110.168 178.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 239' ' ' PHE . 6.2 tptt -150.87 23.79 0.76 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.377 -178.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 238' ' ' LYS . 8.9 p90 38.31 60.48 1.28 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.521 0.677 . . . . 0.0 109.533 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.835 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -121.7 136.53 54.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.727 179.683 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 241' ' ' TRP . . . . . 0.713 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.2 OUTLIER -118.65 130.58 55.94 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.771 -179.905 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.458 ' CB ' ' O ' ' A' ' 273' ' ' VAL . 0.8 OUTLIER -137.09 132.7 34.47 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.427 0.632 . . . . 0.0 111.115 -177.815 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.825 HD21 HG21 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -110.08 136.97 48.49 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.131 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.769 ' N ' HD12 ' A' ' 243' ' ' LEU . 4.2 p -122.6 162.82 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 120.733 0.301 . . . . 0.0 110.359 -179.735 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.691 ' HB2' ' CA ' ' A' ' 270' ' ' GLY . 12.2 m-20 -99.38 149.1 23.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.182 0.515 . . . . 0.0 111.707 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.659 ' HG3' ' HB3' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -116.34 95.0 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.424 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 51.33 60.81 6.84 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.812 -177.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.5 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 0.3 OUTLIER -72.86 72.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.858 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.789 HD21 ' O ' ' A' ' 224' ' ' GLU . 1.2 pp -54.33 -57.54 10.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.26 0.552 . . . . 0.0 110.189 178.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.643 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.5 OUTLIER -69.52 -25.97 64.29 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.774 -179.712 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.5 ' HA2' ' HB2' ' A' ' 248' ' ' SER . . . 89.94 132.11 4.73 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.779 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.736 ' C ' HD23 ' A' ' 253' ' ' LEU . 79.7 m -92.59 151.62 20.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 252' ' ' THR . 0.0 OUTLIER -144.76 128.56 17.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.939 0.399 . . . . 0.0 111.659 -179.989 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . 0.852 HG22 HG23 ' A' ' 281' ' ' ILE . 50.1 t -101.44 131.95 48.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.251 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 49.12 31.85 3.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.149 0.499 . . . . 0.0 110.557 -178.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 78.04 36.89 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.33 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.503 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.5 OUTLIER -148.2 120.45 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.938 179.784 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 258' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 252' ' ' THR . 72.4 p -67.28 85.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.42 0.628 . . . . 0.0 110.91 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . 0.767 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -80.12 -15.42 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.636 -178.629 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.527 ' O ' ' HA2' ' A' ' 270' ' ' GLY . 2.8 m . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.497 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' A' ' 269' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 269' ' ' TRP . . . . . 0.649 ' CE3' ' HA ' ' A' ' 246' ' ' MET . 26.7 t-105 -85.19 78.68 9.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.275 -177.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . 0.691 ' CA ' ' HB2' ' A' ' 245' ' ' ASP . . . 36.04 -160.87 0.01 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 118.984 2.354 . . . . 0.0 118.984 172.176 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.11 94.24 3.53 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 111.418 -2.391 . . . . 0.0 105.99 175.11 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.426 ' HD3' HG23 ' A' ' 244' ' ' VAL . 1.0 OUTLIER -24.4 109.01 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.872 3.048 . . . . 0.0 115.929 -176.912 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 273' ' ' VAL . . . . . 0.667 HG21 HG12 ' A' ' 259' ' ' ILE . 17.5 t -115.95 159.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.314 179.128 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.502 ' N ' HG12 ' A' ' 273' ' ' VAL . 81.9 mm-40 -94.19 130.98 40.21 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.261 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -94.33 161.51 14.21 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.089 -177.258 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.587 ' H ' HD23 ' A' ' 275' ' ' LEU . . . -142.51 155.27 45.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.287 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 25.7 t -61.73 134.73 57.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.852 179.301 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.2 OUTLIER 83.66 7.25 0.66 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.925 -179.418 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 279' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 291' ' ' VAL . 0.7 OUTLIER -82.92 126.93 33.03 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.358 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -100.38 132.02 46.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 119.619 -0.833 . . . . 0.0 111.161 -179.524 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 281' ' ' ILE . . . . . 0.852 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -107.41 156.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.336 179.184 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 252' ' ' THR . 9.3 m -144.51 116.64 8.39 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 283' ' ' LEU . . . . . 0.75 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -120.01 49.52 1.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.523 -178.307 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 179.97 -142.24 5.03 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.106 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.6 t -87.7 -37.11 16.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.998 0.428 . . . . 0.0 110.211 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -152.72 3.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.238 179.706 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.886 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.3 m -77.54 106.11 9.11 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 117.753 0.252 . . . . 0.0 111.102 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.81 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.9 mtpt -127.98 133.36 49.17 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.364 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.693 ' CG1' HD12 ' A' ' 281' ' ' ILE . 8.7 p -113.32 136.51 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.345 -179.386 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 290' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 3.1 t80 -77.98 133.06 38.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 279' ' ' ASP . 2.6 t -113.69 124.7 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.466 -178.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.417 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -143.53 153.05 42.19 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.891 -179.744 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.713 HD12 ' CE3' ' A' ' 241' ' ' TRP . 1.5 mt -139.69 129.83 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.43 160.04 35.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 111.142 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 180' ' ' SER . 0.3 OUTLIER -99.02 174.31 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.665 179.578 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -179.691 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.619 ' HA ' HG23 ' A' ' 201' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.765 0.317 . . . . 0.0 110.882 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.567 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.39 84.02 1.14 Allowed Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.402 ' HG ' ' HG ' ' A' ' 200' ' ' SER . 27.0 t -165.08 -72.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.2 OUTLIER -139.25 -178.92 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.7 m95 -150.52 134.22 16.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 184' ' ' LEU . 2.7 tp -119.99 139.96 51.68 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.49 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.762 ' O ' HD12 ' A' ' 184' ' ' LEU . 4.4 m-85 -138.94 137.94 36.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.441 0.639 . . . . 0.0 110.043 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.883 HD22 ' CE1' ' A' ' 196' ' ' HIS . 5.2 mp -132.7 151.45 51.97 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.019 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.11 122.37 12.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.872 HG21 HD12 ' A' ' 194' ' ' LEU . 42.1 t -64.6 118.75 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 288' ' ' LYS . 3.7 tt -97.96 -23.94 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 114.398 1.259 . . . . 0.0 114.398 -176.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.758 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -161.85 92.41 0.85 Allowed 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.541 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.603 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.58 -173.78 30.65 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.447 ' HG3' ' CA ' ' A' ' 222' ' ' ASP . 74.3 Cg_endo -79.88 30.58 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.179 1.919 . . . . 0.0 111.822 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.865 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.28 23.95 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.627 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.603 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.9 mt -39.63 113.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.072 0.463 . . . . 0.0 111.699 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.9 9.63 2.45 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.524 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.872 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -99.37 135.08 41.3 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.702 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 27.1 mt-30 -129.67 147.46 51.46 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.217 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.944 ' CD2' HG21 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -136.26 130.05 32.44 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.599 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 182' ' ' LEU . . . -144.63 166.02 26.37 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.942 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.83 HG13 ' CH2' ' A' ' 234' ' ' TRP . 3.2 p -175.21 157.22 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.098 0.475 . . . . 0.0 111.073 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.483 ' N ' HG22 ' A' ' 198' ' ' VAL . 65.8 m-80 -90.92 149.13 22.02 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.872 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.528 ' CB ' ' HE1' ' A' ' 234' ' ' TRP . 54.8 p -66.82 -3.29 6.47 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.709 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.619 HG23 ' HA ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -102.45 5.45 39.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.741 0.305 . . . . 0.0 111.444 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -87.35 127.34 35.2 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.04 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.5 t -90.56 -87.3 0.19 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.53 11.59 6.85 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.12 -11.0 9.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.917 0.389 . . . . 0.0 110.875 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.793 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.5 tt -70.11 -57.76 5.78 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -42.83 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.29 1.993 . . . . 0.0 112.745 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.944 HG21 ' CD2' ' A' ' 196' ' ' HIS . 99.2 t -69.59 164.3 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.183 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.664 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 3.8 mtmm -139.64 95.03 2.85 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.901 HD23 HD12 ' A' ' 218' ' ' LEU . 1.3 mp -83.78 127.32 33.72 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.488 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -169.11 172.05 43.22 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.02 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.984 ' HB2' HG13 ' A' ' 225' ' ' VAL . 3.0 ttt85 -71.46 -76.16 0.11 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 213' ' ' VAL . 11.7 p -133.66 110.18 14.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.135 0.493 . . . . 0.0 110.991 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.497 ' HB2' ' HD2' ' A' ' 215' ' ' PRO . 0.0 OUTLIER 171.4 179.81 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.592 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.497 ' HD2' ' HB2' ' A' ' 214' ' ' SER . 45.2 Cg_exo -56.65 -3.42 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 121.946 1.764 . . . . 0.0 112.478 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.535 ' HA ' ' HB3' ' A' ' 209' ' ' LYS . 0.4 OUTLIER -43.24 158.62 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.971 0.415 . . . . 0.0 111.535 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -83.68 -30.46 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.289 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.901 HD12 HD23 ' A' ' 210' ' ' LEU . 18.7 mt -113.88 127.99 56.22 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -88.62 84.78 6.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.487 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.718 HD21 ' HB3' ' A' ' 218' ' ' LEU . 1.7 mm? -100.94 66.74 1.17 Allowed 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.604 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 0.4 OUTLIER -62.07 54.35 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 220' ' ' LEU . 19.8 t0 -105.33 125.5 51.05 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.1 p -40.15 -31.83 0.15 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.49 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 0.0 OUTLIER -53.32 -40.36 64.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.795 0.331 . . . . 0.0 111.11 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.984 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.5 p -99.89 96.33 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 83.1 p -41.63 -51.86 3.92 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.047 0.451 . . . . 0.0 111.145 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -142.72 -54.07 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.31 128.67 21.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.119 0.485 . . . . 0.0 109.964 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.602 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.2 OUTLIER -94.62 -56.88 2.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.211 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -150.45 177.24 10.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.37 0.605 . . . . 0.0 112.469 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.743 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.7 OUTLIER -157.93 178.67 9.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.152 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 4.8 mt -133.23 145.58 33.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 121.434 0.635 . . . . 0.0 111.734 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.94 131.37 5.18 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.939 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 16.3 p90 -125.3 167.02 15.48 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.99 133.43 56.04 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 114.233 -1.349 . . . . 0.0 112.503 -178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 48.0 t -91.52 0.44 57.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.11 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.2 m -79.01 -46.3 18.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.833 0.825 . . . . 0.0 109.457 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.413 ' C ' ' CG ' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -111.77 9.53 20.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.936 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.413 ' CG ' ' C ' ' A' ' 238' ' ' LYS . 10.2 p90 43.75 65.9 0.92 Allowed 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.593 0.711 . . . . 0.0 109.924 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.939 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -135.61 145.82 47.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.269 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.76 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.9 OUTLIER -121.37 114.4 21.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.601 -1.182 . . . . 0.0 109.935 -179.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.673 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 24.1 mt-10 -131.36 146.46 52.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 121.956 0.884 . . . . 0.0 113.156 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.771 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.6 pp -110.98 153.61 25.3 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.829 -1.532 . . . . 0.0 110.935 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.741 HG21 ' CD1' ' A' ' 269' ' ' TRP . 1.4 p -122.71 162.23 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.434 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.41 ' CG ' ' HB3' ' A' ' 260' ' ' SER . 5.2 m-20 -112.6 100.62 8.87 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 120.986 0.422 . . . . 0.0 111.988 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.697 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -78.15 106.11 9.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.678 178.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 49.19 65.0 2.96 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.252 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.446 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 0.0 OUTLIER -71.35 64.32 0.39 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -177.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.673 HD12 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -48.39 -62.32 1.55 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.023 0.439 . . . . 0.0 110.166 178.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.556 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . 0.4 OUTLIER -77.02 -31.71 56.56 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.854 179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.574 ' HA3' ' ND1' ' A' ' 261' ' ' HIS . . . 99.19 149.09 24.06 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.172 -0.922 . . . . 0.0 114.006 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 282' ' ' THR . 2.9 m -115.95 107.63 15.22 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.722 0.409 . . . . 0.0 110.57 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.621 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.1 OUTLIER -98.52 128.87 45.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.122 0.487 . . . . 0.0 111.554 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.647 HG23 HD11 ' A' ' 259' ' ' ILE . 91.9 t -99.7 134.02 40.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.678 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.473 HD22 HG12 ' A' ' 254' ' ' VAL . 16.1 p30 47.93 38.01 8.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.279 0.561 . . . . 0.0 110.068 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.0 t 67.51 36.69 3.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.731 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -144.64 111.81 5.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.245 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.567 ' CB ' ' NE2' ' A' ' 261' ' ' HIS . 60.0 p -58.17 87.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.134 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.765 HG12 HG11 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -88.97 -18.18 7.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.886 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 9.7 t -130.87 -10.17 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.701 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 7.4 p80 -110.99 44.26 0.22 Allowed Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 176.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.886 ' HD3' ' C ' ' A' ' 260' ' ' SER . 10.6 Cg_exo -74.37 -4.95 16.21 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.11 1.873 . . . . 0.0 113.859 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 266' ' ' SER . 8.8 t0 -135.76 100.55 4.5 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.108 0.48 . . . . 0.0 111.872 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.443 HD22 ' H ' ' A' ' 264' ' ' LEU . 3.5 mm? -54.2 -85.78 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.924 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -38.93 -29.55 0.09 OUTLIER Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.536 -0.364 . . . . 0.0 113.672 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.485 ' HB2' ' HB3' ' A' ' 263' ' ' ASP . 0.3 OUTLIER -65.28 -40.56 94.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 49.5 22.52 0.75 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -54.87 154.67 4.98 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.408 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.741 ' CD1' HG21 ' A' ' 244' ' ' VAL . 38.4 t-105 -67.91 -23.32 65.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.276 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 73.38 167.76 13.51 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.748 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -102.68 143.77 27.28 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.614 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.5 Cg_exo -51.32 121.45 8.42 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.308 2.006 . . . . 0.0 113.12 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.765 HG11 HG12 ' A' ' 259' ' ' ILE . 70.2 t -96.42 132.15 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.3 125.65 29.67 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.408 -178.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.841 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -94.59 165.5 12.49 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.51 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.551 ' HB3' ' OD1' ' A' ' 279' ' ' ASP . . . -144.1 162.87 35.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.207 0.527 . . . . 0.0 112.418 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.554 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 13.4 p -60.61 128.55 37.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.428 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.8 m-20 86.05 7.84 0.33 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.279 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.551 ' OD1' ' HB3' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -75.89 -171.46 1.64 Allowed 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.4 OUTLIER -160.73 133.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.102 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.698 HD12 ' CG2' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -111.63 149.85 14.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.987 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.571 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -139.33 112.4 8.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.746 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -110.77 45.01 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.059 -177.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.33 -132.29 2.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 119.321 -1.419 . . . . 0.0 113.64 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 10.9 t -89.87 -43.68 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.654 0.264 . . . . 0.0 110.529 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.2 t -148.37 -0.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.758 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 25.8 m -69.04 102.57 1.65 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.257 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.658 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.5 ttmt -121.01 127.01 51.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.664 -178.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.698 ' CG2' HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -109.77 132.69 57.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.294 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.462 ' HD1' ' CG2' ' A' ' 280' ' ' ILE . 2.1 t80 -76.86 137.05 38.93 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.872 0.368 . . . . 0.0 110.194 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.677 HG13 HD11 ' A' ' 184' ' ' LEU . 1.3 t -106.04 115.75 48.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.262 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.74 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -129.79 142.6 50.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.912 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.841 HD11 HD23 ' A' ' 275' ' ' LEU . 6.4 mt -139.0 115.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.157 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.77 154.18 45.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.804 0.335 . . . . 0.0 110.924 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 88.7 p -87.95 -173.2 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.726 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.52 116.19 2.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.52 101.38 13.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.982 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.854 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.613 ' HB2' HG23 ' A' ' 201' ' ' THR . 57.6 mt . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 120.6 0.238 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.886 ' N ' HG21 ' A' ' 201' ' ' THR . . . 104.32 99.79 2.58 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.916 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.563 ' HB3' ' HB3' ' A' ' 200' ' ' SER . 1.1 m -179.54 -89.74 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.499 0.19 . . . . 0.0 111.16 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.9 OUTLIER -139.53 179.95 6.26 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 2.7 m95 -141.07 132.29 26.49 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.9 HD11 ' CD2' ' A' ' 184' ' ' LEU . 3.0 tp -121.94 133.56 54.84 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.116 177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.779 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.4 m-85 -129.71 132.19 46.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.677 0.751 . . . . 0.0 110.246 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.9 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.5 mm? -117.97 140.68 49.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.832 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.7 OUTLIER -137.35 118.48 14.45 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.874 HG21 HD12 ' A' ' 194' ' ' LEU . 5.7 t -67.15 103.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 121.164 0.507 . . . . 0.0 109.657 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.884 HG22 ' O ' ' A' ' 288' ' ' LYS . 7.0 tt -87.38 -20.84 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.859 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.54 97.02 0.4 Allowed 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.496 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.601 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.85 -169.57 25.36 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.598 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 87.1 Cg_endo -81.13 30.12 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.12 1.88 . . . . 0.0 111.313 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.874 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.48 24.68 0.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.372 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.601 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.8 mt -39.65 106.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.805 0.336 . . . . 0.0 111.851 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.62 2.42 2.55 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.182 -1.009 . . . . 0.0 113.469 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.874 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER -98.02 167.93 10.59 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.8 mt-30 -159.97 149.21 17.72 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.371 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.781 ' HE1' HG11 ' A' ' 289' ' ' VAL . 1.7 p-80 -135.42 128.66 31.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.341 0.591 . . . . 0.0 109.93 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.24 163.03 34.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.475 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.955 HG21 ' HA ' ' A' ' 206' ' ' LEU . 6.1 p -173.2 157.34 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.041 0.448 . . . . 0.0 111.066 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.7 OUTLIER -90.41 153.47 20.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.988 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.563 ' HB3' ' HB3' ' A' ' 179' ' ' SER . 12.4 t -69.49 -6.07 28.19 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.218 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.886 HG21 ' N ' ' A' ' 178' ' ' GLY . 0.6 OUTLIER -99.35 7.6 45.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.862 -179.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.424 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 1.0 OUTLIER -86.41 138.56 31.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.797 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.0 m -90.22 -85.67 0.21 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.02 22.77 9.84 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.424 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 3.0 pttt -119.67 -11.85 9.35 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.868 0.365 . . . . 0.0 110.87 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.955 ' HA ' HG21 ' A' ' 198' ' ' VAL . 7.7 tt -71.22 -58.52 3.9 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -42.86 97.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.575 2.184 . . . . 0.0 113.127 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.743 HG11 ' CD2' ' A' ' 196' ' ' HIS . 60.9 t -69.07 164.78 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 208' ' ' VAL . 17.5 mtpt -138.08 96.57 3.22 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.992 HD23 HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -84.3 125.37 32.2 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.88 166.97 38.38 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.418 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.886 ' HD3' HG12 ' A' ' 213' ' ' VAL . 9.9 ttt180 -69.33 -77.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.886 HG12 ' HD3' ' A' ' 212' ' ' ARG . 8.8 p -138.28 110.95 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.386 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.616 ' CB ' ' HD2' ' A' ' 215' ' ' PRO . 0.3 OUTLIER 171.98 -178.61 0.08 OUTLIER Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.778 -179.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.616 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 24.0 Cg_endo -61.68 12.64 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 122.002 1.801 . . . . 0.0 113.02 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -57.51 -173.61 0.01 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.91 0.386 . . . . 0.0 111.265 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -104.79 -30.04 10.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.09 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.992 HD12 HD23 ' A' ' 210' ' ' LEU . 0.4 OUTLIER -110.95 133.66 53.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.072 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -98.45 82.23 2.84 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.162 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.779 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.8 mm? -103.73 83.5 2.14 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.598 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 24.6 pttt -58.94 65.04 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.766 0.317 . . . . 0.0 111.61 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.61 ' N ' ' O ' ' A' ' 220' ' ' LEU . 6.7 m-20 -93.48 144.01 25.76 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.446 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.7 t -85.76 -4.14 59.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.519 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.495 ' OE2' HG22 ' A' ' 285' ' ' THR . 12.7 pm0 -101.24 -16.29 17.02 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 61.9 t -97.93 77.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.893 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -34.03 -50.87 0.4 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.98 0.419 . . . . 0.0 111.535 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.4 -49.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.573 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.468 ' HG2' ' OG ' ' A' ' 216' ' ' SER . 1.6 mtmm -144.08 129.73 19.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.443 . . . . 0.0 110.915 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.554 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 3.1 t60 -96.32 -55.97 2.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.578 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -148.57 177.49 9.44 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.666 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -156.58 173.17 17.32 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.932 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 35.6 mt -132.77 145.16 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.199 0.523 . . . . 0.0 112.225 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.418 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -160.62 148.66 16.21 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.817 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 8.1 p90 -140.88 165.57 27.15 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.728 1.011 . . . . 0.0 113.728 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.4 ' HB2' ' CD ' ' A' ' 240' ' ' LYS . 1.1 m120 -117.35 133.95 55.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.726 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 10.2 t -90.58 2.02 56.21 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.333 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 4.5 m -76.28 -25.88 55.35 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.71 0.767 . . . . 0.0 110.238 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -145.87 23.47 1.38 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.123 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 238' ' ' LYS . 15.6 p90 36.97 62.16 0.82 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.51 0.671 . . . . 0.0 110.194 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.817 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -124.97 141.12 52.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.456 178.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.713 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -124.61 123.24 39.63 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.664 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.6 pt-20 -137.09 143.4 42.55 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.935 0.874 . . . . 0.0 112.826 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.795 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.4 pp -111.2 150.68 29.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.431 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.661 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -117.78 162.79 15.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.495 ' CG ' ' HB2' ' A' ' 260' ' ' SER . 1.8 m-20 -112.03 105.79 14.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.555 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -73.32 99.18 2.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.463 177.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.63 64.49 4.17 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.291 -0.957 . . . . 0.0 111.504 -178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -68.5 64.67 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.902 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.42 -51.85 65.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.622 178.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.902 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.3 OUTLIER -74.31 -31.71 62.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.117 0.484 . . . . 0.0 110.914 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.89 90.09 1.35 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.017 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.602 HG22 ' CD1' ' A' ' 281' ' ' ILE . 1.9 m -46.24 159.2 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.835 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -149.64 137.82 20.54 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.432 0.634 . . . . 0.0 111.85 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 1.07 HG23 HD12 ' A' ' 259' ' ' ILE . 99.7 t -112.15 128.2 68.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.608 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.18 44.61 24.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.129 0.49 . . . . 0.0 110.209 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 m 62.35 24.7 14.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.991 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -130.65 110.51 11.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.42 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 8.7 t -58.79 98.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.512 0.672 . . . . 0.0 111.747 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 1.07 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -77.52 -37.68 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.216 -179.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.913 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 42.1 t -59.8 170.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.461 ' O ' ' N ' ' A' ' 263' ' ' ASP . 0.1 OUTLIER -88.87 97.52 0.9 Allowed Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 119.305 0.957 . . . . 0.0 108.714 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.913 ' HD3' ' O ' ' A' ' 260' ' ' SER . 83.8 Cg_exo -55.43 79.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.578 0 C-N-CA 123.197 2.598 . . . . 0.0 112.997 -178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 261' ' ' HIS . 0.7 OUTLIER -133.88 86.23 2.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.822 -1.535 . . . . 0.0 110.315 179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.726 HD22 ' H ' ' A' ' 264' ' ' LEU . 0.0 OUTLIER -47.33 -30.77 3.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.338 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -87.04 -41.85 6.51 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.332 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.412 ' CB ' ' HB3' ' A' ' 263' ' ' ASP . 20.4 m -61.91 -39.75 93.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.925 0.393 . . . . 0.0 111.961 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 267' ' ' ARG . 5.4 mmt180 46.58 22.6 0.18 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.896 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -53.91 153.58 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.196 0.522 . . . . 0.0 111.725 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.661 ' NE1' HG11 ' A' ' 244' ' ' VAL . 42.5 t-105 -65.92 -24.85 66.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.217 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 77.66 159.87 12.44 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.7 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -94.29 142.11 24.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.661 0.267 . . . . 0.0 110.543 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 76.0 Cg_exo -48.44 113.73 0.94 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.502 2.134 . . . . 0.0 112.901 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.616 HG21 ' CG1' ' A' ' 259' ' ' ILE . 85.0 t -94.19 136.14 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.713 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -84.36 128.34 34.52 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.7 -179.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.873 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -94.0 165.8 12.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.198 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.0 156.59 46.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 60.1 p -60.86 130.38 46.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.987 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.0 OUTLIER 81.28 -2.95 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.406 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.893 ' O ' HG23 ' A' ' 291' ' ' VAL . 0.1 OUTLIER -77.91 138.98 39.19 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.723 -0.391 . . . . 0.0 110.126 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 280' ' ' ILE . 0.9 OUTLIER -99.0 123.48 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.345 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.73 HG12 HG22 ' A' ' 254' ' ' VAL . 0.3 OUTLIER -103.4 158.79 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.189 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.835 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 47.5 m -151.06 130.3 12.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.659 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -123.74 42.3 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -178.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -177.17 -134.53 2.02 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 119.683 -1.246 . . . . 0.0 113.578 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.495 HG22 ' OE2' ' A' ' 224' ' ' GLU . 4.7 t -90.59 -47.87 7.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.702 0.287 . . . . 0.0 110.703 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.55 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -139.37 0.93 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 179.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.859 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.7 m -75.85 101.03 4.97 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.527 0.204 . . . . 0.0 111.182 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.884 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -120.38 129.56 53.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.231 0.539 . . . . 0.0 111.47 -179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.781 HG11 ' HE1' ' A' ' 196' ' ' HIS . 0.2 OUTLIER -109.84 132.53 57.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.649 -178.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 278' ' ' ASP . 1.4 t80 -77.46 133.35 38.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.981 0.42 . . . . 0.0 110.353 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.2 OUTLIER -102.46 114.27 41.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.008 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.517 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -124.39 133.73 53.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.446 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.868 HD11 HD23 ' A' ' 275' ' ' LEU . 3.7 mt -132.72 134.66 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.377 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.51 165.67 30.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.852 0.358 . . . . 0.0 111.129 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 13.7 m -97.74 177.79 5.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.781 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -159.36 116.49 2.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -75.66 86.44 2.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.876 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.86 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.63 ' HB2' HG23 ' A' ' 201' ' ' THR . 3.7 mm? . . . . . 0 CA--C 1.533 0.29 0 CA-C-O 120.566 0.222 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.595 ' N ' HG21 ' A' ' 201' ' ' THR . . . 99.39 106.28 2.7 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.792 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.494 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 0.2 OUTLIER -179.81 -86.98 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.585 0.231 . . . . 0.0 110.549 178.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -140.26 -178.53 5.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.9 m95 -143.59 132.35 22.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.936 HD11 ' CD2' ' A' ' 184' ' ' LEU . 1.2 tp -120.88 134.86 55.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.246 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.913 ' N ' HD12 ' A' ' 182' ' ' LEU . 5.7 m-85 -133.42 138.77 46.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.706 0.765 . . . . 0.0 109.823 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.936 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.1 mm? -122.09 139.1 54.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.906 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.15 114.95 13.66 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.959 HG21 HD12 ' A' ' 194' ' ' LEU . 11.2 t -64.33 102.83 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.074 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.926 HG22 ' O ' ' A' ' 288' ' ' LYS . 15.1 tt -83.59 -28.43 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.784 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -162.08 99.66 1.08 Allowed 'General case' 0 C--O 1.221 -0.413 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.467 ' H ' ' CG1' ' A' ' 192' ' ' ILE . . . -162.18 -169.91 26.21 Favored Glycine 0 CA--C 1.519 0.338 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.673 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 87.6 Cg_endo -83.67 30.85 0.52 Allowed 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.52 2.147 . . . . 0.0 111.748 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.938 ' HB1' HD21 ' A' ' 194' ' ' LEU . . . -162.83 24.3 0.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.303 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.47 HD11 ' HA ' ' A' ' 188' ' ' ALA . 8.4 mt -39.32 108.64 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.471 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.98 3.4 2.56 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.027 -1.082 . . . . 0.0 113.48 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.959 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -97.42 169.43 9.75 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 117.636 0.718 . . . . 0.0 109.14 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.1 mt-30 -160.06 147.63 16.54 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.563 -178.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.948 ' CE1' HD11 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -135.87 129.04 31.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.88 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.52 170.04 16.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.003 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.789 HG21 ' HG ' ' A' ' 206' ' ' LEU . 8.5 p -177.4 153.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.2 0.524 . . . . 0.0 112.244 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 180' ' ' SER . 5.9 t-20 -88.48 150.54 23.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.969 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.479 ' HA ' ' CE2' ' A' ' 234' ' ' TRP . 5.9 t -68.69 -4.85 17.23 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.347 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.63 HG23 ' HB2' ' A' ' 177' ' ' LEU . 0.6 OUTLIER -101.04 20.34 15.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.808 0.337 . . . . 0.0 111.744 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.8 OUTLIER -103.24 112.46 25.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.775 0.321 . . . . 0.0 110.363 179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 16.5 m -72.72 -89.93 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 45.6 t -89.32 14.51 10.96 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 111.511 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.502 ' O ' ' HG3' ' A' ' 205' ' ' LYS . 13.9 pttt -125.75 54.5 1.5 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.789 ' HG ' HG21 ' A' ' 198' ' ' VAL . 10.3 tt -143.58 -56.3 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.539 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.794 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 5.5 Cg_exo -41.36 100.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.995 1.796 . . . . 0.0 112.791 -177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 209' ' ' LYS . 87.8 t -67.96 163.9 2.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.996 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.694 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 31.5 mtmt -135.77 96.31 3.4 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.823 HD23 HD12 ' A' ' 218' ' ' LEU . 0.5 OUTLIER -83.28 128.34 34.41 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.091 178.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.476 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -173.59 174.85 46.27 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.745 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 1.003 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -69.04 -72.32 0.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.996 0.427 . . . . 0.0 111.873 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.881 HG22 ' H ' ' A' ' 214' ' ' SER . 10.1 p -128.86 -142.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.728 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.881 ' H ' HG22 ' A' ' 213' ' ' VAL . 2.5 m 66.9 -179.42 0.04 OUTLIER Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 118.441 0.564 . . . . 0.0 110.228 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.551 ' CD ' ' HB3' ' A' ' 214' ' ' SER . 22.6 Cg_exo -65.31 7.75 0.28 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.656 2.238 . . . . 0.0 113.558 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.6 m -48.87 173.16 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.714 0.292 . . . . 0.0 110.909 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.06 -31.43 13.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.252 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.948 HD11 ' CE1' ' A' ' 196' ' ' HIS . 0.7 OUTLIER -104.06 133.65 48.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.831 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 191' ' ' ALA . . . -100.48 74.99 1.74 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.83 0.348 . . . . 0.0 110.804 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.92 HD21 HD13 ' A' ' 218' ' ' LEU . 2.8 mm? -99.85 80.0 2.28 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.673 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -53.26 67.6 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.175 0.512 . . . . 0.0 110.802 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.729 ' N ' ' O ' ' A' ' 220' ' ' LEU . 1.7 m-20 -99.65 128.67 45.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.402 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.7 p -73.46 -4.8 35.96 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.295 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.566 ' O ' HD11 ' A' ' 249' ' ' LEU . 6.0 pm0 -93.03 -25.0 18.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.698 0.285 . . . . 0.0 111.258 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.003 HG13 ' HB2' ' A' ' 212' ' ' ARG . 3.4 p -105.49 85.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -32.39 -46.49 0.13 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.628 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.95 -52.37 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.616 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -141.79 128.78 20.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.139 0.495 . . . . 0.0 110.618 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.575 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 3.8 t60 -100.41 -56.26 2.39 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.281 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.53 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -139.38 172.88 12.16 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.694 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.2 OUTLIER -162.53 174.49 12.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.276 179.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.794 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.0 mt -130.79 144.81 36.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.577 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.85 163.44 34.09 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.667 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.7 OUTLIER -96.86 150.63 20.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.337 -1.301 . . . . 0.0 114.255 -176.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 239' ' ' PHE . 0.8 OUTLIER -118.91 94.14 4.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.217 -1.356 . . . . 0.0 107.716 175.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 13.8 p -78.16 -25.44 47.25 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 32.3 m -74.24 -21.06 59.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.584 0.707 . . . . 0.0 109.713 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 33.0 tptt -123.01 6.23 9.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.344 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 235' ' ' ASN . 13.0 p90 36.98 43.55 0.31 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 120.713 0.292 . . . . 0.0 111.003 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -115.19 174.97 5.71 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.183 0.516 . . . . 0.0 109.697 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.565 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -127.95 119.64 25.96 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.866 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 0.0 OUTLIER -143.13 152.34 41.71 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.946 0.879 . . . . 0.0 112.851 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.864 HD22 HD12 ' A' ' 281' ' ' ILE . 3.4 pp -116.79 154.04 31.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 113.986 -1.461 . . . . 0.0 111.765 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.753 HG21 ' CD1' ' A' ' 269' ' ' TRP . 3.3 p -121.3 163.7 18.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.669 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 269' ' ' TRP . 1.0 OUTLIER -106.09 101.4 10.89 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.151 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.558 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -70.6 97.46 1.33 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.728 177.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 52.33 64.65 3.85 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.27 -0.967 . . . . 0.0 111.213 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -76.32 66.89 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 -178.036 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.846 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -54.77 -49.97 69.59 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.846 ' N ' HD22 ' A' ' 249' ' ' LEU . 2.6 t-20 -72.19 -30.19 64.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.971 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 91.81 85.06 1.48 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.836 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.509 ' C ' HD23 ' A' ' 253' ' ' LEU . 1.8 m -46.03 158.61 0.09 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.51 0.155 . . . . 0.0 111.077 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.635 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -149.83 137.26 19.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.968 0.413 . . . . 0.0 111.808 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.762 HG22 HG13 ' A' ' 281' ' ' ILE . 75.2 t -111.28 132.2 60.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.014 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.52 ' HA ' HG13 ' A' ' 280' ' ' ILE . 0.5 OUTLIER 55.2 41.78 31.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 110.306 -179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 75.6 m 63.43 33.9 13.31 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.561 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.16 109.76 5.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.025 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 3.1 t -55.82 94.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.665 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.4 OUTLIER -79.85 -20.59 12.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.04 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.73 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 6.3 t -68.71 166.9 16.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 175.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.531 ' O ' ' N ' ' A' ' 263' ' ' ASP . 8.4 m80 -68.34 104.53 0.72 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 120.328 1.422 . . . . 0.0 109.241 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.73 ' HD3' ' O ' ' A' ' 260' ' ' SER . 96.8 Cg_exo -53.34 79.52 0.02 OUTLIER 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.893 2.395 . . . . 0.0 112.284 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.55 ' C ' HD22 ' A' ' 264' ' ' LEU . 71.4 m-20 -79.34 -176.65 5.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.642 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.55 HD22 ' C ' ' A' ' 263' ' ' ASP . 1.9 mm? -112.68 -47.38 3.07 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.652 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -154.68 23.9 0.64 Allowed Glycine 0 CA--C 1.521 0.441 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.252 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 267' ' ' ARG . 0.4 OUTLIER -64.14 -69.86 0.26 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.419 0.688 . . . . 0.0 112.357 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.0 OUTLIER 85.59 15.12 0.15 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.244 -179.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -53.05 160.64 0.96 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.061 0.458 . . . . 0.0 111.185 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.753 ' CD1' HG21 ' A' ' 244' ' ' VAL . 36.0 t-105 -71.9 -26.52 62.35 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 75.3 164.28 13.39 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.743 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -98.5 146.14 31.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.723 0.297 . . . . 0.0 110.469 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 89.2 Cg_exo -48.83 142.55 18.97 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 122.725 2.283 . . . . 0.0 113.072 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.665 HG21 ' HB ' ' A' ' 259' ' ' ILE . 86.9 t -124.89 136.25 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 10.5 mt-10 -84.37 132.82 34.55 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 118.788 -1.165 . . . . 0.0 111.844 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.973 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -97.05 165.98 11.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.396 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.13 158.34 44.05 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 93.2 p -60.61 129.25 40.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.063 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.462 ' HA ' ' CE2' ' A' ' 290' ' ' TYR . 38.5 m-20 82.47 -0.06 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.838 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.638 ' O ' HG23 ' A' ' 280' ' ' ILE . 0.9 OUTLIER -68.29 -170.08 0.17 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 279' ' ' ASP . 1.0 OUTLIER -161.02 124.3 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.076 177.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.864 HD12 HD22 ' A' ' 243' ' ' LEU . 0.2 OUTLIER -105.55 155.39 6.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.122 179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 287' ' ' THR . 0.2 OUTLIER -141.62 123.28 15.14 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.216 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.693 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -116.37 38.07 3.52 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.766 -178.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.4 ' HA3' ' HG3' ' A' ' 224' ' ' GLU . . . 178.68 -122.04 0.79 Allowed Glycine 0 N--CA 1.454 -0.141 0 C-N-CA 119.042 -1.551 . . . . 0.0 114.22 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.466 HG22 ' OE1' ' A' ' 224' ' ' GLU . 4.7 t -95.17 -51.72 4.5 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -141.54 2.17 1.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.72 -0.392 . . . . 0.0 112.007 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.784 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.9 m -72.57 104.77 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.806 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.926 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.4 OUTLIER -120.47 127.25 52.05 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.829 -178.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.3 OUTLIER -110.03 130.07 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.796 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.471 ' CD1' ' CG2' ' A' ' 280' ' ' ILE . 1.6 t80 -77.42 133.57 38.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.306 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.973 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -101.12 116.25 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.488 -179.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.34 135.81 48.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.77 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.729 HD11 HD23 ' A' ' 275' ' ' LEU . 13.6 mt -134.08 142.11 41.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.738 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 2.0 m -152.79 160.91 43.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.94 0.4 . . . . 0.0 111.089 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.96 175.23 6.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -120.92 116.36 24.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.008 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -85.0 86.41 7.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.743 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.839 179.942 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.669 ' HA ' HG23 ' A' ' 201' ' ' THR . 35.7 mt . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.723 0.297 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.461 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.77 92.85 1.81 Allowed Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.959 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.1 m -176.42 -78.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.001 0.429 . . . . 0.0 110.049 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -137.6 -173.33 3.46 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.661 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.5 m95 -150.4 132.95 15.72 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 292' ' ' ARG . 5.0 tp -116.25 130.22 56.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.807 176.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.661 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 4.6 m-85 -127.17 134.65 50.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.57 0.7 . . . . 0.0 110.564 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.913 HD13 ' ND1' ' A' ' 196' ' ' HIS . 1.1 mp -133.25 146.97 51.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.901 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.435 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 8.5 tt0 -142.21 124.76 15.77 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.92 HG21 HD12 ' A' ' 194' ' ' LEU . 11.8 t -62.09 119.8 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.719 HG22 ' O ' ' A' ' 288' ' ' LYS . 4.3 tt -101.05 -22.78 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.814 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.91 93.56 0.72 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.578 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.96 -170.35 26.58 Favored Glycine 0 CA--C 1.518 0.244 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.587 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 89.5 Cg_endo -81.32 30.3 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.032 1.822 . . . . 0.0 111.55 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.896 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -160.96 22.9 0.13 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.744 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.578 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.0 mt -39.77 109.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.916 0.389 . . . . 0.0 111.602 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.97 8.95 2.02 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.613 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.92 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -98.36 153.8 18.3 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 5.9 mt-30 -150.08 148.77 29.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.591 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.913 ' ND1' HD13 ' A' ' 184' ' ' LEU . 2.0 p80 -138.5 132.64 31.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.268 0.556 . . . . 0.0 110.47 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.73 169.93 18.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.746 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.626 HG13 ' CH2' ' A' ' 234' ' ' TRP . 2.7 p -177.64 157.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.197 0.522 . . . . 0.0 110.749 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.631 ' HB2' HD22 ' A' ' 177' ' ' LEU . 5.9 m120 -90.47 147.59 23.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.781 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.523 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 30.5 m -60.66 -6.17 1.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.92 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.669 HG23 ' HA ' ' A' ' 177' ' ' LEU . 9.1 t -102.34 32.19 3.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.154 0.502 . . . . 0.0 111.106 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.469 ' HB2' ' HG2' ' A' ' 205' ' ' LYS . 77.9 p -110.54 132.32 54.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.893 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.547 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 56.9 m -85.57 -84.31 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.8 21.72 14.08 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.547 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -115.88 -8.95 11.89 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.765 178.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.865 HD11 ' CE2' ' A' ' 234' ' ' TRP . 4.0 tt -69.8 -57.0 6.97 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.719 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.2 Cg_endo -43.32 86.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.797 2.331 . . . . 0.0 113.761 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.789 HG11 ' CG ' ' A' ' 196' ' ' HIS . 57.6 t -70.16 99.98 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.775 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 216' ' ' SER . 0.0 OUTLIER -69.48 87.26 0.46 Allowed 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.029 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -69.14 127.4 32.98 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.48 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -168.38 169.97 41.87 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.638 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.855 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -53.02 -95.84 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.788 -0.706 . . . . 0.0 112.606 -178.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.639 HG12 ' HD3' ' A' ' 212' ' ' ARG . 10.9 p -127.65 -7.69 4.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 O-C-N 122.187 -0.321 . . . . 0.0 111.812 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.469 ' CB ' ' CD ' ' A' ' 215' ' ' PRO . 0.3 OUTLIER -55.44 -177.22 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.493 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.469 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 53.1 Cg_exo -55.8 -1.21 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.397 2.065 . . . . 0.0 113.073 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -44.71 166.28 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.938 0.399 . . . . 0.0 111.432 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -83.93 -32.59 25.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.26 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.029 HD12 HD23 ' A' ' 210' ' ' LEU . 0.9 OUTLIER -105.46 131.88 52.32 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -97.48 82.76 3.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.768 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.687 HD21 HD13 ' A' ' 218' ' ' LEU . 2.9 mm? -104.47 64.53 0.75 Allowed 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.855 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -53.59 66.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.068 -178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.644 ' N ' ' O ' ' A' ' 220' ' ' LEU . 4.8 t0 -121.82 139.92 53.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.206 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.4 p -53.24 -31.33 42.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.624 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.56 ' CG ' ' HB3' ' A' ' 222' ' ' ASP . 2.9 pt-20 -49.6 -41.72 42.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.096 0.474 . . . . 0.0 110.147 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.721 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.6 p -103.18 110.93 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.68 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 31.4 t -56.03 -56.07 25.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.233 0.539 . . . . 0.0 109.823 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -137.08 -51.91 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.57 ' CB ' ' HG2' ' A' ' 246' ' ' MET . 0.7 OUTLIER -141.35 125.65 17.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.167 0.508 . . . . 0.0 109.889 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.634 ' CE1' ' HB3' ' A' ' 250' ' ' ASN . 0.5 OUTLIER -92.45 -60.64 1.78 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.3 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -145.23 173.76 11.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.677 ' HA ' HD12 ' A' ' 210' ' ' LEU . 24.6 tt0 -153.28 161.78 42.0 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.6 mt -124.13 147.86 28.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.802 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.716 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.25 163.23 33.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.865 ' CE2' HD11 ' A' ' 206' ' ' LEU . 3.1 p90 -153.86 165.32 36.44 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.513 ' HB2' ' HD2' ' A' ' 240' ' ' LYS . 20.4 m-20 -117.44 133.47 55.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.311 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.49 3.04 55.07 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.091 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.2 m -76.99 -30.14 55.81 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.603 0.716 . . . . 0.0 110.071 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.428 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 38.0 tptt -139.89 22.01 2.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.511 -1.222 . . . . 0.0 109.789 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 238' ' ' LYS . 15.5 p90 37.74 62.94 0.84 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.523 0.678 . . . . 0.0 110.16 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.839 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -125.47 142.32 51.57 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.7 178.251 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.769 ' CE3' HD13 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -129.15 123.23 31.59 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.957 -179.036 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.54 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.1 pt-20 -141.26 151.56 43.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 122.258 1.028 . . . . 0.0 113.323 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.644 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.2 pp -113.5 158.83 20.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.031 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.83 HG21 ' NE1' ' A' ' 269' ' ' TRP . 4.1 p -136.82 162.35 34.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.844 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.412 ' N ' HG22 ' A' ' 244' ' ' VAL . 14.3 t70 -81.89 123.61 28.99 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.57 ' HG2' ' CB ' ' A' ' 228' ' ' LYS . 10.4 tpt -76.77 32.42 0.13 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.47 50.31 32.67 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 121.249 -0.501 . . . . 0.0 112.707 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 5.5 t -99.05 179.1 4.72 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.839 0.352 . . . . 0.0 110.912 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.697 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -105.89 -29.54 9.92 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.697 ' H ' HD13 ' A' ' 249' ' ' LEU . 1.3 t-20 -75.31 -35.9 61.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.311 0.577 . . . . 0.0 112.244 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 262' ' ' PRO . . . 93.29 166.72 38.21 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.197 -0.91 . . . . 0.0 113.017 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.586 ' HB ' HD11 ' A' ' 259' ' ' ILE . 7.6 m -120.89 160.59 23.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.51 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.708 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.3 OUTLIER -146.32 121.02 9.84 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.257 0.551 . . . . 0.0 111.117 179.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.886 HG23 HD12 ' A' ' 259' ' ' ILE . 61.6 t -97.49 129.01 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.046 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.473 ' HA ' HD12 ' A' ' 280' ' ' ILE . 2.5 m-20 53.85 42.62 31.68 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.191 0.52 . . . . 0.0 110.282 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 15.8 m 65.02 22.26 12.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.952 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 0.1 OUTLIER -123.52 101.48 7.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.23 179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 26.3 p -54.74 101.05 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.075 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.886 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -78.81 -52.41 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.751 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.738 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 0.8 OUTLIER -58.15 174.94 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.466 ' CG ' ' HD3' ' A' ' 268' ' ' LYS . 14.4 m170 -105.38 88.42 2.61 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 118.203 0.456 . . . . 0.0 110.146 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.738 ' HD3' ' O ' ' A' ' 260' ' ' SER . 42.1 Cg_endo -93.29 32.19 0.24 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.069 2.513 . . . . 0.0 112.754 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -79.2 -126.8 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.641 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.577 ' N ' HD23 ' A' ' 264' ' ' LEU . 0.3 OUTLIER -45.01 -63.13 0.99 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.412 ' N ' ' HG ' ' A' ' 264' ' ' LEU . . . 168.94 37.25 0.02 OUTLIER Glycine 0 CA--C 1.517 0.208 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.99 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 1.8 m -59.48 -32.6 70.41 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 248' ' ' SER . 5.0 ttp-105 44.13 21.56 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.782 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.466 ' HD3' ' CG ' ' A' ' 261' ' ' HIS . 8.0 ptmt -61.28 151.76 31.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.995 0.518 . . . . 0.0 111.561 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.83 ' NE1' HG21 ' A' ' 244' ' ' VAL . 7.0 t-105 -66.2 -26.09 67.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.043 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.433 ' O ' ' HD1' ' A' ' 269' ' ' TRP . . . 73.11 168.76 13.85 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.622 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.75 145.72 30.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.569 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 50.6 Cg_exo -53.24 110.55 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.483 2.122 . . . . 0.0 112.967 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.817 HG21 ' HB ' ' A' ' 259' ' ' ILE . 90.1 t -89.4 132.24 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.1 mt-10 -79.59 126.12 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.711 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.972 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -93.9 166.19 12.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.98 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.609 ' HB3' ' OD2' ' A' ' 279' ' ' ASP . . . -143.4 158.69 43.44 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.233 0.54 . . . . 0.0 112.39 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 42.7 p -56.51 127.5 31.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.349 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.607 ' HB2' ' O ' ' A' ' 277' ' ' SER . 73.6 m-20 82.67 1.65 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.859 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 291' ' ' VAL . 69.4 m-20 -78.87 133.84 36.95 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.53 ' HB ' ' HD3' ' A' ' 288' ' ' LYS . 0.8 OUTLIER -94.28 125.21 46.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.694 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.566 HD13 ' H ' ' A' ' 282' ' ' THR . 0.3 OUTLIER -105.14 155.8 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.137 178.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.681 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -148.73 132.52 16.98 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.721 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -128.34 53.1 1.84 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.444 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 169.1 -129.84 1.94 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 119.596 -1.287 . . . . 0.0 113.613 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.0 t -95.76 -47.85 6.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.335 0.112 . . . . 0.0 110.92 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.402 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.7 t -139.88 -6.25 1.29 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.335 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.814 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 29.3 m -69.11 101.25 1.4 Allowed 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 120.781 0.325 . . . . 0.0 110.279 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.719 ' O ' HG22 ' A' ' 187' ' ' ILE . 20.4 ttmt -118.65 126.45 51.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.067 0.46 . . . . 0.0 111.576 -178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -110.79 131.91 60.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.424 -178.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.4 t80 -77.18 137.46 38.88 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.076 0.465 . . . . 0.0 109.942 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.923 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.5 t -105.19 112.27 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.022 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.797 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -126.55 139.42 53.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.069 -179.001 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.972 HD11 HD23 ' A' ' 275' ' ' LEU . 3.4 mt -136.26 132.22 49.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.73 152.78 45.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.956 0.408 . . . . 0.0 111.259 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.46 159.31 15.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.61 121.21 31.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.925 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 297' ' ' ASN . 2.6 p-10 -80.37 86.34 5.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.875 179.934 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.583 ' HA ' HG23 ' A' ' 201' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.692 0.282 . . . . 0.0 110.715 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.577 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.4 94.15 1.92 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.1 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.504 ' HB3' ' OG ' ' A' ' 200' ' ' SER . 2.9 m -169.49 -72.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.2 OUTLIER -138.03 -179.15 5.6 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.152 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.632 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 9.8 m95 -147.89 133.34 18.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.812 HD11 ' CD2' ' A' ' 184' ' ' LEU . 3.6 tp -118.65 132.97 56.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.722 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.666 ' N ' HD12 ' A' ' 182' ' ' LEU . 9.2 m-85 -128.32 126.0 39.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.669 0.747 . . . . 0.0 110.165 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.812 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.2 mm? -108.81 133.74 52.45 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.675 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.565 ' C ' HG23 ' A' ' 289' ' ' VAL . 0.4 OUTLIER -129.9 108.02 9.81 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.83 HG21 HD12 ' A' ' 194' ' ' LEU . 40.8 t -60.97 104.98 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 288' ' ' LYS . 12.4 tt -89.28 -24.85 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -175.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.72 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.8 96.66 0.74 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.538 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.677 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.11 -168.64 24.32 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.478 ' HB2' ' CG ' ' A' ' 221' ' ' LYS . 93.2 Cg_endo -82.91 30.53 0.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.243 1.962 . . . . 0.0 110.97 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.947 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.95 23.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.624 179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.677 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.0 mt -39.34 109.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.89 6.33 2.89 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.072 -1.061 . . . . 0.0 113.717 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.947 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER -100.14 139.66 35.48 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 117.841 0.821 . . . . 0.0 109.117 178.189 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 29.8 mt-30 -134.38 151.22 51.08 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.787 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.661 ' NE2' HG22 ' A' ' 208' ' ' VAL . 59.4 t60 -144.92 138.96 27.27 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.569 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -145.75 166.12 26.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.639 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.8 HG13 ' CH2' ' A' ' 234' ' ' TRP . 7.9 p -169.22 152.66 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.731 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.505 ' HA ' ' O ' ' A' ' 180' ' ' SER . 2.8 m120 -88.93 144.57 26.09 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.972 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.526 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 97.8 p -60.32 -7.72 2.17 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.595 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.583 HG23 ' HA ' ' A' ' 177' ' ' LEU . 7.6 t -98.49 24.53 7.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.912 0.387 . . . . 0.0 110.685 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.434 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -106.04 119.02 38.11 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.362 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.1 t -71.68 -77.28 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 11.0 m -105.0 23.07 14.18 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -119.7 -10.38 9.58 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.578 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.987 ' O ' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -82.11 -32.37 0.59 Allowed Pre-proline 0 C--N 1.331 -0.229 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.105 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 206' ' ' LEU . 29.9 Cg_exo -59.23 100.46 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.14 1.227 . . . . 0.0 111.733 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.724 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 4.9 t -68.62 160.65 4.57 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.417 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.8 OUTLIER -137.4 86.48 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.011 HD23 HD12 ' A' ' 218' ' ' LEU . 0.4 OUTLIER -77.67 125.81 29.91 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 120.633 -0.427 . . . . 0.0 109.963 179.12 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.05 172.98 45.07 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.767 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.959 ' HB2' HG13 ' A' ' 225' ' ' VAL . 16.2 ttt-85 -71.62 -70.66 0.31 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.325 -0.438 . . . . 0.0 112.145 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.81 HG22 ' H ' ' A' ' 214' ' ' SER . 9.3 p -125.59 -149.24 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.952 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.81 ' H ' HG22 ' A' ' 213' ' ' VAL . 1.0 OUTLIER 66.94 -178.0 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 58.8 Cg_endo -73.85 45.73 1.16 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 121.807 1.671 . . . . 0.0 112.702 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.35 165.92 24.17 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.445 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.36 -38.46 13.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.836 -0.345 . . . . 0.0 110.161 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.011 HD12 HD23 ' A' ' 210' ' ' LEU . 3.1 mt -105.82 129.94 53.89 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -93.46 79.38 4.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.904 0.383 . . . . 0.0 111.173 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.754 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -101.55 83.95 2.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 177.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.478 ' CG ' ' HB2' ' A' ' 190' ' ' PRO . 3.5 pttp -60.2 59.72 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.981 0.42 . . . . 0.0 111.81 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.876 ' HB2' HG12 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -89.1 126.7 35.56 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 37.2 p -67.04 -7.53 23.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.218 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -87.31 -22.52 25.08 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.095 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.959 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.6 p -106.54 83.46 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.3 p -35.0 -41.42 0.14 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.69 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.35 -57.6 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.608 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.3 OUTLIER -138.81 130.81 28.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.211 0.529 . . . . 0.0 110.316 179.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.61 ' HB3' ' HB2' ' A' ' 283' ' ' LEU . 2.2 t60 -101.07 -56.45 2.31 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.888 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.528 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -147.35 173.21 12.81 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.249 0.547 . . . . 0.0 112.273 -178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.724 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -156.3 179.85 8.84 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.824 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.458 HG12 ' HB3' ' A' ' 243' ' ' LEU . 19.8 mt -139.23 149.68 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.544 0.688 . . . . 0.0 112.436 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.89 160.67 31.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.8 ' CH2' HG13 ' A' ' 198' ' ' VAL . 5.3 p90 -149.58 165.51 32.02 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -116.49 132.98 56.53 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.138 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.07 0.27 57.26 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.867 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.16 -29.38 48.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.699 0.761 . . . . 0.0 109.963 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.444 ' HD3' ' HD3' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -138.44 23.12 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.388 -1.278 . . . . 0.0 110.129 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 238' ' ' LYS . 23.1 p90 37.0 59.09 1.11 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.355 0.597 . . . . 0.0 110.115 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.74 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 1.2 mptp? -122.72 141.37 51.86 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.105 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.687 ' CE3' ' CE3' ' A' ' 234' ' ' TRP . 2.1 m95 -124.46 121.61 35.33 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.912 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.8 pt-20 -138.57 144.86 40.05 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.731 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.8 pp -111.46 152.57 27.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.369 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.847 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 6.1 p -123.41 165.1 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 122.859 0.464 . . . . 0.0 110.586 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.852 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 5.1 t0 -107.39 116.6 32.22 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.851 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -75.76 99.12 4.31 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 176.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 267' ' ' ARG . . . 57.46 69.05 1.39 Allowed Glycine 0 CA--C 1.52 0.386 0 C-N-CA 119.98 -1.105 . . . . 0.0 111.578 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 56.0 p -61.5 43.54 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 1.014 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.6 -54.19 49.68 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.622 0.646 . . . . 0.0 109.911 178.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 1.014 ' N ' HD22 ' A' ' 249' ' ' LEU . 2.1 t-20 -77.87 -38.12 46.65 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.244 0.545 . . . . 0.0 110.672 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.552 ' CA ' ' HB2' ' A' ' 261' ' ' HIS . . . 93.79 96.87 1.54 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.13 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.55 ' C ' HD23 ' A' ' 253' ' ' LEU . 0.7 OUTLIER -55.87 165.17 0.97 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.662 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -150.97 140.02 21.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.285 0.564 . . . . 0.0 111.455 178.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.586 HG23 HD11 ' A' ' 259' ' ' ILE . 93.1 t -114.33 132.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.788 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.57 ' HA ' HG13 ' A' ' 280' ' ' ILE . 16.9 t-20 53.43 42.22 32.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.126 0.489 . . . . 0.0 110.28 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.2 p 63.52 32.35 14.25 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.835 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -138.88 110.32 7.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 52.4 p -60.12 88.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.431 0.634 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.82 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -90.75 -7.57 10.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.164 -0.925 . . . . 0.0 112.601 -178.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.852 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 38.9 m -105.7 -17.54 14.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.65 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 3.6 t-160 -108.75 23.58 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 72.4 Cg_exo -42.66 -46.95 8.06 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.915 1.743 . . . . 0.0 112.501 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.72 93.07 3.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.294 0.568 . . . . 0.0 110.316 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.884 ' H ' HD23 ' A' ' 264' ' ' LEU . 0.2 OUTLIER -47.98 -43.39 29.58 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.166 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -37.44 -31.63 0.07 OUTLIER Glycine 0 C--N 1.329 0.15 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.387 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 268' ' ' LYS . 52.0 m -75.97 -68.67 0.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.48 ' O ' ' HA2' ' A' ' 247' ' ' GLY . 1.6 tpp180 71.57 -19.63 0.25 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 266' ' ' SER . 0.0 OUTLIER -73.36 -134.93 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -176.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.851 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 0.0 OUTLIER -75.36 -25.38 57.65 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.646 -178.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.2 -174.55 7.47 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.581 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -111.94 157.71 38.84 Favored Pre-proline 0 C--N 1.333 -0.144 0 CA-C-N 117.482 0.641 . . . . 0.0 110.866 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.731 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 21.3 Cg_exo -66.91 138.23 47.54 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.86 2.374 . . . . 0.0 113.892 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.82 HG21 ' HB ' ' A' ' 259' ' ' ILE . 74.3 t -114.51 142.28 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.683 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.0 mm-40 -85.28 127.12 34.2 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 118.803 -1.159 . . . . 0.0 112.316 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.874 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -95.05 164.85 12.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.018 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.1 160.0 41.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.588 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 80.1 p -59.77 132.24 53.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.509 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.5 OUTLIER 84.01 7.46 0.6 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.285 -179.51 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.659 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 3.0 m-20 -79.72 -167.31 1.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.57 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -160.34 134.92 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.301 177.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 1.036 HG22 HG12 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -107.09 157.21 7.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.985 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.69 HG23 ' CG ' ' A' ' 288' ' ' LYS . 0.7 OUTLIER -149.18 117.81 6.58 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.662 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -115.57 43.9 1.98 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.976 -178.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 172.28 -123.39 1.01 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 119.209 -1.472 . . . . 0.0 113.741 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.0 t -92.88 -51.16 5.21 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.5 0.185 . . . . 0.0 111.5 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.586 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -143.6 -3.63 0.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 40.4 m -67.09 104.03 1.32 Allowed 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 117.811 0.278 . . . . 0.0 110.807 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.781 ' O ' HG22 ' A' ' 187' ' ' ILE . 3.6 mtpt -125.49 134.66 51.96 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.498 -0.481 . . . . 0.0 112.264 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 1.036 HG12 HG22 ' A' ' 281' ' ' ILE . 9.6 p -112.98 136.92 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.289 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.443 ' HD1' HG22 ' A' ' 280' ' ' ILE . 2.0 t80 -77.66 137.06 38.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.011 0.434 . . . . 0.0 110.249 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.55 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -103.98 110.48 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.625 -179.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -129.99 134.57 47.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.586 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.685 HD11 HD23 ' A' ' 275' ' ' LEU . 4.6 mt -133.15 143.14 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 5.7 t -150.35 157.17 42.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.338 . . . . 0.0 110.813 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 2.8 m -87.65 -176.94 5.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.892 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -154.89 116.3 4.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -158.63 103.61 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.794 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.837 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.671 ' HB2' ' HA ' ' A' ' 201' ' ' THR . 2.3 mm? . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.452 0.168 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 201' ' ' THR . . . 112.5 128.27 4.98 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.19 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.594 ' O ' ' HB3' ' A' ' 296' ' ' GLN . 22.4 m -95.05 94.58 8.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.9 0.381 . . . . 0.0 111.647 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 16.0 m -144.97 179.12 7.55 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.1 m95 -143.01 135.18 27.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 3.5 tp -118.29 123.5 45.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.502 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 3.3 m-85 -123.63 134.85 53.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.681 0.753 . . . . 0.0 110.679 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.999 HD13 ' CE1' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -135.48 145.39 47.09 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.497 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.557 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 39.8 tt0 -140.11 127.39 21.2 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.869 HG21 HD12 ' A' ' 194' ' ' LEU . 16.9 t -64.97 107.72 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.5 tt -91.47 -21.51 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.834 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.55 94.56 0.7 Allowed 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.722 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.14 -177.99 35.65 Favored Glycine 0 CA--C 1.518 0.225 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.534 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 88.2 Cg_endo -76.84 31.84 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 CA-C-N 119.591 1.696 . . . . 0.0 111.579 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.831 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.57 23.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.336 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.722 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.5 mt -39.81 111.34 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.85 6.89 2.45 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.011 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.869 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -98.72 154.59 17.86 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.736 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.3 mt-30 -151.66 148.67 28.22 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.213 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.999 ' CE1' HD13 ' A' ' 184' ' ' LEU . 1.1 p80 -136.31 130.74 33.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.308 0.575 . . . . 0.0 109.828 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.97 163.72 35.28 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.243 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.66 HG21 ' HB2' ' A' ' 206' ' ' LEU . 9.4 p -174.28 160.99 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.292 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 180' ' ' SER . 7.3 m120 -87.86 146.02 25.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.601 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.416 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 9.3 t -62.84 -5.26 2.67 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.854 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.671 ' HA ' ' HB2' ' A' ' 177' ' ' LEU . 2.7 t -91.82 34.79 0.98 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.039 0.447 . . . . 0.0 110.617 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.961 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 8.5 m -137.25 92.88 2.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.249 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 11.3 t -66.68 -73.3 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.392 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.0 t -89.93 -2.06 58.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.584 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.961 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.1 OUTLIER -115.63 47.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.045 0.45 . . . . 0.0 111.132 -179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.857 ' H ' ' CD ' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -152.28 -26.65 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 179.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.857 ' CD ' ' H ' ' A' ' 206' ' ' LEU . 33.0 Cg_exo -55.05 102.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 CA-C-N 121.02 1.4 . . . . 0.0 111.739 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.588 HG11 ' ND1' ' A' ' 196' ' ' HIS . 17.1 t -68.34 165.78 2.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.086 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.568 ' N ' HG12 ' A' ' 208' ' ' VAL . 1.5 mtpt -134.99 88.38 2.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.151 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.072 HD23 HD12 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -75.75 128.29 34.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.563 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -175.3 176.62 47.3 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.155 -1.021 . . . . 0.0 113.556 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 1.005 ' HB2' HG13 ' A' ' 225' ' ' VAL . 6.1 ttt180 -71.47 -72.06 0.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.876 0.47 . . . . 0.0 111.477 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.657 HG22 ' H ' ' A' ' 214' ' ' SER . 8.0 p -125.49 -139.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.648 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.684 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.3 OUTLIER 61.78 -179.92 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 118.894 0.77 . . . . 0.0 109.928 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 47.0 Cg_endo -70.46 31.24 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 121.836 1.691 . . . . 0.0 113.205 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 214' ' ' SER . 3.9 m -65.03 157.71 27.63 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.796 0.331 . . . . 0.0 110.837 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.4 -30.36 23.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.533 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.072 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -110.01 133.51 53.11 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -94.95 77.32 3.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.522 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.785 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -100.44 66.88 1.29 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.647 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 0.3 OUTLIER -61.59 45.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -177.293 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.534 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 10.3 t0 -94.1 124.05 37.87 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 5.4 t -39.55 -32.07 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.228 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.867 ' O ' HD11 ' A' ' 249' ' ' LEU . 0.6 OUTLIER -52.11 -37.42 54.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 110.366 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.005 HG13 ' HB2' ' A' ' 212' ' ' ARG . 4.3 p -103.51 102.14 13.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.496 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.437 ' O ' ' HD2' ' A' ' 212' ' ' ARG . 78.6 p -45.17 -62.2 1.35 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.08 0.466 . . . . 0.0 111.032 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -132.19 -50.58 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.684 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 0.1 OUTLIER -143.05 131.25 21.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.015 -0.592 . . . . 0.0 109.782 178.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.649 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.3 t60 -95.82 -55.58 2.95 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.327 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -143.65 172.81 12.3 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.578 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -157.48 177.66 11.18 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.727 179.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.792 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.0 mt -135.78 150.17 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.885 0.374 . . . . 0.0 111.985 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.59 163.71 37.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.217 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.613 ' CE3' HD21 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -91.92 149.46 21.54 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -176.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.432 ' HB3' ' CB ' ' A' ' 240' ' ' LYS . 7.9 t-20 -119.78 80.83 1.64 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 5.9 p -68.61 -19.97 64.47 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 82.5 m -81.21 -32.16 33.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.425 0.631 . . . . 0.0 110.885 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.583 ' HD3' ' HD3' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -117.7 15.29 14.49 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.889 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.417 ' C ' ' O ' ' A' ' 238' ' ' LYS . 10.0 p90 38.9 71.98 0.15 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.583 ' HD3' ' HD3' ' A' ' 238' ' ' LYS . 6.0 mptt -137.84 148.21 45.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.445 -1.252 . . . . 0.0 112.375 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.71 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.5 OUTLIER -116.97 104.73 11.57 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.5 mt-10 -126.26 146.8 49.86 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.5 pp -116.12 149.76 38.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.767 -1.56 . . . . 0.0 110.984 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.691 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -118.87 162.31 17.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.547 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 248' ' ' SER . 11.5 m-20 -115.6 99.26 7.21 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.172 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.822 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.36 108.81 9.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.207 0.527 . . . . 0.0 110.588 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 51.61 62.5 5.48 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.114 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 5.8 t -80.6 76.17 7.46 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.972 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.47 -48.83 78.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.972 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -74.68 -28.02 60.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.414 -179.188 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.522 ' O ' HD23 ' A' ' 253' ' ' LEU . . . 87.3 99.05 0.86 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.858 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.563 ' C ' HD23 ' A' ' 253' ' ' LEU . 4.9 m -60.31 159.22 10.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.359 0.123 . . . . 0.0 110.77 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.715 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -148.09 124.51 10.97 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-O 121.027 0.442 . . . . 0.0 111.374 179.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.887 HG22 HG23 ' A' ' 281' ' ' ILE . 90.9 t -101.26 132.02 47.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.819 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.428 ' HA ' HG13 ' A' ' 280' ' ' ILE . 32.0 t-20 51.27 39.58 24.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.069 0.461 . . . . 0.0 110.29 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 1.6 t 65.82 22.14 11.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.51 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -121.45 100.49 7.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.007 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 59.9 p -51.84 97.9 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.072 0.463 . . . . 0.0 112.19 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.928 HG21 HG11 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -78.14 -54.21 12.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.874 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.544 ' N ' HG12 ' A' ' 259' ' ' ILE . 2.0 t -46.21 160.48 0.07 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.535 ' CE1' ' HD3' ' A' ' 268' ' ' LYS . 59.3 m-70 -53.51 107.38 0.84 Allowed Pre-proline 0 C--N 1.327 -0.379 0 O-C-N 121.676 -0.64 . . . . 0.0 111.811 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.85 14.19 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.079 2.519 . . . . 0.0 112.188 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.436 ' H ' ' C ' ' A' ' 261' ' ' HIS . 0.9 OUTLIER -103.21 112.47 25.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.981 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.85 164.71 9.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.364 0.602 . . . . 0.0 112.355 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.31 -20.09 2.75 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.747 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.572 ' O ' ' HB2' ' A' ' 267' ' ' ARG . 0.6 OUTLIER -75.93 -77.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.981 0.391 . . . . 0.0 111.633 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.0 OUTLIER 85.2 17.0 0.14 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.965 0.412 . . . . 0.0 111.206 -179.188 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.535 ' HD3' ' CE1' ' A' ' 261' ' ' HIS . 15.2 mtpt -50.65 153.98 1.5 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.283 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.822 ' CZ3' ' HB2' ' A' ' 246' ' ' MET . 36.8 t-105 -66.19 -26.58 67.46 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.452 ' HA2' ' CD2' ' A' ' 261' ' ' HIS . . . 76.92 160.88 11.58 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.911 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -94.56 146.47 31.52 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -45.88 147.87 3.04 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.166 1.911 . . . . 0.0 111.503 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.928 HG11 HG21 ' A' ' 259' ' ' ILE . 85.9 t -132.14 127.18 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.71 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.01 128.08 33.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 119.025 -1.07 . . . . 0.0 112.154 -178.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 1.022 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -93.11 164.38 13.28 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.957 179.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.02 159.23 42.64 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 57.2 p -62.48 132.1 51.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.245 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 81.8 -0.89 1.56 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.013 -179.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.72 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -71.97 -167.02 0.26 Allowed 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.6 OUTLIER -162.7 133.37 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.444 177.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.887 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -109.9 156.18 10.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.483 178.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.715 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 5.8 m -147.42 112.82 5.59 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.779 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -112.1 46.43 1.16 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.614 -177.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -178.79 -129.74 1.34 Allowed Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 119.654 -1.26 . . . . 0.0 113.882 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.641 HG22 ' HG3' ' A' ' 224' ' ' GLU . 5.4 t -97.59 -41.05 8.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.0 110.501 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.608 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -149.25 3.09 0.58 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.835 179.239 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.834 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 57.3 m -77.06 104.66 7.67 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.745 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -127.02 133.51 50.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.343 -179.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.85 ' CG2' HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -110.82 136.76 45.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.311 -179.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 4.0 t80 -76.41 135.22 39.45 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 1.022 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.3 t -103.37 113.51 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.099 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.481 ' HD2' ' H ' ' A' ' 293' ' ' ILE . 6.7 tpt180 -126.43 145.5 50.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.705 HD11 HD23 ' A' ' 275' ' ' LEU . 7.1 mt -143.32 116.94 3.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.908 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 6.1 t -125.48 155.76 40.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 0.0 110.725 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.02 162.25 24.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.204 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.594 ' HB3' ' O ' ' A' ' 179' ' ' SER . 5.5 tp60 -94.11 135.3 35.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.952 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -86.57 86.05 7.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.818 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.96 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.559 HD23 ' ND2' ' A' ' 199' ' ' ASN . 3.2 mp . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 120.607 0.241 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.442 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.54 64.76 0.39 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.786 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.636 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 0.3 OUTLIER -137.21 -77.81 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.875 0.369 . . . . 0.0 110.021 179.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.4 OUTLIER -135.25 179.31 6.4 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.678 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.0 m95 -144.02 127.77 17.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.871 HD11 ' CD1' ' A' ' 184' ' ' LEU . 1.2 tp -120.07 129.68 54.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.392 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.852 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.2 m-85 -130.25 135.8 48.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.786 0.803 . . . . 0.0 111.814 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.991 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -132.03 148.65 52.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.963 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.606 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 26.5 tt0 -140.64 124.96 17.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.709 HG21 HD12 ' A' ' 194' ' ' LEU . 17.4 t -60.8 108.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 120.388 -0.525 . . . . 0.0 109.925 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.2 tt -92.38 -18.38 7.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.798 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.53 93.6 0.34 Allowed 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.589 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.736 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.03 -172.06 27.84 Favored Glycine 0 CA--C 1.518 0.257 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.621 ' O ' ' HG2' ' A' ' 221' ' ' LYS . 83.5 Cg_endo -80.41 29.06 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.232 1.954 . . . . 0.0 111.61 178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.847 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.75 27.13 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.736 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.1 mt -41.76 111.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.063 0.458 . . . . 0.0 112.136 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 8.16 2.26 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.11 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.847 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -101.18 136.28 41.29 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.697 0.761 . . . . 0.0 109.057 178.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.606 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 7.9 mt-30 -136.17 155.81 49.6 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.494 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.991 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -148.84 147.58 28.9 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.355 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.544 ' C ' ' HZ3' ' A' ' 181' ' ' TRP . . . -151.25 149.48 29.45 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.619 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.927 HG13 ' CH2' ' A' ' 234' ' ' TRP . 5.2 p -153.77 153.83 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.432 0.634 . . . . 0.0 111.542 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 180' ' ' SER . 6.3 m-80 -91.27 148.57 22.25 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.679 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 179' ' ' SER . 32.8 p -66.31 -0.63 2.73 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.636 ' HB ' ' HB2' ' A' ' 179' ' ' SER . 2.1 t -103.17 26.78 7.85 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.432 0.634 . . . . 0.0 110.457 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.627 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 55.8 p -114.32 123.22 48.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.692 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.497 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 22.9 m -91.07 -80.88 0.33 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 1.3 t -82.34 6.46 16.93 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.497 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -117.26 -12.13 10.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.958 0.408 . . . . 0.0 110.939 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.747 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.8 tt -68.0 -60.97 4.58 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.295 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.619 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.6 Cg_endo -42.6 99.38 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.32 2.014 . . . . 0.0 112.571 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.895 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 2.3 t -67.38 160.44 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.438 ' N ' ' CG1' ' A' ' 208' ' ' VAL . 3.7 mtpt -133.83 93.11 3.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.026 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -84.5 121.89 28.23 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.75 167.48 38.54 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.527 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.934 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.1 OUTLIER -57.42 -88.18 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.586 HG12 ' HD3' ' A' ' 212' ' ' ARG . 13.1 p -126.89 -10.61 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 111.62 -178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.609 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.6 OUTLIER -52.34 179.78 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.461 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 36.1 Cg_exo -60.05 10.83 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.417 2.078 . . . . 0.0 113.202 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 214' ' ' SER . 1.0 OUTLIER -52.39 -178.11 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.16 0.505 . . . . 0.0 111.461 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 209' ' ' LYS . 17.6 m-20 -99.24 -31.42 11.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.51 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.026 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -104.33 127.61 52.01 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -94.27 82.24 4.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.91 0.386 . . . . 0.0 111.889 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.857 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.9 mm? -102.68 91.49 4.22 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 6.5 ptpt -61.53 60.94 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.319 0.58 . . . . 0.0 111.147 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 220' ' ' LEU . 3.3 m-20 -93.15 146.59 23.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.702 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 54.2 p -86.77 -18.46 31.04 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.56 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.569 ' OE1' HG22 ' A' ' 285' ' ' THR . 0.0 OUTLIER -79.48 -18.65 51.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.76 0.314 . . . . 0.0 111.466 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.934 HG13 ' HB2' ' A' ' 212' ' ' ARG . 3.0 p -109.37 81.45 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.023 0.44 . . . . 0.0 110.583 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.8 p -37.71 -39.45 0.34 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.514 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.37 -55.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.947 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.609 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 0.6 OUTLIER -140.75 130.82 24.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.115 0.483 . . . . 0.0 110.782 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.603 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.8 OUTLIER -96.57 -57.02 2.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.442 179.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 244' ' ' VAL . . . -151.57 175.81 11.96 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.555 0.693 . . . . 0.0 112.449 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.895 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -152.52 173.32 15.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.974 -179.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 9.0 mt -125.03 143.37 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.913 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.24 129.07 4.25 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 177.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.927 ' CH2' HG13 ' A' ' 198' ' ' VAL . 4.5 p90 -119.32 166.43 13.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.754 0.788 . . . . 0.0 112.624 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 240' ' ' LYS . 1.9 m-20 -113.66 133.25 55.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.201 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.44 -1.83 52.92 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.088 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.8 m -78.83 -23.86 44.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.518 0.675 . . . . 0.0 109.937 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.518 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 13.9 tptt -141.82 16.61 2.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.373 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 15.3 p90 42.83 60.44 2.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.537 0.684 . . . . 0.0 109.774 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.785 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 2.0 mptp? -124.08 141.25 52.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.91 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.663 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -124.68 127.02 46.65 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.316 -179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.835 ' HG2' ' HG3' ' A' ' 274' ' ' GLU . 24.5 mt-10 -134.87 139.85 45.35 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.824 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -92.37 143.1 26.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.738 -1.574 . . . . 0.0 107.45 177.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.517 ' O ' ' HB1' ' A' ' 230' ' ' ALA . 1.3 p -140.16 161.64 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.272 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.714 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 10.5 t0 -84.93 135.03 34.23 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 120.881 0.372 . . . . 0.0 110.716 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.538 ' HG3' ' HG2' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -89.74 31.33 0.95 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.18 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.56 47.45 56.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.418 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.46 175.21 6.65 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.915 0.358 . . . . 0.0 111.077 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.694 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -101.67 -30.08 11.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.737 179.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.694 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -75.82 -33.29 60.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.467 0.651 . . . . 0.0 111.579 -178.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.499 ' CA ' ' HB3' ' A' ' 261' ' ' HIS . . . 93.27 160.47 35.38 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.133 -0.94 . . . . 0.0 113.769 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' A' ' 260' ' ' SER . 7.6 m -117.98 157.37 26.88 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.049 -0.575 . . . . 0.0 110.763 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.682 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -144.87 141.82 29.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.041 0.448 . . . . 0.0 110.681 178.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.564 HG23 HD11 ' A' ' 259' ' ' ILE . 60.0 t -114.89 128.99 71.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.053 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.658 ' HA ' HD12 ' A' ' 280' ' ' ILE . 40.6 t30 55.93 48.68 17.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.099 0.476 . . . . 0.0 110.24 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 18.7 m 56.33 29.12 14.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.66 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.401 ' O ' HG23 ' A' ' 259' ' ' ILE . 1.7 t60 -133.3 103.4 5.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.816 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.585 ' HA ' ' HB3' ' A' ' 253' ' ' LEU . 64.8 p -55.03 89.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.286 0.565 . . . . 0.0 110.877 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.93 ' HB ' HG21 ' A' ' 273' ' ' VAL . 2.6 pp -94.66 -8.19 9.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 113.229 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.714 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 3.3 m -118.9 -22.08 7.48 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -176.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.647 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 22.1 p-80 -111.12 38.12 0.15 Allowed Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.661 ' HD3' ' C ' ' A' ' 260' ' ' SER . 39.2 Cg_exo -59.14 -16.04 31.47 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 121.474 1.449 . . . . 0.0 112.904 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -130.33 94.93 3.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.299 0.571 . . . . 0.0 111.418 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.827 ' H ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -57.4 169.13 0.66 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.246 179.055 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 66.2 -19.05 0.18 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.686 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 264' ' ' LEU . 7.8 p -77.27 -36.35 54.45 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 49.3 27.23 1.82 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.113 0.483 . . . . 0.0 110.804 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.434 ' NZ ' ' HA2' ' A' ' 270' ' ' GLY . 0.1 OUTLIER -69.64 164.36 23.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.07 -179.362 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.432 ' CZ3' ' HE3' ' A' ' 246' ' ' MET . 19.5 t-105 -78.29 -18.79 54.8 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.299 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.434 ' HA2' ' NZ ' ' A' ' 268' ' ' LYS . . . 71.78 173.29 18.31 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.33 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -105.0 138.31 19.47 Favored Pre-proline 0 N--CA 1.454 -0.245 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -50.28 111.43 0.53 Allowed 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.602 2.202 . . . . 0.0 113.316 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.93 HG21 ' HB ' ' A' ' 259' ' ' ILE . 39.6 t -97.97 139.53 19.97 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.835 ' HG3' ' HG2' ' A' ' 242' ' ' GLU . 1.7 mp0 -80.1 124.79 29.06 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.869 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -91.81 165.98 12.99 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.99 177.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.721 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.72 159.19 42.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 13.7 t -59.88 128.33 36.38 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.958 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.442 ' CB ' ' O ' ' A' ' 277' ' ' SER . 12.8 m-20 87.98 5.77 0.24 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.885 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.721 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -80.94 -163.29 0.57 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.658 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.7 OUTLIER -161.52 131.02 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.365 177.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.867 HD12 ' CG2' ' A' ' 289' ' ' VAL . 0.0 OUTLIER -104.46 156.3 5.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.117 0.484 . . . . 0.0 110.018 178.163 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.682 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 3.2 m -147.43 114.41 6.15 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.743 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.92 44.4 1.79 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.143 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.87 -131.54 1.79 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.585 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.569 HG22 ' OE1' ' A' ' 224' ' ' GLU . 2.6 t -92.36 -51.35 5.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.703 0.287 . . . . 0.0 110.522 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.584 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -138.58 -0.91 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.577 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.798 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 29.9 m -70.26 103.06 2.26 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 120.643 0.258 . . . . 0.0 110.953 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.679 ' O ' HG22 ' A' ' 187' ' ' ILE . 1.3 mtpp -126.01 137.78 53.68 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.349 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.867 ' CG2' HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -115.54 134.81 57.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.457 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.645 ' HD1' HG23 ' A' ' 280' ' ' ILE . 2.1 t80 -76.5 141.23 41.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.548 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -107.26 109.61 28.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.422 -179.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.416 ' O ' HD12 ' A' ' 182' ' ' LEU . 4.9 tpt180 -124.29 141.28 52.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.606 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.547 HG12 HD13 ' A' ' 182' ' ' LEU . 9.3 mt -138.76 133.16 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.02 156.46 43.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.733 0.301 . . . . 0.0 111.001 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.32 -174.75 4.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.031 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -158.44 116.39 2.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -164.7 109.74 0.95 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.842 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.927 -179.936 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.579 ' HA ' HG23 ' A' ' 201' ' ' THR . 1.1 mp . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.616 0.246 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.548 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.45 64.63 0.39 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.72 -0.753 . . . . 0.0 113.581 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 0.2 OUTLIER -133.8 -70.02 0.53 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.932 0.396 . . . . 0.0 110.319 178.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.577 ' HB2' ' OG ' ' A' ' 200' ' ' SER . 0.8 OUTLIER -138.79 -175.42 4.13 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.734 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 14.1 m95 -148.12 134.01 19.08 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.738 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 2.2 tp -112.98 119.78 39.11 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.458 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.734 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 5.6 m-85 -117.12 127.43 54.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.677 0.751 . . . . 0.0 110.66 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.613 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -118.28 134.62 54.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.526 -1.215 . . . . 0.0 109.676 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.541 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 2.3 tt0 -131.06 112.3 12.78 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.911 HG21 HD11 ' A' ' 220' ' ' LEU . 18.8 t -61.99 107.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.889 HG22 ' O ' ' A' ' 288' ' ' LYS . 11.0 tt -88.53 -26.01 5.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.743 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.31 98.35 0.71 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.325 -0.55 . . . . 0.0 112.418 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.604 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.1 -162.06 12.8 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.466 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 88.5 Cg_endo -86.59 27.93 0.56 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.677 2.251 . . . . 0.0 111.324 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.872 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -162.07 25.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.418 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.604 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.9 mt -39.63 107.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.52 5.47 2.28 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.203 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.872 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.9 OUTLIER -102.81 133.7 47.44 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.544 0.687 . . . . 0.0 110.076 179.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.8 mt-30 -131.13 153.96 48.83 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.763 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.568 ' NE2' ' HB3' ' A' ' 217' ' ' ASP . 1.6 t-80 -144.28 138.66 28.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.134 0.492 . . . . 0.0 110.832 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.738 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.92 156.08 44.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.591 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.795 HG21 ' CB ' ' A' ' 206' ' ' LEU . 12.3 p -157.69 149.01 9.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.348 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.569 ' OD1' HD23 ' A' ' 177' ' ' LEU . 0.5 OUTLIER -91.65 140.56 29.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.317 179.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.577 ' OG ' ' HB2' ' A' ' 180' ' ' SER . 0.9 OUTLIER -62.23 -6.88 3.46 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.579 HG23 ' HA ' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -93.76 28.55 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.323 0.582 . . . . 0.0 110.742 179.216 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.766 ' OG ' ' HB3' ' A' ' 206' ' ' LEU . 89.2 p -101.02 140.87 34.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.358 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -70.94 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 111.315 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.41 33.04 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.004 0.43 . . . . 0.0 110.752 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -117.15 4.13 12.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.862 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.989 HD13 ' HD3' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -98.69 -19.19 0.21 Allowed Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.989 ' HD3' HD13 ' A' ' 206' ' ' LEU . 10.8 Cg_endo -58.14 97.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 CA-C-N 120.836 1.334 . . . . 0.0 111.058 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 58.5 t -67.64 164.07 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.276 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.66 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.3 OUTLIER -139.73 86.0 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.509 -178.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.041 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -74.94 130.38 39.28 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.869 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.432 ' HA2' HG11 ' A' ' 225' ' ' VAL . . . -176.13 178.57 47.53 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.588 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.533 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 15.5 ttt180 -76.48 -67.13 0.72 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.816 HG22 ' H ' ' A' ' 214' ' ' SER . 9.8 p -125.99 -145.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.331 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 213' ' ' VAL . 1.1 p 64.78 179.9 0.04 OUTLIER Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 57.7 Cg_endo -73.15 39.37 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.913 1.742 . . . . 0.0 112.597 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 3.2 p -70.05 151.98 44.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.836 0.35 . . . . 0.0 110.553 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.568 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 2.8 m-20 -75.62 -38.15 59.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.086 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.041 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -103.21 130.33 50.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.6 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -98.72 86.28 3.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.841 0.353 . . . . 0.0 111.078 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.911 HD11 HG21 ' A' ' 186' ' ' VAL . 2.3 mm? -108.03 69.66 0.74 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.41 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 6.7 pttt -47.75 72.82 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.919 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.677 ' N ' ' O ' ' A' ' 220' ' ' LEU . 41.8 t0 -101.58 137.45 39.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.468 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.0 p -76.89 -3.98 41.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.348 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -99.73 -22.39 15.4 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 90.4 t -96.73 76.37 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.419 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 225' ' ' VAL . 49.0 m -31.5 -48.68 0.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.999 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.6 -58.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.1 OUTLIER -141.81 131.39 23.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.2 0.524 . . . . 0.0 110.336 179.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.627 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.6 t60 -99.5 -54.88 2.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.175 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -141.65 175.54 9.61 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.72 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -165.88 176.94 7.48 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.578 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.4 mt -135.27 148.99 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.682 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.17 164.11 38.01 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.46 ' CH2' ' CZ3' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -89.32 146.15 24.89 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 -176.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.532 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 0.9 OUTLIER -119.33 81.28 1.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.515 175.023 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.7 p -64.77 -20.64 66.47 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 94.1 m -80.91 -30.87 35.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.33 0.586 . . . . 0.0 110.334 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.598 ' HD2' ' HE2' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -108.59 5.25 24.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.064 178.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 235' ' ' ASN . 2.8 p90 38.48 42.73 0.58 Allowed 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.245 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.598 ' HE2' ' HD2' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -118.64 173.95 6.55 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.279 0.562 . . . . 0.0 109.503 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.696 ' CZ3' HG23 ' A' ' 293' ' ' ILE . 2.0 m0 -121.88 113.41 19.6 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 13.7 pt-20 -133.26 149.13 51.98 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.715 ' O ' HD12 ' A' ' 243' ' ' LEU . 3.8 pp -115.05 152.15 32.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.06 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.868 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.7 OUTLIER -118.98 163.12 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 248' ' ' SER . 0.4 OUTLIER -104.73 110.66 23.08 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.601 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.82 100.49 5.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.656 177.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.73 63.44 5.12 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.541 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 3.1 p -67.33 55.74 0.05 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.771 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.51 -46.52 80.51 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.771 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -78.91 -35.62 43.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.559 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 89.71 87.4 1.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.89 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.525 ' C ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -45.24 164.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.47 0.176 . . . . 0.0 111.288 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.613 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -151.84 134.17 15.24 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.213 0.53 . . . . 0.0 111.686 178.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.629 HG23 ' CG1' ' A' ' 259' ' ' ILE . 96.6 t -110.65 137.61 42.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.225 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 49.45 35.41 8.09 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.207 0.527 . . . . 0.0 110.173 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 14.6 m 69.44 29.33 4.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.442 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -131.5 102.22 5.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.349 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 8.8 t -53.39 87.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.698 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.766 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.0 OUTLIER -90.18 6.86 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.932 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.457 ' HB3' ' N ' ' A' ' 252' ' ' THR . 2.4 t -99.21 -17.11 18.29 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.678 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 0.0 OUTLIER -103.31 14.77 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 87.9 Cg_exo -48.1 -50.02 12.81 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.326 1.35 . . . . 0.0 110.186 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 266' ' ' SER . 28.6 m-20 -75.72 79.59 2.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 113.211 -1.813 . . . . 0.0 110.627 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 264' ' ' LEU . 2.4 pt? -55.33 134.2 49.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.443 . . . . 0.0 111.223 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 85.21 -4.87 84.86 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.884 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.586 ' C ' ' H ' ' A' ' 268' ' ' LYS . 99.2 p -79.14 -67.9 0.71 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.044 0.422 . . . . 0.0 111.704 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.564 ' HB2' ' O ' ' A' ' 266' ' ' SER . 1.0 OUTLIER 68.63 -20.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.802 0.728 . . . . 0.0 111.854 -178.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.586 ' H ' ' C ' ' A' ' 266' ' ' SER . 25.6 ttpt -74.33 -129.47 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.418 0.895 . . . . 0.0 113.418 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.868 ' NE1' HG11 ' A' ' 244' ' ' VAL . 3.4 t-105 -82.73 -29.14 29.99 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.72 -174.52 8.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.532 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -101.54 137.87 19.72 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 117.397 0.598 . . . . 0.0 110.497 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.704 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 75.6 Cg_exo -51.63 122.9 11.11 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.704 2.269 . . . . 0.0 113.621 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.766 HG21 ' HB ' ' A' ' 259' ' ' ILE . 98.7 t -94.12 141.11 15.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -82.93 130.13 35.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.033 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.792 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -96.46 163.25 13.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.895 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.31 160.33 41.19 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.296 0.569 . . . . 0.0 112.487 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.601 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 38.3 t -59.89 125.63 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.609 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.522 ' HA ' ' CZ ' ' A' ' 290' ' ' TYR . 14.8 m-20 85.97 0.77 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.736 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.662 ' O ' HG23 ' A' ' 291' ' ' VAL . 2.3 m-20 -82.06 133.7 35.3 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.703 HG23 ' HD1' ' A' ' 290' ' ' TYR . 1.0 OUTLIER -101.91 130.36 51.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.992 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 1.054 HG22 HG12 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -99.46 155.15 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.998 178.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.613 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -144.83 118.97 9.44 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 176.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.67 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.87 44.53 1.76 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.2 -122.93 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 119.277 -1.44 . . . . 0.0 113.843 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.2 t -93.44 -51.74 4.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.915 -0.142 . . . . 0.0 111.188 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -142.65 -2.63 1.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.743 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 35.7 m -65.94 102.39 0.78 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 117.853 0.297 . . . . 0.0 110.614 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.889 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -117.63 123.73 46.87 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.752 -178.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 1.054 HG12 HG22 ' A' ' 281' ' ' ILE . 2.5 p -108.41 134.08 51.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.636 0.255 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.703 ' HD1' HG23 ' A' ' 280' ' ' ILE . 1.4 t80 -77.65 130.26 36.62 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.2 t -104.01 115.91 46.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.894 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.601 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -129.3 146.64 51.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.576 -179.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.792 HD11 HD23 ' A' ' 275' ' ' LEU . 9.1 mt -139.78 140.77 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.52 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.6 t -152.3 161.44 42.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.373 . . . . 0.0 111.29 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 54.5 p -102.97 141.52 35.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.533 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -112.39 146.92 37.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.772 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -127.41 86.88 2.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.109 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.88 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.475 ' O ' ' CG2' ' A' ' 201' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.769 0.319 . . . . 0.0 110.179 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.731 ' HA3' HG21 ' A' ' 201' ' ' THR . . . 116.51 -138.12 14.15 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.535 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.475 ' C ' ' HB3' ' A' ' 296' ' ' GLN . 2.5 m -165.81 38.85 0.06 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.233 -0.484 . . . . 0.0 111.507 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 73.1 m -163.62 163.15 24.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.415 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 49.0 m95 -156.82 143.02 18.1 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.752 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 0.4 OUTLIER -118.79 106.16 12.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 14.2 m-85 -101.91 136.44 41.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.997 0.903 . . . . 0.0 112.179 -178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.529 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 0.4 OUTLIER -126.74 136.21 52.12 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.058 -1.428 . . . . 0.0 109.404 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -133.34 116.53 16.21 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.975 HG21 HD11 ' A' ' 220' ' ' LEU . 18.4 t -62.53 116.15 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.2 tt -96.63 -23.21 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.39 91.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.54 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.685 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.86 -174.75 32.12 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.604 -0.598 . . . . 0.0 111.604 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.567 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 60.4 Cg_endo -75.34 27.56 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.371 2.047 . . . . 0.0 111.568 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.898 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -161.4 31.51 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.94 0.4 . . . . 0.0 110.0 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.685 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.1 mt -47.8 107.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.622 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.93 7.16 2.09 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.122 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 186' ' ' VAL . 0.6 OUTLIER -101.44 112.18 24.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.802 0.81 . . . . 0.0 109.906 179.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.0 mt-30 -111.03 152.62 26.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.554 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.527 ' O ' HD12 ' A' ' 184' ' ' LEU . 1.1 t-80 -144.04 136.56 26.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.137 0.494 . . . . 0.0 110.527 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.752 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -142.06 165.18 28.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.254 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.882 HG13 ' CH2' ' A' ' 234' ' ' TRP . 0.6 OUTLIER -165.04 148.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.528 179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 180' ' ' SER . 18.2 t-20 -88.57 137.18 32.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.474 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.589 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 32.4 t -49.32 -14.36 0.09 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.887 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.731 HG21 ' HA3' ' A' ' 178' ' ' GLY . 2.0 t -102.11 7.32 41.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -103.78 114.07 28.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.885 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 2.7 m -91.26 -67.39 0.86 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.69 -5.49 2.76 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.7 -1.81 11.05 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.126 -0.359 . . . . 0.0 111.313 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.9 HD21 ' CE3' ' A' ' 234' ' ' TRP . 1.3 tt -71.58 -61.66 2.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.4 Cg_endo -44.01 84.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.45 2.1 . . . . 0.0 113.276 -177.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' A' ' 206' ' ' LEU . 88.0 t -74.53 92.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.746 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.47 ' N ' ' HB2' ' A' ' 217' ' ' ASP . 0.7 OUTLIER -69.36 98.59 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.054 HD23 HD12 ' A' ' 218' ' ' LEU . 1.4 mp -82.65 128.79 34.67 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.396 -0.522 . . . . 0.0 109.778 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -179.11 179.37 48.91 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.899 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.909 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -68.06 -76.39 0.09 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -178.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.815 HG22 ' H ' ' A' ' 214' ' ' SER . 8.0 p -126.57 -141.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.39 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.815 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.1 OUTLIER 64.72 -175.88 0.03 OUTLIER Pre-proline 0 C--O 1.232 0.135 0 CA-C-N 118.314 0.506 . . . . 0.0 110.247 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 21.8 Cg_exo -65.66 10.03 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.745 2.297 . . . . 0.0 113.423 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 39.4 m -48.83 169.03 0.02 OUTLIER 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.741 0.305 . . . . 0.0 111.092 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.47 ' HB2' ' N ' ' A' ' 209' ' ' LYS . 1.7 m-20 -95.48 -34.81 11.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.343 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.054 HD12 HD23 ' A' ' 210' ' ' LEU . 5.0 mt -105.81 127.31 53.02 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.62 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -92.57 80.02 4.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.724 0.297 . . . . 0.0 110.711 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.975 HD11 HG21 ' A' ' 186' ' ' VAL . 2.7 mm? -103.7 92.71 4.55 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.406 ' C ' ' HG2' ' A' ' 190' ' ' PRO . 1.3 mtmt -60.1 58.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.674 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.928 ' HB3' HG12 ' A' ' 225' ' ' VAL . 5.5 t0 -92.72 124.88 37.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.349 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.7 p -69.05 -10.5 57.88 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.108 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.402 ' HG3' ' OD1' ' A' ' 250' ' ' ASN . 0.8 OUTLIER -82.57 -24.76 33.81 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.783 0.325 . . . . 0.0 110.928 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.928 HG12 ' HB3' ' A' ' 222' ' ' ASP . 3.0 p -108.41 79.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.1 m -35.17 -36.16 0.05 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.737 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.23 -58.01 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.976 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.492 ' C ' HG23 ' A' ' 225' ' ' VAL . 2.6 mtpp -143.19 132.48 23.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.135 0.493 . . . . 0.0 110.556 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.541 ' CB ' ' HB2' ' A' ' 283' ' ' LEU . 0.6 OUTLIER -102.16 -57.0 2.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.376 179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -141.83 171.21 14.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.192 0.52 . . . . 0.0 112.036 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.783 ' HA ' HD12 ' A' ' 210' ' ' LEU . 1.0 OUTLIER -152.54 159.36 43.29 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.486 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.616 HG12 ' HB3' ' A' ' 243' ' ' LEU . 19.4 mt -123.73 145.73 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-O 121.432 0.634 . . . . 0.0 111.87 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.852 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -161.41 150.51 16.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.9 ' CE3' HD21 ' A' ' 206' ' ' LEU . 3.2 p90 -138.76 165.64 26.46 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.12 132.43 56.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.792 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 73.4 m -88.99 2.09 54.5 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.872 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 21.4 m -78.63 -19.48 52.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.643 0.735 . . . . 0.0 110.276 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -150.73 23.63 0.78 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.496 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 14.2 p90 37.44 59.58 1.18 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.214 0.53 . . . . 0.0 110.446 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.822 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -128.63 143.12 50.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.673 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.694 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -123.42 122.5 38.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.774 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.8 pt-20 -134.18 142.35 47.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.698 0.761 . . . . 0.0 112.354 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.4 pp -107.82 152.76 23.95 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.784 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.856 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -115.75 162.24 13.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.663 0.268 . . . . 0.0 110.963 -179.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.519 ' HB3' ' OG ' ' A' ' 260' ' ' SER . 1.2 m-20 -106.22 111.05 23.49 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.605 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -76.93 103.42 6.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.203 177.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.87 70.59 0.92 Allowed Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.51 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.2 m -62.0 40.96 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.878 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.52 -52.54 64.37 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.793 -0.567 . . . . 0.0 109.881 178.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.878 ' H ' HD13 ' A' ' 249' ' ' LEU . 2.7 m120 -80.32 -39.36 28.83 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.145 0.498 . . . . 0.0 111.681 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 88.89 87.36 1.23 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.804 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.693 ' N ' ' HB3' ' A' ' 260' ' ' SER . 2.9 m -45.44 170.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.279 0.232 . . . . 0.0 110.553 178.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.561 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.3 OUTLIER -149.11 133.66 17.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.205 0.526 . . . . 0.0 111.461 177.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.876 HG23 ' CD1' ' A' ' 259' ' ' ILE . 86.0 t -109.83 133.11 56.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.083 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.464 ' HA ' HG13 ' A' ' 280' ' ' ILE . 3.3 m-20 51.11 44.41 28.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.174 0.512 . . . . 0.0 110.07 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 2.3 m 64.18 26.93 13.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.763 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.441 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.1 OUTLIER -129.75 115.67 17.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.208 179.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 5.8 t -67.46 89.82 0.23 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.03 0.443 . . . . 0.0 111.548 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.876 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -89.36 0.33 8.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.431 -178.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.693 ' HB3' ' N ' ' A' ' 252' ' ' THR . 14.0 t -100.08 -16.69 17.78 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.7 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 0.8 OUTLIER -103.23 16.87 0.05 OUTLIER Pre-proline 0 N--CA 1.454 -0.266 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.7 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 43.8 Cg_endo -90.84 40.82 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.874 1.716 . . . . 0.0 111.144 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -151.56 85.58 1.32 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.986 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.509 ' N ' HD22 ' A' ' 264' ' ' LEU . 3.4 mm? -69.72 -37.83 76.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.066 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -88.05 -3.83 79.03 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.489 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 268' ' ' LYS . 3.1 m -97.84 -70.33 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.5 OUTLIER 67.68 -19.15 0.13 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.476 0.655 . . . . 0.0 112.061 -178.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 266' ' ' SER . 0.1 OUTLIER -72.9 -129.09 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.536 -177.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.856 ' NE1' HG11 ' A' ' 244' ' ' VAL . 1.4 t-105 -77.68 -15.7 58.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.92 0.488 . . . . 0.0 112.232 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 59.94 -174.19 4.53 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.488 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -107.18 134.07 20.06 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 117.905 0.852 . . . . 0.0 110.494 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 96.4 Cg_exo -45.0 125.08 6.41 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.771 2.314 . . . . 0.0 113.521 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.806 HG21 ' CG1' ' A' ' 259' ' ' ILE . 74.9 t -98.77 129.3 49.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.694 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -77.13 128.65 34.79 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.46 -178.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.986 HD22 HG11 ' A' ' 291' ' ' VAL . 0.6 OUTLIER -87.27 163.5 16.82 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.031 -178.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.408 ' HA ' ' HZ3' ' A' ' 241' ' ' TRP . . . -137.82 145.86 42.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.395 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 2.9 t -56.64 126.0 24.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.017 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.2 m-20 90.27 4.52 0.13 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.344 0.657 . . . . 0.0 111.949 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' ' 280' ' ' ILE . 0.6 OUTLIER -79.91 -164.51 0.68 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.789 HG22 ' HA ' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -162.3 136.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.594 -0.442 . . . . 0.0 111.406 178.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.935 HG22 HG12 ' A' ' 289' ' ' VAL . 0.1 OUTLIER -108.46 156.64 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.607 179.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.693 ' OG1' ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -145.81 117.27 8.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.699 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -113.07 44.61 1.49 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.79 -133.26 2.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.433 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 286' ' ' THR . 6.8 t -88.45 -49.44 6.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.643 0.259 . . . . 0.0 110.956 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.521 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.6 t -139.68 -7.3 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.728 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 49.0 m -63.97 101.31 0.38 Allowed 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.693 ' HG3' ' OG1' ' A' ' 282' ' ' THR . 1.7 ttmt -118.8 129.51 55.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.637 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.935 HG12 HG22 ' A' ' 281' ' ' ILE . 0.3 OUTLIER -106.98 128.49 61.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.542 0.21 . . . . 0.0 111.52 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.789 ' HA ' HG22 ' A' ' 280' ' ' ILE . 7.1 t80 -76.79 136.99 39.0 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.986 HG11 HD22 ' A' ' 275' ' ' LEU . 8.0 t -113.89 115.17 48.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.535 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.61 142.32 39.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.773 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.552 HD12 ' CE3' ' A' ' 241' ' ' TRP . 0.5 OUTLIER -129.89 147.24 33.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.501 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -152.67 129.54 10.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 0.0 111.482 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 8.7 p -81.42 159.37 24.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.58 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.475 ' HB3' ' C ' ' A' ' 179' ' ' SER . 3.7 tp-100 -110.9 119.42 39.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.687 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . 0.459 HD22 ' HA ' ' A' ' 297' ' ' ASN . 0.1 OUTLIER -75.87 92.15 3.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.289 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.868 179.701 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.523 ' HA ' ' CG2' ' A' ' 201' ' ' THR . 2.0 mp . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.653 0.263 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.653 ' N ' HG21 ' A' ' 201' ' ' THR . . . 110.97 79.6 1.04 Allowed Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.261 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 77.2 p -149.5 -74.07 0.17 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.063 0.459 . . . . 0.0 109.851 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 295' ' ' SER . 0.6 OUTLIER -142.87 -175.53 4.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.946 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.7 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.5 m95 -143.24 131.62 22.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -178.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.799 HD11 ' CD1' ' A' ' 184' ' ' LEU . 3.4 tp -114.07 128.41 56.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.943 177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.783 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.4 m-85 -130.27 129.94 43.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 121.747 0.784 . . . . 0.0 111.588 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.983 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -130.84 146.36 52.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.775 176.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.525 ' C ' HG12 ' A' ' 289' ' ' VAL . 0.6 OUTLIER -140.19 127.21 20.85 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.456 -0.497 . . . . 0.0 112.308 -177.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.879 HG21 HD11 ' A' ' 220' ' ' LEU . 9.7 t -64.5 106.06 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.1 tt -90.6 -19.01 7.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -176.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.819 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.63 95.02 0.62 Allowed 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 120.268 -0.573 . . . . 0.0 112.466 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.71 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.2 -179.54 37.75 Favored Glycine 0 C--O 1.228 -0.26 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.597 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 58.9 Cg_endo -74.6 30.17 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 CA-C-N 119.433 1.617 . . . . 0.0 111.269 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.791 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -160.2 26.38 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.71 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.0 mt -42.11 108.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.07 7.57 1.75 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.099 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.845 ' O ' HG23 ' A' ' 186' ' ' VAL . 1.1 mp -100.86 119.72 39.08 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.139 0.971 . . . . 0.0 109.818 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 8.1 mt-30 -122.54 153.64 38.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.208 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.983 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -146.67 145.42 30.02 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.059 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -150.22 143.46 24.99 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.892 HG21 ' HA ' ' A' ' 206' ' ' LEU . 12.0 p -149.01 149.94 14.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.418 0.628 . . . . 0.0 111.309 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.516 ' HB3' HG22 ' A' ' 201' ' ' THR . 71.9 m-80 -87.72 148.14 24.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.356 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.561 ' CB ' ' HZ2' ' A' ' 234' ' ' TRP . 1.0 OUTLIER -65.55 -7.64 15.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.387 179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.653 HG21 ' N ' ' A' ' 178' ' ' GLY . 3.1 t -92.35 5.62 49.92 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.95 0.405 . . . . 0.0 111.209 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.668 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -94.93 113.68 25.42 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.57 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.8 m -60.1 -108.46 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.2 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 22.8 m -78.58 25.52 0.25 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.668 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.54 -10.55 10.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.93 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.892 ' HA ' HG21 ' A' ' 198' ' ' VAL . 9.0 tt -77.06 -49.22 2.45 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.557 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 206' ' ' LEU . 52.9 Cg_exo -46.48 100.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.467 1.445 . . . . 0.0 111.653 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.874 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 4.7 t -66.83 163.33 2.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 216' ' ' SER . 0.0 OUTLIER -138.38 92.55 2.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.57 -0.287 . . . . 0.0 110.851 -179.358 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.055 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -83.91 127.32 33.76 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.513 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -173.31 178.11 45.41 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.136 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 1.003 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 8.5 ttt180 -63.38 -86.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.605 HG12 ' HD3' ' A' ' 212' ' ' ARG . 14.5 p -133.67 -4.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.631 ' HB2' ' CD ' ' A' ' 215' ' ' PRO . 67.5 p -53.76 -178.85 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.631 ' CD ' ' HB2' ' A' ' 214' ' ' SER . 32.6 Cg_exo -61.08 17.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.307 2.004 . . . . 0.0 112.709 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 214' ' ' SER . 6.4 m -58.39 -178.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.218 0.532 . . . . 0.0 111.619 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.1 -31.92 11.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.506 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.055 HD12 HD23 ' A' ' 210' ' ' LEU . 1.1 mt -103.46 124.89 49.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.62 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.596 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -94.67 86.42 4.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.795 0.331 . . . . 0.0 110.465 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 1.003 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 2.7 mm? -109.62 96.6 6.37 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -64.28 51.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.897 ' HB2' HG12 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -84.9 138.14 32.7 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 18.2 p -78.95 -11.09 59.99 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.121 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.437 ' CG ' ' HA3' ' A' ' 284' ' ' GLY . 0.0 OUTLIER -84.39 -20.34 32.06 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.769 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.897 HG12 ' HB2' ' A' ' 222' ' ' ASP . 7.5 p -113.91 69.79 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-O 120.872 0.367 . . . . 0.0 110.069 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -35.2 -33.28 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.193 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 225' ' ' VAL . . . -144.1 -67.75 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.361 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -140.38 128.48 22.23 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.32 0.581 . . . . 0.0 111.176 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 248' ' ' SER . 0.3 OUTLIER -95.8 -60.69 1.59 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.508 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.675 ' HB3' ' CD2' ' A' ' 283' ' ' LEU . . . -150.35 163.02 39.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.904 -177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.98 ' O ' HD13 ' A' ' 243' ' ' LEU . 0.0 OUTLIER -138.76 -179.14 5.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.908 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.952 HG12 HD22 ' A' ' 243' ' ' LEU . 14.8 mt -131.1 141.55 45.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.012 0.435 . . . . 0.0 110.81 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.94 133.48 5.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.886 ' CZ2' HD11 ' A' ' 206' ' ' LEU . 1.8 p90 -124.41 165.72 17.23 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -115.82 133.61 55.85 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.827 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 31.4 p -92.97 3.04 56.44 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.469 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 89.8 m -80.85 -27.99 36.25 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.42 0.629 . . . . 0.0 110.065 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 4.6 tptt -137.09 19.19 2.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.02 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.433 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 27.9 p90 40.43 60.03 1.94 Allowed 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.5 0.667 . . . . 0.0 109.861 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.77 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -125.12 143.63 50.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.322 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.824 ' CH2' HG23 ' A' ' 293' ' ' ILE . 11.6 m0 -123.79 125.16 44.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.497 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 1.1 pt-20 -129.06 134.87 48.28 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.98 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.1 OUTLIER -107.0 124.74 50.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.665 -1.607 . . . . 0.0 107.048 177.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.761 HG11 ' CZ2' ' A' ' 269' ' ' TRP . 4.8 p -126.39 164.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 O-C-N 122.111 -0.368 . . . . 0.0 111.609 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 260' ' ' SER . 15.9 t0 -88.53 127.8 35.54 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.728 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -84.51 44.44 1.04 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.411 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 269' ' ' TRP . . . 65.46 57.26 11.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.64 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.716 ' HB3' ' HA ' ' A' ' 229' ' ' HIS . 56.1 p -99.87 148.29 24.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.81 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.762 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -79.44 -37.67 36.47 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.961 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.762 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -74.01 -31.25 62.86 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.844 0.354 . . . . 0.0 111.494 -179.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 95.3 163.96 34.68 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.946 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.724 ' C ' HD23 ' A' ' 253' ' ' LEU . 25.0 m -125.22 156.61 38.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.84 0.353 . . . . 0.0 110.877 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.724 HD23 ' C ' ' A' ' 252' ' ' THR . 0.1 OUTLIER -148.68 126.41 11.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.987 0.423 . . . . 0.0 111.41 179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 1.048 HG23 HD12 ' A' ' 259' ' ' ILE . 36.0 t -102.25 127.64 55.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.735 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 53.14 41.22 32.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.983 0.421 . . . . 0.0 110.34 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 16.6 m 62.99 20.22 12.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.404 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -117.06 90.97 3.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.92 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 96.1 p -45.79 97.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.596 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 1.048 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -78.63 -52.65 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.248 179.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.568 ' N ' HG12 ' A' ' 259' ' ' ILE . 19.7 p -52.24 162.99 0.43 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 268' ' ' LYS . 0.4 OUTLIER -56.73 109.31 1.61 Allowed Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.933 179.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -59.44 -3.89 2.14 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.464 2.11 . . . . 0.0 112.942 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.4 101.88 9.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.192 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 264' ' ' LEU . 9.6 mt -48.24 -25.46 1.54 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -93.12 -11.21 58.91 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.141 -1.028 . . . . 0.0 112.892 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 1.9 m -81.26 -35.91 30.58 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.727 ' HG2' ' HA ' ' A' ' 249' ' ' LEU . 15.3 mtm180 44.85 22.38 0.06 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 261' ' ' HIS . 2.5 mttt -62.49 157.77 19.49 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.27 0.628 . . . . 0.0 112.102 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.761 ' CZ2' HG11 ' A' ' 244' ' ' VAL . 0.4 OUTLIER -72.86 -24.95 60.94 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.157 -0.928 . . . . 0.0 108.662 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.596 ' O ' ' HD1' ' A' ' 269' ' ' TRP . . . 79.52 166.17 31.93 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.747 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 273' ' ' VAL . 8.7 m-20 -89.74 138.64 27.93 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 117.397 0.598 . . . . 0.0 109.929 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.409 ' HB2' ' OE1' ' A' ' 242' ' ' GLU . 9.7 Cg_endo -52.75 108.63 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.504 2.136 . . . . 0.0 112.753 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 242' ' ' GLU . 40.0 t -102.0 147.24 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.674 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 20.9 mm-40 -85.53 130.21 34.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.51 0.671 . . . . 0.0 112.766 -177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.829 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -95.74 164.51 12.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.934 179.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.15 159.4 42.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 23.9 p -57.92 129.32 41.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.327 178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.8 m-20 87.93 7.74 0.18 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.287 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.688 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.7 OUTLIER -80.72 -164.28 0.7 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.5 OUTLIER -162.27 135.17 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 177.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.877 ' CG2' HG22 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -123.6 93.76 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 287' ' ' THR . 0.6 OUTLIER -79.0 121.96 25.59 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.685 HD23 HG23 ' A' ' 252' ' ' THR . 0.3 OUTLIER -106.69 50.03 0.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.459 -0.497 . . . . 0.0 112.254 -178.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 162.54 -115.94 0.68 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 119.571 -1.299 . . . . 0.0 113.807 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.477 HG23 ' H ' ' A' ' 286' ' ' THR . 1.2 t -96.1 -57.62 2.3 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.594 0.235 . . . . 0.0 110.727 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -135.32 0.33 2.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.916 179.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.819 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 45.1 m -75.12 102.94 5.1 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 121.353 -0.139 . . . . 0.0 111.248 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.747 ' O ' HG22 ' A' ' 187' ' ' ILE . 3.4 ptpt -129.08 135.46 48.94 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.222 0.534 . . . . 0.0 112.091 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.871 HG23 HD12 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -108.49 135.63 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.046 -179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.2 t80 -77.0 137.93 39.3 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 279' ' ' ASP . 0.1 OUTLIER -106.68 110.79 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.78 -178.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.519 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -119.39 140.6 50.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.775 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.824 HG23 ' CH2' ' A' ' 241' ' ' TRP . 32.3 mt -138.63 134.37 42.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.1 t -152.47 161.76 42.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.865 0.364 . . . . 0.0 111.207 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 36.6 p -104.86 157.97 16.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.819 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -117.22 116.25 26.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.772 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.51 86.41 6.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.588 ' HB3' HD22 ' A' ' 199' ' ' ASN . 2.6 mp . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.835 0.35 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.569 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.64 99.11 2.19 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.532 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 13.6 p -179.59 -77.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.766 0.317 . . . . 0.0 110.483 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.711 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 20.9 m -135.27 157.99 45.5 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.0 m95 -127.59 132.29 49.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -178.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.781 HD23 ' HZ3' ' A' ' 234' ' ' TRP . 2.2 tp -117.72 129.88 55.98 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.244 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.734 ' N ' HD12 ' A' ' 182' ' ' LEU . 11.2 m-85 -125.95 133.15 51.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.681 0.753 . . . . 0.0 110.436 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.799 HD11 HD12 ' A' ' 232' ' ' ILE . 3.3 mt -123.84 141.37 52.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.889 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -134.8 111.3 9.8 Favored 'General case' 0 C--N 1.334 -0.09 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 194' ' ' LEU . 8.8 t -58.64 117.98 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.6 tt -101.91 -24.41 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -175.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.758 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -155.86 91.2 1.27 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.994 0.815 . . . . 0.0 112.479 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -162.64 -165.89 20.48 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.43 ' HG3' ' CG ' ' A' ' 222' ' ' ASP . 58.6 Cg_endo -92.43 33.1 0.26 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.971 2.447 . . . . 0.0 111.509 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.842 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -162.34 29.22 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.459 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.689 HD11 ' N ' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -47.87 111.12 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.052 0.453 . . . . 0.0 111.322 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.12 4.52 2.58 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.666 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.883 ' O ' HG23 ' A' ' 186' ' ' VAL . 0.8 OUTLIER -102.33 118.9 37.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.599 0.714 . . . . 0.0 109.578 178.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.734 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 14.0 mt-30 -114.68 149.85 36.11 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.785 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.534 ' NE2' ' HB3' ' A' ' 217' ' ' ASP . 1.0 OUTLIER -138.48 133.26 32.47 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.102 178.436 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.59 156.62 43.36 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.399 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 206' ' ' LEU . 4.5 p -162.19 156.37 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.625 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.711 ' HA ' ' O ' ' A' ' 180' ' ' SER . 46.2 m-20 -94.78 145.73 24.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.619 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.502 ' CB ' ' HE1' ' A' ' 234' ' ' TRP . 28.3 p -58.34 -0.31 0.09 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.081 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.578 HG23 ' HA ' ' A' ' 177' ' ' LEU . 1.4 t -106.72 14.4 26.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.857 0.36 . . . . 0.0 111.301 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.453 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -106.33 124.53 49.73 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.179 179.362 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 m -87.48 -83.03 0.21 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 26.2 m -84.09 13.27 5.25 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.453 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -118.03 -14.31 9.97 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.015 0.436 . . . . 0.0 110.624 178.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.775 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.6 tt -65.69 -55.32 24.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.827 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.8 Cg_endo -42.84 92.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.653 2.235 . . . . 0.0 113.453 -178.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 231' ' ' GLN . 41.6 t -71.46 90.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.708 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.561 ' N ' ' HB2' ' A' ' 217' ' ' ASP . 0.7 OUTLIER -68.16 78.81 0.24 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 231' ' ' GLN . 3.1 mp -65.35 129.55 40.13 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.975 -0.453 . . . . 0.0 110.043 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . -173.59 171.62 44.62 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.46 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.66 ' HB2' ' HB ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -70.56 -74.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.893 0.477 . . . . 0.0 112.074 -179.155 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.647 HG22 ' H ' ' A' ' 214' ' ' SER . 9.9 p -124.28 -142.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.363 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.647 ' H ' HG22 ' A' ' 213' ' ' VAL . 1.9 m 60.5 173.25 0.06 OUTLIER Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 118.972 0.805 . . . . 0.0 109.616 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 37.5 Cg_endo -65.71 28.58 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.076 1.851 . . . . 0.0 113.064 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 214' ' ' SER . 8.1 m -57.47 167.01 1.09 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.749 0.309 . . . . 0.0 110.756 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.561 ' HB2' ' N ' ' A' ' 209' ' ' LYS . 9.7 m-20 -89.0 -43.01 11.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.874 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.814 HD23 HD21 ' A' ' 220' ' ' LEU . 3.4 tp -99.07 131.63 44.97 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.74 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -95.68 75.75 3.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.954 0.407 . . . . 0.0 110.785 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.817 HD11 HG21 ' A' ' 186' ' ' VAL . 2.6 mm? -103.96 62.87 0.76 Allowed 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.645 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 2.2 pttt -54.57 57.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 220' ' ' LEU . 10.0 t0 -88.75 153.81 20.78 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.2 p -73.18 -4.72 34.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.505 ' HG3' ' HA3' ' A' ' 284' ' ' GLY . 1.4 pt-20 -91.74 -21.79 20.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.977 0.418 . . . . 0.0 110.26 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.784 HG13 ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -96.94 102.88 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.083 179.089 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 73.0 m -53.18 -49.26 67.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.468 0.651 . . . . 0.0 109.885 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 228' ' ' LYS . . . -148.34 -50.62 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.552 ' HD2' ' HD2' ' A' ' 209' ' ' LYS . 8.1 mttm -145.87 134.74 22.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.012 -0.594 . . . . 0.0 110.082 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.784 ' CG ' HG13 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -101.18 -53.84 2.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.181 179.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.652 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -148.97 170.32 18.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.865 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -152.68 170.24 20.75 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.764 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.827 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 5.7 mt -121.06 143.62 32.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.483 0.659 . . . . 0.0 111.814 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.591 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.14 126.3 4.2 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 177.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.799 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 10.5 p90 -120.32 166.85 12.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.546 HD21 ' HB2' ' A' ' 240' ' ' LYS . 1.0 OUTLIER -115.58 133.58 55.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.02 -179.042 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.27 -0.88 52.49 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.71 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 18.6 m -78.97 -39.33 34.63 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.904 0.859 . . . . 0.0 109.382 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.608 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 10.0 tptm -117.8 10.08 13.15 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.21 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 10.6 p90 44.92 63.83 1.58 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.42 0.629 . . . . 0.0 109.772 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.799 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 2.1 mptp? -130.69 140.56 50.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.092 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.691 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 1.8 m95 -121.41 124.01 43.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.942 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 6.7 pt-20 -138.29 147.17 43.31 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.782 ' HG ' HG13 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -95.25 151.34 19.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 112.859 -1.973 . . . . 0.0 108.474 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.486 HG21 ' HE1' ' A' ' 269' ' ' TRP . 2.2 p -145.57 161.79 12.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.867 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 17.4 t0 -84.25 139.44 32.35 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.561 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.417 ' HE2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -85.02 30.56 0.58 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.0 41.02 97.51 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.646 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.521 ' O ' ' HG3' ' A' ' 267' ' ' ARG . 9.5 t -86.54 172.28 10.42 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.864 0.364 . . . . 0.0 111.264 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.69 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -96.95 -30.95 12.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.809 179.283 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.69 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.8 OUTLIER -75.53 -29.65 59.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.805 -179.382 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.521 ' HA3' ' CG ' ' A' ' 261' ' ' HIS . . . 85.62 152.55 19.14 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.742 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.652 HG21 ' HB2' ' A' ' 230' ' ' ALA . 87.6 m -108.94 154.73 21.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.463 -0.368 . . . . 0.0 110.772 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.759 ' O ' HD13 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -138.06 136.43 36.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.159 178.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.974 HG22 HD11 ' A' ' 281' ' ' ILE . 89.6 t -107.6 127.45 63.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.971 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 1.01 ' HA ' HD12 ' A' ' 280' ' ' ILE . 27.2 t-20 56.56 50.54 12.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.376 0.608 . . . . 0.0 109.985 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.56 32.51 17.11 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.927 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.415 ' O ' ' N ' ' A' ' 259' ' ' ILE . 0.1 OUTLIER -137.95 111.54 8.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.823 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.556 ' CB ' ' CE1' ' A' ' 261' ' ' HIS . 78.3 p -60.41 83.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.306 0.574 . . . . 0.0 110.34 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.979 ' HB ' HG21 ' A' ' 273' ' ' VAL . 2.6 pp -87.85 -9.49 10.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.815 -178.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.674 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 0.1 OUTLIER -119.99 -21.65 7.02 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.199 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.643 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 34.2 p-80 -112.07 40.88 0.2 Allowed Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.674 ' HD3' ' C ' ' A' ' 260' ' ' SER . 38.2 Cg_exo -57.65 -24.92 65.21 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.848 1.698 . . . . 0.0 113.33 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 266' ' ' SER . 57.0 m-20 -118.76 110.18 16.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.198 0.523 . . . . 0.0 111.898 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.61 156.92 33.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.982 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 75.18 -17.45 3.04 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.84 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.566 ' HB2' ' O ' ' A' ' 263' ' ' ASP . 0.4 OUTLIER -75.69 -38.69 58.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.976 0.417 . . . . 0.0 111.445 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 248' ' ' SER . 0.6 OUTLIER 53.07 24.8 3.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.988 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -65.77 165.38 12.87 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.781 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.521 ' CZ2' ' OE1' ' A' ' 231' ' ' GLN . 7.7 t-105 -81.02 -16.93 51.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.541 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 72.22 174.22 22.85 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.462 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -105.59 137.15 19.22 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.153 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.24 115.75 2.08 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.654 2.236 . . . . 0.0 113.789 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.979 HG21 ' HB ' ' A' ' 259' ' ' ILE . 80.9 t -103.96 135.18 42.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.7 OUTLIER -75.56 127.8 33.88 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -176.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.847 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.29 164.65 13.45 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 114.232 -1.349 . . . . 0.0 109.517 178.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.82 159.3 42.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 28.3 t -61.38 129.28 40.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.367 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 277' ' ' SER . 0.4 OUTLIER 83.74 6.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.387 -178.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 16.0 t0 -81.1 -165.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 1.01 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.8 OUTLIER -160.4 126.39 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.368 178.129 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.974 HD11 HG22 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -100.58 148.21 7.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.774 ' C ' HD13 ' A' ' 283' ' ' LEU . 13.9 m -140.53 136.81 33.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.612 0.72 . . . . 0.0 111.56 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.774 HD13 ' C ' ' A' ' 282' ' ' THR . 0.0 OUTLIER -136.95 134.78 37.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.359 178.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.505 ' HA3' ' HG3' ' A' ' 224' ' ' GLU . . . 95.64 -137.91 13.67 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.346 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.459 HG22 ' OE1' ' A' ' 224' ' ' GLU . 11.6 t -99.33 -30.16 12.38 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.898 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -156.53 5.14 0.16 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.758 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 7.4 m -73.47 107.14 5.58 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.881 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.718 ' O ' HG22 ' A' ' 187' ' ' ILE . 11.6 ttmm -127.81 134.83 49.47 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.17 0.509 . . . . 0.0 111.807 -178.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 16.7 t -115.44 135.38 55.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.809 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.596 ' CD1' HG23 ' A' ' 280' ' ' ILE . 2.5 t80 -76.9 137.98 39.45 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.122 0.487 . . . . 0.0 110.666 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.847 HG11 ' HB2' ' A' ' 275' ' ' LEU . 3.7 t -105.11 112.23 37.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.718 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.464 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -129.26 138.45 51.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.743 -0.208 . . . . 0.0 110.872 -179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.672 HD11 HD23 ' A' ' 275' ' ' LEU . 4.1 mt -138.78 122.36 19.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.23 162.34 32.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.383 . . . . 0.0 110.835 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.6 -165.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.988 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -144.34 115.84 8.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.767 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -104.23 86.56 2.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.983 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.887 179.911 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.56 ' HB2' ' OG1' ' A' ' 201' ' ' THR . 73.8 mt . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.744 ' N ' HG21 ' A' ' 201' ' ' THR . . . 113.88 101.06 2.43 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.706 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.416 ' HB2' ' N ' ' A' ' 201' ' ' THR . 0.8 OUTLIER -178.42 -89.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.61 0.205 . . . . 0.0 111.167 179.12 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -142.24 -171.91 3.48 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.0 m95 -145.56 130.34 18.11 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.914 HD11 ' CD2' ' A' ' 184' ' ' LEU . 4.0 tp -119.82 136.56 54.42 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.059 176.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.763 ' N ' HD12 ' A' ' 182' ' ' LEU . 3.5 m-85 -134.16 130.23 37.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.762 0.792 . . . . 0.0 109.809 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.914 ' CD2' HD11 ' A' ' 182' ' ' LEU . 3.7 mm? -116.98 139.43 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.276 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.529 ' C ' HG13 ' A' ' 289' ' ' VAL . 3.5 tt0 -135.49 111.96 9.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.871 HG21 HD12 ' A' ' 194' ' ' LEU . 14.3 t -60.58 110.01 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.0 tt -92.64 -19.28 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.767 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -168.9 95.21 0.34 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.88 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.673 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.63 -173.25 30.06 Favored Glycine 0 C--O 1.228 -0.256 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.553 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 94.6 Cg_endo -81.43 31.8 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 121.926 1.751 . . . . 0.0 110.91 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.879 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -160.83 24.12 0.14 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.077 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.673 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.3 mt -40.84 108.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.863 0.364 . . . . 0.0 111.979 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.62 6.03 2.13 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.375 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.879 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -95.94 143.86 26.76 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 177.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 16.6 mt-30 -139.88 147.12 40.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.421 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.936 ' ND1' HG21 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -136.82 131.05 32.75 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.392 0.615 . . . . 0.0 110.421 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.643 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.93 152.76 43.83 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.019 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.815 HG13 ' CH2' ' A' ' 234' ' ' TRP . 5.3 p -166.38 156.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.196 0.522 . . . . 0.0 110.937 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 180' ' ' SER . 1.2 m120 -93.38 147.31 23.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.405 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.53 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 1.4 t -64.58 -3.22 2.92 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.978 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.744 HG21 ' N ' ' A' ' 178' ' ' GLY . 3.5 t -89.15 12.15 16.62 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.775 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.469 ' HG ' ' HB3' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -95.2 144.32 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.946 0.403 . . . . 0.0 111.238 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.53 -60.89 1.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.082 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.57 25.39 4.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.331 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.409 ' HG2' ' OG ' ' A' ' 202' ' ' SER . 0.2 OUTLIER -115.42 -1.05 12.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.764 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.96 ' O ' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -94.57 -22.96 0.24 Allowed Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.551 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.634 ' CD ' ' N ' ' A' ' 206' ' ' LEU . 22.2 Cg_exo -61.57 94.29 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.113 1.209 . . . . 0.0 111.384 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.936 HG21 ' ND1' ' A' ' 196' ' ' HIS . 45.5 t -80.61 102.06 6.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.34 0.591 . . . . 0.0 111.254 -179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 216' ' ' SER . 0.0 OUTLIER -69.46 97.22 0.97 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.624 -179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.077 HD23 HD12 ' A' ' 218' ' ' LEU . 1.5 mp -75.85 125.3 28.82 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.446 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -169.2 171.97 43.23 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.385 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.892 ' HB2' HG13 ' A' ' 225' ' ' VAL . 4.8 ttt180 -58.53 -90.12 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.478 ' O ' HG22 ' A' ' 213' ' ' VAL . 10.6 p -127.5 -9.57 4.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.622 ' HB3' ' HE2' ' A' ' 228' ' ' LYS . 0.1 OUTLIER -53.82 -173.86 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.713 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 27.0 Cg_exo -62.42 3.89 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.438 2.092 . . . . 0.0 112.877 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.543 ' HA ' ' HB3' ' A' ' 209' ' ' LYS . 0.9 OUTLIER -49.76 165.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.895 0.378 . . . . 0.0 111.577 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.539 ' HB3' HG13 ' A' ' 208' ' ' VAL . 3.4 m-20 -86.01 -31.36 22.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.679 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.077 HD12 HD23 ' A' ' 210' ' ' LEU . 2.9 mt -107.93 130.8 55.01 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -92.26 79.83 5.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.816 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.796 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.1 mm? -103.81 86.24 2.57 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.739 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 7.4 ptpt -59.51 20.1 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.607 ' HB3' HG12 ' A' ' 225' ' ' VAL . 6.3 t0 -48.99 125.73 11.03 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.2 t -63.41 -12.23 29.17 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.436 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 285' ' ' THR . 0.1 OUTLIER -82.49 -17.24 45.84 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.779 0.323 . . . . 0.0 110.544 179.159 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.892 HG13 ' HB2' ' A' ' 212' ' ' ARG . 7.4 p -108.83 94.5 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.065 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -46.14 -45.22 16.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.036 0.446 . . . . 0.0 110.836 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.43 -50.38 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.476 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.622 ' HE2' ' HB3' ' A' ' 214' ' ' SER . 7.0 mttt -139.41 126.55 21.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.111 0.482 . . . . 0.0 110.466 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.704 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.5 t60 -100.54 -58.07 1.98 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.752 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -141.1 173.15 11.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.812 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.808 ' HA ' HD12 ' A' ' 210' ' ' LEU . 61.2 tt0 -151.98 154.3 35.77 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.302 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.0 mt -111.96 140.6 30.75 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-O 121.197 0.522 . . . . 0.0 111.276 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.415 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.35 149.87 17.61 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.815 ' CH2' HG13 ' A' ' 198' ' ' VAL . 4.0 p90 -139.47 166.34 24.83 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -115.42 132.77 56.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.748 -1.569 . . . . 0.0 112.138 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.7 m -92.81 -1.07 57.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.949 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.3 m -77.58 -28.19 51.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.674 0.749 . . . . 0.0 109.876 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.408 ' HB3' ' HD3' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -139.32 19.18 2.58 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.804 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.7 p90 39.84 62.09 1.31 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.578 0.704 . . . . 0.0 109.56 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.742 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 1.4 mptm? -122.91 138.95 54.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.902 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.657 ' CE3' HD13 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -123.43 122.35 38.05 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.492 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 7.8 pt-20 -130.68 145.53 51.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 122.388 1.09 . . . . 0.0 113.872 -177.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.695 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -102.24 138.44 39.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.988 178.103 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.728 HG21 ' NE1' ' A' ' 269' ' ' TRP . 3.7 p -133.47 162.42 39.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.78 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.479 ' HB2' ' CB ' ' A' ' 260' ' ' SER . 25.1 t0 -88.16 139.66 30.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.311 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.532 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -86.98 32.54 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.102 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.86 47.92 77.51 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.916 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.45 -178.55 5.14 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.867 0.365 . . . . 0.0 111.152 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.738 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -106.0 -28.32 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.139 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.738 ' H ' HD13 ' A' ' 249' ' ' LEU . 8.1 t-20 -75.37 -36.07 61.01 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.127 0.489 . . . . 0.0 111.622 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.12 116.24 1.71 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.825 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.645 ' C ' HD23 ' A' ' 253' ' ' LEU . 16.7 m -70.98 165.29 23.75 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.708 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -149.28 128.85 13.12 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.314 0.578 . . . . 0.0 111.394 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 1.046 HG23 HD12 ' A' ' 259' ' ' ILE . 86.1 t -105.57 132.81 51.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.453 178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.618 HD22 HG12 ' A' ' 254' ' ' VAL . 12.2 p30 50.08 39.31 18.92 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.094 0.473 . . . . 0.0 110.084 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.95 27.68 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.534 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 0.4 OUTLIER -129.74 103.18 6.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.243 179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 7.6 t -51.46 95.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.61 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 1.046 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -77.72 -23.01 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.416 -178.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.479 ' CB ' ' HB2' ' A' ' 245' ' ' ASP . 24.7 p -74.37 169.19 18.17 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.408 ' C ' ' H ' ' A' ' 263' ' ' ASP . 0.2 OUTLIER -56.01 106.15 0.63 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 119.514 1.052 . . . . 0.0 111.086 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.5 17.91 0.52 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 123.004 2.469 . . . . 0.0 112.01 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 266' ' ' SER . 27.7 t70 -103.64 122.89 45.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.227 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 42.6 mt -55.56 148.64 15.34 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.527 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.47 -22.57 4.56 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.464 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 268' ' ' LYS . 2.0 t -95.12 76.43 3.48 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.074 0.95 . . . . 0.0 109.129 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 6.2 mtm105 -74.55 33.56 0.09 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.132 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 266' ' ' SER . 19.0 mttt -61.73 161.9 9.42 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.728 ' NE1' HG21 ' A' ' 244' ' ' VAL . 13.0 t-105 -72.96 -18.92 61.33 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.98 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 75.9 168.91 26.54 Favored Glycine 0 C--N 1.333 0.405 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.403 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -99.66 134.64 20.94 Favored Pre-proline 0 N--CA 1.454 -0.272 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.116 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.17 108.76 0.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.608 2.206 . . . . 0.0 113.687 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.543 HG21 ' HB ' ' A' ' 259' ' ' ILE . 81.3 t -100.38 141.65 16.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 242' ' ' GLU . 0.0 OUTLIER -83.03 129.3 35.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.07 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.772 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.91 165.72 12.52 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 113.786 -1.552 . . . . 0.0 109.022 178.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.637 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.49 161.99 36.98 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.3 OUTLIER -60.24 130.33 46.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.126 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 277' ' ' SER . 18.0 m-20 82.86 3.08 1.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.952 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.637 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 2.6 t0 -75.1 -162.56 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.547 HG23 ' CD1' ' A' ' 290' ' ' TYR . 0.5 OUTLIER -161.73 127.96 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.994 178.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.651 HG13 ' HG ' ' A' ' 243' ' ' LEU . 0.2 OUTLIER -107.78 157.29 8.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.302 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.708 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 5.6 m -150.64 134.94 17.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -129.27 47.56 2.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.337 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 177.12 -125.69 1.04 Allowed Glycine 0 N--CA 1.454 -0.154 0 C-N-CA 119.493 -1.337 . . . . 0.0 113.638 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.47 ' N ' ' HG3' ' A' ' 224' ' ' GLU . 3.8 t -99.98 -37.23 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 0.0 110.823 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.561 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -149.74 -10.12 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.767 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 87.2 m -66.34 106.06 1.61 Allowed 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 117.77 0.259 . . . . 0.0 110.582 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.636 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -131.55 139.04 49.14 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.39 0.614 . . . . 0.0 111.619 -179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.63 HG13 ' N ' ' A' ' 186' ' ' VAL . 4.5 t -116.77 136.54 53.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.329 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.621 ' O ' HD13 ' A' ' 184' ' ' LEU . 1.8 t80 -76.75 136.09 39.02 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.102 0.477 . . . . 0.0 109.917 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.621 HG11 ' HB2' ' A' ' 275' ' ' LEU . 1.8 t -102.52 110.96 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.659 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.632 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -123.35 137.93 54.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.698 -179.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.657 HD13 ' CE3' ' A' ' 241' ' ' TRP . 2.5 mt -137.62 117.93 16.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.42 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -123.5 146.63 47.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.897 0.38 . . . . 0.0 111.226 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.75 167.7 14.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.873 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -113.99 125.6 54.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.957 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -164.28 86.49 0.47 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.951 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.509 ' HB3' ' CG ' ' A' ' 199' ' ' ASN . 3.4 mp . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 120.333 0.111 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.68 ' HA3' ' CG2' ' A' ' 201' ' ' THR . . . 116.13 162.36 13.09 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.972 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.833 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 16.4 p -89.53 23.83 2.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.169 -0.515 . . . . 0.0 111.212 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 25.1 m -147.81 140.42 24.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.168 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.733 ' HB3' ' CE1' ' A' ' 183' ' ' PHE . 3.7 m95 -142.77 133.48 25.3 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.448 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.918 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.5 OUTLIER -121.82 130.31 53.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.918 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.7 OUTLIER -132.28 143.14 49.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.712 0.768 . . . . 0.0 111.308 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.803 ' CD1' HD11 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -137.9 148.69 45.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.402 177.522 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.478 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 9.0 tt0 -137.77 125.11 21.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.968 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.726 HG21 HD12 ' A' ' 194' ' ' LEU . 18.9 t -64.69 119.6 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.803 HG22 ' O ' ' A' ' 288' ' ' LYS . 3.8 tp -104.15 -23.41 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -175.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.817 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -159.2 91.8 1.04 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.47 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.631 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.71 -171.66 28.07 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.496 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 73.2 Cg_endo -81.43 31.26 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.878 1.719 . . . . 0.0 111.664 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.789 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.4 25.32 0.11 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.582 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.631 HG12 ' H ' ' A' ' 189' ' ' GLY . 7.5 mt -43.13 114.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.073 0.398 . . . . 0.0 112.073 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 130.77 7.23 3.43 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.277 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.789 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -98.69 132.57 43.97 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.478 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 20.3 mt-30 -130.58 151.9 50.54 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.665 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.709 ' O ' HD22 ' A' ' 184' ' ' LEU . 1.4 t60 -143.23 139.79 30.4 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.255 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -131.84 148.08 52.53 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.05 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.848 HG21 ' HA ' ' A' ' 206' ' ' LEU . 11.8 p -159.16 141.77 5.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.513 ' OD1' ' CH2' ' A' ' 181' ' ' TRP . 3.1 m120 -88.03 161.55 17.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.013 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.517 ' HB2' ' NE1' ' A' ' 234' ' ' TRP . 60.0 p -68.78 -48.64 63.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.342 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.68 ' CG2' ' HA3' ' A' ' 178' ' ' GLY . 0.0 OUTLIER -62.23 1.84 0.29 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.63 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -83.04 129.7 35.06 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 178.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -89.72 -95.88 0.11 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.12 11.19 2.42 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -116.49 -17.79 10.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.684 0.278 . . . . 0.0 110.765 179.352 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.862 ' O ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -76.93 -42.93 2.81 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.801 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 6.2 Cg_endo -51.89 96.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.209 1.11 . . . . 0.0 112.118 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.67 ' O ' ' HG3' ' A' ' 231' ' ' GLN . 78.5 t -67.36 151.19 10.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -128.29 93.61 3.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.04 HD23 HD12 ' A' ' 218' ' ' LEU . 0.7 OUTLIER -84.76 127.88 34.33 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.306 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.514 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -173.39 174.21 45.97 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.51 -0.852 . . . . 0.0 113.02 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.906 ' HB2' HG13 ' A' ' 225' ' ' VAL . 2.0 ttm180 -69.98 -75.03 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.812 0.445 . . . . 0.0 111.834 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.668 HG22 ' H ' ' A' ' 214' ' ' SER . 9.2 p -121.82 -145.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.668 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.3 OUTLIER 65.91 179.03 0.05 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 118.731 0.696 . . . . 0.0 109.85 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 49.7 Cg_endo -69.58 28.7 0.17 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.089 1.859 . . . . 0.0 113.435 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 214' ' ' SER . 6.3 m -61.96 160.57 12.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.699 0.285 . . . . 0.0 110.679 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.77 -31.27 21.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.883 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.04 HD12 HD23 ' A' ' 210' ' ' LEU . 4.8 mt -111.49 133.13 53.99 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -92.52 76.46 5.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.415 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.783 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.1 mm? -97.99 62.52 1.58 Allowed 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.598 ' HA ' ' CG ' ' A' ' 212' ' ' ARG . 8.2 pttt -59.56 50.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 220' ' ' LEU . 22.6 t0 -97.32 124.4 41.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 t -39.82 -27.88 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.642 ' HG2' ' HA2' ' A' ' 284' ' ' GLY . 0.4 OUTLIER -60.8 -39.9 90.62 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.097 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.906 HG13 ' HB2' ' A' ' 212' ' ' ARG . 1.7 p -97.75 93.93 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 2.0 m -35.29 -62.05 0.41 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.105 0.479 . . . . 0.0 111.445 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 228' ' ' LYS . . . -133.33 -47.76 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 227' ' ' GLY . 3.6 mttt -144.19 127.3 16.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.493 -0.354 . . . . 0.0 110.172 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.478 ' O ' ' N ' ' A' ' 246' ' ' MET . 4.4 t60 -96.09 -55.67 2.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.637 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.461 ' O ' HD12 ' A' ' 210' ' ' LEU . . . -140.12 159.65 41.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.411 0.624 . . . . 0.0 112.614 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.67 ' HG3' ' O ' ' A' ' 208' ' ' VAL . 0.1 OUTLIER -145.72 161.96 38.7 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.704 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.801 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 7.6 mt -124.13 149.4 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.8 162.03 41.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.661 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.675 ' CE3' HD21 ' A' ' 206' ' ' LEU . 0.6 OUTLIER -98.39 157.39 16.23 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -176.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 240' ' ' LYS . 2.0 t-20 -121.55 71.46 0.97 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.156 -1.384 . . . . 0.0 107.478 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 p -56.48 -19.44 15.38 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.134 0.791 . . . . 0.0 113.134 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.9 m -75.54 -21.39 57.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.463 0.649 . . . . 0.0 110.567 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.53 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 0.3 OUTLIER -137.19 17.84 2.98 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.374 -179.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.407 ' O ' ' CD2' ' A' ' 239' ' ' PHE . 19.7 p90 42.67 68.0 0.54 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 235' ' ' ASN . 0.2 OUTLIER -130.19 144.48 51.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.295 -179.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.56 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -119.29 102.96 9.07 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.572 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 4.5 pt-20 -125.96 144.71 50.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.107 0.956 . . . . 0.0 113.002 -177.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 1.005 HD11 HD11 ' A' ' 259' ' ' ILE . 2.6 pp -115.94 149.96 37.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.681 -1.599 . . . . 0.0 111.208 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.754 HG21 ' CD1' ' A' ' 269' ' ' TRP . 2.0 p -113.99 163.06 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.657 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.494 ' OD2' ' HA ' ' A' ' 260' ' ' SER . 6.1 m-20 -112.25 101.84 10.05 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.521 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -65.56 96.46 0.26 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.417 178.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.59 69.88 1.13 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.356 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.418 ' CB ' ' HB2' ' A' ' 260' ' ' SER . 0.4 OUTLIER -65.4 57.92 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -177.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 250' ' ' ASN . 0.8 OUTLIER -53.38 -57.72 9.62 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.31 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.593 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.7 OUTLIER -78.77 -30.1 45.42 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.264 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.429 ' O ' HD23 ' A' ' 253' ' ' LEU . . . 92.07 125.82 3.67 Favored Glycine 0 N--CA 1.439 -1.114 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.513 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.465 ' O ' HG12 ' A' ' 259' ' ' ILE . 25.7 m -88.67 114.96 25.84 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 122.155 0.182 . . . . 0.0 110.601 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -103.98 130.51 51.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.278 0.561 . . . . 0.0 112.512 -178.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.88 ' CG2' HD13 ' A' ' 259' ' ' ILE . 33.1 t -108.55 131.95 57.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.63 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 280' ' ' ILE . 3.3 t-20 52.15 32.01 9.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.125 0.488 . . . . 0.0 109.877 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.8 m 68.82 21.04 7.84 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.686 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.2 m170 -120.49 93.35 4.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.802 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 21.7 p -43.79 97.17 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.356 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 1.005 HD11 HD11 ' A' ' 243' ' ' LEU . 14.4 pt -77.29 -53.88 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.535 ' N ' HG13 ' A' ' 259' ' ' ILE . 36.9 p -45.8 160.44 0.06 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.464 ' C ' ' H ' ' A' ' 263' ' ' ASP . 48.9 p-80 -55.43 108.05 1.06 Allowed Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 118.597 0.635 . . . . 0.0 111.673 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.53 22.39 0.34 Allowed 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.863 2.375 . . . . 0.0 111.63 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.464 ' H ' ' C ' ' A' ' 261' ' ' HIS . 0.1 OUTLIER -107.49 112.1 24.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.355 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 86.3 mt -65.75 164.58 14.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.299 0.571 . . . . 0.0 112.237 -179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 80.01 -22.46 4.29 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.178 -0.919 . . . . 0.0 114.269 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' A' ' 267' ' ' ARG . 36.8 m -81.49 -71.37 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.318 0.559 . . . . 0.0 112.335 -178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.8 OUTLIER 79.52 17.7 0.8 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.747 0.308 . . . . 0.0 111.153 -179.022 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -46.85 156.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.754 ' CD1' HG21 ' A' ' 244' ' ' VAL . 28.2 t-105 -67.17 -24.87 65.92 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 79.97 157.81 14.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.663 -0.699 . . . . 0.0 113.099 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -96.6 140.94 22.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 85.8 Cg_exo -46.39 119.0 2.8 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.575 2.184 . . . . 0.0 112.788 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.854 ' HB ' HD12 ' A' ' 259' ' ' ILE . 84.9 t -100.91 136.22 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -85.0 128.6 34.7 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.97 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.926 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.48 165.58 12.96 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.08 -179.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -137.43 155.61 49.13 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.582 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 89.0 p -63.78 133.21 53.06 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.258 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.582 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.0 OUTLIER 79.27 -4.99 2.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.254 -178.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.654 ' O ' HG23 ' A' ' 280' ' ' ILE . 3.5 t70 -67.61 -167.24 0.06 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.654 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.7 OUTLIER -162.09 131.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.645 178.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.943 HG22 HG12 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -104.02 148.13 9.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.667 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 1.6 m -138.89 116.95 11.71 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.482 ' O ' ' HB ' ' A' ' 287' ' ' THR . 0.1 OUTLIER -113.44 136.54 52.68 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.444 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.642 ' HA2' ' HG2' ' A' ' 224' ' ' GLU . . . 82.91 -129.14 8.88 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.666 178.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 t -95.11 -31.65 13.46 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -159.67 8.15 0.1 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -179.577 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 14.9 m -69.51 99.26 1.23 Allowed 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.542 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.803 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -111.86 115.26 28.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.456 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.943 HG12 HG22 ' A' ' 281' ' ' ILE . 4.4 p -103.17 131.03 52.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 122.205 -0.31 . . . . 0.0 110.827 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.2 t80 -76.22 132.49 39.94 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.926 HG11 ' HB2' ' A' ' 275' ' ' LEU . 2.6 t -103.56 114.62 43.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.652 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.52 ' HD2' ' H ' ' A' ' 293' ' ' ILE . 5.6 tpt180 -132.0 143.85 50.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.235 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.753 HD11 HD23 ' A' ' 275' ' ' LEU . 8.8 mt -143.13 122.53 8.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.697 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.79 159.1 38.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 110.941 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 9.7 m -89.29 -179.12 5.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.833 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 2.8 tp60 -115.4 120.66 40.31 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.484 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -77.37 88.42 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.316 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.738 179.702 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.629 HD23 ' CZ2' ' A' ' 181' ' ' TRP . 1.3 mp . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 121.184 0.516 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.738 ' HA3' HG21 ' A' ' 201' ' ' THR . . . 70.75 165.6 6.03 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.817 -0.629 . . . . 0.0 113.353 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.746 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 0.3 OUTLIER -87.94 33.21 0.72 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.887 -0.656 . . . . 0.0 111.978 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.458 ' HB3' ' OG ' ' A' ' 200' ' ' SER . 0.5 OUTLIER -142.75 135.27 27.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 10.9 m95 -147.09 142.06 26.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.849 -178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.789 HD11 ' CD1' ' A' ' 184' ' ' LEU . 1.5 tp -125.96 122.72 36.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.701 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.4 m-85 -121.31 141.23 51.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.795 0.807 . . . . 0.0 111.313 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.971 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -139.65 149.01 43.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.526 178.668 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.523 ' C ' HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -139.52 125.98 20.36 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.789 HG21 HD12 ' A' ' 194' ' ' LEU . 21.7 t -62.06 116.48 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.909 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.5 tt -100.03 -19.34 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -176.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.851 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.54 91.9 0.6 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.719 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -160.9 -171.12 26.43 Favored Glycine 0 CA--C 1.519 0.318 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.68 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 64.0 Cg_endo -81.59 32.54 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.006 1.804 . . . . 0.0 111.311 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.845 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.49 22.12 0.12 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.574 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.719 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.4 mt -39.81 111.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.08 7.65 3.19 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.109 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.845 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.2 OUTLIER -96.24 131.9 42.25 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.441 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 14.1 mt-30 -129.07 151.11 50.11 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.465 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.971 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -146.87 148.14 31.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.771 -179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -141.23 144.73 34.88 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.778 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.931 HG21 ' HA ' ' A' ' 206' ' ' LEU . 2.1 p -147.66 139.04 18.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.393 0.616 . . . . 0.0 111.437 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.54 HD22 HG23 ' A' ' 201' ' ' THR . 2.6 p-10 -92.65 148.36 22.13 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.768 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.568 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 61.5 m -66.19 -1.12 2.95 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.738 HG21 ' HA3' ' A' ' 178' ' ' GLY . 0.1 OUTLIER -111.38 11.66 21.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.054 0.454 . . . . 0.0 111.0 178.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.705 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -106.74 120.04 40.94 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.746 178.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -76.41 0.45 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 8.5 t -62.93 1.51 0.41 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -122.15 -10.19 8.58 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.083 -0.385 . . . . 0.0 110.814 178.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.931 ' HA ' HG21 ' A' ' 198' ' ' VAL . 5.1 tt -62.09 -63.38 4.3 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.618 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.7 Cg_endo -43.03 88.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.412 2.075 . . . . 0.0 113.174 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.741 ' O ' HG12 ' A' ' 208' ' ' VAL . 1.7 t -69.51 85.7 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.461 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 216' ' ' SER . 1.3 mtpt -69.82 97.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.134 HD23 HD12 ' A' ' 218' ' ' LEU . 1.5 mp -82.93 127.94 33.99 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.424 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -167.35 167.61 40.0 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.01 -1.09 . . . . 0.0 113.571 -178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.924 ' HG2' ' HA ' ' A' ' 221' ' ' LYS . 4.7 ttt180 -56.54 -90.75 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.696 HG12 ' HD3' ' A' ' 212' ' ' ARG . 14.0 p -124.01 -9.89 6.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.69 0.281 . . . . 0.0 111.477 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.545 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 0.6 OUTLIER -50.88 178.94 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.217 179.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 21.0 Cg_endo -63.51 13.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 121.661 1.574 . . . . 0.0 112.493 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.532 ' H ' ' C ' ' A' ' 214' ' ' SER . 16.3 m -52.82 166.96 0.17 Allowed 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 111.193 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -84.75 -26.09 27.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.761 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.134 HD12 HD23 ' A' ' 210' ' ' LEU . 1.2 mt -111.53 130.99 55.55 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -94.96 82.09 3.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.726 0.298 . . . . 0.0 111.355 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.77 HD21 HD13 ' A' ' 218' ' ' LEU . 3.2 mm? -102.14 63.85 0.92 Allowed 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.924 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -51.9 72.32 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.445 -178.728 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.68 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 3.4 t0 -127.49 137.18 52.59 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-O 120.992 0.425 . . . . 0.0 110.774 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 43.9 t -51.31 -36.84 44.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.477 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.628 ' CD ' ' HA3' ' A' ' 284' ' ' GLY . 2.4 pt-20 -44.71 -45.71 9.95 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.015 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.879 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.2 p -102.29 107.68 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.655 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.63 -51.7 20.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.224 0.535 . . . . 0.0 110.61 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.94 -46.67 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.41 ' NZ ' ' HG2' ' A' ' 215' ' ' PRO . 0.1 OUTLIER -136.64 120.63 17.62 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.733 ' CD2' ' HB3' ' A' ' 283' ' ' LEU . 5.4 t60 -92.2 -61.1 1.68 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.702 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.449 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -140.08 176.84 8.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.526 0.679 . . . . 0.0 112.315 -178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.738 ' HA ' HD12 ' A' ' 210' ' ' LEU . 10.6 tt0 -159.19 162.69 36.33 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.909 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.593 HG12 ' HB3' ' A' ' 243' ' ' LEU . 54.4 mt -124.72 144.31 35.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.563 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.716 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -160.87 163.41 32.02 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.12 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.886 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 12.1 p90 -154.91 166.59 33.07 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -115.47 133.14 56.32 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.004 -1.453 . . . . 0.0 112.304 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.48 -2.87 57.94 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.295 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 1.5 m -76.43 -26.03 55.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.768 0.794 . . . . 0.0 110.231 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 239' ' ' PHE . 10.9 tptt -138.8 21.91 2.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.648 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.445 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 7.7 p90 35.48 60.09 0.76 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.638 0.732 . . . . 0.0 109.722 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.886 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.1 OUTLIER -125.09 141.0 52.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.126 179.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.792 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 1.3 m95 -122.25 126.51 48.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.395 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.4 pt-20 -143.2 144.52 32.21 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.808 0.813 . . . . 0.0 113.142 -177.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.659 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.5 pp -111.09 152.08 27.36 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.776 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.692 HG21 ' CD1' ' A' ' 269' ' ' TRP . 2.8 p -121.32 163.18 19.48 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.617 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 248' ' ' SER . 2.6 m-20 -105.27 104.41 14.14 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.512 ' HG2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -71.4 97.26 1.59 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.428 177.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 53.09 65.67 3.23 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.312 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.526 ' HB2' ' HB3' ' A' ' 245' ' ' ASP . 0.2 OUTLIER -70.32 59.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 1.016 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -54.35 -52.69 60.82 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.338 178.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 1.016 ' N ' HD22 ' A' ' 249' ' ' LEU . 25.5 m-20 -74.37 -30.98 62.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.933 0.397 . . . . 0.0 111.304 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 95.55 99.56 1.79 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.19 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.808 HG23 HD12 ' A' ' 283' ' ' LEU . 1.6 m -64.97 114.85 4.83 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.021 -0.105 . . . . 0.0 110.993 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 258' ' ' SER . 2.4 mt -101.57 130.02 47.78 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.489 -0.484 . . . . 0.0 112.009 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.913 HG23 HD12 ' A' ' 259' ' ' ILE . 99.0 t -105.48 127.66 60.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.859 ' HA ' HD12 ' A' ' 280' ' ' ILE . 1.8 t30 55.14 40.75 31.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.064 0.459 . . . . 0.0 110.215 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.12 32.1 21.84 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.859 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.532 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.6 OUTLIER -138.83 107.93 6.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.795 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.469 ' HB3' HD22 ' A' ' 253' ' ' LEU . 25.0 p -55.15 91.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.541 0.686 . . . . 0.0 111.45 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.965 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -78.56 -23.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.788 -178.413 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.756 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 13.9 t -80.75 -174.26 4.65 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 175.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 263' ' ' ASP . 1.7 t-160 -103.41 78.63 0.29 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 119.248 0.931 . . . . 0.0 110.047 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.756 ' HD3' ' O ' ' A' ' 260' ' ' SER . 16.1 Cg_exo -43.21 84.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.388 2.725 . . . . 0.0 113.539 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 266' ' ' SER . 1.0 OUTLIER -124.73 94.1 4.09 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.17 -1.377 . . . . 0.0 110.034 179.231 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.814 HD22 ' H ' ' A' ' 264' ' ' LEU . 1.6 mm? -47.6 -40.47 19.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.454 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -80.17 -27.05 53.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.686 -0.769 . . . . 0.0 113.446 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 263' ' ' ASP . 10.5 p -78.87 -44.19 23.39 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.505 ' HD3' ' HB3' ' A' ' 249' ' ' LEU . 0.5 OUTLIER 49.9 25.55 1.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.048 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.39 159.9 4.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.436 0.636 . . . . 0.0 112.076 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.692 ' CD1' HG21 ' A' ' 244' ' ' VAL . 20.5 t-105 -72.82 -22.58 60.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.598 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 74.44 163.63 10.21 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.574 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -99.99 150.63 37.04 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.729 0.3 . . . . 0.0 110.397 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.61 145.4 17.2 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.411 2.074 . . . . 0.0 112.514 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.965 HG21 ' CG1' ' A' ' 259' ' ' ILE . 93.6 t -130.87 130.22 64.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.771 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 3.2 mp0 -80.83 129.02 34.31 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 118.936 -1.106 . . . . 0.0 112.877 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.869 HD23 HD11 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -94.02 166.7 12.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 113.787 -1.551 . . . . 0.0 109.935 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.629 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.62 159.62 41.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.151 0.5 . . . . 0.0 112.014 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 278' ' ' ASP . 0.1 OUTLIER -62.0 129.4 40.73 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.143 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.464 ' CB ' ' O ' ' A' ' 277' ' ' SER . 0.3 OUTLIER 86.73 1.52 0.52 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.309 -179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.629 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -72.72 -170.98 0.76 Allowed 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.453 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.859 HD12 ' HA ' ' A' ' 255' ' ' ASN . 1.0 OUTLIER -163.22 122.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 176.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.825 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -97.12 156.12 3.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.156 177.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 288' ' ' LYS . 21.3 m -141.51 114.68 8.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.912 HD22 ' O ' ' A' ' 287' ' ' THR . 0.0 OUTLIER -113.8 141.48 47.25 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.335 179.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.628 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 84.52 -133.32 11.73 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.126 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 t -97.93 -36.03 10.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.658 0.266 . . . . 0.0 111.516 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -152.37 7.49 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.912 ' O ' HD22 ' A' ' 283' ' ' LEU . 25.8 m -76.78 101.16 5.73 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.838 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.909 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -124.54 134.39 53.0 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.072 -179.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.523 HG23 ' C ' ' A' ' 185' ' ' GLU . 9.1 p -113.53 139.61 38.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.876 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.613 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 1.8 t80 -76.55 132.17 39.36 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.765 0.317 . . . . 0.0 110.232 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 275' ' ' LEU . 6.1 t -103.01 112.01 34.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.479 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.52 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.4 OUTLIER -129.47 138.11 51.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 0.0 111.338 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.869 HD11 HD23 ' A' ' 275' ' ' LEU . 13.3 mt -132.89 139.79 48.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.431 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 40.7 m -155.49 164.21 38.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.913 0.387 . . . . 0.0 111.423 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.26 -173.22 2.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.683 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.746 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 11.8 tp60 -112.55 134.49 54.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.727 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -150.98 92.97 1.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.687 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.024 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.617 HD23 HD21 ' A' ' 199' ' ' ASN . 5.1 mp . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.738 0.304 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.552 ' H ' HG21 ' A' ' 201' ' ' THR . . . 107.81 60.81 0.56 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.92 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 23.5 p -125.96 -60.12 1.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 110.387 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.514 ' OG ' ' HB3' ' A' ' 200' ' ' SER . 0.1 OUTLIER -142.56 -174.36 4.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.626 179.125 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 3.2 m95 -148.57 138.97 22.58 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.545 -0.462 . . . . 0.0 112.203 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.972 HD11 ' CD2' ' A' ' 184' ' ' LEU . 0.3 OUTLIER -123.77 140.71 52.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.96 178.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.845 ' N ' HD12 ' A' ' 182' ' ' LEU . 6.2 m-85 -137.7 140.54 40.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.535 0.684 . . . . 0.0 110.442 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.972 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.0 mm? -123.96 140.95 52.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.889 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.519 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -135.35 116.7 14.61 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.981 HG21 HD12 ' A' ' 194' ' ' LEU . 6.0 t -66.98 98.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 288' ' ' LYS . 9.0 tt -82.03 -24.5 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.843 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -166.24 98.9 0.62 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.685 ' HA3' HG23 ' A' ' 287' ' ' THR . . . -162.49 -169.15 25.46 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.545 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 98.0 Cg_endo -80.13 29.67 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.358 2.038 . . . . 0.0 110.642 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.795 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.13 25.92 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.637 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.6 mt -40.82 106.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.969 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.43 2.65 2.88 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.898 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.981 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -96.73 165.19 12.25 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 118.106 0.953 . . . . 0.0 108.692 177.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 5.0 mt-30 -156.72 146.18 20.6 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.063 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.923 ' CD2' HG11 ' A' ' 208' ' ' VAL . 0.3 OUTLIER -136.12 128.43 30.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.183 0.516 . . . . 0.0 109.852 179.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 182' ' ' LEU . . . -130.8 165.1 23.72 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.899 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.613 HG11 ' HG ' ' A' ' 206' ' ' LEU . 11.9 p -175.25 143.86 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-O 121.327 0.584 . . . . 0.0 112.264 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.617 HD21 HD23 ' A' ' 177' ' ' LEU . 14.0 p30 -85.78 147.96 26.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.382 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.514 ' HB3' ' OG ' ' A' ' 180' ' ' SER . 15.3 t -62.65 -9.42 8.97 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.564 HG21 ' HA ' ' A' ' 177' ' ' LEU . 2.9 t -95.04 36.85 1.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.973 0.416 . . . . 0.0 111.882 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.427 ' HB2' ' CG ' ' A' ' 205' ' ' LYS . 4.7 p -128.59 108.74 10.75 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.403 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 3.4 m -70.71 -86.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.228 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 68.7 m -86.99 8.37 23.58 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.427 ' CG ' ' HB2' ' A' ' 202' ' ' SER . 9.0 pttt -118.41 52.74 1.01 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.796 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 8.2 tt -143.77 -52.4 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.943 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 3.7 Cg_exo -40.57 93.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.41 2.074 . . . . 0.0 113.384 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.923 HG11 ' CD2' ' A' ' 196' ' ' HIS . 59.8 t -73.25 107.91 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.923 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.624 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 19.5 mtmt -77.91 90.99 4.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.446 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.964 HD23 HD12 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -78.51 136.75 37.65 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . 164.63 -161.22 34.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.964 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.714 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.0 OUTLIER -73.65 171.72 12.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.393 -0.404 . . . . 0.0 111.487 -179.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 213' ' ' VAL . 7.2 p -73.87 110.95 8.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 122.2 1.0 . . . . 0.0 111.833 -176.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.582 ' CB ' ' CD ' ' A' ' 215' ' ' PRO . 12.4 p -171.11 -163.0 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 113.435 -1.711 . . . . 0.0 107.864 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.582 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 62.3 Cg_exo -51.8 -12.0 1.05 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.475 1.45 . . . . 0.0 112.665 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.421 ' OG ' ' HG2' ' A' ' 228' ' ' LYS . 0.1 OUTLIER -51.45 -178.36 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.962 0.411 . . . . 0.0 111.714 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.41 -37.72 8.73 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.964 HD12 HD23 ' A' ' 210' ' ' LEU . 0.4 OUTLIER -100.47 140.53 34.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.641 179.087 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -103.06 78.18 1.62 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.892 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.772 HD21 HD13 ' A' ' 218' ' ' LEU . 2.9 mm? -102.49 91.72 4.36 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.545 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 1.5 ptpt -66.44 56.03 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.962 0.411 . . . . 0.0 110.653 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.551 ' HB3' HG12 ' A' ' 225' ' ' VAL . 0.3 OUTLIER -88.96 123.35 33.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.518 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.0 p -66.25 -7.11 16.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.664 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.515 ' O ' HD11 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -87.87 -24.47 23.66 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.759 0.314 . . . . 0.0 110.699 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 225' ' ' VAL . 7.2 p -100.66 93.4 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.02 0.438 . . . . 0.0 110.835 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.15 -38.71 18.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.053 0.454 . . . . 0.0 110.808 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.13 -57.53 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.786 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' A' ' 211' ' ' GLY . 25.4 mtmm -143.7 129.02 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.421 0.629 . . . . 0.0 111.688 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.517 ' HE1' ' HB2' ' A' ' 250' ' ' ASN . 2.0 t60 -89.84 -61.82 1.6 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.154 179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.564 ' C ' ' HE3' ' A' ' 246' ' ' MET . . . -140.72 171.17 14.47 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.663 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.8 OUTLIER -157.88 168.89 25.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.24 179.013 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.943 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 8.0 mt -125.39 138.16 55.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.604 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.48 163.64 32.4 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.671 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -96.25 148.0 23.19 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -176.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.491 ' HB2' ' HD3' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -119.53 71.99 0.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.276 174.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.7 p -54.11 -21.13 7.86 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 46.3 m -73.72 -27.86 61.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.632 0.73 . . . . 0.0 109.33 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.433 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 20.0 tptt -116.31 6.29 13.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.465 179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 235' ' ' ASN . 8.0 p90 37.05 49.56 0.83 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.885 0.374 . . . . 0.0 110.669 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.491 ' HD3' ' HB2' ' A' ' 235' ' ' ASN . 0.0 OUTLIER -119.8 176.21 5.51 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.236 0.541 . . . . 0.0 109.78 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.839 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -124.61 110.0 13.88 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 0.7 OUTLIER -132.15 151.2 51.91 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.703 ' O ' HD12 ' A' ' 243' ' ' LEU . 3.3 pp -119.16 152.65 36.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 113.579 -1.646 . . . . 0.0 111.456 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.592 HG13 ' HE1' ' A' ' 246' ' ' MET . 4.7 p -119.33 162.6 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.139 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 13.6 m-20 -118.86 121.8 40.85 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.677 ' HB3' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -93.83 107.85 19.69 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 109.957 178.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 267' ' ' ARG . . . 48.59 62.34 4.51 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.374 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.23 74.75 0.23 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.809 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -59.66 -48.77 80.36 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.859 178.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.809 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -78.7 -39.51 36.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.048 0.451 . . . . 0.0 110.851 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.736 ' HA3' ' HB3' ' A' ' 262' ' ' PRO . . . 97.05 93.0 1.87 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.359 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.61 HG22 ' CD1' ' A' ' 281' ' ' ILE . 1.9 m -47.29 156.59 0.24 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.297 -0.261 . . . . 0.0 110.297 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.715 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -148.12 130.23 15.45 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.179 0.514 . . . . 0.0 111.521 179.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.974 HG23 HD12 ' A' ' 259' ' ' ILE . 55.5 t -104.14 130.04 55.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.829 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 55.09 42.33 30.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.048 0.451 . . . . 0.0 110.329 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.15 23.1 12.31 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.992 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.7 112.03 15.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.373 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 85.9 p -63.12 99.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.431 0.634 . . . . 0.0 112.174 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.974 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -79.45 -47.68 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.774 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.714 ' O ' ' HD3' ' A' ' 262' ' ' PRO . 4.7 t -56.06 171.74 0.24 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.469 ' CD2' ' HD3' ' A' ' 268' ' ' LYS . 0.5 OUTLIER -102.75 92.05 3.24 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.249 0.477 . . . . 0.0 110.104 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.736 ' HB3' ' HA3' ' A' ' 251' ' ' GLY . 17.3 Cg_endo -95.54 32.09 0.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.808 3.006 . . . . 0.0 112.946 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.512 ' HB3' HD22 ' A' ' 264' ' ' LEU . 10.1 t0 -78.69 -134.35 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.763 ' N ' HD22 ' A' ' 264' ' ' LEU . 0.0 OUTLIER -44.26 -100.85 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.606 ' H ' HD23 ' A' ' 264' ' ' LEU . . . -150.35 37.53 0.91 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.548 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.492 ' H ' HD23 ' A' ' 264' ' ' LEU . 47.4 t -63.39 -32.78 74.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.782 0.325 . . . . 0.0 111.704 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.534 ' HB3' ' HA2' ' A' ' 247' ' ' GLY . 31.1 mmt-85 41.22 20.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.422 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.469 ' HD3' ' CD2' ' A' ' 261' ' ' HIS . 11.2 ptmt -60.33 157.46 13.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.701 0.8 . . . . 0.0 112.521 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.677 ' CH2' ' HB3' ' A' ' 246' ' ' MET . 2.8 m95 -63.77 -30.31 71.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.234 -0.893 . . . . 0.0 108.768 177.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 72.53 165.13 8.13 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.15 122.86 72.35 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 119.768 -0.773 . . . . 0.0 109.701 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 34.2 Cg_exo -31.05 111.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.21 2.607 . . . . 0.0 112.846 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.714 HG11 HG21 ' A' ' 259' ' ' ILE . 62.5 t -87.58 130.18 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.388 -178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -78.3 131.71 37.16 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.977 -179.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.727 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -98.0 164.26 12.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.121 -179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.6 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.85 152.67 45.3 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.647 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.9 OUTLIER -54.62 130.89 41.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.362 179.031 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.647 ' HB2' ' O ' ' A' ' 277' ' ' SER . 9.0 m-20 82.17 -3.65 1.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.738 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.951 ' O ' HG23 ' A' ' 291' ' ' VAL . 1.2 m-20 -77.24 141.15 40.15 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.744 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.513 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -100.72 124.79 54.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 119.789 -0.765 . . . . 0.0 109.728 178.541 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.791 HG12 HG22 ' A' ' 254' ' ' VAL . 0.3 OUTLIER -110.46 94.61 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -82.49 138.38 34.35 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 121.524 -0.735 . . . . 0.0 109.589 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.753 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -130.39 53.1 1.97 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.372 -179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 168.16 -122.5 1.03 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 119.494 -1.336 . . . . 0.0 113.43 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 6.5 t -98.0 -44.8 6.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.636 0.255 . . . . 0.0 110.675 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.525 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -147.64 1.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 179.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.843 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.1 m -79.32 104.75 10.15 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.785 ' O ' HG22 ' A' ' 187' ' ' ILE . 9.0 ptpt -126.19 131.02 52.08 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 121.796 0.807 . . . . 0.0 111.931 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.621 HG11 ' CE1' ' A' ' 196' ' ' HIS . 14.9 t -106.2 132.1 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.758 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 278' ' ' ASP . 1.7 t80 -77.17 130.89 37.91 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.951 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.2 OUTLIER -100.75 113.64 37.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.734 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -131.09 136.16 48.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.742 0.306 . . . . 0.0 110.82 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.839 HD12 ' CE3' ' A' ' 241' ' ' TRP . 2.4 mt -135.46 139.65 46.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 3.2 m -142.81 156.09 44.91 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.776 0.322 . . . . 0.0 111.14 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.3 m -85.73 159.22 19.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -86.82 145.53 26.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.786 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -144.72 95.04 2.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.996 179.921 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.507 ' HA ' ' CG2' ' A' ' 201' ' ' THR . 2.6 mp . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 120.621 0.248 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.667 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.12 97.59 2.15 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.231 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.77 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.42 175.25 9.69 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.652 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 4.6 m95 -145.29 131.77 19.75 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.672 HD23 ' HZ3' ' A' ' 234' ' ' TRP . 5.1 tp -118.12 128.2 54.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.214 177.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 1.1 m-85 -128.99 138.57 52.03 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.553 0.692 . . . . 0.0 110.799 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.77 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.5 mp -140.89 153.01 45.51 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.586 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.604 ' C ' HG23 ' A' ' 289' ' ' VAL . 23.3 tt0 -144.61 124.85 13.73 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.674 ' N ' HG23 ' A' ' 289' ' ' VAL . 22.0 t -59.49 113.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.7 tt -97.02 -20.76 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -176.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.719 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -157.76 91.27 1.12 Allowed 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 120.207 -0.597 . . . . 0.0 112.327 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.757 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.76 178.57 38.45 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.477 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 71.9 Cg_endo -75.4 32.13 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 121.79 1.66 . . . . 0.0 111.185 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.719 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -163.94 28.92 0.08 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.966 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.757 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.7 mt -43.55 119.75 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 121.112 0.482 . . . . 0.0 112.239 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 136.24 -48.46 0.92 Allowed Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.726 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.719 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.7 OUTLIER -40.9 143.84 0.33 Allowed 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.302 0.573 . . . . 0.0 110.752 -179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.77 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 20.8 mt-30 -141.64 152.03 43.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.776 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.818 ' HE1' HG21 ' A' ' 289' ' ' VAL . 3.9 p-80 -139.63 131.59 27.78 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.268 0.556 . . . . 0.0 109.635 178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.86 153.6 40.34 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.38 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.9 HG21 ' HA ' ' A' ' 206' ' ' LEU . 7.2 p -160.92 161.24 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.349 0.595 . . . . 0.0 111.725 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.569 ' N ' HG22 ' A' ' 198' ' ' VAL . 1.4 t-20 -98.59 143.33 29.11 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.705 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.496 ' HA ' ' HE1' ' A' ' 234' ' ' TRP . 16.2 t -60.76 1.48 0.14 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.667 HG21 ' N ' ' A' ' 178' ' ' GLY . 1.3 t -107.09 -8.08 16.65 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.601 0.36 . . . . 0.0 111.562 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.495 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.6 OUTLIER -69.05 118.13 11.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.027 0.441 . . . . 0.0 110.452 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 72.8 m -66.42 -101.93 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.1 m -91.41 20.1 5.55 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.24 -9.0 11.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.205 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.9 ' HA ' HG21 ' A' ' 198' ' ' VAL . 7.8 tt -67.74 -61.21 4.55 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.681 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -43.28 101.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.005 1.803 . . . . 0.0 112.395 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.94 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 98.7 t -67.26 165.52 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.564 ' N ' HG12 ' A' ' 208' ' ' VAL . 15.7 mtmt -136.9 90.12 2.51 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.992 HD23 HD12 ' A' ' 218' ' ' LEU . 0.5 OUTLIER -79.97 123.91 28.23 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.138 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . -165.98 167.69 39.35 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.391 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 1.094 ' HB2' HG13 ' A' ' 225' ' ' VAL . 4.7 ttt-85 -66.36 -73.01 0.14 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.738 HG13 ' HG2' ' A' ' 215' ' ' PRO . 15.0 p -79.39 159.42 4.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.463 ' N ' HG22 ' A' ' 213' ' ' VAL . 1.0 OUTLIER -31.07 -52.78 0.42 Allowed Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -178.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.738 ' HG2' HG13 ' A' ' 213' ' ' VAL . 2.9 Cg_endo -42.52 -24.76 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.205 1.936 . . . . 0.0 113.153 -177.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.429 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 0.1 OUTLIER -83.93 156.51 22.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -69.96 -36.24 75.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.564 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.992 HD12 HD23 ' A' ' 210' ' ' LEU . 2.0 mt -103.68 134.35 47.15 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.427 ' O ' HD11 ' A' ' 194' ' ' LEU . . . -90.31 73.32 7.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.562 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.838 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -97.15 68.39 2.25 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.594 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 2.2 pttt -60.71 39.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -177.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.52 ' HB3' ' HG3' ' A' ' 224' ' ' GLU . 12.4 t0 -90.23 131.23 36.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 24.5 p -46.51 -33.57 4.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.207 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.52 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 1.1 pp20? -52.21 -32.03 34.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.341 . . . . 0.0 111.233 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.094 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.1 p -104.33 97.72 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.54 -46.99 14.37 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.203 0.525 . . . . 0.0 110.574 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.32 -50.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.428 ' HB2' ' SD ' ' A' ' 246' ' ' MET . 3.6 mptp? -140.85 127.01 19.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.237 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.653 ' HA ' ' HB2' ' A' ' 248' ' ' SER . 0.2 OUTLIER -94.55 -55.22 3.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.631 179.368 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' A' ' 252' ' ' THR . . . -151.87 177.0 10.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.286 0.565 . . . . 0.0 111.996 -178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.94 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 3.9 mt-30 -156.84 -178.01 7.04 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.222 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.858 HG12 HD11 ' A' ' 243' ' ' LEU . 0.9 OUTLIER -125.36 141.76 44.28 Favored 'Isoleucine or valine' 0 C--N 1.342 0.256 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.249 179.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.24 127.18 3.79 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.85 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.8 p90 -124.92 167.53 14.56 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -112.62 133.16 54.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.137 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.22 -1.96 50.58 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.515 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.7 m -80.55 -35.04 34.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.588 0.709 . . . . 0.0 109.593 178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.529 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 33.8 tptt -121.91 10.4 10.17 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.596 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 24.4 p90 45.18 63.04 1.89 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.495 0.664 . . . . 0.0 109.694 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.85 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.2 OUTLIER -129.14 138.18 51.63 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.121 179.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.724 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -119.91 126.75 51.67 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.731 179.043 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' A' ' 272' ' ' PRO . 27.1 mt-10 -142.58 146.35 34.5 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.859 HD23 ' CD1' ' A' ' 281' ' ' ILE . 0.3 OUTLIER -97.92 150.94 20.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.767 -1.561 . . . . 0.0 109.486 178.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.613 HG21 ' NE1' ' A' ' 269' ' ' TRP . 4.5 p -141.67 162.85 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.901 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.606 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 18.8 t70 -84.63 138.82 32.48 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.412 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.547 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -88.92 31.63 0.85 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.722 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.47 50.48 59.17 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.769 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.653 ' HB2' ' HA ' ' A' ' 229' ' ' HIS . 32.6 t -92.6 168.97 10.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.836 0.35 . . . . 0.0 111.146 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 250' ' ' ASN . 3.1 pp -93.01 -43.82 8.72 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.439 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.592 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.8 OUTLIER -68.32 -19.03 64.65 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.546 0.689 . . . . 0.0 109.921 -178.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.596 ' HA3' ' CG ' ' A' ' 261' ' ' HIS . . . 76.27 147.75 2.24 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.364 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.727 HG23 HD23 ' A' ' 283' ' ' LEU . 6.0 m -103.66 152.29 21.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.608 0.242 . . . . 0.0 110.99 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.716 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -140.13 138.88 35.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.974 0.416 . . . . 0.0 110.053 177.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.851 HG23 ' CD1' ' A' ' 259' ' ' ILE . 95.5 t -110.03 133.62 54.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.956 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.873 ' HA ' HD12 ' A' ' 280' ' ' ILE . 14.7 p30 52.98 38.32 26.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.332 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.47 36.87 2.11 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.436 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.633 ' O ' HG23 ' A' ' 259' ' ' ILE . 20.0 t-80 -148.29 117.53 6.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 91.9 p -63.5 86.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.251 0.548 . . . . 0.0 110.275 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.851 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -84.92 -13.08 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.229 -178.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.801 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 1.5 t -124.34 -16.87 6.26 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.668 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 57.2 t60 -111.35 43.74 0.22 Allowed Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.801 ' HD3' ' C ' ' A' ' 260' ' ' SER . 22.8 Cg_exo -66.05 -2.05 6.2 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.042 1.828 . . . . 0.0 113.506 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.701 ' O ' ' HB2' ' A' ' 266' ' ' SER . 38.2 m-20 -135.87 101.1 4.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.446 0.641 . . . . 0.0 111.167 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.853 ' H ' HD23 ' A' ' 264' ' ' LEU . 0.4 OUTLIER -63.31 147.54 50.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.266 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 82.53 -31.49 2.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.56 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.701 ' HB2' ' O ' ' A' ' 263' ' ' ASP . 2.9 m -59.83 -42.0 92.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.129 0.49 . . . . 0.0 111.571 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 248' ' ' SER . 30.4 ttp180 53.72 28.06 7.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.947 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -68.96 168.3 13.99 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.472 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.613 ' NE1' HG21 ' A' ' 244' ' ' VAL . 14.7 t-105 -84.61 -19.59 32.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.705 179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 64.25 -172.98 16.1 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.782 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.487 ' HB2' ' HD2' ' A' ' 272' ' ' PRO . 29.2 p30 -110.38 158.97 33.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 117.524 0.662 . . . . 0.0 110.304 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.621 ' HB2' ' HB2' ' A' ' 242' ' ' GLU . 58.7 Cg_endo -72.99 114.3 4.0 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.296 1.997 . . . . 0.0 113.628 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.724 HG21 ' HB ' ' A' ' 259' ' ' ILE . 66.9 t -97.38 138.53 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.182 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.3 pm0 -76.24 123.45 25.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 122.131 0.967 . . . . 0.0 113.572 -176.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.85 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -90.87 163.96 14.21 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.525 -1.671 . . . . 0.0 109.167 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.639 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -146.87 162.75 38.02 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.634 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 26.3 t -60.34 127.77 33.41 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.849 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.634 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 86.09 7.85 0.32 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.273 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.639 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -83.61 -166.66 1.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.6 OUTLIER -161.48 128.84 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.603 177.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.859 ' CD1' HD23 ' A' ' 243' ' ' LEU . 0.0 OUTLIER -99.28 147.13 7.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.716 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 0.6 OUTLIER -134.17 125.57 28.15 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.627 0.727 . . . . 0.0 110.226 178.158 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.727 HD23 HG23 ' A' ' 252' ' ' THR . 0.1 OUTLIER -125.72 131.61 52.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.897 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.425 ' HA3' ' CG ' ' A' ' 224' ' ' GLU . . . 86.26 -127.95 8.6 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.143 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 t -96.94 -30.67 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -160.46 5.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.719 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 7.2 m -64.69 99.67 0.34 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.898 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.812 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -117.97 125.21 49.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -177.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.818 HG21 ' HE1' ' A' ' 196' ' ' HIS . 6.3 p -113.26 136.47 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.841 -0.163 . . . . 0.0 111.224 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.671 ' HD1' HG23 ' A' ' 280' ' ' ILE . 1.0 OUTLIER -78.19 140.54 38.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.884 0.373 . . . . 0.0 110.373 -179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.4 OUTLIER -108.82 114.13 45.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.046 -179.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.603 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.9 OUTLIER -130.05 140.99 50.77 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.812 -179.445 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.667 HG12 HD13 ' A' ' 182' ' ' LEU . 11.6 mt -138.95 119.87 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 181' ' ' TRP . 0.1 OUTLIER -130.81 149.99 52.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.881 0.372 . . . . 0.0 111.268 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.86 164.07 16.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.4 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.433 HE21 ' HA ' ' A' ' 296' ' ' GLN . 0.0 OUTLIER -117.19 137.64 52.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.981 0.42 . . . . 0.0 111.486 -179.773 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . 0.469 ' ND2' ' N ' ' A' ' 297' ' ' ASN . 0.4 OUTLIER -119.54 87.35 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.022 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.916 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.514 ' N ' HD22 ' A' ' 177' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.767 0.318 . . . . 0.0 110.896 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.65 -123.71 6.02 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.434 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 90.5 p -179.24 103.32 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.841 0.353 . . . . 0.0 111.041 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.615 ' N ' ' HB3' ' A' ' 296' ' ' GLN . 0.1 OUTLIER -174.62 165.8 3.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.508 0.671 . . . . 0.0 112.167 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 1.2 m95 -137.22 135.71 37.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.188 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.937 HD11 ' CD2' ' A' ' 184' ' ' LEU . 1.1 tp -126.66 133.97 50.84 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.883 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.0 m-85 -133.42 137.1 45.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.63 0.728 . . . . 0.0 110.447 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.937 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.3 mm? -119.62 139.72 51.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.414 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -134.49 112.25 10.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 220' ' ' LEU . 40.6 t -60.1 98.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.132 0.492 . . . . 0.0 109.907 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.815 HG22 ' O ' ' A' ' 288' ' ' LYS . 11.5 tt -77.04 -23.2 14.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.929 -177.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.802 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -167.96 99.95 0.46 Allowed 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.492 ' HA3' HG23 ' A' ' 287' ' ' THR . . . -161.9 -177.0 34.59 Favored Glycine 0 CA--C 1.519 0.342 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.679 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 64.0 Cg_endo -79.82 34.5 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 121.96 1.773 . . . . 0.0 111.573 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.987 ' HB3' HD13 ' A' ' 220' ' ' LEU . . . -162.99 26.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 192' ' ' ILE . 0.7 OUTLIER -39.16 106.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.908 0.385 . . . . 0.0 110.592 -179.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.89 3.41 1.74 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.105 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.911 HD21 ' HB1' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -99.31 141.74 31.7 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 117.724 0.762 . . . . 0.0 109.296 177.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 22.2 mt-30 -137.05 147.88 46.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.802 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 1.003 ' ND1' HD21 ' A' ' 218' ' ' LEU . 0.0 OUTLIER -137.41 128.09 26.96 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.021 -179.372 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -148.13 164.58 33.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.582 HG13 ' CH2' ' A' ' 234' ' ' TRP . 3.5 p -171.19 158.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.336 0.589 . . . . 0.0 110.798 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.722 ' HB3' HG22 ' A' ' 201' ' ' THR . 8.0 m120 -88.14 146.77 25.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.268 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.848 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 2.6 t -66.65 -3.85 7.44 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.901 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.722 HG22 ' HB3' ' A' ' 199' ' ' ASN . 1.4 t -93.44 36.9 1.06 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.159 0.504 . . . . 0.0 110.44 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.811 ' O ' HD12 ' A' ' 206' ' ' LEU . 15.4 m -131.25 96.37 4.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.073 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.433 ' N ' ' HG ' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -55.9 -76.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.799 -178.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.91 12.33 34.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.681 0.277 . . . . 0.0 111.465 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 10.4 pttt -118.42 52.18 1.04 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.048 0.452 . . . . 0.0 110.539 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 1.067 ' H ' ' HD2' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -147.76 -30.44 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 1.067 ' HD2' ' H ' ' A' ' 206' ' ' LEU . 3.1 Cg_endo -45.38 99.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 121.088 1.424 . . . . 0.0 112.078 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.583 HG11 ' CD2' ' A' ' 196' ' ' HIS . 61.9 t -68.76 160.77 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.872 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.753 ' HB2' ' HB2' ' A' ' 217' ' ' ASP . 13.6 mtpp -136.8 127.74 27.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.805 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.821 HD21 ' HB3' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -126.61 148.32 49.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.127 0.489 . . . . 0.0 111.496 178.429 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . 153.45 -157.07 27.15 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.633 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.683 ' HB2' ' O ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -69.2 157.06 37.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.641 0.258 . . . . 0.0 111.355 -179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.568 ' HB ' ' HB1' ' A' ' 219' ' ' ALA . 7.2 p -77.42 123.43 34.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.777 0.799 . . . . 0.0 113.127 -176.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.739 ' CB ' ' HD3' ' A' ' 215' ' ' PRO . 0.8 OUTLIER 160.27 -81.7 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 114.176 -1.374 . . . . 0.0 109.718 178.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.739 ' HD3' ' CB ' ' A' ' 214' ' ' SER . 16.6 Cg_endo -98.28 -14.4 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.255 1.97 . . . . 0.0 113.254 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.2 174.05 11.12 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.753 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.5 OUTLIER -88.49 -36.4 16.47 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.935 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.003 HD21 ' ND1' ' A' ' 196' ' ' HIS . 10.7 mt -94.04 132.69 38.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.568 ' HB1' ' HB ' ' A' ' 213' ' ' VAL . . . -95.36 72.59 3.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.927 0.394 . . . . 0.0 110.0 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.987 HD13 ' HB3' ' A' ' 191' ' ' ALA . 3.1 mm? -96.23 88.05 4.68 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.679 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 8.0 ptpt -57.63 63.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.054 0.454 . . . . 0.0 110.849 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 220' ' ' LEU . 2.0 m-20 -95.59 149.64 21.22 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.989 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.0 t -90.93 -5.8 54.97 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.11 178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.46 ' O ' HD11 ' A' ' 249' ' ' LEU . 4.5 pm0 -93.88 -21.13 19.43 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.564 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.683 ' O ' ' HB2' ' A' ' 212' ' ' ARG . 3.1 p -111.85 82.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 30.7 t -34.76 -44.35 0.21 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.835 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.11 -48.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.876 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -145.5 131.14 18.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.97 0.414 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.606 ' CD2' ' HB2' ' A' ' 283' ' ' LEU . 7.0 t60 -102.77 -49.81 3.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.447 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.821 ' HB3' HD21 ' A' ' 210' ' ' LEU . . . -147.65 179.08 7.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.204 0.526 . . . . 0.0 112.389 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.553 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -162.38 172.92 14.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.663 -179.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.743 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 10.9 mt -129.05 149.09 33.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.567 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.451 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -159.87 155.44 25.66 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.848 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 4.8 p90 -137.94 156.4 47.9 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.29 123.28 49.02 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.251 -1.34 . . . . 0.0 111.028 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 p -84.06 -4.32 58.68 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.515 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.0 m -77.8 -22.25 50.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.325 0.583 . . . . 0.0 110.392 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -144.47 20.71 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.855 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 17.6 p90 40.82 64.88 0.88 Allowed 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.461 0.648 . . . . 0.0 109.811 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.635 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 10.5 mptt -128.31 141.4 51.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.058 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.745 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 4.8 m95 -120.69 117.25 27.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.211 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.3 mt-10 -133.93 141.78 47.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.779 0.8 . . . . 0.0 113.11 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.702 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.2 pp -108.13 154.0 22.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.253 -1.339 . . . . 0.0 110.658 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.609 HG11 ' HE1' ' A' ' 269' ' ' TRP . 0.5 OUTLIER -125.51 163.28 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.75 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 1.9 t0 -97.92 156.94 16.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.651 0.739 . . . . 0.0 112.502 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.562 ' N ' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -130.66 90.55 2.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.348 178.681 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 49.18 69.16 1.08 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.288 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.431 ' O ' ' CE1' ' A' ' 261' ' ' HIS . 0.1 OUTLIER -79.68 70.44 6.18 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.097 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.988 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.74 -51.44 67.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.944 178.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.988 ' N ' HD22 ' A' ' 249' ' ' LEU . 1.1 p-10 -72.74 -33.27 66.27 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.303 0.573 . . . . 0.0 110.977 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.563 ' HA2' ' CG ' ' A' ' 261' ' ' HIS . . . 100.95 101.19 2.46 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.922 179.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.613 ' C ' HD23 ' A' ' 253' ' ' LEU . 11.3 m -64.9 160.12 21.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 252' ' ' THR . 0.2 OUTLIER -156.55 153.86 29.35 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.301 0.572 . . . . 0.0 112.418 -179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.878 HG22 HG13 ' A' ' 281' ' ' ILE . 78.0 t -129.99 130.47 66.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.268 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.594 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 54.1 t30 59.21 38.58 23.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.027 0.442 . . . . 0.0 110.319 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.1 36.58 5.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.041 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.72 ' O ' HG23 ' A' ' 259' ' ' ILE . 12.2 m80 -148.61 118.92 7.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.998 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 252' ' ' THR . 25.1 p -62.67 94.85 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.383 0.611 . . . . 0.0 110.456 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.824 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -95.6 -17.98 6.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.563 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 0.6 OUTLIER -112.96 -14.03 13.05 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.602 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.635 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 8.9 t60 -107.6 24.02 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.635 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 86.4 Cg_exo -47.29 -17.75 0.6 Allowed 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.563 1.509 . . . . 0.0 112.335 179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.521 ' CG ' ' HB2' ' A' ' 268' ' ' LYS . 0.9 OUTLIER -79.64 92.27 5.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.156 -179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 264' ' ' LEU . 13.0 mt -47.21 -95.8 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -82.9 8.9 61.45 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.593 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.507 ' CB ' ' HB3' ' A' ' 263' ' ' ASP . 0.5 OUTLIER -72.64 -52.66 14.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 266' ' ' SER . 8.1 mmt85 74.17 14.7 3.77 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.594 0.711 . . . . 0.0 109.458 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.521 ' HB2' ' CG ' ' A' ' 263' ' ' ASP . 4.7 mtpt -49.8 164.41 0.1 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.366 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.609 ' HE1' HG11 ' A' ' 244' ' ' VAL . 39.5 t-105 -71.46 -25.64 62.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.6 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 82.03 160.92 27.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.764 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -98.34 151.7 37.62 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.792 0.329 . . . . 0.0 111.142 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.644 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 32.5 Cg_exo -58.63 115.9 2.87 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.894 2.396 . . . . 0.0 113.479 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.68 HG21 HG12 ' A' ' 259' ' ' ILE . 78.4 t -99.76 138.16 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.745 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.2 pp20? -83.71 129.41 34.95 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.229 -0.988 . . . . 0.0 112.174 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.963 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -94.32 164.32 13.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.755 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.06 160.01 41.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.282 0.563 . . . . 0.0 112.074 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.681 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 6.1 p -61.61 131.01 48.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.127 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.681 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.2 m-20 85.21 5.68 0.51 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.873 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.9 m-20 -79.11 -168.07 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.917 HD13 ' N ' ' A' ' 280' ' ' ILE . 0.1 OUTLIER -160.36 128.21 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 176.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.878 HG13 HG22 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -103.25 154.49 5.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.162 178.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.714 HG23 ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -142.17 116.93 9.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.65 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.72 40.62 2.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.049 -178.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.447 ' CA ' ' HG3' ' A' ' 224' ' ' GLU . . . 179.37 -130.99 1.6 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 119.57 -1.3 . . . . 0.0 113.555 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 5.0 t -92.09 -49.49 6.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.595 0.235 . . . . 0.0 111.21 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -139.75 0.67 1.83 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.802 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.5 m -72.58 103.66 3.62 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 121.248 -0.181 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.815 ' O ' HG22 ' A' ' 187' ' ' ILE . 10.9 mtpt -121.45 129.55 53.04 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.667 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.701 HG13 HD12 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -107.83 129.71 61.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.539 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 278' ' ' ASP . 4.4 t80 -77.52 137.2 38.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.888 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -104.69 114.01 43.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.626 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.11 129.73 42.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.664 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.804 HD11 ' CD2' ' A' ' 275' ' ' LEU . 16.8 mt -126.84 139.24 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.546 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.66 142.64 50.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.672 0.272 . . . . 0.0 110.388 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 41.1 p -79.7 150.52 30.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.07 0.462 . . . . 0.0 110.864 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.615 ' HB3' ' N ' ' A' ' 180' ' ' SER . 2.8 tp-100 -118.14 133.32 56.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.491 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -135.34 88.17 2.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.849 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.711 ' HA ' HG23 ' A' ' 201' ' ' THR . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 120.676 0.274 . . . . 0.0 110.791 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.475 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.8 103.9 2.42 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.382 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.574 ' N ' HD21 ' A' ' 199' ' ' ASN . 0.6 OUTLIER -179.9 -71.33 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.076 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.98 -179.5 6.11 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.0 m95 -149.0 133.88 18.0 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.943 HD11 ' CD2' ' A' ' 184' ' ' LEU . 0.9 OUTLIER -119.23 133.13 55.93 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.045 177.014 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.927 ' N ' HD12 ' A' ' 182' ' ' LEU . 6.2 m-85 -132.44 137.24 47.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.776 0.798 . . . . 0.0 110.975 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.943 ' CD2' HD11 ' A' ' 182' ' ' LEU . 4.5 mm? -120.97 140.52 51.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.494 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 3.6 tt0 -134.93 114.3 12.39 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -178.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.647 HG21 HD12 ' A' ' 194' ' ' LEU . 2.6 t -59.52 110.33 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.327 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.849 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.2 tt -95.61 -23.77 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.744 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.84 95.09 0.7 Allowed 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.441 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.585 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.4 -178.07 35.96 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.5 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 73.0 Cg_endo -78.52 32.36 0.45 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.153 1.902 . . . . 0.0 111.642 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.875 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.77 22.63 0.12 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.187 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.585 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -40.24 108.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.65 5.01 1.53 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.865 -1.16 . . . . 0.0 113.788 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.875 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -100.41 170.04 8.68 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 22.1 mt-30 -159.92 148.74 17.46 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.928 0.394 . . . . 0.0 111.6 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.785 ' CE1' ' HB3' ' A' ' 184' ' ' LEU . 0.7 OUTLIER -134.27 124.76 26.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.469 0.652 . . . . 0.0 109.467 178.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -145.22 168.66 19.88 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.357 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.792 HG13 ' CH2' ' A' ' 234' ' ' TRP . 2.3 p -178.03 160.8 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.424 0.631 . . . . 0.0 111.529 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.799 ' ND2' HG22 ' A' ' 201' ' ' THR . 0.7 OUTLIER -96.1 148.62 22.5 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.974 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.479 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 13.3 p -65.46 -1.18 2.33 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.799 HG22 ' ND2' ' A' ' 199' ' ' ASN . 0.6 OUTLIER -109.73 10.52 24.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.795 0.331 . . . . 0.0 111.44 179.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.432 ' OG ' ' HG3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -87.9 137.83 31.99 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.057 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 61.1 m -90.14 -88.29 0.17 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 43.9 m -93.47 20.18 7.55 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.432 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.2 OUTLIER -118.05 -11.57 10.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.059 0.456 . . . . 0.0 110.742 178.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.736 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.8 tt -74.15 -60.59 1.43 Allowed Pre-proline 0 N--CA 1.453 -0.29 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.828 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 2.0 Cg_endo -42.99 99.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.338 2.025 . . . . 0.0 112.639 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.675 HG11 ' CD2' ' A' ' 196' ' ' HIS . 99.1 t -69.26 158.39 6.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.971 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.718 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 16.4 mtpt -138.25 77.86 1.65 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -178.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.808 HD12 ' HA ' ' A' ' 231' ' ' GLN . 3.7 mp -65.5 122.39 17.08 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.116 -0.365 . . . . 0.0 110.655 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.549 ' O ' ' O ' ' A' ' 218' ' ' LEU . . . -164.32 166.37 37.72 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.941 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 1.07 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -67.12 -70.83 0.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -177.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.749 HG22 ' HD2' ' A' ' 215' ' ' PRO . 14.9 p -78.48 157.34 4.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 213' ' ' VAL . 0.1 OUTLIER -30.07 -54.89 0.34 Allowed Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -178.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.749 ' HD2' HG22 ' A' ' 213' ' ' VAL . 55.0 Cg_exo -36.83 -30.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.854 2.37 . . . . 0.0 113.133 -178.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.437 ' CB ' ' HA3' ' A' ' 211' ' ' GLY . 0.9 OUTLIER -81.91 154.92 25.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.616 0.246 . . . . 0.0 110.512 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.571 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -69.24 -40.53 77.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.328 . . . . 0.0 110.194 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.742 ' HB3' HD23 ' A' ' 220' ' ' LEU . 2.6 tp -97.47 130.16 44.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.561 ' C ' HD22 ' A' ' 220' ' ' LEU . . . -90.04 76.84 6.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.01 0.433 . . . . 0.0 110.963 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.792 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.5 mm? -106.69 90.64 3.39 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.445 ' CG ' ' HB2' ' A' ' 190' ' ' PRO . 4.6 pttt -64.0 36.65 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.873 ' HB3' HG12 ' A' ' 225' ' ' VAL . 26.5 t0 -65.65 132.89 49.92 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.9 p -73.55 -4.53 34.55 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.255 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.93 -18.73 24.24 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.717 0.294 . . . . 0.0 110.545 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.07 HG13 ' HB2' ' A' ' 212' ' ' ARG . 5.4 p -107.58 86.37 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.172 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -37.23 -42.95 0.49 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.346 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.39 -49.91 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 246' ' ' MET . 0.0 OUTLIER -143.5 135.32 26.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.461 . . . . 0.0 110.016 179.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.601 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.1 t60 -106.12 -52.95 2.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -148.34 176.04 10.59 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.808 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -159.17 178.51 9.93 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.881 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 18.7 mt -137.22 147.63 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 121.471 0.653 . . . . 0.0 112.405 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.455 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -161.65 158.5 26.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.807 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 7.0 p90 -147.48 166.81 26.13 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -116.0 133.58 55.88 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.352 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 82.1 p -93.23 1.19 57.17 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.262 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.0 m -79.31 -37.92 36.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.888 0.851 . . . . 0.0 109.652 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 50.5 tptt -124.9 13.58 8.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.068 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 20.3 p90 42.47 61.27 2.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.528 0.68 . . . . 0.0 109.87 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.807 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.4 OUTLIER -125.32 137.57 54.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.146 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.725 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -118.95 120.33 36.97 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.062 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.578 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 6.9 mt-10 -138.32 144.04 40.22 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.836 0.827 . . . . 0.0 112.629 -177.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.784 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.5 pp -105.01 152.02 23.23 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.13 -1.395 . . . . 0.0 110.474 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 269' ' ' TRP . 4.3 p -122.37 163.36 20.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 110.587 -0.153 . . . . 0.0 110.587 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.406 ' OD1' ' HB ' ' A' ' 252' ' ' THR . 0.3 OUTLIER -105.96 156.43 18.39 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.676 ' HA ' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -80.97 149.17 29.46 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.5 ' HA2' ' C ' ' A' ' 268' ' ' LYS . . . -53.21 10.84 0.01 OUTLIER Glycine 0 C--N 1.317 -0.508 0 N-CA-C 115.569 0.988 . . . . 0.0 115.569 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 246' ' ' MET . 0.6 OUTLIER -89.4 130.48 35.76 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.025 1.412 . . . . 0.0 110.77 179.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.669 ' C ' HD13 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -57.16 6.04 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.66 ' N ' HD13 ' A' ' 249' ' ' LEU . 4.9 m-20 -70.0 -40.25 75.4 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 119.666 1.121 . . . . 0.0 109.847 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 72.57 119.02 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.391 -0.822 . . . . 0.0 113.126 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.64 ' C ' HD23 ' A' ' 253' ' ' LEU . 76.7 m -73.5 172.07 12.0 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.305 0.242 . . . . 0.0 110.457 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.661 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -144.4 121.23 11.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.174 0.512 . . . . 0.0 110.567 177.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.726 HG23 HD11 ' A' ' 259' ' ' ILE . 89.9 t -97.15 134.97 32.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.759 179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.447 HD22 HG12 ' A' ' 254' ' ' VAL . 11.9 p30 49.58 34.54 7.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.147 0.499 . . . . 0.0 110.104 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.55 36.64 1.24 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.831 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -144.61 112.49 6.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.646 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 77.7 p -61.03 85.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 110.811 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.923 HG12 HG11 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -84.98 -13.29 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.263 -179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.55 ' N ' HD12 ' A' ' 259' ' ' ILE . 17.0 p -100.01 -14.21 18.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.639 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 0.3 OUTLIER -109.76 24.54 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.442 177.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 84.1 Cg_exo -45.98 -48.22 13.05 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.986 1.791 . . . . 0.0 112.963 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.56 100.01 6.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.119 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 19.2 mt -48.24 -24.83 1.29 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.113 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -49.4 -28.23 9.21 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.314 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.587 ' C ' ' H ' ' A' ' 268' ' ' LYS . 10.1 m -89.27 -67.41 0.84 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 119.726 -0.178 . . . . 0.0 111.368 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.429 ' HG2' ' CB ' ' A' ' 249' ' ' LEU . 13.4 mtm180 68.81 -22.51 0.14 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.25 0.548 . . . . 0.0 112.333 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 266' ' ' SER . 0.0 OUTLIER -68.73 -136.39 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.205 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.72 ' O ' HG22 ' A' ' 244' ' ' VAL . 11.6 t-105 -71.54 -16.38 62.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.06 -175.92 4.96 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -109.51 151.15 42.02 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 117.857 0.829 . . . . 0.0 110.95 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.628 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 34.6 Cg_exo -60.27 117.65 4.43 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.777 2.318 . . . . 0.0 113.463 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.923 HG11 HG12 ' A' ' 259' ' ' ILE . 97.6 t -95.49 137.06 24.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.5 OUTLIER -83.36 125.04 31.23 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.864 -179.013 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.947 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -90.25 164.33 14.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.566 179.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.7 157.37 45.54 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.258 0.551 . . . . 0.0 112.043 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.493 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 68.3 p -58.21 127.81 33.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.483 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 84.24 8.84 0.5 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.418 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.6 t0 -83.18 -165.54 1.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.519 HG23 ' CD1' ' A' ' 290' ' ' TYR . 0.5 OUTLIER -162.36 134.45 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.592 177.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.897 HD12 HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -108.57 156.6 9.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.67 178.471 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.661 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.3 m -146.52 113.8 6.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.755 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -114.64 47.8 1.21 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.589 -178.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 172.58 -125.14 1.13 Allowed Glycine 0 CA--C 1.517 0.205 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.453 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.5 t -96.9 -47.13 5.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.644 0.259 . . . . 0.0 111.244 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -144.83 -6.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 61.6 m -64.93 103.44 0.72 Allowed 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.432 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.849 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.8 mtpt -124.78 134.53 52.75 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.034 0.445 . . . . 0.0 111.259 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.897 HG23 HD12 ' A' ' 281' ' ' ILE . 0.1 OUTLIER -114.97 134.24 58.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.69 -178.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.524 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.3 t80 -76.98 139.49 40.12 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.971 0.415 . . . . 0.0 110.261 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.947 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -106.32 113.13 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.846 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.91 144.86 50.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.516 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.709 HD11 ' CD2' ' A' ' 275' ' ' LEU . 11.5 mt -144.15 116.81 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.443 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.1 m -123.74 147.52 47.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.951 0.405 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 70.4 m -80.8 -178.31 6.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.015 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -150.05 116.13 5.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -148.49 97.01 2.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.965 179.877 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.597 ' HA ' HG23 ' A' ' 201' ' ' THR . 1.1 mp . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.769 0.319 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.538 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.98 82.14 0.96 Allowed Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.233 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 31.8 t -161.02 -76.02 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.9 0.381 . . . . 0.0 109.979 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.7 OUTLIER -141.5 -176.14 4.63 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.567 ' O ' HG23 ' A' ' 293' ' ' ILE . 6.6 m95 -147.2 132.32 18.3 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.604 HD23 ' HZ3' ' A' ' 234' ' ' TRP . 6.1 tp -117.86 127.47 53.9 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.092 176.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 16.9 m-85 -125.74 136.5 53.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.676 0.751 . . . . 0.0 110.932 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.845 HD13 ' ND1' ' A' ' 196' ' ' HIS . 1.4 mp -138.13 149.84 46.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.917 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.486 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 12.9 tt0 -145.09 127.09 15.52 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.613 HG21 HD12 ' A' ' 194' ' ' LEU . 13.4 t -64.07 114.87 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.505 HG22 ' CB ' ' A' ' 288' ' ' LYS . 8.7 tt -99.01 -20.17 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -175.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.808 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.74 91.39 0.56 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.968 -0.693 . . . . 0.0 112.421 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.808 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.82 -172.68 29.53 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.689 ' HB2' ' HD2' ' A' ' 221' ' ' LYS . 70.7 Cg_endo -77.0 26.84 0.44 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.121 1.881 . . . . 0.0 111.931 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.821 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.0 29.91 0.12 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.114 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.808 HG12 ' H ' ' A' ' 189' ' ' GLY . 5.3 mt -42.84 116.74 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 138.46 -51.78 0.76 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.341 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.821 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -38.56 149.43 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.282 0.563 . . . . 0.0 111.215 -178.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.745 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 18.6 mt-30 -148.63 149.97 32.44 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.813 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.845 ' ND1' HD13 ' A' ' 184' ' ' LEU . 2.0 p80 -136.93 126.95 25.96 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.251 0.548 . . . . 0.0 109.847 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.6 161.26 38.97 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.476 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.909 HG13 ' CH2' ' A' ' 234' ' ' TRP . 4.0 p -172.61 160.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 111.812 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 180' ' ' SER . 29.9 m-80 -88.74 150.12 23.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.24 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.566 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 40.6 t -64.08 -9.01 13.78 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.623 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.597 HG23 ' HA ' ' A' ' 177' ' ' LEU . 1.8 t -101.18 34.47 2.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.209 0.528 . . . . 0.0 111.061 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.44 ' HB2' ' HG2' ' A' ' 205' ' ' LYS . 35.9 p -116.13 129.74 56.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.634 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.446 ' H ' ' HE2' ' A' ' 205' ' ' LYS . 4.0 m -90.33 -86.93 0.19 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 35.0 m -86.8 14.24 7.5 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 -178.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.446 ' HE2' ' H ' ' A' ' 203' ' ' SER . 0.0 OUTLIER -115.83 -13.46 11.36 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.995 0.426 . . . . 0.0 110.412 178.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.773 HD11 ' CE2' ' A' ' 234' ' ' TRP . 6.4 tt -70.4 -60.29 3.4 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.314 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.609 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.0 OUTLIER -43.51 97.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.562 2.175 . . . . 0.0 113.47 -178.56 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.74 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 98.9 t -68.32 163.16 3.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 3.6 mtpp -139.66 85.81 2.07 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.06 HD23 HD12 ' A' ' 218' ' ' LEU . 0.5 OUTLIER -73.67 126.43 30.29 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.163 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.447 ' HA3' ' OG ' ' A' ' 216' ' ' SER . . . -170.09 173.15 44.12 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.943 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 1.059 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -70.58 -75.12 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.922 HG13 ' HG2' ' A' ' 215' ' ' PRO . 11.3 p -78.99 160.13 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -176.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.507 ' N ' HG22 ' A' ' 213' ' ' VAL . 0.6 OUTLIER -27.68 -52.59 0.23 Allowed Pre-proline 0 N--CA 1.469 0.524 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -178.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.922 ' HG2' HG13 ' A' ' 213' ' ' VAL . 5.0 Cg_exo -38.5 -29.77 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.634 2.223 . . . . 0.0 112.962 -178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.447 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 0.7 OUTLIER -82.98 151.24 25.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.648 179.011 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -31.03 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.108 0.48 . . . . 0.0 109.967 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.06 HD12 HD23 ' A' ' 210' ' ' LEU . 0.8 OUTLIER -105.74 131.24 53.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.234 178.591 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -91.23 77.75 5.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.84 0.353 . . . . 0.0 111.808 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.793 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 3.2 mm? -101.26 87.09 3.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.689 ' HD2' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -59.65 24.03 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.108 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.619 ' H ' ' C ' ' A' ' 220' ' ' LEU . 5.7 m-20 -54.48 115.04 1.9 Allowed 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.805 0.336 . . . . 0.0 110.791 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.3 t -56.31 -16.21 5.17 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.804 ' O ' HD11 ' A' ' 249' ' ' LEU . 1.9 pm0 -83.19 -23.51 32.82 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.059 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.4 p -97.18 92.26 2.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.825 0.345 . . . . 0.0 110.084 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 36.1 m -37.89 -48.18 1.12 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.271 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.06 -50.1 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.698 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.415 ' HD3' ' CB ' ' A' ' 216' ' ' SER . 0.4 OUTLIER -141.26 125.87 17.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.424 0.63 . . . . 0.0 110.738 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.519 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.9 t60 -89.8 -62.17 1.53 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.6 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -145.32 178.01 8.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.39 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.74 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -160.81 178.25 9.62 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.659 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.551 HG12 ' HB3' ' A' ' 243' ' ' LEU . 6.5 mt -138.85 149.92 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.149 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.427 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -161.24 143.49 12.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.091 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.909 ' CH2' HG13 ' A' ' 198' ' ' VAL . 5.2 p90 -131.89 165.25 24.29 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.65 133.78 55.6 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.645 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 95.5 p -91.75 0.71 57.47 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.264 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.8 m -77.72 -32.33 52.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.7 0.762 . . . . 0.0 109.825 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.541 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -134.78 16.22 3.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.383 -1.281 . . . . 0.0 110.308 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.416 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 17.8 p90 43.73 62.46 1.91 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.459 0.647 . . . . 0.0 109.609 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.802 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 5.1 mptt -125.86 140.58 52.54 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.207 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.717 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -125.21 118.0 25.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.37 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 5.7 pt-20 -133.97 148.09 51.11 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.994 0.902 . . . . 0.0 112.821 -178.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.838 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.3 pp -112.19 149.71 31.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 113.925 -1.488 . . . . 0.0 110.843 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 1.032 HG22 ' HB3' ' A' ' 269' ' ' TRP . 0.8 OUTLIER -124.46 160.86 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.617 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 9.2 m-20 -110.7 108.66 18.62 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.547 ' CE ' ' HG2' ' A' ' 231' ' ' GLN . 1.8 ptp -86.38 106.85 17.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 50.25 62.73 4.84 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.224 -0.988 . . . . 0.0 111.173 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.405 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 2.8 p -79.14 71.35 5.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.866 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.08 -56.64 17.5 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.844 179.54 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.866 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.4 OUTLIER -73.35 -27.11 61.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.871 0.367 . . . . 0.0 111.017 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 261' ' ' HIS . . . 91.16 135.22 6.37 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.81 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.569 HG22 ' CD1' ' A' ' 281' ' ' ILE . 3.5 m -97.3 156.84 16.26 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.687 ' HG ' ' HB ' ' A' ' 282' ' ' THR . 0.2 OUTLIER -149.04 139.17 22.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.077 0.465 . . . . 0.0 111.297 179.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.628 HG23 HD11 ' A' ' 259' ' ' ILE . 48.9 t -109.83 133.02 56.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.266 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.692 ' HA ' HG13 ' A' ' 280' ' ' ILE . 11.4 p30 53.02 38.07 26.36 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 121.256 0.551 . . . . 0.0 110.689 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 6.2 m 70.68 36.75 1.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.876 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.01 113.18 6.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.947 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 69.0 p -63.82 82.78 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.471 0.653 . . . . 0.0 110.384 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.78 HG12 HG11 ' A' ' 273' ' ' VAL . 0.4 OUTLIER -81.31 -10.75 12.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.73 -178.141 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.664 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 15.4 m -122.98 -13.89 7.72 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.711 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 41.7 t-80 -111.51 35.62 0.12 Allowed Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 176.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.711 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 37.8 Cg_exo -58.91 -29.07 89.32 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.919 1.746 . . . . 0.0 113.917 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.81 111.14 19.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.491 0.662 . . . . 0.0 111.324 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.792 ' H ' HD23 ' A' ' 264' ' ' LEU . 0.3 OUTLIER -69.99 160.01 32.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.665 -179.517 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 74.23 -28.47 0.99 Allowed Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.923 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 264' ' ' LEU . 4.2 m -65.72 -38.49 89.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.569 ' HD3' ' HA ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER 54.02 24.58 4.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.037 -178.235 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.449 ' HG3' ' H ' ' A' ' 270' ' ' GLY . 2.6 ptmm? -81.35 171.93 14.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.013 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 1.032 ' HB3' HG22 ' A' ' 244' ' ' VAL . 0.5 OUTLIER -79.71 -6.17 56.67 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.709 179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.449 ' H ' ' HG3' ' A' ' 268' ' ' LYS . . . 74.85 -106.93 2.17 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 119.485 -1.34 . . . . 0.0 109.759 -177.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.52 ' O ' HG23 ' A' ' 273' ' ' VAL . 0.7 OUTLIER -152.14 125.1 4.1 Favored Pre-proline 0 C--N 1.309 -1.16 0 CA-C-N 115.163 -0.519 . . . . 0.0 110.67 174.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.595 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 84.9 Cg_exo -38.66 102.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 121.723 1.616 . . . . 0.0 110.04 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.78 HG11 HG12 ' A' ' 259' ' ' ILE . 45.3 t -93.08 139.04 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 C-N-CA 120.145 -0.622 . . . . 0.0 112.299 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.717 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.4 mm-40 -84.55 127.5 34.08 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.255 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.983 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.56 164.76 13.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.37 179.531 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.633 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -143.85 161.24 39.17 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.579 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 1.5 m -62.27 131.93 51.0 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.778 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' A' ' 277' ' ' SER . 34.6 m-20 80.16 -0.2 2.02 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.414 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -71.73 -164.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.701 HG22 ' HD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -157.13 123.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.161 177.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.737 HG22 HG23 ' A' ' 289' ' ' VAL . 0.3 OUTLIER -104.89 157.73 5.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.945 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.687 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 2.9 m -150.38 126.58 10.63 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.713 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -121.85 49.96 1.49 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -178.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 175.26 -134.26 2.67 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 119.652 -1.261 . . . . 0.0 113.496 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.422 HG22 ' OE2' ' A' ' 224' ' ' GLU . 9.5 t -89.44 -38.63 13.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.119 0.485 . . . . 0.0 109.805 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -151.65 -5.63 0.25 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.11 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.808 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 26.3 m -66.63 99.95 0.64 Allowed 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 121.196 0.522 . . . . 0.0 111.353 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.563 ' O ' HG22 ' A' ' 289' ' ' VAL . 17.0 mttt -99.13 178.93 4.77 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.592 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.737 HG23 HG22 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -162.72 120.0 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.088 177.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.701 ' HD1' HG22 ' A' ' 280' ' ' ILE . 1.7 t80 -75.76 136.98 40.28 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.53 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.983 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -107.2 111.36 35.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.183 -178.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 9.0 tpt85 -128.24 144.14 51.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.458 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.609 HD12 ' CZ3' ' A' ' 241' ' ' TRP . 20.9 mt -143.01 123.75 10.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.26 153.46 46.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.696 0.284 . . . . 0.0 110.533 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 73.1 m -80.63 174.95 11.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.821 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.89 133.82 49.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.93 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -155.97 87.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.775 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.946 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.461 ' HB3' ' ND2' ' A' ' 199' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.639 0.257 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 1.006 ' HA3' HG21 ' A' ' 201' ' ' THR . . . 115.88 -115.45 3.38 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.24 -0.505 . . . . 0.0 113.911 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 17.8 p -166.13 26.17 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 1.8 m -160.07 160.06 32.66 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 121.244 -0.183 . . . . 0.0 110.875 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.618 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 17.8 m95 -151.09 148.8 28.75 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -178.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.893 HD11 ' CD1' ' A' ' 184' ' ' LEU . 0.1 OUTLIER -128.36 127.57 42.9 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.021 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.845 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.3 m-85 -125.69 142.09 51.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.908 0.861 . . . . 0.0 112.531 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.893 ' CD1' HD11 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -137.66 147.44 44.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.022 176.421 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.499 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 0.6 OUTLIER -139.56 129.45 24.83 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -177.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.827 HG21 HD12 ' A' ' 194' ' ' LEU . 26.9 t -66.41 116.18 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.697 HG22 ' O ' ' A' ' 288' ' ' LYS . 4.7 tt -99.01 -22.2 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.887 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -160.63 92.54 0.96 Allowed 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.714 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.4 -169.8 25.19 Favored Glycine 0 CA--C 1.516 0.116 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 178.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.635 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 96.3 Cg_endo -81.02 28.45 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.042 1.828 . . . . 0.0 111.631 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.836 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.51 24.31 0.12 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.912 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.714 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.5 mt -39.53 114.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.876 0.37 . . . . 0.0 111.954 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.24 7.74 4.34 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.924 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.836 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -97.12 128.25 43.85 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 10.8 mt-30 -127.71 150.84 49.6 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.022 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.726 ' O ' HD22 ' A' ' 184' ' ' LEU . 1.0 OUTLIER -141.62 142.05 33.43 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.83 179.387 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -132.5 136.33 46.59 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.189 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.655 HG21 ' HG ' ' A' ' 206' ' ' LEU . 12.3 p -141.39 130.92 24.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.487 0.66 . . . . 0.0 111.863 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.461 ' ND2' ' HB3' ' A' ' 177' ' ' LEU . 8.8 p30 -85.88 145.56 27.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.949 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.452 ' HG ' ' HE1' ' A' ' 234' ' ' TRP . 12.2 t -63.55 -3.55 2.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.69 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 1.006 HG21 ' HA3' ' A' ' 178' ' ' GLY . 0.5 OUTLIER -105.52 6.46 32.31 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.971 0.359 . . . . 0.0 111.971 -179.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.504 ' HA ' ' HE3' ' A' ' 205' ' ' LYS . 0.4 OUTLIER -85.69 130.59 34.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.0 110.289 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.9 t -90.65 -90.16 0.16 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 24.7 p -84.51 14.81 4.17 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.504 ' HE3' ' HA ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -123.49 -14.39 7.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.036 0.446 . . . . 0.0 110.522 179.038 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.655 ' HG ' HG21 ' A' ' 198' ' ' VAL . 7.8 tt -65.61 -62.53 4.36 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.75 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -43.17 99.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.36 2.04 . . . . 0.0 112.584 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 87.3 t -68.36 164.71 2.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.902 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 25.5 mtmt -141.41 94.57 2.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.049 HD23 HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -87.96 131.03 34.76 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.28 173.65 45.31 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.993 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.876 ' HD3' HG12 ' A' ' 213' ' ' VAL . 12.2 ttt180 -71.15 -74.96 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.963 0.411 . . . . 0.0 111.808 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.876 HG12 ' HD3' ' A' ' 212' ' ' ARG . 10.2 p -140.54 110.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.462 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.578 ' CB ' ' HD2' ' A' ' 215' ' ' PRO . 0.3 OUTLIER 178.61 179.89 0.23 Allowed Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.962 -179.026 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 37.0 Cg_endo -66.1 25.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 121.907 1.738 . . . . 0.0 112.331 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.546 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -68.21 -172.93 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.966 0.412 . . . . 0.0 111.242 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.425 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 13.3 m-20 -104.7 -29.48 10.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.474 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.049 HD12 HD23 ' A' ' 210' ' ' LEU . 5.7 mt -112.64 131.68 55.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -98.25 87.72 3.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.567 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.661 HD11 ' CG2' ' A' ' 186' ' ' VAL . 3.0 mm? -103.72 59.65 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.681 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -53.2 73.19 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.22 -178.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.635 ' CB ' ' HG3' ' A' ' 190' ' ' PRO . 7.0 t0 -116.58 143.11 46.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.003 0.43 . . . . 0.0 110.311 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.5 t -63.5 -5.3 3.6 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.541 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.697 ' HG2' HG22 ' A' ' 285' ' ' THR . 0.1 OUTLIER -86.79 -30.73 21.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 109.869 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 212' ' ' ARG . 0.1 OUTLIER -95.62 107.68 19.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.601 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -49.38 71.69 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.137 0.494 . . . . 0.0 110.297 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 228' ' ' LYS . . . -148.1 -51.06 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.1 OUTLIER -145.81 125.11 13.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.013 0.435 . . . . 0.0 110.479 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.574 ' HB2' ' CG1' ' A' ' 225' ' ' VAL . 2.5 t60 -84.56 -58.95 2.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.196 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.902 ' HB3' HD22 ' A' ' 283' ' ' LEU . . . -152.23 175.53 12.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.498 -177.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.731 ' HA ' HD12 ' A' ' 210' ' ' LEU . 0.0 OUTLIER -155.55 179.96 8.68 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.817 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.75 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.5 mt -135.79 149.44 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.091 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.41 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.4 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -153.69 164.35 38.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.635 ' CD2' HD11 ' A' ' 206' ' ' LEU . 0.6 OUTLIER -93.33 153.43 18.55 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.018 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 239' ' ' PHE . 2.3 m-20 -119.35 71.02 0.85 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.722 -1.581 . . . . 0.0 106.975 174.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.1 p -53.87 -23.24 11.93 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.9 m -74.38 -27.12 60.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.549 0.69 . . . . 0.0 109.235 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.512 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -117.25 8.66 13.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.334 178.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.507 ' N ' ' O ' ' A' ' 235' ' ' ASN . 2.7 p90 38.38 39.47 0.29 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.622 0.248 . . . . 0.0 111.039 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.462 ' HD2' ' HB3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -112.27 179.96 3.85 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.423 0.63 . . . . 0.0 110.009 -179.699 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.784 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -131.02 115.0 15.88 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.917 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.57 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 14.0 pt-20 -137.65 151.72 48.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.692 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.4 pp -116.34 153.85 31.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.053 -1.431 . . . . 0.0 111.802 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.805 HG21 ' CD1' ' A' ' 269' ' ' TRP . 2.1 p -121.7 162.69 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.672 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.775 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 8.3 t0 -102.49 116.88 33.52 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -77.53 98.0 5.21 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 56.2 70.18 1.05 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.9 -1.143 . . . . 0.0 110.704 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 19.5 p -62.87 48.15 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.973 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -56.58 -49.81 73.76 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.231 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.973 ' N ' HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.5 -39.02 28.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.538 ' CA ' ' HB2' ' A' ' 261' ' ' HIS . . . 93.52 93.39 1.54 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.614 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 1.06 HG23 HD23 ' A' ' 283' ' ' LEU . 20.0 m -50.2 164.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.689 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -150.29 139.7 21.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.328 0.585 . . . . 0.0 111.303 179.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.872 HG22 HG12 ' A' ' 281' ' ' ILE . 70.3 t -114.37 137.13 48.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.748 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.677 ' HA ' HG13 ' A' ' 280' ' ' ILE . 23.4 p30 47.69 34.98 4.06 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.307 0.575 . . . . 0.0 110.421 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 72.87 35.35 1.02 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.481 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 259' ' ' ILE . 64.5 t-80 -137.56 111.42 8.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.714 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 5.4 t -63.05 84.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.454 0.645 . . . . 0.0 110.992 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.868 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -84.28 -8.49 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.724 -178.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.775 ' HB3' ' HB2' ' A' ' 245' ' ' ASP . 21.4 m -101.75 -23.9 14.14 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.607 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 0.2 OUTLIER -109.68 33.0 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 178.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.607 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 71.0 Cg_exo -47.63 -55.04 4.33 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 121.526 1.484 . . . . 0.0 111.782 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -111.89 102.4 10.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.175 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.445 ' HA ' ' CE1' ' A' ' 261' ' ' HIS . 34.6 mt -52.96 -22.6 5.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.538 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -50.23 -24.64 7.14 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.873 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 268' ' ' LYS . 0.3 OUTLIER -91.82 -63.28 1.27 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.746 -0.267 . . . . 0.0 111.599 -179.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER 67.79 -17.8 0.15 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.286 0.494 . . . . 0.0 112.144 -179.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.614 ' HE3' ' HB2' ' A' ' 269' ' ' TRP . 13.2 ttpt -76.23 -125.08 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.805 ' CD1' HG21 ' A' ' 244' ' ' VAL . 12.2 t-105 -83.66 -27.46 29.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.435 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 62.79 -178.29 5.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.203 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -105.09 146.89 33.57 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.106 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.692 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 71.8 Cg_exo -49.88 148.99 11.8 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.594 2.196 . . . . 0.0 112.857 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.841 HG11 HG13 ' A' ' 259' ' ' ILE . 69.2 t -129.86 136.31 59.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.4 mp0 -81.53 128.14 33.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 118.794 -1.162 . . . . 0.0 112.052 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 1.031 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -93.0 165.93 12.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.027 178.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.683 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.28 161.73 37.28 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.682 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 3.7 p -62.64 130.04 43.24 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.281 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' A' ' 277' ' ' SER . 30.9 m-20 81.87 -1.48 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.449 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.683 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.2 OUTLIER -70.8 -162.83 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.723 HG22 ' HD1' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -159.97 129.09 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.226 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.872 HG12 HG22 ' A' ' 254' ' ' VAL . 0.3 OUTLIER -117.3 93.04 2.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -178.519 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 288' ' ' LYS . 1.8 m -79.56 129.51 34.54 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 1.06 HD23 HG23 ' A' ' 252' ' ' THR . 0.5 OUTLIER -118.92 50.53 1.2 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.424 -178.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.528 ' HA3' ' CD ' ' A' ' 224' ' ' GLU . . . 162.73 -119.01 0.85 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 119.198 -1.477 . . . . 0.0 113.673 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.697 HG22 ' HG2' ' A' ' 224' ' ' GLU . 1.7 t -95.51 -58.75 2.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.374 0.131 . . . . 0.0 111.159 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.494 ' H ' HG23 ' A' ' 285' ' ' THR . 1.3 t -134.08 -1.28 2.97 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.762 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.887 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 40.4 m -72.51 102.14 3.15 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.697 ' O ' HG22 ' A' ' 187' ' ' ILE . 12.7 ttmt -119.4 123.36 43.92 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.104 0.478 . . . . 0.0 111.286 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 1.1 t -103.01 129.86 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.964 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.723 ' HD1' HG22 ' A' ' 280' ' ' ILE . 0.6 OUTLIER -77.36 133.85 38.62 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 120.659 -0.416 . . . . 0.0 109.912 -179.309 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 1.031 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -103.44 112.81 38.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.633 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -130.59 141.14 50.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.949 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.784 HD12 ' CE3' ' A' ' 241' ' ' TRP . 2.1 mt -138.98 143.2 32.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 41.8 t -151.67 164.23 37.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.1 -169.87 2.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.428 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -123.25 122.0 37.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.77 0.319 . . . . 0.0 111.067 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . 0.472 HD22 ' HA ' ' A' ' 297' ' ' ASN . 1.5 t-20 -81.98 90.75 6.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.019 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.65 ' HA ' HG23 ' A' ' 201' ' ' THR . 1.5 mp . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.664 0.269 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.578 ' N ' HG21 ' A' ' 201' ' ' THR . . . 116.02 87.33 1.36 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.827 -0.702 . . . . 0.0 113.33 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.448 ' OG ' HG22 ' A' ' 201' ' ' THR . 5.9 p -165.28 -71.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.044 0.449 . . . . 0.0 109.896 179.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.6 OUTLIER -141.76 -176.81 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.459 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.672 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.9 m95 -147.65 130.58 16.21 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 -178.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.57 ' HB2' ' HZ3' ' A' ' 241' ' ' TRP . 5.2 tp -113.27 124.37 52.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.058 177.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.672 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 6.5 m-85 -123.39 130.27 52.48 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.713 0.768 . . . . 0.0 110.791 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.837 HD13 ' CD2' ' A' ' 196' ' ' HIS . 1.2 mp -131.6 142.61 49.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.346 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.573 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 24.6 tt0 -140.2 124.8 18.08 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.272 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.767 HG21 HD12 ' A' ' 194' ' ' LEU . 11.1 t -61.33 113.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 288' ' ' LYS . 8.6 tt -97.05 -20.46 5.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.739 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -164.69 95.01 0.71 Allowed 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.919 -179.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.767 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -162.32 -175.81 33.74 Favored Glycine 0 N--CA 1.453 -0.232 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 178.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.547 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 96.3 Cg_endo -79.23 30.95 0.47 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.782 1.655 . . . . 0.0 110.966 178.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.941 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.81 24.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.767 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.2 mt -39.55 113.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.75 11.26 2.98 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.3 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.941 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -100.67 155.89 17.63 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.823 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.744 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 27.2 mt-30 -150.61 151.3 32.35 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.801 -177.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.837 ' CD2' HD13 ' A' ' 184' ' ' LEU . 3.7 p-80 -138.56 128.62 25.49 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -143.08 164.43 30.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.407 -179.099 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.828 HG21 ' HA ' ' A' ' 206' ' ' LEU . 5.9 p -172.84 156.76 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.4 0.619 . . . . 0.0 111.726 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.505 ' N ' HG22 ' A' ' 198' ' ' VAL . 3.3 m120 -91.52 144.76 25.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.395 178.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.455 ' HB2' ' CZ2' ' A' ' 234' ' ' TRP . 3.2 t -61.37 -4.52 1.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.455 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.65 HG23 ' HA ' ' A' ' 177' ' ' LEU . 4.9 t -102.08 0.54 35.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.593 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -75.12 138.27 41.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.418 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.2 m -87.18 -89.08 0.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.2 18.8 17.8 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.777 0.323 . . . . 0.0 111.722 -178.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.57 -6.88 11.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.525 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.828 ' HA ' HG21 ' A' ' 198' ' ' VAL . 7.5 tt -75.6 -62.53 0.77 Allowed Pre-proline 0 N--CA 1.453 -0.28 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.795 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.8 Cg_endo -42.7 99.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.254 1.969 . . . . 0.0 112.765 -178.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.73 HG11 ' CD2' ' A' ' 196' ' ' HIS . 43.1 t -69.54 165.31 2.56 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.757 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 4.3 mtpp -135.18 90.19 2.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.028 HD23 HD12 ' A' ' 218' ' ' LEU . 0.8 OUTLIER -78.11 124.93 28.62 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.891 -179.945 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.56 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . 177.01 -173.72 46.52 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.823 179.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.755 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 0.6 OUTLIER -60.32 155.92 16.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.583 0.23 . . . . 0.0 110.936 -179.755 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 213' ' ' VAL . 10.0 p -77.29 119.43 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.892 0.854 . . . . 0.0 113.204 -176.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.759 ' CB ' ' HD3' ' A' ' 215' ' ' PRO . 0.6 OUTLIER 160.88 -75.99 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.709 178.92 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.759 ' HD3' ' CB ' ' A' ' 214' ' ' SER . 42.9 Cg_endo -100.9 -14.82 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.653 2.235 . . . . 0.0 112.837 179.16 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.447 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 1.2 m -80.21 157.29 26.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.003 0.43 . . . . 0.0 111.758 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.524 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.7 OUTLIER -73.16 -37.23 66.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.805 178.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.028 HD12 HD23 ' A' ' 210' ' ' LEU . 1.7 mt -98.06 134.85 40.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.583 178.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.736 ' HB3' HD22 ' A' ' 194' ' ' LEU . . . -89.39 76.21 7.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.003 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.807 ' CD2' ' HB3' ' A' ' 218' ' ' LEU . 2.8 mm? -109.36 94.68 5.16 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.547 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -64.71 24.56 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.656 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.944 ' HB3' HG12 ' A' ' 225' ' ' VAL . 0.4 OUTLIER -55.75 116.05 2.71 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 179.222 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.4 t -58.73 -20.38 48.6 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.823 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.545 ' CG ' ' HB2' ' A' ' 250' ' ' ASN . 2.3 tp10 -75.11 -19.57 59.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 0.0 110.812 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.944 HG12 ' HB3' ' A' ' 222' ' ' ASP . 5.8 p -124.37 64.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.921 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 10.1 p -46.12 -31.93 2.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.834 -179.336 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -125.69 -78.86 0.32 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.375 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm -139.29 131.0 27.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.076 0.465 . . . . 0.0 110.74 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 245' ' ' ASP . 0.3 OUTLIER -99.59 -55.94 2.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.637 178.908 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.636 ' HB2' ' OD2' ' A' ' 245' ' ' ASP . . . -148.97 164.9 33.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.542 0.687 . . . . 0.0 112.563 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.628 ' HB2' ' O ' ' A' ' 208' ' ' VAL . 0.0 OUTLIER -149.97 -178.24 6.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.623 -1.171 . . . . 0.0 109.522 -179.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.795 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.1 mt -135.9 151.86 29.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 121.071 0.463 . . . . 0.0 112.198 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -155.23 163.69 39.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.163 178.213 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.784 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.8 OUTLIER -91.4 152.66 20.31 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -176.286 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 239' ' ' PHE . 26.8 t-20 -120.58 72.29 0.95 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 174.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.8 t -59.77 -15.83 23.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -175.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 90.7 m -84.33 -35.58 23.15 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.44 0.638 . . . . 0.0 110.625 -179.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.486 ' HE3' ' CE1' ' A' ' 239' ' ' PHE . 0.0 OUTLIER -112.6 11.83 19.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.355 179.881 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.486 ' CE1' ' HE3' ' A' ' 238' ' ' LYS . 12.5 p90 42.25 69.55 0.36 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 238' ' ' LYS . 2.0 mptp? -136.96 147.29 46.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.296 -178.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.735 ' CZ3' HG23 ' A' ' 293' ' ' ILE . 0.5 OUTLIER -114.14 103.46 11.14 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 178.656 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 27.6 mt-10 -125.08 143.63 50.82 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.104 0.954 . . . . 0.0 113.286 -176.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.81 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.4 pp -109.0 151.59 26.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.296 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 1.018 HG22 ' HB2' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -125.06 154.09 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.182 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.636 ' OD2' ' HB2' ' A' ' 230' ' ' ALA . 5.5 m-20 -117.04 100.49 7.78 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.607 ' HA ' ' CE3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -64.17 106.64 1.11 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.012 178.332 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.72 68.32 1.75 Allowed Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.577 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 267' ' ' ARG . 52.2 p -76.87 61.04 1.86 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.618 ' HA ' ' HD3' ' A' ' 267' ' ' ARG . 1.6 tm? -49.84 -60.01 3.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.149 0.5 . . . . 0.0 110.139 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.545 ' HB2' ' CG ' ' A' ' 224' ' ' GLU . 4.1 t-20 -69.72 -22.34 63.4 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.832 -179.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 81.67 84.57 0.76 Allowed Glycine 0 N--CA 1.437 -1.278 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.549 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.769 ' C ' HD23 ' A' ' 253' ' ' LEU . 55.7 m -46.46 164.87 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.555 0.178 . . . . 0.0 110.641 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.769 HD23 ' C ' ' A' ' 252' ' ' THR . 0.1 OUTLIER -148.38 126.69 12.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.26 0.552 . . . . 0.0 112.103 179.033 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.745 HG23 HD11 ' A' ' 259' ' ' ILE . 99.8 t -101.95 129.27 53.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.359 178.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 280' ' ' ILE . 52.6 t-20 53.35 43.06 31.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.138 0.494 . . . . 0.0 110.195 -179.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.36 31.02 17.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.062 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.406 ' O ' ' N ' ' A' ' 259' ' ' ILE . 0.1 OUTLIER -136.73 106.83 6.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.558 179.648 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 60.1 p -57.6 87.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.267 0.556 . . . . 0.0 110.76 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.785 ' HB ' HG21 ' A' ' 273' ' ' VAL . 1.0 OUTLIER -88.34 -2.38 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.37 -178.961 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.651 ' OG ' ' HB ' ' A' ' 252' ' ' THR . 1.4 m -99.09 -13.54 19.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.683 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 2.1 t60 -107.24 15.68 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 179.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 84.8 Cg_exo -47.78 -37.59 28.41 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.596 1.531 . . . . 0.0 110.327 179.018 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.584 ' O ' ' HB2' ' A' ' 266' ' ' SER . 77.4 m-20 -76.59 98.74 4.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.25 -1.795 . . . . 0.0 111.064 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 92.3 mt -66.21 133.33 50.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.739 0.305 . . . . 0.0 110.794 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 76.45 5.65 82.68 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.676 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.584 ' HB2' ' O ' ' A' ' 263' ' ' ASP . 0.5 OUTLIER -85.74 -60.29 2.06 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 122.905 -0.173 . . . . 0.0 111.168 -179.862 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.618 ' HD3' ' HA ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER 73.87 -2.87 2.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.123 0.487 . . . . 0.0 111.256 -178.479 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.558 ' HD3' ' CD1' ' A' ' 269' ' ' TRP . 2.7 ptpt -91.26 -143.55 0.18 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -176.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 1.018 ' HB2' HG22 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -95.0 -10.81 29.8 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 179.556 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.522 ' H ' ' HG3' ' A' ' 268' ' ' LYS . . . 58.06 -148.37 36.43 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 118.833 -1.651 . . . . 0.0 111.171 -178.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -96.36 126.51 43.58 Favored Pre-proline 0 C--N 1.324 -0.51 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.507 179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 4.0 Cg_exo -38.74 120.69 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.983 2.456 . . . . 0.0 111.887 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.785 HG21 ' HB ' ' A' ' 259' ' ' ILE . 48.5 t -94.36 135.3 29.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.921 -177.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -81.7 127.16 32.63 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.545 0.688 . . . . 0.0 110.984 -179.874 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.924 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.49 162.63 14.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.96 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.11 156.76 45.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.047 0.451 . . . . 0.0 112.054 -179.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.655 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 29.7 p -59.05 128.76 38.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.004 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.655 ' HB2' ' O ' ' A' ' 277' ' ' SER . 30.7 m-20 87.13 2.45 0.44 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.143 179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -75.78 -166.08 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.546 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.523 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.7 OUTLIER -161.51 130.82 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.085 178.208 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.65 HD12 HG23 ' A' ' 289' ' ' VAL . 0.0 OUTLIER -112.22 156.97 13.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.052 0.453 . . . . 0.0 111.321 178.436 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.658 HG23 ' CG ' ' A' ' 288' ' ' LYS . 1.9 m -141.7 119.17 11.58 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.314 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.617 HD23 ' CG2' ' A' ' 252' ' ' THR . 0.7 OUTLIER -111.84 47.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.898 -178.253 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 167.22 -128.14 1.69 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 119.621 -1.276 . . . . 0.0 113.796 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.8 t -89.9 -46.65 8.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.622 0.249 . . . . 0.0 111.137 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 188' ' ' ALA . 3.5 t -144.0 -7.36 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.739 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 47.6 m -64.15 103.21 0.59 Allowed 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 110.416 -0.216 . . . . 0.0 110.416 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.757 ' O ' HG22 ' A' ' 187' ' ' ILE . 5.5 mtpt -124.72 133.05 53.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 111.318 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.65 HG23 HD12 ' A' ' 281' ' ' ILE . 0.1 OUTLIER -112.21 135.5 51.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.564 -179.311 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.4 t80 -77.05 139.29 39.99 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.7 OUTLIER -110.28 114.11 46.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.544 -178.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 11.8 tpt180 -127.65 148.28 50.38 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.801 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.735 HG23 ' CZ3' ' A' ' 241' ' ' TRP . 14.3 mt -141.13 113.36 4.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.58 156.09 45.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.826 0.346 . . . . 0.0 110.762 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 22.8 m -90.51 162.04 15.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.873 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -86.61 135.04 33.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.032 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.56 86.48 6.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.004 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 179.961 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.754 ' C ' HG21 ' A' ' 201' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 121.177 0.513 . . . . 0.0 111.323 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.63 ' N ' HG21 ' A' ' 201' ' ' THR . . . 65.02 172.11 3.16 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 121.682 0.601 . . . . 0.0 113.689 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.941 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 40.2 t -110.43 42.12 1.63 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.408 -0.896 . . . . 0.0 112.403 -178.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 1.4 t -151.09 145.6 25.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.039 0.447 . . . . 0.0 111.206 179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.711 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 9.9 m95 -149.53 137.79 20.64 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.29 -178.307 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.951 HD12 ' N ' ' A' ' 183' ' ' PHE . 1.2 tp -119.85 131.05 55.17 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.951 ' N ' HD12 ' A' ' 182' ' ' LEU . 1.7 m-85 -130.32 141.12 50.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.83 0.824 . . . . 0.0 111.595 179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.989 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -139.46 152.73 47.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.994 178.079 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.539 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 17.7 tt0 -143.56 126.25 16.04 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.729 HG21 HD12 ' A' ' 194' ' ' LEU . 10.9 t -62.01 115.52 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.2 tt -100.56 -22.11 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -176.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.816 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -161.58 91.03 0.81 Allowed 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 120.062 -0.655 . . . . 0.0 112.601 -178.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.611 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.89 -170.54 26.76 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 178.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.524 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 91.6 Cg_endo -81.81 29.34 0.54 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.253 1.969 . . . . 0.0 111.589 178.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.821 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.05 27.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.611 HG12 ' H ' ' A' ' 189' ' ' GLY . 7.8 mt -45.38 112.11 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.877 0.37 . . . . 0.0 111.506 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 135.47 6.05 2.17 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.223 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.821 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.2 OUTLIER -98.47 138.94 34.95 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.703 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.539 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 17.1 mt-30 -137.92 153.08 49.53 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.515 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.989 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -147.83 147.76 30.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.634 -179.693 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -147.56 166.67 26.64 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.991 -179.241 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 1.015 HG21 ' HA ' ' A' ' 206' ' ' LEU . 5.7 p -171.82 147.92 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.535 0.683 . . . . 0.0 111.984 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.466 ' OD1' ' CZ2' ' A' ' 181' ' ' TRP . 0.8 OUTLIER -93.11 147.87 22.49 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.693 179.219 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 24.8 p -65.88 -2.23 3.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.255 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.754 HG21 ' C ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -102.77 -4.17 25.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.032 179.661 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.623 ' O ' ' HB2' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -94.27 125.51 38.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.548 179.871 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.401 ' O ' ' HD2' ' A' ' 207' ' ' PRO . 62.2 p -91.54 -81.28 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.12 3.21 0.63 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -177.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.475 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -120.87 -8.32 9.42 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.128 -0.358 . . . . 0.0 111.573 179.851 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 1.015 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.6 tt -71.9 -61.25 2.03 Favored Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.572 ' CD ' ' HB3' ' A' ' 206' ' ' LEU . 1.7 Cg_endo -43.75 96.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.967 1.778 . . . . 0.0 112.764 -178.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.903 ' O ' ' HB3' ' A' ' 231' ' ' GLN . 3.4 t -68.62 157.85 6.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.95 179.068 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 217' ' ' ASP . 4.5 mtmm -135.71 93.48 2.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.607 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.042 HD23 HD12 ' A' ' 218' ' ' LEU . 1.0 OUTLIER -86.86 123.19 31.71 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.735 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -168.14 169.72 41.6 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.504 -179.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.864 ' HA ' ' O ' ' A' ' 220' ' ' LEU . 14.7 ttt180 -72.01 -74.4 0.16 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -179.014 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 213' ' ' VAL . 8.6 p -138.94 115.08 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 216' ' ' SER . 0.3 OUTLIER 169.18 -176.29 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.1 -179.578 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 16.4 Cg_exo -67.96 23.26 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.47 2.113 . . . . 0.0 112.589 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 214' ' ' SER . 3.5 m -64.23 -150.43 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.987 -179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.8 OUTLIER -132.16 -34.04 1.28 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.486 179.809 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.042 HD12 HD23 ' A' ' 210' ' ' LEU . 1.1 mt -105.47 126.08 51.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -92.09 83.1 5.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.887 0.375 . . . . 0.0 111.432 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.864 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.3 mm? -104.69 89.44 3.19 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.472 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 0.1 OUTLIER -64.0 38.99 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.618 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.524 ' HA ' ' HG3' ' A' ' 190' ' ' PRO . 12.6 t0 -64.18 123.32 18.79 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.925 0.393 . . . . 0.0 110.18 179.191 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 60.1 p -67.45 -4.33 10.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.871 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -19.02 18.11 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.673 HG22 ' ND1' ' A' ' 229' ' ' HIS . 79.0 t -93.81 81.98 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.459 -1.246 . . . . 0.0 109.49 178.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -38.68 -48.01 1.42 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.441 -179.038 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.58 -55.38 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.693 ' HB2' ' HG3' ' A' ' 246' ' ' MET . 0.2 OUTLIER -140.93 128.31 21.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.998 0.427 . . . . 0.0 110.772 179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.673 ' ND1' HG22 ' A' ' 225' ' ' VAL . 0.7 OUTLIER -98.22 -59.71 1.7 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.46 179.088 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 244' ' ' VAL . . . -149.22 170.89 17.43 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.903 ' HB3' ' O ' ' A' ' 208' ' ' VAL . 1.7 mt-30 -151.58 173.64 14.39 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.745 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.546 HG12 HD22 ' A' ' 243' ' ' LEU . 3.5 mt -127.03 143.13 41.49 Favored 'Isoleucine or valine' 0 C--N 1.338 0.076 0 CA-C-O 121.519 0.676 . . . . 0.0 112.19 179.063 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.74 127.34 3.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.942 ' CH2' HG13 ' A' ' 198' ' ' VAL . 5.7 p90 -118.08 166.05 13.01 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -178.034 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.96 132.87 56.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.269 -1.332 . . . . 0.0 112.058 -179.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.09 -0.26 57.1 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.453 179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 19.8 m -79.02 -36.76 40.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.731 0.777 . . . . 0.0 109.521 178.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -126.38 17.4 7.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.476 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 12.8 p90 41.12 59.2 2.36 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.463 0.649 . . . . 0.0 110.014 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.735 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.97 138.4 54.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.624 179.872 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.64 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.71 120.02 32.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.89 179.571 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 21.8 mt-10 -132.97 144.03 49.85 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -177.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.851 HD13 ' O ' ' A' ' 231' ' ' GLN . 0.2 OUTLIER -89.03 146.8 24.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 112.959 -1.928 . . . . 0.0 108.4 178.064 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.721 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 6.0 p -122.32 163.47 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 118.718 0.69 . . . . 0.0 109.316 178.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.53 ' CG ' ' HA ' ' A' ' 260' ' ' SER . 2.0 m-20 -118.84 110.14 16.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -177.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.737 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -79.82 105.15 10.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.466 178.148 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 55.29 69.38 1.28 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.14 -1.029 . . . . 0.0 111.205 -179.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.01 45.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.905 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -58.37 -54.03 51.61 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.781 -0.575 . . . . 0.0 109.846 178.38 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.905 ' H ' HD13 ' A' ' 249' ' ' LEU . 1.4 m-20 -79.12 -34.11 43.71 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.003 0.43 . . . . 0.0 110.627 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 260' ' ' SER . . . 87.46 98.42 0.88 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.774 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.542 ' C ' HD23 ' A' ' 253' ' ' LEU . 3.1 m -61.07 170.56 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.479 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.3 OUTLIER -153.25 127.0 8.83 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.433 178.54 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.554 HG22 HG13 ' A' ' 281' ' ' ILE . 86.1 t -103.44 130.58 53.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.522 178.347 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.51 ' HA ' HG13 ' A' ' 280' ' ' ILE . 23.8 t-20 54.03 48.8 20.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.096 0.474 . . . . 0.0 110.216 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.84 23.51 8.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -127.74 105.71 8.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.257 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 86.7 p -55.62 86.4 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.488 -179.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.802 ' HB ' HG21 ' A' ' 273' ' ' VAL . 2.9 pp -86.15 20.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.332 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.958 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 78.5 p -94.49 -20.85 19.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.344 -178.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.643 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 0.0 OUTLIER -108.35 47.35 0.18 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.636 178.157 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.958 ' HD3' ' C ' ' A' ' 260' ' ' SER . 3.0 Cg_exo -82.6 26.46 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.668 2.245 . . . . 0.0 111.763 179.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.595 ' C ' HD22 ' A' ' 264' ' ' LEU . 1.5 m-20 -137.68 -159.22 0.93 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.595 HD22 ' C ' ' A' ' 263' ' ' ASP . 1.4 mm? -113.63 -49.96 2.86 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 118.445 0.566 . . . . 0.0 110.509 177.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -141.02 26.96 2.46 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.123 -179.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.575 ' C ' ' H ' ' A' ' 268' ' ' LYS . 66.1 p -65.68 -62.78 1.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.516 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 266' ' ' SER . 0.0 OUTLIER 68.02 -23.68 0.13 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.831 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.575 ' H ' ' C ' ' A' ' 266' ' ' SER . 5.3 ttmt -68.7 -127.15 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.692 -177.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.737 ' CH2' ' HG2' ' A' ' 246' ' ' MET . 0.0 OUTLIER -79.67 -14.58 58.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.149 -178.994 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 59.62 -172.34 5.09 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -178.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -113.68 131.94 22.81 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 118.242 1.021 . . . . 0.0 110.178 179.102 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.49 ' HB3' ' HB2' ' A' ' 242' ' ' GLU . 80.0 Cg_exo -44.83 119.92 2.59 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.809 2.339 . . . . 0.0 114.055 -178.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.802 HG21 ' HB ' ' A' ' 259' ' ' ILE . 49.3 t -104.14 133.02 49.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.594 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -75.15 128.11 34.75 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -176.678 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.828 HD13 ' H ' ' A' ' 275' ' ' LEU . 0.0 OUTLIER -92.44 165.09 13.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 113.86 -1.518 . . . . 0.0 108.864 178.088 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.52 158.43 44.01 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.57 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.705 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 5.5 p -58.25 130.09 45.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.652 178.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.705 ' HB2' ' O ' ' A' ' 277' ' ' SER . 1.1 m-20 85.55 7.15 0.41 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.831 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.675 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 1.8 m-20 -78.78 -169.52 1.79 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 255' ' ' ASN . 0.5 OUTLIER -160.78 129.51 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 177.488 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.863 ' CG2' HG23 ' A' ' 289' ' ' VAL . 1.0 OUTLIER -106.15 157.05 6.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.809 0.337 . . . . 0.0 111.394 179.762 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.531 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.7 m -145.98 116.71 7.66 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 177.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.66 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -110.65 45.03 1.18 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.087 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 170.87 -128.81 1.68 Allowed Glycine 0 C--N 1.329 0.174 0 C-N-CA 119.317 -1.42 . . . . 0.0 114.201 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 t -86.49 -48.33 8.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.694 0.283 . . . . 0.0 110.78 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.2 t -146.43 -4.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.816 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 17.0 m -66.92 104.29 1.33 Allowed 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.25 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.749 ' O ' HG22 ' A' ' 187' ' ' ILE . 1.3 ptmt -126.81 135.84 51.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.267 0.556 . . . . 0.0 111.581 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.863 HG23 ' CG2' ' A' ' 281' ' ' ILE . 0.1 OUTLIER -111.92 135.18 52.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.093 -178.927 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 4.6 t80 -76.89 138.84 39.99 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.049 -179.438 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.401 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -109.91 112.09 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.753 -178.545 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 183' ' ' PHE . 0.0 OUTLIER -137.34 145.55 43.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.88 179.866 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.679 HG12 HD13 ' A' ' 182' ' ' LEU . 1.3 mt -135.82 145.79 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.634 -179.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.01 139.68 18.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.988 0.423 . . . . 0.0 111.494 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.51 165.97 22.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.975 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.941 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 51.6 tp60 -95.7 159.61 14.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.984 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -83.53 86.34 7.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.059 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -179.963 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.511 ' HA ' HG23 ' A' ' 201' ' ' THR . 2.9 mp . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.762 0.315 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.586 ' N ' HG21 ' A' ' 201' ' ' THR . . . 115.61 103.09 2.39 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.843 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 39.4 t -179.29 -76.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.974 0.416 . . . . 0.0 109.892 179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.591 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 3.1 m -139.23 174.92 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.727 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 7.1 m95 -140.06 130.41 25.32 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.945 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.5 OUTLIER -119.87 131.51 55.28 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.151 177.719 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.945 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.4 OUTLIER -135.92 145.68 46.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.891 0.853 . . . . 0.0 111.263 -179.858 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.675 HD21 ' HB3' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -144.14 149.8 37.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.837 178.588 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 1.3 tt0 -137.03 124.82 22.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.019 -177.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.911 HG21 HD11 ' A' ' 220' ' ' LEU . 40.1 t -64.21 116.3 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.922 HG22 ' O ' ' A' ' 288' ' ' LYS . 8.7 tt -99.94 -23.3 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -175.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.88 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -155.42 91.21 1.3 Allowed 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.494 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.559 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.27 -177.11 35.94 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.542 ' HG3' ' HB3' ' A' ' 222' ' ' ASP . 74.0 Cg_endo -77.98 31.79 0.44 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.08 1.853 . . . . 0.0 111.788 178.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.829 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -161.64 21.52 0.12 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.794 178.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.559 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.7 mt -39.63 113.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.371 . . . . 0.0 111.656 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 131.7 7.96 2.9 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.901 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.829 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.6 OUTLIER -99.34 109.19 21.83 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.814 0.816 . . . . 0.0 109.749 178.771 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.453 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 16.4 mt-30 -111.39 153.79 25.55 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.727 -179.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.675 ' HB3' HD21 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -146.43 146.41 30.58 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.88 179.921 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.31 153.4 40.5 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.769 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.785 HG21 ' HG ' ' A' ' 206' ' ' LEU . 14.8 p -155.35 146.48 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.349 0.595 . . . . 0.0 111.82 179.594 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.591 ' HA ' ' O ' ' A' ' 180' ' ' SER . 0.8 OUTLIER -85.06 145.81 27.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.546 178.128 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.445 ' HB2' ' CZ2' ' A' ' 234' ' ' TRP . 5.7 t -63.15 -6.97 4.82 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.11 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.586 HG21 ' N ' ' A' ' 178' ' ' GLY . 3.7 t -101.95 42.84 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.302 0.572 . . . . 0.0 111.323 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.461 ' HB2' ' CG ' ' A' ' 205' ' ' LYS . 6.3 p -135.0 106.27 6.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.523 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.7 m -76.02 -87.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.83 5.32 7.98 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -178.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.461 ' CG ' ' HB2' ' A' ' 202' ' ' SER . 2.4 pttt -122.48 56.27 1.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.89 HD11 ' CE3' ' A' ' 234' ' ' TRP . 7.9 tt -146.34 -53.84 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -177.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.975 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 3.4 Cg_exo -40.59 96.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.374 2.049 . . . . 0.0 113.076 -177.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 231' ' ' GLN . 61.7 t -74.96 97.83 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.337 0.062 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.167 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.729 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 6.0 mtmm -69.69 93.41 0.72 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.108 HD23 HD12 ' A' ' 218' ' ' LEU . 0.7 OUTLIER -78.53 129.55 34.97 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.611 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 179.55 -177.27 48.16 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.097 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.909 ' HB2' HG12 ' A' ' 225' ' ' VAL . 55.5 ttt180 -82.4 -68.66 0.68 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.094 0.558 . . . . 0.0 112.448 -178.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.864 HG22 ' H ' ' A' ' 214' ' ' SER . 9.6 p -116.9 -151.7 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.099 -179.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.864 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.5 OUTLIER 66.37 173.31 0.08 OUTLIER Pre-proline 0 C--O 1.231 0.118 0 O-C-N 122.125 -0.36 . . . . 0.0 110.264 -179.806 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 214' ' ' SER . 72.0 Cg_endo -74.27 40.63 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.475 2.116 . . . . 0.0 113.336 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 209' ' ' LYS . 0.6 OUTLIER -71.56 168.01 18.53 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.616 0.246 . . . . 0.0 110.347 179.365 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.489 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 1.8 m-20 -85.02 -34.36 22.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.371 . . . . 0.0 110.605 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.108 HD12 HD23 ' A' ' 210' ' ' LEU . 1.8 mt -101.83 127.68 48.53 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.652 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -97.36 82.11 3.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.935 0.398 . . . . 0.0 110.992 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.911 HD11 HG21 ' A' ' 186' ' ' VAL . 2.5 mm? -105.97 73.36 0.99 Allowed 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 177.184 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.28 60.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.623 ' N ' ' HG3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -107.26 127.79 53.85 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.961 0.41 . . . . 0.0 110.188 178.615 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.3 p -48.24 -24.62 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.454 0.645 . . . . 0.0 111.58 178.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.914 ' O ' HG23 ' A' ' 225' ' ' VAL . 0.2 OUTLIER -109.92 73.2 0.83 Allowed 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.215 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.914 HG23 ' O ' ' A' ' 224' ' ' GLU . 1.9 t 169.72 3.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 CA-C-N 113.08 -1.873 . . . . 0.0 108.626 179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.886 ' O ' ' HB3' ' A' ' 212' ' ' ARG . 0.3 OUTLIER -7.23 -116.47 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.628 1.571 . . . . 0.0 114.635 -179.297 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.518 ' H ' ' HB3' ' A' ' 226' ' ' SER . . . -52.49 -89.54 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.736 -1.221 . . . . 0.0 112.029 -178.198 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.644 ' O ' ' O ' ' A' ' 246' ' ' MET . 6.5 mttm -146.96 138.76 24.38 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.07 0.462 . . . . 0.0 109.95 179.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.602 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.1 OUTLIER -96.21 -59.94 1.73 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.58 -179.626 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -149.19 177.66 9.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.621 0.724 . . . . 0.0 112.474 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.729 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 3.8 pt20 -159.36 172.8 17.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.422 179.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.975 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 4.9 mt -126.77 143.82 38.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.42 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.308 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.485 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -145.5 162.53 37.17 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.721 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.89 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.6 OUTLIER -92.33 152.84 19.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.471 -177.05 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 239' ' ' PHE . 0.1 OUTLIER -119.29 71.33 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 175.16 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 17.8 p -54.61 -23.97 19.29 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -176.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.8 m -74.77 -22.15 58.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.556 0.693 . . . . 0.0 109.343 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 240' ' ' LYS . 22.5 tptt -122.98 8.95 9.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.4 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.522 ' N ' ' O ' ' A' ' 235' ' ' ASN . 8.0 p90 39.92 42.93 1.15 Allowed 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.332 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' A' ' 238' ' ' LYS . 0.0 OUTLIER -120.42 -179.02 3.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.489 0.662 . . . . 0.0 110.58 -179.643 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 1.039 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -131.86 119.82 21.72 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.783 -179.309 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 6.0 pt-20 -139.84 152.36 46.43 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.776 0.798 . . . . 0.0 113.099 -178.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.8 pp -111.16 153.29 25.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.775 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.796 HG11 ' NE1' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -123.14 162.34 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.55 -179.432 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.666 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 2.2 t0 -95.4 100.36 12.14 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 120.777 0.322 . . . . 0.0 111.508 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.644 ' O ' ' O ' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -87.09 90.57 8.4 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.041 178.964 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.719 ' HA2' ' HG3' ' A' ' 267' ' ' ARG . . . 48.01 70.67 0.69 Allowed Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.933 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.414 ' OG ' ' CD2' ' A' ' 229' ' ' HIS . 3.2 t -95.6 78.23 3.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -178.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.578 HD13 ' C ' ' A' ' 249' ' ' LEU . 1.6 tm? -52.75 -58.85 5.53 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.142 0.496 . . . . 0.0 109.776 177.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.568 ' N ' HD13 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -68.33 -29.25 67.95 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.92 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.498 ' O ' ' CD2' ' A' ' 229' ' ' HIS . . . 101.32 156.43 26.89 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.726 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.551 ' C ' HD23 ' A' ' 253' ' ' LEU . 46.7 m -124.86 155.18 39.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.819 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -150.06 145.6 26.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.036 0.446 . . . . 0.0 111.558 179.621 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.858 HG23 ' CD1' ' A' ' 259' ' ' ILE . 75.2 t -116.9 138.3 47.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.095 178.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.483 ' HA ' HG13 ' A' ' 280' ' ' ILE . 3.8 p-10 49.0 37.08 9.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.211 0.529 . . . . 0.0 110.471 -178.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.06 36.85 1.33 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.127 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.708 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.1 OUTLIER -146.45 116.8 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.075 -179.916 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 51.7 p -62.09 90.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.298 0.571 . . . . 0.0 110.746 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.861 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.1 OUTLIER -92.98 -11.79 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.352 -177.758 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.793 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 0.2 OUTLIER -122.01 -19.44 6.64 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -176.509 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.668 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 14.6 t-80 -110.7 42.59 0.2 Allowed Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.793 ' HD3' ' C ' ' A' ' 260' ' ' SER . 23.2 Cg_exo -65.86 -27.61 51.29 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 121.887 1.725 . . . . 0.0 113.546 -178.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -119.73 95.78 4.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.804 0.335 . . . . 0.0 111.052 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.731 ' H ' HD23 ' A' ' 264' ' ' LEU . 0.6 OUTLIER -61.7 173.65 0.95 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.757 179.001 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 64.41 -19.44 0.1 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.369 -0.919 . . . . 0.0 112.494 -179.048 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.604 ' H ' ' C ' ' A' ' 264' ' ' LEU . 0.5 OUTLIER -80.2 -35.13 36.76 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 122.806 0.442 . . . . 0.0 111.703 -179.738 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.719 ' HG3' ' HA2' ' A' ' 247' ' ' GLY . 0.0 OUTLIER 44.77 21.95 0.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.38 -179.331 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -62.94 165.83 6.39 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 123.715 0.806 . . . . 0.0 112.392 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.796 ' NE1' HG11 ' A' ' 244' ' ' VAL . 30.9 t-105 -77.34 -24.81 50.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.354 178.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 63.02 -179.01 5.66 Favored Glycine 0 C--N 1.33 0.239 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.322 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -107.82 134.15 20.18 Favored Pre-proline 0 C--N 1.332 -0.17 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.511 179.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.668 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 1.3 Cg_endo -44.93 136.64 9.84 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 123.166 2.577 . . . . 0.0 113.926 -178.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.861 HG21 ' CG1' ' A' ' 259' ' ' ILE . 62.2 t -109.21 129.43 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 4.0 pt-20 -74.31 132.24 41.89 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.417 -178.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.829 HD22 HG11 ' A' ' 291' ' ' VAL . 1.2 mt -89.1 163.22 15.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.973 -178.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -135.81 144.33 45.66 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.729 179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 6.4 m -55.92 131.9 48.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.189 178.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 84.58 1.76 0.82 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.133 -179.26 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.604 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 3.2 t70 -72.96 -166.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 279' ' ' ASP . 0.6 OUTLIER -160.4 133.49 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.896 178.542 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.65 HG12 HG22 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -110.94 156.57 12.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.061 0.458 . . . . 0.0 111.286 179.692 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.605 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 3.0 m -148.89 123.5 9.79 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.752 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -120.95 39.58 3.77 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.457 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -176.1 -136.42 2.35 Favored Glycine 0 C--N 1.328 0.095 0 C-N-CA 119.331 -1.414 . . . . 0.0 113.702 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.644 HG22 ' HG3' ' A' ' 224' ' ' GLU . 14.1 t -87.15 -48.85 7.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.588 0.232 . . . . 0.0 110.695 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.435 ' O ' ' HD2' ' A' ' 288' ' ' LYS . 1.3 t -140.25 2.32 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.319 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 31.7 m -74.93 102.09 4.66 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.69 0.281 . . . . 0.0 110.261 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.922 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -123.51 133.2 54.04 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.31 0.576 . . . . 0.0 110.918 -179.874 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.517 HG23 HG22 ' A' ' 281' ' ' ILE . 1.2 t -107.9 130.61 60.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.372 -178.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.5 t80 -76.15 136.7 39.79 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 121.012 0.434 . . . . 0.0 110.309 -178.189 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.829 HG11 HD22 ' A' ' 275' ' ' LEU . 3.5 t -102.25 107.81 22.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.196 -178.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.32 122.4 37.62 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 1.039 HD12 ' CE3' ' A' ' 241' ' ' TRP . 1.2 mt -132.58 146.51 32.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -177.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.7 t -152.2 166.13 32.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 111.146 -179.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 7.0 m -94.57 159.77 14.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.631 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -113.7 116.05 28.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.926 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -95.5 107.18 19.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.769 HD23 ' ND2' ' A' ' 199' ' ' ASN . 5.2 mp . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.731 0.3 . . . . 0.0 110.527 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.707 ' HA3' ' CG2' ' A' ' 201' ' ' THR . . . 77.09 166.86 26.55 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 121.141 -0.552 . . . . 0.0 113.093 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.659 ' HA ' ' CB ' ' A' ' 296' ' ' GLN . 0.5 OUTLIER -93.92 41.02 1.08 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.147 -0.527 . . . . 0.0 112.196 -179.419 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.5 OUTLIER -146.49 140.69 26.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.068 0.461 . . . . 0.0 110.935 179.761 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 5.3 m95 -146.88 139.45 24.96 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.13 -178.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 197' ' ' ALA . 8.8 tp -116.88 124.53 49.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.634 178.053 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 5.7 m-85 -123.87 131.54 53.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.775 0.798 . . . . 0.0 110.197 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 1.018 HD13 ' CD2' ' A' ' 196' ' ' HIS . 1.0 OUTLIER -131.45 142.69 50.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.331 -179.69 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.584 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 2.9 tt0 -139.39 124.68 19.06 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.873 HG21 HD12 ' A' ' 194' ' ' LEU . 10.5 t -62.95 104.84 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.102 0.477 . . . . 0.0 110.462 178.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.6 tt -87.03 -24.26 6.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 113.124 0.786 . . . . 0.0 113.124 -177.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.738 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -166.64 98.62 0.57 Allowed 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.874 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.714 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.9 -175.04 32.51 Favored Glycine 0 N--CA 1.452 -0.272 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 178.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.563 ' O ' ' HG2' ' A' ' 221' ' ' LYS . 89.1 Cg_endo -77.31 28.71 0.43 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.099 1.866 . . . . 0.0 111.533 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.85 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.15 27.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.714 HG12 ' H ' ' A' ' 189' ' ' GLY . 6.4 mt -39.97 111.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.453 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 132.58 6.56 2.94 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.257 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.873 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -99.51 162.2 13.16 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.883 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.735 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 12.7 mt-30 -156.59 149.67 24.07 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.076 -178.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 1.018 ' CD2' HD13 ' A' ' 184' ' ' LEU . 4.0 p-80 -136.98 129.06 29.46 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.682 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -139.12 164.62 29.3 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.075 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.588 HG21 ' HG ' ' A' ' 206' ' ' LEU . 10.1 p -175.32 155.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 121.56 0.695 . . . . 0.0 112.704 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.769 ' ND2' HD23 ' A' ' 177' ' ' LEU . 4.0 m-80 -90.39 147.8 23.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.832 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.596 ' HA ' ' CE2' ' A' ' 234' ' ' TRP . 65.2 m -56.03 -49.92 72.37 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.107 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.707 ' CG2' ' HA3' ' A' ' 178' ' ' GLY . 0.1 OUTLIER -62.93 5.18 0.14 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.607 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.797 ' HB3' ' HB2' ' A' ' 206' ' ' LEU . 0.3 OUTLIER -87.19 105.14 17.0 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.294 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.445 ' HB3' ' H ' ' A' ' 204' ' ' SER . 1.0 OUTLIER -67.83 -107.48 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.099 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.445 ' H ' ' HB3' ' A' ' 203' ' ' SER . 3.2 m -70.48 6.23 1.48 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.128 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.488 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 8.9 pttt -120.32 55.98 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.212 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.829 HD11 ' CE3' ' A' ' 234' ' ' TRP . 8.0 tt -149.15 -59.87 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.791 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 4.5 Cg_exo -41.09 99.89 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.185 1.923 . . . . 0.0 112.189 -177.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.755 HG11 ' CD2' ' A' ' 196' ' ' HIS . 31.9 t -68.82 166.88 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.015 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.637 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -139.38 92.1 2.55 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.63 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.077 HD23 HD12 ' A' ' 218' ' ' LEU . 0.6 OUTLIER -76.79 125.24 28.95 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.324 178.895 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -166.22 168.59 39.97 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.64 -179.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.996 ' HB2' HG13 ' A' ' 225' ' ' VAL . 1.5 ttt85 -60.72 -78.72 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.619 HG12 ' HD3' ' A' ' 212' ' ' ARG . 12.4 p -133.42 -12.4 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.98 0.419 . . . . 0.0 111.735 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.639 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 1.4 m -49.85 176.5 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.732 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.639 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 28.4 Cg_endo -62.03 18.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.134 1.89 . . . . 0.0 112.667 179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.57 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.6 OUTLIER -58.59 -178.99 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 111.31 179.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -96.57 -31.55 12.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.138 179.238 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.077 HD12 HD23 ' A' ' 210' ' ' LEU . 1.4 mt -104.66 131.42 52.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.619 178.609 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -98.09 82.5 2.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.596 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.831 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.3 mm? -102.2 86.37 2.83 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 190' ' ' PRO . 0.0 OUTLIER -60.07 67.83 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.856 179.865 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.921 ' HB3' HG12 ' A' ' 225' ' ' VAL . 5.3 t0 -97.77 151.17 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.232 179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.5 p -90.38 -9.79 46.31 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.541 -0.464 . . . . 0.0 111.194 178.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.64 -20.64 24.67 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.427 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.996 HG13 ' HB2' ' A' ' 212' ' ' ARG . 3.6 p -107.26 86.76 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.4 m -37.62 -42.23 0.53 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.413 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.33 -55.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 179.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 246' ' ' MET . 0.9 OUTLIER -140.42 133.37 29.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.996 0.427 . . . . 0.0 109.93 179.122 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.6 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 1.9 t60 -98.27 -54.21 3.12 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.281 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.415 ' C ' HD12 ' A' ' 210' ' ' LEU . . . -146.56 177.24 9.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 112.212 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.728 ' NE2' HG12 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -163.72 175.8 10.19 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.475 -179.822 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.791 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 6.9 mt -132.8 148.96 31.47 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.757 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 207' ' ' PRO . 0.1 OUTLIER -149.8 164.65 34.75 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.56 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.829 ' CE3' HD11 ' A' ' 206' ' ' LEU . 0.4 OUTLIER -110.55 112.96 25.22 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.285 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.37 82.89 4.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.6 t -61.65 -9.2 5.63 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -176.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 55.2 m -74.7 -32.98 62.33 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.17 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.58 ' HG2' ' HG2' ' A' ' 240' ' ' LYS . 5.4 tptm -110.54 0.22 17.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.901 -1.499 . . . . 0.0 109.245 177.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.405 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 17.4 p90 41.32 47.86 3.1 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.087 0.47 . . . . 0.0 110.272 179.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.617 ' HE2' ' HG2' ' A' ' 242' ' ' GLU . 0.0 OUTLIER -119.88 170.34 9.33 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.574 -179.915 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 1.004 ' CZ3' HG23 ' A' ' 293' ' ' ILE . 1.3 m0 -119.4 108.58 14.75 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.617 ' HG2' ' HE2' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -133.89 147.65 51.16 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.744 ' O ' HD12 ' A' ' 243' ' ' LEU . 3.4 pp -111.92 152.16 28.35 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.357 -1.747 . . . . 0.0 110.59 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.834 HG21 ' CD1' ' A' ' 269' ' ' TRP . 1.2 p -117.99 162.92 15.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.558 0.218 . . . . 0.0 110.527 179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 269' ' ' TRP . 0.3 OUTLIER -103.18 111.25 23.53 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -177.983 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.606 ' HG2' ' CH2' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -79.36 95.72 5.8 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.692 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 58.73 64.0 4.7 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.023 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 21.8 p -64.59 50.34 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -177.321 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.877 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -55.56 -50.74 69.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.872 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.877 ' H ' HD13 ' A' ' 249' ' ' LEU . 5.1 t30 -77.72 -37.15 50.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.469 -179.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 90.1 85.91 1.35 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.218 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.548 ' N ' ' HB3' ' A' ' 260' ' ' SER . 0.5 OUTLIER -45.69 166.56 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 119.87 -0.11 . . . . 0.0 110.789 179.137 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 281' ' ' ILE . 0.2 OUTLIER -150.83 127.23 10.69 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 179.089 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.771 HG22 HG13 ' A' ' 281' ' ' ILE . 99.5 t -107.39 131.32 57.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.646 178.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 57.57 40.15 27.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.232 0.539 . . . . 0.0 109.852 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 7.9 p 61.53 24.78 14.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.445 -179.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.42 97.64 4.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.604 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 0.2 OUTLIER -46.4 93.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.6 -179.605 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.83 ' HB ' HG21 ' A' ' 273' ' ' VAL . 0.0 OUTLIER -94.87 6.23 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.452 -178.855 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.548 ' HB3' ' N ' ' A' ' 252' ' ' THR . 2.0 t -99.23 -19.52 17.07 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.159 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.666 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 0.6 OUTLIER -106.78 21.43 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 179.828 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.666 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 50.9 Cg_exo -51.27 -43.35 49.58 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.184 1.256 . . . . 0.0 109.622 178.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 266' ' ' SER . 33.1 p30 -75.87 81.71 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 112.296 -2.229 . . . . 0.0 110.924 -179.148 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.719 ' H ' HD23 ' A' ' 264' ' ' LEU . 1.5 pt? -54.92 134.04 48.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.616 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 78.73 -4.49 60.58 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.033 -0.603 . . . . 0.0 113.647 179.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 263' ' ' ASP . 3.6 m -83.06 -63.04 1.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.049 0.424 . . . . 0.0 111.682 -179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.39 -12.79 0.33 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 266' ' ' SER . 3.5 ttmm -80.52 -130.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -175.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.834 ' CD1' HG21 ' A' ' 244' ' ' VAL . 1.8 t-105 -80.7 -30.89 36.31 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.17 -171.55 7.8 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.204 -0.998 . . . . 0.0 111.14 -179.079 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -106.5 134.9 19.6 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 117.65 0.725 . . . . 0.0 111.158 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 84.2 Cg_exo -43.03 124.11 3.52 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.214 2.61 . . . . 0.0 113.74 -178.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.83 HG21 ' HB ' ' A' ' 259' ' ' ILE . 87.9 t -99.27 139.28 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.616 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.4 OUTLIER -86.45 131.05 34.29 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 119.099 -1.041 . . . . 0.0 111.979 -178.954 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.948 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -96.59 163.91 12.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.496 -179.795 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.657 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.5 158.48 43.8 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 8.5 t -61.55 131.44 50.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.803 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.61 ' HB2' ' O ' ' A' ' 277' ' ' SER . 2.7 m-20 85.4 -1.94 0.82 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.18 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.657 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -71.34 -166.78 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.44 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.59 HG23 ' HD1' ' A' ' 290' ' ' TYR . 0.8 OUTLIER -161.37 128.19 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.729 -0.214 . . . . 0.0 110.454 177.299 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.771 HG13 HG22 ' A' ' 254' ' ' VAL . 1.0 OUTLIER -108.74 155.13 9.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.706 179.23 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.629 ' OG1' ' HG3' ' A' ' 288' ' ' LYS . 0.2 OUTLIER -142.2 121.82 13.37 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.551 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.72 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -113.71 45.18 1.48 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.145 -178.008 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 170.26 -123.13 1.03 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 119.2 -1.476 . . . . 0.0 114.114 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.0 t -91.59 -54.8 3.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.828 -0.186 . . . . 0.0 111.273 -179.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.573 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -139.94 -3.17 1.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.471 -179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 26.9 m -67.57 103.0 1.25 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 117.853 0.297 . . . . 0.0 110.58 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.662 ' O ' HG22 ' A' ' 187' ' ' ILE . 7.9 ttmt -118.39 130.98 56.29 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -178.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.672 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -113.43 133.02 60.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.653 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.59 ' HD1' HG23 ' A' ' 280' ' ' ILE . 4.4 t80 -76.34 136.16 39.54 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.014 0.435 . . . . 0.0 110.031 -178.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.948 HG11 ' HB2' ' A' ' 275' ' ' LEU . 1.0 OUTLIER -103.46 110.68 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.404 -179.107 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.19 135.24 55.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.508 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 1.004 HG23 ' CZ3' ' A' ' 241' ' ' TRP . 16.0 mt -131.41 133.51 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.867 -179.652 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 43.3 m -156.58 159.98 39.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.836 0.35 . . . . 0.0 110.798 179.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 52.1 m -86.97 177.54 7.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.845 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.659 ' CB ' ' HA ' ' A' ' 179' ' ' SER . 0.0 OUTLIER -81.27 126.27 31.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.898 -179.653 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -148.42 86.38 1.54 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.683 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 -179.912 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.821 ' C ' HG21 ' A' ' 201' ' ' THR . 1.2 mt . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.067 0.46 . . . . 0.0 111.748 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.564 ' N ' HG21 ' A' ' 201' ' ' THR . . . 64.24 -123.61 28.14 Favored Glycine 0 C--N 1.335 0.507 0 CA-C-N 115.725 -0.67 . . . . 0.0 114.747 177.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.507 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 0.1 OUTLIER -179.02 48.03 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.804 -0.698 . . . . 0.0 111.273 -178.675 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 13.4 t -159.56 156.78 28.66 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.789 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 15.8 m95 -150.48 146.71 26.8 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -177.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.896 HD11 ' CD2' ' A' ' 184' ' ' LEU . 0.8 OUTLIER -122.26 134.54 54.68 Favored 'General case' 0 C--O 1.22 -0.491 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.841 ' N ' HD12 ' A' ' 182' ' ' LEU . 13.3 m-85 -130.25 136.86 49.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.67 0.747 . . . . 0.0 110.466 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.896 ' CD2' HD11 ' A' ' 182' ' ' LEU . 2.4 mm? -123.4 138.91 54.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.049 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -134.55 117.15 15.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -178.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.796 HG21 HD12 ' A' ' 194' ' ' LEU . 27.0 t -65.59 118.2 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.001 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.768 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.2 tt -98.04 -26.89 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -176.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.883 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -158.01 94.34 1.31 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.677 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.76 -174.58 31.81 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 178.255 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.462 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 85.2 Cg_endo -80.6 32.09 0.5 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.02 1.813 . . . . 0.0 110.785 178.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.796 ' HB1' HD21 ' A' ' 194' ' ' LEU . . . -161.26 21.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.749 179.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.677 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.1 mt -38.99 113.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.797 0.332 . . . . 0.0 111.612 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 128.95 5.9 4.66 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.76 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.796 HD12 HG21 ' A' ' 186' ' ' VAL . 0.2 OUTLIER -93.29 139.87 30.16 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.111 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 12.4 mt-30 -133.26 143.55 49.17 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.662 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.886 ' CG ' HG11 ' A' ' 208' ' ' VAL . 0.0 OUTLIER -134.83 128.55 32.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.772 -179.537 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -140.82 162.81 34.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.773 -179.195 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.708 HG21 ' HA ' ' A' ' 206' ' ' LEU . 12.3 p -173.3 153.03 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.413 178.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.588 ' HB2' HG22 ' A' ' 201' ' ' THR . 0.3 OUTLIER -90.74 145.59 24.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.919 179.52 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.939 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 0.1 OUTLIER -62.59 -2.2 1.03 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.203 179.517 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.821 HG21 ' C ' ' A' ' 177' ' ' LEU . 1.2 t -101.63 13.74 34.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.827 0.346 . . . . 0.0 110.8 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.514 ' CB ' ' HG2' ' A' ' 205' ' ' LYS . 0.6 OUTLIER -103.96 117.34 34.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.166 179.761 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 1.4 m -76.92 -84.29 0.07 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -178.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.9 t -90.4 15.71 10.14 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.514 ' HG2' ' CB ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -115.46 -10.4 11.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.731 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.912 HD13 ' HD3' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -90.09 -18.89 0.23 Allowed Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -179.747 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.912 ' HD3' HD13 ' A' ' 206' ' ' LEU . 30.1 Cg_endo -65.43 84.44 0.21 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 CA-C-N 120.905 1.359 . . . . 0.0 111.468 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.886 HG11 ' CG ' ' A' ' 196' ' ' HIS . 47.1 t -70.56 108.15 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.148 -178.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.742 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -79.98 84.5 5.72 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.603 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.72 ' HB2' ' O ' ' A' ' 230' ' ' ALA . 4.7 mp -74.93 136.01 41.4 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 118.742 0.701 . . . . 0.0 109.325 178.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.672 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . 178.38 -177.02 48.33 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.773 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 1.068 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -71.52 -74.75 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.092 -0.554 . . . . 0.0 111.638 -179.536 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.848 HG22 ' H ' ' A' ' 214' ' ' SER . 7.6 p -117.0 -145.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.88 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.848 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.6 OUTLIER 61.0 -179.38 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.178 0 O-C-N 121.98 -0.45 . . . . 0.0 109.905 -179.578 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 214' ' ' SER . 21.5 Cg_exo -66.4 24.2 0.1 OUTLIER 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.646 2.231 . . . . 0.0 113.765 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.558 ' HA ' ' HG3' ' A' ' 209' ' ' LYS . 68.2 m -53.0 152.05 4.31 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-O 120.617 0.246 . . . . 0.0 110.848 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.53 ' HB3' HG13 ' A' ' 208' ' ' VAL . 0.6 OUTLIER -84.14 -29.25 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.379 179.742 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.67 ' HB3' HD21 ' A' ' 220' ' ' LEU . 36.1 mt -115.65 132.53 56.6 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.136 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -87.96 81.65 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.682 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.672 ' N ' HD22 ' A' ' 220' ' ' LEU . 1.8 mm? -100.3 64.09 1.16 Allowed 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.559 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -60.78 35.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -177.097 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 224' ' ' GLU . 3.1 t70 -87.94 125.44 34.51 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 76.8 p -39.73 -30.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 222' ' ' ASP . 9.8 pt-20 -51.88 -42.23 62.53 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.989 0.424 . . . . 0.0 110.838 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.068 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.7 p -96.87 106.17 18.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.835 179.017 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.5 t -47.22 -68.56 0.18 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.018 0.437 . . . . 0.0 110.452 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -128.32 -45.1 0.2 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 178.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.672 ' HA ' ' HA3' ' A' ' 211' ' ' GLY . 0.4 OUTLIER -143.45 127.65 17.64 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.087 -0.557 . . . . 0.0 109.555 178.953 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.832 ' CE1' ' HB3' ' A' ' 248' ' ' SER . 1.2 t60 -92.12 -55.19 3.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.534 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.72 ' O ' ' HB2' ' A' ' 210' ' ' LEU . . . -155.35 150.76 27.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.742 ' HB3' ' HA ' ' A' ' 209' ' ' LYS . 0.1 OUTLIER -131.88 179.87 5.82 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.979 179.428 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.866 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.0 mt -126.93 139.4 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.847 179.157 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.747 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -159.83 129.98 5.52 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.383 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.939 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 5.4 p90 -111.61 151.6 28.58 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 115.656 1.725 . . . . 0.0 115.656 -175.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 239' ' ' PHE . 1.5 t-20 -73.32 126.8 30.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 112.493 -2.14 . . . . 0.0 111.007 177.69 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.5 t -89.19 -29.73 19.08 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 2.0 m -77.95 -30.95 50.63 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.699 178.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.446 ' O ' ' CG ' ' A' ' 239' ' ' PHE . 1.5 tptm -108.23 -2.32 19.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.598 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 235' ' ' ASN . 27.9 p90 43.44 42.39 3.81 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 178.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -122.37 140.35 52.78 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.579 0.704 . . . . 0.0 110.382 178.507 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.843 ' HA ' ' HB3' ' A' ' 234' ' ' TRP . 2.9 m95 -89.45 121.96 32.18 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.634 -1.167 . . . . 0.0 110.078 -179.393 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 3.0 mt-10 -140.51 151.18 44.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.004 0.907 . . . . 0.0 113.196 -178.258 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.612 ' CD2' HD12 ' A' ' 281' ' ' ILE . 3.8 pp -117.36 156.51 27.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.125 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.614 HG11 ' HE1' ' A' ' 269' ' ' TRP . 1.3 p -128.91 162.92 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.719 0.295 . . . . 0.0 111.746 -178.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 269' ' ' TRP . 0.4 OUTLIER -92.17 156.43 17.34 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.438 0.637 . . . . 0.0 111.367 179.481 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.694 ' O ' ' N ' ' A' ' 248' ' ' SER . 0.0 OUTLIER -127.86 87.8 2.67 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.768 179.174 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 267' ' ' ARG . . . 55.29 -46.83 0.01 OUTLIER Glycine 0 C--N 1.341 0.818 0 CA-C-O 121.402 0.446 . . . . 0.0 113.948 179.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.832 ' HB3' ' CE1' ' A' ' 229' ' ' HIS . 4.1 m -38.81 85.26 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.599 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.65 ' O ' ' HG ' ' A' ' 249' ' ' LEU . 8.7 tp -55.5 2.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 -178.49 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.587 ' HB2' ' CE1' ' A' ' 229' ' ' HIS . 3.8 m120 -71.67 15.92 0.13 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.568 1.531 . . . . 0.0 111.511 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 249' ' ' LEU . . . 42.49 84.64 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.111 179.606 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.473 ' C ' HD23 ' A' ' 253' ' ' LEU . 1.0 OUTLIER -47.43 156.45 0.27 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.714 0.257 . . . . 0.0 110.593 179.406 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.612 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -144.8 128.94 17.66 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.05 0.453 . . . . 0.0 111.384 178.729 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.946 HG23 HD12 ' A' ' 259' ' ' ILE . 85.2 t -104.77 132.06 52.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.681 178.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 52.13 41.63 30.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.134 0.492 . . . . 0.0 110.15 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.62 24.49 11.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.969 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 254' ' ' VAL . 9.6 m80 -127.39 108.71 11.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.037 179.39 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 3.3 t -58.56 97.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.148 0.499 . . . . 0.0 111.558 -179.292 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.946 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -78.66 -54.74 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.717 -179.171 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.542 ' N ' HG12 ' A' ' 259' ' ' ILE . 6.9 p -51.43 165.99 0.14 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.441 ' O ' ' CG ' ' A' ' 261' ' ' HIS . 23.1 p-80 -57.48 109.54 1.84 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 118.591 0.632 . . . . 0.0 112.059 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 261' ' ' HIS . 6.8 Cg_exo -75.24 21.68 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.039 2.493 . . . . 0.0 111.781 178.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 261' ' ' HIS . 2.1 m-20 -100.17 117.74 35.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.63 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.536 ' HA ' HD11 ' A' ' 249' ' ' LEU . 3.8 mm? -69.12 155.93 39.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.285 -179.114 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 71.71 -10.96 3.62 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.927 179.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 268' ' ' LYS . 0.4 OUTLIER -80.48 -30.92 37.4 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.944 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 247' ' ' GLY . 0.0 OUTLIER 42.58 17.78 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.45 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 266' ' ' SER . 6.9 tptt -53.4 153.21 4.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.229 0.538 . . . . 0.0 110.993 -178.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.614 ' HE1' HG11 ' A' ' 244' ' ' VAL . 18.6 t-105 -67.72 -27.91 67.21 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.068 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.65 154.44 18.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.98 179.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -91.45 150.74 41.77 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.599 0.238 . . . . 0.0 110.624 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.39 144.54 31.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.36 2.04 . . . . 0.0 112.076 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.795 HG11 HG21 ' A' ' 259' ' ' ILE . 92.8 t -132.15 131.87 61.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.163 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.7 pm0 -80.74 132.87 35.58 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.009 -1.076 . . . . 0.0 112.229 -178.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 1.031 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -96.82 165.13 12.26 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.526 -179.74 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -141.6 162.14 36.21 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -178.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.656 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 20.3 p -69.97 132.84 46.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.253 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 277' ' ' SER . 42.7 m-20 82.98 -8.51 1.15 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.975 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.3 OUTLIER -62.1 -168.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.193 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.51 ' CG2' ' HD1' ' A' ' 290' ' ' TYR . 0.6 OUTLIER -161.11 120.96 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.406 178.341 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.871 HG13 HG22 ' A' ' 254' ' ' VAL . 0.4 OUTLIER -105.08 157.66 5.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.072 179.742 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.661 HG23 ' CG ' ' A' ' 288' ' ' LYS . 1.7 m -143.02 120.7 11.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.661 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -117.7 47.1 1.61 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.298 -178.449 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 175.2 -137.13 3.68 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 119.418 -1.373 . . . . 0.0 113.044 -179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 12.1 t -90.01 -36.32 15.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.836 0.351 . . . . 0.0 110.598 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.1 t -151.92 0.91 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.883 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 24.5 m -75.65 105.22 6.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.62 179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.768 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.1 mtpt -122.99 127.51 48.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.908 0.385 . . . . 0.0 111.246 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.491 HG13 ' HA ' ' A' ' 186' ' ' VAL . 0.2 OUTLIER -107.69 133.59 52.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.537 -178.717 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.675 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.0 t80 -77.38 131.16 37.91 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.897 0.379 . . . . 0.0 110.098 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 1.031 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -103.05 117.87 49.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.304 -178.906 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.656 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -137.6 141.66 41.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.033 -179.822 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.739 HD11 HD23 ' A' ' 275' ' ' LEU . 6.2 mt -136.27 133.0 49.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.735 179.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 22.7 t -133.18 158.78 41.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.963 0.411 . . . . 0.0 111.264 -179.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.7 150.34 21.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.654 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 9.1 tp-100 -109.7 139.16 45.07 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.705 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -86.05 104.44 15.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.381 -179.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.899 179.599 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.577 ' HB3' ' OG1' ' A' ' 201' ' ' THR . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.657 0 CA-C-O 120.798 0.332 . . . . 0.0 111.517 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.419 ' O ' ' CG2' ' A' ' 201' ' ' THR . . . 117.08 103.27 2.27 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 -179.193 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 2.1 t -70.87 101.31 2.11 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 1.5 m -145.93 164.6 31.51 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 176.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.575 ' CB ' ' CZ ' ' A' ' 183' ' ' PHE . 90.8 m95 -156.97 146.78 20.74 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.771 HD11 ' CD1' ' A' ' 184' ' ' LEU . 0.2 OUTLIER -122.8 106.45 10.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 113.64 -1.618 . . . . 0.0 106.797 176.155 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.575 ' CZ ' ' CB ' ' A' ' 181' ' ' TRP . 1.8 m-85 -105.83 138.53 41.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.936 0.874 . . . . 0.0 113.007 -177.685 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.913 ' N ' HD22 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -135.63 146.57 48.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.067 177.406 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.488 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 1.6 tt0 -140.9 127.4 20.02 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -176.841 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.972 HG21 HD11 ' A' ' 220' ' ' LEU . 10.7 t -62.14 116.51 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.173 178.363 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.811 HG22 ' O ' ' A' ' 288' ' ' LYS . 6.1 tt -97.22 -22.47 4.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.748 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -163.28 91.21 0.69 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.672 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.84 -177.64 35.08 Favored Glycine 0 C--O 1.228 -0.224 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 178.161 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.52 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 84.4 Cg_endo -76.99 32.72 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 121.907 1.738 . . . . 0.0 111.802 178.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.9 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -161.47 28.74 0.13 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.797 178.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.672 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -47.74 111.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.379 179.491 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.94 10.06 2.94 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.683 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.9 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.4 OUTLIER -101.39 105.38 16.41 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.983 0.897 . . . . 0.0 109.944 178.837 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.488 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 8.5 mt-30 -105.83 156.19 18.57 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.715 -179.419 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.871 ' ND1' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -149.44 147.2 27.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.299 179.716 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.457 ' HB2' ' HD2' ' A' ' 183' ' ' PHE . . . -149.02 158.29 44.07 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.587 -179.751 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.74 HG21 ' HA ' ' A' ' 206' ' ' LEU . 9.8 p -159.96 148.57 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.655 178.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 180' ' ' SER . 2.1 m120 -85.49 140.72 30.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.863 179.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.954 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 9.8 m -56.71 -10.93 1.14 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.635 179.285 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 177' ' ' LEU . 4.2 t -97.14 9.07 43.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.797 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.89 ' O ' HD12 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -96.53 103.14 15.03 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.932 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.413 ' O ' ' CD1' ' A' ' 206' ' ' LEU . 1.9 m -62.98 -89.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.62 13.25 7.25 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.981 -0.449 . . . . 0.0 111.642 -179.098 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.667 ' HG2' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -111.51 -2.61 15.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.645 -179.447 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 1.058 HD13 ' HD3' ' A' ' 207' ' ' PRO . 0.0 OUTLIER -100.35 -27.67 0.23 Allowed Pre-proline 0 C--O 1.232 0.15 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 179.867 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 1.058 ' HD3' HD13 ' A' ' 206' ' ' LEU . 9.7 Cg_endo -54.1 100.14 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.867 0 CA-C-N 121.329 1.51 . . . . 0.0 111.11 -179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 59.5 t -68.46 155.22 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.273 -179.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.608 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -135.87 90.48 2.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.202 -179.164 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.067 HD23 HD12 ' A' ' 218' ' ' LEU . 0.9 OUTLIER -81.45 127.77 33.16 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.638 -179.99 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.565 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . -172.56 171.44 44.32 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.066 -179.623 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.986 ' HB2' HG13 ' A' ' 225' ' ' VAL . 5.3 ttm180 -67.04 -74.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.297 0.57 . . . . 0.0 111.774 -179.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.679 HG22 ' H ' ' A' ' 214' ' ' SER . 9.4 p -124.15 -138.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.278 -179.351 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.679 ' H ' HG22 ' A' ' 213' ' ' VAL . 0.7 OUTLIER 59.74 179.26 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 119.131 0.878 . . . . 0.0 109.606 -179.966 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.658 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 38.4 Cg_endo -67.43 25.86 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.039 1.826 . . . . 0.0 113.758 -179.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 214' ' ' SER . 0.5 OUTLIER -58.43 152.7 17.3 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.686 0.279 . . . . 0.0 110.695 179.471 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.474 ' HB2' ' HB2' ' A' ' 209' ' ' LYS . 0.3 OUTLIER -79.94 -32.0 40.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.895 0.379 . . . . 0.0 110.117 179.484 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.067 HD12 HD23 ' A' ' 210' ' ' LEU . 1.2 mt -106.48 129.05 54.51 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.373 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.638 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -92.71 81.47 4.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.791 0.329 . . . . 0.0 111.502 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.972 HD11 HG21 ' A' ' 186' ' ' VAL . 2.5 mm? -108.48 62.22 0.61 Allowed 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.846 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 10.2 pttt -51.91 55.8 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -177.482 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 220' ' ' LEU . 22.1 t0 -100.62 149.64 23.55 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.759 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 29.5 t -64.47 -34.61 78.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.477 -179.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.526 ' O ' HD11 ' A' ' 249' ' ' LEU . 0.0 OUTLIER -48.9 -39.94 27.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.442 -179.591 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.986 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.3 p -103.45 89.26 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.448 179.248 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -34.82 -45.77 0.27 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.705 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.37 -53.57 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.559 ' HB2' ' SD ' ' A' ' 246' ' ' MET . 0.0 OUTLIER -144.71 135.2 24.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.194 0.521 . . . . 0.0 109.667 178.73 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.708 ' CG ' ' HB2' ' A' ' 283' ' ' LEU . 0.8 OUTLIER -104.2 -56.08 2.25 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.284 -179.961 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -141.76 172.42 12.71 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.506 0.669 . . . . 0.0 112.485 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.703 ' HG3' HG12 ' A' ' 244' ' ' VAL . 1.5 pt20 -158.52 173.46 16.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.319 179.648 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 9.8 mt -134.31 151.58 32.37 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.791 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.422 ' HA ' HD21 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -162.01 148.18 13.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.713 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.954 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 2.5 p90 -130.17 163.24 27.09 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -178.369 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.47 123.79 50.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 113.718 -1.583 . . . . 0.0 111.256 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 24.1 t -84.01 -1.77 55.35 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.099 179.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.5 m -80.8 -33.74 34.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.599 0.714 . . . . 0.0 109.984 179.15 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.497 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 19.5 tptm -129.41 16.3 6.02 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.504 -1.225 . . . . 0.0 109.95 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.417 ' O ' ' HD2' ' A' ' 240' ' ' LYS . 9.0 p90 40.05 60.3 1.76 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.476 0.655 . . . . 0.0 109.545 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.597 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.2 OUTLIER -123.81 138.55 54.48 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.364 179.661 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.68 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -117.2 114.77 24.13 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.123 178.761 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 35.3 mt-10 -130.83 141.88 50.36 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.757 0.789 . . . . 0.0 112.373 -177.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.749 HD22 HD12 ' A' ' 281' ' ' ILE . 3.8 pp -108.26 152.6 24.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.125 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.703 HG12 ' HG3' ' A' ' 231' ' ' GLN . 0.7 OUTLIER -123.44 162.24 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.573 -179.404 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.706 ' HB2' ' HB3' ' A' ' 260' ' ' SER . 1.1 m-20 -111.28 101.09 9.6 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.914 178.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.871 ' HB2' ' CZ3' ' A' ' 269' ' ' TRP . 0.0 OUTLIER -84.94 106.5 16.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.971 0.415 . . . . 0.0 109.924 179.347 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.556 ' HA2' ' HG3' ' A' ' 267' ' ' ARG . . . 48.19 67.31 1.65 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.803 -178.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.561 ' O ' ' CE1' ' A' ' 261' ' ' HIS . 0.3 OUTLIER -89.04 74.6 8.08 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.42 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.853 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -51.34 -56.26 14.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.611 179.33 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.853 ' N ' HD22 ' A' ' 249' ' ' LEU . 1.2 t-20 -71.07 -25.96 62.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.167 0.508 . . . . 0.0 110.965 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.589 ' HA2' ' CG ' ' A' ' 261' ' ' HIS . . . 89.49 136.79 6.15 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.483 -0.78 . . . . 0.0 113.753 179.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.59 ' C ' HD23 ' A' ' 253' ' ' LEU . 24.1 m -100.71 155.68 17.76 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.117 179.284 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.666 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.2 OUTLIER -146.57 145.45 30.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.087 0.47 . . . . 0.0 111.615 179.623 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.841 HG23 ' CD1' ' A' ' 259' ' ' ILE . 45.6 t -114.09 131.19 66.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.345 179.026 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.766 HD22 HG12 ' A' ' 254' ' ' VAL . 11.1 p30 51.37 39.68 24.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.517 -178.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 4.4 p 72.17 37.11 1.01 Allowed 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.692 179.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.552 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.5 OUTLIER -148.84 117.0 6.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.069 179.949 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 253' ' ' LEU . 83.8 p -64.68 87.6 0.06 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.504 0.669 . . . . 0.0 110.655 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.927 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -83.89 -17.9 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 114.878 -1.056 . . . . 0.0 113.82 -177.952 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.785 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 20.3 m -120.21 -14.99 8.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -177.388 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.683 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 67.9 t60 -110.41 41.37 0.17 Allowed Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 177.429 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.785 ' HD3' ' C ' ' A' ' 260' ' ' SER . 23.6 Cg_exo -64.92 -4.38 8.7 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.546 1.497 . . . . 0.0 113.273 -179.345 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.472 ' CG ' ' HB2' ' A' ' 266' ' ' SER . 14.8 t0 -138.82 99.79 3.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.283 0.563 . . . . 0.0 111.501 -179.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.651 ' H ' HD23 ' A' ' 264' ' ' LEU . 0.1 OUTLIER -50.58 -79.95 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.494 -178.962 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -46.35 -20.75 0.6 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.818 -0.706 . . . . 0.0 114.001 -178.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.472 ' HB2' ' CG ' ' A' ' 263' ' ' ASP . 0.4 OUTLIER -70.01 -42.44 73.02 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.301 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.556 ' HG3' ' HA2' ' A' ' 247' ' ' GLY . 2.2 ttt180 50.77 24.95 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 110.114 -179.169 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.461 ' HD3' ' H ' ' A' ' 270' ' ' GLY . 0.6 OUTLIER -58.16 156.24 9.98 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.032 -178.838 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.871 ' CZ3' ' HB2' ' A' ' 246' ' ' MET . 46.1 t-105 -70.01 -24.46 63.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.361 179.526 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.461 ' H ' ' HD3' ' A' ' 268' ' ' LYS . . . 70.88 170.74 9.99 Favored Glycine 0 CA--C 1.512 -0.141 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.932 178.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -102.62 146.66 32.78 Favored Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.221 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.695 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 51.3 Cg_exo -54.14 121.75 10.21 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.04 1.827 . . . . 0.0 112.574 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.927 HG21 ' CG1' ' A' ' 259' ' ' ILE . 70.1 t -99.22 133.15 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 0.0 OUTLIER -78.46 123.73 27.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 119.059 -1.056 . . . . 0.0 111.622 -178.89 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.871 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -89.12 165.12 14.7 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.656 179.752 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -144.54 161.57 38.78 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.404 -0.518 . . . . 0.0 112.273 -179.117 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 0.2 OUTLIER -62.3 124.44 20.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.359 179.361 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 277' ' ' SER . 10.1 m-20 88.58 7.71 0.14 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.499 -179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.7 OUTLIER -79.01 -169.33 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.361 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.673 ' HB ' ' HD3' ' A' ' 288' ' ' LYS . 0.9 OUTLIER -160.04 129.37 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.059 178.163 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.905 HG22 HG23 ' A' ' 289' ' ' VAL . 0.8 OUTLIER -109.84 152.31 11.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.669 178.783 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 252' ' ' THR . 0.2 OUTLIER -138.54 126.77 22.86 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.925 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.708 ' HB2' ' CG ' ' A' ' 229' ' ' HIS . 0.0 OUTLIER -120.03 40.56 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.201 -178.794 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 250' ' ' ASN . . . 177.57 -131.3 1.76 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 119.613 -1.279 . . . . 0.0 113.533 179.695 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.1 t -89.28 -43.9 10.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.703 0.287 . . . . 0.0 110.797 -179.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.9 t -146.58 -1.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.439 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.748 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.9 m -68.99 99.9 1.14 Allowed 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.35 179.054 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.811 ' O ' HG22 ' A' ' 187' ' ' ILE . 1.3 ttmt -118.34 131.0 56.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.459 -178.572 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.905 HG23 HG22 ' A' ' 281' ' ' ILE . 0.0 OUTLIER -114.03 132.23 63.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 121.381 -0.128 . . . . 0.0 111.085 -179.486 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.64 ' HD1' HG22 ' A' ' 280' ' ' ILE . 1.1 t80 -77.35 142.22 39.46 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 110.647 -178.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.871 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.2 OUTLIER -110.39 115.97 51.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.631 -179.268 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -138.72 153.21 48.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.085 -179.629 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.459 HD12 ' CZ3' ' A' ' 241' ' ' TRP . 3.8 mt -144.23 120.72 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.345 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.03 158.57 39.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.947 0.403 . . . . 0.0 110.975 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.4 p -101.34 -173.49 2.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.671 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.17 130.62 54.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.841 179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -164.14 95.89 0.78 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.806 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 -179.864 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.736 ' HA ' HG23 ' A' ' 201' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 120.588 0.233 . . . . 0.0 110.452 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.67 60.29 0.35 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.83 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.419 ' HB3' ' OG ' ' A' ' 200' ' ' SER . 1.3 m -128.52 -70.28 0.69 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -136.11 -176.1 4.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.085 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.701 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 23.8 m95 -145.83 131.44 18.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.9 OUTLIER -115.13 124.04 50.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.703 176.551 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.737 ' N ' HD12 ' A' ' 182' ' ' LEU . 7.5 m-85 -124.64 133.82 53.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.39 0.614 . . . . 0.0 110.776 179.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.633 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -139.75 149.35 43.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.9 178.289 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.58 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 13.1 tt0 -141.23 128.4 20.89 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 1.119 HG21 HD12 ' A' ' 194' ' ' LEU . 48.2 t -65.52 112.65 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 176.385 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.722 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.6 tt -97.25 -21.64 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -176.075 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.853 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -157.96 92.38 1.18 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.564 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.676 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.1 -163.69 16.37 Favored Glycine 0 CA--C 1.518 0.273 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.523 ' HD3' ' OD2' ' A' ' 222' ' ' ASP . 91.6 Cg_endo -85.73 28.6 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.96 2.44 . . . . 0.0 110.971 178.277 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.86 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -160.22 23.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.981 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.676 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.6 mt -39.57 109.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 111.675 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 129.32 10.12 3.11 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.902 -1.142 . . . . 0.0 113.438 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 1.119 HD12 HG21 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -96.65 129.12 44.1 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.754 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.58 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 15.8 mt-30 -128.96 151.5 49.61 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.264 -178.367 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.608 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 0.0 OUTLIER -145.14 145.4 31.37 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.18 179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -149.74 154.44 38.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.893 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.806 HG21 ' HA ' ' A' ' 206' ' ' LEU . 7.5 p -164.89 153.7 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 110.818 179.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' A' ' 180' ' ' SER . 4.3 m120 -90.19 149.4 22.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.64 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.514 ' CA ' ' HZ2' ' A' ' 234' ' ' TRP . 49.2 p -65.5 -9.22 24.15 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.691 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.736 HG23 ' HA ' ' A' ' 177' ' ' LEU . 2.3 t -96.64 25.33 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.461 0.648 . . . . 0.0 110.098 178.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.475 ' HB3' ' CG ' ' A' ' 205' ' ' LYS . 35.8 m -104.3 119.14 38.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.432 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 70.2 m -66.71 -84.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.968 -179.122 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 47.7 m -105.12 26.78 8.9 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.475 ' CG ' ' HB3' ' A' ' 202' ' ' SER . 0.0 OUTLIER -117.85 -14.49 10.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.788 0.328 . . . . 0.0 111.141 179.596 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.941 HD22 ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -81.4 -38.03 0.92 Allowed Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.163 -179.527 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.781 ' N ' HD13 ' A' ' 206' ' ' LEU . 9.7 Cg_endo -54.11 102.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 120.875 1.05 . . . . 0.0 111.676 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 40.8 t -68.91 159.32 5.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.206 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 231' ' ' GLN . 41.0 mtmt -140.6 95.62 2.89 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.471 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.934 HD23 HD12 ' A' ' 218' ' ' LEU . 0.4 OUTLIER -83.84 123.94 30.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.382 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.545 ' HA3' ' OG ' ' A' ' 216' ' ' SER . . . -159.55 163.09 33.35 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.195 -179.423 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.797 ' HD2' ' HB ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -60.15 -91.05 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.302 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.434 ' H ' ' HB3' ' A' ' 212' ' ' ARG . 7.5 p -116.37 -15.15 9.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 0.0 110.938 -179.27 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.789 ' HB3' ' HD2' ' A' ' 215' ' ' PRO . 52.9 m -51.78 174.04 0.12 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.783 178.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.789 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 19.3 Cg_endo -58.36 7.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.062 1.841 . . . . 0.0 112.942 179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.545 ' OG ' ' HA3' ' A' ' 211' ' ' GLY . 17.8 m -45.81 157.42 0.11 Allowed 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.949 0.405 . . . . 0.0 111.479 179.648 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.539 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 0.4 OUTLIER -71.06 -32.28 68.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.896 -179.256 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.934 HD12 HD23 ' A' ' 210' ' ' LEU . 12.0 mt -106.52 129.57 54.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.028 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -90.31 85.8 6.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 111.689 -179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.765 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 1.3 mm? -105.28 83.72 2.01 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.19 44.17 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.693 ' CA ' ' HD3' ' A' ' 212' ' ' ARG . 0.7 OUTLIER -76.56 167.34 22.01 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 122.255 -0.278 . . . . 0.0 110.554 179.318 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.4 p -95.27 -0.97 52.4 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 179.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.22 -27.25 13.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.917 0.78 . . . . 0.0 112.763 -176.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.797 ' HB ' ' HD2' ' A' ' 212' ' ' ARG . 32.7 t -92.97 91.3 3.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.055 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -42.98 -41.77 3.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.378 -179.114 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.39 -57.51 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.055 179.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.464 ' HB2' ' HG2' ' A' ' 246' ' ' MET . 8.0 mttt -146.38 130.55 17.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.003 0.43 . . . . 0.0 111.151 179.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.635 ' ND1' HG22 ' A' ' 225' ' ' VAL . 1.4 t60 -90.59 -57.92 2.66 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.458 178.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -147.67 -175.0 4.69 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.661 ' O ' ' HB2' ' A' ' 243' ' ' LEU . 0.0 OUTLIER -163.7 177.53 8.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.396 179.648 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 17.7 mt -137.82 147.53 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 121.301 0.572 . . . . 0.0 112.51 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.48 147.16 13.88 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.131 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.85 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.6 p90 -137.79 165.66 25.9 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -178.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.582 ' HB2' ' HD2' ' A' ' 240' ' ' LYS . 1.4 m-80 -117.57 133.65 55.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.219 -1.355 . . . . 0.0 112.204 -179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.1 m -89.52 4.9 47.74 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.609 179.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.6 m -77.83 -37.5 48.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.821 0.819 . . . . 0.0 109.653 178.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 238' ' ' LYS . 6.1 tptm -126.26 14.98 7.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.261 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 238' ' ' LYS . 18.6 p90 41.68 61.22 1.93 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.933 0.873 . . . . 0.0 108.673 -179.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.85 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -128.5 145.97 50.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.259 -179.855 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.726 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.0 OUTLIER -128.92 125.53 37.74 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.021 -178.914 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 9.5 pt-20 -138.53 146.91 42.5 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.842 0.83 . . . . 0.0 113.116 -178.254 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 243' ' ' LEU . 2.4 pp -112.19 152.11 28.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.773 179.365 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.808 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 7.3 p -117.06 163.82 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 120.42 0.152 . . . . 0.0 110.962 -179.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.48 ' OD2' ' HA3' ' A' ' 270' ' ' GLY . 0.0 OUTLIER -107.33 105.95 16.15 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.52 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.55 ' CE ' ' HA ' ' A' ' 246' ' ' MET . 2.3 tpt -78.43 103.68 8.53 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.129 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 267' ' ' ARG . . . 55.3 65.07 3.81 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.083 -1.056 . . . . 0.0 111.005 -178.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.9 p -68.21 53.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -177.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.792 HD22 ' N ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -57.55 -50.61 72.53 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.297 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.792 ' N ' HD22 ' A' ' 249' ' ' LEU . 6.1 t-20 -79.19 -34.78 42.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.053 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 89.84 102.1 1.11 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.238 179.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.69 HG23 ' HB3' ' A' ' 283' ' ' LEU . 0.5 OUTLIER -56.88 163.99 1.73 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.893 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.735 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.3 OUTLIER -154.31 136.59 14.87 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.424 0.63 . . . . 0.0 112.458 179.99 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 1.015 HG23 HD12 ' A' ' 259' ' ' ILE . 53.3 t -109.15 133.55 53.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.244 178.464 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.52 ' HA ' HG13 ' A' ' 280' ' ' ILE . 14.4 p30 49.56 33.9 6.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.177 0.513 . . . . 0.0 110.695 -179.577 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 4.1 m 76.83 27.79 0.72 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.83 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.489 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.0 OUTLIER -129.65 110.12 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.147 179.494 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 252' ' ' THR . 86.5 p -62.97 84.71 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.171 0.51 . . . . 0.0 111.748 -179.275 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 1.015 HD12 HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -79.82 -8.19 11.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.12 -179.481 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 2.0 m -91.42 -13.71 31.86 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.671 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 2.8 t-160 -105.99 16.57 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -179.82 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.671 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 71.1 Cg_exo -49.51 -44.83 33.47 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.399 1.4 . . . . 0.0 110.338 178.72 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 266' ' ' SER . 29.0 p-10 -76.02 95.4 3.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 113.308 -1.769 . . . . 0.0 111.177 -179.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.09 139.15 52.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.584 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 78.58 -1.64 71.24 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.907 -179.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' A' ' 267' ' ' ARG . 0.4 OUTLIER -82.51 -72.93 0.42 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.957 0.378 . . . . 0.0 110.888 -179.751 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.617 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.0 OUTLIER 73.48 -21.35 0.26 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.307 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.494 ' HD3' ' CB ' ' A' ' 266' ' ' SER . 0.0 OUTLIER -72.94 -132.89 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -176.881 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.808 ' CZ3' HG13 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -76.12 -26.05 55.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.87 -178.159 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.48 ' HA3' ' OD2' ' A' ' 245' ' ' ASP . . . 61.85 -173.54 7.61 Favored Glycine 0 CA--C 1.515 0.093 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.266 -179.081 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 272' ' ' PRO . 23.0 m-20 -108.36 148.16 37.07 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 117.846 0.823 . . . . 0.0 111.239 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.727 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 31.9 Cg_exo -60.06 122.57 11.59 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.08 2.52 . . . . 0.0 114.008 -178.751 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.607 HG21 ' HB ' ' A' ' 259' ' ' ILE . 71.4 t -98.95 138.01 24.68 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.656 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 1.2 mp0 -83.03 127.48 33.6 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.987 -179.201 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.94 ' H ' HD13 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -93.32 164.16 13.33 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.776 179.81 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -141.76 158.11 44.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.268 0.556 . . . . 0.0 112.181 -179.816 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 292' ' ' ARG . 10.8 p -55.39 128.55 34.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.928 179.532 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.1 OUTLIER 81.13 8.49 1.1 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.693 179.829 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.511 ' OD2' ' HB ' ' A' ' 291' ' ' VAL . 0.0 OUTLIER -88.4 137.17 32.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.001 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.675 HG22 ' HD1' ' A' ' 290' ' ' TYR . 1.0 OUTLIER -97.43 129.62 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.664 179.527 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.956 HG12 HG22 ' A' ' 254' ' ' VAL . 0.4 OUTLIER -112.39 94.39 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -178.748 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.697 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 7.0 m -82.94 142.49 31.37 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.699 ' N ' HD13 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -134.76 47.43 2.37 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.04 -179.865 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.85 -125.23 1.1 Allowed Glycine 0 C--N 1.329 0.194 0 C-N-CA 119.879 -1.153 . . . . 0.0 113.469 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.5 t -95.64 -45.32 7.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.717 0.294 . . . . 0.0 110.747 -179.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.66 -0.17 0.84 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.812 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.853 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 25.5 m -75.4 102.13 5.04 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 120.621 0.248 . . . . 0.0 111.345 -179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.722 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -122.44 131.43 53.87 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 121.498 0.666 . . . . 0.0 111.044 179.792 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.43 HG23 HD11 ' A' ' 283' ' ' LEU . 2.4 t -107.81 131.76 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.54 -177.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.675 ' HD1' HG22 ' A' ' 280' ' ' ILE . 1.0 OUTLIER -76.95 132.49 39.07 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.694 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.511 ' HB ' ' OD2' ' A' ' 279' ' ' ASP . 2.5 t -110.89 117.35 54.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.634 -178.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.2 OUTLIER -136.73 150.99 48.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.847 -179.464 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.726 HD12 ' CE3' ' A' ' 241' ' ' TRP . 3.1 mt -143.21 127.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.366 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.61 153.34 43.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.813 179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 5.0 m -85.94 168.07 14.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.137 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -114.28 117.81 32.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 -179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . 0.527 ' N ' HD22 ' A' ' 297' ' ' ASN . 1.6 m-80 -80.85 89.85 5.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.968 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.953 179.854 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.567 ' C ' HG21 ' A' ' 201' ' ' THR . 19.9 mt . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 120.447 0.165 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.945 ' N ' HG21 ' A' ' 201' ' ' THR . . . 98.37 94.34 1.99 Allowed Glycine 0 C--N 1.341 0.807 0 C-N-CA 121.151 -0.547 . . . . 0.0 114.112 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.751 ' HB2' ' HB ' ' A' ' 201' ' ' THR . 4.6 t -178.98 -91.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.675 0.238 . . . . 0.0 111.143 179.194 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.1 OUTLIER -137.22 179.93 6.1 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.577 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.687 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 3.2 m95 -143.52 130.88 20.95 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.929 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.4 OUTLIER -122.08 130.28 53.12 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.017 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.929 ' N ' HD12 ' A' ' 182' ' ' LEU . 0.2 OUTLIER -133.18 146.22 51.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.77 0.795 . . . . 0.0 111.393 179.979 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -146.84 153.32 40.03 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.009 178.955 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.535 ' HB2' ' HG2' ' A' ' 195' ' ' GLN . 0.1 OUTLIER -142.02 133.35 26.44 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.183 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.912 HG11 HD11 ' A' ' 220' ' ' LEU . 40.0 t -66.4 116.04 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.017 0.436 . . . . 0.0 110.148 177.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.868 HG22 ' O ' ' A' ' 288' ' ' LYS . 5.2 tt -97.45 -24.16 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -177.09 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.848 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -160.11 93.55 1.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.681 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.733 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.91 -173.25 30.34 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 178.357 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.624 ' HG3' ' CB ' ' A' ' 222' ' ' ASP . 96.9 Cg_endo -80.16 32.65 0.5 Allowed 'Trans proline' 0 C--N 1.347 0.49 0 CA-C-N 119.452 1.626 . . . . 0.0 111.587 178.684 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.812 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -162.95 23.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.627 178.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.733 HG12 ' H ' ' A' ' 189' ' ' GLY . 4.8 mt -39.41 114.3 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.536 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 127.56 10.54 3.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.519 179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.812 HD11 ' CB ' ' A' ' 191' ' ' ALA . 0.1 OUTLIER -99.66 131.16 45.83 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.964 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.535 ' HG2' ' HB2' ' A' ' 185' ' ' GLU . 20.9 mt-30 -128.01 153.89 46.24 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.358 -178.392 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.723 ' CD2' ' HB3' ' A' ' 217' ' ' ASP . 0.0 OUTLIER -145.57 146.03 31.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.165 178.968 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -146.56 144.51 29.62 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.273 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.995 HG21 ' HA ' ' A' ' 206' ' ' LEU . 10.2 p -146.51 147.81 17.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.332 0.587 . . . . 0.0 110.816 179.281 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.581 ' OD1' HG23 ' A' ' 201' ' ' THR . 21.4 p30 -95.07 150.47 20.15 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.265 -179.45 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.509 ' N ' ' HZ2' ' A' ' 234' ' ' TRP . 48.2 t -70.67 1.04 5.78 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.474 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.945 HG21 ' N ' ' A' ' 178' ' ' GLY . 0.0 OUTLIER -104.17 11.63 34.82 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.25 0.548 . . . . 0.0 110.784 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 13.4 m -91.3 132.13 36.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.059 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.47 -77.41 0.39 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.261 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 2.5 m -101.68 20.62 15.87 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.735 0.303 . . . . 0.0 111.59 -179.287 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -123.16 -15.03 7.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.942 0.401 . . . . 0.0 110.807 179.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.995 ' HA ' HG21 ' A' ' 198' ' ' VAL . 6.9 tt -59.08 -60.51 10.31 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.405 -179.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.778 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 1.9 Cg_endo -42.59 98.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.629 2.219 . . . . 0.0 113.016 -178.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.561 ' O ' ' HB2' ' A' ' 231' ' ' GLN . 59.7 t -68.04 163.57 2.94 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.732 ' O ' ' HB2' ' A' ' 217' ' ' ASP . 0.5 OUTLIER -142.64 115.09 8.49 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.222 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.964 HD21 ' HB3' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -116.67 145.88 43.13 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.657 -0.652 . . . . 0.0 111.236 178.145 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' A' ' 225' ' ' VAL . . . 170.85 -174.74 44.7 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.753 -179.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 1.088 ' HB2' HG13 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -65.11 -77.4 0.06 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.054 0.454 . . . . 0.0 111.85 -178.89 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.809 HG22 ' H ' ' A' ' 214' ' ' SER . 13.7 p -128.28 -138.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.234 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.809 ' H ' HG22 ' A' ' 213' ' ' VAL . 5.0 m 67.39 173.59 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 118.897 0.771 . . . . 0.0 109.378 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.77 ' HD2' ' HB3' ' A' ' 214' ' ' SER . 40.0 Cg_endo -66.59 18.15 0.1 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 121.907 1.738 . . . . 0.0 112.694 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 214' ' ' SER . 1.9 m -54.91 178.68 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.143 0 CA-C-O 120.721 0.296 . . . . 0.0 110.739 179.851 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.732 ' HB2' ' O ' ' A' ' 209' ' ' LYS . 14.0 m-20 -100.98 -35.87 9.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.469 -179.591 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.685 ' HB3' ' CD2' ' A' ' 220' ' ' LEU . 6.2 mt -100.39 129.08 46.32 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.231 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.448 ' O ' ' CB ' ' A' ' 191' ' ' ALA . . . -95.04 79.19 3.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.633 0.254 . . . . 0.0 110.634 -179.736 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.912 HD11 HG11 ' A' ' 186' ' ' VAL . 3.0 mm? -100.74 66.37 1.2 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 177.74 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.718 ' HA ' ' HG2' ' A' ' 212' ' ' ARG . 1.8 pttt -50.22 69.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.825 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.652 ' N ' ' O ' ' A' ' 220' ' ' LEU . 2.5 t0 -124.72 140.05 53.29 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.214 0.53 . . . . 0.0 110.05 178.104 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.9 t -54.96 -40.34 69.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.437 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.419 ' HB3' ' HA2' ' A' ' 284' ' ' GLY . 2.4 mm-40 -41.94 -42.97 2.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.364 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.088 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.4 p -102.36 79.83 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.215 179.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -33.05 -42.43 0.08 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.114 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -146.17 -55.79 0.02 OUTLIER Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.035 179.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.547 ' O ' ' HB3' ' A' ' 246' ' ' MET . 30.4 mtmm -145.17 129.46 17.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.786 0.327 . . . . 0.0 110.156 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.544 ' HB3' HD22 ' A' ' 283' ' ' LEU . 0.1 OUTLIER -93.88 -53.53 3.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.118 179.702 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.964 ' HB3' HD21 ' A' ' 210' ' ' LEU . . . -151.33 -179.22 7.18 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -177.683 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.842 ' HG2' ' HE1' ' A' ' 246' ' ' MET . 0.4 OUTLIER -161.2 -178.01 6.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.295 178.404 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.778 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 23.7 mt -140.52 148.67 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.17 0.509 . . . . 0.0 111.482 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.68 137.2 8.7 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.96 ' CH2' HG13 ' A' ' 198' ' ' VAL . 3.2 p90 -131.62 166.46 21.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.616 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.548 ' H ' ' HD2' ' A' ' 240' ' ' LYS . 11.0 t-20 -116.43 134.17 55.17 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 113.868 -1.514 . . . . 0.0 112.953 -178.671 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.5 t -90.53 -1.1 57.88 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.946 178.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 35.4 m -77.02 -28.95 55.11 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.718 0.771 . . . . 0.0 110.015 178.509 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.45 15.09 3.45 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.693 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 8.4 p90 41.9 58.97 2.69 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.196 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.895 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -126.34 145.87 50.26 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.165 -1.379 . . . . 0.0 109.712 -179.612 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.716 ' O ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -129.51 124.86 35.0 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.035 -178.935 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -139.71 142.7 36.86 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.758 0.79 . . . . 0.0 112.78 -178.181 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.735 ' O ' HD12 ' A' ' 243' ' ' LEU . 1.8 pp -108.07 156.38 19.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.221 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.499 HG22 ' HE3' ' A' ' 269' ' ' TRP . 5.1 p -124.47 163.24 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.379 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.613 ' CG ' ' HB3' ' A' ' 260' ' ' SER . 6.6 m-20 -107.91 125.47 51.53 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.152 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.842 ' HE1' ' HG2' ' A' ' 231' ' ' GLN . 0.0 OUTLIER -85.77 94.28 9.09 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.738 178.374 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 47.74 68.4 1.22 Allowed Glycine 0 C--N 1.329 0.16 0 C-N-CA 119.544 -1.312 . . . . 0.0 110.475 -179.451 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.529 ' HB2' ' HB3' ' A' ' 261' ' ' HIS . 85.8 p -64.32 58.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.567 HD13 ' N ' ' A' ' 250' ' ' ASN . 1.2 tm? -54.26 -60.63 3.08 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.224 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.567 ' N ' HD13 ' A' ' 249' ' ' LEU . 1.1 t-20 -71.1 -30.16 66.18 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.006 -179.678 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.476 ' CA ' ' CG ' ' A' ' 261' ' ' HIS . . . 100.48 118.66 4.28 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.672 178.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.914 HG23 HD23 ' A' ' 283' ' ' LEU . 1.4 m -92.74 105.59 17.7 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 282' ' ' THR . 0.1 OUTLIER -98.75 139.25 34.72 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.253 0.549 . . . . 0.0 112.367 -178.279 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.85 HG22 HG23 ' A' ' 281' ' ' ILE . 41.4 t -109.61 127.42 66.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.953 178.126 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.843 ' HA ' HD12 ' A' ' 280' ' ' ILE . 7.2 t-20 55.01 38.34 30.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.082 0.468 . . . . 0.0 110.248 -178.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.38 34.96 12.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.594 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.725 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.5 OUTLIER -140.96 113.18 7.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.522 -179.84 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.467 ' CB ' ' NE2' ' A' ' 261' ' ' HIS . 83.7 p -58.9 88.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.533 0.683 . . . . 0.0 110.562 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.934 ' CG1' HG21 ' A' ' 273' ' ' VAL . 0.2 OUTLIER -88.67 -21.8 6.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -177.222 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.819 ' C ' ' HD3' ' A' ' 262' ' ' PRO . 0.1 OUTLIER -127.73 -12.89 5.38 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -176.457 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.676 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 16.6 p80 -110.51 43.04 0.2 Allowed Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 177.53 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.819 ' HD3' ' C ' ' A' ' 260' ' ' SER . 21.8 Cg_exo -66.93 -4.45 11.39 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.86 1.707 . . . . 0.0 113.564 -178.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.433 ' HB3' ' OG ' ' A' ' 266' ' ' SER . 5.0 m-20 -137.46 97.44 3.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.318 . . . . 0.0 111.291 -179.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 264' ' ' LEU . 4.3 mm? -56.12 -55.85 28.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.242 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.3 -18.23 34.94 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.022 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.433 ' OG ' ' HB3' ' A' ' 263' ' ' ASP . 34.9 m -81.97 -35.95 28.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.955 0.407 . . . . 0.0 111.957 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . . . . . . . . . 24.9 ttp180 48.99 26.0 1.23 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.198 0.523 . . . . 0.0 110.304 -178.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 169.94 12.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.38 -179.548 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.596 ' CH2' ' HG3' ' A' ' 246' ' ' MET . 83.7 m95 -80.33 -20.58 43.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.306 178.371 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 68.87 174.96 10.09 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -177.326 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.69 125.27 65.6 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 118.141 0.971 . . . . 0.0 110.52 -179.486 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.1 Cg_exo -35.25 119.63 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.807 2.338 . . . . 0.0 111.638 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.934 HG21 ' CG1' ' A' ' 259' ' ' ILE . 97.7 t -101.15 136.6 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.671 -177.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 11.9 mt-10 -82.4 128.38 34.19 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.868 179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.987 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -92.17 165.2 13.26 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.992 -179.464 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.673 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -142.08 159.03 43.05 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.689 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 84.9 p -62.89 130.71 46.0 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.426 179.188 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.5 OUTLIER 83.66 -0.66 1.09 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.122 -179.237 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.673 ' HB2' ' O ' ' A' ' 276' ' ' ALA . 0.1 OUTLIER -71.07 -170.27 0.44 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.931 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.843 HD12 ' HA ' ' A' ' 255' ' ' ASN . 0.8 OUTLIER -162.07 124.59 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 177.349 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.85 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -99.27 150.28 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.149 176.363 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.688 ' O ' ' HG ' ' A' ' 253' ' ' LEU . 1.8 m -134.68 122.2 21.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.662 0.744 . . . . 0.0 109.357 178.091 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.914 HD23 HG23 ' A' ' 252' ' ' THR . 0.0 OUTLIER -122.13 136.93 54.97 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.593 179.598 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.472 ' HA2' ' CG ' ' A' ' 250' ' ' ASN . . . 88.11 -132.4 11.19 Favored Glycine 0 C--N 1.312 -0.753 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.315 179.522 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.8 t -100.03 -33.43 10.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.445 0.164 . . . . 0.0 111.18 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -152.79 8.21 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -179.751 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.848 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 12.7 m -74.53 102.43 4.51 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.043 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.868 ' O ' HG22 ' A' ' 187' ' ' ILE . 15.6 ttmt -120.04 125.37 48.16 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.63 -179.311 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 184' ' ' LEU . 1.0 OUTLIER -107.4 135.57 45.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.719 -0.219 . . . . 0.0 110.607 179.701 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.653 ' HD1' HG23 ' A' ' 280' ' ' ILE . 2.2 t80 -78.13 136.67 37.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.615 -179.393 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.987 HG11 ' HB2' ' A' ' 275' ' ' LEU . 1.8 t -105.45 114.86 46.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.393 -179.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -133.87 138.82 45.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.162 -179.636 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.762 HD11 HD23 ' A' ' 275' ' ' LEU . 14.2 mt -135.74 143.22 37.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 7.6 t -146.29 153.25 40.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.977 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 78.2 p -86.16 162.51 18.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.312 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -106.05 125.31 50.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.952 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . 0.541 ' ND2' ' H ' ' A' ' 297' ' ' ASN . 2.9 p30 -78.87 88.28 4.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.088 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.777 HD23 HD21 ' A' ' 199' ' ' ASN . 1.0 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 115.93 57.69 0.33 Allowed Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.429 179.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.441 ' HB2' HG22 ' A' ' 201' ' ' THR . 11.7 m -128.61 -69.02 0.73 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.833 0.349 . . . . 0.0 110.401 178.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.5 OUTLIER -135.21 178.23 7.19 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.406 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.716 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 22.0 m95 -144.29 130.9 20.03 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.864 HD23 ' CZ3' ' A' ' 234' ' ' TRP . 0.4 OUTLIER -121.44 107.95 13.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.035 177.883 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.716 ' CZ ' ' HB3' ' A' ' 181' ' ' TRP . 0.9 OUTLIER -106.88 140.13 40.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.864 0.84 . . . . 0.0 112.081 -179.565 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 1.008 HD23 ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -133.48 144.11 49.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.165 177.401 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.57 ' HG3' ' HG3' ' A' ' 195' ' ' GLN . 16.1 tt0 -137.74 125.79 22.86 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.947 HG21 HD12 ' A' ' 194' ' ' LEU . 9.6 t -65.52 112.26 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.578 177.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.816 HG22 ' O ' ' A' ' 288' ' ' LYS . 7.4 tt -95.03 -22.44 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.102 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.88 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -165.85 93.75 0.56 Allowed 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 119.742 -0.783 . . . . 0.0 112.691 -179.331 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.776 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -161.63 -171.05 27.18 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 178.257 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.762 ' HB2' ' HG3' ' A' ' 221' ' ' LYS . 93.6 Cg_endo -79.41 30.57 0.47 Allowed 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.053 1.835 . . . . 0.0 111.77 178.948 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.865 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -161.59 27.29 0.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.227 -0.656 . . . . 0.0 109.227 178.314 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.776 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.3 mt -41.2 107.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.818 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.63 8.17 2.26 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.741 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.947 HD12 HG21 ' A' ' 186' ' ' VAL . 0.1 OUTLIER -97.59 132.99 42.74 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.939 0.876 . . . . 0.0 108.705 177.878 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.57 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 17.8 mt-30 -133.22 152.9 51.94 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.211 -1.358 . . . . 0.0 110.193 -178.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 1.008 ' CD2' HD23 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -148.25 148.31 30.33 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.097 -179.757 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.453 ' C ' ' HZ3' ' A' ' 181' ' ' TRP . . . -147.42 140.07 24.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.337 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.91 HG13 ' CH2' ' A' ' 234' ' ' TRP . 5.2 p -143.29 149.6 18.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.427 0.632 . . . . 0.0 110.458 178.435 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.777 HD21 HD23 ' A' ' 177' ' ' LEU . 4.5 p30 -95.8 151.83 19.03 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.758 -179.516 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.542 ' HA ' ' HE1' ' A' ' 234' ' ' TRP . 80.5 p -67.41 -1.33 4.63 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -178.542 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.728 HG23 ' HA ' ' A' ' 177' ' ' LEU . 0.6 OUTLIER -109.6 15.49 22.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.941 0.4 . . . . 0.0 111.27 179.265 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.52 143.93 26.66 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.064 179.26 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 5.0 m -89.04 -94.46 0.1 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.354 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.86 31.01 2.47 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.302 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.64 -11.73 8.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 110.751 179.18 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.774 ' HA ' HG21 ' A' ' 198' ' ' VAL . 4.7 tt -67.5 -58.04 9.27 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.591 -179.152 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.654 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 2.0 Cg_endo -41.93 90.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.639 2.226 . . . . 0.0 112.438 -178.7 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.684 ' O ' HG12 ' A' ' 208' ' ' VAL . 2.2 t -71.56 91.0 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.209 -179.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 231' ' ' GLN . 12.2 mtmt -69.96 87.2 0.54 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.987 HD23 HD12 ' A' ' 218' ' ' LEU . 2.0 mp -74.55 128.67 36.13 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 228' ' ' LYS . . . -177.78 -177.33 46.51 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.486 -179.551 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 0.961 ' HD3' HG12 ' A' ' 213' ' ' VAL . 0.2 OUTLIER -57.18 -93.2 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -178.017 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.961 HG12 ' HD3' ' A' ' 212' ' ' ARG . 11.5 p -158.3 158.75 2.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.165 -0.614 . . . . 0.0 112.355 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.998 ' HB2' ' HD3' ' A' ' 215' ' ' PRO . 24.4 m 103.16 -74.06 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.831 179.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.998 ' HD3' ' HB2' ' A' ' 214' ' ' SER . 95.9 Cg_endo -96.01 -35.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.079 1.853 . . . . 0.0 113.182 179.545 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.448 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 0.9 OUTLIER -57.02 145.87 29.05 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.142 0.496 . . . . 0.0 112.209 -178.958 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.04 -33.06 69.95 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.454 179.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.987 HD12 HD23 ' A' ' 210' ' ' LEU . 1.6 mt -100.21 135.24 41.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.557 178.284 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -93.64 73.5 4.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.951 -178.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.93 ' O ' ' HA ' ' A' ' 212' ' ' ARG . 3.1 mm? -99.48 94.69 6.54 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.776 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.762 ' HG3' ' HB2' ' A' ' 190' ' ' PRO . 28.0 pttt -65.11 53.63 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.232 0.539 . . . . 0.0 110.048 178.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 220' ' ' LEU . 4.1 m-20 -87.81 116.2 25.8 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.223 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 11.5 p -60.51 -15.53 28.07 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.877 -179.347 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 222' ' ' ASP . 0.0 OUTLIER -79.22 -21.33 46.41 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.576 0.227 . . . . 0.0 110.838 179.686 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.012 ' HB ' ' HD1' ' A' ' 229' ' ' HIS . 2.8 p -107.61 80.9 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.16 -30.22 0.74 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 111.188 -179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -145.87 -59.66 0.02 OUTLIER Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.194 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.867 ' HB2' ' HG3' ' A' ' 246' ' ' MET . 0.3 OUTLIER -144.49 133.59 22.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.785 0.326 . . . . 0.0 110.354 -179.824 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 1.012 ' HD1' ' HB ' ' A' ' 225' ' ' VAL . 0.4 OUTLIER -93.43 -58.7 2.21 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.738 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 210' ' ' LEU . . . -147.45 165.48 30.13 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.788 -178.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.724 ' HA ' HD12 ' A' ' 210' ' ' LEU . 17.9 tt0 -143.11 157.44 44.51 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.657 179.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.695 HG13 HD11 ' A' ' 210' ' ' LEU . 23.7 mt -121.54 145.75 27.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.918 179.53 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.724 ' HA ' HD22 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -161.79 160.58 28.46 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.28 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.91 ' CH2' HG13 ' A' ' 198' ' ' VAL . 3.6 p90 -149.68 165.73 31.5 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.018 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -117.31 133.6 55.8 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.854 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -0.12 57.32 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.107 179.093 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -76.15 -20.15 57.84 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.659 0.742 . . . . 0.0 110.052 178.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.661 ' O ' ' HD3' ' A' ' 240' ' ' LYS . 7.5 tptm -151.6 20.58 0.72 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.596 -178.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 23.8 p90 41.01 57.81 2.67 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.391 0.615 . . . . 0.0 109.926 -179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.792 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.8 OUTLIER -120.63 137.5 54.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.938 179.352 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.734 ' HA ' ' CB ' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -120.49 122.25 40.23 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.95 179.963 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 273' ' ' VAL . 1.0 OUTLIER -139.37 142.25 37.56 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.941 0.876 . . . . 0.0 112.784 -178.391 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.753 ' O ' ' HA ' ' A' ' 272' ' ' PRO . 3.0 pp -110.31 155.09 22.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.001 -1.454 . . . . 0.0 110.691 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.909 HG13 ' CZ3' ' A' ' 269' ' ' TRP . 5.0 p -117.33 163.02 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 122.239 -0.288 . . . . 0.0 111.102 -179.452 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 260' ' ' SER . 0.0 OUTLIER -105.95 113.09 26.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.318 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.867 ' HG3' ' HB2' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -81.39 105.77 12.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.665 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 267' ' ' ARG . . . 54.35 65.6 3.37 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.409 -0.9 . . . . 0.0 111.71 -178.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.76 49.79 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.772 HD13 ' H ' ' A' ' 250' ' ' ASN . 0.0 OUTLIER -58.11 -47.67 82.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.702 178.431 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.772 ' H ' HD13 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.38 -33.09 37.44 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.014 -179.159 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.529 ' N ' HD22 ' A' ' 250' ' ' ASN . . . 92.02 85.4 1.49 Allowed Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.122 -178.851 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 258' ' ' SER . 2.9 m -46.55 168.3 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.641 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.665 ' N ' HD23 ' A' ' 253' ' ' LEU . 0.3 OUTLIER -154.97 136.2 13.99 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 119.9 -0.72 . . . . 0.0 112.749 179.381 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 1.038 HG22 HG13 ' A' ' 281' ' ' ILE . 67.1 t -115.16 130.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.154 178.481 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . 0.674 ' HA ' HD12 ' A' ' 280' ' ' ILE . 1.1 t-20 56.16 37.68 29.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.106 0.479 . . . . 0.0 109.932 -179.25 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.67 25.69 9.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.637 -179.488 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.694 ' O ' HG23 ' A' ' 259' ' ' ILE . 3.1 t-80 -128.02 101.35 6.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.675 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 252' ' ' THR . 10.4 t -53.51 92.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.327 0.584 . . . . 0.0 111.167 -179.71 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.961 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.2 OUTLIER -88.88 -9.14 10.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.004 -178.284 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 245' ' ' ASP . 25.2 m -92.04 -12.81 32.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.359 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.742 ' N ' ' HD3' ' A' ' 262' ' ' PRO . 1.6 t-160 -106.35 22.53 0.05 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 179.468 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.742 ' HD3' ' N ' ' A' ' 261' ' ' HIS . 31.3 Cg_exo -57.44 -44.82 38.97 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.288 1.325 . . . . 0.0 110.184 178.688 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -75.55 84.15 2.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 113.519 -1.673 . . . . 0.0 111.293 -179.176 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.639 ' H ' HD23 ' A' ' 264' ' ' LEU . 2.0 pt? -59.62 132.06 52.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.796 179.781 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 87.86 -13.11 61.83 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.883 -179.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.571 ' O ' ' HB2' ' A' ' 267' ' ' ARG . 0.1 OUTLIER -72.56 -69.25 0.42 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 119.362 -0.351 . . . . 0.0 111.024 -179.855 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.3 OUTLIER 70.19 -20.98 0.18 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.671 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.532 ' H ' ' C ' ' A' ' 266' ' ' SER . 4.1 mtpp -73.82 -127.08 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -177.018 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.909 ' CZ3' HG13 ' A' ' 244' ' ' VAL . 0.0 OUTLIER -80.31 -23.13 40.87 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -177.785 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.476 ' HA3' ' OD2' ' A' ' 245' ' ' ASP . . . 62.0 -175.74 6.39 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.241 -0.981 . . . . 0.0 110.929 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 272' ' ' PRO . 1.7 m-20 -105.6 141.74 23.29 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 117.983 0.891 . . . . 0.0 111.141 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.753 ' HA ' ' O ' ' A' ' 243' ' ' LEU . 74.1 Cg_exo -51.97 123.14 11.8 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.856 2.371 . . . . 0.0 113.517 -179.447 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.622 HG11 HG13 ' A' ' 259' ' ' ILE . 95.2 t -100.9 140.91 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.272 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 241' ' ' TRP . 2.1 mt-10 -86.92 129.24 34.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.745 -179.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.869 ' HB2' HG11 ' A' ' 291' ' ' VAL . 0.0 OUTLIER -95.41 164.67 12.72 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.93 -179.516 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 279' ' ' ASP . . . -140.67 157.4 45.49 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 29.3 t -61.02 129.44 41.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.25 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.621 ' HB2' ' O ' ' A' ' 277' ' ' SER . 5.8 m-20 82.43 -1.15 1.38 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.519 -179.728 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.725 ' O ' HG23 ' A' ' 291' ' ' VAL . 0.1 OUTLIER -79.11 137.86 37.67 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.079 179.473 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 255' ' ' ASN . 1.1 pp -102.08 127.11 55.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 119.836 -0.745 . . . . 0.0 112.04 179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 1.038 HG13 HG22 ' A' ' 254' ' ' VAL . 0.4 OUTLIER -105.96 159.54 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.995 0.426 . . . . 0.0 111.287 178.971 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.649 ' HB ' ' HG ' ' A' ' 253' ' ' LEU . 1.9 m -145.54 122.91 11.62 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.149 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.657 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -119.01 47.93 1.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.833 -179.44 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 173.03 -134.9 3.1 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.85 -1.167 . . . . 0.0 113.042 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.51 HG22 ' OE1' ' A' ' 224' ' ' GLU . 1.8 t -87.8 -51.62 5.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.785 0.326 . . . . 0.0 110.382 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.59 ' O ' ' O ' ' A' ' 188' ' ' ALA . 1.3 t -137.86 -2.19 1.93 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.292 179.337 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 28.6 m -70.92 102.77 2.47 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.885 0.374 . . . . 0.0 111.103 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.816 ' O ' HG22 ' A' ' 187' ' ' ILE . 0.4 OUTLIER -121.27 128.55 52.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.922 -179.215 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.719 HG23 ' CG2' ' A' ' 281' ' ' ILE . 0.0 OUTLIER -108.3 133.5 53.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.087 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 2.1 t80 -76.43 134.78 39.48 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.682 -179.221 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.869 HG11 ' HB2' ' A' ' 275' ' ' LEU . 0.6 OUTLIER -104.38 113.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.044 -179.988 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 277' ' ' SER . 0.0 OUTLIER -129.06 141.86 51.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.749 -179.785 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.761 HD11 HD23 ' A' ' 275' ' ' LEU . 6.6 mt -137.63 138.17 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.286 -179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.29 131.56 16.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.695 0.283 . . . . 0.0 111.071 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.408 ' HA ' ' OG ' ' A' ' 180' ' ' SER . 23.8 p -79.77 143.19 34.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.091 0.472 . . . . 0.0 111.193 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.04 147.33 26.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.628 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -141.81 94.51 2.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.973 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 . . . . . 0 C--O 1.234 0.267 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.818 179.826 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.578 ' HB3' ' CG ' ' A' ' 199' ' ' ASN . 1.0 OUTLIER . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.375 0.131 . . . . 0.0 110.782 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.711 ' HA3' ' CG2' ' A' ' 201' ' ' THR . . . 117.2 158.93 11.28 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.434 -0.888 . . . . 0.0 113.837 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.89 ' HA ' ' HB3' ' A' ' 296' ' ' GLN . 0.4 OUTLIER -89.11 29.06 1.1 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.304 -0.448 . . . . 0.0 111.806 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 199' ' ' ASN . 0.3 OUTLIER -153.58 146.97 24.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.229 0.538 . . . . 0.0 110.75 179.84 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' TRP . . . . . 0.702 ' HB3' ' CZ ' ' A' ' 183' ' ' PHE . 37.0 m95 -148.16 139.44 23.44 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.38 -178.069 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 183' ' ' PHE . 0.9 OUTLIER -114.9 120.98 41.78 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 176.049 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 183' ' ' PHE . . . . . 0.725 ' N ' HD12 ' A' ' 182' ' ' LEU . 2.3 m-85 -121.56 135.41 55.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.445 0.641 . . . . 0.0 110.358 179.747 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 290' ' ' TYR . 0.0 OUTLIER -140.57 148.36 40.85 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.355 179.211 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.647 ' C ' HG23 ' A' ' 289' ' ' VAL . 1.7 tt0 -137.56 124.46 21.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.2 -177.556 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 1.014 HG21 HD11 ' A' ' 220' ' ' LEU . 40.3 t -63.05 108.74 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.379 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.81 HG22 ' O ' ' A' ' 288' ' ' LYS . 10.9 tt -87.92 -26.64 5.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -176.118 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.886 ' O ' ' HA ' ' A' ' 287' ' ' THR . . . -158.8 96.31 1.35 Allowed 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.443 -179.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.676 ' H ' HG12 ' A' ' 192' ' ' ILE . . . -163.49 173.91 39.66 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.891 -0.883 . . . . 0.0 110.891 178.546 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.51 ' HG3' ' HA ' ' A' ' 222' ' ' ASP . 37.6 Cg_endo -69.47 32.92 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 121.823 1.682 . . . . 0.0 111.266 178.141 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.831 ' HB1' ' CD1' ' A' ' 194' ' ' LEU . . . -160.65 20.53 0.14 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.308 179.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.676 HG12 ' H ' ' A' ' 189' ' ' GLY . 3.1 mt -38.94 108.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.721 0.296 . . . . 0.0 111.761 179.496 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 134.31 8.07 2.1 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.154 -1.022 . . . . 0.0 113.018 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.831 ' CD1' ' HB1' ' A' ' 191' ' ' ALA . 0.8 OUTLIER -101.47 112.89 25.57 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.917 0.865 . . . . 0.0 109.74 178.75 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.469 ' HG3' ' HG3' ' A' ' 185' ' ' GLU . 5.7 mt-30 -114.65 154.69 27.94 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.947 -1.478 . . . . 0.0 110.565 -179.149 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.564 ' CD2' ' HB3' ' A' ' 217' ' ' ASP . 0.0 OUTLIER -147.84 148.08 30.5 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.381 0.61 . . . . 0.0 111.154 179.636 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 182' ' ' LEU . . . -144.01 152.27 40.81 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.044 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 1.053 HG21 ' HA ' ' A' ' 206' ' ' LEU . 8.1 p -167.03 150.29 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.911 0.386 . . . . 0.0 111.278 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 180' ' ' SER . 1.0 OUTLIER -92.46 155.28 17.95 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -179.369 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.675 ' HA ' ' CZ2' ' A' ' 234' ' ' TRP . 3.6 m -56.3 -48.74 76.06 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.522 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.711 ' CG2' ' HA3' ' A' ' 178' ' ' GLY . 0.0 OUTLIER -67.66 14.11 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.251 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . 0.548 ' HB2' ' O ' ' A' ' 199' ' ' ASN . 0.3 OUTLIER -91.99 118.89 31.2 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.997 0.427 . . . . 0.0 110.005 179.2 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -67.14 -107.51 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -178.523 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 4.4 m -80.98 21.02 0.73 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.527 ' HG3' ' OG ' ' A' ' 202' ' ' SER . 0.0 OUTLIER -114.17 -19.23 11.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 178.944 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 1.053 ' HA ' HG21 ' A' ' 198' ' ' VAL . 0.0 OUTLIER -70.71 -33.78 3.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.274 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.675 ' HA ' ' O ' ' A' ' 232' ' ' ILE . 38.6 Cg_exo -55.47 101.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 121.016 1.144 . . . . 0.0 111.721 179.538 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.433 HG11 HD11 ' A' ' 184' ' ' LEU . 49.0 t -84.78 90.9 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.694 -179.163 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.637 ' HD2' ' HA ' ' A' ' 216' ' ' SER . 11.9 mttt -71.01 109.11 4.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -179.008 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.105 HD23 HD12 ' A' ' 218' ' ' LEU . 1.6 mp -94.38 131.78 39.68 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.013 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -179.55 -176.39 47.1 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.057 -179.575 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . 1.002 ' HB2' HG13 ' A' ' 225' ' ' VAL . 30.6 ttt-85 -80.76 -69.64 0.59 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.639 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 213' ' ' VAL . 9.1 p -141.88 118.8 7.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.27 0.557 . . . . 0.0 110.529 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . 0.604 ' HB2' ' HD2' ' A' ' 215' ' ' PRO . 0.0 OUTLIER 168.9 176.85 0.07 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.735 -178.973 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 214' ' ' SER . 41.1 Cg_endo -67.47 23.5 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 121.831 1.687 . . . . 0.0 112.243 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 216' ' ' SER . . . . . 0.637 ' HA ' ' HD2' ' A' ' 209' ' ' LYS . 1.1 m -62.62 -151.77 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.438 179.806 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.564 ' HB3' ' CD2' ' A' ' 196' ' ' HIS . 52.1 m-20 -130.9 -34.32 1.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.957 0.408 . . . . 0.0 110.466 179.643 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.105 HD12 HD23 ' A' ' 210' ' ' LEU . 4.0 mt -103.71 125.33 50.12 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 177.111 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.582 ' H ' HD22 ' A' ' 194' ' ' LEU . . . -94.08 87.67 5.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.863 0.364 . . . . 0.0 110.223 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 1.014 HD11 HG21 ' A' ' 186' ' ' VAL . 2.0 mm? -110.45 92.42 4.04 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.411 ' HA ' ' HG3' ' A' ' 212' ' ' ARG . 0.0 OUTLIER -62.48 36.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.214 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.905 ' HB2' HG12 ' A' ' 225' ' ' VAL . 0.5 OUTLIER -64.67 111.88 2.95 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.076 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.5 p -53.02 -19.15 2.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.562 0.22 . . . . 0.0 111.322 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.789 ' O ' HD21 ' A' ' 249' ' ' LEU . 3.0 pm0 -75.36 -28.69 59.64 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.929 179.674 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 1.002 HG13 ' HB2' ' A' ' 212' ' ' ARG . 2.8 p -97.41 92.42 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.042 178.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 35.1 m -40.96 -40.71 1.47 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.371 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -147.4 -54.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.53 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . 0.659 ' HB3' ' HG3' ' A' ' 246' ' ' MET . 0.1 OUTLIER -144.25 126.69 15.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.749 0.309 . . . . 0.0 110.539 179.99 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.63 ' C ' ' HG2' ' A' ' 246' ' ' MET . 0.6 OUTLIER -96.54 -51.64 4.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 -179.961 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.781 ' HB1' HD11 ' A' ' 243' ' ' LEU . . . -142.42 165.44 27.41 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . 0.835 ' HA ' HD12 ' A' ' 210' ' ' LEU . 1.3 tm0? -149.89 160.88 43.23 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.597 179.471 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.675 ' O ' ' HA ' ' A' ' 207' ' ' PRO . 3.9 mt -124.9 144.43 34.93 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 CA-C-O 121.271 0.557 . . . . 0.0 111.744 179.018 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.707 HG22 ' OE1' ' A' ' 231' ' ' GLN . 0.1 OUTLIER -161.38 164.3 30.07 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.118 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 234' ' ' TRP . . . . . 0.835 ' HB2' ' O ' ' A' ' 240' ' ' LYS . 1.8 p90 -157.58 167.46 30.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.796 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -115.0 131.72 56.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.542 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.49 -0.61 57.62 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.27 179.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.1 m -73.6 -21.79 60.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.696 0.76 . . . . 0.0 110.168 178.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 239' ' ' PHE . 6.2 tptt -150.87 23.79 0.76 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.377 -178.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 238' ' ' LYS . 8.9 p90 38.31 60.48 1.28 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 121.521 0.677 . . . . 0.0 109.533 -179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.835 ' O ' ' HB2' ' A' ' 234' ' ' TRP . 0.0 OUTLIER -121.7 136.53 54.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.727 179.683 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 241' ' ' TRP . . . . . 0.713 ' CE3' HD12 ' A' ' 293' ' ' ILE . 0.2 OUTLIER -118.65 130.58 55.94 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.771 -179.905 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.458 ' CB ' ' O ' ' A' ' 273' ' ' VAL . 0.8 OUTLIER -137.09 132.7 34.47 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.427 0.632 . . . . 0.0 111.115 -177.815 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.825 HD21 HG21 ' A' ' 281' ' ' ILE . 0.2 OUTLIER -110.08 136.97 48.49 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.131 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.769 ' N ' HD12 ' A' ' 243' ' ' LEU . 4.2 p -122.6 162.82 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-O 120.733 0.301 . . . . 0.0 110.359 -179.735 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.691 ' HB2' ' CA ' ' A' ' 270' ' ' GLY . 12.2 m-20 -99.38 149.1 23.51 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.182 0.515 . . . . 0.0 111.707 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.659 ' HG3' ' HB3' ' A' ' 228' ' ' LYS . 0.0 OUTLIER -116.34 95.0 4.86 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.424 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 51.33 60.81 6.84 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.812 -177.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.5 ' HB2' ' HA2' ' A' ' 251' ' ' GLY . 0.3 OUTLIER -72.86 72.02 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.858 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.789 HD21 ' O ' ' A' ' 224' ' ' GLU . 1.2 pp -54.33 -57.54 10.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.26 0.552 . . . . 0.0 110.189 178.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.643 ' N ' HD12 ' A' ' 249' ' ' LEU . 0.5 OUTLIER -69.52 -25.97 64.29 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.774 -179.712 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.5 ' HA2' ' HB2' ' A' ' 248' ' ' SER . . . 89.94 132.11 4.73 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.779 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.736 ' C ' HD23 ' A' ' 253' ' ' LEU . 79.7 m -92.59 151.62 20.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.466 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.736 HD23 ' C ' ' A' ' 252' ' ' THR . 0.0 OUTLIER -144.76 128.56 17.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.939 0.399 . . . . 0.0 111.659 -179.989 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.852 HG22 HG23 ' A' ' 281' ' ' ILE . 50.1 t -101.44 131.95 48.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.251 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 49.12 31.85 3.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.149 0.499 . . . . 0.0 110.557 -178.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 256' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 78.04 36.89 0.22 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.33 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.503 ' O ' HG23 ' A' ' 259' ' ' ILE . 0.5 OUTLIER -148.2 120.45 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.938 179.784 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 252' ' ' THR . 72.4 p -67.28 85.13 0.15 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.42 0.628 . . . . 0.0 110.91 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . 0.767 ' CD1' HG23 ' A' ' 254' ' ' VAL . 0.1 OUTLIER -80.12 -15.42 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.636 -178.629 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.527 ' O ' ' HA2' ' A' ' 270' ' ' GLY . 2.8 m -101.61 -10.8 19.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . 0.666 ' N ' ' CD ' ' A' ' 262' ' ' PRO . 10.0 t-80 -106.76 18.06 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 179.498 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 262' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 261' ' ' HIS . 95.7 Cg_exo -45.01 -29.13 3.58 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.578 1.519 . . . . 0.0 111.264 179.167 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.619 ' O ' ' HB2' ' A' ' 266' ' ' SER . 0.4 OUTLIER -76.64 92.24 3.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.051 -179.654 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 95.3 mt -48.12 129.97 15.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.041 0.448 . . . . 0.0 111.887 -179.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 74.08 21.87 78.55 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.279 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.619 ' HB2' ' O ' ' A' ' 263' ' ' ASP . 0.1 OUTLIER -78.74 -68.57 0.64 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 117.018 0.409 . . . . 0.0 111.374 -179.861 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 267' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 266' ' ' SER . 0.1 OUTLIER 66.38 -17.8 0.11 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.256 -0.577 . . . . 0.0 112.412 -179.173 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.581 ' H ' ' C ' ' A' ' 266' ' ' SER . 0.2 OUTLIER -81.09 -138.49 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -175.981 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 269' ' ' TRP . . . . . 0.649 ' CE3' ' HA ' ' A' ' 246' ' ' MET . 26.7 t-105 -85.19 78.68 9.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.337 -0.847 . . . . 0.0 113.275 -177.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.691 ' CA ' ' HB2' ' A' ' 245' ' ' ASP . . . 36.04 -160.87 0.01 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 118.984 2.354 . . . . 0.0 118.984 172.176 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.11 94.24 3.53 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 111.418 -2.391 . . . . 0.0 105.99 175.11 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.426 ' HD3' HG23 ' A' ' 244' ' ' VAL . 1.0 OUTLIER -24.4 109.01 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.872 3.048 . . . . 0.0 115.929 -176.912 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 273' ' ' VAL . . . . . 0.667 HG21 HG12 ' A' ' 259' ' ' ILE . 17.5 t -115.95 159.34 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.314 179.128 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.502 ' N ' HG12 ' A' ' 273' ' ' VAL . 81.9 mm-40 -94.19 130.98 40.21 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.261 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 276' ' ' ALA . 0.4 OUTLIER -94.33 161.51 14.21 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.089 -177.258 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.587 ' H ' HD23 ' A' ' 275' ' ' LEU . . . -142.51 155.27 45.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.287 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 278' ' ' ASP . 25.7 t -61.73 134.73 57.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.852 179.301 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 277' ' ' SER . 0.2 OUTLIER 83.66 7.25 0.66 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.925 -179.418 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 279' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 291' ' ' VAL . 0.7 OUTLIER -82.92 126.93 33.03 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.358 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 290' ' ' TYR . 0.9 OUTLIER -100.38 132.02 46.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 119.619 -0.833 . . . . 0.0 111.161 -179.524 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 281' ' ' ILE . . . . . 0.852 HG23 HG22 ' A' ' 254' ' ' VAL . 0.0 OUTLIER -107.41 156.77 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.016 -0.673 . . . . 0.0 111.336 179.184 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 252' ' ' THR . 9.3 m -144.51 116.64 8.39 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 283' ' ' LEU . . . . . 0.75 ' H ' HD22 ' A' ' 283' ' ' LEU . 0.0 OUTLIER -120.01 49.52 1.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.523 -178.307 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 179.97 -142.24 5.03 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 119.83 -1.176 . . . . 0.0 113.106 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.6 t -87.7 -37.11 16.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.998 0.428 . . . . 0.0 110.211 179.598 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -152.72 3.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.238 179.706 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.886 ' HA ' ' O ' ' A' ' 188' ' ' ALA . 16.3 m -77.54 106.11 9.11 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 117.753 0.252 . . . . 0.0 111.102 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.81 ' O ' HG22 ' A' ' 187' ' ' ILE . 2.9 mtpt -127.98 133.36 49.17 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.364 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.693 ' CG1' HD12 ' A' ' 281' ' ' ILE . 8.7 p -113.32 136.51 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.345 -179.386 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 290' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 184' ' ' LEU . 3.1 t80 -77.98 133.06 38.07 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.071 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 279' ' ' ASP . 2.6 t -113.69 124.7 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.466 -178.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.417 ' O ' HD12 ' A' ' 182' ' ' LEU . 0.1 OUTLIER -143.53 153.05 42.19 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.891 -179.744 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.713 HD12 ' CE3' ' A' ' 241' ' ' TRP . 1.5 mt -139.69 129.83 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 294' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.43 160.04 35.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 111.142 -179.73 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 180' ' ' SER . 0.3 OUTLIER -99.02 174.31 6.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.665 179.578 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 296' ' ' GLN . . . . . 0.89 ' HB3' ' HA ' ' A' ' 179' ' ' SER . 3.5 tp-100 -109.99 116.09 30.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 -179.691 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 297' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -117.69 86.38 2.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.878 179.792 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.964 . . . . . . . . 0 0 . 1 stop_ save_